data_1bfi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bfi _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.57 -3.02 10.29 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.612 2.208 . . . . 0.0 112.103 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.443 ' CD2' HD22 ' A' ' 83' ' ' LEU . 72.5 m-70 -66.78 -29.71 69.73 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -63.36 -22.37 66.84 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.583 ' O ' ' OG1' ' A' ' 10' ' ' THR . 94.9 m-20 -92.25 119.95 32.34 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.52 0.676 . . . . 0.0 110.441 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 72.3 tt0 -69.32 -40.33 77.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.59 -0.694 . . . . 0.0 109.496 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.508 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -64.1 -20.53 66.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.655 -0.653 . . . . 0.0 111.443 -178.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.583 ' OG1' ' O ' ' A' ' 7' ' ' ASP . 7.6 p -64.49 -37.31 87.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.794 -1.191 . . . . 0.0 110.196 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.588 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -119.24 -14.81 9.23 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.939 -1.1 . . . . 0.0 109.819 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 8' ' ' GLU . 62.6 t30 -89.7 120.07 30.65 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 110.599 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.97 36.28 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.89 -33.54 20.74 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 85.6 p -63.05 -31.98 73.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.945 -1.327 . . . . 0.0 109.036 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.508 ' HG ' ' HB3' ' A' ' 20' ' ' LYS . 32.8 t -61.6 138.51 58.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.379 -0.826 . . . . 0.0 109.718 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -81.57 163.91 22.29 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.299 -0.876 . . . . 0.0 109.867 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -57.17 -44.78 83.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -0.817 . . . . 0.0 109.465 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -65.36 -42.72 92.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.069 -1.019 . . . . 0.0 108.638 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HB3' ' HG ' ' A' ' 16' ' ' SER . 44.5 tptt -61.05 -36.25 79.09 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.48 -37.33 77.97 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.53 -0.731 . . . . 0.0 109.646 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 26' ' ' ARG . 81.3 mm-40 -58.39 -45.19 88.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.109 -0.994 . . . . 0.0 108.384 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -62.09 -44.19 97.21 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.4 -40.2 95.32 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.413 -0.804 . . . . 0.0 108.87 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.7 mt -75.73 -29.93 59.06 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.556 ' NH1' ' HG2' ' A' ' 26' ' ' ARG . 31.6 mtt-85 -79.63 136.3 36.79 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.717 -0.614 . . . . 0.0 109.645 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.78 -8.65 76.45 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -96.12 137.85 34.58 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.242 -1.152 . . . . 0.0 109.878 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -69.52 162.78 26.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.459 -0.775 . . . . 0.0 109.191 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.611 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 73.9 m-20 -60.18 142.91 53.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.372 -0.83 . . . . 0.0 109.189 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.39 -30.51 8.47 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.0 m -76.16 135.78 39.79 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.239 -1.154 . . . . 0.0 109.044 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.595 ' CE1' ' CD2' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -140.84 162.94 34.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.938 -1.101 . . . . 0.0 108.923 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.481 HD23 ' HG ' ' A' ' 47' ' ' SER . 2.8 pp -134.16 154.55 51.15 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.122 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.587 ' CG2' ' SG ' ' A' ' 46' ' ' CYS . 95.5 t -113.65 138.24 44.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.557 ' NH1' ' HG3' ' A' ' 36' ' ' ARG . 5.4 ptm180 -150.51 169.96 20.26 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.037 -1.04 . . . . 0.0 109.362 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.476 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 3.2 pt-20 . . . . . 0 C--N 1.303 -1.439 0 O-C-N 120.938 -1.101 . . . . 0.0 108.838 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.593 ' O ' ' O ' ' A' ' 59' ' ' ILE . 97.7 m-85 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.306 0.574 . . . . 0.0 109.903 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -164.66 144.4 7.35 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.022 -1.049 . . . . 0.0 109.357 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.587 ' SG ' ' CG2' ' A' ' 35' ' ' VAL . 78.5 m -121.02 136.84 54.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.543 ' CB ' ' HD1' ' A' ' 56' ' ' HIS . 92.6 p -105.19 143.36 33.47 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.554 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.454 HG11 ' N ' ' A' ' 49' ' ' VAL . 43.7 t -125.06 158.95 32.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.574 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.454 ' N ' HG11 ' A' ' 48' ' ' VAL . 67.9 t -109.92 130.99 62.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.552 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 9.9 t -123.22 152.13 27.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.132 -0.98 . . . . 0.0 110.652 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.611 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 66.0 t0 -50.34 -12.03 0.08 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.547 0.689 . . . . 0.0 109.858 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.55 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -104.9 -49.96 0.98 Allowed Glycine 0 C--N 1.287 -2.142 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.253 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.55 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 75.0 mt-10 -161.29 177.01 10.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.885 -1.362 . . . . 0.0 111.209 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.5 t -89.64 135.13 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HZ1' HD23 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -117.8 161.9 18.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.986 -1.071 . . . . 0.0 111.484 -178.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.543 ' HD1' ' CB ' ' A' ' 47' ' ' SER . 4.5 m-70 -124.06 76.07 1.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 88.4 m -60.83 146.45 46.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.168 -0.957 . . . . 0.0 109.382 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.5 p -106.26 135.87 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.22 -0.925 . . . . 0.0 111.467 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.593 ' O ' ' O ' ' A' ' 44' ' ' TYR . 64.6 mt -124.81 141.47 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.3 t30 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 120.162 -1.586 . . . . 0.0 111.331 -177.977 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.7 m . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 121.538 0.685 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.02 -29.84 68.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.731 . . . . 0.0 110.053 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -58.9 -42.83 90.53 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -68.61 -35.39 77.26 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.49 -49.49 77.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.396 -0.815 . . . . 0.0 109.204 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.28 -43.22 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.581 -0.699 . . . . 0.0 109.745 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.443 HD22 ' CD2' ' A' ' 5' ' ' HIS . 92.7 mt -62.61 -51.5 67.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.035 -1.041 . . . . 0.0 110.608 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.699 ' CE1' ' OG1' ' A' ' 88' ' ' THR . 59.3 t-80 -71.47 -36.36 71.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.77 -1.206 . . . . 0.0 110.457 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.623 ' OH ' ' CD2' ' A' ' 90' ' ' LEU . 29.1 t80 -59.98 -20.62 58.62 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.909 -1.119 . . . . 0.0 108.842 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.503 ' CG ' ' O ' ' A' ' 101' ' ' LEU . 1.1 tm0? -80.07 -25.8 39.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.234 -0.916 . . . . 0.0 108.626 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -97.8 -7.56 30.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.218 -0.926 . . . . 0.0 109.07 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.699 ' OG1' ' CE1' ' A' ' 84' ' ' HIS . 32.4 m -96.99 139.77 32.51 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.214 -0.929 . . . . 0.0 109.152 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.6 t -87.65 130.24 34.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.14 -0.975 . . . . 0.0 109.358 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.623 ' CD2' ' OH ' ' A' ' 85' ' ' TYR . 10.4 mp -71.82 -17.23 62.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.316 -0.865 . . . . 0.0 109.972 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.703 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.6 p -37.52 -41.93 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.175 -0.953 . . . . 0.0 110.162 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -47.95 -30.34 4.15 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.484 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.51 ' C ' ' H ' ' A' ' 95' ' ' ASP . 94.4 m-70 -83.44 130.31 35.02 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.089 -1.007 . . . . 0.0 108.989 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 58.22 7.73 0.7 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 93' ' ' HIS . 54.7 t0 45.25 35.01 1.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.418 -0.801 . . . . 0.0 109.197 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 55.9 m -156.95 15.48 0.28 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.817 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.703 ' O ' ' N ' ' A' ' 91' ' ' VAL . 68.0 mt -101.62 73.91 1.48 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -79.1 85.15 5.02 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.727 0.775 . . . . 0.0 109.928 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.503 HG21 ' H ' ' A' ' 100' ' ' THR . 8.1 p -165.44 163.57 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.733 0.778 . . . . 0.0 109.081 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 102' ' ' ALA . 68.0 p -135.16 131.96 37.42 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.664 ' C ' ' CD1' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -52.43 95.57 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.406 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -91.81 -51.53 5.18 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.403 -1.436 . . . . 0.0 111.888 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.442 ' CD2' ' HB2' ' A' ' 102' ' ' ALA . 98.5 m-85 -129.06 137.37 30.86 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.743 -1.223 . . . . 0.0 112.043 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -52.98 160.53 4.1 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.232 1.955 . . . . 0.0 111.28 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.409 HG11 ' N ' ' A' ' 106' ' ' TYR . 3.2 p -74.27 -31.82 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.685 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.409 ' N ' HG11 ' A' ' 105' ' ' VAL . 16.0 m-85 -112.03 34.14 4.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.875 . . . . 0.0 109.281 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.548 -0.72 . . . . 0.0 109.706 179.941 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -51.51 -14.64 2.05 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.812 1.675 . . . . 0.0 110.925 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.457 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 91.1 m-70 -66.47 -12.93 59.84 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -63.42 -32.28 73.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 108.85 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.575 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 92.3 m-20 -100.53 134.19 43.85 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.352 -0.843 . . . . 0.0 110.004 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 12' ' ' ASN . 95.5 mt-10 -69.27 -27.26 65.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 109.988 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.507 ' CG ' ' N ' ' A' ' 10' ' ' THR . 33.3 pttt -60.79 -35.46 76.53 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 110.508 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.67 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 10.6 p -59.75 -33.39 71.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 110.113 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.67 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -120.78 -37.27 3.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.893 -1.129 . . . . 0.0 110.165 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -86.21 123.85 31.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.993 -1.067 . . . . 0.0 110.47 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.5 t -94.05 -4.95 10.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.79 -162.15 19.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -80.68 61.55 4.4 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.318 -1.107 . . . . 0.0 109.417 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.1 p -79.2 156.7 28.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.299 -0.876 . . . . 0.0 109.092 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -70.18 142.72 52.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.191 -0.943 . . . . 0.0 109.453 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.604 HH11 ' NH2' ' A' ' 36' ' ' ARG . 48.6 mtt-85 -59.46 -38.81 81.75 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.054 -1.029 . . . . 0.0 109.388 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.65 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 40.0 p-10 -62.65 -42.82 99.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.0 -1.062 . . . . 0.0 108.484 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.65 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 80.3 tttt -60.51 -36.6 78.74 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.233 -0.917 . . . . 0.0 109.066 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.702 ' CB ' HH11 ' A' ' 36' ' ' ARG . . . -58.57 -34.03 70.59 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.647 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 75.3 tt0 -58.7 -42.63 89.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.68 -46.94 87.54 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.697 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -67.16 -33.86 76.32 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.582 ' CD1' ' HG ' ' A' ' 47' ' ' SER . 22.7 mt -80.85 -16.01 54.82 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.731 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -74.61 122.43 23.15 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.555 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.82 19.54 78.83 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.18 135.79 38.62 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.359 -1.083 . . . . 0.0 109.685 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.686 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.9 OUTLIER -74.88 157.63 34.74 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.66 0.743 . . . . 0.0 110.157 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.513 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 48.4 p30 -62.25 169.36 2.85 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.88 -28.44 1.89 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 30' ' ' ASP . 76.7 m -80.56 121.03 25.29 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.869 -1.371 . . . . 0.0 108.984 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -136.06 167.26 21.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.908 -1.12 . . . . 0.0 110.517 -179.32 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 1.1 pt? -148.91 161.29 42.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.454 -0.779 . . . . 0.0 110.588 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.527 HG21 ' HG ' ' A' ' 46' ' ' CYS . 65.8 t -106.74 132.73 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.704 ' NH2' ' CD2' ' A' ' 56' ' ' HIS . 35.6 ptt180 -147.75 173.14 13.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 108.884 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.47 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 53.0 mt-10 . . . . . 0 C--N 1.304 -1.389 0 O-C-N 120.83 -1.169 . . . . 0.0 109.268 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.608 ' O ' ' O ' ' A' ' 59' ' ' ILE . 57.2 m-85 . . . . . 0 N--CA 1.495 1.775 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 57' ' ' CYS . . . -159.75 153.88 23.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.77 -1.207 . . . . 0.0 109.973 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.527 ' HG ' HG21 ' A' ' 35' ' ' VAL . 85.4 m -109.5 125.86 52.93 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.582 ' HG ' ' CD1' ' A' ' 25' ' ' LEU . 26.1 t -92.05 127.0 37.36 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.06 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.429 ' CG1' ' N ' ' A' ' 49' ' ' VAL . 74.3 t -126.1 163.71 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.187 -0.946 . . . . 0.0 109.978 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.429 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 39.2 t -124.6 132.76 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.488 HG13 ' NZ ' ' A' ' 55' ' ' LYS . 11.4 p -123.34 156.35 29.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.995 -1.066 . . . . 0.0 109.671 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.423 ' OD1' ' OD2' ' A' ' 30' ' ' ASP . 87.2 m-20 -49.97 -17.17 0.35 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.943 0.878 . . . . 0.0 109.634 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.581 ' O ' ' OE2' ' A' ' 53' ' ' GLU . . . -86.18 -59.22 1.88 Allowed Glycine 0 C--N 1.287 -2.142 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.667 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.581 ' OE2' ' O ' ' A' ' 52' ' ' GLY . 61.3 mm-40 -163.22 -165.53 1.1 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.25 -1.147 . . . . 0.0 110.554 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -93.36 123.37 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.488 ' NZ ' HG13 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -122.45 149.15 44.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.911 -1.118 . . . . 0.0 110.905 -179.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.704 ' CD2' ' NH2' ' A' ' 36' ' ' ARG . 23.6 m80 -113.31 101.88 9.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.579 -0.701 . . . . 0.0 109.544 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' CYS . 52.5 t -72.91 130.04 39.5 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.26 138.63 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.246 -0.909 . . . . 0.0 111.878 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.608 ' O ' ' O ' ' A' ' 44' ' ' TYR . 10.9 mm -124.93 111.59 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 . . . . . 0 N--CA 1.5 2.055 0 O-C-N 120.647 -1.283 . . . . 0.0 112.182 -178.248 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.559 0.695 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.16 -34.05 73.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 110.03 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.72 -43.74 80.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.188 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -66.9 -30.53 70.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.228 -0.92 . . . . 0.0 108.856 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.542 ' CD2' ' CE2' ' A' ' 85' ' ' TYR . 9.2 tt -60.6 -40.9 93.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 108.987 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.2 t -66.86 -44.17 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.361 -0.837 . . . . 0.0 109.819 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.428 HD22 ' CD2' ' A' ' 5' ' ' HIS . 85.0 mt -67.45 -43.09 81.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.419 -0.8 . . . . 0.0 110.439 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -60.02 -40.56 89.72 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.215 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.542 ' CE2' ' CD2' ' A' ' 81' ' ' LEU . 7.4 m-30 -67.34 -24.31 65.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 0.0 108.789 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.453 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 38.1 tt0 -61.32 -36.94 81.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -91.44 -16.71 26.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.303 -0.873 . . . . 0.0 109.592 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.4 m -100.84 129.92 46.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.131 -0.981 . . . . 0.0 109.228 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 t -81.67 132.56 35.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 109.915 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 91' ' ' VAL . 76.2 mt -69.01 -13.07 62.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.477 -0.764 . . . . 0.0 109.715 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.76 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.8 p -36.66 -33.75 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.464 -0.773 . . . . 0.0 110.011 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 90' ' ' LEU . 20.0 tt0 -65.86 -50.07 65.86 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLN . 84.3 t60 -51.43 -47.53 63.0 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.689 ' O ' ' N ' ' A' ' 96' ' ' SER . 13.1 t-20 -126.29 111.25 14.33 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.54 ' C ' ' O ' ' A' ' 94' ' ' ASN . 99.7 m-20 -35.98 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.886 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 94' ' ' ASN . 71.1 m -108.37 27.07 9.71 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.736 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.76 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.5 mt -97.96 65.84 1.81 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.563 -1.336 . . . . 0.0 108.2 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.79 75.57 6.47 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.81 -1.182 . . . . 0.0 109.41 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.5 t -153.56 153.62 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.522 -0.736 . . . . 0.0 109.805 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.2 p -134.33 156.79 47.85 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.503 HD21 ' CG ' ' A' ' 33' ' ' PHE . 11.6 mt -76.48 71.65 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.706 -1.246 . . . . 0.0 108.007 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.3 -33.76 9.91 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.169 -0.957 . . . . 0.0 112.111 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.4 m-85 -113.97 109.29 49.93 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.503 -1.373 . . . . 0.0 111.977 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.422 ' CB ' ' O ' ' A' ' 10' ' ' THR . 19.0 Cg_exo -59.97 148.61 88.21 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.083 1.855 . . . . 0.0 110.276 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.503 HG12 ' CD2' ' A' ' 106' ' ' TYR . 9.1 p -67.25 -34.59 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.822 -1.174 . . . . 0.0 108.77 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.503 ' CD2' HG12 ' A' ' 105' ' ' VAL . 38.6 m-85 -108.14 39.4 1.97 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.447 -0.783 . . . . 0.0 110.191 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.905 0 O-C-N 120.996 -1.065 . . . . 0.0 109.599 179.462 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.425 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 28.5 Cg_endo -64.3 -6.9 12.59 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.7 2.267 . . . . 0.0 112.288 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.473 ' NE2' HG13 ' A' ' 82' ' ' VAL . 7.3 m80 -67.37 -21.31 65.63 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 108.965 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -59.68 -34.2 72.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.776 -1.203 . . . . 0.0 108.236 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -97.18 126.76 42.57 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.175 -0.953 . . . . 0.0 109.354 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.614 ' CG ' ' OD1' ' A' ' 12' ' ' ASN . 23.2 tt0 -68.07 -28.27 67.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.6 -0.688 . . . . 0.0 110.125 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.706 ' NZ ' ' O ' ' A' ' 106' ' ' TYR . 2.3 tmpt? -62.44 -27.19 68.94 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.261 -0.9 . . . . 0.0 111.623 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.727 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 41.7 p -62.57 -29.74 70.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.991 -1.068 . . . . 0.0 112.127 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.759 ' CE3' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -123.86 -31.23 3.44 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.189 -1.57 . . . . 0.0 110.34 179.457 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.759 ' ND2' ' CE3' ' A' ' 11' ' ' TRP . 1.2 m-80 -73.74 130.81 40.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.132 -0.98 . . . . 0.0 109.663 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.9 t -115.79 -11.16 12.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.633 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.81 -152.42 21.81 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.1 p -83.46 112.07 19.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -1.123 . . . . 0.0 109.524 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.0 m -126.07 143.13 51.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.073 -1.017 . . . . 0.0 110.152 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.653 ' ND2' ' ND2' ' A' ' 19' ' ' ASN . 59.5 t-20 -67.11 148.38 51.93 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.576 -0.702 . . . . 0.0 109.26 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.514 ' HA ' HH12 ' A' ' 36' ' ' ARG . 85.5 mtm180 -61.05 -40.35 93.29 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 110.022 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 44.0 p30 -61.49 -33.14 73.27 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.085 -1.009 . . . . 0.0 108.977 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.674 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 7.3 tppt? -77.76 -34.75 52.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.127 -0.983 . . . . 0.0 108.945 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.5 92.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -0.793 . . . . 0.0 109.349 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 26' ' ' ARG . 14.4 pt-20 -60.12 -46.01 91.07 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.0 -1.063 . . . . 0.0 108.442 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.428 ' N ' ' HG3' ' A' ' 22' ' ' GLU . 98.3 m-20 -56.07 -42.44 76.67 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.31 -29.75 67.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.319 -0.863 . . . . 0.0 109.163 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.475 HD12 ' HG ' ' A' ' 47' ' ' SER . 11.5 mt -91.68 -9.93 42.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -0.792 . . . . 0.0 109.134 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 22' ' ' GLU . 1.1 ttt180 -90.75 125.8 35.81 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.195 -0.94 . . . . 0.0 109.476 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.2 1.02 61.23 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -96.9 141.1 30.5 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.403 -1.057 . . . . 0.0 108.16 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -72.82 151.74 41.89 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.275 -0.891 . . . . 0.0 108.854 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -50.95 147.99 4.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 109.287 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.79 -20.82 44.52 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.5 m -86.27 122.33 30.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -1.079 . . . . 0.0 110.074 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.538 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.8 OUTLIER -136.46 167.22 21.76 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.366 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 pp -140.63 160.12 40.7 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.664 -0.815 . . . . 0.0 109.545 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.36 125.65 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.416 -0.803 . . . . 0.0 109.756 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.514 HH12 ' HA ' ' A' ' 18' ' ' ARG . 29.0 ptt180 -143.9 -174.06 4.16 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.301 -1.537 0 O-C-N 120.825 -1.172 . . . . 0.0 108.985 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.585 ' O ' ' O ' ' A' ' 59' ' ' ILE . 31.9 m-85 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -155.42 138.72 15.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.904 -1.122 . . . . 0.0 110.059 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 57' ' ' CYS . 29.5 p -111.1 125.42 53.75 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.913 -1.117 . . . . 0.0 108.237 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.514 ' OG ' ' O ' ' A' ' 55' ' ' LYS . 44.2 t -108.21 138.13 45.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 0.0 109.845 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.424 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 10.2 p -131.97 164.22 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.052 -1.03 . . . . 0.0 110.31 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.424 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 86.7 t -109.93 127.33 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.701 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 7.9 p -160.02 168.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.888 -1.133 . . . . 0.0 110.909 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.509 ' N ' HG23 ' A' ' 50' ' ' VAL . 61.6 t0 40.88 24.28 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.831 -0.543 . . . . 0.0 110.731 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 80.1 -1.85 78.35 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.053 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.49 ' HB3' ' HZ3' ' A' ' 55' ' ' LYS . 15.3 tp10 -119.88 143.58 47.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.335 . . . . 0.0 110.489 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 83.7 t -82.59 127.66 39.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.566 0.698 . . . . 0.0 109.163 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.701 ' NZ ' ' O ' ' A' ' 50' ' ' VAL . 6.6 mptt -110.16 158.15 18.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.0 110.933 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -130.36 73.96 1.56 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.422 -0.798 . . . . 0.0 109.539 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.462 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 42.2 t -63.92 136.78 57.64 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.404 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.78 139.84 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.84 0.829 . . . . 0.0 111.989 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.585 ' O ' ' O ' ' A' ' 44' ' ' TYR . 20.0 mm -118.23 144.96 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.6 m120 . . . . . 0 N--CA 1.495 1.786 0 O-C-N 120.842 -1.161 . . . . 0.0 109.631 179.663 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 122.003 0.906 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.6 mt -59.63 -28.28 67.08 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -53.27 -42.39 66.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.83 -1.168 . . . . 0.0 108.016 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.615 ' OE2' ' CE1' ' A' ' 84' ' ' HIS . 7.2 tm-20 -63.92 -37.04 85.96 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.448 ' C ' ' CD2' ' A' ' 81' ' ' LEU . 8.2 tt -59.2 -48.04 83.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 0.0 109.203 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.473 HG13 ' NE2' ' A' ' 5' ' ' HIS . 97.2 t -60.68 -39.31 81.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.042 -1.036 . . . . 0.0 108.579 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.426 ' O ' ' HB3' ' A' ' 86' ' ' GLN . 79.6 mt -64.17 -35.12 79.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.384 -0.822 . . . . 0.0 109.965 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.615 ' CE1' ' OE2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -56.27 -48.65 76.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.723 -1.236 . . . . 0.0 110.027 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.481 ' CG ' HD13 ' A' ' 101' ' ' LEU . 73.3 m-85 -61.74 -30.09 70.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.914 -1.116 . . . . 0.0 109.353 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' ' 83' ' ' LEU . 37.3 tt0 -60.96 -34.87 75.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.43 -0.793 . . . . 0.0 109.558 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -96.4 -11.18 26.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 110.621 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.2 m -114.34 129.74 56.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.748 -1.22 . . . . 0.0 110.746 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.7 t -76.47 124.6 27.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.759 -0.588 . . . . 0.0 109.786 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.726 ' O ' ' N ' ' A' ' 92' ' ' GLN . 5.0 mp -67.41 -31.44 71.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.478 -0.763 . . . . 0.0 111.316 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.761 ' CG1' ' H ' ' A' ' 92' ' ' GLN . 7.6 p 12.31 -75.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.597 0 O-C-N 121.844 -0.535 . . . . 0.0 110.285 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.761 ' H ' ' CG1' ' A' ' 91' ' ' VAL . 26.5 tt0 62.63 -175.98 0.14 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.421 -0.8 . . . . 0.0 111.105 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.703 ' H ' ' CG ' ' A' ' 92' ' ' GLN . 88.4 m-70 -58.44 -35.54 72.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.55 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -50.64 -25.48 4.28 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 60.0 14.6 4.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.678 -0.639 . . . . 0.0 109.751 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.42 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 54.7 p -132.33 9.19 4.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.968 -1.082 . . . . 0.0 109.751 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.732 ' O ' ' N ' ' A' ' 91' ' ' VAL . 83.9 mt -96.58 36.57 1.36 Allowed 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.441 ' OD1' ' HB ' ' A' ' 91' ' ' VAL . 98.7 m-20 -75.98 70.34 2.68 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.8 p -159.47 159.35 2.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.0 p -121.8 149.21 43.65 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.538 HD21 ' CG ' ' A' ' 33' ' ' PHE . 56.3 mt -73.94 69.13 1.4 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -98.2 -24.62 15.2 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.444 -0.785 . . . . 0.0 112.548 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.455 ' CE2' ' O ' ' A' ' 104' ' ' PRO . 80.8 t80 -114.02 131.01 23.37 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.268 -1.52 . . . . 0.0 110.97 -178.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.455 ' O ' ' CE2' ' A' ' 103' ' ' TYR . 63.3 Cg_endo -76.14 149.33 32.08 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 123.354 2.703 . . . . 0.0 112.182 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.5 p -78.5 -17.83 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.025 -1.047 . . . . 0.0 109.776 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.706 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . 33.9 m-85 -132.18 56.35 1.83 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.025 -1.047 . . . . 0.0 110.569 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.5 0 O-C-N 121.15 -0.969 . . . . 0.0 109.844 179.624 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.495 ' O ' ' OG1' ' A' ' 10' ' ' THR . 28.9 Cg_endo -68.55 -3.86 11.92 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.35 2.033 . . . . 0.0 111.974 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -80.93 -6.33 58.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 110.016 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -76.11 -31.14 58.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.197 -0.939 . . . . 0.0 110.111 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -105.18 132.78 50.97 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.235 -0.916 . . . . 0.0 109.981 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.675 ' O ' ' N ' ' A' ' 12' ' ' ASN . 95.9 mt-10 -66.77 -29.33 69.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.477 -0.764 . . . . 0.0 110.57 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.46 ' CG ' ' N ' ' A' ' 10' ' ' THR . 3.0 pttt -57.66 -33.58 68.46 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.336 -0.853 . . . . 0.0 111.0 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.697 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 47.2 p -65.67 -30.91 71.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.888 -1.132 . . . . 0.0 110.704 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.697 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -119.82 -28.86 5.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.673 -1.267 . . . . 0.0 109.78 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' A' ' 8' ' ' GLU . 56.2 t-20 -83.63 130.62 34.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.605 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -96.35 -12.82 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.287 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.13 -157.96 34.1 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 95.2 p -63.83 132.68 51.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.149 -1.207 . . . . 0.0 109.801 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.9 t -176.71 165.46 2.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 109.619 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -95.12 147.8 23.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.468 -0.77 . . . . 0.0 109.747 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.607 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.72 -35.57 74.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.164 -0.96 . . . . 0.0 110.016 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -57.17 -46.06 83.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.684 -1.26 . . . . 0.0 108.43 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.695 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 79.9 tttt -59.98 -35.11 74.31 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -60.04 -38.93 84.2 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' ARG . 97.1 mt-10 -53.64 -47.51 70.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.863 . . . . 0.0 108.823 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.695 ' ND2' ' O ' ' A' ' 20' ' ' LYS . 9.5 p30 -62.11 -41.29 98.08 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.674 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 79.2 mt -65.09 -30.21 71.14 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 21' ' ' ALA . 19.2 mt -93.1 -10.73 34.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.444 -0.785 . . . . 0.0 109.817 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.564 ' CG ' ' N ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -79.71 -49.53 11.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 109.635 -179.088 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.564 ' N ' ' CG ' ' A' ' 26' ' ' ARG . . . -87.99 25.95 8.21 Favored Glycine 0 C--N 1.287 -2.188 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -115.11 125.34 53.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.25 -1.147 . . . . 0.0 110.521 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -72.77 159.33 33.97 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.497 -0.752 . . . . 0.0 109.142 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 59.9 p30 -57.36 151.2 16.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.056 -1.028 . . . . 0.0 110.172 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.17 -18.46 55.55 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.1 m -100.67 127.43 47.08 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.165 -1.197 . . . . 0.0 109.09 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.505 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -130.4 161.27 31.72 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.034 178.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 pp -129.35 155.07 46.23 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.636 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.487 HG21 ' CE2' ' A' ' 33' ' ' PHE . 72.6 t -116.26 131.14 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.777 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.632 ' CB ' ' CZ ' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -146.11 -141.91 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 108.928 179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 . . . . . 0 C--N 1.301 -1.504 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.611 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.594 ' O ' ' O ' ' A' ' 59' ' ' ILE . 74.8 m-85 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -169.05 142.36 2.82 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.094 -1.004 . . . . 0.0 109.053 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 57' ' ' CYS . 16.8 p -124.93 148.15 48.5 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.264 -0.898 . . . . 0.0 108.808 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.419 ' HG ' HD23 ' A' ' 25' ' ' LEU . 77.3 p -120.21 143.2 48.39 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.684 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.453 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 1.5 p -130.6 155.23 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.476 -0.765 . . . . 0.0 109.766 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.453 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 69.9 t -110.8 132.64 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.761 -0.587 . . . . 0.0 110.099 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.557 HG11 ' H ' ' A' ' 52' ' ' GLY . 8.3 p -122.04 156.27 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.0 -1.063 . . . . 0.0 108.876 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 59.4 t0 -49.3 -18.3 0.35 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.873 0.844 . . . . 0.0 110.022 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.557 ' H ' HG11 ' A' ' 50' ' ' VAL . . . -92.1 -52.81 2.15 Favored Glycine 0 C--N 1.286 -2.23 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.585 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 44.6 mt-10 -161.11 169.37 22.51 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.724 -1.456 . . . . 0.0 112.028 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.8 t -85.86 136.78 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -131.8 150.86 52.02 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.576 -1.328 . . . . 0.0 111.776 -178.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.532 ' CD2' ' HE ' ' A' ' 18' ' ' ARG . 29.2 m80 -110.66 117.45 33.52 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' A' ' 46' ' ' CYS . 48.8 t -104.08 129.23 51.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.87 -1.144 . . . . 0.0 108.574 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' A' ' 58' ' ' VAL . 4.7 p -94.68 132.72 37.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 111.292 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.594 ' O ' ' O ' ' A' ' 44' ' ' TYR . 98.0 mt -118.12 140.89 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 . . . . . 0 N--CA 1.494 1.738 0 O-C-N 120.967 -1.083 . . . . 0.0 109.349 -179.603 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.4 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.393 0.616 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.93 -37.39 82.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.548 -0.72 . . . . 0.0 109.461 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -56.71 -42.82 79.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.476 -0.765 . . . . 0.0 109.044 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -64.63 -33.53 76.16 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.229 -0.919 . . . . 0.0 109.15 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 10.2 tt -59.82 -48.17 82.77 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 109.535 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 95.5 t -67.53 -37.19 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.204 -0.935 . . . . 0.0 109.17 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.409 ' O ' ' HG2' ' A' ' 86' ' ' GLN . 52.3 tp -66.49 -47.73 72.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.285 -0.884 . . . . 0.0 110.359 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -63.11 -40.43 97.61 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.994 -1.066 . . . . 0.0 110.317 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 81' ' ' LEU . 3.9 m-85 -62.15 -29.67 70.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.469 -0.769 . . . . 0.0 111.501 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.612 ' O ' ' OG1' ' A' ' 100' ' ' THR . 5.8 pt20 -66.91 -29.09 68.88 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.301 -1.499 . . . . 0.0 108.334 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -79.18 -39.65 32.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.401 -0.812 . . . . 0.0 109.829 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.0 t -79.61 154.21 28.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.006 . . . . 0.0 109.993 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.5 t -104.55 133.18 49.85 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.609 ' N ' ' CD2' ' A' ' 90' ' ' LEU . 3.1 mm? -70.51 -10.92 60.44 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.513 -0.742 . . . . 0.0 110.319 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.685 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.4 p -40.14 -43.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.135 -0.978 . . . . 0.0 109.812 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.5 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 9.7 tt0 -38.58 -36.63 0.26 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.906 -0.496 . . . . 0.0 110.766 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.707 ' O ' ' N ' ' A' ' 95' ' ' ASP . 23.4 t-160 -64.87 124.65 22.57 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.951 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.512 ' ND2' ' NE2' ' A' ' 93' ' ' HIS . 78.5 m-20 44.28 9.71 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.034 -1.041 . . . . 0.0 109.278 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 93' ' ' HIS . 81.8 m-20 57.62 43.78 21.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.299 -0.876 . . . . 0.0 110.873 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.2 m -151.61 4.64 0.43 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.556 -1.34 . . . . 0.0 111.415 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.715 ' CD2' ' N ' ' A' ' 97' ' ' LEU . 2.1 mm? -100.47 70.68 1.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.607 -1.308 . . . . 0.0 107.774 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -79.73 94.63 5.78 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.049 0.928 . . . . 0.0 109.748 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.619 ' CG2' ' H ' ' A' ' 100' ' ' THR . 7.1 p -174.06 -177.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.619 ' H ' ' CG2' ' A' ' 99' ' ' VAL . 9.0 t -160.42 166.73 28.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.014 -1.054 . . . . 0.0 109.501 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.505 HD21 ' CG ' ' A' ' 33' ' ' PHE . 18.6 mt -79.96 63.73 4.58 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.44 -26.46 19.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.937 -0.477 . . . . 0.0 112.092 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -122.41 134.22 24.76 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.279 -1.513 . . . . 0.0 111.455 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.55 148.98 43.28 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 122.699 2.266 . . . . 0.0 111.302 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.484 HG12 ' CD2' ' A' ' 106' ' ' TYR . 9.0 p -72.41 -18.61 19.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.266 -0.896 . . . . 0.0 108.756 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.484 ' CD2' HG12 ' A' ' 105' ' ' VAL . 39.7 m-85 -131.42 65.18 1.57 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.478 -0.764 . . . . 0.0 110.023 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.788 0 O-C-N 120.962 -1.086 . . . . 0.0 110.024 179.836 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.4 HD13 ' N ' ' A' ' 3' ' ' LEU . 7.0 mp . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.29 0.567 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.19 -2.93 6.46 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.696 2.264 . . . . 0.0 111.443 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -65.89 -31.91 73.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.34 -0.85 . . . . 0.0 108.96 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -61.31 -18.27 57.75 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.627 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.675 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 94.6 m-20 -96.9 110.14 22.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.33 -0.856 . . . . 0.0 110.314 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.524 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 80.1 tt0 -69.27 -30.64 68.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.423 -0.798 . . . . 0.0 109.78 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 pttt -69.56 -11.56 60.93 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.431 -0.793 . . . . 0.0 110.76 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.509 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 43.9 p -85.32 -22.88 28.33 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.821 -1.175 . . . . 0.0 112.258 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.675 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -122.51 -26.77 4.52 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.256 -1.528 . . . . 0.0 109.839 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.632 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 14.9 p-10 -80.14 142.07 35.13 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.874 -1.141 . . . . 0.0 109.855 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.1 p -112.34 -16.84 8.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.05 -164.0 51.16 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.0 p -58.11 133.74 55.85 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.212 -1.169 . . . . 0.0 108.578 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.6 t -172.09 154.74 3.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.313 -0.867 . . . . 0.0 109.385 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -76.16 144.73 40.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.972 -1.08 . . . . 0.0 109.357 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.433 ' HG2' ' HE ' ' A' ' 36' ' ' ARG . 86.0 mtm180 -59.85 -39.51 85.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -57.9 -38.9 76.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.818 -1.176 . . . . 0.0 109.017 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -58.18 -34.25 70.12 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -62.51 -35.97 81.08 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.521 ' CG ' ' NE ' ' A' ' 26' ' ' ARG . 71.7 tt0 -55.95 -50.14 71.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.081 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -60.31 -44.17 95.69 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.976 -1.078 . . . . 0.0 108.272 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.46 HD12 ' HH ' ' A' ' 106' ' ' TYR . 86.8 mt -66.72 -30.3 70.51 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 21' ' ' ALA . 7.0 mt -92.86 -6.44 48.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.213 -0.93 . . . . 0.0 109.505 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.555 HH11 ' HG2' ' A' ' 26' ' ' ARG . 20.7 mtt-85 -100.59 137.39 39.05 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.328 -0.857 . . . . 0.0 109.641 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.44 -2.17 86.28 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -103.39 147.08 27.55 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.998 -1.295 . . . . 0.0 110.004 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.731 ' CG ' HH11 ' A' ' 29' ' ' ARG . 2.1 mtt-85 -74.73 161.61 29.47 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.598 0.713 . . . . 0.0 110.75 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.555 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 60.3 t0 -59.91 143.09 52.37 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.429 -0.794 . . . . 0.0 109.677 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 106.98 -25.04 23.58 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.6 m -78.99 122.46 26.2 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.258 -1.142 . . . . 0.0 108.775 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.555 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -134.19 173.64 11.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.712 -1.243 . . . . 0.0 110.713 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.74 159.84 44.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.723 -0.61 . . . . 0.0 109.676 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.7 t -110.2 127.75 66.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.278 -0.889 . . . . 0.0 108.758 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.745 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -145.2 -175.85 4.86 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 C--N 1.302 -1.478 0 O-C-N 120.928 -1.107 . . . . 0.0 108.378 179.388 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -160.31 133.51 6.73 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.59 -1.318 . . . . 0.0 110.292 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 57' ' ' CYS . 14.3 p -106.31 135.11 48.38 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.684 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.468 ' HG ' ' HD1' ' A' ' 56' ' ' HIS . 55.0 m -104.74 138.22 41.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.2 t -131.99 152.93 37.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.188 -0.945 . . . . 0.0 109.921 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.555 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 58.0 t -100.71 122.05 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.495 HG11 ' NZ ' ' A' ' 55' ' ' LYS . 13.4 p -160.47 172.44 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.678 -1.264 . . . . 0.0 111.861 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.498 ' HB3' ' NZ ' ' A' ' 55' ' ' LYS . 64.6 t0 48.44 20.52 0.3 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.526 0.679 . . . . 0.0 109.57 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.31 10.74 85.7 Favored Glycine 0 C--N 1.295 -1.749 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.106 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.663 ' CG ' ' NZ ' ' A' ' 55' ' ' LYS . 16.7 pt-20 -139.98 157.84 45.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.727 -1.455 . . . . 0.0 110.472 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.425 ' CG1' HD12 ' A' ' 25' ' ' LEU . 74.9 t -78.85 142.09 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 110.097 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.663 ' NZ ' ' CG ' ' A' ' 53' ' ' GLU . 0.9 OUTLIER -119.83 153.54 35.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.496 -0.753 . . . . 0.0 110.419 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.468 ' HD1' ' HG ' ' A' ' 47' ' ' SER . 8.9 m-70 -126.98 74.94 1.54 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.439 -0.788 . . . . 0.0 108.947 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.496 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 44.3 t -65.97 138.86 58.1 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.369 -0.832 . . . . 0.0 109.365 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.78 139.89 23.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.508 -0.745 . . . . 0.0 110.547 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.9 mt -118.44 129.97 73.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.01 -1.056 . . . . 0.0 110.867 -179.43 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.1 p . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.375 0.607 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.4 mt -59.9 -35.27 74.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.413 -0.804 . . . . 0.0 110.082 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -57.37 -40.85 79.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.01 -1.056 . . . . 0.0 109.212 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -69.86 -34.65 73.88 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.082 -1.011 . . . . 0.0 109.228 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.52 ' C ' ' CD1' ' A' ' 81' ' ' LEU . 3.0 tm? -60.64 -49.29 78.13 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.098 -1.001 . . . . 0.0 110.819 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.47 HG11 ' N ' ' A' ' 83' ' ' LEU . 2.4 p -65.5 -37.64 80.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 120.844 -1.16 . . . . 0.0 109.485 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.47 ' N ' HG11 ' A' ' 82' ' ' VAL . 54.6 tp -68.52 -45.74 71.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.299 -0.876 . . . . 0.0 110.842 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -61.85 -40.02 93.89 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.119 -0.988 . . . . 0.0 110.143 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -71.02 -24.28 62.34 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.943 -1.098 . . . . 0.0 110.91 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.585 ' O ' ' OE1' ' A' ' 86' ' ' GLN . 0.7 OUTLIER -61.66 -22.92 65.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.023 -1.048 . . . . 0.0 108.768 179.156 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -101.59 -33.85 9.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.4 -0.812 . . . . 0.0 108.98 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.5 m -82.55 142.62 31.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.407 -0.808 . . . . 0.0 109.893 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.3 m -96.68 129.94 43.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.596 -0.69 . . . . 0.0 109.97 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.727 ' O ' ' N ' ' A' ' 92' ' ' GLN . 1.6 mt -65.6 -12.48 53.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.38 -0.825 . . . . 0.0 111.794 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.738 ' N ' ' O ' ' A' ' 97' ' ' LEU . 8.2 p -9.23 -53.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.015 0 O-C-N 121.409 -0.807 . . . . 0.0 111.466 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.727 ' N ' ' O ' ' A' ' 90' ' ' LEU . 54.3 tt0 -36.41 146.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 109.575 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.683 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 7.7 t-160 103.94 -120.13 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.192 0.52 . . . . 0.0 109.777 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' A' ' 96' ' ' SER . 30.4 m120 -72.16 13.3 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 109.387 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.501 ' H ' ' C ' ' A' ' 93' ' ' HIS . 94.5 m-20 62.39 3.74 1.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.632 -0.667 . . . . 0.0 109.751 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.443 ' C ' ' H ' ' A' ' 98' ' ' ASN . 14.6 m -116.19 7.94 14.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.943 -1.098 . . . . 0.0 109.006 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.738 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.4 mm? -84.05 26.45 0.74 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.445 ' N ' ' HA ' ' A' ' 91' ' ' VAL . 11.7 t-20 -75.41 75.21 2.49 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 122.277 1.037 . . . . 0.0 108.824 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.455 HG21 ' N ' ' A' ' 100' ' ' THR . 6.7 p -147.4 158.07 9.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.455 ' N ' HG21 ' A' ' 99' ' ' VAL . 18.8 p -125.11 159.54 31.21 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.83 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.555 HD21 ' CG ' ' A' ' 33' ' ' PHE . 51.6 mt -80.02 70.35 6.58 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.491 ' CB ' HE22 ' A' ' 86' ' ' GLN . . . -96.69 -27.24 14.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.453 -0.779 . . . . 0.0 111.7 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -114.06 107.86 51.49 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.621 -1.299 . . . . 0.0 111.215 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -59.65 145.03 99.24 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.236 1.957 . . . . 0.0 110.509 178.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.491 HG11 ' N ' ' A' ' 106' ' ' TYR . 7.0 p -70.57 -31.61 46.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.072 -1.018 . . . . 0.0 108.893 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.491 ' N ' HG11 ' A' ' 105' ' ' VAL . 75.9 m-85 -111.54 31.51 6.08 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.558 -0.714 . . . . 0.0 109.737 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 106' ' ' TYR . . . . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.948 . . . . 0.0 109.311 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.7 mt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -70.85 -4.33 14.55 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.805 1.67 . . . . 0.0 111.189 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.413 ' HD1' HG13 ' A' ' 82' ' ' VAL . 77.1 m-70 -73.05 -22.61 60.59 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -60.94 -31.69 71.23 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.938 -1.102 . . . . 0.0 109.4 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.51 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 81.6 m-20 -92.53 131.99 37.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.091 -1.006 . . . . 0.0 110.16 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.543 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 60.8 tt0 -70.46 -31.61 68.83 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.847 0.832 . . . . 0.0 109.901 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 tmpt? -62.14 -27.42 68.93 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.75 -0.594 . . . . 0.0 112.368 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.6 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 23.6 p -68.83 -27.14 65.58 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.487 -1.383 . . . . 0.0 112.187 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.652 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -120.04 -28.47 5.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.239 -1.538 . . . . 0.0 109.445 179.529 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -79.75 125.1 29.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.237 -0.915 . . . . 0.0 109.531 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -99.81 -3.23 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 109.528 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.8 -148.74 26.21 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.1 m -83.08 102.98 12.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.254 . . . . 0.0 109.985 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.467 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 32.9 t -124.37 146.29 48.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.432 -0.792 . . . . 0.0 109.401 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.68 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 57.4 p30 -79.72 154.34 28.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 108.77 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.581 ' CG ' ' NH2' ' A' ' 36' ' ' ARG . 74.5 mtt180 -59.83 -35.89 75.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.144 -0.973 . . . . 0.0 109.603 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -59.75 -42.87 94.19 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.45 -0.781 . . . . 0.0 109.651 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.68 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 79.6 tttt -68.12 -37.75 81.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.855 -1.153 . . . . 0.0 109.257 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.55 -31.35 72.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.443 -0.786 . . . . 0.0 108.967 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 26' ' ' ARG . 61.7 tt0 -59.49 -49.6 77.15 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -57.84 -39.02 76.71 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.0 mt -71.25 -27.15 63.25 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.249 -0.907 . . . . 0.0 108.869 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.2 mt -96.78 -9.56 28.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 109.302 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -91.85 124.5 36.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.8 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.64 21.94 79.3 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -104.62 126.66 51.92 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -57.82 144.69 37.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.461 -0.774 . . . . 0.0 110.514 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 54.8 p30 -54.34 155.85 3.6 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.659 -0.651 . . . . 0.0 109.439 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.81 -30.96 9.28 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.8 m -81.81 127.28 32.81 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.522 -0.987 . . . . 0.0 109.067 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.519 ' CD1' ' HB2' ' A' ' 101' ' ' LEU . 0.6 OUTLIER -134.45 153.37 51.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.053 -1.029 . . . . 0.0 108.986 179.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.491 ' CD2' ' CG2' ' A' ' 105' ' ' VAL . 6.7 mt -107.28 172.26 6.93 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.004 0.907 . . . . 0.0 110.589 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.443 HG21 ' SG ' ' A' ' 46' ' ' CYS . 73.4 t -147.21 110.12 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.581 ' NH2' ' CG ' ' A' ' 18' ' ' ARG . 2.8 ptt180 -145.54 -179.3 6.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.016 -1.052 . . . . 0.0 109.834 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--N 1.304 -1.382 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.965 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' ILE . 70.8 m-85 . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.44 144.57 22.96 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.044 -1.035 . . . . 0.0 108.94 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.443 ' SG ' HG21 ' A' ' 35' ' ' VAL . 20.8 m -114.07 126.61 55.29 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 108.451 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 34' ' ' LEU . 50.5 m -88.59 131.24 35.03 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.499 -0.75 . . . . 0.0 109.382 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.528 HG21 ' HZ3' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -125.28 142.11 43.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.139 -0.976 . . . . 0.0 109.459 179.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.95 127.06 65.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.357 -0.839 . . . . 0.0 109.833 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.584 HG11 ' H ' ' A' ' 53' ' ' GLU . 4.9 p -111.84 161.45 10.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.082 -1.011 . . . . 0.0 109.957 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.413 ' H ' HG21 ' A' ' 50' ' ' VAL . 66.1 t0 -65.48 60.14 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 169.32 -36.28 0.19 Allowed Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.6 -1.286 . . . . 0.0 111.126 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.584 ' H ' HG11 ' A' ' 50' ' ' VAL . 78.2 tt0 -156.36 143.22 18.75 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.389 -1.653 . . . . 0.0 112.396 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.403 ' H ' HG21 ' A' ' 54' ' ' VAL . 34.5 m -79.62 134.33 27.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.533 ' CB ' ' HZ1' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -124.97 161.08 27.46 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.824 -1.172 . . . . 0.0 111.695 -178.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -121.35 100.85 7.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.392 0.615 . . . . 0.0 109.362 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.433 ' O ' ' N ' ' A' ' 46' ' ' CYS . 49.2 t -85.3 129.33 34.83 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.85 135.86 28.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.423 -0.798 . . . . 0.0 111.145 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 44' ' ' TYR . 48.7 mm -106.53 128.01 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.2 m120 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 120.974 -1.079 . . . . 0.0 110.358 -178.915 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.1 m . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 121.94 0.876 . . . . 0.0 111.667 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 79.1 mt -65.62 -31.65 72.79 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.527 0.68 . . . . 0.0 109.239 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -60.52 -41.24 94.01 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.392 -0.818 . . . . 0.0 108.941 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.507 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 99.0 mt-10 -62.79 -43.83 97.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.146 -0.971 . . . . 0.0 109.158 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.49 ' C ' ' CD2' ' A' ' 81' ' ' LEU . 7.1 tt -61.27 -43.58 98.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 109.907 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.413 HG13 ' HD1' ' A' ' 5' ' ' HIS . 82.2 t -71.1 -37.29 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 86' ' ' GLN . 86.4 mt -67.58 -42.87 81.81 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.241 -0.912 . . . . 0.0 109.634 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 80' ' ' GLU . 84.0 m-70 -69.11 -38.26 78.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.073 -1.017 . . . . 0.0 110.9 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -72.36 -17.71 61.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.37 -0.831 . . . . 0.0 111.876 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.26 -24.56 51.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.287 -1.508 . . . . 0.0 108.241 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.43 ' N ' ' HG3' ' A' ' 86' ' ' GLN . 83.0 t60 -96.47 -15.31 21.8 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.533 -0.729 . . . . 0.0 109.59 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.4 m -102.87 139.94 37.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.062 -1.024 . . . . 0.0 109.007 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.1 p -88.6 135.5 33.46 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.465 -0.772 . . . . 0.0 110.685 -178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 93' ' ' HIS . 77.0 mt -69.73 -10.27 57.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.642 -0.661 . . . . 0.0 110.088 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.728 ' N ' ' O ' ' A' ' 97' ' ' LEU . 9.9 p -33.98 -40.56 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.975 -1.078 . . . . 0.0 110.132 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.472 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 81.2 mt-30 -75.97 -5.9 48.46 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.356 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.546 ' N ' ' O ' ' A' ' 90' ' ' LEU . 53.4 t-80 -59.53 -43.55 93.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.66 -1.275 . . . . 0.0 108.42 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.41 ' CB ' HD22 ' A' ' 97' ' ' LEU . 16.3 t30 -148.71 19.85 1.02 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.415 ' CA ' ' O ' ' A' ' 91' ' ' VAL . 49.1 t0 64.68 38.77 6.81 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.365 0.602 . . . . 0.0 109.773 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 62.6 m -168.19 2.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.851 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -101.62 64.47 0.99 Allowed 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.16 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -79.06 71.11 5.52 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.275 -0.891 . . . . 0.0 110.723 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.9 p -148.5 158.41 7.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.7 p -122.27 150.66 42.01 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.528 ' O ' ' CD1' ' A' ' 101' ' ' LEU . 2.2 pp -88.34 47.14 1.46 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.204 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.33 -4.83 57.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.7 -0.625 . . . . 0.0 111.368 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -112.96 120.4 40.69 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.612 -1.305 . . . . 0.0 110.068 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.407 ' HB2' ' O ' ' A' ' 10' ' ' THR . 26.5 Cg_endo -73.29 146.48 40.39 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.681 2.254 . . . . 0.0 112.04 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.504 HG11 ' N ' ' A' ' 106' ' ' TYR . 9.2 p -80.88 -25.46 10.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.574 -0.704 . . . . 0.0 110.667 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.504 ' N ' HG11 ' A' ' 105' ' ' VAL . 2.4 m-85 -112.8 47.62 1.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.222 -0.924 . . . . 0.0 110.577 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.473 0 O-C-N 120.928 -1.107 . . . . 0.0 108.242 178.848 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.633 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 3.2 mm? . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.36 -1.85 9.63 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.907 2.404 . . . . 0.0 111.383 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.479 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 30.2 m170 -65.63 -21.42 66.57 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.793 -0.567 . . . . 0.0 109.767 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -58.97 -23.5 61.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.116 -0.99 . . . . 0.0 109.427 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.714 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 72.8 m-20 -105.74 134.38 48.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 109.915 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 12' ' ' ASN . 92.5 mt-10 -71.31 -30.01 65.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.952 . . . . 0.0 110.341 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.648 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -60.26 -31.38 70.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.041 -1.037 . . . . 0.0 110.23 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.599 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 22.7 p -67.39 -32.21 72.96 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.345 -0.847 . . . . 0.0 110.926 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.714 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -131.72 -3.72 3.68 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.534 -1.354 . . . . 0.0 111.199 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 8' ' ' GLU . 58.4 t30 -96.1 117.74 31.31 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.477 -1.389 . . . . 0.0 111.524 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.554 ' CG1' ' OG ' ' A' ' 16' ' ' SER . 11.9 t -134.71 33.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.6 -30.21 26.79 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.3 m -60.29 -38.5 83.81 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.058 -1.26 . . . . 0.0 109.414 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.554 ' OG ' ' CG1' ' A' ' 13' ' ' VAL . 74.4 m -67.11 142.2 57.17 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.3 -0.875 . . . . 0.0 110.746 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -83.55 166.14 18.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.597 -0.689 . . . . 0.0 109.205 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.555 ' CG ' HH12 ' A' ' 36' ' ' ARG . 38.0 ttp180 -59.35 -40.7 87.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.092 -1.005 . . . . 0.0 109.426 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -59.74 -45.67 91.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.049 -1.032 . . . . 0.0 108.504 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -67.96 -33.62 75.01 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.64 92.77 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 26' ' ' ARG . 99.0 mt-10 -55.43 -48.04 75.04 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -60.57 -44.19 96.45 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.406 HD23 ' OH ' ' A' ' 106' ' ' TYR . 95.3 mt -64.11 -41.18 97.34 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.7 mt -69.31 -32.65 71.91 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' GLU . 97.6 mtt180 -85.25 2.46 43.82 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.409 0.623 . . . . 0.0 109.801 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.56 8.47 32.38 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.731 ' HZ1' ' CG2' ' A' ' 105' ' ' VAL . 11.9 pttt -142.82 157.51 44.54 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.89 -1.359 . . . . 0.0 110.69 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.719 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.0 OUTLIER -85.56 163.86 18.12 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.029 0.919 . . . . 0.0 111.577 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.556 ' OD1' ' C ' ' A' ' 50' ' ' VAL . 76.4 m-20 -42.96 159.81 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.63 0.728 . . . . 0.0 110.442 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.412 ' H ' HG12 ' A' ' 99' ' ' VAL . . . 85.47 -27.08 5.36 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.7 m -86.4 124.77 33.11 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.326 -1.102 . . . . 0.0 108.432 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.644 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -132.9 173.12 11.73 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.137 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.644 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -150.3 166.46 29.9 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.23 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.52 HG21 ' HG ' ' A' ' 46' ' ' CYS . 46.8 t -112.31 140.36 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.555 HH12 ' CG ' ' A' ' 18' ' ' ARG . 12.6 ptt180 -153.71 178.2 10.13 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.014 -1.054 . . . . 0.0 109.036 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 . . . . . 0 C--N 1.302 -1.481 0 O-C-N 120.83 -1.169 . . . . 0.0 108.237 179.456 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.147 0.498 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.03 148.91 17.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.213 -0.929 . . . . 0.0 110.695 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.52 ' HG ' HG21 ' A' ' 35' ' ' VAL . 75.8 m -111.2 124.31 51.96 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.198 -0.939 . . . . 0.0 108.631 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 69.0 m -91.2 139.82 30.39 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.115 -0.99 . . . . 0.0 110.151 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.2 t -133.51 157.44 42.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.9 135.97 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.556 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -123.78 158.51 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.747 -1.221 . . . . 0.0 109.664 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.542 ' CA ' ' OD2' ' A' ' 30' ' ' ASP . 66.2 t0 -67.23 61.79 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.633 0.73 . . . . 0.0 109.934 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 172.1 -40.38 0.17 Allowed Glycine 0 C--N 1.292 -1.888 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.481 ' HB3' ' NZ ' ' A' ' 55' ' ' LYS . 79.0 tt0 -162.38 160.49 26.56 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.118 -1.225 . . . . 0.0 110.84 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.403 ' N ' ' HG2' ' A' ' 53' ' ' GLU . 43.8 t -88.13 126.33 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.481 ' NZ ' ' HB3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -114.52 155.71 25.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.841 -1.162 . . . . 0.0 110.297 -178.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 57.3 m170 -116.43 119.83 36.88 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.415 -0.803 . . . . 0.0 108.888 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.507 ' O ' ' N ' ' A' ' 46' ' ' CYS . 41.8 t -92.46 124.2 36.32 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.28 133.4 37.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 121.114 -0.991 . . . . 0.0 111.094 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.505 ' CD1' ' SG ' ' A' ' 46' ' ' CYS . 96.7 mt -119.33 130.31 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 . . . . . 0 C--N 1.299 -1.599 0 O-C-N 121.076 -1.015 . . . . 0.0 110.097 -179.23 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.53 0.681 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.7 mt -61.4 -38.13 85.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.383 -0.823 . . . . 0.0 109.545 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -59.68 -39.09 83.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.269 -0.895 . . . . 0.0 108.807 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -65.58 -42.5 91.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 109.001 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.419 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 8.4 tt -61.09 -42.83 99.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.367 -0.833 . . . . 0.0 109.183 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.472 HG13 ' ND1' ' A' ' 5' ' ' HIS . 70.5 t -67.09 -47.04 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.306 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.406 HD22 ' ND1' ' A' ' 5' ' ' HIS . 69.1 mt -67.48 -43.04 81.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.481 -0.762 . . . . 0.0 110.104 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -61.47 -42.58 99.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 0.0 109.885 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.419 ' CD1' ' O ' ' A' ' 81' ' ' LEU . 5.0 m-85 -60.58 -28.38 68.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.16 -0.962 . . . . 0.0 109.632 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -65.4 -34.92 79.44 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.935 -1.103 . . . . 0.0 108.769 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -84.56 -25.18 28.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.349 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.1 m -88.78 129.33 35.58 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.911 -1.118 . . . . 0.0 109.679 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.5 m -81.51 133.52 35.4 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 91' ' ' VAL . 86.6 mt -71.84 -19.04 62.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.297 -0.877 . . . . 0.0 111.964 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.785 ' O ' ' N ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -34.23 -51.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.874 -1.142 . . . . 0.0 110.228 -178.251 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -54.72 -29.13 52.57 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.077 0.465 . . . . 0.0 110.56 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.533 ' N ' ' O ' ' A' ' 90' ' ' LEU . 64.4 t-80 -50.05 -48.14 53.09 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.939 -1.101 . . . . 0.0 108.797 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.485 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 64.9 t-20 -140.18 19.85 2.43 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.785 ' N ' ' O ' ' A' ' 91' ' ' VAL . 53.5 t0 59.92 8.16 1.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.1 p -137.22 11.56 3.04 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.278 -0.889 . . . . 0.0 109.571 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.712 ' O ' ' N ' ' A' ' 91' ' ' VAL . 23.7 mt -103.32 69.94 1.03 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.705 -1.247 . . . . 0.0 108.509 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.491 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 41.5 p-10 -78.25 69.28 4.43 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.608 0.718 . . . . 0.0 110.395 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 100' ' ' THR . 53.9 t -156.38 158.09 3.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.469 0.652 . . . . 0.0 109.514 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.471 ' N ' ' CG1' ' A' ' 99' ' ' VAL . 72.8 p -131.17 164.09 26.27 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.575 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.514 HD11 ' H ' ' A' ' 101' ' ' LEU . 6.2 mp -82.71 68.12 9.05 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -97.94 -27.02 14.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.601 -0.687 . . . . 0.0 111.225 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -112.66 132.67 22.13 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 120.692 -1.255 . . . . 0.0 111.091 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.14 142.67 24.76 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.764 2.976 . . . . 0.0 111.975 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.731 ' CG2' ' HZ1' ' A' ' 28' ' ' LYS . 9.7 p -76.7 -33.13 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.159 -0.963 . . . . 0.0 111.954 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.529 ' N ' HG11 ' A' ' 105' ' ' VAL . 9.3 m-85 -130.15 60.56 1.61 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.55 -1.344 . . . . 0.0 110.889 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.625 0 C-N-CA 119.271 -0.971 . . . . 0.0 109.524 179.011 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.192 0.52 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.51 -16.92 5.91 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.671 2.247 . . . . 0.0 111.771 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.619 ' NE2' ' OE1' ' A' ' 86' ' ' GLN . 96.4 m-70 -67.18 -19.94 65.65 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.377 -0.827 . . . . 0.0 109.872 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -60.19 -36.59 77.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.868 -1.145 . . . . 0.0 109.506 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.606 ' OD2' ' NZ ' ' A' ' 9' ' ' LYS . 47.9 t0 -92.17 123.23 35.36 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.078 -1.014 . . . . 0.0 109.827 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.51 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 19.8 tt0 -64.44 -30.54 71.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.725 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.606 ' NZ ' ' OD2' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -61.48 -35.18 76.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.702 -0.624 . . . . 0.0 111.553 -179.327 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.721 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 13.7 p -51.63 -39.91 58.95 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.996 -1.065 . . . . 0.0 110.389 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.721 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -117.09 -19.29 9.79 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.857 -1.152 . . . . 0.0 110.684 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 49.4 t-20 -89.53 123.76 33.92 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.872 -1.142 . . . . 0.0 111.253 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.7 -16.0 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.302 -0.873 . . . . 0.0 109.207 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.425 ' N ' ' OD1' ' A' ' 12' ' ' ASN . . . 78.87 -141.37 24.29 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.495 ' HA ' ' NH2' ' A' ' 36' ' ' ARG . 36.8 t -81.76 104.53 12.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -1.093 . . . . 0.0 108.748 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 t -135.29 135.09 40.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.448 -0.782 . . . . 0.0 109.93 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -64.61 143.39 57.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.112 -0.993 . . . . 0.0 109.694 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.516 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 37.9 mtt-85 -60.17 -33.44 72.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.0 108.779 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -59.67 -43.41 94.01 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -62.41 -34.3 76.47 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.09 -35.13 76.18 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 26' ' ' ARG . 94.9 mt-10 -60.07 -45.83 91.58 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.819 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -63.17 -43.0 99.48 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.29 -36.66 79.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.0 109.27 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.486 HD21 ' CG2' ' A' ' 49' ' ' VAL . 56.1 mt -87.21 -15.13 39.13 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.141 -0.974 . . . . 0.0 109.047 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 22' ' ' GLU . 16.1 mtp180 -77.71 -22.42 50.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.13 -0.981 . . . . 0.0 109.372 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.43 19.84 23.79 Favored Glycine 0 C--N 1.285 -2.282 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.489 ' CB ' ' HZ1' ' A' ' 28' ' ' LYS . 5.1 ttmm -105.91 131.15 53.57 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.571 -0.958 . . . . 0.0 111.456 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -85.39 166.44 16.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.681 -0.637 . . . . 0.0 110.149 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.633 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 63.4 t0 -63.15 142.08 58.52 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.446 -0.784 . . . . 0.0 110.475 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.627 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 100.87 -19.28 52.85 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.422 HG23 ' HZ3' ' A' ' 28' ' ' LYS . 60.4 m -97.14 136.35 37.8 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.136 -1.214 . . . . 0.0 109.272 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.47 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -139.37 172.79 12.3 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.755 -1.216 . . . . 0.0 109.892 179.385 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' A' ' 46' ' ' CYS . 0.7 OUTLIER -139.7 153.96 47.36 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.816 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.5 t -104.63 136.8 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.969 -1.082 . . . . 0.0 108.527 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.704 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -144.69 -169.9 3.27 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 108.924 -178.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.704 ' H ' ' CD ' ' A' ' 36' ' ' ARG . 9.8 mt-10 . . . . . 0 C--N 1.303 -1.446 0 O-C-N 120.909 -1.12 . . . . 0.0 108.234 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.537 ' O ' ' O ' ' A' ' 59' ' ' ILE . 94.9 m-85 . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 121.918 0.866 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.4 129.5 8.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.436 -0.79 . . . . 0.0 109.154 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 57' ' ' CYS . 20.6 p -112.93 154.44 26.4 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.5 m -118.73 142.89 47.26 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.089 -0.645 . . . . 0.0 109.493 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.517 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 1.9 p -132.58 161.3 41.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.298 -0.876 . . . . 0.0 108.901 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.517 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 47.5 t -117.44 132.47 67.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.65 ' C ' ' H ' ' A' ' 52' ' ' GLY . 8.6 p -115.91 164.44 12.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.224 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.633 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 95.9 m-20 -59.66 28.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.981 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.65 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -154.58 -38.0 0.02 OUTLIER Glycine 0 N--CA 1.483 1.785 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.629 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.569 ' CD ' ' O ' ' A' ' 52' ' ' GLY . 55.0 mp0 -159.26 164.58 34.84 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.65 -1.5 . . . . 0.0 112.512 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.8 t -89.33 141.15 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.583 ' HZ1' ' N ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -131.04 165.71 22.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.843 -1.161 . . . . 0.0 111.617 -178.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -128.42 75.84 1.66 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 46.3 t -56.6 134.24 54.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.205 -0.934 . . . . 0.0 109.62 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.86 134.41 42.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.582 0.705 . . . . 0.0 110.112 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.537 ' O ' ' O ' ' A' ' 44' ' ' TYR . 49.5 mm -108.41 129.34 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 . . . . . 0 N--CA 1.495 1.809 0 O-C-N 120.857 -1.152 . . . . 0.0 110.793 -178.702 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.0 p . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.517 0.675 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.29 -32.06 72.74 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.559 -0.713 . . . . 0.0 109.395 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -59.6 -41.19 89.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.896 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -75.41 -26.68 58.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.094 -1.004 . . . . 0.0 109.601 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.6 tt -67.99 -42.25 81.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.164 -0.96 . . . . 0.0 110.371 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.514 ' CG1' ' N ' ' A' ' 83' ' ' LEU . 4.3 p -68.61 -46.73 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.204 -0.935 . . . . 0.0 110.359 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.514 ' N ' ' CG1' ' A' ' 82' ' ' VAL . 85.9 mt -66.02 -40.05 90.73 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.898 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.436 ' HA ' ' CD2' ' A' ' 87' ' ' HIS . 21.3 t60 -58.65 -41.21 85.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.297 -0.877 . . . . 0.0 110.233 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.401 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 7.2 m-30 -74.62 -25.75 59.43 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.088 -1.007 . . . . 0.0 109.67 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.619 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 30.5 tt0 -63.92 -36.57 84.4 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.998 -1.064 . . . . 0.0 110.33 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.471 ' CE1' ' OG1' ' A' ' 88' ' ' THR . 21.7 p80 -93.21 -7.05 46.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.057 -1.027 . . . . 0.0 109.272 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' CE1' ' A' ' 87' ' ' HIS . 33.3 m -105.59 138.3 42.01 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 108.895 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -89.79 130.14 36.09 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 109.268 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.562 ' O ' ' C ' ' A' ' 91' ' ' VAL . 83.0 mt -71.27 -18.65 62.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.658 -0.651 . . . . 0.0 110.246 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.73 ' N ' ' O ' ' A' ' 97' ' ' LEU . 14.7 p -31.36 -47.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.314 -0.866 . . . . 0.0 109.638 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.542 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 76.6 mt-30 -57.61 -45.66 85.08 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.131 -178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.484 ' HD1' ' HA ' ' A' ' 90' ' ' LEU . 75.1 m80 -48.53 -50.42 32.1 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.807 ' O ' ' N ' ' A' ' 96' ' ' SER . 97.7 m-20 -134.31 114.19 12.74 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 94' ' ' ASN . 84.1 m-20 -31.73 -19.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.525 -0.734 . . . . 0.0 111.393 -177.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.807 ' N ' ' O ' ' A' ' 94' ' ' ASN . 54.6 m -107.66 20.46 18.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.635 -1.291 . . . . 0.0 111.698 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.73 ' O ' ' N ' ' A' ' 91' ' ' VAL . 8.3 mt -97.7 57.43 1.35 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.444 -1.41 . . . . 0.0 109.263 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -78.32 86.03 4.43 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.386 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.9 p -168.7 151.88 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.9 p -131.68 159.34 38.64 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.469 -0.77 . . . . 0.0 109.342 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.47 HD21 ' CG ' ' A' ' 33' ' ' PHE . 19.2 mt -78.22 69.79 4.48 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.942 -1.099 . . . . 0.0 108.175 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.57 -31.45 16.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.451 -0.78 . . . . 0.0 112.714 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -122.53 136.14 26.31 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.507 -1.371 . . . . 0.0 111.393 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.435 ' CB ' ' HB ' ' A' ' 10' ' ' THR . 68.0 Cg_endo -77.08 152.88 31.81 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 123.133 2.556 . . . . 0.0 111.956 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.408 HG13 ' CB ' ' A' ' 34' ' ' LEU . 9.6 p -79.16 -16.41 13.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.093 -1.004 . . . . 0.0 110.626 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -129.73 61.18 1.57 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.073 -1.017 . . . . 0.0 111.016 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.638 0 O-C-N 121.132 -0.98 . . . . 0.0 108.795 178.497 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.593 ' O ' ' OG1' ' A' ' 10' ' ' THR . 26.8 Cg_exo -58.96 -11.77 13.33 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.948 1.765 . . . . 0.0 111.576 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.533 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 98.0 m-70 -67.2 -31.7 72.27 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.803 -0.561 . . . . 0.0 110.749 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.771 ' HD1' ' N ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -63.06 -15.4 56.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 0.0 110.153 -178.758 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.771 ' N ' ' HD1' ' A' ' 6' ' ' HIS . 27.1 t0 -102.51 126.14 49.47 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.723 ' O ' ' N ' ' A' ' 12' ' ' ASN . 4.0 mp0 -66.18 -27.29 67.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 110.644 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.63 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -62.69 -39.05 92.77 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.988 -1.07 . . . . 0.0 109.689 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.652 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 22.1 p -59.04 -33.76 71.13 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.694 -0.629 . . . . 0.0 109.909 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.693 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -123.91 -31.59 3.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.808 -1.183 . . . . 0.0 111.728 -179.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.723 ' N ' ' O ' ' A' ' 8' ' ' GLU . 28.5 t-20 -87.84 130.65 34.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.539 -1.35 . . . . 0.0 110.857 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -107.48 -6.52 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASN . . . 92.77 -161.86 26.13 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.4 p -67.44 153.59 43.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -1.14 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 t -163.59 150.51 12.23 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.424 -0.797 . . . . 0.0 109.407 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 18' ' ' ARG . 11.0 m120 -88.12 7.95 29.18 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 4.5 mmp_? 66.73 9.01 6.37 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.468 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.715 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 36.5 p-10 -77.52 -53.67 7.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.071 -1.018 . . . . 0.0 108.27 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.715 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 45.1 pttt -68.88 -26.29 65.05 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -56.62 -45.62 81.39 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 26' ' ' ARG . 59.2 mm-40 -59.16 -47.04 86.78 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -62.8 -42.68 99.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.414 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 79.0 mt -69.94 -29.97 67.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 109.504 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' ALA . 16.0 mt -89.79 -13.28 36.98 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 22' ' ' GLU . 89.5 mtt180 -91.5 115.27 27.9 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.62 2.89 50.05 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.414 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 36.4 mmtt -100.77 137.82 38.64 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.225 -1.162 . . . . 0.0 109.212 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -69.64 156.49 38.87 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.664 -0.648 . . . . 0.0 109.695 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 63.2 t0 -57.81 141.92 47.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.587 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 108.7 -27.82 12.62 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.4 m -79.85 120.8 24.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.133 -1.216 . . . . 0.0 108.437 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -139.89 176.57 8.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.851 -1.156 . . . . 0.0 110.931 -178.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.68 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -150.76 161.63 42.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.576 -0.703 . . . . 0.0 110.233 179.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.48 HG21 ' SG ' ' A' ' 46' ' ' CYS . 43.7 t -107.16 139.97 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.467 HH22 ' HB3' ' A' ' 56' ' ' HIS . 1.1 ppt_? -158.72 -160.21 0.85 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 . . . . . 0 C--N 1.306 -1.325 0 O-C-N 120.567 -1.333 . . . . 0.0 109.079 -179.568 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HB1' ' NH1' ' A' ' 36' ' ' ARG . . . -159.38 151.61 21.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.978 -1.076 . . . . 0.0 110.062 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.497 ' SG ' ' CD1' ' A' ' 59' ' ' ILE . 77.0 m -113.46 124.07 51.53 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.2 t -94.7 130.81 41.06 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.106 -0.997 . . . . 0.0 109.022 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.9 p -135.19 168.44 23.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.482 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.6 t -115.19 134.3 58.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.1 t -112.85 161.25 11.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.044 -1.035 . . . . 0.0 109.801 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.457 ' N ' HG12 ' A' ' 50' ' ' VAL . 64.6 m-20 -62.25 56.13 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.029 0.443 . . . . 0.0 109.99 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 164.37 -36.71 0.29 Allowed Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.208 -1.472 . . . . 0.0 111.018 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.511 ' OE1' ' C ' ' A' ' 52' ' ' GLY . 60.7 mp0 -153.91 161.06 42.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.638 -1.507 . . . . 0.0 110.972 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.1 t -91.9 138.47 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' CE ' ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -124.07 168.73 12.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.903 -1.123 . . . . 0.0 110.948 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.467 ' HB3' HH22 ' A' ' 36' ' ' ARG . 71.0 m-70 -129.79 73.67 1.54 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.464 ' SG ' HD12 ' A' ' 90' ' ' LEU . 73.0 m -50.7 148.1 4.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.315 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.1 t -116.16 134.5 59.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.891 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.497 ' CD1' ' SG ' ' A' ' 46' ' ' CYS . 67.1 mt -117.46 139.17 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 m120 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.8 -1.187 . . . . 0.0 109.689 -179.737 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.61 -37.73 88.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.466 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 3.7 ttmp? -58.91 -45.33 90.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.887 -1.133 . . . . 0.0 109.175 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.13 -29.14 68.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.19 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.6 tt -58.6 -43.75 89.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.285 -0.885 . . . . 0.0 110.014 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.84 -44.39 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.716 -1.24 . . . . 0.0 109.718 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.483 HD21 ' N ' ' A' ' 83' ' ' LEU . 3.8 mm? -67.15 -42.38 84.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 109.555 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.676 ' O ' ' CE1' ' A' ' 87' ' ' HIS . 60.1 t60 -60.28 -39.73 87.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.417 -0.802 . . . . 0.0 110.801 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.457 ' HA ' ' OG1' ' A' ' 88' ' ' THR . 4.9 m-30 -71.08 -25.5 62.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.478 -0.764 . . . . 0.0 112.526 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 83' ' ' LEU . 9.2 pt20 -61.23 -30.56 70.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.348 -1.47 . . . . 0.0 110.312 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.676 ' CE1' ' O ' ' A' ' 84' ' ' HIS . 31.2 p-80 -92.7 -5.49 51.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.75 -1.219 . . . . 0.0 109.188 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 85' ' ' TYR . 56.2 p -98.36 139.76 33.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.158 -0.964 . . . . 0.0 109.455 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.2 t -97.81 126.73 43.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.451 -0.781 . . . . 0.0 109.452 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.647 ' O ' ' N ' ' A' ' 92' ' ' GLN . 81.8 mt -67.05 -20.04 65.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.983 -1.073 . . . . 0.0 109.833 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.774 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.7 p -10.67 -58.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.834 -0.542 . . . . 0.0 110.171 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.647 ' N ' ' O ' ' A' ' 90' ' ' LEU . 9.5 tp-100 -35.17 155.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 92' ' ' GLN . 59.5 t-80 55.49 107.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.814 ' O ' ' N ' ' A' ' 96' ' ' SER . 70.9 m-20 56.69 71.84 0.54 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.603 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 94.2 m-20 -29.84 -20.0 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.814 ' N ' ' O ' ' A' ' 94' ' ' ASN . 87.1 p -77.43 15.5 0.77 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.671 -1.268 . . . . 0.0 110.922 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.774 ' O ' ' N ' ' A' ' 91' ' ' VAL . 70.5 mt -95.68 41.67 1.1 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 95' ' ' ASP . 64.1 m-80 -78.39 79.28 4.83 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.321 -0.862 . . . . 0.0 110.073 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.521 ' CG2' ' OD1' ' A' ' 30' ' ' ASP . 7.4 p -153.31 157.93 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.8 p -130.26 157.46 42.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.105 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.51 HD21 ' CG ' ' A' ' 33' ' ' PHE . 19.0 mt -82.21 65.73 7.47 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.7 -28.37 12.52 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.476 ' CD1' ' HD2' ' A' ' 104' ' ' PRO . 68.1 t80 -110.48 127.09 27.57 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.14 -1.6 . . . . 0.0 110.973 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.476 ' HD2' ' CD1' ' A' ' 103' ' ' TYR . 61.1 Cg_endo -74.82 146.81 33.92 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 123.039 2.493 . . . . 0.0 112.533 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.483 HG11 ' N ' ' A' ' 106' ' ' TYR . 9.9 p -83.26 -32.05 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.122 -0.986 . . . . 0.0 110.604 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.483 ' N ' HG11 ' A' ' 105' ' ' VAL . 35.2 m-85 -129.64 59.35 1.61 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.787 -1.196 . . . . 0.0 110.856 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.416 -0.802 . . . . 0.0 109.772 179.0 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.593 ' O ' ' OG1' ' A' ' 10' ' ' THR . 26.8 Cg_exo -58.96 -11.77 13.33 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.948 1.765 . . . . 0.0 111.576 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.533 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 98.0 m-70 -67.2 -31.7 72.27 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.803 -0.561 . . . . 0.0 110.749 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.771 ' HD1' ' N ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -63.06 -15.4 56.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 0.0 110.153 -178.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.771 ' N ' ' HD1' ' A' ' 6' ' ' HIS . 27.1 t0 -102.51 126.14 49.47 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.723 ' O ' ' N ' ' A' ' 12' ' ' ASN . 4.0 mp0 -66.18 -27.29 67.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 110.644 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.63 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -62.69 -39.05 92.77 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.988 -1.07 . . . . 0.0 109.689 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.652 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 22.1 p -59.04 -33.76 71.13 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.694 -0.629 . . . . 0.0 109.909 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.693 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -123.91 -31.59 3.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.808 -1.183 . . . . 0.0 111.728 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.723 ' N ' ' O ' ' A' ' 8' ' ' GLU . 28.5 t-20 -87.84 130.65 34.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.539 -1.35 . . . . 0.0 110.857 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -107.48 -6.52 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASN . . . 92.77 -161.86 26.13 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.4 p -67.44 153.59 43.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -1.14 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 t -163.59 150.51 12.23 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.424 -0.797 . . . . 0.0 109.407 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 18' ' ' ARG . 11.0 m120 -88.12 7.95 29.18 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 4.5 mmp_? 66.73 9.01 6.37 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.468 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.715 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 36.5 p-10 -77.52 -53.67 7.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.071 -1.018 . . . . 0.0 108.27 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.715 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 45.1 pttt -68.88 -26.29 65.05 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -56.62 -45.62 81.39 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 26' ' ' ARG . 59.2 mm-40 -59.16 -47.04 86.78 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -62.8 -42.68 99.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.414 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 79.0 mt -69.94 -29.97 67.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 109.504 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' ALA . 16.0 mt -89.79 -13.28 36.98 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 22' ' ' GLU . 89.5 mtt180 -91.5 115.27 27.9 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.62 2.89 50.05 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.414 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 36.4 mmtt -100.77 137.82 38.64 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.225 -1.162 . . . . 0.0 109.212 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -69.64 156.49 38.87 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.664 -0.648 . . . . 0.0 109.695 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 63.2 t0 -57.81 141.92 47.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.587 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 108.7 -27.82 12.62 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.4 m -79.85 120.8 24.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.133 -1.216 . . . . 0.0 108.437 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -139.89 176.57 8.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.851 -1.156 . . . . 0.0 110.931 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.68 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -150.76 161.63 42.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.576 -0.703 . . . . 0.0 110.233 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.48 HG21 ' SG ' ' A' ' 46' ' ' CYS . 43.7 t -107.16 139.97 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.467 HH22 ' HB3' ' A' ' 56' ' ' HIS . 1.1 ppt_? -158.72 -160.21 0.85 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 . . . . . 0 C--N 1.306 -1.325 0 O-C-N 120.567 -1.333 . . . . 0.0 109.079 -179.568 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HB1' ' NH1' ' A' ' 36' ' ' ARG . . . -159.38 151.61 21.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.978 -1.076 . . . . 0.0 110.062 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.497 ' SG ' ' CD1' ' A' ' 59' ' ' ILE . 77.0 m -113.46 124.07 51.53 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.2 t -94.7 130.81 41.06 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.106 -0.997 . . . . 0.0 109.022 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.9 p -135.19 168.44 23.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.482 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.6 t -115.19 134.3 58.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.1 t -112.85 161.25 11.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.044 -1.035 . . . . 0.0 109.801 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.457 ' N ' HG12 ' A' ' 50' ' ' VAL . 64.6 m-20 -62.25 56.13 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.029 0.443 . . . . 0.0 109.99 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 164.37 -36.71 0.29 Allowed Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.208 -1.472 . . . . 0.0 111.018 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.511 ' OE1' ' C ' ' A' ' 52' ' ' GLY . 60.7 mp0 -153.91 161.06 42.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.638 -1.507 . . . . 0.0 110.972 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.1 t -91.9 138.47 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' CE ' ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -124.07 168.73 12.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.903 -1.123 . . . . 0.0 110.948 -179.445 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.467 ' HB3' HH22 ' A' ' 36' ' ' ARG . 71.0 m-70 -129.79 73.67 1.54 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.464 ' SG ' HD12 ' A' ' 90' ' ' LEU . 73.0 m -50.7 148.1 4.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.315 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.1 t -116.16 134.5 59.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.891 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.497 ' CD1' ' SG ' ' A' ' 46' ' ' CYS . 67.1 mt -117.46 139.17 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 m120 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.8 -1.187 . . . . 0.0 109.689 -179.737 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.61 -37.73 88.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.466 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 3.7 ttmp? -58.91 -45.33 90.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.887 -1.133 . . . . 0.0 109.175 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.13 -29.14 68.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.19 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.6 tt -58.6 -43.75 89.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.285 -0.885 . . . . 0.0 110.014 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.84 -44.39 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.716 -1.24 . . . . 0.0 109.718 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.483 HD21 ' N ' ' A' ' 83' ' ' LEU . 3.8 mm? -67.15 -42.38 84.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 109.555 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.676 ' O ' ' CE1' ' A' ' 87' ' ' HIS . 60.1 t60 -60.28 -39.73 87.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.417 -0.802 . . . . 0.0 110.801 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.457 ' HA ' ' OG1' ' A' ' 88' ' ' THR . 4.9 m-30 -71.08 -25.5 62.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.478 -0.764 . . . . 0.0 112.526 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 83' ' ' LEU . 9.2 pt20 -61.23 -30.56 70.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.348 -1.47 . . . . 0.0 110.312 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.676 ' CE1' ' O ' ' A' ' 84' ' ' HIS . 31.2 p-80 -92.7 -5.49 51.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.75 -1.219 . . . . 0.0 109.188 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 85' ' ' TYR . 56.2 p -98.36 139.76 33.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.158 -0.964 . . . . 0.0 109.455 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.2 t -97.81 126.73 43.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.451 -0.781 . . . . 0.0 109.452 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.647 ' O ' ' N ' ' A' ' 92' ' ' GLN . 81.8 mt -67.05 -20.04 65.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.983 -1.073 . . . . 0.0 109.833 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.774 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.7 p -10.67 -58.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.834 -0.542 . . . . 0.0 110.171 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.647 ' N ' ' O ' ' A' ' 90' ' ' LEU . 9.5 tp-100 -35.17 155.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 92' ' ' GLN . 59.5 t-80 55.49 107.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.814 ' O ' ' N ' ' A' ' 96' ' ' SER . 70.9 m-20 56.69 71.84 0.54 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.603 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 94.2 m-20 -29.84 -20.0 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.814 ' N ' ' O ' ' A' ' 94' ' ' ASN . 87.1 p -77.43 15.5 0.77 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.671 -1.268 . . . . 0.0 110.922 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.774 ' O ' ' N ' ' A' ' 91' ' ' VAL . 70.5 mt -95.68 41.67 1.1 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 95' ' ' ASP . 64.1 m-80 -78.39 79.28 4.83 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.321 -0.862 . . . . 0.0 110.073 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.521 ' CG2' ' OD1' ' A' ' 30' ' ' ASP . 7.4 p -153.31 157.93 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.8 p -130.26 157.46 42.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.105 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.51 HD21 ' CG ' ' A' ' 33' ' ' PHE . 19.0 mt -82.21 65.73 7.47 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.7 -28.37 12.52 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.476 ' CD1' ' HD2' ' A' ' 104' ' ' PRO . 68.1 t80 -110.48 127.09 27.57 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.14 -1.6 . . . . 0.0 110.973 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.476 ' HD2' ' CD1' ' A' ' 103' ' ' TYR . 61.1 Cg_endo -74.82 146.81 33.92 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 123.039 2.493 . . . . 0.0 112.533 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.483 HG11 ' N ' ' A' ' 106' ' ' TYR . 9.9 p -83.26 -32.05 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.122 -0.986 . . . . 0.0 110.604 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.483 ' N ' HG11 ' A' ' 105' ' ' VAL . 35.2 m-85 -129.64 59.35 1.61 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.787 -1.196 . . . . 0.0 110.856 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.416 -0.802 . . . . 0.0 109.772 179.0 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.4 -2.35 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.613 2.209 . . . . 0.0 111.998 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.665 ' CD2' ' OE1' ' A' ' 86' ' ' GLN . 4.7 m80 -67.76 -24.52 65.35 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.898 -1.126 . . . . 0.0 109.493 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -58.13 -29.85 65.86 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.595 ' O ' ' OG1' ' A' ' 10' ' ' THR . 94.5 m-20 -89.0 121.73 31.65 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.481 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 46.5 tt0 -69.9 -34.58 73.71 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.07 -1.019 . . . . 0.0 109.585 -178.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.46 -21.98 66.2 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 110.95 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 7' ' ' ASP . 8.1 p -64.05 -35.29 80.26 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.776 -1.203 . . . . 0.0 109.978 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.608 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -115.97 -34.3 4.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.94 -1.1 . . . . 0.0 110.182 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -88.1 125.69 34.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.071 -1.018 . . . . 0.0 110.543 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 m -108.59 -13.13 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.2 -158.59 30.34 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.482 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 73.7 m -61.52 148.41 42.16 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.18 -1.188 . . . . 0.0 108.524 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.463 ' HB3' ' NE ' ' A' ' 36' ' ' ARG . 40.4 t -168.87 167.61 10.85 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 109.355 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -88.89 134.7 33.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.235 -0.916 . . . . 0.0 109.281 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.492 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 44.8 mtt-85 -59.98 -36.22 76.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.845 -1.159 . . . . 0.0 110.287 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -54.53 -48.24 72.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 0.0 111.121 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -69.57 -26.43 64.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.385 -1.447 . . . . 0.0 109.3 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.542 ' CB ' HH12 ' A' ' 36' ' ' ARG . . . -57.34 -43.44 83.43 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -59.58 -44.02 93.47 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -60.15 -48.63 80.91 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.27 -36.49 83.83 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.401 HD12 ' CG1' ' A' ' 54' ' ' VAL . 4.0 mt -82.01 -4.43 56.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.221 -0.924 . . . . 0.0 109.432 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.17 131.38 37.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.33 -0.856 . . . . 0.0 110.5 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.06 1.79 88.52 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -100.23 128.19 46.35 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.209 -1.171 . . . . 0.0 110.108 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 30' ' ' ASP . 41.9 ttm180 -62.29 147.75 47.12 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 53.3 p-10 -47.39 156.0 0.3 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.928 -1.107 . . . . 0.0 108.769 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' H ' HG22 ' A' ' 99' ' ' VAL . . . 99.47 -33.87 5.87 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 60.0 m -72.54 123.93 24.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.167 -1.196 . . . . 0.0 108.831 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.736 ' CD1' ' N ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -145.4 172.24 13.47 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 118.385 -1.326 . . . . 0.0 111.051 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.736 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -148.75 159.76 43.83 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.184 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 11' ' ' TRP . 14.7 t -101.5 138.85 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.625 ' O ' ' O ' ' A' ' 45' ' ' ALA . 32.2 ttm180 -150.58 160.38 43.84 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 109.5 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.508 ' OE1' ' N ' ' A' ' 37' ' ' GLU . 16.0 pm0 . . . . . 0 C--N 1.301 -1.518 0 O-C-N 120.63 -1.294 . . . . 0.0 109.304 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' A' ' 59' ' ' ILE . 44.2 m-85 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.298 0.57 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.625 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -171.77 155.9 4.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.165 -0.96 . . . . 0.0 108.984 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 57' ' ' CYS . 22.1 p -133.13 142.91 48.93 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.496 -1.377 . . . . 0.0 109.285 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.465 ' HB3' ' HD1' ' A' ' 56' ' ' HIS . 89.2 p -116.86 139.28 50.79 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.53 -0.731 . . . . 0.0 109.744 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 14.9 p -133.29 166.6 28.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.383 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.431 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 53.7 t -103.69 137.49 32.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.667 ' C ' ' H ' ' A' ' 52' ' ' GLY . 41.4 t -116.99 152.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.153 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.495 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 62.1 t0 -52.7 2.2 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.095 0.474 . . . . 0.0 110.328 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.667 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -136.19 -32.66 0.26 Allowed Glycine 0 N--CA 1.485 1.952 0 C-N-CA 118.894 -1.622 . . . . 0.0 112.248 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 64.2 mt-10 -158.52 163.57 36.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.444 -1.621 . . . . 0.0 111.399 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.414 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 66.1 t -76.63 136.99 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 54' ' ' VAL . 60.8 mmtt -114.9 150.89 34.92 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.823 -1.173 . . . . 0.0 111.347 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.465 ' HD1' ' HB3' ' A' ' 47' ' ' SER . 43.9 m-70 -131.69 70.04 1.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 98.0 m -62.22 142.71 57.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 109.566 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.7 138.28 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.49 -0.756 . . . . 0.0 109.496 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.558 ' O ' ' O ' ' A' ' 44' ' ' TYR . 90.9 mt -123.08 136.64 59.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.282 -0.886 . . . . 0.0 109.183 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.3 m120 . . . . . 0 N--CA 1.495 1.788 0 O-C-N 120.88 -1.138 . . . . 0.0 109.301 179.944 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 121.417 0.627 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.23 -37.63 86.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.871 . . . . 0.0 109.084 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -53.77 -44.09 69.77 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.02 -42.5 72.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.386 -0.821 . . . . 0.0 109.989 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.495 ' C ' ' CD2' ' A' ' 81' ' ' LEU . 6.9 tt -59.8 -46.13 90.18 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.254 -0.904 . . . . 0.0 109.338 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.425 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 72.0 t -63.06 -45.93 97.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 109.599 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 68.6 mt -61.53 -40.1 93.46 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.539 -0.726 . . . . 0.0 110.305 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.58 ' O ' ' OG1' ' A' ' 88' ' ' THR . 60.1 t-80 -52.0 -48.67 64.33 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.165 -0.959 . . . . 0.0 110.195 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -71.48 -20.71 62.04 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.126 -0.984 . . . . 0.0 112.027 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.665 ' OE1' ' CD2' ' A' ' 5' ' ' HIS . 27.7 mt-30 -61.56 -36.02 79.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.645 -1.284 . . . . 0.0 109.382 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -93.5 -37.09 12.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.432 -0.792 . . . . 0.0 109.033 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.58 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 7.7 p -89.6 139.82 30.16 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.431 -0.793 . . . . 0.0 110.29 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.6 t -81.39 136.84 35.72 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.564 -0.71 . . . . 0.0 109.48 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.769 ' O ' ' N ' ' A' ' 92' ' ' GLN . 8.0 mt -61.46 -41.8 97.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.434 -0.791 . . . . 0.0 111.012 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.614 ' N ' ' O ' ' A' ' 97' ' ' LEU . 71.8 t 40.29 -81.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.225 -0.922 . . . . 0.0 109.234 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.769 ' N ' ' O ' ' A' ' 90' ' ' LEU . 0.7 OUTLIER 84.44 171.86 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 0.0 110.475 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.459 ' H ' ' HG3' ' A' ' 92' ' ' GLN . 65.0 m80 -60.93 -37.85 83.74 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 88.4 m-20 -57.93 -18.13 21.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 94' ' ' ASN . 97.7 m-20 61.28 23.23 13.49 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.8 m -134.01 11.49 3.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.57 -1.332 . . . . 0.0 111.195 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.614 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.4 mp -104.02 46.24 0.93 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.602 ' OD1' ' CG2' ' A' ' 91' ' ' VAL . 74.3 m-20 -78.08 67.46 3.92 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.448 -177.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 31' ' ' GLY . 7.4 p -132.2 159.04 43.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.403 ' HG1' ' HB1' ' A' ' 102' ' ' ALA . 40.5 p -110.65 152.36 26.58 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.273 -0.892 . . . . 0.0 108.793 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.524 ' HB3' ' CE2' ' A' ' 33' ' ' PHE . 91.5 mt -93.26 30.23 1.73 Allowed 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.403 ' HB1' ' HG1' ' A' ' 100' ' ' THR . . . -76.7 -9.19 58.49 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 32' ' ' THR . 73.7 m-85 -121.83 103.77 39.82 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.375 -1.453 . . . . 0.0 111.602 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -61.01 160.92 24.01 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.02 1.813 . . . . 0.0 110.805 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.09 -22.9 7.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.205 -0.935 . . . . 0.0 109.78 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -111.13 34.39 4.08 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.093 -1.004 . . . . 0.0 110.254 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.308 179.414 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.498 1.97 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.52 -1.31 6.36 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.234 1.956 . . . . 0.0 111.988 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.633 ' NE2' ' OE1' ' A' ' 86' ' ' GLN . 88.7 m-70 -69.69 -32.36 70.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.106 -0.996 . . . . 0.0 108.606 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -60.99 -32.78 72.34 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.343 -0.848 . . . . 0.0 108.807 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.4 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 68.6 m-20 -92.67 129.22 38.66 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.686 0.755 . . . . 0.0 110.814 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.525 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 75.6 tt0 -77.73 -23.45 49.36 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.3 -0.875 . . . . 0.0 110.68 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -17.85 63.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.187 -0.946 . . . . 0.0 111.528 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.609 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 47.1 p -73.42 -26.69 61.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.732 -1.23 . . . . 0.0 111.305 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.609 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -123.58 -21.91 5.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.505 -1.372 . . . . 0.0 109.773 179.073 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -83.62 121.35 27.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 110.882 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' A' ' 15' ' ' SER . 2.2 t -134.61 33.32 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -30.96 -31.68 0.01 OUTLIER Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.63 ' N ' ' O ' ' A' ' 13' ' ' VAL . 89.2 p -69.54 -21.18 63.67 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.804 -1.409 . . . . 0.0 109.965 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 13' ' ' VAL . 41.9 t -66.62 149.38 50.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.068 -1.02 . . . . 0.0 110.269 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.415 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 92.7 m-20 -114.52 167.57 10.62 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.061 -1.024 . . . . 0.0 109.654 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -56.84 -43.54 81.22 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.266 -0.897 . . . . 0.0 109.26 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -65.82 -46.55 78.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.161 -0.962 . . . . 0.0 108.717 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.415 ' HB3' ' H ' ' A' ' 17' ' ' ASN . 82.3 tttt -65.02 -36.37 84.18 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -57.13 -37.81 72.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 108.878 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.603 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 97.1 mt-10 -59.01 -44.17 91.65 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -63.84 -44.1 94.19 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.447 -0.783 . . . . 0.0 108.975 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.622 ' O ' ' CD ' ' A' ' 28' ' ' LYS . 96.1 mt -71.23 -26.19 62.82 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.335 -0.853 . . . . 0.0 108.837 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 21' ' ' ALA . 21.1 mt -94.09 -11.84 29.75 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.603 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 16.6 mmt180 -97.74 134.48 40.85 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.28 -0.38 88.95 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.622 ' CD ' ' O ' ' A' ' 24' ' ' LEU . 19.0 mtpp -105.06 136.65 44.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.094 -1.239 . . . . 0.0 109.468 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -68.27 160.69 28.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.163 -0.96 . . . . 0.0 110.476 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.691 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 84.4 m-20 -57.99 149.45 23.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.518 -0.739 . . . . 0.0 110.218 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.549 ' H ' HG22 ' A' ' 99' ' ' VAL . . . 104.71 -30.64 9.71 Favored Glycine 0 N--CA 1.486 2.015 0 C-N-CA 119.41 -1.376 . . . . 0.0 110.222 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 85.0 m -80.17 120.35 24.18 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.418 -1.048 . . . . 0.0 108.207 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.554 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -135.61 164.96 26.65 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 118.806 -1.158 . . . . 0.0 109.656 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.01 157.0 47.21 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.398 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 11' ' ' TRP . 85.5 t -115.41 124.79 72.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.37 -0.831 . . . . 0.0 108.985 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.679 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -152.56 177.35 10.74 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 4.3 pm0 . . . . . 0 C--N 1.298 -1.644 0 O-C-N 121.088 -1.007 . . . . 0.0 108.861 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.655 ' O ' ' O ' ' A' ' 59' ' ' ILE . 96.0 m-85 . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -158.15 137.49 11.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.348 -1.47 . . . . 0.0 109.794 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 20.9 p -116.9 129.87 56.34 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.149 -0.969 . . . . 0.0 109.092 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.515 ' CB ' ' HD1' ' A' ' 56' ' ' HIS . 12.7 t -107.58 138.7 43.33 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.657 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.537 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 10.4 p -128.56 170.75 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.498 -0.751 . . . . 0.0 109.766 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.537 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 85.4 t -114.71 134.12 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.586 HG11 ' H ' ' A' ' 53' ' ' GLU . 3.9 p -125.25 157.48 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.696 -1.253 . . . . 0.0 110.161 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.691 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 43.2 p30 -49.59 -10.31 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.662 0.744 . . . . 0.0 110.398 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.592 ' N ' ' OD1' ' A' ' 51' ' ' ASP . . . -98.33 -58.41 0.96 Allowed Glycine 0 C--N 1.287 -2.179 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.586 ' H ' HG11 ' A' ' 50' ' ' VAL . 61.5 mt-10 -164.68 -175.21 3.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.395 -1.062 . . . . 0.0 109.725 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.411 ' H ' HG21 ' A' ' 54' ' ' VAL . 18.0 m -90.84 119.87 38.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -119.54 156.71 29.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.435 -1.416 . . . . 0.0 110.454 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.515 ' HD1' ' CB ' ' A' ' 47' ' ' SER . 93.8 m-70 -111.76 127.87 55.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.48 -0.762 . . . . 0.0 109.974 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.7 t -105.24 128.56 53.49 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 p -86.35 136.51 22.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.845 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.655 ' O ' ' O ' ' A' ' 44' ' ' TYR . 51.5 mm -118.96 126.74 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.7 m120 . . . . . 0 N--CA 1.496 1.857 0 O-C-N 120.586 -1.321 . . . . 0.0 110.436 -178.776 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.2 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.455 0.645 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.6 mt -61.42 -39.8 92.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.367 -0.833 . . . . 0.0 109.606 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -59.04 -40.07 83.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.124 -0.985 . . . . 0.0 108.946 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -64.2 -36.52 84.32 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.4 -0.812 . . . . 0.0 109.192 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.86 -46.02 90.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.053 -1.029 . . . . 0.0 110.225 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.4 t -63.24 -41.18 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.006 -1.059 . . . . 0.0 109.647 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.493 HD22 ' CD2' ' A' ' 5' ' ' HIS . 76.3 mt -63.16 -43.77 97.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.924 -1.11 . . . . 0.0 111.323 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -64.84 -43.74 92.06 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.863 -1.148 . . . . 0.0 111.021 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -65.64 -24.64 67.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.616 -1.302 . . . . 0.0 109.055 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.633 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 33.5 tt0 -67.57 -33.16 74.46 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.376 -0.827 . . . . 0.0 109.607 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -95.0 -14.09 24.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.119 -0.988 . . . . 0.0 109.292 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.9 m -108.05 129.97 55.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 109.527 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.0 t -72.95 139.9 47.05 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.978 -1.076 . . . . 0.0 108.614 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.687 ' O ' ' C ' ' A' ' 91' ' ' VAL . 7.6 mp -69.0 -16.03 63.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.116 -0.99 . . . . 0.0 110.688 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.695 ' N ' ' O ' ' A' ' 97' ' ' LEU . 74.6 t -10.15 -64.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.589 0 O-C-N 121.75 -0.594 . . . . 0.0 109.918 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 90' ' ' LEU . 91.3 mt-30 34.71 -142.24 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.402 ' O ' ' N ' ' A' ' 95' ' ' ASP . 82.9 t60 -52.44 -50.07 63.33 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.711 ' O ' ' N ' ' A' ' 96' ' ' SER . 7.7 m120 -69.7 83.3 0.44 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 94' ' ' ASN . 62.9 t0 -44.03 -10.74 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.421 -0.799 . . . . 0.0 108.903 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.711 ' N ' ' O ' ' A' ' 94' ' ' ASN . 89.3 p -100.56 4.45 43.48 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.507 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.695 ' O ' ' N ' ' A' ' 91' ' ' VAL . 8.3 mt -76.83 50.31 0.7 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.078 -1.639 . . . . 0.0 108.404 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -77.37 80.62 3.87 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.252 -0.905 . . . . 0.0 109.861 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.549 HG22 ' H ' ' A' ' 31' ' ' GLY . 6.6 p -161.53 162.94 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.487 ' H ' HG21 ' A' ' 99' ' ' VAL . 44.4 p -129.94 155.85 45.39 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.087 -1.008 . . . . 0.0 109.936 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.554 HD21 ' CG ' ' A' ' 33' ' ' PHE . 18.4 mt -89.15 53.9 2.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.021 -1.049 . . . . 0.0 108.673 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.457 ' CB ' ' HG3' ' A' ' 86' ' ' GLN . . . -89.66 -18.09 27.12 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.73 -0.606 . . . . 0.0 112.37 -178.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' THR . 88.4 t80 -116.61 110.16 42.81 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 120.265 -1.522 . . . . 0.0 110.448 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -59.6 146.96 93.8 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.875 1.716 . . . . 0.0 110.926 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.472 HG12 ' CD2' ' A' ' 106' ' ' TYR . 11.4 p -67.99 -22.43 27.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.686 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.472 ' CD2' HG12 ' A' ' 105' ' ' VAL . 59.9 m-85 -128.75 60.88 1.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.903 . . . . 0.0 109.39 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.489 0 O-C-N 120.971 -1.081 . . . . 0.0 108.657 179.82 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.441 ' HB3' ' CD2' ' A' ' 6' ' ' HIS . 13.8 tp . . . . . 0 N--CA 1.485 1.318 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -49.86 -20.95 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.994 1.796 . . . . 0.0 112.082 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.701 ' CD2' HE22 ' A' ' 86' ' ' GLN . 30.2 m-70 -71.57 -29.69 65.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.453 -0.78 . . . . 0.0 109.838 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.441 ' CD2' ' HB3' ' A' ' 3' ' ' LEU . 80.3 m-70 -67.48 -21.68 65.51 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.558 ' O ' ' OG1' ' A' ' 10' ' ' THR . 76.3 m-20 -95.84 113.33 24.95 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.449 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 32.0 tt0 -70.31 -32.97 70.96 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.473 -0.767 . . . . 0.0 110.801 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.502 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -71.2 -13.62 61.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.758 -1.214 . . . . 0.0 110.945 -178.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.576 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 6.6 p -62.97 -37.49 87.32 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.68 -1.262 . . . . 0.0 108.666 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.719 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -117.33 -27.8 6.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.944 -1.098 . . . . 0.0 110.074 179.042 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -86.6 119.66 27.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.924 -1.11 . . . . 0.0 110.442 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 15' ' ' SER . 9.8 p -140.72 31.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -39.12 -20.34 0.01 OUTLIER Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.608 ' N ' ' O ' ' A' ' 13' ' ' VAL . 87.5 p -61.42 -17.52 54.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -1.131 . . . . 0.0 108.589 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.1 m -94.15 145.16 24.89 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.725 0.774 . . . . 0.0 110.731 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.66 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 54.8 p30 -79.64 167.39 20.75 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.394 -0.816 . . . . 0.0 109.335 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.523 ' CG ' ' NH1' ' A' ' 36' ' ' ARG . 81.1 mtm180 -61.05 -39.9 91.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.596 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -63.05 -44.29 96.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.645 -1.285 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.66 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 22.5 tptm -61.13 -35.51 77.26 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.221 -0.924 . . . . 0.0 108.901 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.04 74.32 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 26' ' ' ARG . 94.8 mt-10 -57.63 -45.4 85.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.35 -40.33 93.86 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.8 mt -67.95 -39.56 83.38 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.527 ' CD1' ' OG ' ' A' ' 47' ' ' SER . 3.6 mt -82.83 -16.82 46.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.342 -0.848 . . . . 0.0 108.799 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' GLU . 10.6 mmm180 -93.78 -28.4 15.92 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.959 0.885 . . . . 0.0 109.691 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.99 9.17 70.42 Favored Glycine 0 C--N 1.286 -2.231 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -124.2 145.54 49.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.499 -1.0 . . . . 0.0 110.001 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -77.67 165.53 24.14 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.395 0.617 . . . . 0.0 110.199 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.538 ' CG ' ' OD1' ' A' ' 51' ' ' ASP . 18.2 p-10 -53.02 158.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.92 -33.8 4.51 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.2 m -77.07 125.61 29.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -1.032 . . . . 0.0 108.311 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.518 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -135.88 170.65 15.66 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.966 -1.083 . . . . 0.0 110.274 -178.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -149.26 165.85 30.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.196 -0.94 . . . . 0.0 111.007 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.429 HG21 ' HG ' ' A' ' 46' ' ' CYS . 73.9 t -120.51 121.48 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.731 ' NH1' ' O ' ' A' ' 37' ' ' GLU . 6.8 ptm180 -134.84 -176.24 4.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.438 -0.788 . . . . 0.0 108.949 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.731 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 56.0 mt-10 . . . . . 0 N--CA 1.488 1.459 0 O-C-N 120.871 -1.143 . . . . 0.0 108.494 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' ILE . 98.1 m-85 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.413 0.625 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -145.74 133.43 21.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.711 -0.618 . . . . 0.0 109.924 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.609 ' O ' ' CB ' ' A' ' 57' ' ' CYS . 57.3 m -100.0 113.89 26.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.544 -1.347 . . . . 0.0 107.893 178.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.527 ' OG ' ' CD1' ' A' ' 25' ' ' LEU . 33.4 t -91.71 140.77 29.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.133 -0.98 . . . . 0.0 109.83 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.5 t -130.89 156.31 42.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.46 -0.775 . . . . 0.0 109.888 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.4 t -101.12 135.94 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.713 ' C ' ' H ' ' A' ' 52' ' ' GLY . 2.6 t -122.05 147.78 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.542 -1.349 . . . . 0.0 111.124 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.538 ' OD1' ' CG ' ' A' ' 30' ' ' ASP . 82.0 m-20 -55.06 9.36 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.231 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.713 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -135.97 -39.09 0.16 Allowed Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.619 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.539 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 21.6 tt0 -163.14 164.17 25.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.572 -1.546 . . . . 0.0 110.537 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.539 ' N ' ' CG ' ' A' ' 53' ' ' GLU . 96.1 t -67.42 134.69 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.075 -1.015 . . . . 0.0 108.686 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -112.04 139.02 47.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.831 -1.168 . . . . 0.0 109.12 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -120.57 87.74 2.81 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.609 ' CB ' ' O ' ' A' ' 46' ' ' CYS . 0.5 OUTLIER -70.79 139.66 51.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.154 -0.966 . . . . 0.0 108.723 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.41 129.57 62.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 111.241 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 44' ' ' TYR . 46.8 mm -108.13 117.05 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 120.943 -1.098 . . . . 0.0 110.312 -178.579 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 121.634 0.73 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.9 mt -66.09 -40.62 90.94 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.708 -0.62 . . . . 0.0 109.875 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -64.95 -40.17 94.6 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.974 -1.078 . . . . 0.0 108.533 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -67.31 -33.07 74.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.369 -0.832 . . . . 0.0 109.029 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.568 ' C ' ' CD1' ' A' ' 81' ' ' LEU . 2.5 tm? -60.54 -45.18 94.81 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.213 -0.93 . . . . 0.0 108.613 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.98 -42.92 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.347 -0.846 . . . . 0.0 109.176 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.549 ' CD2' ' CD2' ' A' ' 5' ' ' HIS . 96.5 mt -60.23 -43.87 95.68 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.435 -0.791 . . . . 0.0 111.177 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -63.44 -40.14 96.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.533 -1.354 . . . . 0.0 110.565 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -64.12 -22.63 67.01 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.901 -1.124 . . . . 0.0 110.698 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.701 HE22 ' CD2' ' A' ' 5' ' ' HIS . 6.7 mt-30 -68.99 -32.62 72.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.456 -1.402 . . . . 0.0 109.024 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -88.14 -19.29 27.18 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.323 -0.861 . . . . 0.0 109.648 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 79.0 m -100.64 127.74 46.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.571 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.1 p -81.27 139.7 35.29 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.513 -0.742 . . . . 0.0 109.401 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.535 ' O ' ' C ' ' A' ' 91' ' ' VAL . 4.3 mp -75.86 -17.64 59.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.535 -0.728 . . . . 0.0 109.996 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.707 ' N ' ' O ' ' A' ' 97' ' ' LEU . 5.1 p -31.23 -44.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.355 -0.84 . . . . 0.0 110.482 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.542 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 9.7 pt20 -66.16 -10.91 45.71 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.264 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.579 ' O ' ' ND2' ' A' ' 94' ' ' ASN . 0.3 OUTLIER -63.26 -47.0 84.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.582 -1.324 . . . . 0.0 107.893 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 93' ' ' HIS . 10.6 m120 -138.43 20.2 2.74 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.627 ' N ' ' O ' ' A' ' 91' ' ' VAL . 94.6 m-20 61.05 17.33 7.89 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.2 m -146.54 9.56 1.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.707 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.6 mm? -97.25 68.18 2.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -78.36 79.76 4.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 110.358 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.6 p -163.69 156.24 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 121.573 0.701 . . . . 0.0 109.59 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.1 p -130.44 153.94 48.25 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.139 -0.975 . . . . 0.0 108.681 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.511 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 17.7 mt -78.61 67.85 4.46 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.51 -27.65 14.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.126 -0.984 . . . . 0.0 111.897 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.47 130.84 24.38 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 120.77 -1.206 . . . . 0.0 111.43 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -74.51 153.41 44.35 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.734 2.289 . . . . 0.0 110.897 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.481 HG11 ' N ' ' A' ' 106' ' ' TYR . 7.7 p -76.74 -30.9 19.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.187 -0.945 . . . . 0.0 109.791 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.481 ' N ' HG11 ' A' ' 105' ' ' VAL . 50.0 m-85 -113.61 54.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.148 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.417 0.627 . . . . 0.0 109.913 -179.925 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.441 ' HB3' ' CD2' ' A' ' 6' ' ' HIS . 13.8 tp . . . . . 0 N--CA 1.485 1.318 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -49.86 -20.95 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.994 1.796 . . . . 0.0 112.082 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.701 ' CD2' HE22 ' A' ' 86' ' ' GLN . 30.2 m-70 -71.57 -29.69 65.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.453 -0.78 . . . . 0.0 109.838 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.441 ' CD2' ' HB3' ' A' ' 3' ' ' LEU . 80.3 m-70 -67.48 -21.68 65.51 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.558 ' O ' ' OG1' ' A' ' 10' ' ' THR . 76.3 m-20 -95.84 113.33 24.95 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.449 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 32.0 tt0 -70.31 -32.97 70.96 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.473 -0.767 . . . . 0.0 110.801 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.502 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -71.2 -13.62 61.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.758 -1.214 . . . . 0.0 110.945 -178.288 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.576 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 6.6 p -62.97 -37.49 87.32 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.68 -1.262 . . . . 0.0 108.666 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.719 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -117.33 -27.8 6.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.944 -1.098 . . . . 0.0 110.074 179.042 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -86.6 119.66 27.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.924 -1.11 . . . . 0.0 110.442 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 15' ' ' SER . 9.8 p -140.72 31.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -39.12 -20.34 0.01 OUTLIER Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.608 ' N ' ' O ' ' A' ' 13' ' ' VAL . 87.5 p -61.42 -17.52 54.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -1.131 . . . . 0.0 108.589 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.1 m -94.15 145.16 24.89 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.725 0.774 . . . . 0.0 110.731 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.66 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 54.8 p30 -79.64 167.39 20.75 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.394 -0.816 . . . . 0.0 109.335 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.523 ' CG ' ' NH1' ' A' ' 36' ' ' ARG . 81.1 mtm180 -61.05 -39.9 91.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.596 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -63.05 -44.29 96.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.645 -1.285 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.66 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 22.5 tptm -61.13 -35.51 77.26 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.221 -0.924 . . . . 0.0 108.901 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.04 74.32 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 26' ' ' ARG . 94.8 mt-10 -57.63 -45.4 85.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.35 -40.33 93.86 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.8 mt -67.95 -39.56 83.38 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.527 ' CD1' ' OG ' ' A' ' 47' ' ' SER . 3.6 mt -82.83 -16.82 46.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.342 -0.848 . . . . 0.0 108.799 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' GLU . 10.6 mmm180 -93.78 -28.4 15.92 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.959 0.885 . . . . 0.0 109.691 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.99 9.17 70.42 Favored Glycine 0 C--N 1.286 -2.231 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -124.2 145.54 49.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.499 -1.0 . . . . 0.0 110.001 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -77.67 165.53 24.14 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.395 0.617 . . . . 0.0 110.199 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.538 ' CG ' ' OD1' ' A' ' 51' ' ' ASP . 18.2 p-10 -53.02 158.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.92 -33.8 4.51 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.2 m -77.07 125.61 29.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -1.032 . . . . 0.0 108.311 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.518 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -135.88 170.65 15.66 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.966 -1.083 . . . . 0.0 110.274 -178.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -149.26 165.85 30.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.196 -0.94 . . . . 0.0 111.007 -179.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.429 HG21 ' HG ' ' A' ' 46' ' ' CYS . 73.9 t -120.51 121.48 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.731 ' NH1' ' O ' ' A' ' 37' ' ' GLU . 6.8 ptm180 -134.84 -176.24 4.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.438 -0.788 . . . . 0.0 108.949 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.731 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 56.0 mt-10 . . . . . 0 N--CA 1.488 1.459 0 O-C-N 120.871 -1.143 . . . . 0.0 108.494 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' ILE . 98.1 m-85 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.413 0.625 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -145.74 133.43 21.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.711 -0.618 . . . . 0.0 109.924 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.609 ' O ' ' CB ' ' A' ' 57' ' ' CYS . 57.3 m -100.0 113.89 26.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.544 -1.347 . . . . 0.0 107.893 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.527 ' OG ' ' CD1' ' A' ' 25' ' ' LEU . 33.4 t -91.71 140.77 29.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.133 -0.98 . . . . 0.0 109.83 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.5 t -130.89 156.31 42.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.46 -0.775 . . . . 0.0 109.888 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.4 t -101.12 135.94 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.713 ' C ' ' H ' ' A' ' 52' ' ' GLY . 2.6 t -122.05 147.78 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.542 -1.349 . . . . 0.0 111.124 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.538 ' OD1' ' CG ' ' A' ' 30' ' ' ASP . 82.0 m-20 -55.06 9.36 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.231 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.713 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -135.97 -39.09 0.16 Allowed Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.619 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.539 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 21.6 tt0 -163.14 164.17 25.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.572 -1.546 . . . . 0.0 110.537 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.539 ' N ' ' CG ' ' A' ' 53' ' ' GLU . 96.1 t -67.42 134.69 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.075 -1.015 . . . . 0.0 108.686 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -112.04 139.02 47.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.831 -1.168 . . . . 0.0 109.12 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -120.57 87.74 2.81 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.609 ' CB ' ' O ' ' A' ' 46' ' ' CYS . 0.5 OUTLIER -70.79 139.66 51.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.154 -0.966 . . . . 0.0 108.723 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.41 129.57 62.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 111.241 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 44' ' ' TYR . 46.8 mm -108.13 117.05 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 120.943 -1.098 . . . . 0.0 110.312 -178.579 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 121.634 0.73 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.9 mt -66.09 -40.62 90.94 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.708 -0.62 . . . . 0.0 109.875 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -64.95 -40.17 94.6 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.974 -1.078 . . . . 0.0 108.533 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -67.31 -33.07 74.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.369 -0.832 . . . . 0.0 109.029 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.568 ' C ' ' CD1' ' A' ' 81' ' ' LEU . 2.5 tm? -60.54 -45.18 94.81 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.213 -0.93 . . . . 0.0 108.613 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.98 -42.92 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.347 -0.846 . . . . 0.0 109.176 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.549 ' CD2' ' CD2' ' A' ' 5' ' ' HIS . 96.5 mt -60.23 -43.87 95.68 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.435 -0.791 . . . . 0.0 111.177 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -63.44 -40.14 96.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.533 -1.354 . . . . 0.0 110.565 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -64.12 -22.63 67.01 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.901 -1.124 . . . . 0.0 110.698 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.701 HE22 ' CD2' ' A' ' 5' ' ' HIS . 6.7 mt-30 -68.99 -32.62 72.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.456 -1.402 . . . . 0.0 109.024 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -88.14 -19.29 27.18 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.323 -0.861 . . . . 0.0 109.648 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 79.0 m -100.64 127.74 46.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.571 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.1 p -81.27 139.7 35.29 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.513 -0.742 . . . . 0.0 109.401 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.535 ' O ' ' C ' ' A' ' 91' ' ' VAL . 4.3 mp -75.86 -17.64 59.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.535 -0.728 . . . . 0.0 109.996 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.707 ' N ' ' O ' ' A' ' 97' ' ' LEU . 5.1 p -31.23 -44.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.355 -0.84 . . . . 0.0 110.482 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.542 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 9.7 pt20 -66.16 -10.91 45.71 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.264 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.579 ' O ' ' ND2' ' A' ' 94' ' ' ASN . 0.3 OUTLIER -63.26 -47.0 84.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.582 -1.324 . . . . 0.0 107.893 179.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 93' ' ' HIS . 10.6 m120 -138.43 20.2 2.74 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.627 ' N ' ' O ' ' A' ' 91' ' ' VAL . 94.6 m-20 61.05 17.33 7.89 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.2 m -146.54 9.56 1.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.707 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.6 mm? -97.25 68.18 2.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -78.36 79.76 4.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 110.358 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.6 p -163.69 156.24 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 121.573 0.701 . . . . 0.0 109.59 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.1 p -130.44 153.94 48.25 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.139 -0.975 . . . . 0.0 108.681 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.511 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 17.7 mt -78.61 67.85 4.46 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.51 -27.65 14.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.126 -0.984 . . . . 0.0 111.897 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.47 130.84 24.38 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 120.77 -1.206 . . . . 0.0 111.43 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -74.51 153.41 44.35 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.734 2.289 . . . . 0.0 110.897 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.481 HG11 ' N ' ' A' ' 106' ' ' TYR . 7.7 p -76.74 -30.9 19.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.187 -0.945 . . . . 0.0 109.791 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.481 ' N ' HG11 ' A' ' 105' ' ' VAL . 50.0 m-85 -113.61 54.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.148 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.417 0.627 . . . . 0.0 109.913 -179.925 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.41 -4.53 8.24 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.403 2.069 . . . . 0.0 112.661 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.484 ' HA ' ' HE1' ' A' ' 11' ' ' TRP . 93.6 m-70 -79.45 -16.32 56.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.156 -0.965 . . . . 0.0 109.712 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -61.3 -48.35 81.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.703 -1.248 . . . . 0.0 109.331 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.5 129.86 45.71 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.589 ' O ' ' N ' ' A' ' 12' ' ' ASN . 7.4 pm0 -73.03 -2.61 21.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.119 -0.988 . . . . 0.0 109.932 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.56 ' CG ' ' N ' ' A' ' 10' ' ' THR . 36.7 pttt -59.82 -35.95 75.79 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 109.392 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.645 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 69.4 p -66.76 -28.83 68.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.654 -0.653 . . . . 0.0 111.398 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.645 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -126.69 -15.23 5.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.418 -1.426 . . . . 0.0 111.679 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 8' ' ' GLU . 46.4 t30 -102.67 118.55 37.09 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.406 -1.434 . . . . 0.0 111.511 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.693 ' CG1' ' HE ' ' A' ' 36' ' ' ARG . 9.9 p -135.89 37.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -31.59 -26.42 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 13' ' ' VAL . 99.0 p -61.61 -4.94 1.57 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.659 -1.495 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.429 ' HG ' HG12 ' A' ' 13' ' ' VAL . 58.1 m -93.77 162.01 14.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.669 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -113.77 164.83 13.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.756 HH21 ' CD2' ' A' ' 56' ' ' HIS . 5.5 mmm180 -58.36 -42.22 86.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.004 -1.06 . . . . 0.0 109.988 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -61.91 -44.14 97.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.865 -1.147 . . . . 0.0 108.817 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -66.06 -29.67 70.05 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.422 -0.798 . . . . 0.0 109.1 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.61 -40.52 95.11 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.354 -0.841 . . . . 0.0 109.225 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.33 -43.55 96.31 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -64.4 -43.49 94.26 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.2 mt -70.33 -36.41 74.24 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.317 -0.865 . . . . 0.0 108.878 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.536 ' N ' ' O ' ' A' ' 21' ' ' ALA . 41.3 mt -75.87 -12.6 60.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.73 126.07 30.48 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.57 9.49 78.58 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mmpp? -99.2 126.67 45.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.149 -1.206 . . . . 0.0 109.476 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -77.97 160.76 27.99 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 67.2 t0 -53.92 140.93 29.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.68 . . . . 0.0 110.617 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 110.09 -28.61 10.2 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 91.4 m -83.73 121.0 26.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.254 -1.144 . . . . 0.0 110.062 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.551 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -133.68 156.35 48.08 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.738 -1.226 . . . . 0.0 111.301 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.645 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -111.37 160.15 17.33 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.697 0.761 . . . . 0.0 111.058 -177.712 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.8 t -132.21 112.69 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.693 ' HE ' ' CG1' ' A' ' 13' ' ' VAL . 69.5 mtt180 -136.92 172.99 12.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.925 -1.109 . . . . 0.0 110.033 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.302 -1.481 0 O-C-N 121.019 -1.051 . . . . 0.0 108.385 179.129 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' A' ' 59' ' ' ILE . 91.5 m-85 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 121.147 0.499 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.2 137.57 24.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 108.589 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 33.3 m -107.26 131.18 54.48 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.892 -1.13 . . . . 0.0 108.872 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 34' ' ' LEU . 1.3 p -90.4 132.82 35.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.414 -0.804 . . . . 0.0 110.183 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.44 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 3.7 p -132.83 157.02 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.937 -1.102 . . . . 0.0 110.583 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.443 ' C ' ' NZ ' ' A' ' 55' ' ' LYS . 60.4 t -118.14 146.66 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.812 ' N ' ' NZ ' ' A' ' 55' ' ' LYS . 13.2 t -120.44 161.31 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 0.0 110.296 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.567 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 43.4 p-10 -58.21 6.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.696 -0.628 . . . . 0.0 110.27 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -149.61 -19.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.364 0 C-N-CA 118.958 -1.591 . . . . 0.0 112.252 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.738 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 68.8 tt0 -156.49 169.01 25.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.193 -1.769 . . . . 0.0 111.224 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.547 ' N ' ' CG ' ' A' ' 53' ' ' GLU . 96.9 t -118.53 128.14 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.381 -0.824 . . . . 0.0 109.207 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.812 ' NZ ' ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -122.05 179.82 4.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.774 -1.204 . . . . 0.0 110.447 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.756 ' CD2' HH21 ' A' ' 18' ' ' ARG . 23.6 m80 -127.63 82.43 2.09 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.3 m -56.22 135.14 53.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.015 -1.053 . . . . 0.0 108.83 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.23 133.54 47.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 110.422 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 44' ' ' TYR . 27.1 mm -104.63 123.01 58.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.922 -178.431 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.5 m . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.75 -37.71 88.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.097 . . . . 0.0 109.635 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -58.49 -40.09 81.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.967 -1.083 . . . . 0.0 108.568 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.1 -32.83 73.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.453 0.645 . . . . 0.0 109.455 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 tp -53.96 -48.71 70.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.331 -0.855 . . . . 0.0 109.524 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.5 t -66.22 -43.51 91.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 108.825 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.52 -44.0 83.71 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.497 -0.752 . . . . 0.0 110.115 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -60.44 -44.09 96.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 111.152 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.451 ' CE1' ' HG ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -75.78 -21.84 57.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.046 -1.034 . . . . 0.0 110.373 -179.182 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.607 ' O ' ' OE1' ' A' ' 86' ' ' GLN . 0.2 OUTLIER -67.36 -41.99 84.19 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.004 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -73.97 -39.79 63.46 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.652 -0.655 . . . . 0.0 110.037 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 85' ' ' TYR . 33.1 m -97.7 140.39 32.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.145 -0.972 . . . . 0.0 110.558 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.1 p -84.81 143.22 29.23 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.72 -0.612 . . . . 0.0 109.981 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.544 ' O ' ' C ' ' A' ' 91' ' ' VAL . 8.3 mp -73.02 -18.24 61.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.325 -0.86 . . . . 0.0 109.497 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.709 ' N ' ' O ' ' A' ' 97' ' ' LEU . 3.9 p -34.0 -44.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.196 -0.94 . . . . 0.0 109.911 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.554 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 10.2 tp-100 -47.8 -45.9 30.04 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.714 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.64 ' C ' ' H ' ' A' ' 95' ' ' ASP . 83.7 t60 -62.32 131.71 50.24 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.579 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.446 ' ND2' ' CD2' ' A' ' 93' ' ' HIS . 88.1 m-20 54.27 -0.65 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.64 ' H ' ' C ' ' A' ' 93' ' ' HIS . 89.8 m-20 56.77 24.44 9.1 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.08 -1.012 . . . . 0.0 110.26 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.6 m -144.27 12.07 1.55 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.778 -1.201 . . . . 0.0 110.593 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.709 ' O ' ' N ' ' A' ' 91' ' ' VAL . 6.8 mp -99.14 73.76 1.93 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -78.2 75.98 4.73 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 p -152.69 155.18 6.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.552 0.692 . . . . 0.0 109.734 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 102' ' ' ALA . 81.4 p -129.31 135.46 48.78 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.551 HD21 ' CG ' ' A' ' 33' ' ' PHE . 62.1 mt -72.52 70.12 0.89 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.471 ' HB3' ' NE2' ' A' ' 86' ' ' GLN . . . -117.23 -7.54 11.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.848 -0.532 . . . . 0.0 111.935 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 32' ' ' THR . 97.5 m-85 -120.73 100.89 46.23 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.398 -1.439 . . . . 0.0 110.67 -178.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -59.67 145.64 97.58 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.613 1.542 . . . . 0.0 110.309 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.441 HG12 ' CD2' ' A' ' 106' ' ' TYR . 2.6 p -67.86 -34.11 65.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 120.882 -1.136 . . . . 0.0 108.482 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.441 ' CD2' HG12 ' A' ' 105' ' ' VAL . 57.9 m-85 -106.08 44.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.437 -0.789 . . . . 0.0 110.584 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 0.0 109.418 179.534 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.41 -4.53 8.24 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.403 2.069 . . . . 0.0 112.661 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.484 ' HA ' ' HE1' ' A' ' 11' ' ' TRP . 93.6 m-70 -79.45 -16.32 56.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.156 -0.965 . . . . 0.0 109.712 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -61.3 -48.35 81.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.703 -1.248 . . . . 0.0 109.331 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.5 129.86 45.71 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.589 ' O ' ' N ' ' A' ' 12' ' ' ASN . 7.4 pm0 -73.03 -2.61 21.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.119 -0.988 . . . . 0.0 109.932 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.56 ' CG ' ' N ' ' A' ' 10' ' ' THR . 36.7 pttt -59.82 -35.95 75.79 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 109.392 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.645 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 69.4 p -66.76 -28.83 68.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.654 -0.653 . . . . 0.0 111.398 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.645 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -126.69 -15.23 5.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.418 -1.426 . . . . 0.0 111.679 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 8' ' ' GLU . 46.4 t30 -102.67 118.55 37.09 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.406 -1.434 . . . . 0.0 111.511 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.693 ' CG1' ' HE ' ' A' ' 36' ' ' ARG . 9.9 p -135.89 37.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -31.59 -26.42 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 13' ' ' VAL . 99.0 p -61.61 -4.94 1.57 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.659 -1.495 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.429 ' HG ' HG12 ' A' ' 13' ' ' VAL . 58.1 m -93.77 162.01 14.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.669 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -113.77 164.83 13.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.756 HH21 ' CD2' ' A' ' 56' ' ' HIS . 5.5 mmm180 -58.36 -42.22 86.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.004 -1.06 . . . . 0.0 109.988 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -61.91 -44.14 97.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.865 -1.147 . . . . 0.0 108.817 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -66.06 -29.67 70.05 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.422 -0.798 . . . . 0.0 109.1 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.61 -40.52 95.11 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.354 -0.841 . . . . 0.0 109.225 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.33 -43.55 96.31 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -64.4 -43.49 94.26 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.2 mt -70.33 -36.41 74.24 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.317 -0.865 . . . . 0.0 108.878 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.536 ' N ' ' O ' ' A' ' 21' ' ' ALA . 41.3 mt -75.87 -12.6 60.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.73 126.07 30.48 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.57 9.49 78.58 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mmpp? -99.2 126.67 45.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.149 -1.206 . . . . 0.0 109.476 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -77.97 160.76 27.99 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 67.2 t0 -53.92 140.93 29.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.68 . . . . 0.0 110.617 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 110.09 -28.61 10.2 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 91.4 m -83.73 121.0 26.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.254 -1.144 . . . . 0.0 110.062 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.551 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -133.68 156.35 48.08 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.738 -1.226 . . . . 0.0 111.301 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.645 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -111.37 160.15 17.33 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.697 0.761 . . . . 0.0 111.058 -177.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.8 t -132.21 112.69 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.693 ' HE ' ' CG1' ' A' ' 13' ' ' VAL . 69.5 mtt180 -136.92 172.99 12.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.925 -1.109 . . . . 0.0 110.033 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.302 -1.481 0 O-C-N 121.019 -1.051 . . . . 0.0 108.385 179.129 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' A' ' 59' ' ' ILE . 91.5 m-85 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 121.147 0.499 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.2 137.57 24.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 108.589 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 33.3 m -107.26 131.18 54.48 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.892 -1.13 . . . . 0.0 108.872 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 34' ' ' LEU . 1.3 p -90.4 132.82 35.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.414 -0.804 . . . . 0.0 110.183 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.44 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 3.7 p -132.83 157.02 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.937 -1.102 . . . . 0.0 110.583 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.443 ' C ' ' NZ ' ' A' ' 55' ' ' LYS . 60.4 t -118.14 146.66 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.812 ' N ' ' NZ ' ' A' ' 55' ' ' LYS . 13.2 t -120.44 161.31 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 0.0 110.296 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.567 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 43.4 p-10 -58.21 6.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.696 -0.628 . . . . 0.0 110.27 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -149.61 -19.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.364 0 C-N-CA 118.958 -1.591 . . . . 0.0 112.252 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.738 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 68.8 tt0 -156.49 169.01 25.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.193 -1.769 . . . . 0.0 111.224 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.547 ' N ' ' CG ' ' A' ' 53' ' ' GLU . 96.9 t -118.53 128.14 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.381 -0.824 . . . . 0.0 109.207 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.812 ' NZ ' ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -122.05 179.82 4.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.774 -1.204 . . . . 0.0 110.447 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.756 ' CD2' HH21 ' A' ' 18' ' ' ARG . 23.6 m80 -127.63 82.43 2.09 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.3 m -56.22 135.14 53.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.015 -1.053 . . . . 0.0 108.83 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.23 133.54 47.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 110.422 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 44' ' ' TYR . 27.1 mm -104.63 123.01 58.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.922 -178.431 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.5 m . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.75 -37.71 88.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.097 . . . . 0.0 109.635 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -58.49 -40.09 81.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.967 -1.083 . . . . 0.0 108.568 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.1 -32.83 73.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.453 0.645 . . . . 0.0 109.455 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 tp -53.96 -48.71 70.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.331 -0.855 . . . . 0.0 109.524 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.5 t -66.22 -43.51 91.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 108.825 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.52 -44.0 83.71 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.497 -0.752 . . . . 0.0 110.115 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -60.44 -44.09 96.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 111.152 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.451 ' CE1' ' HG ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -75.78 -21.84 57.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.046 -1.034 . . . . 0.0 110.373 -179.182 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.607 ' O ' ' OE1' ' A' ' 86' ' ' GLN . 0.2 OUTLIER -67.36 -41.99 84.19 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.004 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -73.97 -39.79 63.46 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.652 -0.655 . . . . 0.0 110.037 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 85' ' ' TYR . 33.1 m -97.7 140.39 32.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.145 -0.972 . . . . 0.0 110.558 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.1 p -84.81 143.22 29.23 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.72 -0.612 . . . . 0.0 109.981 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.544 ' O ' ' C ' ' A' ' 91' ' ' VAL . 8.3 mp -73.02 -18.24 61.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.325 -0.86 . . . . 0.0 109.497 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.709 ' N ' ' O ' ' A' ' 97' ' ' LEU . 3.9 p -34.0 -44.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.196 -0.94 . . . . 0.0 109.911 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.554 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 10.2 tp-100 -47.8 -45.9 30.04 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.714 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.64 ' C ' ' H ' ' A' ' 95' ' ' ASP . 83.7 t60 -62.32 131.71 50.24 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.579 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.446 ' ND2' ' CD2' ' A' ' 93' ' ' HIS . 88.1 m-20 54.27 -0.65 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.64 ' H ' ' C ' ' A' ' 93' ' ' HIS . 89.8 m-20 56.77 24.44 9.1 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.08 -1.012 . . . . 0.0 110.26 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.6 m -144.27 12.07 1.55 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.778 -1.201 . . . . 0.0 110.593 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.709 ' O ' ' N ' ' A' ' 91' ' ' VAL . 6.8 mp -99.14 73.76 1.93 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -78.2 75.98 4.73 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 p -152.69 155.18 6.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.552 0.692 . . . . 0.0 109.734 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 102' ' ' ALA . 81.4 p -129.31 135.46 48.78 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.551 HD21 ' CG ' ' A' ' 33' ' ' PHE . 62.1 mt -72.52 70.12 0.89 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.471 ' HB3' ' NE2' ' A' ' 86' ' ' GLN . . . -117.23 -7.54 11.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.848 -0.532 . . . . 0.0 111.935 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 32' ' ' THR . 97.5 m-85 -120.73 100.89 46.23 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.398 -1.439 . . . . 0.0 110.67 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -59.67 145.64 97.58 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.613 1.542 . . . . 0.0 110.309 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.441 HG12 ' CD2' ' A' ' 106' ' ' TYR . 2.6 p -67.86 -34.11 65.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 120.882 -1.136 . . . . 0.0 108.482 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.441 ' CD2' HG12 ' A' ' 105' ' ' VAL . 57.9 m-85 -106.08 44.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.437 -0.789 . . . . 0.0 110.584 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 0.0 109.418 179.534 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.538 ' HB3' ' CD2' ' A' ' 6' ' ' HIS . 25.0 tp . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -56.03 -6.25 1.2 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.04 1.826 . . . . 0.0 111.744 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.471 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 84.0 m-70 -88.67 -12.72 41.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 110.641 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.538 ' CD2' ' HB3' ' A' ' 3' ' ' LEU . 78.7 m-70 -60.94 -40.52 93.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.779 -1.201 . . . . 0.0 108.963 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.4 ' CB ' ' HE2' ' A' ' 9' ' ' LYS . 79.1 m-20 -108.96 130.15 55.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.283 -0.885 . . . . 0.0 109.244 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.684 ' O ' ' N ' ' A' ' 12' ' ' ASN . 3.6 pm0 -73.59 -7.68 52.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.038 -1.039 . . . . 0.0 110.304 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.508 ' CG ' ' N ' ' A' ' 10' ' ' THR . 6.1 pttt -60.54 -36.4 78.35 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.065 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.656 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 38.0 p -61.51 -31.97 71.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.564 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.656 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -121.44 -12.6 8.55 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.916 -1.115 . . . . 0.0 110.457 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 8' ' ' GLU . 57.8 t30 -88.69 116.55 27.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.908 -1.12 . . . . 0.0 111.231 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 15' ' ' SER . 9.9 p -140.08 31.67 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 CA-C-O 122.007 0.908 . . . . 0.0 108.831 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -42.82 -22.43 0.15 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 13' ' ' VAL . 59.5 m -67.99 -36.77 80.56 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.019 -1.283 . . . . 0.0 110.106 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.651 ' O ' ' NE ' ' A' ' 36' ' ' ARG . 47.3 t -65.71 147.66 53.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.302 -0.874 . . . . 0.0 110.133 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.516 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 76.1 m-20 -86.66 163.65 17.26 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -60.0 -40.65 89.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.093 -1.005 . . . . 0.0 109.767 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -60.06 -42.97 95.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.008 -1.057 . . . . 0.0 109.503 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.5 tttm -64.89 -28.77 69.76 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.144 -0.972 . . . . 0.0 108.455 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.712 ' CB ' HH22 ' A' ' 36' ' ' ARG . . . -58.43 -41.83 85.92 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 26' ' ' ARG . 98.4 mt-10 -61.13 -44.73 96.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.106 -0.996 . . . . 0.0 108.343 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -60.36 -46.29 90.48 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.474 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 79.7 mt -63.17 -40.17 96.76 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mt -72.19 -31.95 66.36 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.533 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -68.28 132.61 47.42 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.806 -0.559 . . . . 0.0 109.59 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.17 9.76 84.69 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 47.7 mmtt -108.74 133.29 53.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.07 -1.253 . . . . 0.0 109.438 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -75.6 168.87 19.2 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.344 -0.847 . . . . 0.0 109.41 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 59.1 t0 -59.07 140.83 55.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.587 -0.695 . . . . 0.0 110.328 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.457 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 109.01 -26.57 14.99 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.406 ' O ' HG21 ' A' ' 48' ' ' VAL . 84.9 m -63.35 121.47 13.85 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.408 ' CD2' HD21 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -138.41 145.13 40.62 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.96 -1.088 . . . . 0.0 111.406 -178.113 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.434 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 0.7 OUTLIER -142.95 157.9 44.12 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.621 0.724 . . . . 0.0 109.905 178.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.474 HG21 ' SG ' ' A' ' 46' ' ' CYS . 97.7 t -104.05 139.52 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.78 ' CB ' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -147.88 164.07 34.84 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.717 -1.239 . . . . 0.0 108.751 -177.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.673 ' OE1' ' CE1' ' A' ' 44' ' ' TYR . 66.6 mm-40 . . . . . 0 C--N 1.305 -1.343 0 O-C-N 120.522 -1.361 . . . . 0.0 108.122 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.673 ' CE1' ' OE1' ' A' ' 37' ' ' GLU . 98.5 m-85 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.868 0.366 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.598 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -163.34 143.49 8.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.008 -1.058 . . . . 0.0 109.905 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 57' ' ' CYS . 60.6 m -115.13 143.41 45.25 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.426 ' OG ' ' CG ' ' A' ' 34' ' ' LEU . 97.0 p -113.6 144.69 42.48 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.931 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.48 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -152.97 158.56 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 121.675 0.75 . . . . 0.0 110.257 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.48 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 53.3 t -98.78 142.5 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.544 ' CG1' ' CD ' ' A' ' 55' ' ' LYS . 12.8 p -155.59 150.52 10.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 C-N-CA 118.128 -1.429 . . . . 0.0 112.166 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.613 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 65.5 t0 36.13 33.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.813 -0.554 . . . . 0.0 111.954 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 81.36 3.99 90.53 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 118.958 -1.591 . . . . 0.0 111.307 178.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -127.24 134.53 50.07 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.845 -1.386 . . . . 0.0 110.077 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 72.3 t -81.41 129.12 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.301 0.572 . . . . 0.0 109.522 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.544 ' CD ' ' CG1' ' A' ' 50' ' ' VAL . 5.7 mptt -130.82 148.15 52.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.359 -0.838 . . . . 0.0 110.292 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -107.3 107.18 17.99 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.65 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.543 ' N ' ' O ' ' A' ' 46' ' ' CYS . 52.6 t -68.96 126.71 30.64 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.9 t -93.3 131.41 40.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.387 -0.821 . . . . 0.0 111.279 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.446 HD11 HG21 ' A' ' 59' ' ' ILE . 37.9 mm -108.65 133.29 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.3 m120 . . . . . 0 N--CA 1.495 1.819 0 O-C-N 120.778 -1.201 . . . . 0.0 110.875 -179.231 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.723 ' HG ' ' H ' ' A' ' 80' ' ' GLU . 68.8 p . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.596 0.712 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.1 mt -60.22 -43.95 95.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.714 . . . . 0.0 109.266 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -61.08 -43.17 99.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.436 -0.79 . . . . 0.0 109.841 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.723 ' H ' ' HG ' ' A' ' 77' ' ' SER . 87.8 tt0 -63.65 -40.1 96.0 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.056 -1.027 . . . . 0.0 109.773 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.468 ' C ' ' CD2' ' A' ' 81' ' ' LEU . 8.5 tt -61.27 -44.9 96.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.963 . . . . 0.0 109.909 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.8 t -64.01 -38.73 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.066 -1.021 . . . . 0.0 109.175 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 86' ' ' GLN . 62.5 tp -63.93 -46.82 83.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.746 . . . . 0.0 111.227 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -67.91 -40.45 83.43 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.624 -1.297 . . . . 0.0 110.764 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.446 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 5.2 m-85 -61.24 -29.09 69.62 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.396 -0.815 . . . . 0.0 110.247 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -68.01 -13.83 62.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.756 -1.215 . . . . 0.0 109.85 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -103.21 -31.07 10.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.043 -1.036 . . . . 0.0 109.948 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.0 m -87.37 141.28 28.75 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.074 -1.016 . . . . 0.0 110.737 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.0 m -88.79 124.18 33.91 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.764 ' O ' ' N ' ' A' ' 92' ' ' GLN . 21.7 mt -60.76 -40.69 93.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.835 . . . . 0.0 111.18 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.721 ' N ' ' O ' ' A' ' 97' ' ' LEU . 4.2 t 31.84 -81.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.595 0 O-C-N 120.959 -1.088 . . . . 0.0 110.001 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.764 ' N ' ' O ' ' A' ' 90' ' ' LEU . 54.9 mt-30 56.22 -159.2 0.22 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.568 -0.708 . . . . 0.0 111.779 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -55.11 -44.11 74.65 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.321 -0.862 . . . . 0.0 109.286 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.678 ' O ' ' N ' ' A' ' 96' ' ' SER . 30.1 m120 -81.14 91.13 6.09 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 94' ' ' ASN . 50.5 t0 -43.64 -8.95 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.474 -0.766 . . . . 0.0 110.43 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 94' ' ' ASN . 95.0 p -89.77 -0.09 57.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.832 -1.167 . . . . 0.0 112.19 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.721 ' O ' ' N ' ' A' ' 91' ' ' VAL . 68.7 mt -83.81 30.83 0.49 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.646 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 16.6 p30 -76.26 53.9 0.85 Allowed 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.97 0.891 . . . . 0.0 108.973 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.5 150.88 33.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 102' ' ' ALA . 43.7 p -114.28 150.68 34.05 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.408 HD21 ' CD2' ' A' ' 33' ' ' PHE . 30.4 mt -71.7 68.06 0.59 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -100.87 -25.41 14.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 112.228 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -116.05 104.05 52.7 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.376 -1.453 . . . . 0.0 111.181 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.89 159.41 17.91 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.609 2.206 . . . . 0.0 110.433 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' A' ' 106' ' ' TYR . 13.2 p -78.59 -28.71 14.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 120.737 -1.227 . . . . 0.0 108.115 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.487 ' CD2' HG11 ' A' ' 105' ' ' VAL . 57.1 m-85 -112.07 29.98 7.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.487 -0.758 . . . . 0.0 109.159 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.903 . . . . 0.0 109.082 179.858 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.437 ' O ' ' OG1' ' A' ' 10' ' ' THR . 78.5 Cg_exo -48.66 -19.99 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.39 2.06 . . . . 0.0 112.675 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -67.35 -26.08 66.3 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.925 -1.109 . . . . 0.0 109.741 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -63.4 -39.21 93.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.196 -0.94 . . . . 0.0 110.8 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.528 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 69.2 m-20 -93.16 128.7 39.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.991 -1.068 . . . . 0.0 110.421 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.707 ' O ' ' N ' ' A' ' 12' ' ' ASN . 94.0 mt-10 -66.87 -26.55 66.95 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.239 -0.913 . . . . 0.0 110.479 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HG2' ' H ' ' A' ' 10' ' ' THR . 1.2 pttp -60.86 -35.92 77.82 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.194 -0.941 . . . . 0.0 111.339 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.536 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 2.7 p -60.23 -33.14 71.85 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 109.895 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.654 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -122.67 -20.84 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 111.098 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.707 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -91.82 119.21 31.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.723 -1.235 . . . . 0.0 110.257 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.98 -4.54 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.301 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.83 -142.21 30.54 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.466 ' OG ' ' OE2' ' A' ' 37' ' ' GLU . 72.8 m -82.49 121.2 26.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.324 . . . . 0.0 109.115 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.0 t -141.24 148.14 39.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 110.154 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.668 HD21 ' N ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -74.24 134.3 42.68 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.163 -0.961 . . . . 0.0 108.752 178.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.668 ' N ' HD21 ' A' ' 17' ' ' ASN . 23.7 mtp180 -59.36 -33.06 70.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.489 -0.757 . . . . 0.0 109.836 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 13.9 p-10 -59.71 -46.3 89.51 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.857 -1.137 . . . . 0.0 108.41 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 29.5 tttt -64.62 -39.78 94.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 109.034 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.78 78.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.086 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.22 -40.48 77.59 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -60.15 -44.71 94.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.1 mt -66.16 -31.79 72.84 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.468 -0.77 . . . . 0.0 109.263 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.9 mt -91.3 -4.12 56.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.551 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 27' ' ' GLY . 2.9 tpt180 -91.58 125.51 36.34 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . 70.63 24.99 76.43 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -106.67 139.97 40.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -1.214 . . . . 0.0 108.676 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -71.43 149.09 46.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.326 -0.859 . . . . 0.0 110.867 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.557 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 64.3 t0 -58.7 144.17 44.37 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.498 0.666 . . . . 0.0 110.072 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 104.66 -24.87 27.38 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 85.4 m -81.58 124.86 29.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.986 -1.302 . . . . 0.0 109.128 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.458 ' CG ' HD21 ' A' ' 101' ' ' LEU . 1.1 p90 -140.03 164.89 28.81 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.16 -1.416 . . . . 0.0 111.601 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -137.27 156.97 47.64 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.673 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 11' ' ' TRP . 53.1 t -110.43 134.4 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.604 HH12 ' CG ' ' A' ' 18' ' ' ARG . 75.7 mtm180 -130.39 -179.49 5.29 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.426 -0.796 . . . . 0.0 109.235 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.466 ' OE2' ' OG ' ' A' ' 15' ' ' SER . 8.7 pt-20 . . . . . 0 C--N 1.302 -1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 108.999 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.454 ' O ' ' O ' ' A' ' 59' ' ' ILE . 86.8 m-85 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.251 0.548 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -147.15 132.87 18.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 109.686 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 27.4 p -102.6 117.69 35.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 108.974 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.5 m -98.77 127.28 44.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 108.868 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.502 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 7.5 p -127.89 166.39 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 110.536 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.557 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 15.5 t -108.16 138.18 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 52' ' ' GLY . 54.2 t -114.24 148.32 17.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.421 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.451 ' N ' HG11 ' A' ' 50' ' ' VAL . 61.4 t0 -50.64 -12.96 0.11 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.119 0.961 . . . . 0.0 108.601 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.558 ' O ' ' CD ' ' A' ' 53' ' ' GLU . . . -102.95 -51.1 1.03 Allowed Glycine 0 C--N 1.289 -2.05 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.558 ' CD ' ' O ' ' A' ' 52' ' ' GLY . 70.6 mm-40 -160.32 -177.44 6.25 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.865 -1.373 . . . . 0.0 110.428 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -94.21 128.27 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.552 -0.718 . . . . 0.0 109.405 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HZ1' ' C ' ' A' ' 53' ' ' GLU . 9.3 mptt -128.89 148.63 50.93 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.262 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -104.55 98.22 8.02 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.2 m -82.61 145.12 29.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.715 -1.241 . . . . 0.0 109.103 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.9 p -107.11 139.85 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.233 -0.917 . . . . 0.0 112.877 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 44' ' ' TYR . 49.9 mm -107.11 126.77 63.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 176.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 m120 . . . . . 0 N--CA 1.495 1.802 0 O-C-N 120.827 -1.171 . . . . 0.0 110.81 -177.936 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.521 0.677 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -36.72 77.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.703 -0.623 . . . . 0.0 109.672 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -60.0 -40.89 90.74 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.011 -1.055 . . . . 0.0 108.63 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.11 -31.1 70.47 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.479 HD23 ' CE1' ' A' ' 85' ' ' TYR . 1.3 tm? -59.73 -45.77 91.15 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.424 HG23 ' CZ3' ' A' ' 11' ' ' TRP . 98.0 t -65.01 -45.0 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.03 . . . . 0.0 108.81 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.47 -43.01 77.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 110.057 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.499 ' O ' ' OG1' ' A' ' 88' ' ' THR . 53.6 t-80 -60.72 -42.71 97.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.353 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.479 ' CE1' HD23 ' A' ' 81' ' ' LEU . 4.6 m-30 -68.87 -25.1 64.46 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.083 -1.01 . . . . 0.0 109.387 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.579 ' OE1' ' ND1' ' A' ' 87' ' ' HIS . 1.3 tm0? -61.95 -34.68 76.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.217 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.579 ' ND1' ' OE1' ' A' ' 86' ' ' GLN . 87.9 m-70 -95.08 -18.73 20.74 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.015 -1.053 . . . . 0.0 110.888 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -102.67 133.09 48.27 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.036 -1.04 . . . . 0.0 109.9 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.3 t -74.21 133.51 42.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.417 -0.802 . . . . 0.0 109.48 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 92' ' ' GLN . 8.8 mp -62.51 -29.23 70.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.476 -0.765 . . . . 0.0 110.573 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.748 ' CG1' ' H ' ' A' ' 92' ' ' GLN . 8.6 p 2.34 -66.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 121.318 0.58 . . . . 0.0 111.492 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.748 ' H ' ' CG1' ' A' ' 91' ' ' VAL . 19.6 pt20 35.28 -149.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.826 0.822 . . . . 0.0 111.503 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.727 ' C ' ' H ' ' A' ' 95' ' ' ASP . 63.8 m80 -50.55 171.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.37 -0.831 . . . . 0.0 109.951 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 13.4 m120 63.02 -22.19 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.727 ' H ' ' C ' ' A' ' 93' ' ' HIS . 86.0 m-20 53.95 31.37 13.31 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.739 -0.601 . . . . 0.0 109.676 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.7 m -134.33 -0.5 2.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.807 -1.183 . . . . 0.0 111.24 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 96.0 mt -82.09 57.55 3.59 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -79.7 84.77 5.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.647 0.737 . . . . 0.0 109.33 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.5 ' CG2' ' OD1' ' A' ' 30' ' ' ASP . 3.0 p -159.94 155.98 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.5 p -122.42 146.06 47.7 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.082 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.458 HD21 ' CG ' ' A' ' 33' ' ' PHE . 34.8 mt -80.19 65.86 5.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 108.698 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.68 -22.86 15.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.855 . . . . 0.0 112.296 -178.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -115.18 114.05 43.46 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.46 -1.4 . . . . 0.0 110.897 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.408 ' CB ' ' O ' ' A' ' 10' ' ' THR . 10.5 Cg_exo -63.06 156.27 55.9 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.982 1.788 . . . . 0.0 111.227 178.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.73 -30.33 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.942 -1.099 . . . . 0.0 109.455 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -99.88 30.98 3.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.082 -1.011 . . . . 0.0 110.208 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 109.143 179.647 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.437 ' O ' ' OG1' ' A' ' 10' ' ' THR . 78.5 Cg_exo -48.66 -19.99 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.39 2.06 . . . . 0.0 112.675 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -67.35 -26.08 66.3 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.925 -1.109 . . . . 0.0 109.741 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -63.4 -39.21 93.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.196 -0.94 . . . . 0.0 110.8 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.528 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 69.2 m-20 -93.16 128.7 39.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.991 -1.068 . . . . 0.0 110.421 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.707 ' O ' ' N ' ' A' ' 12' ' ' ASN . 94.0 mt-10 -66.87 -26.55 66.95 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.239 -0.913 . . . . 0.0 110.479 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HG2' ' H ' ' A' ' 10' ' ' THR . 1.2 pttp -60.86 -35.92 77.82 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.194 -0.941 . . . . 0.0 111.339 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.536 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 2.7 p -60.23 -33.14 71.85 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 109.895 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.654 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -122.67 -20.84 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 111.098 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.707 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -91.82 119.21 31.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.723 -1.235 . . . . 0.0 110.257 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.98 -4.54 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.301 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.83 -142.21 30.54 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.466 ' OG ' ' OE2' ' A' ' 37' ' ' GLU . 72.8 m -82.49 121.2 26.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.324 . . . . 0.0 109.115 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.0 t -141.24 148.14 39.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 110.154 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.668 HD21 ' N ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -74.24 134.3 42.68 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.163 -0.961 . . . . 0.0 108.752 178.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.668 ' N ' HD21 ' A' ' 17' ' ' ASN . 23.7 mtp180 -59.36 -33.06 70.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.489 -0.757 . . . . 0.0 109.836 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 13.9 p-10 -59.71 -46.3 89.51 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.857 -1.137 . . . . 0.0 108.41 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 29.5 tttt -64.62 -39.78 94.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 109.034 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.78 78.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.086 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.22 -40.48 77.59 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -60.15 -44.71 94.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.1 mt -66.16 -31.79 72.84 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.468 -0.77 . . . . 0.0 109.263 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.9 mt -91.3 -4.12 56.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.551 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 27' ' ' GLY . 2.9 tpt180 -91.58 125.51 36.34 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . 70.63 24.99 76.43 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -106.67 139.97 40.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -1.214 . . . . 0.0 108.676 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -71.43 149.09 46.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.326 -0.859 . . . . 0.0 110.867 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.557 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 64.3 t0 -58.7 144.17 44.37 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.498 0.666 . . . . 0.0 110.072 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 104.66 -24.87 27.38 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 85.4 m -81.58 124.86 29.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.986 -1.302 . . . . 0.0 109.128 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.458 ' CG ' HD21 ' A' ' 101' ' ' LEU . 1.1 p90 -140.03 164.89 28.81 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.16 -1.416 . . . . 0.0 111.601 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -137.27 156.97 47.64 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.673 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 11' ' ' TRP . 53.1 t -110.43 134.4 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.604 HH12 ' CG ' ' A' ' 18' ' ' ARG . 75.7 mtm180 -130.39 -179.49 5.29 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.426 -0.796 . . . . 0.0 109.235 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.466 ' OE2' ' OG ' ' A' ' 15' ' ' SER . 8.7 pt-20 . . . . . 0 C--N 1.302 -1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 108.999 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.454 ' O ' ' O ' ' A' ' 59' ' ' ILE . 86.8 m-85 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.251 0.548 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -147.15 132.87 18.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 109.686 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 27.4 p -102.6 117.69 35.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 108.974 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.5 m -98.77 127.28 44.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 108.868 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.502 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 7.5 p -127.89 166.39 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 110.536 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.557 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 15.5 t -108.16 138.18 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 52' ' ' GLY . 54.2 t -114.24 148.32 17.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.421 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.451 ' N ' HG11 ' A' ' 50' ' ' VAL . 61.4 t0 -50.64 -12.96 0.11 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.119 0.961 . . . . 0.0 108.601 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.558 ' O ' ' CD ' ' A' ' 53' ' ' GLU . . . -102.95 -51.1 1.03 Allowed Glycine 0 C--N 1.289 -2.05 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.558 ' CD ' ' O ' ' A' ' 52' ' ' GLY . 70.6 mm-40 -160.32 -177.44 6.25 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.865 -1.373 . . . . 0.0 110.428 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -94.21 128.27 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.552 -0.718 . . . . 0.0 109.405 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HZ1' ' C ' ' A' ' 53' ' ' GLU . 9.3 mptt -128.89 148.63 50.93 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.262 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -104.55 98.22 8.02 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.2 m -82.61 145.12 29.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.715 -1.241 . . . . 0.0 109.103 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.9 p -107.11 139.85 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.233 -0.917 . . . . 0.0 112.877 -176.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 44' ' ' TYR . 49.9 mm -107.11 126.77 63.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 176.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 m120 . . . . . 0 N--CA 1.495 1.802 0 O-C-N 120.827 -1.171 . . . . 0.0 110.81 -177.936 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.521 0.677 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -36.72 77.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.703 -0.623 . . . . 0.0 109.672 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -60.0 -40.89 90.74 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.011 -1.055 . . . . 0.0 108.63 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.11 -31.1 70.47 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.479 HD23 ' CE1' ' A' ' 85' ' ' TYR . 1.3 tm? -59.73 -45.77 91.15 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.424 HG23 ' CZ3' ' A' ' 11' ' ' TRP . 98.0 t -65.01 -45.0 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.03 . . . . 0.0 108.81 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.47 -43.01 77.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 110.057 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.499 ' O ' ' OG1' ' A' ' 88' ' ' THR . 53.6 t-80 -60.72 -42.71 97.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.353 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.479 ' CE1' HD23 ' A' ' 81' ' ' LEU . 4.6 m-30 -68.87 -25.1 64.46 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.083 -1.01 . . . . 0.0 109.387 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.579 ' OE1' ' ND1' ' A' ' 87' ' ' HIS . 1.3 tm0? -61.95 -34.68 76.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.217 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.579 ' ND1' ' OE1' ' A' ' 86' ' ' GLN . 87.9 m-70 -95.08 -18.73 20.74 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.015 -1.053 . . . . 0.0 110.888 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -102.67 133.09 48.27 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.036 -1.04 . . . . 0.0 109.9 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.3 t -74.21 133.51 42.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.417 -0.802 . . . . 0.0 109.48 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 92' ' ' GLN . 8.8 mp -62.51 -29.23 70.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.476 -0.765 . . . . 0.0 110.573 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.748 ' CG1' ' H ' ' A' ' 92' ' ' GLN . 8.6 p 2.34 -66.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 121.318 0.58 . . . . 0.0 111.492 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.748 ' H ' ' CG1' ' A' ' 91' ' ' VAL . 19.6 pt20 35.28 -149.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.826 0.822 . . . . 0.0 111.503 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.727 ' C ' ' H ' ' A' ' 95' ' ' ASP . 63.8 m80 -50.55 171.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.37 -0.831 . . . . 0.0 109.951 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 13.4 m120 63.02 -22.19 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.727 ' H ' ' C ' ' A' ' 93' ' ' HIS . 86.0 m-20 53.95 31.37 13.31 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.739 -0.601 . . . . 0.0 109.676 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.7 m -134.33 -0.5 2.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.807 -1.183 . . . . 0.0 111.24 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 96.0 mt -82.09 57.55 3.59 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -79.7 84.77 5.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.647 0.737 . . . . 0.0 109.33 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.5 ' CG2' ' OD1' ' A' ' 30' ' ' ASP . 3.0 p -159.94 155.98 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.5 p -122.42 146.06 47.7 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.082 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.458 HD21 ' CG ' ' A' ' 33' ' ' PHE . 34.8 mt -80.19 65.86 5.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 108.698 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.68 -22.86 15.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.855 . . . . 0.0 112.296 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -115.18 114.05 43.46 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.46 -1.4 . . . . 0.0 110.897 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.408 ' CB ' ' O ' ' A' ' 10' ' ' THR . 10.5 Cg_exo -63.06 156.27 55.9 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.982 1.788 . . . . 0.0 111.227 178.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.73 -30.33 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.942 -1.099 . . . . 0.0 109.455 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -99.88 30.98 3.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.082 -1.011 . . . . 0.0 110.208 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 109.143 179.647 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -54.88 -12.06 4.32 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.145 1.897 . . . . 0.0 111.612 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.816 ' NE2' ' NE2' ' A' ' 86' ' ' GLN . 83.8 m-70 -65.22 -31.8 73.15 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.354 -0.841 . . . . 0.0 109.349 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -61.85 -22.02 65.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.387 -0.82 . . . . 0.0 109.234 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.715 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 71.6 m-20 -90.93 114.47 26.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.31 -0.869 . . . . 0.0 109.443 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.552 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 39.7 tt0 -67.22 -37.86 84.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.015 -1.053 . . . . 0.0 109.898 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.43 ' HG2' ' N ' ' A' ' 10' ' ' THR . 0.4 OUTLIER -62.89 -29.06 70.47 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.487 -0.758 . . . . 0.0 110.642 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.627 ' OG1' ' O ' ' A' ' 7' ' ' ASP . 9.6 p -59.65 -35.12 73.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.132 -0.98 . . . . 0.0 110.381 -178.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.715 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -124.77 -5.69 7.49 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.738 -1.226 . . . . 0.0 110.125 179.568 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 8' ' ' GLU . 51.3 t-20 -96.76 129.2 44.22 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.989 -1.069 . . . . 0.0 110.441 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.9 t -107.13 -12.04 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.84 . . . . 0.0 109.524 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.42 -154.16 50.09 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 88.7 p -68.57 143.13 54.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.05 -1.264 . . . . 0.0 109.622 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.7 p -157.98 154.94 28.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 109.81 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.682 ' C ' ' H ' ' A' ' 19' ' ' ASN . 58.9 t30 -89.02 19.81 3.97 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.529 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.0 OUTLIER 58.8 -12.89 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.389 -0.819 . . . . 0.0 109.787 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.682 ' H ' ' C ' ' A' ' 17' ' ' ASN . 57.8 t-20 -67.53 -46.7 72.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.615 -1.303 . . . . 0.0 108.425 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.434 ' CB ' ' HZ1' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -65.37 -27.34 68.5 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.784 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -57.28 -43.94 83.56 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.573 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 68.4 mm-40 -61.14 -44.91 96.6 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -63.53 -45.63 89.72 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.445 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 83.0 mt -67.19 -36.83 82.57 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 21' ' ' ALA . 55.4 mt -82.05 -9.01 59.69 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.573 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 14.2 mmm180 -102.69 123.4 46.32 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.9 -4.49 63.18 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 34.4 mmtt -98.64 138.99 35.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.079 -1.248 . . . . 0.0 109.504 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -73.24 161.21 30.81 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.698 -0.626 . . . . 0.0 109.76 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 57.4 p-10 -58.66 149.47 25.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.23 -0.919 . . . . 0.0 109.9 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.27 -25.53 27.88 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 27.7 m -80.51 120.37 24.4 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.424 -1.045 . . . . 0.0 108.696 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.53 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -130.67 161.69 31.08 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.389 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.55 167.79 19.38 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.699 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.7 t -130.81 129.27 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.908 -1.12 . . . . 0.0 110.654 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.739 HH21 ' HG ' ' A' ' 47' ' ' SER . 67.8 mtm180 -129.45 -149.77 0.41 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 . . . . . 0 C--N 1.306 -1.288 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.863 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.495 ' O ' ' O ' ' A' ' 59' ' ' ILE . 98.1 m-85 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.412 0.625 . . . . 0.0 109.959 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.91 133.09 23.02 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.457 -0.777 . . . . 0.0 109.123 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 17.1 p -115.87 134.61 54.82 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.206 -0.933 . . . . 0.0 109.502 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.739 ' HG ' HH21 ' A' ' 36' ' ' ARG . 70.7 m -98.65 146.15 26.15 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.597 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.477 HG11 ' H ' ' A' ' 49' ' ' VAL . 67.6 t -129.37 160.8 39.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.435 -0.79 . . . . 0.0 108.871 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.477 ' H ' HG11 ' A' ' 48' ' ' VAL . 63.2 t -118.5 128.33 75.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 52' ' ' GLY . 9.3 p -126.03 156.37 36.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.859 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.84 -18.39 0.27 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.639 0.733 . . . . 0.0 109.911 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.518 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -85.22 -59.57 1.93 Allowed Glycine 0 C--N 1.284 -2.348 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -164.85 -165.93 0.98 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.169 -1.195 . . . . 0.0 110.629 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.5 t -95.05 130.62 43.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.615 ' HZ2' HD21 ' A' ' 94' ' ' ASN . 0.7 OUTLIER -117.75 156.81 27.63 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.71 -1.244 . . . . 0.0 110.823 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.569 ' ND1' ' OG ' ' A' ' 47' ' ' SER . 25.5 m-70 -120.83 71.32 0.93 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.8 m -60.17 143.84 51.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 109.804 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.13 143.08 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.672 -0.643 . . . . 0.0 110.58 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.495 ' O ' ' O ' ' A' ' 44' ' ' TYR . 44.8 mm -115.49 140.44 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.2 m120 . . . . . 0 N--CA 1.497 1.888 0 O-C-N 120.553 -1.342 . . . . 0.0 110.549 -179.111 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.36 0.6 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.2 mt -57.28 -34.67 68.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.363 -0.835 . . . . 0.0 109.301 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -58.65 -40.14 82.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 0.0 108.612 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.24 -40.12 89.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.339 -0.851 . . . . 0.0 109.287 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.43 -46.49 89.89 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.208 -0.932 . . . . 0.0 109.132 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.51 -43.7 83.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.464 -0.772 . . . . 0.0 108.987 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.44 HD11 ' CD2' ' A' ' 5' ' ' HIS . 15.1 tp -65.86 -45.16 83.17 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.243 -0.911 . . . . 0.0 110.214 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -64.44 -40.28 95.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.978 -1.076 . . . . 0.0 111.182 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -75.51 -14.85 60.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.928 -1.108 . . . . 0.0 111.738 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.816 ' NE2' ' NE2' ' A' ' 5' ' ' HIS . 1.6 pt20 -66.86 -25.59 66.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.507 -1.37 . . . . 0.0 108.853 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -88.17 -36.41 16.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 109.896 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.42 HG21 ' N ' ' A' ' 89' ' ' SER . 91.2 m -83.26 149.42 26.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 0.0 110.513 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.42 ' N ' HG21 ' A' ' 88' ' ' THR . 15.0 m -99.05 130.21 45.37 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.573 0.702 . . . . 0.0 110.549 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.707 ' O ' ' N ' ' A' ' 92' ' ' GLN . 1.8 mt -62.06 -15.73 46.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.49 -0.756 . . . . 0.0 110.034 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.755 ' N ' ' O ' ' A' ' 97' ' ' LEU . 9.1 p -21.63 -38.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.87 -0.519 . . . . 0.0 111.297 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.707 ' N ' ' O ' ' A' ' 90' ' ' LEU . 5.3 pt20 -60.67 -42.83 97.85 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.486 ' N ' ' HG3' ' A' ' 92' ' ' GLN . 43.2 m-70 -59.73 -44.3 93.83 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.739 ' O ' ' N ' ' A' ' 96' ' ' SER . 98.1 m-20 -131.68 116.31 17.17 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 94' ' ' ASN . 80.7 m-20 -40.87 -12.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.288 -0.882 . . . . 0.0 109.892 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.739 ' N ' ' O ' ' A' ' 94' ' ' ASN . 46.1 t -112.75 22.07 14.89 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.74 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.755 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.9 mt -95.67 56.62 1.79 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.783 -1.198 . . . . 0.0 108.896 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -77.85 69.72 4.12 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.124 -0.985 . . . . 0.0 108.87 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.439 HG11 ' N ' ' A' ' 100' ' ' THR . 86.2 t -149.55 154.33 9.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 86' ' ' GLN . 9.8 p -129.46 164.16 24.3 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.53 HD21 ' CG ' ' A' ' 33' ' ' PHE . 28.5 mt -78.78 70.63 5.15 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.894 -1.129 . . . . 0.0 108.169 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.91 -31.33 13.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.804 . . . . 0.0 112.356 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 32' ' ' THR . 59.7 m-85 -113.45 113.57 48.22 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 120.23 -1.544 . . . . 0.0 111.763 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.5 146.83 96.16 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.726 1.617 . . . . 0.0 110.615 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.95 -38.1 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.013 -1.054 . . . . 0.0 110.442 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 53.7 m-85 -101.24 27.62 6.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.064 -1.023 . . . . 0.0 109.974 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.12 -0.988 . . . . 0.0 110.156 -179.832 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 4.1 mm? . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -57.2 -12.43 10.1 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.721 1.614 . . . . 0.0 111.445 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -54.9 -25.99 32.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.627 -0.671 . . . . 0.0 110.424 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -61.39 -28.93 69.6 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.957 -1.089 . . . . 0.0 110.293 -179.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.655 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 88.9 m-20 -98.14 131.82 44.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.724 -1.235 . . . . 0.0 110.743 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.685 ' O ' ' N ' ' A' ' 12' ' ' ASN . 79.5 mt-10 -67.34 -27.13 66.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.467 -0.771 . . . . 0.0 109.139 179.163 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.47 ' CG ' ' N ' ' A' ' 10' ' ' THR . 37.6 pttt -59.64 -34.54 72.94 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.424 -0.797 . . . . 0.0 110.825 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.691 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 49.0 p -67.91 -26.34 65.93 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.392 -0.817 . . . . 0.0 111.013 -178.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.691 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -125.79 -25.15 3.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.617 -1.302 . . . . 0.0 110.543 179.636 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.685 ' N ' ' O ' ' A' ' 8' ' ' GLU . 8.8 p-10 -91.03 138.13 31.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.784 -1.197 . . . . 0.0 110.191 -178.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.0 p -111.52 -9.78 11.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.325 -0.859 . . . . 0.0 109.738 -179.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.82 50.39 3.53 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.797 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.489 ' HA ' ' H ' ' A' ' 37' ' ' GLU . 17.3 t 59.07 65.81 1.15 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.889 -1.36 . . . . 0.0 110.766 178.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.628 ' O ' ' CZ ' ' A' ' 36' ' ' ARG . 95.5 p -77.78 166.67 22.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.169 -0.957 . . . . 0.0 109.659 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.63 ' C ' HH12 ' A' ' 36' ' ' ARG . 86.1 m-20 -73.34 142.95 47.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.977 -1.077 . . . . 0.0 109.238 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.61 ' N ' HH12 ' A' ' 36' ' ' ARG . 35.0 mtm180 -60.22 -35.66 75.93 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.402 -0.811 . . . . 0.0 109.639 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -64.07 -43.71 94.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.939 -1.1 . . . . 0.0 109.08 179.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -68.46 -37.82 80.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.902 -1.124 . . . . 0.0 108.74 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.6 72.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.175 -0.953 . . . . 0.0 109.012 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 26' ' ' ARG . 67.3 tt0 -59.67 -48.85 80.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.241 -0.912 . . . . 0.0 108.827 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -60.25 -41.09 92.46 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.0 mt -66.76 -36.51 82.6 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.3 mt -86.93 -10.07 54.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.086 -1.009 . . . . 0.0 108.606 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.547 HH11 ' HG3' ' A' ' 26' ' ' ARG . 11.9 mmm-85 -100.45 135.36 42.01 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.418 0.628 . . . . 0.0 110.241 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.28 2.91 90.69 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -105.06 141.85 35.89 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.146 -1.208 . . . . 0.0 109.482 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -66.21 153.56 42.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.572 -0.705 . . . . 0.0 110.025 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.578 ' OD2' ' CA ' ' A' ' 51' ' ' ASP . 84.5 m-20 -58.74 144.67 42.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 0.0 109.486 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.41 -20.88 34.07 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.5 m -86.45 119.95 27.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.244 -1.151 . . . . 0.0 108.972 179.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.544 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -136.73 167.92 20.51 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.107 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.654 ' CD1' ' OG ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -140.29 157.11 46.08 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.002 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.481 HG21 ' HG ' ' A' ' 46' ' ' CYS . 47.4 t -106.97 133.47 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.991 -1.068 . . . . 0.0 108.604 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.63 HH12 ' C ' ' A' ' 17' ' ' ASN . 14.2 ptm180 -152.37 -177.52 6.25 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.112 -0.992 . . . . 0.0 109.35 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.489 ' H ' ' HA ' ' A' ' 15' ' ' SER . 32.9 tt0 . . . . . 0 C--N 1.3 -1.571 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -168.39 139.3 2.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.988 -1.07 . . . . 0.0 110.324 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.481 ' HG ' HG21 ' A' ' 35' ' ' VAL . 63.1 m -108.64 126.47 53.01 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.686 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.654 ' OG ' ' CD1' ' A' ' 34' ' ' LEU . 3.0 p -110.62 129.87 55.71 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.874 -1.141 . . . . 0.0 110.15 -179.01 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 7.2 p -127.53 161.47 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.039 -1.038 . . . . 0.0 109.812 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.455 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 45.1 t -101.74 129.13 53.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.778 ' CG1' ' HZ3' ' A' ' 55' ' ' LYS . 48.0 t -122.71 154.57 27.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 120.87 -1.144 . . . . 0.0 110.367 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.578 ' CA ' ' OD2' ' A' ' 30' ' ' ASP . 59.0 t0 -49.01 -17.68 0.22 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.546 0.688 . . . . 0.0 110.026 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.483 ' H ' HG13 ' A' ' 50' ' ' VAL . . . -94.52 -56.96 1.3 Allowed Glycine 0 C--N 1.283 -2.409 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -165.34 170.25 14.85 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.028 -1.277 . . . . 0.0 110.65 -179.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.2 m -73.19 137.24 23.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.778 ' HZ3' ' CG1' ' A' ' 50' ' ' VAL . 8.4 mttt -125.27 156.13 39.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.753 -1.217 . . . . 0.0 111.366 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -121.96 78.07 1.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 46' ' ' CYS . 74.5 m -58.95 131.57 51.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.444 -1.41 . . . . 0.0 108.138 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.95 125.8 62.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.411 -0.805 . . . . 0.0 110.993 -178.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.87 134.56 61.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 23.4 p30 . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.013 -1.055 . . . . 0.0 110.004 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.0 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.841 0.829 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mt -60.25 -35.77 76.26 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.202 0.525 . . . . 0.0 109.928 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.407 ' O ' HG11 ' A' ' 82' ' ' VAL . 71.1 tttt -52.44 -49.07 65.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.019 -1.051 . . . . 0.0 109.923 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -74.33 -20.24 60.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.942 -1.099 . . . . 0.0 108.71 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.533 ' CD2' ' CE2' ' A' ' 85' ' ' TYR . 7.4 tt -67.17 -43.88 81.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.554 -0.716 . . . . 0.0 109.606 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 83' ' ' LEU . 3.0 p -65.17 -43.93 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.077 -1.015 . . . . 0.0 109.027 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.533 ' N ' ' CG1' ' A' ' 82' ' ' VAL . 66.1 tp -67.68 -43.87 79.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.425 -0.797 . . . . 0.0 109.567 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -61.79 -39.97 93.55 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.495 -0.753 . . . . 0.0 110.167 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.533 ' CE2' ' CD2' ' A' ' 81' ' ' LEU . 5.8 m-30 -63.53 -27.36 69.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.92 -1.112 . . . . 0.0 109.187 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' A' ' 102' ' ' ALA . 17.6 tt0 -64.69 -35.23 80.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 110.071 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -91.06 -18.32 24.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.105 -0.997 . . . . 0.0 109.726 -179.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.7 m -101.76 122.96 44.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.897 . . . . 0.0 109.33 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.3 t -72.22 133.95 45.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.326 -0.859 . . . . 0.0 109.026 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.761 ' O ' ' N ' ' A' ' 92' ' ' GLN . 66.2 mt -60.84 -43.85 97.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 111.066 -179.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.698 ' N ' ' O ' ' A' ' 97' ' ' LEU . 74.6 t 18.71 -79.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 CA-C-N 118.436 0.562 . . . . 0.0 109.649 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.761 ' N ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER 73.05 -176.23 0.17 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.378 -0.826 . . . . 0.0 110.854 178.247 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.464 ' H ' ' HG2' ' A' ' 92' ' ' GLN . 82.7 t60 -59.72 -38.88 82.88 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.383 -0.823 . . . . 0.0 109.114 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -55.05 -28.73 54.47 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 61.21 36.73 17.83 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.81 -0.556 . . . . 0.0 109.797 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.5 p -138.67 0.49 2.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.865 -1.147 . . . . 0.0 111.153 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.698 ' O ' ' N ' ' A' ' 91' ' ' VAL . 63.4 mt -100.21 61.69 1.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.755 -1.216 . . . . 0.0 107.976 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -80.68 69.3 7.18 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.971 -1.081 . . . . 0.0 109.92 -178.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.2 t -152.99 149.63 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.1 p -119.81 152.06 37.85 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.288 -0.883 . . . . 0.0 108.863 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.544 HD21 ' CG ' ' A' ' 33' ' ' PHE . 31.9 mt -76.22 69.09 2.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.404 ' HA ' ' OE1' ' A' ' 86' ' ' GLN . . . -100.25 -23.99 14.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.461 -0.774 . . . . 0.0 113.031 -177.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -114.52 105.66 53.37 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.15 -1.594 . . . . 0.0 110.795 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.438 ' CB ' ' O ' ' A' ' 10' ' ' THR . 19.3 Cg_exo -59.75 144.98 99.34 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.976 1.784 . . . . 0.0 111.024 178.405 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 106' ' ' TYR . 8.2 p -67.24 -22.6 29.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.024 -1.047 . . . . 0.0 109.279 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.473 ' CD2' HG11 ' A' ' 105' ' ' VAL . 67.5 m-85 -123.79 63.28 1.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.545 0.688 . . . . 0.0 110.738 -179.273 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 24.7 mt . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.532 ' O ' ' OG1' ' A' ' 10' ' ' THR . 37.1 Cg_endo -69.2 -3.84 12.45 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.288 1.992 . . . . 0.0 111.812 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.473 ' CG ' HD22 ' A' ' 83' ' ' LEU . 96.8 m-70 -83.97 -16.26 44.77 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.46 -0.775 . . . . 0.0 109.68 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -61.75 -36.49 81.17 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.585 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 54.2 p-10 -106.2 130.11 54.13 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.595 0.712 . . . . 0.0 109.497 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.575 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.7 OUTLIER -70.24 -9.43 55.86 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 109.725 -179.687 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HA ' ' OD1' ' A' ' 12' ' ' ASN . 2.2 ttpt -61.5 -36.93 81.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.603 -0.685 . . . . 0.0 110.864 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.532 ' OG1' ' O ' ' A' ' 4' ' ' PRO . 54.3 p -66.47 -20.07 65.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 112.416 -177.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.558 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -134.43 -12.7 2.38 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 119.965 -1.709 . . . . 0.0 111.168 179.168 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.659 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 19.3 p-10 -95.66 127.06 41.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.588 -1.32 . . . . 0.0 111.571 -178.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.2 m -146.01 34.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.9 -34.43 7.27 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.2 p -66.69 -12.17 57.27 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.143 -1.21 . . . . 0.0 109.508 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.613 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 57.8 m -79.78 142.71 35.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.237 -0.914 . . . . 0.0 110.753 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.675 ' C ' HH12 ' A' ' 36' ' ' ARG . 8.4 p30 -80.13 156.47 26.99 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.416 -0.802 . . . . 0.0 109.609 179.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.81 ' N ' HH22 ' A' ' 36' ' ' ARG . 45.8 mtm180 -63.63 -37.31 86.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.122 -0.986 . . . . 0.0 110.713 -178.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.675 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 46.3 p-10 -57.92 -43.96 86.57 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.431 -1.418 . . . . 0.0 108.689 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.675 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 42.7 tttt -66.24 -31.06 71.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.928 -1.108 . . . . 0.0 108.301 178.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.477 ' HB3' HH11 ' A' ' 36' ' ' ARG . . . -60.31 -38.6 84.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.893 . . . . 0.0 108.831 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 26' ' ' ARG . 98.1 mt-10 -59.02 -47.59 84.65 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -60.19 -43.45 95.9 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.487 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 99.1 mt -66.18 -36.66 83.68 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.516 ' CD1' ' OG ' ' A' ' 47' ' ' SER . 10.3 mt -89.2 -7.52 55.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.843 . . . . 0.0 109.513 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 22' ' ' GLU . 14.6 mmm180 -96.37 -25.94 15.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.99 -1.069 . . . . 0.0 109.691 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.09 10.31 56.83 Favored Glycine 0 C--N 1.288 -2.12 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 178.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 7.7 mmpt? -114.53 141.33 47.87 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.428 -1.042 . . . . 0.0 110.568 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.93 168.42 15.03 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.491 0.663 . . . . 0.0 110.042 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.539 ' OD1' ' CG2' ' A' ' 99' ' ' VAL . 67.6 t0 -56.28 141.95 39.5 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.39 -0.819 . . . . 0.0 109.709 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.495 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 107.64 -31.85 7.66 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 97.4 m -86.37 127.41 34.81 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.166 -1.196 . . . . 0.0 109.539 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.48 ' CE2' HD12 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -139.46 172.45 12.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.63 -1.294 . . . . 0.0 109.806 178.896 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.426 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -139.51 169.24 18.11 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.66 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 11' ' ' TRP . 71.5 t -120.17 132.94 68.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 -179.587 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.81 HH22 ' N ' ' A' ' 18' ' ' ARG . 40.7 mtp180 -144.01 -156.8 0.72 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.367 -0.833 . . . . 0.0 108.976 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 . . . . . 0 C--N 1.304 -1.385 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.51 -179.922 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 59' ' ' ILE . 58.7 m-85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.094 0.473 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -159.21 135.13 8.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 109.032 178.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.458 ' SG ' ' CD1' ' A' ' 59' ' ' ILE . 4.6 m -115.16 139.98 49.46 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.71 ' HG ' ' CE1' ' A' ' 56' ' ' HIS . 46.4 t -108.21 133.39 52.52 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.941 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 7.6 p -129.74 157.67 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 121.905 0.86 . . . . 0.0 110.307 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.463 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 89.4 t -99.45 134.82 37.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.502 ' CB ' ' HZ1' ' A' ' 55' ' ' LYS . 75.7 t -121.29 150.52 24.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.725 -1.235 . . . . 0.0 109.793 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -46.97 -18.8 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.813 0.816 . . . . 0.0 109.757 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . -92.35 -56.25 1.59 Allowed Glycine 0 C--N 1.283 -2.405 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -164.04 -176.47 4.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -1.155 . . . . 0.0 110.444 -179.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.9 t -87.49 135.85 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.203 -0.936 . . . . 0.0 108.764 178.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HZ1' ' CB ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -133.22 157.53 45.16 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.004 -1.06 . . . . 0.0 111.318 -178.837 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.71 ' CE1' ' HG ' ' A' ' 47' ' ' SER . 6.0 m-70 -113.19 97.53 6.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.6 m -71.53 141.71 50.11 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.65 134.12 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.867 -1.146 . . . . 0.0 112.46 -177.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.458 ' CD1' ' SG ' ' A' ' 46' ' ' CYS . 96.1 mt -105.72 139.71 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 177.489 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.0 m120 . . . . . 0 N--CA 1.502 2.138 0 O-C-N 120.368 -1.457 . . . . 0.0 111.976 -177.656 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.457 0.646 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 71.0 mt -62.68 -32.71 73.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.425 -0.797 . . . . 0.0 109.523 179.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -60.09 -42.38 94.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.209 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -65.71 -28.89 69.39 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.507 ' C ' ' CD2' ' A' ' 81' ' ' LEU . 6.7 tt -58.33 -46.44 86.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.629 -0.669 . . . . 0.0 110.006 -179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.0 t -73.72 -41.96 54.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.942 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.473 HD22 ' CG ' ' A' ' 5' ' ' HIS . 68.6 mt -65.39 -43.88 89.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.375 -0.828 . . . . 0.0 109.79 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.531 ' O ' ' OG1' ' A' ' 88' ' ' THR . 58.8 t-80 -62.24 -42.08 99.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.011 -1.056 . . . . 0.0 110.146 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.403 ' O ' ' O ' ' A' ' 88' ' ' THR . 5.6 m-85 -70.22 -27.79 64.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 111.171 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.49 ' HG2' ' N ' ' A' ' 87' ' ' HIS . 0.4 OUTLIER -64.6 -32.76 74.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.651 -1.28 . . . . 0.0 109.368 -179.118 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.49 ' N ' ' HG2' ' A' ' 86' ' ' GLN . 43.4 m170 -89.78 -30.1 18.22 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.268 -0.895 . . . . 0.0 109.083 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 2.9 p -95.52 140.52 30.25 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.42 -0.8 . . . . 0.0 110.127 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.6 p -80.23 140.16 36.38 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.691 -0.63 . . . . 0.0 109.817 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.689 ' O ' ' C ' ' A' ' 91' ' ' VAL . 7.9 mp -67.32 -26.98 66.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 110.549 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.747 ' N ' ' O ' ' A' ' 97' ' ' LEU . 95.9 t -1.75 -67.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 CA-C-O 121.62 0.724 . . . . 0.0 110.056 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.675 ' N ' ' O ' ' A' ' 90' ' ' LEU . 32.8 mm-40 35.15 -123.91 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.485 0.659 . . . . 0.0 111.175 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.537 ' C ' ' H ' ' A' ' 95' ' ' ASP . 19.1 p80 -71.55 165.65 23.46 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.475 -0.766 . . . . 0.0 109.862 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.654 ' O ' ' N ' ' A' ' 96' ' ' SER . 9.2 m120 61.89 2.86 0.81 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 93' ' ' HIS . 94.9 m-20 33.37 28.65 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.746 -0.596 . . . . 0.0 109.592 179.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.654 ' N ' ' O ' ' A' ' 94' ' ' ASN . 80.1 p -130.02 3.28 4.83 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.852 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.747 ' O ' ' N ' ' A' ' 91' ' ' VAL . 87.2 mt -83.31 56.75 3.67 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.553 -1.342 . . . . 0.0 107.723 178.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.41 90.22 4.42 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.082 0.944 . . . . 0.0 109.53 -179.275 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.539 ' CG2' ' OD1' ' A' ' 30' ' ' ASP . 4.2 p -169.48 159.13 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.431 ' N ' HG23 ' A' ' 99' ' ' VAL . 66.7 p -128.06 151.52 49.08 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.19 -0.944 . . . . 0.0 109.984 -179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.48 HD12 ' CE2' ' A' ' 33' ' ' PHE . 32.4 mt -84.46 65.72 9.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.02 -1.05 . . . . 0.0 108.425 179.438 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -94.4 -22.6 18.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.387 -0.821 . . . . 0.0 112.519 -177.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -118.09 112.19 38.24 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.111 -1.618 . . . . 0.0 111.071 -178.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.414 ' CB ' ' HB ' ' A' ' 10' ' ' THR . 33.1 Cg_exo -58.0 143.87 95.48 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.492 2.128 . . . . 0.0 111.406 177.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.438 HG11 ' N ' ' A' ' 106' ' ' TYR . 11.6 p -71.88 -27.67 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.064 -1.022 . . . . 0.0 109.614 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.438 ' N ' HG11 ' A' ' 105' ' ' VAL . 3.2 m-85 -114.05 29.28 8.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.194 -0.941 . . . . 0.0 109.769 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.479 0 O-C-N 121.108 -0.995 . . . . 0.0 109.525 -179.908 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 3.5 mm? . . . . . 0 N--CA 1.502 2.128 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.35 -2.04 9.19 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.683 2.255 . . . . 0.0 112.301 179.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.546 ' CD2' ' CD2' ' A' ' 83' ' ' LEU . 91.6 m-70 -73.6 -24.52 60.06 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.37 -0.831 . . . . 0.0 110.028 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -60.3 -34.03 73.2 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.215 -0.928 . . . . 0.0 108.791 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.684 ' OD2' ' NZ ' ' A' ' 9' ' ' LYS . 99.9 m-20 -109.02 119.06 38.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.093 -1.005 . . . . 0.0 109.91 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 12' ' ' ASN . 94.6 mt-10 -65.16 -16.37 63.43 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.684 ' NZ ' ' OD2' ' A' ' 7' ' ' ASP . 26.2 pttt -59.71 -37.48 78.99 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.17 -0.956 . . . . 0.0 110.396 -179.281 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.681 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 23.3 p -55.79 -35.97 66.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.512 -0.743 . . . . 0.0 110.212 -179.263 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.681 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -121.59 -33.01 3.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.77 -1.206 . . . . 0.0 110.723 179.634 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.669 ' N ' ' O ' ' A' ' 8' ' ' GLU . 64.0 t30 -83.08 128.18 34.25 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.02 -1.05 . . . . 0.0 111.366 -178.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.741 ' O ' ' N ' ' A' ' 16' ' ' SER . 24.0 m -139.7 30.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.567 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -24.78 -45.23 0.01 OUTLIER Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 13' ' ' VAL . 81.5 p -51.69 -16.78 0.71 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.547 -0.972 . . . . 0.0 108.807 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.741 ' N ' ' O ' ' A' ' 13' ' ' VAL . 89.1 p -70.0 159.49 33.69 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.692 0.758 . . . . 0.0 110.011 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.438 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 79.6 m-20 -122.98 165.16 17.2 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -59.75 -43.35 94.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.641 -1.287 . . . . 0.0 109.312 -179.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -64.47 -42.98 95.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 108.622 179.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.438 ' HB3' ' H ' ' A' ' 17' ' ' ASN . 21.1 ttmm -69.07 -35.52 76.61 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.51 74.85 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 26' ' ' ARG . 88.0 tt0 -57.78 -47.2 83.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.935 -1.103 . . . . 0.0 108.741 179.195 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -60.03 -43.81 95.07 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.71 -27.59 66.95 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.0 mt -94.28 -5.43 46.76 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.314 -0.866 . . . . 0.0 109.239 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.629 HH11 ' HG2' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -94.04 123.87 37.69 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.784 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.06 4.52 74.65 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -99.91 134.74 42.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.101 -1.235 . . . . 0.0 109.811 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -69.94 159.72 33.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.518 -0.739 . . . . 0.0 109.615 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.67 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 88.3 m-20 -59.72 147.32 38.2 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.635 0.731 . . . . 0.0 110.039 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.63 -22.89 37.85 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -179.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 67.6 m -81.37 114.02 19.86 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.294 -1.121 . . . . 0.0 108.831 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -132.21 170.49 14.95 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.086 -179.475 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.68 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 1.9 pp -147.37 157.88 43.75 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.56 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.463 HG21 ' SG ' ' A' ' 46' ' ' CYS . 48.3 t -103.9 128.5 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.156 -0.965 . . . . 0.0 108.443 178.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.699 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -144.02 173.85 11.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 108.823 -179.364 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--N 1.307 -1.271 0 O-C-N 120.827 -1.171 . . . . 0.0 108.382 179.569 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.588 ' O ' ' O ' ' A' ' 59' ' ' ILE . 92.8 m-85 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 120.974 0.416 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.52 ' HB3' HH12 ' A' ' 36' ' ' ARG . . . -162.54 133.83 5.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.858 -1.152 . . . . 0.0 109.544 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.504 ' N ' ' O ' ' A' ' 57' ' ' CYS . 60.0 m -108.18 130.64 55.12 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.474 ' HG ' ' HD1' ' A' ' 56' ' ' HIS . 32.9 t -108.18 134.5 50.95 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.196 -0.94 . . . . 0.0 109.953 -178.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.2 p -133.58 167.72 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.21 -0.931 . . . . 0.0 110.278 -179.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.3 t -121.23 133.69 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.609 -0.682 . . . . 0.0 109.667 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.782 ' CG1' ' HZ2' ' A' ' 55' ' ' LYS . 7.3 p -127.61 160.29 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.076 -1.015 . . . . 0.0 109.968 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.67 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 54.5 m-20 -50.21 -20.35 1.01 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.712 0.768 . . . . 0.0 110.078 -179.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.81 -58.68 2.2 Favored Glycine 0 C--N 1.285 -2.253 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.806 ' N ' ' NZ ' ' A' ' 55' ' ' LYS . 1.3 tt0 -167.07 -165.09 0.67 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.292 -1.122 . . . . 0.0 111.322 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.3 t -97.59 123.8 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.485 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.806 ' NZ ' ' N ' ' A' ' 53' ' ' GLU . 11.5 mptt -118.95 152.48 36.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.465 -1.397 . . . . 0.0 110.941 -179.334 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.474 ' HD1' ' HG ' ' A' ' 47' ' ' SER . 87.6 m-70 -115.16 112.64 22.84 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 46' ' ' CYS . 49.1 t -88.21 124.74 34.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.077 -1.014 . . . . 0.0 108.536 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.531 ' O ' ' CG1' ' A' ' 58' ' ' VAL . 4.8 p -101.07 122.64 53.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.079 -1.013 . . . . 0.0 110.906 -178.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.588 ' O ' ' O ' ' A' ' 44' ' ' TYR . 88.6 mt -116.57 137.96 48.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.7 t30 . . . . . 0 N--CA 1.498 1.968 0 O-C-N 120.566 -1.334 . . . . 0.0 111.511 -178.618 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.539 ' OG ' ' OE2' ' A' ' 80' ' ' GLU . 84.5 p . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 121.403 0.621 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.4 -43.77 98.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.417 -0.802 . . . . 0.0 110.879 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.435 ' O ' HG11 ' A' ' 82' ' ' VAL . 19.9 tttt -60.86 -39.75 90.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.755 -1.215 . . . . 0.0 108.707 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.614 ' N ' ' OE1' ' A' ' 80' ' ' GLU . 0.3 OUTLIER -73.43 -40.03 64.55 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.177 -0.952 . . . . 0.0 109.383 179.006 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.9 -49.51 77.4 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.839 -0.538 . . . . 0.0 110.599 -178.373 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 83' ' ' LEU . 4.3 p -59.76 -44.22 93.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.913 -1.117 . . . . 0.0 108.495 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.546 ' CD2' ' CD2' ' A' ' 5' ' ' HIS . 91.2 mt -61.69 -45.39 94.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.208 -0.932 . . . . 0.0 111.273 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -61.25 -40.39 93.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.756 -1.215 . . . . 0.0 110.001 -178.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -71.41 -26.75 62.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.249 -0.907 . . . . 0.0 111.311 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.595 ' OE1' ' O ' ' A' ' 101' ' ' LEU . 2.2 mt-30 -65.01 -33.65 76.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.662 -1.274 . . . . 0.0 109.163 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -96.76 -19.28 19.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.013 -1.054 . . . . 0.0 110.753 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.4 m -99.53 131.18 45.7 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.804 -1.185 . . . . 0.0 109.726 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.3 p -74.97 135.65 41.34 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.514 0.673 . . . . 0.0 109.939 -179.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.743 ' O ' ' N ' ' A' ' 92' ' ' GLN . 0.6 OUTLIER -61.74 -43.7 98.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.531 -0.731 . . . . 0.0 110.627 -179.679 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.757 ' N ' ' O ' ' A' ' 97' ' ' LEU . 72.0 t 26.79 -84.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.743 ' N ' ' O ' ' A' ' 90' ' ' LEU . 18.0 tt0 77.32 -179.51 0.14 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.787 178.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.513 ' H ' ' HG2' ' A' ' 92' ' ' GLN . 81.6 t60 -56.08 -39.84 72.72 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.606 ' C ' HD21 ' A' ' 94' ' ' ASN . 0.2 OUTLIER -50.44 -28.3 8.01 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.178 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 60.1 t0 63.88 24.36 13.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.78 -0.575 . . . . 0.0 110.309 178.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 68.9 m -136.91 10.89 3.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.03 -1.044 . . . . 0.0 110.167 179.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.757 ' O ' ' N ' ' A' ' 91' ' ' VAL . 87.1 mt -99.78 50.96 0.92 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.582 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 42.1 p30 -77.43 60.09 1.99 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.501 -0.749 . . . . 0.0 110.646 -178.397 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.98 162.96 38.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.3 p -125.06 168.87 12.77 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.312 1.053 . . . . 0.0 110.611 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.595 ' O ' ' OE1' ' A' ' 86' ' ' GLN . 6.9 mp -98.17 33.41 2.18 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.41 ' HA ' ' NE2' ' A' ' 86' ' ' GLN . . . -74.39 -15.49 60.92 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.64 -0.663 . . . . 0.0 112.13 -178.093 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 32' ' ' THR . 96.8 m-85 -114.91 108.48 48.57 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.249 -1.532 . . . . 0.0 111.339 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.54 145.65 95.41 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.257 1.971 . . . . 0.0 110.845 177.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 106' ' ' TYR . 7.3 p -65.5 -33.07 61.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.896 -1.128 . . . . 0.0 109.335 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.46 ' N ' HG11 ' A' ' 105' ' ' VAL . 28.4 m-85 -122.69 50.46 1.5 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.018 -1.051 . . . . 0.0 110.067 179.061 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 109.592 179.766 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -57.33 -9.33 4.75 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.745 1.63 . . . . 0.0 111.55 179.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.442 ' CG ' HD22 ' A' ' 83' ' ' LEU . 82.6 m-70 -60.44 -29.15 68.83 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.607 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -68.0 -23.03 64.97 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.696 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 83.7 m-20 -90.05 120.64 31.41 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.388 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 45.0 tt0 -67.63 -30.67 70.29 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.393 -0.817 . . . . 0.0 110.294 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.556 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -63.36 -31.71 72.93 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.264 -0.898 . . . . 0.0 111.573 -178.805 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.423 HG21 ' CB ' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -66.49 -29.66 69.82 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.226 -0.921 . . . . 0.0 111.641 -177.044 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.696 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -123.02 -8.44 8.3 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.652 -1.28 . . . . 0.0 110.585 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 8' ' ' GLU . 13.5 t-20 -97.92 118.3 34.19 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.1 -1.0 . . . . 0.0 110.629 -178.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 16' ' ' SER . 10.2 m -140.46 27.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.489 -0.757 . . . . 0.0 109.179 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -41.32 -30.56 0.49 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.391 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.8 t -59.84 -34.58 73.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -1.076 . . . . 0.0 108.827 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 13' ' ' VAL . 70.1 m -60.48 142.2 55.48 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.584 0.707 . . . . 0.0 110.654 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -79.9 162.44 24.99 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.624 0.726 . . . . 0.0 109.568 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.505 ' CB ' HH12 ' A' ' 36' ' ' ARG . 22.9 ttp180 -57.31 -44.9 84.55 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.89 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -39.34 91.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.149 -0.969 . . . . 0.0 108.713 179.064 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -63.78 -27.74 69.39 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.381 0.61 . . . . 0.0 109.46 179.529 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.55 96.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.905 . . . . 0.0 109.672 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 26' ' ' ARG . 96.3 mt-10 -60.57 -41.23 94.18 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -60.37 -41.61 94.11 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' CD ' ' A' ' 28' ' ' LYS . 77.0 mt -67.26 -29.36 68.96 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.433 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -89.74 -14.11 35.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.351 -0.843 . . . . 0.0 108.933 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 22' ' ' GLU . 5.1 mtp180 -88.37 129.88 35.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.502 -0.749 . . . . 0.0 110.882 -179.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.27 3.27 90.2 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.498 ' CD ' ' O ' ' A' ' 24' ' ' LEU . 12.3 mtpt -103.56 131.08 51.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.282 -1.128 . . . . 0.0 110.359 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.719 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.1 OUTLIER -60.56 147.37 41.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 110.348 -179.115 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.559 ' OD2' ' OD1' ' A' ' 51' ' ' ASP . 65.1 m-20 -50.1 151.93 1.84 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.75 -37.93 3.46 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.414 HG22 ' NZ ' ' A' ' 28' ' ' LYS . 88.4 m -68.14 128.28 35.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.43 -1.041 . . . . 0.0 109.151 179.742 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 101' ' ' LEU . 0.6 OUTLIER -139.04 161.8 36.48 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.856 179.968 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.29 162.86 32.4 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.547 0.689 . . . . 0.0 110.167 -179.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 11' ' ' TRP . 90.6 t -118.12 131.14 71.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.505 HH12 ' CB ' ' A' ' 18' ' ' ARG . 11.0 ptm180 -135.56 -176.0 4.13 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 109.584 -179.226 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 C--N 1.304 -1.382 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.703 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.457 ' O ' ' N ' ' A' ' 59' ' ' ILE . 96.8 m-85 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -139.39 135.06 33.28 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.563 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.5 ' SG ' HD13 ' A' ' 59' ' ' ILE . 28.9 p -107.92 124.88 50.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.235 -0.916 . . . . 0.0 108.8 179.36 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.7 p -109.63 139.67 44.37 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.531 -0.731 . . . . 0.0 110.275 -179.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -129.26 159.73 40.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.275 -0.891 . . . . 0.0 109.787 179.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.4 t -96.6 134.13 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.557 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 62.0 t -125.44 145.61 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.758 -1.214 . . . . 0.0 110.561 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.559 ' OD1' ' OD2' ' A' ' 30' ' ' ASP . 15.1 m-20 -44.15 -20.42 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.581 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -90.17 -59.87 1.44 Allowed Glycine 0 C--N 1.291 -1.948 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.581 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 70.0 mt-10 -162.18 169.64 20.45 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.952 -1.322 . . . . 0.0 110.312 -178.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.0 m -65.33 138.51 23.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HZ1' ' C ' ' A' ' 53' ' ' GLU . 16.6 mmtm -116.3 140.66 49.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.629 -1.294 . . . . 0.0 111.966 -178.053 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -115.3 96.77 5.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 46' ' ' CYS . 80.2 m -99.49 122.12 42.12 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.083 -1.011 . . . . 0.0 108.92 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.9 t -76.89 140.01 17.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.553 0.692 . . . . 0.0 110.545 -179.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.5 HD13 ' SG ' ' A' ' 46' ' ' CYS . 47.2 mm -108.96 129.96 62.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.4 m120 . . . . . 0 N--CA 1.498 1.936 0 O-C-N 121.168 -0.958 . . . . 0.0 110.084 -179.109 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.69 0.757 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 81' ' ' LEU . 89.6 mt -62.08 -34.71 76.8 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.465 -0.772 . . . . 0.0 109.516 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 78' ' ' LEU . 87.3 mttt -47.74 -42.04 24.46 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.406 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 65.6 mt-10 -64.87 -37.31 87.19 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.454 ' C ' ' CD2' ' A' ' 81' ' ' LEU . 8.2 tt -59.63 -42.62 93.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.566 -0.709 . . . . 0.0 110.164 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.8 t -65.77 -44.97 92.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.99 -1.069 . . . . 0.0 109.467 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.442 HD22 ' CG ' ' A' ' 5' ' ' HIS . 81.2 mt -68.34 -39.02 82.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.395 -0.816 . . . . 0.0 111.274 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.558 ' O ' ' CE1' ' A' ' 87' ' ' HIS . 52.8 m80 -64.66 -42.43 95.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.016 -1.052 . . . . 0.0 110.192 -178.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 7.1 m-30 -73.83 -16.68 61.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.857 -1.152 . . . . 0.0 109.34 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -67.81 -35.87 79.4 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.282 -0.886 . . . . 0.0 109.234 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 84' ' ' HIS . 22.8 p-80 -92.61 -22.66 19.35 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.267 -0.896 . . . . 0.0 109.664 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.8 m -92.41 128.42 38.26 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.134 -0.979 . . . . 0.0 109.386 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.6 p -77.67 131.58 37.8 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.437 -0.79 . . . . 0.0 109.665 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.524 ' O ' ' C ' ' A' ' 91' ' ' VAL . 98.9 mt -69.74 -17.46 63.45 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.498 -0.751 . . . . 0.0 110.024 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.749 ' N ' ' O ' ' A' ' 97' ' ' LEU . 9.7 p -31.99 -46.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 121.205 -0.934 . . . . 0.0 110.382 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.565 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 18.1 tt0 -43.97 -27.68 0.39 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.227 0.537 . . . . 0.0 110.128 -179.388 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.48 ' C ' ' H ' ' A' ' 95' ' ' ASP . 94.5 m-70 -81.66 119.54 23.95 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.005 -1.059 . . . . 0.0 108.189 178.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 11.3 m120 61.42 2.61 0.67 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.64 -0.663 . . . . 0.0 109.507 -179.244 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.59 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 66.7 t0 57.44 23.65 9.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.551 -0.718 . . . . 0.0 110.349 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.9 m -140.68 11.35 2.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.81 -1.181 . . . . 0.0 109.688 179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.749 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.8 mm? -97.93 66.2 1.85 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.913 -1.117 . . . . 0.0 108.679 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.631 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 16.5 p30 -79.16 78.86 5.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.938 -1.101 . . . . 0.0 110.37 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.617 ' CG2' ' O ' ' A' ' 98' ' ' ASN . 40.8 t -166.38 154.26 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.522 -0.736 . . . . 0.0 109.816 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.8 p -130.53 164.29 25.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.893 . . . . 0.0 109.452 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.6 ' N ' ' CD1' ' A' ' 101' ' ' LEU . 4.2 mp -79.17 67.31 4.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -92.16 -22.76 19.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 111.519 -178.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.65 137.94 28.65 Favored Pre-proline 0 C--N 1.307 -1.277 0 O-C-N 120.713 -1.242 . . . . 0.0 111.006 -178.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.09 157.23 30.32 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.277 2.652 . . . . 0.0 111.582 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 106' ' ' TYR . 12.2 p -92.76 -27.68 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.345 -0.847 . . . . 0.0 112.089 -178.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.464 ' N ' HG11 ' A' ' 105' ' ' VAL . 73.1 t80 -132.52 64.99 1.6 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.411 -1.431 . . . . 0.0 111.87 -178.069 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.423 ' CB ' HG21 ' A' ' 10' ' ' THR . . . . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.058 -1.026 . . . . 0.0 109.006 178.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.5 mt . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -49.06 -19.54 2.52 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.888 2.392 . . . . 0.0 111.659 178.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.48 ' CD2' HD22 ' A' ' 83' ' ' LEU . 85.1 m-70 -65.11 -17.01 64.11 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.655 0.741 . . . . 0.0 109.438 -178.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -64.98 -36.76 85.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.503 -0.748 . . . . 0.0 109.57 178.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -96.79 129.55 44.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 110.431 -179.068 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.676 ' O ' ' N ' ' A' ' 12' ' ' ASN . 96.6 mt-10 -72.32 -31.32 65.57 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.562 0.696 . . . . 0.0 109.824 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -59.83 -24.82 64.49 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.684 -179.636 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.67 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 52.2 p -67.85 -29.35 68.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.111 -0.993 . . . . 0.0 110.347 -179.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.67 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.8 -23.77 2.78 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.916 -1.115 . . . . 0.0 109.572 178.652 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.676 ' N ' ' O ' ' A' ' 8' ' ' GLU . 65.6 t30 -80.57 125.84 30.49 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.09 0.948 . . . . 0.0 111.284 -178.396 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.605 ' O ' ' O ' ' A' ' 14' ' ' GLY . 93.8 t -132.57 32.79 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 13' ' ' VAL . . . -42.64 177.19 0.01 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 14' ' ' GLY . 27.9 t 61.47 27.4 16.96 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.516 -0.991 . . . . 0.0 108.711 -179.499 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.2 m -129.08 136.81 50.74 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.459 -0.775 . . . . 0.0 109.673 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.601 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 26.7 p30 -80.19 167.81 19.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.53 -0.731 . . . . 0.0 109.782 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 36' ' ' ARG . 41.7 mtt-85 -63.65 -32.73 74.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.94 . . . . 0.0 110.039 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -64.29 -46.46 83.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.243 -0.911 . . . . 0.0 109.113 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.601 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 18.0 ttmm -62.34 -40.32 95.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -0.834 . . . . 0.0 109.218 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -59.9 -38.11 81.34 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.366 -0.834 . . . . 0.0 109.332 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.573 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 55.3 tt0 -59.98 -44.07 94.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.869 -1.144 . . . . 0.0 108.892 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -62.26 -39.14 91.92 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 77.7 mt -73.67 -31.78 63.65 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 21' ' ' ALA . 7.9 mt -89.38 -10.23 47.37 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.573 ' NH2' ' OE2' ' A' ' 22' ' ' GLU . 75.3 mtt180 -88.75 120.34 30.06 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.136 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.46 -4.99 62.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 25.7 mmtt -87.06 150.9 23.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.35 -1.088 . . . . 0.0 109.598 179.644 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.539 ' HG2' HH11 ' A' ' 29' ' ' ARG . 7.1 mmt-85 -82.67 154.96 24.61 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.316 0.579 . . . . 0.0 110.479 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -55.12 139.72 40.72 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.35 -15.46 56.16 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 35.3 m -88.55 121.79 31.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.402 -1.057 . . . . 0.0 109.197 179.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.56 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -138.44 167.46 21.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.007 -1.058 . . . . 0.0 110.742 179.888 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.53 156.23 44.55 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.485 -179.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG21 ' HG ' ' A' ' 46' ' ' CYS . 46.0 t -108.11 124.26 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.875 . . . . 0.0 108.82 179.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -138.75 178.88 6.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 108.974 -179.486 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.515 ' O ' ' CZ ' ' A' ' 36' ' ' ARG . 10.8 tt0 . . . . . 0 N--CA 1.485 1.287 0 O-C-N 120.814 -1.179 . . . . 0.0 108.67 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.63 ' O ' ' O ' ' A' ' 59' ' ' ILE . 96.1 m-85 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.603 0.716 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.8 135.97 10.93 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.967 -1.083 . . . . 0.0 109.486 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.502 ' HG ' HG21 ' A' ' 35' ' ' VAL . 70.6 m -108.03 117.15 33.39 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.8 m -102.18 133.81 46.44 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.854 -1.154 . . . . 0.0 109.704 -178.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.508 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 2.4 p -129.73 160.28 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.295 -0.878 . . . . 0.0 109.642 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.508 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 55.8 t -108.47 136.76 43.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.505 ' C ' ' H ' ' A' ' 52' ' ' GLY . 74.8 t -121.59 151.45 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.093 -1.004 . . . . 0.0 109.978 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -49.71 -15.24 0.16 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.067 0.937 . . . . 0.0 108.796 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -94.21 -59.21 1.18 Allowed Glycine 0 C--N 1.285 -2.28 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -162.15 176.66 10.43 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.122 -1.222 . . . . 0.0 110.384 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.06 138.96 18.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HZ1' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -125.58 162.05 25.83 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.761 -179.919 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -128.64 80.31 1.96 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.488 -0.758 . . . . 0.0 110.336 -179.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 46' ' ' CYS . 82.1 m -59.8 145.02 46.9 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.788 -1.195 . . . . 0.0 108.402 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -115.98 130.42 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.013 -1.054 . . . . 0.0 111.272 -178.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.63 ' O ' ' O ' ' A' ' 44' ' ' TYR . 3.7 mp -123.04 128.4 75.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 . . . . . 0 N--CA 1.497 1.886 0 O-C-N 120.557 -1.34 . . . . 0.0 109.455 179.512 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.2 m . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.226 0.536 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.4 mt -60.02 -36.29 76.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.299 -0.876 . . . . 0.0 109.764 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -59.38 -41.05 88.44 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.101 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.439 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 81.9 mt-10 -61.66 -35.06 76.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 108.656 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.0 tt -58.12 -42.55 86.02 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.557 -0.714 . . . . 0.0 109.436 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.34 -39.56 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.007 -1.058 . . . . 0.0 108.582 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.48 HD22 ' CD2' ' A' ' 5' ' ' HIS . 92.6 mt -66.44 -41.8 88.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.402 -0.812 . . . . 0.0 109.718 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.439 ' CD2' ' O ' ' A' ' 80' ' ' GLU . 14.6 m170 -60.47 -42.36 96.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 110.382 -179.213 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.408 ' O ' ' O ' ' A' ' 88' ' ' THR . 3.7 m-85 -69.53 -23.62 63.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.783 -1.198 . . . . 0.0 108.979 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -64.02 -38.12 89.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.491 -0.756 . . . . 0.0 109.231 179.541 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -90.26 -19.69 23.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 0.0 109.199 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 85' ' ' TYR . 42.1 m -99.01 140.99 32.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.529 -0.732 . . . . 0.0 109.256 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.3 t -89.65 128.94 36.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.868 . . . . 0.0 109.47 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.667 ' O ' ' N ' ' A' ' 92' ' ' GLN . 10.1 mp -60.56 -22.85 64.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.344 -0.847 . . . . 0.0 110.467 -179.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.719 ' N ' ' O ' ' A' ' 97' ' ' LEU . 11.6 p -26.56 -37.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.346 -0.846 . . . . 0.0 110.584 -179.184 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.667 ' N ' ' O ' ' A' ' 90' ' ' LEU . 35.0 mt-30 -40.8 179.25 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.885 0.85 . . . . 0.0 111.756 -178.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 61.25 -108.84 0.35 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.496 0.665 . . . . 0.0 109.972 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -60.72 -5.43 1.28 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.494 -0.754 . . . . 0.0 110.366 -179.358 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 65.7 t0 57.27 28.47 15.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.772 -1.205 . . . . 0.0 109.128 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -143.22 13.04 1.8 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 110.304 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.719 ' O ' ' N ' ' A' ' 91' ' ' VAL . 7.7 mp -101.23 70.14 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.875 -1.14 . . . . 0.0 107.955 178.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -78.79 87.4 4.67 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.389 -0.819 . . . . 0.0 110.114 -178.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.488 HG23 ' N ' ' A' ' 100' ' ' THR . 12.6 p -163.05 160.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 121.686 0.755 . . . . 0.0 109.158 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.488 ' N ' HG23 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -130.8 133.47 45.99 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.14 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.56 HD21 ' CG ' ' A' ' 33' ' ' PHE . 37.6 mt -69.62 74.5 0.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -116.56 -10.04 11.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.832 . . . . 0.0 110.952 -178.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 32' ' ' THR . 69.2 t80 -120.65 103.4 43.7 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.619 -1.301 . . . . 0.0 110.433 -178.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.97 146.53 86.66 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.622 2.215 . . . . 0.0 111.533 178.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' A' ' 106' ' ' TYR . 9.5 p -69.43 -35.37 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.911 -1.118 . . . . 0.0 109.57 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.456 ' CD2' HG12 ' A' ' 105' ' ' VAL . 38.8 m-85 -119.39 54.88 0.97 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.157 -0.964 . . . . 0.0 110.74 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.539 0 O-C-N 121.133 -0.979 . . . . 0.0 108.376 178.812 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.5 mt . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -49.06 -19.54 2.52 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.888 2.392 . . . . 0.0 111.659 178.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.48 ' CD2' HD22 ' A' ' 83' ' ' LEU . 85.1 m-70 -65.11 -17.01 64.11 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.655 0.741 . . . . 0.0 109.438 -178.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -64.98 -36.76 85.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.503 -0.748 . . . . 0.0 109.57 178.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -96.79 129.55 44.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 110.431 -179.068 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.676 ' O ' ' N ' ' A' ' 12' ' ' ASN . 96.6 mt-10 -72.32 -31.32 65.57 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.562 0.696 . . . . 0.0 109.824 179.717 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -59.83 -24.82 64.49 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.684 -179.636 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.67 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 52.2 p -67.85 -29.35 68.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.111 -0.993 . . . . 0.0 110.347 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.67 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.8 -23.77 2.78 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.916 -1.115 . . . . 0.0 109.572 178.652 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.676 ' N ' ' O ' ' A' ' 8' ' ' GLU . 65.6 t30 -80.57 125.84 30.49 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.09 0.948 . . . . 0.0 111.284 -178.396 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.605 ' O ' ' O ' ' A' ' 14' ' ' GLY . 93.8 t -132.57 32.79 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 13' ' ' VAL . . . -42.64 177.19 0.01 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 14' ' ' GLY . 27.9 t 61.47 27.4 16.96 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.516 -0.991 . . . . 0.0 108.711 -179.499 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.2 m -129.08 136.81 50.74 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.459 -0.775 . . . . 0.0 109.673 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.601 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 26.7 p30 -80.19 167.81 19.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.53 -0.731 . . . . 0.0 109.782 -179.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 36' ' ' ARG . 41.7 mtt-85 -63.65 -32.73 74.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.94 . . . . 0.0 110.039 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -64.29 -46.46 83.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.243 -0.911 . . . . 0.0 109.113 -179.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.601 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 18.0 ttmm -62.34 -40.32 95.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -0.834 . . . . 0.0 109.218 179.566 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -59.9 -38.11 81.34 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.366 -0.834 . . . . 0.0 109.332 -179.584 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.573 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 55.3 tt0 -59.98 -44.07 94.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.869 -1.144 . . . . 0.0 108.892 179.548 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -62.26 -39.14 91.92 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 77.7 mt -73.67 -31.78 63.65 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.432 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 21' ' ' ALA . 7.9 mt -89.38 -10.23 47.37 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.573 ' NH2' ' OE2' ' A' ' 22' ' ' GLU . 75.3 mtt180 -88.75 120.34 30.06 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.136 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.46 -4.99 62.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.715 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 25.7 mmtt -87.06 150.9 23.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.35 -1.088 . . . . 0.0 109.598 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.539 ' HG2' HH11 ' A' ' 29' ' ' ARG . 7.1 mmt-85 -82.67 154.96 24.61 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.316 0.579 . . . . 0.0 110.479 -179.475 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -55.12 139.72 40.72 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.35 -15.46 56.16 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 35.3 m -88.55 121.79 31.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.402 -1.057 . . . . 0.0 109.197 179.315 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.56 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -138.44 167.46 21.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.007 -1.058 . . . . 0.0 110.742 179.888 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.53 156.23 44.55 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.485 -179.325 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG21 ' HG ' ' A' ' 46' ' ' CYS . 46.0 t -108.11 124.26 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.875 . . . . 0.0 108.82 179.521 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -138.75 178.88 6.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 108.974 -179.486 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.515 ' O ' ' CZ ' ' A' ' 36' ' ' ARG . 10.8 tt0 . . . . . 0 N--CA 1.485 1.287 0 O-C-N 120.814 -1.179 . . . . 0.0 108.67 179.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.63 ' O ' ' O ' ' A' ' 59' ' ' ILE . 96.1 m-85 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.603 0.716 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.8 135.97 10.93 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.967 -1.083 . . . . 0.0 109.486 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.502 ' HG ' HG21 ' A' ' 35' ' ' VAL . 70.6 m -108.03 117.15 33.39 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.648 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.8 m -102.18 133.81 46.44 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.854 -1.154 . . . . 0.0 109.704 -178.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.508 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 2.4 p -129.73 160.28 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.295 -0.878 . . . . 0.0 109.642 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.508 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 55.8 t -108.47 136.76 43.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.505 ' C ' ' H ' ' A' ' 52' ' ' GLY . 74.8 t -121.59 151.45 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.093 -1.004 . . . . 0.0 109.978 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -49.71 -15.24 0.16 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.067 0.937 . . . . 0.0 108.796 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -94.21 -59.21 1.18 Allowed Glycine 0 C--N 1.285 -2.28 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.65 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -162.15 176.66 10.43 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.122 -1.222 . . . . 0.0 110.384 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.06 138.96 18.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HZ1' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -125.58 162.05 25.83 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.761 -179.919 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -128.64 80.31 1.96 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.488 -0.758 . . . . 0.0 110.336 -179.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 46' ' ' CYS . 82.1 m -59.8 145.02 46.9 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.788 -1.195 . . . . 0.0 108.402 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -115.98 130.42 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.013 -1.054 . . . . 0.0 111.272 -178.331 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.63 ' O ' ' O ' ' A' ' 44' ' ' TYR . 3.7 mp -123.04 128.4 75.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.361 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 . . . . . 0 N--CA 1.497 1.886 0 O-C-N 120.557 -1.34 . . . . 0.0 109.455 179.512 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.2 m . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.226 0.536 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.4 mt -60.02 -36.29 76.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.299 -0.876 . . . . 0.0 109.764 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -59.38 -41.05 88.44 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.101 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.439 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 81.9 mt-10 -61.66 -35.06 76.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 108.656 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.0 tt -58.12 -42.55 86.02 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.557 -0.714 . . . . 0.0 109.436 179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.34 -39.56 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.007 -1.058 . . . . 0.0 108.582 179.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.48 HD22 ' CD2' ' A' ' 5' ' ' HIS . 92.6 mt -66.44 -41.8 88.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.402 -0.812 . . . . 0.0 109.718 179.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.439 ' CD2' ' O ' ' A' ' 80' ' ' GLU . 14.6 m170 -60.47 -42.36 96.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 110.382 -179.213 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.408 ' O ' ' O ' ' A' ' 88' ' ' THR . 3.7 m-85 -69.53 -23.62 63.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.783 -1.198 . . . . 0.0 108.979 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -64.02 -38.12 89.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.491 -0.756 . . . . 0.0 109.231 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -90.26 -19.69 23.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 0.0 109.199 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 85' ' ' TYR . 42.1 m -99.01 140.99 32.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.529 -0.732 . . . . 0.0 109.256 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.3 t -89.65 128.94 36.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.868 . . . . 0.0 109.47 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.667 ' O ' ' N ' ' A' ' 92' ' ' GLN . 10.1 mp -60.56 -22.85 64.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.344 -0.847 . . . . 0.0 110.467 -179.558 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.719 ' N ' ' O ' ' A' ' 97' ' ' LEU . 11.6 p -26.56 -37.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.346 -0.846 . . . . 0.0 110.584 -179.184 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.667 ' N ' ' O ' ' A' ' 90' ' ' LEU . 35.0 mt-30 -40.8 179.25 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.885 0.85 . . . . 0.0 111.756 -178.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 61.25 -108.84 0.35 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.496 0.665 . . . . 0.0 109.972 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -60.72 -5.43 1.28 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.494 -0.754 . . . . 0.0 110.366 -179.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 65.7 t0 57.27 28.47 15.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.772 -1.205 . . . . 0.0 109.128 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -143.22 13.04 1.8 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 110.304 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.719 ' O ' ' N ' ' A' ' 91' ' ' VAL . 7.7 mp -101.23 70.14 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.875 -1.14 . . . . 0.0 107.955 178.773 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -78.79 87.4 4.67 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.389 -0.819 . . . . 0.0 110.114 -178.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.488 HG23 ' N ' ' A' ' 100' ' ' THR . 12.6 p -163.05 160.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 121.686 0.755 . . . . 0.0 109.158 179.306 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.488 ' N ' HG23 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -130.8 133.47 45.99 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.14 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.56 HD21 ' CG ' ' A' ' 33' ' ' PHE . 37.6 mt -69.62 74.5 0.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -116.56 -10.04 11.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.832 . . . . 0.0 110.952 -178.719 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 32' ' ' THR . 69.2 t80 -120.65 103.4 43.7 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.619 -1.301 . . . . 0.0 110.433 -178.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.97 146.53 86.66 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.622 2.215 . . . . 0.0 111.533 178.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' A' ' 106' ' ' TYR . 9.5 p -69.43 -35.37 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.911 -1.118 . . . . 0.0 109.57 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.456 ' CD2' HG12 ' A' ' 105' ' ' VAL . 38.8 m-85 -119.39 54.88 0.97 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.157 -0.964 . . . . 0.0 110.74 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.539 0 O-C-N 121.133 -0.979 . . . . 0.0 108.376 178.812 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -51.27 -17.86 4.49 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.013 1.809 . . . . 0.0 111.563 178.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -63.24 -23.26 67.34 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.523 -0.735 . . . . 0.0 110.4 -179.074 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -66.1 -37.95 87.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.815 -1.178 . . . . 0.0 109.599 -179.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.572 ' O ' ' OG1' ' A' ' 10' ' ' THR . 84.9 m-20 -96.44 127.2 42.21 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.156 -0.965 . . . . 0.0 109.535 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.502 ' HG3' ' CH2' ' A' ' 11' ' ' TRP . 38.1 mp0 -71.08 -28.45 64.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 109.21 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HG3' ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -58.67 -22.54 57.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.657 -179.422 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.741 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 17.2 p -66.03 -31.62 72.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 179.584 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.741 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.6 -31.77 1.98 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.83 -1.169 . . . . 0.0 110.64 -179.387 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.637 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 6.6 p-10 -80.26 146.48 31.64 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 110.422 -178.496 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.54 -3.95 5.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.9 -130.44 33.32 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.6 m -67.75 137.62 55.58 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.229 -1.16 . . . . 0.0 108.641 179.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -163.67 165.01 23.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.478 -0.764 . . . . 0.0 108.954 -179.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.524 ' C ' HH12 ' A' ' 36' ' ' ARG . 68.3 m-80 -106.36 141.03 38.35 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 179.156 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.528 ' HG3' HH11 ' A' ' 18' ' ' ARG . 14.8 mtm-85 -61.24 -36.91 81.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.761 -1.212 . . . . 0.0 109.649 -179.565 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -60.1 -49.32 78.11 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.069 -1.02 . . . . 0.0 110.165 -179.37 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.6 pttt -68.03 -27.27 66.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.722 -1.236 . . . . 0.0 108.579 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.41 -33.44 73.71 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.816 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 26' ' ' ARG . 97.9 mt-10 -60.9 -47.45 86.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.52 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -60.01 -44.3 94.66 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.694 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 59.3 mt -69.11 -25.24 64.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.968 -1.082 . . . . 0.0 108.196 178.343 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 21' ' ' ALA . 44.1 mt -96.3 -10.07 28.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.837 . . . . 0.0 109.318 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.666 ' N ' ' O ' ' A' ' 22' ' ' GLU . 61.7 mtm180 -107.48 131.25 54.51 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.431 -0.793 . . . . 0.0 110.582 -179.19 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.42 -4.28 43.78 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.694 ' NZ ' ' O ' ' A' ' 24' ' ' LEU . 14.6 ptpt -122.98 154.85 37.87 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.003 -1.293 . . . . 0.0 110.929 -179.384 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.478 ' HG2' ' N ' ' A' ' 30' ' ' ASP . 26.9 ttm180 -73.95 160.01 31.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.529 0.681 . . . . 0.0 110.871 -179.004 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.478 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 8.9 p-10 -59.19 167.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.7 0.762 . . . . 0.0 110.128 179.598 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.13 -33.94 5.6 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.4 m -82.06 119.9 24.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -1.114 . . . . 0.0 108.891 179.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' A' ' 101' ' ' LEU . 1.0 OUTLIER -136.23 164.65 27.59 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.598 -1.241 . . . . 0.0 110.964 -179.521 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.443 HD21 ' CG1' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -131.89 165.75 23.17 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.509 0.671 . . . . 0.0 110.152 -179.567 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.503 HG21 ' HG ' ' A' ' 46' ' ' CYS . 55.1 t -116.67 121.95 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.078 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.524 HH12 ' C ' ' A' ' 17' ' ' ASN . 14.7 ptm180 -142.4 -176.21 4.75 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.592 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.602 ' O ' ' O ' ' A' ' 59' ' ' ILE . 93.8 m-85 . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.409 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -154.98 140.63 17.99 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.659 -1.276 . . . . 0.0 110.245 -179.147 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.54 ' SG ' ' CD1' ' A' ' 59' ' ' ILE . 84.1 m -106.29 118.34 36.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 74.0 m -91.93 127.46 37.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.504 -0.748 . . . . 0.0 109.259 -179.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.81 145.96 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.856 -1.153 . . . . 0.0 110.423 -179.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.0 t -92.29 144.03 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.349 -0.844 . . . . 0.0 108.743 178.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.64 HG11 ' H ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -123.23 158.95 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.035 -1.04 . . . . 0.0 109.624 179.833 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -65.8 57.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.535 -0.728 . . . . 0.0 110.492 -178.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.493 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . 169.46 -33.54 0.18 Allowed Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.307 -1.425 . . . . 0.0 111.295 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.64 ' H ' HG11 ' A' ' 50' ' ' VAL . 88.8 mt-10 -159.74 165.61 32.14 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.9 -1.353 . . . . 0.0 110.486 -179.544 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 t -97.32 125.78 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.801 . . . . 0.0 109.19 178.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.552 ' HZ3' ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -120.38 146.01 46.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.927 -1.108 . . . . 0.0 110.745 -179.273 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -111.75 87.76 2.64 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.446 -0.784 . . . . 0.0 108.918 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 63.2 m -66.9 139.42 57.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.908 . . . . 0.0 109.186 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -106.57 134.36 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.277 -179.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.602 ' O ' ' O ' ' A' ' 44' ' ' TYR . 31.4 mt -121.85 144.87 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.4 -0.813 . . . . 0.0 108.822 179.233 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.464 ' N ' HG21 ' A' ' 59' ' ' ILE . 14.4 t-20 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.019 -1.05 . . . . 0.0 109.032 -179.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.7 p . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.523 0.678 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.65 -27.1 68.7 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.612 -0.68 . . . . 0.0 109.715 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 83' ' ' LEU . 64.0 mttp -59.55 -44.78 93.15 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.826 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.38 -37.96 87.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.336 -0.853 . . . . 0.0 109.328 179.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.442 ' C ' ' CD2' ' A' ' 81' ' ' LEU . 7.5 tt -57.6 -41.95 82.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 108.914 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.47 -45.23 98.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.048 -1.033 . . . . 0.0 109.298 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.481 ' CD1' ' O ' ' A' ' 79' ' ' LYS . 6.4 mp -62.53 -37.74 87.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.871 -1.143 . . . . 0.0 109.58 179.417 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -59.53 -46.69 88.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.524 -0.735 . . . . 0.0 110.966 -179.217 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.544 ' O ' ' O ' ' A' ' 88' ' ' THR . 4.4 m-85 -67.59 -28.4 67.73 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.498 -1.376 . . . . 0.0 109.585 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -58.91 -38.06 78.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 109.164 -179.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -86.14 -36.16 19.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.134 -0.979 . . . . 0.0 109.276 179.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.544 ' O ' ' O ' ' A' ' 85' ' ' TYR . 1.8 p -90.05 139.38 30.67 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.373 -0.83 . . . . 0.0 109.675 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 m -93.1 140.57 29.35 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.601 0.715 . . . . 0.0 109.835 -179.769 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.655 ' O ' ' C ' ' A' ' 91' ' ' VAL . 5.8 mt -61.09 -41.14 96.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 111.238 -178.905 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.783 ' N ' ' O ' ' A' ' 97' ' ' LEU . 87.2 t 16.29 -83.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 121.41 -0.806 . . . . 0.0 109.834 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 90' ' ' LEU . 1.3 tp60 75.77 -176.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 110.222 179.282 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -60.09 -38.74 83.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.642 -0.661 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -52.52 -24.95 9.04 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.013 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 61.53 20.31 11.12 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 178.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.0 m -130.51 7.26 4.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.693 -1.254 . . . . 0.0 111.172 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.783 ' O ' ' N ' ' A' ' 91' ' ' VAL . 83.2 mt -98.5 53.67 1.04 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.09 78.47 3.63 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.548 -178.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.2 t -154.31 147.92 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.809 0.814 . . . . 0.0 109.533 179.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.465 ' HG1' ' HB1' ' A' ' 102' ' ' ALA . 48.2 p -121.24 153.67 37.34 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.316 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.514 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 79.0 mt -82.25 71.05 9.31 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.465 ' HB1' ' HG1' ' A' ' 100' ' ' THR . . . -107.38 -17.87 14.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.62 -0.675 . . . . 0.0 112.074 -178.09 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -110.91 123.77 34.59 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.573 -1.329 . . . . 0.0 110.083 -178.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -77.45 145.06 23.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.488 2.125 . . . . 0.0 110.636 178.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.517 HG12 ' CD2' ' A' ' 106' ' ' TYR . 12.0 p -72.21 -22.01 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.535 -1.353 . . . . 0.0 109.38 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.517 ' CD2' HG12 ' A' ' 105' ' ' VAL . 72.3 m-85 -129.19 64.35 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.768 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 108.819 179.451 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -51.27 -17.86 4.49 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.013 1.809 . . . . 0.0 111.563 178.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -63.24 -23.26 67.34 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.523 -0.735 . . . . 0.0 110.4 -179.074 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -66.1 -37.95 87.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.815 -1.178 . . . . 0.0 109.599 -179.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.572 ' O ' ' OG1' ' A' ' 10' ' ' THR . 84.9 m-20 -96.44 127.2 42.21 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.156 -0.965 . . . . 0.0 109.535 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.502 ' HG3' ' CH2' ' A' ' 11' ' ' TRP . 38.1 mp0 -71.08 -28.45 64.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 109.21 179.56 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HG3' ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -58.67 -22.54 57.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.657 -179.422 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.741 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 17.2 p -66.03 -31.62 72.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.741 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.6 -31.77 1.98 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.83 -1.169 . . . . 0.0 110.64 -179.387 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.637 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 6.6 p-10 -80.26 146.48 31.64 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 110.422 -178.496 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.54 -3.95 5.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.9 -130.44 33.32 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.6 m -67.75 137.62 55.58 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.229 -1.16 . . . . 0.0 108.641 179.369 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -163.67 165.01 23.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.478 -0.764 . . . . 0.0 108.954 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.524 ' C ' HH12 ' A' ' 36' ' ' ARG . 68.3 m-80 -106.36 141.03 38.35 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 179.156 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.528 ' HG3' HH11 ' A' ' 18' ' ' ARG . 14.8 mtm-85 -61.24 -36.91 81.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.761 -1.212 . . . . 0.0 109.649 -179.565 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -60.1 -49.32 78.11 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.069 -1.02 . . . . 0.0 110.165 -179.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.6 pttt -68.03 -27.27 66.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.722 -1.236 . . . . 0.0 108.579 179.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.41 -33.44 73.71 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.816 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 26' ' ' ARG . 97.9 mt-10 -60.9 -47.45 86.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.52 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -60.01 -44.3 94.66 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.694 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 59.3 mt -69.11 -25.24 64.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.968 -1.082 . . . . 0.0 108.196 178.343 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 21' ' ' ALA . 44.1 mt -96.3 -10.07 28.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.837 . . . . 0.0 109.318 179.683 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.666 ' N ' ' O ' ' A' ' 22' ' ' GLU . 61.7 mtm180 -107.48 131.25 54.51 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.431 -0.793 . . . . 0.0 110.582 -179.19 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.42 -4.28 43.78 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.208 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.694 ' NZ ' ' O ' ' A' ' 24' ' ' LEU . 14.6 ptpt -122.98 154.85 37.87 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.003 -1.293 . . . . 0.0 110.929 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.478 ' HG2' ' N ' ' A' ' 30' ' ' ASP . 26.9 ttm180 -73.95 160.01 31.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.529 0.681 . . . . 0.0 110.871 -179.004 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.478 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 8.9 p-10 -59.19 167.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.7 0.762 . . . . 0.0 110.128 179.598 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.13 -33.94 5.6 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.561 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.4 m -82.06 119.9 24.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -1.114 . . . . 0.0 108.891 179.559 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' A' ' 101' ' ' LEU . 1.0 OUTLIER -136.23 164.65 27.59 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.598 -1.241 . . . . 0.0 110.964 -179.521 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.443 HD21 ' CG1' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -131.89 165.75 23.17 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.509 0.671 . . . . 0.0 110.152 -179.567 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.503 HG21 ' HG ' ' A' ' 46' ' ' CYS . 55.1 t -116.67 121.95 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.078 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.524 HH12 ' C ' ' A' ' 17' ' ' ASN . 14.7 ptm180 -142.4 -176.21 4.75 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.41 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.592 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.602 ' O ' ' O ' ' A' ' 59' ' ' ILE . 93.8 m-85 . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.409 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -154.98 140.63 17.99 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.659 -1.276 . . . . 0.0 110.245 -179.147 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.54 ' SG ' ' CD1' ' A' ' 59' ' ' ILE . 84.1 m -106.29 118.34 36.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 74.0 m -91.93 127.46 37.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.504 -0.748 . . . . 0.0 109.259 -179.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.81 145.96 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.856 -1.153 . . . . 0.0 110.423 -179.559 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.0 t -92.29 144.03 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.349 -0.844 . . . . 0.0 108.743 178.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.64 HG11 ' H ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -123.23 158.95 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.035 -1.04 . . . . 0.0 109.624 179.833 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -65.8 57.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.535 -0.728 . . . . 0.0 110.492 -178.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.493 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . 169.46 -33.54 0.18 Allowed Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.307 -1.425 . . . . 0.0 111.295 179.089 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.64 ' H ' HG11 ' A' ' 50' ' ' VAL . 88.8 mt-10 -159.74 165.61 32.14 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.9 -1.353 . . . . 0.0 110.486 -179.544 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 t -97.32 125.78 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.801 . . . . 0.0 109.19 178.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.552 ' HZ3' ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -120.38 146.01 46.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.927 -1.108 . . . . 0.0 110.745 -179.273 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -111.75 87.76 2.64 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.446 -0.784 . . . . 0.0 108.918 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 63.2 m -66.9 139.42 57.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.908 . . . . 0.0 109.186 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -106.57 134.36 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.277 -179.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.602 ' O ' ' O ' ' A' ' 44' ' ' TYR . 31.4 mt -121.85 144.87 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.4 -0.813 . . . . 0.0 108.822 179.233 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.464 ' N ' HG21 ' A' ' 59' ' ' ILE . 14.4 t-20 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.019 -1.05 . . . . 0.0 109.032 -179.703 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.7 p . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.523 0.678 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.65 -27.1 68.7 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.612 -0.68 . . . . 0.0 109.715 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 83' ' ' LEU . 64.0 mttp -59.55 -44.78 93.15 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.826 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.38 -37.96 87.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.336 -0.853 . . . . 0.0 109.328 179.103 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.442 ' C ' ' CD2' ' A' ' 81' ' ' LEU . 7.5 tt -57.6 -41.95 82.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 108.914 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.47 -45.23 98.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.048 -1.033 . . . . 0.0 109.298 179.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.481 ' CD1' ' O ' ' A' ' 79' ' ' LYS . 6.4 mp -62.53 -37.74 87.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.871 -1.143 . . . . 0.0 109.58 179.417 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -59.53 -46.69 88.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.524 -0.735 . . . . 0.0 110.966 -179.217 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.544 ' O ' ' O ' ' A' ' 88' ' ' THR . 4.4 m-85 -67.59 -28.4 67.73 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.498 -1.376 . . . . 0.0 109.585 -179.624 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -58.91 -38.06 78.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 109.164 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -86.14 -36.16 19.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.134 -0.979 . . . . 0.0 109.276 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.544 ' O ' ' O ' ' A' ' 85' ' ' TYR . 1.8 p -90.05 139.38 30.67 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.373 -0.83 . . . . 0.0 109.675 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 m -93.1 140.57 29.35 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.601 0.715 . . . . 0.0 109.835 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.655 ' O ' ' C ' ' A' ' 91' ' ' VAL . 5.8 mt -61.09 -41.14 96.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 111.238 -178.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.783 ' N ' ' O ' ' A' ' 97' ' ' LEU . 87.2 t 16.29 -83.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 121.41 -0.806 . . . . 0.0 109.834 -179.44 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 90' ' ' LEU . 1.3 tp60 75.77 -176.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 110.222 179.282 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -60.09 -38.74 83.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.642 -0.661 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -52.52 -24.95 9.04 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.013 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 61.53 20.31 11.12 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 178.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.0 m -130.51 7.26 4.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.693 -1.254 . . . . 0.0 111.172 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.783 ' O ' ' N ' ' A' ' 91' ' ' VAL . 83.2 mt -98.5 53.67 1.04 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.09 78.47 3.63 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.548 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.2 t -154.31 147.92 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.809 0.814 . . . . 0.0 109.533 179.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.465 ' HG1' ' HB1' ' A' ' 102' ' ' ALA . 48.2 p -121.24 153.67 37.34 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.316 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.514 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 79.0 mt -82.25 71.05 9.31 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.244 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.465 ' HB1' ' HG1' ' A' ' 100' ' ' THR . . . -107.38 -17.87 14.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.62 -0.675 . . . . 0.0 112.074 -178.09 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -110.91 123.77 34.59 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.573 -1.329 . . . . 0.0 110.083 -178.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -77.45 145.06 23.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.488 2.125 . . . . 0.0 110.636 178.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.517 HG12 ' CD2' ' A' ' 106' ' ' TYR . 12.0 p -72.21 -22.01 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.535 -1.353 . . . . 0.0 109.38 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.517 ' CD2' HG12 ' A' ' 105' ' ' VAL . 72.3 m-85 -129.19 64.35 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.768 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 108.819 179.451 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.416 ' O ' ' OG1' ' A' ' 10' ' ' THR . 24.2 Cg_endo -65.11 -8.44 18.42 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.175 1.917 . . . . 0.0 111.778 -179.216 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.633 ' NE2' ' OE1' ' A' ' 86' ' ' GLN . 89.9 m-70 -65.94 -26.5 67.61 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.538 -0.726 . . . . 0.0 109.809 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -64.23 -29.82 70.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.982 -1.074 . . . . 0.0 110.036 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.488 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 95.6 m-20 -105.06 131.52 52.46 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.085 -1.01 . . . . 0.0 110.332 -179.545 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 12' ' ' ASN . 91.5 mt-10 -69.69 -23.3 63.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.536 -0.727 . . . . 0.0 109.504 179.325 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.43 ' CG ' ' N ' ' A' ' 10' ' ' THR . 34.5 pttt -61.36 -31.57 71.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.409 -0.807 . . . . 0.0 111.367 -178.823 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.559 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 53.6 p -70.61 -24.9 62.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.769 -1.207 . . . . 0.0 110.914 -178.452 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.605 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -124.51 -29.6 3.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.643 -1.285 . . . . 0.0 110.419 179.057 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 8' ' ' GLU . 49.0 t-20 -86.3 123.38 31.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 110.651 -178.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.62 0.59 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.43 -0.794 . . . . 0.0 109.19 179.278 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.49 -153.69 52.22 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 88.2 p -68.9 148.32 50.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.378 -1.072 . . . . 0.0 108.429 179.201 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.56 ' O ' ' CZ ' ' A' ' 36' ' ' ARG . 47.3 t -175.16 156.34 2.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 108.826 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.641 ' ND2' ' CG ' ' A' ' 19' ' ' ASN . 49.9 t30 -78.19 140.8 38.94 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.543 179.832 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.919 ' N ' HH22 ' A' ' 36' ' ' ARG . 42.3 mtt-85 -60.18 -34.42 73.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.253 -0.904 . . . . 0.0 110.701 -179.181 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.645 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 42.3 p-10 -60.02 -40.33 88.94 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.804 -1.185 . . . . 0.0 108.702 179.773 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.645 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 62.1 tttp -64.24 -40.92 97.03 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.322 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.01 76.99 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.31 -0.869 . . . . 0.0 108.91 179.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 26' ' ' ARG . 98.1 mt-10 -59.57 -48.94 79.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.175 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.687 ' OD1' ' N ' ' A' ' 24' ' ' LEU . 8.6 p30 -60.02 -40.06 87.98 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.687 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 85.1 mt -66.99 -29.96 69.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.245 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.7 mt -93.7 -7.7 42.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.628 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 22' ' ' GLU . 2.0 ttm180 -97.23 128.77 44.4 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.277 -0.89 . . . . 0.0 109.789 -179.526 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.69 16.99 78.31 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.16 133.37 53.29 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.537 -0.978 . . . . 0.0 109.642 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -60.65 156.73 16.03 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.901 0.858 . . . . 0.0 111.106 -179.488 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 50' ' ' VAL . 87.7 m-20 -63.85 151.85 41.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.586 -0.696 . . . . 0.0 109.383 179.012 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.03 -22.04 42.9 Favored Glycine 0 N--CA 1.499 2.888 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.165 179.473 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.2 m -83.57 121.41 27.2 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.085 -1.244 . . . . 0.0 108.604 179.427 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.499 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -137.74 162.95 32.54 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.902 -1.124 . . . . 0.0 110.066 179.941 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.11 147.37 40.14 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.067 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 11' ' ' TRP . 54.9 t -92.58 132.03 38.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.04 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.919 HH22 ' N ' ' A' ' 18' ' ' ARG . 7.6 ttt180 -142.41 -172.65 3.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.267 -0.896 . . . . 0.0 108.86 -178.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.755 ' H ' ' CG ' ' A' ' 36' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--N 1.304 -1.371 0 O-C-N 120.985 -1.072 . . . . 0.0 108.952 -179.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.595 ' O ' ' O ' ' A' ' 59' ' ' ILE . 30.5 m-85 . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.445 0.641 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.598 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -175.8 145.12 0.66 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.062 -1.024 . . . . 0.0 108.477 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 57' ' ' CYS . 31.8 p -125.24 154.85 41.03 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.561 -1.337 . . . . 0.0 109.268 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.568 ' OG ' ' O ' ' A' ' 55' ' ' LYS . 41.1 t -119.75 138.9 53.04 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.636 0.731 . . . . 0.0 110.344 -178.519 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -130.73 146.0 34.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.463 -0.773 . . . . 0.0 109.388 179.88 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.1 t -91.75 133.36 33.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.475 -0.766 . . . . 0.0 109.13 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 52' ' ' GLY . 0.7 OUTLIER -122.49 163.13 21.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.256 -0.977 . . . . 0.0 110.667 -179.77 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.528 ' C ' ' OD1' ' A' ' 51' ' ' ASP . 47.5 p30 -62.89 50.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.665 -179.06 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 178.48 -43.22 0.09 OUTLIER Glycine 0 C--N 1.295 -1.695 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.896 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 44.6 mm-40 -158.87 166.81 31.02 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.07 -1.253 . . . . 0.0 111.224 -179.324 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.401 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 5.3 m -73.11 146.92 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.525 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.568 ' O ' ' OG ' ' A' ' 47' ' ' SER . 11.2 mmtm -113.63 146.66 39.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.889 -1.132 . . . . 0.0 110.557 -179.335 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -125.54 65.79 1.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.61 -0.681 . . . . 0.0 109.687 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.459 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 74.4 m -59.47 144.91 45.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.073 -1.017 . . . . 0.0 108.891 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.4 138.49 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.932 0.872 . . . . 0.0 112.127 -178.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.595 ' O ' ' O ' ' A' ' 44' ' ' TYR . 48.4 mm -115.74 133.45 62.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.141 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.503 2.204 0 O-C-N 120.564 -1.335 . . . . 0.0 110.917 -178.287 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.278 0.561 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.5 mt -59.56 -40.36 87.04 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -55.38 -40.61 71.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.444 -0.785 . . . . 0.0 109.379 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.19 -40.49 96.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 tt -58.82 -43.7 90.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.098 -179.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.67 -38.64 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.76 -1.212 . . . . 0.0 109.188 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.524 ' CD2' ' CD2' ' A' ' 5' ' ' HIS . 90.7 mt -74.89 -38.53 61.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.063 -1.023 . . . . 0.0 110.437 -179.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 -64.7 -39.36 93.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.802 -1.186 . . . . 0.0 109.792 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -66.82 -27.66 67.74 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.149 -0.97 . . . . 0.0 108.875 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.633 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 41.6 tt0 -63.79 -34.72 78.53 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.539 -0.726 . . . . 0.0 109.292 178.926 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -90.62 -13.47 34.3 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.028 -1.045 . . . . 0.0 110.163 -179.152 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.1 m -100.71 136.04 41.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 110.438 -179.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 t -85.99 125.55 33.47 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.282 -0.886 . . . . 0.0 108.934 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.722 ' O ' ' N ' ' A' ' 92' ' ' GLN . 87.1 mt -66.87 -20.05 65.85 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.407 -0.808 . . . . 0.0 110.332 -179.243 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.728 ' N ' ' O ' ' A' ' 97' ' ' LEU . 11.8 p -15.17 -48.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 O-C-N 121.684 -0.635 . . . . 0.0 110.372 179.457 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.722 ' N ' ' O ' ' A' ' 90' ' ' LEU . 34.0 tt0 53.92 179.41 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.483 -0.761 . . . . 0.0 110.807 178.777 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.578 ' H ' ' CG ' ' A' ' 92' ' ' GLN . 91.4 m-70 -60.06 -29.53 68.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.587 -0.695 . . . . 0.0 109.383 -179.719 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -56.96 -24.01 49.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.083 -1.011 . . . . 0.0 108.795 179.361 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.5 t70 61.93 41.67 11.09 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.518 -0.739 . . . . 0.0 110.432 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.7 m -148.19 -2.56 0.52 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.648 -1.283 . . . . 0.0 111.151 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 92.8 mt -102.16 52.0 0.81 Allowed 'General case' 0 C--N 1.29 -2.006 0 O-C-N 121.13 -0.982 . . . . 0.0 108.413 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.485 HD22 HG22 ' A' ' 91' ' ' VAL . 3.3 m-80 -78.09 70.35 4.44 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.769 0.795 . . . . 0.0 109.807 -178.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.475 HG11 ' N ' ' A' ' 100' ' ' THR . 25.9 t -149.67 153.02 11.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.475 ' N ' HG11 ' A' ' 99' ' ' VAL . 24.2 p -124.21 156.99 35.83 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.26 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.499 HD21 ' CG ' ' A' ' 33' ' ' PHE . 30.7 mt -82.58 69.48 9.36 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.912 -1.117 . . . . 0.0 108.694 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.421 ' CB ' ' HG3' ' A' ' 86' ' ' GLN . . . -105.09 -18.79 14.03 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.508 -0.745 . . . . 0.0 112.077 -178.004 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -112.44 109.62 53.59 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.414 -1.429 . . . . 0.0 112.101 -177.709 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -62.35 143.72 94.12 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.074 1.85 . . . . 0.0 111.169 178.153 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.529 HG12 ' CD2' ' A' ' 106' ' ' TYR . 12.5 p -68.66 -36.92 76.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 120.745 -1.222 . . . . 0.0 108.904 179.345 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.529 ' CD2' HG12 ' A' ' 105' ' ' VAL . 55.7 m-85 -109.13 42.48 1.43 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.386 -0.821 . . . . 0.0 109.61 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 108.857 -179.986 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -51.51 -14.64 2.05 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.812 1.675 . . . . 0.0 110.925 179.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.457 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 91.1 m-70 -66.47 -12.93 59.84 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.541 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -63.42 -32.28 73.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 108.85 179.011 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.575 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 92.3 m-20 -100.53 134.19 43.85 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.352 -0.843 . . . . 0.0 110.004 -179.666 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 12' ' ' ASN . 95.5 mt-10 -69.27 -27.26 65.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 109.988 179.566 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.507 ' CG ' ' N ' ' A' ' 10' ' ' THR . 33.3 pttt -60.79 -35.46 76.53 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 110.508 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.67 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 10.6 p -59.75 -33.39 71.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 110.113 -178.827 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.67 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -120.78 -37.27 3.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.893 -1.129 . . . . 0.0 110.165 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -86.21 123.85 31.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.993 -1.067 . . . . 0.0 110.47 -179.214 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.5 t -94.05 -4.95 10.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.79 -162.15 19.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.498 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -80.68 61.55 4.4 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.318 -1.107 . . . . 0.0 109.417 -179.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.1 p -79.2 156.7 28.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.299 -0.876 . . . . 0.0 109.092 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -70.18 142.72 52.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.191 -0.943 . . . . 0.0 109.453 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.604 HH11 ' NH2' ' A' ' 36' ' ' ARG . 48.6 mtt-85 -59.46 -38.81 81.75 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.054 -1.029 . . . . 0.0 109.388 179.816 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.65 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 40.0 p-10 -62.65 -42.82 99.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.0 -1.062 . . . . 0.0 108.484 179.363 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.65 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 80.3 tttt -60.51 -36.6 78.74 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.233 -0.917 . . . . 0.0 109.066 179.41 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.702 ' CB ' HH11 ' A' ' 36' ' ' ARG . . . -58.57 -34.03 70.59 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.647 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 75.3 tt0 -58.7 -42.63 89.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.247 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.68 -46.94 87.54 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.697 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -67.16 -33.86 76.32 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.863 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.582 ' CD1' ' HG ' ' A' ' 47' ' ' SER . 22.7 mt -80.85 -16.01 54.82 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.146 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.731 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -74.61 122.43 23.15 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.555 -179.727 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.82 19.54 78.83 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.518 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.18 135.79 38.62 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.359 -1.083 . . . . 0.0 109.685 -179.446 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.686 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.9 OUTLIER -74.88 157.63 34.74 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.66 0.743 . . . . 0.0 110.157 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.513 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 48.4 p30 -62.25 169.36 2.85 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.283 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.88 -28.44 1.89 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 30' ' ' ASP . 76.7 m -80.56 121.03 25.29 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.869 -1.371 . . . . 0.0 108.984 179.658 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -136.06 167.26 21.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.908 -1.12 . . . . 0.0 110.517 -179.32 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 1.1 pt? -148.91 161.29 42.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.454 -0.779 . . . . 0.0 110.588 179.475 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.527 HG21 ' HG ' ' A' ' 46' ' ' CYS . 65.8 t -106.74 132.73 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.37 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.704 ' NH2' ' CD2' ' A' ' 56' ' ' HIS . 35.6 ptt180 -147.75 173.14 13.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 108.884 -178.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.47 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 53.0 mt-10 . . . . . 0 C--N 1.304 -1.389 0 O-C-N 120.83 -1.169 . . . . 0.0 109.268 179.447 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.608 ' O ' ' O ' ' A' ' 59' ' ' ILE . 57.2 m-85 . . . . . 0 N--CA 1.495 1.775 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 57' ' ' CYS . . . -159.75 153.88 23.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.77 -1.207 . . . . 0.0 109.973 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.527 ' HG ' HG21 ' A' ' 35' ' ' VAL . 85.4 m -109.5 125.86 52.93 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.563 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.582 ' HG ' ' CD1' ' A' ' 25' ' ' LEU . 26.1 t -92.05 127.0 37.36 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.06 -179.682 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.429 ' CG1' ' N ' ' A' ' 49' ' ' VAL . 74.3 t -126.1 163.71 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.187 -0.946 . . . . 0.0 109.978 -179.403 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.429 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 39.2 t -124.6 132.76 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.488 HG13 ' NZ ' ' A' ' 55' ' ' LYS . 11.4 p -123.34 156.35 29.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.995 -1.066 . . . . 0.0 109.671 -179.782 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.423 ' OD1' ' OD2' ' A' ' 30' ' ' ASP . 87.2 m-20 -49.97 -17.17 0.35 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.943 0.878 . . . . 0.0 109.634 -179.429 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.581 ' O ' ' OE2' ' A' ' 53' ' ' GLU . . . -86.18 -59.22 1.88 Allowed Glycine 0 C--N 1.287 -2.142 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.667 -179.175 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.581 ' OE2' ' O ' ' A' ' 52' ' ' GLY . 61.3 mm-40 -163.22 -165.53 1.1 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.25 -1.147 . . . . 0.0 110.554 -178.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -93.36 123.37 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.488 ' NZ ' HG13 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -122.45 149.15 44.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.911 -1.118 . . . . 0.0 110.905 -179.495 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.704 ' CD2' ' NH2' ' A' ' 36' ' ' ARG . 23.6 m80 -113.31 101.88 9.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.579 -0.701 . . . . 0.0 109.544 179.194 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' CYS . 52.5 t -72.91 130.04 39.5 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.26 138.63 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.246 -0.909 . . . . 0.0 111.878 -177.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.608 ' O ' ' O ' ' A' ' 44' ' ' TYR . 10.9 mm -124.93 111.59 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 . . . . . 0 N--CA 1.5 2.055 0 O-C-N 120.647 -1.283 . . . . 0.0 112.182 -178.248 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.559 0.695 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.16 -34.05 73.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 110.03 179.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.72 -43.74 80.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.188 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -66.9 -30.53 70.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.228 -0.92 . . . . 0.0 108.856 179.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.542 ' CD2' ' CE2' ' A' ' 85' ' ' TYR . 9.2 tt -60.6 -40.9 93.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 108.987 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.2 t -66.86 -44.17 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.361 -0.837 . . . . 0.0 109.819 179.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.428 HD22 ' CD2' ' A' ' 5' ' ' HIS . 85.0 mt -67.45 -43.09 81.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.419 -0.8 . . . . 0.0 110.439 -179.119 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -60.02 -40.56 89.72 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.215 -179.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.542 ' CE2' ' CD2' ' A' ' 81' ' ' LEU . 7.4 m-30 -67.34 -24.31 65.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 0.0 108.789 -179.783 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.453 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 38.1 tt0 -61.32 -36.94 81.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 178.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -91.44 -16.71 26.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.303 -0.873 . . . . 0.0 109.592 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.4 m -100.84 129.92 46.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.131 -0.981 . . . . 0.0 109.228 179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 t -81.67 132.56 35.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 109.915 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 91' ' ' VAL . 76.2 mt -69.01 -13.07 62.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.477 -0.764 . . . . 0.0 109.715 179.23 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.76 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.8 p -36.66 -33.75 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.464 -0.773 . . . . 0.0 110.011 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 90' ' ' LEU . 20.0 tt0 -65.86 -50.07 65.86 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 -178.658 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLN . 84.3 t60 -51.43 -47.53 63.0 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 179.443 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.689 ' O ' ' N ' ' A' ' 96' ' ' SER . 13.1 t-20 -126.29 111.25 14.33 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.477 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.54 ' C ' ' O ' ' A' ' 94' ' ' ASN . 99.7 m-20 -35.98 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.886 -178.488 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 94' ' ' ASN . 71.1 m -108.37 27.07 9.71 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.736 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.76 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.5 mt -97.96 65.84 1.81 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.563 -1.336 . . . . 0.0 108.2 178.676 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.79 75.57 6.47 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.81 -1.182 . . . . 0.0 109.41 -178.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.5 t -153.56 153.62 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.522 -0.736 . . . . 0.0 109.805 -179.266 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.2 p -134.33 156.79 47.85 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.154 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.503 HD21 ' CG ' ' A' ' 33' ' ' PHE . 11.6 mt -76.48 71.65 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.706 -1.246 . . . . 0.0 108.007 179.333 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.3 -33.76 9.91 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.169 -0.957 . . . . 0.0 112.111 -177.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.4 m-85 -113.97 109.29 49.93 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.503 -1.373 . . . . 0.0 111.977 -177.654 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.422 ' CB ' ' O ' ' A' ' 10' ' ' THR . 19.0 Cg_exo -59.97 148.61 88.21 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.083 1.855 . . . . 0.0 110.276 176.924 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.503 HG12 ' CD2' ' A' ' 106' ' ' TYR . 9.1 p -67.25 -34.59 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.822 -1.174 . . . . 0.0 108.77 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.503 ' CD2' HG12 ' A' ' 105' ' ' VAL . 38.6 m-85 -108.14 39.4 1.97 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.447 -0.783 . . . . 0.0 110.191 179.828 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.905 0 O-C-N 120.996 -1.065 . . . . 0.0 109.599 179.462 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 121.438 0.637 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -67.08 145.58 55.19 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.293 -0.879 . . . . 0.0 108.845 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.9 mt -93.84 139.26 22.63 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.57 -3.02 10.29 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.612 2.208 . . . . 0.0 112.103 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.443 ' CD2' HD22 ' A' ' 83' ' ' LEU . 72.5 m-70 -66.78 -29.71 69.73 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -63.36 -22.37 66.84 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.583 ' O ' ' OG1' ' A' ' 10' ' ' THR . 94.9 m-20 -92.25 119.95 32.34 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.52 0.676 . . . . 0.0 110.441 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 72.3 tt0 -69.32 -40.33 77.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.59 -0.694 . . . . 0.0 109.496 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.508 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -64.1 -20.53 66.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.655 -0.653 . . . . 0.0 111.443 -178.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.583 ' OG1' ' O ' ' A' ' 7' ' ' ASP . 7.6 p -64.49 -37.31 87.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.794 -1.191 . . . . 0.0 110.196 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.588 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -119.24 -14.81 9.23 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.939 -1.1 . . . . 0.0 109.819 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 8' ' ' GLU . 62.6 t30 -89.7 120.07 30.65 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 110.599 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.97 36.28 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.89 -33.54 20.74 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 85.6 p -63.05 -31.98 73.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.945 -1.327 . . . . 0.0 109.036 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.508 ' HG ' ' HB3' ' A' ' 20' ' ' LYS . 32.8 t -61.6 138.51 58.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.379 -0.826 . . . . 0.0 109.718 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -81.57 163.91 22.29 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.299 -0.876 . . . . 0.0 109.867 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -57.17 -44.78 83.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -0.817 . . . . 0.0 109.465 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -65.36 -42.72 92.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.069 -1.019 . . . . 0.0 108.638 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HB3' ' HG ' ' A' ' 16' ' ' SER . 44.5 tptt -61.05 -36.25 79.09 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.48 -37.33 77.97 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.53 -0.731 . . . . 0.0 109.646 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 26' ' ' ARG . 81.3 mm-40 -58.39 -45.19 88.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.109 -0.994 . . . . 0.0 108.384 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -62.09 -44.19 97.21 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.4 -40.2 95.32 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.413 -0.804 . . . . 0.0 108.87 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.7 mt -75.73 -29.93 59.06 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.556 ' NH1' ' HG2' ' A' ' 26' ' ' ARG . 31.6 mtt-85 -79.63 136.3 36.79 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.717 -0.614 . . . . 0.0 109.645 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.78 -8.65 76.45 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -96.12 137.85 34.58 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.242 -1.152 . . . . 0.0 109.878 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -69.52 162.78 26.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.459 -0.775 . . . . 0.0 109.191 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.611 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 73.9 m-20 -60.18 142.91 53.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.372 -0.83 . . . . 0.0 109.189 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.39 -30.51 8.47 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.0 m -76.16 135.78 39.79 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.239 -1.154 . . . . 0.0 109.044 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.595 ' CE1' ' CD2' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -140.84 162.94 34.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.938 -1.101 . . . . 0.0 108.923 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.481 HD23 ' HG ' ' A' ' 47' ' ' SER . 2.8 pp -134.16 154.55 51.15 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.122 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.587 ' CG2' ' SG ' ' A' ' 46' ' ' CYS . 95.5 t -113.65 138.24 44.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.557 ' NH1' ' HG3' ' A' ' 36' ' ' ARG . 5.4 ptm180 -150.51 169.96 20.26 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.037 -1.04 . . . . 0.0 109.362 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.616 ' C ' ' H ' ' A' ' 39' ' ' SER . 3.2 pt-20 -101.23 175.8 5.46 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.938 -1.101 . . . . 0.0 108.838 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.598 ' O ' ' OG ' ' A' ' 39' ' ' SER . 39.8 m -77.86 9.09 3.8 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.616 ' H ' ' C ' ' A' ' 37' ' ' GLU . 21.2 p 85.19 -77.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.366 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.607 ' N ' ' OG ' ' A' ' 39' ' ' SER . 96.7 mttt -100.09 -25.92 14.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -0.967 . . . . 0.0 110.187 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -84.14 150.41 25.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.004 -1.06 . . . . 0.0 109.229 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.32 5.48 20.5 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 120.277 -0.963 . . . . 0.0 110.893 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.6 t -78.77 143.58 35.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.811 -1.406 . . . . 0.0 109.036 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.593 ' O ' ' O ' ' A' ' 59' ' ' ILE . 97.7 m-85 -113.16 161.24 17.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.135 -0.978 . . . . 0.0 109.903 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -164.66 144.4 7.35 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.022 -1.049 . . . . 0.0 109.357 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.587 ' SG ' ' CG2' ' A' ' 35' ' ' VAL . 78.5 m -121.02 136.84 54.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.543 ' CB ' ' HD1' ' A' ' 56' ' ' HIS . 92.6 p -105.19 143.36 33.47 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.554 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.454 HG11 ' N ' ' A' ' 49' ' ' VAL . 43.7 t -125.06 158.95 32.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.574 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.454 ' N ' HG11 ' A' ' 48' ' ' VAL . 67.9 t -109.92 130.99 62.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.552 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 9.9 t -123.22 152.13 27.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.132 -0.98 . . . . 0.0 110.652 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.611 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 66.0 t0 -50.34 -12.03 0.08 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.547 0.689 . . . . 0.0 109.858 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.55 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -104.9 -49.96 0.98 Allowed Glycine 0 C--N 1.287 -2.142 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.253 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.55 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 75.0 mt-10 -161.29 177.01 10.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.885 -1.362 . . . . 0.0 111.209 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.5 t -89.64 135.13 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HZ1' HD23 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -117.8 161.9 18.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.986 -1.071 . . . . 0.0 111.484 -178.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.543 ' HD1' ' CB ' ' A' ' 47' ' ' SER . 4.5 m-70 -124.06 76.07 1.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 88.4 m -60.83 146.45 46.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.168 -0.957 . . . . 0.0 109.382 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.5 p -106.26 135.87 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.22 -0.925 . . . . 0.0 111.467 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.593 ' O ' ' O ' ' A' ' 44' ' ' TYR . 64.6 mt -124.81 141.47 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 66' ' ' TYR . 49.3 t30 -143.51 119.72 10.82 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.162 -1.586 . . . . 0.0 111.331 -177.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' NZ ' ' CB ' ' A' ' 61' ' ' LYS . 8.6 mtmp? -94.16 119.57 33.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.491 -0.756 . . . . 0.0 110.465 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.552 ' O ' ' C ' ' A' ' 63' ' ' ALA . 91.5 m -138.96 165.92 25.84 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.552 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -37.55 -35.78 0.14 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.902 -1.124 . . . . 0.0 108.077 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.48 ' N ' ' O ' ' A' ' 62' ' ' THR . 84.1 m -138.03 39.34 2.34 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.773 -0.579 . . . . 0.0 109.593 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.702 ' O ' ' CD2' ' A' ' 66' ' ' TYR . . . -139.55 158.05 25.37 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.702 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 97.6 m-85 -168.07 -8.17 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.527 -0.984 . . . . 0.0 109.207 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.01 -72.94 0.23 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -97.33 110.63 23.15 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 176.8 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.878 -1.139 . . . . 0.0 109.617 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.646 ' O ' ' O ' ' A' ' 73' ' ' ASN . 76.6 mm-40 -119.57 153.81 54.27 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.476 ' C ' ' O ' ' A' ' 70' ' ' GLU . 84.0 Cg_exo -34.29 -41.62 0.24 Allowed 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 121.835 1.69 . . . . 0.0 111.022 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -69.22 -44.33 72.28 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.282 -0.886 . . . . 0.0 109.041 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.646 ' O ' ' O ' ' A' ' 70' ' ' GLU . 52.3 p30 -122.36 142.98 49.94 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.524 -0.735 . . . . 0.0 109.887 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 98.8 mt -145.34 99.54 3.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.626 -1.296 . . . . 0.0 109.683 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.69 ' OH ' ' ND1' ' A' ' 84' ' ' HIS . 92.5 m-85 -79.88 130.25 35.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 110.25 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.0 m -90.75 -34.59 15.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.406 -0.809 . . . . 0.0 111.022 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.7 m -126.67 155.93 41.84 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.639 -1.288 . . . . 0.0 110.545 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.02 -29.84 68.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.731 . . . . 0.0 110.053 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -58.9 -42.83 90.53 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -68.61 -35.39 77.26 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.49 -49.49 77.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.396 -0.815 . . . . 0.0 109.204 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.28 -43.22 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.581 -0.699 . . . . 0.0 109.745 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.443 HD22 ' CD2' ' A' ' 5' ' ' HIS . 92.7 mt -62.61 -51.5 67.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.035 -1.041 . . . . 0.0 110.608 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.699 ' CE1' ' OG1' ' A' ' 88' ' ' THR . 59.3 t-80 -71.47 -36.36 71.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.77 -1.206 . . . . 0.0 110.457 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.623 ' OH ' ' CD2' ' A' ' 90' ' ' LEU . 29.1 t80 -59.98 -20.62 58.62 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.909 -1.119 . . . . 0.0 108.842 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.503 ' CG ' ' O ' ' A' ' 101' ' ' LEU . 1.1 tm0? -80.07 -25.8 39.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.234 -0.916 . . . . 0.0 108.626 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -97.8 -7.56 30.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.218 -0.926 . . . . 0.0 109.07 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.699 ' OG1' ' CE1' ' A' ' 84' ' ' HIS . 32.4 m -96.99 139.77 32.51 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.214 -0.929 . . . . 0.0 109.152 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.6 t -87.65 130.24 34.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.14 -0.975 . . . . 0.0 109.358 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.623 ' CD2' ' OH ' ' A' ' 85' ' ' TYR . 10.4 mp -71.82 -17.23 62.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.316 -0.865 . . . . 0.0 109.972 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.703 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.6 p -37.52 -41.93 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.175 -0.953 . . . . 0.0 110.162 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -47.95 -30.34 4.15 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.484 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.51 ' C ' ' H ' ' A' ' 95' ' ' ASP . 94.4 m-70 -83.44 130.31 35.02 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.089 -1.007 . . . . 0.0 108.989 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 58.22 7.73 0.7 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 93' ' ' HIS . 54.7 t0 45.25 35.01 1.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.418 -0.801 . . . . 0.0 109.197 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 55.9 m -156.95 15.48 0.28 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.817 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.703 ' O ' ' N ' ' A' ' 91' ' ' VAL . 68.0 mt -101.62 73.91 1.48 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -79.1 85.15 5.02 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.727 0.775 . . . . 0.0 109.928 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.503 HG21 ' H ' ' A' ' 100' ' ' THR . 8.1 p -165.44 163.57 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.733 0.778 . . . . 0.0 109.081 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 102' ' ' ALA . 68.0 p -135.16 131.96 37.42 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.664 ' C ' ' CD1' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -52.43 95.57 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.406 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -91.81 -51.53 5.18 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.403 -1.436 . . . . 0.0 111.888 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.442 ' CD2' ' HB2' ' A' ' 102' ' ' ALA . 98.5 m-85 -129.06 137.37 30.86 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.743 -1.223 . . . . 0.0 112.043 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -52.98 160.53 4.1 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.232 1.955 . . . . 0.0 111.28 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.409 HG11 ' N ' ' A' ' 106' ' ' TYR . 3.2 p -74.27 -31.82 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.685 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.409 ' N ' HG11 ' A' ' 105' ' ' VAL . 16.0 m-85 -112.03 34.14 4.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.875 . . . . 0.0 109.281 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.65 -42.09 35.97 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.548 -0.72 . . . . 0.0 109.706 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -67.78 -29.85 69.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.892 . . . . 0.0 110.508 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -93.1 126.02 37.99 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.086 -1.009 . . . . 0.0 110.234 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -130.2 150.14 51.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.372 -0.83 . . . . 0.0 109.448 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.713 ' CG ' HH11 ' A' ' 111' ' ' ARG . 1.4 mtt-85 . . . . . 0 C--N 1.298 -1.656 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.23 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.469 0.652 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.33 140.25 58.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -0.966 . . . . 0.0 109.265 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.1 mt -100.79 134.1 20.72 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.14 -0.975 . . . . 0.0 109.392 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -51.51 -14.64 2.05 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.812 1.675 . . . . 0.0 110.925 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.457 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 91.1 m-70 -66.47 -12.93 59.84 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -63.42 -32.28 73.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 108.85 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.575 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 92.3 m-20 -100.53 134.19 43.85 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.352 -0.843 . . . . 0.0 110.004 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 12' ' ' ASN . 95.5 mt-10 -69.27 -27.26 65.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 109.988 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.507 ' CG ' ' N ' ' A' ' 10' ' ' THR . 33.3 pttt -60.79 -35.46 76.53 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 110.508 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.67 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 10.6 p -59.75 -33.39 71.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 110.113 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.67 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -120.78 -37.27 3.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.893 -1.129 . . . . 0.0 110.165 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -86.21 123.85 31.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.993 -1.067 . . . . 0.0 110.47 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.5 t -94.05 -4.95 10.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.79 -162.15 19.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -80.68 61.55 4.4 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.318 -1.107 . . . . 0.0 109.417 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.1 p -79.2 156.7 28.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.299 -0.876 . . . . 0.0 109.092 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -70.18 142.72 52.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.191 -0.943 . . . . 0.0 109.453 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.604 HH11 ' NH2' ' A' ' 36' ' ' ARG . 48.6 mtt-85 -59.46 -38.81 81.75 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.054 -1.029 . . . . 0.0 109.388 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.65 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 40.0 p-10 -62.65 -42.82 99.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.0 -1.062 . . . . 0.0 108.484 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.65 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 80.3 tttt -60.51 -36.6 78.74 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.233 -0.917 . . . . 0.0 109.066 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.702 ' CB ' HH11 ' A' ' 36' ' ' ARG . . . -58.57 -34.03 70.59 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.647 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 75.3 tt0 -58.7 -42.63 89.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.68 -46.94 87.54 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.697 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -67.16 -33.86 76.32 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.582 ' CD1' ' HG ' ' A' ' 47' ' ' SER . 22.7 mt -80.85 -16.01 54.82 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.731 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -74.61 122.43 23.15 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.555 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.82 19.54 78.83 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.18 135.79 38.62 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.359 -1.083 . . . . 0.0 109.685 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.686 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.9 OUTLIER -74.88 157.63 34.74 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.66 0.743 . . . . 0.0 110.157 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.513 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 48.4 p30 -62.25 169.36 2.85 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.88 -28.44 1.89 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 30' ' ' ASP . 76.7 m -80.56 121.03 25.29 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.869 -1.371 . . . . 0.0 108.984 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -136.06 167.26 21.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.908 -1.12 . . . . 0.0 110.517 -179.32 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 1.1 pt? -148.91 161.29 42.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.454 -0.779 . . . . 0.0 110.588 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.527 HG21 ' HG ' ' A' ' 46' ' ' CYS . 65.8 t -106.74 132.73 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.704 ' NH2' ' CD2' ' A' ' 56' ' ' HIS . 35.6 ptt180 -147.75 173.14 13.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 108.884 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.69 ' C ' ' H ' ' A' ' 39' ' ' SER . 53.0 mt-10 -124.33 170.54 10.7 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.83 -1.169 . . . . 0.0 109.268 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.646 ' O ' ' CB ' ' A' ' 39' ' ' SER . 57.7 m -75.39 15.51 0.45 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.69 ' H ' ' C ' ' A' ' 37' ' ' GLU . 6.4 t 97.86 131.03 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.828 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.473 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 67.1 mmtt 62.32 -143.77 0.4 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.508 -0.745 . . . . 0.0 109.103 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -101.57 20.11 16.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -0.847 . . . . 0.0 109.629 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.06 -52.62 51.03 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.062 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 44' ' ' TYR . 53.1 t -161.0 166.58 28.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.99 -1.3 . . . . 0.0 110.246 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.608 ' O ' ' O ' ' A' ' 59' ' ' ILE . 57.2 m-85 -123.66 145.83 48.67 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.279 -0.888 . . . . 0.0 109.048 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 57' ' ' CYS . . . -159.75 153.88 23.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.77 -1.207 . . . . 0.0 109.973 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.527 ' HG ' HG21 ' A' ' 35' ' ' VAL . 85.4 m -109.5 125.86 52.93 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.582 ' HG ' ' CD1' ' A' ' 25' ' ' LEU . 26.1 t -92.05 127.0 37.36 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.06 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.429 ' CG1' ' N ' ' A' ' 49' ' ' VAL . 74.3 t -126.1 163.71 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.187 -0.946 . . . . 0.0 109.978 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.429 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 39.2 t -124.6 132.76 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.488 HG13 ' NZ ' ' A' ' 55' ' ' LYS . 11.4 p -123.34 156.35 29.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.995 -1.066 . . . . 0.0 109.671 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.423 ' OD1' ' OD2' ' A' ' 30' ' ' ASP . 87.2 m-20 -49.97 -17.17 0.35 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.943 0.878 . . . . 0.0 109.634 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.581 ' O ' ' OE2' ' A' ' 53' ' ' GLU . . . -86.18 -59.22 1.88 Allowed Glycine 0 C--N 1.287 -2.142 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.667 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.581 ' OE2' ' O ' ' A' ' 52' ' ' GLY . 61.3 mm-40 -163.22 -165.53 1.1 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.25 -1.147 . . . . 0.0 110.554 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -93.36 123.37 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.488 ' NZ ' HG13 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -122.45 149.15 44.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.911 -1.118 . . . . 0.0 110.905 -179.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.704 ' CD2' ' NH2' ' A' ' 36' ' ' ARG . 23.6 m80 -113.31 101.88 9.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.579 -0.701 . . . . 0.0 109.544 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' CYS . 52.5 t -72.91 130.04 39.5 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.26 138.63 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.246 -0.909 . . . . 0.0 111.878 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.608 ' O ' ' O ' ' A' ' 44' ' ' TYR . 10.9 mm -124.93 111.59 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.695 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 83.6 m-20 -118.59 170.48 8.92 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.647 -1.283 . . . . 0.0 112.182 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -128.29 30.52 5.18 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.327 -1.483 . . . . 0.0 108.985 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.7 p -79.45 -174.93 4.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.314 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.37 -28.35 66.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.19 -0.944 . . . . 0.0 109.616 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.9 p -79.0 -5.59 54.27 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.217 -0.927 . . . . 0.0 109.206 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.663 ' C ' ' H ' ' A' ' 67' ' ' GLY . . . 81.54 171.54 45.62 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.695 ' CA ' ' O ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -64.44 30.8 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.951 -1.323 . . . . 0.0 110.537 -179.244 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.663 ' H ' ' C ' ' A' ' 65' ' ' GLY . . . 88.51 -42.89 3.08 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.63 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 89.7 m-85 -90.43 -6.08 55.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.347 -1.09 . . . . 0.0 110.278 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.63 3.88 45.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.213 -0.929 . . . . 0.0 109.154 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.702 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 46.2 tt0 -59.64 -35.31 28.44 Favored Pre-proline 0 C--N 1.304 -1.379 0 C-N-CA 119.006 -1.078 . . . . 0.0 108.678 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 9.8 Cg_exo -72.81 174.16 12.29 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.634 2.222 . . . . 0.0 111.071 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -62.57 -12.32 22.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.034 -1.041 . . . . 0.0 109.566 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -101.36 102.56 13.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.912 -1.117 . . . . 0.0 110.472 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.495 HD11 ' N ' ' A' ' 74' ' ' LEU . 5.6 mp -106.25 7.4 31.4 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.633 ' OH ' ' CD2' ' A' ' 84' ' ' HIS . 71.4 m-85 60.58 175.02 0.1 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.371 -0.83 . . . . 0.0 109.19 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.7 t -103.71 -48.72 3.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.122 -0.986 . . . . 0.0 110.048 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.8 m -126.3 154.77 42.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.094 -1.004 . . . . 0.0 110.183 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.16 -34.05 73.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 110.03 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.72 -43.74 80.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.188 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -66.9 -30.53 70.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.228 -0.92 . . . . 0.0 108.856 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.542 ' CD2' ' CE2' ' A' ' 85' ' ' TYR . 9.2 tt -60.6 -40.9 93.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 108.987 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.2 t -66.86 -44.17 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.361 -0.837 . . . . 0.0 109.819 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.428 HD22 ' CD2' ' A' ' 5' ' ' HIS . 85.0 mt -67.45 -43.09 81.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.419 -0.8 . . . . 0.0 110.439 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.633 ' CD2' ' OH ' ' A' ' 75' ' ' TYR . 83.9 t60 -60.02 -40.56 89.72 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.215 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.63 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 7.4 m-30 -67.34 -24.31 65.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 0.0 108.789 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.453 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 38.1 tt0 -61.32 -36.94 81.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -91.44 -16.71 26.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.303 -0.873 . . . . 0.0 109.592 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.4 m -100.84 129.92 46.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.131 -0.981 . . . . 0.0 109.228 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 t -81.67 132.56 35.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 109.915 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 91' ' ' VAL . 76.2 mt -69.01 -13.07 62.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.477 -0.764 . . . . 0.0 109.715 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.76 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.8 p -36.66 -33.75 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.464 -0.773 . . . . 0.0 110.011 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 90' ' ' LEU . 20.0 tt0 -65.86 -50.07 65.86 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLN . 84.3 t60 -51.43 -47.53 63.0 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.689 ' O ' ' N ' ' A' ' 96' ' ' SER . 13.1 t-20 -126.29 111.25 14.33 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.54 ' C ' ' O ' ' A' ' 94' ' ' ASN . 99.7 m-20 -35.98 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.886 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 94' ' ' ASN . 71.1 m -108.37 27.07 9.71 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.736 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.76 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.5 mt -97.96 65.84 1.81 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.563 -1.336 . . . . 0.0 108.2 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.79 75.57 6.47 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.81 -1.182 . . . . 0.0 109.41 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.5 t -153.56 153.62 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.522 -0.736 . . . . 0.0 109.805 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.2 p -134.33 156.79 47.85 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.503 HD21 ' CG ' ' A' ' 33' ' ' PHE . 11.6 mt -76.48 71.65 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.706 -1.246 . . . . 0.0 108.007 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.3 -33.76 9.91 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.169 -0.957 . . . . 0.0 112.111 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.4 m-85 -113.97 109.29 49.93 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.503 -1.373 . . . . 0.0 111.977 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.422 ' CB ' ' O ' ' A' ' 10' ' ' THR . 19.0 Cg_exo -59.97 148.61 88.21 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.083 1.855 . . . . 0.0 110.276 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.567 ' O ' ' OE1' ' A' ' 109' ' ' GLN . 9.1 p -67.25 -34.59 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.822 -1.174 . . . . 0.0 108.77 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.503 ' CD2' HG12 ' A' ' 105' ' ' VAL . 38.6 m-85 -108.14 39.4 1.97 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.447 -0.783 . . . . 0.0 110.191 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.99 117.4 23.36 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.996 -1.065 . . . . 0.0 109.599 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 49.46 45.93 23.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.334 -0.854 . . . . 0.0 109.975 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.567 ' OE1' ' O ' ' A' ' 105' ' ' VAL . 41.9 mt-30 -104.42 135.01 46.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.795 -1.191 . . . . 0.0 110.122 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -61.38 -35.44 77.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.578 -0.701 . . . . 0.0 110.146 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.482 ' HA ' ' HE ' ' A' ' 111' ' ' ARG . 4.6 tpm_? . . . . . 0 N--CA 1.493 1.716 0 O-C-N 120.961 -1.087 . . . . 0.0 109.217 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -63.33 133.46 54.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.222 -0.924 . . . . 0.0 110.059 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.5 mt -90.32 145.61 33.0 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.425 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 28.5 Cg_endo -64.3 -6.9 12.59 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.7 2.267 . . . . 0.0 112.288 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.473 ' NE2' HG13 ' A' ' 82' ' ' VAL . 7.3 m80 -67.37 -21.31 65.63 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 108.965 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -59.68 -34.2 72.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.776 -1.203 . . . . 0.0 108.236 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -97.18 126.76 42.57 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.175 -0.953 . . . . 0.0 109.354 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.614 ' CG ' ' OD1' ' A' ' 12' ' ' ASN . 23.2 tt0 -68.07 -28.27 67.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.6 -0.688 . . . . 0.0 110.125 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.706 ' NZ ' ' O ' ' A' ' 106' ' ' TYR . 2.3 tmpt? -62.44 -27.19 68.94 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.261 -0.9 . . . . 0.0 111.623 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.727 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 41.7 p -62.57 -29.74 70.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.991 -1.068 . . . . 0.0 112.127 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.759 ' CE3' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -123.86 -31.23 3.44 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.189 -1.57 . . . . 0.0 110.34 179.457 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.759 ' ND2' ' CE3' ' A' ' 11' ' ' TRP . 1.2 m-80 -73.74 130.81 40.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.132 -0.98 . . . . 0.0 109.663 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.9 t -115.79 -11.16 12.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.633 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.81 -152.42 21.81 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.1 p -83.46 112.07 19.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -1.123 . . . . 0.0 109.524 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.0 m -126.07 143.13 51.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.073 -1.017 . . . . 0.0 110.152 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.653 ' ND2' ' ND2' ' A' ' 19' ' ' ASN . 59.5 t-20 -67.11 148.38 51.93 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.576 -0.702 . . . . 0.0 109.26 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.514 ' HA ' HH12 ' A' ' 36' ' ' ARG . 85.5 mtm180 -61.05 -40.35 93.29 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 110.022 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 44.0 p30 -61.49 -33.14 73.27 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.085 -1.009 . . . . 0.0 108.977 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.674 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 7.3 tppt? -77.76 -34.75 52.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.127 -0.983 . . . . 0.0 108.945 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.5 92.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -0.793 . . . . 0.0 109.349 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 26' ' ' ARG . 14.4 pt-20 -60.12 -46.01 91.07 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.0 -1.063 . . . . 0.0 108.442 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.428 ' N ' ' HG3' ' A' ' 22' ' ' GLU . 98.3 m-20 -56.07 -42.44 76.67 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.31 -29.75 67.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.319 -0.863 . . . . 0.0 109.163 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.475 HD12 ' HG ' ' A' ' 47' ' ' SER . 11.5 mt -91.68 -9.93 42.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -0.792 . . . . 0.0 109.134 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 22' ' ' GLU . 1.1 ttt180 -90.75 125.8 35.81 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.195 -0.94 . . . . 0.0 109.476 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.2 1.02 61.23 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -96.9 141.1 30.5 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.403 -1.057 . . . . 0.0 108.16 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -72.82 151.74 41.89 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.275 -0.891 . . . . 0.0 108.854 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -50.95 147.99 4.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 109.287 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.79 -20.82 44.52 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.5 m -86.27 122.33 30.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -1.079 . . . . 0.0 110.074 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.538 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.8 OUTLIER -136.46 167.22 21.76 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.366 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 pp -140.63 160.12 40.7 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.664 -0.815 . . . . 0.0 109.545 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.36 125.65 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.416 -0.803 . . . . 0.0 109.756 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.514 HH12 ' HA ' ' A' ' 18' ' ' ARG . 29.0 ptt180 -143.9 -174.06 4.16 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.72 ' C ' ' H ' ' A' ' 39' ' ' SER . 0.3 OUTLIER -105.08 173.55 6.26 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.825 -1.172 . . . . 0.0 108.985 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.66 ' O ' ' CB ' ' A' ' 39' ' ' SER . 70.9 m -76.75 14.22 0.86 Allowed 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.72 ' H ' ' C ' ' A' ' 37' ' ' GLU . 83.3 p 112.76 -37.58 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.222 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.497 ' C ' ' OE1' ' A' ' 37' ' ' GLU . 65.3 tttm -96.18 123.32 39.75 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.565 ' C ' ' OE1' ' A' ' 41' ' ' GLN . 1.1 tm0? -47.94 -16.95 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.464 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 40' ' ' LYS . . . -64.27 -37.53 94.65 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 120.217 -0.992 . . . . 0.0 110.837 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.3 t -111.51 152.3 27.64 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.801 -1.411 . . . . 0.0 110.05 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.585 ' O ' ' O ' ' A' ' 59' ' ' ILE . 31.9 m-85 -115.48 155.69 27.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.396 -0.815 . . . . 0.0 109.054 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -155.42 138.72 15.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.904 -1.122 . . . . 0.0 110.059 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 57' ' ' CYS . 29.5 p -111.1 125.42 53.75 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.913 -1.117 . . . . 0.0 108.237 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.514 ' OG ' ' O ' ' A' ' 55' ' ' LYS . 44.2 t -108.21 138.13 45.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 0.0 109.845 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.424 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 10.2 p -131.97 164.22 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.052 -1.03 . . . . 0.0 110.31 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.424 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 86.7 t -109.93 127.33 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.701 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 7.9 p -160.02 168.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.888 -1.133 . . . . 0.0 110.909 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.509 ' N ' HG23 ' A' ' 50' ' ' VAL . 61.6 t0 40.88 24.28 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.831 -0.543 . . . . 0.0 110.731 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 80.1 -1.85 78.35 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.053 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.49 ' HB3' ' HZ3' ' A' ' 55' ' ' LYS . 15.3 tp10 -119.88 143.58 47.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.335 . . . . 0.0 110.489 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 83.7 t -82.59 127.66 39.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.566 0.698 . . . . 0.0 109.163 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.701 ' NZ ' ' O ' ' A' ' 50' ' ' VAL . 6.6 mptt -110.16 158.15 18.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.0 110.933 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -130.36 73.96 1.56 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.422 -0.798 . . . . 0.0 109.539 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.462 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 42.2 t -63.92 136.78 57.64 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.404 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.78 139.84 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.84 0.829 . . . . 0.0 111.989 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.585 ' O ' ' O ' ' A' ' 44' ' ' TYR . 20.0 mm -118.23 144.96 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 22.6 m120 -112.32 161.08 17.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.842 -1.161 . . . . 0.0 109.631 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -122.09 21.07 10.6 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.869 -1.144 . . . . 0.0 110.193 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 65' ' ' GLY . 89.6 m -96.6 154.79 17.07 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.89 -1.131 . . . . 0.0 109.128 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -43.95 -52.48 6.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.797 -1.19 . . . . 0.0 109.017 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.0 m -89.16 -0.75 57.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.026 -1.046 . . . . 0.0 108.414 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 66' ' ' TYR . . . -79.62 -97.39 0.3 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.526 ' O ' ' O ' ' A' ' 65' ' ' GLY . 43.7 m-85 46.75 -178.95 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.586 -0.949 . . . . 0.0 109.215 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.68 -39.45 93.73 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.632 ' CE2' ' OH ' ' A' ' 85' ' ' TYR . 35.5 m-85 -131.2 -58.8 0.99 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.112 -1.228 . . . . 0.0 109.062 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 68.0 30.19 6.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.92 . . . . 0.0 110.377 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -69.02 155.41 93.62 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.166 -0.959 . . . . 0.0 109.291 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -43.04 -21.25 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.956 2.437 . . . . 0.0 112.579 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.413 ' O ' ' HB3' ' A' ' 73' ' ' ASN . 98.0 m-85 -68.08 -6.92 25.34 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.353 -0.842 . . . . 0.0 109.19 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 53.2 t30 64.02 141.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.366 -0.834 . . . . 0.0 109.191 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.575 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 98.2 mt -74.17 -118.15 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.217 -0.927 . . . . 0.0 109.215 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.676 ' CD1' ' OE2' ' A' ' 80' ' ' GLU . 50.6 m-85 -149.13 -165.04 2.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.867 -1.146 . . . . 0.0 111.164 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.1 t -67.86 -40.99 83.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.258 -0.901 . . . . 0.0 111.878 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -137.56 157.9 45.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.484 -1.385 . . . . 0.0 111.424 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.6 mt -59.63 -28.28 67.08 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -53.27 -42.39 66.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.83 -1.168 . . . . 0.0 108.016 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.676 ' OE2' ' CD1' ' A' ' 75' ' ' TYR . 7.2 tm-20 -63.92 -37.04 85.96 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.448 ' C ' ' CD2' ' A' ' 81' ' ' LEU . 8.2 tt -59.2 -48.04 83.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 0.0 109.203 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.473 HG13 ' NE2' ' A' ' 5' ' ' HIS . 97.2 t -60.68 -39.31 81.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.042 -1.036 . . . . 0.0 108.579 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.426 ' O ' ' HB3' ' A' ' 86' ' ' GLN . 79.6 mt -64.17 -35.12 79.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.384 -0.822 . . . . 0.0 109.965 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.615 ' CE1' ' OE2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -56.27 -48.65 76.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.723 -1.236 . . . . 0.0 110.027 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.632 ' OH ' ' CE2' ' A' ' 68' ' ' PHE . 73.3 m-85 -61.74 -30.09 70.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.914 -1.116 . . . . 0.0 109.353 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' ' 83' ' ' LEU . 37.3 tt0 -60.96 -34.87 75.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.43 -0.793 . . . . 0.0 109.558 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -96.4 -11.18 26.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 110.621 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.2 m -114.34 129.74 56.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.748 -1.22 . . . . 0.0 110.746 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.7 t -76.47 124.6 27.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.759 -0.588 . . . . 0.0 109.786 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.726 ' O ' ' N ' ' A' ' 92' ' ' GLN . 5.0 mp -67.41 -31.44 71.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.478 -0.763 . . . . 0.0 111.316 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.761 ' CG1' ' H ' ' A' ' 92' ' ' GLN . 7.6 p 12.31 -75.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.597 0 O-C-N 121.844 -0.535 . . . . 0.0 110.285 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.761 ' H ' ' CG1' ' A' ' 91' ' ' VAL . 26.5 tt0 62.63 -175.98 0.14 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.421 -0.8 . . . . 0.0 111.105 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.703 ' H ' ' CG ' ' A' ' 92' ' ' GLN . 88.4 m-70 -58.44 -35.54 72.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.55 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -50.64 -25.48 4.28 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 60.0 14.6 4.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.678 -0.639 . . . . 0.0 109.751 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.42 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 54.7 p -132.33 9.19 4.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.968 -1.082 . . . . 0.0 109.751 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.732 ' O ' ' N ' ' A' ' 91' ' ' VAL . 83.9 mt -96.58 36.57 1.36 Allowed 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.441 ' OD1' ' HB ' ' A' ' 91' ' ' VAL . 98.7 m-20 -75.98 70.34 2.68 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.8 p -159.47 159.35 2.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.0 p -121.8 149.21 43.65 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.538 HD21 ' CG ' ' A' ' 33' ' ' PHE . 56.3 mt -73.94 69.13 1.4 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -98.2 -24.62 15.2 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.444 -0.785 . . . . 0.0 112.548 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.455 ' CE2' ' O ' ' A' ' 104' ' ' PRO . 80.8 t80 -114.02 131.01 23.37 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.268 -1.52 . . . . 0.0 110.97 -178.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.455 ' O ' ' CE2' ' A' ' 103' ' ' TYR . 63.3 Cg_endo -76.14 149.33 32.08 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 123.354 2.703 . . . . 0.0 112.182 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.5 p -78.5 -17.83 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.025 -1.047 . . . . 0.0 109.776 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.706 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . 33.9 m-85 -132.18 56.35 1.83 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.025 -1.047 . . . . 0.0 110.569 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.84 132.97 50.9 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.15 -0.969 . . . . 0.0 109.844 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -67.74 -43.33 80.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.144 -0.972 . . . . 0.0 109.468 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 51.73 57.86 6.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.322 -0.861 . . . . 0.0 109.314 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.741 HH11 ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -61.69 -33.14 73.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.0 109.771 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.74 ' CG ' HH11 ' A' ' 111' ' ' ARG . 2.2 mtt-85 . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.115 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.9 p30 -73.28 175.39 6.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.338 -0.851 . . . . 0.0 109.725 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.7 mt -93.01 129.72 38.65 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.226 -0.922 . . . . 0.0 109.669 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.495 ' O ' ' OG1' ' A' ' 10' ' ' THR . 28.9 Cg_endo -68.55 -3.86 11.92 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.35 2.033 . . . . 0.0 111.974 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -80.93 -6.33 58.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 110.016 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -76.11 -31.14 58.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.197 -0.939 . . . . 0.0 110.111 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -105.18 132.78 50.97 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.235 -0.916 . . . . 0.0 109.981 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.675 ' O ' ' N ' ' A' ' 12' ' ' ASN . 95.9 mt-10 -66.77 -29.33 69.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.477 -0.764 . . . . 0.0 110.57 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.46 ' CG ' ' N ' ' A' ' 10' ' ' THR . 3.0 pttt -57.66 -33.58 68.46 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.336 -0.853 . . . . 0.0 111.0 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.697 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 47.2 p -65.67 -30.91 71.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.888 -1.132 . . . . 0.0 110.704 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.697 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -119.82 -28.86 5.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.673 -1.267 . . . . 0.0 109.78 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' A' ' 8' ' ' GLU . 56.2 t-20 -83.63 130.62 34.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.605 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -96.35 -12.82 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.287 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.13 -157.96 34.1 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 95.2 p -63.83 132.68 51.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.149 -1.207 . . . . 0.0 109.801 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.9 t -176.71 165.46 2.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 109.619 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -95.12 147.8 23.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.468 -0.77 . . . . 0.0 109.747 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.781 ' NH1' ' HG ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -59.72 -35.57 74.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.164 -0.96 . . . . 0.0 110.016 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -57.17 -46.06 83.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.684 -1.26 . . . . 0.0 108.43 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.695 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 79.9 tttt -59.98 -35.11 74.31 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -60.04 -38.93 84.2 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' ARG . 97.1 mt-10 -53.64 -47.51 70.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.863 . . . . 0.0 108.823 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.695 ' ND2' ' O ' ' A' ' 20' ' ' LYS . 9.5 p30 -62.11 -41.29 98.08 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.674 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 79.2 mt -65.09 -30.21 71.14 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 21' ' ' ALA . 19.2 mt -93.1 -10.73 34.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.444 -0.785 . . . . 0.0 109.817 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.564 ' CG ' ' N ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -79.71 -49.53 11.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 109.635 -179.088 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.564 ' N ' ' CG ' ' A' ' 26' ' ' ARG . . . -87.99 25.95 8.21 Favored Glycine 0 C--N 1.287 -2.188 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -115.11 125.34 53.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.25 -1.147 . . . . 0.0 110.521 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -72.77 159.33 33.97 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.497 -0.752 . . . . 0.0 109.142 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 59.9 p30 -57.36 151.2 16.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.056 -1.028 . . . . 0.0 110.172 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.17 -18.46 55.55 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.1 m -100.67 127.43 47.08 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.165 -1.197 . . . . 0.0 109.09 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.505 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -130.4 161.27 31.72 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.034 178.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 pp -129.35 155.07 46.23 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.636 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.487 HG21 ' CE2' ' A' ' 33' ' ' PHE . 72.6 t -116.26 131.14 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.777 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.632 ' CB ' ' CZ ' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -146.11 -141.91 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 108.928 179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.698 ' C ' ' H ' ' A' ' 39' ' ' SER . 45.9 mp0 -107.56 174.91 5.68 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.633 ' O ' ' CB ' ' A' ' 39' ' ' SER . 61.0 m -76.37 15.66 0.57 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.781 ' HG ' ' NH1' ' A' ' 18' ' ' ARG . 4.0 m 101.97 -43.47 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.089 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -89.51 149.31 22.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 108.968 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -67.4 144.97 55.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.026 -1.046 . . . . 0.0 109.693 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.45 6.45 62.66 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.5 m -129.66 159.25 37.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.042 -1.27 . . . . 0.0 110.031 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.594 ' O ' ' O ' ' A' ' 59' ' ' ILE . 74.8 m-85 -122.61 149.58 43.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.031 -1.043 . . . . 0.0 109.015 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -169.05 142.36 2.82 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.094 -1.004 . . . . 0.0 109.053 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 57' ' ' CYS . 16.8 p -124.93 148.15 48.5 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.264 -0.898 . . . . 0.0 108.808 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.419 ' HG ' HD23 ' A' ' 25' ' ' LEU . 77.3 p -120.21 143.2 48.39 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.684 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.453 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 1.5 p -130.6 155.23 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.476 -0.765 . . . . 0.0 109.766 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.453 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 69.9 t -110.8 132.64 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.761 -0.587 . . . . 0.0 110.099 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.557 HG11 ' H ' ' A' ' 52' ' ' GLY . 8.3 p -122.04 156.27 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.0 -1.063 . . . . 0.0 108.876 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 59.4 t0 -49.3 -18.3 0.35 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.873 0.844 . . . . 0.0 110.022 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.557 ' H ' HG11 ' A' ' 50' ' ' VAL . . . -92.1 -52.81 2.15 Favored Glycine 0 C--N 1.286 -2.23 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.585 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 44.6 mt-10 -161.11 169.37 22.51 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.724 -1.456 . . . . 0.0 112.028 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.8 t -85.86 136.78 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -131.8 150.86 52.02 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.576 -1.328 . . . . 0.0 111.776 -178.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.532 ' CD2' ' HE ' ' A' ' 18' ' ' ARG . 29.2 m80 -110.66 117.45 33.52 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' A' ' 46' ' ' CYS . 48.8 t -104.08 129.23 51.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.87 -1.144 . . . . 0.0 108.574 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' A' ' 58' ' ' VAL . 4.7 p -94.68 132.72 37.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 111.292 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.594 ' O ' ' O ' ' A' ' 44' ' ' TYR . 98.0 mt -118.12 140.89 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 96.5 m-20 -112.31 148.25 34.6 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.967 -1.083 . . . . 0.0 109.349 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HD2' ' CE1' ' A' ' 44' ' ' TYR . 11.5 ttmt -113.68 103.19 10.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.826 -1.171 . . . . 0.0 110.08 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.578 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 89.1 m -162.21 170.11 19.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 109.298 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.437 ' N ' ' CG2' ' A' ' 62' ' ' THR . . . -59.95 -41.67 92.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.114 -0.991 . . . . 0.0 109.805 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.5 m -112.94 5.55 17.36 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.104 -0.997 . . . . 0.0 109.822 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.68 -88.01 1.2 Allowed Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.709 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 62' ' ' THR . 82.3 m-85 56.66 177.62 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.08 -1.247 . . . . 0.0 109.604 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.38 -87.61 0.27 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.708 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 6.9 m-30 -87.78 131.91 34.34 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.101 -1.235 . . . . 0.0 109.405 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.99 -5.58 6.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.031 -1.043 . . . . 0.0 109.19 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.748 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 69.2 mm-40 -68.26 -32.41 3.9 Favored Pre-proline 0 C--N 1.307 -1.281 0 O-C-N 121.127 -0.983 . . . . 0.0 109.254 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.748 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 17.0 Cg_exo -65.51 -7.47 16.25 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.348 2.032 . . . . 0.0 111.297 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.703 ' CD1' ' O ' ' A' ' 71' ' ' PRO . 50.2 p90 45.52 44.59 10.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.337 -0.852 . . . . 0.0 109.568 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 74' ' ' LEU . 10.9 m120 -109.98 -16.34 13.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.455 -0.778 . . . . 0.0 109.866 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 73' ' ' ASN . 57.5 tp 43.6 84.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.958 -1.089 . . . . 0.0 109.301 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -59.87 133.53 56.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.038 -1.038 . . . . 0.0 109.719 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.1 m -68.02 -37.68 81.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.474 -0.766 . . . . 0.0 110.216 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.4 t -140.69 156.86 46.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.954 -1.091 . . . . 0.0 110.147 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.93 -37.39 82.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.548 -0.72 . . . . 0.0 109.461 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -56.71 -42.82 79.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.476 -0.765 . . . . 0.0 109.044 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -64.63 -33.53 76.16 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.229 -0.919 . . . . 0.0 109.15 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 10.2 tt -59.82 -48.17 82.77 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 109.535 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 95.5 t -67.53 -37.19 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.204 -0.935 . . . . 0.0 109.17 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.409 ' O ' ' HG2' ' A' ' 86' ' ' GLN . 52.3 tp -66.49 -47.73 72.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.285 -0.884 . . . . 0.0 110.359 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -63.11 -40.43 97.61 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.994 -1.066 . . . . 0.0 110.317 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.708 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 3.9 m-85 -62.15 -29.67 70.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.469 -0.769 . . . . 0.0 111.501 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.612 ' O ' ' OG1' ' A' ' 100' ' ' THR . 5.8 pt20 -66.91 -29.09 68.88 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.301 -1.499 . . . . 0.0 108.334 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -79.18 -39.65 32.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.401 -0.812 . . . . 0.0 109.829 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.0 t -79.61 154.21 28.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.006 . . . . 0.0 109.993 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.5 t -104.55 133.18 49.85 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.609 ' N ' ' CD2' ' A' ' 90' ' ' LEU . 3.1 mm? -70.51 -10.92 60.44 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.513 -0.742 . . . . 0.0 110.319 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.685 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.4 p -40.14 -43.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.135 -0.978 . . . . 0.0 109.812 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.5 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 9.7 tt0 -38.58 -36.63 0.26 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.906 -0.496 . . . . 0.0 110.766 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.707 ' O ' ' N ' ' A' ' 95' ' ' ASP . 23.4 t-160 -64.87 124.65 22.57 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.951 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.512 ' ND2' ' NE2' ' A' ' 93' ' ' HIS . 78.5 m-20 44.28 9.71 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.034 -1.041 . . . . 0.0 109.278 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 93' ' ' HIS . 81.8 m-20 57.62 43.78 21.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.299 -0.876 . . . . 0.0 110.873 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.2 m -151.61 4.64 0.43 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.556 -1.34 . . . . 0.0 111.415 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.715 ' CD2' ' N ' ' A' ' 97' ' ' LEU . 2.1 mm? -100.47 70.68 1.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.607 -1.308 . . . . 0.0 107.774 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -79.73 94.63 5.78 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.049 0.928 . . . . 0.0 109.748 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.619 ' CG2' ' H ' ' A' ' 100' ' ' THR . 7.1 p -174.06 -177.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.619 ' H ' ' CG2' ' A' ' 99' ' ' VAL . 9.0 t -160.42 166.73 28.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.014 -1.054 . . . . 0.0 109.501 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.505 HD21 ' CG ' ' A' ' 33' ' ' PHE . 18.6 mt -79.96 63.73 4.58 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.44 -26.46 19.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.937 -0.477 . . . . 0.0 112.092 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -122.41 134.22 24.76 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.279 -1.513 . . . . 0.0 111.455 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.55 148.98 43.28 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 122.699 2.266 . . . . 0.0 111.302 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.484 HG12 ' CD2' ' A' ' 106' ' ' TYR . 9.0 p -72.41 -18.61 19.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.266 -0.896 . . . . 0.0 108.756 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.484 ' CD2' HG12 ' A' ' 105' ' ' VAL . 39.7 m-85 -131.42 65.18 1.57 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.478 -0.764 . . . . 0.0 110.023 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.52 144.56 51.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.962 -1.086 . . . . 0.0 110.024 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -58.13 136.94 57.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.281 -0.887 . . . . 0.0 110.258 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -74.91 151.26 38.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.316 -0.865 . . . . 0.0 108.98 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 111' ' ' ARG . 56.2 mtp180 -120.71 150.08 41.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.904 -1.123 . . . . 0.0 108.949 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.556 ' HG2' HH11 ' A' ' 111' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.008 -1.057 . . . . 0.0 109.274 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -74.95 163.38 27.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.994 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.4 HD13 ' N ' ' A' ' 3' ' ' LEU . 7.0 mp -102.58 147.74 34.48 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.535 -0.728 . . . . 0.0 110.204 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.19 -2.93 6.46 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.696 2.264 . . . . 0.0 111.443 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -65.89 -31.91 73.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.34 -0.85 . . . . 0.0 108.96 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -61.31 -18.27 57.75 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.627 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.675 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 94.6 m-20 -96.9 110.14 22.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.33 -0.856 . . . . 0.0 110.314 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.524 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 80.1 tt0 -69.27 -30.64 68.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.423 -0.798 . . . . 0.0 109.78 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 pttt -69.56 -11.56 60.93 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.431 -0.793 . . . . 0.0 110.76 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.509 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 43.9 p -85.32 -22.88 28.33 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.821 -1.175 . . . . 0.0 112.258 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.675 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -122.51 -26.77 4.52 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.256 -1.528 . . . . 0.0 109.839 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.632 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 14.9 p-10 -80.14 142.07 35.13 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.874 -1.141 . . . . 0.0 109.855 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.1 p -112.34 -16.84 8.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.05 -164.0 51.16 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.0 p -58.11 133.74 55.85 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.212 -1.169 . . . . 0.0 108.578 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.6 t -172.09 154.74 3.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.313 -0.867 . . . . 0.0 109.385 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -76.16 144.73 40.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.972 -1.08 . . . . 0.0 109.357 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.433 ' HG2' ' HE ' ' A' ' 36' ' ' ARG . 86.0 mtm180 -59.85 -39.51 85.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -57.9 -38.9 76.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.818 -1.176 . . . . 0.0 109.017 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -58.18 -34.25 70.12 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -62.51 -35.97 81.08 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.521 ' CG ' ' NE ' ' A' ' 26' ' ' ARG . 71.7 tt0 -55.95 -50.14 71.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.081 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -60.31 -44.17 95.69 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.976 -1.078 . . . . 0.0 108.272 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.46 HD12 ' HH ' ' A' ' 106' ' ' TYR . 86.8 mt -66.72 -30.3 70.51 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 21' ' ' ALA . 7.0 mt -92.86 -6.44 48.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.213 -0.93 . . . . 0.0 109.505 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.555 HH11 ' HG2' ' A' ' 26' ' ' ARG . 20.7 mtt-85 -100.59 137.39 39.05 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.328 -0.857 . . . . 0.0 109.641 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.44 -2.17 86.28 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -103.39 147.08 27.55 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.998 -1.295 . . . . 0.0 110.004 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.731 ' CG ' HH11 ' A' ' 29' ' ' ARG . 2.1 mtt-85 -74.73 161.61 29.47 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.598 0.713 . . . . 0.0 110.75 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.555 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 60.3 t0 -59.91 143.09 52.37 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.429 -0.794 . . . . 0.0 109.677 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 106.98 -25.04 23.58 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.6 m -78.99 122.46 26.2 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.258 -1.142 . . . . 0.0 108.775 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.555 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -134.19 173.64 11.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.712 -1.243 . . . . 0.0 110.713 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.74 159.84 44.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.723 -0.61 . . . . 0.0 109.676 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.7 t -110.2 127.75 66.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.278 -0.889 . . . . 0.0 108.758 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.745 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -145.2 -175.85 4.86 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.725 ' C ' ' H ' ' A' ' 39' ' ' SER . 97.8 mt-10 -103.83 169.78 8.31 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.928 -1.107 . . . . 0.0 108.378 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.631 ' O ' ' CB ' ' A' ' 39' ' ' SER . 97.8 p -75.76 12.1 1.17 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 178.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.725 ' H ' ' C ' ' A' ' 37' ' ' GLU . 16.5 p 99.71 -17.2 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 113.533 -1.667 . . . . 0.0 108.301 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -87.65 141.4 28.63 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -60.33 -36.02 76.98 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.968 -1.083 . . . . 0.0 109.739 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.71 32.24 5.95 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.566 -1.302 . . . . 0.0 111.689 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.493 ' SG ' ' OG ' ' A' ' 38' ' ' SER . 48.1 t -137.51 149.56 46.87 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.715 -1.462 . . . . 0.0 109.681 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -127.5 143.0 51.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.225 -0.922 . . . . 0.0 109.84 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -160.31 133.51 6.73 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.59 -1.318 . . . . 0.0 110.292 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 57' ' ' CYS . 14.3 p -106.31 135.11 48.38 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.684 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.468 ' HG ' ' HD1' ' A' ' 56' ' ' HIS . 55.0 m -104.74 138.22 41.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.2 t -131.99 152.93 37.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.188 -0.945 . . . . 0.0 109.921 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.555 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 58.0 t -100.71 122.05 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.495 HG11 ' NZ ' ' A' ' 55' ' ' LYS . 13.4 p -160.47 172.44 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.678 -1.264 . . . . 0.0 111.861 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.498 ' HB3' ' NZ ' ' A' ' 55' ' ' LYS . 64.6 t0 48.44 20.52 0.3 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.526 0.679 . . . . 0.0 109.57 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.31 10.74 85.7 Favored Glycine 0 C--N 1.295 -1.749 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.106 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.663 ' CG ' ' NZ ' ' A' ' 55' ' ' LYS . 16.7 pt-20 -139.98 157.84 45.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.727 -1.455 . . . . 0.0 110.472 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.425 ' CG1' HD12 ' A' ' 25' ' ' LEU . 74.9 t -78.85 142.09 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 110.097 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.663 ' NZ ' ' CG ' ' A' ' 53' ' ' GLU . 0.9 OUTLIER -119.83 153.54 35.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.496 -0.753 . . . . 0.0 110.419 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.468 ' HD1' ' HG ' ' A' ' 47' ' ' SER . 8.9 m-70 -126.98 74.94 1.54 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.439 -0.788 . . . . 0.0 108.947 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.496 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 44.3 t -65.97 138.86 58.1 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.369 -0.832 . . . . 0.0 109.365 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.78 139.89 23.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.508 -0.745 . . . . 0.0 110.547 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.9 mt -118.44 129.97 73.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.596 ' O ' ' O ' ' A' ' 66' ' ' TYR . 90.5 m-20 -129.52 123.7 32.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.01 -1.056 . . . . 0.0 110.867 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 20.8 ptmt -109.36 123.42 49.28 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.336 -0.852 . . . . 0.0 109.764 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.7 ' O ' ' N ' ' A' ' 64' ' ' THR . 14.2 m -132.22 97.75 4.22 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 108.591 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 54.29 -81.4 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.843 -1.161 . . . . 0.0 108.055 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.7 ' N ' ' O ' ' A' ' 62' ' ' THR . 64.1 p -112.88 19.89 16.92 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.729 ' O ' ' CG ' ' A' ' 66' ' ' TYR . . . -94.59 175.07 33.96 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.729 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 89.3 m-85 -169.55 -163.51 0.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.486 ' HA2' ' H ' ' A' ' 60' ' ' ASN . . . -74.73 -50.5 9.12 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.682 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 96.9 m-85 -113.33 125.21 54.03 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.456 -1.026 . . . . 0.0 109.768 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.31 0.52 7.04 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.011 -1.056 . . . . 0.0 109.734 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.639 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 55.1 tt0 -63.19 -38.0 37.21 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.92 . . . . 0.0 110.543 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 37.8 Cg_endo -85.22 159.06 11.3 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.773 2.315 . . . . 0.0 111.311 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 72' ' ' TYR . 78.3 t80 -86.89 59.85 5.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.877 -1.14 . . . . 0.0 108.234 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.685 ' C ' HD21 ' A' ' 73' ' ' ASN . 0.2 OUTLIER -104.11 -48.69 3.8 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.046 -1.034 . . . . 0.0 110.779 -178.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.4 mt 54.89 68.58 0.84 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.799 -1.188 . . . . 0.0 109.05 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -53.22 127.2 23.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.12 -0.987 . . . . 0.0 109.855 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.9 m -72.3 -36.0 68.81 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.512 -0.743 . . . . 0.0 110.118 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.1 p -143.09 158.66 43.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.163 -0.961 . . . . 0.0 110.35 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.4 mt -59.9 -35.27 74.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.413 -0.804 . . . . 0.0 110.082 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -57.37 -40.85 79.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.01 -1.056 . . . . 0.0 109.212 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -69.86 -34.65 73.88 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.082 -1.011 . . . . 0.0 109.228 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.52 ' C ' ' CD1' ' A' ' 81' ' ' LEU . 3.0 tm? -60.64 -49.29 78.13 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.098 -1.001 . . . . 0.0 110.819 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.47 HG11 ' N ' ' A' ' 83' ' ' LEU . 2.4 p -65.5 -37.64 80.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 120.844 -1.16 . . . . 0.0 109.485 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.47 ' N ' HG11 ' A' ' 82' ' ' VAL . 54.6 tp -68.52 -45.74 71.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.299 -0.876 . . . . 0.0 110.842 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -61.85 -40.02 93.89 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.119 -0.988 . . . . 0.0 110.143 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.682 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 1.8 m-85 -71.02 -24.28 62.34 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.943 -1.098 . . . . 0.0 110.91 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.585 ' O ' ' OE1' ' A' ' 86' ' ' GLN . 0.7 OUTLIER -61.66 -22.92 65.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.023 -1.048 . . . . 0.0 108.768 179.156 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -101.59 -33.85 9.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.4 -0.812 . . . . 0.0 108.98 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.5 m -82.55 142.62 31.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.407 -0.808 . . . . 0.0 109.893 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.3 m -96.68 129.94 43.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.596 -0.69 . . . . 0.0 109.97 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.727 ' O ' ' N ' ' A' ' 92' ' ' GLN . 1.6 mt -65.6 -12.48 53.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.38 -0.825 . . . . 0.0 111.794 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.738 ' N ' ' O ' ' A' ' 97' ' ' LEU . 8.2 p -9.23 -53.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.015 0 O-C-N 121.409 -0.807 . . . . 0.0 111.466 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.727 ' N ' ' O ' ' A' ' 90' ' ' LEU . 54.3 tt0 -36.41 146.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 109.575 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.683 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 7.7 t-160 103.94 -120.13 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.192 0.52 . . . . 0.0 109.777 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' A' ' 96' ' ' SER . 30.4 m120 -72.16 13.3 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 109.387 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.501 ' H ' ' C ' ' A' ' 93' ' ' HIS . 94.5 m-20 62.39 3.74 1.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.632 -0.667 . . . . 0.0 109.751 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.443 ' C ' ' H ' ' A' ' 98' ' ' ASN . 14.6 m -116.19 7.94 14.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.943 -1.098 . . . . 0.0 109.006 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.738 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.4 mm? -84.05 26.45 0.74 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.445 ' N ' ' HA ' ' A' ' 91' ' ' VAL . 11.7 t-20 -75.41 75.21 2.49 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 122.277 1.037 . . . . 0.0 108.824 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.455 HG21 ' N ' ' A' ' 100' ' ' THR . 6.7 p -147.4 158.07 9.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.455 ' N ' HG21 ' A' ' 99' ' ' VAL . 18.8 p -125.11 159.54 31.21 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.83 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.555 HD21 ' CG ' ' A' ' 33' ' ' PHE . 51.6 mt -80.02 70.35 6.58 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.491 ' CB ' HE22 ' A' ' 86' ' ' GLN . . . -96.69 -27.24 14.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.453 -0.779 . . . . 0.0 111.7 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -114.06 107.86 51.49 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.621 -1.299 . . . . 0.0 111.215 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -59.65 145.03 99.24 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.236 1.957 . . . . 0.0 110.509 178.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.491 HG11 ' N ' ' A' ' 106' ' ' TYR . 7.0 p -70.57 -31.61 46.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.072 -1.018 . . . . 0.0 108.893 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.491 ' N ' HG11 ' A' ' 105' ' ' VAL . 75.9 m-85 -111.54 31.51 6.08 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.558 -0.714 . . . . 0.0 109.737 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 106' ' ' TYR . . . -42.0 128.6 3.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.948 . . . . 0.0 109.311 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -127.68 138.8 52.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.124 -0.985 . . . . 0.0 110.076 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -74.05 148.85 41.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -0.987 . . . . 0.0 108.934 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.749 HH11 ' CG ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -66.4 136.87 56.37 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.333 -0.854 . . . . 0.0 109.926 -179.286 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 117.84 -1.076 . . . . 0.0 108.815 179.425 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.493 ' C ' ' OD1' ' A' ' 2' ' ' ASP . 55.3 p30 -70.68 163.61 26.75 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.336 -0.853 . . . . 0.0 109.793 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.7 mt -98.65 135.01 21.2 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -70.85 -4.33 14.55 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.805 1.67 . . . . 0.0 111.189 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.413 ' HD1' HG13 ' A' ' 82' ' ' VAL . 77.1 m-70 -73.05 -22.61 60.59 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -60.94 -31.69 71.23 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.938 -1.102 . . . . 0.0 109.4 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.51 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 81.6 m-20 -92.53 131.99 37.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.091 -1.006 . . . . 0.0 110.16 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.543 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 60.8 tt0 -70.46 -31.61 68.83 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.847 0.832 . . . . 0.0 109.901 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 tmpt? -62.14 -27.42 68.93 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.75 -0.594 . . . . 0.0 112.368 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.6 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 23.6 p -68.83 -27.14 65.58 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.487 -1.383 . . . . 0.0 112.187 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.652 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -120.04 -28.47 5.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.239 -1.538 . . . . 0.0 109.445 179.529 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -79.75 125.1 29.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.237 -0.915 . . . . 0.0 109.531 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -99.81 -3.23 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 109.528 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.8 -148.74 26.21 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.1 m -83.08 102.98 12.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.254 . . . . 0.0 109.985 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.467 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 32.9 t -124.37 146.29 48.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.432 -0.792 . . . . 0.0 109.401 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.68 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 57.4 p30 -79.72 154.34 28.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 108.77 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.581 ' CG ' ' NH2' ' A' ' 36' ' ' ARG . 74.5 mtt180 -59.83 -35.89 75.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.144 -0.973 . . . . 0.0 109.603 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -59.75 -42.87 94.19 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.45 -0.781 . . . . 0.0 109.651 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.68 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 79.6 tttt -68.12 -37.75 81.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.855 -1.153 . . . . 0.0 109.257 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.55 -31.35 72.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.443 -0.786 . . . . 0.0 108.967 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 26' ' ' ARG . 61.7 tt0 -59.49 -49.6 77.15 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -57.84 -39.02 76.71 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.0 mt -71.25 -27.15 63.25 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.249 -0.907 . . . . 0.0 108.869 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.2 mt -96.78 -9.56 28.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 109.302 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -91.85 124.5 36.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.8 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.64 21.94 79.3 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -104.62 126.66 51.92 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -57.82 144.69 37.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.461 -0.774 . . . . 0.0 110.514 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 54.8 p30 -54.34 155.85 3.6 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.659 -0.651 . . . . 0.0 109.439 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.81 -30.96 9.28 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.8 m -81.81 127.28 32.81 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.522 -0.987 . . . . 0.0 109.067 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.519 ' CD1' ' HB2' ' A' ' 101' ' ' LEU . 0.6 OUTLIER -134.45 153.37 51.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.053 -1.029 . . . . 0.0 108.986 179.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.491 ' CD2' ' CG2' ' A' ' 105' ' ' VAL . 6.7 mt -107.28 172.26 6.93 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.004 0.907 . . . . 0.0 110.589 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.443 HG21 ' SG ' ' A' ' 46' ' ' CYS . 73.4 t -147.21 110.12 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.581 ' NH2' ' CG ' ' A' ' 18' ' ' ARG . 2.8 ptt180 -145.54 -179.3 6.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.016 -1.052 . . . . 0.0 109.834 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.697 ' C ' ' H ' ' A' ' 39' ' ' SER . 8.0 pt-20 -91.65 173.79 7.7 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.683 ' O ' ' N ' ' A' ' 40' ' ' LYS . 67.4 m -78.11 18.39 0.52 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.697 ' H ' ' C ' ' A' ' 37' ' ' GLU . 44.3 m 61.09 -51.42 0.11 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.652 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 38' ' ' SER . 61.0 tttp -101.31 128.9 47.25 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.659 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 2.6 tt0 85.25 -173.6 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.448 -0.783 . . . . 0.0 109.217 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.479 ' H ' ' HG2' ' A' ' 41' ' ' GLN . . . -107.78 32.2 7.31 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 90.6 m -85.91 153.89 21.89 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.999 -1.295 . . . . 0.0 109.002 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' ILE . 70.8 m-85 -124.93 148.25 48.46 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.44 144.57 22.96 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.044 -1.035 . . . . 0.0 108.94 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.443 ' SG ' HG21 ' A' ' 35' ' ' VAL . 20.8 m -114.07 126.61 55.29 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 108.451 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 34' ' ' LEU . 50.5 m -88.59 131.24 35.03 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.499 -0.75 . . . . 0.0 109.382 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.528 HG21 ' HZ3' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -125.28 142.11 43.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.139 -0.976 . . . . 0.0 109.459 179.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.95 127.06 65.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.357 -0.839 . . . . 0.0 109.833 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.584 HG11 ' H ' ' A' ' 53' ' ' GLU . 4.9 p -111.84 161.45 10.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.082 -1.011 . . . . 0.0 109.957 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.413 ' H ' HG21 ' A' ' 50' ' ' VAL . 66.1 t0 -65.48 60.14 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 169.32 -36.28 0.19 Allowed Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.6 -1.286 . . . . 0.0 111.126 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.584 ' H ' HG11 ' A' ' 50' ' ' VAL . 78.2 tt0 -156.36 143.22 18.75 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.389 -1.653 . . . . 0.0 112.396 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.403 ' H ' HG21 ' A' ' 54' ' ' VAL . 34.5 m -79.62 134.33 27.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.533 ' CB ' ' HZ1' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -124.97 161.08 27.46 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.824 -1.172 . . . . 0.0 111.695 -178.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -121.35 100.85 7.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.392 0.615 . . . . 0.0 109.362 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.433 ' O ' ' N ' ' A' ' 46' ' ' CYS . 49.2 t -85.3 129.33 34.83 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.85 135.86 28.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.423 -0.798 . . . . 0.0 111.145 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 44' ' ' TYR . 48.7 mm -106.53 128.01 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' A' ' 66' ' ' TYR . 8.2 m120 -116.08 116.18 27.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.974 -1.079 . . . . 0.0 110.358 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HZ3' HD12 ' A' ' 78' ' ' LEU . 12.9 mttp -99.67 120.69 40.09 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.388 -0.82 . . . . 0.0 109.645 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.663 ' O ' ' N ' ' A' ' 64' ' ' THR . 45.9 p -140.43 55.66 1.6 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 109.411 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.4 -47.29 0.23 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.663 ' N ' ' O ' ' A' ' 62' ' ' THR . 52.2 m -118.93 -17.07 9.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.349 -0.844 . . . . 0.0 109.502 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.75 ' O ' ' CG ' ' A' ' 66' ' ' TYR . . . -87.13 170.33 41.11 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.75 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 98.3 m-85 -168.32 -11.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.839 -0.801 . . . . 0.0 109.29 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.43 145.69 8.98 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.705 ' CD2' ' OH ' ' A' ' 85' ' ' TYR . 2.5 m-85 59.0 36.79 24.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.953 -1.322 . . . . 0.0 108.402 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.602 ' CB ' ' OD1' ' A' ' 73' ' ' ASN . . . -57.85 148.49 25.17 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 108.88 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.753 ' O ' ' N ' ' A' ' 72' ' ' TYR . 66.3 tt0 -135.11 145.11 52.91 Favored Pre-proline 0 C--N 1.296 -1.719 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.482 ' C ' ' O ' ' A' ' 70' ' ' GLU . 51.4 Cg_exo -25.85 -29.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.909 2.406 . . . . 0.0 111.946 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.753 ' N ' ' O ' ' A' ' 70' ' ' GLU . 45.5 p90 -122.74 61.23 1.01 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.7 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 82.5 m-20 -44.78 144.89 1.03 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.469 -0.769 . . . . 0.0 109.914 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.0 tp -166.09 87.81 0.37 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.699 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.466 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 97.1 m-85 -145.5 86.21 1.74 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.166 -0.959 . . . . 0.0 109.279 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.9 p -66.7 -41.17 88.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.331 -0.855 . . . . 0.0 109.884 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.1 m -130.8 155.2 47.09 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.129 -0.982 . . . . 0.0 111.667 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.467 HD12 ' HZ3' ' A' ' 61' ' ' LYS . 79.1 mt -65.62 -31.65 72.79 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.527 0.68 . . . . 0.0 109.239 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -60.52 -41.24 94.01 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.392 -0.818 . . . . 0.0 108.941 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.507 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 99.0 mt-10 -62.79 -43.83 97.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.146 -0.971 . . . . 0.0 109.158 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.49 ' C ' ' CD2' ' A' ' 81' ' ' LEU . 7.1 tt -61.27 -43.58 98.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 109.907 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.413 HG13 ' HD1' ' A' ' 5' ' ' HIS . 82.2 t -71.1 -37.29 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 86' ' ' GLN . 86.4 mt -67.58 -42.87 81.81 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.241 -0.912 . . . . 0.0 109.634 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 80' ' ' GLU . 84.0 m-70 -69.11 -38.26 78.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.073 -1.017 . . . . 0.0 110.9 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.705 ' OH ' ' CD2' ' A' ' 68' ' ' PHE . 5.4 m-85 -72.36 -17.71 61.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.37 -0.831 . . . . 0.0 111.876 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.26 -24.56 51.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.287 -1.508 . . . . 0.0 108.241 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.43 ' N ' ' HG3' ' A' ' 86' ' ' GLN . 83.0 t60 -96.47 -15.31 21.8 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.533 -0.729 . . . . 0.0 109.59 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.4 m -102.87 139.94 37.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.062 -1.024 . . . . 0.0 109.007 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.1 p -88.6 135.5 33.46 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.465 -0.772 . . . . 0.0 110.685 -178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 93' ' ' HIS . 77.0 mt -69.73 -10.27 57.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.642 -0.661 . . . . 0.0 110.088 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.728 ' N ' ' O ' ' A' ' 97' ' ' LEU . 9.9 p -33.98 -40.56 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.975 -1.078 . . . . 0.0 110.132 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.472 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 81.2 mt-30 -75.97 -5.9 48.46 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.356 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.546 ' N ' ' O ' ' A' ' 90' ' ' LEU . 53.4 t-80 -59.53 -43.55 93.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.66 -1.275 . . . . 0.0 108.42 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.41 ' CB ' HD22 ' A' ' 97' ' ' LEU . 16.3 t30 -148.71 19.85 1.02 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.415 ' CA ' ' O ' ' A' ' 91' ' ' VAL . 49.1 t0 64.68 38.77 6.81 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.365 0.602 . . . . 0.0 109.773 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 62.6 m -168.19 2.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.851 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -101.62 64.47 0.99 Allowed 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.16 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -79.06 71.11 5.52 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.275 -0.891 . . . . 0.0 110.723 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.9 p -148.5 158.41 7.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.7 p -122.27 150.66 42.01 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.528 ' O ' ' CD1' ' A' ' 101' ' ' LEU . 2.2 pp -88.34 47.14 1.46 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.204 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.33 -4.83 57.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.7 -0.625 . . . . 0.0 111.368 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -112.96 120.4 40.69 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.612 -1.305 . . . . 0.0 110.068 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.407 ' HB2' ' O ' ' A' ' 10' ' ' THR . 26.5 Cg_endo -73.29 146.48 40.39 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.681 2.254 . . . . 0.0 112.04 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.504 HG11 ' N ' ' A' ' 106' ' ' TYR . 9.2 p -80.88 -25.46 10.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.574 -0.704 . . . . 0.0 110.667 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.504 ' N ' HG11 ' A' ' 105' ' ' VAL . 2.4 m-85 -112.8 47.62 1.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.222 -0.924 . . . . 0.0 110.577 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.41 95.32 6.38 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.928 -1.107 . . . . 0.0 108.242 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -65.54 -37.6 87.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.306 -0.872 . . . . 0.0 109.775 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -60.69 -41.77 95.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.674 -0.641 . . . . 0.0 110.668 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.491 ' O ' ' OXT' ' A' ' 111' ' ' ARG . 33.3 mmt180 -75.22 -28.85 60.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.983 -1.073 . . . . 0.0 109.27 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.491 ' OXT' ' O ' ' A' ' 110' ' ' ARG . 32.4 ttm180 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.691 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.464 ' C ' ' OD1' ' A' ' 2' ' ' ASP . 53.0 p30 -76.97 170.41 16.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.157 -0.964 . . . . 0.0 109.134 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.633 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 3.2 mm? -71.51 139.73 84.1 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.178 -0.951 . . . . 0.0 108.899 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.36 -1.85 9.63 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.907 2.404 . . . . 0.0 111.383 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.479 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 30.2 m170 -65.63 -21.42 66.57 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.793 -0.567 . . . . 0.0 109.767 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -58.97 -23.5 61.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.116 -0.99 . . . . 0.0 109.427 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.714 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 72.8 m-20 -105.74 134.38 48.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 109.915 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 12' ' ' ASN . 92.5 mt-10 -71.31 -30.01 65.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.952 . . . . 0.0 110.341 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.648 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -60.26 -31.38 70.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.041 -1.037 . . . . 0.0 110.23 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.599 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 22.7 p -67.39 -32.21 72.96 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.345 -0.847 . . . . 0.0 110.926 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.714 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -131.72 -3.72 3.68 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.534 -1.354 . . . . 0.0 111.199 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 8' ' ' GLU . 58.4 t30 -96.1 117.74 31.31 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.477 -1.389 . . . . 0.0 111.524 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.554 ' CG1' ' OG ' ' A' ' 16' ' ' SER . 11.9 t -134.71 33.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.6 -30.21 26.79 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.3 m -60.29 -38.5 83.81 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.058 -1.26 . . . . 0.0 109.414 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.554 ' OG ' ' CG1' ' A' ' 13' ' ' VAL . 74.4 m -67.11 142.2 57.17 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.3 -0.875 . . . . 0.0 110.746 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -83.55 166.14 18.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.597 -0.689 . . . . 0.0 109.205 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.555 ' CG ' HH12 ' A' ' 36' ' ' ARG . 38.0 ttp180 -59.35 -40.7 87.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.092 -1.005 . . . . 0.0 109.426 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -59.74 -45.67 91.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.049 -1.032 . . . . 0.0 108.504 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -67.96 -33.62 75.01 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.64 92.77 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 26' ' ' ARG . 99.0 mt-10 -55.43 -48.04 75.04 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -60.57 -44.19 96.45 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.406 HD23 ' OH ' ' A' ' 106' ' ' TYR . 95.3 mt -64.11 -41.18 97.34 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.7 mt -69.31 -32.65 71.91 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' GLU . 97.6 mtt180 -85.25 2.46 43.82 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.409 0.623 . . . . 0.0 109.801 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.56 8.47 32.38 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.731 ' HZ1' ' CG2' ' A' ' 105' ' ' VAL . 11.9 pttt -142.82 157.51 44.54 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.89 -1.359 . . . . 0.0 110.69 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.719 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.0 OUTLIER -85.56 163.86 18.12 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.029 0.919 . . . . 0.0 111.577 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.556 ' OD1' ' C ' ' A' ' 50' ' ' VAL . 76.4 m-20 -42.96 159.81 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.63 0.728 . . . . 0.0 110.442 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' H ' HG12 ' A' ' 99' ' ' VAL . . . 85.47 -27.08 5.36 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.7 m -86.4 124.77 33.11 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.326 -1.102 . . . . 0.0 108.432 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.644 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -132.9 173.12 11.73 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.137 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.644 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -150.3 166.46 29.9 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.23 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.52 HG21 ' HG ' ' A' ' 46' ' ' CYS . 46.8 t -112.31 140.36 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.555 HH12 ' CG ' ' A' ' 18' ' ' ARG . 12.6 ptt180 -153.71 178.2 10.13 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.014 -1.054 . . . . 0.0 109.036 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.69 ' C ' ' H ' ' A' ' 39' ' ' SER . 11.3 pm0 -87.4 169.69 12.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.83 -1.169 . . . . 0.0 108.237 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.734 ' N ' ' O ' ' A' ' 43' ' ' CYS . 58.8 p -76.63 9.43 2.77 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.69 ' H ' ' C ' ' A' ' 37' ' ' GLU . 6.2 m 83.13 -116.58 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.569 -1.651 . . . . 0.0 109.725 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -91.3 -2.25 57.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.988 -1.07 . . . . 0.0 110.232 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -70.01 -33.24 71.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.864 -1.147 . . . . 0.0 110.024 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.08 -5.91 42.61 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.734 ' O ' ' N ' ' A' ' 38' ' ' SER . 71.2 m -103.62 169.15 8.7 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.225 -1.162 . . . . 0.0 109.799 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -106.58 162.23 13.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.347 -0.846 . . . . 0.0 109.758 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.03 148.91 17.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.213 -0.929 . . . . 0.0 110.695 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.52 ' HG ' HG21 ' A' ' 35' ' ' VAL . 75.8 m -111.2 124.31 51.96 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.198 -0.939 . . . . 0.0 108.631 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 69.0 m -91.2 139.82 30.39 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.115 -0.99 . . . . 0.0 110.151 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.2 t -133.51 157.44 42.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.9 135.97 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.556 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -123.78 158.51 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.747 -1.221 . . . . 0.0 109.664 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.542 ' CA ' ' OD2' ' A' ' 30' ' ' ASP . 66.2 t0 -67.23 61.79 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.633 0.73 . . . . 0.0 109.934 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 172.1 -40.38 0.17 Allowed Glycine 0 C--N 1.292 -1.888 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.481 ' HB3' ' NZ ' ' A' ' 55' ' ' LYS . 79.0 tt0 -162.38 160.49 26.56 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.118 -1.225 . . . . 0.0 110.84 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.403 ' N ' ' HG2' ' A' ' 53' ' ' GLU . 43.8 t -88.13 126.33 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.481 ' NZ ' ' HB3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -114.52 155.71 25.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.841 -1.162 . . . . 0.0 110.297 -178.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 57.3 m170 -116.43 119.83 36.88 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.415 -0.803 . . . . 0.0 108.888 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.507 ' O ' ' N ' ' A' ' 46' ' ' CYS . 41.8 t -92.46 124.2 36.32 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.28 133.4 37.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 121.114 -0.991 . . . . 0.0 111.094 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.505 ' CD1' ' SG ' ' A' ' 46' ' ' CYS . 96.7 mt -119.33 130.31 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.58 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 75.5 m-20 -111.22 123.59 50.5 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.076 -1.015 . . . . 0.0 110.097 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -92.79 38.07 1.02 Allowed 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.698 ' O ' ' N ' ' A' ' 64' ' ' THR . 75.1 m -105.69 -177.25 3.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.655 -0.653 . . . . 0.0 109.343 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.637 ' H ' ' CG2' ' A' ' 62' ' ' THR . . . -44.3 -8.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 109.656 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.698 ' N ' ' O ' ' A' ' 62' ' ' THR . 60.5 p -81.47 -8.75 59.77 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.203 -0.936 . . . . 0.0 108.531 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.57 80.06 0.14 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.58 ' CA ' ' O ' ' A' ' 60' ' ' ASN . 86.5 m-85 57.46 -132.87 1.3 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.075 -1.25 . . . . 0.0 109.783 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -140.65 173.89 22.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.71 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 7.2 m-30 58.59 36.43 25.1 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.171 -1.193 . . . . 0.0 109.53 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.48 2.54 54.46 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.088 -1.007 . . . . 0.0 109.621 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.629 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 55.9 mp0 -63.5 -35.94 19.83 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 110.652 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 61.5 Cg_endo -84.24 15.6 2.13 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.959 1.773 . . . . 0.0 111.44 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 60.1 37.78 20.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.676 -0.64 . . . . 0.0 109.288 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.484 ' OD1' ' CE1' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -132.32 75.8 1.66 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 110.006 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.655 ' O ' ' CD1' ' A' ' 74' ' ' LEU . 3.0 pp -119.52 104.09 10.0 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.574 ' CD2' ' OE1' ' A' ' 80' ' ' GLU . 78.9 m-85 -67.68 156.06 37.78 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.276 -0.89 . . . . 0.0 109.98 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 90.9 p -85.42 -11.78 53.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.7 -0.625 . . . . 0.0 111.423 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 t -114.36 141.74 47.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.655 -1.278 . . . . 0.0 110.391 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.7 mt -61.4 -38.13 85.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.383 -0.823 . . . . 0.0 109.545 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -59.68 -39.09 83.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.269 -0.895 . . . . 0.0 108.807 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.574 ' OE1' ' CD2' ' A' ' 75' ' ' TYR . 20.6 mm-40 -65.58 -42.5 91.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 109.001 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.419 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 8.4 tt -61.09 -42.83 99.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.367 -0.833 . . . . 0.0 109.183 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.472 HG13 ' ND1' ' A' ' 5' ' ' HIS . 70.5 t -67.09 -47.04 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.306 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.406 HD22 ' ND1' ' A' ' 5' ' ' HIS . 69.1 mt -67.48 -43.04 81.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.481 -0.762 . . . . 0.0 110.104 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.484 ' CE1' ' OD1' ' A' ' 73' ' ' ASN . 85.7 t60 -61.47 -42.58 99.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 0.0 109.885 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.71 ' CZ ' ' CD2' ' A' ' 68' ' ' PHE . 5.0 m-85 -60.58 -28.38 68.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.16 -0.962 . . . . 0.0 109.632 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -65.4 -34.92 79.44 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.935 -1.103 . . . . 0.0 108.769 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -84.56 -25.18 28.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.349 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.1 m -88.78 129.33 35.58 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.911 -1.118 . . . . 0.0 109.679 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.5 m -81.51 133.52 35.4 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 91' ' ' VAL . 86.6 mt -71.84 -19.04 62.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.297 -0.877 . . . . 0.0 111.964 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.785 ' O ' ' N ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -34.23 -51.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.874 -1.142 . . . . 0.0 110.228 -178.251 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -54.72 -29.13 52.57 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.077 0.465 . . . . 0.0 110.56 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.533 ' N ' ' O ' ' A' ' 90' ' ' LEU . 64.4 t-80 -50.05 -48.14 53.09 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.939 -1.101 . . . . 0.0 108.797 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.485 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 64.9 t-20 -140.18 19.85 2.43 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.785 ' N ' ' O ' ' A' ' 91' ' ' VAL . 53.5 t0 59.92 8.16 1.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.1 p -137.22 11.56 3.04 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.278 -0.889 . . . . 0.0 109.571 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.712 ' O ' ' N ' ' A' ' 91' ' ' VAL . 23.7 mt -103.32 69.94 1.03 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.705 -1.247 . . . . 0.0 108.509 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.491 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 41.5 p-10 -78.25 69.28 4.43 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.608 0.718 . . . . 0.0 110.395 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 100' ' ' THR . 53.9 t -156.38 158.09 3.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.469 0.652 . . . . 0.0 109.514 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.471 ' N ' ' CG1' ' A' ' 99' ' ' VAL . 72.8 p -131.17 164.09 26.27 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.575 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.514 HD11 ' H ' ' A' ' 101' ' ' LEU . 6.2 mp -82.71 68.12 9.05 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -97.94 -27.02 14.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.601 -0.687 . . . . 0.0 111.225 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -112.66 132.67 22.13 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 120.692 -1.255 . . . . 0.0 111.091 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.14 142.67 24.76 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.764 2.976 . . . . 0.0 111.975 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.731 ' CG2' ' HZ1' ' A' ' 28' ' ' LYS . 9.7 p -76.7 -33.13 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.159 -0.963 . . . . 0.0 111.954 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.529 ' N ' HG11 ' A' ' 105' ' ' VAL . 9.3 m-85 -130.15 60.56 1.61 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.55 -1.344 . . . . 0.0 110.889 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -87.97 134.87 33.63 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.271 -0.971 . . . . 0.0 109.524 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.28 139.35 46.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.529 -0.732 . . . . 0.0 110.205 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -93.35 0.82 57.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 109.599 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -61.93 -40.73 96.51 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.179 -0.951 . . . . 0.0 110.503 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.761 ' CB ' HH11 ' A' ' 111' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 O-C-N 120.901 -1.124 . . . . 0.0 109.48 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.474 ' C ' ' OD1' ' A' ' 2' ' ' ASP . 58.3 p30 -76.02 169.42 18.21 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.415 -0.803 . . . . 0.0 109.17 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.4 mt -91.84 116.08 65.79 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.104 -0.997 . . . . 0.0 109.985 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.51 -16.92 5.91 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.671 2.247 . . . . 0.0 111.771 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.619 ' NE2' ' OE1' ' A' ' 86' ' ' GLN . 96.4 m-70 -67.18 -19.94 65.65 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.377 -0.827 . . . . 0.0 109.872 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -60.19 -36.59 77.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.868 -1.145 . . . . 0.0 109.506 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.606 ' OD2' ' NZ ' ' A' ' 9' ' ' LYS . 47.9 t0 -92.17 123.23 35.36 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.078 -1.014 . . . . 0.0 109.827 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.51 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 19.8 tt0 -64.44 -30.54 71.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.725 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.606 ' NZ ' ' OD2' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -61.48 -35.18 76.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.702 -0.624 . . . . 0.0 111.553 -179.327 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.721 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 13.7 p -51.63 -39.91 58.95 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.996 -1.065 . . . . 0.0 110.389 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.721 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -117.09 -19.29 9.79 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.857 -1.152 . . . . 0.0 110.684 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 49.4 t-20 -89.53 123.76 33.92 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.872 -1.142 . . . . 0.0 111.253 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.7 -16.0 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.302 -0.873 . . . . 0.0 109.207 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' N ' ' OD1' ' A' ' 12' ' ' ASN . . . 78.87 -141.37 24.29 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.495 ' HA ' ' NH2' ' A' ' 36' ' ' ARG . 36.8 t -81.76 104.53 12.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -1.093 . . . . 0.0 108.748 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 t -135.29 135.09 40.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.448 -0.782 . . . . 0.0 109.93 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -64.61 143.39 57.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.112 -0.993 . . . . 0.0 109.694 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.597 ' CZ ' ' OG ' ' A' ' 39' ' ' SER . 37.9 mtt-85 -60.17 -33.44 72.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.0 108.779 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -59.67 -43.41 94.01 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -62.41 -34.3 76.47 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.09 -35.13 76.18 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 26' ' ' ARG . 94.9 mt-10 -60.07 -45.83 91.58 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.819 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -63.17 -43.0 99.48 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.29 -36.66 79.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.0 109.27 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.486 HD21 ' CG2' ' A' ' 49' ' ' VAL . 56.1 mt -87.21 -15.13 39.13 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.141 -0.974 . . . . 0.0 109.047 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 22' ' ' GLU . 16.1 mtp180 -77.71 -22.42 50.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.13 -0.981 . . . . 0.0 109.372 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.43 19.84 23.79 Favored Glycine 0 C--N 1.285 -2.282 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.489 ' CB ' ' HZ1' ' A' ' 28' ' ' LYS . 5.1 ttmm -105.91 131.15 53.57 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.571 -0.958 . . . . 0.0 111.456 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -85.39 166.44 16.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.681 -0.637 . . . . 0.0 110.149 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.633 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 63.4 t0 -63.15 142.08 58.52 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.446 -0.784 . . . . 0.0 110.475 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.627 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 100.87 -19.28 52.85 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.422 HG23 ' HZ3' ' A' ' 28' ' ' LYS . 60.4 m -97.14 136.35 37.8 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.136 -1.214 . . . . 0.0 109.272 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.47 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -139.37 172.79 12.3 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.755 -1.216 . . . . 0.0 109.892 179.385 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' A' ' 46' ' ' CYS . 0.7 OUTLIER -139.7 153.96 47.36 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.816 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.5 t -104.63 136.8 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.969 -1.082 . . . . 0.0 108.527 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.704 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -144.69 -169.9 3.27 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 108.924 -178.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.704 ' H ' ' CD ' ' A' ' 36' ' ' ARG . 9.8 mt-10 -100.66 -178.53 3.81 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.909 -1.12 . . . . 0.0 108.234 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.5 m -77.86 14.21 1.15 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.629 ' H ' ' C ' ' A' ' 37' ' ' GLU . 50.8 m 62.45 15.39 7.75 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.178 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -172.02 -76.99 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.537 -0.727 . . . . 0.0 109.688 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.613 ' C ' ' H ' ' A' ' 43' ' ' CYS . 97.5 mt-30 -60.34 147.95 38.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.087 -1.008 . . . . 0.0 109.874 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.82 9.86 0.1 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.613 ' H ' ' C ' ' A' ' 41' ' ' GLN . 80.3 m -80.44 168.85 18.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -1.195 . . . . 0.0 109.144 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.537 ' O ' ' O ' ' A' ' 59' ' ' ILE . 94.9 m-85 -108.53 155.62 20.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.979 -1.076 . . . . 0.0 110.732 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.4 129.5 8.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.436 -0.79 . . . . 0.0 109.154 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 57' ' ' CYS . 20.6 p -112.93 154.44 26.4 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.5 m -118.73 142.89 47.26 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.089 -0.645 . . . . 0.0 109.493 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.517 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 1.9 p -132.58 161.3 41.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.298 -0.876 . . . . 0.0 108.901 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.517 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 47.5 t -117.44 132.47 67.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.65 ' C ' ' H ' ' A' ' 52' ' ' GLY . 8.6 p -115.91 164.44 12.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.224 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.633 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 95.9 m-20 -59.66 28.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.981 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.65 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -154.58 -38.0 0.02 OUTLIER Glycine 0 N--CA 1.483 1.785 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.629 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.569 ' CD ' ' O ' ' A' ' 52' ' ' GLY . 55.0 mp0 -159.26 164.58 34.84 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.65 -1.5 . . . . 0.0 112.512 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.8 t -89.33 141.15 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.583 ' HZ1' ' N ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -131.04 165.71 22.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.843 -1.161 . . . . 0.0 111.617 -178.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -128.42 75.84 1.66 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 46.3 t -56.6 134.24 54.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.205 -0.934 . . . . 0.0 109.62 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.86 134.41 42.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.582 0.705 . . . . 0.0 110.112 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.537 ' O ' ' O ' ' A' ' 44' ' ' TYR . 49.5 mm -108.41 129.34 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.522 ' O ' ' O ' ' A' ' 66' ' ' TYR . 77.5 m-20 -114.67 126.69 55.16 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.857 -1.152 . . . . 0.0 110.793 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -111.07 122.31 47.55 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.153 -0.967 . . . . 0.0 109.485 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.552 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 54.4 m -119.6 -12.14 9.34 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 62' ' ' THR . . . 155.2 -48.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.1 m -153.99 60.01 0.72 Allowed 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.47 -49.56 0.03 OUTLIER Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.38 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.522 ' O ' ' O ' ' A' ' 60' ' ' ASN . 96.7 m-85 58.65 -132.42 1.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -1.151 . . . . 0.0 109.106 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 66' ' ' TYR . . . -59.7 -148.48 0.01 OUTLIER Glycine 0 N--CA 1.493 2.5 0 O-C-N 121.023 -1.048 . . . . 0.0 110.586 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.651 ' CE2' ' NE2' ' A' ' 93' ' ' HIS . 42.7 p90 -69.62 130.59 42.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.822 -1.399 . . . . 0.0 109.636 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.62 139.35 53.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.121 -0.987 . . . . 0.0 109.771 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.708 ' O ' ' N ' ' A' ' 72' ' ' TYR . 69.4 mt-10 -70.6 157.54 89.9 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.463 ' C ' ' O ' ' A' ' 70' ' ' GLU . 76.8 Cg_exo -30.96 -25.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.41 2.073 . . . . 0.0 111.485 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.708 ' N ' ' O ' ' A' ' 70' ' ' GLU . 94.2 m-85 -119.73 117.18 27.55 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -60.93 125.11 22.5 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.361 -0.837 . . . . 0.0 109.664 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.5 mt -116.86 0.16 12.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.408 -0.808 . . . . 0.0 109.384 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -94.6 130.99 40.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 0.0 110.384 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.7 t -106.74 -43.07 4.79 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.905 -1.122 . . . . 0.0 110.652 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.0 p -137.48 166.14 24.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.848 -1.158 . . . . 0.0 109.823 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.29 -32.06 72.74 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.559 -0.713 . . . . 0.0 109.395 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -59.6 -41.19 89.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.896 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -75.41 -26.68 58.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.094 -1.004 . . . . 0.0 109.601 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.6 tt -67.99 -42.25 81.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.164 -0.96 . . . . 0.0 110.371 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.514 ' CG1' ' N ' ' A' ' 83' ' ' LEU . 4.3 p -68.61 -46.73 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.204 -0.935 . . . . 0.0 110.359 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.514 ' N ' ' CG1' ' A' ' 82' ' ' VAL . 85.9 mt -66.02 -40.05 90.73 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.898 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.436 ' HA ' ' CD2' ' A' ' 87' ' ' HIS . 21.3 t60 -58.65 -41.21 85.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.297 -0.877 . . . . 0.0 110.233 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.597 ' CZ ' ' CZ ' ' A' ' 68' ' ' PHE . 7.2 m-30 -74.62 -25.75 59.43 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.088 -1.007 . . . . 0.0 109.67 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.619 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 30.5 tt0 -63.92 -36.57 84.4 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.998 -1.064 . . . . 0.0 110.33 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.471 ' CE1' ' OG1' ' A' ' 88' ' ' THR . 21.7 p80 -93.21 -7.05 46.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.057 -1.027 . . . . 0.0 109.272 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' CE1' ' A' ' 87' ' ' HIS . 33.3 m -105.59 138.3 42.01 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 108.895 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -89.79 130.14 36.09 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 109.268 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.562 ' O ' ' C ' ' A' ' 91' ' ' VAL . 83.0 mt -71.27 -18.65 62.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.658 -0.651 . . . . 0.0 110.246 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.73 ' N ' ' O ' ' A' ' 97' ' ' LEU . 14.7 p -31.36 -47.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.314 -0.866 . . . . 0.0 109.638 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.542 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 76.6 mt-30 -57.61 -45.66 85.08 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.131 -178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.651 ' NE2' ' CE2' ' A' ' 68' ' ' PHE . 75.1 m80 -48.53 -50.42 32.1 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.807 ' O ' ' N ' ' A' ' 96' ' ' SER . 97.7 m-20 -134.31 114.19 12.74 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 94' ' ' ASN . 84.1 m-20 -31.73 -19.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.525 -0.734 . . . . 0.0 111.393 -177.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.807 ' N ' ' O ' ' A' ' 94' ' ' ASN . 54.6 m -107.66 20.46 18.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.635 -1.291 . . . . 0.0 111.698 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.73 ' O ' ' N ' ' A' ' 91' ' ' VAL . 8.3 mt -97.7 57.43 1.35 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.444 -1.41 . . . . 0.0 109.263 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -78.32 86.03 4.43 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.386 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.9 p -168.7 151.88 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.9 p -131.68 159.34 38.64 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.469 -0.77 . . . . 0.0 109.342 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.47 HD21 ' CG ' ' A' ' 33' ' ' PHE . 19.2 mt -78.22 69.79 4.48 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.942 -1.099 . . . . 0.0 108.175 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.57 -31.45 16.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.451 -0.78 . . . . 0.0 112.714 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -122.53 136.14 26.31 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.507 -1.371 . . . . 0.0 111.393 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.435 ' CB ' ' HB ' ' A' ' 10' ' ' THR . 68.0 Cg_endo -77.08 152.88 31.81 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 123.133 2.556 . . . . 0.0 111.956 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.408 HG13 ' CB ' ' A' ' 34' ' ' LEU . 9.6 p -79.16 -16.41 13.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.093 -1.004 . . . . 0.0 110.626 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -129.73 61.18 1.57 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.073 -1.017 . . . . 0.0 111.016 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.69 119.18 25.74 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.132 -0.98 . . . . 0.0 108.795 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -114.87 124.82 52.7 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.945 -1.097 . . . . 0.0 109.538 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -111.46 -12.67 13.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.378 -0.826 . . . . 0.0 109.005 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.702 HH11 ' CG ' ' A' ' 110' ' ' ARG . 1.5 mtt-85 -121.63 146.52 46.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.897 . . . . 0.0 110.458 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.735 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.43 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.528 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.432 ' H1 ' ' H ' ' A' ' 2' ' ' ASP . 85.2 tt0 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.0 0.428 . . . . 0.0 109.861 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.432 ' H ' ' H1 ' ' A' ' 1' ' ' GLU . 52.1 t0 -79.7 124.76 28.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.17 -0.956 . . . . 0.0 109.834 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.0 mt -101.45 118.7 59.37 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 108.679 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.593 ' O ' ' OG1' ' A' ' 10' ' ' THR . 26.8 Cg_exo -58.96 -11.77 13.33 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.948 1.765 . . . . 0.0 111.576 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.533 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 98.0 m-70 -67.2 -31.7 72.27 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.803 -0.561 . . . . 0.0 110.749 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.771 ' HD1' ' N ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -63.06 -15.4 56.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 0.0 110.153 -178.758 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.771 ' N ' ' HD1' ' A' ' 6' ' ' HIS . 27.1 t0 -102.51 126.14 49.47 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.723 ' O ' ' N ' ' A' ' 12' ' ' ASN . 4.0 mp0 -66.18 -27.29 67.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 110.644 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.63 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -62.69 -39.05 92.77 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.988 -1.07 . . . . 0.0 109.689 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.652 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 22.1 p -59.04 -33.76 71.13 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.694 -0.629 . . . . 0.0 109.909 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.693 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -123.91 -31.59 3.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.808 -1.183 . . . . 0.0 111.728 -179.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.723 ' N ' ' O ' ' A' ' 8' ' ' GLU . 28.5 t-20 -87.84 130.65 34.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.539 -1.35 . . . . 0.0 110.857 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -107.48 -6.52 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASN . . . 92.77 -161.86 26.13 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.4 p -67.44 153.59 43.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -1.14 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 t -163.59 150.51 12.23 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.424 -0.797 . . . . 0.0 109.407 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 18' ' ' ARG . 11.0 m120 -88.12 7.95 29.18 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 4.5 mmp_? 66.73 9.01 6.37 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.468 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.715 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 36.5 p-10 -77.52 -53.67 7.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.071 -1.018 . . . . 0.0 108.27 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.715 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 45.1 pttt -68.88 -26.29 65.05 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -56.62 -45.62 81.39 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 26' ' ' ARG . 59.2 mm-40 -59.16 -47.04 86.78 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -62.8 -42.68 99.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.414 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 79.0 mt -69.94 -29.97 67.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 109.504 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' ALA . 16.0 mt -89.79 -13.28 36.98 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 22' ' ' GLU . 89.5 mtt180 -91.5 115.27 27.9 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.62 2.89 50.05 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.414 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 36.4 mmtt -100.77 137.82 38.64 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.225 -1.162 . . . . 0.0 109.212 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -69.64 156.49 38.87 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.664 -0.648 . . . . 0.0 109.695 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 63.2 t0 -57.81 141.92 47.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.587 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 108.7 -27.82 12.62 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.4 m -79.85 120.8 24.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.133 -1.216 . . . . 0.0 108.437 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -139.89 176.57 8.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.851 -1.156 . . . . 0.0 110.931 -178.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.68 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -150.76 161.63 42.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.576 -0.703 . . . . 0.0 110.233 179.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.48 HG21 ' SG ' ' A' ' 46' ' ' CYS . 43.7 t -107.16 139.97 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.467 HH22 ' HB3' ' A' ' 56' ' ' HIS . 1.1 ppt_? -158.72 -160.21 0.85 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.656 ' C ' ' H ' ' A' ' 39' ' ' SER . 82.7 mt-10 -100.19 174.27 6.23 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.567 -1.333 . . . . 0.0 109.079 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.668 ' N ' ' O ' ' A' ' 43' ' ' CYS . 33.6 m -76.67 12.98 1.1 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.656 ' H ' ' C ' ' A' ' 37' ' ' GLU . 7.2 t 85.85 -113.61 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.757 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -86.9 -9.72 55.04 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.123 -0.985 . . . . 0.0 110.722 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -71.56 -35.89 70.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.74 -1.225 . . . . 0.0 110.062 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.3 -14.55 58.15 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.668 ' O ' ' N ' ' A' ' 38' ' ' SER . 76.9 m -79.73 160.06 26.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.28 . . . . 0.0 109.329 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -85.65 154.43 21.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.016 -1.053 . . . . 0.0 109.187 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HB1' ' NH1' ' A' ' 36' ' ' ARG . . . -159.38 151.61 21.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.978 -1.076 . . . . 0.0 110.062 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.497 ' SG ' ' CD1' ' A' ' 59' ' ' ILE . 77.0 m -113.46 124.07 51.53 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.2 t -94.7 130.81 41.06 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.106 -0.997 . . . . 0.0 109.022 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.9 p -135.19 168.44 23.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.482 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.6 t -115.19 134.3 58.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.1 t -112.85 161.25 11.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.044 -1.035 . . . . 0.0 109.801 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.457 ' N ' HG12 ' A' ' 50' ' ' VAL . 64.6 m-20 -62.25 56.13 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.029 0.443 . . . . 0.0 109.99 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 164.37 -36.71 0.29 Allowed Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.208 -1.472 . . . . 0.0 111.018 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.511 ' OE1' ' C ' ' A' ' 52' ' ' GLY . 60.7 mp0 -153.91 161.06 42.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.638 -1.507 . . . . 0.0 110.972 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.1 t -91.9 138.47 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' CE ' ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -124.07 168.73 12.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.903 -1.123 . . . . 0.0 110.948 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.467 ' HB3' HH22 ' A' ' 36' ' ' ARG . 71.0 m-70 -129.79 73.67 1.54 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.464 ' SG ' HD12 ' A' ' 90' ' ' LEU . 73.0 m -50.7 148.1 4.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.315 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.1 t -116.16 134.5 59.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.891 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.497 ' CD1' ' SG ' ' A' ' 46' ' ' CYS . 67.1 mt -117.46 139.17 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.532 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 10.0 m120 -126.58 131.55 51.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.8 -1.187 . . . . 0.0 109.689 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -97.54 120.75 38.48 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.338 -0.851 . . . . 0.0 110.435 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.577 ' CG2' ' H ' ' A' ' 64' ' ' THR . 4.9 t -153.56 175.48 13.16 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.412 -0.805 . . . . 0.0 108.927 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.97 -19.33 6.52 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.314 -0.866 . . . . 0.0 108.952 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.61 ' O ' ' CG2' ' A' ' 64' ' ' THR . 12.4 t -162.92 78.69 0.46 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.111 -0.993 . . . . 0.0 109.95 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.651 ' C ' ' H ' ' A' ' 67' ' ' GLY . . . -161.64 -71.73 0.02 OUTLIER Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.806 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.532 ' CA ' ' O ' ' A' ' 60' ' ' ASN . 83.4 m-85 57.63 -4.98 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.22 -1.165 . . . . 0.0 109.548 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.651 ' H ' ' C ' ' A' ' 65' ' ' GLY . . . 134.57 -97.72 0.3 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.518 ' O ' ' OH ' ' A' ' 75' ' ' TYR . 27.2 m-85 -80.22 130.94 35.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.349 -1.089 . . . . 0.0 108.79 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.04 -14.3 4.97 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.675 -1.266 . . . . 0.0 110.022 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.67 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 11.3 tp10 -64.47 -36.79 19.9 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.018 -1.051 . . . . 0.0 109.422 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 69.5 Cg_endo -89.97 -58.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.624 2.216 . . . . 0.0 110.68 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -122.92 105.45 10.01 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.549 ' C ' ' OD1' ' A' ' 73' ' ' ASN . 42.2 p30 -90.66 22.19 3.65 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.19 -0.944 . . . . 0.0 109.645 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.2 tp -158.14 103.5 1.83 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.22 -0.925 . . . . 0.0 110.166 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.518 ' OH ' ' O ' ' A' ' 68' ' ' PHE . 27.6 m-85 -95.64 139.71 31.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.358 -0.839 . . . . 0.0 109.64 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.524 ' OG ' ' CD ' ' A' ' 80' ' ' GLU . 84.1 p -65.45 -44.37 87.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.203 -0.935 . . . . 0.0 110.901 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -166.93 162.44 15.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.924 -1.11 . . . . 0.0 109.489 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.61 -37.73 88.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.466 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 3.7 ttmp? -58.91 -45.33 90.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.887 -1.133 . . . . 0.0 109.175 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.524 ' CD ' ' OG ' ' A' ' 76' ' ' SER . 51.7 mt-10 -67.13 -29.14 68.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.19 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.6 tt -58.6 -43.75 89.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.285 -0.885 . . . . 0.0 110.014 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.84 -44.39 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.716 -1.24 . . . . 0.0 109.718 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.483 HD21 ' N ' ' A' ' 83' ' ' LEU . 3.8 mm? -67.15 -42.38 84.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 109.555 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.676 ' O ' ' CE1' ' A' ' 87' ' ' HIS . 60.1 t60 -60.28 -39.73 87.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.417 -0.802 . . . . 0.0 110.801 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.457 ' HA ' ' OG1' ' A' ' 88' ' ' THR . 4.9 m-30 -71.08 -25.5 62.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.478 -0.764 . . . . 0.0 112.526 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 83' ' ' LEU . 9.2 pt20 -61.23 -30.56 70.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.348 -1.47 . . . . 0.0 110.312 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.676 ' CE1' ' O ' ' A' ' 84' ' ' HIS . 31.2 p-80 -92.7 -5.49 51.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.75 -1.219 . . . . 0.0 109.188 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 85' ' ' TYR . 56.2 p -98.36 139.76 33.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.158 -0.964 . . . . 0.0 109.455 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.2 t -97.81 126.73 43.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.451 -0.781 . . . . 0.0 109.452 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.647 ' O ' ' N ' ' A' ' 92' ' ' GLN . 81.8 mt -67.05 -20.04 65.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.983 -1.073 . . . . 0.0 109.833 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.774 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.7 p -10.67 -58.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.834 -0.542 . . . . 0.0 110.171 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.647 ' N ' ' O ' ' A' ' 90' ' ' LEU . 9.5 tp-100 -35.17 155.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 92' ' ' GLN . 59.5 t-80 55.49 107.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.814 ' O ' ' N ' ' A' ' 96' ' ' SER . 70.9 m-20 56.69 71.84 0.54 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.603 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 94.2 m-20 -29.84 -20.0 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.814 ' N ' ' O ' ' A' ' 94' ' ' ASN . 87.1 p -77.43 15.5 0.77 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.671 -1.268 . . . . 0.0 110.922 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.774 ' O ' ' N ' ' A' ' 91' ' ' VAL . 70.5 mt -95.68 41.67 1.1 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 95' ' ' ASP . 64.1 m-80 -78.39 79.28 4.83 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.321 -0.862 . . . . 0.0 110.073 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.521 ' CG2' ' OD1' ' A' ' 30' ' ' ASP . 7.4 p -153.31 157.93 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.8 p -130.26 157.46 42.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.105 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.51 HD21 ' CG ' ' A' ' 33' ' ' PHE . 19.0 mt -82.21 65.73 7.47 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.7 -28.37 12.52 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.476 ' CD1' ' HD2' ' A' ' 104' ' ' PRO . 68.1 t80 -110.48 127.09 27.57 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.14 -1.6 . . . . 0.0 110.973 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.476 ' HD2' ' CD1' ' A' ' 103' ' ' TYR . 61.1 Cg_endo -74.82 146.81 33.92 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 123.039 2.493 . . . . 0.0 112.533 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.483 HG11 ' N ' ' A' ' 106' ' ' TYR . 9.9 p -83.26 -32.05 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.122 -0.986 . . . . 0.0 110.604 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.483 ' N ' HG11 ' A' ' 105' ' ' VAL . 35.2 m-85 -129.64 59.35 1.61 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.787 -1.196 . . . . 0.0 110.856 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -94.28 144.49 25.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.416 -0.802 . . . . 0.0 109.772 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -117.45 157.07 26.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.515 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -78.16 124.0 27.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.272 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.534 ' NH1' ' HG2' ' A' ' 110' ' ' ARG . 2.0 mtt-85 -128.87 170.58 13.21 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.237 -0.914 . . . . 0.0 109.517 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.724 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.604 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.009 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.432 ' H1 ' ' H ' ' A' ' 2' ' ' ASP . 85.2 tt0 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.0 0.428 . . . . 0.0 109.861 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.432 ' H ' ' H1 ' ' A' ' 1' ' ' GLU . 52.1 t0 -79.7 124.76 28.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.17 -0.956 . . . . 0.0 109.834 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.0 mt -101.45 118.7 59.37 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 108.679 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.593 ' O ' ' OG1' ' A' ' 10' ' ' THR . 26.8 Cg_exo -58.96 -11.77 13.33 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.948 1.765 . . . . 0.0 111.576 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.533 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 98.0 m-70 -67.2 -31.7 72.27 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.803 -0.561 . . . . 0.0 110.749 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.771 ' HD1' ' N ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -63.06 -15.4 56.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 0.0 110.153 -178.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.771 ' N ' ' HD1' ' A' ' 6' ' ' HIS . 27.1 t0 -102.51 126.14 49.47 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.723 ' O ' ' N ' ' A' ' 12' ' ' ASN . 4.0 mp0 -66.18 -27.29 67.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 110.644 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.63 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -62.69 -39.05 92.77 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.988 -1.07 . . . . 0.0 109.689 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.652 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 22.1 p -59.04 -33.76 71.13 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.694 -0.629 . . . . 0.0 109.909 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.693 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -123.91 -31.59 3.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.808 -1.183 . . . . 0.0 111.728 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.723 ' N ' ' O ' ' A' ' 8' ' ' GLU . 28.5 t-20 -87.84 130.65 34.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.539 -1.35 . . . . 0.0 110.857 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -107.48 -6.52 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASN . . . 92.77 -161.86 26.13 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.4 p -67.44 153.59 43.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -1.14 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 t -163.59 150.51 12.23 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.424 -0.797 . . . . 0.0 109.407 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 18' ' ' ARG . 11.0 m120 -88.12 7.95 29.18 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 4.5 mmp_? 66.73 9.01 6.37 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.468 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.715 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 36.5 p-10 -77.52 -53.67 7.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.071 -1.018 . . . . 0.0 108.27 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.715 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 45.1 pttt -68.88 -26.29 65.05 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -56.62 -45.62 81.39 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 26' ' ' ARG . 59.2 mm-40 -59.16 -47.04 86.78 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -62.8 -42.68 99.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.414 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 79.0 mt -69.94 -29.97 67.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 109.504 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' ALA . 16.0 mt -89.79 -13.28 36.98 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 22' ' ' GLU . 89.5 mtt180 -91.5 115.27 27.9 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.62 2.89 50.05 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.414 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 36.4 mmtt -100.77 137.82 38.64 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.225 -1.162 . . . . 0.0 109.212 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -69.64 156.49 38.87 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.664 -0.648 . . . . 0.0 109.695 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 63.2 t0 -57.81 141.92 47.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.587 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 108.7 -27.82 12.62 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.4 m -79.85 120.8 24.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.133 -1.216 . . . . 0.0 108.437 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -139.89 176.57 8.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.851 -1.156 . . . . 0.0 110.931 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.68 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -150.76 161.63 42.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.576 -0.703 . . . . 0.0 110.233 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.48 HG21 ' SG ' ' A' ' 46' ' ' CYS . 43.7 t -107.16 139.97 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.467 HH22 ' HB3' ' A' ' 56' ' ' HIS . 1.1 ppt_? -158.72 -160.21 0.85 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.656 ' C ' ' H ' ' A' ' 39' ' ' SER . 82.7 mt-10 -100.19 174.27 6.23 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.567 -1.333 . . . . 0.0 109.079 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.668 ' N ' ' O ' ' A' ' 43' ' ' CYS . 33.6 m -76.67 12.98 1.1 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.656 ' H ' ' C ' ' A' ' 37' ' ' GLU . 7.2 t 85.85 -113.61 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.757 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -86.9 -9.72 55.04 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.123 -0.985 . . . . 0.0 110.722 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -71.56 -35.89 70.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.74 -1.225 . . . . 0.0 110.062 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.3 -14.55 58.15 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.668 ' O ' ' N ' ' A' ' 38' ' ' SER . 76.9 m -79.73 160.06 26.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.28 . . . . 0.0 109.329 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -85.65 154.43 21.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.016 -1.053 . . . . 0.0 109.187 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HB1' ' NH1' ' A' ' 36' ' ' ARG . . . -159.38 151.61 21.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.978 -1.076 . . . . 0.0 110.062 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.497 ' SG ' ' CD1' ' A' ' 59' ' ' ILE . 77.0 m -113.46 124.07 51.53 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.2 t -94.7 130.81 41.06 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.106 -0.997 . . . . 0.0 109.022 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.9 p -135.19 168.44 23.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.482 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.6 t -115.19 134.3 58.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.1 t -112.85 161.25 11.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.044 -1.035 . . . . 0.0 109.801 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.457 ' N ' HG12 ' A' ' 50' ' ' VAL . 64.6 m-20 -62.25 56.13 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.029 0.443 . . . . 0.0 109.99 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 164.37 -36.71 0.29 Allowed Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.208 -1.472 . . . . 0.0 111.018 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.511 ' OE1' ' C ' ' A' ' 52' ' ' GLY . 60.7 mp0 -153.91 161.06 42.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.638 -1.507 . . . . 0.0 110.972 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.1 t -91.9 138.47 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' CE ' ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -124.07 168.73 12.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.903 -1.123 . . . . 0.0 110.948 -179.445 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.467 ' HB3' HH22 ' A' ' 36' ' ' ARG . 71.0 m-70 -129.79 73.67 1.54 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.464 ' SG ' HD12 ' A' ' 90' ' ' LEU . 73.0 m -50.7 148.1 4.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.315 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.1 t -116.16 134.5 59.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.891 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.497 ' CD1' ' SG ' ' A' ' 46' ' ' CYS . 67.1 mt -117.46 139.17 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.532 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 10.0 m120 -126.58 131.55 51.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.8 -1.187 . . . . 0.0 109.689 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -97.54 120.75 38.48 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.338 -0.851 . . . . 0.0 110.435 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.577 ' CG2' ' H ' ' A' ' 64' ' ' THR . 4.9 t -153.56 175.48 13.16 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.412 -0.805 . . . . 0.0 108.927 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.97 -19.33 6.52 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.314 -0.866 . . . . 0.0 108.952 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.61 ' O ' ' CG2' ' A' ' 64' ' ' THR . 12.4 t -162.92 78.69 0.46 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.111 -0.993 . . . . 0.0 109.95 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.651 ' C ' ' H ' ' A' ' 67' ' ' GLY . . . -161.64 -71.73 0.02 OUTLIER Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.806 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.532 ' CA ' ' O ' ' A' ' 60' ' ' ASN . 83.4 m-85 57.63 -4.98 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.22 -1.165 . . . . 0.0 109.548 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.651 ' H ' ' C ' ' A' ' 65' ' ' GLY . . . 134.57 -97.72 0.3 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.518 ' O ' ' OH ' ' A' ' 75' ' ' TYR . 27.2 m-85 -80.22 130.94 35.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.349 -1.089 . . . . 0.0 108.79 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.04 -14.3 4.97 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.675 -1.266 . . . . 0.0 110.022 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.67 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 11.3 tp10 -64.47 -36.79 19.9 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.018 -1.051 . . . . 0.0 109.422 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 69.5 Cg_endo -89.97 -58.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.624 2.216 . . . . 0.0 110.68 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -122.92 105.45 10.01 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.549 ' C ' ' OD1' ' A' ' 73' ' ' ASN . 42.2 p30 -90.66 22.19 3.65 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.19 -0.944 . . . . 0.0 109.645 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.2 tp -158.14 103.5 1.83 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.22 -0.925 . . . . 0.0 110.166 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.518 ' OH ' ' O ' ' A' ' 68' ' ' PHE . 27.6 m-85 -95.64 139.71 31.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.358 -0.839 . . . . 0.0 109.64 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.524 ' OG ' ' CD ' ' A' ' 80' ' ' GLU . 84.1 p -65.45 -44.37 87.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.203 -0.935 . . . . 0.0 110.901 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -166.93 162.44 15.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.924 -1.11 . . . . 0.0 109.489 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.61 -37.73 88.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.466 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 3.7 ttmp? -58.91 -45.33 90.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.887 -1.133 . . . . 0.0 109.175 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.524 ' CD ' ' OG ' ' A' ' 76' ' ' SER . 51.7 mt-10 -67.13 -29.14 68.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.19 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.6 tt -58.6 -43.75 89.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.285 -0.885 . . . . 0.0 110.014 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.84 -44.39 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.716 -1.24 . . . . 0.0 109.718 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.483 HD21 ' N ' ' A' ' 83' ' ' LEU . 3.8 mm? -67.15 -42.38 84.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 109.555 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.676 ' O ' ' CE1' ' A' ' 87' ' ' HIS . 60.1 t60 -60.28 -39.73 87.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.417 -0.802 . . . . 0.0 110.801 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.457 ' HA ' ' OG1' ' A' ' 88' ' ' THR . 4.9 m-30 -71.08 -25.5 62.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.478 -0.764 . . . . 0.0 112.526 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 83' ' ' LEU . 9.2 pt20 -61.23 -30.56 70.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.348 -1.47 . . . . 0.0 110.312 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.676 ' CE1' ' O ' ' A' ' 84' ' ' HIS . 31.2 p-80 -92.7 -5.49 51.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.75 -1.219 . . . . 0.0 109.188 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 85' ' ' TYR . 56.2 p -98.36 139.76 33.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.158 -0.964 . . . . 0.0 109.455 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.2 t -97.81 126.73 43.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.451 -0.781 . . . . 0.0 109.452 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.647 ' O ' ' N ' ' A' ' 92' ' ' GLN . 81.8 mt -67.05 -20.04 65.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.983 -1.073 . . . . 0.0 109.833 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.774 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.7 p -10.67 -58.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.834 -0.542 . . . . 0.0 110.171 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.647 ' N ' ' O ' ' A' ' 90' ' ' LEU . 9.5 tp-100 -35.17 155.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 92' ' ' GLN . 59.5 t-80 55.49 107.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.814 ' O ' ' N ' ' A' ' 96' ' ' SER . 70.9 m-20 56.69 71.84 0.54 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.603 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 94.2 m-20 -29.84 -20.0 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.814 ' N ' ' O ' ' A' ' 94' ' ' ASN . 87.1 p -77.43 15.5 0.77 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.671 -1.268 . . . . 0.0 110.922 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.774 ' O ' ' N ' ' A' ' 91' ' ' VAL . 70.5 mt -95.68 41.67 1.1 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 95' ' ' ASP . 64.1 m-80 -78.39 79.28 4.83 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.321 -0.862 . . . . 0.0 110.073 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.521 ' CG2' ' OD1' ' A' ' 30' ' ' ASP . 7.4 p -153.31 157.93 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.8 p -130.26 157.46 42.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.105 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.51 HD21 ' CG ' ' A' ' 33' ' ' PHE . 19.0 mt -82.21 65.73 7.47 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.7 -28.37 12.52 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.476 ' CD1' ' HD2' ' A' ' 104' ' ' PRO . 68.1 t80 -110.48 127.09 27.57 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.14 -1.6 . . . . 0.0 110.973 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.476 ' HD2' ' CD1' ' A' ' 103' ' ' TYR . 61.1 Cg_endo -74.82 146.81 33.92 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 123.039 2.493 . . . . 0.0 112.533 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.483 HG11 ' N ' ' A' ' 106' ' ' TYR . 9.9 p -83.26 -32.05 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.122 -0.986 . . . . 0.0 110.604 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.483 ' N ' HG11 ' A' ' 105' ' ' VAL . 35.2 m-85 -129.64 59.35 1.61 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.787 -1.196 . . . . 0.0 110.856 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -94.28 144.49 25.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.416 -0.802 . . . . 0.0 109.772 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -117.45 157.07 26.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.515 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -78.16 124.0 27.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.272 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.534 ' NH1' ' HG2' ' A' ' 110' ' ' ARG . 2.0 mtt-85 -128.87 170.58 13.21 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.237 -0.914 . . . . 0.0 109.517 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.724 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.604 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.009 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.538 0.685 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 64.6 t0 -58.44 139.35 55.66 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.418 -0.802 . . . . 0.0 109.559 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.504 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 92.6 mt -94.71 129.57 35.85 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 109.583 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.4 -2.35 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.613 2.209 . . . . 0.0 111.998 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.665 ' CD2' ' OE1' ' A' ' 86' ' ' GLN . 4.7 m80 -67.76 -24.52 65.35 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.898 -1.126 . . . . 0.0 109.493 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -58.13 -29.85 65.86 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.595 ' O ' ' OG1' ' A' ' 10' ' ' THR . 94.5 m-20 -89.0 121.73 31.65 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.481 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 46.5 tt0 -69.9 -34.58 73.71 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.07 -1.019 . . . . 0.0 109.585 -178.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.46 -21.98 66.2 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 110.95 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 7' ' ' ASP . 8.1 p -64.05 -35.29 80.26 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.776 -1.203 . . . . 0.0 109.978 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.608 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -115.97 -34.3 4.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.94 -1.1 . . . . 0.0 110.182 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -88.1 125.69 34.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.071 -1.018 . . . . 0.0 110.543 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 m -108.59 -13.13 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.2 -158.59 30.34 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.482 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 73.7 m -61.52 148.41 42.16 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.18 -1.188 . . . . 0.0 108.524 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.463 ' HB3' ' NE ' ' A' ' 36' ' ' ARG . 40.4 t -168.87 167.61 10.85 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 109.355 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -88.89 134.7 33.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.235 -0.916 . . . . 0.0 109.281 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.492 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 44.8 mtt-85 -59.98 -36.22 76.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.845 -1.159 . . . . 0.0 110.287 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -54.53 -48.24 72.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 0.0 111.121 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -69.57 -26.43 64.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.385 -1.447 . . . . 0.0 109.3 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.542 ' CB ' HH12 ' A' ' 36' ' ' ARG . . . -57.34 -43.44 83.43 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -59.58 -44.02 93.47 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -60.15 -48.63 80.91 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.27 -36.49 83.83 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.401 HD12 ' CG1' ' A' ' 54' ' ' VAL . 4.0 mt -82.01 -4.43 56.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.221 -0.924 . . . . 0.0 109.432 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.17 131.38 37.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.33 -0.856 . . . . 0.0 110.5 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.06 1.79 88.52 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -100.23 128.19 46.35 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.209 -1.171 . . . . 0.0 110.108 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 30' ' ' ASP . 41.9 ttm180 -62.29 147.75 47.12 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 53.3 p-10 -47.39 156.0 0.3 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.928 -1.107 . . . . 0.0 108.769 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' H ' HG22 ' A' ' 99' ' ' VAL . . . 99.47 -33.87 5.87 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 60.0 m -72.54 123.93 24.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.167 -1.196 . . . . 0.0 108.831 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.736 ' CD1' ' N ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -145.4 172.24 13.47 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 118.385 -1.326 . . . . 0.0 111.051 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.736 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -148.75 159.76 43.83 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.184 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 11' ' ' TRP . 14.7 t -101.5 138.85 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.625 ' O ' ' O ' ' A' ' 45' ' ' ALA . 32.2 ttm180 -150.58 160.38 43.84 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 109.5 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.643 ' C ' ' H ' ' A' ' 39' ' ' SER . 16.0 pm0 -102.24 174.65 5.83 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.63 -1.294 . . . . 0.0 109.304 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.584 ' O ' ' CB ' ' A' ' 39' ' ' SER . 60.3 p -75.48 3.93 8.38 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 178.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.643 ' H ' ' C ' ' A' ' 37' ' ' GLU . 1.8 m 91.9 -19.93 0.11 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.497 -1.683 . . . . 0.0 109.349 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -90.36 120.47 31.51 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -49.33 132.55 20.18 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.224 -0.923 . . . . 0.0 109.351 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.99 0.85 41.9 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.47 ' HB3' ' HG ' ' A' ' 38' ' ' SER . 42.2 t -131.67 140.16 49.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.34 -1.094 . . . . 0.0 109.074 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' A' ' 59' ' ' ILE . 44.2 m-85 -127.11 163.38 23.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.164 -0.96 . . . . 0.0 109.84 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.625 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -171.77 155.9 4.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.165 -0.96 . . . . 0.0 108.984 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 57' ' ' CYS . 22.1 p -133.13 142.91 48.93 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.496 -1.377 . . . . 0.0 109.285 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.465 ' HB3' ' HD1' ' A' ' 56' ' ' HIS . 89.2 p -116.86 139.28 50.79 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.53 -0.731 . . . . 0.0 109.744 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 14.9 p -133.29 166.6 28.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.383 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.431 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 53.7 t -103.69 137.49 32.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.667 ' C ' ' H ' ' A' ' 52' ' ' GLY . 41.4 t -116.99 152.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.153 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.495 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 62.1 t0 -52.7 2.2 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.095 0.474 . . . . 0.0 110.328 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.667 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -136.19 -32.66 0.26 Allowed Glycine 0 N--CA 1.485 1.952 0 C-N-CA 118.894 -1.622 . . . . 0.0 112.248 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 64.2 mt-10 -158.52 163.57 36.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.444 -1.621 . . . . 0.0 111.399 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.414 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 66.1 t -76.63 136.99 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 54' ' ' VAL . 60.8 mmtt -114.9 150.89 34.92 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.823 -1.173 . . . . 0.0 111.347 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.465 ' HD1' ' HB3' ' A' ' 47' ' ' SER . 43.9 m-70 -131.69 70.04 1.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 98.0 m -62.22 142.71 57.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 109.566 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.7 138.28 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.49 -0.756 . . . . 0.0 109.496 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.558 ' O ' ' O ' ' A' ' 44' ' ' TYR . 90.9 mt -123.08 136.64 59.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.282 -0.886 . . . . 0.0 109.183 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 12.3 m120 -102.55 166.85 10.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.88 -1.138 . . . . 0.0 109.301 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.36 10.33 9.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.582 -1.324 . . . . 0.0 110.092 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.423 ' CG2' ' N ' ' A' ' 63' ' ' ALA . 87.9 m -79.51 167.62 20.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.085 -1.009 . . . . 0.0 109.446 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 62' ' ' THR . . . -55.68 -50.18 70.96 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.293 -0.88 . . . . 0.0 108.963 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.3 m -92.97 -0.41 57.22 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.296 -0.878 . . . . 0.0 108.98 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 66' ' ' TYR . . . -78.69 -101.13 0.22 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.575 ' O ' ' O ' ' A' ' 65' ' ' GLY . 69.7 m-85 53.47 164.79 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.192 -1.181 . . . . 0.0 108.496 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.35 -77.41 0.26 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.71 ' CE1' ' OH ' ' A' ' 85' ' ' TYR . 35.5 m-85 -106.36 118.15 35.9 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.467 -1.019 . . . . 0.0 109.247 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 73' ' ' ASN . . . -107.98 -54.54 2.48 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.139 -0.975 . . . . 0.0 110.336 -179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.62 175.31 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.059 -1.026 . . . . 0.0 108.487 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -51.89 -32.78 48.65 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.24 1.96 . . . . 0.0 112.987 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -151.32 8.65 0.54 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.921 -1.112 . . . . 0.0 111.157 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 69' ' ' ALA . 29.5 m120 -100.34 81.21 2.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.386 -1.446 . . . . 0.0 109.324 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.61 98.37 6.35 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.586 ' OH ' ' CG ' ' A' ' 84' ' ' HIS . 87.7 m-85 -54.6 130.84 41.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.379 -0.826 . . . . 0.0 109.702 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.1 t -68.97 -36.22 77.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.426 -0.796 . . . . 0.0 111.671 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.4 m -130.54 159.49 36.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.579 -1.326 . . . . 0.0 110.742 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.23 -37.63 86.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.871 . . . . 0.0 109.084 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -53.77 -44.09 69.77 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.02 -42.5 72.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.386 -0.821 . . . . 0.0 109.989 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.495 ' C ' ' CD2' ' A' ' 81' ' ' LEU . 6.9 tt -59.8 -46.13 90.18 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.254 -0.904 . . . . 0.0 109.338 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.425 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 72.0 t -63.06 -45.93 97.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 109.599 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 68.6 mt -61.53 -40.1 93.46 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.539 -0.726 . . . . 0.0 110.305 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.586 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 60.1 t-80 -52.0 -48.67 64.33 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.165 -0.959 . . . . 0.0 110.195 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.71 ' OH ' ' CE1' ' A' ' 68' ' ' PHE . 27.2 m-85 -71.48 -20.71 62.04 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.126 -0.984 . . . . 0.0 112.027 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.665 ' OE1' ' CD2' ' A' ' 5' ' ' HIS . 27.7 mt-30 -61.56 -36.02 79.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.645 -1.284 . . . . 0.0 109.382 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -93.5 -37.09 12.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.432 -0.792 . . . . 0.0 109.033 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.58 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 7.7 p -89.6 139.82 30.16 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.431 -0.793 . . . . 0.0 110.29 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.6 t -81.39 136.84 35.72 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.564 -0.71 . . . . 0.0 109.48 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.769 ' O ' ' N ' ' A' ' 92' ' ' GLN . 8.0 mt -61.46 -41.8 97.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.434 -0.791 . . . . 0.0 111.012 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.614 ' N ' ' O ' ' A' ' 97' ' ' LEU . 71.8 t 40.29 -81.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.225 -0.922 . . . . 0.0 109.234 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.769 ' N ' ' O ' ' A' ' 90' ' ' LEU . 0.7 OUTLIER 84.44 171.86 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 0.0 110.475 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.459 ' H ' ' HG3' ' A' ' 92' ' ' GLN . 65.0 m80 -60.93 -37.85 83.74 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 88.4 m-20 -57.93 -18.13 21.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 94' ' ' ASN . 97.7 m-20 61.28 23.23 13.49 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.8 m -134.01 11.49 3.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.57 -1.332 . . . . 0.0 111.195 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.614 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.4 mp -104.02 46.24 0.93 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.602 ' OD1' ' CG2' ' A' ' 91' ' ' VAL . 74.3 m-20 -78.08 67.46 3.92 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.448 -177.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 31' ' ' GLY . 7.4 p -132.2 159.04 43.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.403 ' HG1' ' HB1' ' A' ' 102' ' ' ALA . 40.5 p -110.65 152.36 26.58 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.273 -0.892 . . . . 0.0 108.793 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.524 ' HB3' ' CE2' ' A' ' 33' ' ' PHE . 91.5 mt -93.26 30.23 1.73 Allowed 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.403 ' HB1' ' HG1' ' A' ' 100' ' ' THR . . . -76.7 -9.19 58.49 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 32' ' ' THR . 73.7 m-85 -121.83 103.77 39.82 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.375 -1.453 . . . . 0.0 111.602 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -61.01 160.92 24.01 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.02 1.813 . . . . 0.0 110.805 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.09 -22.9 7.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.205 -0.935 . . . . 0.0 109.78 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -111.13 34.39 4.08 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.093 -1.004 . . . . 0.0 110.254 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.33 152.01 46.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.308 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -77.05 161.15 28.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.002 -1.061 . . . . 0.0 110.053 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 60.35 32.49 20.69 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.586 -0.696 . . . . 0.0 109.962 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.538 ' NH1' ' HG3' ' A' ' 110' ' ' ARG . 29.9 ttm-85 -127.62 137.78 52.65 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.006 -1.059 . . . . 0.0 109.442 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.719 ' CG ' HH11 ' A' ' 111' ' ' ARG . 1.6 mtt-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.643 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.44 144.49 49.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.362 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.32 143.33 26.17 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.34 -0.85 . . . . 0.0 109.656 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.52 -1.31 6.36 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.234 1.956 . . . . 0.0 111.988 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.633 ' NE2' ' OE1' ' A' ' 86' ' ' GLN . 88.7 m-70 -69.69 -32.36 70.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.106 -0.996 . . . . 0.0 108.606 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -60.99 -32.78 72.34 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.343 -0.848 . . . . 0.0 108.807 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.4 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 68.6 m-20 -92.67 129.22 38.66 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.686 0.755 . . . . 0.0 110.814 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.525 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 75.6 tt0 -77.73 -23.45 49.36 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.3 -0.875 . . . . 0.0 110.68 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -17.85 63.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.187 -0.946 . . . . 0.0 111.528 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.609 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 47.1 p -73.42 -26.69 61.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.732 -1.23 . . . . 0.0 111.305 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.609 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -123.58 -21.91 5.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.505 -1.372 . . . . 0.0 109.773 179.073 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -83.62 121.35 27.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 110.882 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' A' ' 15' ' ' SER . 2.2 t -134.61 33.32 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -30.96 -31.68 0.01 OUTLIER Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.63 ' N ' ' O ' ' A' ' 13' ' ' VAL . 89.2 p -69.54 -21.18 63.67 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.804 -1.409 . . . . 0.0 109.965 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 13' ' ' VAL . 41.9 t -66.62 149.38 50.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.068 -1.02 . . . . 0.0 110.269 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.415 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 92.7 m-20 -114.52 167.57 10.62 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.061 -1.024 . . . . 0.0 109.654 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -56.84 -43.54 81.22 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.266 -0.897 . . . . 0.0 109.26 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -65.82 -46.55 78.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.161 -0.962 . . . . 0.0 108.717 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.415 ' HB3' ' H ' ' A' ' 17' ' ' ASN . 82.3 tttt -65.02 -36.37 84.18 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -57.13 -37.81 72.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 108.878 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.603 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 97.1 mt-10 -59.01 -44.17 91.65 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -63.84 -44.1 94.19 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.447 -0.783 . . . . 0.0 108.975 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.622 ' O ' ' CD ' ' A' ' 28' ' ' LYS . 96.1 mt -71.23 -26.19 62.82 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.335 -0.853 . . . . 0.0 108.837 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 21' ' ' ALA . 21.1 mt -94.09 -11.84 29.75 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.603 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 16.6 mmt180 -97.74 134.48 40.85 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.28 -0.38 88.95 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.622 ' CD ' ' O ' ' A' ' 24' ' ' LEU . 19.0 mtpp -105.06 136.65 44.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.094 -1.239 . . . . 0.0 109.468 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -68.27 160.69 28.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.163 -0.96 . . . . 0.0 110.476 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.691 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 84.4 m-20 -57.99 149.45 23.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.518 -0.739 . . . . 0.0 110.218 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.549 ' H ' HG22 ' A' ' 99' ' ' VAL . . . 104.71 -30.64 9.71 Favored Glycine 0 N--CA 1.486 2.015 0 C-N-CA 119.41 -1.376 . . . . 0.0 110.222 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 85.0 m -80.17 120.35 24.18 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.418 -1.048 . . . . 0.0 108.207 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.554 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -135.61 164.96 26.65 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 118.806 -1.158 . . . . 0.0 109.656 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.01 157.0 47.21 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.398 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 11' ' ' TRP . 85.5 t -115.41 124.79 72.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.37 -0.831 . . . . 0.0 108.985 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.679 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -152.56 177.35 10.74 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.694 ' C ' ' H ' ' A' ' 39' ' ' SER . 4.3 pm0 -101.88 168.09 9.65 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.088 -1.007 . . . . 0.0 108.861 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.639 ' O ' ' CB ' ' A' ' 39' ' ' SER . 59.8 p -74.22 9.01 1.81 Allowed 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.694 ' H ' ' C ' ' A' ' 37' ' ' GLU . 12.4 p 93.32 -22.18 0.07 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.729 -1.578 . . . . 0.0 108.452 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -74.41 149.85 40.27 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.508 -0.745 . . . . 0.0 109.147 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -76.42 131.71 39.24 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.297 -0.877 . . . . 0.0 109.195 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.49 -1.81 79.67 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 87.7 m -111.54 135.66 51.8 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.351 -1.087 . . . . 0.0 109.605 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.655 ' O ' ' O ' ' A' ' 59' ' ' ILE . 96.0 m-85 -126.92 149.24 49.9 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.965 -1.084 . . . . 0.0 109.146 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -158.15 137.49 11.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.348 -1.47 . . . . 0.0 109.794 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 20.9 p -116.9 129.87 56.34 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.149 -0.969 . . . . 0.0 109.092 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.515 ' CB ' ' HD1' ' A' ' 56' ' ' HIS . 12.7 t -107.58 138.7 43.33 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.657 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.537 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 10.4 p -128.56 170.75 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.498 -0.751 . . . . 0.0 109.766 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.537 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 85.4 t -114.71 134.12 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.586 HG11 ' H ' ' A' ' 53' ' ' GLU . 3.9 p -125.25 157.48 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.696 -1.253 . . . . 0.0 110.161 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.691 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 43.2 p30 -49.59 -10.31 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.662 0.744 . . . . 0.0 110.398 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.592 ' N ' ' OD1' ' A' ' 51' ' ' ASP . . . -98.33 -58.41 0.96 Allowed Glycine 0 C--N 1.287 -2.179 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.586 ' H ' HG11 ' A' ' 50' ' ' VAL . 61.5 mt-10 -164.68 -175.21 3.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.395 -1.062 . . . . 0.0 109.725 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.411 ' H ' HG21 ' A' ' 54' ' ' VAL . 18.0 m -90.84 119.87 38.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -119.54 156.71 29.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.435 -1.416 . . . . 0.0 110.454 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.515 ' HD1' ' CB ' ' A' ' 47' ' ' SER . 93.8 m-70 -111.76 127.87 55.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.48 -0.762 . . . . 0.0 109.974 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.7 t -105.24 128.56 53.49 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 p -86.35 136.51 22.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.845 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.655 ' O ' ' O ' ' A' ' 44' ' ' TYR . 51.5 mm -118.96 126.74 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.633 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 25.7 m120 -121.62 171.54 8.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.586 -1.321 . . . . 0.0 110.436 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -132.2 61.97 1.65 Allowed 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.3 -1.5 . . . . 0.0 108.772 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.679 ' O ' ' N ' ' A' ' 64' ' ' THR . 32.4 m -135.76 171.24 14.75 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.478 ' H ' HG21 ' A' ' 62' ' ' THR . . . -45.88 -6.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.379 -0.826 . . . . 0.0 109.918 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.679 ' N ' ' O ' ' A' ' 62' ' ' THR . 91.2 m -78.65 -21.09 48.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.149 -0.97 . . . . 0.0 109.537 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 67' ' ' GLY . . . 81.85 67.8 1.49 Allowed Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.633 ' HA ' ' O ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER 33.73 32.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.567 -0.961 . . . . 0.0 110.221 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 65' ' ' GLY . . . 90.01 -40.81 3.0 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.642 ' CD2' ' OH ' ' A' ' 85' ' ' TYR . 97.5 m-85 -95.9 123.69 39.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -1.08 . . . . 0.0 109.38 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.96 7.66 5.58 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.152 -0.967 . . . . 0.0 109.629 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.789 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 19.4 pt-20 -126.51 13.5 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.001 -1.062 . . . . 0.0 111.572 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.789 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 39.6 Cg_endo -71.31 -69.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.489 1.46 . . . . 0.0 112.024 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -143.49 60.01 1.39 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.887 . . . . 0.0 110.247 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 36.1 m120 58.39 48.81 11.74 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.324 -0.86 . . . . 0.0 110.437 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.0 mt 61.97 115.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.267 -0.896 . . . . 0.0 110.43 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -57.77 134.05 55.92 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.486 -0.759 . . . . 0.0 109.688 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.5 m -66.81 -38.55 86.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.825 . . . . 0.0 110.359 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.2 p -142.63 161.37 38.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.913 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.6 mt -61.42 -39.8 92.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.367 -0.833 . . . . 0.0 109.606 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -59.04 -40.07 83.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.124 -0.985 . . . . 0.0 108.946 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -64.2 -36.52 84.32 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.4 -0.812 . . . . 0.0 109.192 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.86 -46.02 90.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.053 -1.029 . . . . 0.0 110.225 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.4 t -63.24 -41.18 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.006 -1.059 . . . . 0.0 109.647 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.493 HD22 ' CD2' ' A' ' 5' ' ' HIS . 76.3 mt -63.16 -43.77 97.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.924 -1.11 . . . . 0.0 111.323 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -64.84 -43.74 92.06 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.863 -1.148 . . . . 0.0 111.021 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.642 ' OH ' ' CD2' ' A' ' 68' ' ' PHE . 19.0 m-85 -65.64 -24.64 67.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.616 -1.302 . . . . 0.0 109.055 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.633 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 33.5 tt0 -67.57 -33.16 74.46 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.376 -0.827 . . . . 0.0 109.607 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -95.0 -14.09 24.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.119 -0.988 . . . . 0.0 109.292 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.9 m -108.05 129.97 55.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 109.527 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.0 t -72.95 139.9 47.05 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.978 -1.076 . . . . 0.0 108.614 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.687 ' O ' ' C ' ' A' ' 91' ' ' VAL . 7.6 mp -69.0 -16.03 63.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.116 -0.99 . . . . 0.0 110.688 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.695 ' N ' ' O ' ' A' ' 97' ' ' LEU . 74.6 t -10.15 -64.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.589 0 O-C-N 121.75 -0.594 . . . . 0.0 109.918 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 90' ' ' LEU . 91.3 mt-30 34.71 -142.24 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.402 ' O ' ' N ' ' A' ' 95' ' ' ASP . 82.9 t60 -52.44 -50.07 63.33 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.711 ' O ' ' N ' ' A' ' 96' ' ' SER . 7.7 m120 -69.7 83.3 0.44 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 94' ' ' ASN . 62.9 t0 -44.03 -10.74 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.421 -0.799 . . . . 0.0 108.903 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.711 ' N ' ' O ' ' A' ' 94' ' ' ASN . 89.3 p -100.56 4.45 43.48 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.507 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.695 ' O ' ' N ' ' A' ' 91' ' ' VAL . 8.3 mt -76.83 50.31 0.7 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.078 -1.639 . . . . 0.0 108.404 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -77.37 80.62 3.87 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.252 -0.905 . . . . 0.0 109.861 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.549 HG22 ' H ' ' A' ' 31' ' ' GLY . 6.6 p -161.53 162.94 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.487 ' H ' HG21 ' A' ' 99' ' ' VAL . 44.4 p -129.94 155.85 45.39 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.087 -1.008 . . . . 0.0 109.936 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.554 HD21 ' CG ' ' A' ' 33' ' ' PHE . 18.4 mt -89.15 53.9 2.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.021 -1.049 . . . . 0.0 108.673 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.457 ' CB ' ' HG3' ' A' ' 86' ' ' GLN . . . -89.66 -18.09 27.12 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.73 -0.606 . . . . 0.0 112.37 -178.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' THR . 88.4 t80 -116.61 110.16 42.81 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 120.265 -1.522 . . . . 0.0 110.448 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -59.6 146.96 93.8 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.875 1.716 . . . . 0.0 110.926 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.472 HG12 ' CD2' ' A' ' 106' ' ' TYR . 11.4 p -67.99 -22.43 27.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.686 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.472 ' CD2' HG12 ' A' ' 105' ' ' VAL . 59.9 m-85 -128.75 60.88 1.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.903 . . . . 0.0 109.39 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.97 -4.86 14.49 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.971 -1.081 . . . . 0.0 108.657 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -109.03 137.8 46.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 110.051 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -63.89 145.61 55.52 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.412 -0.805 . . . . 0.0 109.273 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 1.243 ' CZ ' ' NH2' ' A' ' 110' ' ' ARG . 42.4 mtp180 -88.82 130.47 35.37 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 . . . . . 0 N--CA 1.494 1.754 0 O-C-N 120.954 -1.091 . . . . 0.0 108.97 -179.757 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -68.7 146.43 52.98 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 109.559 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.441 ' HB3' ' CD2' ' A' ' 6' ' ' HIS . 13.8 tp -88.88 125.99 60.83 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 121.076 -1.015 . . . . 0.0 108.364 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -49.86 -20.95 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.994 1.796 . . . . 0.0 112.082 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.701 ' CD2' HE22 ' A' ' 86' ' ' GLN . 30.2 m-70 -71.57 -29.69 65.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.453 -0.78 . . . . 0.0 109.838 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.441 ' CD2' ' HB3' ' A' ' 3' ' ' LEU . 80.3 m-70 -67.48 -21.68 65.51 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.558 ' O ' ' OG1' ' A' ' 10' ' ' THR . 76.3 m-20 -95.84 113.33 24.95 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.449 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 32.0 tt0 -70.31 -32.97 70.96 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.473 -0.767 . . . . 0.0 110.801 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.502 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -71.2 -13.62 61.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.758 -1.214 . . . . 0.0 110.945 -178.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.576 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 6.6 p -62.97 -37.49 87.32 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.68 -1.262 . . . . 0.0 108.666 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.719 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -117.33 -27.8 6.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.944 -1.098 . . . . 0.0 110.074 179.042 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -86.6 119.66 27.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.924 -1.11 . . . . 0.0 110.442 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 15' ' ' SER . 9.8 p -140.72 31.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -39.12 -20.34 0.01 OUTLIER Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.608 ' N ' ' O ' ' A' ' 13' ' ' VAL . 87.5 p -61.42 -17.52 54.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -1.131 . . . . 0.0 108.589 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.1 m -94.15 145.16 24.89 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.725 0.774 . . . . 0.0 110.731 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.66 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 54.8 p30 -79.64 167.39 20.75 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.394 -0.816 . . . . 0.0 109.335 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.523 ' CG ' ' NH1' ' A' ' 36' ' ' ARG . 81.1 mtm180 -61.05 -39.9 91.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.596 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -63.05 -44.29 96.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.645 -1.285 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.66 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 22.5 tptm -61.13 -35.51 77.26 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.221 -0.924 . . . . 0.0 108.901 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.04 74.32 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 26' ' ' ARG . 94.8 mt-10 -57.63 -45.4 85.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.35 -40.33 93.86 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.8 mt -67.95 -39.56 83.38 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.527 ' CD1' ' OG ' ' A' ' 47' ' ' SER . 3.6 mt -82.83 -16.82 46.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.342 -0.848 . . . . 0.0 108.799 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' GLU . 10.6 mmm180 -93.78 -28.4 15.92 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.959 0.885 . . . . 0.0 109.691 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.99 9.17 70.42 Favored Glycine 0 C--N 1.286 -2.231 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -124.2 145.54 49.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.499 -1.0 . . . . 0.0 110.001 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -77.67 165.53 24.14 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.395 0.617 . . . . 0.0 110.199 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.538 ' CG ' ' OD1' ' A' ' 51' ' ' ASP . 18.2 p-10 -53.02 158.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.92 -33.8 4.51 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.2 m -77.07 125.61 29.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -1.032 . . . . 0.0 108.311 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.518 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -135.88 170.65 15.66 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.966 -1.083 . . . . 0.0 110.274 -178.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -149.26 165.85 30.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.196 -0.94 . . . . 0.0 111.007 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.429 HG21 ' HG ' ' A' ' 46' ' ' CYS . 73.9 t -120.51 121.48 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.731 ' NH1' ' O ' ' A' ' 37' ' ' GLU . 6.8 ptm180 -134.84 -176.24 4.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.438 -0.788 . . . . 0.0 108.949 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.731 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 56.0 mt-10 -94.18 175.25 6.77 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.871 -1.143 . . . . 0.0 108.494 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.648 ' O ' ' CB ' ' A' ' 39' ' ' SER . 20.9 m -75.95 11.27 1.48 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 178.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.648 ' CB ' ' O ' ' A' ' 38' ' ' SER . 4.8 t 98.45 -71.89 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.602 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -110.08 -45.96 3.52 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.462 -1.399 . . . . 0.0 111.831 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.471 ' NE2' ' SG ' ' A' ' 43' ' ' CYS . 6.7 pt20 -69.41 160.54 31.16 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.306 -1.496 . . . . 0.0 110.049 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.54 48.21 2.85 Favored Glycine 0 N--CA 1.496 2.67 0 O-C-N 121.163 -0.96 . . . . 0.0 110.972 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.471 ' SG ' ' NE2' ' A' ' 41' ' ' GLN . 89.5 m -114.81 155.03 27.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.999 -1.295 . . . . 0.0 109.029 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' ILE . 98.1 m-85 -115.46 153.19 31.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.071 -1.018 . . . . 0.0 110.705 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -145.74 133.43 21.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.711 -0.618 . . . . 0.0 109.924 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.609 ' O ' ' CB ' ' A' ' 57' ' ' CYS . 57.3 m -100.0 113.89 26.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.544 -1.347 . . . . 0.0 107.893 178.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.527 ' OG ' ' CD1' ' A' ' 25' ' ' LEU . 33.4 t -91.71 140.77 29.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.133 -0.98 . . . . 0.0 109.83 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.5 t -130.89 156.31 42.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.46 -0.775 . . . . 0.0 109.888 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.4 t -101.12 135.94 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.713 ' C ' ' H ' ' A' ' 52' ' ' GLY . 2.6 t -122.05 147.78 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.542 -1.349 . . . . 0.0 111.124 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.538 ' OD1' ' CG ' ' A' ' 30' ' ' ASP . 82.0 m-20 -55.06 9.36 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.231 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.713 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -135.97 -39.09 0.16 Allowed Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.619 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.539 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 21.6 tt0 -163.14 164.17 25.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.572 -1.546 . . . . 0.0 110.537 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.539 ' N ' ' CG ' ' A' ' 53' ' ' GLU . 96.1 t -67.42 134.69 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.075 -1.015 . . . . 0.0 108.686 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -112.04 139.02 47.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.831 -1.168 . . . . 0.0 109.12 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -120.57 87.74 2.81 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.609 ' CB ' ' O ' ' A' ' 46' ' ' CYS . 0.5 OUTLIER -70.79 139.66 51.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.154 -0.966 . . . . 0.0 108.723 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.41 129.57 62.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 111.241 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 44' ' ' TYR . 46.8 mm -108.13 117.05 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.598 ' O ' ' C ' ' A' ' 66' ' ' TYR . 64.4 t30 -95.17 113.02 24.66 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.943 -1.098 . . . . 0.0 110.312 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -83.86 119.37 24.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.822 -1.174 . . . . 0.0 109.871 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 64' ' ' THR . 86.4 m -141.11 158.65 43.63 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.74 -42.07 71.15 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.975 -1.078 . . . . 0.0 108.937 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.406 ' H ' HG23 ' A' ' 62' ' ' THR . 32.5 p -113.15 12.99 19.21 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.099 -1.0 . . . . 0.0 111.124 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 66' ' ' TYR . . . -126.95 -145.57 6.28 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.378 -1.391 . . . . 0.0 110.258 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.598 ' C ' ' O ' ' A' ' 60' ' ' ASN . 38.1 t80 163.78 -14.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.596 ' CA ' ' H ' ' A' ' 60' ' ' ASN . . . 135.67 -83.14 0.28 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.249 -1.941 . . . . 0.0 108.249 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.697 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 35.3 m-85 -80.45 151.88 29.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.334 -1.098 . . . . 0.0 109.684 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.439 ' HB3' ' ND2' ' A' ' 73' ' ' ASN . . . -134.36 33.26 3.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 110.472 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.733 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 7.8 tp10 -61.15 -35.44 23.99 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.754 -1.216 . . . . 0.0 108.673 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.733 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 73.4 Cg_endo -95.62 19.07 0.63 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 123.485 2.79 . . . . 0.0 110.795 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.439 ' HB2' ' O ' ' A' ' 71' ' ' PRO . 59.3 m-85 68.9 38.45 2.06 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.439 ' ND2' ' HB3' ' A' ' 69' ' ' ALA . 19.8 m120 57.57 43.77 22.07 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.0 mt -114.82 31.11 6.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.183 -0.948 . . . . 0.0 110.67 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.414 ' OH ' ' CB ' ' A' ' 68' ' ' PHE . 53.3 m-85 -58.83 149.01 27.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.926 -1.109 . . . . 0.0 109.212 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.3 t -96.03 -44.97 7.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.05 -1.031 . . . . 0.0 110.044 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.1 t -139.98 151.21 45.32 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 110.18 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.9 mt -66.09 -40.62 90.94 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.708 -0.62 . . . . 0.0 109.875 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -64.95 -40.17 94.6 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.974 -1.078 . . . . 0.0 108.533 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -67.31 -33.07 74.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.369 -0.832 . . . . 0.0 109.029 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.568 ' C ' ' CD1' ' A' ' 81' ' ' LEU . 2.5 tm? -60.54 -45.18 94.81 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.213 -0.93 . . . . 0.0 108.613 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.98 -42.92 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.347 -0.846 . . . . 0.0 109.176 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.549 ' CD2' ' CD2' ' A' ' 5' ' ' HIS . 96.5 mt -60.23 -43.87 95.68 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.435 -0.791 . . . . 0.0 111.177 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -63.44 -40.14 96.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.533 -1.354 . . . . 0.0 110.565 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.697 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 5.4 m-85 -64.12 -22.63 67.01 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.901 -1.124 . . . . 0.0 110.698 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.701 HE22 ' CD2' ' A' ' 5' ' ' HIS . 6.7 mt-30 -68.99 -32.62 72.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.456 -1.402 . . . . 0.0 109.024 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -88.14 -19.29 27.18 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.323 -0.861 . . . . 0.0 109.648 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 79.0 m -100.64 127.74 46.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.571 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.1 p -81.27 139.7 35.29 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.513 -0.742 . . . . 0.0 109.401 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.535 ' O ' ' C ' ' A' ' 91' ' ' VAL . 4.3 mp -75.86 -17.64 59.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.535 -0.728 . . . . 0.0 109.996 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.707 ' N ' ' O ' ' A' ' 97' ' ' LEU . 5.1 p -31.23 -44.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.355 -0.84 . . . . 0.0 110.482 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.542 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 9.7 pt20 -66.16 -10.91 45.71 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.264 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.579 ' O ' ' ND2' ' A' ' 94' ' ' ASN . 0.3 OUTLIER -63.26 -47.0 84.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.582 -1.324 . . . . 0.0 107.893 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 93' ' ' HIS . 10.6 m120 -138.43 20.2 2.74 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.627 ' N ' ' O ' ' A' ' 91' ' ' VAL . 94.6 m-20 61.05 17.33 7.89 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.2 m -146.54 9.56 1.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.707 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.6 mm? -97.25 68.18 2.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -78.36 79.76 4.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 110.358 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.6 p -163.69 156.24 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 121.573 0.701 . . . . 0.0 109.59 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.1 p -130.44 153.94 48.25 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.139 -0.975 . . . . 0.0 108.681 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.511 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 17.7 mt -78.61 67.85 4.46 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.51 -27.65 14.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.126 -0.984 . . . . 0.0 111.897 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.47 130.84 24.38 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 120.77 -1.206 . . . . 0.0 111.43 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -74.51 153.41 44.35 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.734 2.289 . . . . 0.0 110.897 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.481 HG11 ' N ' ' A' ' 106' ' ' TYR . 7.7 p -76.74 -30.9 19.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.187 -0.945 . . . . 0.0 109.791 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.481 ' N ' HG11 ' A' ' 105' ' ' VAL . 50.0 m-85 -113.61 54.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.148 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.54 136.78 58.06 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.417 0.627 . . . . 0.0 109.913 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -80.31 -4.09 51.99 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.082 -1.011 . . . . 0.0 109.133 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -72.54 143.08 48.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.046 -1.034 . . . . 0.0 108.947 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.699 HH11 ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER 59.42 49.91 8.2 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.507 -0.746 . . . . 0.0 109.111 -179.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.666 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.169 -0.92 . . . . 0.0 109.348 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -68.7 146.43 52.98 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 109.559 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.441 ' HB3' ' CD2' ' A' ' 6' ' ' HIS . 13.8 tp -88.88 125.99 60.83 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 121.076 -1.015 . . . . 0.0 108.364 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -49.86 -20.95 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.994 1.796 . . . . 0.0 112.082 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.701 ' CD2' HE22 ' A' ' 86' ' ' GLN . 30.2 m-70 -71.57 -29.69 65.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.453 -0.78 . . . . 0.0 109.838 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.441 ' CD2' ' HB3' ' A' ' 3' ' ' LEU . 80.3 m-70 -67.48 -21.68 65.51 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.558 ' O ' ' OG1' ' A' ' 10' ' ' THR . 76.3 m-20 -95.84 113.33 24.95 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.449 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 32.0 tt0 -70.31 -32.97 70.96 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.473 -0.767 . . . . 0.0 110.801 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.502 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -71.2 -13.62 61.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.758 -1.214 . . . . 0.0 110.945 -178.288 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.576 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 6.6 p -62.97 -37.49 87.32 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.68 -1.262 . . . . 0.0 108.666 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.719 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -117.33 -27.8 6.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.944 -1.098 . . . . 0.0 110.074 179.042 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -86.6 119.66 27.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.924 -1.11 . . . . 0.0 110.442 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 15' ' ' SER . 9.8 p -140.72 31.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -39.12 -20.34 0.01 OUTLIER Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.608 ' N ' ' O ' ' A' ' 13' ' ' VAL . 87.5 p -61.42 -17.52 54.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -1.131 . . . . 0.0 108.589 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.1 m -94.15 145.16 24.89 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.725 0.774 . . . . 0.0 110.731 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.66 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 54.8 p30 -79.64 167.39 20.75 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.394 -0.816 . . . . 0.0 109.335 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.523 ' CG ' ' NH1' ' A' ' 36' ' ' ARG . 81.1 mtm180 -61.05 -39.9 91.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.596 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -63.05 -44.29 96.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.645 -1.285 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.66 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 22.5 tptm -61.13 -35.51 77.26 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.221 -0.924 . . . . 0.0 108.901 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.04 74.32 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 26' ' ' ARG . 94.8 mt-10 -57.63 -45.4 85.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.35 -40.33 93.86 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.8 mt -67.95 -39.56 83.38 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.527 ' CD1' ' OG ' ' A' ' 47' ' ' SER . 3.6 mt -82.83 -16.82 46.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.342 -0.848 . . . . 0.0 108.799 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' GLU . 10.6 mmm180 -93.78 -28.4 15.92 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.959 0.885 . . . . 0.0 109.691 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.99 9.17 70.42 Favored Glycine 0 C--N 1.286 -2.231 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -124.2 145.54 49.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.499 -1.0 . . . . 0.0 110.001 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -77.67 165.53 24.14 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.395 0.617 . . . . 0.0 110.199 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.538 ' CG ' ' OD1' ' A' ' 51' ' ' ASP . 18.2 p-10 -53.02 158.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.92 -33.8 4.51 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.2 m -77.07 125.61 29.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -1.032 . . . . 0.0 108.311 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.518 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -135.88 170.65 15.66 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.966 -1.083 . . . . 0.0 110.274 -178.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -149.26 165.85 30.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.196 -0.94 . . . . 0.0 111.007 -179.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.429 HG21 ' HG ' ' A' ' 46' ' ' CYS . 73.9 t -120.51 121.48 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.731 ' NH1' ' O ' ' A' ' 37' ' ' GLU . 6.8 ptm180 -134.84 -176.24 4.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.438 -0.788 . . . . 0.0 108.949 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.731 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 56.0 mt-10 -94.18 175.25 6.77 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.871 -1.143 . . . . 0.0 108.494 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.648 ' O ' ' CB ' ' A' ' 39' ' ' SER . 20.9 m -75.95 11.27 1.48 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.648 ' CB ' ' O ' ' A' ' 38' ' ' SER . 4.8 t 98.45 -71.89 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.602 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -110.08 -45.96 3.52 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.462 -1.399 . . . . 0.0 111.831 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.471 ' NE2' ' SG ' ' A' ' 43' ' ' CYS . 6.7 pt20 -69.41 160.54 31.16 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.306 -1.496 . . . . 0.0 110.049 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.54 48.21 2.85 Favored Glycine 0 N--CA 1.496 2.67 0 O-C-N 121.163 -0.96 . . . . 0.0 110.972 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.471 ' SG ' ' NE2' ' A' ' 41' ' ' GLN . 89.5 m -114.81 155.03 27.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.999 -1.295 . . . . 0.0 109.029 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' ILE . 98.1 m-85 -115.46 153.19 31.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.071 -1.018 . . . . 0.0 110.705 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -145.74 133.43 21.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.711 -0.618 . . . . 0.0 109.924 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.609 ' O ' ' CB ' ' A' ' 57' ' ' CYS . 57.3 m -100.0 113.89 26.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.544 -1.347 . . . . 0.0 107.893 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.527 ' OG ' ' CD1' ' A' ' 25' ' ' LEU . 33.4 t -91.71 140.77 29.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.133 -0.98 . . . . 0.0 109.83 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.5 t -130.89 156.31 42.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.46 -0.775 . . . . 0.0 109.888 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.4 t -101.12 135.94 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.713 ' C ' ' H ' ' A' ' 52' ' ' GLY . 2.6 t -122.05 147.78 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.542 -1.349 . . . . 0.0 111.124 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.538 ' OD1' ' CG ' ' A' ' 30' ' ' ASP . 82.0 m-20 -55.06 9.36 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.231 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.713 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -135.97 -39.09 0.16 Allowed Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.619 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.539 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 21.6 tt0 -163.14 164.17 25.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.572 -1.546 . . . . 0.0 110.537 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.539 ' N ' ' CG ' ' A' ' 53' ' ' GLU . 96.1 t -67.42 134.69 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.075 -1.015 . . . . 0.0 108.686 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -112.04 139.02 47.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.831 -1.168 . . . . 0.0 109.12 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -120.57 87.74 2.81 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.609 ' CB ' ' O ' ' A' ' 46' ' ' CYS . 0.5 OUTLIER -70.79 139.66 51.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.154 -0.966 . . . . 0.0 108.723 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.41 129.57 62.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 111.241 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 44' ' ' TYR . 46.8 mm -108.13 117.05 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.598 ' O ' ' C ' ' A' ' 66' ' ' TYR . 64.4 t30 -95.17 113.02 24.66 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.943 -1.098 . . . . 0.0 110.312 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -83.86 119.37 24.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.822 -1.174 . . . . 0.0 109.871 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 64' ' ' THR . 86.4 m -141.11 158.65 43.63 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.74 -42.07 71.15 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.975 -1.078 . . . . 0.0 108.937 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.406 ' H ' HG23 ' A' ' 62' ' ' THR . 32.5 p -113.15 12.99 19.21 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.099 -1.0 . . . . 0.0 111.124 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 66' ' ' TYR . . . -126.95 -145.57 6.28 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.378 -1.391 . . . . 0.0 110.258 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.598 ' C ' ' O ' ' A' ' 60' ' ' ASN . 38.1 t80 163.78 -14.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.596 ' CA ' ' H ' ' A' ' 60' ' ' ASN . . . 135.67 -83.14 0.28 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.249 -1.941 . . . . 0.0 108.249 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.697 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 35.3 m-85 -80.45 151.88 29.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.334 -1.098 . . . . 0.0 109.684 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.439 ' HB3' ' ND2' ' A' ' 73' ' ' ASN . . . -134.36 33.26 3.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 110.472 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.733 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 7.8 tp10 -61.15 -35.44 23.99 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.754 -1.216 . . . . 0.0 108.673 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.733 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 73.4 Cg_endo -95.62 19.07 0.63 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 123.485 2.79 . . . . 0.0 110.795 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.439 ' HB2' ' O ' ' A' ' 71' ' ' PRO . 59.3 m-85 68.9 38.45 2.06 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.439 ' ND2' ' HB3' ' A' ' 69' ' ' ALA . 19.8 m120 57.57 43.77 22.07 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.0 mt -114.82 31.11 6.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.183 -0.948 . . . . 0.0 110.67 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.414 ' OH ' ' CB ' ' A' ' 68' ' ' PHE . 53.3 m-85 -58.83 149.01 27.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.926 -1.109 . . . . 0.0 109.212 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.3 t -96.03 -44.97 7.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.05 -1.031 . . . . 0.0 110.044 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.1 t -139.98 151.21 45.32 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 110.18 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.9 mt -66.09 -40.62 90.94 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.708 -0.62 . . . . 0.0 109.875 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -64.95 -40.17 94.6 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.974 -1.078 . . . . 0.0 108.533 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -67.31 -33.07 74.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.369 -0.832 . . . . 0.0 109.029 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.568 ' C ' ' CD1' ' A' ' 81' ' ' LEU . 2.5 tm? -60.54 -45.18 94.81 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.213 -0.93 . . . . 0.0 108.613 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.98 -42.92 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.347 -0.846 . . . . 0.0 109.176 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.549 ' CD2' ' CD2' ' A' ' 5' ' ' HIS . 96.5 mt -60.23 -43.87 95.68 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.435 -0.791 . . . . 0.0 111.177 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -63.44 -40.14 96.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.533 -1.354 . . . . 0.0 110.565 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.697 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 5.4 m-85 -64.12 -22.63 67.01 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.901 -1.124 . . . . 0.0 110.698 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.701 HE22 ' CD2' ' A' ' 5' ' ' HIS . 6.7 mt-30 -68.99 -32.62 72.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.456 -1.402 . . . . 0.0 109.024 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -88.14 -19.29 27.18 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.323 -0.861 . . . . 0.0 109.648 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 79.0 m -100.64 127.74 46.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.571 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.1 p -81.27 139.7 35.29 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.513 -0.742 . . . . 0.0 109.401 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.535 ' O ' ' C ' ' A' ' 91' ' ' VAL . 4.3 mp -75.86 -17.64 59.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.535 -0.728 . . . . 0.0 109.996 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.707 ' N ' ' O ' ' A' ' 97' ' ' LEU . 5.1 p -31.23 -44.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.355 -0.84 . . . . 0.0 110.482 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.542 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 9.7 pt20 -66.16 -10.91 45.71 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.264 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.579 ' O ' ' ND2' ' A' ' 94' ' ' ASN . 0.3 OUTLIER -63.26 -47.0 84.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.582 -1.324 . . . . 0.0 107.893 179.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 93' ' ' HIS . 10.6 m120 -138.43 20.2 2.74 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.627 ' N ' ' O ' ' A' ' 91' ' ' VAL . 94.6 m-20 61.05 17.33 7.89 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.2 m -146.54 9.56 1.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.707 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.6 mm? -97.25 68.18 2.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -78.36 79.76 4.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 110.358 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.6 p -163.69 156.24 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 121.573 0.701 . . . . 0.0 109.59 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.1 p -130.44 153.94 48.25 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.139 -0.975 . . . . 0.0 108.681 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.511 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 17.7 mt -78.61 67.85 4.46 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.51 -27.65 14.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.126 -0.984 . . . . 0.0 111.897 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.47 130.84 24.38 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 120.77 -1.206 . . . . 0.0 111.43 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -74.51 153.41 44.35 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.734 2.289 . . . . 0.0 110.897 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.481 HG11 ' N ' ' A' ' 106' ' ' TYR . 7.7 p -76.74 -30.9 19.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.187 -0.945 . . . . 0.0 109.791 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.481 ' N ' HG11 ' A' ' 105' ' ' VAL . 50.0 m-85 -113.61 54.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.148 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.54 136.78 58.06 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.417 0.627 . . . . 0.0 109.913 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -80.31 -4.09 51.99 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.082 -1.011 . . . . 0.0 109.133 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -72.54 143.08 48.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.046 -1.034 . . . . 0.0 108.947 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.699 HH11 ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER 59.42 49.91 8.2 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.507 -0.746 . . . . 0.0 109.111 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.666 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.169 -0.92 . . . . 0.0 109.348 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -71.37 144.32 49.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.403 -0.811 . . . . 0.0 110.484 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.2 mt -98.6 136.19 20.85 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.41 -4.53 8.24 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.403 2.069 . . . . 0.0 112.661 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.484 ' HA ' ' HE1' ' A' ' 11' ' ' TRP . 93.6 m-70 -79.45 -16.32 56.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.156 -0.965 . . . . 0.0 109.712 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -61.3 -48.35 81.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.703 -1.248 . . . . 0.0 109.331 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.5 129.86 45.71 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.589 ' O ' ' N ' ' A' ' 12' ' ' ASN . 7.4 pm0 -73.03 -2.61 21.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.119 -0.988 . . . . 0.0 109.932 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.56 ' CG ' ' N ' ' A' ' 10' ' ' THR . 36.7 pttt -59.82 -35.95 75.79 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 109.392 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.645 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 69.4 p -66.76 -28.83 68.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.654 -0.653 . . . . 0.0 111.398 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.645 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -126.69 -15.23 5.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.418 -1.426 . . . . 0.0 111.679 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 8' ' ' GLU . 46.4 t30 -102.67 118.55 37.09 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.406 -1.434 . . . . 0.0 111.511 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.693 ' CG1' ' HE ' ' A' ' 36' ' ' ARG . 9.9 p -135.89 37.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -31.59 -26.42 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 13' ' ' VAL . 99.0 p -61.61 -4.94 1.57 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.659 -1.495 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.429 ' HG ' HG12 ' A' ' 13' ' ' VAL . 58.1 m -93.77 162.01 14.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.669 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -113.77 164.83 13.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.756 HH21 ' CD2' ' A' ' 56' ' ' HIS . 5.5 mmm180 -58.36 -42.22 86.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.004 -1.06 . . . . 0.0 109.988 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -61.91 -44.14 97.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.865 -1.147 . . . . 0.0 108.817 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -66.06 -29.67 70.05 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.422 -0.798 . . . . 0.0 109.1 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.61 -40.52 95.11 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.354 -0.841 . . . . 0.0 109.225 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.33 -43.55 96.31 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -64.4 -43.49 94.26 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.2 mt -70.33 -36.41 74.24 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.317 -0.865 . . . . 0.0 108.878 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.536 ' N ' ' O ' ' A' ' 21' ' ' ALA . 41.3 mt -75.87 -12.6 60.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.73 126.07 30.48 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.57 9.49 78.58 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mmpp? -99.2 126.67 45.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.149 -1.206 . . . . 0.0 109.476 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -77.97 160.76 27.99 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 67.2 t0 -53.92 140.93 29.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.68 . . . . 0.0 110.617 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 110.09 -28.61 10.2 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 91.4 m -83.73 121.0 26.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.254 -1.144 . . . . 0.0 110.062 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.551 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -133.68 156.35 48.08 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.738 -1.226 . . . . 0.0 111.301 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.645 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -111.37 160.15 17.33 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.697 0.761 . . . . 0.0 111.058 -177.712 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.8 t -132.21 112.69 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.693 ' HE ' ' CG1' ' A' ' 13' ' ' VAL . 69.5 mtt180 -136.92 172.99 12.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.925 -1.109 . . . . 0.0 110.033 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.696 ' C ' ' H ' ' A' ' 39' ' ' SER . 8.6 pt-20 -85.82 172.1 11.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.019 -1.051 . . . . 0.0 108.385 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.658 ' N ' ' O ' ' A' ' 43' ' ' CYS . 73.2 m -79.18 18.31 0.68 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 177.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.696 ' H ' ' C ' ' A' ' 37' ' ' GLU . 40.9 p 67.16 -110.05 0.13 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.727 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.625 ' N ' ' OG ' ' A' ' 39' ' ' SER . 58.8 tttm -60.29 -40.04 89.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.928 -1.108 . . . . 0.0 110.182 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -78.57 150.72 32.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.917 -1.114 . . . . 0.0 109.369 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.6 4.72 49.81 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.658 ' O ' ' N ' ' A' ' 38' ' ' SER . 88.7 m -79.25 156.61 28.04 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.163 -1.198 . . . . 0.0 109.789 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' A' ' 59' ' ' ILE . 91.5 m-85 -119.93 149.78 41.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.633 -0.667 . . . . 0.0 110.155 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.2 137.57 24.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 108.589 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 33.3 m -107.26 131.18 54.48 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.892 -1.13 . . . . 0.0 108.872 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 34' ' ' LEU . 1.3 p -90.4 132.82 35.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.414 -0.804 . . . . 0.0 110.183 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.44 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 3.7 p -132.83 157.02 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.937 -1.102 . . . . 0.0 110.583 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.443 ' C ' ' NZ ' ' A' ' 55' ' ' LYS . 60.4 t -118.14 146.66 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.812 ' N ' ' NZ ' ' A' ' 55' ' ' LYS . 13.2 t -120.44 161.31 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 0.0 110.296 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.567 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 43.4 p-10 -58.21 6.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.696 -0.628 . . . . 0.0 110.27 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -149.61 -19.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.364 0 C-N-CA 118.958 -1.591 . . . . 0.0 112.252 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.738 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 68.8 tt0 -156.49 169.01 25.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.193 -1.769 . . . . 0.0 111.224 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.547 ' N ' ' CG ' ' A' ' 53' ' ' GLU . 96.9 t -118.53 128.14 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.381 -0.824 . . . . 0.0 109.207 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.812 ' NZ ' ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -122.05 179.82 4.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.774 -1.204 . . . . 0.0 110.447 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.756 ' CD2' HH21 ' A' ' 18' ' ' ARG . 23.6 m80 -127.63 82.43 2.09 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.3 m -56.22 135.14 53.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.015 -1.053 . . . . 0.0 108.83 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.23 133.54 47.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 110.422 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 44' ' ' TYR . 27.1 mm -104.63 123.01 58.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.636 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 10.2 m120 -108.19 122.77 47.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.922 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -108.37 128.47 54.79 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.587 ' CG2' ' H ' ' A' ' 64' ' ' THR . 1.8 t -130.41 -175.6 3.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.971 -1.08 . . . . 0.0 108.786 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.515 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -42.02 -26.8 0.1 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.587 ' H ' ' CG2' ' A' ' 62' ' ' THR . 74.6 m -160.25 72.47 0.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.734 ' O ' ' CG ' ' A' ' 66' ' ' TYR . . . -160.56 179.99 35.7 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.393 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.734 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 88.2 m-85 -168.0 -4.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.96 -130.64 2.19 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.693 ' CZ ' ' OH ' ' A' ' 75' ' ' TYR . 41.8 p90 -96.12 110.53 22.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.876 -1.367 . . . . 0.0 109.149 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.49 127.53 54.65 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.668 0.746 . . . . 0.0 109.49 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.656 ' O ' ' N ' ' A' ' 73' ' ' ASN . 98.3 mt-10 -125.57 155.13 72.6 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.494 ' C ' ' O ' ' A' ' 70' ' ' GLU . 50.0 Cg_exo -33.7 -32.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.629 1.553 . . . . 0.0 110.684 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 70' ' ' GLU . 73.7 t80 -94.27 -33.22 13.33 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.656 ' N ' ' O ' ' A' ' 70' ' ' GLU . 11.4 m120 -101.6 127.6 48.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.752 -0.592 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.7 mt -151.28 96.75 2.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.29 -0.881 . . . . 0.0 109.932 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.693 ' OH ' ' CZ ' ' A' ' 68' ' ' PHE . 71.4 m-85 -62.6 127.49 31.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.874 -1.141 . . . . 0.0 109.17 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.778 ' HG ' ' N ' ' A' ' 77' ' ' SER . 72.6 p -89.18 -52.44 5.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 0.0 109.571 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.778 ' N ' ' HG ' ' A' ' 76' ' ' SER . 67.5 m -141.45 168.65 19.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.371 -0.83 . . . . 0.0 109.032 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.75 -37.71 88.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.097 . . . . 0.0 109.635 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -58.49 -40.09 81.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.967 -1.083 . . . . 0.0 108.568 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.1 -32.83 73.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.453 0.645 . . . . 0.0 109.455 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.429 HD11 ' CD1' ' A' ' 75' ' ' TYR . 14.7 tp -53.96 -48.71 70.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.331 -0.855 . . . . 0.0 109.524 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.5 t -66.22 -43.51 91.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 108.825 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.52 -44.0 83.71 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.497 -0.752 . . . . 0.0 110.115 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -60.44 -44.09 96.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 111.152 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.456 ' OH ' ' CE1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -75.78 -21.84 57.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.046 -1.034 . . . . 0.0 110.373 -179.182 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.607 ' O ' ' OE1' ' A' ' 86' ' ' GLN . 0.2 OUTLIER -67.36 -41.99 84.19 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.004 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -73.97 -39.79 63.46 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.652 -0.655 . . . . 0.0 110.037 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 85' ' ' TYR . 33.1 m -97.7 140.39 32.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.145 -0.972 . . . . 0.0 110.558 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.1 p -84.81 143.22 29.23 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.72 -0.612 . . . . 0.0 109.981 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.544 ' O ' ' C ' ' A' ' 91' ' ' VAL . 8.3 mp -73.02 -18.24 61.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.325 -0.86 . . . . 0.0 109.497 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.709 ' N ' ' O ' ' A' ' 97' ' ' LEU . 3.9 p -34.0 -44.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.196 -0.94 . . . . 0.0 109.911 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.554 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 10.2 tp-100 -47.8 -45.9 30.04 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.714 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.64 ' C ' ' H ' ' A' ' 95' ' ' ASP . 83.7 t60 -62.32 131.71 50.24 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.579 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.446 ' ND2' ' CD2' ' A' ' 93' ' ' HIS . 88.1 m-20 54.27 -0.65 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.64 ' H ' ' C ' ' A' ' 93' ' ' HIS . 89.8 m-20 56.77 24.44 9.1 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.08 -1.012 . . . . 0.0 110.26 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.6 m -144.27 12.07 1.55 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.778 -1.201 . . . . 0.0 110.593 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.709 ' O ' ' N ' ' A' ' 91' ' ' VAL . 6.8 mp -99.14 73.76 1.93 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -78.2 75.98 4.73 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 p -152.69 155.18 6.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.552 0.692 . . . . 0.0 109.734 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 102' ' ' ALA . 81.4 p -129.31 135.46 48.78 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.551 HD21 ' CG ' ' A' ' 33' ' ' PHE . 62.1 mt -72.52 70.12 0.89 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.471 ' HB3' ' NE2' ' A' ' 86' ' ' GLN . . . -117.23 -7.54 11.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.848 -0.532 . . . . 0.0 111.935 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 32' ' ' THR . 97.5 m-85 -120.73 100.89 46.23 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.398 -1.439 . . . . 0.0 110.67 -178.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -59.67 145.64 97.58 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.613 1.542 . . . . 0.0 110.309 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.441 HG12 ' CD2' ' A' ' 106' ' ' TYR . 2.6 p -67.86 -34.11 65.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 120.882 -1.136 . . . . 0.0 108.482 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.441 ' CD2' HG12 ' A' ' 105' ' ' VAL . 57.9 m-85 -106.08 44.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.437 -0.789 . . . . 0.0 110.584 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.84 -70.55 0.71 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 0.0 109.418 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -59.93 -41.08 91.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 109.269 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -95.25 133.65 38.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.279 -0.888 . . . . 0.0 109.844 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.482 ' O ' ' C ' ' A' ' 111' ' ' ARG . 71.0 mtm180 -116.99 143.7 45.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 108.784 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.576 HH11 ' HB3' ' A' ' 111' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.108 -0.949 . . . . 0.0 110.225 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -71.37 144.32 49.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.403 -0.811 . . . . 0.0 110.484 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.2 mt -98.6 136.19 20.85 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.41 -4.53 8.24 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.403 2.069 . . . . 0.0 112.661 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.484 ' HA ' ' HE1' ' A' ' 11' ' ' TRP . 93.6 m-70 -79.45 -16.32 56.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.156 -0.965 . . . . 0.0 109.712 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -61.3 -48.35 81.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.703 -1.248 . . . . 0.0 109.331 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.5 129.86 45.71 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.589 ' O ' ' N ' ' A' ' 12' ' ' ASN . 7.4 pm0 -73.03 -2.61 21.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.119 -0.988 . . . . 0.0 109.932 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.56 ' CG ' ' N ' ' A' ' 10' ' ' THR . 36.7 pttt -59.82 -35.95 75.79 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 109.392 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.645 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 69.4 p -66.76 -28.83 68.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.654 -0.653 . . . . 0.0 111.398 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.645 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -126.69 -15.23 5.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.418 -1.426 . . . . 0.0 111.679 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 8' ' ' GLU . 46.4 t30 -102.67 118.55 37.09 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.406 -1.434 . . . . 0.0 111.511 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.693 ' CG1' ' HE ' ' A' ' 36' ' ' ARG . 9.9 p -135.89 37.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -31.59 -26.42 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 13' ' ' VAL . 99.0 p -61.61 -4.94 1.57 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.659 -1.495 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.429 ' HG ' HG12 ' A' ' 13' ' ' VAL . 58.1 m -93.77 162.01 14.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.669 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -113.77 164.83 13.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.756 HH21 ' CD2' ' A' ' 56' ' ' HIS . 5.5 mmm180 -58.36 -42.22 86.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.004 -1.06 . . . . 0.0 109.988 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -61.91 -44.14 97.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.865 -1.147 . . . . 0.0 108.817 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -66.06 -29.67 70.05 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.422 -0.798 . . . . 0.0 109.1 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.61 -40.52 95.11 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.354 -0.841 . . . . 0.0 109.225 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.33 -43.55 96.31 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -64.4 -43.49 94.26 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.2 mt -70.33 -36.41 74.24 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.317 -0.865 . . . . 0.0 108.878 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.536 ' N ' ' O ' ' A' ' 21' ' ' ALA . 41.3 mt -75.87 -12.6 60.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.73 126.07 30.48 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.57 9.49 78.58 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mmpp? -99.2 126.67 45.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.149 -1.206 . . . . 0.0 109.476 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -77.97 160.76 27.99 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 67.2 t0 -53.92 140.93 29.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.68 . . . . 0.0 110.617 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 110.09 -28.61 10.2 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 91.4 m -83.73 121.0 26.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.254 -1.144 . . . . 0.0 110.062 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.551 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -133.68 156.35 48.08 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.738 -1.226 . . . . 0.0 111.301 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.645 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -111.37 160.15 17.33 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.697 0.761 . . . . 0.0 111.058 -177.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.8 t -132.21 112.69 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.693 ' HE ' ' CG1' ' A' ' 13' ' ' VAL . 69.5 mtt180 -136.92 172.99 12.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.925 -1.109 . . . . 0.0 110.033 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.696 ' C ' ' H ' ' A' ' 39' ' ' SER . 8.6 pt-20 -85.82 172.1 11.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.019 -1.051 . . . . 0.0 108.385 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.658 ' N ' ' O ' ' A' ' 43' ' ' CYS . 73.2 m -79.18 18.31 0.68 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 177.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.696 ' H ' ' C ' ' A' ' 37' ' ' GLU . 40.9 p 67.16 -110.05 0.13 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.727 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.625 ' N ' ' OG ' ' A' ' 39' ' ' SER . 58.8 tttm -60.29 -40.04 89.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.928 -1.108 . . . . 0.0 110.182 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -78.57 150.72 32.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.917 -1.114 . . . . 0.0 109.369 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.6 4.72 49.81 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.658 ' O ' ' N ' ' A' ' 38' ' ' SER . 88.7 m -79.25 156.61 28.04 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.163 -1.198 . . . . 0.0 109.789 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' A' ' 59' ' ' ILE . 91.5 m-85 -119.93 149.78 41.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.633 -0.667 . . . . 0.0 110.155 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.2 137.57 24.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 108.589 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 33.3 m -107.26 131.18 54.48 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.892 -1.13 . . . . 0.0 108.872 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 34' ' ' LEU . 1.3 p -90.4 132.82 35.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.414 -0.804 . . . . 0.0 110.183 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.44 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 3.7 p -132.83 157.02 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.937 -1.102 . . . . 0.0 110.583 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.443 ' C ' ' NZ ' ' A' ' 55' ' ' LYS . 60.4 t -118.14 146.66 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.812 ' N ' ' NZ ' ' A' ' 55' ' ' LYS . 13.2 t -120.44 161.31 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 0.0 110.296 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.567 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 43.4 p-10 -58.21 6.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.696 -0.628 . . . . 0.0 110.27 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -149.61 -19.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.364 0 C-N-CA 118.958 -1.591 . . . . 0.0 112.252 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.738 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 68.8 tt0 -156.49 169.01 25.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.193 -1.769 . . . . 0.0 111.224 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.547 ' N ' ' CG ' ' A' ' 53' ' ' GLU . 96.9 t -118.53 128.14 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.381 -0.824 . . . . 0.0 109.207 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.812 ' NZ ' ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -122.05 179.82 4.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.774 -1.204 . . . . 0.0 110.447 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.756 ' CD2' HH21 ' A' ' 18' ' ' ARG . 23.6 m80 -127.63 82.43 2.09 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.3 m -56.22 135.14 53.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.015 -1.053 . . . . 0.0 108.83 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.23 133.54 47.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 110.422 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 44' ' ' TYR . 27.1 mm -104.63 123.01 58.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.636 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 10.2 m120 -108.19 122.77 47.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.922 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -108.37 128.47 54.79 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.587 ' CG2' ' H ' ' A' ' 64' ' ' THR . 1.8 t -130.41 -175.6 3.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.971 -1.08 . . . . 0.0 108.786 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.515 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -42.02 -26.8 0.1 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.587 ' H ' ' CG2' ' A' ' 62' ' ' THR . 74.6 m -160.25 72.47 0.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.734 ' O ' ' CG ' ' A' ' 66' ' ' TYR . . . -160.56 179.99 35.7 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.393 -178.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.734 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 88.2 m-85 -168.0 -4.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.96 -130.64 2.19 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.693 ' CZ ' ' OH ' ' A' ' 75' ' ' TYR . 41.8 p90 -96.12 110.53 22.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.876 -1.367 . . . . 0.0 109.149 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.49 127.53 54.65 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.668 0.746 . . . . 0.0 109.49 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.656 ' O ' ' N ' ' A' ' 73' ' ' ASN . 98.3 mt-10 -125.57 155.13 72.6 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.494 ' C ' ' O ' ' A' ' 70' ' ' GLU . 50.0 Cg_exo -33.7 -32.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.629 1.553 . . . . 0.0 110.684 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 70' ' ' GLU . 73.7 t80 -94.27 -33.22 13.33 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.656 ' N ' ' O ' ' A' ' 70' ' ' GLU . 11.4 m120 -101.6 127.6 48.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.752 -0.592 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.7 mt -151.28 96.75 2.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.29 -0.881 . . . . 0.0 109.932 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.693 ' OH ' ' CZ ' ' A' ' 68' ' ' PHE . 71.4 m-85 -62.6 127.49 31.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.874 -1.141 . . . . 0.0 109.17 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.778 ' HG ' ' N ' ' A' ' 77' ' ' SER . 72.6 p -89.18 -52.44 5.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 0.0 109.571 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.778 ' N ' ' HG ' ' A' ' 76' ' ' SER . 67.5 m -141.45 168.65 19.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.371 -0.83 . . . . 0.0 109.032 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.75 -37.71 88.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.097 . . . . 0.0 109.635 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -58.49 -40.09 81.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.967 -1.083 . . . . 0.0 108.568 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.1 -32.83 73.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.453 0.645 . . . . 0.0 109.455 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.429 HD11 ' CD1' ' A' ' 75' ' ' TYR . 14.7 tp -53.96 -48.71 70.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.331 -0.855 . . . . 0.0 109.524 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.5 t -66.22 -43.51 91.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 108.825 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.52 -44.0 83.71 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.497 -0.752 . . . . 0.0 110.115 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -60.44 -44.09 96.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 111.152 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.456 ' OH ' ' CE1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -75.78 -21.84 57.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.046 -1.034 . . . . 0.0 110.373 -179.182 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.607 ' O ' ' OE1' ' A' ' 86' ' ' GLN . 0.2 OUTLIER -67.36 -41.99 84.19 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.004 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -73.97 -39.79 63.46 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.652 -0.655 . . . . 0.0 110.037 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 85' ' ' TYR . 33.1 m -97.7 140.39 32.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.145 -0.972 . . . . 0.0 110.558 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.1 p -84.81 143.22 29.23 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.72 -0.612 . . . . 0.0 109.981 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.544 ' O ' ' C ' ' A' ' 91' ' ' VAL . 8.3 mp -73.02 -18.24 61.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.325 -0.86 . . . . 0.0 109.497 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.709 ' N ' ' O ' ' A' ' 97' ' ' LEU . 3.9 p -34.0 -44.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.196 -0.94 . . . . 0.0 109.911 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.554 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 10.2 tp-100 -47.8 -45.9 30.04 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.714 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.64 ' C ' ' H ' ' A' ' 95' ' ' ASP . 83.7 t60 -62.32 131.71 50.24 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.579 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.446 ' ND2' ' CD2' ' A' ' 93' ' ' HIS . 88.1 m-20 54.27 -0.65 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.64 ' H ' ' C ' ' A' ' 93' ' ' HIS . 89.8 m-20 56.77 24.44 9.1 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.08 -1.012 . . . . 0.0 110.26 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.6 m -144.27 12.07 1.55 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.778 -1.201 . . . . 0.0 110.593 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.709 ' O ' ' N ' ' A' ' 91' ' ' VAL . 6.8 mp -99.14 73.76 1.93 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -78.2 75.98 4.73 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 p -152.69 155.18 6.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.552 0.692 . . . . 0.0 109.734 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 102' ' ' ALA . 81.4 p -129.31 135.46 48.78 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.551 HD21 ' CG ' ' A' ' 33' ' ' PHE . 62.1 mt -72.52 70.12 0.89 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.471 ' HB3' ' NE2' ' A' ' 86' ' ' GLN . . . -117.23 -7.54 11.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.848 -0.532 . . . . 0.0 111.935 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 32' ' ' THR . 97.5 m-85 -120.73 100.89 46.23 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.398 -1.439 . . . . 0.0 110.67 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -59.67 145.64 97.58 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.613 1.542 . . . . 0.0 110.309 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.441 HG12 ' CD2' ' A' ' 106' ' ' TYR . 2.6 p -67.86 -34.11 65.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 120.882 -1.136 . . . . 0.0 108.482 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.441 ' CD2' HG12 ' A' ' 105' ' ' VAL . 57.9 m-85 -106.08 44.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.437 -0.789 . . . . 0.0 110.584 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.84 -70.55 0.71 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 0.0 109.418 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -59.93 -41.08 91.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 109.269 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -95.25 133.65 38.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.279 -0.888 . . . . 0.0 109.844 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.482 ' O ' ' C ' ' A' ' 111' ' ' ARG . 71.0 mtm180 -116.99 143.7 45.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 108.784 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.576 HH11 ' HB3' ' A' ' 111' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.108 -0.949 . . . . 0.0 110.225 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.297 0.57 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -97.22 18.54 14.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 109.788 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.538 ' HB3' ' CD2' ' A' ' 6' ' ' HIS . 25.0 tp -115.41 115.92 41.96 Favored Pre-proline 0 C--N 1.297 -1.687 0 O-C-N 121.433 -0.792 . . . . 0.0 109.172 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -56.03 -6.25 1.2 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.04 1.826 . . . . 0.0 111.744 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.471 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 84.0 m-70 -88.67 -12.72 41.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 110.641 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.538 ' CD2' ' HB3' ' A' ' 3' ' ' LEU . 78.7 m-70 -60.94 -40.52 93.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.779 -1.201 . . . . 0.0 108.963 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.4 ' CB ' ' HE2' ' A' ' 9' ' ' LYS . 79.1 m-20 -108.96 130.15 55.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.283 -0.885 . . . . 0.0 109.244 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.684 ' O ' ' N ' ' A' ' 12' ' ' ASN . 3.6 pm0 -73.59 -7.68 52.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.038 -1.039 . . . . 0.0 110.304 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.508 ' CG ' ' N ' ' A' ' 10' ' ' THR . 6.1 pttt -60.54 -36.4 78.35 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.065 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.656 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 38.0 p -61.51 -31.97 71.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.564 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.656 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -121.44 -12.6 8.55 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.916 -1.115 . . . . 0.0 110.457 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 8' ' ' GLU . 57.8 t30 -88.69 116.55 27.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.908 -1.12 . . . . 0.0 111.231 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 15' ' ' SER . 9.9 p -140.08 31.67 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 CA-C-O 122.007 0.908 . . . . 0.0 108.831 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -42.82 -22.43 0.15 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 13' ' ' VAL . 59.5 m -67.99 -36.77 80.56 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.019 -1.283 . . . . 0.0 110.106 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.651 ' O ' ' NE ' ' A' ' 36' ' ' ARG . 47.3 t -65.71 147.66 53.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.302 -0.874 . . . . 0.0 110.133 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.516 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 76.1 m-20 -86.66 163.65 17.26 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -60.0 -40.65 89.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.093 -1.005 . . . . 0.0 109.767 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -60.06 -42.97 95.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.008 -1.057 . . . . 0.0 109.503 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.5 tttm -64.89 -28.77 69.76 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.144 -0.972 . . . . 0.0 108.455 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.712 ' CB ' HH22 ' A' ' 36' ' ' ARG . . . -58.43 -41.83 85.92 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 26' ' ' ARG . 98.4 mt-10 -61.13 -44.73 96.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.106 -0.996 . . . . 0.0 108.343 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -60.36 -46.29 90.48 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.474 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 79.7 mt -63.17 -40.17 96.76 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mt -72.19 -31.95 66.36 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.533 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -68.28 132.61 47.42 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.806 -0.559 . . . . 0.0 109.59 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.17 9.76 84.69 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 47.7 mmtt -108.74 133.29 53.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.07 -1.253 . . . . 0.0 109.438 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -75.6 168.87 19.2 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.344 -0.847 . . . . 0.0 109.41 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 59.1 t0 -59.07 140.83 55.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.587 -0.695 . . . . 0.0 110.328 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.457 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 109.01 -26.57 14.99 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.406 ' O ' HG21 ' A' ' 48' ' ' VAL . 84.9 m -63.35 121.47 13.85 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.408 ' CD2' HD21 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -138.41 145.13 40.62 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.96 -1.088 . . . . 0.0 111.406 -178.113 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.434 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 0.7 OUTLIER -142.95 157.9 44.12 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.621 0.724 . . . . 0.0 109.905 178.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.474 HG21 ' SG ' ' A' ' 46' ' ' CYS . 97.7 t -104.05 139.52 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.78 ' CB ' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -147.88 164.07 34.84 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.717 -1.239 . . . . 0.0 108.751 -177.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.681 ' C ' ' H ' ' A' ' 39' ' ' SER . 66.6 mm-40 -87.03 170.24 11.72 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.522 -1.361 . . . . 0.0 108.122 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.652 ' N ' ' O ' ' A' ' 43' ' ' CYS . 88.2 p -77.1 12.98 1.21 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.681 ' H ' ' C ' ' A' ' 37' ' ' GLU . 1.7 t 91.27 -129.25 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.128 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -90.01 1.85 55.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.104 -0.998 . . . . 0.0 109.468 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.47 ' HB2' ' HG ' ' A' ' 38' ' ' SER . 91.1 mm-40 -69.56 -30.12 67.84 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.126 -0.984 . . . . 0.0 110.525 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.94 -13.14 49.63 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.652 ' O ' ' N ' ' A' ' 38' ' ' SER . 95.1 m -89.93 160.51 16.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -1.168 . . . . 0.0 109.269 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.673 ' CE1' ' OE1' ' A' ' 37' ' ' GLU . 98.5 m-85 -105.02 157.03 17.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 110.159 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.598 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -163.34 143.49 8.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.008 -1.058 . . . . 0.0 109.905 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 57' ' ' CYS . 60.6 m -115.13 143.41 45.25 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.426 ' OG ' ' CG ' ' A' ' 34' ' ' LEU . 97.0 p -113.6 144.69 42.48 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.931 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.48 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -152.97 158.56 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 121.675 0.75 . . . . 0.0 110.257 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.48 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 53.3 t -98.78 142.5 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.544 ' CG1' ' CD ' ' A' ' 55' ' ' LYS . 12.8 p -155.59 150.52 10.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 C-N-CA 118.128 -1.429 . . . . 0.0 112.166 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.613 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 65.5 t0 36.13 33.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.813 -0.554 . . . . 0.0 111.954 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 81.36 3.99 90.53 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 118.958 -1.591 . . . . 0.0 111.307 178.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -127.24 134.53 50.07 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.845 -1.386 . . . . 0.0 110.077 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 72.3 t -81.41 129.12 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.301 0.572 . . . . 0.0 109.522 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.544 ' CD ' ' CG1' ' A' ' 50' ' ' VAL . 5.7 mptt -130.82 148.15 52.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.359 -0.838 . . . . 0.0 110.292 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -107.3 107.18 17.99 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.65 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.543 ' N ' ' O ' ' A' ' 46' ' ' CYS . 52.6 t -68.96 126.71 30.64 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.9 t -93.3 131.41 40.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.387 -0.821 . . . . 0.0 111.279 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.479 ' CG2' ' O ' ' A' ' 66' ' ' TYR . 37.9 mm -108.65 133.29 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 66' ' ' TYR . 26.3 m120 -121.13 126.99 51.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.778 -1.201 . . . . 0.0 110.875 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -105.85 125.72 51.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.47 -0.769 . . . . 0.0 109.023 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 64' ' ' THR . 99.5 m -127.58 174.81 8.75 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.558 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -36.12 -30.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 108.894 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.606 ' N ' ' O ' ' A' ' 62' ' ' THR . 88.7 m -153.23 58.41 0.77 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.264 -0.897 . . . . 0.0 109.627 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -150.58 -168.93 15.94 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.581 ' O ' ' N ' ' A' ' 60' ' ' ASN . 88.8 t80 -165.3 -61.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.43 -1.041 . . . . 0.0 109.055 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.456 ' HA2' ' H ' ' A' ' 60' ' ' ASN . . . -118.26 -165.53 13.43 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -66.78 145.35 55.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.999 -1.295 . . . . 0.0 109.24 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.54 144.83 32.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.409 -0.807 . . . . 0.0 109.818 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.691 ' O ' ' N ' ' A' ' 72' ' ' TYR . 70.6 mm-40 -132.69 158.83 74.73 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.479 ' C ' ' O ' ' A' ' 70' ' ' GLU . 50.4 Cg_exo -33.72 -24.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.62 1.547 . . . . 0.0 110.756 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.691 ' N ' ' O ' ' A' ' 70' ' ' GLU . 97.6 m-85 -114.44 122.04 45.4 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 72' ' ' TYR . 36.9 p-10 -43.56 158.11 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.287 -0.883 . . . . 0.0 109.834 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.4 ' CD1' ' H ' ' A' ' 67' ' ' GLY . 95.1 mt -68.8 174.24 4.54 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.266 1.032 . . . . 0.0 109.008 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.832 ' CZ ' ' CG ' ' A' ' 84' ' ' HIS . 97.5 m-85 -82.28 152.37 26.36 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.899 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 80.2 p -74.65 -22.97 58.61 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.494 -0.754 . . . . 0.0 111.535 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.723 ' HG ' ' H ' ' A' ' 80' ' ' GLU . 68.8 p -120.54 146.25 46.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.545 -1.347 . . . . 0.0 110.213 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.495 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 88.1 mt -60.22 -43.95 95.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.714 . . . . 0.0 109.266 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -61.08 -43.17 99.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.436 -0.79 . . . . 0.0 109.841 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.723 ' H ' ' HG ' ' A' ' 77' ' ' SER . 87.8 tt0 -63.65 -40.1 96.0 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.056 -1.027 . . . . 0.0 109.773 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.47 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . 8.5 tt -61.27 -44.9 96.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.963 . . . . 0.0 109.909 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.8 t -64.01 -38.73 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.066 -1.021 . . . . 0.0 109.175 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 86' ' ' GLN . 62.5 tp -63.93 -46.82 83.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.746 . . . . 0.0 111.227 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.832 ' CG ' ' CZ ' ' A' ' 75' ' ' TYR . 48.0 m80 -67.91 -40.45 83.43 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.624 -1.297 . . . . 0.0 110.764 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.446 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 5.2 m-85 -61.24 -29.09 69.62 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.396 -0.815 . . . . 0.0 110.247 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -68.01 -13.83 62.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.756 -1.215 . . . . 0.0 109.85 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -103.21 -31.07 10.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.043 -1.036 . . . . 0.0 109.948 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.0 m -87.37 141.28 28.75 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.074 -1.016 . . . . 0.0 110.737 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.0 m -88.79 124.18 33.91 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.764 ' O ' ' N ' ' A' ' 92' ' ' GLN . 21.7 mt -60.76 -40.69 93.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.835 . . . . 0.0 111.18 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.721 ' N ' ' O ' ' A' ' 97' ' ' LEU . 4.2 t 31.84 -81.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.595 0 O-C-N 120.959 -1.088 . . . . 0.0 110.001 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.764 ' N ' ' O ' ' A' ' 90' ' ' LEU . 54.9 mt-30 56.22 -159.2 0.22 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.568 -0.708 . . . . 0.0 111.779 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -55.11 -44.11 74.65 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.321 -0.862 . . . . 0.0 109.286 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.678 ' O ' ' N ' ' A' ' 96' ' ' SER . 30.1 m120 -81.14 91.13 6.09 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 94' ' ' ASN . 50.5 t0 -43.64 -8.95 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.474 -0.766 . . . . 0.0 110.43 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 94' ' ' ASN . 95.0 p -89.77 -0.09 57.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.832 -1.167 . . . . 0.0 112.19 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.721 ' O ' ' N ' ' A' ' 91' ' ' VAL . 68.7 mt -83.81 30.83 0.49 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.646 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 16.6 p30 -76.26 53.9 0.85 Allowed 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.97 0.891 . . . . 0.0 108.973 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.5 150.88 33.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 102' ' ' ALA . 43.7 p -114.28 150.68 34.05 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.408 HD21 ' CD2' ' A' ' 33' ' ' PHE . 30.4 mt -71.7 68.06 0.59 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -100.87 -25.41 14.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 112.228 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -116.05 104.05 52.7 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.376 -1.453 . . . . 0.0 111.181 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.89 159.41 17.91 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.609 2.206 . . . . 0.0 110.433 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' A' ' 106' ' ' TYR . 13.2 p -78.59 -28.71 14.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 120.737 -1.227 . . . . 0.0 108.115 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.487 ' CD2' HG11 ' A' ' 105' ' ' VAL . 57.1 m-85 -112.07 29.98 7.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.487 -0.758 . . . . 0.0 109.159 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.81 141.02 54.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.903 . . . . 0.0 109.082 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 58.65 55.53 4.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.458 -0.776 . . . . 0.0 109.522 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -87.41 137.69 32.12 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 108.862 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.455 ' O ' ' OXT' ' A' ' 111' ' ' ARG . 41.8 ttm180 -109.83 128.81 55.56 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.091 -1.006 . . . . 0.0 109.124 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.607 ' HG2' HH11 ' A' ' 111' ' ' ARG . 7.3 ttt-85 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.221 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.272 0.558 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -82.17 124.89 30.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.0 108.854 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.2 tp -99.3 128.4 31.89 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 120.818 -1.176 . . . . 0.0 108.623 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' O ' ' OG1' ' A' ' 10' ' ' THR . 78.5 Cg_exo -48.66 -19.99 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.39 2.06 . . . . 0.0 112.675 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -67.35 -26.08 66.3 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.925 -1.109 . . . . 0.0 109.741 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -63.4 -39.21 93.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.196 -0.94 . . . . 0.0 110.8 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.528 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 69.2 m-20 -93.16 128.7 39.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.991 -1.068 . . . . 0.0 110.421 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.707 ' O ' ' N ' ' A' ' 12' ' ' ASN . 94.0 mt-10 -66.87 -26.55 66.95 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.239 -0.913 . . . . 0.0 110.479 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HG2' ' H ' ' A' ' 10' ' ' THR . 1.2 pttp -60.86 -35.92 77.82 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.194 -0.941 . . . . 0.0 111.339 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.536 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 2.7 p -60.23 -33.14 71.85 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 109.895 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.654 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -122.67 -20.84 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 111.098 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.707 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -91.82 119.21 31.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.723 -1.235 . . . . 0.0 110.257 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.98 -4.54 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.301 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.83 -142.21 30.54 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.466 ' OG ' ' OE2' ' A' ' 37' ' ' GLU . 72.8 m -82.49 121.2 26.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.324 . . . . 0.0 109.115 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.0 t -141.24 148.14 39.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 110.154 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.668 HD21 ' N ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -74.24 134.3 42.68 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.163 -0.961 . . . . 0.0 108.752 178.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.668 ' N ' HD21 ' A' ' 17' ' ' ASN . 23.7 mtp180 -59.36 -33.06 70.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.489 -0.757 . . . . 0.0 109.836 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 13.9 p-10 -59.71 -46.3 89.51 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.857 -1.137 . . . . 0.0 108.41 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 29.5 tttt -64.62 -39.78 94.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 109.034 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.78 78.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.086 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.22 -40.48 77.59 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -60.15 -44.71 94.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.1 mt -66.16 -31.79 72.84 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.468 -0.77 . . . . 0.0 109.263 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.9 mt -91.3 -4.12 56.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.551 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 27' ' ' GLY . 2.9 tpt180 -91.58 125.51 36.34 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . 70.63 24.99 76.43 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -106.67 139.97 40.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -1.214 . . . . 0.0 108.676 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -71.43 149.09 46.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.326 -0.859 . . . . 0.0 110.867 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.557 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 64.3 t0 -58.7 144.17 44.37 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.498 0.666 . . . . 0.0 110.072 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 104.66 -24.87 27.38 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 85.4 m -81.58 124.86 29.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.986 -1.302 . . . . 0.0 109.128 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.458 ' CG ' HD21 ' A' ' 101' ' ' LEU . 1.1 p90 -140.03 164.89 28.81 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.16 -1.416 . . . . 0.0 111.601 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -137.27 156.97 47.64 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.673 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 11' ' ' TRP . 53.1 t -110.43 134.4 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.604 HH12 ' CG ' ' A' ' 18' ' ' ARG . 75.7 mtm180 -130.39 -179.49 5.29 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.426 -0.796 . . . . 0.0 109.235 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.699 ' C ' ' H ' ' A' ' 39' ' ' SER . 8.7 pt-20 -105.27 173.03 6.48 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 108.999 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' A' ' 43' ' ' CYS . 51.3 m -78.49 18.29 0.58 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.699 ' H ' ' C ' ' A' ' 37' ' ' GLU . 33.2 t 61.08 142.58 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.988 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 41' ' ' GLN . 37.7 mttp 59.27 34.26 22.93 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -0.916 . . . . 0.0 109.131 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 40' ' ' LYS . 59.9 tt0 58.52 148.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.827 . . . . 0.0 109.512 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.598 ' O ' ' SG ' ' A' ' 43' ' ' CYS . . . 151.81 -66.29 0.35 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.598 ' SG ' ' O ' ' A' ' 42' ' ' GLY . 82.0 m -156.19 -172.63 4.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.686 -1.479 . . . . 0.0 109.643 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.454 ' O ' ' O ' ' A' ' 59' ' ' ILE . 86.8 m-85 -117.45 158.68 24.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 109.617 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -147.15 132.87 18.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 109.686 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 27.4 p -102.6 117.69 35.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 108.974 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.5 m -98.77 127.28 44.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 108.868 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.502 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 7.5 p -127.89 166.39 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 110.536 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.557 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 15.5 t -108.16 138.18 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 52' ' ' GLY . 54.2 t -114.24 148.32 17.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.421 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.451 ' N ' HG11 ' A' ' 50' ' ' VAL . 61.4 t0 -50.64 -12.96 0.11 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.119 0.961 . . . . 0.0 108.601 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.558 ' O ' ' CD ' ' A' ' 53' ' ' GLU . . . -102.95 -51.1 1.03 Allowed Glycine 0 C--N 1.289 -2.05 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.558 ' CD ' ' O ' ' A' ' 52' ' ' GLY . 70.6 mm-40 -160.32 -177.44 6.25 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.865 -1.373 . . . . 0.0 110.428 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -94.21 128.27 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.552 -0.718 . . . . 0.0 109.405 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HZ1' ' C ' ' A' ' 53' ' ' GLU . 9.3 mptt -128.89 148.63 50.93 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.262 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -104.55 98.22 8.02 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.2 m -82.61 145.12 29.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.715 -1.241 . . . . 0.0 109.103 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.9 p -107.11 139.85 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.233 -0.917 . . . . 0.0 112.877 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 44' ' ' TYR . 49.9 mm -107.11 126.77 63.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 176.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.64 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 21.6 m120 -114.9 125.28 53.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.827 -1.171 . . . . 0.0 110.81 -177.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -109.36 122.68 47.9 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.506 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.694 ' O ' ' N ' ' A' ' 64' ' ' THR . 74.3 p -140.22 167.48 22.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 109.554 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -40.07 -18.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.694 ' N ' ' O ' ' A' ' 62' ' ' THR . 84.8 m -153.47 40.77 0.53 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.576 -0.703 . . . . 0.0 109.431 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.677 ' O ' ' CD2' ' A' ' 66' ' ' TYR . . . -144.5 169.3 26.5 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.391 -1.385 . . . . 0.0 110.693 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.677 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 59.0 m-85 -168.19 -18.94 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.69 -85.56 0.11 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 73' ' ' ASN . 51.3 m-85 -103.43 139.2 39.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.145 -1.209 . . . . 0.0 109.336 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 73' ' ' ASN . . . -127.0 7.65 6.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.182 -0.949 . . . . 0.0 110.332 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.737 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 35.7 mp0 -106.22 -27.0 0.19 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.912 -1.118 . . . . 0.0 110.935 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 94.5 Cg_endo -89.17 -59.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.6 2.2 . . . . 0.0 111.991 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.712 ' CE1' ' NE2' ' A' ' 84' ' ' HIS . 93.7 m-85 -118.13 16.07 14.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.134 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 68' ' ' PHE . 35.1 m120 61.77 -124.59 0.8 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.389 -0.82 . . . . 0.0 110.7 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.427 ' H ' HD21 ' A' ' 74' ' ' LEU . 1.2 mm? -102.13 107.55 18.67 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.222 -0.924 . . . . 0.0 108.54 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.475 ' CG ' HD21 ' A' ' 81' ' ' LEU . 98.8 m-85 -50.34 145.04 6.67 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.6 m -60.17 -43.47 95.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.522 -0.736 . . . . 0.0 111.313 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p -152.11 169.21 22.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.861 -1.149 . . . . 0.0 109.995 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -36.72 77.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.703 -0.623 . . . . 0.0 109.672 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -60.0 -40.89 90.74 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.011 -1.055 . . . . 0.0 108.63 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.11 -31.1 70.47 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.479 HD23 ' CE1' ' A' ' 85' ' ' TYR . 1.3 tm? -59.73 -45.77 91.15 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.424 HG23 ' CZ3' ' A' ' 11' ' ' TRP . 98.0 t -65.01 -45.0 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.03 . . . . 0.0 108.81 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.47 -43.01 77.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 110.057 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.712 ' NE2' ' CE1' ' A' ' 72' ' ' TYR . 53.6 t-80 -60.72 -42.71 97.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.353 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.479 ' CE1' HD23 ' A' ' 81' ' ' LEU . 4.6 m-30 -68.87 -25.1 64.46 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.083 -1.01 . . . . 0.0 109.387 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.579 ' OE1' ' ND1' ' A' ' 87' ' ' HIS . 1.3 tm0? -61.95 -34.68 76.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.217 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.579 ' ND1' ' OE1' ' A' ' 86' ' ' GLN . 87.9 m-70 -95.08 -18.73 20.74 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.015 -1.053 . . . . 0.0 110.888 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -102.67 133.09 48.27 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.036 -1.04 . . . . 0.0 109.9 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.3 t -74.21 133.51 42.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.417 -0.802 . . . . 0.0 109.48 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 92' ' ' GLN . 8.8 mp -62.51 -29.23 70.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.476 -0.765 . . . . 0.0 110.573 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.748 ' CG1' ' H ' ' A' ' 92' ' ' GLN . 8.6 p 2.34 -66.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 121.318 0.58 . . . . 0.0 111.492 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.748 ' H ' ' CG1' ' A' ' 91' ' ' VAL . 19.6 pt20 35.28 -149.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.826 0.822 . . . . 0.0 111.503 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.727 ' C ' ' H ' ' A' ' 95' ' ' ASP . 63.8 m80 -50.55 171.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.37 -0.831 . . . . 0.0 109.951 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 13.4 m120 63.02 -22.19 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.727 ' H ' ' C ' ' A' ' 93' ' ' HIS . 86.0 m-20 53.95 31.37 13.31 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.739 -0.601 . . . . 0.0 109.676 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.7 m -134.33 -0.5 2.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.807 -1.183 . . . . 0.0 111.24 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 96.0 mt -82.09 57.55 3.59 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -79.7 84.77 5.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.647 0.737 . . . . 0.0 109.33 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.5 ' CG2' ' OD1' ' A' ' 30' ' ' ASP . 3.0 p -159.94 155.98 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.5 p -122.42 146.06 47.7 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.082 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.458 HD21 ' CG ' ' A' ' 33' ' ' PHE . 34.8 mt -80.19 65.86 5.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 108.698 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.68 -22.86 15.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.855 . . . . 0.0 112.296 -178.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -115.18 114.05 43.46 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.46 -1.4 . . . . 0.0 110.897 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.408 ' CB ' ' O ' ' A' ' 10' ' ' THR . 10.5 Cg_exo -63.06 156.27 55.9 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.982 1.788 . . . . 0.0 111.227 178.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.73 -30.33 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.942 -1.099 . . . . 0.0 109.455 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.445 ' C ' ' H ' ' A' ' 108' ' ' GLN . 43.8 m-85 -99.88 30.98 3.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.082 -1.011 . . . . 0.0 110.208 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.95 20.07 0.5 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 109.143 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' A' ' 106' ' ' TYR . 10.8 tt0 -53.71 137.61 37.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.271 -0.893 . . . . 0.0 109.528 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -94.13 140.81 29.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.97 . . . . 0.0 109.708 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.677 HH11 ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -104.99 132.37 51.31 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.216 -0.927 . . . . 0.0 109.248 179.383 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 . . . . . 0 C--N 1.299 -1.628 0 CA-C-O 118.159 -0.924 . . . . 0.0 109.339 179.43 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.272 0.558 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -82.17 124.89 30.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.0 108.854 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.2 tp -99.3 128.4 31.89 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 120.818 -1.176 . . . . 0.0 108.623 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' O ' ' OG1' ' A' ' 10' ' ' THR . 78.5 Cg_exo -48.66 -19.99 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.39 2.06 . . . . 0.0 112.675 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -67.35 -26.08 66.3 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.925 -1.109 . . . . 0.0 109.741 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -63.4 -39.21 93.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.196 -0.94 . . . . 0.0 110.8 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.528 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 69.2 m-20 -93.16 128.7 39.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.991 -1.068 . . . . 0.0 110.421 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.707 ' O ' ' N ' ' A' ' 12' ' ' ASN . 94.0 mt-10 -66.87 -26.55 66.95 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.239 -0.913 . . . . 0.0 110.479 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HG2' ' H ' ' A' ' 10' ' ' THR . 1.2 pttp -60.86 -35.92 77.82 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.194 -0.941 . . . . 0.0 111.339 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.536 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 2.7 p -60.23 -33.14 71.85 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 109.895 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.654 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -122.67 -20.84 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 111.098 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.707 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -91.82 119.21 31.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.723 -1.235 . . . . 0.0 110.257 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.98 -4.54 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.301 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.83 -142.21 30.54 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.466 ' OG ' ' OE2' ' A' ' 37' ' ' GLU . 72.8 m -82.49 121.2 26.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.324 . . . . 0.0 109.115 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.0 t -141.24 148.14 39.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 110.154 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.668 HD21 ' N ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -74.24 134.3 42.68 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.163 -0.961 . . . . 0.0 108.752 178.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.668 ' N ' HD21 ' A' ' 17' ' ' ASN . 23.7 mtp180 -59.36 -33.06 70.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.489 -0.757 . . . . 0.0 109.836 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 13.9 p-10 -59.71 -46.3 89.51 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.857 -1.137 . . . . 0.0 108.41 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 29.5 tttt -64.62 -39.78 94.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 109.034 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.78 78.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.086 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.22 -40.48 77.59 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -60.15 -44.71 94.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.1 mt -66.16 -31.79 72.84 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.468 -0.77 . . . . 0.0 109.263 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.9 mt -91.3 -4.12 56.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.551 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 27' ' ' GLY . 2.9 tpt180 -91.58 125.51 36.34 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . 70.63 24.99 76.43 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -106.67 139.97 40.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -1.214 . . . . 0.0 108.676 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -71.43 149.09 46.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.326 -0.859 . . . . 0.0 110.867 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.557 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 64.3 t0 -58.7 144.17 44.37 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.498 0.666 . . . . 0.0 110.072 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 104.66 -24.87 27.38 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 85.4 m -81.58 124.86 29.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.986 -1.302 . . . . 0.0 109.128 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.458 ' CG ' HD21 ' A' ' 101' ' ' LEU . 1.1 p90 -140.03 164.89 28.81 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.16 -1.416 . . . . 0.0 111.601 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -137.27 156.97 47.64 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.673 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 11' ' ' TRP . 53.1 t -110.43 134.4 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.604 HH12 ' CG ' ' A' ' 18' ' ' ARG . 75.7 mtm180 -130.39 -179.49 5.29 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.426 -0.796 . . . . 0.0 109.235 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.699 ' C ' ' H ' ' A' ' 39' ' ' SER . 8.7 pt-20 -105.27 173.03 6.48 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 108.999 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' A' ' 43' ' ' CYS . 51.3 m -78.49 18.29 0.58 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.699 ' H ' ' C ' ' A' ' 37' ' ' GLU . 33.2 t 61.08 142.58 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.988 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 41' ' ' GLN . 37.7 mttp 59.27 34.26 22.93 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -0.916 . . . . 0.0 109.131 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 40' ' ' LYS . 59.9 tt0 58.52 148.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.827 . . . . 0.0 109.512 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.598 ' O ' ' SG ' ' A' ' 43' ' ' CYS . . . 151.81 -66.29 0.35 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.598 ' SG ' ' O ' ' A' ' 42' ' ' GLY . 82.0 m -156.19 -172.63 4.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.686 -1.479 . . . . 0.0 109.643 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.454 ' O ' ' O ' ' A' ' 59' ' ' ILE . 86.8 m-85 -117.45 158.68 24.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 109.617 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -147.15 132.87 18.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 109.686 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 27.4 p -102.6 117.69 35.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 108.974 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.5 m -98.77 127.28 44.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 108.868 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.502 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 7.5 p -127.89 166.39 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 110.536 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.557 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 15.5 t -108.16 138.18 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 52' ' ' GLY . 54.2 t -114.24 148.32 17.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.421 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.451 ' N ' HG11 ' A' ' 50' ' ' VAL . 61.4 t0 -50.64 -12.96 0.11 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.119 0.961 . . . . 0.0 108.601 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.558 ' O ' ' CD ' ' A' ' 53' ' ' GLU . . . -102.95 -51.1 1.03 Allowed Glycine 0 C--N 1.289 -2.05 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.558 ' CD ' ' O ' ' A' ' 52' ' ' GLY . 70.6 mm-40 -160.32 -177.44 6.25 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.865 -1.373 . . . . 0.0 110.428 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -94.21 128.27 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.552 -0.718 . . . . 0.0 109.405 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HZ1' ' C ' ' A' ' 53' ' ' GLU . 9.3 mptt -128.89 148.63 50.93 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.262 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -104.55 98.22 8.02 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.2 m -82.61 145.12 29.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.715 -1.241 . . . . 0.0 109.103 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.9 p -107.11 139.85 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.233 -0.917 . . . . 0.0 112.877 -176.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 44' ' ' TYR . 49.9 mm -107.11 126.77 63.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 176.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.64 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 21.6 m120 -114.9 125.28 53.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.827 -1.171 . . . . 0.0 110.81 -177.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -109.36 122.68 47.9 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.506 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.694 ' O ' ' N ' ' A' ' 64' ' ' THR . 74.3 p -140.22 167.48 22.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 109.554 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -40.07 -18.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.694 ' N ' ' O ' ' A' ' 62' ' ' THR . 84.8 m -153.47 40.77 0.53 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.576 -0.703 . . . . 0.0 109.431 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.677 ' O ' ' CD2' ' A' ' 66' ' ' TYR . . . -144.5 169.3 26.5 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.391 -1.385 . . . . 0.0 110.693 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.677 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 59.0 m-85 -168.19 -18.94 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.69 -85.56 0.11 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 73' ' ' ASN . 51.3 m-85 -103.43 139.2 39.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.145 -1.209 . . . . 0.0 109.336 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 73' ' ' ASN . . . -127.0 7.65 6.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.182 -0.949 . . . . 0.0 110.332 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.737 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 35.7 mp0 -106.22 -27.0 0.19 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.912 -1.118 . . . . 0.0 110.935 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 94.5 Cg_endo -89.17 -59.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.6 2.2 . . . . 0.0 111.991 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.712 ' CE1' ' NE2' ' A' ' 84' ' ' HIS . 93.7 m-85 -118.13 16.07 14.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.134 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 68' ' ' PHE . 35.1 m120 61.77 -124.59 0.8 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.389 -0.82 . . . . 0.0 110.7 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.427 ' H ' HD21 ' A' ' 74' ' ' LEU . 1.2 mm? -102.13 107.55 18.67 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.222 -0.924 . . . . 0.0 108.54 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.475 ' CG ' HD21 ' A' ' 81' ' ' LEU . 98.8 m-85 -50.34 145.04 6.67 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.6 m -60.17 -43.47 95.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.522 -0.736 . . . . 0.0 111.313 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p -152.11 169.21 22.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.861 -1.149 . . . . 0.0 109.995 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -36.72 77.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.703 -0.623 . . . . 0.0 109.672 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -60.0 -40.89 90.74 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.011 -1.055 . . . . 0.0 108.63 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.11 -31.1 70.47 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.479 HD23 ' CE1' ' A' ' 85' ' ' TYR . 1.3 tm? -59.73 -45.77 91.15 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.424 HG23 ' CZ3' ' A' ' 11' ' ' TRP . 98.0 t -65.01 -45.0 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.03 . . . . 0.0 108.81 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.47 -43.01 77.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 110.057 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.712 ' NE2' ' CE1' ' A' ' 72' ' ' TYR . 53.6 t-80 -60.72 -42.71 97.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.353 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.479 ' CE1' HD23 ' A' ' 81' ' ' LEU . 4.6 m-30 -68.87 -25.1 64.46 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.083 -1.01 . . . . 0.0 109.387 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.579 ' OE1' ' ND1' ' A' ' 87' ' ' HIS . 1.3 tm0? -61.95 -34.68 76.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.217 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.579 ' ND1' ' OE1' ' A' ' 86' ' ' GLN . 87.9 m-70 -95.08 -18.73 20.74 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.015 -1.053 . . . . 0.0 110.888 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -102.67 133.09 48.27 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.036 -1.04 . . . . 0.0 109.9 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.3 t -74.21 133.51 42.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.417 -0.802 . . . . 0.0 109.48 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 92' ' ' GLN . 8.8 mp -62.51 -29.23 70.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.476 -0.765 . . . . 0.0 110.573 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.748 ' CG1' ' H ' ' A' ' 92' ' ' GLN . 8.6 p 2.34 -66.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 121.318 0.58 . . . . 0.0 111.492 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.748 ' H ' ' CG1' ' A' ' 91' ' ' VAL . 19.6 pt20 35.28 -149.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.826 0.822 . . . . 0.0 111.503 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.727 ' C ' ' H ' ' A' ' 95' ' ' ASP . 63.8 m80 -50.55 171.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.37 -0.831 . . . . 0.0 109.951 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 13.4 m120 63.02 -22.19 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.727 ' H ' ' C ' ' A' ' 93' ' ' HIS . 86.0 m-20 53.95 31.37 13.31 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.739 -0.601 . . . . 0.0 109.676 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.7 m -134.33 -0.5 2.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.807 -1.183 . . . . 0.0 111.24 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 96.0 mt -82.09 57.55 3.59 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -79.7 84.77 5.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.647 0.737 . . . . 0.0 109.33 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.5 ' CG2' ' OD1' ' A' ' 30' ' ' ASP . 3.0 p -159.94 155.98 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.5 p -122.42 146.06 47.7 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.082 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.458 HD21 ' CG ' ' A' ' 33' ' ' PHE . 34.8 mt -80.19 65.86 5.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 108.698 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.68 -22.86 15.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.855 . . . . 0.0 112.296 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -115.18 114.05 43.46 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.46 -1.4 . . . . 0.0 110.897 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.408 ' CB ' ' O ' ' A' ' 10' ' ' THR . 10.5 Cg_exo -63.06 156.27 55.9 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.982 1.788 . . . . 0.0 111.227 178.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.73 -30.33 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.942 -1.099 . . . . 0.0 109.455 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.445 ' C ' ' H ' ' A' ' 108' ' ' GLN . 43.8 m-85 -99.88 30.98 3.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.082 -1.011 . . . . 0.0 110.208 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.95 20.07 0.5 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 109.143 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' A' ' 106' ' ' TYR . 10.8 tt0 -53.71 137.61 37.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.271 -0.893 . . . . 0.0 109.528 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -94.13 140.81 29.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.97 . . . . 0.0 109.708 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.677 HH11 ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -104.99 132.37 51.31 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.216 -0.927 . . . . 0.0 109.248 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 . . . . . 0 C--N 1.299 -1.628 0 CA-C-O 118.159 -0.924 . . . . 0.0 109.339 179.43 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.323 0.582 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -66.88 132.6 48.33 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.132 -0.98 . . . . 0.0 109.149 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 mp -94.46 126.49 47.76 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.307 -0.871 . . . . 0.0 109.558 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -54.88 -12.06 4.32 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.145 1.897 . . . . 0.0 111.612 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.816 ' NE2' ' NE2' ' A' ' 86' ' ' GLN . 83.8 m-70 -65.22 -31.8 73.15 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.354 -0.841 . . . . 0.0 109.349 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -61.85 -22.02 65.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.387 -0.82 . . . . 0.0 109.234 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.715 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 71.6 m-20 -90.93 114.47 26.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.31 -0.869 . . . . 0.0 109.443 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.552 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 39.7 tt0 -67.22 -37.86 84.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.015 -1.053 . . . . 0.0 109.898 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.43 ' HG2' ' N ' ' A' ' 10' ' ' THR . 0.4 OUTLIER -62.89 -29.06 70.47 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.487 -0.758 . . . . 0.0 110.642 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.627 ' OG1' ' O ' ' A' ' 7' ' ' ASP . 9.6 p -59.65 -35.12 73.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.132 -0.98 . . . . 0.0 110.381 -178.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.715 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -124.77 -5.69 7.49 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.738 -1.226 . . . . 0.0 110.125 179.568 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 8' ' ' GLU . 51.3 t-20 -96.76 129.2 44.22 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.989 -1.069 . . . . 0.0 110.441 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.9 t -107.13 -12.04 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.84 . . . . 0.0 109.524 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.42 -154.16 50.09 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 88.7 p -68.57 143.13 54.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.05 -1.264 . . . . 0.0 109.622 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.7 p -157.98 154.94 28.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 109.81 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.682 ' C ' ' H ' ' A' ' 19' ' ' ASN . 58.9 t30 -89.02 19.81 3.97 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.529 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.0 OUTLIER 58.8 -12.89 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.389 -0.819 . . . . 0.0 109.787 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.682 ' H ' ' C ' ' A' ' 17' ' ' ASN . 57.8 t-20 -67.53 -46.7 72.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.615 -1.303 . . . . 0.0 108.425 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.434 ' CB ' ' HZ1' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -65.37 -27.34 68.5 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.784 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -57.28 -43.94 83.56 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.573 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 68.4 mm-40 -61.14 -44.91 96.6 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -63.53 -45.63 89.72 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.445 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 83.0 mt -67.19 -36.83 82.57 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 21' ' ' ALA . 55.4 mt -82.05 -9.01 59.69 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.573 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 14.2 mmm180 -102.69 123.4 46.32 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.9 -4.49 63.18 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 34.4 mmtt -98.64 138.99 35.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.079 -1.248 . . . . 0.0 109.504 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -73.24 161.21 30.81 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.698 -0.626 . . . . 0.0 109.76 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 57.4 p-10 -58.66 149.47 25.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.23 -0.919 . . . . 0.0 109.9 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.27 -25.53 27.88 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 27.7 m -80.51 120.37 24.4 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.424 -1.045 . . . . 0.0 108.696 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.53 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -130.67 161.69 31.08 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.389 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.55 167.79 19.38 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.699 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.7 t -130.81 129.27 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.908 -1.12 . . . . 0.0 110.654 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.739 HH21 ' HG ' ' A' ' 47' ' ' SER . 67.8 mtm180 -129.45 -149.77 0.41 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.563 ' C ' ' H ' ' A' ' 39' ' ' SER . 71.7 mm-40 -105.65 173.32 6.36 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.655 ' O ' ' CB ' ' A' ' 39' ' ' SER . 63.3 p -78.19 5.43 10.25 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 177.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.655 ' CB ' ' O ' ' A' ' 38' ' ' SER . 23.0 p 99.02 -91.05 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.734 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.637 ' N ' ' OG ' ' A' ' 39' ' ' SER . 7.2 pttm -121.84 0.74 9.83 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.094 -1.004 . . . . 0.0 109.552 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.484 ' HB2' ' HG ' ' A' ' 38' ' ' SER . 32.3 mt-30 -79.2 -15.5 57.96 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.206 -0.934 . . . . 0.0 109.828 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.16 -12.14 68.77 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.603 ' O ' ' N ' ' A' ' 38' ' ' SER . 97.1 m -87.44 177.07 7.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.165 -1.197 . . . . 0.0 109.404 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.495 ' O ' ' O ' ' A' ' 59' ' ' ILE . 98.1 m-85 -110.69 153.35 25.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.903 -1.123 . . . . 0.0 109.959 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.91 133.09 23.02 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.457 -0.777 . . . . 0.0 109.123 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 17.1 p -115.87 134.61 54.82 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.206 -0.933 . . . . 0.0 109.502 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.739 ' HG ' HH21 ' A' ' 36' ' ' ARG . 70.7 m -98.65 146.15 26.15 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.597 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.477 HG11 ' H ' ' A' ' 49' ' ' VAL . 67.6 t -129.37 160.8 39.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.435 -0.79 . . . . 0.0 108.871 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.477 ' H ' HG11 ' A' ' 48' ' ' VAL . 63.2 t -118.5 128.33 75.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 52' ' ' GLY . 9.3 p -126.03 156.37 36.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.859 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.84 -18.39 0.27 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.639 0.733 . . . . 0.0 109.911 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.518 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -85.22 -59.57 1.93 Allowed Glycine 0 C--N 1.284 -2.348 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -164.85 -165.93 0.98 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.169 -1.195 . . . . 0.0 110.629 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.5 t -95.05 130.62 43.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.615 ' HZ2' HD21 ' A' ' 94' ' ' ASN . 0.7 OUTLIER -117.75 156.81 27.63 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.71 -1.244 . . . . 0.0 110.823 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.569 ' ND1' ' OG ' ' A' ' 47' ' ' SER . 25.5 m-70 -120.83 71.32 0.93 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.8 m -60.17 143.84 51.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 109.804 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.13 143.08 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.672 -0.643 . . . . 0.0 110.58 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.495 ' O ' ' O ' ' A' ' 44' ' ' TYR . 44.8 mm -115.49 140.44 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.592 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 11.2 m120 -114.34 129.44 56.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.553 -1.342 . . . . 0.0 110.549 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -90.45 120.02 31.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.412 -0.805 . . . . 0.0 110.139 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.48 HG21 ' H ' ' A' ' 63' ' ' ALA . 90.7 m -159.63 165.41 32.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.276 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.48 ' H ' HG21 ' A' ' 62' ' ' THR . . . -60.68 -41.58 95.4 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.27 30.06 6.18 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.454 -0.779 . . . . 0.0 110.535 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' A' ' 67' ' ' GLY . . . -120.66 -75.29 0.41 Allowed Glycine 0 N--CA 1.497 2.766 0 C-N-CA 119.355 -1.402 . . . . 0.0 110.939 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.592 ' CA ' ' O ' ' A' ' 60' ' ' ASN . 81.7 m-85 63.08 -9.82 0.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.181 -1.188 . . . . 0.0 108.94 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.618 ' H ' ' C ' ' A' ' 65' ' ' GLY . . . 135.86 -68.03 0.54 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.821 ' CE2' ' CZ ' ' A' ' 85' ' ' TYR . 91.9 m-85 -105.15 129.87 53.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.98 -1.306 . . . . 0.0 109.092 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.31 -6.94 0.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.044 -1.035 . . . . 0.0 109.857 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.702 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 32.0 tt0 -65.94 -35.31 10.63 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.151 -0.968 . . . . 0.0 109.93 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 1.4 Cg_endo -80.61 -46.16 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.87 2.38 . . . . 0.0 112.205 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.433 ' CE2' ' HB2' ' A' ' 74' ' ' LEU . 54.5 t80 -157.14 142.56 17.35 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -97.69 111.36 23.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.248 -0.907 . . . . 0.0 110.108 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -158.58 -125.48 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.716 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.449 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 47.1 m-85 58.76 51.7 7.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.12 -0.987 . . . . 0.0 109.785 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.467 ' N ' ' OE1' ' A' ' 80' ' ' GLU . 74.7 m -56.09 -33.63 65.25 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.25 -0.906 . . . . 0.0 109.538 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.9 t -128.17 151.3 49.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.96 . . . . 0.0 109.879 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.2 mt -57.28 -34.67 68.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.363 -0.835 . . . . 0.0 109.301 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -58.65 -40.14 82.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 0.0 108.612 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 76' ' ' SER . 98.0 mt-10 -60.24 -40.12 89.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.339 -0.851 . . . . 0.0 109.287 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.43 -46.49 89.89 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.208 -0.932 . . . . 0.0 109.132 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.51 -43.7 83.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.464 -0.772 . . . . 0.0 108.987 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.44 HD11 ' CD2' ' A' ' 5' ' ' HIS . 15.1 tp -65.86 -45.16 83.17 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.243 -0.911 . . . . 0.0 110.214 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -64.44 -40.28 95.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.978 -1.076 . . . . 0.0 111.182 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.821 ' CZ ' ' CE2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -75.51 -14.85 60.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.928 -1.108 . . . . 0.0 111.738 -178.245 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.816 ' NE2' ' NE2' ' A' ' 5' ' ' HIS . 1.6 pt20 -66.86 -25.59 66.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.507 -1.37 . . . . 0.0 108.853 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -88.17 -36.41 16.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 109.896 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.42 HG21 ' N ' ' A' ' 89' ' ' SER . 91.2 m -83.26 149.42 26.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 0.0 110.513 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.42 ' N ' HG21 ' A' ' 88' ' ' THR . 15.0 m -99.05 130.21 45.37 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.573 0.702 . . . . 0.0 110.549 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.707 ' O ' ' N ' ' A' ' 92' ' ' GLN . 1.8 mt -62.06 -15.73 46.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.49 -0.756 . . . . 0.0 110.034 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.755 ' N ' ' O ' ' A' ' 97' ' ' LEU . 9.1 p -21.63 -38.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.87 -0.519 . . . . 0.0 111.297 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.707 ' N ' ' O ' ' A' ' 90' ' ' LEU . 5.3 pt20 -60.67 -42.83 97.85 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.486 ' N ' ' HG3' ' A' ' 92' ' ' GLN . 43.2 m-70 -59.73 -44.3 93.83 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.739 ' O ' ' N ' ' A' ' 96' ' ' SER . 98.1 m-20 -131.68 116.31 17.17 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 94' ' ' ASN . 80.7 m-20 -40.87 -12.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.288 -0.882 . . . . 0.0 109.892 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.739 ' N ' ' O ' ' A' ' 94' ' ' ASN . 46.1 t -112.75 22.07 14.89 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.74 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.755 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.9 mt -95.67 56.62 1.79 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.783 -1.198 . . . . 0.0 108.896 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -77.85 69.72 4.12 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.124 -0.985 . . . . 0.0 108.87 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.439 HG11 ' N ' ' A' ' 100' ' ' THR . 86.2 t -149.55 154.33 9.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 86' ' ' GLN . 9.8 p -129.46 164.16 24.3 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.53 HD21 ' CG ' ' A' ' 33' ' ' PHE . 28.5 mt -78.78 70.63 5.15 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.894 -1.129 . . . . 0.0 108.169 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.91 -31.33 13.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.804 . . . . 0.0 112.356 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 32' ' ' THR . 59.7 m-85 -113.45 113.57 48.22 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 120.23 -1.544 . . . . 0.0 111.763 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.5 146.83 96.16 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.726 1.617 . . . . 0.0 110.615 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.95 -38.1 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.013 -1.054 . . . . 0.0 110.442 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 53.7 m-85 -101.24 27.62 6.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.064 -1.023 . . . . 0.0 109.974 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.43 140.49 58.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.12 -0.988 . . . . 0.0 110.156 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -92.44 135.63 33.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.915 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -93.82 2.61 56.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.0 109.479 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.467 ' O ' ' OXT' ' A' ' 111' ' ' ARG . 23.0 tpt180 -115.67 139.1 50.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.051 -1.03 . . . . 0.0 109.424 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.467 ' OXT' ' O ' ' A' ' 110' ' ' ARG . 93.1 mtt180 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.855 -1.069 . . . . 0.0 109.665 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 49.8 p-10 -64.93 148.61 51.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.398 -0.814 . . . . 0.0 109.682 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 4.1 mm? -89.35 138.07 28.8 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.208 -0.932 . . . . 0.0 108.992 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -57.2 -12.43 10.1 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.721 1.614 . . . . 0.0 111.445 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -54.9 -25.99 32.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.627 -0.671 . . . . 0.0 110.424 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -61.39 -28.93 69.6 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.957 -1.089 . . . . 0.0 110.293 -179.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.655 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 88.9 m-20 -98.14 131.82 44.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.724 -1.235 . . . . 0.0 110.743 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.685 ' O ' ' N ' ' A' ' 12' ' ' ASN . 79.5 mt-10 -67.34 -27.13 66.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.467 -0.771 . . . . 0.0 109.139 179.163 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.47 ' CG ' ' N ' ' A' ' 10' ' ' THR . 37.6 pttt -59.64 -34.54 72.94 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.424 -0.797 . . . . 0.0 110.825 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.691 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 49.0 p -67.91 -26.34 65.93 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.392 -0.817 . . . . 0.0 111.013 -178.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.691 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -125.79 -25.15 3.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.617 -1.302 . . . . 0.0 110.543 179.636 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.685 ' N ' ' O ' ' A' ' 8' ' ' GLU . 8.8 p-10 -91.03 138.13 31.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.784 -1.197 . . . . 0.0 110.191 -178.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.0 p -111.52 -9.78 11.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.325 -0.859 . . . . 0.0 109.738 -179.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.82 50.39 3.53 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.797 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.489 ' HA ' ' H ' ' A' ' 37' ' ' GLU . 17.3 t 59.07 65.81 1.15 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.889 -1.36 . . . . 0.0 110.766 178.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.628 ' O ' ' CZ ' ' A' ' 36' ' ' ARG . 95.5 p -77.78 166.67 22.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.169 -0.957 . . . . 0.0 109.659 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.63 ' C ' HH12 ' A' ' 36' ' ' ARG . 86.1 m-20 -73.34 142.95 47.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.977 -1.077 . . . . 0.0 109.238 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.61 ' N ' HH12 ' A' ' 36' ' ' ARG . 35.0 mtm180 -60.22 -35.66 75.93 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.402 -0.811 . . . . 0.0 109.639 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -64.07 -43.71 94.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.939 -1.1 . . . . 0.0 109.08 179.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -68.46 -37.82 80.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.902 -1.124 . . . . 0.0 108.74 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.6 72.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.175 -0.953 . . . . 0.0 109.012 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 26' ' ' ARG . 67.3 tt0 -59.67 -48.85 80.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.241 -0.912 . . . . 0.0 108.827 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -60.25 -41.09 92.46 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.0 mt -66.76 -36.51 82.6 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.3 mt -86.93 -10.07 54.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.086 -1.009 . . . . 0.0 108.606 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.547 HH11 ' HG3' ' A' ' 26' ' ' ARG . 11.9 mmm-85 -100.45 135.36 42.01 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.418 0.628 . . . . 0.0 110.241 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.28 2.91 90.69 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -105.06 141.85 35.89 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.146 -1.208 . . . . 0.0 109.482 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -66.21 153.56 42.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.572 -0.705 . . . . 0.0 110.025 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.578 ' OD2' ' CA ' ' A' ' 51' ' ' ASP . 84.5 m-20 -58.74 144.67 42.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 0.0 109.486 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.41 -20.88 34.07 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.5 m -86.45 119.95 27.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.244 -1.151 . . . . 0.0 108.972 179.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.544 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -136.73 167.92 20.51 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.107 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.654 ' CD1' ' OG ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -140.29 157.11 46.08 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.002 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.481 HG21 ' HG ' ' A' ' 46' ' ' CYS . 47.4 t -106.97 133.47 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.991 -1.068 . . . . 0.0 108.604 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.63 HH12 ' C ' ' A' ' 17' ' ' ASN . 14.2 ptm180 -152.37 -177.52 6.25 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.112 -0.992 . . . . 0.0 109.35 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.753 ' C ' ' H ' ' A' ' 39' ' ' SER . 32.9 tt0 -106.58 166.15 10.77 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.612 ' O ' ' OG ' ' A' ' 39' ' ' SER . 60.1 m -76.28 19.75 0.23 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 177.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.753 ' H ' ' C ' ' A' ' 37' ' ' GLU . 99.8 p 60.83 -77.36 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.74 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.697 ' O ' ' CB ' ' A' ' 41' ' ' GLN . 61.1 tttp -92.65 131.37 37.8 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.697 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 65.4 tt0 116.79 -33.92 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.44 2.94 84.72 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.3 t -78.52 134.36 37.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.179 -1.189 . . . . 0.0 109.692 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -81.32 165.01 21.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.872 . . . . 0.0 109.666 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -168.39 139.3 2.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.988 -1.07 . . . . 0.0 110.324 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.481 ' HG ' HG21 ' A' ' 35' ' ' VAL . 63.1 m -108.64 126.47 53.01 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.686 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.654 ' OG ' ' CD1' ' A' ' 34' ' ' LEU . 3.0 p -110.62 129.87 55.71 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.874 -1.141 . . . . 0.0 110.15 -179.01 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 7.2 p -127.53 161.47 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.039 -1.038 . . . . 0.0 109.812 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.455 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 45.1 t -101.74 129.13 53.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.778 ' CG1' ' HZ3' ' A' ' 55' ' ' LYS . 48.0 t -122.71 154.57 27.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 120.87 -1.144 . . . . 0.0 110.367 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.578 ' CA ' ' OD2' ' A' ' 30' ' ' ASP . 59.0 t0 -49.01 -17.68 0.22 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.546 0.688 . . . . 0.0 110.026 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.483 ' H ' HG13 ' A' ' 50' ' ' VAL . . . -94.52 -56.96 1.3 Allowed Glycine 0 C--N 1.283 -2.409 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -165.34 170.25 14.85 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.028 -1.277 . . . . 0.0 110.65 -179.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.2 m -73.19 137.24 23.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.778 ' HZ3' ' CG1' ' A' ' 50' ' ' VAL . 8.4 mttt -125.27 156.13 39.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.753 -1.217 . . . . 0.0 111.366 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -121.96 78.07 1.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 46' ' ' CYS . 74.5 m -58.95 131.57 51.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.444 -1.41 . . . . 0.0 108.138 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.95 125.8 62.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.411 -0.805 . . . . 0.0 110.993 -178.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.87 134.56 61.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.604 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 23.4 p30 -123.98 133.81 53.61 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.013 -1.055 . . . . 0.0 110.004 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.422 ' O ' ' CG ' ' A' ' 61' ' ' LYS . 17.1 pttp -100.29 120.63 40.22 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.965 0.888 . . . . 0.0 109.992 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.603 ' O ' ' C ' ' A' ' 63' ' ' ALA . 85.6 m -144.05 153.71 42.48 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.603 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -30.71 -43.88 0.05 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.371 -0.83 . . . . 0.0 109.284 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 62' ' ' THR . 0.1 OUTLIER -120.71 22.96 10.99 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.23 -0.919 . . . . 0.0 109.976 179.495 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.713 ' O ' ' CG ' ' A' ' 66' ' ' TYR . . . -128.01 170.03 19.55 Favored Glycine 0 N--CA 1.497 2.741 0 C-N-CA 119.28 -1.438 . . . . 0.0 111.167 -178.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.713 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 97.3 m-85 -168.45 -30.17 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.731 0.777 . . . . 0.0 109.322 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 69' ' ' ALA . . . 145.43 -163.31 28.19 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 -179.37 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -67.11 -1.82 4.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.851 -1.382 . . . . 0.0 108.045 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.478 ' H ' ' C ' ' A' ' 67' ' ' GLY . . . -49.99 142.32 9.46 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.437 0.636 . . . . 0.0 109.918 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 73' ' ' ASN . 57.0 tt0 -108.03 138.97 20.25 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -39.28 -38.09 1.26 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.828 1.685 . . . . 0.0 111.737 -179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -64.0 -35.77 81.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.329 -0.857 . . . . 0.0 109.274 179.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.743 ' O ' ' N ' ' A' ' 75' ' ' TYR . 81.0 m-20 -75.93 -82.82 0.07 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.247 -0.908 . . . . 0.0 109.316 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.549 ' C ' ' O ' ' A' ' 73' ' ' ASN . 57.8 mt -27.51 82.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.497 0.665 . . . . 0.0 110.085 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.743 ' N ' ' O ' ' A' ' 73' ' ' ASN . 57.7 t80 -64.12 -41.65 97.16 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.417 -0.802 . . . . 0.0 109.632 -179.514 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.618 ' HG ' ' N ' ' A' ' 77' ' ' SER . 83.5 p -162.94 -49.51 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.344 -0.942 . . . . 0.0 111.496 -179.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.618 ' N ' ' HG ' ' A' ' 76' ' ' SER . 89.0 p -143.08 173.62 11.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.674 -1.266 . . . . 0.0 111.108 -178.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mt -60.25 -35.77 76.26 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.202 0.525 . . . . 0.0 109.928 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.407 ' O ' HG11 ' A' ' 82' ' ' VAL . 71.1 tttt -52.44 -49.07 65.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.019 -1.051 . . . . 0.0 109.923 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.564 ' OE1' ' OG ' ' A' ' 76' ' ' SER . 84.3 mt-10 -74.33 -20.24 60.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.942 -1.099 . . . . 0.0 108.71 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.533 ' CD2' ' CE2' ' A' ' 85' ' ' TYR . 7.4 tt -67.17 -43.88 81.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.554 -0.716 . . . . 0.0 109.606 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 83' ' ' LEU . 3.0 p -65.17 -43.93 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.077 -1.015 . . . . 0.0 109.027 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.533 ' N ' ' CG1' ' A' ' 82' ' ' VAL . 66.1 tp -67.68 -43.87 79.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.425 -0.797 . . . . 0.0 109.567 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -61.79 -39.97 93.55 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.495 -0.753 . . . . 0.0 110.167 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.533 ' CE2' ' CD2' ' A' ' 81' ' ' LEU . 5.8 m-30 -63.53 -27.36 69.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.92 -1.112 . . . . 0.0 109.187 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' A' ' 102' ' ' ALA . 17.6 tt0 -64.69 -35.23 80.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 110.071 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -91.06 -18.32 24.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.105 -0.997 . . . . 0.0 109.726 -179.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.7 m -101.76 122.96 44.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.897 . . . . 0.0 109.33 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.3 t -72.22 133.95 45.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.326 -0.859 . . . . 0.0 109.026 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.761 ' O ' ' N ' ' A' ' 92' ' ' GLN . 66.2 mt -60.84 -43.85 97.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 111.066 -179.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.698 ' N ' ' O ' ' A' ' 97' ' ' LEU . 74.6 t 18.71 -79.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 CA-C-N 118.436 0.562 . . . . 0.0 109.649 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.761 ' N ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER 73.05 -176.23 0.17 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.378 -0.826 . . . . 0.0 110.854 178.247 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.464 ' H ' ' HG2' ' A' ' 92' ' ' GLN . 82.7 t60 -59.72 -38.88 82.88 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.383 -0.823 . . . . 0.0 109.114 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -55.05 -28.73 54.47 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 61.21 36.73 17.83 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.81 -0.556 . . . . 0.0 109.797 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.5 p -138.67 0.49 2.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.865 -1.147 . . . . 0.0 111.153 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.698 ' O ' ' N ' ' A' ' 91' ' ' VAL . 63.4 mt -100.21 61.69 1.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.755 -1.216 . . . . 0.0 107.976 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -80.68 69.3 7.18 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.971 -1.081 . . . . 0.0 109.92 -178.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.2 t -152.99 149.63 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.1 p -119.81 152.06 37.85 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.288 -0.883 . . . . 0.0 108.863 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.544 HD21 ' CG ' ' A' ' 33' ' ' PHE . 31.9 mt -76.22 69.09 2.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.404 ' HA ' ' OE1' ' A' ' 86' ' ' GLN . . . -100.25 -23.99 14.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.461 -0.774 . . . . 0.0 113.031 -177.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -114.52 105.66 53.37 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.15 -1.594 . . . . 0.0 110.795 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.438 ' CB ' ' O ' ' A' ' 10' ' ' THR . 19.3 Cg_exo -59.75 144.98 99.34 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.976 1.784 . . . . 0.0 111.024 178.405 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 106' ' ' TYR . 8.2 p -67.24 -22.6 29.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.024 -1.047 . . . . 0.0 109.279 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.473 ' CD2' HG11 ' A' ' 105' ' ' VAL . 67.5 m-85 -123.79 63.28 1.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.51 -143.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.545 0.688 . . . . 0.0 110.738 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -83.16 -154.85 0.15 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.403 -0.81 . . . . 0.0 109.919 -179.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 63.45 39.49 9.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.719 . . . . 0.0 109.587 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.551 ' O ' ' OXT' ' A' ' 111' ' ' ARG . 12.7 mtm180 -134.28 154.47 51.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.507 -0.745 . . . . 0.0 109.057 179.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.551 ' OXT' ' O ' ' A' ' 110' ' ' ARG . 30.0 ttm-85 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.452 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.317 0.579 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -91.03 123.38 34.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.465 -0.772 . . . . 0.0 109.314 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 24.7 mt -96.1 138.85 21.59 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.967 -1.083 . . . . 0.0 109.242 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.532 ' O ' ' OG1' ' A' ' 10' ' ' THR . 37.1 Cg_endo -69.2 -3.84 12.45 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.288 1.992 . . . . 0.0 111.812 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.473 ' CG ' HD22 ' A' ' 83' ' ' LEU . 96.8 m-70 -83.97 -16.26 44.77 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.46 -0.775 . . . . 0.0 109.68 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -61.75 -36.49 81.17 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.585 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 54.2 p-10 -106.2 130.11 54.13 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.595 0.712 . . . . 0.0 109.497 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.575 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.7 OUTLIER -70.24 -9.43 55.86 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 109.725 -179.687 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HA ' ' OD1' ' A' ' 12' ' ' ASN . 2.2 ttpt -61.5 -36.93 81.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.603 -0.685 . . . . 0.0 110.864 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.532 ' OG1' ' O ' ' A' ' 4' ' ' PRO . 54.3 p -66.47 -20.07 65.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 112.416 -177.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.558 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -134.43 -12.7 2.38 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 119.965 -1.709 . . . . 0.0 111.168 179.168 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.659 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 19.3 p-10 -95.66 127.06 41.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.588 -1.32 . . . . 0.0 111.571 -178.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.2 m -146.01 34.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.9 -34.43 7.27 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.2 p -66.69 -12.17 57.27 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.143 -1.21 . . . . 0.0 109.508 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.613 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 57.8 m -79.78 142.71 35.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.237 -0.914 . . . . 0.0 110.753 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.675 ' C ' HH12 ' A' ' 36' ' ' ARG . 8.4 p30 -80.13 156.47 26.99 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.416 -0.802 . . . . 0.0 109.609 179.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.81 ' N ' HH22 ' A' ' 36' ' ' ARG . 45.8 mtm180 -63.63 -37.31 86.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.122 -0.986 . . . . 0.0 110.713 -178.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.675 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 46.3 p-10 -57.92 -43.96 86.57 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.431 -1.418 . . . . 0.0 108.689 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.675 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 42.7 tttt -66.24 -31.06 71.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.928 -1.108 . . . . 0.0 108.301 178.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.477 ' HB3' HH11 ' A' ' 36' ' ' ARG . . . -60.31 -38.6 84.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.893 . . . . 0.0 108.831 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 26' ' ' ARG . 98.1 mt-10 -59.02 -47.59 84.65 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -60.19 -43.45 95.9 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.487 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 99.1 mt -66.18 -36.66 83.68 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.516 ' CD1' ' OG ' ' A' ' 47' ' ' SER . 10.3 mt -89.2 -7.52 55.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.843 . . . . 0.0 109.513 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 22' ' ' GLU . 14.6 mmm180 -96.37 -25.94 15.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.99 -1.069 . . . . 0.0 109.691 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.09 10.31 56.83 Favored Glycine 0 C--N 1.288 -2.12 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 178.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 7.7 mmpt? -114.53 141.33 47.87 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.428 -1.042 . . . . 0.0 110.568 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.93 168.42 15.03 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.491 0.663 . . . . 0.0 110.042 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.539 ' OD1' ' CG2' ' A' ' 99' ' ' VAL . 67.6 t0 -56.28 141.95 39.5 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.39 -0.819 . . . . 0.0 109.709 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.495 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 107.64 -31.85 7.66 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 97.4 m -86.37 127.41 34.81 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.166 -1.196 . . . . 0.0 109.539 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.48 ' CE2' HD12 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -139.46 172.45 12.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.63 -1.294 . . . . 0.0 109.806 178.896 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.426 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -139.51 169.24 18.11 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.66 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 11' ' ' TRP . 71.5 t -120.17 132.94 68.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 -179.587 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.81 HH22 ' N ' ' A' ' 18' ' ' ARG . 40.7 mtp180 -144.01 -156.8 0.72 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.367 -0.833 . . . . 0.0 108.976 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.721 ' C ' ' H ' ' A' ' 39' ' ' SER . 63.9 mm-40 -108.26 172.74 6.66 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.51 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.673 ' O ' ' CB ' ' A' ' 39' ' ' SER . 82.6 p -76.16 12.71 1.08 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.721 ' H ' ' C ' ' A' ' 37' ' ' GLU . 19.0 t 111.06 127.83 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.958 -1.473 . . . . 0.0 108.261 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt 60.96 -148.78 0.42 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.445 ' N ' ' CD ' ' A' ' 41' ' ' GLN . 27.3 mp0 -109.05 143.18 38.71 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.198 -0.939 . . . . 0.0 109.656 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.99 -61.65 0.39 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.332 179.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 75.4 m -130.81 -176.12 3.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -1.085 . . . . 0.0 109.546 -179.529 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 59' ' ' ILE . 58.7 m-85 -118.24 154.22 32.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.839 . . . . 0.0 109.886 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -159.21 135.13 8.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 109.032 178.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.458 ' SG ' ' CD1' ' A' ' 59' ' ' ILE . 4.6 m -115.16 139.98 49.46 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.71 ' HG ' ' CE1' ' A' ' 56' ' ' HIS . 46.4 t -108.21 133.39 52.52 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.941 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 7.6 p -129.74 157.67 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 121.905 0.86 . . . . 0.0 110.307 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.463 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 89.4 t -99.45 134.82 37.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.502 ' CB ' ' HZ1' ' A' ' 55' ' ' LYS . 75.7 t -121.29 150.52 24.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.725 -1.235 . . . . 0.0 109.793 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -46.97 -18.8 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.813 0.816 . . . . 0.0 109.757 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . -92.35 -56.25 1.59 Allowed Glycine 0 C--N 1.283 -2.405 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -164.04 -176.47 4.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -1.155 . . . . 0.0 110.444 -179.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.9 t -87.49 135.85 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.203 -0.936 . . . . 0.0 108.764 178.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HZ1' ' CB ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -133.22 157.53 45.16 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.004 -1.06 . . . . 0.0 111.318 -178.837 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.71 ' CE1' ' HG ' ' A' ' 47' ' ' SER . 6.0 m-70 -113.19 97.53 6.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.6 m -71.53 141.71 50.11 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.65 134.12 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.867 -1.146 . . . . 0.0 112.46 -177.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.516 ' CG2' ' O ' ' A' ' 66' ' ' TYR . 96.1 mt -105.72 139.71 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 177.489 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.631 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 33.0 m120 -124.22 134.14 53.34 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.368 -1.457 . . . . 0.0 111.976 -177.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -107.34 121.75 45.2 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.585 0.707 . . . . 0.0 109.494 178.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 32.3 p -130.63 176.87 7.82 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -45.05 -30.69 1.12 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.42 -0.8 . . . . 0.0 109.391 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.3 t -144.04 7.56 1.4 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.185 -0.947 . . . . 0.0 109.125 179.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.642 ' N ' ' OG1' ' A' ' 62' ' ' THR . . . -93.26 -170.65 39.59 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.631 ' CA ' ' O ' ' A' ' 60' ' ' ASN . 0.4 OUTLIER 178.1 -26.13 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.429 -1.042 . . . . 0.0 109.162 179.903 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.96 -145.11 7.43 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.2 m-30 -52.48 146.21 10.18 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.82 -1.4 . . . . 0.0 108.313 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.58 27.37 4.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.593 -1.317 . . . . 0.0 110.265 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.705 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 12.7 tp10 -107.26 -35.61 0.17 Allowed Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 120.73 -1.232 . . . . 0.0 109.593 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 56.5 Cg_endo -87.65 -30.62 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.414 2.076 . . . . 0.0 113.044 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.608 ' HH ' ' HH ' ' A' ' 85' ' ' TYR . 44.9 p90 -154.38 160.19 41.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.967 . . . . 0.0 110.037 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 73' ' ' ASN . 6.5 p-10 -106.38 105.6 15.71 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.126 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.9 tp 49.42 95.69 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.188 -0.945 . . . . 0.0 111.007 178.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -56.11 153.54 8.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.025 -1.047 . . . . 0.0 109.296 178.847 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.4 p -58.83 -40.4 84.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -0.846 . . . . 0.0 110.8 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.7 m -149.21 159.52 44.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.897 -1.127 . . . . 0.0 110.176 -179.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 71.0 mt -62.68 -32.71 73.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.425 -0.797 . . . . 0.0 109.523 179.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -60.09 -42.38 94.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.209 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -65.71 -28.89 69.39 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.507 ' C ' ' CD2' ' A' ' 81' ' ' LEU . 6.7 tt -58.33 -46.44 86.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.629 -0.669 . . . . 0.0 110.006 -179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.0 t -73.72 -41.96 54.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.942 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.473 HD22 ' CG ' ' A' ' 5' ' ' HIS . 68.6 mt -65.39 -43.88 89.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.375 -0.828 . . . . 0.0 109.79 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.531 ' O ' ' OG1' ' A' ' 88' ' ' THR . 58.8 t-80 -62.24 -42.08 99.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.011 -1.056 . . . . 0.0 110.146 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.608 ' HH ' ' HH ' ' A' ' 72' ' ' TYR . 5.6 m-85 -70.22 -27.79 64.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 111.171 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.49 ' HG2' ' N ' ' A' ' 87' ' ' HIS . 0.4 OUTLIER -64.6 -32.76 74.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.651 -1.28 . . . . 0.0 109.368 -179.118 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.49 ' N ' ' HG2' ' A' ' 86' ' ' GLN . 43.4 m170 -89.78 -30.1 18.22 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.268 -0.895 . . . . 0.0 109.083 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 2.9 p -95.52 140.52 30.25 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.42 -0.8 . . . . 0.0 110.127 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.6 p -80.23 140.16 36.38 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.691 -0.63 . . . . 0.0 109.817 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.689 ' O ' ' C ' ' A' ' 91' ' ' VAL . 7.9 mp -67.32 -26.98 66.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 110.549 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.747 ' N ' ' O ' ' A' ' 97' ' ' LEU . 95.9 t -1.75 -67.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 CA-C-O 121.62 0.724 . . . . 0.0 110.056 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.675 ' N ' ' O ' ' A' ' 90' ' ' LEU . 32.8 mm-40 35.15 -123.91 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.485 0.659 . . . . 0.0 111.175 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.537 ' C ' ' H ' ' A' ' 95' ' ' ASP . 19.1 p80 -71.55 165.65 23.46 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.475 -0.766 . . . . 0.0 109.862 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.654 ' O ' ' N ' ' A' ' 96' ' ' SER . 9.2 m120 61.89 2.86 0.81 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 93' ' ' HIS . 94.9 m-20 33.37 28.65 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.746 -0.596 . . . . 0.0 109.592 179.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.654 ' N ' ' O ' ' A' ' 94' ' ' ASN . 80.1 p -130.02 3.28 4.83 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.852 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.747 ' O ' ' N ' ' A' ' 91' ' ' VAL . 87.2 mt -83.31 56.75 3.67 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.553 -1.342 . . . . 0.0 107.723 178.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.41 90.22 4.42 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.082 0.944 . . . . 0.0 109.53 -179.275 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.539 ' CG2' ' OD1' ' A' ' 30' ' ' ASP . 4.2 p -169.48 159.13 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.431 ' N ' HG23 ' A' ' 99' ' ' VAL . 66.7 p -128.06 151.52 49.08 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.19 -0.944 . . . . 0.0 109.984 -179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.48 HD12 ' CE2' ' A' ' 33' ' ' PHE . 32.4 mt -84.46 65.72 9.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.02 -1.05 . . . . 0.0 108.425 179.438 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -94.4 -22.6 18.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.387 -0.821 . . . . 0.0 112.519 -177.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -118.09 112.19 38.24 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.111 -1.618 . . . . 0.0 111.071 -178.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.414 ' CB ' ' HB ' ' A' ' 10' ' ' THR . 33.1 Cg_exo -58.0 143.87 95.48 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.492 2.128 . . . . 0.0 111.406 177.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.438 HG11 ' N ' ' A' ' 106' ' ' TYR . 11.6 p -71.88 -27.67 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.064 -1.022 . . . . 0.0 109.614 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.438 ' N ' HG11 ' A' ' 105' ' ' VAL . 3.2 m-85 -114.05 29.28 8.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.194 -0.941 . . . . 0.0 109.769 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.89 130.59 47.24 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.108 -0.995 . . . . 0.0 109.525 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -119.72 147.22 44.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 109.212 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -98.67 134.65 41.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.956 -1.09 . . . . 0.0 109.56 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -66.0 -39.54 90.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.315 -0.866 . . . . 0.0 110.375 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 0.0 109.831 -179.211 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -114.88 33.01 5.64 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.603 -0.685 . . . . 0.0 109.656 179.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 3.5 mm? -70.9 148.16 94.47 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 121.497 -0.752 . . . . 0.0 109.674 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.35 -2.04 9.19 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.683 2.255 . . . . 0.0 112.301 179.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.546 ' CD2' ' CD2' ' A' ' 83' ' ' LEU . 91.6 m-70 -73.6 -24.52 60.06 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.37 -0.831 . . . . 0.0 110.028 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -60.3 -34.03 73.2 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.215 -0.928 . . . . 0.0 108.791 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.684 ' OD2' ' NZ ' ' A' ' 9' ' ' LYS . 99.9 m-20 -109.02 119.06 38.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.093 -1.005 . . . . 0.0 109.91 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 12' ' ' ASN . 94.6 mt-10 -65.16 -16.37 63.43 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.684 ' NZ ' ' OD2' ' A' ' 7' ' ' ASP . 26.2 pttt -59.71 -37.48 78.99 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.17 -0.956 . . . . 0.0 110.396 -179.281 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.681 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 23.3 p -55.79 -35.97 66.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.512 -0.743 . . . . 0.0 110.212 -179.263 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.681 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -121.59 -33.01 3.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.77 -1.206 . . . . 0.0 110.723 179.634 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.669 ' N ' ' O ' ' A' ' 8' ' ' GLU . 64.0 t30 -83.08 128.18 34.25 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.02 -1.05 . . . . 0.0 111.366 -178.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.741 ' O ' ' N ' ' A' ' 16' ' ' SER . 24.0 m -139.7 30.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.567 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -24.78 -45.23 0.01 OUTLIER Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 13' ' ' VAL . 81.5 p -51.69 -16.78 0.71 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.547 -0.972 . . . . 0.0 108.807 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.741 ' N ' ' O ' ' A' ' 13' ' ' VAL . 89.1 p -70.0 159.49 33.69 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.692 0.758 . . . . 0.0 110.011 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.438 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 79.6 m-20 -122.98 165.16 17.2 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -59.75 -43.35 94.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.641 -1.287 . . . . 0.0 109.312 -179.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -64.47 -42.98 95.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 108.622 179.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.438 ' HB3' ' H ' ' A' ' 17' ' ' ASN . 21.1 ttmm -69.07 -35.52 76.61 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.51 74.85 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 26' ' ' ARG . 88.0 tt0 -57.78 -47.2 83.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.935 -1.103 . . . . 0.0 108.741 179.195 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -60.03 -43.81 95.07 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.71 -27.59 66.95 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.0 mt -94.28 -5.43 46.76 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.314 -0.866 . . . . 0.0 109.239 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.629 HH11 ' HG2' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -94.04 123.87 37.69 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.784 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.06 4.52 74.65 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -99.91 134.74 42.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.101 -1.235 . . . . 0.0 109.811 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -69.94 159.72 33.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.518 -0.739 . . . . 0.0 109.615 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.67 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 88.3 m-20 -59.72 147.32 38.2 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.635 0.731 . . . . 0.0 110.039 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.63 -22.89 37.85 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -179.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 67.6 m -81.37 114.02 19.86 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.294 -1.121 . . . . 0.0 108.831 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -132.21 170.49 14.95 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.086 -179.475 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.68 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 1.9 pp -147.37 157.88 43.75 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.56 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.463 HG21 ' SG ' ' A' ' 46' ' ' CYS . 48.3 t -103.9 128.5 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.156 -0.965 . . . . 0.0 108.443 178.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.699 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -144.02 173.85 11.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 108.823 -179.364 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.708 ' C ' ' H ' ' A' ' 39' ' ' SER . 6.0 tt0 -106.96 164.11 12.41 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 120.827 -1.171 . . . . 0.0 108.382 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.601 ' C ' ' H ' ' A' ' 40' ' ' LYS . 53.6 m -75.83 30.09 0.11 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.708 ' H ' ' C ' ' A' ' 37' ' ' GLU . 68.8 m 67.19 -11.92 0.26 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.08 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.601 ' H ' ' C ' ' A' ' 38' ' ' SER . 61.4 tttt -91.42 120.59 32.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.54 -0.725 . . . . 0.0 109.73 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -47.67 126.08 9.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.996 -1.065 . . . . 0.0 110.677 -179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.31 4.42 66.37 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.66 178.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.541 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 52.8 t -111.58 151.31 28.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.848 -1.383 . . . . 0.0 108.018 178.507 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.588 ' O ' ' O ' ' A' ' 59' ' ' ILE . 92.8 m-85 -130.13 151.87 50.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.901 -1.125 . . . . 0.0 109.92 -179.01 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.52 ' HB3' HH12 ' A' ' 36' ' ' ARG . . . -162.54 133.83 5.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.858 -1.152 . . . . 0.0 109.544 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.504 ' N ' ' O ' ' A' ' 57' ' ' CYS . 60.0 m -108.18 130.64 55.12 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.474 ' HG ' ' HD1' ' A' ' 56' ' ' HIS . 32.9 t -108.18 134.5 50.95 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.196 -0.94 . . . . 0.0 109.953 -178.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.2 p -133.58 167.72 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.21 -0.931 . . . . 0.0 110.278 -179.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.3 t -121.23 133.69 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.609 -0.682 . . . . 0.0 109.667 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.782 ' CG1' ' HZ2' ' A' ' 55' ' ' LYS . 7.3 p -127.61 160.29 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.076 -1.015 . . . . 0.0 109.968 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.67 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 54.5 m-20 -50.21 -20.35 1.01 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.712 0.768 . . . . 0.0 110.078 -179.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.81 -58.68 2.2 Favored Glycine 0 C--N 1.285 -2.253 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.806 ' N ' ' NZ ' ' A' ' 55' ' ' LYS . 1.3 tt0 -167.07 -165.09 0.67 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.292 -1.122 . . . . 0.0 111.322 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.3 t -97.59 123.8 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.485 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.806 ' NZ ' ' N ' ' A' ' 53' ' ' GLU . 11.5 mptt -118.95 152.48 36.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.465 -1.397 . . . . 0.0 110.941 -179.334 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.474 ' HD1' ' HG ' ' A' ' 47' ' ' SER . 87.6 m-70 -115.16 112.64 22.84 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 46' ' ' CYS . 49.1 t -88.21 124.74 34.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.077 -1.014 . . . . 0.0 108.536 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.531 ' O ' ' CG1' ' A' ' 58' ' ' VAL . 4.8 p -101.07 122.64 53.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.079 -1.013 . . . . 0.0 110.906 -178.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.588 ' O ' ' O ' ' A' ' 44' ' ' TYR . 88.6 mt -116.57 137.96 48.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.682 ' O ' ' N ' ' A' ' 67' ' ' GLY . 50.7 t30 -132.97 144.73 50.31 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.566 -1.334 . . . . 0.0 111.511 -178.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -95.16 96.02 8.93 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.447 -0.783 . . . . 0.0 108.993 179.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.6 p -151.12 -134.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.83 . . . . 0.0 109.256 -179.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.9 -32.78 61.4 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.659 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 46.1 p -93.67 -2.6 53.74 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.562 -0.711 . . . . 0.0 109.332 179.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.628 ' O ' ' CG ' ' A' ' 66' ' ' TYR . . . 54.53 4.27 0.36 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.628 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 91.8 m-85 -160.38 5.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.957 -1.319 . . . . 0.0 109.398 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.682 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 53.68 -91.73 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 107.824 -2.111 . . . . 0.0 107.824 -179.246 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.625 ' CE2' ' OH ' ' A' ' 85' ' ' TYR . 5.2 t80 -63.91 117.25 6.71 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.302 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.568 ' O ' ' O ' ' A' ' 70' ' ' GLU . . . 177.27 27.63 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.267 -0.896 . . . . 0.0 109.512 -178.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.568 ' O ' ' O ' ' A' ' 69' ' ' ALA . 99.5 mt-10 56.75 153.26 0.07 OUTLIER Pre-proline 0 C--N 1.304 -1.392 0 C-N-CA 119.541 -0.864 . . . . 0.0 108.813 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.38 -22.25 0.34 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.364 2.043 . . . . 0.0 111.817 179.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.488 ' O ' ' O ' ' A' ' 69' ' ' ALA . 99.8 m-85 -110.22 134.26 52.41 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.419 ' OD1' ' HA ' ' A' ' 64' ' ' THR . 11.2 m120 -82.27 107.66 15.12 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.151 -0.968 . . . . 0.0 109.237 -179.42 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 79.8 mt -111.07 4.22 19.24 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.397 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.708 ' CD2' ' CD1' ' A' ' 81' ' ' LEU . 4.7 m-30 -94.93 133.44 38.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.048 -1.033 . . . . 0.0 109.394 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.416 ' O ' ' OH ' ' A' ' 66' ' ' TYR . 86.4 p -94.6 -44.8 7.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.525 -0.734 . . . . 0.0 111.326 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.539 ' OG ' ' OE2' ' A' ' 80' ' ' GLU . 84.5 p -155.6 165.7 35.78 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.817 -1.177 . . . . 0.0 110.301 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.4 -43.77 98.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.417 -0.802 . . . . 0.0 110.879 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.435 ' O ' HG11 ' A' ' 82' ' ' VAL . 19.9 tttt -60.86 -39.75 90.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.755 -1.215 . . . . 0.0 108.707 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.614 ' N ' ' OE1' ' A' ' 80' ' ' GLU . 0.3 OUTLIER -73.43 -40.03 64.55 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.177 -0.952 . . . . 0.0 109.383 179.006 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.708 ' CD1' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -59.9 -49.51 77.4 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.839 -0.538 . . . . 0.0 110.599 -178.373 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 83' ' ' LEU . 4.3 p -59.76 -44.22 93.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.913 -1.117 . . . . 0.0 108.495 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.546 ' CD2' ' CD2' ' A' ' 5' ' ' HIS . 91.2 mt -61.69 -45.39 94.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.208 -0.932 . . . . 0.0 111.273 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -61.25 -40.39 93.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.756 -1.215 . . . . 0.0 110.001 -178.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.625 ' OH ' ' CE2' ' A' ' 68' ' ' PHE . 22.4 m-85 -71.41 -26.75 62.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.249 -0.907 . . . . 0.0 111.311 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.595 ' OE1' ' O ' ' A' ' 101' ' ' LEU . 2.2 mt-30 -65.01 -33.65 76.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.662 -1.274 . . . . 0.0 109.163 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -96.76 -19.28 19.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.013 -1.054 . . . . 0.0 110.753 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.4 m -99.53 131.18 45.7 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.804 -1.185 . . . . 0.0 109.726 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.3 p -74.97 135.65 41.34 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.514 0.673 . . . . 0.0 109.939 -179.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.743 ' O ' ' N ' ' A' ' 92' ' ' GLN . 0.6 OUTLIER -61.74 -43.7 98.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.531 -0.731 . . . . 0.0 110.627 -179.679 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.757 ' N ' ' O ' ' A' ' 97' ' ' LEU . 72.0 t 26.79 -84.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.743 ' N ' ' O ' ' A' ' 90' ' ' LEU . 18.0 tt0 77.32 -179.51 0.14 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.787 178.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.513 ' H ' ' HG2' ' A' ' 92' ' ' GLN . 81.6 t60 -56.08 -39.84 72.72 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.606 ' C ' HD21 ' A' ' 94' ' ' ASN . 0.2 OUTLIER -50.44 -28.3 8.01 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.178 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 60.1 t0 63.88 24.36 13.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.78 -0.575 . . . . 0.0 110.309 178.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 68.9 m -136.91 10.89 3.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.03 -1.044 . . . . 0.0 110.167 179.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.757 ' O ' ' N ' ' A' ' 91' ' ' VAL . 87.1 mt -99.78 50.96 0.92 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.582 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 42.1 p30 -77.43 60.09 1.99 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.501 -0.749 . . . . 0.0 110.646 -178.397 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.98 162.96 38.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.3 p -125.06 168.87 12.77 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.312 1.053 . . . . 0.0 110.611 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.595 ' O ' ' OE1' ' A' ' 86' ' ' GLN . 6.9 mp -98.17 33.41 2.18 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.41 ' HA ' ' NE2' ' A' ' 86' ' ' GLN . . . -74.39 -15.49 60.92 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.64 -0.663 . . . . 0.0 112.13 -178.093 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 32' ' ' THR . 96.8 m-85 -114.91 108.48 48.57 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.249 -1.532 . . . . 0.0 111.339 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.54 145.65 95.41 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.257 1.971 . . . . 0.0 110.845 177.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 106' ' ' TYR . 7.3 p -65.5 -33.07 61.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.896 -1.128 . . . . 0.0 109.335 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.46 ' N ' HG11 ' A' ' 105' ' ' VAL . 28.4 m-85 -122.69 50.46 1.5 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.018 -1.051 . . . . 0.0 110.067 179.061 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.5 141.09 58.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 109.592 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -57.36 134.97 56.46 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 108.832 179.327 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -80.71 146.22 31.18 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -124.06 156.52 36.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.352 -0.842 . . . . 0.0 109.411 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.671 179.948 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.418 ' H1 ' ' H ' ' A' ' 2' ' ' ASP . 71.8 tt0 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.55 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 46.4 p30 -66.71 150.94 48.35 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.13 -0.981 . . . . 0.0 109.336 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.5 mt -104.56 120.24 51.09 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.433 -0.792 . . . . 0.0 109.205 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -57.33 -9.33 4.75 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.745 1.63 . . . . 0.0 111.55 179.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.442 ' CG ' HD22 ' A' ' 83' ' ' LEU . 82.6 m-70 -60.44 -29.15 68.83 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.607 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -68.0 -23.03 64.97 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.696 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 83.7 m-20 -90.05 120.64 31.41 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.388 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 45.0 tt0 -67.63 -30.67 70.29 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.393 -0.817 . . . . 0.0 110.294 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.556 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -63.36 -31.71 72.93 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.264 -0.898 . . . . 0.0 111.573 -178.805 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.423 HG21 ' CB ' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -66.49 -29.66 69.82 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.226 -0.921 . . . . 0.0 111.641 -177.044 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.696 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -123.02 -8.44 8.3 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.652 -1.28 . . . . 0.0 110.585 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 8' ' ' GLU . 13.5 t-20 -97.92 118.3 34.19 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.1 -1.0 . . . . 0.0 110.629 -178.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 16' ' ' SER . 10.2 m -140.46 27.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.489 -0.757 . . . . 0.0 109.179 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -41.32 -30.56 0.49 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.391 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.8 t -59.84 -34.58 73.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -1.076 . . . . 0.0 108.827 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 13' ' ' VAL . 70.1 m -60.48 142.2 55.48 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.584 0.707 . . . . 0.0 110.654 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -79.9 162.44 24.99 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.624 0.726 . . . . 0.0 109.568 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.505 ' CB ' HH12 ' A' ' 36' ' ' ARG . 22.9 ttp180 -57.31 -44.9 84.55 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.89 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -39.34 91.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.149 -0.969 . . . . 0.0 108.713 179.064 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -63.78 -27.74 69.39 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.381 0.61 . . . . 0.0 109.46 179.529 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.55 96.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.905 . . . . 0.0 109.672 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 26' ' ' ARG . 96.3 mt-10 -60.57 -41.23 94.18 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -60.37 -41.61 94.11 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' CD ' ' A' ' 28' ' ' LYS . 77.0 mt -67.26 -29.36 68.96 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.433 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -89.74 -14.11 35.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.351 -0.843 . . . . 0.0 108.933 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 22' ' ' GLU . 5.1 mtp180 -88.37 129.88 35.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.502 -0.749 . . . . 0.0 110.882 -179.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.27 3.27 90.2 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.498 ' CD ' ' O ' ' A' ' 24' ' ' LEU . 12.3 mtpt -103.56 131.08 51.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.282 -1.128 . . . . 0.0 110.359 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.719 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.1 OUTLIER -60.56 147.37 41.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 110.348 -179.115 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.559 ' OD2' ' OD1' ' A' ' 51' ' ' ASP . 65.1 m-20 -50.1 151.93 1.84 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.75 -37.93 3.46 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.414 HG22 ' NZ ' ' A' ' 28' ' ' LYS . 88.4 m -68.14 128.28 35.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.43 -1.041 . . . . 0.0 109.151 179.742 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 101' ' ' LEU . 0.6 OUTLIER -139.04 161.8 36.48 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.856 179.968 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.29 162.86 32.4 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.547 0.689 . . . . 0.0 110.167 -179.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 11' ' ' TRP . 90.6 t -118.12 131.14 71.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.505 HH12 ' CB ' ' A' ' 18' ' ' ARG . 11.0 ptm180 -135.56 -176.0 4.13 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 109.584 -179.226 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.652 ' C ' ' H ' ' A' ' 39' ' ' SER . 10.4 pt-20 -100.07 166.59 10.95 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.553 ' O ' ' CB ' ' A' ' 39' ' ' SER . 24.9 m -75.84 8.53 3.01 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 177.524 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.652 ' H ' ' C ' ' A' ' 37' ' ' GLU . 11.6 m 96.9 -99.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.099 -1.409 . . . . 0.0 110.054 178.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -91.01 -5.45 55.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.826 -1.171 . . . . 0.0 110.577 -179.149 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.631 ' O ' ' N ' ' A' ' 43' ' ' CYS . 98.7 mt-30 -96.03 137.03 35.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.99 -1.068 . . . . 0.0 110.461 -179.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.87 36.61 0.06 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.631 ' N ' ' O ' ' A' ' 41' ' ' GLN . 77.8 m -112.89 159.76 18.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.304 . . . . 0.0 110.012 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.457 ' O ' ' N ' ' A' ' 59' ' ' ILE . 96.8 m-85 -120.62 149.88 41.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.359 -0.838 . . . . 0.0 109.152 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -139.39 135.06 33.28 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.563 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.5 ' SG ' HD13 ' A' ' 59' ' ' ILE . 28.9 p -107.92 124.88 50.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.235 -0.916 . . . . 0.0 108.8 179.36 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.7 p -109.63 139.67 44.37 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.531 -0.731 . . . . 0.0 110.275 -179.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -129.26 159.73 40.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.275 -0.891 . . . . 0.0 109.787 179.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.4 t -96.6 134.13 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.557 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 62.0 t -125.44 145.61 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.758 -1.214 . . . . 0.0 110.561 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.559 ' OD1' ' OD2' ' A' ' 30' ' ' ASP . 15.1 m-20 -44.15 -20.42 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.581 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -90.17 -59.87 1.44 Allowed Glycine 0 C--N 1.291 -1.948 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.581 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 70.0 mt-10 -162.18 169.64 20.45 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.952 -1.322 . . . . 0.0 110.312 -178.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.0 m -65.33 138.51 23.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HZ1' ' C ' ' A' ' 53' ' ' GLU . 16.6 mmtm -116.3 140.66 49.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.629 -1.294 . . . . 0.0 111.966 -178.053 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -115.3 96.77 5.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 46' ' ' CYS . 80.2 m -99.49 122.12 42.12 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.083 -1.011 . . . . 0.0 108.92 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.9 t -76.89 140.01 17.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.553 0.692 . . . . 0.0 110.545 -179.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.5 HD13 ' SG ' ' A' ' 46' ' ' CYS . 47.2 mm -108.96 129.96 62.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.574 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 8.4 m120 -116.66 108.16 15.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.168 -0.958 . . . . 0.0 110.084 -179.109 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -96.4 117.94 31.9 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.393 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.67 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 62.5 p -147.22 170.09 17.98 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.332 -0.855 . . . . 0.0 108.738 179.328 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.51 -39.15 70.12 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.064 -1.023 . . . . 0.0 109.669 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.0 m -115.59 -12.78 11.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.129 -0.982 . . . . 0.0 110.718 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.67 ' N ' ' OG1' ' A' ' 62' ' ' THR . . . -93.45 -170.39 39.21 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 119.906 -1.14 . . . . 0.0 110.676 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.574 ' CA ' ' O ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER 175.22 -167.18 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.595 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -50.94 -48.56 45.06 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.564 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.771 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 54.9 m-85 -111.22 -17.71 13.13 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.572 -0.957 . . . . 0.0 108.984 178.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 56.09 36.9 28.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.462 -0.774 . . . . 0.0 111.323 179.119 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.703 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 97.8 mt-10 -102.88 137.37 19.27 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.92 -1.113 . . . . 0.0 108.811 179.536 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -39.79 -17.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.747 2.298 . . . . 0.0 113.072 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 70' ' ' GLU . 94.5 m-85 -90.17 -2.69 58.1 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.899 -1.125 . . . . 0.0 110.219 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.792 ' ND2' ' N ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -106.2 -111.29 0.28 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.225 -0.922 . . . . 0.0 109.307 -179.835 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.792 ' N ' ' ND2' ' A' ' 73' ' ' ASN . 90.5 mt 60.02 29.54 19.1 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.762 -1.211 . . . . 0.0 110.025 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.736 ' CE1' ' NE2' ' A' ' 84' ' ' HIS . 80.1 m-85 -57.19 151.79 14.92 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.171 -0.956 . . . . 0.0 109.0 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 96.0 p -66.67 -30.34 70.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.433 -0.792 . . . . 0.0 111.712 -177.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 t -139.71 155.87 47.11 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.716 -1.24 . . . . 0.0 111.338 -178.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 81' ' ' LEU . 89.6 mt -62.08 -34.71 76.8 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.465 -0.772 . . . . 0.0 109.516 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 78' ' ' LEU . 87.3 mttt -47.74 -42.04 24.46 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.406 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 65.6 mt-10 -64.87 -37.31 87.19 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.454 ' C ' ' CD2' ' A' ' 81' ' ' LEU . 8.2 tt -59.63 -42.62 93.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.566 -0.709 . . . . 0.0 110.164 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.8 t -65.77 -44.97 92.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.99 -1.069 . . . . 0.0 109.467 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.442 HD22 ' CG ' ' A' ' 5' ' ' HIS . 81.2 mt -68.34 -39.02 82.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.395 -0.816 . . . . 0.0 111.274 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.736 ' NE2' ' CE1' ' A' ' 75' ' ' TYR . 52.8 m80 -64.66 -42.43 95.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.016 -1.052 . . . . 0.0 110.192 -178.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.771 ' CZ ' ' CD2' ' A' ' 68' ' ' PHE . 7.1 m-30 -73.83 -16.68 61.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.857 -1.152 . . . . 0.0 109.34 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -67.81 -35.87 79.4 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.282 -0.886 . . . . 0.0 109.234 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 84' ' ' HIS . 22.8 p-80 -92.61 -22.66 19.35 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.267 -0.896 . . . . 0.0 109.664 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.8 m -92.41 128.42 38.26 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.134 -0.979 . . . . 0.0 109.386 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.6 p -77.67 131.58 37.8 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.437 -0.79 . . . . 0.0 109.665 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.524 ' O ' ' C ' ' A' ' 91' ' ' VAL . 98.9 mt -69.74 -17.46 63.45 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.498 -0.751 . . . . 0.0 110.024 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.749 ' N ' ' O ' ' A' ' 97' ' ' LEU . 9.7 p -31.99 -46.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 121.205 -0.934 . . . . 0.0 110.382 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.565 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 18.1 tt0 -43.97 -27.68 0.39 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.227 0.537 . . . . 0.0 110.128 -179.388 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.554 ' NE2' ' CE1' ' A' ' 68' ' ' PHE . 94.5 m-70 -81.66 119.54 23.95 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.005 -1.059 . . . . 0.0 108.189 178.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 11.3 m120 61.42 2.61 0.67 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.64 -0.663 . . . . 0.0 109.507 -179.244 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.59 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 66.7 t0 57.44 23.65 9.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.551 -0.718 . . . . 0.0 110.349 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.9 m -140.68 11.35 2.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.81 -1.181 . . . . 0.0 109.688 179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.749 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.8 mm? -97.93 66.2 1.85 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.913 -1.117 . . . . 0.0 108.679 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.631 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 16.5 p30 -79.16 78.86 5.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.938 -1.101 . . . . 0.0 110.37 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.617 ' CG2' ' O ' ' A' ' 98' ' ' ASN . 40.8 t -166.38 154.26 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.522 -0.736 . . . . 0.0 109.816 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.8 p -130.53 164.29 25.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.893 . . . . 0.0 109.452 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.6 ' N ' ' CD1' ' A' ' 101' ' ' LEU . 4.2 mp -79.17 67.31 4.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -92.16 -22.76 19.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 111.519 -178.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.65 137.94 28.65 Favored Pre-proline 0 C--N 1.307 -1.277 0 O-C-N 120.713 -1.242 . . . . 0.0 111.006 -178.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.09 157.23 30.32 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.277 2.652 . . . . 0.0 111.582 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 106' ' ' TYR . 12.2 p -92.76 -27.68 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.345 -0.847 . . . . 0.0 112.089 -178.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.464 ' N ' HG11 ' A' ' 105' ' ' VAL . 73.1 t80 -132.52 64.99 1.6 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.411 -1.431 . . . . 0.0 111.87 -178.069 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.423 ' CB ' HG21 ' A' ' 10' ' ' THR . . . -89.69 140.56 29.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.058 -1.026 . . . . 0.0 109.006 178.156 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -61.71 136.78 58.13 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.954 -1.091 . . . . 0.0 109.849 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -100.51 -9.04 22.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 108.844 179.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -76.83 130.31 37.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.498 -0.751 . . . . 0.0 109.818 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 . . . . . 0 C--N 1.301 -1.521 0 CA-C-O 117.911 -1.042 . . . . 0.0 109.033 179.514 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.472 ' HB2' ' ND1' ' A' ' 6' ' ' HIS . 58.0 p30 -76.76 170.06 17.16 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.5 mt -91.5 136.26 26.97 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.864 -1.147 . . . . 0.0 109.702 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -49.06 -19.54 2.52 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.888 2.392 . . . . 0.0 111.659 178.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.48 ' CD2' HD22 ' A' ' 83' ' ' LEU . 85.1 m-70 -65.11 -17.01 64.11 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.655 0.741 . . . . 0.0 109.438 -178.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.472 ' ND1' ' HB2' ' A' ' 2' ' ' ASP . 38.2 m170 -64.98 -36.76 85.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.503 -0.748 . . . . 0.0 109.57 178.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -96.79 129.55 44.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 110.431 -179.068 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.676 ' O ' ' N ' ' A' ' 12' ' ' ASN . 96.6 mt-10 -72.32 -31.32 65.57 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.562 0.696 . . . . 0.0 109.824 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -59.83 -24.82 64.49 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.684 -179.636 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.67 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 52.2 p -67.85 -29.35 68.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.111 -0.993 . . . . 0.0 110.347 -179.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.67 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.8 -23.77 2.78 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.916 -1.115 . . . . 0.0 109.572 178.652 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.676 ' N ' ' O ' ' A' ' 8' ' ' GLU . 65.6 t30 -80.57 125.84 30.49 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.09 0.948 . . . . 0.0 111.284 -178.396 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.605 ' O ' ' O ' ' A' ' 14' ' ' GLY . 93.8 t -132.57 32.79 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 13' ' ' VAL . . . -42.64 177.19 0.01 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 14' ' ' GLY . 27.9 t 61.47 27.4 16.96 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.516 -0.991 . . . . 0.0 108.711 -179.499 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.2 m -129.08 136.81 50.74 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.459 -0.775 . . . . 0.0 109.673 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.601 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 26.7 p30 -80.19 167.81 19.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.53 -0.731 . . . . 0.0 109.782 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 36' ' ' ARG . 41.7 mtt-85 -63.65 -32.73 74.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.94 . . . . 0.0 110.039 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -64.29 -46.46 83.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.243 -0.911 . . . . 0.0 109.113 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.601 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 18.0 ttmm -62.34 -40.32 95.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -0.834 . . . . 0.0 109.218 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -59.9 -38.11 81.34 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.366 -0.834 . . . . 0.0 109.332 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.573 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 55.3 tt0 -59.98 -44.07 94.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.869 -1.144 . . . . 0.0 108.892 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -62.26 -39.14 91.92 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 77.7 mt -73.67 -31.78 63.65 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 21' ' ' ALA . 7.9 mt -89.38 -10.23 47.37 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.573 ' NH2' ' OE2' ' A' ' 22' ' ' GLU . 75.3 mtt180 -88.75 120.34 30.06 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.136 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.46 -4.99 62.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 25.7 mmtt -87.06 150.9 23.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.35 -1.088 . . . . 0.0 109.598 179.644 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.539 ' HG2' HH11 ' A' ' 29' ' ' ARG . 7.1 mmt-85 -82.67 154.96 24.61 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.316 0.579 . . . . 0.0 110.479 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -55.12 139.72 40.72 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.35 -15.46 56.16 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 35.3 m -88.55 121.79 31.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.402 -1.057 . . . . 0.0 109.197 179.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.56 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -138.44 167.46 21.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.007 -1.058 . . . . 0.0 110.742 179.888 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.53 156.23 44.55 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.485 -179.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG21 ' HG ' ' A' ' 46' ' ' CYS . 46.0 t -108.11 124.26 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.875 . . . . 0.0 108.82 179.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -138.75 178.88 6.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 108.974 -179.486 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.763 ' C ' ' H ' ' A' ' 39' ' ' SER . 10.8 tt0 -99.33 164.09 12.27 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.814 -1.179 . . . . 0.0 108.67 179.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.632 ' C ' ' H ' ' A' ' 40' ' ' LYS . 50.8 m -75.73 33.14 0.11 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.272 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.763 ' H ' ' C ' ' A' ' 37' ' ' GLU . 49.5 m 64.88 -14.6 0.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.677 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.632 ' H ' ' C ' ' A' ' 38' ' ' SER . 39.3 ttpt -98.91 125.75 44.41 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -49.85 133.88 21.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.462 -0.774 . . . . 0.0 110.92 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.14 3.07 70.33 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.242 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.415 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 80.8 m -112.84 150.51 31.59 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.907 -1.349 . . . . 0.0 109.76 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.63 ' O ' ' O ' ' A' ' 59' ' ' ILE . 96.1 m-85 -133.47 151.19 51.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.055 -1.028 . . . . 0.0 110.281 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.8 135.97 10.93 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.967 -1.083 . . . . 0.0 109.486 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.502 ' HG ' HG21 ' A' ' 35' ' ' VAL . 70.6 m -108.03 117.15 33.39 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.8 m -102.18 133.81 46.44 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.854 -1.154 . . . . 0.0 109.704 -178.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.508 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 2.4 p -129.73 160.28 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.295 -0.878 . . . . 0.0 109.642 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.508 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 55.8 t -108.47 136.76 43.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.505 ' C ' ' H ' ' A' ' 52' ' ' GLY . 74.8 t -121.59 151.45 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.093 -1.004 . . . . 0.0 109.978 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -49.71 -15.24 0.16 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.067 0.937 . . . . 0.0 108.796 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -94.21 -59.21 1.18 Allowed Glycine 0 C--N 1.285 -2.28 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -162.15 176.66 10.43 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.122 -1.222 . . . . 0.0 110.384 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.06 138.96 18.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HZ1' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -125.58 162.05 25.83 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.761 -179.919 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -128.64 80.31 1.96 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.488 -0.758 . . . . 0.0 110.336 -179.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 46' ' ' CYS . 82.1 m -59.8 145.02 46.9 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.788 -1.195 . . . . 0.0 108.402 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -115.98 130.42 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.013 -1.054 . . . . 0.0 111.272 -178.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.63 ' O ' ' O ' ' A' ' 44' ' ' TYR . 3.7 mp -123.04 128.4 75.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.641 ' O ' ' N ' ' A' ' 66' ' ' TYR . 92.4 m-20 -115.97 119.25 35.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.557 -1.34 . . . . 0.0 109.455 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -75.23 106.9 6.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.785 -1.197 . . . . 0.0 109.311 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.645 ' CG2' ' H ' ' A' ' 63' ' ' ALA . 72.0 m -160.56 -176.28 5.48 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.645 ' H ' ' CG2' ' A' ' 62' ' ' THR . . . -56.33 -47.21 79.21 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.402 ' CG2' ' O ' ' A' ' 64' ' ' THR . 91.0 m -141.95 48.77 1.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.505 -0.747 . . . . 0.0 109.461 179.223 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.69 ' O ' ' N ' ' A' ' 67' ' ' GLY . . . -118.85 -18.83 4.61 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.741 ' CD1' ' OH ' ' A' ' 75' ' ' TYR . 96.0 m-85 -36.99 -23.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.048 -1.266 . . . . 0.0 109.247 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.69 ' N ' ' O ' ' A' ' 65' ' ' GLY . . . 96.74 -102.86 2.83 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.503 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.657 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 73.1 m-85 -53.58 146.83 12.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.038 -1.272 . . . . 0.0 110.401 -179.451 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.18 133.83 15.63 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.6 ' O ' ' OD1' ' A' ' 73' ' ' ASN . 70.6 mt-10 -115.89 155.88 47.24 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.357 -0.839 . . . . 0.0 109.342 -179.141 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.649 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 84.7 Cg_exo -45.92 110.05 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.315 2.01 . . . . 0.0 112.349 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.745 ' CD2' ' O ' ' A' ' 72' ' ' TYR . 54.0 p90 44.19 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.674 -0.641 . . . . 0.0 110.06 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.656 ' OD1' ' N ' ' A' ' 74' ' ' LEU . 5.7 p30 166.99 -73.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -1.0 . . . . 0.0 109.532 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.751 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 25.3 mt 55.87 23.8 6.88 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.214 -0.929 . . . . 0.0 109.373 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.751 ' CG ' ' O ' ' A' ' 74' ' ' LEU . 52.2 p90 48.82 118.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.666 0.746 . . . . 0.0 109.61 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.5 p -61.37 -37.88 84.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.092 -1.005 . . . . 0.0 110.692 -178.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.2 m -127.12 153.67 45.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.88 -1.137 . . . . 0.0 110.104 -178.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.4 mt -60.02 -36.29 76.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.299 -0.876 . . . . 0.0 109.764 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -59.38 -41.05 88.44 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.101 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.439 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 81.9 mt-10 -61.66 -35.06 76.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 108.656 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.0 tt -58.12 -42.55 86.02 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.557 -0.714 . . . . 0.0 109.436 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.34 -39.56 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.007 -1.058 . . . . 0.0 108.582 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.48 HD22 ' CD2' ' A' ' 5' ' ' HIS . 92.6 mt -66.44 -41.8 88.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.402 -0.812 . . . . 0.0 109.718 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.439 ' CD2' ' O ' ' A' ' 80' ' ' GLU . 14.6 m170 -60.47 -42.36 96.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 110.382 -179.213 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.657 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 3.7 m-85 -69.53 -23.62 63.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.783 -1.198 . . . . 0.0 108.979 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -64.02 -38.12 89.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.491 -0.756 . . . . 0.0 109.231 179.541 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -90.26 -19.69 23.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 0.0 109.199 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 85' ' ' TYR . 42.1 m -99.01 140.99 32.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.529 -0.732 . . . . 0.0 109.256 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.3 t -89.65 128.94 36.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.868 . . . . 0.0 109.47 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.667 ' O ' ' N ' ' A' ' 92' ' ' GLN . 10.1 mp -60.56 -22.85 64.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.344 -0.847 . . . . 0.0 110.467 -179.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.719 ' N ' ' O ' ' A' ' 97' ' ' LEU . 11.6 p -26.56 -37.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.346 -0.846 . . . . 0.0 110.584 -179.184 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.667 ' N ' ' O ' ' A' ' 90' ' ' LEU . 35.0 mt-30 -40.8 179.25 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.885 0.85 . . . . 0.0 111.756 -178.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.427 ' NE2' ' CE2' ' A' ' 68' ' ' PHE . 87.2 m-70 61.25 -108.84 0.35 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.496 0.665 . . . . 0.0 109.972 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -60.72 -5.43 1.28 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.494 -0.754 . . . . 0.0 110.366 -179.358 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 65.7 t0 57.27 28.47 15.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.772 -1.205 . . . . 0.0 109.128 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -143.22 13.04 1.8 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 110.304 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.719 ' O ' ' N ' ' A' ' 91' ' ' VAL . 7.7 mp -101.23 70.14 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.875 -1.14 . . . . 0.0 107.955 178.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -78.79 87.4 4.67 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.389 -0.819 . . . . 0.0 110.114 -178.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.488 HG23 ' N ' ' A' ' 100' ' ' THR . 12.6 p -163.05 160.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 121.686 0.755 . . . . 0.0 109.158 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.488 ' N ' HG23 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -130.8 133.47 45.99 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.14 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.56 HD21 ' CG ' ' A' ' 33' ' ' PHE . 37.6 mt -69.62 74.5 0.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -116.56 -10.04 11.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.832 . . . . 0.0 110.952 -178.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 32' ' ' THR . 69.2 t80 -120.65 103.4 43.7 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.619 -1.301 . . . . 0.0 110.433 -178.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.97 146.53 86.66 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.622 2.215 . . . . 0.0 111.533 178.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' A' ' 106' ' ' TYR . 9.5 p -69.43 -35.37 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.911 -1.118 . . . . 0.0 109.57 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.456 ' CD2' HG12 ' A' ' 105' ' ' VAL . 38.8 m-85 -119.39 54.88 0.97 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.157 -0.964 . . . . 0.0 110.74 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.73 116.97 8.22 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.133 -0.979 . . . . 0.0 108.376 178.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -60.11 -37.99 81.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.12 -0.988 . . . . 0.0 110.2 -179.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -62.22 -43.55 98.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.834 -1.166 . . . . 0.0 109.23 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -66.55 -34.44 77.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 109.722 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.274 -179.416 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.472 ' HB2' ' ND1' ' A' ' 6' ' ' HIS . 58.0 p30 -76.76 170.06 17.16 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.5 mt -91.5 136.26 26.97 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.864 -1.147 . . . . 0.0 109.702 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -49.06 -19.54 2.52 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.888 2.392 . . . . 0.0 111.659 178.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.48 ' CD2' HD22 ' A' ' 83' ' ' LEU . 85.1 m-70 -65.11 -17.01 64.11 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.655 0.741 . . . . 0.0 109.438 -178.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.472 ' ND1' ' HB2' ' A' ' 2' ' ' ASP . 38.2 m170 -64.98 -36.76 85.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.503 -0.748 . . . . 0.0 109.57 178.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -96.79 129.55 44.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 110.431 -179.068 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.676 ' O ' ' N ' ' A' ' 12' ' ' ASN . 96.6 mt-10 -72.32 -31.32 65.57 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.562 0.696 . . . . 0.0 109.824 179.717 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -59.83 -24.82 64.49 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.684 -179.636 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.67 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 52.2 p -67.85 -29.35 68.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.111 -0.993 . . . . 0.0 110.347 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.67 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.8 -23.77 2.78 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.916 -1.115 . . . . 0.0 109.572 178.652 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.676 ' N ' ' O ' ' A' ' 8' ' ' GLU . 65.6 t30 -80.57 125.84 30.49 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.09 0.948 . . . . 0.0 111.284 -178.396 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.605 ' O ' ' O ' ' A' ' 14' ' ' GLY . 93.8 t -132.57 32.79 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 13' ' ' VAL . . . -42.64 177.19 0.01 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 14' ' ' GLY . 27.9 t 61.47 27.4 16.96 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.516 -0.991 . . . . 0.0 108.711 -179.499 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.2 m -129.08 136.81 50.74 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.459 -0.775 . . . . 0.0 109.673 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.601 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 26.7 p30 -80.19 167.81 19.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.53 -0.731 . . . . 0.0 109.782 -179.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 36' ' ' ARG . 41.7 mtt-85 -63.65 -32.73 74.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.94 . . . . 0.0 110.039 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -64.29 -46.46 83.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.243 -0.911 . . . . 0.0 109.113 -179.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.601 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 18.0 ttmm -62.34 -40.32 95.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -0.834 . . . . 0.0 109.218 179.566 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -59.9 -38.11 81.34 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.366 -0.834 . . . . 0.0 109.332 -179.584 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.573 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 55.3 tt0 -59.98 -44.07 94.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.869 -1.144 . . . . 0.0 108.892 179.548 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -62.26 -39.14 91.92 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 77.7 mt -73.67 -31.78 63.65 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.432 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 21' ' ' ALA . 7.9 mt -89.38 -10.23 47.37 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.573 ' NH2' ' OE2' ' A' ' 22' ' ' GLU . 75.3 mtt180 -88.75 120.34 30.06 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.136 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.46 -4.99 62.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.715 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 25.7 mmtt -87.06 150.9 23.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.35 -1.088 . . . . 0.0 109.598 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.539 ' HG2' HH11 ' A' ' 29' ' ' ARG . 7.1 mmt-85 -82.67 154.96 24.61 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.316 0.579 . . . . 0.0 110.479 -179.475 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -55.12 139.72 40.72 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.35 -15.46 56.16 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 35.3 m -88.55 121.79 31.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.402 -1.057 . . . . 0.0 109.197 179.315 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.56 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -138.44 167.46 21.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.007 -1.058 . . . . 0.0 110.742 179.888 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.53 156.23 44.55 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.485 -179.325 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG21 ' HG ' ' A' ' 46' ' ' CYS . 46.0 t -108.11 124.26 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.875 . . . . 0.0 108.82 179.521 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -138.75 178.88 6.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 108.974 -179.486 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.763 ' C ' ' H ' ' A' ' 39' ' ' SER . 10.8 tt0 -99.33 164.09 12.27 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.814 -1.179 . . . . 0.0 108.67 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.632 ' C ' ' H ' ' A' ' 40' ' ' LYS . 50.8 m -75.73 33.14 0.11 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.272 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.763 ' H ' ' C ' ' A' ' 37' ' ' GLU . 49.5 m 64.88 -14.6 0.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.677 -178.57 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.632 ' H ' ' C ' ' A' ' 38' ' ' SER . 39.3 ttpt -98.91 125.75 44.41 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.658 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -49.85 133.88 21.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.462 -0.774 . . . . 0.0 110.92 -178.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.14 3.07 70.33 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.242 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.415 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 80.8 m -112.84 150.51 31.59 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.907 -1.349 . . . . 0.0 109.76 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.63 ' O ' ' O ' ' A' ' 59' ' ' ILE . 96.1 m-85 -133.47 151.19 51.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.055 -1.028 . . . . 0.0 110.281 -179.399 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.8 135.97 10.93 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.967 -1.083 . . . . 0.0 109.486 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.502 ' HG ' HG21 ' A' ' 35' ' ' VAL . 70.6 m -108.03 117.15 33.39 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.648 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.8 m -102.18 133.81 46.44 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.854 -1.154 . . . . 0.0 109.704 -178.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.508 ' CG2' ' N ' ' A' ' 49' ' ' VAL . 2.4 p -129.73 160.28 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.295 -0.878 . . . . 0.0 109.642 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.508 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 55.8 t -108.47 136.76 43.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.505 ' C ' ' H ' ' A' ' 52' ' ' GLY . 74.8 t -121.59 151.45 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.093 -1.004 . . . . 0.0 109.978 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -49.71 -15.24 0.16 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.067 0.937 . . . . 0.0 108.796 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -94.21 -59.21 1.18 Allowed Glycine 0 C--N 1.285 -2.28 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.65 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -162.15 176.66 10.43 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.122 -1.222 . . . . 0.0 110.384 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.06 138.96 18.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HZ1' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -125.58 162.05 25.83 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.761 -179.919 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -128.64 80.31 1.96 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.488 -0.758 . . . . 0.0 110.336 -179.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 46' ' ' CYS . 82.1 m -59.8 145.02 46.9 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.788 -1.195 . . . . 0.0 108.402 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -115.98 130.42 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.013 -1.054 . . . . 0.0 111.272 -178.331 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.63 ' O ' ' O ' ' A' ' 44' ' ' TYR . 3.7 mp -123.04 128.4 75.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.361 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.641 ' O ' ' N ' ' A' ' 66' ' ' TYR . 92.4 m-20 -115.97 119.25 35.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.557 -1.34 . . . . 0.0 109.455 179.512 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -75.23 106.9 6.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.785 -1.197 . . . . 0.0 109.311 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.645 ' CG2' ' H ' ' A' ' 63' ' ' ALA . 72.0 m -160.56 -176.28 5.48 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.645 ' H ' ' CG2' ' A' ' 62' ' ' THR . . . -56.33 -47.21 79.21 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.691 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.402 ' CG2' ' O ' ' A' ' 64' ' ' THR . 91.0 m -141.95 48.77 1.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.505 -0.747 . . . . 0.0 109.461 179.223 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.69 ' O ' ' N ' ' A' ' 67' ' ' GLY . . . -118.85 -18.83 4.61 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.837 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.741 ' CD1' ' OH ' ' A' ' 75' ' ' TYR . 96.0 m-85 -36.99 -23.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.048 -1.266 . . . . 0.0 109.247 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.69 ' N ' ' O ' ' A' ' 65' ' ' GLY . . . 96.74 -102.86 2.83 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.657 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 73.1 m-85 -53.58 146.83 12.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.038 -1.272 . . . . 0.0 110.401 -179.451 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.18 133.83 15.63 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.365 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.6 ' O ' ' OD1' ' A' ' 73' ' ' ASN . 70.6 mt-10 -115.89 155.88 47.24 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.357 -0.839 . . . . 0.0 109.342 -179.141 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.649 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 84.7 Cg_exo -45.92 110.05 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.315 2.01 . . . . 0.0 112.349 -179.754 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.745 ' CD2' ' O ' ' A' ' 72' ' ' TYR . 54.0 p90 44.19 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.674 -0.641 . . . . 0.0 110.06 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.656 ' OD1' ' N ' ' A' ' 74' ' ' LEU . 5.7 p30 166.99 -73.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -1.0 . . . . 0.0 109.532 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.751 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 25.3 mt 55.87 23.8 6.88 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.214 -0.929 . . . . 0.0 109.373 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.751 ' CG ' ' O ' ' A' ' 74' ' ' LEU . 52.2 p90 48.82 118.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.666 0.746 . . . . 0.0 109.61 -179.588 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.5 p -61.37 -37.88 84.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.092 -1.005 . . . . 0.0 110.692 -178.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.2 m -127.12 153.67 45.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.88 -1.137 . . . . 0.0 110.104 -178.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.4 mt -60.02 -36.29 76.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.299 -0.876 . . . . 0.0 109.764 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -59.38 -41.05 88.44 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.101 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.439 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 81.9 mt-10 -61.66 -35.06 76.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 108.656 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.0 tt -58.12 -42.55 86.02 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.557 -0.714 . . . . 0.0 109.436 179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.34 -39.56 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.007 -1.058 . . . . 0.0 108.582 179.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.48 HD22 ' CD2' ' A' ' 5' ' ' HIS . 92.6 mt -66.44 -41.8 88.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.402 -0.812 . . . . 0.0 109.718 179.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.439 ' CD2' ' O ' ' A' ' 80' ' ' GLU . 14.6 m170 -60.47 -42.36 96.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 110.382 -179.213 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.657 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 3.7 m-85 -69.53 -23.62 63.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.783 -1.198 . . . . 0.0 108.979 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -64.02 -38.12 89.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.491 -0.756 . . . . 0.0 109.231 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -90.26 -19.69 23.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 0.0 109.199 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 85' ' ' TYR . 42.1 m -99.01 140.99 32.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.529 -0.732 . . . . 0.0 109.256 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.3 t -89.65 128.94 36.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.868 . . . . 0.0 109.47 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.667 ' O ' ' N ' ' A' ' 92' ' ' GLN . 10.1 mp -60.56 -22.85 64.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.344 -0.847 . . . . 0.0 110.467 -179.558 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.719 ' N ' ' O ' ' A' ' 97' ' ' LEU . 11.6 p -26.56 -37.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.346 -0.846 . . . . 0.0 110.584 -179.184 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.667 ' N ' ' O ' ' A' ' 90' ' ' LEU . 35.0 mt-30 -40.8 179.25 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.885 0.85 . . . . 0.0 111.756 -178.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.427 ' NE2' ' CE2' ' A' ' 68' ' ' PHE . 87.2 m-70 61.25 -108.84 0.35 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.496 0.665 . . . . 0.0 109.972 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -60.72 -5.43 1.28 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.494 -0.754 . . . . 0.0 110.366 -179.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 65.7 t0 57.27 28.47 15.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.772 -1.205 . . . . 0.0 109.128 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -143.22 13.04 1.8 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 110.304 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.719 ' O ' ' N ' ' A' ' 91' ' ' VAL . 7.7 mp -101.23 70.14 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.875 -1.14 . . . . 0.0 107.955 178.773 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -78.79 87.4 4.67 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.389 -0.819 . . . . 0.0 110.114 -178.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.488 HG23 ' N ' ' A' ' 100' ' ' THR . 12.6 p -163.05 160.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 121.686 0.755 . . . . 0.0 109.158 179.306 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.488 ' N ' HG23 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -130.8 133.47 45.99 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.14 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.56 HD21 ' CG ' ' A' ' 33' ' ' PHE . 37.6 mt -69.62 74.5 0.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -116.56 -10.04 11.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.832 . . . . 0.0 110.952 -178.719 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 32' ' ' THR . 69.2 t80 -120.65 103.4 43.7 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.619 -1.301 . . . . 0.0 110.433 -178.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.97 146.53 86.66 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.622 2.215 . . . . 0.0 111.533 178.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' A' ' 106' ' ' TYR . 9.5 p -69.43 -35.37 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.911 -1.118 . . . . 0.0 109.57 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.456 ' CD2' HG12 ' A' ' 105' ' ' VAL . 38.8 m-85 -119.39 54.88 0.97 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.157 -0.964 . . . . 0.0 110.74 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.73 116.97 8.22 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.133 -0.979 . . . . 0.0 108.376 178.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -60.11 -37.99 81.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.12 -0.988 . . . . 0.0 110.2 -179.582 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -62.22 -43.55 98.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.834 -1.166 . . . . 0.0 109.23 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -66.55 -34.44 77.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 109.722 -179.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.274 -179.416 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.379 0.609 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -82.02 122.63 28.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.115 -0.991 . . . . 0.0 109.18 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.3 mt -94.53 127.76 42.71 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 -179.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -51.27 -17.86 4.49 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.013 1.809 . . . . 0.0 111.563 178.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -63.24 -23.26 67.34 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.523 -0.735 . . . . 0.0 110.4 -179.074 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -66.1 -37.95 87.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.815 -1.178 . . . . 0.0 109.599 -179.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.572 ' O ' ' OG1' ' A' ' 10' ' ' THR . 84.9 m-20 -96.44 127.2 42.21 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.156 -0.965 . . . . 0.0 109.535 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.502 ' HG3' ' CH2' ' A' ' 11' ' ' TRP . 38.1 mp0 -71.08 -28.45 64.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 109.21 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HG3' ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -58.67 -22.54 57.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.657 -179.422 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.741 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 17.2 p -66.03 -31.62 72.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 179.584 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.741 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.6 -31.77 1.98 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.83 -1.169 . . . . 0.0 110.64 -179.387 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.637 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 6.6 p-10 -80.26 146.48 31.64 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 110.422 -178.496 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.54 -3.95 5.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.9 -130.44 33.32 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.6 m -67.75 137.62 55.58 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.229 -1.16 . . . . 0.0 108.641 179.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -163.67 165.01 23.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.478 -0.764 . . . . 0.0 108.954 -179.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.524 ' C ' HH12 ' A' ' 36' ' ' ARG . 68.3 m-80 -106.36 141.03 38.35 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 179.156 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.528 ' HG3' HH11 ' A' ' 18' ' ' ARG . 14.8 mtm-85 -61.24 -36.91 81.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.761 -1.212 . . . . 0.0 109.649 -179.565 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -60.1 -49.32 78.11 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.069 -1.02 . . . . 0.0 110.165 -179.37 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.6 pttt -68.03 -27.27 66.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.722 -1.236 . . . . 0.0 108.579 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.41 -33.44 73.71 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.816 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 26' ' ' ARG . 97.9 mt-10 -60.9 -47.45 86.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.52 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -60.01 -44.3 94.66 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.694 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 59.3 mt -69.11 -25.24 64.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.968 -1.082 . . . . 0.0 108.196 178.343 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 21' ' ' ALA . 44.1 mt -96.3 -10.07 28.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.837 . . . . 0.0 109.318 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.666 ' N ' ' O ' ' A' ' 22' ' ' GLU . 61.7 mtm180 -107.48 131.25 54.51 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.431 -0.793 . . . . 0.0 110.582 -179.19 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.42 -4.28 43.78 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.694 ' NZ ' ' O ' ' A' ' 24' ' ' LEU . 14.6 ptpt -122.98 154.85 37.87 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.003 -1.293 . . . . 0.0 110.929 -179.384 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.478 ' HG2' ' N ' ' A' ' 30' ' ' ASP . 26.9 ttm180 -73.95 160.01 31.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.529 0.681 . . . . 0.0 110.871 -179.004 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.478 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 8.9 p-10 -59.19 167.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.7 0.762 . . . . 0.0 110.128 179.598 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.13 -33.94 5.6 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.4 m -82.06 119.9 24.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -1.114 . . . . 0.0 108.891 179.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' A' ' 101' ' ' LEU . 1.0 OUTLIER -136.23 164.65 27.59 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.598 -1.241 . . . . 0.0 110.964 -179.521 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.443 HD21 ' CG1' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -131.89 165.75 23.17 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.509 0.671 . . . . 0.0 110.152 -179.567 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.503 HG21 ' HG ' ' A' ' 46' ' ' CYS . 55.1 t -116.67 121.95 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.078 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.524 HH12 ' C ' ' A' ' 17' ' ' ASN . 14.7 ptm180 -142.4 -176.21 4.75 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.756 ' C ' ' H ' ' A' ' 39' ' ' SER . 36.7 tt0 -100.74 163.66 12.22 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.592 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.433 ' N ' ' HG2' ' A' ' 37' ' ' GLU . 29.2 t -75.88 16.9 0.36 Allowed 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 178.092 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.756 ' H ' ' C ' ' A' ' 37' ' ' GLU . 10.4 t 71.78 -65.7 0.33 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.012 -1.449 . . . . 0.0 108.143 -178.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 86.9 mttt -100.28 166.8 10.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.748 -0.595 . . . . 0.0 109.548 179.361 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 43' ' ' CYS . 1.8 mm-40 68.83 13.14 8.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.74 . . . . 0.0 109.694 179.636 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . 40.05 28.01 0.15 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.586 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' GLN . 31.4 t -86.41 135.13 33.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.267 . . . . 0.0 109.771 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.602 ' O ' ' O ' ' A' ' 59' ' ' ILE . 93.8 m-85 -79.97 152.04 29.71 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.448 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.409 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -154.98 140.63 17.99 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.659 -1.276 . . . . 0.0 110.245 -179.147 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.54 ' SG ' ' CD1' ' A' ' 59' ' ' ILE . 84.1 m -106.29 118.34 36.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 74.0 m -91.93 127.46 37.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.504 -0.748 . . . . 0.0 109.259 -179.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.81 145.96 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.856 -1.153 . . . . 0.0 110.423 -179.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.0 t -92.29 144.03 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.349 -0.844 . . . . 0.0 108.743 178.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.64 HG11 ' H ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -123.23 158.95 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.035 -1.04 . . . . 0.0 109.624 179.833 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -65.8 57.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.535 -0.728 . . . . 0.0 110.492 -178.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.493 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . 169.46 -33.54 0.18 Allowed Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.307 -1.425 . . . . 0.0 111.295 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.64 ' H ' HG11 ' A' ' 50' ' ' VAL . 88.8 mt-10 -159.74 165.61 32.14 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.9 -1.353 . . . . 0.0 110.486 -179.544 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 t -97.32 125.78 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.801 . . . . 0.0 109.19 178.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.552 ' HZ3' ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -120.38 146.01 46.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.927 -1.108 . . . . 0.0 110.745 -179.273 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -111.75 87.76 2.64 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.446 -0.784 . . . . 0.0 108.918 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 63.2 m -66.9 139.42 57.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.908 . . . . 0.0 109.186 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -106.57 134.36 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.277 -179.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.602 ' O ' ' O ' ' A' ' 44' ' ' TYR . 31.4 mt -121.85 144.87 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.4 -0.813 . . . . 0.0 108.822 179.233 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.464 ' N ' HG21 ' A' ' 59' ' ' ILE . 14.4 t-20 -114.13 119.24 36.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.019 -1.05 . . . . 0.0 109.032 -179.703 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -84.49 114.76 22.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.853 -1.154 . . . . 0.0 109.719 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.7 m -148.5 164.05 35.36 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.535 -0.728 . . . . 0.0 109.214 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.1 -50.93 71.24 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 108.929 179.368 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.4 p -116.99 18.91 14.54 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.117 -0.989 . . . . 0.0 111.433 -179.329 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 69' ' ' ALA . . . -107.52 -78.92 1.15 Allowed Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.133 -1.508 . . . . 0.0 111.582 -178.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.498 ' O ' ' O ' ' A' ' 67' ' ' GLY . 93.8 m-85 68.28 -162.9 0.2 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.235 -1.156 . . . . 0.0 109.437 -178.458 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 66' ' ' TYR . . . -54.29 -114.63 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -59.98 -45.91 91.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -1.121 . . . . 0.0 109.706 -179.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 65' ' ' GLY . . . 68.79 7.51 6.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.367 -0.833 . . . . 0.0 109.997 179.816 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.671 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 98.0 mt-10 -109.23 -33.28 0.16 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.877 -1.139 . . . . 0.0 110.748 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.671 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 97.0 Cg_endo -92.27 44.25 0.38 Allowed 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.961 2.44 . . . . 0.0 112.449 -179.79 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 59.27 49.77 8.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.46 -0.775 . . . . 0.0 109.615 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 75' ' ' TYR . 3.8 m120 -99.64 12.22 37.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.363 -179.714 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.14 65.18 0.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.938 -1.101 . . . . 0.0 108.936 179.811 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.709 ' OH ' ' CG ' ' A' ' 84' ' ' HIS . 58.8 m-85 -75.48 146.6 40.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.457 -0.777 . . . . 0.0 110.206 -179.898 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.5 t -60.53 -38.49 84.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.525 -0.734 . . . . 0.0 110.19 -179.485 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.7 p -134.38 157.12 47.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.03 -1.044 . . . . 0.0 110.118 -178.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.65 -27.1 68.7 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.612 -0.68 . . . . 0.0 109.715 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 83' ' ' LEU . 64.0 mttp -59.55 -44.78 93.15 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.826 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.38 -37.96 87.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.336 -0.853 . . . . 0.0 109.328 179.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.442 ' C ' ' CD2' ' A' ' 81' ' ' LEU . 7.5 tt -57.6 -41.95 82.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 108.914 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.47 -45.23 98.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.048 -1.033 . . . . 0.0 109.298 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.481 ' CD1' ' O ' ' A' ' 79' ' ' LYS . 6.4 mp -62.53 -37.74 87.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.871 -1.143 . . . . 0.0 109.58 179.417 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.709 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 11.6 t-160 -59.53 -46.69 88.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.524 -0.735 . . . . 0.0 110.966 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.544 ' O ' ' O ' ' A' ' 88' ' ' THR . 4.4 m-85 -67.59 -28.4 67.73 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.498 -1.376 . . . . 0.0 109.585 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -58.91 -38.06 78.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 109.164 -179.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -86.14 -36.16 19.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.134 -0.979 . . . . 0.0 109.276 179.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.544 ' O ' ' O ' ' A' ' 85' ' ' TYR . 1.8 p -90.05 139.38 30.67 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.373 -0.83 . . . . 0.0 109.675 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 m -93.1 140.57 29.35 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.601 0.715 . . . . 0.0 109.835 -179.769 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.655 ' O ' ' C ' ' A' ' 91' ' ' VAL . 5.8 mt -61.09 -41.14 96.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 111.238 -178.905 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.783 ' N ' ' O ' ' A' ' 97' ' ' LEU . 87.2 t 16.29 -83.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 121.41 -0.806 . . . . 0.0 109.834 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 90' ' ' LEU . 1.3 tp60 75.77 -176.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 110.222 179.282 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -60.09 -38.74 83.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.642 -0.661 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -52.52 -24.95 9.04 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.013 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 61.53 20.31 11.12 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 178.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.0 m -130.51 7.26 4.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.693 -1.254 . . . . 0.0 111.172 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.783 ' O ' ' N ' ' A' ' 91' ' ' VAL . 83.2 mt -98.5 53.67 1.04 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.09 78.47 3.63 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.548 -178.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.2 t -154.31 147.92 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.809 0.814 . . . . 0.0 109.533 179.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.465 ' HG1' ' HB1' ' A' ' 102' ' ' ALA . 48.2 p -121.24 153.67 37.34 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.316 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.514 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 79.0 mt -82.25 71.05 9.31 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.465 ' HB1' ' HG1' ' A' ' 100' ' ' THR . . . -107.38 -17.87 14.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.62 -0.675 . . . . 0.0 112.074 -178.09 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -110.91 123.77 34.59 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.573 -1.329 . . . . 0.0 110.083 -178.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -77.45 145.06 23.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.488 2.125 . . . . 0.0 110.636 178.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.517 HG12 ' CD2' ' A' ' 106' ' ' TYR . 12.0 p -72.21 -22.01 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.535 -1.353 . . . . 0.0 109.38 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.517 ' CD2' HG12 ' A' ' 105' ' ' VAL . 72.3 m-85 -129.19 64.35 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.768 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.88 77.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 108.819 179.451 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -156.34 57.02 0.57 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 59.03 31.87 21.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.842 . . . . 0.0 110.174 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.603 ' HG2' HH11 ' A' ' 110' ' ' ARG . 24.1 ttt-85 -68.75 144.04 54.48 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.011 -1.055 . . . . 0.0 109.207 -179.87 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.735 ' CG ' HH11 ' A' ' 111' ' ' ARG . 1.9 mtt-85 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.087 -1.008 . . . . 0.0 109.324 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.379 0.609 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -82.02 122.63 28.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.115 -0.991 . . . . 0.0 109.18 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.3 mt -94.53 127.76 42.71 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 -179.47 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -51.27 -17.86 4.49 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.013 1.809 . . . . 0.0 111.563 178.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -63.24 -23.26 67.34 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.523 -0.735 . . . . 0.0 110.4 -179.074 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -66.1 -37.95 87.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.815 -1.178 . . . . 0.0 109.599 -179.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.572 ' O ' ' OG1' ' A' ' 10' ' ' THR . 84.9 m-20 -96.44 127.2 42.21 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.156 -0.965 . . . . 0.0 109.535 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.502 ' HG3' ' CH2' ' A' ' 11' ' ' TRP . 38.1 mp0 -71.08 -28.45 64.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 109.21 179.56 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HG3' ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -58.67 -22.54 57.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.657 -179.422 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.741 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 17.2 p -66.03 -31.62 72.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.741 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.6 -31.77 1.98 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.83 -1.169 . . . . 0.0 110.64 -179.387 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.637 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 6.6 p-10 -80.26 146.48 31.64 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 110.422 -178.496 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.54 -3.95 5.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.9 -130.44 33.32 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.6 m -67.75 137.62 55.58 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.229 -1.16 . . . . 0.0 108.641 179.369 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -163.67 165.01 23.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.478 -0.764 . . . . 0.0 108.954 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.524 ' C ' HH12 ' A' ' 36' ' ' ARG . 68.3 m-80 -106.36 141.03 38.35 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 179.156 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.528 ' HG3' HH11 ' A' ' 18' ' ' ARG . 14.8 mtm-85 -61.24 -36.91 81.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.761 -1.212 . . . . 0.0 109.649 -179.565 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -60.1 -49.32 78.11 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.069 -1.02 . . . . 0.0 110.165 -179.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.6 pttt -68.03 -27.27 66.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.722 -1.236 . . . . 0.0 108.579 179.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.41 -33.44 73.71 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.816 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 26' ' ' ARG . 97.9 mt-10 -60.9 -47.45 86.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.52 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -60.01 -44.3 94.66 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.694 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 59.3 mt -69.11 -25.24 64.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.968 -1.082 . . . . 0.0 108.196 178.343 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 21' ' ' ALA . 44.1 mt -96.3 -10.07 28.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.837 . . . . 0.0 109.318 179.683 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.666 ' N ' ' O ' ' A' ' 22' ' ' GLU . 61.7 mtm180 -107.48 131.25 54.51 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.431 -0.793 . . . . 0.0 110.582 -179.19 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.42 -4.28 43.78 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.208 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.694 ' NZ ' ' O ' ' A' ' 24' ' ' LEU . 14.6 ptpt -122.98 154.85 37.87 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.003 -1.293 . . . . 0.0 110.929 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.478 ' HG2' ' N ' ' A' ' 30' ' ' ASP . 26.9 ttm180 -73.95 160.01 31.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.529 0.681 . . . . 0.0 110.871 -179.004 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.478 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 8.9 p-10 -59.19 167.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.7 0.762 . . . . 0.0 110.128 179.598 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.13 -33.94 5.6 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.561 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.4 m -82.06 119.9 24.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -1.114 . . . . 0.0 108.891 179.559 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' A' ' 101' ' ' LEU . 1.0 OUTLIER -136.23 164.65 27.59 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.598 -1.241 . . . . 0.0 110.964 -179.521 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.443 HD21 ' CG1' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -131.89 165.75 23.17 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.509 0.671 . . . . 0.0 110.152 -179.567 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.503 HG21 ' HG ' ' A' ' 46' ' ' CYS . 55.1 t -116.67 121.95 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.078 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.524 HH12 ' C ' ' A' ' 17' ' ' ASN . 14.7 ptm180 -142.4 -176.21 4.75 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.41 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.756 ' C ' ' H ' ' A' ' 39' ' ' SER . 36.7 tt0 -100.74 163.66 12.22 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.592 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.433 ' N ' ' HG2' ' A' ' 37' ' ' GLU . 29.2 t -75.88 16.9 0.36 Allowed 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 178.092 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.756 ' H ' ' C ' ' A' ' 37' ' ' GLU . 10.4 t 71.78 -65.7 0.33 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.012 -1.449 . . . . 0.0 108.143 -178.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 86.9 mttt -100.28 166.8 10.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.748 -0.595 . . . . 0.0 109.548 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 43' ' ' CYS . 1.8 mm-40 68.83 13.14 8.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.74 . . . . 0.0 109.694 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . 40.05 28.01 0.15 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.586 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' GLN . 31.4 t -86.41 135.13 33.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.267 . . . . 0.0 109.771 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.602 ' O ' ' O ' ' A' ' 59' ' ' ILE . 93.8 m-85 -79.97 152.04 29.71 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.448 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.409 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -154.98 140.63 17.99 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.659 -1.276 . . . . 0.0 110.245 -179.147 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.54 ' SG ' ' CD1' ' A' ' 59' ' ' ILE . 84.1 m -106.29 118.34 36.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 74.0 m -91.93 127.46 37.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.504 -0.748 . . . . 0.0 109.259 -179.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.81 145.96 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.856 -1.153 . . . . 0.0 110.423 -179.559 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.0 t -92.29 144.03 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.349 -0.844 . . . . 0.0 108.743 178.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.64 HG11 ' H ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -123.23 158.95 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.035 -1.04 . . . . 0.0 109.624 179.833 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -65.8 57.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.535 -0.728 . . . . 0.0 110.492 -178.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.493 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . 169.46 -33.54 0.18 Allowed Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.307 -1.425 . . . . 0.0 111.295 179.089 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.64 ' H ' HG11 ' A' ' 50' ' ' VAL . 88.8 mt-10 -159.74 165.61 32.14 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.9 -1.353 . . . . 0.0 110.486 -179.544 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 t -97.32 125.78 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.801 . . . . 0.0 109.19 178.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.552 ' HZ3' ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -120.38 146.01 46.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.927 -1.108 . . . . 0.0 110.745 -179.273 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -111.75 87.76 2.64 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.446 -0.784 . . . . 0.0 108.918 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 63.2 m -66.9 139.42 57.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.908 . . . . 0.0 109.186 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -106.57 134.36 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.277 -179.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.602 ' O ' ' O ' ' A' ' 44' ' ' TYR . 31.4 mt -121.85 144.87 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.4 -0.813 . . . . 0.0 108.822 179.233 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.464 ' N ' HG21 ' A' ' 59' ' ' ILE . 14.4 t-20 -114.13 119.24 36.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.019 -1.05 . . . . 0.0 109.032 -179.703 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -84.49 114.76 22.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.853 -1.154 . . . . 0.0 109.719 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.7 m -148.5 164.05 35.36 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.535 -0.728 . . . . 0.0 109.214 179.782 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.1 -50.93 71.24 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 108.929 179.368 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.4 p -116.99 18.91 14.54 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.117 -0.989 . . . . 0.0 111.433 -179.329 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 69' ' ' ALA . . . -107.52 -78.92 1.15 Allowed Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.133 -1.508 . . . . 0.0 111.582 -178.894 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.498 ' O ' ' O ' ' A' ' 67' ' ' GLY . 93.8 m-85 68.28 -162.9 0.2 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.235 -1.156 . . . . 0.0 109.437 -178.458 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 66' ' ' TYR . . . -54.29 -114.63 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.671 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -59.98 -45.91 91.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -1.121 . . . . 0.0 109.706 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 65' ' ' GLY . . . 68.79 7.51 6.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.367 -0.833 . . . . 0.0 109.997 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.671 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 98.0 mt-10 -109.23 -33.28 0.16 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.877 -1.139 . . . . 0.0 110.748 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.671 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 97.0 Cg_endo -92.27 44.25 0.38 Allowed 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.961 2.44 . . . . 0.0 112.449 -179.79 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 59.27 49.77 8.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.46 -0.775 . . . . 0.0 109.615 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 75' ' ' TYR . 3.8 m120 -99.64 12.22 37.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.363 -179.714 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.14 65.18 0.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.938 -1.101 . . . . 0.0 108.936 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.709 ' OH ' ' CG ' ' A' ' 84' ' ' HIS . 58.8 m-85 -75.48 146.6 40.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.457 -0.777 . . . . 0.0 110.206 -179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.5 t -60.53 -38.49 84.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.525 -0.734 . . . . 0.0 110.19 -179.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.7 p -134.38 157.12 47.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.03 -1.044 . . . . 0.0 110.118 -178.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.65 -27.1 68.7 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.612 -0.68 . . . . 0.0 109.715 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 83' ' ' LEU . 64.0 mttp -59.55 -44.78 93.15 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.826 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.38 -37.96 87.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.336 -0.853 . . . . 0.0 109.328 179.103 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.442 ' C ' ' CD2' ' A' ' 81' ' ' LEU . 7.5 tt -57.6 -41.95 82.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 108.914 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.47 -45.23 98.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.048 -1.033 . . . . 0.0 109.298 179.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.481 ' CD1' ' O ' ' A' ' 79' ' ' LYS . 6.4 mp -62.53 -37.74 87.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.871 -1.143 . . . . 0.0 109.58 179.417 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.709 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 11.6 t-160 -59.53 -46.69 88.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.524 -0.735 . . . . 0.0 110.966 -179.217 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.544 ' O ' ' O ' ' A' ' 88' ' ' THR . 4.4 m-85 -67.59 -28.4 67.73 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.498 -1.376 . . . . 0.0 109.585 -179.624 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -58.91 -38.06 78.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 109.164 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -86.14 -36.16 19.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.134 -0.979 . . . . 0.0 109.276 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.544 ' O ' ' O ' ' A' ' 85' ' ' TYR . 1.8 p -90.05 139.38 30.67 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.373 -0.83 . . . . 0.0 109.675 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 m -93.1 140.57 29.35 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.601 0.715 . . . . 0.0 109.835 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.655 ' O ' ' C ' ' A' ' 91' ' ' VAL . 5.8 mt -61.09 -41.14 96.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 111.238 -178.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.783 ' N ' ' O ' ' A' ' 97' ' ' LEU . 87.2 t 16.29 -83.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 121.41 -0.806 . . . . 0.0 109.834 -179.44 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 90' ' ' LEU . 1.3 tp60 75.77 -176.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 110.222 179.282 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -60.09 -38.74 83.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.642 -0.661 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -52.52 -24.95 9.04 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.013 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 61.53 20.31 11.12 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 178.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.0 m -130.51 7.26 4.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.693 -1.254 . . . . 0.0 111.172 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.783 ' O ' ' N ' ' A' ' 91' ' ' VAL . 83.2 mt -98.5 53.67 1.04 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.09 78.47 3.63 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.548 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.2 t -154.31 147.92 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.809 0.814 . . . . 0.0 109.533 179.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.465 ' HG1' ' HB1' ' A' ' 102' ' ' ALA . 48.2 p -121.24 153.67 37.34 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.316 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.514 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 79.0 mt -82.25 71.05 9.31 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.244 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.465 ' HB1' ' HG1' ' A' ' 100' ' ' THR . . . -107.38 -17.87 14.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.62 -0.675 . . . . 0.0 112.074 -178.09 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -110.91 123.77 34.59 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.573 -1.329 . . . . 0.0 110.083 -178.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -77.45 145.06 23.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.488 2.125 . . . . 0.0 110.636 178.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.517 HG12 ' CD2' ' A' ' 106' ' ' TYR . 12.0 p -72.21 -22.01 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.535 -1.353 . . . . 0.0 109.38 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.517 ' CD2' HG12 ' A' ' 105' ' ' VAL . 72.3 m-85 -129.19 64.35 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.768 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.88 77.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 108.819 179.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -156.34 57.02 0.57 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 59.03 31.87 21.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.842 . . . . 0.0 110.174 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.603 ' HG2' HH11 ' A' ' 110' ' ' ARG . 24.1 ttt-85 -68.75 144.04 54.48 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.011 -1.055 . . . . 0.0 109.207 -179.87 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.735 ' CG ' HH11 ' A' ' 111' ' ' ARG . 1.9 mtt-85 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.087 -1.008 . . . . 0.0 109.324 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -67.44 146.64 53.81 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.989 -1.069 . . . . 0.0 109.034 179.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.8 mt -82.11 141.49 46.78 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.13 -0.981 . . . . 0.0 108.76 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.416 ' O ' ' OG1' ' A' ' 10' ' ' THR . 24.2 Cg_endo -65.11 -8.44 18.42 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.175 1.917 . . . . 0.0 111.778 -179.216 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.633 ' NE2' ' OE1' ' A' ' 86' ' ' GLN . 89.9 m-70 -65.94 -26.5 67.61 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.538 -0.726 . . . . 0.0 109.809 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -64.23 -29.82 70.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.982 -1.074 . . . . 0.0 110.036 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.488 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 95.6 m-20 -105.06 131.52 52.46 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.085 -1.01 . . . . 0.0 110.332 -179.545 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 12' ' ' ASN . 91.5 mt-10 -69.69 -23.3 63.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.536 -0.727 . . . . 0.0 109.504 179.325 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.43 ' CG ' ' N ' ' A' ' 10' ' ' THR . 34.5 pttt -61.36 -31.57 71.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.409 -0.807 . . . . 0.0 111.367 -178.823 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.559 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 53.6 p -70.61 -24.9 62.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.769 -1.207 . . . . 0.0 110.914 -178.452 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.605 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -124.51 -29.6 3.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.643 -1.285 . . . . 0.0 110.419 179.057 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 8' ' ' GLU . 49.0 t-20 -86.3 123.38 31.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 110.651 -178.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.62 0.59 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.43 -0.794 . . . . 0.0 109.19 179.278 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.49 -153.69 52.22 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 88.2 p -68.9 148.32 50.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.378 -1.072 . . . . 0.0 108.429 179.201 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.56 ' O ' ' CZ ' ' A' ' 36' ' ' ARG . 47.3 t -175.16 156.34 2.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 108.826 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.641 ' ND2' ' CG ' ' A' ' 19' ' ' ASN . 49.9 t30 -78.19 140.8 38.94 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.543 179.832 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.919 ' N ' HH22 ' A' ' 36' ' ' ARG . 42.3 mtt-85 -60.18 -34.42 73.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.253 -0.904 . . . . 0.0 110.701 -179.181 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.645 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 42.3 p-10 -60.02 -40.33 88.94 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.804 -1.185 . . . . 0.0 108.702 179.773 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.645 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 62.1 tttp -64.24 -40.92 97.03 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.322 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.01 76.99 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.31 -0.869 . . . . 0.0 108.91 179.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 26' ' ' ARG . 98.1 mt-10 -59.57 -48.94 79.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.175 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.687 ' OD1' ' N ' ' A' ' 24' ' ' LEU . 8.6 p30 -60.02 -40.06 87.98 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.687 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 85.1 mt -66.99 -29.96 69.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.245 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.7 mt -93.7 -7.7 42.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.628 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 22' ' ' GLU . 2.0 ttm180 -97.23 128.77 44.4 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.277 -0.89 . . . . 0.0 109.789 -179.526 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.69 16.99 78.31 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.16 133.37 53.29 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.537 -0.978 . . . . 0.0 109.642 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -60.65 156.73 16.03 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.901 0.858 . . . . 0.0 111.106 -179.488 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 50' ' ' VAL . 87.7 m-20 -63.85 151.85 41.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.586 -0.696 . . . . 0.0 109.383 179.012 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.03 -22.04 42.9 Favored Glycine 0 N--CA 1.499 2.888 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.165 179.473 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.2 m -83.57 121.41 27.2 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.085 -1.244 . . . . 0.0 108.604 179.427 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.499 ' CG ' HD21 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -137.74 162.95 32.54 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.902 -1.124 . . . . 0.0 110.066 179.941 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.11 147.37 40.14 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.067 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 11' ' ' TRP . 54.9 t -92.58 132.03 38.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.04 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.919 HH22 ' N ' ' A' ' 18' ' ' ARG . 7.6 ttt180 -142.41 -172.65 3.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.267 -0.896 . . . . 0.0 108.86 -178.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.755 ' H ' ' CG ' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -105.89 169.2 8.62 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.985 -1.072 . . . . 0.0 108.952 -179.948 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.644 ' O ' ' CB ' ' A' ' 39' ' ' SER . 21.7 m -77.65 17.17 0.56 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 177.378 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.723 ' H ' ' C ' ' A' ' 37' ' ' GLU . 4.7 m 101.44 -30.58 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.257 -179.416 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.427 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 71.3 mmtt -85.98 147.15 26.35 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -67.17 -29.83 69.63 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.253 -0.904 . . . . 0.0 110.352 -179.16 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.23 11.89 70.8 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.346 -179.261 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 40' ' ' LYS . 89.2 m -118.57 156.54 28.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.207 -1.172 . . . . 0.0 109.185 179.505 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.595 ' O ' ' O ' ' A' ' 59' ' ' ILE . 30.5 m-85 -130.68 153.84 48.55 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.317 -0.864 . . . . 0.0 110.023 -179.569 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.598 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -175.8 145.12 0.66 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.062 -1.024 . . . . 0.0 108.477 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 57' ' ' CYS . 31.8 p -125.24 154.85 41.03 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.561 -1.337 . . . . 0.0 109.268 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.568 ' OG ' ' O ' ' A' ' 55' ' ' LYS . 41.1 t -119.75 138.9 53.04 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.636 0.731 . . . . 0.0 110.344 -178.519 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -130.73 146.0 34.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.463 -0.773 . . . . 0.0 109.388 179.88 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.1 t -91.75 133.36 33.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.475 -0.766 . . . . 0.0 109.13 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 52' ' ' GLY . 0.7 OUTLIER -122.49 163.13 21.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.256 -0.977 . . . . 0.0 110.667 -179.77 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.528 ' C ' ' OD1' ' A' ' 51' ' ' ASP . 47.5 p30 -62.89 50.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.665 -179.06 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 178.48 -43.22 0.09 OUTLIER Glycine 0 C--N 1.295 -1.695 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.896 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 44.6 mm-40 -158.87 166.81 31.02 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.07 -1.253 . . . . 0.0 111.224 -179.324 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.401 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 5.3 m -73.11 146.92 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.525 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.568 ' O ' ' OG ' ' A' ' 47' ' ' SER . 11.2 mmtm -113.63 146.66 39.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.889 -1.132 . . . . 0.0 110.557 -179.335 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -125.54 65.79 1.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.61 -0.681 . . . . 0.0 109.687 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.459 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 74.4 m -59.47 144.91 45.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.073 -1.017 . . . . 0.0 108.891 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.4 138.49 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.932 0.872 . . . . 0.0 112.127 -178.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.595 ' O ' ' O ' ' A' ' 44' ' ' TYR . 48.4 mm -115.74 133.45 62.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.141 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 62' ' ' THR . 81.3 m-20 -116.69 102.57 9.56 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.564 -1.335 . . . . 0.0 110.917 -178.287 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 59.6 tttp -62.71 80.29 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.651 -1.28 . . . . 0.0 108.841 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 60' ' ' ASN . 69.1 p -131.8 176.45 8.34 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.361 -0.837 . . . . 0.0 109.109 -179.661 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.75 -42.93 68.73 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.545 ' O ' ' CG2' ' A' ' 64' ' ' THR . 12.6 t -147.7 66.22 1.11 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.438 -0.789 . . . . 0.0 109.711 -179.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 67' ' ' GLY . . . -157.0 -10.64 0.05 OUTLIER Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.601 -1.285 . . . . 0.0 111.107 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.626 ' OH ' ' O ' ' A' ' 75' ' ' TYR . 42.3 p90 -57.42 -6.89 0.5 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.539 -1.565 . . . . 0.0 109.944 -179.276 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 65' ' ' GLY . . . -151.03 -166.78 14.05 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.695 ' CD2' ' OH ' ' A' ' 85' ' ' TYR . 35.8 m-85 -66.84 158.11 31.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -1.173 . . . . 0.0 108.777 179.789 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.38 7.72 45.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.788 . . . . 0.0 109.503 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.699 ' O ' ' N ' ' A' ' 72' ' ' TYR . 98.3 mt-10 -51.76 154.54 3.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.452 -0.78 . . . . 0.0 109.795 -179.701 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 73' ' ' ASN . 71.3 Cg_exo -39.72 -9.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.737 2.291 . . . . 0.0 111.769 179.367 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.699 ' N ' ' O ' ' A' ' 70' ' ' GLU . 9.4 m-30 -52.05 -20.69 2.6 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.174 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.59 ' O ' ' O ' ' A' ' 74' ' ' LEU . 88.1 m-20 64.06 40.54 7.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.773 -0.58 . . . . 0.0 111.498 178.857 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.633 ' CD2' ' N ' ' A' ' 74' ' ' LEU . 3.0 mm? 52.77 115.64 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.926 -1.109 . . . . 0.0 110.099 178.58 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.718 ' OH ' ' CG ' ' A' ' 84' ' ' HIS . 97.8 m-85 -60.05 147.6 38.68 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.952 0.882 . . . . 0.0 110.781 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 64.6 m -65.18 -39.76 93.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.437 -0.789 . . . . 0.0 111.532 -178.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.7 m -123.38 147.19 47.33 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.659 -1.276 . . . . 0.0 110.123 -178.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.5 mt -59.56 -40.36 87.04 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -55.38 -40.61 71.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.444 -0.785 . . . . 0.0 109.379 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.19 -40.49 96.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 tt -58.82 -43.7 90.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.098 -179.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.67 -38.64 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.76 -1.212 . . . . 0.0 109.188 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.524 ' CD2' ' CD2' ' A' ' 5' ' ' HIS . 90.7 mt -74.89 -38.53 61.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.063 -1.023 . . . . 0.0 110.437 -179.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.718 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 65.8 t-80 -64.7 -39.36 93.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.802 -1.186 . . . . 0.0 109.792 -179.631 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.695 ' OH ' ' CD2' ' A' ' 68' ' ' PHE . 4.8 m-30 -66.82 -27.66 67.74 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.149 -0.97 . . . . 0.0 108.875 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.633 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 41.6 tt0 -63.79 -34.72 78.53 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.539 -0.726 . . . . 0.0 109.292 178.926 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -90.62 -13.47 34.3 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.028 -1.045 . . . . 0.0 110.163 -179.152 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.1 m -100.71 136.04 41.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 110.438 -179.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 t -85.99 125.55 33.47 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.282 -0.886 . . . . 0.0 108.934 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.722 ' O ' ' N ' ' A' ' 92' ' ' GLN . 87.1 mt -66.87 -20.05 65.85 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.407 -0.808 . . . . 0.0 110.332 -179.243 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.728 ' N ' ' O ' ' A' ' 97' ' ' LEU . 11.8 p -15.17 -48.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 O-C-N 121.684 -0.635 . . . . 0.0 110.372 179.457 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.722 ' N ' ' O ' ' A' ' 90' ' ' LEU . 34.0 tt0 53.92 179.41 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.483 -0.761 . . . . 0.0 110.807 178.777 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.578 ' H ' ' CG ' ' A' ' 92' ' ' GLN . 91.4 m-70 -60.06 -29.53 68.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.587 -0.695 . . . . 0.0 109.383 -179.719 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -56.96 -24.01 49.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.083 -1.011 . . . . 0.0 108.795 179.361 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.5 t70 61.93 41.67 11.09 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.518 -0.739 . . . . 0.0 110.432 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.7 m -148.19 -2.56 0.52 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.648 -1.283 . . . . 0.0 111.151 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 92.8 mt -102.16 52.0 0.81 Allowed 'General case' 0 C--N 1.29 -2.006 0 O-C-N 121.13 -0.982 . . . . 0.0 108.413 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.485 HD22 HG22 ' A' ' 91' ' ' VAL . 3.3 m-80 -78.09 70.35 4.44 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.769 0.795 . . . . 0.0 109.807 -178.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.475 HG11 ' N ' ' A' ' 100' ' ' THR . 25.9 t -149.67 153.02 11.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.475 ' N ' HG11 ' A' ' 99' ' ' VAL . 24.2 p -124.21 156.99 35.83 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.26 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.499 HD21 ' CG ' ' A' ' 33' ' ' PHE . 30.7 mt -82.58 69.48 9.36 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.912 -1.117 . . . . 0.0 108.694 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.421 ' CB ' ' HG3' ' A' ' 86' ' ' GLN . . . -105.09 -18.79 14.03 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.508 -0.745 . . . . 0.0 112.077 -178.004 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -112.44 109.62 53.59 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.414 -1.429 . . . . 0.0 112.101 -177.709 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -62.35 143.72 94.12 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.074 1.85 . . . . 0.0 111.169 178.153 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.529 HG12 ' CD2' ' A' ' 106' ' ' TYR . 12.5 p -68.66 -36.92 76.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 120.745 -1.222 . . . . 0.0 108.904 179.345 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.529 ' CD2' HG12 ' A' ' 105' ' ' VAL . 55.7 m-85 -109.13 42.48 1.43 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.386 -0.821 . . . . 0.0 109.61 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.91 126.15 24.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 108.857 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -130.72 141.55 50.39 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.972 -1.08 . . . . 0.0 109.148 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -102.34 127.26 49.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.005 -1.059 . . . . 0.0 110.035 -179.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.413 ' HG2' ' N ' ' A' ' 111' ' ' ARG . 7.8 ttt180 -130.04 148.64 51.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.313 -0.867 . . . . 0.0 109.385 179.668 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.413 ' N ' ' HG2' ' A' ' 110' ' ' ARG . 61.7 mtp180 . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.037 -1.039 . . . . 0.0 109.769 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.469 0.652 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.33 140.25 58.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -0.966 . . . . 0.0 109.265 179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.1 mt -100.79 134.1 20.72 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.14 -0.975 . . . . 0.0 109.392 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -51.51 -14.64 2.05 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.812 1.675 . . . . 0.0 110.925 179.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.457 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 91.1 m-70 -66.47 -12.93 59.84 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.541 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -63.42 -32.28 73.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 108.85 179.011 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.575 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 92.3 m-20 -100.53 134.19 43.85 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.352 -0.843 . . . . 0.0 110.004 -179.666 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 12' ' ' ASN . 95.5 mt-10 -69.27 -27.26 65.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 109.988 179.566 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.507 ' CG ' ' N ' ' A' ' 10' ' ' THR . 33.3 pttt -60.79 -35.46 76.53 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 110.508 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.67 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 10.6 p -59.75 -33.39 71.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 110.113 -178.827 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.67 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -120.78 -37.27 3.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.893 -1.129 . . . . 0.0 110.165 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -86.21 123.85 31.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.993 -1.067 . . . . 0.0 110.47 -179.214 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.5 t -94.05 -4.95 10.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.79 -162.15 19.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.498 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -80.68 61.55 4.4 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.318 -1.107 . . . . 0.0 109.417 -179.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.1 p -79.2 156.7 28.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.299 -0.876 . . . . 0.0 109.092 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -70.18 142.72 52.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.191 -0.943 . . . . 0.0 109.453 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.604 HH11 ' NH2' ' A' ' 36' ' ' ARG . 48.6 mtt-85 -59.46 -38.81 81.75 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.054 -1.029 . . . . 0.0 109.388 179.816 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.65 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 40.0 p-10 -62.65 -42.82 99.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.0 -1.062 . . . . 0.0 108.484 179.363 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.65 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 80.3 tttt -60.51 -36.6 78.74 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.233 -0.917 . . . . 0.0 109.066 179.41 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.702 ' CB ' HH11 ' A' ' 36' ' ' ARG . . . -58.57 -34.03 70.59 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.647 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 75.3 tt0 -58.7 -42.63 89.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.247 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.68 -46.94 87.54 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.697 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -67.16 -33.86 76.32 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.863 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.582 ' CD1' ' HG ' ' A' ' 47' ' ' SER . 22.7 mt -80.85 -16.01 54.82 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.146 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.731 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -74.61 122.43 23.15 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.555 -179.727 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.82 19.54 78.83 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.518 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.18 135.79 38.62 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.359 -1.083 . . . . 0.0 109.685 -179.446 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.686 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.9 OUTLIER -74.88 157.63 34.74 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.66 0.743 . . . . 0.0 110.157 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.513 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 48.4 p30 -62.25 169.36 2.85 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.283 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.88 -28.44 1.89 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 30' ' ' ASP . 76.7 m -80.56 121.03 25.29 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.869 -1.371 . . . . 0.0 108.984 179.658 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -136.06 167.26 21.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.908 -1.12 . . . . 0.0 110.517 -179.32 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 1.1 pt? -148.91 161.29 42.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.454 -0.779 . . . . 0.0 110.588 179.475 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.527 HG21 ' HG ' ' A' ' 46' ' ' CYS . 65.8 t -106.74 132.73 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.37 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.704 ' NH2' ' CD2' ' A' ' 56' ' ' HIS . 35.6 ptt180 -147.75 173.14 13.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 108.884 -178.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.69 ' C ' ' H ' ' A' ' 39' ' ' SER . 53.0 mt-10 -124.33 170.54 10.7 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.83 -1.169 . . . . 0.0 109.268 179.447 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.646 ' O ' ' CB ' ' A' ' 39' ' ' SER . 57.7 m -75.39 15.51 0.45 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 178.164 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.69 ' H ' ' C ' ' A' ' 37' ' ' GLU . 6.4 t 97.86 131.03 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.828 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.473 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 67.1 mmtt 62.32 -143.77 0.4 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.508 -0.745 . . . . 0.0 109.103 -179.474 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -101.57 20.11 16.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -0.847 . . . . 0.0 109.629 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.06 -52.62 51.03 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.062 -179.325 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 44' ' ' TYR . 53.1 t -161.0 166.58 28.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.99 -1.3 . . . . 0.0 110.246 -179.646 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.608 ' O ' ' O ' ' A' ' 59' ' ' ILE . 57.2 m-85 -123.66 145.83 48.67 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.279 -0.888 . . . . 0.0 109.048 179.168 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 57' ' ' CYS . . . -159.75 153.88 23.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.77 -1.207 . . . . 0.0 109.973 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.527 ' HG ' HG21 ' A' ' 35' ' ' VAL . 85.4 m -109.5 125.86 52.93 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.563 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.582 ' HG ' ' CD1' ' A' ' 25' ' ' LEU . 26.1 t -92.05 127.0 37.36 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.06 -179.682 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.429 ' CG1' ' N ' ' A' ' 49' ' ' VAL . 74.3 t -126.1 163.71 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.187 -0.946 . . . . 0.0 109.978 -179.403 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.429 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 39.2 t -124.6 132.76 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.488 HG13 ' NZ ' ' A' ' 55' ' ' LYS . 11.4 p -123.34 156.35 29.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.995 -1.066 . . . . 0.0 109.671 -179.782 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.423 ' OD1' ' OD2' ' A' ' 30' ' ' ASP . 87.2 m-20 -49.97 -17.17 0.35 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.943 0.878 . . . . 0.0 109.634 -179.429 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.581 ' O ' ' OE2' ' A' ' 53' ' ' GLU . . . -86.18 -59.22 1.88 Allowed Glycine 0 C--N 1.287 -2.142 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.667 -179.175 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.581 ' OE2' ' O ' ' A' ' 52' ' ' GLY . 61.3 mm-40 -163.22 -165.53 1.1 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.25 -1.147 . . . . 0.0 110.554 -178.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -93.36 123.37 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.488 ' NZ ' HG13 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -122.45 149.15 44.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.911 -1.118 . . . . 0.0 110.905 -179.495 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.704 ' CD2' ' NH2' ' A' ' 36' ' ' ARG . 23.6 m80 -113.31 101.88 9.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.579 -0.701 . . . . 0.0 109.544 179.194 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' CYS . 52.5 t -72.91 130.04 39.5 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.26 138.63 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.246 -0.909 . . . . 0.0 111.878 -177.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.608 ' O ' ' O ' ' A' ' 44' ' ' TYR . 10.9 mm -124.93 111.59 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.695 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 83.6 m-20 -118.59 170.48 8.92 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.647 -1.283 . . . . 0.0 112.182 -178.248 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -128.29 30.52 5.18 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.327 -1.483 . . . . 0.0 108.985 179.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.7 p -79.45 -174.93 4.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.314 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.37 -28.35 66.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.19 -0.944 . . . . 0.0 109.616 -179.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.9 p -79.0 -5.59 54.27 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.217 -0.927 . . . . 0.0 109.206 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.663 ' C ' ' H ' ' A' ' 67' ' ' GLY . . . 81.54 171.54 45.62 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.695 ' CA ' ' O ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -64.44 30.8 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.951 -1.323 . . . . 0.0 110.537 -179.244 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.663 ' H ' ' C ' ' A' ' 65' ' ' GLY . . . 88.51 -42.89 3.08 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.63 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 89.7 m-85 -90.43 -6.08 55.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.347 -1.09 . . . . 0.0 110.278 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.63 3.88 45.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.213 -0.929 . . . . 0.0 109.154 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.702 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 46.2 tt0 -59.64 -35.31 28.44 Favored Pre-proline 0 C--N 1.304 -1.379 0 C-N-CA 119.006 -1.078 . . . . 0.0 108.678 -179.667 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 9.8 Cg_exo -72.81 174.16 12.29 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.634 2.222 . . . . 0.0 111.071 178.451 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -62.57 -12.32 22.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.034 -1.041 . . . . 0.0 109.566 179.609 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -101.36 102.56 13.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.912 -1.117 . . . . 0.0 110.472 -179.316 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.495 HD11 ' N ' ' A' ' 74' ' ' LEU . 5.6 mp -106.25 7.4 31.4 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.633 ' OH ' ' CD2' ' A' ' 84' ' ' HIS . 71.4 m-85 60.58 175.02 0.1 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.371 -0.83 . . . . 0.0 109.19 -179.481 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.7 t -103.71 -48.72 3.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.122 -0.986 . . . . 0.0 110.048 -179.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.8 m -126.3 154.77 42.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.094 -1.004 . . . . 0.0 110.183 -179.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.16 -34.05 73.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 110.03 179.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.72 -43.74 80.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.188 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -66.9 -30.53 70.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.228 -0.92 . . . . 0.0 108.856 179.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.542 ' CD2' ' CE2' ' A' ' 85' ' ' TYR . 9.2 tt -60.6 -40.9 93.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 108.987 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.2 t -66.86 -44.17 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.361 -0.837 . . . . 0.0 109.819 179.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.428 HD22 ' CD2' ' A' ' 5' ' ' HIS . 85.0 mt -67.45 -43.09 81.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.419 -0.8 . . . . 0.0 110.439 -179.119 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.633 ' CD2' ' OH ' ' A' ' 75' ' ' TYR . 83.9 t60 -60.02 -40.56 89.72 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.215 -179.194 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.63 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 7.4 m-30 -67.34 -24.31 65.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 0.0 108.789 -179.783 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.453 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 38.1 tt0 -61.32 -36.94 81.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 178.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -91.44 -16.71 26.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.303 -0.873 . . . . 0.0 109.592 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.4 m -100.84 129.92 46.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.131 -0.981 . . . . 0.0 109.228 179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 t -81.67 132.56 35.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 109.915 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 91' ' ' VAL . 76.2 mt -69.01 -13.07 62.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.477 -0.764 . . . . 0.0 109.715 179.23 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.76 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.8 p -36.66 -33.75 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.464 -0.773 . . . . 0.0 110.011 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 90' ' ' LEU . 20.0 tt0 -65.86 -50.07 65.86 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 -178.658 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLN . 84.3 t60 -51.43 -47.53 63.0 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 179.443 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.689 ' O ' ' N ' ' A' ' 96' ' ' SER . 13.1 t-20 -126.29 111.25 14.33 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.477 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.54 ' C ' ' O ' ' A' ' 94' ' ' ASN . 99.7 m-20 -35.98 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.886 -178.488 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 94' ' ' ASN . 71.1 m -108.37 27.07 9.71 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.736 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.76 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.5 mt -97.96 65.84 1.81 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.563 -1.336 . . . . 0.0 108.2 178.676 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.79 75.57 6.47 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.81 -1.182 . . . . 0.0 109.41 -178.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.5 t -153.56 153.62 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.522 -0.736 . . . . 0.0 109.805 -179.266 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.2 p -134.33 156.79 47.85 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.154 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.503 HD21 ' CG ' ' A' ' 33' ' ' PHE . 11.6 mt -76.48 71.65 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.706 -1.246 . . . . 0.0 108.007 179.333 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.3 -33.76 9.91 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.169 -0.957 . . . . 0.0 112.111 -177.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.4 m-85 -113.97 109.29 49.93 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.503 -1.373 . . . . 0.0 111.977 -177.654 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.422 ' CB ' ' O ' ' A' ' 10' ' ' THR . 19.0 Cg_exo -59.97 148.61 88.21 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.083 1.855 . . . . 0.0 110.276 176.924 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.567 ' O ' ' OE1' ' A' ' 109' ' ' GLN . 9.1 p -67.25 -34.59 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.822 -1.174 . . . . 0.0 108.77 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.503 ' CD2' HG12 ' A' ' 105' ' ' VAL . 38.6 m-85 -108.14 39.4 1.97 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.447 -0.783 . . . . 0.0 110.191 179.828 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.99 117.4 23.36 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.996 -1.065 . . . . 0.0 109.599 179.462 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 49.46 45.93 23.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.334 -0.854 . . . . 0.0 109.975 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.567 ' OE1' ' O ' ' A' ' 105' ' ' VAL . 41.9 mt-30 -104.42 135.01 46.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.795 -1.191 . . . . 0.0 110.122 -179.801 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -61.38 -35.44 77.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.578 -0.701 . . . . 0.0 110.146 -179.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.482 ' HA ' ' HE ' ' A' ' 111' ' ' ARG . 4.6 tpm_? . . . . . 0 N--CA 1.493 1.716 0 O-C-N 120.961 -1.087 . . . . 0.0 109.217 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.57 -3.02 10.29 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.612 2.208 . . . . 0.0 112.103 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -66.78 -29.71 69.73 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -63.36 -22.37 66.84 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.583 ' O ' ' OG1' ' A' ' 10' ' ' THR . 94.9 m-20 -92.25 119.95 32.34 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.52 0.676 . . . . 0.0 110.441 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 72.3 tt0 -69.32 -40.33 77.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.59 -0.694 . . . . 0.0 109.496 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.58 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -64.1 -20.53 66.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.655 -0.653 . . . . 0.0 111.443 -178.656 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.583 ' OG1' ' O ' ' A' ' 7' ' ' ASP . 7.6 p -64.49 -37.31 87.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.794 -1.191 . . . . 0.0 110.196 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.588 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -119.24 -14.81 9.23 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.939 -1.1 . . . . 0.0 109.819 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 8' ' ' GLU . 62.6 t30 -89.7 120.07 30.65 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 110.599 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.715 ' CG2' HD13 ' A' ' 34' ' ' LEU . 27.7 m -137.97 36.28 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.89 -33.54 20.74 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 85.6 p -63.05 -31.98 73.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.945 -1.327 . . . . 0.0 109.036 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.8 t -61.6 138.51 58.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.379 -0.826 . . . . 0.0 109.718 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -81.57 163.91 22.29 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.299 -0.876 . . . . 0.0 109.867 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -57.17 -44.78 83.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -0.817 . . . . 0.0 109.465 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -65.36 -42.72 92.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.069 -1.019 . . . . 0.0 108.638 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -61.05 -36.25 79.09 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.48 -37.33 77.97 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.53 -0.731 . . . . 0.0 109.646 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 26' ' ' ARG . 81.3 mm-40 -58.39 -45.19 88.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.109 -0.994 . . . . 0.0 108.384 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -62.09 -44.19 97.21 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.421 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 82.4 mt -64.4 -40.2 95.32 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.413 -0.804 . . . . 0.0 108.87 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.729 HD13 ' CG1' ' A' ' 54' ' ' VAL . 36.7 mt -75.73 -29.93 59.06 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.568 ' NH1' ' HG2' ' A' ' 26' ' ' ARG . 31.6 mtt-85 -79.63 136.3 36.79 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.717 -0.614 . . . . 0.0 109.645 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.78 -8.65 76.45 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 24' ' ' LEU . 28.7 mmtm -96.12 137.85 34.58 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.242 -1.152 . . . . 0.0 109.878 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -69.52 162.78 26.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.459 -0.775 . . . . 0.0 109.191 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.611 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 73.9 m-20 -60.18 142.91 53.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.372 -0.83 . . . . 0.0 109.189 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.39 -30.51 8.47 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.0 m -76.16 135.78 39.79 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.239 -1.154 . . . . 0.0 109.044 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.889 ' CD1' HD13 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -140.84 162.94 34.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.938 -1.101 . . . . 0.0 108.923 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.715 HD13 ' CG2' ' A' ' 13' ' ' VAL . 2.8 pp -134.16 154.55 51.15 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.122 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.043 HG22 ' SG ' ' A' ' 46' ' ' CYS . 95.5 t -113.65 138.24 44.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.559 ' NH1' ' HG3' ' A' ' 36' ' ' ARG . 5.4 ptm180 -150.51 169.96 20.26 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.037 -1.04 . . . . 0.0 109.362 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.476 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 3.2 pt-20 . . . . . 0 C--N 1.303 -1.439 0 O-C-N 120.938 -1.101 . . . . 0.0 108.838 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.593 ' O ' ' O ' ' A' ' 59' ' ' ILE . 97.7 m-85 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.306 0.574 . . . . 0.0 109.903 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -164.66 144.4 7.35 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.022 -1.049 . . . . 0.0 109.357 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 1.043 ' SG ' HG22 ' A' ' 35' ' ' VAL . 78.5 m -121.02 136.84 54.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.495 ' OG ' HD11 ' A' ' 25' ' ' LEU . 92.6 p -105.19 143.36 33.47 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.554 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.806 HG22 ' HB2' ' A' ' 33' ' ' PHE . 43.7 t -125.06 158.95 32.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.574 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.454 ' N ' HG12 ' A' ' 48' ' ' VAL . 67.9 t -109.92 130.99 62.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.935 HG12 ' H ' ' A' ' 52' ' ' GLY . 9.9 t -123.22 152.13 27.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.132 -0.98 . . . . 0.0 110.652 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.611 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 66.0 t0 -50.34 -12.03 0.08 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.547 0.689 . . . . 0.0 109.858 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.935 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -104.9 -49.96 0.98 Allowed Glycine 0 C--N 1.287 -2.142 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.253 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.55 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 75.0 mt-10 -161.29 177.01 10.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.885 -1.362 . . . . 0.0 111.209 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.729 ' CG1' HD13 ' A' ' 25' ' ' LEU . 53.5 t -89.64 135.13 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.8 161.9 18.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.986 -1.071 . . . . 0.0 111.484 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -124.06 76.07 1.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 88.4 m -60.83 146.45 46.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.168 -0.957 . . . . 0.0 109.382 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 58' ' ' VAL . 5.5 p -106.26 135.87 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.22 -0.925 . . . . 0.0 111.467 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.73 HD12 ' SG ' ' A' ' 46' ' ' CYS . 64.6 mt -124.81 141.47 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.3 t30 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 120.162 -1.586 . . . . 0.0 111.331 -177.977 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.7 m . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 121.538 0.685 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 78' ' ' LEU . 82.1 mt -68.02 -29.84 68.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.731 . . . . 0.0 110.053 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -58.9 -42.83 90.53 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -68.61 -35.39 77.26 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.568 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.5 tt -59.49 -49.49 77.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.396 -0.815 . . . . 0.0 109.204 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.803 HG13 HD21 ' A' ' 101' ' ' LEU . 99.0 t -61.28 -43.22 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.581 -0.699 . . . . 0.0 109.745 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.61 -51.5 67.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.035 -1.041 . . . . 0.0 110.608 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.699 ' CE1' ' OG1' ' A' ' 88' ' ' THR . 59.3 t-80 -71.47 -36.36 71.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.77 -1.206 . . . . 0.0 110.457 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.751 ' OH ' HD21 ' A' ' 90' ' ' LEU . 29.1 t80 -59.98 -20.62 58.62 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.909 -1.119 . . . . 0.0 108.842 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.503 ' CG ' ' O ' ' A' ' 101' ' ' LEU . 1.1 tm0? -80.07 -25.8 39.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.234 -0.916 . . . . 0.0 108.626 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -97.8 -7.56 30.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.218 -0.926 . . . . 0.0 109.07 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.699 ' OG1' ' CE1' ' A' ' 84' ' ' HIS . 32.4 m -96.99 139.77 32.51 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.214 -0.929 . . . . 0.0 109.152 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.527 ' OG ' HG12 ' A' ' 91' ' ' VAL . 40.6 t -87.65 130.24 34.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.14 -0.975 . . . . 0.0 109.358 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.751 HD21 ' OH ' ' A' ' 85' ' ' TYR . 10.4 mp -71.82 -17.23 62.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.316 -0.865 . . . . 0.0 109.972 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.703 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.6 p -37.52 -41.93 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.175 -0.953 . . . . 0.0 110.162 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.473 ' N ' HG13 ' A' ' 91' ' ' VAL . 54.9 tt0 -47.95 -30.34 4.15 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.484 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.842 ' HB2' HD12 ' A' ' 97' ' ' LEU . 94.4 m-70 -83.44 130.31 35.02 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.089 -1.007 . . . . 0.0 108.989 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 58.22 7.73 0.7 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.46 ' H ' ' C ' ' A' ' 93' ' ' HIS . 54.7 t0 45.25 35.01 1.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.418 -0.801 . . . . 0.0 109.197 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 55.9 m -156.95 15.48 0.28 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.817 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.842 HD12 ' HB2' ' A' ' 93' ' ' HIS . 68.0 mt -101.62 73.91 1.48 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -79.1 85.15 5.02 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.727 0.775 . . . . 0.0 109.928 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.401 HG22 ' N ' ' A' ' 100' ' ' THR . 8.1 p -165.44 163.57 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.733 0.778 . . . . 0.0 109.081 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 102' ' ' ALA . 68.0 p -135.16 131.96 37.42 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.937 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -52.43 95.57 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.406 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -91.81 -51.53 5.18 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.403 -1.436 . . . . 0.0 111.888 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -129.06 137.37 30.86 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.743 -1.223 . . . . 0.0 112.043 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.46 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 32.6 Cg_exo -52.98 160.53 4.1 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.232 1.955 . . . . 0.0 111.28 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.413 ' H ' HG12 ' A' ' 105' ' ' VAL . 3.2 p -74.27 -31.82 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.685 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -112.03 34.14 4.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.875 . . . . 0.0 109.281 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 104' ' ' PRO . . . . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.548 -0.72 . . . . 0.0 109.706 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -51.51 -14.64 2.05 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.812 1.675 . . . . 0.0 110.925 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.466 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 91.1 m-70 -66.47 -12.93 59.84 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -63.42 -32.28 73.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 108.85 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.575 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 92.3 m-20 -100.53 134.19 43.85 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.352 -0.843 . . . . 0.0 110.004 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 12' ' ' ASN . 95.5 mt-10 -69.27 -27.26 65.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 109.988 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.507 ' CG ' ' N ' ' A' ' 10' ' ' THR . 33.3 pttt -60.79 -35.46 76.53 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 110.508 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.669 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 10.6 p -59.75 -33.39 71.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 110.113 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.669 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -120.78 -37.27 3.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.893 -1.129 . . . . 0.0 110.165 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -86.21 123.85 31.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.993 -1.067 . . . . 0.0 110.47 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.474 ' O ' HG12 ' A' ' 13' ' ' VAL . 74.5 t -94.05 -4.95 10.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.79 -162.15 19.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -80.68 61.55 4.4 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.318 -1.107 . . . . 0.0 109.417 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.1 p -79.2 156.7 28.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.299 -0.876 . . . . 0.0 109.092 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -70.18 142.72 52.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.191 -0.943 . . . . 0.0 109.453 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.618 HH11 ' NH2' ' A' ' 36' ' ' ARG . 48.6 mtt-85 -59.46 -38.81 81.75 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.054 -1.029 . . . . 0.0 109.388 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.65 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 40.0 p-10 -62.65 -42.82 99.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.0 -1.062 . . . . 0.0 108.484 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.65 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 80.3 tttt -60.51 -36.6 78.74 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.233 -0.917 . . . . 0.0 109.066 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.71 ' CB ' HH11 ' A' ' 36' ' ' ARG . . . -58.57 -34.03 70.59 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.647 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 75.3 tt0 -58.7 -42.63 89.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.68 -46.94 87.54 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.697 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -67.16 -33.86 76.32 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.863 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.883 HD11 ' OG ' ' A' ' 47' ' ' SER . 22.7 mt -80.85 -16.01 54.82 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.742 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -74.61 122.43 23.15 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.555 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.82 19.54 78.83 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.505 ' HE2' HG21 ' A' ' 32' ' ' THR . 0.2 OUTLIER -97.18 135.79 38.62 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.359 -1.083 . . . . 0.0 109.685 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.699 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.9 OUTLIER -74.88 157.63 34.74 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.66 0.743 . . . . 0.0 110.157 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.513 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 48.4 p30 -62.25 169.36 2.85 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.88 -28.44 1.89 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.505 HG21 ' HE2' ' A' ' 28' ' ' LYS . 76.7 m -80.56 121.03 25.29 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.869 -1.371 . . . . 0.0 108.984 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.806 ' HB2' HG22 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -136.06 167.26 21.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.908 -1.12 . . . . 0.0 110.517 -179.32 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 1.1 pt? -148.91 161.29 42.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.454 -0.779 . . . . 0.0 110.588 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.475 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 65.8 t -106.74 132.73 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.71 HH11 ' CB ' ' A' ' 21' ' ' ALA . 35.6 ptt180 -147.75 173.14 13.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 108.884 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.479 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 53.0 mt-10 . . . . . 0 C--N 1.304 -1.389 0 O-C-N 120.83 -1.169 . . . . 0.0 109.268 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.608 ' O ' ' O ' ' A' ' 59' ' ' ILE . 57.2 m-85 . . . . . 0 N--CA 1.495 1.775 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 57' ' ' CYS . . . -159.75 153.88 23.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.77 -1.207 . . . . 0.0 109.973 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' CYS . 85.4 m -109.5 125.86 52.93 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.883 ' OG ' HD11 ' A' ' 25' ' ' LEU . 26.1 t -92.05 127.0 37.36 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.06 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.806 HG22 ' HB2' ' A' ' 33' ' ' PHE . 74.3 t -126.1 163.71 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.187 -0.946 . . . . 0.0 109.978 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.602 ' N ' HG12 ' A' ' 48' ' ' VAL . 39.2 t -124.6 132.76 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.701 HG23 ' CG2' ' A' ' 99' ' ' VAL . 11.4 p -123.34 156.35 29.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.995 -1.066 . . . . 0.0 109.671 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.423 ' OD1' ' OD2' ' A' ' 30' ' ' ASP . 87.2 m-20 -49.97 -17.17 0.35 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.943 0.878 . . . . 0.0 109.634 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.581 ' O ' ' OE2' ' A' ' 53' ' ' GLU . . . -86.18 -59.22 1.88 Allowed Glycine 0 C--N 1.287 -2.142 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.667 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.581 ' OE2' ' O ' ' A' ' 52' ' ' GLY . 61.3 mm-40 -163.22 -165.53 1.1 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.25 -1.147 . . . . 0.0 110.554 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.56 ' CG1' HD13 ' A' ' 25' ' ' LEU . 88.8 t -93.36 123.37 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.455 ' NZ ' HG11 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -122.45 149.15 44.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.911 -1.118 . . . . 0.0 110.905 -179.495 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.543 ' CG ' ' NH2' ' A' ' 36' ' ' ARG . 58.6 m-70 -113.31 101.88 9.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.579 -0.701 . . . . 0.0 109.544 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' CYS . 52.5 t -72.91 130.04 39.5 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.26 138.63 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.246 -0.909 . . . . 0.0 111.878 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.608 ' O ' ' O ' ' A' ' 44' ' ' TYR . 10.9 mm -124.93 111.59 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 . . . . . 0 N--CA 1.5 2.055 0 O-C-N 120.647 -1.283 . . . . 0.0 112.182 -178.248 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.559 0.695 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.16 -34.05 73.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 110.03 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.72 -43.74 80.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.188 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -66.9 -30.53 70.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.228 -0.92 . . . . 0.0 108.856 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.904 HD21 ' CE2' ' A' ' 85' ' ' TYR . 9.2 tt -60.6 -40.9 93.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 108.987 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.2 t -66.86 -44.17 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.361 -0.837 . . . . 0.0 109.819 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.426 HD21 ' CB ' ' A' ' 5' ' ' HIS . 85.0 mt -67.45 -43.09 81.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.419 -0.8 . . . . 0.0 110.439 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -60.02 -40.56 89.72 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.215 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.904 ' CE2' HD21 ' A' ' 81' ' ' LEU . 7.4 m-30 -67.34 -24.31 65.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 0.0 108.789 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.453 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 38.1 tt0 -61.32 -36.94 81.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -91.44 -16.71 26.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.303 -0.873 . . . . 0.0 109.592 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.4 m -100.84 129.92 46.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.131 -0.981 . . . . 0.0 109.228 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.543 ' HA ' HG22 ' A' ' 100' ' ' THR . 34.8 t -81.67 132.56 35.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 109.915 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 91' ' ' VAL . 76.2 mt -69.01 -13.07 62.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.477 -0.764 . . . . 0.0 109.715 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.76 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.8 p -36.66 -33.75 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.464 -0.773 . . . . 0.0 110.011 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.45 ' N ' HG13 ' A' ' 91' ' ' VAL . 20.0 tt0 -65.86 -50.07 65.86 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLN . 84.3 t60 -51.43 -47.53 63.0 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.689 ' O ' ' N ' ' A' ' 96' ' ' SER . 13.1 t-20 -126.29 111.25 14.33 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.54 ' C ' ' O ' ' A' ' 94' ' ' ASN . 99.7 m-20 -35.98 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.886 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 94' ' ' ASN . 71.1 m -108.37 27.07 9.71 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.736 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.76 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.5 mt -97.96 65.84 1.81 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.563 -1.336 . . . . 0.0 108.2 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.403 ' C ' HG23 ' A' ' 99' ' ' VAL . 50.6 t-20 -79.79 75.57 6.47 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.81 -1.182 . . . . 0.0 109.41 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.701 ' CG2' HG23 ' A' ' 50' ' ' VAL . 84.5 t -153.56 153.62 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.522 -0.736 . . . . 0.0 109.805 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.543 HG22 ' HA ' ' A' ' 89' ' ' SER . 70.2 p -134.33 156.79 47.85 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.57 HD22 ' CG ' ' A' ' 33' ' ' PHE . 11.6 mt -76.48 71.65 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.706 -1.246 . . . . 0.0 108.007 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.3 -33.76 9.91 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.169 -0.957 . . . . 0.0 112.111 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.4 m-85 -113.97 109.29 49.93 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.503 -1.373 . . . . 0.0 111.977 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.523 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 19.0 Cg_exo -59.97 148.61 88.21 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.083 1.855 . . . . 0.0 110.276 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.502 HG13 ' CD2' ' A' ' 106' ' ' TYR . 9.1 p -67.25 -34.59 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.822 -1.174 . . . . 0.0 108.77 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.502 ' CD2' HG13 ' A' ' 105' ' ' VAL . 38.6 m-85 -108.14 39.4 1.97 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.447 -0.783 . . . . 0.0 110.191 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.523 ' HB2' ' CG ' ' A' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.497 1.905 0 O-C-N 120.996 -1.065 . . . . 0.0 109.599 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.427 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 28.5 Cg_endo -64.3 -6.9 12.59 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.7 2.267 . . . . 0.0 112.288 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.49 ' CD2' HG11 ' A' ' 82' ' ' VAL . 7.3 m80 -67.37 -21.31 65.63 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 108.965 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -59.68 -34.2 72.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.776 -1.203 . . . . 0.0 108.236 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -97.18 126.76 42.57 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.175 -0.953 . . . . 0.0 109.354 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.614 ' CG ' ' OD1' ' A' ' 12' ' ' ASN . 23.2 tt0 -68.07 -28.27 67.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.6 -0.688 . . . . 0.0 110.125 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.706 ' NZ ' ' O ' ' A' ' 106' ' ' TYR . 2.3 tmpt? -62.44 -27.19 68.94 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.261 -0.9 . . . . 0.0 111.623 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.717 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 41.7 p -62.57 -29.74 70.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.991 -1.068 . . . . 0.0 112.127 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.759 ' CE3' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -123.86 -31.23 3.44 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.189 -1.57 . . . . 0.0 110.34 179.457 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.759 ' ND2' ' CE3' ' A' ' 11' ' ' TRP . 1.2 m-80 -73.74 130.81 40.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.132 -0.98 . . . . 0.0 109.663 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 13' ' ' VAL . 60.9 t -115.79 -11.16 12.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.633 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.81 -152.42 21.81 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.1 p -83.46 112.07 19.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -1.123 . . . . 0.0 109.524 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.0 m -126.07 143.13 51.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.073 -1.017 . . . . 0.0 110.152 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.653 ' ND2' ' ND2' ' A' ' 19' ' ' ASN . 59.5 t-20 -67.11 148.38 51.93 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.576 -0.702 . . . . 0.0 109.26 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.545 ' HA ' HH12 ' A' ' 36' ' ' ARG . 85.5 mtm180 -61.05 -40.35 93.29 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 110.022 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 44.0 p30 -61.49 -33.14 73.27 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.085 -1.009 . . . . 0.0 108.977 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.674 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 7.3 tppt? -77.76 -34.75 52.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.127 -0.983 . . . . 0.0 108.945 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.5 92.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -0.793 . . . . 0.0 109.349 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 26' ' ' ARG . 14.4 pt-20 -60.12 -46.01 91.07 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.0 -1.063 . . . . 0.0 108.442 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.437 ' N ' ' HG3' ' A' ' 22' ' ' GLU . 98.3 m-20 -56.07 -42.44 76.67 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.31 -29.75 67.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.319 -0.863 . . . . 0.0 109.163 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.467 HD13 ' CG1' ' A' ' 54' ' ' VAL . 11.5 mt -91.68 -9.93 42.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -0.792 . . . . 0.0 109.134 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 22' ' ' GLU . 1.1 ttt180 -90.75 125.8 35.81 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.195 -0.94 . . . . 0.0 109.476 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.2 1.02 61.23 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -96.9 141.1 30.5 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.403 -1.057 . . . . 0.0 108.16 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -72.82 151.74 41.89 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.275 -0.891 . . . . 0.0 108.854 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -50.95 147.99 4.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 109.287 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.79 -20.82 44.52 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.446 HG23 ' HD2' ' A' ' 103' ' ' TYR . 58.5 m -86.27 122.33 30.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -1.079 . . . . 0.0 110.074 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.875 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.8 OUTLIER -136.46 167.22 21.76 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.366 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 pp -140.63 160.12 40.7 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.664 -0.815 . . . . 0.0 109.545 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.36 125.65 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.416 -0.803 . . . . 0.0 109.756 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.545 HH12 ' HA ' ' A' ' 18' ' ' ARG . 29.0 ptt180 -143.9 -174.06 4.16 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.301 -1.537 0 O-C-N 120.825 -1.172 . . . . 0.0 108.985 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.585 ' O ' ' O ' ' A' ' 59' ' ' ILE . 31.9 m-85 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.415 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -155.42 138.72 15.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.904 -1.122 . . . . 0.0 110.059 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 57' ' ' CYS . 29.5 p -111.1 125.42 53.75 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.913 -1.117 . . . . 0.0 108.237 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 55' ' ' LYS . 44.2 t -108.21 138.13 45.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 0.0 109.845 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 49' ' ' VAL . 10.2 p -131.97 164.22 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.052 -1.03 . . . . 0.0 110.31 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.579 ' N ' HG22 ' A' ' 48' ' ' VAL . 86.7 t -109.93 127.33 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.821 HG13 ' HZ3' ' A' ' 55' ' ' LYS . 7.9 p -160.02 168.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.888 -1.133 . . . . 0.0 110.909 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.646 ' N ' HG22 ' A' ' 50' ' ' VAL . 61.6 t0 40.88 24.28 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.831 -0.543 . . . . 0.0 110.731 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 80.1 -1.85 78.35 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.053 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.855 ' HB3' ' HZ1' ' A' ' 55' ' ' LYS . 15.3 tp10 -119.88 143.58 47.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.335 . . . . 0.0 110.489 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.467 ' CG1' HD13 ' A' ' 25' ' ' LEU . 83.7 t -82.59 127.66 39.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.566 0.698 . . . . 0.0 109.163 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.855 ' HZ1' ' HB3' ' A' ' 53' ' ' GLU . 6.6 mptt -110.16 158.15 18.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.0 110.933 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -130.36 73.96 1.56 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.422 -0.798 . . . . 0.0 109.539 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 42.2 t -63.92 136.78 57.64 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.404 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.78 139.84 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.84 0.829 . . . . 0.0 111.989 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.585 ' O ' ' O ' ' A' ' 44' ' ' TYR . 20.0 mm -118.23 144.96 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 . . . . . 0 N--CA 1.495 1.786 0 O-C-N 120.842 -1.161 . . . . 0.0 109.631 179.663 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 122.003 0.906 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.6 mt -59.63 -28.28 67.08 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -53.27 -42.39 66.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.83 -1.168 . . . . 0.0 108.016 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.415 ' OE2' ' NE2' ' A' ' 84' ' ' HIS . 7.2 tm-20 -63.92 -37.04 85.96 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.709 HD23 ' C ' ' A' ' 81' ' ' LEU . 8.2 tt -59.2 -48.04 83.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 0.0 109.203 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.49 HG11 ' CD2' ' A' ' 5' ' ' HIS . 97.2 t -60.68 -39.31 81.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.042 -1.036 . . . . 0.0 108.579 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 86' ' ' GLN . 79.6 mt -64.17 -35.12 79.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.384 -0.822 . . . . 0.0 109.965 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.415 ' NE2' ' OE2' ' A' ' 80' ' ' GLU . 0.4 OUTLIER -56.27 -48.65 76.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.723 -1.236 . . . . 0.0 110.027 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.743 ' HB2' HD12 ' A' ' 101' ' ' LEU . 73.3 m-85 -61.74 -30.09 70.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.914 -1.116 . . . . 0.0 109.353 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 83' ' ' LEU . 37.3 tt0 -60.96 -34.87 75.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.43 -0.793 . . . . 0.0 109.558 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -96.4 -11.18 26.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 110.621 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.2 m -114.34 129.74 56.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.748 -1.22 . . . . 0.0 110.746 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.7 t -76.47 124.6 27.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.759 -0.588 . . . . 0.0 109.786 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.726 ' O ' ' N ' ' A' ' 92' ' ' GLN . 5.0 mp -67.41 -31.44 71.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.478 -0.763 . . . . 0.0 111.316 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.015 HG13 ' H ' ' A' ' 92' ' ' GLN . 7.6 p 12.31 -75.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.597 0 O-C-N 121.844 -0.535 . . . . 0.0 110.285 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 1.015 ' H ' HG13 ' A' ' 91' ' ' VAL . 26.5 tt0 62.63 -175.98 0.14 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.421 -0.8 . . . . 0.0 111.105 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.68 ' H ' ' CG ' ' A' ' 92' ' ' GLN . 88.4 m-70 -58.44 -35.54 72.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.55 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -50.64 -25.48 4.28 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 60.0 14.6 4.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.678 -0.639 . . . . 0.0 109.751 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.431 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 54.7 p -132.33 9.19 4.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.968 -1.082 . . . . 0.0 109.751 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.732 ' O ' ' N ' ' A' ' 91' ' ' VAL . 83.9 mt -96.58 36.57 1.36 Allowed 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.438 ' OD1' HG23 ' A' ' 91' ' ' VAL . 98.7 m-20 -75.98 70.34 2.68 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.487 ' O ' HD12 ' A' ' 90' ' ' LEU . 12.8 p -159.47 159.35 2.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.477 ' N ' HG22 ' A' ' 99' ' ' VAL . 31.0 p -121.8 149.21 43.65 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.875 HD22 ' CG ' ' A' ' 33' ' ' PHE . 56.3 mt -73.94 69.13 1.4 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.428 ' HA ' HE21 ' A' ' 86' ' ' GLN . . . -98.2 -24.62 15.2 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.444 -0.785 . . . . 0.0 112.548 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.455 ' CE2' ' O ' ' A' ' 104' ' ' PRO . 80.8 t80 -114.02 131.01 23.37 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.268 -1.52 . . . . 0.0 110.97 -178.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.786 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 63.3 Cg_endo -76.14 149.33 32.08 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 123.354 2.703 . . . . 0.0 112.182 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.648 HG13 ' CD2' ' A' ' 106' ' ' TYR . 14.5 p -78.5 -17.83 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.025 -1.047 . . . . 0.0 109.776 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.706 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . 33.9 m-85 -132.18 56.35 1.83 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.025 -1.047 . . . . 0.0 110.569 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.786 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . . . . . . 0 C--N 1.302 -1.5 0 O-C-N 121.15 -0.969 . . . . 0.0 109.844 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 3' ' ' LEU . 95.7 mt . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.495 ' O ' ' OG1' ' A' ' 10' ' ' THR . 28.9 Cg_endo -68.55 -3.86 11.92 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.35 2.033 . . . . 0.0 111.974 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -80.93 -6.33 58.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 110.016 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -76.11 -31.14 58.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.197 -0.939 . . . . 0.0 110.111 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -105.18 132.78 50.97 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.235 -0.916 . . . . 0.0 109.981 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.675 ' O ' ' N ' ' A' ' 12' ' ' ASN . 95.9 mt-10 -66.77 -29.33 69.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.477 -0.764 . . . . 0.0 110.57 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.46 ' CG ' ' N ' ' A' ' 10' ' ' THR . 3.0 pttt -57.66 -33.58 68.46 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.336 -0.853 . . . . 0.0 111.0 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.696 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 47.2 p -65.67 -30.91 71.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.888 -1.132 . . . . 0.0 110.704 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.696 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -119.82 -28.86 5.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.673 -1.267 . . . . 0.0 109.78 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' A' ' 8' ' ' GLU . 56.2 t-20 -83.63 130.62 34.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.605 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.49 HG22 ' HE2' ' A' ' 106' ' ' TYR . 45.0 t -96.35 -12.82 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.287 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.13 -157.96 34.1 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 95.2 p -63.83 132.68 51.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.149 -1.207 . . . . 0.0 109.801 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.9 t -176.71 165.46 2.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 109.619 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -95.12 147.8 23.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.468 -0.77 . . . . 0.0 109.747 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.636 ' HD2' ' CE1' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -59.72 -35.57 74.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.164 -0.96 . . . . 0.0 110.016 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -57.17 -46.06 83.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.684 -1.26 . . . . 0.0 108.43 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.695 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 79.9 tttt -59.98 -35.11 74.31 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 18' ' ' ARG . . . -60.04 -38.93 84.2 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' ARG . 97.1 mt-10 -53.64 -47.51 70.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.863 . . . . 0.0 108.823 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.695 ' ND2' ' O ' ' A' ' 20' ' ' LYS . 9.5 p30 -62.11 -41.29 98.08 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.674 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 79.2 mt -65.09 -30.21 71.14 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 21' ' ' ALA . 19.2 mt -93.1 -10.73 34.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.444 -0.785 . . . . 0.0 109.817 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.564 ' CG ' ' N ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -79.71 -49.53 11.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 109.635 -179.088 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.564 ' N ' ' CG ' ' A' ' 26' ' ' ARG . . . -87.99 25.95 8.21 Favored Glycine 0 C--N 1.287 -2.188 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -115.11 125.34 53.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.25 -1.147 . . . . 0.0 110.521 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -72.77 159.33 33.97 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.497 -0.752 . . . . 0.0 109.142 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 59.9 p30 -57.36 151.2 16.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.056 -1.028 . . . . 0.0 110.172 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.17 -18.46 55.55 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.1 m -100.67 127.43 47.08 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.165 -1.197 . . . . 0.0 109.09 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.64 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -130.4 161.27 31.72 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.034 178.759 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.412 ' HB3' HG21 ' A' ' 105' ' ' VAL . 1.5 pp -129.35 155.07 46.23 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.636 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.6 t -116.26 131.14 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.777 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.632 ' CB ' ' CZ ' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -146.11 -141.91 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 108.928 179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 . . . . . 0 C--N 1.301 -1.504 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.611 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.594 ' O ' ' O ' ' A' ' 59' ' ' ILE . 74.8 m-85 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.517 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -169.05 142.36 2.82 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.094 -1.004 . . . . 0.0 109.053 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 57' ' ' CYS . 16.8 p -124.93 148.15 48.5 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.264 -0.898 . . . . 0.0 108.808 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.3 p -120.21 143.2 48.39 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.684 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.856 HG13 ' NZ ' ' A' ' 55' ' ' LYS . 1.5 p -130.6 155.23 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.476 -0.765 . . . . 0.0 109.766 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.453 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 69.9 t -110.8 132.64 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.761 -0.587 . . . . 0.0 110.099 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.669 HG13 ' H ' ' A' ' 52' ' ' GLY . 8.3 p -122.04 156.27 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.0 -1.063 . . . . 0.0 108.876 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 59.4 t0 -49.3 -18.3 0.35 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.873 0.844 . . . . 0.0 110.022 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.669 ' H ' HG13 ' A' ' 50' ' ' VAL . . . -92.1 -52.81 2.15 Favored Glycine 0 C--N 1.286 -2.23 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.585 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.565 ' H ' ' CG1' ' A' ' 50' ' ' VAL . 44.6 mt-10 -161.11 169.37 22.51 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.724 -1.456 . . . . 0.0 112.028 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.8 t -85.86 136.78 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.856 ' NZ ' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -131.8 150.86 52.02 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.576 -1.328 . . . . 0.0 111.776 -178.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.636 ' CE1' ' HD2' ' A' ' 18' ' ' ARG . 67.9 m-70 -110.66 117.45 33.52 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' A' ' 46' ' ' CYS . 48.8 t -104.08 129.23 51.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.87 -1.144 . . . . 0.0 108.574 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 58' ' ' VAL . 4.7 p -94.68 132.72 37.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 111.292 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.594 ' O ' ' O ' ' A' ' 44' ' ' TYR . 98.0 mt -118.12 140.89 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 . . . . . 0 N--CA 1.494 1.738 0 O-C-N 120.967 -1.083 . . . . 0.0 109.349 -179.603 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.4 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.393 0.616 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.93 -37.39 82.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.548 -0.72 . . . . 0.0 109.461 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -56.71 -42.82 79.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.476 -0.765 . . . . 0.0 109.044 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -64.63 -33.53 76.16 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.229 -0.919 . . . . 0.0 109.15 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 10.2 tt -59.82 -48.17 82.77 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 109.535 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 95.5 t -67.53 -37.19 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.204 -0.935 . . . . 0.0 109.17 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.547 HD12 ' OE1' ' A' ' 86' ' ' GLN . 52.3 tp -66.49 -47.73 72.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.285 -0.884 . . . . 0.0 110.359 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -63.11 -40.43 97.61 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.994 -1.066 . . . . 0.0 110.317 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.589 ' HA ' HG22 ' A' ' 88' ' ' THR . 3.9 m-85 -62.15 -29.67 70.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.469 -0.769 . . . . 0.0 111.501 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.612 ' O ' ' OG1' ' A' ' 100' ' ' THR . 5.8 pt20 -66.91 -29.09 68.88 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.301 -1.499 . . . . 0.0 108.334 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -79.18 -39.65 32.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.401 -0.812 . . . . 0.0 109.829 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 85' ' ' TYR . 5.0 t -79.61 154.21 28.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.006 . . . . 0.0 109.993 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.5 t -104.55 133.18 49.85 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.816 ' N ' HD22 ' A' ' 90' ' ' LEU . 3.1 mm? -70.51 -10.92 60.44 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.513 -0.742 . . . . 0.0 110.319 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.685 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.4 p -40.14 -43.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.135 -0.978 . . . . 0.0 109.812 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.605 ' N ' HG13 ' A' ' 91' ' ' VAL . 65.0 tt0 -38.58 -36.63 0.26 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.906 -0.496 . . . . 0.0 110.766 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.707 ' O ' ' N ' ' A' ' 95' ' ' ASP . 23.4 t-160 -64.87 124.65 22.57 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.951 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 93' ' ' HIS . 33.4 m120 44.28 9.71 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.034 -1.041 . . . . 0.0 109.278 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 93' ' ' HIS . 81.8 m-20 57.62 43.78 21.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.299 -0.876 . . . . 0.0 110.873 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.61 ' C ' HD22 ' A' ' 97' ' ' LEU . 34.2 m -151.61 4.64 0.43 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.556 -1.34 . . . . 0.0 111.415 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.962 HD22 ' N ' ' A' ' 97' ' ' LEU . 2.1 mm? -100.47 70.68 1.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.607 -1.308 . . . . 0.0 107.774 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -79.73 94.63 5.78 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.049 0.928 . . . . 0.0 109.748 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.765 HG22 ' H ' ' A' ' 100' ' ' THR . 7.1 p -174.06 -177.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.765 ' H ' HG22 ' A' ' 99' ' ' VAL . 9.0 t -160.42 166.73 28.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.014 -1.054 . . . . 0.0 109.501 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.64 HD22 ' CG ' ' A' ' 33' ' ' PHE . 18.6 mt -79.96 63.73 4.58 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.44 -26.46 19.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.937 -0.477 . . . . 0.0 112.092 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -122.41 134.22 24.76 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.279 -1.513 . . . . 0.0 111.455 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.55 148.98 43.28 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 122.699 2.266 . . . . 0.0 111.302 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.744 HG13 ' CD2' ' A' ' 106' ' ' TYR . 9.0 p -72.41 -18.61 19.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.266 -0.896 . . . . 0.0 108.756 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.744 ' CD2' HG13 ' A' ' 105' ' ' VAL . 39.7 m-85 -131.42 65.18 1.57 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.478 -0.764 . . . . 0.0 110.023 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.788 0 O-C-N 120.962 -1.086 . . . . 0.0 110.024 179.836 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 3' ' ' LEU . 7.0 mp . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.29 0.567 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.19 -2.93 6.46 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.696 2.264 . . . . 0.0 111.443 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -65.89 -31.91 73.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.34 -0.85 . . . . 0.0 108.96 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -61.31 -18.27 57.75 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.627 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.675 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 94.6 m-20 -96.9 110.14 22.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.33 -0.856 . . . . 0.0 110.314 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.537 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 80.1 tt0 -69.27 -30.64 68.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.423 -0.798 . . . . 0.0 109.78 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 pttt -69.56 -11.56 60.93 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.431 -0.793 . . . . 0.0 110.76 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.509 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 43.9 p -85.32 -22.88 28.33 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.821 -1.175 . . . . 0.0 112.258 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.675 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -122.51 -26.77 4.52 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.256 -1.528 . . . . 0.0 109.839 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.632 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 14.9 p-10 -80.14 142.07 35.13 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.874 -1.141 . . . . 0.0 109.855 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 35' ' ' VAL . 10.1 p -112.34 -16.84 8.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.05 -164.0 51.16 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.0 p -58.11 133.74 55.85 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.212 -1.169 . . . . 0.0 108.578 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.6 t -172.09 154.74 3.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.313 -0.867 . . . . 0.0 109.385 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -76.16 144.73 40.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.972 -1.08 . . . . 0.0 109.357 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.46 ' HG2' ' HE ' ' A' ' 36' ' ' ARG . 86.0 mtm180 -59.85 -39.51 85.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -57.9 -38.9 76.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.818 -1.176 . . . . 0.0 109.017 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -58.18 -34.25 70.12 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -62.51 -35.97 81.08 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.521 ' CG ' ' NE ' ' A' ' 26' ' ' ARG . 71.7 tt0 -55.95 -50.14 71.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.081 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -60.31 -44.17 95.69 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.976 -1.078 . . . . 0.0 108.272 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -66.72 -30.3 70.51 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.574 HD13 ' CG1' ' A' ' 54' ' ' VAL . 7.0 mt -92.86 -6.44 48.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.213 -0.93 . . . . 0.0 109.505 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.586 HH11 ' HG2' ' A' ' 26' ' ' ARG . 20.7 mtt-85 -100.59 137.39 39.05 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.328 -0.857 . . . . 0.0 109.641 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.44 -2.17 86.28 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.563 ' HD3' HG21 ' A' ' 32' ' ' THR . 4.5 mtpt -103.39 147.08 27.55 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.998 -1.295 . . . . 0.0 110.004 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.741 ' CG ' HH11 ' A' ' 29' ' ' ARG . 2.1 mtt-85 -74.73 161.61 29.47 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.598 0.713 . . . . 0.0 110.75 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.555 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 60.3 t0 -59.91 143.09 52.37 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.429 -0.794 . . . . 0.0 109.677 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 106.98 -25.04 23.58 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.563 HG21 ' HD3' ' A' ' 28' ' ' LYS . 60.6 m -78.99 122.46 26.2 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.258 -1.142 . . . . 0.0 108.775 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.845 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -134.19 173.64 11.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.712 -1.243 . . . . 0.0 110.713 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.46 ' CB ' HG11 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -149.74 159.84 44.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.723 -0.61 . . . . 0.0 109.676 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 13' ' ' VAL . 50.7 t -110.2 127.75 66.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.278 -0.889 . . . . 0.0 108.758 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.759 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -145.2 -175.85 4.86 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 C--N 1.302 -1.478 0 O-C-N 120.928 -1.107 . . . . 0.0 108.378 179.388 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -160.31 133.51 6.73 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.59 -1.318 . . . . 0.0 110.292 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' ' 57' ' ' CYS . 14.3 p -106.31 135.11 48.38 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.684 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.462 ' CB ' HD11 ' A' ' 25' ' ' LEU . 55.0 m -104.74 138.22 41.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' ' 33' ' ' PHE . 12.2 t -131.99 152.93 37.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.188 -0.945 . . . . 0.0 109.921 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.555 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 58.0 t -100.71 122.05 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.689 HG22 ' N ' ' A' ' 51' ' ' ASP . 13.4 p -160.47 172.44 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.678 -1.264 . . . . 0.0 111.861 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.689 ' N ' HG22 ' A' ' 50' ' ' VAL . 64.6 t0 48.44 20.52 0.3 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.526 0.679 . . . . 0.0 109.57 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.31 10.74 85.7 Favored Glycine 0 C--N 1.295 -1.749 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.106 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.663 ' CG ' ' NZ ' ' A' ' 55' ' ' LYS . 16.7 pt-20 -139.98 157.84 45.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.727 -1.455 . . . . 0.0 110.472 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.574 ' CG1' HD13 ' A' ' 25' ' ' LEU . 74.9 t -78.85 142.09 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 110.097 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.663 ' NZ ' ' CG ' ' A' ' 53' ' ' GLU . 0.9 OUTLIER -119.83 153.54 35.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.496 -0.753 . . . . 0.0 110.419 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -126.98 74.94 1.54 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.439 -0.788 . . . . 0.0 108.947 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.508 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 44.3 t -65.97 138.86 58.1 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.369 -0.832 . . . . 0.0 109.365 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.78 139.89 23.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.508 -0.745 . . . . 0.0 110.547 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.9 mt -118.44 129.97 73.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.01 -1.056 . . . . 0.0 110.867 -179.43 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.1 p . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.375 0.607 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.4 mt -59.9 -35.27 74.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.413 -0.804 . . . . 0.0 110.082 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.4 ' O ' HG12 ' A' ' 82' ' ' VAL . 38.1 ttmt -57.37 -40.85 79.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.01 -1.056 . . . . 0.0 109.212 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -69.86 -34.65 73.88 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.082 -1.011 . . . . 0.0 109.228 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.802 ' C ' HD13 ' A' ' 81' ' ' LEU . 3.0 tm? -60.64 -49.29 78.13 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.098 -1.001 . . . . 0.0 110.819 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.434 ' CG1' ' N ' ' A' ' 83' ' ' LEU . 2.4 p -65.5 -37.64 80.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 120.844 -1.16 . . . . 0.0 109.485 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.434 ' N ' ' CG1' ' A' ' 82' ' ' VAL . 54.6 tp -68.52 -45.74 71.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.299 -0.876 . . . . 0.0 110.842 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -61.85 -40.02 93.89 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.119 -0.988 . . . . 0.0 110.143 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -71.02 -24.28 62.34 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.943 -1.098 . . . . 0.0 110.91 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.585 ' O ' ' OE1' ' A' ' 86' ' ' GLN . 0.7 OUTLIER -61.66 -22.92 65.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.023 -1.048 . . . . 0.0 108.768 179.156 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -101.59 -33.85 9.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.4 -0.812 . . . . 0.0 108.98 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.5 m -82.55 142.62 31.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.407 -0.808 . . . . 0.0 109.893 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.3 m -96.68 129.94 43.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.596 -0.69 . . . . 0.0 109.97 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.727 ' O ' ' N ' ' A' ' 92' ' ' GLN . 1.6 mt -65.6 -12.48 53.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.38 -0.825 . . . . 0.0 111.794 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.738 ' N ' ' O ' ' A' ' 97' ' ' LEU . 8.2 p -9.23 -53.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.015 0 O-C-N 121.409 -0.807 . . . . 0.0 111.466 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.727 ' N ' ' O ' ' A' ' 90' ' ' LEU . 54.3 tt0 -36.41 146.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 109.575 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.683 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.9 OUTLIER 103.94 -120.13 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.192 0.52 . . . . 0.0 109.777 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 30.4 m120 -72.16 13.3 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 109.387 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 93' ' ' HIS . 94.5 m-20 62.39 3.74 1.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.632 -0.667 . . . . 0.0 109.751 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 98' ' ' ASN . 14.6 m -116.19 7.94 14.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.943 -1.098 . . . . 0.0 109.006 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.803 HD22 ' N ' ' A' ' 97' ' ' LEU . 2.4 mm? -84.05 26.45 0.74 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.463 ' N ' ' HA ' ' A' ' 91' ' ' VAL . 57.0 t30 -75.41 75.21 2.49 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 122.277 1.037 . . . . 0.0 108.824 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.521 HG13 HD12 ' A' ' 90' ' ' LEU . 6.7 p -147.4 158.07 9.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.457 ' N ' HG22 ' A' ' 99' ' ' VAL . 18.8 p -125.11 159.54 31.21 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.83 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.845 HD22 ' CG ' ' A' ' 33' ' ' PHE . 51.6 mt -80.02 70.35 6.58 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.523 ' CB ' HE22 ' A' ' 86' ' ' GLN . . . -96.69 -27.24 14.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.453 -0.779 . . . . 0.0 111.7 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -114.06 107.86 51.49 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.621 -1.299 . . . . 0.0 111.215 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.412 ' CB ' ' HB ' ' A' ' 10' ' ' THR . 20.8 Cg_exo -59.65 145.03 99.24 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.236 1.957 . . . . 0.0 110.509 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.753 HG13 ' CD2' ' A' ' 106' ' ' TYR . 7.0 p -70.57 -31.61 46.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.072 -1.018 . . . . 0.0 108.893 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.753 ' CD2' HG13 ' A' ' 105' ' ' VAL . 75.9 m-85 -111.54 31.51 6.08 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.558 -0.714 . . . . 0.0 109.737 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 106' ' ' TYR . . . . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.948 . . . . 0.0 109.311 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.7 mt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -70.85 -4.33 14.55 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.805 1.67 . . . . 0.0 111.189 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -73.05 -22.61 60.59 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -60.94 -31.69 71.23 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.938 -1.102 . . . . 0.0 109.4 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.51 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 81.6 m-20 -92.53 131.99 37.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.091 -1.006 . . . . 0.0 110.16 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.557 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 60.8 tt0 -70.46 -31.61 68.83 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.847 0.832 . . . . 0.0 109.901 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 tmpt? -62.14 -27.42 68.93 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.75 -0.594 . . . . 0.0 112.368 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.599 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 23.6 p -68.83 -27.14 65.58 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.487 -1.383 . . . . 0.0 112.187 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.652 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -120.04 -28.47 5.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.239 -1.538 . . . . 0.0 109.445 179.529 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -79.75 125.1 29.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.237 -0.915 . . . . 0.0 109.531 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 13' ' ' VAL . 60.0 t -99.81 -3.23 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 109.528 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.8 -148.74 26.21 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.1 m -83.08 102.98 12.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.254 . . . . 0.0 109.985 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.467 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 32.9 t -124.37 146.29 48.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.432 -0.792 . . . . 0.0 109.401 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.68 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 57.4 p30 -79.72 154.34 28.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 108.77 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.581 ' CG ' ' NH2' ' A' ' 36' ' ' ARG . 74.5 mtt180 -59.83 -35.89 75.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.144 -0.973 . . . . 0.0 109.603 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -59.75 -42.87 94.19 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.45 -0.781 . . . . 0.0 109.651 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.68 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 79.6 tttt -68.12 -37.75 81.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.855 -1.153 . . . . 0.0 109.257 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.55 -31.35 72.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.443 -0.786 . . . . 0.0 108.967 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 26' ' ' ARG . 61.7 tt0 -59.49 -49.6 77.15 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -57.84 -39.02 76.71 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 24' ' ' LEU . 78.0 mt -71.25 -27.15 63.25 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.249 -0.907 . . . . 0.0 108.869 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.405 HD23 ' CG2' ' A' ' 49' ' ' VAL . 25.2 mt -96.78 -9.56 28.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 109.302 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -91.85 124.5 36.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.8 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.64 21.94 79.3 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.771 ' HE2' HG21 ' A' ' 32' ' ' THR . 41.7 tptt -104.62 126.66 51.92 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -57.82 144.69 37.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.461 -0.774 . . . . 0.0 110.514 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 54.8 p30 -54.34 155.85 3.6 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.659 -0.651 . . . . 0.0 109.439 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.81 -30.96 9.28 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.771 HG21 ' HE2' ' A' ' 28' ' ' LYS . 93.8 m -81.81 127.28 32.81 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.522 -0.987 . . . . 0.0 109.067 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 101' ' ' LEU . 0.6 OUTLIER -134.45 153.37 51.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.053 -1.029 . . . . 0.0 108.986 179.464 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.753 HD22 HG21 ' A' ' 105' ' ' VAL . 6.7 mt -107.28 172.26 6.93 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.004 0.907 . . . . 0.0 110.589 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.486 HG22 ' SG ' ' A' ' 46' ' ' CYS . 73.4 t -147.21 110.12 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.581 ' NH2' ' CG ' ' A' ' 18' ' ' ARG . 2.8 ptt180 -145.54 -179.3 6.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.016 -1.052 . . . . 0.0 109.834 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--N 1.304 -1.382 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.965 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' ILE . 70.8 m-85 . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.44 144.57 22.96 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.044 -1.035 . . . . 0.0 108.94 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.486 ' SG ' HG22 ' A' ' 35' ' ' VAL . 20.8 m -114.07 126.61 55.29 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 108.451 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 34' ' ' LEU . 50.5 m -88.59 131.24 35.03 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.499 -0.75 . . . . 0.0 109.382 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.449 HG21 ' CD1' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -125.28 142.11 43.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.139 -0.976 . . . . 0.0 109.459 179.835 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.405 ' CG2' HD23 ' A' ' 25' ' ' LEU . 21.5 t -108.95 127.06 65.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.357 -0.839 . . . . 0.0 109.833 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 53' ' ' GLU . 4.9 p -111.84 161.45 10.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.082 -1.011 . . . . 0.0 109.957 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -65.48 60.14 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 169.32 -36.28 0.19 Allowed Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.6 -1.286 . . . . 0.0 111.126 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.565 ' O ' HG12 ' A' ' 50' ' ' VAL . 78.2 tt0 -156.36 143.22 18.75 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.389 -1.653 . . . . 0.0 112.396 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.62 134.33 27.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.575 ' HB2' ' HZ2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -124.97 161.08 27.46 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.824 -1.172 . . . . 0.0 111.695 -178.093 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -121.35 100.85 7.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.392 0.615 . . . . 0.0 109.362 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.46 ' O ' ' N ' ' A' ' 46' ' ' CYS . 49.2 t -85.3 129.33 34.83 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.85 135.86 28.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.423 -0.798 . . . . 0.0 111.145 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 44' ' ' TYR . 48.7 mm -106.53 128.01 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 120.974 -1.079 . . . . 0.0 110.358 -178.915 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.1 m . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 121.94 0.876 . . . . 0.0 111.667 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 78' ' ' LEU . 79.1 mt -65.62 -31.65 72.79 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.527 0.68 . . . . 0.0 109.239 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -60.52 -41.24 94.01 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.392 -0.818 . . . . 0.0 108.941 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.79 -43.83 97.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.146 -0.971 . . . . 0.0 109.158 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.767 HD23 ' C ' ' A' ' 81' ' ' LEU . 7.1 tt -61.27 -43.58 98.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 109.907 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 82.2 t -71.1 -37.29 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 86' ' ' GLN . 86.4 mt -67.58 -42.87 81.81 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.241 -0.912 . . . . 0.0 109.634 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -69.11 -38.26 78.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.073 -1.017 . . . . 0.0 110.9 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.628 ' CB ' HD21 ' A' ' 101' ' ' LEU . 5.4 m-85 -72.36 -17.71 61.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.37 -0.831 . . . . 0.0 111.876 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 83' ' ' LEU . 2.5 pt20 -77.26 -24.56 51.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.287 -1.508 . . . . 0.0 108.241 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.43 ' N ' ' HG3' ' A' ' 86' ' ' GLN . 83.0 t60 -96.47 -15.31 21.8 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.533 -0.729 . . . . 0.0 109.59 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.4 m -102.87 139.94 37.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.062 -1.024 . . . . 0.0 109.007 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.438 ' OG ' HG12 ' A' ' 91' ' ' VAL . 25.1 p -88.6 135.5 33.46 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.465 -0.772 . . . . 0.0 110.685 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.527 ' O ' ' C ' ' A' ' 91' ' ' VAL . 77.0 mt -69.73 -10.27 57.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.642 -0.661 . . . . 0.0 110.088 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.728 ' N ' ' O ' ' A' ' 97' ' ' LEU . 9.9 p -33.98 -40.56 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.975 -1.078 . . . . 0.0 110.132 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.537 ' N ' HG13 ' A' ' 91' ' ' VAL . 81.2 mt-30 -75.97 -5.9 48.46 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.356 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.586 ' HB3' HD23 ' A' ' 97' ' ' LEU . 53.4 t-80 -59.53 -43.55 93.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.66 -1.275 . . . . 0.0 108.42 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.636 ' H ' HD23 ' A' ' 97' ' ' LEU . 16.3 t30 -148.71 19.85 1.02 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.415 ' CA ' ' O ' ' A' ' 91' ' ' VAL . 49.1 t0 64.68 38.77 6.81 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.365 0.602 . . . . 0.0 109.773 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.432 ' H ' HD22 ' A' ' 97' ' ' LEU . 62.6 m -168.19 2.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.851 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.978 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.0 OUTLIER -101.62 64.47 0.99 Allowed 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.16 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -79.06 71.11 5.52 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.275 -0.891 . . . . 0.0 110.723 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.564 ' CG1' HG23 ' A' ' 50' ' ' VAL . 6.9 p -148.5 158.41 7.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.49 ' N ' HG22 ' A' ' 99' ' ' VAL . 58.7 p -122.27 150.66 42.01 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.666 ' O ' HD12 ' A' ' 101' ' ' LEU . 2.2 pp -88.34 47.14 1.46 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.204 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.33 -4.83 57.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.7 -0.625 . . . . 0.0 111.368 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 32' ' ' THR . 88.1 m-85 -112.96 120.4 40.69 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.612 -1.305 . . . . 0.0 110.068 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.793 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 26.5 Cg_endo -73.29 146.48 40.39 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.681 2.254 . . . . 0.0 112.04 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.753 HG21 HD22 ' A' ' 34' ' ' LEU . 9.2 p -80.88 -25.46 10.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.574 -0.704 . . . . 0.0 110.667 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.56 ' HD1' HG13 ' A' ' 105' ' ' VAL . 2.4 m-85 -112.8 47.62 1.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.222 -0.924 . . . . 0.0 110.577 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.793 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . . . . . . 0 C--N 1.302 -1.473 0 O-C-N 120.928 -1.107 . . . . 0.0 108.242 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.805 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.2 mm? . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.36 -1.85 9.63 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.907 2.404 . . . . 0.0 111.383 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.591 ' ND1' HG12 ' A' ' 82' ' ' VAL . 30.2 m170 -65.63 -21.42 66.57 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.793 -0.567 . . . . 0.0 109.767 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.411 ' O ' ' HE3' ' A' ' 79' ' ' LYS . 85.7 m-70 -58.97 -23.5 61.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.116 -0.99 . . . . 0.0 109.427 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.714 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 72.8 m-20 -105.74 134.38 48.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 109.915 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 12' ' ' ASN . 92.5 mt-10 -71.31 -30.01 65.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.952 . . . . 0.0 110.341 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.717 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -60.26 -31.38 70.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.041 -1.037 . . . . 0.0 110.23 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.785 HG22 ' HA ' ' A' ' 107' ' ' ALA . 22.7 p -67.39 -32.21 72.96 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.345 -0.847 . . . . 0.0 110.926 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.714 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -131.72 -3.72 3.68 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.534 -1.354 . . . . 0.0 111.199 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 8' ' ' GLU . 58.4 t30 -96.1 117.74 31.31 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.477 -1.389 . . . . 0.0 111.524 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.637 HG12 ' CB ' ' A' ' 16' ' ' SER . 11.9 t -134.71 33.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.6 -30.21 26.79 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.3 m -60.29 -38.5 83.81 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.058 -1.26 . . . . 0.0 109.414 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.637 ' CB ' HG12 ' A' ' 13' ' ' VAL . 74.4 m -67.11 142.2 57.17 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.3 -0.875 . . . . 0.0 110.746 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -83.55 166.14 18.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.597 -0.689 . . . . 0.0 109.205 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.571 ' CG ' HH12 ' A' ' 36' ' ' ARG . 38.0 ttp180 -59.35 -40.7 87.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.092 -1.005 . . . . 0.0 109.426 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -59.74 -45.67 91.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.049 -1.032 . . . . 0.0 108.504 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -67.96 -33.62 75.01 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.64 92.77 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 26' ' ' ARG . 99.0 mt-10 -55.43 -48.04 75.04 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -60.57 -44.19 96.45 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.11 -41.18 97.34 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.623 HD11 ' HB3' ' A' ' 47' ' ' SER . 17.7 mt -69.31 -32.65 71.91 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' GLU . 97.6 mtt180 -85.25 2.46 43.82 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.409 0.623 . . . . 0.0 109.801 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.56 8.47 32.38 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.831 ' HZ2' ' HB ' ' A' ' 105' ' ' VAL . 11.9 pttt -142.82 157.51 44.54 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.89 -1.359 . . . . 0.0 110.69 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.73 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.0 OUTLIER -85.56 163.86 18.12 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.029 0.919 . . . . 0.0 111.577 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.556 ' OD1' ' C ' ' A' ' 50' ' ' VAL . 76.4 m-20 -42.96 159.81 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.63 0.728 . . . . 0.0 110.442 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.47 -27.08 5.36 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.7 m -86.4 124.77 33.11 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.326 -1.102 . . . . 0.0 108.432 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.786 ' HB2' HG22 ' A' ' 48' ' ' VAL . 0.5 OUTLIER -132.9 173.12 11.73 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.137 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.652 ' CB ' HG11 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -150.3 166.46 29.9 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.23 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.507 HG22 ' SG ' ' A' ' 46' ' ' CYS . 46.8 t -112.31 140.36 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.571 HH12 ' CG ' ' A' ' 18' ' ' ARG . 12.6 ptt180 -153.71 178.2 10.13 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.014 -1.054 . . . . 0.0 109.036 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 11.3 pm0 . . . . . 0 C--N 1.302 -1.481 0 O-C-N 120.83 -1.169 . . . . 0.0 108.237 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.147 0.498 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.03 148.91 17.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.213 -0.929 . . . . 0.0 110.695 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.518 ' SG ' HD11 ' A' ' 59' ' ' ILE . 75.8 m -111.2 124.31 51.96 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.198 -0.939 . . . . 0.0 108.631 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.623 ' HB3' HD11 ' A' ' 25' ' ' LEU . 69.0 m -91.2 139.82 30.39 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.115 -0.99 . . . . 0.0 110.151 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.786 HG22 ' HB2' ' A' ' 33' ' ' PHE . 56.2 t -133.51 157.44 42.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.44 ' N ' HG12 ' A' ' 48' ' ' VAL . 96.0 t -112.9 135.97 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.556 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -123.78 158.51 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.747 -1.221 . . . . 0.0 109.664 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.542 ' CA ' ' OD2' ' A' ' 30' ' ' ASP . 66.2 t0 -67.23 61.79 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.633 0.73 . . . . 0.0 109.934 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 172.1 -40.38 0.17 Allowed Glycine 0 C--N 1.292 -1.888 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.497 ' H ' HG12 ' A' ' 50' ' ' VAL . 79.0 tt0 -162.38 160.49 26.56 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.118 -1.225 . . . . 0.0 110.84 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.553 ' CG1' HD13 ' A' ' 25' ' ' LEU . 43.8 t -88.13 126.33 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' NZ ' ' HB3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -114.52 155.71 25.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.841 -1.162 . . . . 0.0 110.297 -178.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 57.3 m170 -116.43 119.83 36.88 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.415 -0.803 . . . . 0.0 108.888 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.507 ' O ' ' N ' ' A' ' 46' ' ' CYS . 41.8 t -92.46 124.2 36.32 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 58' ' ' VAL . 2.8 p -96.28 133.4 37.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 121.114 -0.991 . . . . 0.0 111.094 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD11 ' SG ' ' A' ' 46' ' ' CYS . 96.7 mt -119.33 130.31 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 . . . . . 0 C--N 1.299 -1.599 0 O-C-N 121.076 -1.015 . . . . 0.0 110.097 -179.23 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.53 0.681 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.7 mt -61.4 -38.13 85.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.383 -0.823 . . . . 0.0 109.545 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 6' ' ' HIS . 24.0 mmtm -59.68 -39.09 83.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.269 -0.895 . . . . 0.0 108.807 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -65.58 -42.5 91.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 109.001 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.571 HD23 ' C ' ' A' ' 81' ' ' LEU . 8.4 tt -61.09 -42.83 99.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.367 -0.833 . . . . 0.0 109.183 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.591 HG12 ' ND1' ' A' ' 5' ' ' HIS . 70.5 t -67.09 -47.04 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.306 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.1 mt -67.48 -43.04 81.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.481 -0.762 . . . . 0.0 110.104 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -61.47 -42.58 99.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 0.0 109.885 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.894 ' HB3' HD13 ' A' ' 101' ' ' LEU . 5.0 m-85 -60.58 -28.38 68.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.16 -0.962 . . . . 0.0 109.632 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -65.4 -34.92 79.44 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.935 -1.103 . . . . 0.0 108.769 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -84.56 -25.18 28.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.349 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.1 m -88.78 129.33 35.58 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.911 -1.118 . . . . 0.0 109.679 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.608 ' HA ' HG22 ' A' ' 100' ' ' THR . 66.5 m -81.51 133.52 35.4 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 91' ' ' VAL . 86.6 mt -71.84 -19.04 62.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.297 -0.877 . . . . 0.0 111.964 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.785 ' O ' ' N ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -34.23 -51.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.874 -1.142 . . . . 0.0 110.228 -178.251 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -54.72 -29.13 52.57 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.077 0.465 . . . . 0.0 110.56 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.798 ' HB3' HD12 ' A' ' 97' ' ' LEU . 64.4 t-80 -50.05 -48.14 53.09 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.939 -1.101 . . . . 0.0 108.797 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.485 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 64.9 t-20 -140.18 19.85 2.43 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.785 ' N ' ' O ' ' A' ' 91' ' ' VAL . 53.5 t0 59.92 8.16 1.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.1 p -137.22 11.56 3.04 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.278 -0.889 . . . . 0.0 109.571 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.798 HD12 ' HB3' ' A' ' 93' ' ' HIS . 23.7 mt -103.32 69.94 1.03 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.705 -1.247 . . . . 0.0 108.509 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.523 ' CA ' HG13 ' A' ' 91' ' ' VAL . 41.5 p-10 -78.25 69.28 4.43 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.608 0.718 . . . . 0.0 110.395 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 100' ' ' THR . 53.9 t -156.38 158.09 3.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.469 0.652 . . . . 0.0 109.514 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.608 HG22 ' HA ' ' A' ' 89' ' ' SER . 72.8 p -131.17 164.09 26.27 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.575 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.894 HD13 ' HB3' ' A' ' 85' ' ' TYR . 6.2 mp -82.71 68.12 9.05 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -97.94 -27.02 14.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.601 -0.687 . . . . 0.0 111.225 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -112.66 132.67 22.13 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 120.692 -1.255 . . . . 0.0 111.091 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.495 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 73.6 Cg_endo -76.14 142.67 24.76 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.764 2.976 . . . . 0.0 111.975 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.831 ' HB ' ' HZ2' ' A' ' 28' ' ' LYS . 9.7 p -76.7 -33.13 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.159 -0.963 . . . . 0.0 111.954 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -130.15 60.56 1.61 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.55 -1.344 . . . . 0.0 110.889 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.785 ' HA ' HG22 ' A' ' 10' ' ' THR . . . . . . . . 0 C--N 1.299 -1.625 0 C-N-CA 119.271 -0.971 . . . . 0.0 109.524 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.192 0.52 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.51 -16.92 5.91 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.671 2.247 . . . . 0.0 111.771 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.619 ' NE2' ' OE1' ' A' ' 86' ' ' GLN . 96.4 m-70 -67.18 -19.94 65.65 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.377 -0.827 . . . . 0.0 109.872 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -60.19 -36.59 77.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.868 -1.145 . . . . 0.0 109.506 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.633 ' OD2' ' NZ ' ' A' ' 9' ' ' LYS . 47.9 t0 -92.17 123.23 35.36 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.078 -1.014 . . . . 0.0 109.827 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.519 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 19.8 tt0 -64.44 -30.54 71.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.725 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.633 ' NZ ' ' OD2' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -61.48 -35.18 76.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.702 -0.624 . . . . 0.0 111.553 -179.327 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.715 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 13.7 p -51.63 -39.91 58.95 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.996 -1.065 . . . . 0.0 110.389 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.715 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -117.09 -19.29 9.79 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.857 -1.152 . . . . 0.0 110.684 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.437 ' CB ' ' HG2' ' A' ' 8' ' ' GLU . 49.4 t-20 -89.53 123.76 33.92 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.872 -1.142 . . . . 0.0 111.253 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 35' ' ' VAL . 27.0 m -100.7 -16.0 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.302 -0.873 . . . . 0.0 109.207 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASN . . . 78.87 -141.37 24.29 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.515 ' HA ' ' NH2' ' A' ' 36' ' ' ARG . 36.8 t -81.76 104.53 12.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -1.093 . . . . 0.0 108.748 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 t -135.29 135.09 40.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.448 -0.782 . . . . 0.0 109.93 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -64.61 143.39 57.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.112 -0.993 . . . . 0.0 109.694 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.525 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 37.9 mtt-85 -60.17 -33.44 72.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.0 108.779 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -59.67 -43.41 94.01 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -62.41 -34.3 76.47 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.09 -35.13 76.18 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 26' ' ' ARG . 94.9 mt-10 -60.07 -45.83 91.58 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.819 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -63.17 -43.0 99.48 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.29 -36.66 79.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.0 109.27 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.633 HD23 ' HD2' ' A' ' 28' ' ' LYS . 56.1 mt -87.21 -15.13 39.13 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.141 -0.974 . . . . 0.0 109.047 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 22' ' ' GLU . 16.1 mtp180 -77.71 -22.42 50.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.13 -0.981 . . . . 0.0 109.372 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.43 19.84 23.79 Favored Glycine 0 C--N 1.285 -2.282 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.68 ' NZ ' HG23 ' A' ' 105' ' ' VAL . 5.1 ttmm -105.91 131.15 53.57 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.571 -0.958 . . . . 0.0 111.456 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -85.39 166.44 16.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.681 -0.637 . . . . 0.0 110.149 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.633 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 63.4 t0 -63.15 142.08 58.52 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.446 -0.784 . . . . 0.0 110.475 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.627 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 100.87 -19.28 52.85 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.43 ' HB ' ' CG ' ' A' ' 28' ' ' LYS . 60.4 m -97.14 136.35 37.8 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.136 -1.214 . . . . 0.0 109.272 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.583 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -139.37 172.79 12.3 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.755 -1.216 . . . . 0.0 109.892 179.385 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.435 ' CD2' HD21 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -139.7 153.96 47.36 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.816 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.58 ' O ' HG22 ' A' ' 13' ' ' VAL . 67.5 t -104.63 136.8 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.969 -1.082 . . . . 0.0 108.527 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.712 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -144.69 -169.9 3.27 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 108.924 -178.17 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.712 ' H ' ' CD ' ' A' ' 36' ' ' ARG . 9.8 mt-10 . . . . . 0 C--N 1.303 -1.446 0 O-C-N 120.909 -1.12 . . . . 0.0 108.234 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.537 ' O ' ' O ' ' A' ' 59' ' ' ILE . 94.9 m-85 . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 121.918 0.866 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.422 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -155.4 129.5 8.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.436 -0.79 . . . . 0.0 109.154 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 57' ' ' CYS . 20.6 p -112.93 154.44 26.4 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.5 m -118.73 142.89 47.26 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.089 -0.645 . . . . 0.0 109.493 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.54 HG22 ' N ' ' A' ' 49' ' ' VAL . 1.9 p -132.58 161.3 41.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.298 -0.876 . . . . 0.0 108.901 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.54 ' N ' HG22 ' A' ' 48' ' ' VAL . 47.5 t -117.44 132.47 67.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.655 ' HB ' ' HZ2' ' A' ' 55' ' ' LYS . 8.6 p -115.91 164.44 12.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.224 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.633 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 95.9 m-20 -59.66 28.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.981 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -154.58 -38.0 0.02 OUTLIER Glycine 0 N--CA 1.483 1.785 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.629 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.569 ' CD ' ' O ' ' A' ' 52' ' ' GLY . 55.0 mp0 -159.26 164.58 34.84 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.65 -1.5 . . . . 0.0 112.512 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.8 t -89.33 141.15 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.655 ' HZ2' ' HB ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -131.04 165.71 22.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.843 -1.161 . . . . 0.0 111.617 -178.186 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -128.42 75.84 1.66 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.48 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 46.3 t -56.6 134.24 54.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.205 -0.934 . . . . 0.0 109.62 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.86 134.41 42.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.582 0.705 . . . . 0.0 110.112 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.537 ' O ' ' O ' ' A' ' 44' ' ' TYR . 49.5 mm -108.41 129.34 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 . . . . . 0 N--CA 1.495 1.809 0 O-C-N 120.857 -1.152 . . . . 0.0 110.793 -178.702 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.0 p . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.517 0.675 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.29 -32.06 72.74 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.559 -0.713 . . . . 0.0 109.395 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.403 ' O ' HG12 ' A' ' 82' ' ' VAL . 61.3 mttp -59.6 -41.19 89.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.896 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -75.41 -26.68 58.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.094 -1.004 . . . . 0.0 109.601 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.6 tt -67.99 -42.25 81.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.164 -0.96 . . . . 0.0 110.371 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 83' ' ' LEU . 4.3 p -68.61 -46.73 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.204 -0.935 . . . . 0.0 110.359 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.53 ' N ' HG13 ' A' ' 82' ' ' VAL . 85.9 mt -66.02 -40.05 90.73 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.898 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.451 ' HA ' ' CD2' ' A' ' 87' ' ' HIS . 21.3 t60 -58.65 -41.21 85.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.297 -0.877 . . . . 0.0 110.233 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.446 ' HB2' HD12 ' A' ' 101' ' ' LEU . 7.2 m-30 -74.62 -25.75 59.43 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.088 -1.007 . . . . 0.0 109.67 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.619 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 30.5 tt0 -63.92 -36.57 84.4 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.998 -1.064 . . . . 0.0 110.33 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.471 ' CE1' ' OG1' ' A' ' 88' ' ' THR . 21.7 p80 -93.21 -7.05 46.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.057 -1.027 . . . . 0.0 109.272 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' CE1' ' A' ' 87' ' ' HIS . 33.3 m -105.59 138.3 42.01 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 108.895 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.522 ' HA ' HG22 ' A' ' 100' ' ' THR . 2.8 m -89.79 130.14 36.09 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 109.268 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.562 ' O ' ' C ' ' A' ' 91' ' ' VAL . 83.0 mt -71.27 -18.65 62.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.658 -0.651 . . . . 0.0 110.246 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.73 ' N ' ' O ' ' A' ' 97' ' ' LEU . 14.7 p -31.36 -47.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.314 -0.866 . . . . 0.0 109.638 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.692 ' N ' HG13 ' A' ' 91' ' ' VAL . 76.6 mt-30 -57.61 -45.66 85.08 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.131 -178.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.455 ' C ' ' O ' ' A' ' 92' ' ' GLN . 75.1 m80 -48.53 -50.42 32.1 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.807 ' O ' ' N ' ' A' ' 96' ' ' SER . 97.7 m-20 -134.31 114.19 12.74 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 94' ' ' ASN . 84.1 m-20 -31.73 -19.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.525 -0.734 . . . . 0.0 111.393 -177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.807 ' N ' ' O ' ' A' ' 94' ' ' ASN . 54.6 m -107.66 20.46 18.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.635 -1.291 . . . . 0.0 111.698 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.73 ' O ' ' N ' ' A' ' 91' ' ' VAL . 8.3 mt -97.7 57.43 1.35 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.444 -1.41 . . . . 0.0 109.263 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -78.32 86.03 4.43 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.386 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.539 HG13 HD12 ' A' ' 90' ' ' LEU . 13.9 p -168.7 151.88 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.522 HG22 ' HA ' ' A' ' 89' ' ' SER . 34.9 p -131.68 159.34 38.64 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.469 -0.77 . . . . 0.0 109.342 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.583 HD22 ' CG ' ' A' ' 33' ' ' PHE . 19.2 mt -78.22 69.79 4.48 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.942 -1.099 . . . . 0.0 108.175 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.57 -31.45 16.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.451 -0.78 . . . . 0.0 112.714 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -122.53 136.14 26.31 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.507 -1.371 . . . . 0.0 111.393 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.785 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 68.0 Cg_endo -77.08 152.88 31.81 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 123.133 2.556 . . . . 0.0 111.956 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.68 HG23 ' NZ ' ' A' ' 28' ' ' LYS . 9.6 p -79.16 -16.41 13.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.093 -1.004 . . . . 0.0 110.626 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.433 ' HE2' HG12 ' A' ' 13' ' ' VAL . 13.2 m-85 -129.73 61.18 1.57 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.073 -1.017 . . . . 0.0 111.016 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.785 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . . . . . . 0 C--N 1.298 -1.638 0 O-C-N 121.132 -0.98 . . . . 0.0 108.795 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -58.96 -11.77 13.33 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.948 1.765 . . . . 0.0 111.576 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.608 ' HB2' HD11 ' A' ' 83' ' ' LEU . 98.0 m-70 -67.2 -31.7 72.27 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.803 -0.561 . . . . 0.0 110.749 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.556 ' ND1' ' N ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -63.06 -15.4 56.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 0.0 110.153 -178.758 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.693 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 27.1 t0 -102.51 126.14 49.47 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.723 ' O ' ' N ' ' A' ' 12' ' ' ASN . 4.0 mp0 -66.18 -27.29 67.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 110.644 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.679 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -62.69 -39.05 92.77 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.988 -1.07 . . . . 0.0 109.689 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.764 HG22 ' HA ' ' A' ' 107' ' ' ALA . 22.1 p -59.04 -33.76 71.13 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.694 -0.629 . . . . 0.0 109.909 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.693 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -123.91 -31.59 3.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.808 -1.183 . . . . 0.0 111.728 -179.692 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.723 ' N ' ' O ' ' A' ' 8' ' ' GLU . 28.5 t-20 -87.84 130.65 34.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.539 -1.35 . . . . 0.0 110.857 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -107.48 -6.52 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASN . . . 92.77 -161.86 26.13 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.4 p -67.44 153.59 43.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -1.14 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 t -163.59 150.51 12.23 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.424 -0.797 . . . . 0.0 109.407 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 18' ' ' ARG . 86.4 m-20 -88.12 7.95 29.18 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.473 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 4.5 mmp_? 66.73 9.01 6.37 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.468 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.715 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 36.5 p-10 -77.52 -53.67 7.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.071 -1.018 . . . . 0.0 108.27 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.715 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 45.1 pttt -68.88 -26.29 65.05 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -56.62 -45.62 81.39 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 26' ' ' ARG . 59.2 mm-40 -59.16 -47.04 86.78 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -62.8 -42.68 99.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 24' ' ' LEU . 79.0 mt -69.94 -29.97 67.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 109.504 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.536 HD11 ' OG ' ' A' ' 47' ' ' SER . 16.0 mt -89.79 -13.28 36.98 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 22' ' ' GLU . 89.5 mtt180 -91.5 115.27 27.9 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.62 2.89 50.05 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.536 ' O ' HG11 ' A' ' 49' ' ' VAL . 36.4 mmtt -100.77 137.82 38.64 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.225 -1.162 . . . . 0.0 109.212 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -69.64 156.49 38.87 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.664 -0.648 . . . . 0.0 109.695 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 63.2 t0 -57.81 141.92 47.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.587 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 108.7 -27.82 12.62 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.465 ' HG1' ' HD2' ' A' ' 103' ' ' TYR . 86.4 m -79.85 120.8 24.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.133 -1.216 . . . . 0.0 108.437 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -139.89 176.57 8.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.851 -1.156 . . . . 0.0 110.931 -178.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.68 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -150.76 161.63 42.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.576 -0.703 . . . . 0.0 110.233 179.215 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.493 HG22 ' SG ' ' A' ' 46' ' ' CYS . 43.7 t -107.16 139.97 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.656 ' NH1' ' HB3' ' A' ' 45' ' ' ALA . 1.1 ppt_? -158.72 -160.21 0.85 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.411 ' O ' ' HD2' ' A' ' 36' ' ' ARG . 82.7 mt-10 . . . . . 0 C--N 1.306 -1.325 0 O-C-N 120.567 -1.333 . . . . 0.0 109.079 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.656 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . . . -159.38 151.61 21.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.978 -1.076 . . . . 0.0 110.062 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.65 ' SG ' HD11 ' A' ' 59' ' ' ILE . 77.0 m -113.46 124.07 51.53 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.536 ' OG ' HD11 ' A' ' 25' ' ' LEU . 45.2 t -94.7 130.81 41.06 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.106 -0.997 . . . . 0.0 109.022 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.565 HG22 ' N ' ' A' ' 49' ' ' VAL . 9.9 p -135.19 168.44 23.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.482 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.565 ' N ' HG22 ' A' ' 48' ' ' VAL . 67.6 t -115.19 134.3 58.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.1 t -112.85 161.25 11.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.044 -1.035 . . . . 0.0 109.801 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 50' ' ' VAL . 64.6 m-20 -62.25 56.13 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.029 0.443 . . . . 0.0 109.99 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 164.37 -36.71 0.29 Allowed Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.208 -1.472 . . . . 0.0 111.018 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.511 ' OE1' ' C ' ' A' ' 52' ' ' GLY . 60.7 mp0 -153.91 161.06 42.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.638 -1.507 . . . . 0.0 110.972 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.405 ' CG1' HD13 ' A' ' 25' ' ' LEU . 97.1 t -91.9 138.47 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' CE ' ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -124.07 168.73 12.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.903 -1.123 . . . . 0.0 110.948 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.475 ' HB3' HH22 ' A' ' 36' ' ' ARG . 71.0 m-70 -129.79 73.67 1.54 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.587 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 73.0 m -50.7 148.1 4.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.315 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.1 t -116.16 134.5 59.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.891 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.65 HD11 ' SG ' ' A' ' 46' ' ' CYS . 67.1 mt -117.46 139.17 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.8 -1.187 . . . . 0.0 109.689 -179.737 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.61 -37.73 88.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.481 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 3.7 ttmp? -58.91 -45.33 90.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.887 -1.133 . . . . 0.0 109.175 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.13 -29.14 68.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.19 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.595 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.6 tt -58.6 -43.75 89.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.285 -0.885 . . . . 0.0 110.014 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.84 -44.39 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.716 -1.24 . . . . 0.0 109.718 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 5' ' ' HIS . 3.8 mm? -67.15 -42.38 84.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 109.555 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.836 ' O ' ' CD2' ' A' ' 87' ' ' HIS . 60.1 t60 -60.28 -39.73 87.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.417 -0.802 . . . . 0.0 110.801 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.467 ' HA ' ' OG1' ' A' ' 88' ' ' THR . 4.9 m-30 -71.08 -25.5 62.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.478 -0.764 . . . . 0.0 112.526 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 83' ' ' LEU . 9.2 pt20 -61.23 -30.56 70.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.348 -1.47 . . . . 0.0 110.312 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.836 ' CD2' ' O ' ' A' ' 84' ' ' HIS . 14.2 p80 -92.7 -5.49 51.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.75 -1.219 . . . . 0.0 109.188 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.688 ' O ' HG22 ' A' ' 100' ' ' THR . 56.2 p -98.36 139.76 33.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.158 -0.964 . . . . 0.0 109.455 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.2 t -97.81 126.73 43.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.451 -0.781 . . . . 0.0 109.452 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.731 HD12 HG13 ' A' ' 99' ' ' VAL . 81.8 mt -67.05 -20.04 65.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.983 -1.073 . . . . 0.0 109.833 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.774 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.7 p -10.67 -58.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.834 -0.542 . . . . 0.0 110.171 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.773 ' H ' HG13 ' A' ' 91' ' ' VAL . 9.5 tp-100 -35.17 155.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 92' ' ' GLN . 59.5 t-80 55.49 107.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.814 ' O ' ' N ' ' A' ' 96' ' ' SER . 22.9 m120 56.69 71.84 0.54 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.603 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 94.2 m-20 -29.84 -20.0 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.814 ' N ' ' O ' ' A' ' 94' ' ' ASN . 87.1 p -77.43 15.5 0.77 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.671 -1.268 . . . . 0.0 110.922 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.774 ' O ' ' N ' ' A' ' 91' ' ' VAL . 70.5 mt -95.68 41.67 1.1 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 95' ' ' ASP . 64.1 m-80 -78.39 79.28 4.83 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.321 -0.862 . . . . 0.0 110.073 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.731 HG13 HD12 ' A' ' 90' ' ' LEU . 7.4 p -153.31 157.93 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 88' ' ' THR . 31.8 p -130.26 157.46 42.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.105 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.515 HD22 ' CG ' ' A' ' 33' ' ' PHE . 19.0 mt -82.21 65.73 7.47 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.7 -28.37 12.52 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.489 ' CD1' ' HD2' ' A' ' 104' ' ' PRO . 68.1 t80 -110.48 127.09 27.57 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.14 -1.6 . . . . 0.0 110.973 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.497 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 61.1 Cg_endo -74.82 146.81 33.92 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 123.039 2.493 . . . . 0.0 112.533 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' A' ' 34' ' ' LEU . 9.9 p -83.26 -32.05 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.122 -0.986 . . . . 0.0 110.604 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.541 ' CD2' HG13 ' A' ' 105' ' ' VAL . 35.2 m-85 -129.64 59.35 1.61 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.787 -1.196 . . . . 0.0 110.856 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.764 ' HA ' HG22 ' A' ' 10' ' ' THR . . . . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.416 -0.802 . . . . 0.0 109.772 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -58.96 -11.77 13.33 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.948 1.765 . . . . 0.0 111.576 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.608 ' HB2' HD11 ' A' ' 83' ' ' LEU . 98.0 m-70 -67.2 -31.7 72.27 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.803 -0.561 . . . . 0.0 110.749 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.556 ' ND1' ' N ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -63.06 -15.4 56.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 0.0 110.153 -178.758 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.693 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 27.1 t0 -102.51 126.14 49.47 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.723 ' O ' ' N ' ' A' ' 12' ' ' ASN . 4.0 mp0 -66.18 -27.29 67.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 110.644 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.679 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -62.69 -39.05 92.77 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.988 -1.07 . . . . 0.0 109.689 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.764 HG22 ' HA ' ' A' ' 107' ' ' ALA . 22.1 p -59.04 -33.76 71.13 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.694 -0.629 . . . . 0.0 109.909 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.693 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -123.91 -31.59 3.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.808 -1.183 . . . . 0.0 111.728 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.723 ' N ' ' O ' ' A' ' 8' ' ' GLU . 28.5 t-20 -87.84 130.65 34.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.539 -1.35 . . . . 0.0 110.857 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -107.48 -6.52 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASN . . . 92.77 -161.86 26.13 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.4 p -67.44 153.59 43.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -1.14 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 t -163.59 150.51 12.23 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.424 -0.797 . . . . 0.0 109.407 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 18' ' ' ARG . 86.4 m-20 -88.12 7.95 29.18 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.473 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 4.5 mmp_? 66.73 9.01 6.37 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.468 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.715 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 36.5 p-10 -77.52 -53.67 7.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.071 -1.018 . . . . 0.0 108.27 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.715 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 45.1 pttt -68.88 -26.29 65.05 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -56.62 -45.62 81.39 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 26' ' ' ARG . 59.2 mm-40 -59.16 -47.04 86.78 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -62.8 -42.68 99.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 24' ' ' LEU . 79.0 mt -69.94 -29.97 67.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 109.504 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.536 HD11 ' OG ' ' A' ' 47' ' ' SER . 16.0 mt -89.79 -13.28 36.98 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 22' ' ' GLU . 89.5 mtt180 -91.5 115.27 27.9 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.62 2.89 50.05 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.536 ' O ' HG11 ' A' ' 49' ' ' VAL . 36.4 mmtt -100.77 137.82 38.64 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.225 -1.162 . . . . 0.0 109.212 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -69.64 156.49 38.87 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.664 -0.648 . . . . 0.0 109.695 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 63.2 t0 -57.81 141.92 47.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.587 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 108.7 -27.82 12.62 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.465 ' HG1' ' HD2' ' A' ' 103' ' ' TYR . 86.4 m -79.85 120.8 24.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.133 -1.216 . . . . 0.0 108.437 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -139.89 176.57 8.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.851 -1.156 . . . . 0.0 110.931 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.68 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -150.76 161.63 42.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.576 -0.703 . . . . 0.0 110.233 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.493 HG22 ' SG ' ' A' ' 46' ' ' CYS . 43.7 t -107.16 139.97 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.656 ' NH1' ' HB3' ' A' ' 45' ' ' ALA . 1.1 ppt_? -158.72 -160.21 0.85 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.411 ' O ' ' HD2' ' A' ' 36' ' ' ARG . 82.7 mt-10 . . . . . 0 C--N 1.306 -1.325 0 O-C-N 120.567 -1.333 . . . . 0.0 109.079 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.656 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . . . -159.38 151.61 21.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.978 -1.076 . . . . 0.0 110.062 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.65 ' SG ' HD11 ' A' ' 59' ' ' ILE . 77.0 m -113.46 124.07 51.53 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.536 ' OG ' HD11 ' A' ' 25' ' ' LEU . 45.2 t -94.7 130.81 41.06 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.106 -0.997 . . . . 0.0 109.022 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.565 HG22 ' N ' ' A' ' 49' ' ' VAL . 9.9 p -135.19 168.44 23.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.482 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.565 ' N ' HG22 ' A' ' 48' ' ' VAL . 67.6 t -115.19 134.3 58.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.1 t -112.85 161.25 11.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.044 -1.035 . . . . 0.0 109.801 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 50' ' ' VAL . 64.6 m-20 -62.25 56.13 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.029 0.443 . . . . 0.0 109.99 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 164.37 -36.71 0.29 Allowed Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.208 -1.472 . . . . 0.0 111.018 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.511 ' OE1' ' C ' ' A' ' 52' ' ' GLY . 60.7 mp0 -153.91 161.06 42.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.638 -1.507 . . . . 0.0 110.972 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.405 ' CG1' HD13 ' A' ' 25' ' ' LEU . 97.1 t -91.9 138.47 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' CE ' ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -124.07 168.73 12.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.903 -1.123 . . . . 0.0 110.948 -179.445 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.475 ' HB3' HH22 ' A' ' 36' ' ' ARG . 71.0 m-70 -129.79 73.67 1.54 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.587 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 73.0 m -50.7 148.1 4.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.315 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.1 t -116.16 134.5 59.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.891 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.65 HD11 ' SG ' ' A' ' 46' ' ' CYS . 67.1 mt -117.46 139.17 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.8 -1.187 . . . . 0.0 109.689 -179.737 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.61 -37.73 88.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.481 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 3.7 ttmp? -58.91 -45.33 90.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.887 -1.133 . . . . 0.0 109.175 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.13 -29.14 68.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.19 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.595 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.6 tt -58.6 -43.75 89.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.285 -0.885 . . . . 0.0 110.014 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.84 -44.39 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.716 -1.24 . . . . 0.0 109.718 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 5' ' ' HIS . 3.8 mm? -67.15 -42.38 84.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 109.555 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.836 ' O ' ' CD2' ' A' ' 87' ' ' HIS . 60.1 t60 -60.28 -39.73 87.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.417 -0.802 . . . . 0.0 110.801 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.467 ' HA ' ' OG1' ' A' ' 88' ' ' THR . 4.9 m-30 -71.08 -25.5 62.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.478 -0.764 . . . . 0.0 112.526 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 83' ' ' LEU . 9.2 pt20 -61.23 -30.56 70.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.348 -1.47 . . . . 0.0 110.312 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.836 ' CD2' ' O ' ' A' ' 84' ' ' HIS . 14.2 p80 -92.7 -5.49 51.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.75 -1.219 . . . . 0.0 109.188 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.688 ' O ' HG22 ' A' ' 100' ' ' THR . 56.2 p -98.36 139.76 33.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.158 -0.964 . . . . 0.0 109.455 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.2 t -97.81 126.73 43.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.451 -0.781 . . . . 0.0 109.452 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.731 HD12 HG13 ' A' ' 99' ' ' VAL . 81.8 mt -67.05 -20.04 65.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.983 -1.073 . . . . 0.0 109.833 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.774 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.7 p -10.67 -58.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.834 -0.542 . . . . 0.0 110.171 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.773 ' H ' HG13 ' A' ' 91' ' ' VAL . 9.5 tp-100 -35.17 155.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 92' ' ' GLN . 59.5 t-80 55.49 107.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.814 ' O ' ' N ' ' A' ' 96' ' ' SER . 22.9 m120 56.69 71.84 0.54 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.603 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 94.2 m-20 -29.84 -20.0 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.814 ' N ' ' O ' ' A' ' 94' ' ' ASN . 87.1 p -77.43 15.5 0.77 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.671 -1.268 . . . . 0.0 110.922 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.774 ' O ' ' N ' ' A' ' 91' ' ' VAL . 70.5 mt -95.68 41.67 1.1 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 95' ' ' ASP . 64.1 m-80 -78.39 79.28 4.83 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.321 -0.862 . . . . 0.0 110.073 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.731 HG13 HD12 ' A' ' 90' ' ' LEU . 7.4 p -153.31 157.93 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 88' ' ' THR . 31.8 p -130.26 157.46 42.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.105 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.515 HD22 ' CG ' ' A' ' 33' ' ' PHE . 19.0 mt -82.21 65.73 7.47 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.7 -28.37 12.52 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.489 ' CD1' ' HD2' ' A' ' 104' ' ' PRO . 68.1 t80 -110.48 127.09 27.57 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.14 -1.6 . . . . 0.0 110.973 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.497 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 61.1 Cg_endo -74.82 146.81 33.92 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 123.039 2.493 . . . . 0.0 112.533 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' A' ' 34' ' ' LEU . 9.9 p -83.26 -32.05 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.122 -0.986 . . . . 0.0 110.604 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.541 ' CD2' HG13 ' A' ' 105' ' ' VAL . 35.2 m-85 -129.64 59.35 1.61 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.787 -1.196 . . . . 0.0 110.856 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.764 ' HA ' HG22 ' A' ' 10' ' ' THR . . . . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.416 -0.802 . . . . 0.0 109.772 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 3' ' ' LEU . 92.6 mt . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.4 -2.35 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.613 2.209 . . . . 0.0 111.998 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.665 ' CD2' ' OE1' ' A' ' 86' ' ' GLN . 4.7 m80 -67.76 -24.52 65.35 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.898 -1.126 . . . . 0.0 109.493 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -58.13 -29.85 65.86 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.595 ' O ' ' OG1' ' A' ' 10' ' ' THR . 94.5 m-20 -89.0 121.73 31.65 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 46.5 tt0 -69.9 -34.58 73.71 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.07 -1.019 . . . . 0.0 109.585 -178.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.469 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -66.46 -21.98 66.2 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 110.95 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 7' ' ' ASP . 8.1 p -64.05 -35.29 80.26 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.776 -1.203 . . . . 0.0 109.978 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.608 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -115.97 -34.3 4.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.94 -1.1 . . . . 0.0 110.182 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -88.1 125.69 34.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.071 -1.018 . . . . 0.0 110.543 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.575 HG21 HH21 ' A' ' 36' ' ' ARG . 24.5 m -108.59 -13.13 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.2 -158.59 30.34 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.482 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 73.7 m -61.52 148.41 42.16 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.18 -1.188 . . . . 0.0 108.524 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.481 ' HB3' ' NE ' ' A' ' 36' ' ' ARG . 40.4 t -168.87 167.61 10.85 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 109.355 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 86.7 m-20 -88.89 134.7 33.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.235 -0.916 . . . . 0.0 109.281 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.496 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 44.8 mtt-85 -59.98 -36.22 76.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.845 -1.159 . . . . 0.0 110.287 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -54.53 -48.24 72.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 0.0 111.121 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 17' ' ' ASN . 14.6 ptpt -69.57 -26.43 64.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.385 -1.447 . . . . 0.0 109.3 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.041 ' HB2' HH12 ' A' ' 36' ' ' ARG . . . -57.34 -43.44 83.43 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -59.58 -44.02 93.47 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -60.15 -48.63 80.91 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.27 -36.49 83.83 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.646 HD13 ' CG1' ' A' ' 54' ' ' VAL . 4.0 mt -82.01 -4.43 56.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.221 -0.924 . . . . 0.0 109.432 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.17 131.38 37.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.33 -0.856 . . . . 0.0 110.5 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.06 1.79 88.52 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.74 ' O ' HG11 ' A' ' 49' ' ' VAL . 36.0 mmtt -100.23 128.19 46.35 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.209 -1.171 . . . . 0.0 110.108 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 30' ' ' ASP . 41.9 ttm180 -62.29 147.75 47.12 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 53.3 p-10 -47.39 156.0 0.3 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.928 -1.107 . . . . 0.0 108.769 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.499 ' H ' HG21 ' A' ' 99' ' ' VAL . . . 99.47 -33.87 5.87 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 60.0 m -72.54 123.93 24.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.167 -1.196 . . . . 0.0 108.831 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.736 ' CD1' ' N ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -145.4 172.24 13.47 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 118.385 -1.326 . . . . 0.0 111.051 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.736 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -148.75 159.76 43.83 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.184 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 11' ' ' TRP . 14.7 t -101.5 138.85 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 1.041 HH12 ' HB2' ' A' ' 21' ' ' ALA . 32.2 ttm180 -150.58 160.38 43.84 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 109.5 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.508 ' OE1' ' N ' ' A' ' 37' ' ' GLU . 16.0 pm0 . . . . . 0 C--N 1.301 -1.518 0 O-C-N 120.63 -1.294 . . . . 0.0 109.304 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' A' ' 59' ' ' ILE . 44.2 m-85 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.298 0.57 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.625 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -171.77 155.9 4.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.165 -0.96 . . . . 0.0 108.984 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 57' ' ' CYS . 22.1 p -133.13 142.91 48.93 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.496 -1.377 . . . . 0.0 109.285 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.2 p -116.86 139.28 50.79 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.53 -0.731 . . . . 0.0 109.744 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.625 HG22 ' N ' ' A' ' 49' ' ' VAL . 14.9 p -133.29 166.6 28.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.383 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.74 HG11 ' O ' ' A' ' 28' ' ' LYS . 53.7 t -103.69 137.49 32.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.623 ' C ' ' H ' ' A' ' 52' ' ' GLY . 41.4 t -116.99 152.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.153 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.495 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 62.1 t0 -52.7 2.2 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.095 0.474 . . . . 0.0 110.328 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.623 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -136.19 -32.66 0.26 Allowed Glycine 0 N--CA 1.485 1.952 0 C-N-CA 118.894 -1.622 . . . . 0.0 112.248 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 64.2 mt-10 -158.52 163.57 36.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.444 -1.621 . . . . 0.0 111.399 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.646 ' CG1' HD13 ' A' ' 25' ' ' LEU . 66.1 t -76.63 136.99 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 54' ' ' VAL . 60.8 mmtt -114.9 150.89 34.92 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.823 -1.173 . . . . 0.0 111.347 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -131.69 70.04 1.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.466 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 98.0 m -62.22 142.71 57.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 109.566 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 58' ' ' VAL . 7.7 p -106.7 138.28 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.49 -0.756 . . . . 0.0 109.496 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.558 ' O ' ' O ' ' A' ' 44' ' ' TYR . 90.9 mt -123.08 136.64 59.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.282 -0.886 . . . . 0.0 109.183 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 N--CA 1.495 1.788 0 O-C-N 120.88 -1.138 . . . . 0.0 109.301 179.944 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 121.417 0.627 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.23 -37.63 86.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.871 . . . . 0.0 109.084 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -53.77 -44.09 69.77 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.02 -42.5 72.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.386 -0.821 . . . . 0.0 109.989 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.772 HD23 ' C ' ' A' ' 81' ' ' LEU . 6.9 tt -59.8 -46.13 90.18 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.254 -0.904 . . . . 0.0 109.338 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.44 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 72.0 t -63.06 -45.93 97.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 109.599 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.67 HD23 ' OE1' ' A' ' 86' ' ' GLN . 68.6 mt -61.53 -40.1 93.46 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.539 -0.726 . . . . 0.0 110.305 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.58 ' O ' ' OG1' ' A' ' 88' ' ' THR . 60.1 t-80 -52.0 -48.67 64.33 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.165 -0.959 . . . . 0.0 110.195 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.803 ' HB2' HD12 ' A' ' 101' ' ' LEU . 27.2 m-85 -71.48 -20.71 62.04 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.126 -0.984 . . . . 0.0 112.027 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.67 ' OE1' HD23 ' A' ' 83' ' ' LEU . 27.7 mt-30 -61.56 -36.02 79.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.645 -1.284 . . . . 0.0 109.382 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -93.5 -37.09 12.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.432 -0.792 . . . . 0.0 109.033 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.58 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 7.7 p -89.6 139.82 30.16 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.431 -0.793 . . . . 0.0 110.29 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.6 t -81.39 136.84 35.72 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.564 -0.71 . . . . 0.0 109.48 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.769 ' O ' ' N ' ' A' ' 92' ' ' GLN . 8.0 mt -61.46 -41.8 97.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.434 -0.791 . . . . 0.0 111.012 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.049 HG22 ' OD1' ' A' ' 98' ' ' ASN . 71.8 t 40.29 -81.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.225 -0.922 . . . . 0.0 109.234 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.769 ' N ' ' O ' ' A' ' 90' ' ' LEU . 0.7 OUTLIER 84.44 171.86 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 0.0 110.475 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.422 ' H ' ' HG3' ' A' ' 92' ' ' GLN . 65.0 m80 -60.93 -37.85 83.74 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 88.4 m-20 -57.93 -18.13 21.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 94' ' ' ASN . 97.7 m-20 61.28 23.23 13.49 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.8 m -134.01 11.49 3.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.57 -1.332 . . . . 0.0 111.195 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.614 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.4 mp -104.02 46.24 0.93 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 1.049 ' OD1' HG22 ' A' ' 91' ' ' VAL . 74.3 m-20 -78.08 67.46 3.92 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.448 -177.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.499 HG21 ' H ' ' A' ' 31' ' ' GLY . 7.4 p -132.2 159.04 43.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.447 ' N ' HG22 ' A' ' 99' ' ' VAL . 40.5 p -110.65 152.36 26.58 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.273 -0.892 . . . . 0.0 108.793 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.803 HD12 ' HB2' ' A' ' 85' ' ' TYR . 91.5 mt -93.26 30.23 1.73 Allowed 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.7 -9.19 58.49 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 32' ' ' THR . 73.7 m-85 -121.83 103.77 39.82 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.375 -1.453 . . . . 0.0 111.602 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -61.01 160.92 24.01 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.02 1.813 . . . . 0.0 110.805 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.09 -22.9 7.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.205 -0.935 . . . . 0.0 109.78 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -111.13 34.39 4.08 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.093 -1.004 . . . . 0.0 110.254 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.308 179.414 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 3' ' ' LEU . 5.4 mp . . . . . 0 N--CA 1.498 1.97 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.412 ' CG ' ' HG2' ' A' ' 104' ' ' PRO . 33.8 Cg_endo -67.52 -1.31 6.36 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.234 1.956 . . . . 0.0 111.988 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.63 ' NE2' ' OE1' ' A' ' 86' ' ' GLN . 88.7 m-70 -69.69 -32.36 70.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.106 -0.996 . . . . 0.0 108.606 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -60.99 -32.78 72.34 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.343 -0.848 . . . . 0.0 108.807 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.4 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 68.6 m-20 -92.67 129.22 38.66 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.686 0.755 . . . . 0.0 110.814 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.536 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 75.6 tt0 -77.73 -23.45 49.36 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.3 -0.875 . . . . 0.0 110.68 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -17.85 63.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.187 -0.946 . . . . 0.0 111.528 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.606 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 47.1 p -73.42 -26.69 61.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.732 -1.23 . . . . 0.0 111.305 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.606 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -123.58 -21.91 5.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.505 -1.372 . . . . 0.0 109.773 179.073 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -83.62 121.35 27.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 110.882 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' A' ' 15' ' ' SER . 2.2 t -134.61 33.32 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -30.96 -31.68 0.01 OUTLIER Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.63 ' N ' ' O ' ' A' ' 13' ' ' VAL . 89.2 p -69.54 -21.18 63.67 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.804 -1.409 . . . . 0.0 109.965 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 13' ' ' VAL . 41.9 t -66.62 149.38 50.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.068 -1.02 . . . . 0.0 110.269 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.49 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 92.7 m-20 -114.52 167.57 10.62 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.061 -1.024 . . . . 0.0 109.654 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -56.84 -43.54 81.22 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.266 -0.897 . . . . 0.0 109.26 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -65.82 -46.55 78.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.161 -0.962 . . . . 0.0 108.717 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.49 ' HB3' ' H ' ' A' ' 17' ' ' ASN . 82.3 tttt -65.02 -36.37 84.18 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -57.13 -37.81 72.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 108.878 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.603 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 97.1 mt-10 -59.01 -44.17 91.65 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.84 -44.1 94.19 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.447 -0.783 . . . . 0.0 108.975 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.622 ' O ' ' CD ' ' A' ' 28' ' ' LYS . 96.1 mt -71.23 -26.19 62.82 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.335 -0.853 . . . . 0.0 108.837 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.445 HD23 HG23 ' A' ' 49' ' ' VAL . 21.1 mt -94.09 -11.84 29.75 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.603 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 16.6 mmt180 -97.74 134.48 40.85 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.28 -0.38 88.95 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.622 ' CD ' ' O ' ' A' ' 24' ' ' LEU . 19.0 mtpp -105.06 136.65 44.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.094 -1.239 . . . . 0.0 109.468 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -68.27 160.69 28.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.163 -0.96 . . . . 0.0 110.476 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.691 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 84.4 m-20 -57.99 149.45 23.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.518 -0.739 . . . . 0.0 110.218 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 100' ' ' THR . . . 104.71 -30.64 9.71 Favored Glycine 0 N--CA 1.486 2.015 0 C-N-CA 119.41 -1.376 . . . . 0.0 110.222 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.541 HG21 ' CE ' ' A' ' 28' ' ' LYS . 85.0 m -80.17 120.35 24.18 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.418 -1.048 . . . . 0.0 108.207 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.53 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -135.61 164.96 26.65 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 118.806 -1.158 . . . . 0.0 109.656 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -134.01 157.0 47.21 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.398 179.664 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 11' ' ' TRP . 85.5 t -115.41 124.79 72.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.37 -0.831 . . . . 0.0 108.985 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.691 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -152.56 177.35 10.74 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 4.3 pm0 . . . . . 0 C--N 1.298 -1.644 0 O-C-N 121.088 -1.007 . . . . 0.0 108.861 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.655 ' O ' ' O ' ' A' ' 59' ' ' ILE . 96.0 m-85 . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.508 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -158.15 137.49 11.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.348 -1.47 . . . . 0.0 109.794 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 20.9 p -116.9 129.87 56.34 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.149 -0.969 . . . . 0.0 109.092 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.7 t -107.58 138.7 43.33 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.657 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.733 HG22 ' N ' ' A' ' 49' ' ' VAL . 10.4 p -128.56 170.75 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.498 -0.751 . . . . 0.0 109.766 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.733 ' N ' HG22 ' A' ' 48' ' ' VAL . 85.4 t -114.71 134.12 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.885 HG13 ' H ' ' A' ' 52' ' ' GLY . 3.9 p -125.25 157.48 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.696 -1.253 . . . . 0.0 110.161 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.691 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 43.2 p30 -49.59 -10.31 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.662 0.744 . . . . 0.0 110.398 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.885 ' H ' HG13 ' A' ' 50' ' ' VAL . . . -98.33 -58.41 0.96 Allowed Glycine 0 C--N 1.287 -2.179 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.567 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 61.5 mt-10 -164.68 -175.21 3.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.395 -1.062 . . . . 0.0 109.725 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 54' ' ' VAL . 18.0 m -90.84 119.87 38.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -119.54 156.71 29.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.435 -1.416 . . . . 0.0 110.454 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -111.76 127.87 55.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.48 -0.762 . . . . 0.0 109.974 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.7 t -105.24 128.56 53.49 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 p -86.35 136.51 22.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.845 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.655 ' O ' ' O ' ' A' ' 44' ' ' TYR . 51.5 mm -118.96 126.74 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.7 m120 . . . . . 0 N--CA 1.496 1.857 0 O-C-N 120.586 -1.321 . . . . 0.0 110.436 -178.776 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.2 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.455 0.645 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.6 mt -61.42 -39.8 92.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.367 -0.833 . . . . 0.0 109.606 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -59.04 -40.07 83.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.124 -0.985 . . . . 0.0 108.946 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.407 ' HG2' ' HD1' ' A' ' 84' ' ' HIS . 85.0 tt0 -64.2 -36.52 84.32 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.4 -0.812 . . . . 0.0 109.192 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.5 tt -59.86 -46.02 90.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.053 -1.029 . . . . 0.0 110.225 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.4 t -63.24 -41.18 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.006 -1.059 . . . . 0.0 109.647 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.464 HD21 ' CD2' ' A' ' 5' ' ' HIS . 76.3 mt -63.16 -43.77 97.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.924 -1.11 . . . . 0.0 111.323 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.407 ' HD1' ' HG2' ' A' ' 80' ' ' GLU . 36.4 m80 -64.84 -43.74 92.06 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.863 -1.148 . . . . 0.0 111.021 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.484 ' CB ' HD12 ' A' ' 101' ' ' LEU . 19.0 m-85 -65.64 -24.64 67.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.616 -1.302 . . . . 0.0 109.055 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.671 ' HG3' ' HB2' ' A' ' 102' ' ' ALA . 33.5 tt0 -67.57 -33.16 74.46 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.376 -0.827 . . . . 0.0 109.607 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -95.0 -14.09 24.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.119 -0.988 . . . . 0.0 109.292 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.9 m -108.05 129.97 55.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 109.527 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.0 t -72.95 139.9 47.05 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.978 -1.076 . . . . 0.0 108.614 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.687 ' O ' ' C ' ' A' ' 91' ' ' VAL . 7.6 mp -69.0 -16.03 63.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.116 -0.99 . . . . 0.0 110.688 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.695 ' N ' ' O ' ' A' ' 97' ' ' LEU . 74.6 t -10.15 -64.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.589 0 O-C-N 121.75 -0.594 . . . . 0.0 109.918 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 90' ' ' LEU . 91.3 mt-30 34.71 -142.24 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.402 ' O ' ' N ' ' A' ' 95' ' ' ASP . 82.9 t60 -52.44 -50.07 63.33 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.711 ' O ' ' N ' ' A' ' 96' ' ' SER . 89.4 m-20 -69.7 83.3 0.44 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 94' ' ' ASN . 62.9 t0 -44.03 -10.74 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.421 -0.799 . . . . 0.0 108.903 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.711 ' N ' ' O ' ' A' ' 94' ' ' ASN . 89.3 p -100.56 4.45 43.48 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.507 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.695 ' O ' ' N ' ' A' ' 91' ' ' VAL . 8.3 mt -76.83 50.31 0.7 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.078 -1.639 . . . . 0.0 108.404 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -77.37 80.62 3.87 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.252 -0.905 . . . . 0.0 109.861 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.626 ' HB ' HG23 ' A' ' 50' ' ' VAL . 6.6 p -161.53 162.94 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.544 ' N ' HG22 ' A' ' 99' ' ' VAL . 44.4 p -129.94 155.85 45.39 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.087 -1.008 . . . . 0.0 109.936 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.53 HD22 ' CG ' ' A' ' 33' ' ' PHE . 18.4 mt -89.15 53.9 2.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.021 -1.049 . . . . 0.0 108.673 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.671 ' HB2' ' HG3' ' A' ' 86' ' ' GLN . . . -89.66 -18.09 27.12 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.73 -0.606 . . . . 0.0 112.37 -178.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.484 ' HD2' ' HG1' ' A' ' 32' ' ' THR . 88.4 t80 -116.61 110.16 42.81 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 120.265 -1.522 . . . . 0.0 110.448 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.412 ' HG2' ' CG ' ' A' ' 4' ' ' PRO . 22.7 Cg_exo -59.6 146.96 93.8 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.875 1.716 . . . . 0.0 110.926 178.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.681 HG13 ' CD2' ' A' ' 106' ' ' TYR . 11.4 p -67.99 -22.43 27.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.686 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.681 ' CD2' HG13 ' A' ' 105' ' ' VAL . 59.9 m-85 -128.75 60.88 1.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.903 . . . . 0.0 109.39 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.489 0 O-C-N 120.971 -1.081 . . . . 0.0 108.657 179.82 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.8 tp . . . . . 0 N--CA 1.485 1.318 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -49.86 -20.95 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.994 1.796 . . . . 0.0 112.082 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.815 ' CE1' HE22 ' A' ' 86' ' ' GLN . 32.2 m170 -71.57 -29.69 65.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.453 -0.78 . . . . 0.0 109.838 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -67.48 -21.68 65.51 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.566 ' O ' ' OG1' ' A' ' 10' ' ' THR . 76.3 m-20 -95.84 113.33 24.95 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.454 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 32.0 tt0 -70.31 -32.97 70.96 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.473 -0.767 . . . . 0.0 110.801 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.572 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -71.2 -13.62 61.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.758 -1.214 . . . . 0.0 110.945 -178.288 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.573 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 6.6 p -62.97 -37.49 87.32 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.68 -1.262 . . . . 0.0 108.666 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.719 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -117.33 -27.8 6.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.944 -1.098 . . . . 0.0 110.074 179.042 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -86.6 119.66 27.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.924 -1.11 . . . . 0.0 110.442 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 15' ' ' SER . 9.8 p -140.72 31.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -39.12 -20.34 0.01 OUTLIER Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.608 ' N ' ' O ' ' A' ' 13' ' ' VAL . 87.5 p -61.42 -17.52 54.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -1.131 . . . . 0.0 108.589 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.1 m -94.15 145.16 24.89 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.725 0.774 . . . . 0.0 110.731 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.621 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 54.8 p30 -79.64 167.39 20.75 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.394 -0.816 . . . . 0.0 109.335 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.523 ' CG ' ' NH1' ' A' ' 36' ' ' ARG . 81.1 mtm180 -61.05 -39.9 91.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.596 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -63.05 -44.29 96.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.645 -1.285 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.621 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 22.5 tptm -61.13 -35.51 77.26 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.221 -0.924 . . . . 0.0 108.901 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.04 74.32 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 26' ' ' ARG . 94.8 mt-10 -57.63 -45.4 85.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.35 -40.33 93.86 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 24' ' ' LEU . 79.8 mt -67.95 -39.56 83.38 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.543 HD11 ' OG ' ' A' ' 47' ' ' SER . 3.6 mt -82.83 -16.82 46.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.342 -0.848 . . . . 0.0 108.799 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' GLU . 10.6 mmm180 -93.78 -28.4 15.92 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.959 0.885 . . . . 0.0 109.691 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.99 9.17 70.42 Favored Glycine 0 C--N 1.286 -2.231 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.526 ' O ' HG11 ' A' ' 49' ' ' VAL . 29.8 mmtm -124.2 145.54 49.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.499 -1.0 . . . . 0.0 110.001 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -77.67 165.53 24.14 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.395 0.617 . . . . 0.0 110.199 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.538 ' CG ' ' OD1' ' A' ' 51' ' ' ASP . 18.2 p-10 -53.02 158.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.92 -33.8 4.51 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.2 m -77.07 125.61 29.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -1.032 . . . . 0.0 108.311 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 101' ' ' LEU . 0.4 OUTLIER -135.88 170.65 15.66 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.966 -1.083 . . . . 0.0 110.274 -178.839 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -149.26 165.85 30.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.196 -0.94 . . . . 0.0 111.007 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.557 HG22 ' SG ' ' A' ' 46' ' ' CYS . 73.9 t -120.51 121.48 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.731 ' NH1' ' O ' ' A' ' 37' ' ' GLU . 6.8 ptm180 -134.84 -176.24 4.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.438 -0.788 . . . . 0.0 108.949 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.731 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 56.0 mt-10 . . . . . 0 N--CA 1.488 1.459 0 O-C-N 120.871 -1.143 . . . . 0.0 108.494 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' ILE . 98.1 m-85 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.413 0.625 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -145.74 133.43 21.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.711 -0.618 . . . . 0.0 109.924 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.609 ' O ' ' CB ' ' A' ' 57' ' ' CYS . 57.3 m -100.0 113.89 26.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.544 -1.347 . . . . 0.0 107.893 178.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.543 ' OG ' HD11 ' A' ' 25' ' ' LEU . 33.4 t -91.71 140.77 29.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.133 -0.98 . . . . 0.0 109.83 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.521 HG13 ' CB ' ' A' ' 33' ' ' PHE . 1.5 t -130.89 156.31 42.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.46 -0.775 . . . . 0.0 109.888 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 28' ' ' LYS . 89.4 t -101.12 135.94 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.799 HG12 ' H ' ' A' ' 52' ' ' GLY . 2.6 t -122.05 147.78 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.542 -1.349 . . . . 0.0 111.124 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.538 ' OD1' ' CG ' ' A' ' 30' ' ' ASP . 82.0 m-20 -55.06 9.36 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.231 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.799 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -135.97 -39.09 0.16 Allowed Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.619 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.539 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 21.6 tt0 -163.14 164.17 25.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.572 -1.546 . . . . 0.0 110.537 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.539 ' N ' ' CG ' ' A' ' 53' ' ' GLU . 96.1 t -67.42 134.69 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.075 -1.015 . . . . 0.0 108.686 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HE3' HD13 ' A' ' 97' ' ' LEU . 40.2 mmtt -112.04 139.02 47.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.831 -1.168 . . . . 0.0 109.12 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -120.57 87.74 2.81 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.609 ' CB ' ' O ' ' A' ' 46' ' ' CYS . 0.5 OUTLIER -70.79 139.66 51.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.154 -0.966 . . . . 0.0 108.723 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.41 129.57 62.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 111.241 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 44' ' ' TYR . 46.8 mm -108.13 117.05 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 120.943 -1.098 . . . . 0.0 110.312 -178.579 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 121.634 0.73 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 78' ' ' LEU . 93.9 mt -66.09 -40.62 90.94 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.708 -0.62 . . . . 0.0 109.875 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -64.95 -40.17 94.6 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.974 -1.078 . . . . 0.0 108.533 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -67.31 -33.07 74.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.369 -0.832 . . . . 0.0 109.029 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.849 ' C ' HD13 ' A' ' 81' ' ' LEU . 2.5 tm? -60.54 -45.18 94.81 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.213 -0.93 . . . . 0.0 108.613 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.98 -42.92 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.347 -0.846 . . . . 0.0 109.176 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.561 HD23 ' OE1' ' A' ' 86' ' ' GLN . 96.5 mt -60.23 -43.87 95.68 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.435 -0.791 . . . . 0.0 111.177 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -63.44 -40.14 96.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.533 -1.354 . . . . 0.0 110.565 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.413 ' CE1' HD21 ' A' ' 81' ' ' LEU . 5.4 m-85 -64.12 -22.63 67.01 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.901 -1.124 . . . . 0.0 110.698 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.815 HE22 ' CE1' ' A' ' 5' ' ' HIS . 5.2 mt-30 -68.99 -32.62 72.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.456 -1.402 . . . . 0.0 109.024 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -88.14 -19.29 27.18 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.323 -0.861 . . . . 0.0 109.648 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 79.0 m -100.64 127.74 46.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.571 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.556 ' HA ' HG22 ' A' ' 100' ' ' THR . 24.1 p -81.27 139.7 35.29 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.513 -0.742 . . . . 0.0 109.401 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.654 HD23 ' CD2' ' A' ' 93' ' ' HIS . 4.3 mp -75.86 -17.64 59.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.535 -0.728 . . . . 0.0 109.996 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.707 ' N ' ' O ' ' A' ' 97' ' ' LEU . 5.1 p -31.23 -44.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.355 -0.84 . . . . 0.0 110.482 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.562 ' N ' HG13 ' A' ' 91' ' ' VAL . 9.7 pt20 -66.16 -10.91 45.71 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.264 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.654 ' CD2' HD23 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -63.26 -47.0 84.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.582 -1.324 . . . . 0.0 107.893 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 93' ' ' HIS . 88.9 m-20 -138.43 20.2 2.74 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.627 ' N ' ' O ' ' A' ' 91' ' ' VAL . 94.6 m-20 61.05 17.33 7.89 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.457 ' C ' HD22 ' A' ' 97' ' ' LEU . 67.2 m -146.54 9.56 1.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.707 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.6 mm? -97.25 68.18 2.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -78.36 79.76 4.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 110.358 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.456 HG22 ' N ' ' A' ' 100' ' ' THR . 7.6 p -163.69 156.24 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 121.573 0.701 . . . . 0.0 109.59 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 89' ' ' SER . 32.1 p -130.44 153.94 48.25 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.139 -0.975 . . . . 0.0 108.681 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.628 ' O ' ' NE2' ' A' ' 86' ' ' GLN . 17.7 mt -78.61 67.85 4.46 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.51 -27.65 14.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.126 -0.984 . . . . 0.0 111.897 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.47 130.84 24.38 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 120.77 -1.206 . . . . 0.0 111.43 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.54 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 38.1 Cg_endo -74.51 153.41 44.35 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.734 2.289 . . . . 0.0 110.897 177.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.564 HG13 ' CD2' ' A' ' 106' ' ' TYR . 7.7 p -76.74 -30.9 19.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.187 -0.945 . . . . 0.0 109.791 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.564 ' CD2' HG13 ' A' ' 105' ' ' VAL . 50.0 m-85 -113.61 54.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.148 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.54 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.417 0.627 . . . . 0.0 109.913 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.8 tp . . . . . 0 N--CA 1.485 1.318 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -49.86 -20.95 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.994 1.796 . . . . 0.0 112.082 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.815 ' CE1' HE22 ' A' ' 86' ' ' GLN . 32.2 m170 -71.57 -29.69 65.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.453 -0.78 . . . . 0.0 109.838 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -67.48 -21.68 65.51 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.566 ' O ' ' OG1' ' A' ' 10' ' ' THR . 76.3 m-20 -95.84 113.33 24.95 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.454 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 32.0 tt0 -70.31 -32.97 70.96 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.473 -0.767 . . . . 0.0 110.801 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.572 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -71.2 -13.62 61.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.758 -1.214 . . . . 0.0 110.945 -178.288 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.573 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 6.6 p -62.97 -37.49 87.32 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.68 -1.262 . . . . 0.0 108.666 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.719 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -117.33 -27.8 6.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.944 -1.098 . . . . 0.0 110.074 179.042 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -86.6 119.66 27.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.924 -1.11 . . . . 0.0 110.442 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 15' ' ' SER . 9.8 p -140.72 31.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -39.12 -20.34 0.01 OUTLIER Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.608 ' N ' ' O ' ' A' ' 13' ' ' VAL . 87.5 p -61.42 -17.52 54.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -1.131 . . . . 0.0 108.589 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.1 m -94.15 145.16 24.89 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.725 0.774 . . . . 0.0 110.731 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.621 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 54.8 p30 -79.64 167.39 20.75 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.394 -0.816 . . . . 0.0 109.335 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.523 ' CG ' ' NH1' ' A' ' 36' ' ' ARG . 81.1 mtm180 -61.05 -39.9 91.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.596 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -63.05 -44.29 96.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.645 -1.285 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.621 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 22.5 tptm -61.13 -35.51 77.26 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.221 -0.924 . . . . 0.0 108.901 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.04 74.32 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 26' ' ' ARG . 94.8 mt-10 -57.63 -45.4 85.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.35 -40.33 93.86 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 24' ' ' LEU . 79.8 mt -67.95 -39.56 83.38 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.543 HD11 ' OG ' ' A' ' 47' ' ' SER . 3.6 mt -82.83 -16.82 46.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.342 -0.848 . . . . 0.0 108.799 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' GLU . 10.6 mmm180 -93.78 -28.4 15.92 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.959 0.885 . . . . 0.0 109.691 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.99 9.17 70.42 Favored Glycine 0 C--N 1.286 -2.231 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.526 ' O ' HG11 ' A' ' 49' ' ' VAL . 29.8 mmtm -124.2 145.54 49.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.499 -1.0 . . . . 0.0 110.001 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -77.67 165.53 24.14 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.395 0.617 . . . . 0.0 110.199 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.538 ' CG ' ' OD1' ' A' ' 51' ' ' ASP . 18.2 p-10 -53.02 158.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.92 -33.8 4.51 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.2 m -77.07 125.61 29.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -1.032 . . . . 0.0 108.311 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 101' ' ' LEU . 0.4 OUTLIER -135.88 170.65 15.66 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.966 -1.083 . . . . 0.0 110.274 -178.839 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -149.26 165.85 30.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.196 -0.94 . . . . 0.0 111.007 -179.566 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.557 HG22 ' SG ' ' A' ' 46' ' ' CYS . 73.9 t -120.51 121.48 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.731 ' NH1' ' O ' ' A' ' 37' ' ' GLU . 6.8 ptm180 -134.84 -176.24 4.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.438 -0.788 . . . . 0.0 108.949 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.731 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 56.0 mt-10 . . . . . 0 N--CA 1.488 1.459 0 O-C-N 120.871 -1.143 . . . . 0.0 108.494 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' ILE . 98.1 m-85 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.413 0.625 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -145.74 133.43 21.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.711 -0.618 . . . . 0.0 109.924 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.609 ' O ' ' CB ' ' A' ' 57' ' ' CYS . 57.3 m -100.0 113.89 26.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.544 -1.347 . . . . 0.0 107.893 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.543 ' OG ' HD11 ' A' ' 25' ' ' LEU . 33.4 t -91.71 140.77 29.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.133 -0.98 . . . . 0.0 109.83 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.521 HG13 ' CB ' ' A' ' 33' ' ' PHE . 1.5 t -130.89 156.31 42.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.46 -0.775 . . . . 0.0 109.888 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 28' ' ' LYS . 89.4 t -101.12 135.94 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.799 HG12 ' H ' ' A' ' 52' ' ' GLY . 2.6 t -122.05 147.78 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.542 -1.349 . . . . 0.0 111.124 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.538 ' OD1' ' CG ' ' A' ' 30' ' ' ASP . 82.0 m-20 -55.06 9.36 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.231 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.799 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -135.97 -39.09 0.16 Allowed Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.619 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.539 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 21.6 tt0 -163.14 164.17 25.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.572 -1.546 . . . . 0.0 110.537 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.539 ' N ' ' CG ' ' A' ' 53' ' ' GLU . 96.1 t -67.42 134.69 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.075 -1.015 . . . . 0.0 108.686 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HE3' HD13 ' A' ' 97' ' ' LEU . 40.2 mmtt -112.04 139.02 47.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.831 -1.168 . . . . 0.0 109.12 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -120.57 87.74 2.81 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.609 ' CB ' ' O ' ' A' ' 46' ' ' CYS . 0.5 OUTLIER -70.79 139.66 51.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.154 -0.966 . . . . 0.0 108.723 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.41 129.57 62.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 111.241 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 44' ' ' TYR . 46.8 mm -108.13 117.05 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 120.943 -1.098 . . . . 0.0 110.312 -178.579 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 121.634 0.73 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 78' ' ' LEU . 93.9 mt -66.09 -40.62 90.94 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.708 -0.62 . . . . 0.0 109.875 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -64.95 -40.17 94.6 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.974 -1.078 . . . . 0.0 108.533 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -67.31 -33.07 74.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.369 -0.832 . . . . 0.0 109.029 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.849 ' C ' HD13 ' A' ' 81' ' ' LEU . 2.5 tm? -60.54 -45.18 94.81 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.213 -0.93 . . . . 0.0 108.613 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.98 -42.92 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.347 -0.846 . . . . 0.0 109.176 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.561 HD23 ' OE1' ' A' ' 86' ' ' GLN . 96.5 mt -60.23 -43.87 95.68 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.435 -0.791 . . . . 0.0 111.177 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -63.44 -40.14 96.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.533 -1.354 . . . . 0.0 110.565 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.413 ' CE1' HD21 ' A' ' 81' ' ' LEU . 5.4 m-85 -64.12 -22.63 67.01 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.901 -1.124 . . . . 0.0 110.698 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.815 HE22 ' CE1' ' A' ' 5' ' ' HIS . 5.2 mt-30 -68.99 -32.62 72.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.456 -1.402 . . . . 0.0 109.024 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -88.14 -19.29 27.18 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.323 -0.861 . . . . 0.0 109.648 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 79.0 m -100.64 127.74 46.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.571 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.556 ' HA ' HG22 ' A' ' 100' ' ' THR . 24.1 p -81.27 139.7 35.29 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.513 -0.742 . . . . 0.0 109.401 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.654 HD23 ' CD2' ' A' ' 93' ' ' HIS . 4.3 mp -75.86 -17.64 59.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.535 -0.728 . . . . 0.0 109.996 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.707 ' N ' ' O ' ' A' ' 97' ' ' LEU . 5.1 p -31.23 -44.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.355 -0.84 . . . . 0.0 110.482 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.562 ' N ' HG13 ' A' ' 91' ' ' VAL . 9.7 pt20 -66.16 -10.91 45.71 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.264 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.654 ' CD2' HD23 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -63.26 -47.0 84.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.582 -1.324 . . . . 0.0 107.893 179.052 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 93' ' ' HIS . 88.9 m-20 -138.43 20.2 2.74 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.627 ' N ' ' O ' ' A' ' 91' ' ' VAL . 94.6 m-20 61.05 17.33 7.89 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.457 ' C ' HD22 ' A' ' 97' ' ' LEU . 67.2 m -146.54 9.56 1.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.707 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.6 mm? -97.25 68.18 2.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -78.36 79.76 4.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 110.358 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.456 HG22 ' N ' ' A' ' 100' ' ' THR . 7.6 p -163.69 156.24 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 121.573 0.701 . . . . 0.0 109.59 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 89' ' ' SER . 32.1 p -130.44 153.94 48.25 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.139 -0.975 . . . . 0.0 108.681 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.628 ' O ' ' NE2' ' A' ' 86' ' ' GLN . 17.7 mt -78.61 67.85 4.46 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.51 -27.65 14.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.126 -0.984 . . . . 0.0 111.897 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.47 130.84 24.38 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 120.77 -1.206 . . . . 0.0 111.43 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.54 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 38.1 Cg_endo -74.51 153.41 44.35 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.734 2.289 . . . . 0.0 110.897 177.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.564 HG13 ' CD2' ' A' ' 106' ' ' TYR . 7.7 p -76.74 -30.9 19.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.187 -0.945 . . . . 0.0 109.791 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.564 ' CD2' HG13 ' A' ' 105' ' ' VAL . 50.0 m-85 -113.61 54.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.148 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.54 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.417 0.627 . . . . 0.0 109.913 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.41 -4.53 8.24 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.403 2.069 . . . . 0.0 112.661 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.51 ' HA ' ' HE1' ' A' ' 11' ' ' TRP . 93.6 m-70 -79.45 -16.32 56.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.156 -0.965 . . . . 0.0 109.712 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -61.3 -48.35 81.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.703 -1.248 . . . . 0.0 109.331 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.5 129.86 45.71 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.589 ' O ' ' N ' ' A' ' 12' ' ' ASN . 7.4 pm0 -73.03 -2.61 21.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.119 -0.988 . . . . 0.0 109.932 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.56 ' CG ' ' N ' ' A' ' 10' ' ' THR . 36.7 pttt -59.82 -35.95 75.79 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 109.392 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.644 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 69.4 p -66.76 -28.83 68.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.654 -0.653 . . . . 0.0 111.398 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.644 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -126.69 -15.23 5.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.418 -1.426 . . . . 0.0 111.679 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 8' ' ' GLU . 2.1 t-20 -102.67 118.55 37.09 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.406 -1.434 . . . . 0.0 111.511 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.733 ' CG1' ' HE ' ' A' ' 36' ' ' ARG . 9.9 p -135.89 37.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -31.59 -26.42 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 13' ' ' VAL . 99.0 p -61.61 -4.94 1.57 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.659 -1.495 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.1 m -93.77 162.01 14.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.669 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -113.77 164.83 13.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.636 HH21 ' CE1' ' A' ' 56' ' ' HIS . 5.5 mmm180 -58.36 -42.22 86.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.004 -1.06 . . . . 0.0 109.988 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -61.91 -44.14 97.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.865 -1.147 . . . . 0.0 108.817 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -66.06 -29.67 70.05 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.422 -0.798 . . . . 0.0 109.1 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.543 ' CB ' HH12 ' A' ' 36' ' ' ARG . . . -61.61 -40.52 95.11 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.354 -0.841 . . . . 0.0 109.225 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.33 -43.55 96.31 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -64.4 -43.49 94.26 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.417 HD12 ' NH2' ' A' ' 36' ' ' ARG . 73.2 mt -70.33 -36.41 74.24 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.317 -0.865 . . . . 0.0 108.878 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.534 HD21 ' OG ' ' A' ' 47' ' ' SER . 41.3 mt -75.87 -12.6 60.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.73 126.07 30.48 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.57 9.49 78.58 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' CD ' HG21 ' A' ' 32' ' ' THR . 5.1 mmpp? -99.2 126.67 45.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.149 -1.206 . . . . 0.0 109.476 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -77.97 160.76 27.99 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 67.2 t0 -53.92 140.93 29.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.68 . . . . 0.0 110.617 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 110.09 -28.61 10.2 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 91.4 m -83.73 121.0 26.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.254 -1.144 . . . . 0.0 110.062 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.717 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -133.68 156.35 48.08 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.738 -1.226 . . . . 0.0 111.301 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.716 HD22 ' C ' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -111.37 160.15 17.33 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.697 0.761 . . . . 0.0 111.058 -177.712 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.75 HG22 ' SG ' ' A' ' 46' ' ' CYS . 37.8 t -132.21 112.69 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.733 ' HE ' ' CG1' ' A' ' 13' ' ' VAL . 69.5 mtt180 -136.92 172.99 12.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.925 -1.109 . . . . 0.0 110.033 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.302 -1.481 0 O-C-N 121.019 -1.051 . . . . 0.0 108.385 179.129 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' A' ' 59' ' ' ILE . 91.5 m-85 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 121.147 0.499 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.2 137.57 24.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 108.589 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.75 ' SG ' HG22 ' A' ' 35' ' ' VAL . 33.3 m -107.26 131.18 54.48 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.892 -1.13 . . . . 0.0 108.872 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.534 ' OG ' HD21 ' A' ' 25' ' ' LEU . 1.3 p -90.4 132.82 35.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.414 -0.804 . . . . 0.0 110.183 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 49' ' ' VAL . 3.7 p -132.83 157.02 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.937 -1.102 . . . . 0.0 110.583 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.679 HG13 HG22 ' A' ' 54' ' ' VAL . 60.4 t -118.14 146.66 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.954 HG23 ' HZ3' ' A' ' 55' ' ' LYS . 13.2 t -120.44 161.31 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 0.0 110.296 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.567 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 43.4 p-10 -58.21 6.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.696 -0.628 . . . . 0.0 110.27 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -149.61 -19.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.364 0 C-N-CA 118.958 -1.591 . . . . 0.0 112.252 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.738 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 68.8 tt0 -156.49 169.01 25.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.193 -1.769 . . . . 0.0 111.224 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.679 HG22 HG13 ' A' ' 49' ' ' VAL . 96.9 t -118.53 128.14 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.381 -0.824 . . . . 0.0 109.207 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.954 ' HZ3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -122.05 179.82 4.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.774 -1.204 . . . . 0.0 110.447 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.636 ' CE1' HH21 ' A' ' 18' ' ' ARG . 67.7 m-70 -127.63 82.43 2.09 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.3 m -56.22 135.14 53.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.015 -1.053 . . . . 0.0 108.83 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 58' ' ' VAL . 9.8 p -104.23 133.54 47.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 110.422 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 44' ' ' TYR . 27.1 mm -104.63 123.01 58.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.922 -178.431 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.5 m . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 78' ' ' LEU . 89.1 mt -63.75 -37.71 88.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.097 . . . . 0.0 109.635 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -58.49 -40.09 81.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.967 -1.083 . . . . 0.0 108.568 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.1 -32.83 73.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.453 0.645 . . . . 0.0 109.455 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.419 HD21 ' CD1' ' A' ' 59' ' ' ILE . 14.7 tp -53.96 -48.71 70.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.331 -0.855 . . . . 0.0 109.524 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.5 t -66.22 -43.51 91.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 108.825 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.52 -44.0 83.71 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.497 -0.752 . . . . 0.0 110.115 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -60.44 -44.09 96.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 111.152 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.615 ' CB ' HD12 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -75.78 -21.84 57.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.046 -1.034 . . . . 0.0 110.373 -179.182 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.773 ' OE1' ' HB2' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -67.36 -41.99 84.19 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.004 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -73.97 -39.79 63.46 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.652 -0.655 . . . . 0.0 110.037 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 85' ' ' TYR . 33.1 m -97.7 140.39 32.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.145 -0.972 . . . . 0.0 110.558 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.407 ' OG ' HG12 ' A' ' 91' ' ' VAL . 54.1 p -84.81 143.22 29.23 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.72 -0.612 . . . . 0.0 109.981 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 90' ' ' LEU . 8.3 mp -73.02 -18.24 61.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.325 -0.86 . . . . 0.0 109.497 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.709 ' N ' ' O ' ' A' ' 97' ' ' LEU . 3.9 p -34.0 -44.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.196 -0.94 . . . . 0.0 109.911 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.554 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 64.8 tp60 -47.8 -45.9 30.04 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.714 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.61 ' C ' ' H ' ' A' ' 95' ' ' ASP . 42.3 t-80 -62.32 131.71 50.24 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.579 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 12.3 m120 54.27 -0.65 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.61 ' H ' ' C ' ' A' ' 93' ' ' HIS . 89.8 m-20 56.77 24.44 9.1 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.08 -1.012 . . . . 0.0 110.26 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.6 m -144.27 12.07 1.55 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.778 -1.201 . . . . 0.0 110.593 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.709 ' O ' ' N ' ' A' ' 91' ' ' VAL . 6.8 mp -99.14 73.76 1.93 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -78.2 75.98 4.73 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.432 ' CG1' HG22 ' A' ' 50' ' ' VAL . 2.6 p -152.69 155.18 6.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.552 0.692 . . . . 0.0 109.734 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 102' ' ' ALA . 81.4 p -129.31 135.46 48.78 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.717 HD22 ' CG ' ' A' ' 33' ' ' PHE . 62.1 mt -72.52 70.12 0.89 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.773 ' HB2' ' OE1' ' A' ' 86' ' ' GLN . . . -117.23 -7.54 11.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.848 -0.532 . . . . 0.0 111.935 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 32' ' ' THR . 97.5 m-85 -120.73 100.89 46.23 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.398 -1.439 . . . . 0.0 110.67 -178.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.536 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 37.2 Cg_exo -59.67 145.64 97.58 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.613 1.542 . . . . 0.0 110.309 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.465 HG21 HD11 ' A' ' 34' ' ' LEU . 2.6 p -67.86 -34.11 65.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 120.882 -1.136 . . . . 0.0 108.482 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.459 ' CD2' HG13 ' A' ' 105' ' ' VAL . 57.9 m-85 -106.08 44.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.437 -0.789 . . . . 0.0 110.584 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 0.0 109.418 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.41 -4.53 8.24 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.403 2.069 . . . . 0.0 112.661 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.51 ' HA ' ' HE1' ' A' ' 11' ' ' TRP . 93.6 m-70 -79.45 -16.32 56.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.156 -0.965 . . . . 0.0 109.712 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -61.3 -48.35 81.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.703 -1.248 . . . . 0.0 109.331 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.5 129.86 45.71 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.589 ' O ' ' N ' ' A' ' 12' ' ' ASN . 7.4 pm0 -73.03 -2.61 21.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.119 -0.988 . . . . 0.0 109.932 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.56 ' CG ' ' N ' ' A' ' 10' ' ' THR . 36.7 pttt -59.82 -35.95 75.79 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 109.392 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.644 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 69.4 p -66.76 -28.83 68.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.654 -0.653 . . . . 0.0 111.398 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.644 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -126.69 -15.23 5.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.418 -1.426 . . . . 0.0 111.679 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 8' ' ' GLU . 2.1 t-20 -102.67 118.55 37.09 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.406 -1.434 . . . . 0.0 111.511 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.733 ' CG1' ' HE ' ' A' ' 36' ' ' ARG . 9.9 p -135.89 37.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -31.59 -26.42 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 13' ' ' VAL . 99.0 p -61.61 -4.94 1.57 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.659 -1.495 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.1 m -93.77 162.01 14.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.669 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -113.77 164.83 13.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.636 HH21 ' CE1' ' A' ' 56' ' ' HIS . 5.5 mmm180 -58.36 -42.22 86.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.004 -1.06 . . . . 0.0 109.988 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -61.91 -44.14 97.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.865 -1.147 . . . . 0.0 108.817 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -66.06 -29.67 70.05 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.422 -0.798 . . . . 0.0 109.1 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.543 ' CB ' HH12 ' A' ' 36' ' ' ARG . . . -61.61 -40.52 95.11 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.354 -0.841 . . . . 0.0 109.225 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.33 -43.55 96.31 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -64.4 -43.49 94.26 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.417 HD12 ' NH2' ' A' ' 36' ' ' ARG . 73.2 mt -70.33 -36.41 74.24 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.317 -0.865 . . . . 0.0 108.878 178.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.534 HD21 ' OG ' ' A' ' 47' ' ' SER . 41.3 mt -75.87 -12.6 60.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.73 126.07 30.48 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.57 9.49 78.58 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' CD ' HG21 ' A' ' 32' ' ' THR . 5.1 mmpp? -99.2 126.67 45.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.149 -1.206 . . . . 0.0 109.476 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -77.97 160.76 27.99 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 67.2 t0 -53.92 140.93 29.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.68 . . . . 0.0 110.617 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 110.09 -28.61 10.2 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 91.4 m -83.73 121.0 26.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.254 -1.144 . . . . 0.0 110.062 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.717 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -133.68 156.35 48.08 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.738 -1.226 . . . . 0.0 111.301 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.716 HD22 ' C ' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -111.37 160.15 17.33 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.697 0.761 . . . . 0.0 111.058 -177.712 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.75 HG22 ' SG ' ' A' ' 46' ' ' CYS . 37.8 t -132.21 112.69 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.733 ' HE ' ' CG1' ' A' ' 13' ' ' VAL . 69.5 mtt180 -136.92 172.99 12.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.925 -1.109 . . . . 0.0 110.033 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.302 -1.481 0 O-C-N 121.019 -1.051 . . . . 0.0 108.385 179.129 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' A' ' 59' ' ' ILE . 91.5 m-85 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 121.147 0.499 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.2 137.57 24.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 108.589 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.75 ' SG ' HG22 ' A' ' 35' ' ' VAL . 33.3 m -107.26 131.18 54.48 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.892 -1.13 . . . . 0.0 108.872 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.534 ' OG ' HD21 ' A' ' 25' ' ' LEU . 1.3 p -90.4 132.82 35.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.414 -0.804 . . . . 0.0 110.183 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 49' ' ' VAL . 3.7 p -132.83 157.02 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.937 -1.102 . . . . 0.0 110.583 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.679 HG13 HG22 ' A' ' 54' ' ' VAL . 60.4 t -118.14 146.66 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.954 HG23 ' HZ3' ' A' ' 55' ' ' LYS . 13.2 t -120.44 161.31 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 0.0 110.296 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.567 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 43.4 p-10 -58.21 6.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.696 -0.628 . . . . 0.0 110.27 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -149.61 -19.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.364 0 C-N-CA 118.958 -1.591 . . . . 0.0 112.252 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.738 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 68.8 tt0 -156.49 169.01 25.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.193 -1.769 . . . . 0.0 111.224 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.679 HG22 HG13 ' A' ' 49' ' ' VAL . 96.9 t -118.53 128.14 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.381 -0.824 . . . . 0.0 109.207 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.954 ' HZ3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -122.05 179.82 4.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.774 -1.204 . . . . 0.0 110.447 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.636 ' CE1' HH21 ' A' ' 18' ' ' ARG . 67.7 m-70 -127.63 82.43 2.09 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.3 m -56.22 135.14 53.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.015 -1.053 . . . . 0.0 108.83 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 58' ' ' VAL . 9.8 p -104.23 133.54 47.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 110.422 -178.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 44' ' ' TYR . 27.1 mm -104.63 123.01 58.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.922 -178.431 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.5 m . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 78' ' ' LEU . 89.1 mt -63.75 -37.71 88.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.097 . . . . 0.0 109.635 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -58.49 -40.09 81.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.967 -1.083 . . . . 0.0 108.568 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.1 -32.83 73.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.453 0.645 . . . . 0.0 109.455 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.419 HD21 ' CD1' ' A' ' 59' ' ' ILE . 14.7 tp -53.96 -48.71 70.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.331 -0.855 . . . . 0.0 109.524 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.5 t -66.22 -43.51 91.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 108.825 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.52 -44.0 83.71 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.497 -0.752 . . . . 0.0 110.115 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -60.44 -44.09 96.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 111.152 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.615 ' CB ' HD12 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -75.78 -21.84 57.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.046 -1.034 . . . . 0.0 110.373 -179.182 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.773 ' OE1' ' HB2' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -67.36 -41.99 84.19 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.004 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -73.97 -39.79 63.46 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.652 -0.655 . . . . 0.0 110.037 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 85' ' ' TYR . 33.1 m -97.7 140.39 32.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.145 -0.972 . . . . 0.0 110.558 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.407 ' OG ' HG12 ' A' ' 91' ' ' VAL . 54.1 p -84.81 143.22 29.23 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.72 -0.612 . . . . 0.0 109.981 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 90' ' ' LEU . 8.3 mp -73.02 -18.24 61.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.325 -0.86 . . . . 0.0 109.497 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.709 ' N ' ' O ' ' A' ' 97' ' ' LEU . 3.9 p -34.0 -44.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.196 -0.94 . . . . 0.0 109.911 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.554 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 64.8 tp60 -47.8 -45.9 30.04 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.714 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.61 ' C ' ' H ' ' A' ' 95' ' ' ASP . 42.3 t-80 -62.32 131.71 50.24 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.579 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 12.3 m120 54.27 -0.65 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.61 ' H ' ' C ' ' A' ' 93' ' ' HIS . 89.8 m-20 56.77 24.44 9.1 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.08 -1.012 . . . . 0.0 110.26 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.6 m -144.27 12.07 1.55 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.778 -1.201 . . . . 0.0 110.593 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.709 ' O ' ' N ' ' A' ' 91' ' ' VAL . 6.8 mp -99.14 73.76 1.93 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -78.2 75.98 4.73 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.432 ' CG1' HG22 ' A' ' 50' ' ' VAL . 2.6 p -152.69 155.18 6.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.552 0.692 . . . . 0.0 109.734 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 102' ' ' ALA . 81.4 p -129.31 135.46 48.78 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.717 HD22 ' CG ' ' A' ' 33' ' ' PHE . 62.1 mt -72.52 70.12 0.89 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.773 ' HB2' ' OE1' ' A' ' 86' ' ' GLN . . . -117.23 -7.54 11.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.848 -0.532 . . . . 0.0 111.935 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 32' ' ' THR . 97.5 m-85 -120.73 100.89 46.23 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.398 -1.439 . . . . 0.0 110.67 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.536 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 37.2 Cg_exo -59.67 145.64 97.58 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.613 1.542 . . . . 0.0 110.309 178.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.465 HG21 HD11 ' A' ' 34' ' ' LEU . 2.6 p -67.86 -34.11 65.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 120.882 -1.136 . . . . 0.0 108.482 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.459 ' CD2' HG13 ' A' ' 105' ' ' VAL . 57.9 m-85 -106.08 44.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.437 -0.789 . . . . 0.0 110.584 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 0.0 109.418 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.535 ' HG ' ' H ' ' A' ' 5' ' ' HIS . 25.0 tp . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -56.03 -6.25 1.2 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.04 1.826 . . . . 0.0 111.744 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.535 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 84.0 m-70 -88.67 -12.72 41.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 110.641 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -60.94 -40.52 93.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.779 -1.201 . . . . 0.0 108.963 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.424 ' CB ' ' HE2' ' A' ' 9' ' ' LYS . 79.1 m-20 -108.96 130.15 55.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.283 -0.885 . . . . 0.0 109.244 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.684 ' O ' ' N ' ' A' ' 12' ' ' ASN . 3.6 pm0 -73.59 -7.68 52.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.038 -1.039 . . . . 0.0 110.304 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.508 ' CG ' ' N ' ' A' ' 10' ' ' THR . 6.1 pttt -60.54 -36.4 78.35 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.065 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.641 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 38.0 p -61.51 -31.97 71.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.564 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.641 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -121.44 -12.6 8.55 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.916 -1.115 . . . . 0.0 110.457 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 8' ' ' GLU . 57.8 t30 -88.69 116.55 27.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.908 -1.12 . . . . 0.0 111.231 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 15' ' ' SER . 9.9 p -140.08 31.67 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 CA-C-O 122.007 0.908 . . . . 0.0 108.831 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -42.82 -22.43 0.15 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 13' ' ' VAL . 59.5 m -67.99 -36.77 80.56 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.019 -1.283 . . . . 0.0 110.106 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.667 ' C ' ' HE ' ' A' ' 36' ' ' ARG . 47.3 t -65.71 147.66 53.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.302 -0.874 . . . . 0.0 110.133 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.516 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 76.1 m-20 -86.66 163.65 17.26 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 61.5 mtp180 -60.0 -40.65 89.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.093 -1.005 . . . . 0.0 109.767 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -60.06 -42.97 95.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.008 -1.057 . . . . 0.0 109.503 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.5 tttm -64.89 -28.77 69.76 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.144 -0.972 . . . . 0.0 108.455 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.905 ' HB2' HH22 ' A' ' 36' ' ' ARG . . . -58.43 -41.83 85.92 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 98.4 mt-10 -61.13 -44.73 96.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.106 -0.996 . . . . 0.0 108.343 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -60.36 -46.29 90.48 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.474 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 79.7 mt -63.17 -40.17 96.76 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.644 HD23 HG23 ' A' ' 49' ' ' VAL . 4.5 mt -72.19 -31.95 66.36 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.526 ' NH1' ' HG3' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -68.28 132.61 47.42 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.806 -0.559 . . . . 0.0 109.59 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.17 9.76 84.69 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.503 ' HB2' HG21 ' A' ' 49' ' ' VAL . 47.7 mmtt -108.74 133.29 53.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.07 -1.253 . . . . 0.0 109.438 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -75.6 168.87 19.2 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.344 -0.847 . . . . 0.0 109.41 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 59.1 t0 -59.07 140.83 55.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.587 -0.695 . . . . 0.0 110.328 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.457 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 109.01 -26.57 14.99 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 48' ' ' VAL . 84.9 m -63.35 121.47 13.85 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.695 ' CD2' HD22 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -138.41 145.13 40.62 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.96 -1.088 . . . . 0.0 111.406 -178.113 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.495 HD23 ' N ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -142.95 157.9 44.12 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.621 0.724 . . . . 0.0 109.905 178.569 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.548 HG22 ' SG ' ' A' ' 46' ' ' CYS . 97.7 t -104.05 139.52 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.905 HH22 ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -147.88 164.07 34.84 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.717 -1.239 . . . . 0.0 108.751 -177.763 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.673 ' OE1' ' CE1' ' A' ' 44' ' ' TYR . 66.6 mm-40 . . . . . 0 C--N 1.305 -1.343 0 O-C-N 120.522 -1.361 . . . . 0.0 108.122 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.673 ' CE1' ' OE1' ' A' ' 37' ' ' GLU . 98.5 m-85 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.868 0.366 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.598 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -163.34 143.49 8.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.008 -1.058 . . . . 0.0 109.905 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.548 ' SG ' HG22 ' A' ' 35' ' ' VAL . 60.6 m -115.13 143.41 45.25 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.581 ' HB2' HD11 ' A' ' 25' ' ' LEU . 97.0 p -113.6 144.69 42.48 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.931 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -152.97 158.56 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 121.675 0.75 . . . . 0.0 110.257 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.644 HG23 HD23 ' A' ' 25' ' ' LEU . 53.3 t -98.78 142.5 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.544 ' CG1' ' CD ' ' A' ' 55' ' ' LYS . 12.8 p -155.59 150.52 10.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 C-N-CA 118.128 -1.429 . . . . 0.0 112.166 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.613 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 65.5 t0 36.13 33.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.813 -0.554 . . . . 0.0 111.954 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 81.36 3.99 90.53 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 118.958 -1.591 . . . . 0.0 111.307 178.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -127.24 134.53 50.07 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.845 -1.386 . . . . 0.0 110.077 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.635 ' CG1' HD13 ' A' ' 25' ' ' LEU . 72.3 t -81.41 129.12 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.301 0.572 . . . . 0.0 109.522 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.544 ' CD ' ' CG1' ' A' ' 50' ' ' VAL . 5.7 mptt -130.82 148.15 52.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.359 -0.838 . . . . 0.0 110.292 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -107.3 107.18 17.99 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.65 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.543 ' N ' ' O ' ' A' ' 46' ' ' CYS . 52.6 t -68.96 126.71 30.64 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.9 t -93.3 131.41 40.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.387 -0.821 . . . . 0.0 111.279 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.9 mm -108.65 133.29 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.3 m120 . . . . . 0 N--CA 1.495 1.819 0 O-C-N 120.778 -1.201 . . . . 0.0 110.875 -179.231 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.8 p . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.596 0.712 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.1 mt -60.22 -43.95 95.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.714 . . . . 0.0 109.266 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -61.08 -43.17 99.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.436 -0.79 . . . . 0.0 109.841 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -63.65 -40.1 96.0 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.056 -1.027 . . . . 0.0 109.773 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.725 HD23 ' C ' ' A' ' 81' ' ' LEU . 8.5 tt -61.27 -44.9 96.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.963 . . . . 0.0 109.909 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.547 HG21 ' CZ3' ' A' ' 11' ' ' TRP . 91.8 t -64.01 -38.73 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.066 -1.021 . . . . 0.0 109.175 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 86' ' ' GLN . 62.5 tp -63.93 -46.82 83.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.746 . . . . 0.0 111.227 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -67.91 -40.45 83.43 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.624 -1.297 . . . . 0.0 110.764 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.453 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 5.2 m-85 -61.24 -29.09 69.62 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.396 -0.815 . . . . 0.0 110.247 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -68.01 -13.83 62.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.756 -1.215 . . . . 0.0 109.85 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -103.21 -31.07 10.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.043 -1.036 . . . . 0.0 109.948 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.0 m -87.37 141.28 28.75 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.074 -1.016 . . . . 0.0 110.737 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.0 m -88.79 124.18 33.91 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.764 ' O ' ' N ' ' A' ' 92' ' ' GLN . 21.7 mt -60.76 -40.69 93.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.835 . . . . 0.0 111.18 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.727 HG12 ' N ' ' A' ' 92' ' ' GLN . 4.2 t 31.84 -81.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.595 0 O-C-N 120.959 -1.088 . . . . 0.0 110.001 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.764 ' N ' ' O ' ' A' ' 90' ' ' LEU . 54.9 mt-30 56.22 -159.2 0.22 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.568 -0.708 . . . . 0.0 111.779 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.437 ' H ' ' HB3' ' A' ' 92' ' ' GLN . 79.6 m-70 -55.11 -44.11 74.65 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.321 -0.862 . . . . 0.0 109.286 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.678 ' O ' ' N ' ' A' ' 96' ' ' SER . 30.1 m120 -81.14 91.13 6.09 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 94' ' ' ASN . 50.5 t0 -43.64 -8.95 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.474 -0.766 . . . . 0.0 110.43 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 94' ' ' ASN . 95.0 p -89.77 -0.09 57.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.832 -1.167 . . . . 0.0 112.19 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.721 ' O ' ' N ' ' A' ' 91' ' ' VAL . 68.7 mt -83.81 30.83 0.49 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.783 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 0.8 OUTLIER -76.26 53.9 0.85 Allowed 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.97 0.891 . . . . 0.0 108.973 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.5 150.88 33.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 102' ' ' ALA . 43.7 p -114.28 150.68 34.05 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.695 HD22 ' CD2' ' A' ' 33' ' ' PHE . 30.4 mt -71.7 68.06 0.59 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -100.87 -25.41 14.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 112.228 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -116.05 104.05 52.7 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.376 -1.453 . . . . 0.0 111.181 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 107' ' ' ALA . 31.6 Cg_exo -57.89 159.41 17.91 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.609 2.206 . . . . 0.0 110.433 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.518 HG13 ' CD2' ' A' ' 106' ' ' TYR . 13.2 p -78.59 -28.71 14.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 120.737 -1.227 . . . . 0.0 108.115 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.518 ' CD2' HG13 ' A' ' 105' ' ' VAL . 57.1 m-85 -112.07 29.98 7.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.487 -0.758 . . . . 0.0 109.159 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.51 ' HB2' ' HD2' ' A' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.903 . . . . 0.0 109.082 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.505 ' O ' ' OG1' ' A' ' 10' ' ' THR . 78.5 Cg_exo -48.66 -19.99 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.39 2.06 . . . . 0.0 112.675 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.2 m170 -67.35 -26.08 66.3 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.925 -1.109 . . . . 0.0 109.741 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -63.4 -39.21 93.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.196 -0.94 . . . . 0.0 110.8 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.528 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 69.2 m-20 -93.16 128.7 39.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.991 -1.068 . . . . 0.0 110.421 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.707 ' O ' ' N ' ' A' ' 12' ' ' ASN . 94.0 mt-10 -66.87 -26.55 66.95 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.239 -0.913 . . . . 0.0 110.479 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.501 ' HG2' ' N ' ' A' ' 10' ' ' THR . 1.2 pttp -60.86 -35.92 77.82 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.194 -0.941 . . . . 0.0 111.339 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.535 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 2.7 p -60.23 -33.14 71.85 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 109.895 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.654 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -122.67 -20.84 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 111.098 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.707 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -91.82 119.21 31.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.723 -1.235 . . . . 0.0 110.257 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.98 -4.54 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.301 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.83 -142.21 30.54 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -82.49 121.2 26.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.324 . . . . 0.0 109.115 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.0 t -141.24 148.14 39.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 110.154 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.503 ' CG ' ' OD1' ' A' ' 19' ' ' ASN . 58.3 t-20 -74.24 134.3 42.68 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.163 -0.961 . . . . 0.0 108.752 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.629 ' CG ' HH12 ' A' ' 36' ' ' ARG . 23.7 mtp180 -59.36 -33.06 70.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.489 -0.757 . . . . 0.0 109.836 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 13.9 p-10 -59.71 -46.3 89.51 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.857 -1.137 . . . . 0.0 108.41 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 29.5 tttt -64.62 -39.78 94.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 109.034 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.78 78.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.086 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.22 -40.48 77.59 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -60.15 -44.71 94.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 24' ' ' LEU . 91.1 mt -66.16 -31.79 72.84 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.468 -0.77 . . . . 0.0 109.263 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.525 HD23 ' CG2' ' A' ' 49' ' ' VAL . 9.9 mt -91.3 -4.12 56.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.551 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 27' ' ' GLY . 2.9 tpt180 -91.58 125.51 36.34 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.476 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . 70.63 24.99 76.43 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.831 ' HE2' HG21 ' A' ' 32' ' ' THR . 37.9 tptt -106.67 139.97 40.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -1.214 . . . . 0.0 108.676 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -71.43 149.09 46.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.326 -0.859 . . . . 0.0 110.867 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.557 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 64.3 t0 -58.7 144.17 44.37 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.498 0.666 . . . . 0.0 110.072 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 104.66 -24.87 27.38 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.831 HG21 ' HE2' ' A' ' 28' ' ' LYS . 85.4 m -81.58 124.86 29.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.986 -1.302 . . . . 0.0 109.128 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.582 ' CG ' HD22 ' A' ' 101' ' ' LEU . 1.1 p90 -140.03 164.89 28.81 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.16 -1.416 . . . . 0.0 111.601 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 34' ' ' LEU . 1.1 pt? -137.27 156.97 47.64 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.673 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 11' ' ' TRP . 53.1 t -110.43 134.4 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.629 HH12 ' CG ' ' A' ' 18' ' ' ARG . 75.7 mtm180 -130.39 -179.49 5.29 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.426 -0.796 . . . . 0.0 109.235 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 C--N 1.302 -1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 108.999 179.458 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.454 ' O ' ' O ' ' A' ' 59' ' ' ILE . 86.8 m-85 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.251 0.548 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.49 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -147.15 132.87 18.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 109.686 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 27.4 p -102.6 117.69 35.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 108.974 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.5 m -98.77 127.28 44.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 108.868 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.65 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.5 p -127.89 166.39 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 110.536 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.65 ' N ' HG22 ' A' ' 48' ' ' VAL . 15.5 t -108.16 138.18 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.876 HG12 ' H ' ' A' ' 52' ' ' GLY . 54.2 t -114.24 148.32 17.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.421 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 61.4 t0 -50.64 -12.96 0.11 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.119 0.961 . . . . 0.0 108.601 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.876 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -102.95 -51.1 1.03 Allowed Glycine 0 C--N 1.289 -2.05 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.593 ' HB2' ' HZ1' ' A' ' 55' ' ' LYS . 70.6 mm-40 -160.32 -177.44 6.25 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.865 -1.373 . . . . 0.0 110.428 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -94.21 128.27 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.552 -0.718 . . . . 0.0 109.405 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.593 ' HZ1' ' HB2' ' A' ' 53' ' ' GLU . 9.3 mptt -128.89 148.63 50.93 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.262 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -104.55 98.22 8.02 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.2 m -82.61 145.12 29.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.715 -1.241 . . . . 0.0 109.103 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 58' ' ' VAL . 6.9 p -107.11 139.85 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.233 -0.917 . . . . 0.0 112.877 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.49 ' H ' ' HA ' ' A' ' 45' ' ' ALA . 49.9 mm -107.11 126.77 63.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 176.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 . . . . . 0 N--CA 1.495 1.802 0 O-C-N 120.827 -1.171 . . . . 0.0 110.81 -177.936 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.521 0.677 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -36.72 77.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.703 -0.623 . . . . 0.0 109.672 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -60.0 -40.89 90.74 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.011 -1.055 . . . . 0.0 108.63 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.11 -31.1 70.47 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.745 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.3 tm? -59.73 -45.77 91.15 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.432 HG21 ' CZ3' ' A' ' 11' ' ' TRP . 98.0 t -65.01 -45.0 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.03 . . . . 0.0 108.81 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.47 -43.01 77.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 110.057 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.499 ' O ' ' OG1' ' A' ' 88' ' ' THR . 53.6 t-80 -60.72 -42.71 97.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.353 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.504 ' CE2' HD11 ' A' ' 81' ' ' LEU . 4.6 m-30 -68.87 -25.1 64.46 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.083 -1.01 . . . . 0.0 109.387 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.579 ' OE1' ' ND1' ' A' ' 87' ' ' HIS . 1.3 tm0? -61.95 -34.68 76.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.217 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.579 ' ND1' ' OE1' ' A' ' 86' ' ' GLN . 87.9 m-70 -95.08 -18.73 20.74 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.015 -1.053 . . . . 0.0 110.888 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -102.67 133.09 48.27 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.036 -1.04 . . . . 0.0 109.9 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.3 t -74.21 133.51 42.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.417 -0.802 . . . . 0.0 109.48 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 92' ' ' GLN . 8.8 mp -62.51 -29.23 70.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.476 -0.765 . . . . 0.0 110.573 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.936 HG13 ' H ' ' A' ' 92' ' ' GLN . 8.6 p 2.34 -66.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 121.318 0.58 . . . . 0.0 111.492 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.936 ' H ' HG13 ' A' ' 91' ' ' VAL . 19.6 pt20 35.28 -149.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.826 0.822 . . . . 0.0 111.503 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.734 ' C ' ' H ' ' A' ' 95' ' ' ASP . 63.8 m80 -50.55 171.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.37 -0.831 . . . . 0.0 109.951 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 78.8 m-20 63.02 -22.19 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.734 ' H ' ' C ' ' A' ' 93' ' ' HIS . 86.0 m-20 53.95 31.37 13.31 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.739 -0.601 . . . . 0.0 109.676 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.7 m -134.33 -0.5 2.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.807 -1.183 . . . . 0.0 111.24 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 96.0 mt -82.09 57.55 3.59 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -79.7 84.77 5.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.647 0.737 . . . . 0.0 109.33 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.554 ' O ' HD13 ' A' ' 90' ' ' LEU . 3.0 p -159.94 155.98 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.428 ' N ' HG22 ' A' ' 99' ' ' VAL . 32.5 p -122.42 146.06 47.7 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.082 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.582 HD22 ' CG ' ' A' ' 33' ' ' PHE . 34.8 mt -80.19 65.86 5.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 108.698 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . . . -99.68 -22.86 15.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.855 . . . . 0.0 112.296 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.2 m-85 -115.18 114.05 43.46 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.46 -1.4 . . . . 0.0 110.897 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.408 ' CB ' ' O ' ' A' ' 10' ' ' THR . 10.5 Cg_exo -63.06 156.27 55.9 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.982 1.788 . . . . 0.0 111.227 178.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.73 -30.33 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.942 -1.099 . . . . 0.0 109.455 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -99.88 30.98 3.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.082 -1.011 . . . . 0.0 110.208 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 109.143 179.647 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.505 ' O ' ' OG1' ' A' ' 10' ' ' THR . 78.5 Cg_exo -48.66 -19.99 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.39 2.06 . . . . 0.0 112.675 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.2 m170 -67.35 -26.08 66.3 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.925 -1.109 . . . . 0.0 109.741 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -63.4 -39.21 93.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.196 -0.94 . . . . 0.0 110.8 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.528 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 69.2 m-20 -93.16 128.7 39.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.991 -1.068 . . . . 0.0 110.421 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.707 ' O ' ' N ' ' A' ' 12' ' ' ASN . 94.0 mt-10 -66.87 -26.55 66.95 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.239 -0.913 . . . . 0.0 110.479 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.501 ' HG2' ' N ' ' A' ' 10' ' ' THR . 1.2 pttp -60.86 -35.92 77.82 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.194 -0.941 . . . . 0.0 111.339 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.535 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 2.7 p -60.23 -33.14 71.85 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 109.895 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.654 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -122.67 -20.84 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 111.098 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.707 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -91.82 119.21 31.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.723 -1.235 . . . . 0.0 110.257 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.98 -4.54 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.301 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.83 -142.21 30.54 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -82.49 121.2 26.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.324 . . . . 0.0 109.115 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.0 t -141.24 148.14 39.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 110.154 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.503 ' CG ' ' OD1' ' A' ' 19' ' ' ASN . 58.3 t-20 -74.24 134.3 42.68 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.163 -0.961 . . . . 0.0 108.752 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.629 ' CG ' HH12 ' A' ' 36' ' ' ARG . 23.7 mtp180 -59.36 -33.06 70.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.489 -0.757 . . . . 0.0 109.836 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 13.9 p-10 -59.71 -46.3 89.51 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.857 -1.137 . . . . 0.0 108.41 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 29.5 tttt -64.62 -39.78 94.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 109.034 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.78 78.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.086 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.22 -40.48 77.59 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -60.15 -44.71 94.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 24' ' ' LEU . 91.1 mt -66.16 -31.79 72.84 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.468 -0.77 . . . . 0.0 109.263 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.525 HD23 ' CG2' ' A' ' 49' ' ' VAL . 9.9 mt -91.3 -4.12 56.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.551 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 27' ' ' GLY . 2.9 tpt180 -91.58 125.51 36.34 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.476 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . 70.63 24.99 76.43 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.831 ' HE2' HG21 ' A' ' 32' ' ' THR . 37.9 tptt -106.67 139.97 40.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -1.214 . . . . 0.0 108.676 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -71.43 149.09 46.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.326 -0.859 . . . . 0.0 110.867 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.557 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 64.3 t0 -58.7 144.17 44.37 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.498 0.666 . . . . 0.0 110.072 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 104.66 -24.87 27.38 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.831 HG21 ' HE2' ' A' ' 28' ' ' LYS . 85.4 m -81.58 124.86 29.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.986 -1.302 . . . . 0.0 109.128 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.582 ' CG ' HD22 ' A' ' 101' ' ' LEU . 1.1 p90 -140.03 164.89 28.81 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.16 -1.416 . . . . 0.0 111.601 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 34' ' ' LEU . 1.1 pt? -137.27 156.97 47.64 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.673 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 11' ' ' TRP . 53.1 t -110.43 134.4 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.629 HH12 ' CG ' ' A' ' 18' ' ' ARG . 75.7 mtm180 -130.39 -179.49 5.29 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.426 -0.796 . . . . 0.0 109.235 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 C--N 1.302 -1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 108.999 179.458 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.454 ' O ' ' O ' ' A' ' 59' ' ' ILE . 86.8 m-85 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.251 0.548 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.49 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -147.15 132.87 18.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 109.686 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 27.4 p -102.6 117.69 35.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 108.974 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.5 m -98.77 127.28 44.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 108.868 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.65 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.5 p -127.89 166.39 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 110.536 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.65 ' N ' HG22 ' A' ' 48' ' ' VAL . 15.5 t -108.16 138.18 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.876 HG12 ' H ' ' A' ' 52' ' ' GLY . 54.2 t -114.24 148.32 17.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.421 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 61.4 t0 -50.64 -12.96 0.11 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.119 0.961 . . . . 0.0 108.601 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.876 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -102.95 -51.1 1.03 Allowed Glycine 0 C--N 1.289 -2.05 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.593 ' HB2' ' HZ1' ' A' ' 55' ' ' LYS . 70.6 mm-40 -160.32 -177.44 6.25 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.865 -1.373 . . . . 0.0 110.428 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -94.21 128.27 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.552 -0.718 . . . . 0.0 109.405 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.593 ' HZ1' ' HB2' ' A' ' 53' ' ' GLU . 9.3 mptt -128.89 148.63 50.93 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.262 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -104.55 98.22 8.02 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.2 m -82.61 145.12 29.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.715 -1.241 . . . . 0.0 109.103 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 58' ' ' VAL . 6.9 p -107.11 139.85 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.233 -0.917 . . . . 0.0 112.877 -176.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.49 ' H ' ' HA ' ' A' ' 45' ' ' ALA . 49.9 mm -107.11 126.77 63.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 176.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 . . . . . 0 N--CA 1.495 1.802 0 O-C-N 120.827 -1.171 . . . . 0.0 110.81 -177.936 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.521 0.677 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -36.72 77.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.703 -0.623 . . . . 0.0 109.672 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -60.0 -40.89 90.74 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.011 -1.055 . . . . 0.0 108.63 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.11 -31.1 70.47 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.745 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.3 tm? -59.73 -45.77 91.15 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.432 HG21 ' CZ3' ' A' ' 11' ' ' TRP . 98.0 t -65.01 -45.0 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.03 . . . . 0.0 108.81 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.47 -43.01 77.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 110.057 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.499 ' O ' ' OG1' ' A' ' 88' ' ' THR . 53.6 t-80 -60.72 -42.71 97.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.353 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.504 ' CE2' HD11 ' A' ' 81' ' ' LEU . 4.6 m-30 -68.87 -25.1 64.46 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.083 -1.01 . . . . 0.0 109.387 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.579 ' OE1' ' ND1' ' A' ' 87' ' ' HIS . 1.3 tm0? -61.95 -34.68 76.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.217 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.579 ' ND1' ' OE1' ' A' ' 86' ' ' GLN . 87.9 m-70 -95.08 -18.73 20.74 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.015 -1.053 . . . . 0.0 110.888 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -102.67 133.09 48.27 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.036 -1.04 . . . . 0.0 109.9 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.3 t -74.21 133.51 42.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.417 -0.802 . . . . 0.0 109.48 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 92' ' ' GLN . 8.8 mp -62.51 -29.23 70.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.476 -0.765 . . . . 0.0 110.573 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.936 HG13 ' H ' ' A' ' 92' ' ' GLN . 8.6 p 2.34 -66.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 121.318 0.58 . . . . 0.0 111.492 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.936 ' H ' HG13 ' A' ' 91' ' ' VAL . 19.6 pt20 35.28 -149.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.826 0.822 . . . . 0.0 111.503 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.734 ' C ' ' H ' ' A' ' 95' ' ' ASP . 63.8 m80 -50.55 171.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.37 -0.831 . . . . 0.0 109.951 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 78.8 m-20 63.02 -22.19 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.734 ' H ' ' C ' ' A' ' 93' ' ' HIS . 86.0 m-20 53.95 31.37 13.31 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.739 -0.601 . . . . 0.0 109.676 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.7 m -134.33 -0.5 2.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.807 -1.183 . . . . 0.0 111.24 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 96.0 mt -82.09 57.55 3.59 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -79.7 84.77 5.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.647 0.737 . . . . 0.0 109.33 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.554 ' O ' HD13 ' A' ' 90' ' ' LEU . 3.0 p -159.94 155.98 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.428 ' N ' HG22 ' A' ' 99' ' ' VAL . 32.5 p -122.42 146.06 47.7 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.082 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.582 HD22 ' CG ' ' A' ' 33' ' ' PHE . 34.8 mt -80.19 65.86 5.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 108.698 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . . . -99.68 -22.86 15.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.855 . . . . 0.0 112.296 -178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.2 m-85 -115.18 114.05 43.46 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.46 -1.4 . . . . 0.0 110.897 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.408 ' CB ' ' O ' ' A' ' 10' ' ' THR . 10.5 Cg_exo -63.06 156.27 55.9 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.982 1.788 . . . . 0.0 111.227 178.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.73 -30.33 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.942 -1.099 . . . . 0.0 109.455 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -99.88 30.98 3.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.082 -1.011 . . . . 0.0 110.208 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 109.143 179.647 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -54.88 -12.06 4.32 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.145 1.897 . . . . 0.0 111.612 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.655 ' NE2' ' OE1' ' A' ' 86' ' ' GLN . 83.8 m-70 -65.22 -31.8 73.15 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.354 -0.841 . . . . 0.0 109.349 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -61.85 -22.02 65.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.387 -0.82 . . . . 0.0 109.234 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.715 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 71.6 m-20 -90.93 114.47 26.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.31 -0.869 . . . . 0.0 109.443 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.552 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 39.7 tt0 -67.22 -37.86 84.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.015 -1.053 . . . . 0.0 109.898 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HG2' ' N ' ' A' ' 10' ' ' THR . 0.4 OUTLIER -62.89 -29.06 70.47 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.487 -0.758 . . . . 0.0 110.642 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.627 ' OG1' ' O ' ' A' ' 7' ' ' ASP . 9.6 p -59.65 -35.12 73.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.132 -0.98 . . . . 0.0 110.381 -178.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.715 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -124.77 -5.69 7.49 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.738 -1.226 . . . . 0.0 110.125 179.568 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 8' ' ' GLU . 51.3 t-20 -96.76 129.2 44.22 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.989 -1.069 . . . . 0.0 110.441 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 13' ' ' VAL . 97.9 t -107.13 -12.04 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.84 . . . . 0.0 109.524 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.42 -154.16 50.09 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 88.7 p -68.57 143.13 54.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.05 -1.264 . . . . 0.0 109.622 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.7 p -157.98 154.94 28.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 109.81 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.645 ' C ' ' H ' ' A' ' 19' ' ' ASN . 58.9 t30 -89.02 19.81 3.97 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.537 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.0 OUTLIER 58.8 -12.89 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.389 -0.819 . . . . 0.0 109.787 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.645 ' H ' ' C ' ' A' ' 17' ' ' ASN . 57.8 t-20 -67.53 -46.7 72.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.615 -1.303 . . . . 0.0 108.425 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.37 -27.34 68.5 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -57.28 -43.94 83.56 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.573 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 68.4 mm-40 -61.14 -44.91 96.6 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -63.53 -45.63 89.72 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.445 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 83.0 mt -67.19 -36.83 82.57 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.541 HD13 ' CG1' ' A' ' 54' ' ' VAL . 55.4 mt -82.05 -9.01 59.69 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.573 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 14.2 mmm180 -102.69 123.4 46.32 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.9 -4.49 63.18 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 34.4 mmtt -98.64 138.99 35.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.079 -1.248 . . . . 0.0 109.504 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -73.24 161.21 30.81 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.698 -0.626 . . . . 0.0 109.76 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 57.4 p-10 -58.66 149.47 25.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.23 -0.919 . . . . 0.0 109.9 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.27 -25.53 27.88 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 27.7 m -80.51 120.37 24.4 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.424 -1.045 . . . . 0.0 108.696 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.782 ' HB2' HG22 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -130.67 161.69 31.08 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.389 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.451 HD21 HD21 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -132.55 167.79 19.38 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.699 -178.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 46' ' ' CYS . 82.7 t -130.81 129.27 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.908 -1.12 . . . . 0.0 110.654 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.668 ' NH2' ' OG ' ' A' ' 47' ' ' SER . 67.8 mtm180 -129.45 -149.77 0.41 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.403 ' H ' ' HB3' ' A' ' 36' ' ' ARG . 71.7 mm-40 . . . . . 0 C--N 1.306 -1.288 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.495 ' O ' ' O ' ' A' ' 59' ' ' ILE . 98.1 m-85 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.412 0.625 . . . . 0.0 109.959 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.91 133.09 23.02 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.457 -0.777 . . . . 0.0 109.123 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.44 ' HB3' HG22 ' A' ' 35' ' ' VAL . 17.1 p -115.87 134.61 54.82 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.206 -0.933 . . . . 0.0 109.502 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.668 ' OG ' ' NH2' ' A' ' 36' ' ' ARG . 70.7 m -98.65 146.15 26.15 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.597 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' ' 33' ' ' PHE . 67.6 t -129.37 160.8 39.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.435 -0.79 . . . . 0.0 108.871 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.551 ' N ' HG12 ' A' ' 48' ' ' VAL . 63.2 t -118.5 128.33 75.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.702 HG23 ' CG2' ' A' ' 99' ' ' VAL . 9.3 p -126.03 156.37 36.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.859 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.442 ' N ' HG22 ' A' ' 50' ' ' VAL . 97.9 m-20 -48.84 -18.39 0.27 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.639 0.733 . . . . 0.0 109.911 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.587 ' H ' HG13 ' A' ' 50' ' ' VAL . . . -85.22 -59.57 1.93 Allowed Glycine 0 C--N 1.284 -2.348 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.425 ' H ' HG13 ' A' ' 50' ' ' VAL . 21.9 pt-20 -164.85 -165.93 0.98 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.169 -1.195 . . . . 0.0 110.629 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.541 ' CG1' HD13 ' A' ' 25' ' ' LEU . 79.5 t -95.05 130.62 43.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.466 ' NZ ' ' HG ' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -117.75 156.81 27.63 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.71 -1.244 . . . . 0.0 110.823 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.513 ' ND1' ' OG ' ' A' ' 47' ' ' SER . 25.5 m-70 -120.83 71.32 0.93 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.8 m -60.17 143.84 51.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 109.804 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.13 143.08 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.672 -0.643 . . . . 0.0 110.58 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.495 ' O ' ' O ' ' A' ' 44' ' ' TYR . 44.8 mm -115.49 140.44 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 . . . . . 0 N--CA 1.497 1.888 0 O-C-N 120.553 -1.342 . . . . 0.0 110.549 -179.111 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.36 0.6 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.2 mt -57.28 -34.67 68.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.363 -0.835 . . . . 0.0 109.301 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -58.65 -40.14 82.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 0.0 108.612 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.24 -40.12 89.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.339 -0.851 . . . . 0.0 109.287 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.43 -46.49 89.89 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.208 -0.932 . . . . 0.0 109.132 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.51 -43.7 83.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.464 -0.772 . . . . 0.0 108.987 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 tp -65.86 -45.16 83.17 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.243 -0.911 . . . . 0.0 110.214 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -64.44 -40.28 95.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.978 -1.076 . . . . 0.0 111.182 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -75.51 -14.85 60.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.928 -1.108 . . . . 0.0 111.738 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.655 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 14.4 pt20 -66.86 -25.59 66.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.507 -1.37 . . . . 0.0 108.853 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -88.17 -36.41 16.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 109.896 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.487 ' O ' HG22 ' A' ' 100' ' ' THR . 91.2 m -83.26 149.42 26.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 0.0 110.513 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.0 m -99.05 130.21 45.37 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.573 0.702 . . . . 0.0 110.549 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.707 ' O ' ' N ' ' A' ' 92' ' ' GLN . 1.8 mt -62.06 -15.73 46.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.49 -0.756 . . . . 0.0 110.034 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.755 ' N ' ' O ' ' A' ' 97' ' ' LEU . 9.1 p -21.63 -38.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.87 -0.519 . . . . 0.0 111.297 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.707 ' N ' ' O ' ' A' ' 90' ' ' LEU . 5.3 pt20 -60.67 -42.83 97.85 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.509 ' N ' ' HG3' ' A' ' 92' ' ' GLN . 43.2 m-70 -59.73 -44.3 93.83 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.739 ' O ' ' N ' ' A' ' 96' ' ' SER . 9.5 m120 -131.68 116.31 17.17 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 94' ' ' ASN . 80.7 m-20 -40.87 -12.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.288 -0.882 . . . . 0.0 109.892 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.739 ' N ' ' O ' ' A' ' 94' ' ' ASN . 46.1 t -112.75 22.07 14.89 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.74 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.755 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.9 mt -95.67 56.62 1.79 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.783 -1.198 . . . . 0.0 108.896 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -77.85 69.72 4.12 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.124 -0.985 . . . . 0.0 108.87 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.702 ' CG2' HG23 ' A' ' 50' ' ' VAL . 86.2 t -149.55 154.33 9.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 86' ' ' GLN . 9.8 p -129.46 164.16 24.3 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.674 HD22 ' CG ' ' A' ' 33' ' ' PHE . 28.5 mt -78.78 70.63 5.15 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.894 -1.129 . . . . 0.0 108.169 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.91 -31.33 13.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.804 . . . . 0.0 112.356 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 32' ' ' THR . 59.7 m-85 -113.45 113.57 48.22 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 120.23 -1.544 . . . . 0.0 111.763 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.5 146.83 96.16 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.726 1.617 . . . . 0.0 110.615 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 106' ' ' TYR . 9.0 p -67.95 -38.1 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.013 -1.054 . . . . 0.0 110.442 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.462 ' HE2' HG22 ' A' ' 13' ' ' VAL . 53.7 m-85 -101.24 27.62 6.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.064 -1.023 . . . . 0.0 109.974 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.12 -0.988 . . . . 0.0 110.156 -179.832 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.526 ' N ' HD22 ' A' ' 3' ' ' LEU . 4.1 mm? . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.44 ' HB3' HG21 ' A' ' 10' ' ' THR . 15.2 Cg_exo -57.2 -12.43 10.1 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.721 1.614 . . . . 0.0 111.445 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -54.9 -25.99 32.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.627 -0.671 . . . . 0.0 110.424 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -61.39 -28.93 69.6 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.957 -1.089 . . . . 0.0 110.293 -179.39 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.655 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 88.9 m-20 -98.14 131.82 44.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.724 -1.235 . . . . 0.0 110.743 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.685 ' O ' ' N ' ' A' ' 12' ' ' ASN . 79.5 mt-10 -67.34 -27.13 66.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.467 -0.771 . . . . 0.0 109.139 179.163 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.47 ' CG ' ' N ' ' A' ' 10' ' ' THR . 37.6 pttt -59.64 -34.54 72.94 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.424 -0.797 . . . . 0.0 110.825 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.69 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 49.0 p -67.91 -26.34 65.93 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.392 -0.817 . . . . 0.0 111.013 -178.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.69 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -125.79 -25.15 3.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.617 -1.302 . . . . 0.0 110.543 179.636 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.685 ' N ' ' O ' ' A' ' 8' ' ' GLU . 8.8 p-10 -91.03 138.13 31.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.784 -1.197 . . . . 0.0 110.191 -178.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.0 p -111.52 -9.78 11.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.325 -0.859 . . . . 0.0 109.738 -179.484 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.82 50.39 3.53 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.797 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.52 ' HA ' ' H ' ' A' ' 37' ' ' GLU . 17.3 t 59.07 65.81 1.15 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.889 -1.36 . . . . 0.0 110.766 178.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.628 ' O ' ' CZ ' ' A' ' 36' ' ' ARG . 95.5 p -77.78 166.67 22.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.169 -0.957 . . . . 0.0 109.659 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.651 ' C ' HH12 ' A' ' 36' ' ' ARG . 86.1 m-20 -73.34 142.95 47.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.977 -1.077 . . . . 0.0 109.238 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.629 ' N ' HH12 ' A' ' 36' ' ' ARG . 35.0 mtm180 -60.22 -35.66 75.93 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.402 -0.811 . . . . 0.0 109.639 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -64.07 -43.71 94.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.939 -1.1 . . . . 0.0 109.08 179.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -68.46 -37.82 80.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.902 -1.124 . . . . 0.0 108.74 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.6 72.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.175 -0.953 . . . . 0.0 109.012 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 26' ' ' ARG . 67.3 tt0 -59.67 -48.85 80.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.241 -0.912 . . . . 0.0 108.827 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -60.25 -41.09 92.46 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.57 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.0 mt -66.76 -36.51 82.6 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.078 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.3 mt -86.93 -10.07 54.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.086 -1.009 . . . . 0.0 108.606 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.55 HH11 ' HG3' ' A' ' 26' ' ' ARG . 11.9 mmm-85 -100.45 135.36 42.01 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.418 0.628 . . . . 0.0 110.241 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.28 2.91 90.69 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -105.06 141.85 35.89 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.146 -1.208 . . . . 0.0 109.482 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -66.21 153.56 42.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.572 -0.705 . . . . 0.0 110.025 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.578 ' OD2' ' CA ' ' A' ' 51' ' ' ASP . 84.5 m-20 -58.74 144.67 42.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 0.0 109.486 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.41 -20.88 34.07 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.499 HG23 ' HD2' ' A' ' 103' ' ' TYR . 62.5 m -86.45 119.95 27.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.244 -1.151 . . . . 0.0 108.972 179.234 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.709 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -136.73 167.92 20.51 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.107 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.654 ' CD1' ' OG ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -140.29 157.11 46.08 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.002 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.443 HG22 ' SG ' ' A' ' 46' ' ' CYS . 47.4 t -106.97 133.47 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.991 -1.068 . . . . 0.0 108.604 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.651 HH12 ' C ' ' A' ' 17' ' ' ASN . 14.2 ptm180 -152.37 -177.52 6.25 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.112 -0.992 . . . . 0.0 109.35 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.52 ' H ' ' HA ' ' A' ' 15' ' ' SER . 32.9 tt0 . . . . . 0 C--N 1.3 -1.571 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.7 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -168.39 139.3 2.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.988 -1.07 . . . . 0.0 110.324 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.443 ' SG ' HG22 ' A' ' 35' ' ' VAL . 63.1 m -108.64 126.47 53.01 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.686 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.654 ' OG ' ' CD1' ' A' ' 34' ' ' LEU . 3.0 p -110.62 129.87 55.71 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.874 -1.141 . . . . 0.0 110.15 -179.01 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.587 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.2 p -127.53 161.47 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.039 -1.038 . . . . 0.0 109.812 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.587 ' N ' HG22 ' A' ' 48' ' ' VAL . 45.1 t -101.74 129.13 53.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.192 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.773 HG11 ' HZ1' ' A' ' 55' ' ' LYS . 48.0 t -122.71 154.57 27.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 120.87 -1.144 . . . . 0.0 110.367 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.578 ' CA ' ' OD2' ' A' ' 30' ' ' ASP . 59.0 t0 -49.01 -17.68 0.22 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.546 0.688 . . . . 0.0 110.026 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.76 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -94.52 -56.96 1.3 Allowed Glycine 0 C--N 1.283 -2.409 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -165.34 170.25 14.85 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.028 -1.277 . . . . 0.0 110.65 -179.29 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.2 m -73.19 137.24 23.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.654 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.773 ' HZ1' HG11 ' A' ' 50' ' ' VAL . 8.4 mttt -125.27 156.13 39.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.753 -1.217 . . . . 0.0 111.366 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -121.96 78.07 1.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 46' ' ' CYS . 74.5 m -58.95 131.57 51.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.444 -1.41 . . . . 0.0 108.138 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.95 125.8 62.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.411 -0.805 . . . . 0.0 110.993 -178.327 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.87 134.56 61.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 23.4 p30 . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.013 -1.055 . . . . 0.0 110.004 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.0 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.841 0.829 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mt -60.25 -35.77 76.26 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.202 0.525 . . . . 0.0 109.928 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.523 ' O ' HG12 ' A' ' 82' ' ' VAL . 71.1 tttt -52.44 -49.07 65.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.019 -1.051 . . . . 0.0 109.923 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -74.33 -20.24 60.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.942 -1.099 . . . . 0.0 108.71 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.984 HD21 ' CE2' ' A' ' 85' ' ' TYR . 7.4 tt -67.17 -43.88 81.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.554 -0.716 . . . . 0.0 109.606 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 83' ' ' LEU . 3.0 p -65.17 -43.93 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.077 -1.015 . . . . 0.0 109.027 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.533 ' N ' ' CG1' ' A' ' 82' ' ' VAL . 66.1 tp -67.68 -43.87 79.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.425 -0.797 . . . . 0.0 109.567 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -61.79 -39.97 93.55 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.495 -0.753 . . . . 0.0 110.167 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.984 ' CE2' HD21 ' A' ' 81' ' ' LEU . 5.8 m-30 -63.53 -27.36 69.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.92 -1.112 . . . . 0.0 109.187 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.535 ' HG3' ' HB2' ' A' ' 102' ' ' ALA . 17.6 tt0 -64.69 -35.23 80.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 110.071 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -91.06 -18.32 24.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.105 -0.997 . . . . 0.0 109.726 -179.309 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.7 m -101.76 122.96 44.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.897 . . . . 0.0 109.33 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.617 ' HA ' HG22 ' A' ' 100' ' ' THR . 20.3 t -72.22 133.95 45.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.326 -0.859 . . . . 0.0 109.026 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.761 ' O ' ' N ' ' A' ' 92' ' ' GLN . 66.2 mt -60.84 -43.85 97.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 111.066 -179.176 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.698 ' N ' ' O ' ' A' ' 97' ' ' LEU . 74.6 t 18.71 -79.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 CA-C-N 118.436 0.562 . . . . 0.0 109.649 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.761 ' N ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER 73.05 -176.23 0.17 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.378 -0.826 . . . . 0.0 110.854 178.247 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.413 ' H ' ' HG2' ' A' ' 92' ' ' GLN . 82.7 t60 -59.72 -38.88 82.88 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.383 -0.823 . . . . 0.0 109.114 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -55.05 -28.73 54.47 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.18 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.442 ' HA ' HG13 ' A' ' 91' ' ' VAL . 97.1 m-20 61.21 36.73 17.83 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.81 -0.556 . . . . 0.0 109.797 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.5 p -138.67 0.49 2.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.865 -1.147 . . . . 0.0 111.153 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.698 ' O ' ' N ' ' A' ' 91' ' ' VAL . 63.4 mt -100.21 61.69 1.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.755 -1.216 . . . . 0.0 107.976 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -80.68 69.3 7.18 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.971 -1.081 . . . . 0.0 109.92 -178.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.764 HG21 HG22 ' A' ' 50' ' ' VAL . 87.2 t -152.99 149.63 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.617 HG22 ' HA ' ' A' ' 89' ' ' SER . 26.1 p -119.81 152.06 37.85 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.288 -0.883 . . . . 0.0 108.863 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.709 HD22 ' CG ' ' A' ' 33' ' ' PHE . 31.9 mt -76.22 69.09 2.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.535 ' HB2' ' HG3' ' A' ' 86' ' ' GLN . . . -100.25 -23.99 14.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.461 -0.774 . . . . 0.0 113.031 -177.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.499 ' HD2' HG23 ' A' ' 32' ' ' THR . 78.2 t80 -114.52 105.66 53.37 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.15 -1.594 . . . . 0.0 110.795 -178.42 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.438 ' CB ' ' O ' ' A' ' 10' ' ' THR . 19.3 Cg_exo -59.75 144.98 99.34 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.976 1.784 . . . . 0.0 111.024 178.405 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.728 HG13 ' CD2' ' A' ' 106' ' ' TYR . 8.2 p -67.24 -22.6 29.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.024 -1.047 . . . . 0.0 109.279 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.728 ' CD2' HG13 ' A' ' 105' ' ' VAL . 67.5 m-85 -123.79 63.28 1.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.545 0.688 . . . . 0.0 110.738 -179.273 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 24.7 mt . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.479 ' O ' ' OG1' ' A' ' 10' ' ' THR . 37.1 Cg_endo -69.2 -3.84 12.45 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.288 1.992 . . . . 0.0 111.812 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.411 ' HA ' ' HE1' ' A' ' 11' ' ' TRP . 53.2 m80 -83.97 -16.26 44.77 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.46 -0.775 . . . . 0.0 109.68 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.43 ' O ' ' NZ ' ' A' ' 79' ' ' LYS . 42.9 m80 -61.75 -36.49 81.17 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.585 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 54.2 p-10 -106.2 130.11 54.13 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.595 0.712 . . . . 0.0 109.497 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.575 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.7 OUTLIER -70.24 -9.43 55.86 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 109.725 -179.687 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HA ' ' OD1' ' A' ' 12' ' ' ASN . 2.2 ttpt -61.5 -36.93 81.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.603 -0.685 . . . . 0.0 110.864 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.516 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 54.3 p -66.47 -20.07 65.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 112.416 -177.854 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.561 ' CZ3' ' HG2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -134.43 -12.7 2.38 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 119.965 -1.709 . . . . 0.0 111.168 179.168 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.659 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 19.3 p-10 -95.66 127.06 41.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.588 -1.32 . . . . 0.0 111.571 -178.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.2 m -146.01 34.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.9 -34.43 7.27 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.13 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.2 p -66.69 -12.17 57.27 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.143 -1.21 . . . . 0.0 109.508 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.613 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 57.8 m -79.78 142.71 35.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.237 -0.914 . . . . 0.0 110.753 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.696 ' C ' HH12 ' A' ' 36' ' ' ARG . 8.4 p30 -80.13 156.47 26.99 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.416 -0.802 . . . . 0.0 109.609 179.212 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.833 ' N ' HH22 ' A' ' 36' ' ' ARG . 45.8 mtm180 -63.63 -37.31 86.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.122 -0.986 . . . . 0.0 110.713 -178.817 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.675 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 46.3 p-10 -57.92 -43.96 86.57 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.431 -1.418 . . . . 0.0 108.689 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.675 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 42.7 tttt -66.24 -31.06 71.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.928 -1.108 . . . . 0.0 108.301 178.919 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.56 ' HB2' ' NH1' ' A' ' 36' ' ' ARG . . . -60.31 -38.6 84.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.893 . . . . 0.0 108.831 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 26' ' ' ARG . 98.1 mt-10 -59.02 -47.59 84.65 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.336 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -60.19 -43.45 95.9 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.487 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 99.1 mt -66.18 -36.66 83.68 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.614 HD23 HG23 ' A' ' 49' ' ' VAL . 10.3 mt -89.2 -7.52 55.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.843 . . . . 0.0 109.513 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 22' ' ' GLU . 14.6 mmm180 -96.37 -25.94 15.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.99 -1.069 . . . . 0.0 109.691 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.09 10.31 56.83 Favored Glycine 0 C--N 1.288 -2.12 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 178.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.816 ' CD ' HG21 ' A' ' 32' ' ' THR . 7.7 mmpt? -114.53 141.33 47.87 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.428 -1.042 . . . . 0.0 110.568 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.93 168.42 15.03 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.491 0.663 . . . . 0.0 110.042 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.539 ' OD1' ' CG2' ' A' ' 99' ' ' VAL . 67.6 t0 -56.28 141.95 39.5 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.39 -0.819 . . . . 0.0 109.709 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.495 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 107.64 -31.85 7.66 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.816 HG21 ' CD ' ' A' ' 28' ' ' LYS . 97.4 m -86.37 127.41 34.81 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.166 -1.196 . . . . 0.0 109.539 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.751 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -139.46 172.45 12.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.63 -1.294 . . . . 0.0 109.806 178.896 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.655 ' HB3' HG11 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -139.51 169.24 18.11 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.66 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.561 HG22 ' SG ' ' A' ' 46' ' ' CYS . 71.5 t -120.17 132.94 68.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 -179.587 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.833 HH22 ' N ' ' A' ' 18' ' ' ARG . 40.7 mtp180 -144.01 -156.8 0.72 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.367 -0.833 . . . . 0.0 108.976 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 . . . . . 0 C--N 1.304 -1.385 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.51 -179.922 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 59' ' ' ILE . 58.7 m-85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.094 0.473 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -159.21 135.13 8.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 109.032 178.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 59' ' ' ILE . 4.6 m -115.16 139.98 49.46 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.516 ' OG ' ' CD1' ' A' ' 25' ' ' LEU . 46.4 t -108.21 133.39 52.52 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.941 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.585 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.6 p -129.74 157.67 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 121.905 0.86 . . . . 0.0 110.307 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.614 HG23 HD23 ' A' ' 25' ' ' LEU . 89.4 t -99.45 134.82 37.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.75 HG22 HG11 ' A' ' 99' ' ' VAL . 75.7 t -121.29 150.52 24.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.725 -1.235 . . . . 0.0 109.793 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -46.97 -18.8 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.813 0.816 . . . . 0.0 109.757 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -92.35 -56.25 1.59 Allowed Glycine 0 C--N 1.283 -2.405 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -164.04 -176.47 4.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -1.155 . . . . 0.0 110.444 -179.338 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.416 HG22 HG22 ' A' ' 49' ' ' VAL . 53.9 t -87.49 135.85 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.203 -0.936 . . . . 0.0 108.764 178.545 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.47 ' HZ2' HG21 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -133.22 157.53 45.16 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.004 -1.06 . . . . 0.0 111.318 -178.837 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -113.19 97.53 6.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.313 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.6 m -71.53 141.71 50.11 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.65 134.12 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.867 -1.146 . . . . 0.0 112.46 -177.618 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.675 HD11 ' SG ' ' A' ' 46' ' ' CYS . 96.1 mt -105.72 139.71 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 177.489 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.0 m120 . . . . . 0 N--CA 1.502 2.138 0 O-C-N 120.368 -1.457 . . . . 0.0 111.976 -177.656 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.457 0.646 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 71.0 mt -62.68 -32.71 73.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.425 -0.797 . . . . 0.0 109.523 179.424 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.43 ' NZ ' ' O ' ' A' ' 6' ' ' HIS . 17.6 mtpp -60.09 -42.38 94.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.209 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -65.71 -28.89 69.39 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.754 HD23 ' O ' ' A' ' 81' ' ' LEU . 6.7 tt -58.33 -46.44 86.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.629 -0.669 . . . . 0.0 110.006 -179.604 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.531 HG21 ' CE3' ' A' ' 11' ' ' TRP . 81.0 t -73.72 -41.96 54.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.942 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 68.6 mt -65.39 -43.88 89.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.375 -0.828 . . . . 0.0 109.79 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.531 ' O ' ' OG1' ' A' ' 88' ' ' THR . 58.8 t-80 -62.24 -42.08 99.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.011 -1.056 . . . . 0.0 110.146 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.411 ' HA ' ' OG1' ' A' ' 88' ' ' THR . 5.6 m-85 -70.22 -27.79 64.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 111.171 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.503 ' HG2' ' N ' ' A' ' 87' ' ' HIS . 4.6 pt20 -64.6 -32.76 74.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.651 -1.28 . . . . 0.0 109.368 -179.118 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.503 ' N ' ' HG2' ' A' ' 86' ' ' GLN . 12.4 m-70 -89.78 -30.1 18.22 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.268 -0.895 . . . . 0.0 109.083 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 2.9 p -95.52 140.52 30.25 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.42 -0.8 . . . . 0.0 110.127 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.6 p -80.23 140.16 36.38 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.691 -0.63 . . . . 0.0 109.817 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.689 ' O ' ' C ' ' A' ' 91' ' ' VAL . 7.9 mp -67.32 -26.98 66.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 110.549 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.747 ' N ' ' O ' ' A' ' 97' ' ' LEU . 95.9 t -1.75 -67.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 CA-C-O 121.62 0.724 . . . . 0.0 110.056 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.675 ' N ' ' O ' ' A' ' 90' ' ' LEU . 32.8 mm-40 35.15 -123.91 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.485 0.659 . . . . 0.0 111.175 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 95' ' ' ASP . 19.1 p80 -71.55 165.65 23.46 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.475 -0.766 . . . . 0.0 109.862 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.654 ' O ' ' N ' ' A' ' 96' ' ' SER . 74.1 m-20 61.89 2.86 0.81 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.633 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 94' ' ' ASN . 94.9 m-20 33.37 28.65 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.746 -0.596 . . . . 0.0 109.592 179.265 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.654 ' N ' ' O ' ' A' ' 94' ' ' ASN . 80.1 p -130.02 3.28 4.83 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.852 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.747 ' O ' ' N ' ' A' ' 91' ' ' VAL . 87.2 mt -83.31 56.75 3.67 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.553 -1.342 . . . . 0.0 107.723 178.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -78.41 90.22 4.42 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.082 0.944 . . . . 0.0 109.53 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.75 HG11 HG22 ' A' ' 50' ' ' VAL . 4.2 p -169.48 159.13 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.502 ' N ' HG22 ' A' ' 99' ' ' VAL . 66.7 p -128.06 151.52 49.08 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.19 -0.944 . . . . 0.0 109.984 -179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.751 HD22 ' CG ' ' A' ' 33' ' ' PHE . 32.4 mt -84.46 65.72 9.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.02 -1.05 . . . . 0.0 108.425 179.438 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -94.4 -22.6 18.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.387 -0.821 . . . . 0.0 112.519 -177.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -118.09 112.19 38.24 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.111 -1.618 . . . . 0.0 111.071 -178.676 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.455 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 33.1 Cg_exo -58.0 143.87 95.48 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.492 2.128 . . . . 0.0 111.406 177.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.655 HG11 ' HB3' ' A' ' 34' ' ' LEU . 11.6 p -71.88 -27.67 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.064 -1.022 . . . . 0.0 109.614 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.424 ' HD1' HG13 ' A' ' 105' ' ' VAL . 3.2 m-85 -114.05 29.28 8.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.194 -0.941 . . . . 0.0 109.769 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.455 ' HB2' ' HB2' ' A' ' 104' ' ' PRO . . . . . . . . 0 C--N 1.302 -1.479 0 O-C-N 121.108 -0.995 . . . . 0.0 109.525 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.707 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.5 mm? . . . . . 0 N--CA 1.502 2.128 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.411 ' CB ' HG21 ' A' ' 10' ' ' THR . 38.3 Cg_endo -69.35 -2.04 9.19 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.683 2.255 . . . . 0.0 112.301 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.561 ' ND1' HD21 ' A' ' 83' ' ' LEU . 41.4 m80 -73.6 -24.52 60.06 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.37 -0.831 . . . . 0.0 110.028 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -60.3 -34.03 73.2 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.215 -0.928 . . . . 0.0 108.791 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.684 ' OD2' ' NZ ' ' A' ' 9' ' ' LYS . 99.9 m-20 -109.02 119.06 38.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.093 -1.005 . . . . 0.0 109.91 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 12' ' ' ASN . 94.6 mt-10 -65.16 -16.37 63.43 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.684 ' NZ ' ' OD2' ' A' ' 7' ' ' ASP . 26.2 pttt -59.71 -37.48 78.99 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.17 -0.956 . . . . 0.0 110.396 -179.281 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.681 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 23.3 p -55.79 -35.97 66.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.512 -0.743 . . . . 0.0 110.212 -179.263 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.681 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -121.59 -33.01 3.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.77 -1.206 . . . . 0.0 110.723 179.634 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 8' ' ' GLU . 64.0 t30 -83.08 128.18 34.25 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.02 -1.05 . . . . 0.0 111.366 -178.772 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.741 ' O ' ' N ' ' A' ' 16' ' ' SER . 24.0 m -139.7 30.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.649 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.567 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -24.78 -45.23 0.01 OUTLIER Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 13' ' ' VAL . 81.5 p -51.69 -16.78 0.71 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.547 -0.972 . . . . 0.0 108.807 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.741 ' N ' ' O ' ' A' ' 13' ' ' VAL . 89.1 p -70.0 159.49 33.69 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.692 0.758 . . . . 0.0 110.011 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.528 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 79.6 m-20 -122.98 165.16 17.2 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.48 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -59.75 -43.35 94.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.641 -1.287 . . . . 0.0 109.312 -179.617 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -64.47 -42.98 95.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 108.622 179.23 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.528 ' HB3' ' H ' ' A' ' 17' ' ' ASN . 21.1 ttmm -69.07 -35.52 76.61 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.51 74.85 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 26' ' ' ARG . 88.0 tt0 -57.78 -47.2 83.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.935 -1.103 . . . . 0.0 108.741 179.195 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -60.03 -43.81 95.07 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.429 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 89.8 mt -67.71 -27.59 66.95 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.569 HD11 ' OG ' ' A' ' 47' ' ' SER . 12.0 mt -94.28 -5.43 46.76 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.314 -0.866 . . . . 0.0 109.239 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.68 HH11 ' HG2' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -94.04 123.87 37.69 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.784 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.06 4.52 74.65 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 24' ' ' LEU . 24.2 mmtm -99.91 134.74 42.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.101 -1.235 . . . . 0.0 109.811 179.766 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -69.94 159.72 33.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.518 -0.739 . . . . 0.0 109.615 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.67 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 88.3 m-20 -59.72 147.32 38.2 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.635 0.731 . . . . 0.0 110.039 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.63 -22.89 37.85 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -179.087 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 67.6 m -81.37 114.02 19.86 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.294 -1.121 . . . . 0.0 108.831 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -132.21 170.49 14.95 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.086 -179.475 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.68 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 1.9 pp -147.37 157.88 43.75 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.56 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.521 HG22 ' SG ' ' A' ' 46' ' ' CYS . 48.3 t -103.9 128.5 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.156 -0.965 . . . . 0.0 108.443 178.699 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.713 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -144.02 173.85 11.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 108.823 -179.364 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--N 1.307 -1.271 0 O-C-N 120.827 -1.171 . . . . 0.0 108.382 179.569 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.588 ' O ' ' O ' ' A' ' 59' ' ' ILE . 92.8 m-85 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 120.974 0.416 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.576 ' HB1' HH12 ' A' ' 36' ' ' ARG . . . -162.54 133.83 5.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.858 -1.152 . . . . 0.0 109.544 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.521 ' SG ' HG22 ' A' ' 35' ' ' VAL . 60.0 m -108.18 130.64 55.12 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.569 ' OG ' HD11 ' A' ' 25' ' ' LEU . 32.9 t -108.18 134.5 50.95 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.196 -0.94 . . . . 0.0 109.953 -178.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.586 HG22 ' N ' ' A' ' 49' ' ' VAL . 9.2 p -133.58 167.72 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.21 -0.931 . . . . 0.0 110.278 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.586 ' N ' HG22 ' A' ' 48' ' ' VAL . 40.3 t -121.23 133.69 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.609 -0.682 . . . . 0.0 109.667 179.522 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.798 HG12 ' HZ2' ' A' ' 55' ' ' LYS . 7.3 p -127.61 160.29 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.076 -1.015 . . . . 0.0 109.968 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.67 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 54.5 m-20 -50.21 -20.35 1.01 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.712 0.768 . . . . 0.0 110.078 -179.586 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.63 ' H ' HG13 ' A' ' 50' ' ' VAL . . . -83.81 -58.68 2.2 Favored Glycine 0 C--N 1.285 -2.253 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.807 ' H ' ' NZ ' ' A' ' 55' ' ' LYS . 1.3 tt0 -167.07 -165.09 0.67 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.292 -1.122 . . . . 0.0 111.322 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.564 ' CG1' HD13 ' A' ' 25' ' ' LEU . 84.3 t -97.59 123.8 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.485 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.807 ' NZ ' ' H ' ' A' ' 53' ' ' GLU . 11.5 mptt -118.95 152.48 36.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.465 -1.397 . . . . 0.0 110.941 -179.334 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -115.16 112.64 22.84 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.732 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 46' ' ' CYS . 49.1 t -88.21 124.74 34.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.077 -1.014 . . . . 0.0 108.536 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 58' ' ' VAL . 4.8 p -101.07 122.64 53.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.079 -1.013 . . . . 0.0 110.906 -178.659 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.588 ' O ' ' O ' ' A' ' 44' ' ' TYR . 88.6 mt -116.57 137.96 48.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.546 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.7 t30 . . . . . 0 N--CA 1.498 1.968 0 O-C-N 120.566 -1.334 . . . . 0.0 111.511 -178.618 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.539 ' OG ' ' OE2' ' A' ' 80' ' ' GLU . 84.5 p . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 121.403 0.621 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.4 -43.77 98.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.417 -0.802 . . . . 0.0 110.879 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.459 ' O ' HG12 ' A' ' 82' ' ' VAL . 19.9 tttt -60.86 -39.75 90.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.755 -1.215 . . . . 0.0 108.707 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.614 ' N ' ' OE1' ' A' ' 80' ' ' GLU . 0.3 OUTLIER -73.43 -40.03 64.55 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.177 -0.952 . . . . 0.0 109.383 179.006 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.9 -49.51 77.4 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.839 -0.538 . . . . 0.0 110.599 -178.373 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 83' ' ' LEU . 4.3 p -59.76 -44.22 93.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.913 -1.117 . . . . 0.0 108.495 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.561 HD21 ' ND1' ' A' ' 5' ' ' HIS . 91.2 mt -61.69 -45.39 94.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.208 -0.932 . . . . 0.0 111.273 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -61.25 -40.39 93.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.756 -1.215 . . . . 0.0 110.001 -178.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.812 ' HB3' HD13 ' A' ' 101' ' ' LEU . 22.4 m-85 -71.41 -26.75 62.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.249 -0.907 . . . . 0.0 111.311 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.744 ' NE2' ' O ' ' A' ' 101' ' ' LEU . 6.8 mt-30 -65.01 -33.65 76.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.662 -1.274 . . . . 0.0 109.163 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -96.76 -19.28 19.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.013 -1.054 . . . . 0.0 110.753 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.4 m -99.53 131.18 45.7 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.804 -1.185 . . . . 0.0 109.726 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.3 p -74.97 135.65 41.34 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.514 0.673 . . . . 0.0 109.939 -179.575 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.743 ' O ' ' N ' ' A' ' 92' ' ' GLN . 0.6 OUTLIER -61.74 -43.7 98.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.531 -0.731 . . . . 0.0 110.627 -179.679 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.757 ' N ' ' O ' ' A' ' 97' ' ' LEU . 72.0 t 26.79 -84.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.743 ' N ' ' O ' ' A' ' 90' ' ' LEU . 18.0 tt0 77.32 -179.51 0.14 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.787 178.738 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.497 ' H ' ' HG2' ' A' ' 92' ' ' GLN . 81.6 t60 -56.08 -39.84 72.72 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -50.44 -28.3 8.01 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.178 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 60.1 t0 63.88 24.36 13.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.78 -0.575 . . . . 0.0 110.309 178.846 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 68.9 m -136.91 10.89 3.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.03 -1.044 . . . . 0.0 110.167 179.636 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.757 ' O ' ' N ' ' A' ' 91' ' ' VAL . 87.1 mt -99.78 50.96 0.92 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.747 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.582 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 42.1 p30 -77.43 60.09 1.99 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.501 -0.749 . . . . 0.0 110.646 -178.397 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.667 ' HB ' HG23 ' A' ' 50' ' ' VAL . 7.6 p -133.98 162.96 38.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.656 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.548 ' N ' HG22 ' A' ' 99' ' ' VAL . 82.3 p -125.06 168.87 12.77 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.312 1.053 . . . . 0.0 110.611 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.812 HD13 ' HB3' ' A' ' 85' ' ' TYR . 6.9 mp -98.17 33.41 2.18 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.683 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.39 -15.49 60.92 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.64 -0.663 . . . . 0.0 112.13 -178.093 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 32' ' ' THR . 96.8 m-85 -114.91 108.48 48.57 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.249 -1.532 . . . . 0.0 111.339 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.54 145.65 95.41 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.257 1.971 . . . . 0.0 110.845 177.419 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.5 -33.07 61.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.896 -1.128 . . . . 0.0 109.335 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -122.69 50.46 1.5 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.018 -1.051 . . . . 0.0 110.067 179.061 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 109.592 179.766 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HB3' HG21 ' A' ' 10' ' ' THR . 16.5 Cg_exo -57.33 -9.33 4.75 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.745 1.63 . . . . 0.0 111.55 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.46 ' CB ' HD21 ' A' ' 83' ' ' LEU . 37.5 m80 -60.44 -29.15 68.83 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.607 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -68.0 -23.03 64.97 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.246 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.696 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 83.7 m-20 -90.05 120.64 31.41 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.388 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 45.0 tt0 -67.63 -30.67 70.29 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.393 -0.817 . . . . 0.0 110.294 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.597 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -63.36 -31.71 72.93 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.264 -0.898 . . . . 0.0 111.573 -178.805 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -66.49 -29.66 69.82 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.226 -0.921 . . . . 0.0 111.641 -177.044 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.696 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -123.02 -8.44 8.3 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.652 -1.28 . . . . 0.0 110.585 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 8' ' ' GLU . 13.5 t-20 -97.92 118.3 34.19 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.1 -1.0 . . . . 0.0 110.629 -178.702 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 16' ' ' SER . 10.2 m -140.46 27.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.489 -0.757 . . . . 0.0 109.179 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -41.32 -30.56 0.49 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.391 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.8 t -59.84 -34.58 73.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -1.076 . . . . 0.0 108.827 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 13' ' ' VAL . 70.1 m -60.48 142.2 55.48 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.584 0.707 . . . . 0.0 110.654 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -79.9 162.44 24.99 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.624 0.726 . . . . 0.0 109.568 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.524 ' CB ' HH12 ' A' ' 36' ' ' ARG . 22.9 ttp180 -57.31 -44.9 84.55 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.89 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -61.67 -39.34 91.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.149 -0.969 . . . . 0.0 108.713 179.064 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -63.78 -27.74 69.39 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.381 0.61 . . . . 0.0 109.46 179.529 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.55 96.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.905 . . . . 0.0 109.672 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 26' ' ' ARG . 96.3 mt-10 -60.57 -41.23 94.18 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.37 -41.61 94.11 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' CD ' ' A' ' 28' ' ' LYS . 77.0 mt -67.26 -29.36 68.96 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.433 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -89.74 -14.11 35.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.351 -0.843 . . . . 0.0 108.933 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 22' ' ' GLU . 5.1 mtp180 -88.37 129.88 35.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.502 -0.749 . . . . 0.0 110.882 -179.392 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.27 3.27 90.2 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.498 ' CD ' ' O ' ' A' ' 24' ' ' LEU . 12.3 mtpt -103.56 131.08 51.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.282 -1.128 . . . . 0.0 110.359 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.733 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.1 OUTLIER -60.56 147.37 41.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 110.348 -179.115 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.559 ' OD2' ' OD1' ' A' ' 51' ' ' ASP . 65.1 m-20 -50.1 151.93 1.84 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.75 -37.93 3.46 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.419 HG21 ' CE ' ' A' ' 28' ' ' LYS . 88.4 m -68.14 128.28 35.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.43 -1.041 . . . . 0.0 109.151 179.742 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.722 ' CE2' HD23 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -139.04 161.8 36.48 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.856 179.968 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.68 ' CB ' HG11 ' A' ' 105' ' ' VAL . 0.7 OUTLIER -137.29 162.86 32.4 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.547 0.689 . . . . 0.0 110.167 -179.498 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 11' ' ' TRP . 90.6 t -118.12 131.14 71.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.524 HH12 ' CB ' ' A' ' 18' ' ' ARG . 11.0 ptm180 -135.56 -176.0 4.13 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 109.584 -179.226 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 C--N 1.304 -1.382 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.703 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.457 ' O ' ' N ' ' A' ' 59' ' ' ILE . 96.8 m-85 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.487 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -139.39 135.06 33.28 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.563 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.729 ' SG ' HD11 ' A' ' 59' ' ' ILE . 28.9 p -107.92 124.88 50.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.235 -0.916 . . . . 0.0 108.8 179.36 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.7 p -109.63 139.67 44.37 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.531 -0.731 . . . . 0.0 110.275 -179.08 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.8 p -129.26 159.73 40.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.275 -0.891 . . . . 0.0 109.787 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.503 ' N ' HG22 ' A' ' 48' ' ' VAL . 39.4 t -96.6 134.13 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.897 HG12 ' H ' ' A' ' 52' ' ' GLY . 62.0 t -125.44 145.61 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.758 -1.214 . . . . 0.0 110.561 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.559 ' OD1' ' OD2' ' A' ' 30' ' ' ASP . 15.1 m-20 -44.15 -20.42 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.897 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -90.17 -59.87 1.44 Allowed Glycine 0 C--N 1.291 -1.948 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.581 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 70.0 mt-10 -162.18 169.64 20.45 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.952 -1.322 . . . . 0.0 110.312 -178.853 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.0 m -65.33 138.51 23.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.891 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.52 ' HZ2' ' HB2' ' A' ' 53' ' ' GLU . 16.6 mmtm -116.3 140.66 49.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.629 -1.294 . . . . 0.0 111.966 -178.053 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -115.3 96.77 5.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.629 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 46' ' ' CYS . 80.2 m -99.49 122.12 42.12 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.083 -1.011 . . . . 0.0 108.92 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.9 t -76.89 140.01 17.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.553 0.692 . . . . 0.0 110.545 -179.278 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.729 HD11 ' SG ' ' A' ' 46' ' ' CYS . 47.2 mm -108.96 129.96 62.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.767 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 N--CA 1.498 1.936 0 O-C-N 121.168 -0.958 . . . . 0.0 110.084 -179.109 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.69 0.757 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 81' ' ' LEU . 89.6 mt -62.08 -34.71 76.8 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.465 -0.772 . . . . 0.0 109.516 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 78' ' ' LEU . 87.3 mttt -47.74 -42.04 24.46 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 65.6 mt-10 -64.87 -37.31 87.19 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.723 HD23 ' C ' ' A' ' 81' ' ' LEU . 8.2 tt -59.63 -42.62 93.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.566 -0.709 . . . . 0.0 110.164 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.8 t -65.77 -44.97 92.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.99 -1.069 . . . . 0.0 109.467 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.46 HD21 ' CB ' ' A' ' 5' ' ' HIS . 81.2 mt -68.34 -39.02 82.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.395 -0.816 . . . . 0.0 111.274 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.558 ' O ' ' CE1' ' A' ' 87' ' ' HIS . 52.8 m80 -64.66 -42.43 95.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.016 -1.052 . . . . 0.0 110.192 -178.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.633 ' CB ' HD13 ' A' ' 101' ' ' LEU . 7.1 m-30 -73.83 -16.68 61.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.857 -1.152 . . . . 0.0 109.34 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -67.81 -35.87 79.4 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.282 -0.886 . . . . 0.0 109.234 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 84' ' ' HIS . 22.8 p-80 -92.61 -22.66 19.35 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.267 -0.896 . . . . 0.0 109.664 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.8 m -92.41 128.42 38.26 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.134 -0.979 . . . . 0.0 109.386 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.584 ' HA ' HG22 ' A' ' 100' ' ' THR . 24.6 p -77.67 131.58 37.8 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.437 -0.79 . . . . 0.0 109.665 -179.373 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.524 ' O ' ' C ' ' A' ' 91' ' ' VAL . 98.9 mt -69.74 -17.46 63.45 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.498 -0.751 . . . . 0.0 110.024 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.749 ' N ' ' O ' ' A' ' 97' ' ' LEU . 9.7 p -31.99 -46.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 121.205 -0.934 . . . . 0.0 110.382 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.649 ' N ' HG13 ' A' ' 91' ' ' VAL . 18.1 tt0 -43.97 -27.68 0.39 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.227 0.537 . . . . 0.0 110.128 -179.388 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.485 ' O ' HD23 ' A' ' 97' ' ' LEU . 94.5 m-70 -81.66 119.54 23.95 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.005 -1.059 . . . . 0.0 108.189 178.8 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 90.5 m-20 61.42 2.61 0.67 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.64 -0.663 . . . . 0.0 109.507 -179.244 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.59 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 66.7 t0 57.44 23.65 9.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.551 -0.718 . . . . 0.0 110.349 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.9 m -140.68 11.35 2.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.81 -1.181 . . . . 0.0 109.688 179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.749 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.8 mm? -97.93 66.2 1.85 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.913 -1.117 . . . . 0.0 108.679 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.836 ' O ' HG23 ' A' ' 99' ' ' VAL . 1.1 p-10 -79.16 78.86 5.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.938 -1.101 . . . . 0.0 110.37 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 98' ' ' ASN . 40.8 t -166.38 154.26 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.522 -0.736 . . . . 0.0 109.816 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 89' ' ' SER . 70.8 p -130.53 164.29 25.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.893 . . . . 0.0 109.452 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.85 ' N ' HD12 ' A' ' 101' ' ' LEU . 4.2 mp -79.17 67.31 4.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.709 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -92.16 -22.76 19.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 111.519 -178.347 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.65 137.94 28.65 Favored Pre-proline 0 C--N 1.307 -1.277 0 O-C-N 120.713 -1.242 . . . . 0.0 111.006 -178.006 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.459 ' HB2' HG22 ' A' ' 10' ' ' THR . 93.3 Cg_endo -78.09 157.23 30.32 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.277 2.652 . . . . 0.0 111.582 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.68 HG11 ' CB ' ' A' ' 34' ' ' LEU . 12.2 p -92.76 -27.68 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.345 -0.847 . . . . 0.0 112.089 -178.709 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 73.1 t80 -132.52 64.99 1.6 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.411 -1.431 . . . . 0.0 111.87 -178.069 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.682 ' HB2' HG22 ' A' ' 10' ' ' THR . . . . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.058 -1.026 . . . . 0.0 109.006 178.156 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.5 mt . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -49.06 -19.54 2.52 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.888 2.392 . . . . 0.0 111.659 178.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 83' ' ' LEU . 85.1 m-70 -65.11 -17.01 64.11 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.655 0.741 . . . . 0.0 109.438 -178.944 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -64.98 -36.76 85.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.503 -0.748 . . . . 0.0 109.57 178.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -96.79 129.55 44.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 110.431 -179.068 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.676 ' O ' ' N ' ' A' ' 12' ' ' ASN . 96.6 mt-10 -72.32 -31.32 65.57 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.562 0.696 . . . . 0.0 109.824 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -59.83 -24.82 64.49 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.684 -179.636 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.67 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 52.2 p -67.85 -29.35 68.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.111 -0.993 . . . . 0.0 110.347 -179.512 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.67 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.8 -23.77 2.78 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.916 -1.115 . . . . 0.0 109.572 178.652 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.676 ' N ' ' O ' ' A' ' 8' ' ' GLU . 65.6 t30 -80.57 125.84 30.49 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.09 0.948 . . . . 0.0 111.284 -178.396 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 13' ' ' VAL . 93.8 t -132.57 32.79 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 13' ' ' VAL . . . -42.64 177.19 0.01 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.9 t 61.47 27.4 16.96 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.516 -0.991 . . . . 0.0 108.711 -179.499 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.514 ' OG ' HG12 ' A' ' 13' ' ' VAL . 69.2 m -129.08 136.81 50.74 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.459 -0.775 . . . . 0.0 109.673 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.588 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 26.7 p30 -80.19 167.81 19.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.53 -0.731 . . . . 0.0 109.782 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 36' ' ' ARG . 41.7 mtt-85 -63.65 -32.73 74.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.94 . . . . 0.0 110.039 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -64.29 -46.46 83.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.243 -0.911 . . . . 0.0 109.113 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.588 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 18.0 ttmm -62.34 -40.32 95.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -0.834 . . . . 0.0 109.218 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -59.9 -38.11 81.34 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.366 -0.834 . . . . 0.0 109.332 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.573 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 55.3 tt0 -59.98 -44.07 94.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.869 -1.144 . . . . 0.0 108.892 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -62.26 -39.14 91.92 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 77.7 mt -73.67 -31.78 63.65 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.464 HD23 HG23 ' A' ' 49' ' ' VAL . 7.9 mt -89.38 -10.23 47.37 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.573 ' NH2' ' OE2' ' A' ' 22' ' ' GLU . 75.3 mtt180 -88.75 120.34 30.06 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.136 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.46 -4.99 62.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.715 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.507 ' HE3' HG23 ' A' ' 105' ' ' VAL . 25.7 mmtt -87.06 150.9 23.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.35 -1.088 . . . . 0.0 109.598 179.644 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.565 ' HG2' HH11 ' A' ' 29' ' ' ARG . 7.1 mmt-85 -82.67 154.96 24.61 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.316 0.579 . . . . 0.0 110.479 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -55.12 139.72 40.72 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.35 -15.46 56.16 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 35.3 m -88.55 121.79 31.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.402 -1.057 . . . . 0.0 109.197 179.315 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -138.44 167.46 21.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.007 -1.058 . . . . 0.0 110.742 179.888 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.53 156.23 44.55 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.485 -179.325 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' TRP . 46.0 t -108.11 124.26 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.875 . . . . 0.0 108.82 179.521 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -138.75 178.88 6.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 108.974 -179.486 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.515 ' O ' ' CZ ' ' A' ' 36' ' ' ARG . 10.8 tt0 . . . . . 0 N--CA 1.485 1.287 0 O-C-N 120.814 -1.179 . . . . 0.0 108.67 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.63 ' O ' ' O ' ' A' ' 59' ' ' ILE . 96.1 m-85 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.603 0.716 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 59' ' ' ILE . . . -157.8 135.97 10.93 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.967 -1.083 . . . . 0.0 109.486 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.552 ' SG ' HD13 ' A' ' 59' ' ' ILE . 70.6 m -108.03 117.15 33.39 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.648 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.8 m -102.18 133.81 46.44 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.854 -1.154 . . . . 0.0 109.704 -178.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.641 HG11 HD22 ' A' ' 90' ' ' LEU . 2.4 p -129.73 160.28 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.295 -0.878 . . . . 0.0 109.642 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.538 ' N ' HG22 ' A' ' 48' ' ' VAL . 55.8 t -108.47 136.76 43.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.743 HG12 ' H ' ' A' ' 52' ' ' GLY . 74.8 t -121.59 151.45 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.093 -1.004 . . . . 0.0 109.978 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -49.71 -15.24 0.16 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.067 0.937 . . . . 0.0 108.796 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.743 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -94.21 -59.21 1.18 Allowed Glycine 0 C--N 1.285 -2.28 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -162.15 176.66 10.43 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.122 -1.222 . . . . 0.0 110.384 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.06 138.96 18.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HE3' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -125.58 162.05 25.83 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.761 -179.919 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -128.64 80.31 1.96 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.488 -0.758 . . . . 0.0 110.336 -179.566 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 46' ' ' CYS . 82.1 m -59.8 145.02 46.9 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.788 -1.195 . . . . 0.0 108.402 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 58' ' ' VAL . 8.7 p -115.98 130.42 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.013 -1.054 . . . . 0.0 111.272 -178.331 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.63 ' O ' ' O ' ' A' ' 44' ' ' TYR . 3.7 mp -123.04 128.4 75.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.361 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 . . . . . 0 N--CA 1.497 1.886 0 O-C-N 120.557 -1.34 . . . . 0.0 109.455 179.512 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.2 m . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.226 0.536 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.4 mt -60.02 -36.29 76.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.299 -0.876 . . . . 0.0 109.764 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -59.38 -41.05 88.44 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.101 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -61.66 -35.06 76.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 108.656 179.575 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.0 tt -58.12 -42.55 86.02 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.557 -0.714 . . . . 0.0 109.436 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.34 -39.56 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.007 -1.058 . . . . 0.0 108.582 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.453 ' CD2' ' CD2' ' A' ' 5' ' ' HIS . 92.6 mt -66.44 -41.8 88.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.402 -0.812 . . . . 0.0 109.718 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.47 -42.36 96.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 110.382 -179.213 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.5 ' HB2' HD12 ' A' ' 101' ' ' LEU . 3.7 m-85 -69.53 -23.62 63.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.783 -1.198 . . . . 0.0 108.979 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -64.02 -38.12 89.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.491 -0.756 . . . . 0.0 109.231 179.541 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -90.26 -19.69 23.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 0.0 109.199 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 85' ' ' TYR . 42.1 m -99.01 140.99 32.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.529 -0.732 . . . . 0.0 109.256 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.3 t -89.65 128.94 36.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.868 . . . . 0.0 109.47 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.667 ' O ' ' N ' ' A' ' 92' ' ' GLN . 10.1 mp -60.56 -22.85 64.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.344 -0.847 . . . . 0.0 110.467 -179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.719 ' N ' ' O ' ' A' ' 97' ' ' LEU . 11.6 p -26.56 -37.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.346 -0.846 . . . . 0.0 110.584 -179.184 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.667 ' N ' ' O ' ' A' ' 90' ' ' LEU . 35.0 mt-30 -40.8 179.25 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.885 0.85 . . . . 0.0 111.756 -178.801 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 61.25 -108.84 0.35 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.496 0.665 . . . . 0.0 109.972 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -60.72 -5.43 1.28 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.494 -0.754 . . . . 0.0 110.366 -179.358 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 65.7 t0 57.27 28.47 15.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.772 -1.205 . . . . 0.0 109.128 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -143.22 13.04 1.8 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 110.304 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.719 ' O ' ' N ' ' A' ' 91' ' ' VAL . 7.7 mp -101.23 70.14 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.875 -1.14 . . . . 0.0 107.955 178.773 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -78.79 87.4 4.67 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.389 -0.819 . . . . 0.0 110.114 -178.631 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.51 HG22 ' N ' ' A' ' 100' ' ' THR . 12.6 p -163.05 160.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 121.686 0.755 . . . . 0.0 109.158 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.51 ' N ' HG22 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -130.8 133.47 45.99 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.14 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.68 HD22 ' CG ' ' A' ' 33' ' ' PHE . 37.6 mt -69.62 74.5 0.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -116.56 -10.04 11.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.832 . . . . 0.0 110.952 -178.719 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 32' ' ' THR . 69.2 t80 -120.65 103.4 43.7 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.619 -1.301 . . . . 0.0 110.433 -178.798 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.97 146.53 86.66 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.622 2.215 . . . . 0.0 111.533 178.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.507 HG23 ' HE3' ' A' ' 28' ' ' LYS . 9.5 p -69.43 -35.37 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.911 -1.118 . . . . 0.0 109.57 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.457 ' CD2' HG13 ' A' ' 105' ' ' VAL . 38.8 m-85 -119.39 54.88 0.97 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.157 -0.964 . . . . 0.0 110.74 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.539 0 O-C-N 121.133 -0.979 . . . . 0.0 108.376 178.812 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.5 mt . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -49.06 -19.54 2.52 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.888 2.392 . . . . 0.0 111.659 178.948 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 83' ' ' LEU . 85.1 m-70 -65.11 -17.01 64.11 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.655 0.741 . . . . 0.0 109.438 -178.944 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -64.98 -36.76 85.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.503 -0.748 . . . . 0.0 109.57 178.995 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -96.79 129.55 44.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 110.431 -179.068 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.676 ' O ' ' N ' ' A' ' 12' ' ' ASN . 96.6 mt-10 -72.32 -31.32 65.57 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.562 0.696 . . . . 0.0 109.824 179.717 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -59.83 -24.82 64.49 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.684 -179.636 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.67 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 52.2 p -67.85 -29.35 68.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.111 -0.993 . . . . 0.0 110.347 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.67 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.8 -23.77 2.78 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.916 -1.115 . . . . 0.0 109.572 178.652 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.676 ' N ' ' O ' ' A' ' 8' ' ' GLU . 65.6 t30 -80.57 125.84 30.49 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.09 0.948 . . . . 0.0 111.284 -178.396 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 13' ' ' VAL . 93.8 t -132.57 32.79 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.867 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 13' ' ' VAL . . . -42.64 177.19 0.01 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.9 t 61.47 27.4 16.96 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.516 -0.991 . . . . 0.0 108.711 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.514 ' OG ' HG12 ' A' ' 13' ' ' VAL . 69.2 m -129.08 136.81 50.74 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.459 -0.775 . . . . 0.0 109.673 -179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.588 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 26.7 p30 -80.19 167.81 19.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.53 -0.731 . . . . 0.0 109.782 -179.789 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 36' ' ' ARG . 41.7 mtt-85 -63.65 -32.73 74.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.94 . . . . 0.0 110.039 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -64.29 -46.46 83.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.243 -0.911 . . . . 0.0 109.113 -179.345 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.588 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 18.0 ttmm -62.34 -40.32 95.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -0.834 . . . . 0.0 109.218 179.566 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -59.9 -38.11 81.34 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.366 -0.834 . . . . 0.0 109.332 -179.584 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.573 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 55.3 tt0 -59.98 -44.07 94.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.869 -1.144 . . . . 0.0 108.892 179.548 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -62.26 -39.14 91.92 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.607 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 77.7 mt -73.67 -31.78 63.65 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.432 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.464 HD23 HG23 ' A' ' 49' ' ' VAL . 7.9 mt -89.38 -10.23 47.37 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.573 ' NH2' ' OE2' ' A' ' 22' ' ' GLU . 75.3 mtt180 -88.75 120.34 30.06 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.136 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.46 -4.99 62.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.715 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.507 ' HE3' HG23 ' A' ' 105' ' ' VAL . 25.7 mmtt -87.06 150.9 23.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.35 -1.088 . . . . 0.0 109.598 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.565 ' HG2' HH11 ' A' ' 29' ' ' ARG . 7.1 mmt-85 -82.67 154.96 24.61 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.316 0.579 . . . . 0.0 110.479 -179.475 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -55.12 139.72 40.72 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.346 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.35 -15.46 56.16 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 35.3 m -88.55 121.79 31.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.402 -1.057 . . . . 0.0 109.197 179.315 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -138.44 167.46 21.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.007 -1.058 . . . . 0.0 110.742 179.888 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.53 156.23 44.55 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.485 -179.325 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' TRP . 46.0 t -108.11 124.26 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.875 . . . . 0.0 108.82 179.521 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -138.75 178.88 6.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 108.974 -179.486 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.515 ' O ' ' CZ ' ' A' ' 36' ' ' ARG . 10.8 tt0 . . . . . 0 N--CA 1.485 1.287 0 O-C-N 120.814 -1.179 . . . . 0.0 108.67 179.831 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.63 ' O ' ' O ' ' A' ' 59' ' ' ILE . 96.1 m-85 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.603 0.716 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 59' ' ' ILE . . . -157.8 135.97 10.93 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.967 -1.083 . . . . 0.0 109.486 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.552 ' SG ' HD13 ' A' ' 59' ' ' ILE . 70.6 m -108.03 117.15 33.39 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.648 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.8 m -102.18 133.81 46.44 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.854 -1.154 . . . . 0.0 109.704 -178.679 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.641 HG11 HD22 ' A' ' 90' ' ' LEU . 2.4 p -129.73 160.28 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.295 -0.878 . . . . 0.0 109.642 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.538 ' N ' HG22 ' A' ' 48' ' ' VAL . 55.8 t -108.47 136.76 43.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.939 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.743 HG12 ' H ' ' A' ' 52' ' ' GLY . 74.8 t -121.59 151.45 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.093 -1.004 . . . . 0.0 109.978 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -49.71 -15.24 0.16 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.067 0.937 . . . . 0.0 108.796 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.743 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -94.21 -59.21 1.18 Allowed Glycine 0 C--N 1.285 -2.28 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.65 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -162.15 176.66 10.43 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.122 -1.222 . . . . 0.0 110.384 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.06 138.96 18.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HE3' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -125.58 162.05 25.83 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.761 -179.919 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -128.64 80.31 1.96 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.488 -0.758 . . . . 0.0 110.336 -179.566 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 46' ' ' CYS . 82.1 m -59.8 145.02 46.9 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.788 -1.195 . . . . 0.0 108.402 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 58' ' ' VAL . 8.7 p -115.98 130.42 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.013 -1.054 . . . . 0.0 111.272 -178.331 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.63 ' O ' ' O ' ' A' ' 44' ' ' TYR . 3.7 mp -123.04 128.4 75.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.361 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 . . . . . 0 N--CA 1.497 1.886 0 O-C-N 120.557 -1.34 . . . . 0.0 109.455 179.512 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.2 m . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.226 0.536 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.4 mt -60.02 -36.29 76.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.299 -0.876 . . . . 0.0 109.764 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -59.38 -41.05 88.44 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.101 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -61.66 -35.06 76.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 108.656 179.575 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.0 tt -58.12 -42.55 86.02 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.557 -0.714 . . . . 0.0 109.436 179.895 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.34 -39.56 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.007 -1.058 . . . . 0.0 108.582 179.211 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.453 ' CD2' ' CD2' ' A' ' 5' ' ' HIS . 92.6 mt -66.44 -41.8 88.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.402 -0.812 . . . . 0.0 109.718 179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.47 -42.36 96.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 110.382 -179.213 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.5 ' HB2' HD12 ' A' ' 101' ' ' LEU . 3.7 m-85 -69.53 -23.62 63.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.783 -1.198 . . . . 0.0 108.979 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -64.02 -38.12 89.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.491 -0.756 . . . . 0.0 109.231 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -90.26 -19.69 23.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 0.0 109.199 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 85' ' ' TYR . 42.1 m -99.01 140.99 32.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.529 -0.732 . . . . 0.0 109.256 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.3 t -89.65 128.94 36.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.868 . . . . 0.0 109.47 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.667 ' O ' ' N ' ' A' ' 92' ' ' GLN . 10.1 mp -60.56 -22.85 64.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.344 -0.847 . . . . 0.0 110.467 -179.558 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.719 ' N ' ' O ' ' A' ' 97' ' ' LEU . 11.6 p -26.56 -37.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.346 -0.846 . . . . 0.0 110.584 -179.184 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.667 ' N ' ' O ' ' A' ' 90' ' ' LEU . 35.0 mt-30 -40.8 179.25 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.885 0.85 . . . . 0.0 111.756 -178.801 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 61.25 -108.84 0.35 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.496 0.665 . . . . 0.0 109.972 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -60.72 -5.43 1.28 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.494 -0.754 . . . . 0.0 110.366 -179.358 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 65.7 t0 57.27 28.47 15.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.772 -1.205 . . . . 0.0 109.128 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -143.22 13.04 1.8 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 110.304 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.719 ' O ' ' N ' ' A' ' 91' ' ' VAL . 7.7 mp -101.23 70.14 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.875 -1.14 . . . . 0.0 107.955 178.773 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -78.79 87.4 4.67 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.389 -0.819 . . . . 0.0 110.114 -178.631 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.51 HG22 ' N ' ' A' ' 100' ' ' THR . 12.6 p -163.05 160.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 121.686 0.755 . . . . 0.0 109.158 179.306 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.51 ' N ' HG22 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -130.8 133.47 45.99 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.14 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.68 HD22 ' CG ' ' A' ' 33' ' ' PHE . 37.6 mt -69.62 74.5 0.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -116.56 -10.04 11.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.832 . . . . 0.0 110.952 -178.719 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 32' ' ' THR . 69.2 t80 -120.65 103.4 43.7 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.619 -1.301 . . . . 0.0 110.433 -178.798 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.97 146.53 86.66 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.622 2.215 . . . . 0.0 111.533 178.946 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.507 HG23 ' HE3' ' A' ' 28' ' ' LYS . 9.5 p -69.43 -35.37 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.911 -1.118 . . . . 0.0 109.57 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.457 ' CD2' HG13 ' A' ' 105' ' ' VAL . 38.8 m-85 -119.39 54.88 0.97 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.157 -0.964 . . . . 0.0 110.74 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.539 0 O-C-N 121.133 -0.979 . . . . 0.0 108.376 178.812 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -51.27 -17.86 4.49 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.013 1.809 . . . . 0.0 111.563 178.903 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -63.24 -23.26 67.34 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.523 -0.735 . . . . 0.0 110.4 -179.074 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -66.1 -37.95 87.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.815 -1.178 . . . . 0.0 109.599 -179.219 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.572 ' O ' ' OG1' ' A' ' 10' ' ' THR . 84.9 m-20 -96.44 127.2 42.21 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.156 -0.965 . . . . 0.0 109.535 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.522 ' HG3' ' CH2' ' A' ' 11' ' ' TRP . 38.1 mp0 -71.08 -28.45 64.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 109.21 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -58.67 -22.54 57.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.657 -179.422 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.732 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 17.2 p -66.03 -31.62 72.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 179.584 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.732 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.6 -31.77 1.98 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.83 -1.169 . . . . 0.0 110.64 -179.387 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.637 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 6.6 p-10 -80.26 146.48 31.64 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 110.422 -178.496 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.54 -3.95 5.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.902 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.9 -130.44 33.32 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.6 m -67.75 137.62 55.58 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.229 -1.16 . . . . 0.0 108.641 179.369 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -163.67 165.01 23.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.478 -0.764 . . . . 0.0 108.954 -179.422 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.54 ' C ' HH12 ' A' ' 36' ' ' ARG . 68.3 m-80 -106.36 141.03 38.35 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 179.156 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.537 ' HG3' HH11 ' A' ' 18' ' ' ARG . 14.8 mtm-85 -61.24 -36.91 81.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.761 -1.212 . . . . 0.0 109.649 -179.565 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -60.1 -49.32 78.11 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.069 -1.02 . . . . 0.0 110.165 -179.37 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 17' ' ' ASN . 7.6 pttt -68.03 -27.27 66.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.722 -1.236 . . . . 0.0 108.579 179.531 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.41 -33.44 73.71 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.816 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 26' ' ' ARG . 97.9 mt-10 -60.9 -47.45 86.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.52 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -60.01 -44.3 94.66 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.079 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.694 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 59.3 mt -69.11 -25.24 64.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.968 -1.082 . . . . 0.0 108.196 178.343 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.525 HD11 ' HB3' ' A' ' 47' ' ' SER . 44.1 mt -96.3 -10.07 28.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.837 . . . . 0.0 109.318 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.666 ' N ' ' O ' ' A' ' 22' ' ' GLU . 61.7 mtm180 -107.48 131.25 54.51 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.431 -0.793 . . . . 0.0 110.582 -179.19 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.42 -4.28 43.78 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.208 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.694 ' NZ ' ' O ' ' A' ' 24' ' ' LEU . 14.6 ptpt -122.98 154.85 37.87 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.003 -1.293 . . . . 0.0 110.929 -179.384 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.482 ' HG2' ' N ' ' A' ' 30' ' ' ASP . 26.9 ttm180 -73.95 160.01 31.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.529 0.681 . . . . 0.0 110.871 -179.004 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.482 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 8.9 p-10 -59.19 167.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.7 0.762 . . . . 0.0 110.128 179.598 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.13 -33.94 5.6 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.4 m -82.06 119.9 24.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -1.114 . . . . 0.0 108.891 179.559 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.808 ' CG ' HD22 ' A' ' 101' ' ' LEU . 1.0 OUTLIER -136.23 164.65 27.59 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.598 -1.241 . . . . 0.0 110.964 -179.521 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.784 HD23 HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -131.89 165.75 23.17 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.509 0.671 . . . . 0.0 110.152 -179.567 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG22 ' SG ' ' A' ' 46' ' ' CYS . 55.1 t -116.67 121.95 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.078 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.54 HH12 ' C ' ' A' ' 17' ' ' ASN . 14.7 ptm180 -142.4 -176.21 4.75 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.592 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.602 ' O ' ' O ' ' A' ' 59' ' ' ILE . 93.8 m-85 . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.413 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -154.98 140.63 17.99 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.659 -1.276 . . . . 0.0 110.245 -179.147 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 59' ' ' ILE . 84.1 m -106.29 118.34 36.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.525 ' HB3' HD11 ' A' ' 25' ' ' LEU . 74.0 m -91.93 127.46 37.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.504 -0.748 . . . . 0.0 109.259 -179.479 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.81 145.96 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.856 -1.153 . . . . 0.0 110.423 -179.559 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.0 t -92.29 144.03 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.349 -0.844 . . . . 0.0 108.743 178.906 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.675 HG12 ' H ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -123.23 158.95 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.035 -1.04 . . . . 0.0 109.624 179.833 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -65.8 57.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.535 -0.728 . . . . 0.0 110.492 -178.535 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 169.46 -33.54 0.18 Allowed Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.307 -1.425 . . . . 0.0 111.295 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.675 ' H ' HG12 ' A' ' 50' ' ' VAL . 88.8 mt-10 -159.74 165.61 32.14 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.9 -1.353 . . . . 0.0 110.486 -179.544 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 t -97.32 125.78 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.801 . . . . 0.0 109.19 178.772 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HE2' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -120.38 146.01 46.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.927 -1.108 . . . . 0.0 110.745 -179.273 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -111.75 87.76 2.64 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.446 -0.784 . . . . 0.0 108.918 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 63.2 m -66.9 139.42 57.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.908 . . . . 0.0 109.186 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -106.57 134.36 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.277 -179.19 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.699 HD12 ' SG ' ' A' ' 46' ' ' CYS . 31.4 mt -121.85 144.87 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.4 -0.813 . . . . 0.0 108.822 179.233 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.019 -1.05 . . . . 0.0 109.032 -179.703 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.7 p . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.523 0.678 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.65 -27.1 68.7 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.612 -0.68 . . . . 0.0 109.715 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 83' ' ' LEU . 64.0 mttp -59.55 -44.78 93.15 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.826 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.38 -37.96 87.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.336 -0.853 . . . . 0.0 109.328 179.103 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 81' ' ' LEU . 7.5 tt -57.6 -41.95 82.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 108.914 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.47 -45.23 98.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.048 -1.033 . . . . 0.0 109.298 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.495 ' H ' HD12 ' A' ' 83' ' ' LEU . 6.4 mp -62.53 -37.74 87.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.871 -1.143 . . . . 0.0 109.58 179.417 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.405 ' O ' ' OG1' ' A' ' 88' ' ' THR . 11.6 t-160 -59.53 -46.69 88.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.524 -0.735 . . . . 0.0 110.966 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.584 ' HB2' HD12 ' A' ' 101' ' ' LEU . 4.4 m-85 -67.59 -28.4 67.73 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.498 -1.376 . . . . 0.0 109.585 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.505 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 1.2 tm0? -58.91 -38.06 78.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 109.164 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -86.14 -36.16 19.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.134 -0.979 . . . . 0.0 109.276 179.361 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.544 ' O ' ' O ' ' A' ' 85' ' ' TYR . 1.8 p -90.05 139.38 30.67 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.373 -0.83 . . . . 0.0 109.675 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.445 ' HA ' HG22 ' A' ' 100' ' ' THR . 37.3 m -93.1 140.57 29.35 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.601 0.715 . . . . 0.0 109.835 -179.769 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.655 ' O ' ' C ' ' A' ' 91' ' ' VAL . 5.8 mt -61.09 -41.14 96.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 111.238 -178.905 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.783 ' N ' ' O ' ' A' ' 97' ' ' LEU . 87.2 t 16.29 -83.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 121.41 -0.806 . . . . 0.0 109.834 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 90' ' ' LEU . 1.3 tp60 75.77 -176.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 110.222 179.282 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -60.09 -38.74 83.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.642 -0.661 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -52.52 -24.95 9.04 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.013 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 61.53 20.31 11.12 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 178.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.0 m -130.51 7.26 4.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.693 -1.254 . . . . 0.0 111.172 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.783 ' O ' ' N ' ' A' ' 91' ' ' VAL . 83.2 mt -98.5 53.67 1.04 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.802 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.09 78.47 3.63 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.548 -178.748 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.626 HG21 HG23 ' A' ' 50' ' ' VAL . 53.2 t -154.31 147.92 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.809 0.814 . . . . 0.0 109.533 179.377 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 89' ' ' SER . 48.2 p -121.24 153.67 37.34 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.316 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.808 HD22 ' CG ' ' A' ' 33' ' ' PHE . 79.0 mt -82.25 71.05 9.31 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . . . -107.38 -17.87 14.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.62 -0.675 . . . . 0.0 112.074 -178.09 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -110.91 123.77 34.59 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.573 -1.329 . . . . 0.0 110.083 -178.875 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 55.2 Cg_endo -77.45 145.06 23.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.488 2.125 . . . . 0.0 110.636 178.87 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.905 HG13 ' CD2' ' A' ' 106' ' ' TYR . 12.0 p -72.21 -22.01 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.535 -1.353 . . . . 0.0 109.38 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.905 ' CD2' HG13 ' A' ' 105' ' ' VAL . 72.3 m-85 -129.19 64.35 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.768 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 108.819 179.451 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -51.27 -17.86 4.49 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.013 1.809 . . . . 0.0 111.563 178.903 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -63.24 -23.26 67.34 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.523 -0.735 . . . . 0.0 110.4 -179.074 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -66.1 -37.95 87.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.815 -1.178 . . . . 0.0 109.599 -179.219 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.572 ' O ' ' OG1' ' A' ' 10' ' ' THR . 84.9 m-20 -96.44 127.2 42.21 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.156 -0.965 . . . . 0.0 109.535 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.522 ' HG3' ' CH2' ' A' ' 11' ' ' TRP . 38.1 mp0 -71.08 -28.45 64.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 109.21 179.56 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -58.67 -22.54 57.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.657 -179.422 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.732 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 17.2 p -66.03 -31.62 72.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.732 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.6 -31.77 1.98 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.83 -1.169 . . . . 0.0 110.64 -179.387 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.637 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 6.6 p-10 -80.26 146.48 31.64 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 110.422 -178.496 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.54 -3.95 5.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.9 -130.44 33.32 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.6 m -67.75 137.62 55.58 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.229 -1.16 . . . . 0.0 108.641 179.369 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -163.67 165.01 23.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.478 -0.764 . . . . 0.0 108.954 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.54 ' C ' HH12 ' A' ' 36' ' ' ARG . 68.3 m-80 -106.36 141.03 38.35 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 179.156 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.537 ' HG3' HH11 ' A' ' 18' ' ' ARG . 14.8 mtm-85 -61.24 -36.91 81.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.761 -1.212 . . . . 0.0 109.649 -179.565 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -60.1 -49.32 78.11 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.069 -1.02 . . . . 0.0 110.165 -179.37 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 17' ' ' ASN . 7.6 pttt -68.03 -27.27 66.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.722 -1.236 . . . . 0.0 108.579 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.41 -33.44 73.71 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.816 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 26' ' ' ARG . 97.9 mt-10 -60.9 -47.45 86.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.52 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -60.01 -44.3 94.66 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.079 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.694 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 59.3 mt -69.11 -25.24 64.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.968 -1.082 . . . . 0.0 108.196 178.343 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.525 HD11 ' HB3' ' A' ' 47' ' ' SER . 44.1 mt -96.3 -10.07 28.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.837 . . . . 0.0 109.318 179.683 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.666 ' N ' ' O ' ' A' ' 22' ' ' GLU . 61.7 mtm180 -107.48 131.25 54.51 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.431 -0.793 . . . . 0.0 110.582 -179.19 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.42 -4.28 43.78 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.208 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.694 ' NZ ' ' O ' ' A' ' 24' ' ' LEU . 14.6 ptpt -122.98 154.85 37.87 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.003 -1.293 . . . . 0.0 110.929 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.482 ' HG2' ' N ' ' A' ' 30' ' ' ASP . 26.9 ttm180 -73.95 160.01 31.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.529 0.681 . . . . 0.0 110.871 -179.004 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.482 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 8.9 p-10 -59.19 167.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.7 0.762 . . . . 0.0 110.128 179.598 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.13 -33.94 5.6 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.561 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.4 m -82.06 119.9 24.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -1.114 . . . . 0.0 108.891 179.559 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.808 ' CG ' HD22 ' A' ' 101' ' ' LEU . 1.0 OUTLIER -136.23 164.65 27.59 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.598 -1.241 . . . . 0.0 110.964 -179.521 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.784 HD23 HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -131.89 165.75 23.17 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.509 0.671 . . . . 0.0 110.152 -179.567 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG22 ' SG ' ' A' ' 46' ' ' CYS . 55.1 t -116.67 121.95 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.078 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.54 HH12 ' C ' ' A' ' 17' ' ' ASN . 14.7 ptm180 -142.4 -176.21 4.75 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.41 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.592 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.602 ' O ' ' O ' ' A' ' 59' ' ' ILE . 93.8 m-85 . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.413 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -154.98 140.63 17.99 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.659 -1.276 . . . . 0.0 110.245 -179.147 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 59' ' ' ILE . 84.1 m -106.29 118.34 36.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.961 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.525 ' HB3' HD11 ' A' ' 25' ' ' LEU . 74.0 m -91.93 127.46 37.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.504 -0.748 . . . . 0.0 109.259 -179.479 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.81 145.96 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.856 -1.153 . . . . 0.0 110.423 -179.559 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.0 t -92.29 144.03 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.349 -0.844 . . . . 0.0 108.743 178.906 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.675 HG12 ' H ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -123.23 158.95 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.035 -1.04 . . . . 0.0 109.624 179.833 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -65.8 57.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.535 -0.728 . . . . 0.0 110.492 -178.535 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 169.46 -33.54 0.18 Allowed Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.307 -1.425 . . . . 0.0 111.295 179.089 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.675 ' H ' HG12 ' A' ' 50' ' ' VAL . 88.8 mt-10 -159.74 165.61 32.14 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.9 -1.353 . . . . 0.0 110.486 -179.544 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 t -97.32 125.78 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.801 . . . . 0.0 109.19 178.772 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HE2' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -120.38 146.01 46.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.927 -1.108 . . . . 0.0 110.745 -179.273 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -111.75 87.76 2.64 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.446 -0.784 . . . . 0.0 108.918 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 63.2 m -66.9 139.42 57.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.908 . . . . 0.0 109.186 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -106.57 134.36 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.277 -179.19 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.699 HD12 ' SG ' ' A' ' 46' ' ' CYS . 31.4 mt -121.85 144.87 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.4 -0.813 . . . . 0.0 108.822 179.233 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.019 -1.05 . . . . 0.0 109.032 -179.703 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.7 p . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.523 0.678 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.65 -27.1 68.7 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.612 -0.68 . . . . 0.0 109.715 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 83' ' ' LEU . 64.0 mttp -59.55 -44.78 93.15 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.826 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.38 -37.96 87.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.336 -0.853 . . . . 0.0 109.328 179.103 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 81' ' ' LEU . 7.5 tt -57.6 -41.95 82.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 108.914 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.47 -45.23 98.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.048 -1.033 . . . . 0.0 109.298 179.591 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.495 ' H ' HD12 ' A' ' 83' ' ' LEU . 6.4 mp -62.53 -37.74 87.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.871 -1.143 . . . . 0.0 109.58 179.417 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.405 ' O ' ' OG1' ' A' ' 88' ' ' THR . 11.6 t-160 -59.53 -46.69 88.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.524 -0.735 . . . . 0.0 110.966 -179.217 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.584 ' HB2' HD12 ' A' ' 101' ' ' LEU . 4.4 m-85 -67.59 -28.4 67.73 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.498 -1.376 . . . . 0.0 109.585 -179.624 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.505 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 1.2 tm0? -58.91 -38.06 78.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 109.164 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -86.14 -36.16 19.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.134 -0.979 . . . . 0.0 109.276 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.544 ' O ' ' O ' ' A' ' 85' ' ' TYR . 1.8 p -90.05 139.38 30.67 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.373 -0.83 . . . . 0.0 109.675 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.445 ' HA ' HG22 ' A' ' 100' ' ' THR . 37.3 m -93.1 140.57 29.35 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.601 0.715 . . . . 0.0 109.835 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.655 ' O ' ' C ' ' A' ' 91' ' ' VAL . 5.8 mt -61.09 -41.14 96.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 111.238 -178.905 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.783 ' N ' ' O ' ' A' ' 97' ' ' LEU . 87.2 t 16.29 -83.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 121.41 -0.806 . . . . 0.0 109.834 -179.44 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 90' ' ' LEU . 1.3 tp60 75.77 -176.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 110.222 179.282 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -60.09 -38.74 83.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.642 -0.661 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -52.52 -24.95 9.04 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.013 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 61.53 20.31 11.12 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 178.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.0 m -130.51 7.26 4.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.693 -1.254 . . . . 0.0 111.172 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.783 ' O ' ' N ' ' A' ' 91' ' ' VAL . 83.2 mt -98.5 53.67 1.04 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.802 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.09 78.47 3.63 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.548 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.626 HG21 HG23 ' A' ' 50' ' ' VAL . 53.2 t -154.31 147.92 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.809 0.814 . . . . 0.0 109.533 179.377 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 89' ' ' SER . 48.2 p -121.24 153.67 37.34 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.316 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.808 HD22 ' CG ' ' A' ' 33' ' ' PHE . 79.0 mt -82.25 71.05 9.31 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.244 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . . . -107.38 -17.87 14.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.62 -0.675 . . . . 0.0 112.074 -178.09 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -110.91 123.77 34.59 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.573 -1.329 . . . . 0.0 110.083 -178.875 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 55.2 Cg_endo -77.45 145.06 23.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.488 2.125 . . . . 0.0 110.636 178.87 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.905 HG13 ' CD2' ' A' ' 106' ' ' TYR . 12.0 p -72.21 -22.01 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.535 -1.353 . . . . 0.0 109.38 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.905 ' CD2' HG13 ' A' ' 105' ' ' VAL . 72.3 m-85 -129.19 64.35 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.768 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 108.819 179.451 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 3' ' ' LEU . 96.8 mt . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.416 ' O ' ' OG1' ' A' ' 10' ' ' THR . 24.2 Cg_endo -65.11 -8.44 18.42 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.175 1.917 . . . . 0.0 111.778 -179.216 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.686 ' CG ' HD21 ' A' ' 83' ' ' LEU . 89.9 m-70 -65.94 -26.5 67.61 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.538 -0.726 . . . . 0.0 109.809 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -64.23 -29.82 70.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.982 -1.074 . . . . 0.0 110.036 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.488 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 95.6 m-20 -105.06 131.52 52.46 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.085 -1.01 . . . . 0.0 110.332 -179.545 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 12' ' ' ASN . 91.5 mt-10 -69.69 -23.3 63.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.536 -0.727 . . . . 0.0 109.504 179.325 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.43 ' CG ' ' N ' ' A' ' 10' ' ' THR . 34.5 pttt -61.36 -31.57 71.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.409 -0.807 . . . . 0.0 111.367 -178.823 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.559 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 53.6 p -70.61 -24.9 62.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.769 -1.207 . . . . 0.0 110.914 -178.452 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.605 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -124.51 -29.6 3.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.643 -1.285 . . . . 0.0 110.419 179.057 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 8' ' ' GLU . 49.0 t-20 -86.3 123.38 31.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 110.651 -178.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 13' ' ' VAL . 7.4 p -101.62 0.59 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.43 -0.794 . . . . 0.0 109.19 179.278 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.49 -153.69 52.22 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 88.2 p -68.9 148.32 50.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.378 -1.072 . . . . 0.0 108.429 179.201 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.56 ' O ' ' CZ ' ' A' ' 36' ' ' ARG . 47.3 t -175.16 156.34 2.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 108.826 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.64 ' C ' HH22 ' A' ' 36' ' ' ARG . 1.5 t-20 -78.19 140.8 38.94 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.543 179.832 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.948 ' N ' HH22 ' A' ' 36' ' ' ARG . 42.3 mtt-85 -60.18 -34.42 73.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.253 -0.904 . . . . 0.0 110.701 -179.181 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.645 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 42.3 p-10 -60.02 -40.33 88.94 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.804 -1.185 . . . . 0.0 108.702 179.773 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.645 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 62.1 tttp -64.24 -40.92 97.03 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.322 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.01 76.99 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.31 -0.869 . . . . 0.0 108.91 179.844 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 26' ' ' ARG . 98.1 mt-10 -59.57 -48.94 79.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.175 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.687 ' OD1' ' N ' ' A' ' 24' ' ' LEU . 8.6 p30 -60.02 -40.06 87.98 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.905 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.687 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 85.1 mt -66.99 -29.96 69.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.245 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.7 mt -93.7 -7.7 42.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.628 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 22' ' ' GLU . 2.0 ttm180 -97.23 128.77 44.4 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.277 -0.89 . . . . 0.0 109.789 -179.526 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.69 16.99 78.31 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.464 ' O ' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -110.16 133.37 53.29 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.537 -0.978 . . . . 0.0 109.642 -179.91 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -60.65 156.73 16.03 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.901 0.858 . . . . 0.0 111.106 -179.488 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 50' ' ' VAL . 87.7 m-20 -63.85 151.85 41.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.586 -0.696 . . . . 0.0 109.383 179.012 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.401 ' HA2' HG13 ' A' ' 99' ' ' VAL . . . 99.03 -22.04 42.9 Favored Glycine 0 N--CA 1.499 2.888 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.165 179.473 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.2 m -83.57 121.41 27.2 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.085 -1.244 . . . . 0.0 108.604 179.427 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.524 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -137.74 162.95 32.54 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.902 -1.124 . . . . 0.0 110.066 179.941 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.11 147.37 40.14 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.067 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 11' ' ' TRP . 54.9 t -92.58 132.03 38.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.04 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.948 HH22 ' N ' ' A' ' 18' ' ' ARG . 7.6 ttt180 -142.41 -172.65 3.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.267 -0.896 . . . . 0.0 108.86 -178.871 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.719 ' H ' ' CG ' ' A' ' 36' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--N 1.304 -1.371 0 O-C-N 120.985 -1.072 . . . . 0.0 108.952 -179.948 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.595 ' O ' ' O ' ' A' ' 59' ' ' ILE . 30.5 m-85 . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.445 0.641 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.598 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -175.8 145.12 0.66 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.062 -1.024 . . . . 0.0 108.477 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 57' ' ' CYS . 31.8 p -125.24 154.85 41.03 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.561 -1.337 . . . . 0.0 109.268 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.568 ' OG ' ' O ' ' A' ' 55' ' ' LYS . 41.1 t -119.75 138.9 53.04 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.636 0.731 . . . . 0.0 110.344 -178.519 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -130.73 146.0 34.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.463 -0.773 . . . . 0.0 109.388 179.88 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 28' ' ' LYS . 40.1 t -91.75 133.36 33.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.475 -0.766 . . . . 0.0 109.13 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 52' ' ' GLY . 0.7 OUTLIER -122.49 163.13 21.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.256 -0.977 . . . . 0.0 110.667 -179.77 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.528 ' C ' ' OD1' ' A' ' 51' ' ' ASP . 47.5 p30 -62.89 50.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.665 -179.06 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 178.48 -43.22 0.09 OUTLIER Glycine 0 C--N 1.295 -1.695 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.896 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 44.6 mm-40 -158.87 166.81 31.02 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.07 -1.253 . . . . 0.0 111.224 -179.324 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.424 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 5.3 m -73.11 146.92 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.525 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.568 ' O ' ' OG ' ' A' ' 47' ' ' SER . 11.2 mmtm -113.63 146.66 39.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.889 -1.132 . . . . 0.0 110.557 -179.335 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -125.54 65.79 1.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.61 -0.681 . . . . 0.0 109.687 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 74.4 m -59.47 144.91 45.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.073 -1.017 . . . . 0.0 108.891 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.4 138.49 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.932 0.872 . . . . 0.0 112.127 -178.328 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.595 ' O ' ' O ' ' A' ' 44' ' ' TYR . 48.4 mm -115.74 133.45 62.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.141 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.503 2.204 0 O-C-N 120.564 -1.335 . . . . 0.0 110.917 -178.287 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.278 0.561 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 78' ' ' LEU . 76.5 mt -59.56 -40.36 87.04 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -55.38 -40.61 71.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.444 -0.785 . . . . 0.0 109.379 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.19 -40.49 96.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.442 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.8 tt -58.82 -43.7 90.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.098 -179.349 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.67 -38.64 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.76 -1.212 . . . . 0.0 109.188 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.686 HD21 ' CG ' ' A' ' 5' ' ' HIS . 90.7 mt -74.89 -38.53 61.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.063 -1.023 . . . . 0.0 110.437 -179.846 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 -64.7 -39.36 93.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.802 -1.186 . . . . 0.0 109.792 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -66.82 -27.66 67.74 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.149 -0.97 . . . . 0.0 108.875 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.644 ' HG3' ' HB2' ' A' ' 102' ' ' ALA . 41.6 tt0 -63.79 -34.72 78.53 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.539 -0.726 . . . . 0.0 109.292 178.926 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -90.62 -13.47 34.3 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.028 -1.045 . . . . 0.0 110.163 -179.152 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.1 m -100.71 136.04 41.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 110.438 -179.678 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 t -85.99 125.55 33.47 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.282 -0.886 . . . . 0.0 108.934 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.722 ' O ' ' N ' ' A' ' 92' ' ' GLN . 87.1 mt -66.87 -20.05 65.85 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.407 -0.808 . . . . 0.0 110.332 -179.243 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.728 ' N ' ' O ' ' A' ' 97' ' ' LEU . 11.8 p -15.17 -48.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 O-C-N 121.684 -0.635 . . . . 0.0 110.372 179.457 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.722 ' N ' ' O ' ' A' ' 90' ' ' LEU . 34.0 tt0 53.92 179.41 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.483 -0.761 . . . . 0.0 110.807 178.777 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.547 ' H ' ' CG ' ' A' ' 92' ' ' GLN . 91.4 m-70 -60.06 -29.53 68.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.587 -0.695 . . . . 0.0 109.383 -179.719 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -56.96 -24.01 49.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.083 -1.011 . . . . 0.0 108.795 179.361 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.474 ' HA ' HG22 ' A' ' 91' ' ' VAL . 27.5 t70 61.93 41.67 11.09 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.518 -0.739 . . . . 0.0 110.432 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.7 m -148.19 -2.56 0.52 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.648 -1.283 . . . . 0.0 111.151 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 92.8 mt -102.16 52.0 0.81 Allowed 'General case' 0 C--N 1.29 -2.006 0 O-C-N 121.13 -0.982 . . . . 0.0 108.413 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.485 ' OD1' HG23 ' A' ' 91' ' ' VAL . 1.8 m120 -78.09 70.35 4.44 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.769 0.795 . . . . 0.0 109.807 -178.802 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.401 HG13 ' HA2' ' A' ' 31' ' ' GLY . 25.9 t -149.67 153.02 11.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.2 p -124.21 156.99 35.83 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.26 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.524 HD22 ' CG ' ' A' ' 33' ' ' PHE . 30.7 mt -82.58 69.48 9.36 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.912 -1.117 . . . . 0.0 108.694 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.644 ' HB2' ' HG3' ' A' ' 86' ' ' GLN . . . -105.09 -18.79 14.03 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.508 -0.745 . . . . 0.0 112.077 -178.004 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -112.44 109.62 53.59 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.414 -1.429 . . . . 0.0 112.101 -177.709 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.404 ' HG2' ' CG ' ' A' ' 4' ' ' PRO . 23.4 Cg_exo -62.35 143.72 94.12 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.074 1.85 . . . . 0.0 111.169 178.153 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.537 HG13 ' CD2' ' A' ' 106' ' ' TYR . 12.5 p -68.66 -36.92 76.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 120.745 -1.222 . . . . 0.0 108.904 179.345 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.537 ' CD2' HG13 ' A' ' 105' ' ' VAL . 55.7 m-85 -109.13 42.48 1.43 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.386 -0.821 . . . . 0.0 109.61 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 108.857 -179.986 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -51.51 -14.64 2.05 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.812 1.675 . . . . 0.0 110.925 179.369 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.466 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 91.1 m-70 -66.47 -12.93 59.84 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.541 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -63.42 -32.28 73.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 108.85 179.011 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.575 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 92.3 m-20 -100.53 134.19 43.85 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.352 -0.843 . . . . 0.0 110.004 -179.666 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 12' ' ' ASN . 95.5 mt-10 -69.27 -27.26 65.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 109.988 179.566 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.507 ' CG ' ' N ' ' A' ' 10' ' ' THR . 33.3 pttt -60.79 -35.46 76.53 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 110.508 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.669 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 10.6 p -59.75 -33.39 71.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 110.113 -178.827 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.669 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -120.78 -37.27 3.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.893 -1.129 . . . . 0.0 110.165 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -86.21 123.85 31.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.993 -1.067 . . . . 0.0 110.47 -179.214 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.474 ' O ' HG12 ' A' ' 13' ' ' VAL . 74.5 t -94.05 -4.95 10.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.906 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.79 -162.15 19.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.498 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -80.68 61.55 4.4 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.318 -1.107 . . . . 0.0 109.417 -179.544 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.1 p -79.2 156.7 28.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.299 -0.876 . . . . 0.0 109.092 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -70.18 142.72 52.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.191 -0.943 . . . . 0.0 109.453 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.618 HH11 ' NH2' ' A' ' 36' ' ' ARG . 48.6 mtt-85 -59.46 -38.81 81.75 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.054 -1.029 . . . . 0.0 109.388 179.816 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.65 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 40.0 p-10 -62.65 -42.82 99.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.0 -1.062 . . . . 0.0 108.484 179.363 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.65 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 80.3 tttt -60.51 -36.6 78.74 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.233 -0.917 . . . . 0.0 109.066 179.41 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.71 ' CB ' HH11 ' A' ' 36' ' ' ARG . . . -58.57 -34.03 70.59 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.647 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 75.3 tt0 -58.7 -42.63 89.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.247 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.68 -46.94 87.54 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.953 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.697 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -67.16 -33.86 76.32 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.863 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.883 HD11 ' OG ' ' A' ' 47' ' ' SER . 22.7 mt -80.85 -16.01 54.82 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.146 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.742 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -74.61 122.43 23.15 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.555 -179.727 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.82 19.54 78.83 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.518 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.505 ' HE2' HG21 ' A' ' 32' ' ' THR . 0.2 OUTLIER -97.18 135.79 38.62 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.359 -1.083 . . . . 0.0 109.685 -179.446 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.699 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.9 OUTLIER -74.88 157.63 34.74 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.66 0.743 . . . . 0.0 110.157 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.513 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 48.4 p30 -62.25 169.36 2.85 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.283 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.88 -28.44 1.89 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.505 HG21 ' HE2' ' A' ' 28' ' ' LYS . 76.7 m -80.56 121.03 25.29 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.869 -1.371 . . . . 0.0 108.984 179.658 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.806 ' HB2' HG22 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -136.06 167.26 21.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.908 -1.12 . . . . 0.0 110.517 -179.32 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 1.1 pt? -148.91 161.29 42.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.454 -0.779 . . . . 0.0 110.588 179.475 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.475 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 65.8 t -106.74 132.73 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.37 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.71 HH11 ' CB ' ' A' ' 21' ' ' ALA . 35.6 ptt180 -147.75 173.14 13.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 108.884 -178.857 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.479 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 53.0 mt-10 . . . . . 0 C--N 1.304 -1.389 0 O-C-N 120.83 -1.169 . . . . 0.0 109.268 179.447 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.608 ' O ' ' O ' ' A' ' 59' ' ' ILE . 57.2 m-85 . . . . . 0 N--CA 1.495 1.775 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 57' ' ' CYS . . . -159.75 153.88 23.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.77 -1.207 . . . . 0.0 109.973 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' CYS . 85.4 m -109.5 125.86 52.93 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.563 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.883 ' OG ' HD11 ' A' ' 25' ' ' LEU . 26.1 t -92.05 127.0 37.36 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.06 -179.682 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.806 HG22 ' HB2' ' A' ' 33' ' ' PHE . 74.3 t -126.1 163.71 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.187 -0.946 . . . . 0.0 109.978 -179.403 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.602 ' N ' HG12 ' A' ' 48' ' ' VAL . 39.2 t -124.6 132.76 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.836 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.701 HG23 ' CG2' ' A' ' 99' ' ' VAL . 11.4 p -123.34 156.35 29.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.995 -1.066 . . . . 0.0 109.671 -179.782 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.423 ' OD1' ' OD2' ' A' ' 30' ' ' ASP . 87.2 m-20 -49.97 -17.17 0.35 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.943 0.878 . . . . 0.0 109.634 -179.429 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.581 ' O ' ' OE2' ' A' ' 53' ' ' GLU . . . -86.18 -59.22 1.88 Allowed Glycine 0 C--N 1.287 -2.142 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.667 -179.175 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.581 ' OE2' ' O ' ' A' ' 52' ' ' GLY . 61.3 mm-40 -163.22 -165.53 1.1 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.25 -1.147 . . . . 0.0 110.554 -178.992 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.56 ' CG1' HD13 ' A' ' 25' ' ' LEU . 88.8 t -93.36 123.37 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.319 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.455 ' NZ ' HG11 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -122.45 149.15 44.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.911 -1.118 . . . . 0.0 110.905 -179.495 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.543 ' CG ' ' NH2' ' A' ' 36' ' ' ARG . 58.6 m-70 -113.31 101.88 9.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.579 -0.701 . . . . 0.0 109.544 179.194 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' CYS . 52.5 t -72.91 130.04 39.5 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.26 138.63 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.246 -0.909 . . . . 0.0 111.878 -177.876 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.608 ' O ' ' O ' ' A' ' 44' ' ' TYR . 10.9 mm -124.93 111.59 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.818 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 . . . . . 0 N--CA 1.5 2.055 0 O-C-N 120.647 -1.283 . . . . 0.0 112.182 -178.248 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.559 0.695 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.16 -34.05 73.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 110.03 179.827 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.72 -43.74 80.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.188 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -66.9 -30.53 70.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.228 -0.92 . . . . 0.0 108.856 179.464 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.904 HD21 ' CE2' ' A' ' 85' ' ' TYR . 9.2 tt -60.6 -40.9 93.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 108.987 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.2 t -66.86 -44.17 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.361 -0.837 . . . . 0.0 109.819 179.752 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.426 HD21 ' CB ' ' A' ' 5' ' ' HIS . 85.0 mt -67.45 -43.09 81.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.419 -0.8 . . . . 0.0 110.439 -179.119 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -60.02 -40.56 89.72 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.215 -179.194 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.904 ' CE2' HD21 ' A' ' 81' ' ' LEU . 7.4 m-30 -67.34 -24.31 65.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 0.0 108.789 -179.783 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.453 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 38.1 tt0 -61.32 -36.94 81.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 178.961 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -91.44 -16.71 26.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.303 -0.873 . . . . 0.0 109.592 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.4 m -100.84 129.92 46.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.131 -0.981 . . . . 0.0 109.228 179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.543 ' HA ' HG22 ' A' ' 100' ' ' THR . 34.8 t -81.67 132.56 35.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 109.915 -179.627 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 91' ' ' VAL . 76.2 mt -69.01 -13.07 62.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.477 -0.764 . . . . 0.0 109.715 179.23 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.76 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.8 p -36.66 -33.75 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.464 -0.773 . . . . 0.0 110.011 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.45 ' N ' HG13 ' A' ' 91' ' ' VAL . 20.0 tt0 -65.86 -50.07 65.86 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 -178.658 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLN . 84.3 t60 -51.43 -47.53 63.0 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 179.443 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.689 ' O ' ' N ' ' A' ' 96' ' ' SER . 13.1 t-20 -126.29 111.25 14.33 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.477 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.54 ' C ' ' O ' ' A' ' 94' ' ' ASN . 99.7 m-20 -35.98 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.886 -178.488 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 94' ' ' ASN . 71.1 m -108.37 27.07 9.71 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.736 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.76 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.5 mt -97.96 65.84 1.81 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.563 -1.336 . . . . 0.0 108.2 178.676 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.403 ' C ' HG23 ' A' ' 99' ' ' VAL . 50.6 t-20 -79.79 75.57 6.47 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.81 -1.182 . . . . 0.0 109.41 -178.998 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.701 ' CG2' HG23 ' A' ' 50' ' ' VAL . 84.5 t -153.56 153.62 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.522 -0.736 . . . . 0.0 109.805 -179.266 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.543 HG22 ' HA ' ' A' ' 89' ' ' SER . 70.2 p -134.33 156.79 47.85 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.154 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.57 HD22 ' CG ' ' A' ' 33' ' ' PHE . 11.6 mt -76.48 71.65 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.706 -1.246 . . . . 0.0 108.007 179.333 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.3 -33.76 9.91 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.169 -0.957 . . . . 0.0 112.111 -177.881 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.4 m-85 -113.97 109.29 49.93 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.503 -1.373 . . . . 0.0 111.977 -177.654 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.523 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 19.0 Cg_exo -59.97 148.61 88.21 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.083 1.855 . . . . 0.0 110.276 176.924 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.502 HG13 ' CD2' ' A' ' 106' ' ' TYR . 9.1 p -67.25 -34.59 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.822 -1.174 . . . . 0.0 108.77 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.502 ' CD2' HG13 ' A' ' 105' ' ' VAL . 38.6 m-85 -108.14 39.4 1.97 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.447 -0.783 . . . . 0.0 110.191 179.828 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.523 ' HB2' ' CG ' ' A' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.497 1.905 0 O-C-N 120.996 -1.065 . . . . 0.0 109.599 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 121.438 0.637 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -67.08 145.58 55.19 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.293 -0.879 . . . . 0.0 108.845 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.9 mt -93.84 139.26 22.63 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.57 -3.02 10.29 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.612 2.208 . . . . 0.0 112.103 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -66.78 -29.71 69.73 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -63.36 -22.37 66.84 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.583 ' O ' ' OG1' ' A' ' 10' ' ' THR . 94.9 m-20 -92.25 119.95 32.34 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.52 0.676 . . . . 0.0 110.441 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 72.3 tt0 -69.32 -40.33 77.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.59 -0.694 . . . . 0.0 109.496 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.58 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -64.1 -20.53 66.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.655 -0.653 . . . . 0.0 111.443 -178.656 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.583 ' OG1' ' O ' ' A' ' 7' ' ' ASP . 7.6 p -64.49 -37.31 87.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.794 -1.191 . . . . 0.0 110.196 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.588 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -119.24 -14.81 9.23 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.939 -1.1 . . . . 0.0 109.819 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 8' ' ' GLU . 62.6 t30 -89.7 120.07 30.65 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 110.599 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.715 ' CG2' HD13 ' A' ' 34' ' ' LEU . 27.7 m -137.97 36.28 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.89 -33.54 20.74 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 85.6 p -63.05 -31.98 73.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.945 -1.327 . . . . 0.0 109.036 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.8 t -61.6 138.51 58.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.379 -0.826 . . . . 0.0 109.718 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -81.57 163.91 22.29 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.299 -0.876 . . . . 0.0 109.867 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -57.17 -44.78 83.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -0.817 . . . . 0.0 109.465 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -65.36 -42.72 92.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.069 -1.019 . . . . 0.0 108.638 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -61.05 -36.25 79.09 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.48 -37.33 77.97 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.53 -0.731 . . . . 0.0 109.646 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 26' ' ' ARG . 81.3 mm-40 -58.39 -45.19 88.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.109 -0.994 . . . . 0.0 108.384 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -62.09 -44.19 97.21 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.421 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 82.4 mt -64.4 -40.2 95.32 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.413 -0.804 . . . . 0.0 108.87 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.729 HD13 ' CG1' ' A' ' 54' ' ' VAL . 36.7 mt -75.73 -29.93 59.06 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.568 ' NH1' ' HG2' ' A' ' 26' ' ' ARG . 31.6 mtt-85 -79.63 136.3 36.79 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.717 -0.614 . . . . 0.0 109.645 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.78 -8.65 76.45 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 24' ' ' LEU . 28.7 mmtm -96.12 137.85 34.58 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.242 -1.152 . . . . 0.0 109.878 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -69.52 162.78 26.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.459 -0.775 . . . . 0.0 109.191 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.611 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 73.9 m-20 -60.18 142.91 53.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.372 -0.83 . . . . 0.0 109.189 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.39 -30.51 8.47 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.0 m -76.16 135.78 39.79 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.239 -1.154 . . . . 0.0 109.044 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.889 ' CD1' HD13 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -140.84 162.94 34.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.938 -1.101 . . . . 0.0 108.923 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.715 HD13 ' CG2' ' A' ' 13' ' ' VAL . 2.8 pp -134.16 154.55 51.15 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.122 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.043 HG22 ' SG ' ' A' ' 46' ' ' CYS . 95.5 t -113.65 138.24 44.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.559 ' NH1' ' HG3' ' A' ' 36' ' ' ARG . 5.4 ptm180 -150.51 169.96 20.26 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.037 -1.04 . . . . 0.0 109.362 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.586 ' C ' ' H ' ' A' ' 39' ' ' SER . 3.2 pt-20 -101.23 175.8 5.46 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.938 -1.101 . . . . 0.0 108.838 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.598 ' O ' ' OG ' ' A' ' 39' ' ' SER . 39.8 m -77.86 9.09 3.8 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.607 ' OG ' ' N ' ' A' ' 40' ' ' LYS . 21.2 p 85.19 -77.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.366 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.607 ' N ' ' OG ' ' A' ' 39' ' ' SER . 96.7 mttt -100.09 -25.92 14.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -0.967 . . . . 0.0 110.187 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -84.14 150.41 25.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.004 -1.06 . . . . 0.0 109.229 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.32 5.48 20.5 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 120.277 -0.963 . . . . 0.0 110.893 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.6 t -78.77 143.58 35.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.811 -1.406 . . . . 0.0 109.036 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.593 ' O ' ' O ' ' A' ' 59' ' ' ILE . 97.7 m-85 -113.16 161.24 17.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.135 -0.978 . . . . 0.0 109.903 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -164.66 144.4 7.35 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.022 -1.049 . . . . 0.0 109.357 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 1.043 ' SG ' HG22 ' A' ' 35' ' ' VAL . 78.5 m -121.02 136.84 54.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.495 ' OG ' HD11 ' A' ' 25' ' ' LEU . 92.6 p -105.19 143.36 33.47 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.554 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.806 HG22 ' HB2' ' A' ' 33' ' ' PHE . 43.7 t -125.06 158.95 32.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.574 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.454 ' N ' HG12 ' A' ' 48' ' ' VAL . 67.9 t -109.92 130.99 62.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.935 HG12 ' H ' ' A' ' 52' ' ' GLY . 9.9 t -123.22 152.13 27.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.132 -0.98 . . . . 0.0 110.652 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.611 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 66.0 t0 -50.34 -12.03 0.08 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.547 0.689 . . . . 0.0 109.858 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.935 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -104.9 -49.96 0.98 Allowed Glycine 0 C--N 1.287 -2.142 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.253 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.55 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 75.0 mt-10 -161.29 177.01 10.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.885 -1.362 . . . . 0.0 111.209 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.729 ' CG1' HD13 ' A' ' 25' ' ' LEU . 53.5 t -89.64 135.13 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.8 161.9 18.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.986 -1.071 . . . . 0.0 111.484 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -124.06 76.07 1.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 88.4 m -60.83 146.45 46.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.168 -0.957 . . . . 0.0 109.382 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 58' ' ' VAL . 5.5 p -106.26 135.87 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.22 -0.925 . . . . 0.0 111.467 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.73 HD12 ' SG ' ' A' ' 46' ' ' CYS . 64.6 mt -124.81 141.47 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 66' ' ' TYR . 49.3 t30 -143.51 119.72 10.82 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.162 -1.586 . . . . 0.0 111.331 -177.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' NZ ' ' CB ' ' A' ' 61' ' ' LYS . 8.6 mtmp? -94.16 119.57 33.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.491 -0.756 . . . . 0.0 110.465 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.552 ' O ' ' C ' ' A' ' 63' ' ' ALA . 91.5 m -138.96 165.92 25.84 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.552 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -37.55 -35.78 0.14 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.902 -1.124 . . . . 0.0 108.077 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.685 HG22 ' O ' ' A' ' 64' ' ' THR . 84.1 m -138.03 39.34 2.34 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.773 -0.579 . . . . 0.0 109.593 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.702 ' O ' ' CD2' ' A' ' 66' ' ' TYR . . . -139.55 158.05 25.37 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.702 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 97.6 m-85 -168.07 -8.17 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.527 -0.984 . . . . 0.0 109.207 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.01 -72.94 0.23 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 76.8 m-85 -97.33 110.63 23.15 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 68' ' ' PHE . . . 176.8 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.878 -1.139 . . . . 0.0 109.617 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.646 ' O ' ' O ' ' A' ' 73' ' ' ASN . 76.6 mm-40 -119.57 153.81 54.27 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.476 ' C ' ' O ' ' A' ' 70' ' ' GLU . 84.0 Cg_exo -34.29 -41.62 0.24 Allowed 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 121.835 1.69 . . . . 0.0 111.022 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -69.22 -44.33 72.28 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.282 -0.886 . . . . 0.0 109.041 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.646 ' O ' ' O ' ' A' ' 70' ' ' GLU . 52.3 p30 -122.36 142.98 49.94 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.524 -0.735 . . . . 0.0 109.887 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 98.8 mt -145.34 99.54 3.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.626 -1.296 . . . . 0.0 109.683 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.69 ' OH ' ' ND1' ' A' ' 84' ' ' HIS . 92.5 m-85 -79.88 130.25 35.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 110.25 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.0 m -90.75 -34.59 15.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.406 -0.809 . . . . 0.0 111.022 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.7 m -126.67 155.93 41.84 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.639 -1.288 . . . . 0.0 110.545 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 78' ' ' LEU . 82.1 mt -68.02 -29.84 68.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.731 . . . . 0.0 110.053 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -58.9 -42.83 90.53 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -68.61 -35.39 77.26 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.568 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.5 tt -59.49 -49.49 77.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.396 -0.815 . . . . 0.0 109.204 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.803 HG13 HD21 ' A' ' 101' ' ' LEU . 99.0 t -61.28 -43.22 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.581 -0.699 . . . . 0.0 109.745 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.61 -51.5 67.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.035 -1.041 . . . . 0.0 110.608 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.699 ' CE1' ' OG1' ' A' ' 88' ' ' THR . 59.3 t-80 -71.47 -36.36 71.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.77 -1.206 . . . . 0.0 110.457 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.751 ' OH ' HD21 ' A' ' 90' ' ' LEU . 29.1 t80 -59.98 -20.62 58.62 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.909 -1.119 . . . . 0.0 108.842 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.503 ' CG ' ' O ' ' A' ' 101' ' ' LEU . 1.1 tm0? -80.07 -25.8 39.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.234 -0.916 . . . . 0.0 108.626 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -97.8 -7.56 30.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.218 -0.926 . . . . 0.0 109.07 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.699 ' OG1' ' CE1' ' A' ' 84' ' ' HIS . 32.4 m -96.99 139.77 32.51 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.214 -0.929 . . . . 0.0 109.152 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.527 ' OG ' HG12 ' A' ' 91' ' ' VAL . 40.6 t -87.65 130.24 34.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.14 -0.975 . . . . 0.0 109.358 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.751 HD21 ' OH ' ' A' ' 85' ' ' TYR . 10.4 mp -71.82 -17.23 62.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.316 -0.865 . . . . 0.0 109.972 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.703 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.6 p -37.52 -41.93 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.175 -0.953 . . . . 0.0 110.162 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.473 ' N ' HG13 ' A' ' 91' ' ' VAL . 54.9 tt0 -47.95 -30.34 4.15 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.484 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.842 ' HB2' HD12 ' A' ' 97' ' ' LEU . 94.4 m-70 -83.44 130.31 35.02 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.089 -1.007 . . . . 0.0 108.989 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 58.22 7.73 0.7 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.46 ' H ' ' C ' ' A' ' 93' ' ' HIS . 54.7 t0 45.25 35.01 1.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.418 -0.801 . . . . 0.0 109.197 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 55.9 m -156.95 15.48 0.28 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.817 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.842 HD12 ' HB2' ' A' ' 93' ' ' HIS . 68.0 mt -101.62 73.91 1.48 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -79.1 85.15 5.02 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.727 0.775 . . . . 0.0 109.928 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.401 HG22 ' N ' ' A' ' 100' ' ' THR . 8.1 p -165.44 163.57 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.733 0.778 . . . . 0.0 109.081 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 102' ' ' ALA . 68.0 p -135.16 131.96 37.42 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.937 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -52.43 95.57 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.406 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -91.81 -51.53 5.18 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.403 -1.436 . . . . 0.0 111.888 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -129.06 137.37 30.86 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.743 -1.223 . . . . 0.0 112.043 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.46 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 32.6 Cg_exo -52.98 160.53 4.1 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.232 1.955 . . . . 0.0 111.28 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.413 ' H ' HG12 ' A' ' 105' ' ' VAL . 3.2 p -74.27 -31.82 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.685 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -112.03 34.14 4.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.875 . . . . 0.0 109.281 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 104' ' ' PRO . . . -77.65 -42.09 35.97 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.548 -0.72 . . . . 0.0 109.706 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -67.78 -29.85 69.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.892 . . . . 0.0 110.508 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -93.1 126.02 37.99 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.086 -1.009 . . . . 0.0 110.234 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -130.2 150.14 51.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.372 -0.83 . . . . 0.0 109.448 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.716 ' CG ' HH11 ' A' ' 111' ' ' ARG . 1.4 mtt-85 . . . . . 0 C--N 1.298 -1.656 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.23 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.469 0.652 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.33 140.25 58.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -0.966 . . . . 0.0 109.265 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.1 mt -100.79 134.1 20.72 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.14 -0.975 . . . . 0.0 109.392 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -51.51 -14.64 2.05 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.812 1.675 . . . . 0.0 110.925 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.466 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 91.1 m-70 -66.47 -12.93 59.84 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -63.42 -32.28 73.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 108.85 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.575 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 92.3 m-20 -100.53 134.19 43.85 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.352 -0.843 . . . . 0.0 110.004 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 12' ' ' ASN . 95.5 mt-10 -69.27 -27.26 65.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 109.988 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.507 ' CG ' ' N ' ' A' ' 10' ' ' THR . 33.3 pttt -60.79 -35.46 76.53 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 110.508 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.669 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 10.6 p -59.75 -33.39 71.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 110.113 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.669 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -120.78 -37.27 3.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.893 -1.129 . . . . 0.0 110.165 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -86.21 123.85 31.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.993 -1.067 . . . . 0.0 110.47 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.474 ' O ' HG12 ' A' ' 13' ' ' VAL . 74.5 t -94.05 -4.95 10.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.79 -162.15 19.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -80.68 61.55 4.4 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.318 -1.107 . . . . 0.0 109.417 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.1 p -79.2 156.7 28.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.299 -0.876 . . . . 0.0 109.092 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -70.18 142.72 52.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.191 -0.943 . . . . 0.0 109.453 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.618 HH11 ' NH2' ' A' ' 36' ' ' ARG . 48.6 mtt-85 -59.46 -38.81 81.75 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.054 -1.029 . . . . 0.0 109.388 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.65 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 40.0 p-10 -62.65 -42.82 99.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.0 -1.062 . . . . 0.0 108.484 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.65 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 80.3 tttt -60.51 -36.6 78.74 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.233 -0.917 . . . . 0.0 109.066 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.71 ' CB ' HH11 ' A' ' 36' ' ' ARG . . . -58.57 -34.03 70.59 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.647 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 75.3 tt0 -58.7 -42.63 89.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.68 -46.94 87.54 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.697 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -67.16 -33.86 76.32 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.883 HD11 ' OG ' ' A' ' 47' ' ' SER . 22.7 mt -80.85 -16.01 54.82 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.742 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -74.61 122.43 23.15 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.555 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.82 19.54 78.83 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.505 ' HE2' HG21 ' A' ' 32' ' ' THR . 0.2 OUTLIER -97.18 135.79 38.62 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.359 -1.083 . . . . 0.0 109.685 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.699 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.9 OUTLIER -74.88 157.63 34.74 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.66 0.743 . . . . 0.0 110.157 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.513 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 48.4 p30 -62.25 169.36 2.85 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.88 -28.44 1.89 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.505 HG21 ' HE2' ' A' ' 28' ' ' LYS . 76.7 m -80.56 121.03 25.29 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.869 -1.371 . . . . 0.0 108.984 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.806 ' HB2' HG22 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -136.06 167.26 21.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.908 -1.12 . . . . 0.0 110.517 -179.32 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 1.1 pt? -148.91 161.29 42.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.454 -0.779 . . . . 0.0 110.588 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.475 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 65.8 t -106.74 132.73 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.71 HH11 ' CB ' ' A' ' 21' ' ' ALA . 35.6 ptt180 -147.75 173.14 13.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 108.884 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.661 ' C ' ' H ' ' A' ' 39' ' ' SER . 53.0 mt-10 -124.33 170.54 10.7 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.83 -1.169 . . . . 0.0 109.268 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.646 ' O ' ' CB ' ' A' ' 39' ' ' SER . 57.7 m -75.39 15.51 0.45 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.661 ' H ' ' C ' ' A' ' 37' ' ' GLU . 6.4 t 97.86 131.03 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.828 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.473 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 67.1 mmtt 62.32 -143.77 0.4 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.508 -0.745 . . . . 0.0 109.103 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -101.57 20.11 16.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -0.847 . . . . 0.0 109.629 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.06 -52.62 51.03 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.062 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 44' ' ' TYR . 53.1 t -161.0 166.58 28.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.99 -1.3 . . . . 0.0 110.246 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.608 ' O ' ' O ' ' A' ' 59' ' ' ILE . 57.2 m-85 -123.66 145.83 48.67 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.279 -0.888 . . . . 0.0 109.048 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 57' ' ' CYS . . . -159.75 153.88 23.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.77 -1.207 . . . . 0.0 109.973 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' CYS . 85.4 m -109.5 125.86 52.93 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.883 ' OG ' HD11 ' A' ' 25' ' ' LEU . 26.1 t -92.05 127.0 37.36 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.06 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.806 HG22 ' HB2' ' A' ' 33' ' ' PHE . 74.3 t -126.1 163.71 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.187 -0.946 . . . . 0.0 109.978 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.602 ' N ' HG12 ' A' ' 48' ' ' VAL . 39.2 t -124.6 132.76 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.701 HG23 ' CG2' ' A' ' 99' ' ' VAL . 11.4 p -123.34 156.35 29.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.995 -1.066 . . . . 0.0 109.671 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.423 ' OD1' ' OD2' ' A' ' 30' ' ' ASP . 87.2 m-20 -49.97 -17.17 0.35 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.943 0.878 . . . . 0.0 109.634 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.581 ' O ' ' OE2' ' A' ' 53' ' ' GLU . . . -86.18 -59.22 1.88 Allowed Glycine 0 C--N 1.287 -2.142 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.667 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.581 ' OE2' ' O ' ' A' ' 52' ' ' GLY . 61.3 mm-40 -163.22 -165.53 1.1 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.25 -1.147 . . . . 0.0 110.554 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.56 ' CG1' HD13 ' A' ' 25' ' ' LEU . 88.8 t -93.36 123.37 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' NZ ' HG11 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -122.45 149.15 44.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.911 -1.118 . . . . 0.0 110.905 -179.495 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.543 ' CG ' ' NH2' ' A' ' 36' ' ' ARG . 58.6 m-70 -113.31 101.88 9.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.579 -0.701 . . . . 0.0 109.544 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' CYS . 52.5 t -72.91 130.04 39.5 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.26 138.63 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.246 -0.909 . . . . 0.0 111.878 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.608 ' O ' ' O ' ' A' ' 44' ' ' TYR . 10.9 mm -124.93 111.59 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.695 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 83.6 m-20 -118.59 170.48 8.92 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.647 -1.283 . . . . 0.0 112.182 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -128.29 30.52 5.18 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.327 -1.483 . . . . 0.0 108.985 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.7 p -79.45 -174.93 4.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.314 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.37 -28.35 66.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.19 -0.944 . . . . 0.0 109.616 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.9 p -79.0 -5.59 54.27 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.217 -0.927 . . . . 0.0 109.206 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.797 ' HA3' ' HB3' ' A' ' 69' ' ' ALA . . . 81.54 171.54 45.62 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.893 ' CE1' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -64.44 30.8 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.951 -1.323 . . . . 0.0 110.537 -179.244 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.623 ' H ' ' C ' ' A' ' 65' ' ' GLY . . . 88.51 -42.89 3.08 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.63 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 89.7 m-85 -90.43 -6.08 55.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.347 -1.09 . . . . 0.0 110.278 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.893 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . . . -99.63 3.88 45.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.213 -0.929 . . . . 0.0 109.154 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.702 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 46.2 tt0 -59.64 -35.31 28.44 Favored Pre-proline 0 C--N 1.304 -1.379 0 C-N-CA 119.006 -1.078 . . . . 0.0 108.678 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 9.8 Cg_exo -72.81 174.16 12.29 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.634 2.222 . . . . 0.0 111.071 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -62.57 -12.32 22.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.034 -1.041 . . . . 0.0 109.566 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -101.36 102.56 13.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.912 -1.117 . . . . 0.0 110.472 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.614 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 5.6 mp -106.25 7.4 31.4 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 60.58 175.02 0.1 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.371 -0.83 . . . . 0.0 109.19 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.7 t -103.71 -48.72 3.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.122 -0.986 . . . . 0.0 110.048 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.8 m -126.3 154.77 42.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.094 -1.004 . . . . 0.0 110.183 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.16 -34.05 73.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 110.03 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.72 -43.74 80.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.188 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -66.9 -30.53 70.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.228 -0.92 . . . . 0.0 108.856 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.904 HD21 ' CE2' ' A' ' 85' ' ' TYR . 9.2 tt -60.6 -40.9 93.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 108.987 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.2 t -66.86 -44.17 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.361 -0.837 . . . . 0.0 109.819 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.426 HD21 ' CB ' ' A' ' 5' ' ' HIS . 85.0 mt -67.45 -43.09 81.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.419 -0.8 . . . . 0.0 110.439 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -60.02 -40.56 89.72 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.215 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.904 ' CE2' HD21 ' A' ' 81' ' ' LEU . 7.4 m-30 -67.34 -24.31 65.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 0.0 108.789 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.453 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 38.1 tt0 -61.32 -36.94 81.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -91.44 -16.71 26.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.303 -0.873 . . . . 0.0 109.592 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.4 m -100.84 129.92 46.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.131 -0.981 . . . . 0.0 109.228 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.543 ' HA ' HG22 ' A' ' 100' ' ' THR . 34.8 t -81.67 132.56 35.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 109.915 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 91' ' ' VAL . 76.2 mt -69.01 -13.07 62.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.477 -0.764 . . . . 0.0 109.715 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.76 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.8 p -36.66 -33.75 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.464 -0.773 . . . . 0.0 110.011 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.45 ' N ' HG13 ' A' ' 91' ' ' VAL . 20.0 tt0 -65.86 -50.07 65.86 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLN . 84.3 t60 -51.43 -47.53 63.0 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.689 ' O ' ' N ' ' A' ' 96' ' ' SER . 13.1 t-20 -126.29 111.25 14.33 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.54 ' C ' ' O ' ' A' ' 94' ' ' ASN . 99.7 m-20 -35.98 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.886 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 94' ' ' ASN . 71.1 m -108.37 27.07 9.71 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.736 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.76 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.5 mt -97.96 65.84 1.81 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.563 -1.336 . . . . 0.0 108.2 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.403 ' C ' HG23 ' A' ' 99' ' ' VAL . 50.6 t-20 -79.79 75.57 6.47 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.81 -1.182 . . . . 0.0 109.41 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.701 ' CG2' HG23 ' A' ' 50' ' ' VAL . 84.5 t -153.56 153.62 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.522 -0.736 . . . . 0.0 109.805 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.543 HG22 ' HA ' ' A' ' 89' ' ' SER . 70.2 p -134.33 156.79 47.85 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.57 HD22 ' CG ' ' A' ' 33' ' ' PHE . 11.6 mt -76.48 71.65 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.706 -1.246 . . . . 0.0 108.007 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.3 -33.76 9.91 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.169 -0.957 . . . . 0.0 112.111 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.4 m-85 -113.97 109.29 49.93 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.503 -1.373 . . . . 0.0 111.977 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.523 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 19.0 Cg_exo -59.97 148.61 88.21 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.083 1.855 . . . . 0.0 110.276 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.567 ' O ' ' OE1' ' A' ' 109' ' ' GLN . 9.1 p -67.25 -34.59 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.822 -1.174 . . . . 0.0 108.77 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.502 ' CD2' HG13 ' A' ' 105' ' ' VAL . 38.6 m-85 -108.14 39.4 1.97 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.447 -0.783 . . . . 0.0 110.191 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.523 ' HB2' ' CG ' ' A' ' 104' ' ' PRO . . . -83.99 117.4 23.36 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.996 -1.065 . . . . 0.0 109.599 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 49.46 45.93 23.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.334 -0.854 . . . . 0.0 109.975 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.567 ' OE1' ' O ' ' A' ' 105' ' ' VAL . 41.9 mt-30 -104.42 135.01 46.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.795 -1.191 . . . . 0.0 110.122 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -61.38 -35.44 77.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.578 -0.701 . . . . 0.0 110.146 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.498 ' HA ' ' HE ' ' A' ' 111' ' ' ARG . 4.6 tpm_? . . . . . 0 N--CA 1.493 1.716 0 O-C-N 120.961 -1.087 . . . . 0.0 109.217 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -63.33 133.46 54.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.222 -0.924 . . . . 0.0 110.059 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.5 mt -90.32 145.61 33.0 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.427 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 28.5 Cg_endo -64.3 -6.9 12.59 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.7 2.267 . . . . 0.0 112.288 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.49 ' CD2' HG11 ' A' ' 82' ' ' VAL . 7.3 m80 -67.37 -21.31 65.63 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 108.965 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -59.68 -34.2 72.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.776 -1.203 . . . . 0.0 108.236 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -97.18 126.76 42.57 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.175 -0.953 . . . . 0.0 109.354 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.614 ' CG ' ' OD1' ' A' ' 12' ' ' ASN . 23.2 tt0 -68.07 -28.27 67.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.6 -0.688 . . . . 0.0 110.125 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.706 ' NZ ' ' O ' ' A' ' 106' ' ' TYR . 2.3 tmpt? -62.44 -27.19 68.94 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.261 -0.9 . . . . 0.0 111.623 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.717 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 41.7 p -62.57 -29.74 70.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.991 -1.068 . . . . 0.0 112.127 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.759 ' CE3' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -123.86 -31.23 3.44 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.189 -1.57 . . . . 0.0 110.34 179.457 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.759 ' ND2' ' CE3' ' A' ' 11' ' ' TRP . 1.2 m-80 -73.74 130.81 40.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.132 -0.98 . . . . 0.0 109.663 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 13' ' ' VAL . 60.9 t -115.79 -11.16 12.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.633 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.81 -152.42 21.81 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.1 p -83.46 112.07 19.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -1.123 . . . . 0.0 109.524 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.0 m -126.07 143.13 51.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.073 -1.017 . . . . 0.0 110.152 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.653 ' ND2' ' ND2' ' A' ' 19' ' ' ASN . 59.5 t-20 -67.11 148.38 51.93 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.576 -0.702 . . . . 0.0 109.26 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.545 ' HA ' HH12 ' A' ' 36' ' ' ARG . 85.5 mtm180 -61.05 -40.35 93.29 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 110.022 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 44.0 p30 -61.49 -33.14 73.27 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.085 -1.009 . . . . 0.0 108.977 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.674 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 7.3 tppt? -77.76 -34.75 52.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.127 -0.983 . . . . 0.0 108.945 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.5 92.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -0.793 . . . . 0.0 109.349 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 26' ' ' ARG . 14.4 pt-20 -60.12 -46.01 91.07 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.0 -1.063 . . . . 0.0 108.442 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.437 ' N ' ' HG3' ' A' ' 22' ' ' GLU . 98.3 m-20 -56.07 -42.44 76.67 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.31 -29.75 67.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.319 -0.863 . . . . 0.0 109.163 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.467 HD13 ' CG1' ' A' ' 54' ' ' VAL . 11.5 mt -91.68 -9.93 42.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -0.792 . . . . 0.0 109.134 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 22' ' ' GLU . 1.1 ttt180 -90.75 125.8 35.81 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.195 -0.94 . . . . 0.0 109.476 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.2 1.02 61.23 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -96.9 141.1 30.5 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.403 -1.057 . . . . 0.0 108.16 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -72.82 151.74 41.89 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.275 -0.891 . . . . 0.0 108.854 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -50.95 147.99 4.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 109.287 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.79 -20.82 44.52 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.446 HG23 ' HD2' ' A' ' 103' ' ' TYR . 58.5 m -86.27 122.33 30.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -1.079 . . . . 0.0 110.074 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.875 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.8 OUTLIER -136.46 167.22 21.76 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.366 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 pp -140.63 160.12 40.7 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.664 -0.815 . . . . 0.0 109.545 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.36 125.65 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.416 -0.803 . . . . 0.0 109.756 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.545 HH12 ' HA ' ' A' ' 18' ' ' ARG . 29.0 ptt180 -143.9 -174.06 4.16 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.671 ' C ' ' H ' ' A' ' 39' ' ' SER . 0.3 OUTLIER -105.08 173.55 6.26 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.825 -1.172 . . . . 0.0 108.985 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.66 ' O ' ' CB ' ' A' ' 39' ' ' SER . 70.9 m -76.75 14.22 0.86 Allowed 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.671 ' H ' ' C ' ' A' ' 37' ' ' GLU . 83.3 p 112.76 -37.58 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.222 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.497 ' C ' ' OE1' ' A' ' 37' ' ' GLU . 65.3 tttm -96.18 123.32 39.75 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.565 ' C ' ' OE1' ' A' ' 41' ' ' GLN . 1.1 tm0? -47.94 -16.95 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.464 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.485 ' H ' ' HG2' ' A' ' 40' ' ' LYS . . . -64.27 -37.53 94.65 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 120.217 -0.992 . . . . 0.0 110.837 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.3 t -111.51 152.3 27.64 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.801 -1.411 . . . . 0.0 110.05 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.585 ' O ' ' O ' ' A' ' 59' ' ' ILE . 31.9 m-85 -115.48 155.69 27.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.396 -0.815 . . . . 0.0 109.054 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.415 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -155.42 138.72 15.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.904 -1.122 . . . . 0.0 110.059 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 57' ' ' CYS . 29.5 p -111.1 125.42 53.75 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.913 -1.117 . . . . 0.0 108.237 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 55' ' ' LYS . 44.2 t -108.21 138.13 45.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 0.0 109.845 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 49' ' ' VAL . 10.2 p -131.97 164.22 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.052 -1.03 . . . . 0.0 110.31 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.579 ' N ' HG22 ' A' ' 48' ' ' VAL . 86.7 t -109.93 127.33 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.821 HG13 ' HZ3' ' A' ' 55' ' ' LYS . 7.9 p -160.02 168.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.888 -1.133 . . . . 0.0 110.909 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.646 ' N ' HG22 ' A' ' 50' ' ' VAL . 61.6 t0 40.88 24.28 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.831 -0.543 . . . . 0.0 110.731 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 80.1 -1.85 78.35 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.053 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.855 ' HB3' ' HZ1' ' A' ' 55' ' ' LYS . 15.3 tp10 -119.88 143.58 47.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.335 . . . . 0.0 110.489 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.467 ' CG1' HD13 ' A' ' 25' ' ' LEU . 83.7 t -82.59 127.66 39.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.566 0.698 . . . . 0.0 109.163 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.855 ' HZ1' ' HB3' ' A' ' 53' ' ' GLU . 6.6 mptt -110.16 158.15 18.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.0 110.933 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -130.36 73.96 1.56 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.422 -0.798 . . . . 0.0 109.539 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 42.2 t -63.92 136.78 57.64 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.404 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.78 139.84 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.84 0.829 . . . . 0.0 111.989 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.585 ' O ' ' O ' ' A' ' 44' ' ' TYR . 20.0 mm -118.23 144.96 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 87.4 m-20 -112.32 161.08 17.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.842 -1.161 . . . . 0.0 109.631 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -122.09 21.07 10.6 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.869 -1.144 . . . . 0.0 110.193 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.47 ' C ' ' H ' ' A' ' 65' ' ' GLY . 89.6 m -96.6 154.79 17.07 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.89 -1.131 . . . . 0.0 109.128 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -43.95 -52.48 6.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.797 -1.19 . . . . 0.0 109.017 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 64' ' ' THR . 85.0 m -89.16 -0.75 57.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.026 -1.046 . . . . 0.0 108.414 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 66' ' ' TYR . . . -79.62 -97.39 0.3 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.623 ' HB3' HD11 ' A' ' 74' ' ' LEU . 43.7 m-85 46.75 -178.95 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.586 -0.949 . . . . 0.0 109.215 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.68 -39.45 93.73 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.628 ' CE2' ' OH ' ' A' ' 85' ' ' TYR . 35.5 m-85 -131.2 -58.8 0.99 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.112 -1.228 . . . . 0.0 109.062 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 68' ' ' PHE . . . 68.0 30.19 6.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.92 . . . . 0.0 110.377 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -69.02 155.41 93.62 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.166 -0.959 . . . . 0.0 109.291 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -43.04 -21.25 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.956 2.437 . . . . 0.0 112.579 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.424 ' O ' ' HB3' ' A' ' 73' ' ' ASN . 98.0 m-85 -68.08 -6.92 25.34 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.353 -0.842 . . . . 0.0 109.19 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 53.2 t30 64.02 141.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.366 -0.834 . . . . 0.0 109.191 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.623 HD11 ' HB3' ' A' ' 66' ' ' TYR . 98.2 mt -74.17 -118.15 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.217 -0.927 . . . . 0.0 109.215 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.676 ' CD1' ' OE2' ' A' ' 80' ' ' GLU . 50.6 m-85 -149.13 -165.04 2.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.867 -1.146 . . . . 0.0 111.164 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.1 t -67.86 -40.99 83.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.258 -0.901 . . . . 0.0 111.878 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -137.56 157.9 45.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.484 -1.385 . . . . 0.0 111.424 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.6 mt -59.63 -28.28 67.08 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -53.27 -42.39 66.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.83 -1.168 . . . . 0.0 108.016 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.676 ' OE2' ' CD1' ' A' ' 75' ' ' TYR . 7.2 tm-20 -63.92 -37.04 85.96 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.709 HD23 ' C ' ' A' ' 81' ' ' LEU . 8.2 tt -59.2 -48.04 83.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 0.0 109.203 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.49 HG11 ' CD2' ' A' ' 5' ' ' HIS . 97.2 t -60.68 -39.31 81.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.042 -1.036 . . . . 0.0 108.579 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 86' ' ' GLN . 79.6 mt -64.17 -35.12 79.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.384 -0.822 . . . . 0.0 109.965 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.615 ' CE1' ' OE2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -56.27 -48.65 76.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.723 -1.236 . . . . 0.0 110.027 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.743 ' HB2' HD12 ' A' ' 101' ' ' LEU . 73.3 m-85 -61.74 -30.09 70.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.914 -1.116 . . . . 0.0 109.353 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 83' ' ' LEU . 37.3 tt0 -60.96 -34.87 75.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.43 -0.793 . . . . 0.0 109.558 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -96.4 -11.18 26.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 110.621 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.2 m -114.34 129.74 56.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.748 -1.22 . . . . 0.0 110.746 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.7 t -76.47 124.6 27.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.759 -0.588 . . . . 0.0 109.786 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.726 ' O ' ' N ' ' A' ' 92' ' ' GLN . 5.0 mp -67.41 -31.44 71.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.478 -0.763 . . . . 0.0 111.316 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.015 HG13 ' H ' ' A' ' 92' ' ' GLN . 7.6 p 12.31 -75.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.597 0 O-C-N 121.844 -0.535 . . . . 0.0 110.285 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 1.015 ' H ' HG13 ' A' ' 91' ' ' VAL . 26.5 tt0 62.63 -175.98 0.14 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.421 -0.8 . . . . 0.0 111.105 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.68 ' H ' ' CG ' ' A' ' 92' ' ' GLN . 88.4 m-70 -58.44 -35.54 72.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.55 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -50.64 -25.48 4.28 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 60.0 14.6 4.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.678 -0.639 . . . . 0.0 109.751 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.431 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 54.7 p -132.33 9.19 4.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.968 -1.082 . . . . 0.0 109.751 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.732 ' O ' ' N ' ' A' ' 91' ' ' VAL . 83.9 mt -96.58 36.57 1.36 Allowed 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.438 ' OD1' HG23 ' A' ' 91' ' ' VAL . 98.7 m-20 -75.98 70.34 2.68 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.487 ' O ' HD12 ' A' ' 90' ' ' LEU . 12.8 p -159.47 159.35 2.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.477 ' N ' HG22 ' A' ' 99' ' ' VAL . 31.0 p -121.8 149.21 43.65 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.875 HD22 ' CG ' ' A' ' 33' ' ' PHE . 56.3 mt -73.94 69.13 1.4 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.428 ' HA ' HE21 ' A' ' 86' ' ' GLN . . . -98.2 -24.62 15.2 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.444 -0.785 . . . . 0.0 112.548 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.455 ' CE2' ' O ' ' A' ' 104' ' ' PRO . 80.8 t80 -114.02 131.01 23.37 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.268 -1.52 . . . . 0.0 110.97 -178.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.786 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 63.3 Cg_endo -76.14 149.33 32.08 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 123.354 2.703 . . . . 0.0 112.182 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.648 HG13 ' CD2' ' A' ' 106' ' ' TYR . 14.5 p -78.5 -17.83 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.025 -1.047 . . . . 0.0 109.776 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.706 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . 33.9 m-85 -132.18 56.35 1.83 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.025 -1.047 . . . . 0.0 110.569 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.786 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . -64.84 132.97 50.9 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.15 -0.969 . . . . 0.0 109.844 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -67.74 -43.33 80.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.144 -0.972 . . . . 0.0 109.468 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 51.73 57.86 6.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.322 -0.861 . . . . 0.0 109.314 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.751 HH11 ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -61.69 -33.14 73.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.0 109.771 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.753 ' CG ' HH11 ' A' ' 111' ' ' ARG . 2.2 mtt-85 . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.115 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.9 p30 -73.28 175.39 6.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.338 -0.851 . . . . 0.0 109.725 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 3' ' ' LEU . 95.7 mt -93.01 129.72 38.65 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.226 -0.922 . . . . 0.0 109.669 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.495 ' O ' ' OG1' ' A' ' 10' ' ' THR . 28.9 Cg_endo -68.55 -3.86 11.92 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.35 2.033 . . . . 0.0 111.974 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -80.93 -6.33 58.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 110.016 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -76.11 -31.14 58.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.197 -0.939 . . . . 0.0 110.111 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -105.18 132.78 50.97 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.235 -0.916 . . . . 0.0 109.981 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.675 ' O ' ' N ' ' A' ' 12' ' ' ASN . 95.9 mt-10 -66.77 -29.33 69.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.477 -0.764 . . . . 0.0 110.57 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.46 ' CG ' ' N ' ' A' ' 10' ' ' THR . 3.0 pttt -57.66 -33.58 68.46 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.336 -0.853 . . . . 0.0 111.0 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.696 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 47.2 p -65.67 -30.91 71.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.888 -1.132 . . . . 0.0 110.704 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.696 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -119.82 -28.86 5.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.673 -1.267 . . . . 0.0 109.78 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' A' ' 8' ' ' GLU . 56.2 t-20 -83.63 130.62 34.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.605 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.49 HG22 ' HE2' ' A' ' 106' ' ' TYR . 45.0 t -96.35 -12.82 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.287 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.13 -157.96 34.1 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 95.2 p -63.83 132.68 51.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.149 -1.207 . . . . 0.0 109.801 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.9 t -176.71 165.46 2.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 109.619 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -95.12 147.8 23.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.468 -0.77 . . . . 0.0 109.747 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.646 HH12 ' C ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -59.72 -35.57 74.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.164 -0.96 . . . . 0.0 110.016 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -57.17 -46.06 83.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.684 -1.26 . . . . 0.0 108.43 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.695 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 79.9 tttt -59.98 -35.11 74.31 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 18' ' ' ARG . . . -60.04 -38.93 84.2 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' ARG . 97.1 mt-10 -53.64 -47.51 70.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.863 . . . . 0.0 108.823 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.695 ' ND2' ' O ' ' A' ' 20' ' ' LYS . 9.5 p30 -62.11 -41.29 98.08 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.674 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 79.2 mt -65.09 -30.21 71.14 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 21' ' ' ALA . 19.2 mt -93.1 -10.73 34.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.444 -0.785 . . . . 0.0 109.817 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.564 ' CG ' ' N ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -79.71 -49.53 11.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 109.635 -179.088 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.564 ' N ' ' CG ' ' A' ' 26' ' ' ARG . . . -87.99 25.95 8.21 Favored Glycine 0 C--N 1.287 -2.188 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -115.11 125.34 53.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.25 -1.147 . . . . 0.0 110.521 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -72.77 159.33 33.97 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.497 -0.752 . . . . 0.0 109.142 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 59.9 p30 -57.36 151.2 16.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.056 -1.028 . . . . 0.0 110.172 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.17 -18.46 55.55 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.1 m -100.67 127.43 47.08 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.165 -1.197 . . . . 0.0 109.09 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.64 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -130.4 161.27 31.72 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.034 178.759 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.412 ' HB3' HG21 ' A' ' 105' ' ' VAL . 1.5 pp -129.35 155.07 46.23 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.636 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.6 t -116.26 131.14 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.777 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.632 ' CB ' ' CZ ' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -146.11 -141.91 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 108.928 179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.659 ' C ' ' H ' ' A' ' 39' ' ' SER . 45.9 mp0 -107.56 174.91 5.68 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.646 ' C ' HH12 ' A' ' 18' ' ' ARG . 61.0 m -76.37 15.66 0.57 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.659 ' H ' ' C ' ' A' ' 37' ' ' GLU . 4.0 m 101.97 -43.47 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.089 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -89.51 149.31 22.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 108.968 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -67.4 144.97 55.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.026 -1.046 . . . . 0.0 109.693 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.45 6.45 62.66 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.5 m -129.66 159.25 37.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.042 -1.27 . . . . 0.0 110.031 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.594 ' O ' ' O ' ' A' ' 59' ' ' ILE . 74.8 m-85 -122.61 149.58 43.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.031 -1.043 . . . . 0.0 109.015 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.517 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -169.05 142.36 2.82 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.094 -1.004 . . . . 0.0 109.053 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 57' ' ' CYS . 16.8 p -124.93 148.15 48.5 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.264 -0.898 . . . . 0.0 108.808 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.3 p -120.21 143.2 48.39 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.684 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.856 HG13 ' NZ ' ' A' ' 55' ' ' LYS . 1.5 p -130.6 155.23 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.476 -0.765 . . . . 0.0 109.766 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.453 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 69.9 t -110.8 132.64 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.761 -0.587 . . . . 0.0 110.099 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.669 HG13 ' H ' ' A' ' 52' ' ' GLY . 8.3 p -122.04 156.27 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.0 -1.063 . . . . 0.0 108.876 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 59.4 t0 -49.3 -18.3 0.35 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.873 0.844 . . . . 0.0 110.022 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.669 ' H ' HG13 ' A' ' 50' ' ' VAL . . . -92.1 -52.81 2.15 Favored Glycine 0 C--N 1.286 -2.23 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.585 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.565 ' H ' ' CG1' ' A' ' 50' ' ' VAL . 44.6 mt-10 -161.11 169.37 22.51 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.724 -1.456 . . . . 0.0 112.028 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.8 t -85.86 136.78 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.856 ' NZ ' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -131.8 150.86 52.02 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.576 -1.328 . . . . 0.0 111.776 -178.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.636 ' CE1' ' HD2' ' A' ' 18' ' ' ARG . 67.9 m-70 -110.66 117.45 33.52 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' A' ' 46' ' ' CYS . 48.8 t -104.08 129.23 51.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.87 -1.144 . . . . 0.0 108.574 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 58' ' ' VAL . 4.7 p -94.68 132.72 37.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 111.292 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.594 ' O ' ' O ' ' A' ' 44' ' ' TYR . 98.0 mt -118.12 140.89 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 96.5 m-20 -112.31 148.25 34.6 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.967 -1.083 . . . . 0.0 109.349 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.46 ' HD2' ' CE1' ' A' ' 44' ' ' TYR . 11.5 ttmt -113.68 103.19 10.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.826 -1.171 . . . . 0.0 110.08 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.618 HG22 ' N ' ' A' ' 63' ' ' ALA . 89.1 m -162.21 170.11 19.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 109.298 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.618 ' N ' HG22 ' A' ' 62' ' ' THR . . . -59.95 -41.67 92.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.114 -0.991 . . . . 0.0 109.805 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 64' ' ' THR . 86.5 m -112.94 5.55 17.36 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.104 -0.997 . . . . 0.0 109.822 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.68 -88.01 1.2 Allowed Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.709 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 62' ' ' THR . 82.3 m-85 56.66 177.62 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.08 -1.247 . . . . 0.0 109.604 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.38 -87.61 0.27 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.692 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 6.9 m-30 -87.78 131.91 34.34 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.101 -1.235 . . . . 0.0 109.405 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.99 -5.58 6.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.031 -1.043 . . . . 0.0 109.19 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.748 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 69.2 mm-40 -68.26 -32.41 3.9 Favored Pre-proline 0 C--N 1.307 -1.281 0 O-C-N 121.127 -0.983 . . . . 0.0 109.254 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.748 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 17.0 Cg_exo -65.51 -7.47 16.25 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.348 2.032 . . . . 0.0 111.297 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.703 ' CD1' ' O ' ' A' ' 71' ' ' PRO . 50.2 p90 45.52 44.59 10.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.337 -0.852 . . . . 0.0 109.568 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 74' ' ' LEU . 91.2 m-20 -109.98 -16.34 13.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.455 -0.778 . . . . 0.0 109.866 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 73' ' ' ASN . 57.5 tp 43.6 84.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.958 -1.089 . . . . 0.0 109.301 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -59.87 133.53 56.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.038 -1.038 . . . . 0.0 109.719 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.1 m -68.02 -37.68 81.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.474 -0.766 . . . . 0.0 110.216 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.4 t -140.69 156.86 46.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.954 -1.091 . . . . 0.0 110.147 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.403 HD11 ' HE3' ' A' ' 61' ' ' LYS . 93.3 mt -60.93 -37.39 82.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.548 -0.72 . . . . 0.0 109.461 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -56.71 -42.82 79.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.476 -0.765 . . . . 0.0 109.044 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -64.63 -33.53 76.16 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.229 -0.919 . . . . 0.0 109.15 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 10.2 tt -59.82 -48.17 82.77 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 109.535 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 95.5 t -67.53 -37.19 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.204 -0.935 . . . . 0.0 109.17 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.547 HD12 ' OE1' ' A' ' 86' ' ' GLN . 52.3 tp -66.49 -47.73 72.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.285 -0.884 . . . . 0.0 110.359 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -63.11 -40.43 97.61 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.994 -1.066 . . . . 0.0 110.317 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.692 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 3.9 m-85 -62.15 -29.67 70.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.469 -0.769 . . . . 0.0 111.501 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.612 ' O ' ' OG1' ' A' ' 100' ' ' THR . 5.8 pt20 -66.91 -29.09 68.88 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.301 -1.499 . . . . 0.0 108.334 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -79.18 -39.65 32.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.401 -0.812 . . . . 0.0 109.829 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 85' ' ' TYR . 5.0 t -79.61 154.21 28.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.006 . . . . 0.0 109.993 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.5 t -104.55 133.18 49.85 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.816 ' N ' HD22 ' A' ' 90' ' ' LEU . 3.1 mm? -70.51 -10.92 60.44 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.513 -0.742 . . . . 0.0 110.319 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.685 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.4 p -40.14 -43.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.135 -0.978 . . . . 0.0 109.812 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.605 ' N ' HG13 ' A' ' 91' ' ' VAL . 65.0 tt0 -38.58 -36.63 0.26 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.906 -0.496 . . . . 0.0 110.766 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.707 ' O ' ' N ' ' A' ' 95' ' ' ASP . 23.4 t-160 -64.87 124.65 22.57 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.951 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 93' ' ' HIS . 33.4 m120 44.28 9.71 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.034 -1.041 . . . . 0.0 109.278 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 93' ' ' HIS . 81.8 m-20 57.62 43.78 21.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.299 -0.876 . . . . 0.0 110.873 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.61 ' C ' HD22 ' A' ' 97' ' ' LEU . 34.2 m -151.61 4.64 0.43 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.556 -1.34 . . . . 0.0 111.415 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.962 HD22 ' N ' ' A' ' 97' ' ' LEU . 2.1 mm? -100.47 70.68 1.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.607 -1.308 . . . . 0.0 107.774 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -79.73 94.63 5.78 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.049 0.928 . . . . 0.0 109.748 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.765 HG22 ' H ' ' A' ' 100' ' ' THR . 7.1 p -174.06 -177.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.765 ' H ' HG22 ' A' ' 99' ' ' VAL . 9.0 t -160.42 166.73 28.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.014 -1.054 . . . . 0.0 109.501 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.64 HD22 ' CG ' ' A' ' 33' ' ' PHE . 18.6 mt -79.96 63.73 4.58 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.44 -26.46 19.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.937 -0.477 . . . . 0.0 112.092 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -122.41 134.22 24.76 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.279 -1.513 . . . . 0.0 111.455 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.55 148.98 43.28 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 122.699 2.266 . . . . 0.0 111.302 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.744 HG13 ' CD2' ' A' ' 106' ' ' TYR . 9.0 p -72.41 -18.61 19.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.266 -0.896 . . . . 0.0 108.756 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.744 ' CD2' HG13 ' A' ' 105' ' ' VAL . 39.7 m-85 -131.42 65.18 1.57 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.478 -0.764 . . . . 0.0 110.023 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.52 144.56 51.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.962 -1.086 . . . . 0.0 110.024 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -58.13 136.94 57.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.281 -0.887 . . . . 0.0 110.258 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -74.91 151.26 38.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.316 -0.865 . . . . 0.0 108.98 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 111' ' ' ARG . 56.2 mtp180 -120.71 150.08 41.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.904 -1.123 . . . . 0.0 108.949 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.589 ' HG2' HH11 ' A' ' 111' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.008 -1.057 . . . . 0.0 109.274 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -74.95 163.38 27.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.994 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 3' ' ' LEU . 7.0 mp -102.58 147.74 34.48 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.535 -0.728 . . . . 0.0 110.204 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.19 -2.93 6.46 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.696 2.264 . . . . 0.0 111.443 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -65.89 -31.91 73.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.34 -0.85 . . . . 0.0 108.96 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -61.31 -18.27 57.75 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.627 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.675 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 94.6 m-20 -96.9 110.14 22.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.33 -0.856 . . . . 0.0 110.314 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.537 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 80.1 tt0 -69.27 -30.64 68.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.423 -0.798 . . . . 0.0 109.78 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 pttt -69.56 -11.56 60.93 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.431 -0.793 . . . . 0.0 110.76 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.509 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 43.9 p -85.32 -22.88 28.33 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.821 -1.175 . . . . 0.0 112.258 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.675 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -122.51 -26.77 4.52 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.256 -1.528 . . . . 0.0 109.839 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.632 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 14.9 p-10 -80.14 142.07 35.13 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.874 -1.141 . . . . 0.0 109.855 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 35' ' ' VAL . 10.1 p -112.34 -16.84 8.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.05 -164.0 51.16 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.0 p -58.11 133.74 55.85 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.212 -1.169 . . . . 0.0 108.578 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.6 t -172.09 154.74 3.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.313 -0.867 . . . . 0.0 109.385 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -76.16 144.73 40.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.972 -1.08 . . . . 0.0 109.357 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.46 ' HG2' ' HE ' ' A' ' 36' ' ' ARG . 86.0 mtm180 -59.85 -39.51 85.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -57.9 -38.9 76.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.818 -1.176 . . . . 0.0 109.017 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -58.18 -34.25 70.12 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -62.51 -35.97 81.08 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.521 ' CG ' ' NE ' ' A' ' 26' ' ' ARG . 71.7 tt0 -55.95 -50.14 71.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.081 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -60.31 -44.17 95.69 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.976 -1.078 . . . . 0.0 108.272 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -66.72 -30.3 70.51 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.574 HD13 ' CG1' ' A' ' 54' ' ' VAL . 7.0 mt -92.86 -6.44 48.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.213 -0.93 . . . . 0.0 109.505 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.586 HH11 ' HG2' ' A' ' 26' ' ' ARG . 20.7 mtt-85 -100.59 137.39 39.05 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.328 -0.857 . . . . 0.0 109.641 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.44 -2.17 86.28 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.563 ' HD3' HG21 ' A' ' 32' ' ' THR . 4.5 mtpt -103.39 147.08 27.55 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.998 -1.295 . . . . 0.0 110.004 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.741 ' CG ' HH11 ' A' ' 29' ' ' ARG . 2.1 mtt-85 -74.73 161.61 29.47 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.598 0.713 . . . . 0.0 110.75 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.555 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 60.3 t0 -59.91 143.09 52.37 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.429 -0.794 . . . . 0.0 109.677 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 106.98 -25.04 23.58 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.563 HG21 ' HD3' ' A' ' 28' ' ' LYS . 60.6 m -78.99 122.46 26.2 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.258 -1.142 . . . . 0.0 108.775 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.845 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -134.19 173.64 11.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.712 -1.243 . . . . 0.0 110.713 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.46 ' CB ' HG11 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -149.74 159.84 44.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.723 -0.61 . . . . 0.0 109.676 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 13' ' ' VAL . 50.7 t -110.2 127.75 66.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.278 -0.889 . . . . 0.0 108.758 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.759 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -145.2 -175.85 4.86 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.678 ' C ' ' H ' ' A' ' 39' ' ' SER . 97.8 mt-10 -103.83 169.78 8.31 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.928 -1.107 . . . . 0.0 108.378 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.631 ' O ' ' CB ' ' A' ' 39' ' ' SER . 97.8 p -75.76 12.1 1.17 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 178.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.678 ' H ' ' C ' ' A' ' 37' ' ' GLU . 16.5 p 99.71 -17.2 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 113.533 -1.667 . . . . 0.0 108.301 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -87.65 141.4 28.63 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -60.33 -36.02 76.98 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.968 -1.083 . . . . 0.0 109.739 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.71 32.24 5.95 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.566 -1.302 . . . . 0.0 111.689 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.514 ' CB ' ' HG ' ' A' ' 38' ' ' SER . 48.1 t -137.51 149.56 46.87 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.715 -1.462 . . . . 0.0 109.681 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -127.5 143.0 51.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.225 -0.922 . . . . 0.0 109.84 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -160.31 133.51 6.73 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.59 -1.318 . . . . 0.0 110.292 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' ' 57' ' ' CYS . 14.3 p -106.31 135.11 48.38 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.684 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.462 ' CB ' HD11 ' A' ' 25' ' ' LEU . 55.0 m -104.74 138.22 41.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' ' 33' ' ' PHE . 12.2 t -131.99 152.93 37.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.188 -0.945 . . . . 0.0 109.921 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.555 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 58.0 t -100.71 122.05 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.689 HG22 ' N ' ' A' ' 51' ' ' ASP . 13.4 p -160.47 172.44 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.678 -1.264 . . . . 0.0 111.861 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.689 ' N ' HG22 ' A' ' 50' ' ' VAL . 64.6 t0 48.44 20.52 0.3 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.526 0.679 . . . . 0.0 109.57 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.31 10.74 85.7 Favored Glycine 0 C--N 1.295 -1.749 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.106 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.663 ' CG ' ' NZ ' ' A' ' 55' ' ' LYS . 16.7 pt-20 -139.98 157.84 45.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.727 -1.455 . . . . 0.0 110.472 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.574 ' CG1' HD13 ' A' ' 25' ' ' LEU . 74.9 t -78.85 142.09 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 110.097 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.663 ' NZ ' ' CG ' ' A' ' 53' ' ' GLU . 0.9 OUTLIER -119.83 153.54 35.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.496 -0.753 . . . . 0.0 110.419 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -126.98 74.94 1.54 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.439 -0.788 . . . . 0.0 108.947 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.508 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 44.3 t -65.97 138.86 58.1 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.369 -0.832 . . . . 0.0 109.365 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.78 139.89 23.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.508 -0.745 . . . . 0.0 110.547 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.9 mt -118.44 129.97 73.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.596 ' O ' ' O ' ' A' ' 66' ' ' TYR . 90.5 m-20 -129.52 123.7 32.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.01 -1.056 . . . . 0.0 110.867 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 20.8 ptmt -109.36 123.42 49.28 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.336 -0.852 . . . . 0.0 109.764 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.7 ' O ' ' N ' ' A' ' 64' ' ' THR . 14.2 m -132.22 97.75 4.22 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 108.591 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 54.29 -81.4 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.843 -1.161 . . . . 0.0 108.055 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.7 ' N ' ' O ' ' A' ' 62' ' ' THR . 64.1 p -112.88 19.89 16.92 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.729 ' O ' ' CG ' ' A' ' 66' ' ' TYR . . . -94.59 175.07 33.96 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.729 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 89.3 m-85 -169.55 -163.51 0.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.492 ' HA2' ' H ' ' A' ' 60' ' ' ASN . . . -74.73 -50.5 9.12 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.682 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 96.9 m-85 -113.33 125.21 54.03 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.456 -1.026 . . . . 0.0 109.768 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.31 0.52 7.04 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.011 -1.056 . . . . 0.0 109.734 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.639 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 55.1 tt0 -63.19 -38.0 37.21 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.92 . . . . 0.0 110.543 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 37.8 Cg_endo -85.22 159.06 11.3 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.773 2.315 . . . . 0.0 111.311 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 72' ' ' TYR . 78.3 t80 -86.89 59.85 5.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.877 -1.14 . . . . 0.0 108.234 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.496 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 55.8 t-20 -104.11 -48.69 3.8 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.046 -1.034 . . . . 0.0 110.779 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 74' ' ' LEU . 96.4 mt 54.89 68.58 0.84 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.799 -1.188 . . . . 0.0 109.05 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.496 ' CE1' ' ND2' ' A' ' 73' ' ' ASN . 92.5 m-85 -53.22 127.2 23.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.12 -0.987 . . . . 0.0 109.855 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.9 m -72.3 -36.0 68.81 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.512 -0.743 . . . . 0.0 110.118 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.1 p -143.09 158.66 43.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.163 -0.961 . . . . 0.0 110.35 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.4 mt -59.9 -35.27 74.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.413 -0.804 . . . . 0.0 110.082 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.4 ' O ' HG12 ' A' ' 82' ' ' VAL . 38.1 ttmt -57.37 -40.85 79.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.01 -1.056 . . . . 0.0 109.212 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -69.86 -34.65 73.88 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.082 -1.011 . . . . 0.0 109.228 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.802 ' C ' HD13 ' A' ' 81' ' ' LEU . 3.0 tm? -60.64 -49.29 78.13 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.098 -1.001 . . . . 0.0 110.819 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.434 ' CG1' ' N ' ' A' ' 83' ' ' LEU . 2.4 p -65.5 -37.64 80.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 120.844 -1.16 . . . . 0.0 109.485 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.434 ' N ' ' CG1' ' A' ' 82' ' ' VAL . 54.6 tp -68.52 -45.74 71.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.299 -0.876 . . . . 0.0 110.842 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -61.85 -40.02 93.89 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.119 -0.988 . . . . 0.0 110.143 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.682 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 1.8 m-85 -71.02 -24.28 62.34 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.943 -1.098 . . . . 0.0 110.91 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.585 ' O ' ' OE1' ' A' ' 86' ' ' GLN . 0.7 OUTLIER -61.66 -22.92 65.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.023 -1.048 . . . . 0.0 108.768 179.156 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -101.59 -33.85 9.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.4 -0.812 . . . . 0.0 108.98 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.5 m -82.55 142.62 31.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.407 -0.808 . . . . 0.0 109.893 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.3 m -96.68 129.94 43.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.596 -0.69 . . . . 0.0 109.97 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.727 ' O ' ' N ' ' A' ' 92' ' ' GLN . 1.6 mt -65.6 -12.48 53.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.38 -0.825 . . . . 0.0 111.794 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.738 ' N ' ' O ' ' A' ' 97' ' ' LEU . 8.2 p -9.23 -53.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.015 0 O-C-N 121.409 -0.807 . . . . 0.0 111.466 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.727 ' N ' ' O ' ' A' ' 90' ' ' LEU . 54.3 tt0 -36.41 146.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 109.575 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.683 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.9 OUTLIER 103.94 -120.13 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.192 0.52 . . . . 0.0 109.777 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 30.4 m120 -72.16 13.3 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 109.387 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 93' ' ' HIS . 94.5 m-20 62.39 3.74 1.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.632 -0.667 . . . . 0.0 109.751 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 98' ' ' ASN . 14.6 m -116.19 7.94 14.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.943 -1.098 . . . . 0.0 109.006 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.803 HD22 ' N ' ' A' ' 97' ' ' LEU . 2.4 mm? -84.05 26.45 0.74 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.463 ' N ' ' HA ' ' A' ' 91' ' ' VAL . 57.0 t30 -75.41 75.21 2.49 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 122.277 1.037 . . . . 0.0 108.824 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.521 HG13 HD12 ' A' ' 90' ' ' LEU . 6.7 p -147.4 158.07 9.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.457 ' N ' HG22 ' A' ' 99' ' ' VAL . 18.8 p -125.11 159.54 31.21 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.83 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.845 HD22 ' CG ' ' A' ' 33' ' ' PHE . 51.6 mt -80.02 70.35 6.58 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.523 ' CB ' HE22 ' A' ' 86' ' ' GLN . . . -96.69 -27.24 14.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.453 -0.779 . . . . 0.0 111.7 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -114.06 107.86 51.49 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.621 -1.299 . . . . 0.0 111.215 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.412 ' CB ' ' HB ' ' A' ' 10' ' ' THR . 20.8 Cg_exo -59.65 145.03 99.24 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.236 1.957 . . . . 0.0 110.509 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.753 HG13 ' CD2' ' A' ' 106' ' ' TYR . 7.0 p -70.57 -31.61 46.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.072 -1.018 . . . . 0.0 108.893 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.753 ' CD2' HG13 ' A' ' 105' ' ' VAL . 75.9 m-85 -111.54 31.51 6.08 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.558 -0.714 . . . . 0.0 109.737 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 106' ' ' TYR . . . -42.0 128.6 3.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.948 . . . . 0.0 109.311 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -127.68 138.8 52.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.124 -0.985 . . . . 0.0 110.076 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -74.05 148.85 41.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -0.987 . . . . 0.0 108.934 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.765 HH11 ' CG ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -66.4 136.87 56.37 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.333 -0.854 . . . . 0.0 109.926 -179.286 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 117.84 -1.076 . . . . 0.0 108.815 179.425 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.493 ' C ' ' OD1' ' A' ' 2' ' ' ASP . 55.3 p30 -70.68 163.61 26.75 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.336 -0.853 . . . . 0.0 109.793 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.7 mt -98.65 135.01 21.2 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -70.85 -4.33 14.55 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.805 1.67 . . . . 0.0 111.189 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -73.05 -22.61 60.59 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -60.94 -31.69 71.23 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.938 -1.102 . . . . 0.0 109.4 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.51 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 81.6 m-20 -92.53 131.99 37.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.091 -1.006 . . . . 0.0 110.16 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.557 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 60.8 tt0 -70.46 -31.61 68.83 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.847 0.832 . . . . 0.0 109.901 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 tmpt? -62.14 -27.42 68.93 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.75 -0.594 . . . . 0.0 112.368 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.599 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 23.6 p -68.83 -27.14 65.58 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.487 -1.383 . . . . 0.0 112.187 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.652 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -120.04 -28.47 5.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.239 -1.538 . . . . 0.0 109.445 179.529 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -79.75 125.1 29.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.237 -0.915 . . . . 0.0 109.531 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 13' ' ' VAL . 60.0 t -99.81 -3.23 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 109.528 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.8 -148.74 26.21 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.1 m -83.08 102.98 12.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.254 . . . . 0.0 109.985 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.467 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 32.9 t -124.37 146.29 48.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.432 -0.792 . . . . 0.0 109.401 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.68 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 57.4 p30 -79.72 154.34 28.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 108.77 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.581 ' CG ' ' NH2' ' A' ' 36' ' ' ARG . 74.5 mtt180 -59.83 -35.89 75.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.144 -0.973 . . . . 0.0 109.603 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -59.75 -42.87 94.19 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.45 -0.781 . . . . 0.0 109.651 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.68 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 79.6 tttt -68.12 -37.75 81.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.855 -1.153 . . . . 0.0 109.257 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.55 -31.35 72.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.443 -0.786 . . . . 0.0 108.967 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 26' ' ' ARG . 61.7 tt0 -59.49 -49.6 77.15 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -57.84 -39.02 76.71 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 24' ' ' LEU . 78.0 mt -71.25 -27.15 63.25 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.249 -0.907 . . . . 0.0 108.869 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.405 HD23 ' CG2' ' A' ' 49' ' ' VAL . 25.2 mt -96.78 -9.56 28.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 109.302 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -91.85 124.5 36.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.8 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.64 21.94 79.3 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.771 ' HE2' HG21 ' A' ' 32' ' ' THR . 41.7 tptt -104.62 126.66 51.92 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -57.82 144.69 37.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.461 -0.774 . . . . 0.0 110.514 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 54.8 p30 -54.34 155.85 3.6 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.659 -0.651 . . . . 0.0 109.439 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.81 -30.96 9.28 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.771 HG21 ' HE2' ' A' ' 28' ' ' LYS . 93.8 m -81.81 127.28 32.81 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.522 -0.987 . . . . 0.0 109.067 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 101' ' ' LEU . 0.6 OUTLIER -134.45 153.37 51.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.053 -1.029 . . . . 0.0 108.986 179.464 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.753 HD22 HG21 ' A' ' 105' ' ' VAL . 6.7 mt -107.28 172.26 6.93 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.004 0.907 . . . . 0.0 110.589 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.486 HG22 ' SG ' ' A' ' 46' ' ' CYS . 73.4 t -147.21 110.12 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.581 ' NH2' ' CG ' ' A' ' 18' ' ' ARG . 2.8 ptt180 -145.54 -179.3 6.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.016 -1.052 . . . . 0.0 109.834 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.667 ' C ' ' H ' ' A' ' 39' ' ' SER . 8.0 pt-20 -91.65 173.79 7.7 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.683 ' O ' ' N ' ' A' ' 40' ' ' LYS . 67.4 m -78.11 18.39 0.52 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.667 ' H ' ' C ' ' A' ' 37' ' ' GLU . 44.3 m 61.09 -51.42 0.11 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.652 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 38' ' ' SER . 61.0 tttp -101.31 128.9 47.25 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.659 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 15.2 tt0 85.25 -173.6 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.448 -0.783 . . . . 0.0 109.217 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.484 ' H ' ' HG2' ' A' ' 41' ' ' GLN . . . -107.78 32.2 7.31 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.406 ' HB2' ' OG ' ' A' ' 38' ' ' SER . 90.6 m -85.91 153.89 21.89 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.999 -1.295 . . . . 0.0 109.002 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' ILE . 70.8 m-85 -124.93 148.25 48.46 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.44 144.57 22.96 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.044 -1.035 . . . . 0.0 108.94 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.486 ' SG ' HG22 ' A' ' 35' ' ' VAL . 20.8 m -114.07 126.61 55.29 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 108.451 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 34' ' ' LEU . 50.5 m -88.59 131.24 35.03 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.499 -0.75 . . . . 0.0 109.382 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.449 HG21 ' CD1' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -125.28 142.11 43.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.139 -0.976 . . . . 0.0 109.459 179.835 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.405 ' CG2' HD23 ' A' ' 25' ' ' LEU . 21.5 t -108.95 127.06 65.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.357 -0.839 . . . . 0.0 109.833 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 53' ' ' GLU . 4.9 p -111.84 161.45 10.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.082 -1.011 . . . . 0.0 109.957 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -65.48 60.14 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 169.32 -36.28 0.19 Allowed Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.6 -1.286 . . . . 0.0 111.126 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.565 ' O ' HG12 ' A' ' 50' ' ' VAL . 78.2 tt0 -156.36 143.22 18.75 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.389 -1.653 . . . . 0.0 112.396 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.62 134.33 27.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.575 ' HB2' ' HZ2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -124.97 161.08 27.46 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.824 -1.172 . . . . 0.0 111.695 -178.093 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -121.35 100.85 7.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.392 0.615 . . . . 0.0 109.362 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.46 ' O ' ' N ' ' A' ' 46' ' ' CYS . 49.2 t -85.3 129.33 34.83 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.85 135.86 28.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.423 -0.798 . . . . 0.0 111.145 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.809 HG23 ' O ' ' A' ' 66' ' ' TYR . 48.7 mm -106.53 128.01 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' A' ' 66' ' ' TYR . 96.9 m-20 -116.08 116.18 27.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.974 -1.079 . . . . 0.0 110.358 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.727 ' NZ ' HD11 ' A' ' 78' ' ' LEU . 12.9 mttp -99.67 120.69 40.09 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.388 -0.82 . . . . 0.0 109.645 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.663 ' O ' ' N ' ' A' ' 64' ' ' THR . 45.9 p -140.43 55.66 1.6 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 109.411 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 62' ' ' THR . . . 63.4 -47.29 0.23 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.663 ' N ' ' O ' ' A' ' 62' ' ' THR . 52.2 m -118.93 -17.07 9.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.349 -0.844 . . . . 0.0 109.502 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.75 ' O ' ' CG ' ' A' ' 66' ' ' TYR . . . -87.13 170.33 41.11 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.809 ' O ' HG23 ' A' ' 59' ' ' ILE . 98.3 m-85 -168.32 -11.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.839 -0.801 . . . . 0.0 109.29 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.43 145.69 8.98 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.705 ' CD2' ' OH ' ' A' ' 85' ' ' TYR . 2.5 m-85 59.0 36.79 24.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.953 -1.322 . . . . 0.0 108.402 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.815 ' HB1' ' OD1' ' A' ' 73' ' ' ASN . . . -57.85 148.49 25.17 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 108.88 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.753 ' O ' ' N ' ' A' ' 72' ' ' TYR . 66.3 tt0 -135.11 145.11 52.91 Favored Pre-proline 0 C--N 1.296 -1.719 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.482 ' C ' ' O ' ' A' ' 70' ' ' GLU . 51.4 Cg_exo -25.85 -29.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.909 2.406 . . . . 0.0 111.946 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.753 ' N ' ' O ' ' A' ' 70' ' ' GLU . 45.5 p90 -122.74 61.23 1.01 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.815 ' OD1' ' HB1' ' A' ' 69' ' ' ALA . 82.5 m-20 -44.78 144.89 1.03 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.469 -0.769 . . . . 0.0 109.914 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.0 tp -166.09 87.81 0.37 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.699 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.477 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 97.1 m-85 -145.5 86.21 1.74 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.166 -0.959 . . . . 0.0 109.279 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.9 p -66.7 -41.17 88.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.331 -0.855 . . . . 0.0 109.884 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.1 m -130.8 155.2 47.09 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.129 -0.982 . . . . 0.0 111.667 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.727 HD11 ' NZ ' ' A' ' 61' ' ' LYS . 79.1 mt -65.62 -31.65 72.79 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.527 0.68 . . . . 0.0 109.239 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -60.52 -41.24 94.01 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.392 -0.818 . . . . 0.0 108.941 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.79 -43.83 97.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.146 -0.971 . . . . 0.0 109.158 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.767 HD23 ' C ' ' A' ' 81' ' ' LEU . 7.1 tt -61.27 -43.58 98.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 109.907 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 82.2 t -71.1 -37.29 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 86' ' ' GLN . 86.4 mt -67.58 -42.87 81.81 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.241 -0.912 . . . . 0.0 109.634 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -69.11 -38.26 78.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.073 -1.017 . . . . 0.0 110.9 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.705 ' OH ' ' CD2' ' A' ' 68' ' ' PHE . 5.4 m-85 -72.36 -17.71 61.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.37 -0.831 . . . . 0.0 111.876 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 83' ' ' LEU . 2.5 pt20 -77.26 -24.56 51.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.287 -1.508 . . . . 0.0 108.241 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.43 ' N ' ' HG3' ' A' ' 86' ' ' GLN . 83.0 t60 -96.47 -15.31 21.8 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.533 -0.729 . . . . 0.0 109.59 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.4 m -102.87 139.94 37.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.062 -1.024 . . . . 0.0 109.007 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.438 ' OG ' HG12 ' A' ' 91' ' ' VAL . 25.1 p -88.6 135.5 33.46 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.465 -0.772 . . . . 0.0 110.685 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.527 ' O ' ' C ' ' A' ' 91' ' ' VAL . 77.0 mt -69.73 -10.27 57.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.642 -0.661 . . . . 0.0 110.088 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.728 ' N ' ' O ' ' A' ' 97' ' ' LEU . 9.9 p -33.98 -40.56 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.975 -1.078 . . . . 0.0 110.132 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.537 ' N ' HG13 ' A' ' 91' ' ' VAL . 81.2 mt-30 -75.97 -5.9 48.46 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.356 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.586 ' HB3' HD23 ' A' ' 97' ' ' LEU . 53.4 t-80 -59.53 -43.55 93.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.66 -1.275 . . . . 0.0 108.42 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.636 ' H ' HD23 ' A' ' 97' ' ' LEU . 16.3 t30 -148.71 19.85 1.02 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.415 ' CA ' ' O ' ' A' ' 91' ' ' VAL . 49.1 t0 64.68 38.77 6.81 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.365 0.602 . . . . 0.0 109.773 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.432 ' H ' HD22 ' A' ' 97' ' ' LEU . 62.6 m -168.19 2.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.851 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.978 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.0 OUTLIER -101.62 64.47 0.99 Allowed 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.16 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -79.06 71.11 5.52 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.275 -0.891 . . . . 0.0 110.723 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.564 ' CG1' HG23 ' A' ' 50' ' ' VAL . 6.9 p -148.5 158.41 7.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.49 ' N ' HG22 ' A' ' 99' ' ' VAL . 58.7 p -122.27 150.66 42.01 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.666 ' O ' HD12 ' A' ' 101' ' ' LEU . 2.2 pp -88.34 47.14 1.46 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.204 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.33 -4.83 57.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.7 -0.625 . . . . 0.0 111.368 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 32' ' ' THR . 88.1 m-85 -112.96 120.4 40.69 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.612 -1.305 . . . . 0.0 110.068 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.793 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 26.5 Cg_endo -73.29 146.48 40.39 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.681 2.254 . . . . 0.0 112.04 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.753 HG21 HD22 ' A' ' 34' ' ' LEU . 9.2 p -80.88 -25.46 10.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.574 -0.704 . . . . 0.0 110.667 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.56 ' HD1' HG13 ' A' ' 105' ' ' VAL . 2.4 m-85 -112.8 47.62 1.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.222 -0.924 . . . . 0.0 110.577 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.793 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . -80.41 95.32 6.38 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.928 -1.107 . . . . 0.0 108.242 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -65.54 -37.6 87.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.306 -0.872 . . . . 0.0 109.775 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -60.69 -41.77 95.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.674 -0.641 . . . . 0.0 110.668 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.491 ' O ' ' OXT' ' A' ' 111' ' ' ARG . 33.3 mmt180 -75.22 -28.85 60.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.983 -1.073 . . . . 0.0 109.27 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.491 ' OXT' ' O ' ' A' ' 110' ' ' ARG . 32.4 ttm180 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.691 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.464 ' C ' ' OD1' ' A' ' 2' ' ' ASP . 53.0 p30 -76.97 170.41 16.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.157 -0.964 . . . . 0.0 109.134 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.805 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.2 mm? -71.51 139.73 84.1 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.178 -0.951 . . . . 0.0 108.899 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.36 -1.85 9.63 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.907 2.404 . . . . 0.0 111.383 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.591 ' ND1' HG12 ' A' ' 82' ' ' VAL . 30.2 m170 -65.63 -21.42 66.57 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.793 -0.567 . . . . 0.0 109.767 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.411 ' O ' ' HE3' ' A' ' 79' ' ' LYS . 85.7 m-70 -58.97 -23.5 61.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.116 -0.99 . . . . 0.0 109.427 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.714 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 72.8 m-20 -105.74 134.38 48.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 109.915 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 12' ' ' ASN . 92.5 mt-10 -71.31 -30.01 65.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.952 . . . . 0.0 110.341 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.717 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -60.26 -31.38 70.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.041 -1.037 . . . . 0.0 110.23 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.785 HG22 ' HA ' ' A' ' 107' ' ' ALA . 22.7 p -67.39 -32.21 72.96 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.345 -0.847 . . . . 0.0 110.926 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.714 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -131.72 -3.72 3.68 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.534 -1.354 . . . . 0.0 111.199 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 8' ' ' GLU . 58.4 t30 -96.1 117.74 31.31 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.477 -1.389 . . . . 0.0 111.524 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.637 HG12 ' CB ' ' A' ' 16' ' ' SER . 11.9 t -134.71 33.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.6 -30.21 26.79 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.3 m -60.29 -38.5 83.81 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.058 -1.26 . . . . 0.0 109.414 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.637 ' CB ' HG12 ' A' ' 13' ' ' VAL . 74.4 m -67.11 142.2 57.17 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.3 -0.875 . . . . 0.0 110.746 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -83.55 166.14 18.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.597 -0.689 . . . . 0.0 109.205 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.571 ' CG ' HH12 ' A' ' 36' ' ' ARG . 38.0 ttp180 -59.35 -40.7 87.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.092 -1.005 . . . . 0.0 109.426 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -59.74 -45.67 91.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.049 -1.032 . . . . 0.0 108.504 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -67.96 -33.62 75.01 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.64 92.77 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 26' ' ' ARG . 99.0 mt-10 -55.43 -48.04 75.04 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -60.57 -44.19 96.45 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.11 -41.18 97.34 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.623 HD11 ' HB3' ' A' ' 47' ' ' SER . 17.7 mt -69.31 -32.65 71.91 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' GLU . 97.6 mtt180 -85.25 2.46 43.82 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.409 0.623 . . . . 0.0 109.801 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.56 8.47 32.38 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.831 ' HZ2' ' HB ' ' A' ' 105' ' ' VAL . 11.9 pttt -142.82 157.51 44.54 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.89 -1.359 . . . . 0.0 110.69 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.73 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.0 OUTLIER -85.56 163.86 18.12 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.029 0.919 . . . . 0.0 111.577 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.556 ' OD1' ' C ' ' A' ' 50' ' ' VAL . 76.4 m-20 -42.96 159.81 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.63 0.728 . . . . 0.0 110.442 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.47 -27.08 5.36 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.7 m -86.4 124.77 33.11 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.326 -1.102 . . . . 0.0 108.432 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.786 ' HB2' HG22 ' A' ' 48' ' ' VAL . 0.5 OUTLIER -132.9 173.12 11.73 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.137 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.652 ' CB ' HG11 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -150.3 166.46 29.9 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.23 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.507 HG22 ' SG ' ' A' ' 46' ' ' CYS . 46.8 t -112.31 140.36 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.571 HH12 ' CG ' ' A' ' 18' ' ' ARG . 12.6 ptt180 -153.71 178.2 10.13 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.014 -1.054 . . . . 0.0 109.036 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.656 ' C ' ' H ' ' A' ' 39' ' ' SER . 11.3 pm0 -87.4 169.69 12.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.83 -1.169 . . . . 0.0 108.237 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.734 ' N ' ' O ' ' A' ' 43' ' ' CYS . 58.8 p -76.63 9.43 2.77 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.656 ' H ' ' C ' ' A' ' 37' ' ' GLU . 6.2 m 83.13 -116.58 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.569 -1.651 . . . . 0.0 109.725 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -91.3 -2.25 57.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.988 -1.07 . . . . 0.0 110.232 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -70.01 -33.24 71.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.864 -1.147 . . . . 0.0 110.024 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.08 -5.91 42.61 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.734 ' O ' ' N ' ' A' ' 38' ' ' SER . 71.2 m -103.62 169.15 8.7 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.225 -1.162 . . . . 0.0 109.799 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -106.58 162.23 13.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.347 -0.846 . . . . 0.0 109.758 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.03 148.91 17.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.213 -0.929 . . . . 0.0 110.695 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.518 ' SG ' HD11 ' A' ' 59' ' ' ILE . 75.8 m -111.2 124.31 51.96 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.198 -0.939 . . . . 0.0 108.631 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.623 ' HB3' HD11 ' A' ' 25' ' ' LEU . 69.0 m -91.2 139.82 30.39 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.115 -0.99 . . . . 0.0 110.151 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.786 HG22 ' HB2' ' A' ' 33' ' ' PHE . 56.2 t -133.51 157.44 42.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.44 ' N ' HG12 ' A' ' 48' ' ' VAL . 96.0 t -112.9 135.97 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.556 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -123.78 158.51 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.747 -1.221 . . . . 0.0 109.664 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.542 ' CA ' ' OD2' ' A' ' 30' ' ' ASP . 66.2 t0 -67.23 61.79 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.633 0.73 . . . . 0.0 109.934 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 172.1 -40.38 0.17 Allowed Glycine 0 C--N 1.292 -1.888 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.497 ' H ' HG12 ' A' ' 50' ' ' VAL . 79.0 tt0 -162.38 160.49 26.56 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.118 -1.225 . . . . 0.0 110.84 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.553 ' CG1' HD13 ' A' ' 25' ' ' LEU . 43.8 t -88.13 126.33 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' NZ ' ' HB3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -114.52 155.71 25.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.841 -1.162 . . . . 0.0 110.297 -178.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 57.3 m170 -116.43 119.83 36.88 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.415 -0.803 . . . . 0.0 108.888 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.507 ' O ' ' N ' ' A' ' 46' ' ' CYS . 41.8 t -92.46 124.2 36.32 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 58' ' ' VAL . 2.8 p -96.28 133.4 37.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 121.114 -0.991 . . . . 0.0 111.094 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD11 ' SG ' ' A' ' 46' ' ' CYS . 96.7 mt -119.33 130.31 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.58 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 75.5 m-20 -111.22 123.59 50.5 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.076 -1.015 . . . . 0.0 110.097 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -92.79 38.07 1.02 Allowed 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.818 HG22 ' H ' ' A' ' 63' ' ' ALA . 75.1 m -105.69 -177.25 3.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.655 -0.653 . . . . 0.0 109.343 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.818 ' H ' HG22 ' A' ' 62' ' ' THR . . . -44.3 -8.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 109.656 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.698 ' N ' ' O ' ' A' ' 62' ' ' THR . 60.5 p -81.47 -8.75 59.77 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.203 -0.936 . . . . 0.0 108.531 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.57 80.06 0.14 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.58 ' CA ' ' O ' ' A' ' 60' ' ' ASN . 86.5 m-85 57.46 -132.87 1.3 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.075 -1.25 . . . . 0.0 109.783 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -140.65 173.89 22.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.71 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 7.2 m-30 58.59 36.43 25.1 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.171 -1.193 . . . . 0.0 109.53 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.411 ' C ' ' HD2' ' A' ' 71' ' ' PRO . . . -95.48 2.54 54.46 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.088 -1.007 . . . . 0.0 109.621 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.629 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 55.9 mp0 -63.5 -35.94 19.83 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 110.652 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 61.5 Cg_endo -84.24 15.6 2.13 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.959 1.773 . . . . 0.0 111.44 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 60.1 37.78 20.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.676 -0.64 . . . . 0.0 109.288 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.484 ' OD1' ' CE1' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -132.32 75.8 1.66 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 110.006 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.839 ' O ' HD12 ' A' ' 74' ' ' LEU . 3.0 pp -119.52 104.09 10.0 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.574 ' CD2' ' OE1' ' A' ' 80' ' ' GLU . 78.9 m-85 -67.68 156.06 37.78 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.276 -0.89 . . . . 0.0 109.98 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 90.9 p -85.42 -11.78 53.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.7 -0.625 . . . . 0.0 111.423 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 t -114.36 141.74 47.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.655 -1.278 . . . . 0.0 110.391 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.7 mt -61.4 -38.13 85.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.383 -0.823 . . . . 0.0 109.545 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 6' ' ' HIS . 24.0 mmtm -59.68 -39.09 83.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.269 -0.895 . . . . 0.0 108.807 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.574 ' OE1' ' CD2' ' A' ' 75' ' ' TYR . 20.6 mm-40 -65.58 -42.5 91.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 109.001 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.571 HD23 ' C ' ' A' ' 81' ' ' LEU . 8.4 tt -61.09 -42.83 99.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.367 -0.833 . . . . 0.0 109.183 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.591 HG12 ' ND1' ' A' ' 5' ' ' HIS . 70.5 t -67.09 -47.04 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.306 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.1 mt -67.48 -43.04 81.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.481 -0.762 . . . . 0.0 110.104 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.484 ' CE1' ' OD1' ' A' ' 73' ' ' ASN . 85.7 t60 -61.47 -42.58 99.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 0.0 109.885 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.894 ' HB3' HD13 ' A' ' 101' ' ' LEU . 5.0 m-85 -60.58 -28.38 68.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.16 -0.962 . . . . 0.0 109.632 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -65.4 -34.92 79.44 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.935 -1.103 . . . . 0.0 108.769 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -84.56 -25.18 28.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.349 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.1 m -88.78 129.33 35.58 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.911 -1.118 . . . . 0.0 109.679 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.608 ' HA ' HG22 ' A' ' 100' ' ' THR . 66.5 m -81.51 133.52 35.4 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 91' ' ' VAL . 86.6 mt -71.84 -19.04 62.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.297 -0.877 . . . . 0.0 111.964 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.785 ' O ' ' N ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -34.23 -51.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.874 -1.142 . . . . 0.0 110.228 -178.251 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -54.72 -29.13 52.57 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.077 0.465 . . . . 0.0 110.56 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.798 ' HB3' HD12 ' A' ' 97' ' ' LEU . 64.4 t-80 -50.05 -48.14 53.09 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.939 -1.101 . . . . 0.0 108.797 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.485 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 64.9 t-20 -140.18 19.85 2.43 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.785 ' N ' ' O ' ' A' ' 91' ' ' VAL . 53.5 t0 59.92 8.16 1.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.1 p -137.22 11.56 3.04 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.278 -0.889 . . . . 0.0 109.571 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.798 HD12 ' HB3' ' A' ' 93' ' ' HIS . 23.7 mt -103.32 69.94 1.03 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.705 -1.247 . . . . 0.0 108.509 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.523 ' CA ' HG13 ' A' ' 91' ' ' VAL . 41.5 p-10 -78.25 69.28 4.43 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.608 0.718 . . . . 0.0 110.395 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 100' ' ' THR . 53.9 t -156.38 158.09 3.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.469 0.652 . . . . 0.0 109.514 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.608 HG22 ' HA ' ' A' ' 89' ' ' SER . 72.8 p -131.17 164.09 26.27 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.575 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.894 HD13 ' HB3' ' A' ' 85' ' ' TYR . 6.2 mp -82.71 68.12 9.05 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -97.94 -27.02 14.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.601 -0.687 . . . . 0.0 111.225 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -112.66 132.67 22.13 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 120.692 -1.255 . . . . 0.0 111.091 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.495 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 73.6 Cg_endo -76.14 142.67 24.76 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.764 2.976 . . . . 0.0 111.975 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.831 ' HB ' ' HZ2' ' A' ' 28' ' ' LYS . 9.7 p -76.7 -33.13 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.159 -0.963 . . . . 0.0 111.954 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -130.15 60.56 1.61 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.55 -1.344 . . . . 0.0 110.889 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.785 ' HA ' HG22 ' A' ' 10' ' ' THR . . . -87.97 134.87 33.63 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.271 -0.971 . . . . 0.0 109.524 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.28 139.35 46.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.529 -0.732 . . . . 0.0 110.205 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -93.35 0.82 57.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 109.599 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -61.93 -40.73 96.51 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.179 -0.951 . . . . 0.0 110.503 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.784 ' CB ' HH11 ' A' ' 111' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 O-C-N 120.901 -1.124 . . . . 0.0 109.48 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.474 ' C ' ' OD1' ' A' ' 2' ' ' ASP . 58.3 p30 -76.02 169.42 18.21 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.415 -0.803 . . . . 0.0 109.17 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.4 mt -91.84 116.08 65.79 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.104 -0.997 . . . . 0.0 109.985 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.51 -16.92 5.91 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.671 2.247 . . . . 0.0 111.771 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.619 ' NE2' ' OE1' ' A' ' 86' ' ' GLN . 96.4 m-70 -67.18 -19.94 65.65 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.377 -0.827 . . . . 0.0 109.872 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -60.19 -36.59 77.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.868 -1.145 . . . . 0.0 109.506 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.633 ' OD2' ' NZ ' ' A' ' 9' ' ' LYS . 47.9 t0 -92.17 123.23 35.36 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.078 -1.014 . . . . 0.0 109.827 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.519 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 19.8 tt0 -64.44 -30.54 71.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.725 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.633 ' NZ ' ' OD2' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -61.48 -35.18 76.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.702 -0.624 . . . . 0.0 111.553 -179.327 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.715 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 13.7 p -51.63 -39.91 58.95 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.996 -1.065 . . . . 0.0 110.389 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.715 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -117.09 -19.29 9.79 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.857 -1.152 . . . . 0.0 110.684 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.437 ' CB ' ' HG2' ' A' ' 8' ' ' GLU . 49.4 t-20 -89.53 123.76 33.92 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.872 -1.142 . . . . 0.0 111.253 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 35' ' ' VAL . 27.0 m -100.7 -16.0 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.302 -0.873 . . . . 0.0 109.207 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASN . . . 78.87 -141.37 24.29 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.515 ' HA ' ' NH2' ' A' ' 36' ' ' ARG . 36.8 t -81.76 104.53 12.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -1.093 . . . . 0.0 108.748 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 t -135.29 135.09 40.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.448 -0.782 . . . . 0.0 109.93 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -64.61 143.39 57.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.112 -0.993 . . . . 0.0 109.694 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.597 ' CZ ' ' OG ' ' A' ' 39' ' ' SER . 37.9 mtt-85 -60.17 -33.44 72.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.0 108.779 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -59.67 -43.41 94.01 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -62.41 -34.3 76.47 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.09 -35.13 76.18 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 26' ' ' ARG . 94.9 mt-10 -60.07 -45.83 91.58 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.819 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -63.17 -43.0 99.48 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.29 -36.66 79.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.0 109.27 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.633 HD23 ' HD2' ' A' ' 28' ' ' LYS . 56.1 mt -87.21 -15.13 39.13 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.141 -0.974 . . . . 0.0 109.047 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 22' ' ' GLU . 16.1 mtp180 -77.71 -22.42 50.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.13 -0.981 . . . . 0.0 109.372 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.43 19.84 23.79 Favored Glycine 0 C--N 1.285 -2.282 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.68 ' NZ ' HG23 ' A' ' 105' ' ' VAL . 5.1 ttmm -105.91 131.15 53.57 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.571 -0.958 . . . . 0.0 111.456 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -85.39 166.44 16.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.681 -0.637 . . . . 0.0 110.149 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.633 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 63.4 t0 -63.15 142.08 58.52 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.446 -0.784 . . . . 0.0 110.475 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.627 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 100.87 -19.28 52.85 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.43 ' HB ' ' CG ' ' A' ' 28' ' ' LYS . 60.4 m -97.14 136.35 37.8 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.136 -1.214 . . . . 0.0 109.272 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.583 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -139.37 172.79 12.3 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.755 -1.216 . . . . 0.0 109.892 179.385 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.435 ' CD2' HD21 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -139.7 153.96 47.36 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.816 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.58 ' O ' HG22 ' A' ' 13' ' ' VAL . 67.5 t -104.63 136.8 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.969 -1.082 . . . . 0.0 108.527 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.712 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -144.69 -169.9 3.27 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 108.924 -178.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.712 ' H ' ' CD ' ' A' ' 36' ' ' ARG . 9.8 mt-10 -100.66 -178.53 3.81 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.909 -1.12 . . . . 0.0 108.234 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.5 m -77.86 14.21 1.15 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.607 ' H ' ' C ' ' A' ' 37' ' ' GLU . 50.8 m 62.45 15.39 7.75 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.178 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -172.02 -76.99 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.537 -0.727 . . . . 0.0 109.688 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.576 ' C ' ' H ' ' A' ' 43' ' ' CYS . 97.5 mt-30 -60.34 147.95 38.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.087 -1.008 . . . . 0.0 109.874 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.82 9.86 0.1 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.576 ' H ' ' C ' ' A' ' 41' ' ' GLN . 80.3 m -80.44 168.85 18.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -1.195 . . . . 0.0 109.144 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.537 ' O ' ' O ' ' A' ' 59' ' ' ILE . 94.9 m-85 -108.53 155.62 20.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.979 -1.076 . . . . 0.0 110.732 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.422 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -155.4 129.5 8.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.436 -0.79 . . . . 0.0 109.154 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 57' ' ' CYS . 20.6 p -112.93 154.44 26.4 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.5 m -118.73 142.89 47.26 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.089 -0.645 . . . . 0.0 109.493 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.54 HG22 ' N ' ' A' ' 49' ' ' VAL . 1.9 p -132.58 161.3 41.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.298 -0.876 . . . . 0.0 108.901 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.54 ' N ' HG22 ' A' ' 48' ' ' VAL . 47.5 t -117.44 132.47 67.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.655 ' HB ' ' HZ2' ' A' ' 55' ' ' LYS . 8.6 p -115.91 164.44 12.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.224 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.633 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 95.9 m-20 -59.66 28.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.981 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -154.58 -38.0 0.02 OUTLIER Glycine 0 N--CA 1.483 1.785 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.629 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.569 ' CD ' ' O ' ' A' ' 52' ' ' GLY . 55.0 mp0 -159.26 164.58 34.84 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.65 -1.5 . . . . 0.0 112.512 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.8 t -89.33 141.15 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.655 ' HZ2' ' HB ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -131.04 165.71 22.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.843 -1.161 . . . . 0.0 111.617 -178.186 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -128.42 75.84 1.66 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.48 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 46.3 t -56.6 134.24 54.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.205 -0.934 . . . . 0.0 109.62 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.86 134.41 42.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.582 0.705 . . . . 0.0 110.112 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.537 ' O ' ' O ' ' A' ' 44' ' ' TYR . 49.5 mm -108.41 129.34 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.522 ' O ' ' O ' ' A' ' 66' ' ' TYR . 77.5 m-20 -114.67 126.69 55.16 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.857 -1.152 . . . . 0.0 110.793 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -111.07 122.31 47.55 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.153 -0.967 . . . . 0.0 109.485 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.714 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 54.4 m -119.6 -12.14 9.34 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 62' ' ' THR . . . 155.2 -48.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.1 m -153.99 60.01 0.72 Allowed 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.47 -49.56 0.03 OUTLIER Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.38 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.522 ' O ' ' O ' ' A' ' 60' ' ' ASN . 96.7 m-85 58.65 -132.42 1.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -1.151 . . . . 0.0 109.106 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 66' ' ' TYR . . . -59.7 -148.48 0.01 OUTLIER Glycine 0 N--CA 1.493 2.5 0 O-C-N 121.023 -1.048 . . . . 0.0 110.586 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.649 ' CE2' ' NE2' ' A' ' 93' ' ' HIS . 42.7 p90 -69.62 130.59 42.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.822 -1.399 . . . . 0.0 109.636 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.62 139.35 53.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.121 -0.987 . . . . 0.0 109.771 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.708 ' O ' ' N ' ' A' ' 72' ' ' TYR . 69.4 mt-10 -70.6 157.54 89.9 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.463 ' C ' ' O ' ' A' ' 70' ' ' GLU . 76.8 Cg_exo -30.96 -25.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.41 2.073 . . . . 0.0 111.485 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.708 ' N ' ' O ' ' A' ' 70' ' ' GLU . 94.2 m-85 -119.73 117.18 27.55 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -60.93 125.11 22.5 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.361 -0.837 . . . . 0.0 109.664 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.5 mt -116.86 0.16 12.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.408 -0.808 . . . . 0.0 109.384 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -94.6 130.99 40.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 0.0 110.384 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.7 t -106.74 -43.07 4.79 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.905 -1.122 . . . . 0.0 110.652 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.0 p -137.48 166.14 24.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.848 -1.158 . . . . 0.0 109.823 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.29 -32.06 72.74 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.559 -0.713 . . . . 0.0 109.395 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.403 ' O ' HG12 ' A' ' 82' ' ' VAL . 61.3 mttp -59.6 -41.19 89.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.896 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -75.41 -26.68 58.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.094 -1.004 . . . . 0.0 109.601 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.6 tt -67.99 -42.25 81.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.164 -0.96 . . . . 0.0 110.371 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 83' ' ' LEU . 4.3 p -68.61 -46.73 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.204 -0.935 . . . . 0.0 110.359 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.53 ' N ' HG13 ' A' ' 82' ' ' VAL . 85.9 mt -66.02 -40.05 90.73 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.898 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.451 ' HA ' ' CD2' ' A' ' 87' ' ' HIS . 21.3 t60 -58.65 -41.21 85.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.297 -0.877 . . . . 0.0 110.233 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.597 ' CZ ' ' CZ ' ' A' ' 68' ' ' PHE . 7.2 m-30 -74.62 -25.75 59.43 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.088 -1.007 . . . . 0.0 109.67 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.619 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 30.5 tt0 -63.92 -36.57 84.4 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.998 -1.064 . . . . 0.0 110.33 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.471 ' CE1' ' OG1' ' A' ' 88' ' ' THR . 21.7 p80 -93.21 -7.05 46.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.057 -1.027 . . . . 0.0 109.272 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' CE1' ' A' ' 87' ' ' HIS . 33.3 m -105.59 138.3 42.01 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 108.895 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.522 ' HA ' HG22 ' A' ' 100' ' ' THR . 2.8 m -89.79 130.14 36.09 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 109.268 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.562 ' O ' ' C ' ' A' ' 91' ' ' VAL . 83.0 mt -71.27 -18.65 62.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.658 -0.651 . . . . 0.0 110.246 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.73 ' N ' ' O ' ' A' ' 97' ' ' LEU . 14.7 p -31.36 -47.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.314 -0.866 . . . . 0.0 109.638 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.692 ' N ' HG13 ' A' ' 91' ' ' VAL . 76.6 mt-30 -57.61 -45.66 85.08 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.131 -178.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.649 ' NE2' ' CE2' ' A' ' 68' ' ' PHE . 75.1 m80 -48.53 -50.42 32.1 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.807 ' O ' ' N ' ' A' ' 96' ' ' SER . 97.7 m-20 -134.31 114.19 12.74 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 94' ' ' ASN . 84.1 m-20 -31.73 -19.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.525 -0.734 . . . . 0.0 111.393 -177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.807 ' N ' ' O ' ' A' ' 94' ' ' ASN . 54.6 m -107.66 20.46 18.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.635 -1.291 . . . . 0.0 111.698 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.73 ' O ' ' N ' ' A' ' 91' ' ' VAL . 8.3 mt -97.7 57.43 1.35 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.444 -1.41 . . . . 0.0 109.263 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -78.32 86.03 4.43 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.386 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.539 HG13 HD12 ' A' ' 90' ' ' LEU . 13.9 p -168.7 151.88 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.522 HG22 ' HA ' ' A' ' 89' ' ' SER . 34.9 p -131.68 159.34 38.64 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.469 -0.77 . . . . 0.0 109.342 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.583 HD22 ' CG ' ' A' ' 33' ' ' PHE . 19.2 mt -78.22 69.79 4.48 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.942 -1.099 . . . . 0.0 108.175 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.57 -31.45 16.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.451 -0.78 . . . . 0.0 112.714 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -122.53 136.14 26.31 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.507 -1.371 . . . . 0.0 111.393 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.785 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 68.0 Cg_endo -77.08 152.88 31.81 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 123.133 2.556 . . . . 0.0 111.956 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.68 HG23 ' NZ ' ' A' ' 28' ' ' LYS . 9.6 p -79.16 -16.41 13.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.093 -1.004 . . . . 0.0 110.626 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.433 ' HE2' HG12 ' A' ' 13' ' ' VAL . 13.2 m-85 -129.73 61.18 1.57 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.073 -1.017 . . . . 0.0 111.016 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.785 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . -85.69 119.18 25.74 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.132 -0.98 . . . . 0.0 108.795 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -114.87 124.82 52.7 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.945 -1.097 . . . . 0.0 109.538 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -111.46 -12.67 13.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.378 -0.826 . . . . 0.0 109.005 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.719 HH11 ' CG ' ' A' ' 110' ' ' ARG . 1.5 mtt-85 -121.63 146.52 46.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.897 . . . . 0.0 110.458 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.75 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.43 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.528 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.0 0.428 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -79.7 124.76 28.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.17 -0.956 . . . . 0.0 109.834 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.0 mt -101.45 118.7 59.37 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 108.679 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -58.96 -11.77 13.33 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.948 1.765 . . . . 0.0 111.576 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.608 ' HB2' HD11 ' A' ' 83' ' ' LEU . 98.0 m-70 -67.2 -31.7 72.27 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.803 -0.561 . . . . 0.0 110.749 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.556 ' ND1' ' N ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -63.06 -15.4 56.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 0.0 110.153 -178.758 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.693 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 27.1 t0 -102.51 126.14 49.47 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.723 ' O ' ' N ' ' A' ' 12' ' ' ASN . 4.0 mp0 -66.18 -27.29 67.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 110.644 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.679 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -62.69 -39.05 92.77 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.988 -1.07 . . . . 0.0 109.689 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.764 HG22 ' HA ' ' A' ' 107' ' ' ALA . 22.1 p -59.04 -33.76 71.13 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.694 -0.629 . . . . 0.0 109.909 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.693 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -123.91 -31.59 3.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.808 -1.183 . . . . 0.0 111.728 -179.692 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.723 ' N ' ' O ' ' A' ' 8' ' ' GLU . 28.5 t-20 -87.84 130.65 34.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.539 -1.35 . . . . 0.0 110.857 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -107.48 -6.52 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASN . . . 92.77 -161.86 26.13 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.4 p -67.44 153.59 43.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -1.14 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 t -163.59 150.51 12.23 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.424 -0.797 . . . . 0.0 109.407 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 18' ' ' ARG . 86.4 m-20 -88.12 7.95 29.18 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 4.5 mmp_? 66.73 9.01 6.37 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.468 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.715 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 36.5 p-10 -77.52 -53.67 7.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.071 -1.018 . . . . 0.0 108.27 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.715 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 45.1 pttt -68.88 -26.29 65.05 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -56.62 -45.62 81.39 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 26' ' ' ARG . 59.2 mm-40 -59.16 -47.04 86.78 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -62.8 -42.68 99.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 24' ' ' LEU . 79.0 mt -69.94 -29.97 67.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 109.504 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.536 HD11 ' OG ' ' A' ' 47' ' ' SER . 16.0 mt -89.79 -13.28 36.98 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 22' ' ' GLU . 89.5 mtt180 -91.5 115.27 27.9 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.62 2.89 50.05 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.536 ' O ' HG11 ' A' ' 49' ' ' VAL . 36.4 mmtt -100.77 137.82 38.64 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.225 -1.162 . . . . 0.0 109.212 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -69.64 156.49 38.87 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.664 -0.648 . . . . 0.0 109.695 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 63.2 t0 -57.81 141.92 47.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.587 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 108.7 -27.82 12.62 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.465 ' HG1' ' HD2' ' A' ' 103' ' ' TYR . 86.4 m -79.85 120.8 24.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.133 -1.216 . . . . 0.0 108.437 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -139.89 176.57 8.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.851 -1.156 . . . . 0.0 110.931 -178.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.68 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -150.76 161.63 42.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.576 -0.703 . . . . 0.0 110.233 179.215 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.493 HG22 ' SG ' ' A' ' 46' ' ' CYS . 43.7 t -107.16 139.97 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.656 ' NH1' ' HB3' ' A' ' 45' ' ' ALA . 1.1 ppt_? -158.72 -160.21 0.85 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.615 ' C ' ' H ' ' A' ' 39' ' ' SER . 82.7 mt-10 -100.19 174.27 6.23 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.567 -1.333 . . . . 0.0 109.079 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.668 ' N ' ' O ' ' A' ' 43' ' ' CYS . 33.6 m -76.67 12.98 1.1 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.615 ' H ' ' C ' ' A' ' 37' ' ' GLU . 7.2 t 85.85 -113.61 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.757 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -86.9 -9.72 55.04 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.123 -0.985 . . . . 0.0 110.722 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -71.56 -35.89 70.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.74 -1.225 . . . . 0.0 110.062 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.3 -14.55 58.15 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.668 ' O ' ' N ' ' A' ' 38' ' ' SER . 76.9 m -79.73 160.06 26.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.28 . . . . 0.0 109.329 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -85.65 154.43 21.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.016 -1.053 . . . . 0.0 109.187 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.656 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . . . -159.38 151.61 21.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.978 -1.076 . . . . 0.0 110.062 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.65 ' SG ' HD11 ' A' ' 59' ' ' ILE . 77.0 m -113.46 124.07 51.53 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.536 ' OG ' HD11 ' A' ' 25' ' ' LEU . 45.2 t -94.7 130.81 41.06 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.106 -0.997 . . . . 0.0 109.022 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.565 HG22 ' N ' ' A' ' 49' ' ' VAL . 9.9 p -135.19 168.44 23.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.482 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.565 ' N ' HG22 ' A' ' 48' ' ' VAL . 67.6 t -115.19 134.3 58.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.1 t -112.85 161.25 11.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.044 -1.035 . . . . 0.0 109.801 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 50' ' ' VAL . 64.6 m-20 -62.25 56.13 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.029 0.443 . . . . 0.0 109.99 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 164.37 -36.71 0.29 Allowed Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.208 -1.472 . . . . 0.0 111.018 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.511 ' OE1' ' C ' ' A' ' 52' ' ' GLY . 60.7 mp0 -153.91 161.06 42.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.638 -1.507 . . . . 0.0 110.972 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.405 ' CG1' HD13 ' A' ' 25' ' ' LEU . 97.1 t -91.9 138.47 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' CE ' ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -124.07 168.73 12.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.903 -1.123 . . . . 0.0 110.948 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.475 ' HB3' HH22 ' A' ' 36' ' ' ARG . 71.0 m-70 -129.79 73.67 1.54 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.587 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 73.0 m -50.7 148.1 4.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.315 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.1 t -116.16 134.5 59.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.891 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.878 HG23 ' O ' ' A' ' 66' ' ' TYR . 67.1 mt -117.46 139.17 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.532 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 97.3 m-20 -126.58 131.55 51.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.8 -1.187 . . . . 0.0 109.689 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -97.54 120.75 38.48 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.338 -0.851 . . . . 0.0 110.435 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 1.029 HG23 ' H ' ' A' ' 64' ' ' THR . 4.9 t -153.56 175.48 13.16 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.412 -0.805 . . . . 0.0 108.927 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.97 -19.33 6.52 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.314 -0.866 . . . . 0.0 108.952 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 1.029 ' H ' HG23 ' A' ' 62' ' ' THR . 12.4 t -162.92 78.69 0.46 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.111 -0.993 . . . . 0.0 109.95 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.621 ' C ' ' H ' ' A' ' 67' ' ' GLY . . . -161.64 -71.73 0.02 OUTLIER Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.806 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.878 ' O ' HG23 ' A' ' 59' ' ' ILE . 83.4 m-85 57.63 -4.98 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.22 -1.165 . . . . 0.0 109.548 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.621 ' H ' ' C ' ' A' ' 65' ' ' GLY . . . 134.57 -97.72 0.3 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.401 ' O ' ' OH ' ' A' ' 75' ' ' TYR . 27.2 m-85 -80.22 130.94 35.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.349 -1.089 . . . . 0.0 108.79 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.04 -14.3 4.97 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.675 -1.266 . . . . 0.0 110.022 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.67 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 11.3 tp10 -64.47 -36.79 19.9 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.018 -1.051 . . . . 0.0 109.422 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 69.5 Cg_endo -89.97 -58.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.624 2.216 . . . . 0.0 110.68 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -122.92 105.45 10.01 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.549 ' C ' ' OD1' ' A' ' 73' ' ' ASN . 42.2 p30 -90.66 22.19 3.65 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.19 -0.944 . . . . 0.0 109.645 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.2 tp -158.14 103.5 1.83 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.22 -0.925 . . . . 0.0 110.166 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.496 ' CD1' ' HB2' ' A' ' 66' ' ' TYR . 27.6 m-85 -95.64 139.71 31.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.358 -0.839 . . . . 0.0 109.64 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.524 ' OG ' ' CD ' ' A' ' 80' ' ' GLU . 84.1 p -65.45 -44.37 87.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.203 -0.935 . . . . 0.0 110.901 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -166.93 162.44 15.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.924 -1.11 . . . . 0.0 109.489 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.61 -37.73 88.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.481 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 3.7 ttmp? -58.91 -45.33 90.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.887 -1.133 . . . . 0.0 109.175 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.524 ' CD ' ' OG ' ' A' ' 76' ' ' SER . 51.7 mt-10 -67.13 -29.14 68.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.19 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.595 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.6 tt -58.6 -43.75 89.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.285 -0.885 . . . . 0.0 110.014 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.84 -44.39 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.716 -1.24 . . . . 0.0 109.718 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 5' ' ' HIS . 3.8 mm? -67.15 -42.38 84.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 109.555 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.836 ' O ' ' CD2' ' A' ' 87' ' ' HIS . 60.1 t60 -60.28 -39.73 87.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.417 -0.802 . . . . 0.0 110.801 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.467 ' HA ' ' OG1' ' A' ' 88' ' ' THR . 4.9 m-30 -71.08 -25.5 62.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.478 -0.764 . . . . 0.0 112.526 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 83' ' ' LEU . 9.2 pt20 -61.23 -30.56 70.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.348 -1.47 . . . . 0.0 110.312 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.836 ' CD2' ' O ' ' A' ' 84' ' ' HIS . 14.2 p80 -92.7 -5.49 51.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.75 -1.219 . . . . 0.0 109.188 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.688 ' O ' HG22 ' A' ' 100' ' ' THR . 56.2 p -98.36 139.76 33.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.158 -0.964 . . . . 0.0 109.455 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.2 t -97.81 126.73 43.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.451 -0.781 . . . . 0.0 109.452 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.731 HD12 HG13 ' A' ' 99' ' ' VAL . 81.8 mt -67.05 -20.04 65.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.983 -1.073 . . . . 0.0 109.833 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.774 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.7 p -10.67 -58.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.834 -0.542 . . . . 0.0 110.171 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.773 ' H ' HG13 ' A' ' 91' ' ' VAL . 9.5 tp-100 -35.17 155.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 92' ' ' GLN . 59.5 t-80 55.49 107.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.814 ' O ' ' N ' ' A' ' 96' ' ' SER . 22.9 m120 56.69 71.84 0.54 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.603 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 94.2 m-20 -29.84 -20.0 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.814 ' N ' ' O ' ' A' ' 94' ' ' ASN . 87.1 p -77.43 15.5 0.77 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.671 -1.268 . . . . 0.0 110.922 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.774 ' O ' ' N ' ' A' ' 91' ' ' VAL . 70.5 mt -95.68 41.67 1.1 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 95' ' ' ASP . 64.1 m-80 -78.39 79.28 4.83 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.321 -0.862 . . . . 0.0 110.073 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.731 HG13 HD12 ' A' ' 90' ' ' LEU . 7.4 p -153.31 157.93 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 88' ' ' THR . 31.8 p -130.26 157.46 42.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.105 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.515 HD22 ' CG ' ' A' ' 33' ' ' PHE . 19.0 mt -82.21 65.73 7.47 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.7 -28.37 12.52 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.489 ' CD1' ' HD2' ' A' ' 104' ' ' PRO . 68.1 t80 -110.48 127.09 27.57 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.14 -1.6 . . . . 0.0 110.973 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.497 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 61.1 Cg_endo -74.82 146.81 33.92 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 123.039 2.493 . . . . 0.0 112.533 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' A' ' 34' ' ' LEU . 9.9 p -83.26 -32.05 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.122 -0.986 . . . . 0.0 110.604 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.541 ' CD2' HG13 ' A' ' 105' ' ' VAL . 35.2 m-85 -129.64 59.35 1.61 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.787 -1.196 . . . . 0.0 110.856 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.764 ' HA ' HG22 ' A' ' 10' ' ' THR . . . -94.28 144.49 25.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.416 -0.802 . . . . 0.0 109.772 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -117.45 157.07 26.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.515 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -78.16 124.0 27.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.272 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.531 ' NH1' ' HG2' ' A' ' 110' ' ' ARG . 2.0 mtt-85 -128.87 170.58 13.21 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.237 -0.914 . . . . 0.0 109.517 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.741 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.604 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.009 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.0 0.428 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -79.7 124.76 28.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.17 -0.956 . . . . 0.0 109.834 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.0 mt -101.45 118.7 59.37 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 108.679 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -58.96 -11.77 13.33 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.948 1.765 . . . . 0.0 111.576 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.608 ' HB2' HD11 ' A' ' 83' ' ' LEU . 98.0 m-70 -67.2 -31.7 72.27 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.803 -0.561 . . . . 0.0 110.749 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.556 ' ND1' ' N ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -63.06 -15.4 56.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 0.0 110.153 -178.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.693 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 27.1 t0 -102.51 126.14 49.47 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.723 ' O ' ' N ' ' A' ' 12' ' ' ASN . 4.0 mp0 -66.18 -27.29 67.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 110.644 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.679 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -62.69 -39.05 92.77 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.988 -1.07 . . . . 0.0 109.689 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.764 HG22 ' HA ' ' A' ' 107' ' ' ALA . 22.1 p -59.04 -33.76 71.13 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.694 -0.629 . . . . 0.0 109.909 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.693 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -123.91 -31.59 3.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.808 -1.183 . . . . 0.0 111.728 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.723 ' N ' ' O ' ' A' ' 8' ' ' GLU . 28.5 t-20 -87.84 130.65 34.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.539 -1.35 . . . . 0.0 110.857 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -107.48 -6.52 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASN . . . 92.77 -161.86 26.13 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.4 p -67.44 153.59 43.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -1.14 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 t -163.59 150.51 12.23 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.424 -0.797 . . . . 0.0 109.407 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 18' ' ' ARG . 86.4 m-20 -88.12 7.95 29.18 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 4.5 mmp_? 66.73 9.01 6.37 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.468 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.715 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 36.5 p-10 -77.52 -53.67 7.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.071 -1.018 . . . . 0.0 108.27 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.715 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 45.1 pttt -68.88 -26.29 65.05 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -56.62 -45.62 81.39 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 26' ' ' ARG . 59.2 mm-40 -59.16 -47.04 86.78 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -62.8 -42.68 99.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 24' ' ' LEU . 79.0 mt -69.94 -29.97 67.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 109.504 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.536 HD11 ' OG ' ' A' ' 47' ' ' SER . 16.0 mt -89.79 -13.28 36.98 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 22' ' ' GLU . 89.5 mtt180 -91.5 115.27 27.9 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.62 2.89 50.05 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.536 ' O ' HG11 ' A' ' 49' ' ' VAL . 36.4 mmtt -100.77 137.82 38.64 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.225 -1.162 . . . . 0.0 109.212 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -69.64 156.49 38.87 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.664 -0.648 . . . . 0.0 109.695 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 63.2 t0 -57.81 141.92 47.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.587 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 108.7 -27.82 12.62 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.465 ' HG1' ' HD2' ' A' ' 103' ' ' TYR . 86.4 m -79.85 120.8 24.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.133 -1.216 . . . . 0.0 108.437 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -139.89 176.57 8.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.851 -1.156 . . . . 0.0 110.931 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.68 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -150.76 161.63 42.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.576 -0.703 . . . . 0.0 110.233 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.493 HG22 ' SG ' ' A' ' 46' ' ' CYS . 43.7 t -107.16 139.97 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.656 ' NH1' ' HB3' ' A' ' 45' ' ' ALA . 1.1 ppt_? -158.72 -160.21 0.85 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.615 ' C ' ' H ' ' A' ' 39' ' ' SER . 82.7 mt-10 -100.19 174.27 6.23 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.567 -1.333 . . . . 0.0 109.079 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.668 ' N ' ' O ' ' A' ' 43' ' ' CYS . 33.6 m -76.67 12.98 1.1 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.615 ' H ' ' C ' ' A' ' 37' ' ' GLU . 7.2 t 85.85 -113.61 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.757 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -86.9 -9.72 55.04 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.123 -0.985 . . . . 0.0 110.722 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -71.56 -35.89 70.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.74 -1.225 . . . . 0.0 110.062 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.3 -14.55 58.15 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.668 ' O ' ' N ' ' A' ' 38' ' ' SER . 76.9 m -79.73 160.06 26.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.28 . . . . 0.0 109.329 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -85.65 154.43 21.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.016 -1.053 . . . . 0.0 109.187 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.656 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . . . -159.38 151.61 21.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.978 -1.076 . . . . 0.0 110.062 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.65 ' SG ' HD11 ' A' ' 59' ' ' ILE . 77.0 m -113.46 124.07 51.53 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.536 ' OG ' HD11 ' A' ' 25' ' ' LEU . 45.2 t -94.7 130.81 41.06 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.106 -0.997 . . . . 0.0 109.022 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.565 HG22 ' N ' ' A' ' 49' ' ' VAL . 9.9 p -135.19 168.44 23.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.482 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.565 ' N ' HG22 ' A' ' 48' ' ' VAL . 67.6 t -115.19 134.3 58.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.1 t -112.85 161.25 11.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.044 -1.035 . . . . 0.0 109.801 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 50' ' ' VAL . 64.6 m-20 -62.25 56.13 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.029 0.443 . . . . 0.0 109.99 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 164.37 -36.71 0.29 Allowed Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.208 -1.472 . . . . 0.0 111.018 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.511 ' OE1' ' C ' ' A' ' 52' ' ' GLY . 60.7 mp0 -153.91 161.06 42.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.638 -1.507 . . . . 0.0 110.972 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.405 ' CG1' HD13 ' A' ' 25' ' ' LEU . 97.1 t -91.9 138.47 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' CE ' ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -124.07 168.73 12.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.903 -1.123 . . . . 0.0 110.948 -179.445 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.475 ' HB3' HH22 ' A' ' 36' ' ' ARG . 71.0 m-70 -129.79 73.67 1.54 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.587 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 73.0 m -50.7 148.1 4.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.315 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.1 t -116.16 134.5 59.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.891 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.878 HG23 ' O ' ' A' ' 66' ' ' TYR . 67.1 mt -117.46 139.17 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.532 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 97.3 m-20 -126.58 131.55 51.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.8 -1.187 . . . . 0.0 109.689 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -97.54 120.75 38.48 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.338 -0.851 . . . . 0.0 110.435 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 1.029 HG23 ' H ' ' A' ' 64' ' ' THR . 4.9 t -153.56 175.48 13.16 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.412 -0.805 . . . . 0.0 108.927 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.97 -19.33 6.52 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.314 -0.866 . . . . 0.0 108.952 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 1.029 ' H ' HG23 ' A' ' 62' ' ' THR . 12.4 t -162.92 78.69 0.46 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.111 -0.993 . . . . 0.0 109.95 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.621 ' C ' ' H ' ' A' ' 67' ' ' GLY . . . -161.64 -71.73 0.02 OUTLIER Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.806 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.878 ' O ' HG23 ' A' ' 59' ' ' ILE . 83.4 m-85 57.63 -4.98 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.22 -1.165 . . . . 0.0 109.548 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.621 ' H ' ' C ' ' A' ' 65' ' ' GLY . . . 134.57 -97.72 0.3 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.401 ' O ' ' OH ' ' A' ' 75' ' ' TYR . 27.2 m-85 -80.22 130.94 35.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.349 -1.089 . . . . 0.0 108.79 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.04 -14.3 4.97 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.675 -1.266 . . . . 0.0 110.022 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.67 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 11.3 tp10 -64.47 -36.79 19.9 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.018 -1.051 . . . . 0.0 109.422 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 69.5 Cg_endo -89.97 -58.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.624 2.216 . . . . 0.0 110.68 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -122.92 105.45 10.01 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.549 ' C ' ' OD1' ' A' ' 73' ' ' ASN . 42.2 p30 -90.66 22.19 3.65 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.19 -0.944 . . . . 0.0 109.645 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.2 tp -158.14 103.5 1.83 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.22 -0.925 . . . . 0.0 110.166 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.496 ' CD1' ' HB2' ' A' ' 66' ' ' TYR . 27.6 m-85 -95.64 139.71 31.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.358 -0.839 . . . . 0.0 109.64 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.524 ' OG ' ' CD ' ' A' ' 80' ' ' GLU . 84.1 p -65.45 -44.37 87.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.203 -0.935 . . . . 0.0 110.901 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -166.93 162.44 15.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.924 -1.11 . . . . 0.0 109.489 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.61 -37.73 88.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.481 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 3.7 ttmp? -58.91 -45.33 90.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.887 -1.133 . . . . 0.0 109.175 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.524 ' CD ' ' OG ' ' A' ' 76' ' ' SER . 51.7 mt-10 -67.13 -29.14 68.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.19 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.595 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.6 tt -58.6 -43.75 89.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.285 -0.885 . . . . 0.0 110.014 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.84 -44.39 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.716 -1.24 . . . . 0.0 109.718 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 5' ' ' HIS . 3.8 mm? -67.15 -42.38 84.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 109.555 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.836 ' O ' ' CD2' ' A' ' 87' ' ' HIS . 60.1 t60 -60.28 -39.73 87.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.417 -0.802 . . . . 0.0 110.801 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.467 ' HA ' ' OG1' ' A' ' 88' ' ' THR . 4.9 m-30 -71.08 -25.5 62.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.478 -0.764 . . . . 0.0 112.526 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 83' ' ' LEU . 9.2 pt20 -61.23 -30.56 70.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.348 -1.47 . . . . 0.0 110.312 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.836 ' CD2' ' O ' ' A' ' 84' ' ' HIS . 14.2 p80 -92.7 -5.49 51.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.75 -1.219 . . . . 0.0 109.188 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.688 ' O ' HG22 ' A' ' 100' ' ' THR . 56.2 p -98.36 139.76 33.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.158 -0.964 . . . . 0.0 109.455 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.2 t -97.81 126.73 43.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.451 -0.781 . . . . 0.0 109.452 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.731 HD12 HG13 ' A' ' 99' ' ' VAL . 81.8 mt -67.05 -20.04 65.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.983 -1.073 . . . . 0.0 109.833 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.774 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.7 p -10.67 -58.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.834 -0.542 . . . . 0.0 110.171 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.773 ' H ' HG13 ' A' ' 91' ' ' VAL . 9.5 tp-100 -35.17 155.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 92' ' ' GLN . 59.5 t-80 55.49 107.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.814 ' O ' ' N ' ' A' ' 96' ' ' SER . 22.9 m120 56.69 71.84 0.54 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.603 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 94.2 m-20 -29.84 -20.0 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.814 ' N ' ' O ' ' A' ' 94' ' ' ASN . 87.1 p -77.43 15.5 0.77 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.671 -1.268 . . . . 0.0 110.922 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.774 ' O ' ' N ' ' A' ' 91' ' ' VAL . 70.5 mt -95.68 41.67 1.1 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 95' ' ' ASP . 64.1 m-80 -78.39 79.28 4.83 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.321 -0.862 . . . . 0.0 110.073 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.731 HG13 HD12 ' A' ' 90' ' ' LEU . 7.4 p -153.31 157.93 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 88' ' ' THR . 31.8 p -130.26 157.46 42.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.105 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.515 HD22 ' CG ' ' A' ' 33' ' ' PHE . 19.0 mt -82.21 65.73 7.47 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.7 -28.37 12.52 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.489 ' CD1' ' HD2' ' A' ' 104' ' ' PRO . 68.1 t80 -110.48 127.09 27.57 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.14 -1.6 . . . . 0.0 110.973 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.497 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 61.1 Cg_endo -74.82 146.81 33.92 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 123.039 2.493 . . . . 0.0 112.533 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' A' ' 34' ' ' LEU . 9.9 p -83.26 -32.05 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.122 -0.986 . . . . 0.0 110.604 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.541 ' CD2' HG13 ' A' ' 105' ' ' VAL . 35.2 m-85 -129.64 59.35 1.61 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.787 -1.196 . . . . 0.0 110.856 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.764 ' HA ' HG22 ' A' ' 10' ' ' THR . . . -94.28 144.49 25.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.416 -0.802 . . . . 0.0 109.772 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -117.45 157.07 26.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.515 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -78.16 124.0 27.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.272 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.531 ' NH1' ' HG2' ' A' ' 110' ' ' ARG . 2.0 mtt-85 -128.87 170.58 13.21 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.237 -0.914 . . . . 0.0 109.517 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.741 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.604 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.009 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.538 0.685 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 64.6 t0 -58.44 139.35 55.66 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.418 -0.802 . . . . 0.0 109.559 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.504 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 92.6 mt -94.71 129.57 35.85 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 109.583 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.4 -2.35 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.613 2.209 . . . . 0.0 111.998 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.665 ' CD2' ' OE1' ' A' ' 86' ' ' GLN . 4.7 m80 -67.76 -24.52 65.35 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.898 -1.126 . . . . 0.0 109.493 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -58.13 -29.85 65.86 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.595 ' O ' ' OG1' ' A' ' 10' ' ' THR . 94.5 m-20 -89.0 121.73 31.65 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 46.5 tt0 -69.9 -34.58 73.71 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.07 -1.019 . . . . 0.0 109.585 -178.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.469 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -66.46 -21.98 66.2 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 110.95 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 7' ' ' ASP . 8.1 p -64.05 -35.29 80.26 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.776 -1.203 . . . . 0.0 109.978 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.608 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -115.97 -34.3 4.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.94 -1.1 . . . . 0.0 110.182 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -88.1 125.69 34.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.071 -1.018 . . . . 0.0 110.543 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.575 HG21 HH21 ' A' ' 36' ' ' ARG . 24.5 m -108.59 -13.13 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.2 -158.59 30.34 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.482 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 73.7 m -61.52 148.41 42.16 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.18 -1.188 . . . . 0.0 108.524 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.481 ' HB3' ' NE ' ' A' ' 36' ' ' ARG . 40.4 t -168.87 167.61 10.85 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 109.355 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 86.7 m-20 -88.89 134.7 33.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.235 -0.916 . . . . 0.0 109.281 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.496 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 44.8 mtt-85 -59.98 -36.22 76.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.845 -1.159 . . . . 0.0 110.287 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -54.53 -48.24 72.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 0.0 111.121 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 17' ' ' ASN . 14.6 ptpt -69.57 -26.43 64.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.385 -1.447 . . . . 0.0 109.3 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.041 ' HB2' HH12 ' A' ' 36' ' ' ARG . . . -57.34 -43.44 83.43 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -59.58 -44.02 93.47 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -60.15 -48.63 80.91 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.27 -36.49 83.83 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.646 HD13 ' CG1' ' A' ' 54' ' ' VAL . 4.0 mt -82.01 -4.43 56.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.221 -0.924 . . . . 0.0 109.432 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.17 131.38 37.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.33 -0.856 . . . . 0.0 110.5 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.06 1.79 88.52 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.74 ' O ' HG11 ' A' ' 49' ' ' VAL . 36.0 mmtt -100.23 128.19 46.35 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.209 -1.171 . . . . 0.0 110.108 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 30' ' ' ASP . 41.9 ttm180 -62.29 147.75 47.12 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 53.3 p-10 -47.39 156.0 0.3 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.928 -1.107 . . . . 0.0 108.769 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.499 ' H ' HG21 ' A' ' 99' ' ' VAL . . . 99.47 -33.87 5.87 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 60.0 m -72.54 123.93 24.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.167 -1.196 . . . . 0.0 108.831 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.736 ' CD1' ' N ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -145.4 172.24 13.47 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 118.385 -1.326 . . . . 0.0 111.051 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.736 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -148.75 159.76 43.83 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.184 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 11' ' ' TRP . 14.7 t -101.5 138.85 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 1.041 HH12 ' HB2' ' A' ' 21' ' ' ALA . 32.2 ttm180 -150.58 160.38 43.84 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 109.5 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.589 ' C ' ' H ' ' A' ' 39' ' ' SER . 16.0 pm0 -102.24 174.65 5.83 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.63 -1.294 . . . . 0.0 109.304 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.584 ' O ' ' CB ' ' A' ' 39' ' ' SER . 60.3 p -75.48 3.93 8.38 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 178.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.589 ' H ' ' C ' ' A' ' 37' ' ' GLU . 1.8 m 91.9 -19.93 0.11 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.497 -1.683 . . . . 0.0 109.349 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -90.36 120.47 31.51 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -49.33 132.55 20.18 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.224 -0.923 . . . . 0.0 109.351 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.99 0.85 41.9 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 42.2 t -131.67 140.16 49.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.34 -1.094 . . . . 0.0 109.074 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' A' ' 59' ' ' ILE . 44.2 m-85 -127.11 163.38 23.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.164 -0.96 . . . . 0.0 109.84 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.625 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -171.77 155.9 4.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.165 -0.96 . . . . 0.0 108.984 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 57' ' ' CYS . 22.1 p -133.13 142.91 48.93 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.496 -1.377 . . . . 0.0 109.285 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.2 p -116.86 139.28 50.79 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.53 -0.731 . . . . 0.0 109.744 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.625 HG22 ' N ' ' A' ' 49' ' ' VAL . 14.9 p -133.29 166.6 28.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.383 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.74 HG11 ' O ' ' A' ' 28' ' ' LYS . 53.7 t -103.69 137.49 32.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.623 ' C ' ' H ' ' A' ' 52' ' ' GLY . 41.4 t -116.99 152.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.153 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.495 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 62.1 t0 -52.7 2.2 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.095 0.474 . . . . 0.0 110.328 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.623 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -136.19 -32.66 0.26 Allowed Glycine 0 N--CA 1.485 1.952 0 C-N-CA 118.894 -1.622 . . . . 0.0 112.248 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 64.2 mt-10 -158.52 163.57 36.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.444 -1.621 . . . . 0.0 111.399 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.646 ' CG1' HD13 ' A' ' 25' ' ' LEU . 66.1 t -76.63 136.99 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 54' ' ' VAL . 60.8 mmtt -114.9 150.89 34.92 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.823 -1.173 . . . . 0.0 111.347 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -131.69 70.04 1.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.466 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 98.0 m -62.22 142.71 57.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 109.566 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 58' ' ' VAL . 7.7 p -106.7 138.28 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.49 -0.756 . . . . 0.0 109.496 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.558 ' O ' ' O ' ' A' ' 44' ' ' TYR . 90.9 mt -123.08 136.64 59.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.282 -0.886 . . . . 0.0 109.183 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 95.5 m-20 -102.55 166.85 10.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.88 -1.138 . . . . 0.0 109.301 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.36 10.33 9.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.582 -1.324 . . . . 0.0 110.092 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 63' ' ' ALA . 87.9 m -79.51 167.62 20.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.085 -1.009 . . . . 0.0 109.446 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.604 ' N ' HG22 ' A' ' 62' ' ' THR . . . -55.68 -50.18 70.96 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.293 -0.88 . . . . 0.0 108.963 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 64' ' ' THR . 92.3 m -92.97 -0.41 57.22 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.296 -0.878 . . . . 0.0 108.98 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 66' ' ' TYR . . . -78.69 -101.13 0.22 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.575 ' O ' ' O ' ' A' ' 65' ' ' GLY . 69.7 m-85 53.47 164.79 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.192 -1.181 . . . . 0.0 108.496 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.35 -77.41 0.26 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.71 ' CE1' ' OH ' ' A' ' 85' ' ' TYR . 35.5 m-85 -106.36 118.15 35.9 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.467 -1.019 . . . . 0.0 109.247 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 73' ' ' ASN . . . -107.98 -54.54 2.48 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.139 -0.975 . . . . 0.0 110.336 -179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.62 175.31 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.059 -1.026 . . . . 0.0 108.487 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -51.89 -32.78 48.65 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.24 1.96 . . . . 0.0 112.987 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -151.32 8.65 0.54 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.921 -1.112 . . . . 0.0 111.157 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 69' ' ' ALA . 29.5 m120 -100.34 81.21 2.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.386 -1.446 . . . . 0.0 109.324 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.61 98.37 6.35 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.586 ' OH ' ' CG ' ' A' ' 84' ' ' HIS . 87.7 m-85 -54.6 130.84 41.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.379 -0.826 . . . . 0.0 109.702 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.1 t -68.97 -36.22 77.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.426 -0.796 . . . . 0.0 111.671 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.4 m -130.54 159.49 36.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.579 -1.326 . . . . 0.0 110.742 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.23 -37.63 86.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.871 . . . . 0.0 109.084 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -53.77 -44.09 69.77 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.02 -42.5 72.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.386 -0.821 . . . . 0.0 109.989 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.772 HD23 ' C ' ' A' ' 81' ' ' LEU . 6.9 tt -59.8 -46.13 90.18 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.254 -0.904 . . . . 0.0 109.338 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.44 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 72.0 t -63.06 -45.93 97.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 109.599 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.67 HD23 ' OE1' ' A' ' 86' ' ' GLN . 68.6 mt -61.53 -40.1 93.46 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.539 -0.726 . . . . 0.0 110.305 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.586 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 60.1 t-80 -52.0 -48.67 64.33 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.165 -0.959 . . . . 0.0 110.195 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.803 ' HB2' HD12 ' A' ' 101' ' ' LEU . 27.2 m-85 -71.48 -20.71 62.04 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.126 -0.984 . . . . 0.0 112.027 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.67 ' OE1' HD23 ' A' ' 83' ' ' LEU . 27.7 mt-30 -61.56 -36.02 79.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.645 -1.284 . . . . 0.0 109.382 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -93.5 -37.09 12.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.432 -0.792 . . . . 0.0 109.033 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.58 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 7.7 p -89.6 139.82 30.16 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.431 -0.793 . . . . 0.0 110.29 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.6 t -81.39 136.84 35.72 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.564 -0.71 . . . . 0.0 109.48 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.769 ' O ' ' N ' ' A' ' 92' ' ' GLN . 8.0 mt -61.46 -41.8 97.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.434 -0.791 . . . . 0.0 111.012 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.049 HG22 ' OD1' ' A' ' 98' ' ' ASN . 71.8 t 40.29 -81.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.225 -0.922 . . . . 0.0 109.234 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.769 ' N ' ' O ' ' A' ' 90' ' ' LEU . 0.7 OUTLIER 84.44 171.86 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 0.0 110.475 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.422 ' H ' ' HG3' ' A' ' 92' ' ' GLN . 65.0 m80 -60.93 -37.85 83.74 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 88.4 m-20 -57.93 -18.13 21.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 94' ' ' ASN . 97.7 m-20 61.28 23.23 13.49 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.8 m -134.01 11.49 3.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.57 -1.332 . . . . 0.0 111.195 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.614 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.4 mp -104.02 46.24 0.93 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 1.049 ' OD1' HG22 ' A' ' 91' ' ' VAL . 74.3 m-20 -78.08 67.46 3.92 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.448 -177.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.499 HG21 ' H ' ' A' ' 31' ' ' GLY . 7.4 p -132.2 159.04 43.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.447 ' N ' HG22 ' A' ' 99' ' ' VAL . 40.5 p -110.65 152.36 26.58 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.273 -0.892 . . . . 0.0 108.793 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.803 HD12 ' HB2' ' A' ' 85' ' ' TYR . 91.5 mt -93.26 30.23 1.73 Allowed 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.7 -9.19 58.49 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 32' ' ' THR . 73.7 m-85 -121.83 103.77 39.82 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.375 -1.453 . . . . 0.0 111.602 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -61.01 160.92 24.01 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.02 1.813 . . . . 0.0 110.805 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.09 -22.9 7.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.205 -0.935 . . . . 0.0 109.78 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -111.13 34.39 4.08 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.093 -1.004 . . . . 0.0 110.254 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.33 152.01 46.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.308 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -77.05 161.15 28.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.002 -1.061 . . . . 0.0 110.053 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 60.35 32.49 20.69 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.586 -0.696 . . . . 0.0 109.962 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.539 ' NH1' ' HG3' ' A' ' 110' ' ' ARG . 29.9 ttm-85 -127.62 137.78 52.65 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.006 -1.059 . . . . 0.0 109.442 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.734 ' CG ' HH11 ' A' ' 111' ' ' ARG . 1.6 mtt-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.643 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.44 144.49 49.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.362 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 3' ' ' LEU . 5.4 mp -94.32 143.33 26.17 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.34 -0.85 . . . . 0.0 109.656 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.412 ' CG ' ' HG2' ' A' ' 104' ' ' PRO . 33.8 Cg_endo -67.52 -1.31 6.36 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.234 1.956 . . . . 0.0 111.988 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.63 ' NE2' ' OE1' ' A' ' 86' ' ' GLN . 88.7 m-70 -69.69 -32.36 70.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.106 -0.996 . . . . 0.0 108.606 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -60.99 -32.78 72.34 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.343 -0.848 . . . . 0.0 108.807 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.4 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 68.6 m-20 -92.67 129.22 38.66 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.686 0.755 . . . . 0.0 110.814 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.536 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 75.6 tt0 -77.73 -23.45 49.36 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.3 -0.875 . . . . 0.0 110.68 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -17.85 63.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.187 -0.946 . . . . 0.0 111.528 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.606 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 47.1 p -73.42 -26.69 61.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.732 -1.23 . . . . 0.0 111.305 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.606 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -123.58 -21.91 5.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.505 -1.372 . . . . 0.0 109.773 179.073 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -83.62 121.35 27.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 110.882 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' A' ' 15' ' ' SER . 2.2 t -134.61 33.32 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -30.96 -31.68 0.01 OUTLIER Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.63 ' N ' ' O ' ' A' ' 13' ' ' VAL . 89.2 p -69.54 -21.18 63.67 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.804 -1.409 . . . . 0.0 109.965 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 13' ' ' VAL . 41.9 t -66.62 149.38 50.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.068 -1.02 . . . . 0.0 110.269 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.49 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 92.7 m-20 -114.52 167.57 10.62 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.061 -1.024 . . . . 0.0 109.654 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -56.84 -43.54 81.22 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.266 -0.897 . . . . 0.0 109.26 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -65.82 -46.55 78.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.161 -0.962 . . . . 0.0 108.717 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.49 ' HB3' ' H ' ' A' ' 17' ' ' ASN . 82.3 tttt -65.02 -36.37 84.18 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -57.13 -37.81 72.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 108.878 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.603 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 97.1 mt-10 -59.01 -44.17 91.65 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.84 -44.1 94.19 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.447 -0.783 . . . . 0.0 108.975 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.622 ' O ' ' CD ' ' A' ' 28' ' ' LYS . 96.1 mt -71.23 -26.19 62.82 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.335 -0.853 . . . . 0.0 108.837 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.445 HD23 HG23 ' A' ' 49' ' ' VAL . 21.1 mt -94.09 -11.84 29.75 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.603 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 16.6 mmt180 -97.74 134.48 40.85 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.28 -0.38 88.95 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.622 ' CD ' ' O ' ' A' ' 24' ' ' LEU . 19.0 mtpp -105.06 136.65 44.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.094 -1.239 . . . . 0.0 109.468 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -68.27 160.69 28.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.163 -0.96 . . . . 0.0 110.476 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.691 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 84.4 m-20 -57.99 149.45 23.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.518 -0.739 . . . . 0.0 110.218 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 100' ' ' THR . . . 104.71 -30.64 9.71 Favored Glycine 0 N--CA 1.486 2.015 0 C-N-CA 119.41 -1.376 . . . . 0.0 110.222 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.541 HG21 ' CE ' ' A' ' 28' ' ' LYS . 85.0 m -80.17 120.35 24.18 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.418 -1.048 . . . . 0.0 108.207 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.53 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -135.61 164.96 26.65 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 118.806 -1.158 . . . . 0.0 109.656 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -134.01 157.0 47.21 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.398 179.664 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 11' ' ' TRP . 85.5 t -115.41 124.79 72.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.37 -0.831 . . . . 0.0 108.985 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.691 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -152.56 177.35 10.74 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.686 ' C ' ' H ' ' A' ' 39' ' ' SER . 4.3 pm0 -101.88 168.09 9.65 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.088 -1.007 . . . . 0.0 108.861 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.639 ' O ' ' CB ' ' A' ' 39' ' ' SER . 59.8 p -74.22 9.01 1.81 Allowed 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.686 ' H ' ' C ' ' A' ' 37' ' ' GLU . 12.4 p 93.32 -22.18 0.07 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.729 -1.578 . . . . 0.0 108.452 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -74.41 149.85 40.27 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.508 -0.745 . . . . 0.0 109.147 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -76.42 131.71 39.24 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.297 -0.877 . . . . 0.0 109.195 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.49 -1.81 79.67 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 87.7 m -111.54 135.66 51.8 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.351 -1.087 . . . . 0.0 109.605 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.655 ' O ' ' O ' ' A' ' 59' ' ' ILE . 96.0 m-85 -126.92 149.24 49.9 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.965 -1.084 . . . . 0.0 109.146 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.508 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -158.15 137.49 11.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.348 -1.47 . . . . 0.0 109.794 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 20.9 p -116.9 129.87 56.34 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.149 -0.969 . . . . 0.0 109.092 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.7 t -107.58 138.7 43.33 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.657 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.733 HG22 ' N ' ' A' ' 49' ' ' VAL . 10.4 p -128.56 170.75 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.498 -0.751 . . . . 0.0 109.766 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.733 ' N ' HG22 ' A' ' 48' ' ' VAL . 85.4 t -114.71 134.12 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.885 HG13 ' H ' ' A' ' 52' ' ' GLY . 3.9 p -125.25 157.48 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.696 -1.253 . . . . 0.0 110.161 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.691 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 43.2 p30 -49.59 -10.31 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.662 0.744 . . . . 0.0 110.398 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.885 ' H ' HG13 ' A' ' 50' ' ' VAL . . . -98.33 -58.41 0.96 Allowed Glycine 0 C--N 1.287 -2.179 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.567 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 61.5 mt-10 -164.68 -175.21 3.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.395 -1.062 . . . . 0.0 109.725 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 54' ' ' VAL . 18.0 m -90.84 119.87 38.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -119.54 156.71 29.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.435 -1.416 . . . . 0.0 110.454 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -111.76 127.87 55.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.48 -0.762 . . . . 0.0 109.974 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.7 t -105.24 128.56 53.49 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 p -86.35 136.51 22.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.845 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.655 ' O ' ' O ' ' A' ' 44' ' ' TYR . 51.5 mm -118.96 126.74 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.638 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 25.7 m120 -121.62 171.54 8.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.586 -1.321 . . . . 0.0 110.436 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -132.2 61.97 1.65 Allowed 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.3 -1.5 . . . . 0.0 108.772 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.679 ' O ' ' N ' ' A' ' 64' ' ' THR . 32.4 m -135.76 171.24 14.75 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.573 ' N ' HG22 ' A' ' 62' ' ' THR . . . -45.88 -6.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.379 -0.826 . . . . 0.0 109.918 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.679 ' N ' ' O ' ' A' ' 62' ' ' THR . 91.2 m -78.65 -21.09 48.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.149 -0.97 . . . . 0.0 109.537 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 67' ' ' GLY . . . 81.85 67.8 1.49 Allowed Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.638 ' HA ' ' O ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER 33.73 32.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.567 -0.961 . . . . 0.0 110.221 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 65' ' ' GLY . . . 90.01 -40.81 3.0 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.642 ' CD2' ' OH ' ' A' ' 85' ' ' TYR . 97.5 m-85 -95.9 123.69 39.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -1.08 . . . . 0.0 109.38 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.96 7.66 5.58 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.152 -0.967 . . . . 0.0 109.629 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.789 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 19.4 pt-20 -126.51 13.5 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.001 -1.062 . . . . 0.0 111.572 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.789 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 39.6 Cg_endo -71.31 -69.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.489 1.46 . . . . 0.0 112.024 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -143.49 60.01 1.39 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.887 . . . . 0.0 110.247 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 36.1 m120 58.39 48.81 11.74 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.324 -0.86 . . . . 0.0 110.437 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.0 mt 61.97 115.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.267 -0.896 . . . . 0.0 110.43 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -57.77 134.05 55.92 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.486 -0.759 . . . . 0.0 109.688 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.5 m -66.81 -38.55 86.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.825 . . . . 0.0 110.359 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.2 p -142.63 161.37 38.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.913 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.6 mt -61.42 -39.8 92.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.367 -0.833 . . . . 0.0 109.606 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -59.04 -40.07 83.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.124 -0.985 . . . . 0.0 108.946 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.407 ' HG2' ' HD1' ' A' ' 84' ' ' HIS . 85.0 tt0 -64.2 -36.52 84.32 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.4 -0.812 . . . . 0.0 109.192 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.5 tt -59.86 -46.02 90.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.053 -1.029 . . . . 0.0 110.225 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.4 t -63.24 -41.18 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.006 -1.059 . . . . 0.0 109.647 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.464 HD21 ' CD2' ' A' ' 5' ' ' HIS . 76.3 mt -63.16 -43.77 97.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.924 -1.11 . . . . 0.0 111.323 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.407 ' HD1' ' HG2' ' A' ' 80' ' ' GLU . 36.4 m80 -64.84 -43.74 92.06 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.863 -1.148 . . . . 0.0 111.021 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.642 ' OH ' ' CD2' ' A' ' 68' ' ' PHE . 19.0 m-85 -65.64 -24.64 67.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.616 -1.302 . . . . 0.0 109.055 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.671 ' HG3' ' HB2' ' A' ' 102' ' ' ALA . 33.5 tt0 -67.57 -33.16 74.46 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.376 -0.827 . . . . 0.0 109.607 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -95.0 -14.09 24.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.119 -0.988 . . . . 0.0 109.292 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.9 m -108.05 129.97 55.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 109.527 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.0 t -72.95 139.9 47.05 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.978 -1.076 . . . . 0.0 108.614 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.687 ' O ' ' C ' ' A' ' 91' ' ' VAL . 7.6 mp -69.0 -16.03 63.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.116 -0.99 . . . . 0.0 110.688 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.695 ' N ' ' O ' ' A' ' 97' ' ' LEU . 74.6 t -10.15 -64.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.589 0 O-C-N 121.75 -0.594 . . . . 0.0 109.918 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 90' ' ' LEU . 91.3 mt-30 34.71 -142.24 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.402 ' O ' ' N ' ' A' ' 95' ' ' ASP . 82.9 t60 -52.44 -50.07 63.33 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.711 ' O ' ' N ' ' A' ' 96' ' ' SER . 89.4 m-20 -69.7 83.3 0.44 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 94' ' ' ASN . 62.9 t0 -44.03 -10.74 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.421 -0.799 . . . . 0.0 108.903 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.711 ' N ' ' O ' ' A' ' 94' ' ' ASN . 89.3 p -100.56 4.45 43.48 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.507 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.695 ' O ' ' N ' ' A' ' 91' ' ' VAL . 8.3 mt -76.83 50.31 0.7 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.078 -1.639 . . . . 0.0 108.404 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -77.37 80.62 3.87 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.252 -0.905 . . . . 0.0 109.861 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.626 ' HB ' HG23 ' A' ' 50' ' ' VAL . 6.6 p -161.53 162.94 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.544 ' N ' HG22 ' A' ' 99' ' ' VAL . 44.4 p -129.94 155.85 45.39 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.087 -1.008 . . . . 0.0 109.936 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.53 HD22 ' CG ' ' A' ' 33' ' ' PHE . 18.4 mt -89.15 53.9 2.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.021 -1.049 . . . . 0.0 108.673 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.671 ' HB2' ' HG3' ' A' ' 86' ' ' GLN . . . -89.66 -18.09 27.12 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.73 -0.606 . . . . 0.0 112.37 -178.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.484 ' HD2' ' HG1' ' A' ' 32' ' ' THR . 88.4 t80 -116.61 110.16 42.81 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 120.265 -1.522 . . . . 0.0 110.448 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.412 ' HG2' ' CG ' ' A' ' 4' ' ' PRO . 22.7 Cg_exo -59.6 146.96 93.8 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.875 1.716 . . . . 0.0 110.926 178.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.681 HG13 ' CD2' ' A' ' 106' ' ' TYR . 11.4 p -67.99 -22.43 27.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.686 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.681 ' CD2' HG13 ' A' ' 105' ' ' VAL . 59.9 m-85 -128.75 60.88 1.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.903 . . . . 0.0 109.39 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.97 -4.86 14.49 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.971 -1.081 . . . . 0.0 108.657 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -109.03 137.8 46.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 110.051 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -63.89 145.61 55.52 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.412 -0.805 . . . . 0.0 109.273 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 1.243 ' CZ ' ' NH2' ' A' ' 110' ' ' ARG . 42.4 mtp180 -88.82 130.47 35.37 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 . . . . . 0 N--CA 1.494 1.754 0 O-C-N 120.954 -1.091 . . . . 0.0 108.97 -179.757 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -68.7 146.43 52.98 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 109.559 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.88 125.99 60.83 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 121.076 -1.015 . . . . 0.0 108.364 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -49.86 -20.95 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.994 1.796 . . . . 0.0 112.082 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.815 ' CE1' HE22 ' A' ' 86' ' ' GLN . 32.2 m170 -71.57 -29.69 65.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.453 -0.78 . . . . 0.0 109.838 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -67.48 -21.68 65.51 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.566 ' O ' ' OG1' ' A' ' 10' ' ' THR . 76.3 m-20 -95.84 113.33 24.95 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.454 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 32.0 tt0 -70.31 -32.97 70.96 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.473 -0.767 . . . . 0.0 110.801 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.572 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -71.2 -13.62 61.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.758 -1.214 . . . . 0.0 110.945 -178.288 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.573 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 6.6 p -62.97 -37.49 87.32 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.68 -1.262 . . . . 0.0 108.666 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.719 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -117.33 -27.8 6.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.944 -1.098 . . . . 0.0 110.074 179.042 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -86.6 119.66 27.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.924 -1.11 . . . . 0.0 110.442 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 15' ' ' SER . 9.8 p -140.72 31.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -39.12 -20.34 0.01 OUTLIER Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.608 ' N ' ' O ' ' A' ' 13' ' ' VAL . 87.5 p -61.42 -17.52 54.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -1.131 . . . . 0.0 108.589 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.1 m -94.15 145.16 24.89 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.725 0.774 . . . . 0.0 110.731 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.621 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 54.8 p30 -79.64 167.39 20.75 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.394 -0.816 . . . . 0.0 109.335 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.523 ' CG ' ' NH1' ' A' ' 36' ' ' ARG . 81.1 mtm180 -61.05 -39.9 91.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.596 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -63.05 -44.29 96.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.645 -1.285 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.621 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 22.5 tptm -61.13 -35.51 77.26 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.221 -0.924 . . . . 0.0 108.901 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.04 74.32 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 26' ' ' ARG . 94.8 mt-10 -57.63 -45.4 85.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.35 -40.33 93.86 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 24' ' ' LEU . 79.8 mt -67.95 -39.56 83.38 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.543 HD11 ' OG ' ' A' ' 47' ' ' SER . 3.6 mt -82.83 -16.82 46.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.342 -0.848 . . . . 0.0 108.799 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' GLU . 10.6 mmm180 -93.78 -28.4 15.92 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.959 0.885 . . . . 0.0 109.691 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.99 9.17 70.42 Favored Glycine 0 C--N 1.286 -2.231 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.526 ' O ' HG11 ' A' ' 49' ' ' VAL . 29.8 mmtm -124.2 145.54 49.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.499 -1.0 . . . . 0.0 110.001 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -77.67 165.53 24.14 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.395 0.617 . . . . 0.0 110.199 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.538 ' CG ' ' OD1' ' A' ' 51' ' ' ASP . 18.2 p-10 -53.02 158.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.92 -33.8 4.51 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.2 m -77.07 125.61 29.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -1.032 . . . . 0.0 108.311 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 101' ' ' LEU . 0.4 OUTLIER -135.88 170.65 15.66 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.966 -1.083 . . . . 0.0 110.274 -178.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -149.26 165.85 30.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.196 -0.94 . . . . 0.0 111.007 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.557 HG22 ' SG ' ' A' ' 46' ' ' CYS . 73.9 t -120.51 121.48 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.731 ' NH1' ' O ' ' A' ' 37' ' ' GLU . 6.8 ptm180 -134.84 -176.24 4.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.438 -0.788 . . . . 0.0 108.949 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.731 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 56.0 mt-10 -94.18 175.25 6.77 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.871 -1.143 . . . . 0.0 108.494 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.648 ' O ' ' CB ' ' A' ' 39' ' ' SER . 20.9 m -75.95 11.27 1.48 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 178.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.648 ' CB ' ' O ' ' A' ' 38' ' ' SER . 4.8 t 98.45 -71.89 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.602 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -110.08 -45.96 3.52 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.462 -1.399 . . . . 0.0 111.831 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -69.41 160.54 31.16 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.306 -1.496 . . . . 0.0 110.049 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.54 48.21 2.85 Favored Glycine 0 N--CA 1.496 2.67 0 O-C-N 121.163 -0.96 . . . . 0.0 110.972 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 89.5 m -114.81 155.03 27.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.999 -1.295 . . . . 0.0 109.029 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' ILE . 98.1 m-85 -115.46 153.19 31.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.071 -1.018 . . . . 0.0 110.705 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -145.74 133.43 21.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.711 -0.618 . . . . 0.0 109.924 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.609 ' O ' ' CB ' ' A' ' 57' ' ' CYS . 57.3 m -100.0 113.89 26.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.544 -1.347 . . . . 0.0 107.893 178.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.543 ' OG ' HD11 ' A' ' 25' ' ' LEU . 33.4 t -91.71 140.77 29.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.133 -0.98 . . . . 0.0 109.83 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.521 HG13 ' CB ' ' A' ' 33' ' ' PHE . 1.5 t -130.89 156.31 42.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.46 -0.775 . . . . 0.0 109.888 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 28' ' ' LYS . 89.4 t -101.12 135.94 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.799 HG12 ' H ' ' A' ' 52' ' ' GLY . 2.6 t -122.05 147.78 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.542 -1.349 . . . . 0.0 111.124 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.538 ' OD1' ' CG ' ' A' ' 30' ' ' ASP . 82.0 m-20 -55.06 9.36 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.231 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.799 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -135.97 -39.09 0.16 Allowed Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.619 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.539 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 21.6 tt0 -163.14 164.17 25.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.572 -1.546 . . . . 0.0 110.537 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.539 ' N ' ' CG ' ' A' ' 53' ' ' GLU . 96.1 t -67.42 134.69 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.075 -1.015 . . . . 0.0 108.686 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HE3' HD13 ' A' ' 97' ' ' LEU . 40.2 mmtt -112.04 139.02 47.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.831 -1.168 . . . . 0.0 109.12 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -120.57 87.74 2.81 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.609 ' CB ' ' O ' ' A' ' 46' ' ' CYS . 0.5 OUTLIER -70.79 139.66 51.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.154 -0.966 . . . . 0.0 108.723 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.41 129.57 62.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 111.241 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 44' ' ' TYR . 46.8 mm -108.13 117.05 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.656 ' H ' ' CA ' ' A' ' 67' ' ' GLY . 64.4 t30 -95.17 113.02 24.66 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.943 -1.098 . . . . 0.0 110.312 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -83.86 119.37 24.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.822 -1.174 . . . . 0.0 109.871 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 63' ' ' ALA . 86.4 m -141.11 158.65 43.63 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.447 ' N ' HG22 ' A' ' 62' ' ' THR . . . -54.74 -42.07 71.15 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.975 -1.078 . . . . 0.0 108.937 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 62' ' ' THR . 32.5 p -113.15 12.99 19.21 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.099 -1.0 . . . . 0.0 111.124 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 66' ' ' TYR . . . -126.95 -145.57 6.28 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.378 -1.391 . . . . 0.0 110.258 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.598 ' C ' ' O ' ' A' ' 60' ' ' ASN . 38.1 t80 163.78 -14.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.656 ' CA ' ' H ' ' A' ' 60' ' ' ASN . . . 135.67 -83.14 0.28 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.249 -1.941 . . . . 0.0 108.249 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.693 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 35.3 m-85 -80.45 151.88 29.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.334 -1.098 . . . . 0.0 109.684 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.36 33.26 3.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 110.472 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.733 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 7.8 tp10 -61.15 -35.44 23.99 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.754 -1.216 . . . . 0.0 108.673 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.733 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 73.4 Cg_endo -95.62 19.07 0.63 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 123.485 2.79 . . . . 0.0 110.795 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 71' ' ' PRO . 59.3 m-85 68.9 38.45 2.06 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 57.57 43.77 22.07 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 74' ' ' LEU . 96.0 mt -114.82 31.11 6.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.183 -0.948 . . . . 0.0 110.67 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.547 ' CD1' HD23 ' A' ' 81' ' ' LEU . 53.3 m-85 -58.83 149.01 27.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.926 -1.109 . . . . 0.0 109.212 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.3 t -96.03 -44.97 7.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.05 -1.031 . . . . 0.0 110.044 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.1 t -139.98 151.21 45.32 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 110.18 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 78' ' ' LEU . 93.9 mt -66.09 -40.62 90.94 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.708 -0.62 . . . . 0.0 109.875 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -64.95 -40.17 94.6 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.974 -1.078 . . . . 0.0 108.533 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -67.31 -33.07 74.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.369 -0.832 . . . . 0.0 109.029 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.849 ' C ' HD13 ' A' ' 81' ' ' LEU . 2.5 tm? -60.54 -45.18 94.81 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.213 -0.93 . . . . 0.0 108.613 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.98 -42.92 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.347 -0.846 . . . . 0.0 109.176 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.561 HD23 ' OE1' ' A' ' 86' ' ' GLN . 96.5 mt -60.23 -43.87 95.68 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.435 -0.791 . . . . 0.0 111.177 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -63.44 -40.14 96.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.533 -1.354 . . . . 0.0 110.565 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.693 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 5.4 m-85 -64.12 -22.63 67.01 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.901 -1.124 . . . . 0.0 110.698 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.815 HE22 ' CE1' ' A' ' 5' ' ' HIS . 5.2 mt-30 -68.99 -32.62 72.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.456 -1.402 . . . . 0.0 109.024 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -88.14 -19.29 27.18 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.323 -0.861 . . . . 0.0 109.648 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 79.0 m -100.64 127.74 46.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.571 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.556 ' HA ' HG22 ' A' ' 100' ' ' THR . 24.1 p -81.27 139.7 35.29 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.513 -0.742 . . . . 0.0 109.401 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.654 HD23 ' CD2' ' A' ' 93' ' ' HIS . 4.3 mp -75.86 -17.64 59.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.535 -0.728 . . . . 0.0 109.996 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.707 ' N ' ' O ' ' A' ' 97' ' ' LEU . 5.1 p -31.23 -44.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.355 -0.84 . . . . 0.0 110.482 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.562 ' N ' HG13 ' A' ' 91' ' ' VAL . 9.7 pt20 -66.16 -10.91 45.71 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.264 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.654 ' CD2' HD23 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -63.26 -47.0 84.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.582 -1.324 . . . . 0.0 107.893 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 93' ' ' HIS . 88.9 m-20 -138.43 20.2 2.74 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.627 ' N ' ' O ' ' A' ' 91' ' ' VAL . 94.6 m-20 61.05 17.33 7.89 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.457 ' C ' HD22 ' A' ' 97' ' ' LEU . 67.2 m -146.54 9.56 1.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.707 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.6 mm? -97.25 68.18 2.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -78.36 79.76 4.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 110.358 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.456 HG22 ' N ' ' A' ' 100' ' ' THR . 7.6 p -163.69 156.24 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 121.573 0.701 . . . . 0.0 109.59 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 89' ' ' SER . 32.1 p -130.44 153.94 48.25 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.139 -0.975 . . . . 0.0 108.681 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.628 ' O ' ' NE2' ' A' ' 86' ' ' GLN . 17.7 mt -78.61 67.85 4.46 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.51 -27.65 14.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.126 -0.984 . . . . 0.0 111.897 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.47 130.84 24.38 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 120.77 -1.206 . . . . 0.0 111.43 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.54 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 38.1 Cg_endo -74.51 153.41 44.35 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.734 2.289 . . . . 0.0 110.897 177.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.564 HG13 ' CD2' ' A' ' 106' ' ' TYR . 7.7 p -76.74 -30.9 19.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.187 -0.945 . . . . 0.0 109.791 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.564 ' CD2' HG13 ' A' ' 105' ' ' VAL . 50.0 m-85 -113.61 54.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.148 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.54 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . -62.54 136.78 58.06 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.417 0.627 . . . . 0.0 109.913 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -80.31 -4.09 51.99 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.082 -1.011 . . . . 0.0 109.133 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -72.54 143.08 48.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.046 -1.034 . . . . 0.0 108.947 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.708 HH11 ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER 59.42 49.91 8.2 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.507 -0.746 . . . . 0.0 109.111 -179.672 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.683 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.169 -0.92 . . . . 0.0 109.348 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -68.7 146.43 52.98 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 109.559 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.88 125.99 60.83 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 121.076 -1.015 . . . . 0.0 108.364 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -49.86 -20.95 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.994 1.796 . . . . 0.0 112.082 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.815 ' CE1' HE22 ' A' ' 86' ' ' GLN . 32.2 m170 -71.57 -29.69 65.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.453 -0.78 . . . . 0.0 109.838 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -67.48 -21.68 65.51 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.566 ' O ' ' OG1' ' A' ' 10' ' ' THR . 76.3 m-20 -95.84 113.33 24.95 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.454 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 32.0 tt0 -70.31 -32.97 70.96 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.473 -0.767 . . . . 0.0 110.801 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.572 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -71.2 -13.62 61.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.758 -1.214 . . . . 0.0 110.945 -178.288 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.573 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 6.6 p -62.97 -37.49 87.32 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.68 -1.262 . . . . 0.0 108.666 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.719 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -117.33 -27.8 6.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.944 -1.098 . . . . 0.0 110.074 179.042 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -86.6 119.66 27.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.924 -1.11 . . . . 0.0 110.442 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 15' ' ' SER . 9.8 p -140.72 31.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -39.12 -20.34 0.01 OUTLIER Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.608 ' N ' ' O ' ' A' ' 13' ' ' VAL . 87.5 p -61.42 -17.52 54.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -1.131 . . . . 0.0 108.589 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.1 m -94.15 145.16 24.89 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.725 0.774 . . . . 0.0 110.731 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.621 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 54.8 p30 -79.64 167.39 20.75 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.394 -0.816 . . . . 0.0 109.335 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.523 ' CG ' ' NH1' ' A' ' 36' ' ' ARG . 81.1 mtm180 -61.05 -39.9 91.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.596 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -63.05 -44.29 96.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.645 -1.285 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.621 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 22.5 tptm -61.13 -35.51 77.26 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.221 -0.924 . . . . 0.0 108.901 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.04 74.32 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 26' ' ' ARG . 94.8 mt-10 -57.63 -45.4 85.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.35 -40.33 93.86 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 24' ' ' LEU . 79.8 mt -67.95 -39.56 83.38 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.543 HD11 ' OG ' ' A' ' 47' ' ' SER . 3.6 mt -82.83 -16.82 46.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.342 -0.848 . . . . 0.0 108.799 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' GLU . 10.6 mmm180 -93.78 -28.4 15.92 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.959 0.885 . . . . 0.0 109.691 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.99 9.17 70.42 Favored Glycine 0 C--N 1.286 -2.231 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.526 ' O ' HG11 ' A' ' 49' ' ' VAL . 29.8 mmtm -124.2 145.54 49.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.499 -1.0 . . . . 0.0 110.001 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -77.67 165.53 24.14 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.395 0.617 . . . . 0.0 110.199 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.538 ' CG ' ' OD1' ' A' ' 51' ' ' ASP . 18.2 p-10 -53.02 158.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.92 -33.8 4.51 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.2 m -77.07 125.61 29.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -1.032 . . . . 0.0 108.311 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 101' ' ' LEU . 0.4 OUTLIER -135.88 170.65 15.66 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.966 -1.083 . . . . 0.0 110.274 -178.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -149.26 165.85 30.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.196 -0.94 . . . . 0.0 111.007 -179.566 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.557 HG22 ' SG ' ' A' ' 46' ' ' CYS . 73.9 t -120.51 121.48 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.731 ' NH1' ' O ' ' A' ' 37' ' ' GLU . 6.8 ptm180 -134.84 -176.24 4.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.438 -0.788 . . . . 0.0 108.949 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.731 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 56.0 mt-10 -94.18 175.25 6.77 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.871 -1.143 . . . . 0.0 108.494 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.648 ' O ' ' CB ' ' A' ' 39' ' ' SER . 20.9 m -75.95 11.27 1.48 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.648 ' CB ' ' O ' ' A' ' 38' ' ' SER . 4.8 t 98.45 -71.89 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.602 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -110.08 -45.96 3.52 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.462 -1.399 . . . . 0.0 111.831 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -69.41 160.54 31.16 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.306 -1.496 . . . . 0.0 110.049 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.54 48.21 2.85 Favored Glycine 0 N--CA 1.496 2.67 0 O-C-N 121.163 -0.96 . . . . 0.0 110.972 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 89.5 m -114.81 155.03 27.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.999 -1.295 . . . . 0.0 109.029 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' ILE . 98.1 m-85 -115.46 153.19 31.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.071 -1.018 . . . . 0.0 110.705 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -145.74 133.43 21.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.711 -0.618 . . . . 0.0 109.924 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.609 ' O ' ' CB ' ' A' ' 57' ' ' CYS . 57.3 m -100.0 113.89 26.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.544 -1.347 . . . . 0.0 107.893 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.543 ' OG ' HD11 ' A' ' 25' ' ' LEU . 33.4 t -91.71 140.77 29.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.133 -0.98 . . . . 0.0 109.83 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.521 HG13 ' CB ' ' A' ' 33' ' ' PHE . 1.5 t -130.89 156.31 42.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.46 -0.775 . . . . 0.0 109.888 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 28' ' ' LYS . 89.4 t -101.12 135.94 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.799 HG12 ' H ' ' A' ' 52' ' ' GLY . 2.6 t -122.05 147.78 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.542 -1.349 . . . . 0.0 111.124 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.538 ' OD1' ' CG ' ' A' ' 30' ' ' ASP . 82.0 m-20 -55.06 9.36 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.231 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.799 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -135.97 -39.09 0.16 Allowed Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.619 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.539 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 21.6 tt0 -163.14 164.17 25.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.572 -1.546 . . . . 0.0 110.537 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.539 ' N ' ' CG ' ' A' ' 53' ' ' GLU . 96.1 t -67.42 134.69 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.075 -1.015 . . . . 0.0 108.686 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HE3' HD13 ' A' ' 97' ' ' LEU . 40.2 mmtt -112.04 139.02 47.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.831 -1.168 . . . . 0.0 109.12 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -120.57 87.74 2.81 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.609 ' CB ' ' O ' ' A' ' 46' ' ' CYS . 0.5 OUTLIER -70.79 139.66 51.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.154 -0.966 . . . . 0.0 108.723 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.41 129.57 62.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 111.241 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 44' ' ' TYR . 46.8 mm -108.13 117.05 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.656 ' H ' ' CA ' ' A' ' 67' ' ' GLY . 64.4 t30 -95.17 113.02 24.66 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.943 -1.098 . . . . 0.0 110.312 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -83.86 119.37 24.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.822 -1.174 . . . . 0.0 109.871 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 63' ' ' ALA . 86.4 m -141.11 158.65 43.63 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.447 ' N ' HG22 ' A' ' 62' ' ' THR . . . -54.74 -42.07 71.15 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.975 -1.078 . . . . 0.0 108.937 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 62' ' ' THR . 32.5 p -113.15 12.99 19.21 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.099 -1.0 . . . . 0.0 111.124 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 66' ' ' TYR . . . -126.95 -145.57 6.28 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.378 -1.391 . . . . 0.0 110.258 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.598 ' C ' ' O ' ' A' ' 60' ' ' ASN . 38.1 t80 163.78 -14.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.656 ' CA ' ' H ' ' A' ' 60' ' ' ASN . . . 135.67 -83.14 0.28 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.249 -1.941 . . . . 0.0 108.249 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.693 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 35.3 m-85 -80.45 151.88 29.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.334 -1.098 . . . . 0.0 109.684 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.36 33.26 3.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 110.472 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.733 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 7.8 tp10 -61.15 -35.44 23.99 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.754 -1.216 . . . . 0.0 108.673 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.733 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 73.4 Cg_endo -95.62 19.07 0.63 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 123.485 2.79 . . . . 0.0 110.795 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 71' ' ' PRO . 59.3 m-85 68.9 38.45 2.06 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 57.57 43.77 22.07 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 74' ' ' LEU . 96.0 mt -114.82 31.11 6.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.183 -0.948 . . . . 0.0 110.67 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.547 ' CD1' HD23 ' A' ' 81' ' ' LEU . 53.3 m-85 -58.83 149.01 27.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.926 -1.109 . . . . 0.0 109.212 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.3 t -96.03 -44.97 7.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.05 -1.031 . . . . 0.0 110.044 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.1 t -139.98 151.21 45.32 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 110.18 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 78' ' ' LEU . 93.9 mt -66.09 -40.62 90.94 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.708 -0.62 . . . . 0.0 109.875 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -64.95 -40.17 94.6 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.974 -1.078 . . . . 0.0 108.533 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -67.31 -33.07 74.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.369 -0.832 . . . . 0.0 109.029 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.849 ' C ' HD13 ' A' ' 81' ' ' LEU . 2.5 tm? -60.54 -45.18 94.81 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.213 -0.93 . . . . 0.0 108.613 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.98 -42.92 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.347 -0.846 . . . . 0.0 109.176 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.561 HD23 ' OE1' ' A' ' 86' ' ' GLN . 96.5 mt -60.23 -43.87 95.68 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.435 -0.791 . . . . 0.0 111.177 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -63.44 -40.14 96.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.533 -1.354 . . . . 0.0 110.565 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.693 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 5.4 m-85 -64.12 -22.63 67.01 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.901 -1.124 . . . . 0.0 110.698 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.815 HE22 ' CE1' ' A' ' 5' ' ' HIS . 5.2 mt-30 -68.99 -32.62 72.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.456 -1.402 . . . . 0.0 109.024 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -88.14 -19.29 27.18 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.323 -0.861 . . . . 0.0 109.648 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 79.0 m -100.64 127.74 46.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.571 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.556 ' HA ' HG22 ' A' ' 100' ' ' THR . 24.1 p -81.27 139.7 35.29 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.513 -0.742 . . . . 0.0 109.401 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.654 HD23 ' CD2' ' A' ' 93' ' ' HIS . 4.3 mp -75.86 -17.64 59.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.535 -0.728 . . . . 0.0 109.996 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.707 ' N ' ' O ' ' A' ' 97' ' ' LEU . 5.1 p -31.23 -44.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.355 -0.84 . . . . 0.0 110.482 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.562 ' N ' HG13 ' A' ' 91' ' ' VAL . 9.7 pt20 -66.16 -10.91 45.71 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.264 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.654 ' CD2' HD23 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -63.26 -47.0 84.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.582 -1.324 . . . . 0.0 107.893 179.052 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 93' ' ' HIS . 88.9 m-20 -138.43 20.2 2.74 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.627 ' N ' ' O ' ' A' ' 91' ' ' VAL . 94.6 m-20 61.05 17.33 7.89 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.457 ' C ' HD22 ' A' ' 97' ' ' LEU . 67.2 m -146.54 9.56 1.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.707 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.6 mm? -97.25 68.18 2.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -78.36 79.76 4.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 110.358 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.456 HG22 ' N ' ' A' ' 100' ' ' THR . 7.6 p -163.69 156.24 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 121.573 0.701 . . . . 0.0 109.59 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 89' ' ' SER . 32.1 p -130.44 153.94 48.25 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.139 -0.975 . . . . 0.0 108.681 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.628 ' O ' ' NE2' ' A' ' 86' ' ' GLN . 17.7 mt -78.61 67.85 4.46 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.51 -27.65 14.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.126 -0.984 . . . . 0.0 111.897 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.47 130.84 24.38 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 120.77 -1.206 . . . . 0.0 111.43 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.54 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 38.1 Cg_endo -74.51 153.41 44.35 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.734 2.289 . . . . 0.0 110.897 177.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.564 HG13 ' CD2' ' A' ' 106' ' ' TYR . 7.7 p -76.74 -30.9 19.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.187 -0.945 . . . . 0.0 109.791 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.564 ' CD2' HG13 ' A' ' 105' ' ' VAL . 50.0 m-85 -113.61 54.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.148 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.54 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . -62.54 136.78 58.06 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.417 0.627 . . . . 0.0 109.913 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -80.31 -4.09 51.99 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.082 -1.011 . . . . 0.0 109.133 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -72.54 143.08 48.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.046 -1.034 . . . . 0.0 108.947 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.708 HH11 ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER 59.42 49.91 8.2 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.507 -0.746 . . . . 0.0 109.111 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.683 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.169 -0.92 . . . . 0.0 109.348 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -71.37 144.32 49.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.403 -0.811 . . . . 0.0 110.484 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.2 mt -98.6 136.19 20.85 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.41 -4.53 8.24 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.403 2.069 . . . . 0.0 112.661 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.51 ' HA ' ' HE1' ' A' ' 11' ' ' TRP . 93.6 m-70 -79.45 -16.32 56.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.156 -0.965 . . . . 0.0 109.712 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -61.3 -48.35 81.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.703 -1.248 . . . . 0.0 109.331 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.5 129.86 45.71 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.589 ' O ' ' N ' ' A' ' 12' ' ' ASN . 7.4 pm0 -73.03 -2.61 21.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.119 -0.988 . . . . 0.0 109.932 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.56 ' CG ' ' N ' ' A' ' 10' ' ' THR . 36.7 pttt -59.82 -35.95 75.79 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 109.392 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.644 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 69.4 p -66.76 -28.83 68.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.654 -0.653 . . . . 0.0 111.398 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.644 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -126.69 -15.23 5.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.418 -1.426 . . . . 0.0 111.679 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 8' ' ' GLU . 2.1 t-20 -102.67 118.55 37.09 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.406 -1.434 . . . . 0.0 111.511 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.733 ' CG1' ' HE ' ' A' ' 36' ' ' ARG . 9.9 p -135.89 37.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -31.59 -26.42 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 13' ' ' VAL . 99.0 p -61.61 -4.94 1.57 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.659 -1.495 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.1 m -93.77 162.01 14.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.669 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -113.77 164.83 13.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.636 HH21 ' CE1' ' A' ' 56' ' ' HIS . 5.5 mmm180 -58.36 -42.22 86.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.004 -1.06 . . . . 0.0 109.988 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -61.91 -44.14 97.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.865 -1.147 . . . . 0.0 108.817 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -66.06 -29.67 70.05 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.422 -0.798 . . . . 0.0 109.1 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.543 ' CB ' HH12 ' A' ' 36' ' ' ARG . . . -61.61 -40.52 95.11 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.354 -0.841 . . . . 0.0 109.225 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.33 -43.55 96.31 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -64.4 -43.49 94.26 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.417 HD12 ' NH2' ' A' ' 36' ' ' ARG . 73.2 mt -70.33 -36.41 74.24 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.317 -0.865 . . . . 0.0 108.878 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.534 HD21 ' OG ' ' A' ' 47' ' ' SER . 41.3 mt -75.87 -12.6 60.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.73 126.07 30.48 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.57 9.49 78.58 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' CD ' HG21 ' A' ' 32' ' ' THR . 5.1 mmpp? -99.2 126.67 45.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.149 -1.206 . . . . 0.0 109.476 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -77.97 160.76 27.99 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 67.2 t0 -53.92 140.93 29.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.68 . . . . 0.0 110.617 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 110.09 -28.61 10.2 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 91.4 m -83.73 121.0 26.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.254 -1.144 . . . . 0.0 110.062 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.717 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -133.68 156.35 48.08 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.738 -1.226 . . . . 0.0 111.301 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.716 HD22 ' C ' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -111.37 160.15 17.33 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.697 0.761 . . . . 0.0 111.058 -177.712 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.75 HG22 ' SG ' ' A' ' 46' ' ' CYS . 37.8 t -132.21 112.69 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.733 ' HE ' ' CG1' ' A' ' 13' ' ' VAL . 69.5 mtt180 -136.92 172.99 12.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.925 -1.109 . . . . 0.0 110.033 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.663 ' C ' ' H ' ' A' ' 39' ' ' SER . 8.6 pt-20 -85.82 172.1 11.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.019 -1.051 . . . . 0.0 108.385 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.658 ' N ' ' O ' ' A' ' 43' ' ' CYS . 73.2 m -79.18 18.31 0.68 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 177.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.663 ' H ' ' C ' ' A' ' 37' ' ' GLU . 40.9 p 67.16 -110.05 0.13 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.727 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.625 ' N ' ' OG ' ' A' ' 39' ' ' SER . 58.8 tttm -60.29 -40.04 89.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.928 -1.108 . . . . 0.0 110.182 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -78.57 150.72 32.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.917 -1.114 . . . . 0.0 109.369 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.6 4.72 49.81 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.658 ' O ' ' N ' ' A' ' 38' ' ' SER . 88.7 m -79.25 156.61 28.04 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.163 -1.198 . . . . 0.0 109.789 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' A' ' 59' ' ' ILE . 91.5 m-85 -119.93 149.78 41.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.633 -0.667 . . . . 0.0 110.155 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.2 137.57 24.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 108.589 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.75 ' SG ' HG22 ' A' ' 35' ' ' VAL . 33.3 m -107.26 131.18 54.48 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.892 -1.13 . . . . 0.0 108.872 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.534 ' OG ' HD21 ' A' ' 25' ' ' LEU . 1.3 p -90.4 132.82 35.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.414 -0.804 . . . . 0.0 110.183 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 49' ' ' VAL . 3.7 p -132.83 157.02 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.937 -1.102 . . . . 0.0 110.583 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.679 HG13 HG22 ' A' ' 54' ' ' VAL . 60.4 t -118.14 146.66 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.954 HG23 ' HZ3' ' A' ' 55' ' ' LYS . 13.2 t -120.44 161.31 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 0.0 110.296 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.567 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 43.4 p-10 -58.21 6.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.696 -0.628 . . . . 0.0 110.27 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -149.61 -19.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.364 0 C-N-CA 118.958 -1.591 . . . . 0.0 112.252 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.738 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 68.8 tt0 -156.49 169.01 25.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.193 -1.769 . . . . 0.0 111.224 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.679 HG22 HG13 ' A' ' 49' ' ' VAL . 96.9 t -118.53 128.14 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.381 -0.824 . . . . 0.0 109.207 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.954 ' HZ3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -122.05 179.82 4.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.774 -1.204 . . . . 0.0 110.447 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.636 ' CE1' HH21 ' A' ' 18' ' ' ARG . 67.7 m-70 -127.63 82.43 2.09 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.3 m -56.22 135.14 53.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.015 -1.053 . . . . 0.0 108.83 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 58' ' ' VAL . 9.8 p -104.23 133.54 47.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 110.422 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.555 HG23 ' O ' ' A' ' 66' ' ' TYR . 27.1 mm -104.63 123.01 58.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.636 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 91.5 m-20 -108.19 122.77 47.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.922 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -108.37 128.47 54.79 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.95 HG23 ' H ' ' A' ' 64' ' ' THR . 1.8 t -130.41 -175.6 3.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.971 -1.08 . . . . 0.0 108.786 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.515 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -42.02 -26.8 0.1 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.95 ' H ' HG23 ' A' ' 62' ' ' THR . 74.6 m -160.25 72.47 0.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.734 ' O ' ' CG ' ' A' ' 66' ' ' TYR . . . -160.56 179.99 35.7 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.393 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.734 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 88.2 m-85 -168.0 -4.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.44 ' H ' ' H ' ' A' ' 66' ' ' TYR . . . 165.96 -130.64 2.19 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.693 ' CZ ' ' OH ' ' A' ' 75' ' ' TYR . 41.8 p90 -96.12 110.53 22.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.876 -1.367 . . . . 0.0 109.149 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.559 ' HB1' HD23 ' A' ' 74' ' ' LEU . . . -116.49 127.53 54.65 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.668 0.746 . . . . 0.0 109.49 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.656 ' O ' ' N ' ' A' ' 73' ' ' ASN . 98.3 mt-10 -125.57 155.13 72.6 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.494 ' C ' ' O ' ' A' ' 70' ' ' GLU . 50.0 Cg_exo -33.7 -32.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.629 1.553 . . . . 0.0 110.684 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 70' ' ' GLU . 73.7 t80 -94.27 -33.22 13.33 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.656 ' N ' ' O ' ' A' ' 70' ' ' GLU . 88.7 m-20 -101.6 127.6 48.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.752 -0.592 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.559 HD23 ' HB1' ' A' ' 69' ' ' ALA . 93.7 mt -151.28 96.75 2.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.29 -0.881 . . . . 0.0 109.932 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.693 ' OH ' ' CZ ' ' A' ' 68' ' ' PHE . 71.4 m-85 -62.6 127.49 31.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.874 -1.141 . . . . 0.0 109.17 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 72.6 p -89.18 -52.44 5.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 0.0 109.571 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.5 m -141.45 168.65 19.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.371 -0.83 . . . . 0.0 109.032 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 78' ' ' LEU . 89.1 mt -63.75 -37.71 88.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.097 . . . . 0.0 109.635 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -58.49 -40.09 81.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.967 -1.083 . . . . 0.0 108.568 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.1 -32.83 73.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.453 0.645 . . . . 0.0 109.455 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.511 HD12 ' CE1' ' A' ' 75' ' ' TYR . 14.7 tp -53.96 -48.71 70.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.331 -0.855 . . . . 0.0 109.524 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.5 t -66.22 -43.51 91.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 108.825 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.52 -44.0 83.71 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.497 -0.752 . . . . 0.0 110.115 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -60.44 -44.09 96.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 111.152 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.615 ' CB ' HD12 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -75.78 -21.84 57.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.046 -1.034 . . . . 0.0 110.373 -179.182 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.773 ' OE1' ' HB2' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -67.36 -41.99 84.19 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.004 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -73.97 -39.79 63.46 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.652 -0.655 . . . . 0.0 110.037 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 85' ' ' TYR . 33.1 m -97.7 140.39 32.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.145 -0.972 . . . . 0.0 110.558 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.407 ' OG ' HG12 ' A' ' 91' ' ' VAL . 54.1 p -84.81 143.22 29.23 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.72 -0.612 . . . . 0.0 109.981 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 90' ' ' LEU . 8.3 mp -73.02 -18.24 61.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.325 -0.86 . . . . 0.0 109.497 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.709 ' N ' ' O ' ' A' ' 97' ' ' LEU . 3.9 p -34.0 -44.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.196 -0.94 . . . . 0.0 109.911 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.554 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 64.8 tp60 -47.8 -45.9 30.04 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.714 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.61 ' C ' ' H ' ' A' ' 95' ' ' ASP . 42.3 t-80 -62.32 131.71 50.24 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.579 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 12.3 m120 54.27 -0.65 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.61 ' H ' ' C ' ' A' ' 93' ' ' HIS . 89.8 m-20 56.77 24.44 9.1 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.08 -1.012 . . . . 0.0 110.26 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.6 m -144.27 12.07 1.55 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.778 -1.201 . . . . 0.0 110.593 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.709 ' O ' ' N ' ' A' ' 91' ' ' VAL . 6.8 mp -99.14 73.76 1.93 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -78.2 75.98 4.73 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.432 ' CG1' HG22 ' A' ' 50' ' ' VAL . 2.6 p -152.69 155.18 6.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.552 0.692 . . . . 0.0 109.734 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 102' ' ' ALA . 81.4 p -129.31 135.46 48.78 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.717 HD22 ' CG ' ' A' ' 33' ' ' PHE . 62.1 mt -72.52 70.12 0.89 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.773 ' HB2' ' OE1' ' A' ' 86' ' ' GLN . . . -117.23 -7.54 11.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.848 -0.532 . . . . 0.0 111.935 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 32' ' ' THR . 97.5 m-85 -120.73 100.89 46.23 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.398 -1.439 . . . . 0.0 110.67 -178.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.536 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 37.2 Cg_exo -59.67 145.64 97.58 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.613 1.542 . . . . 0.0 110.309 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.465 HG21 HD11 ' A' ' 34' ' ' LEU . 2.6 p -67.86 -34.11 65.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 120.882 -1.136 . . . . 0.0 108.482 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.459 ' CD2' HG13 ' A' ' 105' ' ' VAL . 57.9 m-85 -106.08 44.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.437 -0.789 . . . . 0.0 110.584 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 104' ' ' PRO . . . -96.84 -70.55 0.71 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 0.0 109.418 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -59.93 -41.08 91.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 109.269 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -95.25 133.65 38.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.279 -0.888 . . . . 0.0 109.844 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.482 ' O ' ' C ' ' A' ' 111' ' ' ARG . 71.0 mtm180 -116.99 143.7 45.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 108.784 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.598 HH11 ' HB3' ' A' ' 111' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.108 -0.949 . . . . 0.0 110.225 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -71.37 144.32 49.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.403 -0.811 . . . . 0.0 110.484 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.2 mt -98.6 136.19 20.85 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.41 -4.53 8.24 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.403 2.069 . . . . 0.0 112.661 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.51 ' HA ' ' HE1' ' A' ' 11' ' ' TRP . 93.6 m-70 -79.45 -16.32 56.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.156 -0.965 . . . . 0.0 109.712 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -61.3 -48.35 81.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.703 -1.248 . . . . 0.0 109.331 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.5 129.86 45.71 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.589 ' O ' ' N ' ' A' ' 12' ' ' ASN . 7.4 pm0 -73.03 -2.61 21.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.119 -0.988 . . . . 0.0 109.932 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.56 ' CG ' ' N ' ' A' ' 10' ' ' THR . 36.7 pttt -59.82 -35.95 75.79 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 109.392 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.644 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 69.4 p -66.76 -28.83 68.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.654 -0.653 . . . . 0.0 111.398 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.644 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -126.69 -15.23 5.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.418 -1.426 . . . . 0.0 111.679 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 8' ' ' GLU . 2.1 t-20 -102.67 118.55 37.09 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.406 -1.434 . . . . 0.0 111.511 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.733 ' CG1' ' HE ' ' A' ' 36' ' ' ARG . 9.9 p -135.89 37.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -31.59 -26.42 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 13' ' ' VAL . 99.0 p -61.61 -4.94 1.57 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.659 -1.495 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.1 m -93.77 162.01 14.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.669 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -113.77 164.83 13.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.636 HH21 ' CE1' ' A' ' 56' ' ' HIS . 5.5 mmm180 -58.36 -42.22 86.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.004 -1.06 . . . . 0.0 109.988 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -61.91 -44.14 97.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.865 -1.147 . . . . 0.0 108.817 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -66.06 -29.67 70.05 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.422 -0.798 . . . . 0.0 109.1 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.543 ' CB ' HH12 ' A' ' 36' ' ' ARG . . . -61.61 -40.52 95.11 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.354 -0.841 . . . . 0.0 109.225 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.33 -43.55 96.31 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -64.4 -43.49 94.26 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.417 HD12 ' NH2' ' A' ' 36' ' ' ARG . 73.2 mt -70.33 -36.41 74.24 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.317 -0.865 . . . . 0.0 108.878 178.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.534 HD21 ' OG ' ' A' ' 47' ' ' SER . 41.3 mt -75.87 -12.6 60.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.73 126.07 30.48 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.57 9.49 78.58 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' CD ' HG21 ' A' ' 32' ' ' THR . 5.1 mmpp? -99.2 126.67 45.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.149 -1.206 . . . . 0.0 109.476 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -77.97 160.76 27.99 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 67.2 t0 -53.92 140.93 29.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.68 . . . . 0.0 110.617 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 110.09 -28.61 10.2 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 91.4 m -83.73 121.0 26.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.254 -1.144 . . . . 0.0 110.062 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.717 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -133.68 156.35 48.08 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.738 -1.226 . . . . 0.0 111.301 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.716 HD22 ' C ' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -111.37 160.15 17.33 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.697 0.761 . . . . 0.0 111.058 -177.712 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.75 HG22 ' SG ' ' A' ' 46' ' ' CYS . 37.8 t -132.21 112.69 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.733 ' HE ' ' CG1' ' A' ' 13' ' ' VAL . 69.5 mtt180 -136.92 172.99 12.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.925 -1.109 . . . . 0.0 110.033 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.663 ' C ' ' H ' ' A' ' 39' ' ' SER . 8.6 pt-20 -85.82 172.1 11.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.019 -1.051 . . . . 0.0 108.385 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.658 ' N ' ' O ' ' A' ' 43' ' ' CYS . 73.2 m -79.18 18.31 0.68 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 177.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.663 ' H ' ' C ' ' A' ' 37' ' ' GLU . 40.9 p 67.16 -110.05 0.13 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.727 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.625 ' N ' ' OG ' ' A' ' 39' ' ' SER . 58.8 tttm -60.29 -40.04 89.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.928 -1.108 . . . . 0.0 110.182 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -78.57 150.72 32.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.917 -1.114 . . . . 0.0 109.369 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.6 4.72 49.81 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.658 ' O ' ' N ' ' A' ' 38' ' ' SER . 88.7 m -79.25 156.61 28.04 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.163 -1.198 . . . . 0.0 109.789 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' A' ' 59' ' ' ILE . 91.5 m-85 -119.93 149.78 41.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.633 -0.667 . . . . 0.0 110.155 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.2 137.57 24.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 108.589 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.75 ' SG ' HG22 ' A' ' 35' ' ' VAL . 33.3 m -107.26 131.18 54.48 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.892 -1.13 . . . . 0.0 108.872 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.534 ' OG ' HD21 ' A' ' 25' ' ' LEU . 1.3 p -90.4 132.82 35.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.414 -0.804 . . . . 0.0 110.183 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 49' ' ' VAL . 3.7 p -132.83 157.02 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.937 -1.102 . . . . 0.0 110.583 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.679 HG13 HG22 ' A' ' 54' ' ' VAL . 60.4 t -118.14 146.66 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.954 HG23 ' HZ3' ' A' ' 55' ' ' LYS . 13.2 t -120.44 161.31 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 0.0 110.296 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.567 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 43.4 p-10 -58.21 6.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.696 -0.628 . . . . 0.0 110.27 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -149.61 -19.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.364 0 C-N-CA 118.958 -1.591 . . . . 0.0 112.252 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.738 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 68.8 tt0 -156.49 169.01 25.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.193 -1.769 . . . . 0.0 111.224 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.679 HG22 HG13 ' A' ' 49' ' ' VAL . 96.9 t -118.53 128.14 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.381 -0.824 . . . . 0.0 109.207 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.954 ' HZ3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -122.05 179.82 4.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.774 -1.204 . . . . 0.0 110.447 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.636 ' CE1' HH21 ' A' ' 18' ' ' ARG . 67.7 m-70 -127.63 82.43 2.09 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.3 m -56.22 135.14 53.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.015 -1.053 . . . . 0.0 108.83 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 58' ' ' VAL . 9.8 p -104.23 133.54 47.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 110.422 -178.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.555 HG23 ' O ' ' A' ' 66' ' ' TYR . 27.1 mm -104.63 123.01 58.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.636 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 91.5 m-20 -108.19 122.77 47.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.922 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -108.37 128.47 54.79 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.95 HG23 ' H ' ' A' ' 64' ' ' THR . 1.8 t -130.41 -175.6 3.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.971 -1.08 . . . . 0.0 108.786 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.515 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -42.02 -26.8 0.1 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.95 ' H ' HG23 ' A' ' 62' ' ' THR . 74.6 m -160.25 72.47 0.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.734 ' O ' ' CG ' ' A' ' 66' ' ' TYR . . . -160.56 179.99 35.7 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.393 -178.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.734 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 88.2 m-85 -168.0 -4.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.44 ' H ' ' H ' ' A' ' 66' ' ' TYR . . . 165.96 -130.64 2.19 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.693 ' CZ ' ' OH ' ' A' ' 75' ' ' TYR . 41.8 p90 -96.12 110.53 22.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.876 -1.367 . . . . 0.0 109.149 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.559 ' HB1' HD23 ' A' ' 74' ' ' LEU . . . -116.49 127.53 54.65 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.668 0.746 . . . . 0.0 109.49 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.656 ' O ' ' N ' ' A' ' 73' ' ' ASN . 98.3 mt-10 -125.57 155.13 72.6 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.494 ' C ' ' O ' ' A' ' 70' ' ' GLU . 50.0 Cg_exo -33.7 -32.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.629 1.553 . . . . 0.0 110.684 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 70' ' ' GLU . 73.7 t80 -94.27 -33.22 13.33 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.656 ' N ' ' O ' ' A' ' 70' ' ' GLU . 88.7 m-20 -101.6 127.6 48.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.752 -0.592 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.559 HD23 ' HB1' ' A' ' 69' ' ' ALA . 93.7 mt -151.28 96.75 2.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.29 -0.881 . . . . 0.0 109.932 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.693 ' OH ' ' CZ ' ' A' ' 68' ' ' PHE . 71.4 m-85 -62.6 127.49 31.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.874 -1.141 . . . . 0.0 109.17 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 72.6 p -89.18 -52.44 5.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 0.0 109.571 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.5 m -141.45 168.65 19.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.371 -0.83 . . . . 0.0 109.032 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 78' ' ' LEU . 89.1 mt -63.75 -37.71 88.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.097 . . . . 0.0 109.635 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -58.49 -40.09 81.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.967 -1.083 . . . . 0.0 108.568 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.1 -32.83 73.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.453 0.645 . . . . 0.0 109.455 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.511 HD12 ' CE1' ' A' ' 75' ' ' TYR . 14.7 tp -53.96 -48.71 70.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.331 -0.855 . . . . 0.0 109.524 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.5 t -66.22 -43.51 91.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 108.825 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.52 -44.0 83.71 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.497 -0.752 . . . . 0.0 110.115 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -60.44 -44.09 96.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 111.152 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.615 ' CB ' HD12 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -75.78 -21.84 57.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.046 -1.034 . . . . 0.0 110.373 -179.182 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.773 ' OE1' ' HB2' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -67.36 -41.99 84.19 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.004 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -73.97 -39.79 63.46 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.652 -0.655 . . . . 0.0 110.037 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 85' ' ' TYR . 33.1 m -97.7 140.39 32.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.145 -0.972 . . . . 0.0 110.558 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.407 ' OG ' HG12 ' A' ' 91' ' ' VAL . 54.1 p -84.81 143.22 29.23 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.72 -0.612 . . . . 0.0 109.981 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 90' ' ' LEU . 8.3 mp -73.02 -18.24 61.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.325 -0.86 . . . . 0.0 109.497 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.709 ' N ' ' O ' ' A' ' 97' ' ' LEU . 3.9 p -34.0 -44.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.196 -0.94 . . . . 0.0 109.911 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.554 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 64.8 tp60 -47.8 -45.9 30.04 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.714 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.61 ' C ' ' H ' ' A' ' 95' ' ' ASP . 42.3 t-80 -62.32 131.71 50.24 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.579 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 12.3 m120 54.27 -0.65 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.61 ' H ' ' C ' ' A' ' 93' ' ' HIS . 89.8 m-20 56.77 24.44 9.1 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.08 -1.012 . . . . 0.0 110.26 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.6 m -144.27 12.07 1.55 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.778 -1.201 . . . . 0.0 110.593 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.709 ' O ' ' N ' ' A' ' 91' ' ' VAL . 6.8 mp -99.14 73.76 1.93 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -78.2 75.98 4.73 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.432 ' CG1' HG22 ' A' ' 50' ' ' VAL . 2.6 p -152.69 155.18 6.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.552 0.692 . . . . 0.0 109.734 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 102' ' ' ALA . 81.4 p -129.31 135.46 48.78 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.717 HD22 ' CG ' ' A' ' 33' ' ' PHE . 62.1 mt -72.52 70.12 0.89 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.773 ' HB2' ' OE1' ' A' ' 86' ' ' GLN . . . -117.23 -7.54 11.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.848 -0.532 . . . . 0.0 111.935 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 32' ' ' THR . 97.5 m-85 -120.73 100.89 46.23 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.398 -1.439 . . . . 0.0 110.67 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.536 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 37.2 Cg_exo -59.67 145.64 97.58 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.613 1.542 . . . . 0.0 110.309 178.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.465 HG21 HD11 ' A' ' 34' ' ' LEU . 2.6 p -67.86 -34.11 65.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 120.882 -1.136 . . . . 0.0 108.482 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.459 ' CD2' HG13 ' A' ' 105' ' ' VAL . 57.9 m-85 -106.08 44.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.437 -0.789 . . . . 0.0 110.584 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 104' ' ' PRO . . . -96.84 -70.55 0.71 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 0.0 109.418 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -59.93 -41.08 91.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 109.269 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -95.25 133.65 38.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.279 -0.888 . . . . 0.0 109.844 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.482 ' O ' ' C ' ' A' ' 111' ' ' ARG . 71.0 mtm180 -116.99 143.7 45.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 108.784 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.598 HH11 ' HB3' ' A' ' 111' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.108 -0.949 . . . . 0.0 110.225 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.297 0.57 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -97.22 18.54 14.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 109.788 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.535 ' HG ' ' H ' ' A' ' 5' ' ' HIS . 25.0 tp -115.41 115.92 41.96 Favored Pre-proline 0 C--N 1.297 -1.687 0 O-C-N 121.433 -0.792 . . . . 0.0 109.172 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -56.03 -6.25 1.2 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.04 1.826 . . . . 0.0 111.744 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.535 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 84.0 m-70 -88.67 -12.72 41.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 110.641 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -60.94 -40.52 93.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.779 -1.201 . . . . 0.0 108.963 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.424 ' CB ' ' HE2' ' A' ' 9' ' ' LYS . 79.1 m-20 -108.96 130.15 55.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.283 -0.885 . . . . 0.0 109.244 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.684 ' O ' ' N ' ' A' ' 12' ' ' ASN . 3.6 pm0 -73.59 -7.68 52.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.038 -1.039 . . . . 0.0 110.304 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.508 ' CG ' ' N ' ' A' ' 10' ' ' THR . 6.1 pttt -60.54 -36.4 78.35 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.065 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.641 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 38.0 p -61.51 -31.97 71.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.564 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.641 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -121.44 -12.6 8.55 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.916 -1.115 . . . . 0.0 110.457 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 8' ' ' GLU . 57.8 t30 -88.69 116.55 27.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.908 -1.12 . . . . 0.0 111.231 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 15' ' ' SER . 9.9 p -140.08 31.67 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 CA-C-O 122.007 0.908 . . . . 0.0 108.831 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -42.82 -22.43 0.15 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 13' ' ' VAL . 59.5 m -67.99 -36.77 80.56 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.019 -1.283 . . . . 0.0 110.106 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.667 ' C ' ' HE ' ' A' ' 36' ' ' ARG . 47.3 t -65.71 147.66 53.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.302 -0.874 . . . . 0.0 110.133 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.516 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 76.1 m-20 -86.66 163.65 17.26 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 61.5 mtp180 -60.0 -40.65 89.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.093 -1.005 . . . . 0.0 109.767 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -60.06 -42.97 95.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.008 -1.057 . . . . 0.0 109.503 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.5 tttm -64.89 -28.77 69.76 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.144 -0.972 . . . . 0.0 108.455 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.905 ' HB2' HH22 ' A' ' 36' ' ' ARG . . . -58.43 -41.83 85.92 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 98.4 mt-10 -61.13 -44.73 96.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.106 -0.996 . . . . 0.0 108.343 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -60.36 -46.29 90.48 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.474 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 79.7 mt -63.17 -40.17 96.76 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.644 HD23 HG23 ' A' ' 49' ' ' VAL . 4.5 mt -72.19 -31.95 66.36 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.526 ' NH1' ' HG3' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -68.28 132.61 47.42 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.806 -0.559 . . . . 0.0 109.59 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.17 9.76 84.69 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.503 ' HB2' HG21 ' A' ' 49' ' ' VAL . 47.7 mmtt -108.74 133.29 53.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.07 -1.253 . . . . 0.0 109.438 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -75.6 168.87 19.2 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.344 -0.847 . . . . 0.0 109.41 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 59.1 t0 -59.07 140.83 55.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.587 -0.695 . . . . 0.0 110.328 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.457 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 109.01 -26.57 14.99 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 48' ' ' VAL . 84.9 m -63.35 121.47 13.85 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.695 ' CD2' HD22 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -138.41 145.13 40.62 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.96 -1.088 . . . . 0.0 111.406 -178.113 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.495 HD23 ' N ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -142.95 157.9 44.12 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.621 0.724 . . . . 0.0 109.905 178.569 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.548 HG22 ' SG ' ' A' ' 46' ' ' CYS . 97.7 t -104.05 139.52 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.905 HH22 ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -147.88 164.07 34.84 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.717 -1.239 . . . . 0.0 108.751 -177.763 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.673 ' OE1' ' CE1' ' A' ' 44' ' ' TYR . 66.6 mm-40 -87.03 170.24 11.72 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.522 -1.361 . . . . 0.0 108.122 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.652 ' N ' ' O ' ' A' ' 43' ' ' CYS . 88.2 p -77.1 12.98 1.21 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.668 ' H ' ' C ' ' A' ' 37' ' ' GLU . 1.7 t 91.27 -129.25 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.128 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -90.01 1.85 55.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.104 -0.998 . . . . 0.0 109.468 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -69.56 -30.12 67.84 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.126 -0.984 . . . . 0.0 110.525 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.94 -13.14 49.63 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.652 ' O ' ' N ' ' A' ' 38' ' ' SER . 95.1 m -89.93 160.51 16.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -1.168 . . . . 0.0 109.269 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.673 ' CE1' ' OE1' ' A' ' 37' ' ' GLU . 98.5 m-85 -105.02 157.03 17.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 110.159 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.598 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -163.34 143.49 8.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.008 -1.058 . . . . 0.0 109.905 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.548 ' SG ' HG22 ' A' ' 35' ' ' VAL . 60.6 m -115.13 143.41 45.25 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.581 ' HB2' HD11 ' A' ' 25' ' ' LEU . 97.0 p -113.6 144.69 42.48 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.931 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -152.97 158.56 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 121.675 0.75 . . . . 0.0 110.257 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.644 HG23 HD23 ' A' ' 25' ' ' LEU . 53.3 t -98.78 142.5 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.544 ' CG1' ' CD ' ' A' ' 55' ' ' LYS . 12.8 p -155.59 150.52 10.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 C-N-CA 118.128 -1.429 . . . . 0.0 112.166 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.613 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 65.5 t0 36.13 33.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.813 -0.554 . . . . 0.0 111.954 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 81.36 3.99 90.53 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 118.958 -1.591 . . . . 0.0 111.307 178.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -127.24 134.53 50.07 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.845 -1.386 . . . . 0.0 110.077 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.635 ' CG1' HD13 ' A' ' 25' ' ' LEU . 72.3 t -81.41 129.12 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.301 0.572 . . . . 0.0 109.522 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.544 ' CD ' ' CG1' ' A' ' 50' ' ' VAL . 5.7 mptt -130.82 148.15 52.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.359 -0.838 . . . . 0.0 110.292 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -107.3 107.18 17.99 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.65 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.543 ' N ' ' O ' ' A' ' 46' ' ' CYS . 52.6 t -68.96 126.71 30.64 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.9 t -93.3 131.41 40.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.387 -0.821 . . . . 0.0 111.279 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 66' ' ' TYR . 37.9 mm -108.65 133.29 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 66' ' ' TYR . 26.3 m120 -121.13 126.99 51.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.778 -1.201 . . . . 0.0 110.875 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -105.85 125.72 51.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.47 -0.769 . . . . 0.0 109.023 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.707 HG22 ' N ' ' A' ' 63' ' ' ALA . 99.5 m -127.58 174.81 8.75 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.707 ' N ' HG22 ' A' ' 62' ' ' THR . . . -36.12 -30.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 108.894 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.606 ' N ' ' O ' ' A' ' 62' ' ' THR . 88.7 m -153.23 58.41 0.77 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.264 -0.897 . . . . 0.0 109.627 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -150.58 -168.93 15.94 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.581 ' O ' ' N ' ' A' ' 60' ' ' ASN . 88.8 t80 -165.3 -61.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.43 -1.041 . . . . 0.0 109.055 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.718 ' H ' HD13 ' A' ' 74' ' ' LEU . . . -118.26 -165.53 13.43 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.58 ' O ' HD21 ' A' ' 74' ' ' LEU . 25.7 p90 -66.78 145.35 55.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.999 -1.295 . . . . 0.0 109.24 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.54 144.83 32.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.409 -0.807 . . . . 0.0 109.818 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.691 ' O ' ' N ' ' A' ' 72' ' ' TYR . 70.6 mm-40 -132.69 158.83 74.73 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.479 ' C ' ' O ' ' A' ' 70' ' ' GLU . 50.4 Cg_exo -33.72 -24.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.62 1.547 . . . . 0.0 110.756 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.691 ' N ' ' O ' ' A' ' 70' ' ' GLU . 97.6 m-85 -114.44 122.04 45.4 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 72' ' ' TYR . 36.9 p-10 -43.56 158.11 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.287 -0.883 . . . . 0.0 109.834 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.718 HD13 ' H ' ' A' ' 67' ' ' GLY . 95.1 mt -68.8 174.24 4.54 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.266 1.032 . . . . 0.0 109.008 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.832 ' CZ ' ' CG ' ' A' ' 84' ' ' HIS . 97.5 m-85 -82.28 152.37 26.36 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.899 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 80.2 p -74.65 -22.97 58.61 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.494 -0.754 . . . . 0.0 111.535 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.8 p -120.54 146.25 46.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.545 -1.347 . . . . 0.0 110.213 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.581 HD22 ' CE1' ' A' ' 66' ' ' TYR . 88.1 mt -60.22 -43.95 95.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.714 . . . . 0.0 109.266 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -61.08 -43.17 99.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.436 -0.79 . . . . 0.0 109.841 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.494 ' O ' ' HD2' ' A' ' 84' ' ' HIS . 87.8 tt0 -63.65 -40.1 96.0 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.056 -1.027 . . . . 0.0 109.773 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.725 HD23 ' C ' ' A' ' 81' ' ' LEU . 8.5 tt -61.27 -44.9 96.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.963 . . . . 0.0 109.909 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.547 HG21 ' CZ3' ' A' ' 11' ' ' TRP . 91.8 t -64.01 -38.73 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.066 -1.021 . . . . 0.0 109.175 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 86' ' ' GLN . 62.5 tp -63.93 -46.82 83.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.746 . . . . 0.0 111.227 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.832 ' CG ' ' CZ ' ' A' ' 75' ' ' TYR . 62.8 m-70 -67.91 -40.45 83.43 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.624 -1.297 . . . . 0.0 110.764 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.453 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 5.2 m-85 -61.24 -29.09 69.62 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.396 -0.815 . . . . 0.0 110.247 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -68.01 -13.83 62.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.756 -1.215 . . . . 0.0 109.85 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -103.21 -31.07 10.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.043 -1.036 . . . . 0.0 109.948 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.0 m -87.37 141.28 28.75 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.074 -1.016 . . . . 0.0 110.737 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.0 m -88.79 124.18 33.91 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.764 ' O ' ' N ' ' A' ' 92' ' ' GLN . 21.7 mt -60.76 -40.69 93.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.835 . . . . 0.0 111.18 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.727 HG12 ' N ' ' A' ' 92' ' ' GLN . 4.2 t 31.84 -81.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.595 0 O-C-N 120.959 -1.088 . . . . 0.0 110.001 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.764 ' N ' ' O ' ' A' ' 90' ' ' LEU . 54.9 mt-30 56.22 -159.2 0.22 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.568 -0.708 . . . . 0.0 111.779 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.437 ' H ' ' HB3' ' A' ' 92' ' ' GLN . 79.6 m-70 -55.11 -44.11 74.65 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.321 -0.862 . . . . 0.0 109.286 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.678 ' O ' ' N ' ' A' ' 96' ' ' SER . 30.1 m120 -81.14 91.13 6.09 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 94' ' ' ASN . 50.5 t0 -43.64 -8.95 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.474 -0.766 . . . . 0.0 110.43 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 94' ' ' ASN . 95.0 p -89.77 -0.09 57.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.832 -1.167 . . . . 0.0 112.19 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.721 ' O ' ' N ' ' A' ' 91' ' ' VAL . 68.7 mt -83.81 30.83 0.49 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.783 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 0.8 OUTLIER -76.26 53.9 0.85 Allowed 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.97 0.891 . . . . 0.0 108.973 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.5 150.88 33.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 102' ' ' ALA . 43.7 p -114.28 150.68 34.05 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.695 HD22 ' CD2' ' A' ' 33' ' ' PHE . 30.4 mt -71.7 68.06 0.59 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -100.87 -25.41 14.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 112.228 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -116.05 104.05 52.7 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.376 -1.453 . . . . 0.0 111.181 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 107' ' ' ALA . 31.6 Cg_exo -57.89 159.41 17.91 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.609 2.206 . . . . 0.0 110.433 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.518 HG13 ' CD2' ' A' ' 106' ' ' TYR . 13.2 p -78.59 -28.71 14.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 120.737 -1.227 . . . . 0.0 108.115 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.518 ' CD2' HG13 ' A' ' 105' ' ' VAL . 57.1 m-85 -112.07 29.98 7.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.487 -0.758 . . . . 0.0 109.159 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.51 ' HB2' ' HD2' ' A' ' 104' ' ' PRO . . . -58.81 141.02 54.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.903 . . . . 0.0 109.082 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 58.65 55.53 4.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.458 -0.776 . . . . 0.0 109.522 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -87.41 137.69 32.12 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 108.862 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.455 ' O ' ' OXT' ' A' ' 111' ' ' ARG . 41.8 ttm180 -109.83 128.81 55.56 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.091 -1.006 . . . . 0.0 109.124 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.643 ' HG2' HH11 ' A' ' 111' ' ' ARG . 7.3 ttt-85 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.221 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.272 0.558 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -82.17 124.89 30.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.0 108.854 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.2 tp -99.3 128.4 31.89 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 120.818 -1.176 . . . . 0.0 108.623 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.505 ' O ' ' OG1' ' A' ' 10' ' ' THR . 78.5 Cg_exo -48.66 -19.99 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.39 2.06 . . . . 0.0 112.675 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.2 m170 -67.35 -26.08 66.3 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.925 -1.109 . . . . 0.0 109.741 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -63.4 -39.21 93.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.196 -0.94 . . . . 0.0 110.8 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.528 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 69.2 m-20 -93.16 128.7 39.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.991 -1.068 . . . . 0.0 110.421 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.707 ' O ' ' N ' ' A' ' 12' ' ' ASN . 94.0 mt-10 -66.87 -26.55 66.95 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.239 -0.913 . . . . 0.0 110.479 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.501 ' HG2' ' N ' ' A' ' 10' ' ' THR . 1.2 pttp -60.86 -35.92 77.82 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.194 -0.941 . . . . 0.0 111.339 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.535 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 2.7 p -60.23 -33.14 71.85 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 109.895 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.654 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -122.67 -20.84 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 111.098 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.707 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -91.82 119.21 31.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.723 -1.235 . . . . 0.0 110.257 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.98 -4.54 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.301 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.83 -142.21 30.54 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -82.49 121.2 26.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.324 . . . . 0.0 109.115 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.0 t -141.24 148.14 39.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 110.154 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.503 ' CG ' ' OD1' ' A' ' 19' ' ' ASN . 58.3 t-20 -74.24 134.3 42.68 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.163 -0.961 . . . . 0.0 108.752 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.629 ' CG ' HH12 ' A' ' 36' ' ' ARG . 23.7 mtp180 -59.36 -33.06 70.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.489 -0.757 . . . . 0.0 109.836 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 13.9 p-10 -59.71 -46.3 89.51 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.857 -1.137 . . . . 0.0 108.41 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 29.5 tttt -64.62 -39.78 94.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 109.034 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.78 78.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.086 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.22 -40.48 77.59 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -60.15 -44.71 94.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 24' ' ' LEU . 91.1 mt -66.16 -31.79 72.84 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.468 -0.77 . . . . 0.0 109.263 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.525 HD23 ' CG2' ' A' ' 49' ' ' VAL . 9.9 mt -91.3 -4.12 56.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.551 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 27' ' ' GLY . 2.9 tpt180 -91.58 125.51 36.34 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.476 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . 70.63 24.99 76.43 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.831 ' HE2' HG21 ' A' ' 32' ' ' THR . 37.9 tptt -106.67 139.97 40.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -1.214 . . . . 0.0 108.676 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -71.43 149.09 46.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.326 -0.859 . . . . 0.0 110.867 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.557 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 64.3 t0 -58.7 144.17 44.37 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.498 0.666 . . . . 0.0 110.072 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 104.66 -24.87 27.38 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.831 HG21 ' HE2' ' A' ' 28' ' ' LYS . 85.4 m -81.58 124.86 29.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.986 -1.302 . . . . 0.0 109.128 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.582 ' CG ' HD22 ' A' ' 101' ' ' LEU . 1.1 p90 -140.03 164.89 28.81 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.16 -1.416 . . . . 0.0 111.601 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 34' ' ' LEU . 1.1 pt? -137.27 156.97 47.64 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.673 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 11' ' ' TRP . 53.1 t -110.43 134.4 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.629 HH12 ' CG ' ' A' ' 18' ' ' ARG . 75.7 mtm180 -130.39 -179.49 5.29 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.426 -0.796 . . . . 0.0 109.235 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.678 ' C ' ' H ' ' A' ' 39' ' ' SER . 8.7 pt-20 -105.27 173.03 6.48 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 108.999 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 43' ' ' CYS . 51.3 m -78.49 18.29 0.58 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.678 ' H ' ' C ' ' A' ' 37' ' ' GLU . 33.2 t 61.08 142.58 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.988 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 41' ' ' GLN . 37.7 mttp 59.27 34.26 22.93 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -0.916 . . . . 0.0 109.131 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 40' ' ' LYS . 59.9 tt0 58.52 148.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.827 . . . . 0.0 109.512 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.584 ' O ' ' SG ' ' A' ' 43' ' ' CYS . . . 151.81 -66.29 0.35 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 42' ' ' GLY . 82.0 m -156.19 -172.63 4.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.686 -1.479 . . . . 0.0 109.643 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.454 ' O ' ' O ' ' A' ' 59' ' ' ILE . 86.8 m-85 -117.45 158.68 24.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 109.617 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.49 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -147.15 132.87 18.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 109.686 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 27.4 p -102.6 117.69 35.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 108.974 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.5 m -98.77 127.28 44.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 108.868 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.65 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.5 p -127.89 166.39 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 110.536 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.65 ' N ' HG22 ' A' ' 48' ' ' VAL . 15.5 t -108.16 138.18 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.876 HG12 ' H ' ' A' ' 52' ' ' GLY . 54.2 t -114.24 148.32 17.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.421 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 61.4 t0 -50.64 -12.96 0.11 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.119 0.961 . . . . 0.0 108.601 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.876 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -102.95 -51.1 1.03 Allowed Glycine 0 C--N 1.289 -2.05 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.593 ' HB2' ' HZ1' ' A' ' 55' ' ' LYS . 70.6 mm-40 -160.32 -177.44 6.25 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.865 -1.373 . . . . 0.0 110.428 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -94.21 128.27 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.552 -0.718 . . . . 0.0 109.405 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.593 ' HZ1' ' HB2' ' A' ' 53' ' ' GLU . 9.3 mptt -128.89 148.63 50.93 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.262 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -104.55 98.22 8.02 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.2 m -82.61 145.12 29.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.715 -1.241 . . . . 0.0 109.103 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 58' ' ' VAL . 6.9 p -107.11 139.85 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.233 -0.917 . . . . 0.0 112.877 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 66' ' ' TYR . 49.9 mm -107.11 126.77 63.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 176.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.64 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 88.1 m-20 -114.9 125.28 53.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.827 -1.171 . . . . 0.0 110.81 -177.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -109.36 122.68 47.9 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.506 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.694 ' O ' ' N ' ' A' ' 64' ' ' THR . 74.3 p -140.22 167.48 22.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 109.554 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -40.07 -18.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.694 ' N ' ' O ' ' A' ' 62' ' ' THR . 84.8 m -153.47 40.77 0.53 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.576 -0.703 . . . . 0.0 109.431 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.677 ' O ' ' CD2' ' A' ' 66' ' ' TYR . . . -144.5 169.3 26.5 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.391 -1.385 . . . . 0.0 110.693 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.677 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 59.0 m-85 -168.19 -18.94 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.69 -85.56 0.11 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 73' ' ' ASN . 51.3 m-85 -103.43 139.2 39.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.145 -1.209 . . . . 0.0 109.336 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 73' ' ' ASN . . . -127.0 7.65 6.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.182 -0.949 . . . . 0.0 110.332 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.737 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 35.7 mp0 -106.22 -27.0 0.19 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.912 -1.118 . . . . 0.0 110.935 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 94.5 Cg_endo -89.17 -59.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.6 2.2 . . . . 0.0 111.991 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.712 ' CE1' ' NE2' ' A' ' 84' ' ' HIS . 93.7 m-85 -118.13 16.07 14.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.134 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.494 ' HB3' HD22 ' A' ' 74' ' ' LEU . 35.1 m120 61.77 -124.59 0.8 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.389 -0.82 . . . . 0.0 110.7 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.641 HD22 ' N ' ' A' ' 74' ' ' LEU . 1.2 mm? -102.13 107.55 18.67 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.222 -0.924 . . . . 0.0 108.54 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.586 ' CD2' HD23 ' A' ' 81' ' ' LEU . 98.8 m-85 -50.34 145.04 6.67 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.6 m -60.17 -43.47 95.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.522 -0.736 . . . . 0.0 111.313 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p -152.11 169.21 22.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.861 -1.149 . . . . 0.0 109.995 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -36.72 77.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.703 -0.623 . . . . 0.0 109.672 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -60.0 -40.89 90.74 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.011 -1.055 . . . . 0.0 108.63 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.11 -31.1 70.47 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.745 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.3 tm? -59.73 -45.77 91.15 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.432 HG21 ' CZ3' ' A' ' 11' ' ' TRP . 98.0 t -65.01 -45.0 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.03 . . . . 0.0 108.81 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.47 -43.01 77.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 110.057 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.712 ' NE2' ' CE1' ' A' ' 72' ' ' TYR . 53.6 t-80 -60.72 -42.71 97.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.353 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.504 ' CE2' HD11 ' A' ' 81' ' ' LEU . 4.6 m-30 -68.87 -25.1 64.46 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.083 -1.01 . . . . 0.0 109.387 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.579 ' OE1' ' ND1' ' A' ' 87' ' ' HIS . 1.3 tm0? -61.95 -34.68 76.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.217 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.579 ' ND1' ' OE1' ' A' ' 86' ' ' GLN . 87.9 m-70 -95.08 -18.73 20.74 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.015 -1.053 . . . . 0.0 110.888 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -102.67 133.09 48.27 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.036 -1.04 . . . . 0.0 109.9 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.3 t -74.21 133.51 42.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.417 -0.802 . . . . 0.0 109.48 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 92' ' ' GLN . 8.8 mp -62.51 -29.23 70.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.476 -0.765 . . . . 0.0 110.573 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.936 HG13 ' H ' ' A' ' 92' ' ' GLN . 8.6 p 2.34 -66.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 121.318 0.58 . . . . 0.0 111.492 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.936 ' H ' HG13 ' A' ' 91' ' ' VAL . 19.6 pt20 35.28 -149.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.826 0.822 . . . . 0.0 111.503 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.734 ' C ' ' H ' ' A' ' 95' ' ' ASP . 63.8 m80 -50.55 171.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.37 -0.831 . . . . 0.0 109.951 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 78.8 m-20 63.02 -22.19 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.734 ' H ' ' C ' ' A' ' 93' ' ' HIS . 86.0 m-20 53.95 31.37 13.31 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.739 -0.601 . . . . 0.0 109.676 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.7 m -134.33 -0.5 2.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.807 -1.183 . . . . 0.0 111.24 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 96.0 mt -82.09 57.55 3.59 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -79.7 84.77 5.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.647 0.737 . . . . 0.0 109.33 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.554 ' O ' HD13 ' A' ' 90' ' ' LEU . 3.0 p -159.94 155.98 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.428 ' N ' HG22 ' A' ' 99' ' ' VAL . 32.5 p -122.42 146.06 47.7 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.082 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.582 HD22 ' CG ' ' A' ' 33' ' ' PHE . 34.8 mt -80.19 65.86 5.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 108.698 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . . . -99.68 -22.86 15.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.855 . . . . 0.0 112.296 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.2 m-85 -115.18 114.05 43.46 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.46 -1.4 . . . . 0.0 110.897 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.408 ' CB ' ' O ' ' A' ' 10' ' ' THR . 10.5 Cg_exo -63.06 156.27 55.9 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.982 1.788 . . . . 0.0 111.227 178.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.73 -30.33 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.942 -1.099 . . . . 0.0 109.455 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -99.88 30.98 3.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.082 -1.011 . . . . 0.0 110.208 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.95 20.07 0.5 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 109.143 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -53.71 137.61 37.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.271 -0.893 . . . . 0.0 109.528 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -94.13 140.81 29.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.97 . . . . 0.0 109.708 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.687 HH11 ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -104.99 132.37 51.31 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.216 -0.927 . . . . 0.0 109.248 179.383 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 . . . . . 0 C--N 1.299 -1.628 0 CA-C-O 118.159 -0.924 . . . . 0.0 109.339 179.43 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.272 0.558 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -82.17 124.89 30.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.0 108.854 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.2 tp -99.3 128.4 31.89 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 120.818 -1.176 . . . . 0.0 108.623 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.505 ' O ' ' OG1' ' A' ' 10' ' ' THR . 78.5 Cg_exo -48.66 -19.99 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.39 2.06 . . . . 0.0 112.675 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.2 m170 -67.35 -26.08 66.3 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.925 -1.109 . . . . 0.0 109.741 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -63.4 -39.21 93.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.196 -0.94 . . . . 0.0 110.8 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.528 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 69.2 m-20 -93.16 128.7 39.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.991 -1.068 . . . . 0.0 110.421 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.707 ' O ' ' N ' ' A' ' 12' ' ' ASN . 94.0 mt-10 -66.87 -26.55 66.95 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.239 -0.913 . . . . 0.0 110.479 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.501 ' HG2' ' N ' ' A' ' 10' ' ' THR . 1.2 pttp -60.86 -35.92 77.82 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.194 -0.941 . . . . 0.0 111.339 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.535 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 2.7 p -60.23 -33.14 71.85 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 109.895 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.654 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -122.67 -20.84 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 111.098 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.707 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -91.82 119.21 31.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.723 -1.235 . . . . 0.0 110.257 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.98 -4.54 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.301 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.83 -142.21 30.54 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -82.49 121.2 26.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.324 . . . . 0.0 109.115 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.0 t -141.24 148.14 39.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 110.154 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.503 ' CG ' ' OD1' ' A' ' 19' ' ' ASN . 58.3 t-20 -74.24 134.3 42.68 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.163 -0.961 . . . . 0.0 108.752 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.629 ' CG ' HH12 ' A' ' 36' ' ' ARG . 23.7 mtp180 -59.36 -33.06 70.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.489 -0.757 . . . . 0.0 109.836 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 13.9 p-10 -59.71 -46.3 89.51 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.857 -1.137 . . . . 0.0 108.41 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 29.5 tttt -64.62 -39.78 94.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 109.034 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.78 78.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.086 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.22 -40.48 77.59 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -60.15 -44.71 94.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 24' ' ' LEU . 91.1 mt -66.16 -31.79 72.84 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.468 -0.77 . . . . 0.0 109.263 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.525 HD23 ' CG2' ' A' ' 49' ' ' VAL . 9.9 mt -91.3 -4.12 56.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.551 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 27' ' ' GLY . 2.9 tpt180 -91.58 125.51 36.34 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.476 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . 70.63 24.99 76.43 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.831 ' HE2' HG21 ' A' ' 32' ' ' THR . 37.9 tptt -106.67 139.97 40.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -1.214 . . . . 0.0 108.676 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -71.43 149.09 46.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.326 -0.859 . . . . 0.0 110.867 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.557 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 64.3 t0 -58.7 144.17 44.37 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.498 0.666 . . . . 0.0 110.072 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 104.66 -24.87 27.38 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.831 HG21 ' HE2' ' A' ' 28' ' ' LYS . 85.4 m -81.58 124.86 29.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.986 -1.302 . . . . 0.0 109.128 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.582 ' CG ' HD22 ' A' ' 101' ' ' LEU . 1.1 p90 -140.03 164.89 28.81 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.16 -1.416 . . . . 0.0 111.601 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 34' ' ' LEU . 1.1 pt? -137.27 156.97 47.64 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.673 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 11' ' ' TRP . 53.1 t -110.43 134.4 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.629 HH12 ' CG ' ' A' ' 18' ' ' ARG . 75.7 mtm180 -130.39 -179.49 5.29 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.426 -0.796 . . . . 0.0 109.235 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.678 ' C ' ' H ' ' A' ' 39' ' ' SER . 8.7 pt-20 -105.27 173.03 6.48 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 108.999 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 43' ' ' CYS . 51.3 m -78.49 18.29 0.58 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.678 ' H ' ' C ' ' A' ' 37' ' ' GLU . 33.2 t 61.08 142.58 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.988 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 41' ' ' GLN . 37.7 mttp 59.27 34.26 22.93 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -0.916 . . . . 0.0 109.131 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 40' ' ' LYS . 59.9 tt0 58.52 148.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.827 . . . . 0.0 109.512 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.584 ' O ' ' SG ' ' A' ' 43' ' ' CYS . . . 151.81 -66.29 0.35 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 42' ' ' GLY . 82.0 m -156.19 -172.63 4.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.686 -1.479 . . . . 0.0 109.643 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.454 ' O ' ' O ' ' A' ' 59' ' ' ILE . 86.8 m-85 -117.45 158.68 24.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 109.617 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.49 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -147.15 132.87 18.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 109.686 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 27.4 p -102.6 117.69 35.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 108.974 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.5 m -98.77 127.28 44.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 108.868 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.65 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.5 p -127.89 166.39 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 110.536 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.65 ' N ' HG22 ' A' ' 48' ' ' VAL . 15.5 t -108.16 138.18 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.876 HG12 ' H ' ' A' ' 52' ' ' GLY . 54.2 t -114.24 148.32 17.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.421 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 61.4 t0 -50.64 -12.96 0.11 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.119 0.961 . . . . 0.0 108.601 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.876 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -102.95 -51.1 1.03 Allowed Glycine 0 C--N 1.289 -2.05 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.593 ' HB2' ' HZ1' ' A' ' 55' ' ' LYS . 70.6 mm-40 -160.32 -177.44 6.25 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.865 -1.373 . . . . 0.0 110.428 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -94.21 128.27 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.552 -0.718 . . . . 0.0 109.405 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.593 ' HZ1' ' HB2' ' A' ' 53' ' ' GLU . 9.3 mptt -128.89 148.63 50.93 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.262 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -104.55 98.22 8.02 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.2 m -82.61 145.12 29.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.715 -1.241 . . . . 0.0 109.103 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 58' ' ' VAL . 6.9 p -107.11 139.85 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.233 -0.917 . . . . 0.0 112.877 -176.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 66' ' ' TYR . 49.9 mm -107.11 126.77 63.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 176.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.64 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 88.1 m-20 -114.9 125.28 53.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.827 -1.171 . . . . 0.0 110.81 -177.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -109.36 122.68 47.9 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.506 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.694 ' O ' ' N ' ' A' ' 64' ' ' THR . 74.3 p -140.22 167.48 22.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 109.554 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -40.07 -18.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.694 ' N ' ' O ' ' A' ' 62' ' ' THR . 84.8 m -153.47 40.77 0.53 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.576 -0.703 . . . . 0.0 109.431 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.677 ' O ' ' CD2' ' A' ' 66' ' ' TYR . . . -144.5 169.3 26.5 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.391 -1.385 . . . . 0.0 110.693 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.677 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 59.0 m-85 -168.19 -18.94 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.69 -85.56 0.11 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 73' ' ' ASN . 51.3 m-85 -103.43 139.2 39.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.145 -1.209 . . . . 0.0 109.336 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 73' ' ' ASN . . . -127.0 7.65 6.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.182 -0.949 . . . . 0.0 110.332 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.737 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 35.7 mp0 -106.22 -27.0 0.19 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.912 -1.118 . . . . 0.0 110.935 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 94.5 Cg_endo -89.17 -59.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.6 2.2 . . . . 0.0 111.991 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.712 ' CE1' ' NE2' ' A' ' 84' ' ' HIS . 93.7 m-85 -118.13 16.07 14.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.134 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.494 ' HB3' HD22 ' A' ' 74' ' ' LEU . 35.1 m120 61.77 -124.59 0.8 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.389 -0.82 . . . . 0.0 110.7 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.641 HD22 ' N ' ' A' ' 74' ' ' LEU . 1.2 mm? -102.13 107.55 18.67 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.222 -0.924 . . . . 0.0 108.54 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.586 ' CD2' HD23 ' A' ' 81' ' ' LEU . 98.8 m-85 -50.34 145.04 6.67 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.6 m -60.17 -43.47 95.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.522 -0.736 . . . . 0.0 111.313 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p -152.11 169.21 22.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.861 -1.149 . . . . 0.0 109.995 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -36.72 77.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.703 -0.623 . . . . 0.0 109.672 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -60.0 -40.89 90.74 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.011 -1.055 . . . . 0.0 108.63 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.11 -31.1 70.47 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.745 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.3 tm? -59.73 -45.77 91.15 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.432 HG21 ' CZ3' ' A' ' 11' ' ' TRP . 98.0 t -65.01 -45.0 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.03 . . . . 0.0 108.81 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.47 -43.01 77.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 110.057 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.712 ' NE2' ' CE1' ' A' ' 72' ' ' TYR . 53.6 t-80 -60.72 -42.71 97.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.353 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.504 ' CE2' HD11 ' A' ' 81' ' ' LEU . 4.6 m-30 -68.87 -25.1 64.46 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.083 -1.01 . . . . 0.0 109.387 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.579 ' OE1' ' ND1' ' A' ' 87' ' ' HIS . 1.3 tm0? -61.95 -34.68 76.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.217 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.579 ' ND1' ' OE1' ' A' ' 86' ' ' GLN . 87.9 m-70 -95.08 -18.73 20.74 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.015 -1.053 . . . . 0.0 110.888 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -102.67 133.09 48.27 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.036 -1.04 . . . . 0.0 109.9 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.3 t -74.21 133.51 42.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.417 -0.802 . . . . 0.0 109.48 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 92' ' ' GLN . 8.8 mp -62.51 -29.23 70.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.476 -0.765 . . . . 0.0 110.573 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.936 HG13 ' H ' ' A' ' 92' ' ' GLN . 8.6 p 2.34 -66.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 121.318 0.58 . . . . 0.0 111.492 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.936 ' H ' HG13 ' A' ' 91' ' ' VAL . 19.6 pt20 35.28 -149.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.826 0.822 . . . . 0.0 111.503 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.734 ' C ' ' H ' ' A' ' 95' ' ' ASP . 63.8 m80 -50.55 171.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.37 -0.831 . . . . 0.0 109.951 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 78.8 m-20 63.02 -22.19 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.734 ' H ' ' C ' ' A' ' 93' ' ' HIS . 86.0 m-20 53.95 31.37 13.31 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.739 -0.601 . . . . 0.0 109.676 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.7 m -134.33 -0.5 2.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.807 -1.183 . . . . 0.0 111.24 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 96.0 mt -82.09 57.55 3.59 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -79.7 84.77 5.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.647 0.737 . . . . 0.0 109.33 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.554 ' O ' HD13 ' A' ' 90' ' ' LEU . 3.0 p -159.94 155.98 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.428 ' N ' HG22 ' A' ' 99' ' ' VAL . 32.5 p -122.42 146.06 47.7 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.082 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.582 HD22 ' CG ' ' A' ' 33' ' ' PHE . 34.8 mt -80.19 65.86 5.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 108.698 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . . . -99.68 -22.86 15.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.855 . . . . 0.0 112.296 -178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.2 m-85 -115.18 114.05 43.46 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.46 -1.4 . . . . 0.0 110.897 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.408 ' CB ' ' O ' ' A' ' 10' ' ' THR . 10.5 Cg_exo -63.06 156.27 55.9 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.982 1.788 . . . . 0.0 111.227 178.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.73 -30.33 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.942 -1.099 . . . . 0.0 109.455 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -99.88 30.98 3.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.082 -1.011 . . . . 0.0 110.208 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.95 20.07 0.5 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 109.143 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -53.71 137.61 37.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.271 -0.893 . . . . 0.0 109.528 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -94.13 140.81 29.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.97 . . . . 0.0 109.708 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.687 HH11 ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -104.99 132.37 51.31 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.216 -0.927 . . . . 0.0 109.248 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 . . . . . 0 C--N 1.299 -1.628 0 CA-C-O 118.159 -0.924 . . . . 0.0 109.339 179.43 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.323 0.582 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -66.88 132.6 48.33 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.132 -0.98 . . . . 0.0 109.149 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 mp -94.46 126.49 47.76 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.307 -0.871 . . . . 0.0 109.558 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -54.88 -12.06 4.32 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.145 1.897 . . . . 0.0 111.612 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.655 ' NE2' ' OE1' ' A' ' 86' ' ' GLN . 83.8 m-70 -65.22 -31.8 73.15 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.354 -0.841 . . . . 0.0 109.349 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -61.85 -22.02 65.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.387 -0.82 . . . . 0.0 109.234 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.715 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 71.6 m-20 -90.93 114.47 26.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.31 -0.869 . . . . 0.0 109.443 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.552 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 39.7 tt0 -67.22 -37.86 84.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.015 -1.053 . . . . 0.0 109.898 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HG2' ' N ' ' A' ' 10' ' ' THR . 0.4 OUTLIER -62.89 -29.06 70.47 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.487 -0.758 . . . . 0.0 110.642 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.627 ' OG1' ' O ' ' A' ' 7' ' ' ASP . 9.6 p -59.65 -35.12 73.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.132 -0.98 . . . . 0.0 110.381 -178.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.715 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -124.77 -5.69 7.49 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.738 -1.226 . . . . 0.0 110.125 179.568 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 8' ' ' GLU . 51.3 t-20 -96.76 129.2 44.22 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.989 -1.069 . . . . 0.0 110.441 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 13' ' ' VAL . 97.9 t -107.13 -12.04 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.84 . . . . 0.0 109.524 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.42 -154.16 50.09 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 88.7 p -68.57 143.13 54.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.05 -1.264 . . . . 0.0 109.622 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.7 p -157.98 154.94 28.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 109.81 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.645 ' C ' ' H ' ' A' ' 19' ' ' ASN . 58.9 t30 -89.02 19.81 3.97 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.537 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.0 OUTLIER 58.8 -12.89 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.389 -0.819 . . . . 0.0 109.787 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.645 ' H ' ' C ' ' A' ' 17' ' ' ASN . 57.8 t-20 -67.53 -46.7 72.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.615 -1.303 . . . . 0.0 108.425 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.37 -27.34 68.5 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -57.28 -43.94 83.56 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.573 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 68.4 mm-40 -61.14 -44.91 96.6 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -63.53 -45.63 89.72 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.445 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 83.0 mt -67.19 -36.83 82.57 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.541 HD13 ' CG1' ' A' ' 54' ' ' VAL . 55.4 mt -82.05 -9.01 59.69 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.573 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 14.2 mmm180 -102.69 123.4 46.32 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.9 -4.49 63.18 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 34.4 mmtt -98.64 138.99 35.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.079 -1.248 . . . . 0.0 109.504 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -73.24 161.21 30.81 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.698 -0.626 . . . . 0.0 109.76 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 57.4 p-10 -58.66 149.47 25.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.23 -0.919 . . . . 0.0 109.9 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.27 -25.53 27.88 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 27.7 m -80.51 120.37 24.4 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.424 -1.045 . . . . 0.0 108.696 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.782 ' HB2' HG22 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -130.67 161.69 31.08 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.389 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.451 HD21 HD21 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -132.55 167.79 19.38 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.699 -178.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 46' ' ' CYS . 82.7 t -130.81 129.27 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.908 -1.12 . . . . 0.0 110.654 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.668 ' NH2' ' OG ' ' A' ' 47' ' ' SER . 67.8 mtm180 -129.45 -149.77 0.41 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' A' ' 39' ' ' SER . 71.7 mm-40 -105.65 173.32 6.36 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.655 ' O ' ' CB ' ' A' ' 39' ' ' SER . 63.3 p -78.19 5.43 10.25 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 177.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.67 ' OG ' ' N ' ' A' ' 40' ' ' LYS . 23.0 p 99.02 -91.05 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.734 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.67 ' N ' ' OG ' ' A' ' 39' ' ' SER . 7.2 pttm -121.84 0.74 9.83 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.094 -1.004 . . . . 0.0 109.552 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -79.2 -15.5 57.96 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.206 -0.934 . . . . 0.0 109.828 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.16 -12.14 68.77 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.603 ' O ' ' N ' ' A' ' 38' ' ' SER . 97.1 m -87.44 177.07 7.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.165 -1.197 . . . . 0.0 109.404 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.495 ' O ' ' O ' ' A' ' 59' ' ' ILE . 98.1 m-85 -110.69 153.35 25.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.903 -1.123 . . . . 0.0 109.959 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.91 133.09 23.02 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.457 -0.777 . . . . 0.0 109.123 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.44 ' HB3' HG22 ' A' ' 35' ' ' VAL . 17.1 p -115.87 134.61 54.82 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.206 -0.933 . . . . 0.0 109.502 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.668 ' OG ' ' NH2' ' A' ' 36' ' ' ARG . 70.7 m -98.65 146.15 26.15 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.597 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' ' 33' ' ' PHE . 67.6 t -129.37 160.8 39.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.435 -0.79 . . . . 0.0 108.871 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.551 ' N ' HG12 ' A' ' 48' ' ' VAL . 63.2 t -118.5 128.33 75.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.702 HG23 ' CG2' ' A' ' 99' ' ' VAL . 9.3 p -126.03 156.37 36.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.859 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.442 ' N ' HG22 ' A' ' 50' ' ' VAL . 97.9 m-20 -48.84 -18.39 0.27 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.639 0.733 . . . . 0.0 109.911 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.587 ' H ' HG13 ' A' ' 50' ' ' VAL . . . -85.22 -59.57 1.93 Allowed Glycine 0 C--N 1.284 -2.348 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.425 ' H ' HG13 ' A' ' 50' ' ' VAL . 21.9 pt-20 -164.85 -165.93 0.98 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.169 -1.195 . . . . 0.0 110.629 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.541 ' CG1' HD13 ' A' ' 25' ' ' LEU . 79.5 t -95.05 130.62 43.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.466 ' NZ ' ' HG ' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -117.75 156.81 27.63 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.71 -1.244 . . . . 0.0 110.823 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.513 ' ND1' ' OG ' ' A' ' 47' ' ' SER . 25.5 m-70 -120.83 71.32 0.93 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.8 m -60.17 143.84 51.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 109.804 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.13 143.08 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.672 -0.643 . . . . 0.0 110.58 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.495 ' O ' ' O ' ' A' ' 44' ' ' TYR . 44.8 mm -115.49 140.44 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.592 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 89.8 m-20 -114.34 129.44 56.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.553 -1.342 . . . . 0.0 110.549 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -90.45 120.02 31.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.412 -0.805 . . . . 0.0 110.139 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 63' ' ' ALA . 90.7 m -159.63 165.41 32.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.276 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.566 ' N ' HG22 ' A' ' 62' ' ' THR . . . -60.68 -41.58 95.4 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.27 30.06 6.18 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.454 -0.779 . . . . 0.0 110.535 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.607 ' C ' ' H ' ' A' ' 67' ' ' GLY . . . -120.66 -75.29 0.41 Allowed Glycine 0 N--CA 1.497 2.766 0 C-N-CA 119.355 -1.402 . . . . 0.0 110.939 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.592 ' CA ' ' O ' ' A' ' 60' ' ' ASN . 81.7 m-85 63.08 -9.82 0.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.181 -1.188 . . . . 0.0 108.94 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 65' ' ' GLY . . . 135.86 -68.03 0.54 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.821 ' CE2' ' CZ ' ' A' ' 85' ' ' TYR . 91.9 m-85 -105.15 129.87 53.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.98 -1.306 . . . . 0.0 109.092 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.31 -6.94 0.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.044 -1.035 . . . . 0.0 109.857 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.702 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 32.0 tt0 -65.94 -35.31 10.63 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.151 -0.968 . . . . 0.0 109.93 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 1.4 Cg_endo -80.61 -46.16 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.87 2.38 . . . . 0.0 112.205 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.497 ' CE2' HD23 ' A' ' 74' ' ' LEU . 54.5 t80 -157.14 142.56 17.35 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -97.69 111.36 23.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.248 -0.907 . . . . 0.0 110.108 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.497 HD23 ' CE2' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -158.58 -125.48 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.716 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.479 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 47.1 m-85 58.76 51.7 7.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.12 -0.987 . . . . 0.0 109.785 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.467 ' N ' ' OE1' ' A' ' 80' ' ' GLU . 74.7 m -56.09 -33.63 65.25 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.25 -0.906 . . . . 0.0 109.538 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.9 t -128.17 151.3 49.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.96 . . . . 0.0 109.879 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.2 mt -57.28 -34.67 68.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.363 -0.835 . . . . 0.0 109.301 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -58.65 -40.14 82.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 0.0 108.612 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 76' ' ' SER . 98.0 mt-10 -60.24 -40.12 89.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.339 -0.851 . . . . 0.0 109.287 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.43 -46.49 89.89 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.208 -0.932 . . . . 0.0 109.132 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.51 -43.7 83.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.464 -0.772 . . . . 0.0 108.987 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 tp -65.86 -45.16 83.17 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.243 -0.911 . . . . 0.0 110.214 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -64.44 -40.28 95.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.978 -1.076 . . . . 0.0 111.182 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.821 ' CZ ' ' CE2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -75.51 -14.85 60.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.928 -1.108 . . . . 0.0 111.738 -178.245 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.655 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 14.4 pt20 -66.86 -25.59 66.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.507 -1.37 . . . . 0.0 108.853 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -88.17 -36.41 16.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 109.896 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.487 ' O ' HG22 ' A' ' 100' ' ' THR . 91.2 m -83.26 149.42 26.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 0.0 110.513 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.0 m -99.05 130.21 45.37 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.573 0.702 . . . . 0.0 110.549 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.707 ' O ' ' N ' ' A' ' 92' ' ' GLN . 1.8 mt -62.06 -15.73 46.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.49 -0.756 . . . . 0.0 110.034 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.755 ' N ' ' O ' ' A' ' 97' ' ' LEU . 9.1 p -21.63 -38.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.87 -0.519 . . . . 0.0 111.297 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.707 ' N ' ' O ' ' A' ' 90' ' ' LEU . 5.3 pt20 -60.67 -42.83 97.85 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.509 ' N ' ' HG3' ' A' ' 92' ' ' GLN . 43.2 m-70 -59.73 -44.3 93.83 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.739 ' O ' ' N ' ' A' ' 96' ' ' SER . 9.5 m120 -131.68 116.31 17.17 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 94' ' ' ASN . 80.7 m-20 -40.87 -12.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.288 -0.882 . . . . 0.0 109.892 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.739 ' N ' ' O ' ' A' ' 94' ' ' ASN . 46.1 t -112.75 22.07 14.89 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.74 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.755 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.9 mt -95.67 56.62 1.79 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.783 -1.198 . . . . 0.0 108.896 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -77.85 69.72 4.12 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.124 -0.985 . . . . 0.0 108.87 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.702 ' CG2' HG23 ' A' ' 50' ' ' VAL . 86.2 t -149.55 154.33 9.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 86' ' ' GLN . 9.8 p -129.46 164.16 24.3 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.674 HD22 ' CG ' ' A' ' 33' ' ' PHE . 28.5 mt -78.78 70.63 5.15 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.894 -1.129 . . . . 0.0 108.169 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.91 -31.33 13.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.804 . . . . 0.0 112.356 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 32' ' ' THR . 59.7 m-85 -113.45 113.57 48.22 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 120.23 -1.544 . . . . 0.0 111.763 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.5 146.83 96.16 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.726 1.617 . . . . 0.0 110.615 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 106' ' ' TYR . 9.0 p -67.95 -38.1 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.013 -1.054 . . . . 0.0 110.442 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.462 ' HE2' HG22 ' A' ' 13' ' ' VAL . 53.7 m-85 -101.24 27.62 6.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.064 -1.023 . . . . 0.0 109.974 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.43 140.49 58.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.12 -0.988 . . . . 0.0 110.156 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -92.44 135.63 33.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.915 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -93.82 2.61 56.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.0 109.479 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.467 ' O ' ' OXT' ' A' ' 111' ' ' ARG . 23.0 tpt180 -115.67 139.1 50.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.051 -1.03 . . . . 0.0 109.424 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.467 ' OXT' ' O ' ' A' ' 110' ' ' ARG . 93.1 mtt180 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.855 -1.069 . . . . 0.0 109.665 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 49.8 p-10 -64.93 148.61 51.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.398 -0.814 . . . . 0.0 109.682 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.526 ' N ' HD22 ' A' ' 3' ' ' LEU . 4.1 mm? -89.35 138.07 28.8 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.208 -0.932 . . . . 0.0 108.992 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.44 ' HB3' HG21 ' A' ' 10' ' ' THR . 15.2 Cg_exo -57.2 -12.43 10.1 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.721 1.614 . . . . 0.0 111.445 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -54.9 -25.99 32.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.627 -0.671 . . . . 0.0 110.424 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -61.39 -28.93 69.6 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.957 -1.089 . . . . 0.0 110.293 -179.39 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.655 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 88.9 m-20 -98.14 131.82 44.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.724 -1.235 . . . . 0.0 110.743 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.685 ' O ' ' N ' ' A' ' 12' ' ' ASN . 79.5 mt-10 -67.34 -27.13 66.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.467 -0.771 . . . . 0.0 109.139 179.163 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.47 ' CG ' ' N ' ' A' ' 10' ' ' THR . 37.6 pttt -59.64 -34.54 72.94 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.424 -0.797 . . . . 0.0 110.825 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.69 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 49.0 p -67.91 -26.34 65.93 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.392 -0.817 . . . . 0.0 111.013 -178.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.69 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -125.79 -25.15 3.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.617 -1.302 . . . . 0.0 110.543 179.636 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.685 ' N ' ' O ' ' A' ' 8' ' ' GLU . 8.8 p-10 -91.03 138.13 31.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.784 -1.197 . . . . 0.0 110.191 -178.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.0 p -111.52 -9.78 11.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.325 -0.859 . . . . 0.0 109.738 -179.484 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.82 50.39 3.53 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.797 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.52 ' HA ' ' H ' ' A' ' 37' ' ' GLU . 17.3 t 59.07 65.81 1.15 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.889 -1.36 . . . . 0.0 110.766 178.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.628 ' O ' ' CZ ' ' A' ' 36' ' ' ARG . 95.5 p -77.78 166.67 22.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.169 -0.957 . . . . 0.0 109.659 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.651 ' C ' HH12 ' A' ' 36' ' ' ARG . 86.1 m-20 -73.34 142.95 47.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.977 -1.077 . . . . 0.0 109.238 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.629 ' N ' HH12 ' A' ' 36' ' ' ARG . 35.0 mtm180 -60.22 -35.66 75.93 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.402 -0.811 . . . . 0.0 109.639 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -64.07 -43.71 94.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.939 -1.1 . . . . 0.0 109.08 179.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -68.46 -37.82 80.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.902 -1.124 . . . . 0.0 108.74 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.6 72.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.175 -0.953 . . . . 0.0 109.012 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 26' ' ' ARG . 67.3 tt0 -59.67 -48.85 80.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.241 -0.912 . . . . 0.0 108.827 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -60.25 -41.09 92.46 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.57 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.0 mt -66.76 -36.51 82.6 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.078 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.3 mt -86.93 -10.07 54.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.086 -1.009 . . . . 0.0 108.606 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.55 HH11 ' HG3' ' A' ' 26' ' ' ARG . 11.9 mmm-85 -100.45 135.36 42.01 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.418 0.628 . . . . 0.0 110.241 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.28 2.91 90.69 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -105.06 141.85 35.89 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.146 -1.208 . . . . 0.0 109.482 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -66.21 153.56 42.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.572 -0.705 . . . . 0.0 110.025 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.578 ' OD2' ' CA ' ' A' ' 51' ' ' ASP . 84.5 m-20 -58.74 144.67 42.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 0.0 109.486 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.41 -20.88 34.07 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.499 HG23 ' HD2' ' A' ' 103' ' ' TYR . 62.5 m -86.45 119.95 27.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.244 -1.151 . . . . 0.0 108.972 179.234 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.709 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -136.73 167.92 20.51 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.107 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.654 ' CD1' ' OG ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -140.29 157.11 46.08 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.002 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.443 HG22 ' SG ' ' A' ' 46' ' ' CYS . 47.4 t -106.97 133.47 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.991 -1.068 . . . . 0.0 108.604 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.651 HH12 ' C ' ' A' ' 17' ' ' ASN . 14.2 ptm180 -152.37 -177.52 6.25 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.112 -0.992 . . . . 0.0 109.35 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.72 ' C ' ' H ' ' A' ' 39' ' ' SER . 32.9 tt0 -106.58 166.15 10.77 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.612 ' O ' ' OG ' ' A' ' 39' ' ' SER . 60.1 m -76.28 19.75 0.23 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 177.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.72 ' H ' ' C ' ' A' ' 37' ' ' GLU . 99.8 p 60.83 -77.36 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.74 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.697 ' O ' ' CB ' ' A' ' 41' ' ' GLN . 61.1 tttp -92.65 131.37 37.8 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.697 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 65.4 tt0 116.79 -33.92 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.44 2.94 84.72 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.3 t -78.52 134.36 37.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.179 -1.189 . . . . 0.0 109.692 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -81.32 165.01 21.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.872 . . . . 0.0 109.666 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -168.39 139.3 2.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.988 -1.07 . . . . 0.0 110.324 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.443 ' SG ' HG22 ' A' ' 35' ' ' VAL . 63.1 m -108.64 126.47 53.01 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.686 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.654 ' OG ' ' CD1' ' A' ' 34' ' ' LEU . 3.0 p -110.62 129.87 55.71 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.874 -1.141 . . . . 0.0 110.15 -179.01 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.587 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.2 p -127.53 161.47 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.039 -1.038 . . . . 0.0 109.812 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.587 ' N ' HG22 ' A' ' 48' ' ' VAL . 45.1 t -101.74 129.13 53.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.192 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.773 HG11 ' HZ1' ' A' ' 55' ' ' LYS . 48.0 t -122.71 154.57 27.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 120.87 -1.144 . . . . 0.0 110.367 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.578 ' CA ' ' OD2' ' A' ' 30' ' ' ASP . 59.0 t0 -49.01 -17.68 0.22 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.546 0.688 . . . . 0.0 110.026 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.76 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -94.52 -56.96 1.3 Allowed Glycine 0 C--N 1.283 -2.409 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -165.34 170.25 14.85 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.028 -1.277 . . . . 0.0 110.65 -179.29 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.2 m -73.19 137.24 23.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.773 ' HZ1' HG11 ' A' ' 50' ' ' VAL . 8.4 mttt -125.27 156.13 39.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.753 -1.217 . . . . 0.0 111.366 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -121.96 78.07 1.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 46' ' ' CYS . 74.5 m -58.95 131.57 51.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.444 -1.41 . . . . 0.0 108.138 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.95 125.8 62.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.411 -0.805 . . . . 0.0 110.993 -178.327 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.616 HG22 ' HA3' ' A' ' 67' ' ' GLY . 1.2 pt -117.87 134.56 61.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.604 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 23.4 p30 -123.98 133.81 53.61 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.013 -1.055 . . . . 0.0 110.004 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.422 ' O ' ' CG ' ' A' ' 61' ' ' LYS . 17.1 pttp -100.29 120.63 40.22 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.965 0.888 . . . . 0.0 109.992 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.603 ' O ' ' C ' ' A' ' 63' ' ' ALA . 85.6 m -144.05 153.71 42.48 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.603 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -30.71 -43.88 0.05 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.371 -0.83 . . . . 0.0 109.284 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 62' ' ' THR . 0.1 OUTLIER -120.71 22.96 10.99 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.23 -0.919 . . . . 0.0 109.976 179.495 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.713 ' O ' ' CG ' ' A' ' 66' ' ' TYR . . . -128.01 170.03 19.55 Favored Glycine 0 N--CA 1.497 2.741 0 C-N-CA 119.28 -1.438 . . . . 0.0 111.167 -178.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.713 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 97.3 m-85 -168.45 -30.17 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.731 0.777 . . . . 0.0 109.322 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.616 ' HA3' HG22 ' A' ' 59' ' ' ILE . . . 145.43 -163.31 28.19 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 -179.37 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -67.11 -1.82 4.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.851 -1.382 . . . . 0.0 108.045 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.699 ' HB1' ' HG ' ' A' ' 74' ' ' LEU . . . -49.99 142.32 9.46 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.437 0.636 . . . . 0.0 109.918 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 73' ' ' ASN . 57.0 tt0 -108.03 138.97 20.25 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -39.28 -38.09 1.26 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.828 1.685 . . . . 0.0 111.737 -179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -64.0 -35.77 81.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.329 -0.857 . . . . 0.0 109.274 179.399 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.743 ' O ' ' N ' ' A' ' 75' ' ' TYR . 27.3 m120 -75.93 -82.82 0.07 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.247 -0.908 . . . . 0.0 109.316 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.699 ' HG ' ' HB1' ' A' ' 69' ' ' ALA . 57.8 mt -27.51 82.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.497 0.665 . . . . 0.0 110.085 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.743 ' N ' ' O ' ' A' ' 73' ' ' ASN . 57.7 t80 -64.12 -41.65 97.16 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.417 -0.802 . . . . 0.0 109.632 -179.514 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.456 ' OG ' ' OE1' ' A' ' 80' ' ' GLU . 83.5 p -162.94 -49.51 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.344 -0.942 . . . . 0.0 111.496 -179.447 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.0 p -143.08 173.62 11.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.674 -1.266 . . . . 0.0 111.108 -178.127 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mt -60.25 -35.77 76.26 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.202 0.525 . . . . 0.0 109.928 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.523 ' O ' HG12 ' A' ' 82' ' ' VAL . 71.1 tttt -52.44 -49.07 65.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.019 -1.051 . . . . 0.0 109.923 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.456 ' OE1' ' OG ' ' A' ' 76' ' ' SER . 84.3 mt-10 -74.33 -20.24 60.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.942 -1.099 . . . . 0.0 108.71 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.984 HD21 ' CE2' ' A' ' 85' ' ' TYR . 7.4 tt -67.17 -43.88 81.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.554 -0.716 . . . . 0.0 109.606 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 83' ' ' LEU . 3.0 p -65.17 -43.93 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.077 -1.015 . . . . 0.0 109.027 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.533 ' N ' ' CG1' ' A' ' 82' ' ' VAL . 66.1 tp -67.68 -43.87 79.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.425 -0.797 . . . . 0.0 109.567 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -61.79 -39.97 93.55 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.495 -0.753 . . . . 0.0 110.167 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.984 ' CE2' HD21 ' A' ' 81' ' ' LEU . 5.8 m-30 -63.53 -27.36 69.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.92 -1.112 . . . . 0.0 109.187 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.535 ' HG3' ' HB2' ' A' ' 102' ' ' ALA . 17.6 tt0 -64.69 -35.23 80.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 110.071 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -91.06 -18.32 24.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.105 -0.997 . . . . 0.0 109.726 -179.309 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.7 m -101.76 122.96 44.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.897 . . . . 0.0 109.33 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.617 ' HA ' HG22 ' A' ' 100' ' ' THR . 20.3 t -72.22 133.95 45.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.326 -0.859 . . . . 0.0 109.026 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.761 ' O ' ' N ' ' A' ' 92' ' ' GLN . 66.2 mt -60.84 -43.85 97.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 111.066 -179.176 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.698 ' N ' ' O ' ' A' ' 97' ' ' LEU . 74.6 t 18.71 -79.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 CA-C-N 118.436 0.562 . . . . 0.0 109.649 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.761 ' N ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER 73.05 -176.23 0.17 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.378 -0.826 . . . . 0.0 110.854 178.247 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.413 ' H ' ' HG2' ' A' ' 92' ' ' GLN . 82.7 t60 -59.72 -38.88 82.88 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.383 -0.823 . . . . 0.0 109.114 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -55.05 -28.73 54.47 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.18 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.442 ' HA ' HG13 ' A' ' 91' ' ' VAL . 97.1 m-20 61.21 36.73 17.83 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.81 -0.556 . . . . 0.0 109.797 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.5 p -138.67 0.49 2.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.865 -1.147 . . . . 0.0 111.153 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.698 ' O ' ' N ' ' A' ' 91' ' ' VAL . 63.4 mt -100.21 61.69 1.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.755 -1.216 . . . . 0.0 107.976 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -80.68 69.3 7.18 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.971 -1.081 . . . . 0.0 109.92 -178.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.764 HG21 HG22 ' A' ' 50' ' ' VAL . 87.2 t -152.99 149.63 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.617 HG22 ' HA ' ' A' ' 89' ' ' SER . 26.1 p -119.81 152.06 37.85 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.288 -0.883 . . . . 0.0 108.863 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.709 HD22 ' CG ' ' A' ' 33' ' ' PHE . 31.9 mt -76.22 69.09 2.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.535 ' HB2' ' HG3' ' A' ' 86' ' ' GLN . . . -100.25 -23.99 14.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.461 -0.774 . . . . 0.0 113.031 -177.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.499 ' HD2' HG23 ' A' ' 32' ' ' THR . 78.2 t80 -114.52 105.66 53.37 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.15 -1.594 . . . . 0.0 110.795 -178.42 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.438 ' CB ' ' O ' ' A' ' 10' ' ' THR . 19.3 Cg_exo -59.75 144.98 99.34 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.976 1.784 . . . . 0.0 111.024 178.405 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.728 HG13 ' CD2' ' A' ' 106' ' ' TYR . 8.2 p -67.24 -22.6 29.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.024 -1.047 . . . . 0.0 109.279 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.728 ' CD2' HG13 ' A' ' 105' ' ' VAL . 67.5 m-85 -123.79 63.28 1.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.51 -143.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.545 0.688 . . . . 0.0 110.738 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -83.16 -154.85 0.15 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.403 -0.81 . . . . 0.0 109.919 -179.301 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 63.45 39.49 9.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.719 . . . . 0.0 109.587 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.551 ' O ' ' OXT' ' A' ' 111' ' ' ARG . 12.7 mtm180 -134.28 154.47 51.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.507 -0.745 . . . . 0.0 109.057 179.345 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.551 ' OXT' ' O ' ' A' ' 110' ' ' ARG . 30.0 ttm-85 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.452 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.317 0.579 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -91.03 123.38 34.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.465 -0.772 . . . . 0.0 109.314 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 24.7 mt -96.1 138.85 21.59 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.967 -1.083 . . . . 0.0 109.242 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.479 ' O ' ' OG1' ' A' ' 10' ' ' THR . 37.1 Cg_endo -69.2 -3.84 12.45 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.288 1.992 . . . . 0.0 111.812 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.411 ' HA ' ' HE1' ' A' ' 11' ' ' TRP . 53.2 m80 -83.97 -16.26 44.77 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.46 -0.775 . . . . 0.0 109.68 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.43 ' O ' ' NZ ' ' A' ' 79' ' ' LYS . 42.9 m80 -61.75 -36.49 81.17 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.585 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 54.2 p-10 -106.2 130.11 54.13 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.595 0.712 . . . . 0.0 109.497 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.575 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.7 OUTLIER -70.24 -9.43 55.86 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 109.725 -179.687 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HA ' ' OD1' ' A' ' 12' ' ' ASN . 2.2 ttpt -61.5 -36.93 81.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.603 -0.685 . . . . 0.0 110.864 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.516 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 54.3 p -66.47 -20.07 65.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 112.416 -177.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.561 ' CZ3' ' HG2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -134.43 -12.7 2.38 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 119.965 -1.709 . . . . 0.0 111.168 179.168 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.659 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 19.3 p-10 -95.66 127.06 41.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.588 -1.32 . . . . 0.0 111.571 -178.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.2 m -146.01 34.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.9 -34.43 7.27 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.13 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.2 p -66.69 -12.17 57.27 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.143 -1.21 . . . . 0.0 109.508 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.613 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 57.8 m -79.78 142.71 35.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.237 -0.914 . . . . 0.0 110.753 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.696 ' C ' HH12 ' A' ' 36' ' ' ARG . 8.4 p30 -80.13 156.47 26.99 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.416 -0.802 . . . . 0.0 109.609 179.212 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.833 ' N ' HH22 ' A' ' 36' ' ' ARG . 45.8 mtm180 -63.63 -37.31 86.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.122 -0.986 . . . . 0.0 110.713 -178.817 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.675 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 46.3 p-10 -57.92 -43.96 86.57 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.431 -1.418 . . . . 0.0 108.689 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.675 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 42.7 tttt -66.24 -31.06 71.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.928 -1.108 . . . . 0.0 108.301 178.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.56 ' HB2' ' NH1' ' A' ' 36' ' ' ARG . . . -60.31 -38.6 84.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.893 . . . . 0.0 108.831 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 26' ' ' ARG . 98.1 mt-10 -59.02 -47.59 84.65 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.336 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -60.19 -43.45 95.9 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.487 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 99.1 mt -66.18 -36.66 83.68 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.614 HD23 HG23 ' A' ' 49' ' ' VAL . 10.3 mt -89.2 -7.52 55.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.843 . . . . 0.0 109.513 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 22' ' ' GLU . 14.6 mmm180 -96.37 -25.94 15.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.99 -1.069 . . . . 0.0 109.691 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.09 10.31 56.83 Favored Glycine 0 C--N 1.288 -2.12 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 178.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.816 ' CD ' HG21 ' A' ' 32' ' ' THR . 7.7 mmpt? -114.53 141.33 47.87 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.428 -1.042 . . . . 0.0 110.568 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.93 168.42 15.03 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.491 0.663 . . . . 0.0 110.042 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.539 ' OD1' ' CG2' ' A' ' 99' ' ' VAL . 67.6 t0 -56.28 141.95 39.5 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.39 -0.819 . . . . 0.0 109.709 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.495 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 107.64 -31.85 7.66 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.816 HG21 ' CD ' ' A' ' 28' ' ' LYS . 97.4 m -86.37 127.41 34.81 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.166 -1.196 . . . . 0.0 109.539 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.751 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -139.46 172.45 12.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.63 -1.294 . . . . 0.0 109.806 178.896 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.655 ' HB3' HG11 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -139.51 169.24 18.11 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.66 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.561 HG22 ' SG ' ' A' ' 46' ' ' CYS . 71.5 t -120.17 132.94 68.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 -179.587 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.833 HH22 ' N ' ' A' ' 18' ' ' ARG . 40.7 mtp180 -144.01 -156.8 0.72 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.367 -0.833 . . . . 0.0 108.976 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.667 ' C ' ' H ' ' A' ' 39' ' ' SER . 63.9 mm-40 -108.26 172.74 6.66 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.51 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.673 ' O ' ' CB ' ' A' ' 39' ' ' SER . 82.6 p -76.16 12.71 1.08 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.765 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.673 ' CB ' ' O ' ' A' ' 38' ' ' SER . 19.0 t 111.06 127.83 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.958 -1.473 . . . . 0.0 108.261 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt 60.96 -148.78 0.42 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.445 ' N ' ' CD ' ' A' ' 41' ' ' GLN . 27.3 mp0 -109.05 143.18 38.71 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.198 -0.939 . . . . 0.0 109.656 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.99 -61.65 0.39 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.332 179.421 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 75.4 m -130.81 -176.12 3.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -1.085 . . . . 0.0 109.546 -179.529 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 59' ' ' ILE . 58.7 m-85 -118.24 154.22 32.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.839 . . . . 0.0 109.886 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -159.21 135.13 8.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 109.032 178.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 59' ' ' ILE . 4.6 m -115.16 139.98 49.46 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.516 ' OG ' ' CD1' ' A' ' 25' ' ' LEU . 46.4 t -108.21 133.39 52.52 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.941 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.585 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.6 p -129.74 157.67 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 121.905 0.86 . . . . 0.0 110.307 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.614 HG23 HD23 ' A' ' 25' ' ' LEU . 89.4 t -99.45 134.82 37.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.75 HG22 HG11 ' A' ' 99' ' ' VAL . 75.7 t -121.29 150.52 24.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.725 -1.235 . . . . 0.0 109.793 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -46.97 -18.8 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.813 0.816 . . . . 0.0 109.757 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -92.35 -56.25 1.59 Allowed Glycine 0 C--N 1.283 -2.405 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -164.04 -176.47 4.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -1.155 . . . . 0.0 110.444 -179.338 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.416 HG22 HG22 ' A' ' 49' ' ' VAL . 53.9 t -87.49 135.85 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.203 -0.936 . . . . 0.0 108.764 178.545 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.47 ' HZ2' HG21 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -133.22 157.53 45.16 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.004 -1.06 . . . . 0.0 111.318 -178.837 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -113.19 97.53 6.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.313 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.6 m -71.53 141.71 50.11 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.65 134.12 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.867 -1.146 . . . . 0.0 112.46 -177.618 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.675 HD11 ' SG ' ' A' ' 46' ' ' CYS . 96.1 mt -105.72 139.71 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 177.489 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.631 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 33.0 m120 -124.22 134.14 53.34 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.368 -1.457 . . . . 0.0 111.976 -177.656 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -107.34 121.75 45.2 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.585 0.707 . . . . 0.0 109.494 178.494 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.639 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 32.3 p -130.63 176.87 7.82 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -45.05 -30.69 1.12 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.42 -0.8 . . . . 0.0 109.391 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.3 t -144.04 7.56 1.4 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.185 -0.947 . . . . 0.0 109.125 179.469 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.639 ' N ' ' OG1' ' A' ' 62' ' ' THR . . . -93.26 -170.65 39.59 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.631 ' CA ' ' O ' ' A' ' 60' ' ' ASN . 0.4 OUTLIER 178.1 -26.13 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.429 -1.042 . . . . 0.0 109.162 179.903 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.96 -145.11 7.43 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.315 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.2 m-30 -52.48 146.21 10.18 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.82 -1.4 . . . . 0.0 108.313 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.58 27.37 4.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.593 -1.317 . . . . 0.0 110.265 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.718 ' H ' ' CD ' ' A' ' 71' ' ' PRO . 12.7 tp10 -107.26 -35.61 0.17 Allowed Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 120.73 -1.232 . . . . 0.0 109.593 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.718 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 56.5 Cg_endo -87.65 -30.62 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.414 2.076 . . . . 0.0 113.044 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.467 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 44.9 p90 -154.38 160.19 41.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.967 . . . . 0.0 110.037 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 73' ' ' ASN . 6.5 p-10 -106.38 105.6 15.71 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.126 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.9 tp 49.42 95.69 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.188 -0.945 . . . . 0.0 111.007 178.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.72 ' CZ ' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -56.11 153.54 8.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.025 -1.047 . . . . 0.0 109.296 178.847 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.4 p -58.83 -40.4 84.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -0.846 . . . . 0.0 110.8 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.7 m -149.21 159.52 44.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.897 -1.127 . . . . 0.0 110.176 -179.172 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.529 HD21 ' HE1' ' A' ' 66' ' ' TYR . 71.0 mt -62.68 -32.71 73.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.425 -0.797 . . . . 0.0 109.523 179.424 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.43 ' NZ ' ' O ' ' A' ' 6' ' ' HIS . 17.6 mtpp -60.09 -42.38 94.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.209 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -65.71 -28.89 69.39 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.754 HD23 ' O ' ' A' ' 81' ' ' LEU . 6.7 tt -58.33 -46.44 86.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.629 -0.669 . . . . 0.0 110.006 -179.604 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.531 HG21 ' CE3' ' A' ' 11' ' ' TRP . 81.0 t -73.72 -41.96 54.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.942 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 68.6 mt -65.39 -43.88 89.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.375 -0.828 . . . . 0.0 109.79 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.531 ' O ' ' OG1' ' A' ' 88' ' ' THR . 58.8 t-80 -62.24 -42.08 99.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.011 -1.056 . . . . 0.0 110.146 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.411 ' HA ' ' OG1' ' A' ' 88' ' ' THR . 5.6 m-85 -70.22 -27.79 64.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 111.171 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.503 ' HG2' ' N ' ' A' ' 87' ' ' HIS . 4.6 pt20 -64.6 -32.76 74.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.651 -1.28 . . . . 0.0 109.368 -179.118 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.503 ' N ' ' HG2' ' A' ' 86' ' ' GLN . 12.4 m-70 -89.78 -30.1 18.22 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.268 -0.895 . . . . 0.0 109.083 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 2.9 p -95.52 140.52 30.25 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.42 -0.8 . . . . 0.0 110.127 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.6 p -80.23 140.16 36.38 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.691 -0.63 . . . . 0.0 109.817 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.689 ' O ' ' C ' ' A' ' 91' ' ' VAL . 7.9 mp -67.32 -26.98 66.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 110.549 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.747 ' N ' ' O ' ' A' ' 97' ' ' LEU . 95.9 t -1.75 -67.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 CA-C-O 121.62 0.724 . . . . 0.0 110.056 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.675 ' N ' ' O ' ' A' ' 90' ' ' LEU . 32.8 mm-40 35.15 -123.91 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.485 0.659 . . . . 0.0 111.175 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 95' ' ' ASP . 19.1 p80 -71.55 165.65 23.46 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.475 -0.766 . . . . 0.0 109.862 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.654 ' O ' ' N ' ' A' ' 96' ' ' SER . 74.1 m-20 61.89 2.86 0.81 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.633 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 94' ' ' ASN . 94.9 m-20 33.37 28.65 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.746 -0.596 . . . . 0.0 109.592 179.265 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.654 ' N ' ' O ' ' A' ' 94' ' ' ASN . 80.1 p -130.02 3.28 4.83 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.852 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.747 ' O ' ' N ' ' A' ' 91' ' ' VAL . 87.2 mt -83.31 56.75 3.67 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.553 -1.342 . . . . 0.0 107.723 178.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -78.41 90.22 4.42 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.082 0.944 . . . . 0.0 109.53 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.75 HG11 HG22 ' A' ' 50' ' ' VAL . 4.2 p -169.48 159.13 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.502 ' N ' HG22 ' A' ' 99' ' ' VAL . 66.7 p -128.06 151.52 49.08 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.19 -0.944 . . . . 0.0 109.984 -179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.751 HD22 ' CG ' ' A' ' 33' ' ' PHE . 32.4 mt -84.46 65.72 9.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.02 -1.05 . . . . 0.0 108.425 179.438 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -94.4 -22.6 18.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.387 -0.821 . . . . 0.0 112.519 -177.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -118.09 112.19 38.24 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.111 -1.618 . . . . 0.0 111.071 -178.676 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.455 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 33.1 Cg_exo -58.0 143.87 95.48 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.492 2.128 . . . . 0.0 111.406 177.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.655 HG11 ' HB3' ' A' ' 34' ' ' LEU . 11.6 p -71.88 -27.67 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.064 -1.022 . . . . 0.0 109.614 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.424 ' HD1' HG13 ' A' ' 105' ' ' VAL . 3.2 m-85 -114.05 29.28 8.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.194 -0.941 . . . . 0.0 109.769 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.455 ' HB2' ' HB2' ' A' ' 104' ' ' PRO . . . -60.89 130.59 47.24 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.108 -0.995 . . . . 0.0 109.525 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -119.72 147.22 44.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 109.212 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -98.67 134.65 41.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.956 -1.09 . . . . 0.0 109.56 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -66.0 -39.54 90.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.315 -0.866 . . . . 0.0 110.375 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 0.0 109.831 -179.211 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.494 ' OE1' ' N ' ' A' ' 1' ' ' GLU . 58.7 mp0 . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -114.88 33.01 5.64 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.603 -0.685 . . . . 0.0 109.656 179.735 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.707 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.5 mm? -70.9 148.16 94.47 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 121.497 -0.752 . . . . 0.0 109.674 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' CB ' HG21 ' A' ' 10' ' ' THR . 38.3 Cg_endo -69.35 -2.04 9.19 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.683 2.255 . . . . 0.0 112.301 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.561 ' ND1' HD21 ' A' ' 83' ' ' LEU . 41.4 m80 -73.6 -24.52 60.06 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.37 -0.831 . . . . 0.0 110.028 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -60.3 -34.03 73.2 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.215 -0.928 . . . . 0.0 108.791 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.684 ' OD2' ' NZ ' ' A' ' 9' ' ' LYS . 99.9 m-20 -109.02 119.06 38.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.093 -1.005 . . . . 0.0 109.91 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 12' ' ' ASN . 94.6 mt-10 -65.16 -16.37 63.43 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.684 ' NZ ' ' OD2' ' A' ' 7' ' ' ASP . 26.2 pttt -59.71 -37.48 78.99 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.17 -0.956 . . . . 0.0 110.396 -179.281 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.681 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 23.3 p -55.79 -35.97 66.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.512 -0.743 . . . . 0.0 110.212 -179.263 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.681 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -121.59 -33.01 3.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.77 -1.206 . . . . 0.0 110.723 179.634 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 8' ' ' GLU . 64.0 t30 -83.08 128.18 34.25 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.02 -1.05 . . . . 0.0 111.366 -178.772 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.741 ' O ' ' N ' ' A' ' 16' ' ' SER . 24.0 m -139.7 30.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.649 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.567 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -24.78 -45.23 0.01 OUTLIER Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 13' ' ' VAL . 81.5 p -51.69 -16.78 0.71 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.547 -0.972 . . . . 0.0 108.807 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.741 ' N ' ' O ' ' A' ' 13' ' ' VAL . 89.1 p -70.0 159.49 33.69 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.692 0.758 . . . . 0.0 110.011 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.528 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 79.6 m-20 -122.98 165.16 17.2 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.48 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -59.75 -43.35 94.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.641 -1.287 . . . . 0.0 109.312 -179.617 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -64.47 -42.98 95.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 108.622 179.23 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.528 ' HB3' ' H ' ' A' ' 17' ' ' ASN . 21.1 ttmm -69.07 -35.52 76.61 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.51 74.85 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 26' ' ' ARG . 88.0 tt0 -57.78 -47.2 83.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.935 -1.103 . . . . 0.0 108.741 179.195 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -60.03 -43.81 95.07 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.429 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 89.8 mt -67.71 -27.59 66.95 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.569 HD11 ' OG ' ' A' ' 47' ' ' SER . 12.0 mt -94.28 -5.43 46.76 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.314 -0.866 . . . . 0.0 109.239 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.68 HH11 ' HG2' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -94.04 123.87 37.69 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.784 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.06 4.52 74.65 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 24' ' ' LEU . 24.2 mmtm -99.91 134.74 42.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.101 -1.235 . . . . 0.0 109.811 179.766 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -69.94 159.72 33.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.518 -0.739 . . . . 0.0 109.615 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.67 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 88.3 m-20 -59.72 147.32 38.2 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.635 0.731 . . . . 0.0 110.039 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.63 -22.89 37.85 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -179.087 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 67.6 m -81.37 114.02 19.86 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.294 -1.121 . . . . 0.0 108.831 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -132.21 170.49 14.95 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.086 -179.475 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.68 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 1.9 pp -147.37 157.88 43.75 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.56 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.521 HG22 ' SG ' ' A' ' 46' ' ' CYS . 48.3 t -103.9 128.5 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.156 -0.965 . . . . 0.0 108.443 178.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.713 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -144.02 173.85 11.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 108.823 -179.364 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.7 ' C ' ' H ' ' A' ' 39' ' ' SER . 6.0 tt0 -106.96 164.11 12.41 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 120.827 -1.171 . . . . 0.0 108.382 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.548 ' C ' ' H ' ' A' ' 40' ' ' LYS . 53.6 m -75.83 30.09 0.11 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.7 ' H ' ' C ' ' A' ' 37' ' ' GLU . 68.8 m 67.19 -11.92 0.26 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.08 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.588 ' O ' ' CD ' ' A' ' 37' ' ' GLU . 61.4 tttt -91.42 120.59 32.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.54 -0.725 . . . . 0.0 109.73 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -47.67 126.08 9.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.996 -1.065 . . . . 0.0 110.677 -179.342 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.31 4.42 66.37 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.66 178.674 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.541 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 52.8 t -111.58 151.31 28.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.848 -1.383 . . . . 0.0 108.018 178.507 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.588 ' O ' ' O ' ' A' ' 59' ' ' ILE . 92.8 m-85 -130.13 151.87 50.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.901 -1.125 . . . . 0.0 109.92 -179.01 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.576 ' HB1' HH12 ' A' ' 36' ' ' ARG . . . -162.54 133.83 5.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.858 -1.152 . . . . 0.0 109.544 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.521 ' SG ' HG22 ' A' ' 35' ' ' VAL . 60.0 m -108.18 130.64 55.12 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.569 ' OG ' HD11 ' A' ' 25' ' ' LEU . 32.9 t -108.18 134.5 50.95 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.196 -0.94 . . . . 0.0 109.953 -178.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.586 HG22 ' N ' ' A' ' 49' ' ' VAL . 9.2 p -133.58 167.72 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.21 -0.931 . . . . 0.0 110.278 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.586 ' N ' HG22 ' A' ' 48' ' ' VAL . 40.3 t -121.23 133.69 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.609 -0.682 . . . . 0.0 109.667 179.522 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.798 HG12 ' HZ2' ' A' ' 55' ' ' LYS . 7.3 p -127.61 160.29 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.076 -1.015 . . . . 0.0 109.968 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.67 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 54.5 m-20 -50.21 -20.35 1.01 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.712 0.768 . . . . 0.0 110.078 -179.586 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.63 ' H ' HG13 ' A' ' 50' ' ' VAL . . . -83.81 -58.68 2.2 Favored Glycine 0 C--N 1.285 -2.253 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.807 ' H ' ' NZ ' ' A' ' 55' ' ' LYS . 1.3 tt0 -167.07 -165.09 0.67 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.292 -1.122 . . . . 0.0 111.322 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.564 ' CG1' HD13 ' A' ' 25' ' ' LEU . 84.3 t -97.59 123.8 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.485 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.807 ' NZ ' ' H ' ' A' ' 53' ' ' GLU . 11.5 mptt -118.95 152.48 36.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.465 -1.397 . . . . 0.0 110.941 -179.334 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -115.16 112.64 22.84 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 46' ' ' CYS . 49.1 t -88.21 124.74 34.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.077 -1.014 . . . . 0.0 108.536 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 58' ' ' VAL . 4.8 p -101.07 122.64 53.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.079 -1.013 . . . . 0.0 110.906 -178.659 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 66' ' ' TYR . 88.6 mt -116.57 137.96 48.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.546 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.682 ' O ' ' N ' ' A' ' 67' ' ' GLY . 50.7 t30 -132.97 144.73 50.31 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.566 -1.334 . . . . 0.0 111.511 -178.618 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -95.16 96.02 8.93 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.447 -0.783 . . . . 0.0 108.993 179.487 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.6 p -151.12 -134.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.83 . . . . 0.0 109.256 -179.233 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.9 -32.78 61.4 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.399 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.659 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 46.1 p -93.67 -2.6 53.74 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.562 -0.711 . . . . 0.0 109.332 179.364 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.628 ' O ' ' CG ' ' A' ' 66' ' ' TYR . . . 54.53 4.27 0.36 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.672 ' O ' HG23 ' A' ' 59' ' ' ILE . 91.8 m-85 -160.38 5.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.957 -1.319 . . . . 0.0 109.398 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.682 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 53.68 -91.73 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 107.824 -2.111 . . . . 0.0 107.824 -179.246 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.599 ' CE2' ' OH ' ' A' ' 85' ' ' TYR . 5.2 t80 -63.91 117.25 6.71 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.302 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.568 ' O ' ' O ' ' A' ' 70' ' ' GLU . . . 177.27 27.63 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.267 -0.896 . . . . 0.0 109.512 -178.647 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.568 ' O ' ' O ' ' A' ' 69' ' ' ALA . 99.5 mt-10 56.75 153.26 0.07 OUTLIER Pre-proline 0 C--N 1.304 -1.392 0 C-N-CA 119.541 -0.864 . . . . 0.0 108.813 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.38 -22.25 0.34 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.364 2.043 . . . . 0.0 111.817 179.314 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.488 ' O ' ' O ' ' A' ' 69' ' ' ALA . 99.8 m-85 -110.22 134.26 52.41 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 64' ' ' THR . 11.2 m120 -82.27 107.66 15.12 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.151 -0.968 . . . . 0.0 109.237 -179.42 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 79.8 mt -111.07 4.22 19.24 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.397 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.708 ' CD2' ' CD1' ' A' ' 81' ' ' LEU . 4.7 m-30 -94.93 133.44 38.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.048 -1.033 . . . . 0.0 109.394 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.415 ' O ' ' OH ' ' A' ' 66' ' ' TYR . 86.4 p -94.6 -44.8 7.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.525 -0.734 . . . . 0.0 111.326 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.539 ' OG ' ' OE2' ' A' ' 80' ' ' GLU . 84.5 p -155.6 165.7 35.78 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.817 -1.177 . . . . 0.0 110.301 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.4 -43.77 98.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.417 -0.802 . . . . 0.0 110.879 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.459 ' O ' HG12 ' A' ' 82' ' ' VAL . 19.9 tttt -60.86 -39.75 90.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.755 -1.215 . . . . 0.0 108.707 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.614 ' N ' ' OE1' ' A' ' 80' ' ' GLU . 0.3 OUTLIER -73.43 -40.03 64.55 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.177 -0.952 . . . . 0.0 109.383 179.006 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.708 ' CD1' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -59.9 -49.51 77.4 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.839 -0.538 . . . . 0.0 110.599 -178.373 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 83' ' ' LEU . 4.3 p -59.76 -44.22 93.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.913 -1.117 . . . . 0.0 108.495 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.561 HD21 ' ND1' ' A' ' 5' ' ' HIS . 91.2 mt -61.69 -45.39 94.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.208 -0.932 . . . . 0.0 111.273 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -61.25 -40.39 93.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.756 -1.215 . . . . 0.0 110.001 -178.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.812 ' HB3' HD13 ' A' ' 101' ' ' LEU . 22.4 m-85 -71.41 -26.75 62.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.249 -0.907 . . . . 0.0 111.311 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.744 ' NE2' ' O ' ' A' ' 101' ' ' LEU . 6.8 mt-30 -65.01 -33.65 76.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.662 -1.274 . . . . 0.0 109.163 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -96.76 -19.28 19.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.013 -1.054 . . . . 0.0 110.753 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.4 m -99.53 131.18 45.7 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.804 -1.185 . . . . 0.0 109.726 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.3 p -74.97 135.65 41.34 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.514 0.673 . . . . 0.0 109.939 -179.575 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.743 ' O ' ' N ' ' A' ' 92' ' ' GLN . 0.6 OUTLIER -61.74 -43.7 98.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.531 -0.731 . . . . 0.0 110.627 -179.679 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.757 ' N ' ' O ' ' A' ' 97' ' ' LEU . 72.0 t 26.79 -84.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.743 ' N ' ' O ' ' A' ' 90' ' ' LEU . 18.0 tt0 77.32 -179.51 0.14 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.787 178.738 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.497 ' H ' ' HG2' ' A' ' 92' ' ' GLN . 81.6 t60 -56.08 -39.84 72.72 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -50.44 -28.3 8.01 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.178 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 60.1 t0 63.88 24.36 13.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.78 -0.575 . . . . 0.0 110.309 178.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 68.9 m -136.91 10.89 3.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.03 -1.044 . . . . 0.0 110.167 179.636 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.757 ' O ' ' N ' ' A' ' 91' ' ' VAL . 87.1 mt -99.78 50.96 0.92 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.747 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.582 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 42.1 p30 -77.43 60.09 1.99 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.501 -0.749 . . . . 0.0 110.646 -178.397 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.667 ' HB ' HG23 ' A' ' 50' ' ' VAL . 7.6 p -133.98 162.96 38.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.656 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.548 ' N ' HG22 ' A' ' 99' ' ' VAL . 82.3 p -125.06 168.87 12.77 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.312 1.053 . . . . 0.0 110.611 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.812 HD13 ' HB3' ' A' ' 85' ' ' TYR . 6.9 mp -98.17 33.41 2.18 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.39 -15.49 60.92 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.64 -0.663 . . . . 0.0 112.13 -178.093 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 32' ' ' THR . 96.8 m-85 -114.91 108.48 48.57 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.249 -1.532 . . . . 0.0 111.339 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.54 145.65 95.41 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.257 1.971 . . . . 0.0 110.845 177.419 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.5 -33.07 61.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.896 -1.128 . . . . 0.0 109.335 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -122.69 50.46 1.5 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.018 -1.051 . . . . 0.0 110.067 179.061 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.5 141.09 58.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 109.592 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -57.36 134.97 56.46 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 108.832 179.327 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -80.71 146.22 31.18 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -124.06 156.52 36.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.352 -0.842 . . . . 0.0 109.411 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.671 179.948 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.55 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 46.4 p30 -66.71 150.94 48.35 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.13 -0.981 . . . . 0.0 109.336 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.5 mt -104.56 120.24 51.09 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.433 -0.792 . . . . 0.0 109.205 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HB3' HG21 ' A' ' 10' ' ' THR . 16.5 Cg_exo -57.33 -9.33 4.75 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.745 1.63 . . . . 0.0 111.55 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.46 ' CB ' HD21 ' A' ' 83' ' ' LEU . 37.5 m80 -60.44 -29.15 68.83 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.607 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -68.0 -23.03 64.97 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.246 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.696 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 83.7 m-20 -90.05 120.64 31.41 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.388 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 45.0 tt0 -67.63 -30.67 70.29 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.393 -0.817 . . . . 0.0 110.294 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.597 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -63.36 -31.71 72.93 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.264 -0.898 . . . . 0.0 111.573 -178.805 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -66.49 -29.66 69.82 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.226 -0.921 . . . . 0.0 111.641 -177.044 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.696 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -123.02 -8.44 8.3 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.652 -1.28 . . . . 0.0 110.585 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 8' ' ' GLU . 13.5 t-20 -97.92 118.3 34.19 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.1 -1.0 . . . . 0.0 110.629 -178.702 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 16' ' ' SER . 10.2 m -140.46 27.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.489 -0.757 . . . . 0.0 109.179 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -41.32 -30.56 0.49 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.391 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.8 t -59.84 -34.58 73.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -1.076 . . . . 0.0 108.827 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 13' ' ' VAL . 70.1 m -60.48 142.2 55.48 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.584 0.707 . . . . 0.0 110.654 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -79.9 162.44 24.99 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.624 0.726 . . . . 0.0 109.568 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.524 ' CB ' HH12 ' A' ' 36' ' ' ARG . 22.9 ttp180 -57.31 -44.9 84.55 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.89 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -61.67 -39.34 91.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.149 -0.969 . . . . 0.0 108.713 179.064 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -63.78 -27.74 69.39 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.381 0.61 . . . . 0.0 109.46 179.529 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.55 96.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.905 . . . . 0.0 109.672 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 26' ' ' ARG . 96.3 mt-10 -60.57 -41.23 94.18 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.37 -41.61 94.11 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' CD ' ' A' ' 28' ' ' LYS . 77.0 mt -67.26 -29.36 68.96 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.433 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -89.74 -14.11 35.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.351 -0.843 . . . . 0.0 108.933 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 22' ' ' GLU . 5.1 mtp180 -88.37 129.88 35.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.502 -0.749 . . . . 0.0 110.882 -179.392 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.27 3.27 90.2 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.498 ' CD ' ' O ' ' A' ' 24' ' ' LEU . 12.3 mtpt -103.56 131.08 51.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.282 -1.128 . . . . 0.0 110.359 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.733 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.1 OUTLIER -60.56 147.37 41.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 110.348 -179.115 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.559 ' OD2' ' OD1' ' A' ' 51' ' ' ASP . 65.1 m-20 -50.1 151.93 1.84 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.75 -37.93 3.46 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.419 HG21 ' CE ' ' A' ' 28' ' ' LYS . 88.4 m -68.14 128.28 35.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.43 -1.041 . . . . 0.0 109.151 179.742 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.722 ' CE2' HD23 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -139.04 161.8 36.48 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.856 179.968 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.68 ' CB ' HG11 ' A' ' 105' ' ' VAL . 0.7 OUTLIER -137.29 162.86 32.4 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.547 0.689 . . . . 0.0 110.167 -179.498 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 11' ' ' TRP . 90.6 t -118.12 131.14 71.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.524 HH12 ' CB ' ' A' ' 18' ' ' ARG . 11.0 ptm180 -135.56 -176.0 4.13 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 109.584 -179.226 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.632 ' C ' ' H ' ' A' ' 39' ' ' SER . 10.4 pt-20 -100.07 166.59 10.95 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.553 ' O ' ' CB ' ' A' ' 39' ' ' SER . 24.9 m -75.84 8.53 3.01 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 177.524 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.632 ' H ' ' C ' ' A' ' 37' ' ' GLU . 11.6 m 96.9 -99.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.099 -1.409 . . . . 0.0 110.054 178.883 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -91.01 -5.45 55.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.826 -1.171 . . . . 0.0 110.577 -179.149 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.631 ' O ' ' N ' ' A' ' 43' ' ' CYS . 98.7 mt-30 -96.03 137.03 35.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.99 -1.068 . . . . 0.0 110.461 -179.588 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.87 36.61 0.06 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.631 ' N ' ' O ' ' A' ' 41' ' ' GLN . 77.8 m -112.89 159.76 18.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.304 . . . . 0.0 110.012 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.457 ' O ' ' N ' ' A' ' 59' ' ' ILE . 96.8 m-85 -120.62 149.88 41.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.359 -0.838 . . . . 0.0 109.152 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.487 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -139.39 135.06 33.28 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.563 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.729 ' SG ' HD11 ' A' ' 59' ' ' ILE . 28.9 p -107.92 124.88 50.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.235 -0.916 . . . . 0.0 108.8 179.36 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.7 p -109.63 139.67 44.37 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.531 -0.731 . . . . 0.0 110.275 -179.08 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.8 p -129.26 159.73 40.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.275 -0.891 . . . . 0.0 109.787 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.503 ' N ' HG22 ' A' ' 48' ' ' VAL . 39.4 t -96.6 134.13 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.897 HG12 ' H ' ' A' ' 52' ' ' GLY . 62.0 t -125.44 145.61 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.758 -1.214 . . . . 0.0 110.561 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.559 ' OD1' ' OD2' ' A' ' 30' ' ' ASP . 15.1 m-20 -44.15 -20.42 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.897 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -90.17 -59.87 1.44 Allowed Glycine 0 C--N 1.291 -1.948 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.581 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 70.0 mt-10 -162.18 169.64 20.45 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.952 -1.322 . . . . 0.0 110.312 -178.853 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.0 m -65.33 138.51 23.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.52 ' HZ2' ' HB2' ' A' ' 53' ' ' GLU . 16.6 mmtm -116.3 140.66 49.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.629 -1.294 . . . . 0.0 111.966 -178.053 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -115.3 96.77 5.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.629 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 46' ' ' CYS . 80.2 m -99.49 122.12 42.12 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.083 -1.011 . . . . 0.0 108.92 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.9 t -76.89 140.01 17.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.553 0.692 . . . . 0.0 110.545 -179.278 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.729 HD11 ' SG ' ' A' ' 46' ' ' CYS . 47.2 mm -108.96 129.96 62.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.767 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.574 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 89.7 m-20 -116.66 108.16 15.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.168 -0.958 . . . . 0.0 110.084 -179.109 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -96.4 117.94 31.9 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.393 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.67 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 62.5 p -147.22 170.09 17.98 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.332 -0.855 . . . . 0.0 108.738 179.328 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.51 -39.15 70.12 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.064 -1.023 . . . . 0.0 109.669 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.0 m -115.59 -12.78 11.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.129 -0.982 . . . . 0.0 110.718 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.67 ' N ' ' OG1' ' A' ' 62' ' ' THR . . . -93.45 -170.39 39.21 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 119.906 -1.14 . . . . 0.0 110.676 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.574 ' CA ' ' O ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER 175.22 -167.18 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.595 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.504 ' HA3' HD11 ' A' ' 81' ' ' LEU . . . -50.94 -48.56 45.06 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.564 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.771 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 54.9 m-85 -111.22 -17.71 13.13 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.572 -0.957 . . . . 0.0 108.984 178.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 56.09 36.9 28.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.462 -0.774 . . . . 0.0 111.323 179.119 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.703 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 97.8 mt-10 -102.88 137.37 19.27 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.92 -1.113 . . . . 0.0 108.811 179.536 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -39.79 -17.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.747 2.298 . . . . 0.0 113.072 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 70' ' ' GLU . 94.5 m-85 -90.17 -2.69 58.1 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.899 -1.125 . . . . 0.0 110.219 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.792 ' ND2' ' N ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -106.2 -111.29 0.28 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.225 -0.922 . . . . 0.0 109.307 -179.835 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.792 ' N ' ' ND2' ' A' ' 73' ' ' ASN . 90.5 mt 60.02 29.54 19.1 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.762 -1.211 . . . . 0.0 110.025 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.736 ' CE1' ' NE2' ' A' ' 84' ' ' HIS . 80.1 m-85 -57.19 151.79 14.92 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.171 -0.956 . . . . 0.0 109.0 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 96.0 p -66.67 -30.34 70.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.433 -0.792 . . . . 0.0 111.712 -177.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 t -139.71 155.87 47.11 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.716 -1.24 . . . . 0.0 111.338 -178.297 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 81' ' ' LEU . 89.6 mt -62.08 -34.71 76.8 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.465 -0.772 . . . . 0.0 109.516 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 78' ' ' LEU . 87.3 mttt -47.74 -42.04 24.46 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 65.6 mt-10 -64.87 -37.31 87.19 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.723 HD23 ' C ' ' A' ' 81' ' ' LEU . 8.2 tt -59.63 -42.62 93.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.566 -0.709 . . . . 0.0 110.164 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.8 t -65.77 -44.97 92.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.99 -1.069 . . . . 0.0 109.467 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.46 HD21 ' CB ' ' A' ' 5' ' ' HIS . 81.2 mt -68.34 -39.02 82.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.395 -0.816 . . . . 0.0 111.274 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.736 ' NE2' ' CE1' ' A' ' 75' ' ' TYR . 52.8 m80 -64.66 -42.43 95.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.016 -1.052 . . . . 0.0 110.192 -178.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.771 ' CZ ' ' CD2' ' A' ' 68' ' ' PHE . 7.1 m-30 -73.83 -16.68 61.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.857 -1.152 . . . . 0.0 109.34 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -67.81 -35.87 79.4 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.282 -0.886 . . . . 0.0 109.234 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 84' ' ' HIS . 22.8 p-80 -92.61 -22.66 19.35 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.267 -0.896 . . . . 0.0 109.664 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.8 m -92.41 128.42 38.26 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.134 -0.979 . . . . 0.0 109.386 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.584 ' HA ' HG22 ' A' ' 100' ' ' THR . 24.6 p -77.67 131.58 37.8 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.437 -0.79 . . . . 0.0 109.665 -179.373 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.524 ' O ' ' C ' ' A' ' 91' ' ' VAL . 98.9 mt -69.74 -17.46 63.45 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.498 -0.751 . . . . 0.0 110.024 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.749 ' N ' ' O ' ' A' ' 97' ' ' LEU . 9.7 p -31.99 -46.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 121.205 -0.934 . . . . 0.0 110.382 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.649 ' N ' HG13 ' A' ' 91' ' ' VAL . 18.1 tt0 -43.97 -27.68 0.39 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.227 0.537 . . . . 0.0 110.128 -179.388 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.554 ' NE2' ' CE1' ' A' ' 68' ' ' PHE . 94.5 m-70 -81.66 119.54 23.95 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.005 -1.059 . . . . 0.0 108.189 178.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 90.5 m-20 61.42 2.61 0.67 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.64 -0.663 . . . . 0.0 109.507 -179.244 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.59 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 66.7 t0 57.44 23.65 9.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.551 -0.718 . . . . 0.0 110.349 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.9 m -140.68 11.35 2.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.81 -1.181 . . . . 0.0 109.688 179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.749 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.8 mm? -97.93 66.2 1.85 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.913 -1.117 . . . . 0.0 108.679 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.836 ' O ' HG23 ' A' ' 99' ' ' VAL . 1.1 p-10 -79.16 78.86 5.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.938 -1.101 . . . . 0.0 110.37 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 98' ' ' ASN . 40.8 t -166.38 154.26 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.522 -0.736 . . . . 0.0 109.816 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 89' ' ' SER . 70.8 p -130.53 164.29 25.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.893 . . . . 0.0 109.452 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.85 ' N ' HD12 ' A' ' 101' ' ' LEU . 4.2 mp -79.17 67.31 4.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.709 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -92.16 -22.76 19.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 111.519 -178.347 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.65 137.94 28.65 Favored Pre-proline 0 C--N 1.307 -1.277 0 O-C-N 120.713 -1.242 . . . . 0.0 111.006 -178.006 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.459 ' HB2' HG22 ' A' ' 10' ' ' THR . 93.3 Cg_endo -78.09 157.23 30.32 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.277 2.652 . . . . 0.0 111.582 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.68 HG11 ' CB ' ' A' ' 34' ' ' LEU . 12.2 p -92.76 -27.68 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.345 -0.847 . . . . 0.0 112.089 -178.709 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 73.1 t80 -132.52 64.99 1.6 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.411 -1.431 . . . . 0.0 111.87 -178.069 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.682 ' HB2' HG22 ' A' ' 10' ' ' THR . . . -89.69 140.56 29.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.058 -1.026 . . . . 0.0 109.006 178.156 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.407 ' O ' ' HG3' ' A' ' 108' ' ' GLN . 21.4 pt20 -61.71 136.78 58.13 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.954 -1.091 . . . . 0.0 109.849 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -100.51 -9.04 22.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 108.844 179.35 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -76.83 130.31 37.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.498 -0.751 . . . . 0.0 109.818 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 . . . . . 0 C--N 1.301 -1.521 0 CA-C-O 117.911 -1.042 . . . . 0.0 109.033 179.514 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.484 ' HB2' ' ND1' ' A' ' 6' ' ' HIS . 58.0 p30 -76.76 170.06 17.16 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.5 mt -91.5 136.26 26.97 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.864 -1.147 . . . . 0.0 109.702 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -49.06 -19.54 2.52 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.888 2.392 . . . . 0.0 111.659 178.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 83' ' ' LEU . 85.1 m-70 -65.11 -17.01 64.11 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.655 0.741 . . . . 0.0 109.438 -178.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.484 ' ND1' ' HB2' ' A' ' 2' ' ' ASP . 38.2 m170 -64.98 -36.76 85.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.503 -0.748 . . . . 0.0 109.57 178.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -96.79 129.55 44.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 110.431 -179.068 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.676 ' O ' ' N ' ' A' ' 12' ' ' ASN . 96.6 mt-10 -72.32 -31.32 65.57 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.562 0.696 . . . . 0.0 109.824 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -59.83 -24.82 64.49 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.684 -179.636 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.67 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 52.2 p -67.85 -29.35 68.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.111 -0.993 . . . . 0.0 110.347 -179.512 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.67 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.8 -23.77 2.78 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.916 -1.115 . . . . 0.0 109.572 178.652 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.676 ' N ' ' O ' ' A' ' 8' ' ' GLU . 65.6 t30 -80.57 125.84 30.49 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.09 0.948 . . . . 0.0 111.284 -178.396 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 13' ' ' VAL . 93.8 t -132.57 32.79 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 13' ' ' VAL . . . -42.64 177.19 0.01 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.9 t 61.47 27.4 16.96 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.516 -0.991 . . . . 0.0 108.711 -179.499 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.514 ' OG ' HG12 ' A' ' 13' ' ' VAL . 69.2 m -129.08 136.81 50.74 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.459 -0.775 . . . . 0.0 109.673 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.588 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 26.7 p30 -80.19 167.81 19.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.53 -0.731 . . . . 0.0 109.782 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 36' ' ' ARG . 41.7 mtt-85 -63.65 -32.73 74.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.94 . . . . 0.0 110.039 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -64.29 -46.46 83.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.243 -0.911 . . . . 0.0 109.113 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.588 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 18.0 ttmm -62.34 -40.32 95.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -0.834 . . . . 0.0 109.218 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -59.9 -38.11 81.34 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.366 -0.834 . . . . 0.0 109.332 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.573 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 55.3 tt0 -59.98 -44.07 94.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.869 -1.144 . . . . 0.0 108.892 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -62.26 -39.14 91.92 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 77.7 mt -73.67 -31.78 63.65 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.464 HD23 HG23 ' A' ' 49' ' ' VAL . 7.9 mt -89.38 -10.23 47.37 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.573 ' NH2' ' OE2' ' A' ' 22' ' ' GLU . 75.3 mtt180 -88.75 120.34 30.06 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.136 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.46 -4.99 62.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.715 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.507 ' HE3' HG23 ' A' ' 105' ' ' VAL . 25.7 mmtt -87.06 150.9 23.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.35 -1.088 . . . . 0.0 109.598 179.644 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.565 ' HG2' HH11 ' A' ' 29' ' ' ARG . 7.1 mmt-85 -82.67 154.96 24.61 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.316 0.579 . . . . 0.0 110.479 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -55.12 139.72 40.72 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.35 -15.46 56.16 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 35.3 m -88.55 121.79 31.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.402 -1.057 . . . . 0.0 109.197 179.315 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -138.44 167.46 21.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.007 -1.058 . . . . 0.0 110.742 179.888 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.53 156.23 44.55 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.485 -179.325 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' TRP . 46.0 t -108.11 124.26 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.875 . . . . 0.0 108.82 179.521 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -138.75 178.88 6.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 108.974 -179.486 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.735 ' C ' ' H ' ' A' ' 39' ' ' SER . 10.8 tt0 -99.33 164.09 12.27 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.814 -1.179 . . . . 0.0 108.67 179.831 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.632 ' C ' ' H ' ' A' ' 40' ' ' LYS . 50.8 m -75.73 33.14 0.11 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.272 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.735 ' H ' ' C ' ' A' ' 37' ' ' GLU . 49.5 m 64.88 -14.6 0.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.677 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.632 ' H ' ' C ' ' A' ' 38' ' ' SER . 39.3 ttpt -98.91 125.75 44.41 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.658 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -49.85 133.88 21.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.462 -0.774 . . . . 0.0 110.92 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.14 3.07 70.33 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.242 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 80.8 m -112.84 150.51 31.59 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.907 -1.349 . . . . 0.0 109.76 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.63 ' O ' ' O ' ' A' ' 59' ' ' ILE . 96.1 m-85 -133.47 151.19 51.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.055 -1.028 . . . . 0.0 110.281 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 59' ' ' ILE . . . -157.8 135.97 10.93 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.967 -1.083 . . . . 0.0 109.486 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.552 ' SG ' HD13 ' A' ' 59' ' ' ILE . 70.6 m -108.03 117.15 33.39 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.648 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.8 m -102.18 133.81 46.44 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.854 -1.154 . . . . 0.0 109.704 -178.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.641 HG11 HD22 ' A' ' 90' ' ' LEU . 2.4 p -129.73 160.28 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.295 -0.878 . . . . 0.0 109.642 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.538 ' N ' HG22 ' A' ' 48' ' ' VAL . 55.8 t -108.47 136.76 43.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.743 HG12 ' H ' ' A' ' 52' ' ' GLY . 74.8 t -121.59 151.45 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.093 -1.004 . . . . 0.0 109.978 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -49.71 -15.24 0.16 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.067 0.937 . . . . 0.0 108.796 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.743 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -94.21 -59.21 1.18 Allowed Glycine 0 C--N 1.285 -2.28 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -162.15 176.66 10.43 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.122 -1.222 . . . . 0.0 110.384 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.06 138.96 18.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HE3' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -125.58 162.05 25.83 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.761 -179.919 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -128.64 80.31 1.96 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.488 -0.758 . . . . 0.0 110.336 -179.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 46' ' ' CYS . 82.1 m -59.8 145.02 46.9 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.788 -1.195 . . . . 0.0 108.402 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 58' ' ' VAL . 8.7 p -115.98 130.42 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.013 -1.054 . . . . 0.0 111.272 -178.331 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.63 ' O ' ' O ' ' A' ' 44' ' ' TYR . 3.7 mp -123.04 128.4 75.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.361 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.641 ' O ' ' N ' ' A' ' 66' ' ' TYR . 92.4 m-20 -115.97 119.25 35.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.557 -1.34 . . . . 0.0 109.455 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -75.23 106.9 6.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.785 -1.197 . . . . 0.0 109.311 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.896 HG22 ' H ' ' A' ' 63' ' ' ALA . 72.0 m -160.56 -176.28 5.48 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.896 ' H ' HG22 ' A' ' 62' ' ' THR . . . -56.33 -47.21 79.21 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.691 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 64' ' ' THR . 91.0 m -141.95 48.77 1.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.505 -0.747 . . . . 0.0 109.461 179.223 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.69 ' O ' ' N ' ' A' ' 67' ' ' GLY . . . -118.85 -18.83 4.61 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.741 ' CD1' ' OH ' ' A' ' 75' ' ' TYR . 96.0 m-85 -36.99 -23.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.048 -1.266 . . . . 0.0 109.247 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.69 ' N ' ' O ' ' A' ' 65' ' ' GLY . . . 96.74 -102.86 2.83 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.503 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.657 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 73.1 m-85 -53.58 146.83 12.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.038 -1.272 . . . . 0.0 110.401 -179.451 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.18 133.83 15.63 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.6 ' O ' ' OD1' ' A' ' 73' ' ' ASN . 70.6 mt-10 -115.89 155.88 47.24 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.357 -0.839 . . . . 0.0 109.342 -179.141 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.649 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 84.7 Cg_exo -45.92 110.05 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.315 2.01 . . . . 0.0 112.349 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.745 ' CD2' ' O ' ' A' ' 72' ' ' TYR . 54.0 p90 44.19 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.674 -0.641 . . . . 0.0 110.06 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.656 ' OD1' ' N ' ' A' ' 74' ' ' LEU . 5.7 p30 166.99 -73.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -1.0 . . . . 0.0 109.532 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.751 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 25.3 mt 55.87 23.8 6.88 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.214 -0.929 . . . . 0.0 109.373 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.751 ' CG ' ' O ' ' A' ' 74' ' ' LEU . 52.2 p90 48.82 118.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.666 0.746 . . . . 0.0 109.61 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.5 p -61.37 -37.88 84.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.092 -1.005 . . . . 0.0 110.692 -178.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.2 m -127.12 153.67 45.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.88 -1.137 . . . . 0.0 110.104 -178.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.4 mt -60.02 -36.29 76.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.299 -0.876 . . . . 0.0 109.764 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -59.38 -41.05 88.44 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.101 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -61.66 -35.06 76.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 108.656 179.575 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.477 HD12 ' CE2' ' A' ' 75' ' ' TYR . 8.0 tt -58.12 -42.55 86.02 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.557 -0.714 . . . . 0.0 109.436 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.34 -39.56 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.007 -1.058 . . . . 0.0 108.582 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.453 ' CD2' ' CD2' ' A' ' 5' ' ' HIS . 92.6 mt -66.44 -41.8 88.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.402 -0.812 . . . . 0.0 109.718 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.47 -42.36 96.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 110.382 -179.213 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.657 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 3.7 m-85 -69.53 -23.62 63.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.783 -1.198 . . . . 0.0 108.979 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -64.02 -38.12 89.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.491 -0.756 . . . . 0.0 109.231 179.541 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -90.26 -19.69 23.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 0.0 109.199 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 85' ' ' TYR . 42.1 m -99.01 140.99 32.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.529 -0.732 . . . . 0.0 109.256 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.3 t -89.65 128.94 36.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.868 . . . . 0.0 109.47 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.667 ' O ' ' N ' ' A' ' 92' ' ' GLN . 10.1 mp -60.56 -22.85 64.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.344 -0.847 . . . . 0.0 110.467 -179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.719 ' N ' ' O ' ' A' ' 97' ' ' LEU . 11.6 p -26.56 -37.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.346 -0.846 . . . . 0.0 110.584 -179.184 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.667 ' N ' ' O ' ' A' ' 90' ' ' LEU . 35.0 mt-30 -40.8 179.25 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.885 0.85 . . . . 0.0 111.756 -178.801 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.439 ' HE2' ' HE2' ' A' ' 68' ' ' PHE . 87.2 m-70 61.25 -108.84 0.35 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.496 0.665 . . . . 0.0 109.972 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -60.72 -5.43 1.28 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.494 -0.754 . . . . 0.0 110.366 -179.358 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 65.7 t0 57.27 28.47 15.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.772 -1.205 . . . . 0.0 109.128 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -143.22 13.04 1.8 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 110.304 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.719 ' O ' ' N ' ' A' ' 91' ' ' VAL . 7.7 mp -101.23 70.14 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.875 -1.14 . . . . 0.0 107.955 178.773 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -78.79 87.4 4.67 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.389 -0.819 . . . . 0.0 110.114 -178.631 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.51 HG22 ' N ' ' A' ' 100' ' ' THR . 12.6 p -163.05 160.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 121.686 0.755 . . . . 0.0 109.158 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.51 ' N ' HG22 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -130.8 133.47 45.99 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.14 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.68 HD22 ' CG ' ' A' ' 33' ' ' PHE . 37.6 mt -69.62 74.5 0.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -116.56 -10.04 11.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.832 . . . . 0.0 110.952 -178.719 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 32' ' ' THR . 69.2 t80 -120.65 103.4 43.7 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.619 -1.301 . . . . 0.0 110.433 -178.798 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.97 146.53 86.66 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.622 2.215 . . . . 0.0 111.533 178.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.507 HG23 ' HE3' ' A' ' 28' ' ' LYS . 9.5 p -69.43 -35.37 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.911 -1.118 . . . . 0.0 109.57 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.457 ' CD2' HG13 ' A' ' 105' ' ' VAL . 38.8 m-85 -119.39 54.88 0.97 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.157 -0.964 . . . . 0.0 110.74 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.73 116.97 8.22 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.133 -0.979 . . . . 0.0 108.376 178.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -60.11 -37.99 81.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.12 -0.988 . . . . 0.0 110.2 -179.582 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -62.22 -43.55 98.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.834 -1.166 . . . . 0.0 109.23 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -66.55 -34.44 77.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 109.722 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.274 -179.416 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.484 ' HB2' ' ND1' ' A' ' 6' ' ' HIS . 58.0 p30 -76.76 170.06 17.16 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.5 mt -91.5 136.26 26.97 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.864 -1.147 . . . . 0.0 109.702 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -49.06 -19.54 2.52 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.888 2.392 . . . . 0.0 111.659 178.948 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 83' ' ' LEU . 85.1 m-70 -65.11 -17.01 64.11 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.655 0.741 . . . . 0.0 109.438 -178.944 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.484 ' ND1' ' HB2' ' A' ' 2' ' ' ASP . 38.2 m170 -64.98 -36.76 85.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.503 -0.748 . . . . 0.0 109.57 178.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -96.79 129.55 44.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 110.431 -179.068 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.676 ' O ' ' N ' ' A' ' 12' ' ' ASN . 96.6 mt-10 -72.32 -31.32 65.57 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.562 0.696 . . . . 0.0 109.824 179.717 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -59.83 -24.82 64.49 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.684 -179.636 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.67 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 52.2 p -67.85 -29.35 68.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.111 -0.993 . . . . 0.0 110.347 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.67 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.8 -23.77 2.78 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.916 -1.115 . . . . 0.0 109.572 178.652 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.676 ' N ' ' O ' ' A' ' 8' ' ' GLU . 65.6 t30 -80.57 125.84 30.49 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.09 0.948 . . . . 0.0 111.284 -178.396 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 13' ' ' VAL . 93.8 t -132.57 32.79 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.867 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 13' ' ' VAL . . . -42.64 177.19 0.01 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.9 t 61.47 27.4 16.96 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.516 -0.991 . . . . 0.0 108.711 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.514 ' OG ' HG12 ' A' ' 13' ' ' VAL . 69.2 m -129.08 136.81 50.74 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.459 -0.775 . . . . 0.0 109.673 -179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.588 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 26.7 p30 -80.19 167.81 19.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.53 -0.731 . . . . 0.0 109.782 -179.789 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 36' ' ' ARG . 41.7 mtt-85 -63.65 -32.73 74.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.94 . . . . 0.0 110.039 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -64.29 -46.46 83.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.243 -0.911 . . . . 0.0 109.113 -179.345 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.588 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 18.0 ttmm -62.34 -40.32 95.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -0.834 . . . . 0.0 109.218 179.566 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -59.9 -38.11 81.34 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.366 -0.834 . . . . 0.0 109.332 -179.584 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.573 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 55.3 tt0 -59.98 -44.07 94.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.869 -1.144 . . . . 0.0 108.892 179.548 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -62.26 -39.14 91.92 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.607 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 77.7 mt -73.67 -31.78 63.65 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.432 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.464 HD23 HG23 ' A' ' 49' ' ' VAL . 7.9 mt -89.38 -10.23 47.37 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.573 ' NH2' ' OE2' ' A' ' 22' ' ' GLU . 75.3 mtt180 -88.75 120.34 30.06 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.136 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.46 -4.99 62.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.715 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.507 ' HE3' HG23 ' A' ' 105' ' ' VAL . 25.7 mmtt -87.06 150.9 23.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.35 -1.088 . . . . 0.0 109.598 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.565 ' HG2' HH11 ' A' ' 29' ' ' ARG . 7.1 mmt-85 -82.67 154.96 24.61 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.316 0.579 . . . . 0.0 110.479 -179.475 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -55.12 139.72 40.72 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.346 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.35 -15.46 56.16 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 35.3 m -88.55 121.79 31.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.402 -1.057 . . . . 0.0 109.197 179.315 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -138.44 167.46 21.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.007 -1.058 . . . . 0.0 110.742 179.888 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.53 156.23 44.55 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.485 -179.325 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' TRP . 46.0 t -108.11 124.26 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.875 . . . . 0.0 108.82 179.521 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -138.75 178.88 6.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 108.974 -179.486 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.735 ' C ' ' H ' ' A' ' 39' ' ' SER . 10.8 tt0 -99.33 164.09 12.27 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.814 -1.179 . . . . 0.0 108.67 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.632 ' C ' ' H ' ' A' ' 40' ' ' LYS . 50.8 m -75.73 33.14 0.11 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.272 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.735 ' H ' ' C ' ' A' ' 37' ' ' GLU . 49.5 m 64.88 -14.6 0.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.677 -178.57 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.632 ' H ' ' C ' ' A' ' 38' ' ' SER . 39.3 ttpt -98.91 125.75 44.41 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.658 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -49.85 133.88 21.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.462 -0.774 . . . . 0.0 110.92 -178.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.14 3.07 70.33 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.242 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 80.8 m -112.84 150.51 31.59 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.907 -1.349 . . . . 0.0 109.76 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.63 ' O ' ' O ' ' A' ' 59' ' ' ILE . 96.1 m-85 -133.47 151.19 51.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.055 -1.028 . . . . 0.0 110.281 -179.399 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 59' ' ' ILE . . . -157.8 135.97 10.93 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.967 -1.083 . . . . 0.0 109.486 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.552 ' SG ' HD13 ' A' ' 59' ' ' ILE . 70.6 m -108.03 117.15 33.39 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.648 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.8 m -102.18 133.81 46.44 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.854 -1.154 . . . . 0.0 109.704 -178.679 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.641 HG11 HD22 ' A' ' 90' ' ' LEU . 2.4 p -129.73 160.28 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.295 -0.878 . . . . 0.0 109.642 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.538 ' N ' HG22 ' A' ' 48' ' ' VAL . 55.8 t -108.47 136.76 43.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.743 HG12 ' H ' ' A' ' 52' ' ' GLY . 74.8 t -121.59 151.45 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.093 -1.004 . . . . 0.0 109.978 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -49.71 -15.24 0.16 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.067 0.937 . . . . 0.0 108.796 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.743 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -94.21 -59.21 1.18 Allowed Glycine 0 C--N 1.285 -2.28 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.65 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -162.15 176.66 10.43 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.122 -1.222 . . . . 0.0 110.384 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.06 138.96 18.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HE3' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -125.58 162.05 25.83 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.761 -179.919 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -128.64 80.31 1.96 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.488 -0.758 . . . . 0.0 110.336 -179.566 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 46' ' ' CYS . 82.1 m -59.8 145.02 46.9 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.788 -1.195 . . . . 0.0 108.402 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 58' ' ' VAL . 8.7 p -115.98 130.42 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.013 -1.054 . . . . 0.0 111.272 -178.331 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.63 ' O ' ' O ' ' A' ' 44' ' ' TYR . 3.7 mp -123.04 128.4 75.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.361 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.641 ' O ' ' N ' ' A' ' 66' ' ' TYR . 92.4 m-20 -115.97 119.25 35.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.557 -1.34 . . . . 0.0 109.455 179.512 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -75.23 106.9 6.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.785 -1.197 . . . . 0.0 109.311 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.896 HG22 ' H ' ' A' ' 63' ' ' ALA . 72.0 m -160.56 -176.28 5.48 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.896 ' H ' HG22 ' A' ' 62' ' ' THR . . . -56.33 -47.21 79.21 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.691 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 64' ' ' THR . 91.0 m -141.95 48.77 1.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.505 -0.747 . . . . 0.0 109.461 179.223 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.69 ' O ' ' N ' ' A' ' 67' ' ' GLY . . . -118.85 -18.83 4.61 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.837 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.741 ' CD1' ' OH ' ' A' ' 75' ' ' TYR . 96.0 m-85 -36.99 -23.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.048 -1.266 . . . . 0.0 109.247 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.69 ' N ' ' O ' ' A' ' 65' ' ' GLY . . . 96.74 -102.86 2.83 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.657 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 73.1 m-85 -53.58 146.83 12.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.038 -1.272 . . . . 0.0 110.401 -179.451 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.18 133.83 15.63 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.365 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.6 ' O ' ' OD1' ' A' ' 73' ' ' ASN . 70.6 mt-10 -115.89 155.88 47.24 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.357 -0.839 . . . . 0.0 109.342 -179.141 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.649 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 84.7 Cg_exo -45.92 110.05 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.315 2.01 . . . . 0.0 112.349 -179.754 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.745 ' CD2' ' O ' ' A' ' 72' ' ' TYR . 54.0 p90 44.19 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.674 -0.641 . . . . 0.0 110.06 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.656 ' OD1' ' N ' ' A' ' 74' ' ' LEU . 5.7 p30 166.99 -73.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -1.0 . . . . 0.0 109.532 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.751 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 25.3 mt 55.87 23.8 6.88 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.214 -0.929 . . . . 0.0 109.373 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.751 ' CG ' ' O ' ' A' ' 74' ' ' LEU . 52.2 p90 48.82 118.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.666 0.746 . . . . 0.0 109.61 -179.588 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.5 p -61.37 -37.88 84.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.092 -1.005 . . . . 0.0 110.692 -178.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.2 m -127.12 153.67 45.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.88 -1.137 . . . . 0.0 110.104 -178.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.4 mt -60.02 -36.29 76.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.299 -0.876 . . . . 0.0 109.764 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -59.38 -41.05 88.44 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.101 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -61.66 -35.06 76.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 108.656 179.575 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.477 HD12 ' CE2' ' A' ' 75' ' ' TYR . 8.0 tt -58.12 -42.55 86.02 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.557 -0.714 . . . . 0.0 109.436 179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.34 -39.56 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.007 -1.058 . . . . 0.0 108.582 179.211 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.453 ' CD2' ' CD2' ' A' ' 5' ' ' HIS . 92.6 mt -66.44 -41.8 88.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.402 -0.812 . . . . 0.0 109.718 179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.47 -42.36 96.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 110.382 -179.213 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.657 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 3.7 m-85 -69.53 -23.62 63.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.783 -1.198 . . . . 0.0 108.979 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -64.02 -38.12 89.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.491 -0.756 . . . . 0.0 109.231 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -90.26 -19.69 23.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 0.0 109.199 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 85' ' ' TYR . 42.1 m -99.01 140.99 32.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.529 -0.732 . . . . 0.0 109.256 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.3 t -89.65 128.94 36.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.868 . . . . 0.0 109.47 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.667 ' O ' ' N ' ' A' ' 92' ' ' GLN . 10.1 mp -60.56 -22.85 64.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.344 -0.847 . . . . 0.0 110.467 -179.558 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.719 ' N ' ' O ' ' A' ' 97' ' ' LEU . 11.6 p -26.56 -37.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.346 -0.846 . . . . 0.0 110.584 -179.184 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.667 ' N ' ' O ' ' A' ' 90' ' ' LEU . 35.0 mt-30 -40.8 179.25 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.885 0.85 . . . . 0.0 111.756 -178.801 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.439 ' HE2' ' HE2' ' A' ' 68' ' ' PHE . 87.2 m-70 61.25 -108.84 0.35 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.496 0.665 . . . . 0.0 109.972 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -60.72 -5.43 1.28 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.494 -0.754 . . . . 0.0 110.366 -179.358 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 65.7 t0 57.27 28.47 15.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.772 -1.205 . . . . 0.0 109.128 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -143.22 13.04 1.8 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 110.304 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.719 ' O ' ' N ' ' A' ' 91' ' ' VAL . 7.7 mp -101.23 70.14 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.875 -1.14 . . . . 0.0 107.955 178.773 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -78.79 87.4 4.67 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.389 -0.819 . . . . 0.0 110.114 -178.631 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.51 HG22 ' N ' ' A' ' 100' ' ' THR . 12.6 p -163.05 160.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 121.686 0.755 . . . . 0.0 109.158 179.306 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.51 ' N ' HG22 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -130.8 133.47 45.99 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.14 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.68 HD22 ' CG ' ' A' ' 33' ' ' PHE . 37.6 mt -69.62 74.5 0.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -116.56 -10.04 11.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.832 . . . . 0.0 110.952 -178.719 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 32' ' ' THR . 69.2 t80 -120.65 103.4 43.7 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.619 -1.301 . . . . 0.0 110.433 -178.798 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.97 146.53 86.66 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.622 2.215 . . . . 0.0 111.533 178.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.507 HG23 ' HE3' ' A' ' 28' ' ' LYS . 9.5 p -69.43 -35.37 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.911 -1.118 . . . . 0.0 109.57 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.457 ' CD2' HG13 ' A' ' 105' ' ' VAL . 38.8 m-85 -119.39 54.88 0.97 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.157 -0.964 . . . . 0.0 110.74 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.73 116.97 8.22 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.133 -0.979 . . . . 0.0 108.376 178.812 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -60.11 -37.99 81.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.12 -0.988 . . . . 0.0 110.2 -179.582 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -62.22 -43.55 98.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.834 -1.166 . . . . 0.0 109.23 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -66.55 -34.44 77.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 109.722 -179.713 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.274 -179.416 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.379 0.609 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -82.02 122.63 28.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.115 -0.991 . . . . 0.0 109.18 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.3 mt -94.53 127.76 42.71 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 -179.47 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -51.27 -17.86 4.49 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.013 1.809 . . . . 0.0 111.563 178.903 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -63.24 -23.26 67.34 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.523 -0.735 . . . . 0.0 110.4 -179.074 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -66.1 -37.95 87.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.815 -1.178 . . . . 0.0 109.599 -179.219 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.572 ' O ' ' OG1' ' A' ' 10' ' ' THR . 84.9 m-20 -96.44 127.2 42.21 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.156 -0.965 . . . . 0.0 109.535 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.522 ' HG3' ' CH2' ' A' ' 11' ' ' TRP . 38.1 mp0 -71.08 -28.45 64.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 109.21 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -58.67 -22.54 57.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.657 -179.422 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.732 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 17.2 p -66.03 -31.62 72.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 179.584 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.732 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.6 -31.77 1.98 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.83 -1.169 . . . . 0.0 110.64 -179.387 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.637 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 6.6 p-10 -80.26 146.48 31.64 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 110.422 -178.496 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.54 -3.95 5.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.902 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.9 -130.44 33.32 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.6 m -67.75 137.62 55.58 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.229 -1.16 . . . . 0.0 108.641 179.369 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -163.67 165.01 23.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.478 -0.764 . . . . 0.0 108.954 -179.422 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.54 ' C ' HH12 ' A' ' 36' ' ' ARG . 68.3 m-80 -106.36 141.03 38.35 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 179.156 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.537 ' HG3' HH11 ' A' ' 18' ' ' ARG . 14.8 mtm-85 -61.24 -36.91 81.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.761 -1.212 . . . . 0.0 109.649 -179.565 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -60.1 -49.32 78.11 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.069 -1.02 . . . . 0.0 110.165 -179.37 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 17' ' ' ASN . 7.6 pttt -68.03 -27.27 66.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.722 -1.236 . . . . 0.0 108.579 179.531 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.41 -33.44 73.71 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.816 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 26' ' ' ARG . 97.9 mt-10 -60.9 -47.45 86.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.52 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -60.01 -44.3 94.66 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.079 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.694 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 59.3 mt -69.11 -25.24 64.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.968 -1.082 . . . . 0.0 108.196 178.343 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.525 HD11 ' HB3' ' A' ' 47' ' ' SER . 44.1 mt -96.3 -10.07 28.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.837 . . . . 0.0 109.318 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.666 ' N ' ' O ' ' A' ' 22' ' ' GLU . 61.7 mtm180 -107.48 131.25 54.51 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.431 -0.793 . . . . 0.0 110.582 -179.19 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.42 -4.28 43.78 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.208 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.694 ' NZ ' ' O ' ' A' ' 24' ' ' LEU . 14.6 ptpt -122.98 154.85 37.87 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.003 -1.293 . . . . 0.0 110.929 -179.384 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.482 ' HG2' ' N ' ' A' ' 30' ' ' ASP . 26.9 ttm180 -73.95 160.01 31.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.529 0.681 . . . . 0.0 110.871 -179.004 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.482 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 8.9 p-10 -59.19 167.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.7 0.762 . . . . 0.0 110.128 179.598 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.13 -33.94 5.6 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.4 m -82.06 119.9 24.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -1.114 . . . . 0.0 108.891 179.559 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.808 ' CG ' HD22 ' A' ' 101' ' ' LEU . 1.0 OUTLIER -136.23 164.65 27.59 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.598 -1.241 . . . . 0.0 110.964 -179.521 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.784 HD23 HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -131.89 165.75 23.17 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.509 0.671 . . . . 0.0 110.152 -179.567 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG22 ' SG ' ' A' ' 46' ' ' CYS . 55.1 t -116.67 121.95 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.078 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.54 HH12 ' C ' ' A' ' 17' ' ' ASN . 14.7 ptm180 -142.4 -176.21 4.75 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.746 ' C ' ' H ' ' A' ' 39' ' ' SER . 36.7 tt0 -100.74 163.66 12.22 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.592 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.444 ' N ' ' HG2' ' A' ' 37' ' ' GLU . 29.2 t -75.88 16.9 0.36 Allowed 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 178.092 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.746 ' H ' ' C ' ' A' ' 37' ' ' GLU . 10.4 t 71.78 -65.7 0.33 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.012 -1.449 . . . . 0.0 108.143 -178.988 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 86.9 mttt -100.28 166.8 10.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.748 -0.595 . . . . 0.0 109.548 179.361 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 43' ' ' CYS . 1.8 mm-40 68.83 13.14 8.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.74 . . . . 0.0 109.694 179.636 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . 40.05 28.01 0.15 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.586 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' GLN . 31.4 t -86.41 135.13 33.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.267 . . . . 0.0 109.771 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.602 ' O ' ' O ' ' A' ' 59' ' ' ILE . 93.8 m-85 -79.97 152.04 29.71 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.448 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.413 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -154.98 140.63 17.99 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.659 -1.276 . . . . 0.0 110.245 -179.147 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 59' ' ' ILE . 84.1 m -106.29 118.34 36.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.525 ' HB3' HD11 ' A' ' 25' ' ' LEU . 74.0 m -91.93 127.46 37.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.504 -0.748 . . . . 0.0 109.259 -179.479 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.81 145.96 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.856 -1.153 . . . . 0.0 110.423 -179.559 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.0 t -92.29 144.03 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.349 -0.844 . . . . 0.0 108.743 178.906 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.675 HG12 ' H ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -123.23 158.95 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.035 -1.04 . . . . 0.0 109.624 179.833 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -65.8 57.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.535 -0.728 . . . . 0.0 110.492 -178.535 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 169.46 -33.54 0.18 Allowed Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.307 -1.425 . . . . 0.0 111.295 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.675 ' H ' HG12 ' A' ' 50' ' ' VAL . 88.8 mt-10 -159.74 165.61 32.14 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.9 -1.353 . . . . 0.0 110.486 -179.544 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 t -97.32 125.78 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.801 . . . . 0.0 109.19 178.772 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HE2' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -120.38 146.01 46.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.927 -1.108 . . . . 0.0 110.745 -179.273 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -111.75 87.76 2.64 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.446 -0.784 . . . . 0.0 108.918 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 63.2 m -66.9 139.42 57.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.908 . . . . 0.0 109.186 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.411 HG22 ' SG ' ' A' ' 43' ' ' CYS . 5.4 p -106.57 134.36 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.277 -179.19 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.699 HD12 ' SG ' ' A' ' 46' ' ' CYS . 31.4 mt -121.85 144.87 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.4 -0.813 . . . . 0.0 108.822 179.233 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.444 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 14.4 t-20 -114.13 119.24 36.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.019 -1.05 . . . . 0.0 109.032 -179.703 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -84.49 114.76 22.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.853 -1.154 . . . . 0.0 109.719 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.544 HG22 ' N ' ' A' ' 63' ' ' ALA . 58.7 m -148.5 164.05 35.36 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.535 -0.728 . . . . 0.0 109.214 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.544 ' N ' HG22 ' A' ' 62' ' ' THR . . . -57.1 -50.93 71.24 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 108.929 179.368 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.4 p -116.99 18.91 14.54 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.117 -0.989 . . . . 0.0 111.433 -179.329 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.926 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -107.52 -78.92 1.15 Allowed Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.133 -1.508 . . . . 0.0 111.582 -178.894 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.498 ' O ' ' O ' ' A' ' 67' ' ' GLY . 93.8 m-85 68.28 -162.9 0.2 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.235 -1.156 . . . . 0.0 109.437 -178.458 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.625 ' CA ' HG23 ' A' ' 59' ' ' ILE . . . -54.29 -114.63 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.569 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 29.9 m-85 -59.98 -45.91 91.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -1.121 . . . . 0.0 109.706 -179.226 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.926 ' HB2' ' O ' ' A' ' 65' ' ' GLY . . . 68.79 7.51 6.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.367 -0.833 . . . . 0.0 109.997 179.816 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.675 ' H ' ' CD ' ' A' ' 71' ' ' PRO . 98.0 mt-10 -109.23 -33.28 0.16 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.877 -1.139 . . . . 0.0 110.748 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.675 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 97.0 Cg_endo -92.27 44.25 0.38 Allowed 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.961 2.44 . . . . 0.0 112.449 -179.79 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 59.27 49.77 8.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.46 -0.775 . . . . 0.0 109.615 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.532 ' ND2' ' HG2' ' A' ' 71' ' ' PRO . 58.7 m-20 -99.64 12.22 37.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.363 -179.714 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.14 65.18 0.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.938 -1.101 . . . . 0.0 108.936 179.811 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.709 ' OH ' ' CG ' ' A' ' 84' ' ' HIS . 58.8 m-85 -75.48 146.6 40.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.457 -0.777 . . . . 0.0 110.206 -179.898 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.5 t -60.53 -38.49 84.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.525 -0.734 . . . . 0.0 110.19 -179.485 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.7 p -134.38 157.12 47.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.03 -1.044 . . . . 0.0 110.118 -178.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.65 -27.1 68.7 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.612 -0.68 . . . . 0.0 109.715 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 83' ' ' LEU . 64.0 mttp -59.55 -44.78 93.15 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.826 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.38 -37.96 87.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.336 -0.853 . . . . 0.0 109.328 179.103 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 81' ' ' LEU . 7.5 tt -57.6 -41.95 82.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 108.914 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.47 -45.23 98.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.048 -1.033 . . . . 0.0 109.298 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.495 ' H ' HD12 ' A' ' 83' ' ' LEU . 6.4 mp -62.53 -37.74 87.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.871 -1.143 . . . . 0.0 109.58 179.417 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.709 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 11.6 t-160 -59.53 -46.69 88.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.524 -0.735 . . . . 0.0 110.966 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.584 ' HB2' HD12 ' A' ' 101' ' ' LEU . 4.4 m-85 -67.59 -28.4 67.73 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.498 -1.376 . . . . 0.0 109.585 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.505 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 1.2 tm0? -58.91 -38.06 78.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 109.164 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -86.14 -36.16 19.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.134 -0.979 . . . . 0.0 109.276 179.361 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.544 ' O ' ' O ' ' A' ' 85' ' ' TYR . 1.8 p -90.05 139.38 30.67 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.373 -0.83 . . . . 0.0 109.675 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.445 ' HA ' HG22 ' A' ' 100' ' ' THR . 37.3 m -93.1 140.57 29.35 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.601 0.715 . . . . 0.0 109.835 -179.769 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.655 ' O ' ' C ' ' A' ' 91' ' ' VAL . 5.8 mt -61.09 -41.14 96.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 111.238 -178.905 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.783 ' N ' ' O ' ' A' ' 97' ' ' LEU . 87.2 t 16.29 -83.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 121.41 -0.806 . . . . 0.0 109.834 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 90' ' ' LEU . 1.3 tp60 75.77 -176.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 110.222 179.282 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -60.09 -38.74 83.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.642 -0.661 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -52.52 -24.95 9.04 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.013 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 61.53 20.31 11.12 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 178.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.0 m -130.51 7.26 4.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.693 -1.254 . . . . 0.0 111.172 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.783 ' O ' ' N ' ' A' ' 91' ' ' VAL . 83.2 mt -98.5 53.67 1.04 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.802 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.09 78.47 3.63 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.548 -178.748 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.626 HG21 HG23 ' A' ' 50' ' ' VAL . 53.2 t -154.31 147.92 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.809 0.814 . . . . 0.0 109.533 179.377 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 89' ' ' SER . 48.2 p -121.24 153.67 37.34 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.316 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.808 HD22 ' CG ' ' A' ' 33' ' ' PHE . 79.0 mt -82.25 71.05 9.31 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . . . -107.38 -17.87 14.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.62 -0.675 . . . . 0.0 112.074 -178.09 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -110.91 123.77 34.59 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.573 -1.329 . . . . 0.0 110.083 -178.875 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 55.2 Cg_endo -77.45 145.06 23.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.488 2.125 . . . . 0.0 110.636 178.87 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.905 HG13 ' CD2' ' A' ' 106' ' ' TYR . 12.0 p -72.21 -22.01 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.535 -1.353 . . . . 0.0 109.38 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.905 ' CD2' HG13 ' A' ' 105' ' ' VAL . 72.3 m-85 -129.19 64.35 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.768 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . -57.11 -40.88 77.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 108.819 179.451 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -156.34 57.02 0.57 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.956 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 59.03 31.87 21.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.842 . . . . 0.0 110.174 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.63 ' HG2' HH11 ' A' ' 110' ' ' ARG . 24.1 ttt-85 -68.75 144.04 54.48 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.011 -1.055 . . . . 0.0 109.207 -179.87 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.743 ' CG ' HH11 ' A' ' 111' ' ' ARG . 1.9 mtt-85 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.087 -1.008 . . . . 0.0 109.324 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.379 0.609 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -82.02 122.63 28.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.115 -0.991 . . . . 0.0 109.18 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.3 mt -94.53 127.76 42.71 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 -179.47 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -51.27 -17.86 4.49 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.013 1.809 . . . . 0.0 111.563 178.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -63.24 -23.26 67.34 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.523 -0.735 . . . . 0.0 110.4 -179.074 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -66.1 -37.95 87.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.815 -1.178 . . . . 0.0 109.599 -179.219 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.572 ' O ' ' OG1' ' A' ' 10' ' ' THR . 84.9 m-20 -96.44 127.2 42.21 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.156 -0.965 . . . . 0.0 109.535 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.522 ' HG3' ' CH2' ' A' ' 11' ' ' TRP . 38.1 mp0 -71.08 -28.45 64.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 109.21 179.56 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -58.67 -22.54 57.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.657 -179.422 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.732 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 17.2 p -66.03 -31.62 72.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.732 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.6 -31.77 1.98 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.83 -1.169 . . . . 0.0 110.64 -179.387 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.637 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 6.6 p-10 -80.26 146.48 31.64 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 110.422 -178.496 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.54 -3.95 5.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.9 -130.44 33.32 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.6 m -67.75 137.62 55.58 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.229 -1.16 . . . . 0.0 108.641 179.369 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -163.67 165.01 23.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.478 -0.764 . . . . 0.0 108.954 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.54 ' C ' HH12 ' A' ' 36' ' ' ARG . 68.3 m-80 -106.36 141.03 38.35 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 179.156 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.537 ' HG3' HH11 ' A' ' 18' ' ' ARG . 14.8 mtm-85 -61.24 -36.91 81.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.761 -1.212 . . . . 0.0 109.649 -179.565 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -60.1 -49.32 78.11 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.069 -1.02 . . . . 0.0 110.165 -179.37 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 17' ' ' ASN . 7.6 pttt -68.03 -27.27 66.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.722 -1.236 . . . . 0.0 108.579 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.41 -33.44 73.71 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.816 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 26' ' ' ARG . 97.9 mt-10 -60.9 -47.45 86.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.52 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -60.01 -44.3 94.66 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.079 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.694 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 59.3 mt -69.11 -25.24 64.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.968 -1.082 . . . . 0.0 108.196 178.343 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.525 HD11 ' HB3' ' A' ' 47' ' ' SER . 44.1 mt -96.3 -10.07 28.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.837 . . . . 0.0 109.318 179.683 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.666 ' N ' ' O ' ' A' ' 22' ' ' GLU . 61.7 mtm180 -107.48 131.25 54.51 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.431 -0.793 . . . . 0.0 110.582 -179.19 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.42 -4.28 43.78 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.208 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.694 ' NZ ' ' O ' ' A' ' 24' ' ' LEU . 14.6 ptpt -122.98 154.85 37.87 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.003 -1.293 . . . . 0.0 110.929 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.482 ' HG2' ' N ' ' A' ' 30' ' ' ASP . 26.9 ttm180 -73.95 160.01 31.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.529 0.681 . . . . 0.0 110.871 -179.004 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.482 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 8.9 p-10 -59.19 167.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.7 0.762 . . . . 0.0 110.128 179.598 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.13 -33.94 5.6 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.561 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.4 m -82.06 119.9 24.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -1.114 . . . . 0.0 108.891 179.559 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.808 ' CG ' HD22 ' A' ' 101' ' ' LEU . 1.0 OUTLIER -136.23 164.65 27.59 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.598 -1.241 . . . . 0.0 110.964 -179.521 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.784 HD23 HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -131.89 165.75 23.17 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.509 0.671 . . . . 0.0 110.152 -179.567 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG22 ' SG ' ' A' ' 46' ' ' CYS . 55.1 t -116.67 121.95 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.078 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.54 HH12 ' C ' ' A' ' 17' ' ' ASN . 14.7 ptm180 -142.4 -176.21 4.75 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.41 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.746 ' C ' ' H ' ' A' ' 39' ' ' SER . 36.7 tt0 -100.74 163.66 12.22 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.592 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.444 ' N ' ' HG2' ' A' ' 37' ' ' GLU . 29.2 t -75.88 16.9 0.36 Allowed 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 178.092 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.746 ' H ' ' C ' ' A' ' 37' ' ' GLU . 10.4 t 71.78 -65.7 0.33 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.012 -1.449 . . . . 0.0 108.143 -178.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 86.9 mttt -100.28 166.8 10.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.748 -0.595 . . . . 0.0 109.548 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 43' ' ' CYS . 1.8 mm-40 68.83 13.14 8.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.74 . . . . 0.0 109.694 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . 40.05 28.01 0.15 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.586 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' GLN . 31.4 t -86.41 135.13 33.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.267 . . . . 0.0 109.771 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.602 ' O ' ' O ' ' A' ' 59' ' ' ILE . 93.8 m-85 -79.97 152.04 29.71 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.448 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.413 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -154.98 140.63 17.99 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.659 -1.276 . . . . 0.0 110.245 -179.147 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 59' ' ' ILE . 84.1 m -106.29 118.34 36.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.961 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.525 ' HB3' HD11 ' A' ' 25' ' ' LEU . 74.0 m -91.93 127.46 37.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.504 -0.748 . . . . 0.0 109.259 -179.479 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.81 145.96 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.856 -1.153 . . . . 0.0 110.423 -179.559 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.0 t -92.29 144.03 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.349 -0.844 . . . . 0.0 108.743 178.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.675 HG12 ' H ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -123.23 158.95 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.035 -1.04 . . . . 0.0 109.624 179.833 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -65.8 57.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.535 -0.728 . . . . 0.0 110.492 -178.535 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 169.46 -33.54 0.18 Allowed Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.307 -1.425 . . . . 0.0 111.295 179.089 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.675 ' H ' HG12 ' A' ' 50' ' ' VAL . 88.8 mt-10 -159.74 165.61 32.14 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.9 -1.353 . . . . 0.0 110.486 -179.544 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 t -97.32 125.78 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.801 . . . . 0.0 109.19 178.772 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HE2' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -120.38 146.01 46.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.927 -1.108 . . . . 0.0 110.745 -179.273 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -111.75 87.76 2.64 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.446 -0.784 . . . . 0.0 108.918 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 63.2 m -66.9 139.42 57.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.908 . . . . 0.0 109.186 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.411 HG22 ' SG ' ' A' ' 43' ' ' CYS . 5.4 p -106.57 134.36 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.277 -179.19 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.699 HD12 ' SG ' ' A' ' 46' ' ' CYS . 31.4 mt -121.85 144.87 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.4 -0.813 . . . . 0.0 108.822 179.233 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.444 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 14.4 t-20 -114.13 119.24 36.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.019 -1.05 . . . . 0.0 109.032 -179.703 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -84.49 114.76 22.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.853 -1.154 . . . . 0.0 109.719 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.544 HG22 ' N ' ' A' ' 63' ' ' ALA . 58.7 m -148.5 164.05 35.36 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.535 -0.728 . . . . 0.0 109.214 179.782 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.544 ' N ' HG22 ' A' ' 62' ' ' THR . . . -57.1 -50.93 71.24 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 108.929 179.368 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.4 p -116.99 18.91 14.54 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.117 -0.989 . . . . 0.0 111.433 -179.329 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.926 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -107.52 -78.92 1.15 Allowed Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.133 -1.508 . . . . 0.0 111.582 -178.894 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.498 ' O ' ' O ' ' A' ' 67' ' ' GLY . 93.8 m-85 68.28 -162.9 0.2 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.235 -1.156 . . . . 0.0 109.437 -178.458 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.625 ' CA ' HG23 ' A' ' 59' ' ' ILE . . . -54.29 -114.63 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.671 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.569 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 29.9 m-85 -59.98 -45.91 91.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -1.121 . . . . 0.0 109.706 -179.226 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.926 ' HB2' ' O ' ' A' ' 65' ' ' GLY . . . 68.79 7.51 6.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.367 -0.833 . . . . 0.0 109.997 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.675 ' H ' ' CD ' ' A' ' 71' ' ' PRO . 98.0 mt-10 -109.23 -33.28 0.16 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.877 -1.139 . . . . 0.0 110.748 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.675 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 97.0 Cg_endo -92.27 44.25 0.38 Allowed 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.961 2.44 . . . . 0.0 112.449 -179.79 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 59.27 49.77 8.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.46 -0.775 . . . . 0.0 109.615 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.532 ' ND2' ' HG2' ' A' ' 71' ' ' PRO . 58.7 m-20 -99.64 12.22 37.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.363 -179.714 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.14 65.18 0.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.938 -1.101 . . . . 0.0 108.936 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.709 ' OH ' ' CG ' ' A' ' 84' ' ' HIS . 58.8 m-85 -75.48 146.6 40.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.457 -0.777 . . . . 0.0 110.206 -179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.5 t -60.53 -38.49 84.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.525 -0.734 . . . . 0.0 110.19 -179.485 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.7 p -134.38 157.12 47.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.03 -1.044 . . . . 0.0 110.118 -178.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.65 -27.1 68.7 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.612 -0.68 . . . . 0.0 109.715 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 83' ' ' LEU . 64.0 mttp -59.55 -44.78 93.15 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.826 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.38 -37.96 87.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.336 -0.853 . . . . 0.0 109.328 179.103 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 81' ' ' LEU . 7.5 tt -57.6 -41.95 82.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 108.914 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.47 -45.23 98.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.048 -1.033 . . . . 0.0 109.298 179.591 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.495 ' H ' HD12 ' A' ' 83' ' ' LEU . 6.4 mp -62.53 -37.74 87.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.871 -1.143 . . . . 0.0 109.58 179.417 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.709 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 11.6 t-160 -59.53 -46.69 88.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.524 -0.735 . . . . 0.0 110.966 -179.217 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.584 ' HB2' HD12 ' A' ' 101' ' ' LEU . 4.4 m-85 -67.59 -28.4 67.73 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.498 -1.376 . . . . 0.0 109.585 -179.624 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.505 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 1.2 tm0? -58.91 -38.06 78.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 109.164 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -86.14 -36.16 19.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.134 -0.979 . . . . 0.0 109.276 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.544 ' O ' ' O ' ' A' ' 85' ' ' TYR . 1.8 p -90.05 139.38 30.67 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.373 -0.83 . . . . 0.0 109.675 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.445 ' HA ' HG22 ' A' ' 100' ' ' THR . 37.3 m -93.1 140.57 29.35 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.601 0.715 . . . . 0.0 109.835 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.655 ' O ' ' C ' ' A' ' 91' ' ' VAL . 5.8 mt -61.09 -41.14 96.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 111.238 -178.905 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.783 ' N ' ' O ' ' A' ' 97' ' ' LEU . 87.2 t 16.29 -83.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 121.41 -0.806 . . . . 0.0 109.834 -179.44 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 90' ' ' LEU . 1.3 tp60 75.77 -176.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 110.222 179.282 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -60.09 -38.74 83.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.642 -0.661 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -52.52 -24.95 9.04 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.013 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 61.53 20.31 11.12 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 178.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.0 m -130.51 7.26 4.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.693 -1.254 . . . . 0.0 111.172 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.783 ' O ' ' N ' ' A' ' 91' ' ' VAL . 83.2 mt -98.5 53.67 1.04 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.802 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.09 78.47 3.63 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.548 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.626 HG21 HG23 ' A' ' 50' ' ' VAL . 53.2 t -154.31 147.92 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.809 0.814 . . . . 0.0 109.533 179.377 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 89' ' ' SER . 48.2 p -121.24 153.67 37.34 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.316 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.808 HD22 ' CG ' ' A' ' 33' ' ' PHE . 79.0 mt -82.25 71.05 9.31 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.244 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . . . -107.38 -17.87 14.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.62 -0.675 . . . . 0.0 112.074 -178.09 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -110.91 123.77 34.59 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.573 -1.329 . . . . 0.0 110.083 -178.875 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 55.2 Cg_endo -77.45 145.06 23.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.488 2.125 . . . . 0.0 110.636 178.87 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.905 HG13 ' CD2' ' A' ' 106' ' ' TYR . 12.0 p -72.21 -22.01 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.535 -1.353 . . . . 0.0 109.38 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.905 ' CD2' HG13 ' A' ' 105' ' ' VAL . 72.3 m-85 -129.19 64.35 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.768 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . -57.11 -40.88 77.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 108.819 179.451 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -156.34 57.02 0.57 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 59.03 31.87 21.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.842 . . . . 0.0 110.174 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.63 ' HG2' HH11 ' A' ' 110' ' ' ARG . 24.1 ttt-85 -68.75 144.04 54.48 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.011 -1.055 . . . . 0.0 109.207 -179.87 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.743 ' CG ' HH11 ' A' ' 111' ' ' ARG . 1.9 mtt-85 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.087 -1.008 . . . . 0.0 109.324 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -67.44 146.64 53.81 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.989 -1.069 . . . . 0.0 109.034 179.432 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 3' ' ' LEU . 96.8 mt -82.11 141.49 46.78 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.13 -0.981 . . . . 0.0 108.76 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.416 ' O ' ' OG1' ' A' ' 10' ' ' THR . 24.2 Cg_endo -65.11 -8.44 18.42 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.175 1.917 . . . . 0.0 111.778 -179.216 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.686 ' CG ' HD21 ' A' ' 83' ' ' LEU . 89.9 m-70 -65.94 -26.5 67.61 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.538 -0.726 . . . . 0.0 109.809 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -64.23 -29.82 70.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.982 -1.074 . . . . 0.0 110.036 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.488 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 95.6 m-20 -105.06 131.52 52.46 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.085 -1.01 . . . . 0.0 110.332 -179.545 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 12' ' ' ASN . 91.5 mt-10 -69.69 -23.3 63.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.536 -0.727 . . . . 0.0 109.504 179.325 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.43 ' CG ' ' N ' ' A' ' 10' ' ' THR . 34.5 pttt -61.36 -31.57 71.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.409 -0.807 . . . . 0.0 111.367 -178.823 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.559 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 53.6 p -70.61 -24.9 62.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.769 -1.207 . . . . 0.0 110.914 -178.452 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.605 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -124.51 -29.6 3.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.643 -1.285 . . . . 0.0 110.419 179.057 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 8' ' ' GLU . 49.0 t-20 -86.3 123.38 31.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 110.651 -178.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 13' ' ' VAL . 7.4 p -101.62 0.59 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.43 -0.794 . . . . 0.0 109.19 179.278 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.49 -153.69 52.22 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 88.2 p -68.9 148.32 50.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.378 -1.072 . . . . 0.0 108.429 179.201 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.56 ' O ' ' CZ ' ' A' ' 36' ' ' ARG . 47.3 t -175.16 156.34 2.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 108.826 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.64 ' C ' HH22 ' A' ' 36' ' ' ARG . 1.5 t-20 -78.19 140.8 38.94 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.543 179.832 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.948 ' N ' HH22 ' A' ' 36' ' ' ARG . 42.3 mtt-85 -60.18 -34.42 73.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.253 -0.904 . . . . 0.0 110.701 -179.181 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.645 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 42.3 p-10 -60.02 -40.33 88.94 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.804 -1.185 . . . . 0.0 108.702 179.773 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.645 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 62.1 tttp -64.24 -40.92 97.03 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.322 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.01 76.99 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.31 -0.869 . . . . 0.0 108.91 179.844 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 26' ' ' ARG . 98.1 mt-10 -59.57 -48.94 79.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.175 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.687 ' OD1' ' N ' ' A' ' 24' ' ' LEU . 8.6 p30 -60.02 -40.06 87.98 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.905 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.687 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 85.1 mt -66.99 -29.96 69.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.245 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.7 mt -93.7 -7.7 42.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.628 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 22' ' ' GLU . 2.0 ttm180 -97.23 128.77 44.4 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.277 -0.89 . . . . 0.0 109.789 -179.526 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.69 16.99 78.31 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.464 ' O ' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -110.16 133.37 53.29 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.537 -0.978 . . . . 0.0 109.642 -179.91 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -60.65 156.73 16.03 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.901 0.858 . . . . 0.0 111.106 -179.488 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 50' ' ' VAL . 87.7 m-20 -63.85 151.85 41.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.586 -0.696 . . . . 0.0 109.383 179.012 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.401 ' HA2' HG13 ' A' ' 99' ' ' VAL . . . 99.03 -22.04 42.9 Favored Glycine 0 N--CA 1.499 2.888 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.165 179.473 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.2 m -83.57 121.41 27.2 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.085 -1.244 . . . . 0.0 108.604 179.427 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.524 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -137.74 162.95 32.54 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.902 -1.124 . . . . 0.0 110.066 179.941 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.11 147.37 40.14 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.067 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 11' ' ' TRP . 54.9 t -92.58 132.03 38.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.04 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.948 HH22 ' N ' ' A' ' 18' ' ' ARG . 7.6 ttt180 -142.41 -172.65 3.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.267 -0.896 . . . . 0.0 108.86 -178.871 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.719 ' H ' ' CG ' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -105.89 169.2 8.62 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.985 -1.072 . . . . 0.0 108.952 -179.948 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.644 ' O ' ' CB ' ' A' ' 39' ' ' SER . 21.7 m -77.65 17.17 0.56 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 177.378 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.682 ' H ' ' C ' ' A' ' 37' ' ' GLU . 4.7 m 101.44 -30.58 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.257 -179.416 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 71.3 mmtt -85.98 147.15 26.35 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -67.17 -29.83 69.63 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.253 -0.904 . . . . 0.0 110.352 -179.16 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.23 11.89 70.8 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.346 -179.261 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 40' ' ' LYS . 89.2 m -118.57 156.54 28.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.207 -1.172 . . . . 0.0 109.185 179.505 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.595 ' O ' ' O ' ' A' ' 59' ' ' ILE . 30.5 m-85 -130.68 153.84 48.55 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.317 -0.864 . . . . 0.0 110.023 -179.569 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.598 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -175.8 145.12 0.66 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.062 -1.024 . . . . 0.0 108.477 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 57' ' ' CYS . 31.8 p -125.24 154.85 41.03 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.561 -1.337 . . . . 0.0 109.268 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.568 ' OG ' ' O ' ' A' ' 55' ' ' LYS . 41.1 t -119.75 138.9 53.04 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.636 0.731 . . . . 0.0 110.344 -178.519 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -130.73 146.0 34.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.463 -0.773 . . . . 0.0 109.388 179.88 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 28' ' ' LYS . 40.1 t -91.75 133.36 33.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.475 -0.766 . . . . 0.0 109.13 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 52' ' ' GLY . 0.7 OUTLIER -122.49 163.13 21.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.256 -0.977 . . . . 0.0 110.667 -179.77 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.528 ' C ' ' OD1' ' A' ' 51' ' ' ASP . 47.5 p30 -62.89 50.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.665 -179.06 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 178.48 -43.22 0.09 OUTLIER Glycine 0 C--N 1.295 -1.695 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.896 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 44.6 mm-40 -158.87 166.81 31.02 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.07 -1.253 . . . . 0.0 111.224 -179.324 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.424 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 5.3 m -73.11 146.92 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.525 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.568 ' O ' ' OG ' ' A' ' 47' ' ' SER . 11.2 mmtm -113.63 146.66 39.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.889 -1.132 . . . . 0.0 110.557 -179.335 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -125.54 65.79 1.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.61 -0.681 . . . . 0.0 109.687 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 74.4 m -59.47 144.91 45.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.073 -1.017 . . . . 0.0 108.891 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.4 138.49 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.932 0.872 . . . . 0.0 112.127 -178.328 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.919 HG23 ' O ' ' A' ' 66' ' ' TYR . 48.4 mm -115.74 133.45 62.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.141 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 62' ' ' THR . 81.3 m-20 -116.69 102.57 9.56 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.564 -1.335 . . . . 0.0 110.917 -178.287 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.469 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 59.6 tttp -62.71 80.29 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.651 -1.28 . . . . 0.0 108.841 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 60' ' ' ASN . 69.1 p -131.8 176.45 8.34 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.361 -0.837 . . . . 0.0 109.109 -179.661 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.75 -42.93 68.73 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 64' ' ' THR . 12.6 t -147.7 66.22 1.11 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.438 -0.789 . . . . 0.0 109.711 -179.88 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 60' ' ' ASN . . . -157.0 -10.64 0.05 OUTLIER Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.601 -1.285 . . . . 0.0 111.107 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.919 ' O ' HG23 ' A' ' 59' ' ' ILE . 42.3 p90 -57.42 -6.89 0.5 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.539 -1.565 . . . . 0.0 109.944 -179.276 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 65' ' ' GLY . . . -151.03 -166.78 14.05 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.663 ' CD2' ' OH ' ' A' ' 85' ' ' TYR . 35.8 m-85 -66.84 158.11 31.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -1.173 . . . . 0.0 108.777 179.789 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.38 7.72 45.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.788 . . . . 0.0 109.503 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.699 ' O ' ' N ' ' A' ' 72' ' ' TYR . 98.3 mt-10 -51.76 154.54 3.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.452 -0.78 . . . . 0.0 109.795 -179.701 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 73' ' ' ASN . 71.3 Cg_exo -39.72 -9.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.737 2.291 . . . . 0.0 111.769 179.367 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.699 ' N ' ' O ' ' A' ' 70' ' ' GLU . 9.4 m-30 -52.05 -20.69 2.6 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.174 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.59 ' O ' ' O ' ' A' ' 74' ' ' LEU . 88.1 m-20 64.06 40.54 7.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.773 -0.58 . . . . 0.0 111.498 178.857 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.811 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.0 mm? 52.77 115.64 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.926 -1.109 . . . . 0.0 110.099 178.58 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.718 ' OH ' ' CG ' ' A' ' 84' ' ' HIS . 97.8 m-85 -60.05 147.6 38.68 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.952 0.882 . . . . 0.0 110.781 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 64.6 m -65.18 -39.76 93.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.437 -0.789 . . . . 0.0 111.532 -178.817 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.7 m -123.38 147.19 47.33 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.659 -1.276 . . . . 0.0 110.123 -178.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 78' ' ' LEU . 76.5 mt -59.56 -40.36 87.04 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -55.38 -40.61 71.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.444 -0.785 . . . . 0.0 109.379 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.19 -40.49 96.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.442 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.8 tt -58.82 -43.7 90.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.098 -179.349 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.67 -38.64 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.76 -1.212 . . . . 0.0 109.188 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.686 HD21 ' CG ' ' A' ' 5' ' ' HIS . 90.7 mt -74.89 -38.53 61.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.063 -1.023 . . . . 0.0 110.437 -179.846 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.718 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 65.8 t-80 -64.7 -39.36 93.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.802 -1.186 . . . . 0.0 109.792 -179.631 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.663 ' OH ' ' CD2' ' A' ' 68' ' ' PHE . 4.8 m-30 -66.82 -27.66 67.74 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.149 -0.97 . . . . 0.0 108.875 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.644 ' HG3' ' HB2' ' A' ' 102' ' ' ALA . 41.6 tt0 -63.79 -34.72 78.53 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.539 -0.726 . . . . 0.0 109.292 178.926 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -90.62 -13.47 34.3 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.028 -1.045 . . . . 0.0 110.163 -179.152 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.1 m -100.71 136.04 41.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 110.438 -179.678 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 t -85.99 125.55 33.47 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.282 -0.886 . . . . 0.0 108.934 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.722 ' O ' ' N ' ' A' ' 92' ' ' GLN . 87.1 mt -66.87 -20.05 65.85 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.407 -0.808 . . . . 0.0 110.332 -179.243 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.728 ' N ' ' O ' ' A' ' 97' ' ' LEU . 11.8 p -15.17 -48.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 O-C-N 121.684 -0.635 . . . . 0.0 110.372 179.457 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.722 ' N ' ' O ' ' A' ' 90' ' ' LEU . 34.0 tt0 53.92 179.41 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.483 -0.761 . . . . 0.0 110.807 178.777 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.547 ' H ' ' CG ' ' A' ' 92' ' ' GLN . 91.4 m-70 -60.06 -29.53 68.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.587 -0.695 . . . . 0.0 109.383 -179.719 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -56.96 -24.01 49.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.083 -1.011 . . . . 0.0 108.795 179.361 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.474 ' HA ' HG22 ' A' ' 91' ' ' VAL . 27.5 t70 61.93 41.67 11.09 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.518 -0.739 . . . . 0.0 110.432 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.7 m -148.19 -2.56 0.52 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.648 -1.283 . . . . 0.0 111.151 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 92.8 mt -102.16 52.0 0.81 Allowed 'General case' 0 C--N 1.29 -2.006 0 O-C-N 121.13 -0.982 . . . . 0.0 108.413 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.485 ' OD1' HG23 ' A' ' 91' ' ' VAL . 1.8 m120 -78.09 70.35 4.44 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.769 0.795 . . . . 0.0 109.807 -178.802 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.401 HG13 ' HA2' ' A' ' 31' ' ' GLY . 25.9 t -149.67 153.02 11.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.2 p -124.21 156.99 35.83 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.26 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.524 HD22 ' CG ' ' A' ' 33' ' ' PHE . 30.7 mt -82.58 69.48 9.36 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.912 -1.117 . . . . 0.0 108.694 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.644 ' HB2' ' HG3' ' A' ' 86' ' ' GLN . . . -105.09 -18.79 14.03 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.508 -0.745 . . . . 0.0 112.077 -178.004 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -112.44 109.62 53.59 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.414 -1.429 . . . . 0.0 112.101 -177.709 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.404 ' HG2' ' CG ' ' A' ' 4' ' ' PRO . 23.4 Cg_exo -62.35 143.72 94.12 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.074 1.85 . . . . 0.0 111.169 178.153 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.537 HG13 ' CD2' ' A' ' 106' ' ' TYR . 12.5 p -68.66 -36.92 76.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 120.745 -1.222 . . . . 0.0 108.904 179.345 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.537 ' CD2' HG13 ' A' ' 105' ' ' VAL . 55.7 m-85 -109.13 42.48 1.43 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.386 -0.821 . . . . 0.0 109.61 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.91 126.15 24.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 108.857 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -130.72 141.55 50.39 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.972 -1.08 . . . . 0.0 109.148 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -102.34 127.26 49.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.005 -1.059 . . . . 0.0 110.035 -179.552 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.412 ' HG2' ' N ' ' A' ' 111' ' ' ARG . 7.8 ttt180 -130.04 148.64 51.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.313 -0.867 . . . . 0.0 109.385 179.668 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.412 ' N ' ' HG2' ' A' ' 110' ' ' ARG . 61.7 mtp180 . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.037 -1.039 . . . . 0.0 109.769 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.469 0.652 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.33 140.25 58.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -0.966 . . . . 0.0 109.265 179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.1 mt -100.79 134.1 20.72 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.14 -0.975 . . . . 0.0 109.392 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -51.51 -14.64 2.05 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.812 1.675 . . . . 0.0 110.925 179.369 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.466 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 91.1 m-70 -66.47 -12.93 59.84 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.541 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -63.42 -32.28 73.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 108.85 179.011 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.575 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 92.3 m-20 -100.53 134.19 43.85 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.352 -0.843 . . . . 0.0 110.004 -179.666 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 12' ' ' ASN . 95.5 mt-10 -69.27 -27.26 65.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 109.988 179.566 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.507 ' CG ' ' N ' ' A' ' 10' ' ' THR . 33.3 pttt -60.79 -35.46 76.53 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 110.508 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.669 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 10.6 p -59.75 -33.39 71.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 110.113 -178.827 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.669 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -120.78 -37.27 3.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.893 -1.129 . . . . 0.0 110.165 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -86.21 123.85 31.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.993 -1.067 . . . . 0.0 110.47 -179.214 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.474 ' O ' HG12 ' A' ' 13' ' ' VAL . 74.5 t -94.05 -4.95 10.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.906 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.79 -162.15 19.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.498 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -80.68 61.55 4.4 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.318 -1.107 . . . . 0.0 109.417 -179.544 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.1 p -79.2 156.7 28.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.299 -0.876 . . . . 0.0 109.092 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -70.18 142.72 52.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.191 -0.943 . . . . 0.0 109.453 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.618 HH11 ' NH2' ' A' ' 36' ' ' ARG . 48.6 mtt-85 -59.46 -38.81 81.75 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.054 -1.029 . . . . 0.0 109.388 179.816 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.65 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 40.0 p-10 -62.65 -42.82 99.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.0 -1.062 . . . . 0.0 108.484 179.363 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.65 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 80.3 tttt -60.51 -36.6 78.74 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.233 -0.917 . . . . 0.0 109.066 179.41 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.71 ' CB ' HH11 ' A' ' 36' ' ' ARG . . . -58.57 -34.03 70.59 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.647 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 75.3 tt0 -58.7 -42.63 89.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.247 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.68 -46.94 87.54 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.697 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -67.16 -33.86 76.32 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.863 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.883 HD11 ' OG ' ' A' ' 47' ' ' SER . 22.7 mt -80.85 -16.01 54.82 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.146 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.742 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -74.61 122.43 23.15 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.555 -179.727 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.82 19.54 78.83 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.518 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.505 ' HE2' HG21 ' A' ' 32' ' ' THR . 0.2 OUTLIER -97.18 135.79 38.62 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.359 -1.083 . . . . 0.0 109.685 -179.446 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.699 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.9 OUTLIER -74.88 157.63 34.74 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.66 0.743 . . . . 0.0 110.157 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.513 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 48.4 p30 -62.25 169.36 2.85 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.283 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.88 -28.44 1.89 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.505 HG21 ' HE2' ' A' ' 28' ' ' LYS . 76.7 m -80.56 121.03 25.29 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.869 -1.371 . . . . 0.0 108.984 179.658 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.806 ' HB2' HG22 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -136.06 167.26 21.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.908 -1.12 . . . . 0.0 110.517 -179.32 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 1.1 pt? -148.91 161.29 42.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.454 -0.779 . . . . 0.0 110.588 179.475 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.475 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 65.8 t -106.74 132.73 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.37 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.71 HH11 ' CB ' ' A' ' 21' ' ' ALA . 35.6 ptt180 -147.75 173.14 13.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 108.884 -178.857 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.661 ' C ' ' H ' ' A' ' 39' ' ' SER . 53.0 mt-10 -124.33 170.54 10.7 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.83 -1.169 . . . . 0.0 109.268 179.447 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.646 ' O ' ' CB ' ' A' ' 39' ' ' SER . 57.7 m -75.39 15.51 0.45 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 178.164 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.661 ' H ' ' C ' ' A' ' 37' ' ' GLU . 6.4 t 97.86 131.03 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.828 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.473 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 67.1 mmtt 62.32 -143.77 0.4 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.508 -0.745 . . . . 0.0 109.103 -179.474 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -101.57 20.11 16.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -0.847 . . . . 0.0 109.629 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.06 -52.62 51.03 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.062 -179.325 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 44' ' ' TYR . 53.1 t -161.0 166.58 28.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.99 -1.3 . . . . 0.0 110.246 -179.646 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.608 ' O ' ' O ' ' A' ' 59' ' ' ILE . 57.2 m-85 -123.66 145.83 48.67 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.279 -0.888 . . . . 0.0 109.048 179.168 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 57' ' ' CYS . . . -159.75 153.88 23.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.77 -1.207 . . . . 0.0 109.973 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' CYS . 85.4 m -109.5 125.86 52.93 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.563 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.883 ' OG ' HD11 ' A' ' 25' ' ' LEU . 26.1 t -92.05 127.0 37.36 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.06 -179.682 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.806 HG22 ' HB2' ' A' ' 33' ' ' PHE . 74.3 t -126.1 163.71 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.187 -0.946 . . . . 0.0 109.978 -179.403 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.602 ' N ' HG12 ' A' ' 48' ' ' VAL . 39.2 t -124.6 132.76 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.836 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.701 HG23 ' CG2' ' A' ' 99' ' ' VAL . 11.4 p -123.34 156.35 29.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.995 -1.066 . . . . 0.0 109.671 -179.782 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.423 ' OD1' ' OD2' ' A' ' 30' ' ' ASP . 87.2 m-20 -49.97 -17.17 0.35 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.943 0.878 . . . . 0.0 109.634 -179.429 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.581 ' O ' ' OE2' ' A' ' 53' ' ' GLU . . . -86.18 -59.22 1.88 Allowed Glycine 0 C--N 1.287 -2.142 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.667 -179.175 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.581 ' OE2' ' O ' ' A' ' 52' ' ' GLY . 61.3 mm-40 -163.22 -165.53 1.1 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.25 -1.147 . . . . 0.0 110.554 -178.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.56 ' CG1' HD13 ' A' ' 25' ' ' LEU . 88.8 t -93.36 123.37 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.319 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' NZ ' HG11 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -122.45 149.15 44.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.911 -1.118 . . . . 0.0 110.905 -179.495 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.543 ' CG ' ' NH2' ' A' ' 36' ' ' ARG . 58.6 m-70 -113.31 101.88 9.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.579 -0.701 . . . . 0.0 109.544 179.194 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' CYS . 52.5 t -72.91 130.04 39.5 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.26 138.63 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.246 -0.909 . . . . 0.0 111.878 -177.876 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.608 ' O ' ' O ' ' A' ' 44' ' ' TYR . 10.9 mm -124.93 111.59 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.818 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.695 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 83.6 m-20 -118.59 170.48 8.92 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.647 -1.283 . . . . 0.0 112.182 -178.248 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -128.29 30.52 5.18 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.327 -1.483 . . . . 0.0 108.985 179.155 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.7 p -79.45 -174.93 4.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.314 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.37 -28.35 66.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.19 -0.944 . . . . 0.0 109.616 -179.372 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.9 p -79.0 -5.59 54.27 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.217 -0.927 . . . . 0.0 109.206 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.797 ' HA3' ' HB3' ' A' ' 69' ' ' ALA . . . 81.54 171.54 45.62 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.893 ' CE1' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -64.44 30.8 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.951 -1.323 . . . . 0.0 110.537 -179.244 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.623 ' H ' ' C ' ' A' ' 65' ' ' GLY . . . 88.51 -42.89 3.08 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.63 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 89.7 m-85 -90.43 -6.08 55.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.347 -1.09 . . . . 0.0 110.278 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.893 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . . . -99.63 3.88 45.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.213 -0.929 . . . . 0.0 109.154 179.915 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.702 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 46.2 tt0 -59.64 -35.31 28.44 Favored Pre-proline 0 C--N 1.304 -1.379 0 C-N-CA 119.006 -1.078 . . . . 0.0 108.678 -179.667 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 9.8 Cg_exo -72.81 174.16 12.29 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.634 2.222 . . . . 0.0 111.071 178.451 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -62.57 -12.32 22.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.034 -1.041 . . . . 0.0 109.566 179.609 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -101.36 102.56 13.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.912 -1.117 . . . . 0.0 110.472 -179.316 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.614 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 5.6 mp -106.25 7.4 31.4 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 60.58 175.02 0.1 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.371 -0.83 . . . . 0.0 109.19 -179.481 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.7 t -103.71 -48.72 3.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.122 -0.986 . . . . 0.0 110.048 -179.629 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.8 m -126.3 154.77 42.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.094 -1.004 . . . . 0.0 110.183 -179.104 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.16 -34.05 73.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 110.03 179.827 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.72 -43.74 80.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.188 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -66.9 -30.53 70.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.228 -0.92 . . . . 0.0 108.856 179.464 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.904 HD21 ' CE2' ' A' ' 85' ' ' TYR . 9.2 tt -60.6 -40.9 93.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 108.987 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.2 t -66.86 -44.17 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.361 -0.837 . . . . 0.0 109.819 179.752 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.426 HD21 ' CB ' ' A' ' 5' ' ' HIS . 85.0 mt -67.45 -43.09 81.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.419 -0.8 . . . . 0.0 110.439 -179.119 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -60.02 -40.56 89.72 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.215 -179.194 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.904 ' CE2' HD21 ' A' ' 81' ' ' LEU . 7.4 m-30 -67.34 -24.31 65.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 0.0 108.789 -179.783 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.453 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 38.1 tt0 -61.32 -36.94 81.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 178.961 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -91.44 -16.71 26.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.303 -0.873 . . . . 0.0 109.592 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.4 m -100.84 129.92 46.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.131 -0.981 . . . . 0.0 109.228 179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.543 ' HA ' HG22 ' A' ' 100' ' ' THR . 34.8 t -81.67 132.56 35.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 109.915 -179.627 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 91' ' ' VAL . 76.2 mt -69.01 -13.07 62.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.477 -0.764 . . . . 0.0 109.715 179.23 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.76 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.8 p -36.66 -33.75 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.464 -0.773 . . . . 0.0 110.011 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.45 ' N ' HG13 ' A' ' 91' ' ' VAL . 20.0 tt0 -65.86 -50.07 65.86 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 -178.658 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLN . 84.3 t60 -51.43 -47.53 63.0 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 179.443 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.689 ' O ' ' N ' ' A' ' 96' ' ' SER . 13.1 t-20 -126.29 111.25 14.33 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.477 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.54 ' C ' ' O ' ' A' ' 94' ' ' ASN . 99.7 m-20 -35.98 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.886 -178.488 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 94' ' ' ASN . 71.1 m -108.37 27.07 9.71 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.736 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.76 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.5 mt -97.96 65.84 1.81 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.563 -1.336 . . . . 0.0 108.2 178.676 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.403 ' C ' HG23 ' A' ' 99' ' ' VAL . 50.6 t-20 -79.79 75.57 6.47 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.81 -1.182 . . . . 0.0 109.41 -178.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.701 ' CG2' HG23 ' A' ' 50' ' ' VAL . 84.5 t -153.56 153.62 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.522 -0.736 . . . . 0.0 109.805 -179.266 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.543 HG22 ' HA ' ' A' ' 89' ' ' SER . 70.2 p -134.33 156.79 47.85 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.154 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.57 HD22 ' CG ' ' A' ' 33' ' ' PHE . 11.6 mt -76.48 71.65 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.706 -1.246 . . . . 0.0 108.007 179.333 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.3 -33.76 9.91 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.169 -0.957 . . . . 0.0 112.111 -177.881 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.4 m-85 -113.97 109.29 49.93 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.503 -1.373 . . . . 0.0 111.977 -177.654 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.523 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 19.0 Cg_exo -59.97 148.61 88.21 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.083 1.855 . . . . 0.0 110.276 176.924 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.567 ' O ' ' OE1' ' A' ' 109' ' ' GLN . 9.1 p -67.25 -34.59 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.822 -1.174 . . . . 0.0 108.77 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.502 ' CD2' HG13 ' A' ' 105' ' ' VAL . 38.6 m-85 -108.14 39.4 1.97 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.447 -0.783 . . . . 0.0 110.191 179.828 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.523 ' HB2' ' CG ' ' A' ' 104' ' ' PRO . . . -83.99 117.4 23.36 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.996 -1.065 . . . . 0.0 109.599 179.462 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 49.46 45.93 23.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.334 -0.854 . . . . 0.0 109.975 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.567 ' OE1' ' O ' ' A' ' 105' ' ' VAL . 41.9 mt-30 -104.42 135.01 46.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.795 -1.191 . . . . 0.0 110.122 -179.801 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -61.38 -35.44 77.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.578 -0.701 . . . . 0.0 110.146 -179.787 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.498 ' HA ' ' HE ' ' A' ' 111' ' ' ARG . 4.6 tpm_? . . . . . 0 N--CA 1.493 1.716 0 O-C-N 120.961 -1.087 . . . . 0.0 109.217 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.57 -3.02 10.29 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.612 2.208 . . . . 0.0 112.103 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -66.78 -29.71 69.73 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -63.36 -22.37 66.84 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.583 ' O ' ' OG1' ' A' ' 10' ' ' THR . 94.9 m-20 -92.25 119.95 32.34 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.52 0.676 . . . . 0.0 110.441 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 72.3 tt0 -69.32 -40.33 77.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.59 -0.694 . . . . 0.0 109.496 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.58 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -64.1 -20.53 66.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.655 -0.653 . . . . 0.0 111.443 -178.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.583 ' OG1' ' O ' ' A' ' 7' ' ' ASP . 7.6 p -64.49 -37.31 87.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.794 -1.191 . . . . 0.0 110.196 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.588 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -119.24 -14.81 9.23 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.939 -1.1 . . . . 0.0 109.819 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 8' ' ' GLU . 62.6 t30 -89.7 120.07 30.65 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 110.599 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.715 ' CG2' HD13 ' A' ' 34' ' ' LEU . 27.7 m -137.97 36.28 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.89 -33.54 20.74 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 85.6 p -63.05 -31.98 73.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.945 -1.327 . . . . 0.0 109.036 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.8 t -61.6 138.51 58.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.379 -0.826 . . . . 0.0 109.718 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -81.57 163.91 22.29 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.299 -0.876 . . . . 0.0 109.867 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -57.17 -44.78 83.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -0.817 . . . . 0.0 109.465 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -65.36 -42.72 92.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.069 -1.019 . . . . 0.0 108.638 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -61.05 -36.25 79.09 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.48 -37.33 77.97 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.53 -0.731 . . . . 0.0 109.646 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 26' ' ' ARG . 81.3 mm-40 -58.39 -45.19 88.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.109 -0.994 . . . . 0.0 108.384 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 23' ' ' ASN . 9.8 m120 -62.09 -44.19 97.21 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.421 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 82.4 mt -64.4 -40.2 95.32 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.413 -0.804 . . . . 0.0 108.87 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.729 HD13 ' CG1' ' A' ' 54' ' ' VAL . 36.7 mt -75.73 -29.93 59.06 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.568 ' NH1' ' HG2' ' A' ' 26' ' ' ARG . 31.6 mtt-85 -79.63 136.3 36.79 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.717 -0.614 . . . . 0.0 109.645 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.78 -8.65 76.45 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 24' ' ' LEU . 28.7 mmtm -96.12 137.85 34.58 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.242 -1.152 . . . . 0.0 109.878 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -69.52 162.78 26.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.459 -0.775 . . . . 0.0 109.191 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.611 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 73.9 m-20 -60.18 142.91 53.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.372 -0.83 . . . . 0.0 109.189 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.39 -30.51 8.47 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.0 m -76.16 135.78 39.79 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.239 -1.154 . . . . 0.0 109.044 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.889 ' CD1' HD13 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -140.84 162.94 34.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.938 -1.101 . . . . 0.0 108.923 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.715 HD13 ' CG2' ' A' ' 13' ' ' VAL . 2.8 pp -134.16 154.55 51.15 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.122 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.043 HG22 ' SG ' ' A' ' 46' ' ' CYS . 95.5 t -113.65 138.24 44.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.559 ' NH1' ' HG3' ' A' ' 36' ' ' ARG . 5.4 ptm180 -150.51 169.96 20.26 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.037 -1.04 . . . . 0.0 109.362 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.476 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 3.2 pt-20 . . . . . 0 C--N 1.303 -1.439 0 O-C-N 120.938 -1.101 . . . . 0.0 108.838 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.593 ' O ' ' O ' ' A' ' 59' ' ' ILE . 97.7 m-85 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.306 0.574 . . . . 0.0 109.903 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -164.66 144.4 7.35 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.022 -1.049 . . . . 0.0 109.357 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 1.043 ' SG ' HG22 ' A' ' 35' ' ' VAL . 78.5 m -121.02 136.84 54.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.495 ' OG ' HD11 ' A' ' 25' ' ' LEU . 92.6 p -105.19 143.36 33.47 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.554 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.806 HG22 ' HB2' ' A' ' 33' ' ' PHE . 43.7 t -125.06 158.95 32.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.574 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.454 ' N ' HG12 ' A' ' 48' ' ' VAL . 67.9 t -109.92 130.99 62.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.935 HG12 ' H ' ' A' ' 52' ' ' GLY . 9.9 t -123.22 152.13 27.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.132 -0.98 . . . . 0.0 110.652 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.611 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 66.0 t0 -50.34 -12.03 0.08 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.547 0.689 . . . . 0.0 109.858 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.935 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -104.9 -49.96 0.98 Allowed Glycine 0 C--N 1.287 -2.142 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.253 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.55 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 75.0 mt-10 -161.29 177.01 10.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.885 -1.362 . . . . 0.0 111.209 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.729 ' CG1' HD13 ' A' ' 25' ' ' LEU . 53.5 t -89.64 135.13 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.8 161.9 18.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.986 -1.071 . . . . 0.0 111.484 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -124.06 76.07 1.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 88.4 m -60.83 146.45 46.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.168 -0.957 . . . . 0.0 109.382 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 58' ' ' VAL . 5.5 p -106.26 135.87 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.22 -0.925 . . . . 0.0 111.467 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.73 HD12 ' SG ' ' A' ' 46' ' ' CYS . 64.6 mt -124.81 141.47 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.3 t30 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 120.162 -1.586 . . . . 0.0 111.331 -177.977 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.7 m . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 121.538 0.685 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 78' ' ' LEU . 82.1 mt -68.02 -29.84 68.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.731 . . . . 0.0 110.053 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -58.9 -42.83 90.53 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -68.61 -35.39 77.26 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.568 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.5 tt -59.49 -49.49 77.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.396 -0.815 . . . . 0.0 109.204 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.803 HG13 HD21 ' A' ' 101' ' ' LEU . 99.0 t -61.28 -43.22 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.581 -0.699 . . . . 0.0 109.745 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.61 -51.5 67.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.035 -1.041 . . . . 0.0 110.608 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.699 ' CE1' ' OG1' ' A' ' 88' ' ' THR . 59.3 t-80 -71.47 -36.36 71.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.77 -1.206 . . . . 0.0 110.457 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.751 ' OH ' HD21 ' A' ' 90' ' ' LEU . 29.1 t80 -59.98 -20.62 58.62 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.909 -1.119 . . . . 0.0 108.842 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.503 ' CG ' ' O ' ' A' ' 101' ' ' LEU . 1.1 tm0? -80.07 -25.8 39.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.234 -0.916 . . . . 0.0 108.626 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -97.8 -7.56 30.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.218 -0.926 . . . . 0.0 109.07 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.699 ' OG1' ' CE1' ' A' ' 84' ' ' HIS . 32.4 m -96.99 139.77 32.51 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.214 -0.929 . . . . 0.0 109.152 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.527 ' OG ' HG12 ' A' ' 91' ' ' VAL . 40.6 t -87.65 130.24 34.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.14 -0.975 . . . . 0.0 109.358 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.751 HD21 ' OH ' ' A' ' 85' ' ' TYR . 10.4 mp -71.82 -17.23 62.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.316 -0.865 . . . . 0.0 109.972 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.703 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.6 p -37.52 -41.93 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.175 -0.953 . . . . 0.0 110.162 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.473 ' N ' HG13 ' A' ' 91' ' ' VAL . 54.9 tt0 -47.95 -30.34 4.15 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.484 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.842 ' HB2' HD12 ' A' ' 97' ' ' LEU . 94.4 m-70 -83.44 130.31 35.02 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.089 -1.007 . . . . 0.0 108.989 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 58.22 7.73 0.7 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.46 ' H ' ' C ' ' A' ' 93' ' ' HIS . 54.7 t0 45.25 35.01 1.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.418 -0.801 . . . . 0.0 109.197 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 55.9 m -156.95 15.48 0.28 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.817 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.842 HD12 ' HB2' ' A' ' 93' ' ' HIS . 68.0 mt -101.62 73.91 1.48 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -79.1 85.15 5.02 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.727 0.775 . . . . 0.0 109.928 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.401 HG22 ' N ' ' A' ' 100' ' ' THR . 8.1 p -165.44 163.57 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.733 0.778 . . . . 0.0 109.081 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 102' ' ' ALA . 68.0 p -135.16 131.96 37.42 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.937 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -52.43 95.57 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.406 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -91.81 -51.53 5.18 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.403 -1.436 . . . . 0.0 111.888 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -129.06 137.37 30.86 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.743 -1.223 . . . . 0.0 112.043 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.46 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 32.6 Cg_exo -52.98 160.53 4.1 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.232 1.955 . . . . 0.0 111.28 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.413 ' H ' HG12 ' A' ' 105' ' ' VAL . 3.2 p -74.27 -31.82 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.685 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -112.03 34.14 4.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.875 . . . . 0.0 109.281 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 104' ' ' PRO . . . . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.548 -0.72 . . . . 0.0 109.706 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -51.51 -14.64 2.05 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.812 1.675 . . . . 0.0 110.925 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.466 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 91.1 m-70 -66.47 -12.93 59.84 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -63.42 -32.28 73.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 108.85 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.575 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 92.3 m-20 -100.53 134.19 43.85 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.352 -0.843 . . . . 0.0 110.004 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 12' ' ' ASN . 95.5 mt-10 -69.27 -27.26 65.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 109.988 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.507 ' CG ' ' N ' ' A' ' 10' ' ' THR . 33.3 pttt -60.79 -35.46 76.53 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 110.508 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.669 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 10.6 p -59.75 -33.39 71.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 110.113 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.669 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -120.78 -37.27 3.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.893 -1.129 . . . . 0.0 110.165 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -86.21 123.85 31.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.993 -1.067 . . . . 0.0 110.47 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.474 ' O ' HG12 ' A' ' 13' ' ' VAL . 74.5 t -94.05 -4.95 10.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.79 -162.15 19.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -80.68 61.55 4.4 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.318 -1.107 . . . . 0.0 109.417 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.1 p -79.2 156.7 28.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.299 -0.876 . . . . 0.0 109.092 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -70.18 142.72 52.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.191 -0.943 . . . . 0.0 109.453 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.618 HH11 ' NH2' ' A' ' 36' ' ' ARG . 48.6 mtt-85 -59.46 -38.81 81.75 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.054 -1.029 . . . . 0.0 109.388 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.65 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 40.0 p-10 -62.65 -42.82 99.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.0 -1.062 . . . . 0.0 108.484 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.65 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 80.3 tttt -60.51 -36.6 78.74 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.233 -0.917 . . . . 0.0 109.066 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.71 ' CB ' HH11 ' A' ' 36' ' ' ARG . . . -58.57 -34.03 70.59 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.647 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 75.3 tt0 -58.7 -42.63 89.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.68 -46.94 87.54 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.697 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -67.16 -33.86 76.32 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.883 HD11 ' OG ' ' A' ' 47' ' ' SER . 22.7 mt -80.85 -16.01 54.82 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.742 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -74.61 122.43 23.15 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.555 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.82 19.54 78.83 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.505 ' HE2' HG21 ' A' ' 32' ' ' THR . 0.2 OUTLIER -97.18 135.79 38.62 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.359 -1.083 . . . . 0.0 109.685 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.699 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.9 OUTLIER -74.88 157.63 34.74 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.66 0.743 . . . . 0.0 110.157 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.513 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 48.4 p30 -62.25 169.36 2.85 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.88 -28.44 1.89 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.505 HG21 ' HE2' ' A' ' 28' ' ' LYS . 76.7 m -80.56 121.03 25.29 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.869 -1.371 . . . . 0.0 108.984 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.806 ' HB2' HG22 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -136.06 167.26 21.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.908 -1.12 . . . . 0.0 110.517 -179.32 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 1.1 pt? -148.91 161.29 42.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.454 -0.779 . . . . 0.0 110.588 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.475 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 65.8 t -106.74 132.73 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.71 HH11 ' CB ' ' A' ' 21' ' ' ALA . 35.6 ptt180 -147.75 173.14 13.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 108.884 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.479 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 53.0 mt-10 . . . . . 0 C--N 1.304 -1.389 0 O-C-N 120.83 -1.169 . . . . 0.0 109.268 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.608 ' O ' ' O ' ' A' ' 59' ' ' ILE . 57.2 m-85 . . . . . 0 N--CA 1.495 1.775 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 57' ' ' CYS . . . -159.75 153.88 23.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.77 -1.207 . . . . 0.0 109.973 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' CYS . 85.4 m -109.5 125.86 52.93 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.883 ' OG ' HD11 ' A' ' 25' ' ' LEU . 26.1 t -92.05 127.0 37.36 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.06 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.806 HG22 ' HB2' ' A' ' 33' ' ' PHE . 74.3 t -126.1 163.71 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.187 -0.946 . . . . 0.0 109.978 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.602 ' N ' HG12 ' A' ' 48' ' ' VAL . 39.2 t -124.6 132.76 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.701 HG23 ' CG2' ' A' ' 99' ' ' VAL . 11.4 p -123.34 156.35 29.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.995 -1.066 . . . . 0.0 109.671 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.423 ' OD1' ' OD2' ' A' ' 30' ' ' ASP . 87.2 m-20 -49.97 -17.17 0.35 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.943 0.878 . . . . 0.0 109.634 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.581 ' O ' ' OE2' ' A' ' 53' ' ' GLU . . . -86.18 -59.22 1.88 Allowed Glycine 0 C--N 1.287 -2.142 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.667 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.581 ' OE2' ' O ' ' A' ' 52' ' ' GLY . 61.3 mm-40 -163.22 -165.53 1.1 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.25 -1.147 . . . . 0.0 110.554 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.56 ' CG1' HD13 ' A' ' 25' ' ' LEU . 88.8 t -93.36 123.37 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.455 ' NZ ' HG11 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -122.45 149.15 44.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.911 -1.118 . . . . 0.0 110.905 -179.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.704 ' CD2' ' NH2' ' A' ' 36' ' ' ARG . 23.6 m80 -113.31 101.88 9.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.579 -0.701 . . . . 0.0 109.544 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' CYS . 52.5 t -72.91 130.04 39.5 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.26 138.63 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.246 -0.909 . . . . 0.0 111.878 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.608 ' O ' ' O ' ' A' ' 44' ' ' TYR . 10.9 mm -124.93 111.59 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 . . . . . 0 N--CA 1.5 2.055 0 O-C-N 120.647 -1.283 . . . . 0.0 112.182 -178.248 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.559 0.695 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.16 -34.05 73.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 110.03 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.72 -43.74 80.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.188 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -66.9 -30.53 70.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.228 -0.92 . . . . 0.0 108.856 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.904 HD21 ' CE2' ' A' ' 85' ' ' TYR . 9.2 tt -60.6 -40.9 93.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 108.987 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.2 t -66.86 -44.17 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.361 -0.837 . . . . 0.0 109.819 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.426 HD21 ' CB ' ' A' ' 5' ' ' HIS . 85.0 mt -67.45 -43.09 81.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.419 -0.8 . . . . 0.0 110.439 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -60.02 -40.56 89.72 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.215 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.904 ' CE2' HD21 ' A' ' 81' ' ' LEU . 7.4 m-30 -67.34 -24.31 65.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 0.0 108.789 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.453 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 38.1 tt0 -61.32 -36.94 81.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -91.44 -16.71 26.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.303 -0.873 . . . . 0.0 109.592 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.4 m -100.84 129.92 46.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.131 -0.981 . . . . 0.0 109.228 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.543 ' HA ' HG22 ' A' ' 100' ' ' THR . 34.8 t -81.67 132.56 35.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 109.915 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 91' ' ' VAL . 76.2 mt -69.01 -13.07 62.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.477 -0.764 . . . . 0.0 109.715 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.76 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.8 p -36.66 -33.75 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.464 -0.773 . . . . 0.0 110.011 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.45 ' N ' HG13 ' A' ' 91' ' ' VAL . 20.0 tt0 -65.86 -50.07 65.86 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLN . 84.3 t60 -51.43 -47.53 63.0 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.689 ' O ' ' N ' ' A' ' 96' ' ' SER . 13.1 t-20 -126.29 111.25 14.33 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.54 ' C ' ' O ' ' A' ' 94' ' ' ASN . 99.7 m-20 -35.98 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.886 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 94' ' ' ASN . 71.1 m -108.37 27.07 9.71 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.736 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.76 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.5 mt -97.96 65.84 1.81 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.563 -1.336 . . . . 0.0 108.2 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.403 ' C ' HG23 ' A' ' 99' ' ' VAL . 0.8 OUTLIER -79.79 75.57 6.47 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.81 -1.182 . . . . 0.0 109.41 -178.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.701 ' CG2' HG23 ' A' ' 50' ' ' VAL . 84.5 t -153.56 153.62 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.522 -0.736 . . . . 0.0 109.805 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.543 HG22 ' HA ' ' A' ' 89' ' ' SER . 70.2 p -134.33 156.79 47.85 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.57 HD22 ' CG ' ' A' ' 33' ' ' PHE . 11.6 mt -76.48 71.65 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.706 -1.246 . . . . 0.0 108.007 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.3 -33.76 9.91 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.169 -0.957 . . . . 0.0 112.111 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.4 m-85 -113.97 109.29 49.93 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.503 -1.373 . . . . 0.0 111.977 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.523 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 19.0 Cg_exo -59.97 148.61 88.21 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.083 1.855 . . . . 0.0 110.276 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.502 HG13 ' CD2' ' A' ' 106' ' ' TYR . 9.1 p -67.25 -34.59 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.822 -1.174 . . . . 0.0 108.77 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.502 ' CD2' HG13 ' A' ' 105' ' ' VAL . 38.6 m-85 -108.14 39.4 1.97 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.447 -0.783 . . . . 0.0 110.191 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.523 ' HB2' ' CG ' ' A' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.497 1.905 0 O-C-N 120.996 -1.065 . . . . 0.0 109.599 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.427 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 28.5 Cg_endo -64.3 -6.9 12.59 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.7 2.267 . . . . 0.0 112.288 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.49 ' CD2' HG11 ' A' ' 82' ' ' VAL . 7.3 m80 -67.37 -21.31 65.63 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 108.965 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -59.68 -34.2 72.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.776 -1.203 . . . . 0.0 108.236 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -97.18 126.76 42.57 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.175 -0.953 . . . . 0.0 109.354 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.614 ' CG ' ' OD1' ' A' ' 12' ' ' ASN . 23.2 tt0 -68.07 -28.27 67.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.6 -0.688 . . . . 0.0 110.125 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.706 ' NZ ' ' O ' ' A' ' 106' ' ' TYR . 2.3 tmpt? -62.44 -27.19 68.94 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.261 -0.9 . . . . 0.0 111.623 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.717 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 41.7 p -62.57 -29.74 70.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.991 -1.068 . . . . 0.0 112.127 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.759 ' CE3' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -123.86 -31.23 3.44 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.189 -1.57 . . . . 0.0 110.34 179.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.759 ' ND2' ' CE3' ' A' ' 11' ' ' TRP . 1.2 m-80 -73.74 130.81 40.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.132 -0.98 . . . . 0.0 109.663 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 13' ' ' VAL . 60.9 t -115.79 -11.16 12.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.633 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.81 -152.42 21.81 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.1 p -83.46 112.07 19.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -1.123 . . . . 0.0 109.524 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.0 m -126.07 143.13 51.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.073 -1.017 . . . . 0.0 110.152 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.653 ' ND2' ' ND2' ' A' ' 19' ' ' ASN . 59.5 t-20 -67.11 148.38 51.93 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.576 -0.702 . . . . 0.0 109.26 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.545 ' HA ' HH12 ' A' ' 36' ' ' ARG . 85.5 mtm180 -61.05 -40.35 93.29 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 110.022 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 44.0 p30 -61.49 -33.14 73.27 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.085 -1.009 . . . . 0.0 108.977 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.674 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 7.3 tppt? -77.76 -34.75 52.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.127 -0.983 . . . . 0.0 108.945 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.5 92.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -0.793 . . . . 0.0 109.349 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 26' ' ' ARG . 14.4 pt-20 -60.12 -46.01 91.07 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.0 -1.063 . . . . 0.0 108.442 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.437 ' N ' ' HG3' ' A' ' 22' ' ' GLU . 98.3 m-20 -56.07 -42.44 76.67 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.31 -29.75 67.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.319 -0.863 . . . . 0.0 109.163 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.467 HD13 ' CG1' ' A' ' 54' ' ' VAL . 11.5 mt -91.68 -9.93 42.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -0.792 . . . . 0.0 109.134 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 22' ' ' GLU . 1.1 ttt180 -90.75 125.8 35.81 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.195 -0.94 . . . . 0.0 109.476 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.2 1.02 61.23 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -96.9 141.1 30.5 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.403 -1.057 . . . . 0.0 108.16 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -72.82 151.74 41.89 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.275 -0.891 . . . . 0.0 108.854 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -50.95 147.99 4.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 109.287 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.79 -20.82 44.52 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.446 HG23 ' HD2' ' A' ' 103' ' ' TYR . 58.5 m -86.27 122.33 30.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -1.079 . . . . 0.0 110.074 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.875 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.8 OUTLIER -136.46 167.22 21.76 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.366 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 pp -140.63 160.12 40.7 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.664 -0.815 . . . . 0.0 109.545 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.36 125.65 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.416 -0.803 . . . . 0.0 109.756 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.545 HH12 ' HA ' ' A' ' 18' ' ' ARG . 29.0 ptt180 -143.9 -174.06 4.16 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.301 -1.537 0 O-C-N 120.825 -1.172 . . . . 0.0 108.985 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.585 ' O ' ' O ' ' A' ' 59' ' ' ILE . 31.9 m-85 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.415 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -155.42 138.72 15.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.904 -1.122 . . . . 0.0 110.059 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 57' ' ' CYS . 29.5 p -111.1 125.42 53.75 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.913 -1.117 . . . . 0.0 108.237 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 55' ' ' LYS . 44.2 t -108.21 138.13 45.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 0.0 109.845 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 49' ' ' VAL . 10.2 p -131.97 164.22 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.052 -1.03 . . . . 0.0 110.31 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.579 ' N ' HG22 ' A' ' 48' ' ' VAL . 86.7 t -109.93 127.33 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.821 HG13 ' HZ3' ' A' ' 55' ' ' LYS . 7.9 p -160.02 168.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.888 -1.133 . . . . 0.0 110.909 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.646 ' N ' HG22 ' A' ' 50' ' ' VAL . 61.6 t0 40.88 24.28 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.831 -0.543 . . . . 0.0 110.731 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 80.1 -1.85 78.35 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.053 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.855 ' HB3' ' HZ1' ' A' ' 55' ' ' LYS . 15.3 tp10 -119.88 143.58 47.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.335 . . . . 0.0 110.489 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.467 ' CG1' HD13 ' A' ' 25' ' ' LEU . 83.7 t -82.59 127.66 39.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.566 0.698 . . . . 0.0 109.163 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.855 ' HZ1' ' HB3' ' A' ' 53' ' ' GLU . 6.6 mptt -110.16 158.15 18.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.0 110.933 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -130.36 73.96 1.56 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.422 -0.798 . . . . 0.0 109.539 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 42.2 t -63.92 136.78 57.64 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.404 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.78 139.84 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.84 0.829 . . . . 0.0 111.989 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.585 ' O ' ' O ' ' A' ' 44' ' ' TYR . 20.0 mm -118.23 144.96 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.6 m120 . . . . . 0 N--CA 1.495 1.786 0 O-C-N 120.842 -1.161 . . . . 0.0 109.631 179.663 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 122.003 0.906 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.6 mt -59.63 -28.28 67.08 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -53.27 -42.39 66.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.83 -1.168 . . . . 0.0 108.016 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.615 ' OE2' ' CE1' ' A' ' 84' ' ' HIS . 7.2 tm-20 -63.92 -37.04 85.96 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.709 HD23 ' C ' ' A' ' 81' ' ' LEU . 8.2 tt -59.2 -48.04 83.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 0.0 109.203 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.49 HG11 ' CD2' ' A' ' 5' ' ' HIS . 97.2 t -60.68 -39.31 81.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.042 -1.036 . . . . 0.0 108.579 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 86' ' ' GLN . 79.6 mt -64.17 -35.12 79.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.384 -0.822 . . . . 0.0 109.965 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.615 ' CE1' ' OE2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -56.27 -48.65 76.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.723 -1.236 . . . . 0.0 110.027 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.743 ' HB2' HD12 ' A' ' 101' ' ' LEU . 73.3 m-85 -61.74 -30.09 70.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.914 -1.116 . . . . 0.0 109.353 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 83' ' ' LEU . 37.3 tt0 -60.96 -34.87 75.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.43 -0.793 . . . . 0.0 109.558 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -96.4 -11.18 26.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 110.621 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.2 m -114.34 129.74 56.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.748 -1.22 . . . . 0.0 110.746 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.7 t -76.47 124.6 27.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.759 -0.588 . . . . 0.0 109.786 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.726 ' O ' ' N ' ' A' ' 92' ' ' GLN . 5.0 mp -67.41 -31.44 71.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.478 -0.763 . . . . 0.0 111.316 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.015 HG13 ' H ' ' A' ' 92' ' ' GLN . 7.6 p 12.31 -75.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.597 0 O-C-N 121.844 -0.535 . . . . 0.0 110.285 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 1.015 ' H ' HG13 ' A' ' 91' ' ' VAL . 26.5 tt0 62.63 -175.98 0.14 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.421 -0.8 . . . . 0.0 111.105 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.68 ' H ' ' CG ' ' A' ' 92' ' ' GLN . 88.4 m-70 -58.44 -35.54 72.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.55 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -50.64 -25.48 4.28 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 60.0 14.6 4.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.678 -0.639 . . . . 0.0 109.751 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.431 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 54.7 p -132.33 9.19 4.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.968 -1.082 . . . . 0.0 109.751 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.732 ' O ' ' N ' ' A' ' 91' ' ' VAL . 83.9 mt -96.58 36.57 1.36 Allowed 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.438 ' OD1' HG23 ' A' ' 91' ' ' VAL . 98.7 m-20 -75.98 70.34 2.68 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.487 ' O ' HD12 ' A' ' 90' ' ' LEU . 12.8 p -159.47 159.35 2.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.477 ' N ' HG22 ' A' ' 99' ' ' VAL . 31.0 p -121.8 149.21 43.65 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.875 HD22 ' CG ' ' A' ' 33' ' ' PHE . 56.3 mt -73.94 69.13 1.4 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.428 ' HA ' HE21 ' A' ' 86' ' ' GLN . . . -98.2 -24.62 15.2 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.444 -0.785 . . . . 0.0 112.548 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.455 ' CE2' ' O ' ' A' ' 104' ' ' PRO . 80.8 t80 -114.02 131.01 23.37 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.268 -1.52 . . . . 0.0 110.97 -178.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.786 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 63.3 Cg_endo -76.14 149.33 32.08 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 123.354 2.703 . . . . 0.0 112.182 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.648 HG13 ' CD2' ' A' ' 106' ' ' TYR . 14.5 p -78.5 -17.83 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.025 -1.047 . . . . 0.0 109.776 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.706 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . 33.9 m-85 -132.18 56.35 1.83 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.025 -1.047 . . . . 0.0 110.569 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.786 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . . . . . . 0 C--N 1.302 -1.5 0 O-C-N 121.15 -0.969 . . . . 0.0 109.844 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 3' ' ' LEU . 95.7 mt . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.495 ' O ' ' OG1' ' A' ' 10' ' ' THR . 28.9 Cg_endo -68.55 -3.86 11.92 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.35 2.033 . . . . 0.0 111.974 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -80.93 -6.33 58.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 110.016 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -76.11 -31.14 58.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.197 -0.939 . . . . 0.0 110.111 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -105.18 132.78 50.97 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.235 -0.916 . . . . 0.0 109.981 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.675 ' O ' ' N ' ' A' ' 12' ' ' ASN . 95.9 mt-10 -66.77 -29.33 69.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.477 -0.764 . . . . 0.0 110.57 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.46 ' CG ' ' N ' ' A' ' 10' ' ' THR . 3.0 pttt -57.66 -33.58 68.46 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.336 -0.853 . . . . 0.0 111.0 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.696 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 47.2 p -65.67 -30.91 71.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.888 -1.132 . . . . 0.0 110.704 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.696 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -119.82 -28.86 5.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.673 -1.267 . . . . 0.0 109.78 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' A' ' 8' ' ' GLU . 56.2 t-20 -83.63 130.62 34.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.605 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.49 HG22 ' HE2' ' A' ' 106' ' ' TYR . 45.0 t -96.35 -12.82 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.287 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.13 -157.96 34.1 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 95.2 p -63.83 132.68 51.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.149 -1.207 . . . . 0.0 109.801 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.9 t -176.71 165.46 2.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 109.619 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -95.12 147.8 23.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.468 -0.77 . . . . 0.0 109.747 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.609 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.72 -35.57 74.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.164 -0.96 . . . . 0.0 110.016 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -57.17 -46.06 83.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.684 -1.26 . . . . 0.0 108.43 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.695 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 79.9 tttt -59.98 -35.11 74.31 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 18' ' ' ARG . . . -60.04 -38.93 84.2 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' ARG . 97.1 mt-10 -53.64 -47.51 70.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.863 . . . . 0.0 108.823 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.695 ' ND2' ' O ' ' A' ' 20' ' ' LYS . 9.5 p30 -62.11 -41.29 98.08 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.674 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 79.2 mt -65.09 -30.21 71.14 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 21' ' ' ALA . 19.2 mt -93.1 -10.73 34.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.444 -0.785 . . . . 0.0 109.817 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.564 ' CG ' ' N ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -79.71 -49.53 11.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 109.635 -179.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.564 ' N ' ' CG ' ' A' ' 26' ' ' ARG . . . -87.99 25.95 8.21 Favored Glycine 0 C--N 1.287 -2.188 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -115.11 125.34 53.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.25 -1.147 . . . . 0.0 110.521 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -72.77 159.33 33.97 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.497 -0.752 . . . . 0.0 109.142 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 59.9 p30 -57.36 151.2 16.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.056 -1.028 . . . . 0.0 110.172 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.17 -18.46 55.55 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.1 m -100.67 127.43 47.08 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.165 -1.197 . . . . 0.0 109.09 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.64 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -130.4 161.27 31.72 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.034 178.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.412 ' HB3' HG21 ' A' ' 105' ' ' VAL . 1.5 pp -129.35 155.07 46.23 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.636 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.6 t -116.26 131.14 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.777 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.632 ' CB ' ' CZ ' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -146.11 -141.91 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 108.928 179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 . . . . . 0 C--N 1.301 -1.504 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.611 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.594 ' O ' ' O ' ' A' ' 59' ' ' ILE . 74.8 m-85 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.517 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -169.05 142.36 2.82 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.094 -1.004 . . . . 0.0 109.053 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 57' ' ' CYS . 16.8 p -124.93 148.15 48.5 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.264 -0.898 . . . . 0.0 108.808 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.3 p -120.21 143.2 48.39 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.684 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.856 HG13 ' NZ ' ' A' ' 55' ' ' LYS . 1.5 p -130.6 155.23 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.476 -0.765 . . . . 0.0 109.766 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.453 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 69.9 t -110.8 132.64 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.761 -0.587 . . . . 0.0 110.099 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.669 HG13 ' H ' ' A' ' 52' ' ' GLY . 8.3 p -122.04 156.27 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.0 -1.063 . . . . 0.0 108.876 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 59.4 t0 -49.3 -18.3 0.35 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.873 0.844 . . . . 0.0 110.022 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.669 ' H ' HG13 ' A' ' 50' ' ' VAL . . . -92.1 -52.81 2.15 Favored Glycine 0 C--N 1.286 -2.23 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.585 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.565 ' H ' ' CG1' ' A' ' 50' ' ' VAL . 44.6 mt-10 -161.11 169.37 22.51 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.724 -1.456 . . . . 0.0 112.028 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.8 t -85.86 136.78 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.856 ' NZ ' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -131.8 150.86 52.02 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.576 -1.328 . . . . 0.0 111.776 -178.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.571 ' CD2' ' HE ' ' A' ' 18' ' ' ARG . 29.2 m80 -110.66 117.45 33.52 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' A' ' 46' ' ' CYS . 48.8 t -104.08 129.23 51.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.87 -1.144 . . . . 0.0 108.574 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 58' ' ' VAL . 4.7 p -94.68 132.72 37.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 111.292 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.594 ' O ' ' O ' ' A' ' 44' ' ' TYR . 98.0 mt -118.12 140.89 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 . . . . . 0 N--CA 1.494 1.738 0 O-C-N 120.967 -1.083 . . . . 0.0 109.349 -179.603 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.4 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.393 0.616 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.93 -37.39 82.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.548 -0.72 . . . . 0.0 109.461 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -56.71 -42.82 79.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.476 -0.765 . . . . 0.0 109.044 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -64.63 -33.53 76.16 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.229 -0.919 . . . . 0.0 109.15 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 10.2 tt -59.82 -48.17 82.77 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 109.535 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 95.5 t -67.53 -37.19 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.204 -0.935 . . . . 0.0 109.17 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.547 HD12 ' OE1' ' A' ' 86' ' ' GLN . 52.3 tp -66.49 -47.73 72.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.285 -0.884 . . . . 0.0 110.359 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -63.11 -40.43 97.61 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.994 -1.066 . . . . 0.0 110.317 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.589 ' HA ' HG22 ' A' ' 88' ' ' THR . 3.9 m-85 -62.15 -29.67 70.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.469 -0.769 . . . . 0.0 111.501 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.612 ' O ' ' OG1' ' A' ' 100' ' ' THR . 5.8 pt20 -66.91 -29.09 68.88 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.301 -1.499 . . . . 0.0 108.334 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -79.18 -39.65 32.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.401 -0.812 . . . . 0.0 109.829 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 85' ' ' TYR . 5.0 t -79.61 154.21 28.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.006 . . . . 0.0 109.993 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.5 t -104.55 133.18 49.85 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.816 ' N ' HD22 ' A' ' 90' ' ' LEU . 3.1 mm? -70.51 -10.92 60.44 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.513 -0.742 . . . . 0.0 110.319 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.685 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.4 p -40.14 -43.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.135 -0.978 . . . . 0.0 109.812 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.605 ' N ' HG13 ' A' ' 91' ' ' VAL . 9.7 tt0 -38.58 -36.63 0.26 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.906 -0.496 . . . . 0.0 110.766 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.707 ' O ' ' N ' ' A' ' 95' ' ' ASP . 23.4 t-160 -64.87 124.65 22.57 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.951 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.512 ' ND2' ' NE2' ' A' ' 93' ' ' HIS . 78.5 m-20 44.28 9.71 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.034 -1.041 . . . . 0.0 109.278 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 93' ' ' HIS . 81.8 m-20 57.62 43.78 21.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.299 -0.876 . . . . 0.0 110.873 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.61 ' C ' HD22 ' A' ' 97' ' ' LEU . 34.2 m -151.61 4.64 0.43 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.556 -1.34 . . . . 0.0 111.415 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.962 HD22 ' N ' ' A' ' 97' ' ' LEU . 2.1 mm? -100.47 70.68 1.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.607 -1.308 . . . . 0.0 107.774 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -79.73 94.63 5.78 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.049 0.928 . . . . 0.0 109.748 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.765 HG22 ' H ' ' A' ' 100' ' ' THR . 7.1 p -174.06 -177.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.765 ' H ' HG22 ' A' ' 99' ' ' VAL . 9.0 t -160.42 166.73 28.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.014 -1.054 . . . . 0.0 109.501 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.64 HD22 ' CG ' ' A' ' 33' ' ' PHE . 18.6 mt -79.96 63.73 4.58 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.44 -26.46 19.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.937 -0.477 . . . . 0.0 112.092 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -122.41 134.22 24.76 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.279 -1.513 . . . . 0.0 111.455 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.55 148.98 43.28 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 122.699 2.266 . . . . 0.0 111.302 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.744 HG13 ' CD2' ' A' ' 106' ' ' TYR . 9.0 p -72.41 -18.61 19.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.266 -0.896 . . . . 0.0 108.756 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.744 ' CD2' HG13 ' A' ' 105' ' ' VAL . 39.7 m-85 -131.42 65.18 1.57 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.478 -0.764 . . . . 0.0 110.023 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.788 0 O-C-N 120.962 -1.086 . . . . 0.0 110.024 179.836 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 3' ' ' LEU . 7.0 mp . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.29 0.567 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.19 -2.93 6.46 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.696 2.264 . . . . 0.0 111.443 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -65.89 -31.91 73.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.34 -0.85 . . . . 0.0 108.96 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -61.31 -18.27 57.75 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.627 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.675 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 94.6 m-20 -96.9 110.14 22.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.33 -0.856 . . . . 0.0 110.314 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.537 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 80.1 tt0 -69.27 -30.64 68.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.423 -0.798 . . . . 0.0 109.78 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 pttt -69.56 -11.56 60.93 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.431 -0.793 . . . . 0.0 110.76 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.509 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 43.9 p -85.32 -22.88 28.33 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.821 -1.175 . . . . 0.0 112.258 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.675 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -122.51 -26.77 4.52 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.256 -1.528 . . . . 0.0 109.839 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.632 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 14.9 p-10 -80.14 142.07 35.13 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.874 -1.141 . . . . 0.0 109.855 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 35' ' ' VAL . 10.1 p -112.34 -16.84 8.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.05 -164.0 51.16 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.0 p -58.11 133.74 55.85 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.212 -1.169 . . . . 0.0 108.578 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.6 t -172.09 154.74 3.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.313 -0.867 . . . . 0.0 109.385 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -76.16 144.73 40.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.972 -1.08 . . . . 0.0 109.357 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.46 ' HG2' ' HE ' ' A' ' 36' ' ' ARG . 86.0 mtm180 -59.85 -39.51 85.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -57.9 -38.9 76.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.818 -1.176 . . . . 0.0 109.017 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -58.18 -34.25 70.12 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -62.51 -35.97 81.08 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.521 ' CG ' ' NE ' ' A' ' 26' ' ' ARG . 71.7 tt0 -55.95 -50.14 71.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.081 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -60.31 -44.17 95.69 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.976 -1.078 . . . . 0.0 108.272 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -66.72 -30.3 70.51 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.574 HD13 ' CG1' ' A' ' 54' ' ' VAL . 7.0 mt -92.86 -6.44 48.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.213 -0.93 . . . . 0.0 109.505 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.586 HH11 ' HG2' ' A' ' 26' ' ' ARG . 20.7 mtt-85 -100.59 137.39 39.05 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.328 -0.857 . . . . 0.0 109.641 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.44 -2.17 86.28 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.563 ' HD3' HG21 ' A' ' 32' ' ' THR . 4.5 mtpt -103.39 147.08 27.55 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.998 -1.295 . . . . 0.0 110.004 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.741 ' CG ' HH11 ' A' ' 29' ' ' ARG . 2.1 mtt-85 -74.73 161.61 29.47 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.598 0.713 . . . . 0.0 110.75 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.555 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 60.3 t0 -59.91 143.09 52.37 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.429 -0.794 . . . . 0.0 109.677 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 106.98 -25.04 23.58 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.563 HG21 ' HD3' ' A' ' 28' ' ' LYS . 60.6 m -78.99 122.46 26.2 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.258 -1.142 . . . . 0.0 108.775 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.845 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -134.19 173.64 11.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.712 -1.243 . . . . 0.0 110.713 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.46 ' CB ' HG11 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -149.74 159.84 44.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.723 -0.61 . . . . 0.0 109.676 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 13' ' ' VAL . 50.7 t -110.2 127.75 66.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.278 -0.889 . . . . 0.0 108.758 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.759 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -145.2 -175.85 4.86 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 C--N 1.302 -1.478 0 O-C-N 120.928 -1.107 . . . . 0.0 108.378 179.388 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -160.31 133.51 6.73 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.59 -1.318 . . . . 0.0 110.292 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' ' 57' ' ' CYS . 14.3 p -106.31 135.11 48.38 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.684 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.462 ' CB ' HD11 ' A' ' 25' ' ' LEU . 55.0 m -104.74 138.22 41.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' ' 33' ' ' PHE . 12.2 t -131.99 152.93 37.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.188 -0.945 . . . . 0.0 109.921 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.555 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 58.0 t -100.71 122.05 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.689 HG22 ' N ' ' A' ' 51' ' ' ASP . 13.4 p -160.47 172.44 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.678 -1.264 . . . . 0.0 111.861 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.689 ' N ' HG22 ' A' ' 50' ' ' VAL . 64.6 t0 48.44 20.52 0.3 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.526 0.679 . . . . 0.0 109.57 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.31 10.74 85.7 Favored Glycine 0 C--N 1.295 -1.749 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.106 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.663 ' CG ' ' NZ ' ' A' ' 55' ' ' LYS . 16.7 pt-20 -139.98 157.84 45.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.727 -1.455 . . . . 0.0 110.472 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.574 ' CG1' HD13 ' A' ' 25' ' ' LEU . 74.9 t -78.85 142.09 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 110.097 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.663 ' NZ ' ' CG ' ' A' ' 53' ' ' GLU . 0.9 OUTLIER -119.83 153.54 35.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.496 -0.753 . . . . 0.0 110.419 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -126.98 74.94 1.54 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.439 -0.788 . . . . 0.0 108.947 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.508 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 44.3 t -65.97 138.86 58.1 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.369 -0.832 . . . . 0.0 109.365 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.78 139.89 23.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.508 -0.745 . . . . 0.0 110.547 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.9 mt -118.44 129.97 73.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.01 -1.056 . . . . 0.0 110.867 -179.43 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.1 p . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.375 0.607 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.4 mt -59.9 -35.27 74.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.413 -0.804 . . . . 0.0 110.082 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.4 ' O ' HG12 ' A' ' 82' ' ' VAL . 38.1 ttmt -57.37 -40.85 79.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.01 -1.056 . . . . 0.0 109.212 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -69.86 -34.65 73.88 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.082 -1.011 . . . . 0.0 109.228 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.802 ' C ' HD13 ' A' ' 81' ' ' LEU . 3.0 tm? -60.64 -49.29 78.13 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.098 -1.001 . . . . 0.0 110.819 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.434 ' CG1' ' N ' ' A' ' 83' ' ' LEU . 2.4 p -65.5 -37.64 80.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 120.844 -1.16 . . . . 0.0 109.485 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.434 ' N ' ' CG1' ' A' ' 82' ' ' VAL . 54.6 tp -68.52 -45.74 71.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.299 -0.876 . . . . 0.0 110.842 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -61.85 -40.02 93.89 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.119 -0.988 . . . . 0.0 110.143 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -71.02 -24.28 62.34 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.943 -1.098 . . . . 0.0 110.91 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.585 ' O ' ' OE1' ' A' ' 86' ' ' GLN . 0.7 OUTLIER -61.66 -22.92 65.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.023 -1.048 . . . . 0.0 108.768 179.156 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -101.59 -33.85 9.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.4 -0.812 . . . . 0.0 108.98 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.5 m -82.55 142.62 31.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.407 -0.808 . . . . 0.0 109.893 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.3 m -96.68 129.94 43.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.596 -0.69 . . . . 0.0 109.97 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.727 ' O ' ' N ' ' A' ' 92' ' ' GLN . 1.6 mt -65.6 -12.48 53.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.38 -0.825 . . . . 0.0 111.794 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.738 ' N ' ' O ' ' A' ' 97' ' ' LEU . 8.2 p -9.23 -53.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.015 0 O-C-N 121.409 -0.807 . . . . 0.0 111.466 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.727 ' N ' ' O ' ' A' ' 90' ' ' LEU . 54.3 tt0 -36.41 146.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 109.575 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.683 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 7.7 t-160 103.94 -120.13 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.192 0.52 . . . . 0.0 109.777 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 30.4 m120 -72.16 13.3 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 109.387 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 93' ' ' HIS . 94.5 m-20 62.39 3.74 1.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.632 -0.667 . . . . 0.0 109.751 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 98' ' ' ASN . 14.6 m -116.19 7.94 14.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.943 -1.098 . . . . 0.0 109.006 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.803 HD22 ' N ' ' A' ' 97' ' ' LEU . 2.4 mm? -84.05 26.45 0.74 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.463 ' N ' ' HA ' ' A' ' 91' ' ' VAL . 11.7 t-20 -75.41 75.21 2.49 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 122.277 1.037 . . . . 0.0 108.824 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.521 HG13 HD12 ' A' ' 90' ' ' LEU . 6.7 p -147.4 158.07 9.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.457 ' N ' HG22 ' A' ' 99' ' ' VAL . 18.8 p -125.11 159.54 31.21 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.83 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.845 HD22 ' CG ' ' A' ' 33' ' ' PHE . 51.6 mt -80.02 70.35 6.58 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.523 ' CB ' HE22 ' A' ' 86' ' ' GLN . . . -96.69 -27.24 14.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.453 -0.779 . . . . 0.0 111.7 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -114.06 107.86 51.49 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.621 -1.299 . . . . 0.0 111.215 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.412 ' CB ' ' HB ' ' A' ' 10' ' ' THR . 20.8 Cg_exo -59.65 145.03 99.24 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.236 1.957 . . . . 0.0 110.509 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.753 HG13 ' CD2' ' A' ' 106' ' ' TYR . 7.0 p -70.57 -31.61 46.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.072 -1.018 . . . . 0.0 108.893 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.753 ' CD2' HG13 ' A' ' 105' ' ' VAL . 75.9 m-85 -111.54 31.51 6.08 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.558 -0.714 . . . . 0.0 109.737 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 106' ' ' TYR . . . . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.948 . . . . 0.0 109.311 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.7 mt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -70.85 -4.33 14.55 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.805 1.67 . . . . 0.0 111.189 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -73.05 -22.61 60.59 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -60.94 -31.69 71.23 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.938 -1.102 . . . . 0.0 109.4 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.51 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 81.6 m-20 -92.53 131.99 37.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.091 -1.006 . . . . 0.0 110.16 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.557 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 60.8 tt0 -70.46 -31.61 68.83 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.847 0.832 . . . . 0.0 109.901 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 tmpt? -62.14 -27.42 68.93 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.75 -0.594 . . . . 0.0 112.368 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.599 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 23.6 p -68.83 -27.14 65.58 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.487 -1.383 . . . . 0.0 112.187 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.652 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -120.04 -28.47 5.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.239 -1.538 . . . . 0.0 109.445 179.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -79.75 125.1 29.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.237 -0.915 . . . . 0.0 109.531 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 13' ' ' VAL . 60.0 t -99.81 -3.23 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 109.528 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.8 -148.74 26.21 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.1 m -83.08 102.98 12.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.254 . . . . 0.0 109.985 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.467 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 32.9 t -124.37 146.29 48.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.432 -0.792 . . . . 0.0 109.401 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.68 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 57.4 p30 -79.72 154.34 28.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 108.77 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.581 ' CG ' ' NH2' ' A' ' 36' ' ' ARG . 74.5 mtt180 -59.83 -35.89 75.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.144 -0.973 . . . . 0.0 109.603 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -59.75 -42.87 94.19 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.45 -0.781 . . . . 0.0 109.651 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.68 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 79.6 tttt -68.12 -37.75 81.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.855 -1.153 . . . . 0.0 109.257 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.55 -31.35 72.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.443 -0.786 . . . . 0.0 108.967 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 26' ' ' ARG . 61.7 tt0 -59.49 -49.6 77.15 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -57.84 -39.02 76.71 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 24' ' ' LEU . 78.0 mt -71.25 -27.15 63.25 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.249 -0.907 . . . . 0.0 108.869 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.405 HD23 ' CG2' ' A' ' 49' ' ' VAL . 25.2 mt -96.78 -9.56 28.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 109.302 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -91.85 124.5 36.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.8 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.64 21.94 79.3 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.771 ' HE2' HG21 ' A' ' 32' ' ' THR . 41.7 tptt -104.62 126.66 51.92 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -57.82 144.69 37.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.461 -0.774 . . . . 0.0 110.514 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 54.8 p30 -54.34 155.85 3.6 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.659 -0.651 . . . . 0.0 109.439 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.81 -30.96 9.28 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.771 HG21 ' HE2' ' A' ' 28' ' ' LYS . 93.8 m -81.81 127.28 32.81 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.522 -0.987 . . . . 0.0 109.067 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 101' ' ' LEU . 0.6 OUTLIER -134.45 153.37 51.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.053 -1.029 . . . . 0.0 108.986 179.464 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.753 HD22 HG21 ' A' ' 105' ' ' VAL . 6.7 mt -107.28 172.26 6.93 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.004 0.907 . . . . 0.0 110.589 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.486 HG22 ' SG ' ' A' ' 46' ' ' CYS . 73.4 t -147.21 110.12 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.581 ' NH2' ' CG ' ' A' ' 18' ' ' ARG . 2.8 ptt180 -145.54 -179.3 6.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.016 -1.052 . . . . 0.0 109.834 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--N 1.304 -1.382 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.965 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' ILE . 70.8 m-85 . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.44 144.57 22.96 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.044 -1.035 . . . . 0.0 108.94 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.486 ' SG ' HG22 ' A' ' 35' ' ' VAL . 20.8 m -114.07 126.61 55.29 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 108.451 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 34' ' ' LEU . 50.5 m -88.59 131.24 35.03 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.499 -0.75 . . . . 0.0 109.382 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.449 HG21 ' CD1' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -125.28 142.11 43.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.139 -0.976 . . . . 0.0 109.459 179.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.405 ' CG2' HD23 ' A' ' 25' ' ' LEU . 21.5 t -108.95 127.06 65.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.357 -0.839 . . . . 0.0 109.833 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 53' ' ' GLU . 4.9 p -111.84 161.45 10.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.082 -1.011 . . . . 0.0 109.957 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -65.48 60.14 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 169.32 -36.28 0.19 Allowed Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.6 -1.286 . . . . 0.0 111.126 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.565 ' O ' HG12 ' A' ' 50' ' ' VAL . 78.2 tt0 -156.36 143.22 18.75 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.389 -1.653 . . . . 0.0 112.396 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.62 134.33 27.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.575 ' HB2' ' HZ2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -124.97 161.08 27.46 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.824 -1.172 . . . . 0.0 111.695 -178.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -121.35 100.85 7.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.392 0.615 . . . . 0.0 109.362 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.46 ' O ' ' N ' ' A' ' 46' ' ' CYS . 49.2 t -85.3 129.33 34.83 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.85 135.86 28.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.423 -0.798 . . . . 0.0 111.145 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 44' ' ' TYR . 48.7 mm -106.53 128.01 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.2 m120 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 120.974 -1.079 . . . . 0.0 110.358 -178.915 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.1 m . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 121.94 0.876 . . . . 0.0 111.667 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 78' ' ' LEU . 79.1 mt -65.62 -31.65 72.79 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.527 0.68 . . . . 0.0 109.239 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -60.52 -41.24 94.01 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.392 -0.818 . . . . 0.0 108.941 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.507 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 99.0 mt-10 -62.79 -43.83 97.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.146 -0.971 . . . . 0.0 109.158 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.767 HD23 ' C ' ' A' ' 81' ' ' LEU . 7.1 tt -61.27 -43.58 98.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 109.907 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 82.2 t -71.1 -37.29 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 86' ' ' GLN . 86.4 mt -67.58 -42.87 81.81 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.241 -0.912 . . . . 0.0 109.634 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 80' ' ' GLU . 84.0 m-70 -69.11 -38.26 78.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.073 -1.017 . . . . 0.0 110.9 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.628 ' CB ' HD21 ' A' ' 101' ' ' LEU . 5.4 m-85 -72.36 -17.71 61.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.37 -0.831 . . . . 0.0 111.876 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.26 -24.56 51.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.287 -1.508 . . . . 0.0 108.241 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.43 ' N ' ' HG3' ' A' ' 86' ' ' GLN . 83.0 t60 -96.47 -15.31 21.8 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.533 -0.729 . . . . 0.0 109.59 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.4 m -102.87 139.94 37.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.062 -1.024 . . . . 0.0 109.007 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.438 ' OG ' HG12 ' A' ' 91' ' ' VAL . 25.1 p -88.6 135.5 33.46 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.465 -0.772 . . . . 0.0 110.685 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.527 ' O ' ' C ' ' A' ' 91' ' ' VAL . 77.0 mt -69.73 -10.27 57.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.642 -0.661 . . . . 0.0 110.088 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.728 ' N ' ' O ' ' A' ' 97' ' ' LEU . 9.9 p -33.98 -40.56 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.975 -1.078 . . . . 0.0 110.132 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.537 ' N ' HG13 ' A' ' 91' ' ' VAL . 81.2 mt-30 -75.97 -5.9 48.46 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.356 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.586 ' HB3' HD23 ' A' ' 97' ' ' LEU . 53.4 t-80 -59.53 -43.55 93.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.66 -1.275 . . . . 0.0 108.42 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.636 ' H ' HD23 ' A' ' 97' ' ' LEU . 16.3 t30 -148.71 19.85 1.02 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.415 ' CA ' ' O ' ' A' ' 91' ' ' VAL . 49.1 t0 64.68 38.77 6.81 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.365 0.602 . . . . 0.0 109.773 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.432 ' H ' HD22 ' A' ' 97' ' ' LEU . 62.6 m -168.19 2.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.851 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.978 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.0 OUTLIER -101.62 64.47 0.99 Allowed 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.16 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -79.06 71.11 5.52 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.275 -0.891 . . . . 0.0 110.723 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.564 ' CG1' HG23 ' A' ' 50' ' ' VAL . 6.9 p -148.5 158.41 7.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.49 ' N ' HG22 ' A' ' 99' ' ' VAL . 58.7 p -122.27 150.66 42.01 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.666 ' O ' HD12 ' A' ' 101' ' ' LEU . 2.2 pp -88.34 47.14 1.46 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.204 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.33 -4.83 57.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.7 -0.625 . . . . 0.0 111.368 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 32' ' ' THR . 88.1 m-85 -112.96 120.4 40.69 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.612 -1.305 . . . . 0.0 110.068 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.793 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 26.5 Cg_endo -73.29 146.48 40.39 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.681 2.254 . . . . 0.0 112.04 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.753 HG21 HD22 ' A' ' 34' ' ' LEU . 9.2 p -80.88 -25.46 10.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.574 -0.704 . . . . 0.0 110.667 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.56 ' HD1' HG13 ' A' ' 105' ' ' VAL . 2.4 m-85 -112.8 47.62 1.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.222 -0.924 . . . . 0.0 110.577 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.793 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . . . . . . 0 C--N 1.302 -1.473 0 O-C-N 120.928 -1.107 . . . . 0.0 108.242 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.805 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.2 mm? . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.36 -1.85 9.63 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.907 2.404 . . . . 0.0 111.383 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.591 ' ND1' HG12 ' A' ' 82' ' ' VAL . 30.2 m170 -65.63 -21.42 66.57 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.793 -0.567 . . . . 0.0 109.767 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.411 ' O ' ' HE3' ' A' ' 79' ' ' LYS . 85.7 m-70 -58.97 -23.5 61.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.116 -0.99 . . . . 0.0 109.427 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.714 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 72.8 m-20 -105.74 134.38 48.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 109.915 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 12' ' ' ASN . 92.5 mt-10 -71.31 -30.01 65.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.952 . . . . 0.0 110.341 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.717 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -60.26 -31.38 70.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.041 -1.037 . . . . 0.0 110.23 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.785 HG22 ' HA ' ' A' ' 107' ' ' ALA . 22.7 p -67.39 -32.21 72.96 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.345 -0.847 . . . . 0.0 110.926 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.714 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -131.72 -3.72 3.68 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.534 -1.354 . . . . 0.0 111.199 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 8' ' ' GLU . 58.4 t30 -96.1 117.74 31.31 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.477 -1.389 . . . . 0.0 111.524 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.637 HG12 ' CB ' ' A' ' 16' ' ' SER . 11.9 t -134.71 33.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.6 -30.21 26.79 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.3 m -60.29 -38.5 83.81 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.058 -1.26 . . . . 0.0 109.414 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.637 ' CB ' HG12 ' A' ' 13' ' ' VAL . 74.4 m -67.11 142.2 57.17 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.3 -0.875 . . . . 0.0 110.746 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -83.55 166.14 18.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.597 -0.689 . . . . 0.0 109.205 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.571 ' CG ' HH12 ' A' ' 36' ' ' ARG . 38.0 ttp180 -59.35 -40.7 87.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.092 -1.005 . . . . 0.0 109.426 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -59.74 -45.67 91.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.049 -1.032 . . . . 0.0 108.504 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -67.96 -33.62 75.01 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.64 92.77 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 26' ' ' ARG . 99.0 mt-10 -55.43 -48.04 75.04 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -60.57 -44.19 96.45 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.11 -41.18 97.34 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.623 HD11 ' HB3' ' A' ' 47' ' ' SER . 17.7 mt -69.31 -32.65 71.91 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' GLU . 97.6 mtt180 -85.25 2.46 43.82 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.409 0.623 . . . . 0.0 109.801 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.56 8.47 32.38 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.831 ' HZ2' ' HB ' ' A' ' 105' ' ' VAL . 11.9 pttt -142.82 157.51 44.54 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.89 -1.359 . . . . 0.0 110.69 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.73 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.0 OUTLIER -85.56 163.86 18.12 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.029 0.919 . . . . 0.0 111.577 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.556 ' OD1' ' C ' ' A' ' 50' ' ' VAL . 76.4 m-20 -42.96 159.81 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.63 0.728 . . . . 0.0 110.442 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.47 -27.08 5.36 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.7 m -86.4 124.77 33.11 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.326 -1.102 . . . . 0.0 108.432 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.786 ' HB2' HG22 ' A' ' 48' ' ' VAL . 0.5 OUTLIER -132.9 173.12 11.73 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.137 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.652 ' CB ' HG11 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -150.3 166.46 29.9 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.23 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.507 HG22 ' SG ' ' A' ' 46' ' ' CYS . 46.8 t -112.31 140.36 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.571 HH12 ' CG ' ' A' ' 18' ' ' ARG . 12.6 ptt180 -153.71 178.2 10.13 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.014 -1.054 . . . . 0.0 109.036 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 11.3 pm0 . . . . . 0 C--N 1.302 -1.481 0 O-C-N 120.83 -1.169 . . . . 0.0 108.237 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.147 0.498 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.03 148.91 17.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.213 -0.929 . . . . 0.0 110.695 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.518 ' SG ' HD11 ' A' ' 59' ' ' ILE . 75.8 m -111.2 124.31 51.96 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.198 -0.939 . . . . 0.0 108.631 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.623 ' HB3' HD11 ' A' ' 25' ' ' LEU . 69.0 m -91.2 139.82 30.39 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.115 -0.99 . . . . 0.0 110.151 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.786 HG22 ' HB2' ' A' ' 33' ' ' PHE . 56.2 t -133.51 157.44 42.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.44 ' N ' HG12 ' A' ' 48' ' ' VAL . 96.0 t -112.9 135.97 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.556 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -123.78 158.51 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.747 -1.221 . . . . 0.0 109.664 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.542 ' CA ' ' OD2' ' A' ' 30' ' ' ASP . 66.2 t0 -67.23 61.79 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.633 0.73 . . . . 0.0 109.934 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 172.1 -40.38 0.17 Allowed Glycine 0 C--N 1.292 -1.888 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.497 ' H ' HG12 ' A' ' 50' ' ' VAL . 79.0 tt0 -162.38 160.49 26.56 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.118 -1.225 . . . . 0.0 110.84 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.553 ' CG1' HD13 ' A' ' 25' ' ' LEU . 43.8 t -88.13 126.33 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' NZ ' ' HB3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -114.52 155.71 25.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.841 -1.162 . . . . 0.0 110.297 -178.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 57.3 m170 -116.43 119.83 36.88 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.415 -0.803 . . . . 0.0 108.888 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.507 ' O ' ' N ' ' A' ' 46' ' ' CYS . 41.8 t -92.46 124.2 36.32 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 58' ' ' VAL . 2.8 p -96.28 133.4 37.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 121.114 -0.991 . . . . 0.0 111.094 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD11 ' SG ' ' A' ' 46' ' ' CYS . 96.7 mt -119.33 130.31 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 . . . . . 0 C--N 1.299 -1.599 0 O-C-N 121.076 -1.015 . . . . 0.0 110.097 -179.23 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.53 0.681 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.7 mt -61.4 -38.13 85.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.383 -0.823 . . . . 0.0 109.545 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 6' ' ' HIS . 24.0 mmtm -59.68 -39.09 83.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.269 -0.895 . . . . 0.0 108.807 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -65.58 -42.5 91.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 109.001 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.571 HD23 ' C ' ' A' ' 81' ' ' LEU . 8.4 tt -61.09 -42.83 99.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.367 -0.833 . . . . 0.0 109.183 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.591 HG12 ' ND1' ' A' ' 5' ' ' HIS . 70.5 t -67.09 -47.04 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.306 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.1 mt -67.48 -43.04 81.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.481 -0.762 . . . . 0.0 110.104 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -61.47 -42.58 99.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 0.0 109.885 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.894 ' HB3' HD13 ' A' ' 101' ' ' LEU . 5.0 m-85 -60.58 -28.38 68.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.16 -0.962 . . . . 0.0 109.632 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -65.4 -34.92 79.44 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.935 -1.103 . . . . 0.0 108.769 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -84.56 -25.18 28.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.349 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.1 m -88.78 129.33 35.58 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.911 -1.118 . . . . 0.0 109.679 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.608 ' HA ' HG22 ' A' ' 100' ' ' THR . 66.5 m -81.51 133.52 35.4 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 91' ' ' VAL . 86.6 mt -71.84 -19.04 62.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.297 -0.877 . . . . 0.0 111.964 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.785 ' O ' ' N ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -34.23 -51.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.874 -1.142 . . . . 0.0 110.228 -178.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -54.72 -29.13 52.57 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.077 0.465 . . . . 0.0 110.56 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.798 ' HB3' HD12 ' A' ' 97' ' ' LEU . 64.4 t-80 -50.05 -48.14 53.09 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.939 -1.101 . . . . 0.0 108.797 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.485 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 64.9 t-20 -140.18 19.85 2.43 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.785 ' N ' ' O ' ' A' ' 91' ' ' VAL . 53.5 t0 59.92 8.16 1.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.1 p -137.22 11.56 3.04 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.278 -0.889 . . . . 0.0 109.571 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.798 HD12 ' HB3' ' A' ' 93' ' ' HIS . 23.7 mt -103.32 69.94 1.03 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.705 -1.247 . . . . 0.0 108.509 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.523 ' CA ' HG13 ' A' ' 91' ' ' VAL . 41.5 p-10 -78.25 69.28 4.43 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.608 0.718 . . . . 0.0 110.395 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 100' ' ' THR . 53.9 t -156.38 158.09 3.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.469 0.652 . . . . 0.0 109.514 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.608 HG22 ' HA ' ' A' ' 89' ' ' SER . 72.8 p -131.17 164.09 26.27 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.575 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.894 HD13 ' HB3' ' A' ' 85' ' ' TYR . 6.2 mp -82.71 68.12 9.05 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -97.94 -27.02 14.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.601 -0.687 . . . . 0.0 111.225 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -112.66 132.67 22.13 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 120.692 -1.255 . . . . 0.0 111.091 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.495 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 73.6 Cg_endo -76.14 142.67 24.76 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.764 2.976 . . . . 0.0 111.975 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.831 ' HB ' ' HZ2' ' A' ' 28' ' ' LYS . 9.7 p -76.7 -33.13 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.159 -0.963 . . . . 0.0 111.954 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -130.15 60.56 1.61 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.55 -1.344 . . . . 0.0 110.889 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.785 ' HA ' HG22 ' A' ' 10' ' ' THR . . . . . . . . 0 C--N 1.299 -1.625 0 C-N-CA 119.271 -0.971 . . . . 0.0 109.524 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.192 0.52 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.51 -16.92 5.91 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.671 2.247 . . . . 0.0 111.771 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.619 ' NE2' ' OE1' ' A' ' 86' ' ' GLN . 96.4 m-70 -67.18 -19.94 65.65 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.377 -0.827 . . . . 0.0 109.872 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -60.19 -36.59 77.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.868 -1.145 . . . . 0.0 109.506 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.633 ' OD2' ' NZ ' ' A' ' 9' ' ' LYS . 47.9 t0 -92.17 123.23 35.36 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.078 -1.014 . . . . 0.0 109.827 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.519 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 19.8 tt0 -64.44 -30.54 71.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.725 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.633 ' NZ ' ' OD2' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -61.48 -35.18 76.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.702 -0.624 . . . . 0.0 111.553 -179.327 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.715 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 13.7 p -51.63 -39.91 58.95 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.996 -1.065 . . . . 0.0 110.389 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.715 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -117.09 -19.29 9.79 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.857 -1.152 . . . . 0.0 110.684 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.437 ' CB ' ' HG2' ' A' ' 8' ' ' GLU . 49.4 t-20 -89.53 123.76 33.92 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.872 -1.142 . . . . 0.0 111.253 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 35' ' ' VAL . 27.0 m -100.7 -16.0 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.302 -0.873 . . . . 0.0 109.207 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASN . . . 78.87 -141.37 24.29 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.515 ' HA ' ' NH2' ' A' ' 36' ' ' ARG . 36.8 t -81.76 104.53 12.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -1.093 . . . . 0.0 108.748 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 t -135.29 135.09 40.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.448 -0.782 . . . . 0.0 109.93 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -64.61 143.39 57.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.112 -0.993 . . . . 0.0 109.694 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.525 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 37.9 mtt-85 -60.17 -33.44 72.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.0 108.779 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -59.67 -43.41 94.01 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -62.41 -34.3 76.47 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.09 -35.13 76.18 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 26' ' ' ARG . 94.9 mt-10 -60.07 -45.83 91.58 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.819 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -63.17 -43.0 99.48 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.29 -36.66 79.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.0 109.27 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.633 HD23 ' HD2' ' A' ' 28' ' ' LYS . 56.1 mt -87.21 -15.13 39.13 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.141 -0.974 . . . . 0.0 109.047 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 22' ' ' GLU . 16.1 mtp180 -77.71 -22.42 50.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.13 -0.981 . . . . 0.0 109.372 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.43 19.84 23.79 Favored Glycine 0 C--N 1.285 -2.282 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.68 ' NZ ' HG23 ' A' ' 105' ' ' VAL . 5.1 ttmm -105.91 131.15 53.57 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.571 -0.958 . . . . 0.0 111.456 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -85.39 166.44 16.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.681 -0.637 . . . . 0.0 110.149 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.633 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 63.4 t0 -63.15 142.08 58.52 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.446 -0.784 . . . . 0.0 110.475 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.627 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 100.87 -19.28 52.85 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.43 ' HB ' ' CG ' ' A' ' 28' ' ' LYS . 60.4 m -97.14 136.35 37.8 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.136 -1.214 . . . . 0.0 109.272 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.583 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -139.37 172.79 12.3 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.755 -1.216 . . . . 0.0 109.892 179.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.435 ' CD2' HD21 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -139.7 153.96 47.36 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.816 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.58 ' O ' HG22 ' A' ' 13' ' ' VAL . 67.5 t -104.63 136.8 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.969 -1.082 . . . . 0.0 108.527 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.712 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -144.69 -169.9 3.27 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 108.924 -178.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.712 ' H ' ' CD ' ' A' ' 36' ' ' ARG . 9.8 mt-10 . . . . . 0 C--N 1.303 -1.446 0 O-C-N 120.909 -1.12 . . . . 0.0 108.234 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.537 ' O ' ' O ' ' A' ' 59' ' ' ILE . 94.9 m-85 . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 121.918 0.866 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.422 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -155.4 129.5 8.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.436 -0.79 . . . . 0.0 109.154 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 57' ' ' CYS . 20.6 p -112.93 154.44 26.4 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.5 m -118.73 142.89 47.26 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.089 -0.645 . . . . 0.0 109.493 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.54 HG22 ' N ' ' A' ' 49' ' ' VAL . 1.9 p -132.58 161.3 41.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.298 -0.876 . . . . 0.0 108.901 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.54 ' N ' HG22 ' A' ' 48' ' ' VAL . 47.5 t -117.44 132.47 67.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.655 ' HB ' ' HZ2' ' A' ' 55' ' ' LYS . 8.6 p -115.91 164.44 12.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.224 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.633 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 95.9 m-20 -59.66 28.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.981 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -154.58 -38.0 0.02 OUTLIER Glycine 0 N--CA 1.483 1.785 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.629 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.569 ' CD ' ' O ' ' A' ' 52' ' ' GLY . 55.0 mp0 -159.26 164.58 34.84 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.65 -1.5 . . . . 0.0 112.512 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.8 t -89.33 141.15 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.655 ' HZ2' ' HB ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -131.04 165.71 22.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.843 -1.161 . . . . 0.0 111.617 -178.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -128.42 75.84 1.66 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.48 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 46.3 t -56.6 134.24 54.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.205 -0.934 . . . . 0.0 109.62 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.86 134.41 42.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.582 0.705 . . . . 0.0 110.112 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.537 ' O ' ' O ' ' A' ' 44' ' ' TYR . 49.5 mm -108.41 129.34 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 . . . . . 0 N--CA 1.495 1.809 0 O-C-N 120.857 -1.152 . . . . 0.0 110.793 -178.702 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.0 p . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.517 0.675 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.29 -32.06 72.74 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.559 -0.713 . . . . 0.0 109.395 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.403 ' O ' HG12 ' A' ' 82' ' ' VAL . 61.3 mttp -59.6 -41.19 89.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.896 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -75.41 -26.68 58.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.094 -1.004 . . . . 0.0 109.601 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.6 tt -67.99 -42.25 81.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.164 -0.96 . . . . 0.0 110.371 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 83' ' ' LEU . 4.3 p -68.61 -46.73 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.204 -0.935 . . . . 0.0 110.359 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.53 ' N ' HG13 ' A' ' 82' ' ' VAL . 85.9 mt -66.02 -40.05 90.73 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.898 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.451 ' HA ' ' CD2' ' A' ' 87' ' ' HIS . 21.3 t60 -58.65 -41.21 85.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.297 -0.877 . . . . 0.0 110.233 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.446 ' HB2' HD12 ' A' ' 101' ' ' LEU . 7.2 m-30 -74.62 -25.75 59.43 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.088 -1.007 . . . . 0.0 109.67 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.619 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 30.5 tt0 -63.92 -36.57 84.4 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.998 -1.064 . . . . 0.0 110.33 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.471 ' CE1' ' OG1' ' A' ' 88' ' ' THR . 21.7 p80 -93.21 -7.05 46.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.057 -1.027 . . . . 0.0 109.272 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' CE1' ' A' ' 87' ' ' HIS . 33.3 m -105.59 138.3 42.01 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 108.895 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.522 ' HA ' HG22 ' A' ' 100' ' ' THR . 2.8 m -89.79 130.14 36.09 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 109.268 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.562 ' O ' ' C ' ' A' ' 91' ' ' VAL . 83.0 mt -71.27 -18.65 62.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.658 -0.651 . . . . 0.0 110.246 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.73 ' N ' ' O ' ' A' ' 97' ' ' LEU . 14.7 p -31.36 -47.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.314 -0.866 . . . . 0.0 109.638 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.692 ' N ' HG13 ' A' ' 91' ' ' VAL . 76.6 mt-30 -57.61 -45.66 85.08 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.131 -178.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.455 ' C ' ' O ' ' A' ' 92' ' ' GLN . 75.1 m80 -48.53 -50.42 32.1 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.807 ' O ' ' N ' ' A' ' 96' ' ' SER . 97.7 m-20 -134.31 114.19 12.74 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 94' ' ' ASN . 84.1 m-20 -31.73 -19.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.525 -0.734 . . . . 0.0 111.393 -177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.807 ' N ' ' O ' ' A' ' 94' ' ' ASN . 54.6 m -107.66 20.46 18.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.635 -1.291 . . . . 0.0 111.698 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.73 ' O ' ' N ' ' A' ' 91' ' ' VAL . 8.3 mt -97.7 57.43 1.35 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.444 -1.41 . . . . 0.0 109.263 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -78.32 86.03 4.43 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.386 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.539 HG13 HD12 ' A' ' 90' ' ' LEU . 13.9 p -168.7 151.88 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.522 HG22 ' HA ' ' A' ' 89' ' ' SER . 34.9 p -131.68 159.34 38.64 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.469 -0.77 . . . . 0.0 109.342 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.583 HD22 ' CG ' ' A' ' 33' ' ' PHE . 19.2 mt -78.22 69.79 4.48 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.942 -1.099 . . . . 0.0 108.175 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.57 -31.45 16.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.451 -0.78 . . . . 0.0 112.714 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -122.53 136.14 26.31 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.507 -1.371 . . . . 0.0 111.393 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.785 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 68.0 Cg_endo -77.08 152.88 31.81 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 123.133 2.556 . . . . 0.0 111.956 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.68 HG23 ' NZ ' ' A' ' 28' ' ' LYS . 9.6 p -79.16 -16.41 13.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.093 -1.004 . . . . 0.0 110.626 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.433 ' HE2' HG12 ' A' ' 13' ' ' VAL . 13.2 m-85 -129.73 61.18 1.57 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.073 -1.017 . . . . 0.0 111.016 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.785 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . . . . . . 0 C--N 1.298 -1.638 0 O-C-N 121.132 -0.98 . . . . 0.0 108.795 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -58.96 -11.77 13.33 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.948 1.765 . . . . 0.0 111.576 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.608 ' HB2' HD11 ' A' ' 83' ' ' LEU . 98.0 m-70 -67.2 -31.7 72.27 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.803 -0.561 . . . . 0.0 110.749 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.556 ' ND1' ' N ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -63.06 -15.4 56.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 0.0 110.153 -178.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.693 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 27.1 t0 -102.51 126.14 49.47 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.723 ' O ' ' N ' ' A' ' 12' ' ' ASN . 4.0 mp0 -66.18 -27.29 67.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 110.644 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.679 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -62.69 -39.05 92.77 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.988 -1.07 . . . . 0.0 109.689 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.764 HG22 ' HA ' ' A' ' 107' ' ' ALA . 22.1 p -59.04 -33.76 71.13 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.694 -0.629 . . . . 0.0 109.909 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.693 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -123.91 -31.59 3.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.808 -1.183 . . . . 0.0 111.728 -179.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.723 ' N ' ' O ' ' A' ' 8' ' ' GLU . 28.5 t-20 -87.84 130.65 34.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.539 -1.35 . . . . 0.0 110.857 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -107.48 -6.52 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASN . . . 92.77 -161.86 26.13 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.4 p -67.44 153.59 43.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -1.14 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 t -163.59 150.51 12.23 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.424 -0.797 . . . . 0.0 109.407 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 18' ' ' ARG . 11.0 m120 -88.12 7.95 29.18 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.473 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 4.5 mmp_? 66.73 9.01 6.37 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.468 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.715 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 36.5 p-10 -77.52 -53.67 7.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.071 -1.018 . . . . 0.0 108.27 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.715 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 45.1 pttt -68.88 -26.29 65.05 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -56.62 -45.62 81.39 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 26' ' ' ARG . 59.2 mm-40 -59.16 -47.04 86.78 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -62.8 -42.68 99.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 24' ' ' LEU . 79.0 mt -69.94 -29.97 67.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 109.504 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.536 HD11 ' OG ' ' A' ' 47' ' ' SER . 16.0 mt -89.79 -13.28 36.98 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 22' ' ' GLU . 89.5 mtt180 -91.5 115.27 27.9 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.62 2.89 50.05 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.536 ' O ' HG11 ' A' ' 49' ' ' VAL . 36.4 mmtt -100.77 137.82 38.64 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.225 -1.162 . . . . 0.0 109.212 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -69.64 156.49 38.87 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.664 -0.648 . . . . 0.0 109.695 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 63.2 t0 -57.81 141.92 47.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.587 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 108.7 -27.82 12.62 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.465 ' HG1' ' HD2' ' A' ' 103' ' ' TYR . 86.4 m -79.85 120.8 24.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.133 -1.216 . . . . 0.0 108.437 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -139.89 176.57 8.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.851 -1.156 . . . . 0.0 110.931 -178.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.68 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -150.76 161.63 42.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.576 -0.703 . . . . 0.0 110.233 179.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.493 HG22 ' SG ' ' A' ' 46' ' ' CYS . 43.7 t -107.16 139.97 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.656 ' NH1' ' HB3' ' A' ' 45' ' ' ALA . 1.1 ppt_? -158.72 -160.21 0.85 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.411 ' O ' ' HD2' ' A' ' 36' ' ' ARG . 82.7 mt-10 . . . . . 0 C--N 1.306 -1.325 0 O-C-N 120.567 -1.333 . . . . 0.0 109.079 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.656 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . . . -159.38 151.61 21.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.978 -1.076 . . . . 0.0 110.062 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.65 ' SG ' HD11 ' A' ' 59' ' ' ILE . 77.0 m -113.46 124.07 51.53 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.536 ' OG ' HD11 ' A' ' 25' ' ' LEU . 45.2 t -94.7 130.81 41.06 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.106 -0.997 . . . . 0.0 109.022 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.565 HG22 ' N ' ' A' ' 49' ' ' VAL . 9.9 p -135.19 168.44 23.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.482 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.565 ' N ' HG22 ' A' ' 48' ' ' VAL . 67.6 t -115.19 134.3 58.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.1 t -112.85 161.25 11.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.044 -1.035 . . . . 0.0 109.801 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 50' ' ' VAL . 64.6 m-20 -62.25 56.13 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.029 0.443 . . . . 0.0 109.99 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 164.37 -36.71 0.29 Allowed Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.208 -1.472 . . . . 0.0 111.018 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.511 ' OE1' ' C ' ' A' ' 52' ' ' GLY . 60.7 mp0 -153.91 161.06 42.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.638 -1.507 . . . . 0.0 110.972 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.405 ' CG1' HD13 ' A' ' 25' ' ' LEU . 97.1 t -91.9 138.47 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' CE ' ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -124.07 168.73 12.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.903 -1.123 . . . . 0.0 110.948 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.475 ' HB3' HH22 ' A' ' 36' ' ' ARG . 71.0 m-70 -129.79 73.67 1.54 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.587 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 73.0 m -50.7 148.1 4.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.315 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.1 t -116.16 134.5 59.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.891 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.65 HD11 ' SG ' ' A' ' 46' ' ' CYS . 67.1 mt -117.46 139.17 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 m120 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.8 -1.187 . . . . 0.0 109.689 -179.737 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.61 -37.73 88.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.481 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 3.7 ttmp? -58.91 -45.33 90.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.887 -1.133 . . . . 0.0 109.175 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.13 -29.14 68.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.19 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.595 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.6 tt -58.6 -43.75 89.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.285 -0.885 . . . . 0.0 110.014 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.84 -44.39 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.716 -1.24 . . . . 0.0 109.718 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 5' ' ' HIS . 3.8 mm? -67.15 -42.38 84.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 109.555 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.676 ' O ' ' CE1' ' A' ' 87' ' ' HIS . 60.1 t60 -60.28 -39.73 87.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.417 -0.802 . . . . 0.0 110.801 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.467 ' HA ' ' OG1' ' A' ' 88' ' ' THR . 4.9 m-30 -71.08 -25.5 62.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.478 -0.764 . . . . 0.0 112.526 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 83' ' ' LEU . 9.2 pt20 -61.23 -30.56 70.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.348 -1.47 . . . . 0.0 110.312 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.676 ' CE1' ' O ' ' A' ' 84' ' ' HIS . 31.2 p-80 -92.7 -5.49 51.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.75 -1.219 . . . . 0.0 109.188 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.688 ' O ' HG22 ' A' ' 100' ' ' THR . 56.2 p -98.36 139.76 33.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.158 -0.964 . . . . 0.0 109.455 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.2 t -97.81 126.73 43.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.451 -0.781 . . . . 0.0 109.452 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.731 HD12 HG13 ' A' ' 99' ' ' VAL . 81.8 mt -67.05 -20.04 65.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.983 -1.073 . . . . 0.0 109.833 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.774 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.7 p -10.67 -58.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.834 -0.542 . . . . 0.0 110.171 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.773 ' H ' HG13 ' A' ' 91' ' ' VAL . 9.5 tp-100 -35.17 155.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 92' ' ' GLN . 59.5 t-80 55.49 107.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.814 ' O ' ' N ' ' A' ' 96' ' ' SER . 70.9 m-20 56.69 71.84 0.54 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.603 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 94.2 m-20 -29.84 -20.0 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.814 ' N ' ' O ' ' A' ' 94' ' ' ASN . 87.1 p -77.43 15.5 0.77 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.671 -1.268 . . . . 0.0 110.922 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.774 ' O ' ' N ' ' A' ' 91' ' ' VAL . 70.5 mt -95.68 41.67 1.1 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 95' ' ' ASP . 64.1 m-80 -78.39 79.28 4.83 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.321 -0.862 . . . . 0.0 110.073 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.731 HG13 HD12 ' A' ' 90' ' ' LEU . 7.4 p -153.31 157.93 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 88' ' ' THR . 31.8 p -130.26 157.46 42.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.105 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.515 HD22 ' CG ' ' A' ' 33' ' ' PHE . 19.0 mt -82.21 65.73 7.47 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.7 -28.37 12.52 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.489 ' CD1' ' HD2' ' A' ' 104' ' ' PRO . 68.1 t80 -110.48 127.09 27.57 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.14 -1.6 . . . . 0.0 110.973 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.497 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 61.1 Cg_endo -74.82 146.81 33.92 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 123.039 2.493 . . . . 0.0 112.533 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' A' ' 34' ' ' LEU . 9.9 p -83.26 -32.05 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.122 -0.986 . . . . 0.0 110.604 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.541 ' CD2' HG13 ' A' ' 105' ' ' VAL . 35.2 m-85 -129.64 59.35 1.61 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.787 -1.196 . . . . 0.0 110.856 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.764 ' HA ' HG22 ' A' ' 10' ' ' THR . . . . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.416 -0.802 . . . . 0.0 109.772 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -58.96 -11.77 13.33 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.948 1.765 . . . . 0.0 111.576 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.608 ' HB2' HD11 ' A' ' 83' ' ' LEU . 98.0 m-70 -67.2 -31.7 72.27 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.803 -0.561 . . . . 0.0 110.749 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.556 ' ND1' ' N ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -63.06 -15.4 56.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 0.0 110.153 -178.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.693 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 27.1 t0 -102.51 126.14 49.47 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.723 ' O ' ' N ' ' A' ' 12' ' ' ASN . 4.0 mp0 -66.18 -27.29 67.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 110.644 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.679 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -62.69 -39.05 92.77 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.988 -1.07 . . . . 0.0 109.689 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.764 HG22 ' HA ' ' A' ' 107' ' ' ALA . 22.1 p -59.04 -33.76 71.13 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.694 -0.629 . . . . 0.0 109.909 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.693 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -123.91 -31.59 3.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.808 -1.183 . . . . 0.0 111.728 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.723 ' N ' ' O ' ' A' ' 8' ' ' GLU . 28.5 t-20 -87.84 130.65 34.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.539 -1.35 . . . . 0.0 110.857 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -107.48 -6.52 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASN . . . 92.77 -161.86 26.13 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.4 p -67.44 153.59 43.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -1.14 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 t -163.59 150.51 12.23 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.424 -0.797 . . . . 0.0 109.407 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 18' ' ' ARG . 11.0 m120 -88.12 7.95 29.18 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.473 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 4.5 mmp_? 66.73 9.01 6.37 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.468 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.715 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 36.5 p-10 -77.52 -53.67 7.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.071 -1.018 . . . . 0.0 108.27 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.715 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 45.1 pttt -68.88 -26.29 65.05 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -56.62 -45.62 81.39 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 26' ' ' ARG . 59.2 mm-40 -59.16 -47.04 86.78 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -62.8 -42.68 99.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 24' ' ' LEU . 79.0 mt -69.94 -29.97 67.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 109.504 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.536 HD11 ' OG ' ' A' ' 47' ' ' SER . 16.0 mt -89.79 -13.28 36.98 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 22' ' ' GLU . 89.5 mtt180 -91.5 115.27 27.9 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.62 2.89 50.05 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.536 ' O ' HG11 ' A' ' 49' ' ' VAL . 36.4 mmtt -100.77 137.82 38.64 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.225 -1.162 . . . . 0.0 109.212 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -69.64 156.49 38.87 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.664 -0.648 . . . . 0.0 109.695 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 63.2 t0 -57.81 141.92 47.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.587 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 108.7 -27.82 12.62 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.465 ' HG1' ' HD2' ' A' ' 103' ' ' TYR . 86.4 m -79.85 120.8 24.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.133 -1.216 . . . . 0.0 108.437 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -139.89 176.57 8.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.851 -1.156 . . . . 0.0 110.931 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.68 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -150.76 161.63 42.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.576 -0.703 . . . . 0.0 110.233 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.493 HG22 ' SG ' ' A' ' 46' ' ' CYS . 43.7 t -107.16 139.97 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.656 ' NH1' ' HB3' ' A' ' 45' ' ' ALA . 1.1 ppt_? -158.72 -160.21 0.85 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.411 ' O ' ' HD2' ' A' ' 36' ' ' ARG . 82.7 mt-10 . . . . . 0 C--N 1.306 -1.325 0 O-C-N 120.567 -1.333 . . . . 0.0 109.079 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.656 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . . . -159.38 151.61 21.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.978 -1.076 . . . . 0.0 110.062 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.65 ' SG ' HD11 ' A' ' 59' ' ' ILE . 77.0 m -113.46 124.07 51.53 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.536 ' OG ' HD11 ' A' ' 25' ' ' LEU . 45.2 t -94.7 130.81 41.06 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.106 -0.997 . . . . 0.0 109.022 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.565 HG22 ' N ' ' A' ' 49' ' ' VAL . 9.9 p -135.19 168.44 23.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.482 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.565 ' N ' HG22 ' A' ' 48' ' ' VAL . 67.6 t -115.19 134.3 58.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.1 t -112.85 161.25 11.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.044 -1.035 . . . . 0.0 109.801 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 50' ' ' VAL . 64.6 m-20 -62.25 56.13 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.029 0.443 . . . . 0.0 109.99 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 164.37 -36.71 0.29 Allowed Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.208 -1.472 . . . . 0.0 111.018 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.511 ' OE1' ' C ' ' A' ' 52' ' ' GLY . 60.7 mp0 -153.91 161.06 42.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.638 -1.507 . . . . 0.0 110.972 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.405 ' CG1' HD13 ' A' ' 25' ' ' LEU . 97.1 t -91.9 138.47 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' CE ' ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -124.07 168.73 12.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.903 -1.123 . . . . 0.0 110.948 -179.445 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.475 ' HB3' HH22 ' A' ' 36' ' ' ARG . 71.0 m-70 -129.79 73.67 1.54 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.587 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 73.0 m -50.7 148.1 4.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.315 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.1 t -116.16 134.5 59.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.891 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.65 HD11 ' SG ' ' A' ' 46' ' ' CYS . 67.1 mt -117.46 139.17 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 m120 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.8 -1.187 . . . . 0.0 109.689 -179.737 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.61 -37.73 88.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.481 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 3.7 ttmp? -58.91 -45.33 90.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.887 -1.133 . . . . 0.0 109.175 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.13 -29.14 68.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.19 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.595 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.6 tt -58.6 -43.75 89.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.285 -0.885 . . . . 0.0 110.014 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.84 -44.39 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.716 -1.24 . . . . 0.0 109.718 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 5' ' ' HIS . 3.8 mm? -67.15 -42.38 84.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 109.555 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.676 ' O ' ' CE1' ' A' ' 87' ' ' HIS . 60.1 t60 -60.28 -39.73 87.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.417 -0.802 . . . . 0.0 110.801 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.467 ' HA ' ' OG1' ' A' ' 88' ' ' THR . 4.9 m-30 -71.08 -25.5 62.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.478 -0.764 . . . . 0.0 112.526 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 83' ' ' LEU . 9.2 pt20 -61.23 -30.56 70.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.348 -1.47 . . . . 0.0 110.312 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.676 ' CE1' ' O ' ' A' ' 84' ' ' HIS . 31.2 p-80 -92.7 -5.49 51.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.75 -1.219 . . . . 0.0 109.188 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.688 ' O ' HG22 ' A' ' 100' ' ' THR . 56.2 p -98.36 139.76 33.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.158 -0.964 . . . . 0.0 109.455 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.2 t -97.81 126.73 43.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.451 -0.781 . . . . 0.0 109.452 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.731 HD12 HG13 ' A' ' 99' ' ' VAL . 81.8 mt -67.05 -20.04 65.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.983 -1.073 . . . . 0.0 109.833 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.774 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.7 p -10.67 -58.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.834 -0.542 . . . . 0.0 110.171 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.773 ' H ' HG13 ' A' ' 91' ' ' VAL . 9.5 tp-100 -35.17 155.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 92' ' ' GLN . 59.5 t-80 55.49 107.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.814 ' O ' ' N ' ' A' ' 96' ' ' SER . 70.9 m-20 56.69 71.84 0.54 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.603 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 94.2 m-20 -29.84 -20.0 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.814 ' N ' ' O ' ' A' ' 94' ' ' ASN . 87.1 p -77.43 15.5 0.77 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.671 -1.268 . . . . 0.0 110.922 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.774 ' O ' ' N ' ' A' ' 91' ' ' VAL . 70.5 mt -95.68 41.67 1.1 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 95' ' ' ASP . 64.1 m-80 -78.39 79.28 4.83 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.321 -0.862 . . . . 0.0 110.073 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.731 HG13 HD12 ' A' ' 90' ' ' LEU . 7.4 p -153.31 157.93 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 88' ' ' THR . 31.8 p -130.26 157.46 42.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.105 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.515 HD22 ' CG ' ' A' ' 33' ' ' PHE . 19.0 mt -82.21 65.73 7.47 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.7 -28.37 12.52 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.489 ' CD1' ' HD2' ' A' ' 104' ' ' PRO . 68.1 t80 -110.48 127.09 27.57 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.14 -1.6 . . . . 0.0 110.973 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.497 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 61.1 Cg_endo -74.82 146.81 33.92 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 123.039 2.493 . . . . 0.0 112.533 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' A' ' 34' ' ' LEU . 9.9 p -83.26 -32.05 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.122 -0.986 . . . . 0.0 110.604 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.541 ' CD2' HG13 ' A' ' 105' ' ' VAL . 35.2 m-85 -129.64 59.35 1.61 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.787 -1.196 . . . . 0.0 110.856 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.764 ' HA ' HG22 ' A' ' 10' ' ' THR . . . . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.416 -0.802 . . . . 0.0 109.772 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 3' ' ' LEU . 92.6 mt . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.4 -2.35 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.613 2.209 . . . . 0.0 111.998 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.665 ' CD2' ' OE1' ' A' ' 86' ' ' GLN . 4.7 m80 -67.76 -24.52 65.35 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.898 -1.126 . . . . 0.0 109.493 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -58.13 -29.85 65.86 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.595 ' O ' ' OG1' ' A' ' 10' ' ' THR . 94.5 m-20 -89.0 121.73 31.65 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 46.5 tt0 -69.9 -34.58 73.71 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.07 -1.019 . . . . 0.0 109.585 -178.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.469 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -66.46 -21.98 66.2 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 110.95 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 7' ' ' ASP . 8.1 p -64.05 -35.29 80.26 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.776 -1.203 . . . . 0.0 109.978 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.608 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -115.97 -34.3 4.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.94 -1.1 . . . . 0.0 110.182 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -88.1 125.69 34.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.071 -1.018 . . . . 0.0 110.543 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.575 HG21 HH21 ' A' ' 36' ' ' ARG . 24.5 m -108.59 -13.13 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.2 -158.59 30.34 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.482 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 73.7 m -61.52 148.41 42.16 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.18 -1.188 . . . . 0.0 108.524 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.481 ' HB3' ' NE ' ' A' ' 36' ' ' ARG . 40.4 t -168.87 167.61 10.85 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 109.355 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 86.7 m-20 -88.89 134.7 33.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.235 -0.916 . . . . 0.0 109.281 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.496 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 44.8 mtt-85 -59.98 -36.22 76.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.845 -1.159 . . . . 0.0 110.287 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 19' ' ' ASN . 10.2 m120 -54.53 -48.24 72.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 0.0 111.121 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 17' ' ' ASN . 14.6 ptpt -69.57 -26.43 64.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.385 -1.447 . . . . 0.0 109.3 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.041 ' HB2' HH12 ' A' ' 36' ' ' ARG . . . -57.34 -43.44 83.43 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -59.58 -44.02 93.47 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -60.15 -48.63 80.91 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.27 -36.49 83.83 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.646 HD13 ' CG1' ' A' ' 54' ' ' VAL . 4.0 mt -82.01 -4.43 56.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.221 -0.924 . . . . 0.0 109.432 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.17 131.38 37.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.33 -0.856 . . . . 0.0 110.5 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.06 1.79 88.52 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.74 ' O ' HG11 ' A' ' 49' ' ' VAL . 36.0 mmtt -100.23 128.19 46.35 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.209 -1.171 . . . . 0.0 110.108 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 30' ' ' ASP . 41.9 ttm180 -62.29 147.75 47.12 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 53.3 p-10 -47.39 156.0 0.3 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.928 -1.107 . . . . 0.0 108.769 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.499 ' H ' HG21 ' A' ' 99' ' ' VAL . . . 99.47 -33.87 5.87 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 60.0 m -72.54 123.93 24.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.167 -1.196 . . . . 0.0 108.831 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.736 ' CD1' ' N ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -145.4 172.24 13.47 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 118.385 -1.326 . . . . 0.0 111.051 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.736 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -148.75 159.76 43.83 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.184 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 11' ' ' TRP . 14.7 t -101.5 138.85 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 1.041 HH12 ' HB2' ' A' ' 21' ' ' ALA . 32.2 ttm180 -150.58 160.38 43.84 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 109.5 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.508 ' OE1' ' N ' ' A' ' 37' ' ' GLU . 16.0 pm0 . . . . . 0 C--N 1.301 -1.518 0 O-C-N 120.63 -1.294 . . . . 0.0 109.304 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' A' ' 59' ' ' ILE . 44.2 m-85 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.298 0.57 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.625 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -171.77 155.9 4.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.165 -0.96 . . . . 0.0 108.984 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 57' ' ' CYS . 22.1 p -133.13 142.91 48.93 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.496 -1.377 . . . . 0.0 109.285 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.2 p -116.86 139.28 50.79 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.53 -0.731 . . . . 0.0 109.744 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.625 HG22 ' N ' ' A' ' 49' ' ' VAL . 14.9 p -133.29 166.6 28.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.383 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.74 HG11 ' O ' ' A' ' 28' ' ' LYS . 53.7 t -103.69 137.49 32.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.623 ' C ' ' H ' ' A' ' 52' ' ' GLY . 41.4 t -116.99 152.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.153 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.495 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 62.1 t0 -52.7 2.2 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.095 0.474 . . . . 0.0 110.328 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.623 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -136.19 -32.66 0.26 Allowed Glycine 0 N--CA 1.485 1.952 0 C-N-CA 118.894 -1.622 . . . . 0.0 112.248 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 64.2 mt-10 -158.52 163.57 36.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.444 -1.621 . . . . 0.0 111.399 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.646 ' CG1' HD13 ' A' ' 25' ' ' LEU . 66.1 t -76.63 136.99 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 54' ' ' VAL . 60.8 mmtt -114.9 150.89 34.92 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.823 -1.173 . . . . 0.0 111.347 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -131.69 70.04 1.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.466 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 98.0 m -62.22 142.71 57.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 109.566 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 58' ' ' VAL . 7.7 p -106.7 138.28 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.49 -0.756 . . . . 0.0 109.496 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.558 ' O ' ' O ' ' A' ' 44' ' ' TYR . 90.9 mt -123.08 136.64 59.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.282 -0.886 . . . . 0.0 109.183 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.3 m120 . . . . . 0 N--CA 1.495 1.788 0 O-C-N 120.88 -1.138 . . . . 0.0 109.301 179.944 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 121.417 0.627 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.23 -37.63 86.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.871 . . . . 0.0 109.084 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -53.77 -44.09 69.77 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.02 -42.5 72.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.386 -0.821 . . . . 0.0 109.989 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.772 HD23 ' C ' ' A' ' 81' ' ' LEU . 6.9 tt -59.8 -46.13 90.18 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.254 -0.904 . . . . 0.0 109.338 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.44 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 72.0 t -63.06 -45.93 97.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 109.599 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.67 HD23 ' OE1' ' A' ' 86' ' ' GLN . 68.6 mt -61.53 -40.1 93.46 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.539 -0.726 . . . . 0.0 110.305 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.58 ' O ' ' OG1' ' A' ' 88' ' ' THR . 60.1 t-80 -52.0 -48.67 64.33 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.165 -0.959 . . . . 0.0 110.195 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.803 ' HB2' HD12 ' A' ' 101' ' ' LEU . 27.2 m-85 -71.48 -20.71 62.04 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.126 -0.984 . . . . 0.0 112.027 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.67 ' OE1' HD23 ' A' ' 83' ' ' LEU . 27.7 mt-30 -61.56 -36.02 79.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.645 -1.284 . . . . 0.0 109.382 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -93.5 -37.09 12.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.432 -0.792 . . . . 0.0 109.033 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.58 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 7.7 p -89.6 139.82 30.16 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.431 -0.793 . . . . 0.0 110.29 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.6 t -81.39 136.84 35.72 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.564 -0.71 . . . . 0.0 109.48 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.769 ' O ' ' N ' ' A' ' 92' ' ' GLN . 8.0 mt -61.46 -41.8 97.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.434 -0.791 . . . . 0.0 111.012 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.049 HG22 ' OD1' ' A' ' 98' ' ' ASN . 71.8 t 40.29 -81.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.225 -0.922 . . . . 0.0 109.234 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.769 ' N ' ' O ' ' A' ' 90' ' ' LEU . 0.7 OUTLIER 84.44 171.86 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 0.0 110.475 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.422 ' H ' ' HG3' ' A' ' 92' ' ' GLN . 65.0 m80 -60.93 -37.85 83.74 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 88.4 m-20 -57.93 -18.13 21.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 94' ' ' ASN . 97.7 m-20 61.28 23.23 13.49 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.8 m -134.01 11.49 3.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.57 -1.332 . . . . 0.0 111.195 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.614 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.4 mp -104.02 46.24 0.93 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 1.049 ' OD1' HG22 ' A' ' 91' ' ' VAL . 74.3 m-20 -78.08 67.46 3.92 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.448 -177.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.499 HG21 ' H ' ' A' ' 31' ' ' GLY . 7.4 p -132.2 159.04 43.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.447 ' N ' HG22 ' A' ' 99' ' ' VAL . 40.5 p -110.65 152.36 26.58 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.273 -0.892 . . . . 0.0 108.793 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.803 HD12 ' HB2' ' A' ' 85' ' ' TYR . 91.5 mt -93.26 30.23 1.73 Allowed 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.7 -9.19 58.49 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 32' ' ' THR . 73.7 m-85 -121.83 103.77 39.82 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.375 -1.453 . . . . 0.0 111.602 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -61.01 160.92 24.01 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.02 1.813 . . . . 0.0 110.805 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.09 -22.9 7.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.205 -0.935 . . . . 0.0 109.78 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -111.13 34.39 4.08 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.093 -1.004 . . . . 0.0 110.254 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.308 179.414 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 3' ' ' LEU . 5.4 mp . . . . . 0 N--CA 1.498 1.97 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.412 ' CG ' ' HG2' ' A' ' 104' ' ' PRO . 33.8 Cg_endo -67.52 -1.31 6.36 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.234 1.956 . . . . 0.0 111.988 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.63 ' NE2' ' OE1' ' A' ' 86' ' ' GLN . 88.7 m-70 -69.69 -32.36 70.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.106 -0.996 . . . . 0.0 108.606 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -60.99 -32.78 72.34 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.343 -0.848 . . . . 0.0 108.807 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.4 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 68.6 m-20 -92.67 129.22 38.66 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.686 0.755 . . . . 0.0 110.814 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.536 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 75.6 tt0 -77.73 -23.45 49.36 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.3 -0.875 . . . . 0.0 110.68 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -17.85 63.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.187 -0.946 . . . . 0.0 111.528 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.606 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 47.1 p -73.42 -26.69 61.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.732 -1.23 . . . . 0.0 111.305 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.606 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -123.58 -21.91 5.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.505 -1.372 . . . . 0.0 109.773 179.073 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -83.62 121.35 27.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 110.882 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' A' ' 15' ' ' SER . 2.2 t -134.61 33.32 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -30.96 -31.68 0.01 OUTLIER Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.63 ' N ' ' O ' ' A' ' 13' ' ' VAL . 89.2 p -69.54 -21.18 63.67 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.804 -1.409 . . . . 0.0 109.965 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 13' ' ' VAL . 41.9 t -66.62 149.38 50.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.068 -1.02 . . . . 0.0 110.269 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.49 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 92.7 m-20 -114.52 167.57 10.62 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.061 -1.024 . . . . 0.0 109.654 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -56.84 -43.54 81.22 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.266 -0.897 . . . . 0.0 109.26 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -65.82 -46.55 78.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.161 -0.962 . . . . 0.0 108.717 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.49 ' HB3' ' H ' ' A' ' 17' ' ' ASN . 82.3 tttt -65.02 -36.37 84.18 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -57.13 -37.81 72.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 108.878 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.603 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 97.1 mt-10 -59.01 -44.17 91.65 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -63.84 -44.1 94.19 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.447 -0.783 . . . . 0.0 108.975 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.622 ' O ' ' CD ' ' A' ' 28' ' ' LYS . 96.1 mt -71.23 -26.19 62.82 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.335 -0.853 . . . . 0.0 108.837 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.445 HD23 HG23 ' A' ' 49' ' ' VAL . 21.1 mt -94.09 -11.84 29.75 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.603 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 16.6 mmt180 -97.74 134.48 40.85 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.28 -0.38 88.95 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.622 ' CD ' ' O ' ' A' ' 24' ' ' LEU . 19.0 mtpp -105.06 136.65 44.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.094 -1.239 . . . . 0.0 109.468 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -68.27 160.69 28.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.163 -0.96 . . . . 0.0 110.476 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.691 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 84.4 m-20 -57.99 149.45 23.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.518 -0.739 . . . . 0.0 110.218 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 100' ' ' THR . . . 104.71 -30.64 9.71 Favored Glycine 0 N--CA 1.486 2.015 0 C-N-CA 119.41 -1.376 . . . . 0.0 110.222 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.541 HG21 ' CE ' ' A' ' 28' ' ' LYS . 85.0 m -80.17 120.35 24.18 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.418 -1.048 . . . . 0.0 108.207 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.53 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -135.61 164.96 26.65 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 118.806 -1.158 . . . . 0.0 109.656 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -134.01 157.0 47.21 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.398 179.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 11' ' ' TRP . 85.5 t -115.41 124.79 72.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.37 -0.831 . . . . 0.0 108.985 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.691 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -152.56 177.35 10.74 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 4.3 pm0 . . . . . 0 C--N 1.298 -1.644 0 O-C-N 121.088 -1.007 . . . . 0.0 108.861 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.655 ' O ' ' O ' ' A' ' 59' ' ' ILE . 96.0 m-85 . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.508 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -158.15 137.49 11.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.348 -1.47 . . . . 0.0 109.794 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 20.9 p -116.9 129.87 56.34 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.149 -0.969 . . . . 0.0 109.092 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.7 t -107.58 138.7 43.33 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.657 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.733 HG22 ' N ' ' A' ' 49' ' ' VAL . 10.4 p -128.56 170.75 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.498 -0.751 . . . . 0.0 109.766 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.733 ' N ' HG22 ' A' ' 48' ' ' VAL . 85.4 t -114.71 134.12 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.885 HG13 ' H ' ' A' ' 52' ' ' GLY . 3.9 p -125.25 157.48 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.696 -1.253 . . . . 0.0 110.161 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.691 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 43.2 p30 -49.59 -10.31 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.662 0.744 . . . . 0.0 110.398 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.885 ' H ' HG13 ' A' ' 50' ' ' VAL . . . -98.33 -58.41 0.96 Allowed Glycine 0 C--N 1.287 -2.179 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.567 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 61.5 mt-10 -164.68 -175.21 3.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.395 -1.062 . . . . 0.0 109.725 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 54' ' ' VAL . 18.0 m -90.84 119.87 38.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -119.54 156.71 29.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.435 -1.416 . . . . 0.0 110.454 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -111.76 127.87 55.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.48 -0.762 . . . . 0.0 109.974 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.7 t -105.24 128.56 53.49 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 p -86.35 136.51 22.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.845 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.655 ' O ' ' O ' ' A' ' 44' ' ' TYR . 51.5 mm -118.96 126.74 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.7 m120 . . . . . 0 N--CA 1.496 1.857 0 O-C-N 120.586 -1.321 . . . . 0.0 110.436 -178.776 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.2 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.455 0.645 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.6 mt -61.42 -39.8 92.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.367 -0.833 . . . . 0.0 109.606 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -59.04 -40.07 83.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.124 -0.985 . . . . 0.0 108.946 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.407 ' HG2' ' HD1' ' A' ' 84' ' ' HIS . 85.0 tt0 -64.2 -36.52 84.32 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.4 -0.812 . . . . 0.0 109.192 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.5 tt -59.86 -46.02 90.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.053 -1.029 . . . . 0.0 110.225 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.4 t -63.24 -41.18 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.006 -1.059 . . . . 0.0 109.647 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.464 HD21 ' CD2' ' A' ' 5' ' ' HIS . 76.3 mt -63.16 -43.77 97.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.924 -1.11 . . . . 0.0 111.323 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.407 ' HD1' ' HG2' ' A' ' 80' ' ' GLU . 36.4 m80 -64.84 -43.74 92.06 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.863 -1.148 . . . . 0.0 111.021 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.484 ' CB ' HD12 ' A' ' 101' ' ' LEU . 19.0 m-85 -65.64 -24.64 67.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.616 -1.302 . . . . 0.0 109.055 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.671 ' HG3' ' HB2' ' A' ' 102' ' ' ALA . 33.5 tt0 -67.57 -33.16 74.46 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.376 -0.827 . . . . 0.0 109.607 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -95.0 -14.09 24.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.119 -0.988 . . . . 0.0 109.292 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.9 m -108.05 129.97 55.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 109.527 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.0 t -72.95 139.9 47.05 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.978 -1.076 . . . . 0.0 108.614 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.687 ' O ' ' C ' ' A' ' 91' ' ' VAL . 7.6 mp -69.0 -16.03 63.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.116 -0.99 . . . . 0.0 110.688 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.695 ' N ' ' O ' ' A' ' 97' ' ' LEU . 74.6 t -10.15 -64.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.589 0 O-C-N 121.75 -0.594 . . . . 0.0 109.918 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 90' ' ' LEU . 91.3 mt-30 34.71 -142.24 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.402 ' O ' ' N ' ' A' ' 95' ' ' ASP . 82.9 t60 -52.44 -50.07 63.33 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.711 ' O ' ' N ' ' A' ' 96' ' ' SER . 7.7 m120 -69.7 83.3 0.44 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 94' ' ' ASN . 62.9 t0 -44.03 -10.74 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.421 -0.799 . . . . 0.0 108.903 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.711 ' N ' ' O ' ' A' ' 94' ' ' ASN . 89.3 p -100.56 4.45 43.48 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.507 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.695 ' O ' ' N ' ' A' ' 91' ' ' VAL . 8.3 mt -76.83 50.31 0.7 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.078 -1.639 . . . . 0.0 108.404 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -77.37 80.62 3.87 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.252 -0.905 . . . . 0.0 109.861 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.626 ' HB ' HG23 ' A' ' 50' ' ' VAL . 6.6 p -161.53 162.94 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.544 ' N ' HG22 ' A' ' 99' ' ' VAL . 44.4 p -129.94 155.85 45.39 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.087 -1.008 . . . . 0.0 109.936 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.53 HD22 ' CG ' ' A' ' 33' ' ' PHE . 18.4 mt -89.15 53.9 2.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.021 -1.049 . . . . 0.0 108.673 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.671 ' HB2' ' HG3' ' A' ' 86' ' ' GLN . . . -89.66 -18.09 27.12 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.73 -0.606 . . . . 0.0 112.37 -178.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.484 ' HD2' ' HG1' ' A' ' 32' ' ' THR . 88.4 t80 -116.61 110.16 42.81 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 120.265 -1.522 . . . . 0.0 110.448 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.412 ' HG2' ' CG ' ' A' ' 4' ' ' PRO . 22.7 Cg_exo -59.6 146.96 93.8 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.875 1.716 . . . . 0.0 110.926 178.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.681 HG13 ' CD2' ' A' ' 106' ' ' TYR . 11.4 p -67.99 -22.43 27.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.686 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.681 ' CD2' HG13 ' A' ' 105' ' ' VAL . 59.9 m-85 -128.75 60.88 1.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.903 . . . . 0.0 109.39 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.489 0 O-C-N 120.971 -1.081 . . . . 0.0 108.657 179.82 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.467 ' HB3' ' CD2' ' A' ' 6' ' ' HIS . 13.8 tp . . . . . 0 N--CA 1.485 1.318 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -49.86 -20.95 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.994 1.796 . . . . 0.0 112.082 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.732 ' CD2' HE22 ' A' ' 86' ' ' GLN . 30.2 m-70 -71.57 -29.69 65.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.453 -0.78 . . . . 0.0 109.838 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.467 ' CD2' ' HB3' ' A' ' 3' ' ' LEU . 80.3 m-70 -67.48 -21.68 65.51 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.566 ' O ' ' OG1' ' A' ' 10' ' ' THR . 76.3 m-20 -95.84 113.33 24.95 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.454 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 32.0 tt0 -70.31 -32.97 70.96 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.473 -0.767 . . . . 0.0 110.801 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.572 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -71.2 -13.62 61.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.758 -1.214 . . . . 0.0 110.945 -178.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.573 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 6.6 p -62.97 -37.49 87.32 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.68 -1.262 . . . . 0.0 108.666 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.719 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -117.33 -27.8 6.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.944 -1.098 . . . . 0.0 110.074 179.042 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -86.6 119.66 27.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.924 -1.11 . . . . 0.0 110.442 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 15' ' ' SER . 9.8 p -140.72 31.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -39.12 -20.34 0.01 OUTLIER Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.608 ' N ' ' O ' ' A' ' 13' ' ' VAL . 87.5 p -61.42 -17.52 54.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -1.131 . . . . 0.0 108.589 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.1 m -94.15 145.16 24.89 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.725 0.774 . . . . 0.0 110.731 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.621 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 54.8 p30 -79.64 167.39 20.75 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.394 -0.816 . . . . 0.0 109.335 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.523 ' CG ' ' NH1' ' A' ' 36' ' ' ARG . 81.1 mtm180 -61.05 -39.9 91.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.596 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -63.05 -44.29 96.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.645 -1.285 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.621 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 22.5 tptm -61.13 -35.51 77.26 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.221 -0.924 . . . . 0.0 108.901 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.04 74.32 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 26' ' ' ARG . 94.8 mt-10 -57.63 -45.4 85.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.35 -40.33 93.86 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 24' ' ' LEU . 79.8 mt -67.95 -39.56 83.38 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.543 HD11 ' OG ' ' A' ' 47' ' ' SER . 3.6 mt -82.83 -16.82 46.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.342 -0.848 . . . . 0.0 108.799 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' GLU . 10.6 mmm180 -93.78 -28.4 15.92 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.959 0.885 . . . . 0.0 109.691 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.99 9.17 70.42 Favored Glycine 0 C--N 1.286 -2.231 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.526 ' O ' HG11 ' A' ' 49' ' ' VAL . 29.8 mmtm -124.2 145.54 49.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.499 -1.0 . . . . 0.0 110.001 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -77.67 165.53 24.14 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.395 0.617 . . . . 0.0 110.199 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.538 ' CG ' ' OD1' ' A' ' 51' ' ' ASP . 18.2 p-10 -53.02 158.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.92 -33.8 4.51 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.2 m -77.07 125.61 29.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -1.032 . . . . 0.0 108.311 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 101' ' ' LEU . 0.4 OUTLIER -135.88 170.65 15.66 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.966 -1.083 . . . . 0.0 110.274 -178.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -149.26 165.85 30.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.196 -0.94 . . . . 0.0 111.007 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.557 HG22 ' SG ' ' A' ' 46' ' ' CYS . 73.9 t -120.51 121.48 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.731 ' NH1' ' O ' ' A' ' 37' ' ' GLU . 6.8 ptm180 -134.84 -176.24 4.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.438 -0.788 . . . . 0.0 108.949 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.731 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 56.0 mt-10 . . . . . 0 N--CA 1.488 1.459 0 O-C-N 120.871 -1.143 . . . . 0.0 108.494 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' ILE . 98.1 m-85 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.413 0.625 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -145.74 133.43 21.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.711 -0.618 . . . . 0.0 109.924 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.609 ' O ' ' CB ' ' A' ' 57' ' ' CYS . 57.3 m -100.0 113.89 26.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.544 -1.347 . . . . 0.0 107.893 178.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.543 ' OG ' HD11 ' A' ' 25' ' ' LEU . 33.4 t -91.71 140.77 29.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.133 -0.98 . . . . 0.0 109.83 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.521 HG13 ' CB ' ' A' ' 33' ' ' PHE . 1.5 t -130.89 156.31 42.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.46 -0.775 . . . . 0.0 109.888 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 28' ' ' LYS . 89.4 t -101.12 135.94 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.799 HG12 ' H ' ' A' ' 52' ' ' GLY . 2.6 t -122.05 147.78 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.542 -1.349 . . . . 0.0 111.124 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.538 ' OD1' ' CG ' ' A' ' 30' ' ' ASP . 82.0 m-20 -55.06 9.36 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.231 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.799 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -135.97 -39.09 0.16 Allowed Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.619 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.539 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 21.6 tt0 -163.14 164.17 25.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.572 -1.546 . . . . 0.0 110.537 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.539 ' N ' ' CG ' ' A' ' 53' ' ' GLU . 96.1 t -67.42 134.69 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.075 -1.015 . . . . 0.0 108.686 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HE3' HD13 ' A' ' 97' ' ' LEU . 40.2 mmtt -112.04 139.02 47.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.831 -1.168 . . . . 0.0 109.12 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -120.57 87.74 2.81 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.609 ' CB ' ' O ' ' A' ' 46' ' ' CYS . 0.5 OUTLIER -70.79 139.66 51.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.154 -0.966 . . . . 0.0 108.723 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.41 129.57 62.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 111.241 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 44' ' ' TYR . 46.8 mm -108.13 117.05 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 120.943 -1.098 . . . . 0.0 110.312 -178.579 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 121.634 0.73 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 78' ' ' LEU . 93.9 mt -66.09 -40.62 90.94 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.708 -0.62 . . . . 0.0 109.875 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -64.95 -40.17 94.6 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.974 -1.078 . . . . 0.0 108.533 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -67.31 -33.07 74.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.369 -0.832 . . . . 0.0 109.029 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.849 ' C ' HD13 ' A' ' 81' ' ' LEU . 2.5 tm? -60.54 -45.18 94.81 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.213 -0.93 . . . . 0.0 108.613 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.98 -42.92 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.347 -0.846 . . . . 0.0 109.176 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.712 HD23 ' NE2' ' A' ' 86' ' ' GLN . 96.5 mt -60.23 -43.87 95.68 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.435 -0.791 . . . . 0.0 111.177 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -63.44 -40.14 96.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.533 -1.354 . . . . 0.0 110.565 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.413 ' CE1' HD21 ' A' ' 81' ' ' LEU . 5.4 m-85 -64.12 -22.63 67.01 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.901 -1.124 . . . . 0.0 110.698 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.732 HE22 ' CD2' ' A' ' 5' ' ' HIS . 6.7 mt-30 -68.99 -32.62 72.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.456 -1.402 . . . . 0.0 109.024 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -88.14 -19.29 27.18 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.323 -0.861 . . . . 0.0 109.648 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 79.0 m -100.64 127.74 46.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.571 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.556 ' HA ' HG22 ' A' ' 100' ' ' THR . 24.1 p -81.27 139.7 35.29 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.513 -0.742 . . . . 0.0 109.401 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.654 HD23 ' CD2' ' A' ' 93' ' ' HIS . 4.3 mp -75.86 -17.64 59.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.535 -0.728 . . . . 0.0 109.996 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.707 ' N ' ' O ' ' A' ' 97' ' ' LEU . 5.1 p -31.23 -44.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.355 -0.84 . . . . 0.0 110.482 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.562 ' N ' HG13 ' A' ' 91' ' ' VAL . 9.7 pt20 -66.16 -10.91 45.71 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.264 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.654 ' CD2' HD23 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -63.26 -47.0 84.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.582 -1.324 . . . . 0.0 107.893 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 93' ' ' HIS . 10.6 m120 -138.43 20.2 2.74 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.627 ' N ' ' O ' ' A' ' 91' ' ' VAL . 94.6 m-20 61.05 17.33 7.89 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.457 ' C ' HD22 ' A' ' 97' ' ' LEU . 67.2 m -146.54 9.56 1.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.707 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.6 mm? -97.25 68.18 2.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -78.36 79.76 4.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 110.358 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.456 HG22 ' N ' ' A' ' 100' ' ' THR . 7.6 p -163.69 156.24 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 121.573 0.701 . . . . 0.0 109.59 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 89' ' ' SER . 32.1 p -130.44 153.94 48.25 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.139 -0.975 . . . . 0.0 108.681 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.525 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 17.7 mt -78.61 67.85 4.46 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.51 -27.65 14.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.126 -0.984 . . . . 0.0 111.897 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.47 130.84 24.38 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 120.77 -1.206 . . . . 0.0 111.43 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.54 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 38.1 Cg_endo -74.51 153.41 44.35 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.734 2.289 . . . . 0.0 110.897 177.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.564 HG13 ' CD2' ' A' ' 106' ' ' TYR . 7.7 p -76.74 -30.9 19.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.187 -0.945 . . . . 0.0 109.791 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.564 ' CD2' HG13 ' A' ' 105' ' ' VAL . 50.0 m-85 -113.61 54.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.148 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.54 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.417 0.627 . . . . 0.0 109.913 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.467 ' HB3' ' CD2' ' A' ' 6' ' ' HIS . 13.8 tp . . . . . 0 N--CA 1.485 1.318 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -49.86 -20.95 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.994 1.796 . . . . 0.0 112.082 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.732 ' CD2' HE22 ' A' ' 86' ' ' GLN . 30.2 m-70 -71.57 -29.69 65.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.453 -0.78 . . . . 0.0 109.838 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.467 ' CD2' ' HB3' ' A' ' 3' ' ' LEU . 80.3 m-70 -67.48 -21.68 65.51 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.566 ' O ' ' OG1' ' A' ' 10' ' ' THR . 76.3 m-20 -95.84 113.33 24.95 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.454 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 32.0 tt0 -70.31 -32.97 70.96 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.473 -0.767 . . . . 0.0 110.801 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.572 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -71.2 -13.62 61.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.758 -1.214 . . . . 0.0 110.945 -178.288 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.573 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 6.6 p -62.97 -37.49 87.32 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.68 -1.262 . . . . 0.0 108.666 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.719 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -117.33 -27.8 6.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.944 -1.098 . . . . 0.0 110.074 179.042 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -86.6 119.66 27.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.924 -1.11 . . . . 0.0 110.442 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 15' ' ' SER . 9.8 p -140.72 31.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -39.12 -20.34 0.01 OUTLIER Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.608 ' N ' ' O ' ' A' ' 13' ' ' VAL . 87.5 p -61.42 -17.52 54.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -1.131 . . . . 0.0 108.589 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.1 m -94.15 145.16 24.89 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.725 0.774 . . . . 0.0 110.731 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.621 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 54.8 p30 -79.64 167.39 20.75 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.394 -0.816 . . . . 0.0 109.335 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.523 ' CG ' ' NH1' ' A' ' 36' ' ' ARG . 81.1 mtm180 -61.05 -39.9 91.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.596 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -63.05 -44.29 96.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.645 -1.285 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.621 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 22.5 tptm -61.13 -35.51 77.26 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.221 -0.924 . . . . 0.0 108.901 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.04 74.32 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 26' ' ' ARG . 94.8 mt-10 -57.63 -45.4 85.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.35 -40.33 93.86 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 24' ' ' LEU . 79.8 mt -67.95 -39.56 83.38 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.543 HD11 ' OG ' ' A' ' 47' ' ' SER . 3.6 mt -82.83 -16.82 46.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.342 -0.848 . . . . 0.0 108.799 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' GLU . 10.6 mmm180 -93.78 -28.4 15.92 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.959 0.885 . . . . 0.0 109.691 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.99 9.17 70.42 Favored Glycine 0 C--N 1.286 -2.231 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.526 ' O ' HG11 ' A' ' 49' ' ' VAL . 29.8 mmtm -124.2 145.54 49.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.499 -1.0 . . . . 0.0 110.001 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -77.67 165.53 24.14 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.395 0.617 . . . . 0.0 110.199 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.538 ' CG ' ' OD1' ' A' ' 51' ' ' ASP . 18.2 p-10 -53.02 158.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.92 -33.8 4.51 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.2 m -77.07 125.61 29.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -1.032 . . . . 0.0 108.311 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 101' ' ' LEU . 0.4 OUTLIER -135.88 170.65 15.66 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.966 -1.083 . . . . 0.0 110.274 -178.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -149.26 165.85 30.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.196 -0.94 . . . . 0.0 111.007 -179.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.557 HG22 ' SG ' ' A' ' 46' ' ' CYS . 73.9 t -120.51 121.48 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.731 ' NH1' ' O ' ' A' ' 37' ' ' GLU . 6.8 ptm180 -134.84 -176.24 4.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.438 -0.788 . . . . 0.0 108.949 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.731 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 56.0 mt-10 . . . . . 0 N--CA 1.488 1.459 0 O-C-N 120.871 -1.143 . . . . 0.0 108.494 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' ILE . 98.1 m-85 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.413 0.625 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -145.74 133.43 21.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.711 -0.618 . . . . 0.0 109.924 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.609 ' O ' ' CB ' ' A' ' 57' ' ' CYS . 57.3 m -100.0 113.89 26.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.544 -1.347 . . . . 0.0 107.893 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.543 ' OG ' HD11 ' A' ' 25' ' ' LEU . 33.4 t -91.71 140.77 29.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.133 -0.98 . . . . 0.0 109.83 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.521 HG13 ' CB ' ' A' ' 33' ' ' PHE . 1.5 t -130.89 156.31 42.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.46 -0.775 . . . . 0.0 109.888 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 28' ' ' LYS . 89.4 t -101.12 135.94 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.799 HG12 ' H ' ' A' ' 52' ' ' GLY . 2.6 t -122.05 147.78 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.542 -1.349 . . . . 0.0 111.124 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.538 ' OD1' ' CG ' ' A' ' 30' ' ' ASP . 82.0 m-20 -55.06 9.36 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.231 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.799 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -135.97 -39.09 0.16 Allowed Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.619 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.539 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 21.6 tt0 -163.14 164.17 25.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.572 -1.546 . . . . 0.0 110.537 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.539 ' N ' ' CG ' ' A' ' 53' ' ' GLU . 96.1 t -67.42 134.69 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.075 -1.015 . . . . 0.0 108.686 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HE3' HD13 ' A' ' 97' ' ' LEU . 40.2 mmtt -112.04 139.02 47.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.831 -1.168 . . . . 0.0 109.12 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -120.57 87.74 2.81 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.609 ' CB ' ' O ' ' A' ' 46' ' ' CYS . 0.5 OUTLIER -70.79 139.66 51.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.154 -0.966 . . . . 0.0 108.723 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.41 129.57 62.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 111.241 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 44' ' ' TYR . 46.8 mm -108.13 117.05 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 120.943 -1.098 . . . . 0.0 110.312 -178.579 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 121.634 0.73 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 78' ' ' LEU . 93.9 mt -66.09 -40.62 90.94 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.708 -0.62 . . . . 0.0 109.875 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -64.95 -40.17 94.6 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.974 -1.078 . . . . 0.0 108.533 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -67.31 -33.07 74.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.369 -0.832 . . . . 0.0 109.029 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.849 ' C ' HD13 ' A' ' 81' ' ' LEU . 2.5 tm? -60.54 -45.18 94.81 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.213 -0.93 . . . . 0.0 108.613 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.98 -42.92 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.347 -0.846 . . . . 0.0 109.176 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.712 HD23 ' NE2' ' A' ' 86' ' ' GLN . 96.5 mt -60.23 -43.87 95.68 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.435 -0.791 . . . . 0.0 111.177 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -63.44 -40.14 96.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.533 -1.354 . . . . 0.0 110.565 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.413 ' CE1' HD21 ' A' ' 81' ' ' LEU . 5.4 m-85 -64.12 -22.63 67.01 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.901 -1.124 . . . . 0.0 110.698 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.732 HE22 ' CD2' ' A' ' 5' ' ' HIS . 6.7 mt-30 -68.99 -32.62 72.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.456 -1.402 . . . . 0.0 109.024 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -88.14 -19.29 27.18 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.323 -0.861 . . . . 0.0 109.648 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 79.0 m -100.64 127.74 46.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.571 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.556 ' HA ' HG22 ' A' ' 100' ' ' THR . 24.1 p -81.27 139.7 35.29 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.513 -0.742 . . . . 0.0 109.401 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.654 HD23 ' CD2' ' A' ' 93' ' ' HIS . 4.3 mp -75.86 -17.64 59.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.535 -0.728 . . . . 0.0 109.996 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.707 ' N ' ' O ' ' A' ' 97' ' ' LEU . 5.1 p -31.23 -44.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.355 -0.84 . . . . 0.0 110.482 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.562 ' N ' HG13 ' A' ' 91' ' ' VAL . 9.7 pt20 -66.16 -10.91 45.71 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.264 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.654 ' CD2' HD23 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -63.26 -47.0 84.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.582 -1.324 . . . . 0.0 107.893 179.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 93' ' ' HIS . 10.6 m120 -138.43 20.2 2.74 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.627 ' N ' ' O ' ' A' ' 91' ' ' VAL . 94.6 m-20 61.05 17.33 7.89 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.457 ' C ' HD22 ' A' ' 97' ' ' LEU . 67.2 m -146.54 9.56 1.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.707 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.6 mm? -97.25 68.18 2.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -78.36 79.76 4.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 110.358 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.456 HG22 ' N ' ' A' ' 100' ' ' THR . 7.6 p -163.69 156.24 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 121.573 0.701 . . . . 0.0 109.59 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 89' ' ' SER . 32.1 p -130.44 153.94 48.25 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.139 -0.975 . . . . 0.0 108.681 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.525 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 17.7 mt -78.61 67.85 4.46 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.51 -27.65 14.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.126 -0.984 . . . . 0.0 111.897 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.47 130.84 24.38 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 120.77 -1.206 . . . . 0.0 111.43 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.54 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 38.1 Cg_endo -74.51 153.41 44.35 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.734 2.289 . . . . 0.0 110.897 177.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.564 HG13 ' CD2' ' A' ' 106' ' ' TYR . 7.7 p -76.74 -30.9 19.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.187 -0.945 . . . . 0.0 109.791 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.564 ' CD2' HG13 ' A' ' 105' ' ' VAL . 50.0 m-85 -113.61 54.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.148 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.54 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.417 0.627 . . . . 0.0 109.913 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.41 -4.53 8.24 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.403 2.069 . . . . 0.0 112.661 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.51 ' HA ' ' HE1' ' A' ' 11' ' ' TRP . 93.6 m-70 -79.45 -16.32 56.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.156 -0.965 . . . . 0.0 109.712 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -61.3 -48.35 81.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.703 -1.248 . . . . 0.0 109.331 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.5 129.86 45.71 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.589 ' O ' ' N ' ' A' ' 12' ' ' ASN . 7.4 pm0 -73.03 -2.61 21.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.119 -0.988 . . . . 0.0 109.932 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.56 ' CG ' ' N ' ' A' ' 10' ' ' THR . 36.7 pttt -59.82 -35.95 75.79 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 109.392 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.644 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 69.4 p -66.76 -28.83 68.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.654 -0.653 . . . . 0.0 111.398 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.644 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -126.69 -15.23 5.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.418 -1.426 . . . . 0.0 111.679 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 8' ' ' GLU . 46.4 t30 -102.67 118.55 37.09 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.406 -1.434 . . . . 0.0 111.511 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.733 ' CG1' ' HE ' ' A' ' 36' ' ' ARG . 9.9 p -135.89 37.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -31.59 -26.42 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 13' ' ' VAL . 99.0 p -61.61 -4.94 1.57 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.659 -1.495 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.1 m -93.77 162.01 14.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.669 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -113.77 164.83 13.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.771 HH21 ' CD2' ' A' ' 56' ' ' HIS . 5.5 mmm180 -58.36 -42.22 86.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.004 -1.06 . . . . 0.0 109.988 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -61.91 -44.14 97.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.865 -1.147 . . . . 0.0 108.817 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -66.06 -29.67 70.05 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.422 -0.798 . . . . 0.0 109.1 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.543 ' CB ' HH12 ' A' ' 36' ' ' ARG . . . -61.61 -40.52 95.11 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.354 -0.841 . . . . 0.0 109.225 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.33 -43.55 96.31 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -64.4 -43.49 94.26 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.417 HD12 ' NH2' ' A' ' 36' ' ' ARG . 73.2 mt -70.33 -36.41 74.24 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.317 -0.865 . . . . 0.0 108.878 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.534 HD21 ' OG ' ' A' ' 47' ' ' SER . 41.3 mt -75.87 -12.6 60.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.73 126.07 30.48 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.57 9.49 78.58 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' CD ' HG21 ' A' ' 32' ' ' THR . 5.1 mmpp? -99.2 126.67 45.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.149 -1.206 . . . . 0.0 109.476 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -77.97 160.76 27.99 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 67.2 t0 -53.92 140.93 29.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.68 . . . . 0.0 110.617 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 110.09 -28.61 10.2 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 91.4 m -83.73 121.0 26.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.254 -1.144 . . . . 0.0 110.062 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.717 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -133.68 156.35 48.08 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.738 -1.226 . . . . 0.0 111.301 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.716 HD22 ' C ' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -111.37 160.15 17.33 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.697 0.761 . . . . 0.0 111.058 -177.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.75 HG22 ' SG ' ' A' ' 46' ' ' CYS . 37.8 t -132.21 112.69 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.733 ' HE ' ' CG1' ' A' ' 13' ' ' VAL . 69.5 mtt180 -136.92 172.99 12.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.925 -1.109 . . . . 0.0 110.033 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.302 -1.481 0 O-C-N 121.019 -1.051 . . . . 0.0 108.385 179.129 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' A' ' 59' ' ' ILE . 91.5 m-85 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 121.147 0.499 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.2 137.57 24.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 108.589 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.75 ' SG ' HG22 ' A' ' 35' ' ' VAL . 33.3 m -107.26 131.18 54.48 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.892 -1.13 . . . . 0.0 108.872 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.534 ' OG ' HD21 ' A' ' 25' ' ' LEU . 1.3 p -90.4 132.82 35.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.414 -0.804 . . . . 0.0 110.183 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 49' ' ' VAL . 3.7 p -132.83 157.02 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.937 -1.102 . . . . 0.0 110.583 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.679 HG13 HG22 ' A' ' 54' ' ' VAL . 60.4 t -118.14 146.66 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.954 HG23 ' HZ3' ' A' ' 55' ' ' LYS . 13.2 t -120.44 161.31 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 0.0 110.296 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.567 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 43.4 p-10 -58.21 6.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.696 -0.628 . . . . 0.0 110.27 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -149.61 -19.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.364 0 C-N-CA 118.958 -1.591 . . . . 0.0 112.252 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.738 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 68.8 tt0 -156.49 169.01 25.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.193 -1.769 . . . . 0.0 111.224 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.679 HG22 HG13 ' A' ' 49' ' ' VAL . 96.9 t -118.53 128.14 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.381 -0.824 . . . . 0.0 109.207 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.954 ' HZ3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -122.05 179.82 4.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.774 -1.204 . . . . 0.0 110.447 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.771 ' CD2' HH21 ' A' ' 18' ' ' ARG . 23.6 m80 -127.63 82.43 2.09 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.3 m -56.22 135.14 53.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.015 -1.053 . . . . 0.0 108.83 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 58' ' ' VAL . 9.8 p -104.23 133.54 47.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 110.422 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 44' ' ' TYR . 27.1 mm -104.63 123.01 58.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.922 -178.431 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.5 m . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 78' ' ' LEU . 89.1 mt -63.75 -37.71 88.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.097 . . . . 0.0 109.635 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -58.49 -40.09 81.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.967 -1.083 . . . . 0.0 108.568 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.1 -32.83 73.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.453 0.645 . . . . 0.0 109.455 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.419 HD21 ' CD1' ' A' ' 59' ' ' ILE . 14.7 tp -53.96 -48.71 70.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.331 -0.855 . . . . 0.0 109.524 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.5 t -66.22 -43.51 91.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 108.825 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.52 -44.0 83.71 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.497 -0.752 . . . . 0.0 110.115 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -60.44 -44.09 96.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 111.152 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.615 ' CB ' HD12 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -75.78 -21.84 57.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.046 -1.034 . . . . 0.0 110.373 -179.182 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.773 ' OE1' ' HB2' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -67.36 -41.99 84.19 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.004 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -73.97 -39.79 63.46 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.652 -0.655 . . . . 0.0 110.037 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 85' ' ' TYR . 33.1 m -97.7 140.39 32.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.145 -0.972 . . . . 0.0 110.558 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.407 ' OG ' HG12 ' A' ' 91' ' ' VAL . 54.1 p -84.81 143.22 29.23 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.72 -0.612 . . . . 0.0 109.981 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 90' ' ' LEU . 8.3 mp -73.02 -18.24 61.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.325 -0.86 . . . . 0.0 109.497 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.709 ' N ' ' O ' ' A' ' 97' ' ' LEU . 3.9 p -34.0 -44.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.196 -0.94 . . . . 0.0 109.911 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.554 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 10.2 tp-100 -47.8 -45.9 30.04 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.714 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.61 ' C ' ' H ' ' A' ' 95' ' ' ASP . 83.7 t60 -62.32 131.71 50.24 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.579 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.446 ' ND2' ' CD2' ' A' ' 93' ' ' HIS . 88.1 m-20 54.27 -0.65 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.61 ' H ' ' C ' ' A' ' 93' ' ' HIS . 89.8 m-20 56.77 24.44 9.1 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.08 -1.012 . . . . 0.0 110.26 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.6 m -144.27 12.07 1.55 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.778 -1.201 . . . . 0.0 110.593 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.709 ' O ' ' N ' ' A' ' 91' ' ' VAL . 6.8 mp -99.14 73.76 1.93 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -78.2 75.98 4.73 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.432 ' CG1' HG22 ' A' ' 50' ' ' VAL . 2.6 p -152.69 155.18 6.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.552 0.692 . . . . 0.0 109.734 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 102' ' ' ALA . 81.4 p -129.31 135.46 48.78 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.717 HD22 ' CG ' ' A' ' 33' ' ' PHE . 62.1 mt -72.52 70.12 0.89 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.773 ' HB2' ' OE1' ' A' ' 86' ' ' GLN . . . -117.23 -7.54 11.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.848 -0.532 . . . . 0.0 111.935 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 32' ' ' THR . 97.5 m-85 -120.73 100.89 46.23 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.398 -1.439 . . . . 0.0 110.67 -178.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.536 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 37.2 Cg_exo -59.67 145.64 97.58 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.613 1.542 . . . . 0.0 110.309 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.465 HG21 HD11 ' A' ' 34' ' ' LEU . 2.6 p -67.86 -34.11 65.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 120.882 -1.136 . . . . 0.0 108.482 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.459 ' CD2' HG13 ' A' ' 105' ' ' VAL . 57.9 m-85 -106.08 44.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.437 -0.789 . . . . 0.0 110.584 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 0.0 109.418 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.41 -4.53 8.24 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.403 2.069 . . . . 0.0 112.661 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.51 ' HA ' ' HE1' ' A' ' 11' ' ' TRP . 93.6 m-70 -79.45 -16.32 56.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.156 -0.965 . . . . 0.0 109.712 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -61.3 -48.35 81.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.703 -1.248 . . . . 0.0 109.331 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.5 129.86 45.71 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.589 ' O ' ' N ' ' A' ' 12' ' ' ASN . 7.4 pm0 -73.03 -2.61 21.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.119 -0.988 . . . . 0.0 109.932 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.56 ' CG ' ' N ' ' A' ' 10' ' ' THR . 36.7 pttt -59.82 -35.95 75.79 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 109.392 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.644 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 69.4 p -66.76 -28.83 68.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.654 -0.653 . . . . 0.0 111.398 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.644 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -126.69 -15.23 5.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.418 -1.426 . . . . 0.0 111.679 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 8' ' ' GLU . 46.4 t30 -102.67 118.55 37.09 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.406 -1.434 . . . . 0.0 111.511 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.733 ' CG1' ' HE ' ' A' ' 36' ' ' ARG . 9.9 p -135.89 37.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -31.59 -26.42 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 13' ' ' VAL . 99.0 p -61.61 -4.94 1.57 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.659 -1.495 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.1 m -93.77 162.01 14.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.669 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -113.77 164.83 13.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.771 HH21 ' CD2' ' A' ' 56' ' ' HIS . 5.5 mmm180 -58.36 -42.22 86.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.004 -1.06 . . . . 0.0 109.988 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -61.91 -44.14 97.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.865 -1.147 . . . . 0.0 108.817 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -66.06 -29.67 70.05 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.422 -0.798 . . . . 0.0 109.1 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.543 ' CB ' HH12 ' A' ' 36' ' ' ARG . . . -61.61 -40.52 95.11 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.354 -0.841 . . . . 0.0 109.225 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.33 -43.55 96.31 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -64.4 -43.49 94.26 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.417 HD12 ' NH2' ' A' ' 36' ' ' ARG . 73.2 mt -70.33 -36.41 74.24 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.317 -0.865 . . . . 0.0 108.878 178.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.534 HD21 ' OG ' ' A' ' 47' ' ' SER . 41.3 mt -75.87 -12.6 60.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.73 126.07 30.48 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.57 9.49 78.58 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' CD ' HG21 ' A' ' 32' ' ' THR . 5.1 mmpp? -99.2 126.67 45.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.149 -1.206 . . . . 0.0 109.476 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -77.97 160.76 27.99 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 67.2 t0 -53.92 140.93 29.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.68 . . . . 0.0 110.617 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 110.09 -28.61 10.2 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 91.4 m -83.73 121.0 26.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.254 -1.144 . . . . 0.0 110.062 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.717 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -133.68 156.35 48.08 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.738 -1.226 . . . . 0.0 111.301 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.716 HD22 ' C ' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -111.37 160.15 17.33 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.697 0.761 . . . . 0.0 111.058 -177.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.75 HG22 ' SG ' ' A' ' 46' ' ' CYS . 37.8 t -132.21 112.69 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.733 ' HE ' ' CG1' ' A' ' 13' ' ' VAL . 69.5 mtt180 -136.92 172.99 12.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.925 -1.109 . . . . 0.0 110.033 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.302 -1.481 0 O-C-N 121.019 -1.051 . . . . 0.0 108.385 179.129 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' A' ' 59' ' ' ILE . 91.5 m-85 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 121.147 0.499 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.2 137.57 24.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 108.589 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.75 ' SG ' HG22 ' A' ' 35' ' ' VAL . 33.3 m -107.26 131.18 54.48 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.892 -1.13 . . . . 0.0 108.872 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.534 ' OG ' HD21 ' A' ' 25' ' ' LEU . 1.3 p -90.4 132.82 35.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.414 -0.804 . . . . 0.0 110.183 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 49' ' ' VAL . 3.7 p -132.83 157.02 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.937 -1.102 . . . . 0.0 110.583 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.679 HG13 HG22 ' A' ' 54' ' ' VAL . 60.4 t -118.14 146.66 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.954 HG23 ' HZ3' ' A' ' 55' ' ' LYS . 13.2 t -120.44 161.31 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 0.0 110.296 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.567 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 43.4 p-10 -58.21 6.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.696 -0.628 . . . . 0.0 110.27 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -149.61 -19.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.364 0 C-N-CA 118.958 -1.591 . . . . 0.0 112.252 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.738 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 68.8 tt0 -156.49 169.01 25.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.193 -1.769 . . . . 0.0 111.224 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.679 HG22 HG13 ' A' ' 49' ' ' VAL . 96.9 t -118.53 128.14 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.381 -0.824 . . . . 0.0 109.207 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.954 ' HZ3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -122.05 179.82 4.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.774 -1.204 . . . . 0.0 110.447 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.771 ' CD2' HH21 ' A' ' 18' ' ' ARG . 23.6 m80 -127.63 82.43 2.09 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.3 m -56.22 135.14 53.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.015 -1.053 . . . . 0.0 108.83 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 58' ' ' VAL . 9.8 p -104.23 133.54 47.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 110.422 -178.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 44' ' ' TYR . 27.1 mm -104.63 123.01 58.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.922 -178.431 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.5 m . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 78' ' ' LEU . 89.1 mt -63.75 -37.71 88.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.097 . . . . 0.0 109.635 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -58.49 -40.09 81.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.967 -1.083 . . . . 0.0 108.568 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.1 -32.83 73.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.453 0.645 . . . . 0.0 109.455 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.419 HD21 ' CD1' ' A' ' 59' ' ' ILE . 14.7 tp -53.96 -48.71 70.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.331 -0.855 . . . . 0.0 109.524 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.5 t -66.22 -43.51 91.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 108.825 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.52 -44.0 83.71 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.497 -0.752 . . . . 0.0 110.115 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -60.44 -44.09 96.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 111.152 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.615 ' CB ' HD12 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -75.78 -21.84 57.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.046 -1.034 . . . . 0.0 110.373 -179.182 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.773 ' OE1' ' HB2' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -67.36 -41.99 84.19 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.004 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -73.97 -39.79 63.46 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.652 -0.655 . . . . 0.0 110.037 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 85' ' ' TYR . 33.1 m -97.7 140.39 32.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.145 -0.972 . . . . 0.0 110.558 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.407 ' OG ' HG12 ' A' ' 91' ' ' VAL . 54.1 p -84.81 143.22 29.23 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.72 -0.612 . . . . 0.0 109.981 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 90' ' ' LEU . 8.3 mp -73.02 -18.24 61.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.325 -0.86 . . . . 0.0 109.497 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.709 ' N ' ' O ' ' A' ' 97' ' ' LEU . 3.9 p -34.0 -44.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.196 -0.94 . . . . 0.0 109.911 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.554 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 10.2 tp-100 -47.8 -45.9 30.04 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.714 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.61 ' C ' ' H ' ' A' ' 95' ' ' ASP . 83.7 t60 -62.32 131.71 50.24 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.579 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.446 ' ND2' ' CD2' ' A' ' 93' ' ' HIS . 88.1 m-20 54.27 -0.65 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.61 ' H ' ' C ' ' A' ' 93' ' ' HIS . 89.8 m-20 56.77 24.44 9.1 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.08 -1.012 . . . . 0.0 110.26 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.6 m -144.27 12.07 1.55 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.778 -1.201 . . . . 0.0 110.593 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.709 ' O ' ' N ' ' A' ' 91' ' ' VAL . 6.8 mp -99.14 73.76 1.93 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -78.2 75.98 4.73 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.432 ' CG1' HG22 ' A' ' 50' ' ' VAL . 2.6 p -152.69 155.18 6.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.552 0.692 . . . . 0.0 109.734 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 102' ' ' ALA . 81.4 p -129.31 135.46 48.78 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.717 HD22 ' CG ' ' A' ' 33' ' ' PHE . 62.1 mt -72.52 70.12 0.89 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.773 ' HB2' ' OE1' ' A' ' 86' ' ' GLN . . . -117.23 -7.54 11.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.848 -0.532 . . . . 0.0 111.935 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 32' ' ' THR . 97.5 m-85 -120.73 100.89 46.23 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.398 -1.439 . . . . 0.0 110.67 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.536 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 37.2 Cg_exo -59.67 145.64 97.58 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.613 1.542 . . . . 0.0 110.309 178.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.465 HG21 HD11 ' A' ' 34' ' ' LEU . 2.6 p -67.86 -34.11 65.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 120.882 -1.136 . . . . 0.0 108.482 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.459 ' CD2' HG13 ' A' ' 105' ' ' VAL . 57.9 m-85 -106.08 44.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.437 -0.789 . . . . 0.0 110.584 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 0.0 109.418 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.561 ' HB3' ' CD2' ' A' ' 6' ' ' HIS . 25.0 tp . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -56.03 -6.25 1.2 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.04 1.826 . . . . 0.0 111.744 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.535 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 84.0 m-70 -88.67 -12.72 41.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 110.641 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.561 ' CD2' ' HB3' ' A' ' 3' ' ' LEU . 78.7 m-70 -60.94 -40.52 93.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.779 -1.201 . . . . 0.0 108.963 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.424 ' CB ' ' HE2' ' A' ' 9' ' ' LYS . 79.1 m-20 -108.96 130.15 55.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.283 -0.885 . . . . 0.0 109.244 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.684 ' O ' ' N ' ' A' ' 12' ' ' ASN . 3.6 pm0 -73.59 -7.68 52.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.038 -1.039 . . . . 0.0 110.304 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.508 ' CG ' ' N ' ' A' ' 10' ' ' THR . 6.1 pttt -60.54 -36.4 78.35 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.065 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.641 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 38.0 p -61.51 -31.97 71.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.564 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.641 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -121.44 -12.6 8.55 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.916 -1.115 . . . . 0.0 110.457 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 8' ' ' GLU . 57.8 t30 -88.69 116.55 27.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.908 -1.12 . . . . 0.0 111.231 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 15' ' ' SER . 9.9 p -140.08 31.67 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 CA-C-O 122.007 0.908 . . . . 0.0 108.831 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -42.82 -22.43 0.15 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 13' ' ' VAL . 59.5 m -67.99 -36.77 80.56 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.019 -1.283 . . . . 0.0 110.106 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.667 ' C ' ' HE ' ' A' ' 36' ' ' ARG . 47.3 t -65.71 147.66 53.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.302 -0.874 . . . . 0.0 110.133 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.516 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 76.1 m-20 -86.66 163.65 17.26 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 61.5 mtp180 -60.0 -40.65 89.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.093 -1.005 . . . . 0.0 109.767 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -60.06 -42.97 95.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.008 -1.057 . . . . 0.0 109.503 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.5 tttm -64.89 -28.77 69.76 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.144 -0.972 . . . . 0.0 108.455 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.905 ' HB2' HH22 ' A' ' 36' ' ' ARG . . . -58.43 -41.83 85.92 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 98.4 mt-10 -61.13 -44.73 96.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.106 -0.996 . . . . 0.0 108.343 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -60.36 -46.29 90.48 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.474 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 79.7 mt -63.17 -40.17 96.76 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.644 HD23 HG23 ' A' ' 49' ' ' VAL . 4.5 mt -72.19 -31.95 66.36 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.526 ' NH1' ' HG3' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -68.28 132.61 47.42 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.806 -0.559 . . . . 0.0 109.59 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.17 9.76 84.69 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.503 ' HB2' HG21 ' A' ' 49' ' ' VAL . 47.7 mmtt -108.74 133.29 53.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.07 -1.253 . . . . 0.0 109.438 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -75.6 168.87 19.2 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.344 -0.847 . . . . 0.0 109.41 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 59.1 t0 -59.07 140.83 55.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.587 -0.695 . . . . 0.0 110.328 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.457 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 109.01 -26.57 14.99 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 48' ' ' VAL . 84.9 m -63.35 121.47 13.85 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.695 ' CD2' HD22 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -138.41 145.13 40.62 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.96 -1.088 . . . . 0.0 111.406 -178.113 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.495 HD23 ' N ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -142.95 157.9 44.12 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.621 0.724 . . . . 0.0 109.905 178.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.548 HG22 ' SG ' ' A' ' 46' ' ' CYS . 97.7 t -104.05 139.52 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.905 HH22 ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -147.88 164.07 34.84 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.717 -1.239 . . . . 0.0 108.751 -177.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.673 ' OE1' ' CE1' ' A' ' 44' ' ' TYR . 66.6 mm-40 . . . . . 0 C--N 1.305 -1.343 0 O-C-N 120.522 -1.361 . . . . 0.0 108.122 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.673 ' CE1' ' OE1' ' A' ' 37' ' ' GLU . 98.5 m-85 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.868 0.366 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.598 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -163.34 143.49 8.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.008 -1.058 . . . . 0.0 109.905 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.548 ' SG ' HG22 ' A' ' 35' ' ' VAL . 60.6 m -115.13 143.41 45.25 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.581 ' HB2' HD11 ' A' ' 25' ' ' LEU . 97.0 p -113.6 144.69 42.48 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.931 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -152.97 158.56 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 121.675 0.75 . . . . 0.0 110.257 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.644 HG23 HD23 ' A' ' 25' ' ' LEU . 53.3 t -98.78 142.5 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.544 ' CG1' ' CD ' ' A' ' 55' ' ' LYS . 12.8 p -155.59 150.52 10.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 C-N-CA 118.128 -1.429 . . . . 0.0 112.166 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.613 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 65.5 t0 36.13 33.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.813 -0.554 . . . . 0.0 111.954 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 81.36 3.99 90.53 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 118.958 -1.591 . . . . 0.0 111.307 178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -127.24 134.53 50.07 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.845 -1.386 . . . . 0.0 110.077 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.635 ' CG1' HD13 ' A' ' 25' ' ' LEU . 72.3 t -81.41 129.12 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.301 0.572 . . . . 0.0 109.522 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.544 ' CD ' ' CG1' ' A' ' 50' ' ' VAL . 5.7 mptt -130.82 148.15 52.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.359 -0.838 . . . . 0.0 110.292 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -107.3 107.18 17.99 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.65 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.543 ' N ' ' O ' ' A' ' 46' ' ' CYS . 52.6 t -68.96 126.71 30.64 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.9 t -93.3 131.41 40.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.387 -0.821 . . . . 0.0 111.279 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.9 mm -108.65 133.29 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.3 m120 . . . . . 0 N--CA 1.495 1.819 0 O-C-N 120.778 -1.201 . . . . 0.0 110.875 -179.231 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.8 p . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.596 0.712 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.1 mt -60.22 -43.95 95.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.714 . . . . 0.0 109.266 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -61.08 -43.17 99.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.436 -0.79 . . . . 0.0 109.841 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -63.65 -40.1 96.0 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.056 -1.027 . . . . 0.0 109.773 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.725 HD23 ' C ' ' A' ' 81' ' ' LEU . 8.5 tt -61.27 -44.9 96.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.963 . . . . 0.0 109.909 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.547 HG21 ' CZ3' ' A' ' 11' ' ' TRP . 91.8 t -64.01 -38.73 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.066 -1.021 . . . . 0.0 109.175 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 86' ' ' GLN . 62.5 tp -63.93 -46.82 83.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.746 . . . . 0.0 111.227 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -67.91 -40.45 83.43 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.624 -1.297 . . . . 0.0 110.764 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.453 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 5.2 m-85 -61.24 -29.09 69.62 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.396 -0.815 . . . . 0.0 110.247 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -68.01 -13.83 62.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.756 -1.215 . . . . 0.0 109.85 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -103.21 -31.07 10.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.043 -1.036 . . . . 0.0 109.948 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.0 m -87.37 141.28 28.75 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.074 -1.016 . . . . 0.0 110.737 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.0 m -88.79 124.18 33.91 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.764 ' O ' ' N ' ' A' ' 92' ' ' GLN . 21.7 mt -60.76 -40.69 93.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.835 . . . . 0.0 111.18 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.727 HG12 ' N ' ' A' ' 92' ' ' GLN . 4.2 t 31.84 -81.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.595 0 O-C-N 120.959 -1.088 . . . . 0.0 110.001 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.764 ' N ' ' O ' ' A' ' 90' ' ' LEU . 54.9 mt-30 56.22 -159.2 0.22 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.568 -0.708 . . . . 0.0 111.779 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.437 ' H ' ' HB3' ' A' ' 92' ' ' GLN . 79.6 m-70 -55.11 -44.11 74.65 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.321 -0.862 . . . . 0.0 109.286 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.678 ' O ' ' N ' ' A' ' 96' ' ' SER . 30.1 m120 -81.14 91.13 6.09 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 94' ' ' ASN . 50.5 t0 -43.64 -8.95 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.474 -0.766 . . . . 0.0 110.43 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 94' ' ' ASN . 95.0 p -89.77 -0.09 57.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.832 -1.167 . . . . 0.0 112.19 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.721 ' O ' ' N ' ' A' ' 91' ' ' VAL . 68.7 mt -83.81 30.83 0.49 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.646 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 16.6 p30 -76.26 53.9 0.85 Allowed 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.97 0.891 . . . . 0.0 108.973 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.5 150.88 33.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 102' ' ' ALA . 43.7 p -114.28 150.68 34.05 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.695 HD22 ' CD2' ' A' ' 33' ' ' PHE . 30.4 mt -71.7 68.06 0.59 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -100.87 -25.41 14.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 112.228 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -116.05 104.05 52.7 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.376 -1.453 . . . . 0.0 111.181 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 107' ' ' ALA . 31.6 Cg_exo -57.89 159.41 17.91 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.609 2.206 . . . . 0.0 110.433 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.518 HG13 ' CD2' ' A' ' 106' ' ' TYR . 13.2 p -78.59 -28.71 14.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 120.737 -1.227 . . . . 0.0 108.115 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.518 ' CD2' HG13 ' A' ' 105' ' ' VAL . 57.1 m-85 -112.07 29.98 7.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.487 -0.758 . . . . 0.0 109.159 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.51 ' HB2' ' HD2' ' A' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.903 . . . . 0.0 109.082 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.505 ' O ' ' OG1' ' A' ' 10' ' ' THR . 78.5 Cg_exo -48.66 -19.99 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.39 2.06 . . . . 0.0 112.675 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -67.35 -26.08 66.3 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.925 -1.109 . . . . 0.0 109.741 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -63.4 -39.21 93.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.196 -0.94 . . . . 0.0 110.8 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.528 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 69.2 m-20 -93.16 128.7 39.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.991 -1.068 . . . . 0.0 110.421 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.707 ' O ' ' N ' ' A' ' 12' ' ' ASN . 94.0 mt-10 -66.87 -26.55 66.95 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.239 -0.913 . . . . 0.0 110.479 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.501 ' HG2' ' N ' ' A' ' 10' ' ' THR . 1.2 pttp -60.86 -35.92 77.82 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.194 -0.941 . . . . 0.0 111.339 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.535 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 2.7 p -60.23 -33.14 71.85 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 109.895 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.654 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -122.67 -20.84 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 111.098 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.707 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -91.82 119.21 31.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.723 -1.235 . . . . 0.0 110.257 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.98 -4.54 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.301 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.83 -142.21 30.54 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -82.49 121.2 26.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.324 . . . . 0.0 109.115 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.0 t -141.24 148.14 39.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 110.154 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.698 HD22 ' N ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -74.24 134.3 42.68 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.163 -0.961 . . . . 0.0 108.752 178.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.698 ' N ' HD22 ' A' ' 17' ' ' ASN . 23.7 mtp180 -59.36 -33.06 70.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.489 -0.757 . . . . 0.0 109.836 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 13.9 p-10 -59.71 -46.3 89.51 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.857 -1.137 . . . . 0.0 108.41 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 29.5 tttt -64.62 -39.78 94.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 109.034 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.78 78.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.086 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.22 -40.48 77.59 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -60.15 -44.71 94.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 24' ' ' LEU . 91.1 mt -66.16 -31.79 72.84 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.468 -0.77 . . . . 0.0 109.263 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.525 HD23 ' CG2' ' A' ' 49' ' ' VAL . 9.9 mt -91.3 -4.12 56.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.551 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 27' ' ' GLY . 2.9 tpt180 -91.58 125.51 36.34 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.476 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . 70.63 24.99 76.43 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.831 ' HE2' HG21 ' A' ' 32' ' ' THR . 37.9 tptt -106.67 139.97 40.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -1.214 . . . . 0.0 108.676 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -71.43 149.09 46.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.326 -0.859 . . . . 0.0 110.867 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.557 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 64.3 t0 -58.7 144.17 44.37 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.498 0.666 . . . . 0.0 110.072 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 104.66 -24.87 27.38 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.831 HG21 ' HE2' ' A' ' 28' ' ' LYS . 85.4 m -81.58 124.86 29.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.986 -1.302 . . . . 0.0 109.128 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.582 ' CG ' HD22 ' A' ' 101' ' ' LEU . 1.1 p90 -140.03 164.89 28.81 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.16 -1.416 . . . . 0.0 111.601 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 34' ' ' LEU . 1.1 pt? -137.27 156.97 47.64 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.673 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 11' ' ' TRP . 53.1 t -110.43 134.4 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.629 HH12 ' CG ' ' A' ' 18' ' ' ARG . 75.7 mtm180 -130.39 -179.49 5.29 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.426 -0.796 . . . . 0.0 109.235 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 C--N 1.302 -1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 108.999 179.458 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.454 ' O ' ' O ' ' A' ' 59' ' ' ILE . 86.8 m-85 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.251 0.548 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.49 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -147.15 132.87 18.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 109.686 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 27.4 p -102.6 117.69 35.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 108.974 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.5 m -98.77 127.28 44.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 108.868 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.65 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.5 p -127.89 166.39 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 110.536 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.65 ' N ' HG22 ' A' ' 48' ' ' VAL . 15.5 t -108.16 138.18 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.876 HG12 ' H ' ' A' ' 52' ' ' GLY . 54.2 t -114.24 148.32 17.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.421 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 61.4 t0 -50.64 -12.96 0.11 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.119 0.961 . . . . 0.0 108.601 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.876 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -102.95 -51.1 1.03 Allowed Glycine 0 C--N 1.289 -2.05 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.593 ' HB2' ' HZ1' ' A' ' 55' ' ' LYS . 70.6 mm-40 -160.32 -177.44 6.25 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.865 -1.373 . . . . 0.0 110.428 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -94.21 128.27 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.552 -0.718 . . . . 0.0 109.405 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.593 ' HZ1' ' HB2' ' A' ' 53' ' ' GLU . 9.3 mptt -128.89 148.63 50.93 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.262 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -104.55 98.22 8.02 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.2 m -82.61 145.12 29.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.715 -1.241 . . . . 0.0 109.103 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 58' ' ' VAL . 6.9 p -107.11 139.85 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.233 -0.917 . . . . 0.0 112.877 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.49 ' H ' ' HA ' ' A' ' 45' ' ' ALA . 49.9 mm -107.11 126.77 63.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 176.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 m120 . . . . . 0 N--CA 1.495 1.802 0 O-C-N 120.827 -1.171 . . . . 0.0 110.81 -177.936 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.521 0.677 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -36.72 77.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.703 -0.623 . . . . 0.0 109.672 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -60.0 -40.89 90.74 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.011 -1.055 . . . . 0.0 108.63 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.11 -31.1 70.47 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.745 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.3 tm? -59.73 -45.77 91.15 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.432 HG21 ' CZ3' ' A' ' 11' ' ' TRP . 98.0 t -65.01 -45.0 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.03 . . . . 0.0 108.81 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.47 -43.01 77.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 110.057 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.499 ' O ' ' OG1' ' A' ' 88' ' ' THR . 53.6 t-80 -60.72 -42.71 97.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.353 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.504 ' CE2' HD11 ' A' ' 81' ' ' LEU . 4.6 m-30 -68.87 -25.1 64.46 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.083 -1.01 . . . . 0.0 109.387 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.579 ' OE1' ' ND1' ' A' ' 87' ' ' HIS . 1.3 tm0? -61.95 -34.68 76.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.217 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.579 ' ND1' ' OE1' ' A' ' 86' ' ' GLN . 87.9 m-70 -95.08 -18.73 20.74 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.015 -1.053 . . . . 0.0 110.888 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -102.67 133.09 48.27 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.036 -1.04 . . . . 0.0 109.9 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.3 t -74.21 133.51 42.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.417 -0.802 . . . . 0.0 109.48 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 92' ' ' GLN . 8.8 mp -62.51 -29.23 70.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.476 -0.765 . . . . 0.0 110.573 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.936 HG13 ' H ' ' A' ' 92' ' ' GLN . 8.6 p 2.34 -66.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 121.318 0.58 . . . . 0.0 111.492 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.936 ' H ' HG13 ' A' ' 91' ' ' VAL . 19.6 pt20 35.28 -149.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.826 0.822 . . . . 0.0 111.503 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.734 ' C ' ' H ' ' A' ' 95' ' ' ASP . 63.8 m80 -50.55 171.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.37 -0.831 . . . . 0.0 109.951 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 13.4 m120 63.02 -22.19 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.734 ' H ' ' C ' ' A' ' 93' ' ' HIS . 86.0 m-20 53.95 31.37 13.31 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.739 -0.601 . . . . 0.0 109.676 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.7 m -134.33 -0.5 2.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.807 -1.183 . . . . 0.0 111.24 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 96.0 mt -82.09 57.55 3.59 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -79.7 84.77 5.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.647 0.737 . . . . 0.0 109.33 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.554 ' O ' HD13 ' A' ' 90' ' ' LEU . 3.0 p -159.94 155.98 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.428 ' N ' HG22 ' A' ' 99' ' ' VAL . 32.5 p -122.42 146.06 47.7 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.082 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.582 HD22 ' CG ' ' A' ' 33' ' ' PHE . 34.8 mt -80.19 65.86 5.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 108.698 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . . . -99.68 -22.86 15.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.855 . . . . 0.0 112.296 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.2 m-85 -115.18 114.05 43.46 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.46 -1.4 . . . . 0.0 110.897 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.408 ' CB ' ' O ' ' A' ' 10' ' ' THR . 10.5 Cg_exo -63.06 156.27 55.9 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.982 1.788 . . . . 0.0 111.227 178.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.73 -30.33 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.942 -1.099 . . . . 0.0 109.455 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -99.88 30.98 3.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.082 -1.011 . . . . 0.0 110.208 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 109.143 179.647 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.505 ' O ' ' OG1' ' A' ' 10' ' ' THR . 78.5 Cg_exo -48.66 -19.99 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.39 2.06 . . . . 0.0 112.675 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -67.35 -26.08 66.3 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.925 -1.109 . . . . 0.0 109.741 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -63.4 -39.21 93.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.196 -0.94 . . . . 0.0 110.8 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.528 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 69.2 m-20 -93.16 128.7 39.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.991 -1.068 . . . . 0.0 110.421 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.707 ' O ' ' N ' ' A' ' 12' ' ' ASN . 94.0 mt-10 -66.87 -26.55 66.95 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.239 -0.913 . . . . 0.0 110.479 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.501 ' HG2' ' N ' ' A' ' 10' ' ' THR . 1.2 pttp -60.86 -35.92 77.82 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.194 -0.941 . . . . 0.0 111.339 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.535 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 2.7 p -60.23 -33.14 71.85 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 109.895 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.654 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -122.67 -20.84 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 111.098 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.707 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -91.82 119.21 31.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.723 -1.235 . . . . 0.0 110.257 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.98 -4.54 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.301 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.83 -142.21 30.54 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -82.49 121.2 26.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.324 . . . . 0.0 109.115 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.0 t -141.24 148.14 39.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 110.154 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.698 HD22 ' N ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -74.24 134.3 42.68 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.163 -0.961 . . . . 0.0 108.752 178.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.698 ' N ' HD22 ' A' ' 17' ' ' ASN . 23.7 mtp180 -59.36 -33.06 70.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.489 -0.757 . . . . 0.0 109.836 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 13.9 p-10 -59.71 -46.3 89.51 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.857 -1.137 . . . . 0.0 108.41 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 29.5 tttt -64.62 -39.78 94.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 109.034 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.78 78.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.086 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.22 -40.48 77.59 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -60.15 -44.71 94.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 24' ' ' LEU . 91.1 mt -66.16 -31.79 72.84 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.468 -0.77 . . . . 0.0 109.263 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.525 HD23 ' CG2' ' A' ' 49' ' ' VAL . 9.9 mt -91.3 -4.12 56.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.551 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 27' ' ' GLY . 2.9 tpt180 -91.58 125.51 36.34 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.476 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . 70.63 24.99 76.43 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.831 ' HE2' HG21 ' A' ' 32' ' ' THR . 37.9 tptt -106.67 139.97 40.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -1.214 . . . . 0.0 108.676 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -71.43 149.09 46.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.326 -0.859 . . . . 0.0 110.867 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.557 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 64.3 t0 -58.7 144.17 44.37 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.498 0.666 . . . . 0.0 110.072 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 104.66 -24.87 27.38 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.831 HG21 ' HE2' ' A' ' 28' ' ' LYS . 85.4 m -81.58 124.86 29.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.986 -1.302 . . . . 0.0 109.128 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.582 ' CG ' HD22 ' A' ' 101' ' ' LEU . 1.1 p90 -140.03 164.89 28.81 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.16 -1.416 . . . . 0.0 111.601 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 34' ' ' LEU . 1.1 pt? -137.27 156.97 47.64 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.673 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 11' ' ' TRP . 53.1 t -110.43 134.4 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.629 HH12 ' CG ' ' A' ' 18' ' ' ARG . 75.7 mtm180 -130.39 -179.49 5.29 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.426 -0.796 . . . . 0.0 109.235 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 C--N 1.302 -1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 108.999 179.458 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.454 ' O ' ' O ' ' A' ' 59' ' ' ILE . 86.8 m-85 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.251 0.548 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.49 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -147.15 132.87 18.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 109.686 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 27.4 p -102.6 117.69 35.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 108.974 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.5 m -98.77 127.28 44.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 108.868 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.65 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.5 p -127.89 166.39 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 110.536 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.65 ' N ' HG22 ' A' ' 48' ' ' VAL . 15.5 t -108.16 138.18 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.876 HG12 ' H ' ' A' ' 52' ' ' GLY . 54.2 t -114.24 148.32 17.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.421 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 61.4 t0 -50.64 -12.96 0.11 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.119 0.961 . . . . 0.0 108.601 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.876 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -102.95 -51.1 1.03 Allowed Glycine 0 C--N 1.289 -2.05 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.593 ' HB2' ' HZ1' ' A' ' 55' ' ' LYS . 70.6 mm-40 -160.32 -177.44 6.25 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.865 -1.373 . . . . 0.0 110.428 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -94.21 128.27 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.552 -0.718 . . . . 0.0 109.405 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.593 ' HZ1' ' HB2' ' A' ' 53' ' ' GLU . 9.3 mptt -128.89 148.63 50.93 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.262 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -104.55 98.22 8.02 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.2 m -82.61 145.12 29.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.715 -1.241 . . . . 0.0 109.103 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 58' ' ' VAL . 6.9 p -107.11 139.85 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.233 -0.917 . . . . 0.0 112.877 -176.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.49 ' H ' ' HA ' ' A' ' 45' ' ' ALA . 49.9 mm -107.11 126.77 63.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 176.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 m120 . . . . . 0 N--CA 1.495 1.802 0 O-C-N 120.827 -1.171 . . . . 0.0 110.81 -177.936 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.521 0.677 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -36.72 77.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.703 -0.623 . . . . 0.0 109.672 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -60.0 -40.89 90.74 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.011 -1.055 . . . . 0.0 108.63 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.11 -31.1 70.47 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.745 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.3 tm? -59.73 -45.77 91.15 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.432 HG21 ' CZ3' ' A' ' 11' ' ' TRP . 98.0 t -65.01 -45.0 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.03 . . . . 0.0 108.81 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.47 -43.01 77.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 110.057 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.499 ' O ' ' OG1' ' A' ' 88' ' ' THR . 53.6 t-80 -60.72 -42.71 97.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.353 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.504 ' CE2' HD11 ' A' ' 81' ' ' LEU . 4.6 m-30 -68.87 -25.1 64.46 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.083 -1.01 . . . . 0.0 109.387 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.579 ' OE1' ' ND1' ' A' ' 87' ' ' HIS . 1.3 tm0? -61.95 -34.68 76.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.217 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.579 ' ND1' ' OE1' ' A' ' 86' ' ' GLN . 87.9 m-70 -95.08 -18.73 20.74 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.015 -1.053 . . . . 0.0 110.888 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -102.67 133.09 48.27 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.036 -1.04 . . . . 0.0 109.9 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.3 t -74.21 133.51 42.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.417 -0.802 . . . . 0.0 109.48 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 92' ' ' GLN . 8.8 mp -62.51 -29.23 70.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.476 -0.765 . . . . 0.0 110.573 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.936 HG13 ' H ' ' A' ' 92' ' ' GLN . 8.6 p 2.34 -66.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 121.318 0.58 . . . . 0.0 111.492 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.936 ' H ' HG13 ' A' ' 91' ' ' VAL . 19.6 pt20 35.28 -149.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.826 0.822 . . . . 0.0 111.503 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.734 ' C ' ' H ' ' A' ' 95' ' ' ASP . 63.8 m80 -50.55 171.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.37 -0.831 . . . . 0.0 109.951 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 13.4 m120 63.02 -22.19 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.734 ' H ' ' C ' ' A' ' 93' ' ' HIS . 86.0 m-20 53.95 31.37 13.31 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.739 -0.601 . . . . 0.0 109.676 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.7 m -134.33 -0.5 2.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.807 -1.183 . . . . 0.0 111.24 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 96.0 mt -82.09 57.55 3.59 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -79.7 84.77 5.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.647 0.737 . . . . 0.0 109.33 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.554 ' O ' HD13 ' A' ' 90' ' ' LEU . 3.0 p -159.94 155.98 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.428 ' N ' HG22 ' A' ' 99' ' ' VAL . 32.5 p -122.42 146.06 47.7 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.082 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.582 HD22 ' CG ' ' A' ' 33' ' ' PHE . 34.8 mt -80.19 65.86 5.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 108.698 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . . . -99.68 -22.86 15.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.855 . . . . 0.0 112.296 -178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.2 m-85 -115.18 114.05 43.46 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.46 -1.4 . . . . 0.0 110.897 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.408 ' CB ' ' O ' ' A' ' 10' ' ' THR . 10.5 Cg_exo -63.06 156.27 55.9 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.982 1.788 . . . . 0.0 111.227 178.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.73 -30.33 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.942 -1.099 . . . . 0.0 109.455 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -99.88 30.98 3.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.082 -1.011 . . . . 0.0 110.208 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 109.143 179.647 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -54.88 -12.06 4.32 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.145 1.897 . . . . 0.0 111.612 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.816 ' NE2' ' NE2' ' A' ' 86' ' ' GLN . 83.8 m-70 -65.22 -31.8 73.15 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.354 -0.841 . . . . 0.0 109.349 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -61.85 -22.02 65.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.387 -0.82 . . . . 0.0 109.234 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.715 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 71.6 m-20 -90.93 114.47 26.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.31 -0.869 . . . . 0.0 109.443 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.552 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 39.7 tt0 -67.22 -37.86 84.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.015 -1.053 . . . . 0.0 109.898 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HG2' ' N ' ' A' ' 10' ' ' THR . 0.4 OUTLIER -62.89 -29.06 70.47 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.487 -0.758 . . . . 0.0 110.642 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.627 ' OG1' ' O ' ' A' ' 7' ' ' ASP . 9.6 p -59.65 -35.12 73.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.132 -0.98 . . . . 0.0 110.381 -178.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.715 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -124.77 -5.69 7.49 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.738 -1.226 . . . . 0.0 110.125 179.568 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 8' ' ' GLU . 51.3 t-20 -96.76 129.2 44.22 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.989 -1.069 . . . . 0.0 110.441 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 13' ' ' VAL . 97.9 t -107.13 -12.04 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.84 . . . . 0.0 109.524 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.42 -154.16 50.09 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 88.7 p -68.57 143.13 54.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.05 -1.264 . . . . 0.0 109.622 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.7 p -157.98 154.94 28.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 109.81 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.645 ' C ' ' H ' ' A' ' 19' ' ' ASN . 58.9 t30 -89.02 19.81 3.97 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.537 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.0 OUTLIER 58.8 -12.89 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.389 -0.819 . . . . 0.0 109.787 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.645 ' H ' ' C ' ' A' ' 17' ' ' ASN . 57.8 t-20 -67.53 -46.7 72.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.615 -1.303 . . . . 0.0 108.425 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.37 -27.34 68.5 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -57.28 -43.94 83.56 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.573 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 68.4 mm-40 -61.14 -44.91 96.6 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -63.53 -45.63 89.72 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.445 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 83.0 mt -67.19 -36.83 82.57 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.541 HD13 ' CG1' ' A' ' 54' ' ' VAL . 55.4 mt -82.05 -9.01 59.69 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.573 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 14.2 mmm180 -102.69 123.4 46.32 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.9 -4.49 63.18 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 34.4 mmtt -98.64 138.99 35.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.079 -1.248 . . . . 0.0 109.504 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -73.24 161.21 30.81 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.698 -0.626 . . . . 0.0 109.76 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 57.4 p-10 -58.66 149.47 25.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.23 -0.919 . . . . 0.0 109.9 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.27 -25.53 27.88 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 27.7 m -80.51 120.37 24.4 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.424 -1.045 . . . . 0.0 108.696 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.782 ' HB2' HG22 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -130.67 161.69 31.08 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.389 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.451 HD21 HD21 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -132.55 167.79 19.38 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.699 -178.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 46' ' ' CYS . 82.7 t -130.81 129.27 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.908 -1.12 . . . . 0.0 110.654 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.668 ' NH2' ' OG ' ' A' ' 47' ' ' SER . 67.8 mtm180 -129.45 -149.77 0.41 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.403 ' H ' ' HB3' ' A' ' 36' ' ' ARG . 71.7 mm-40 . . . . . 0 C--N 1.306 -1.288 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.495 ' O ' ' O ' ' A' ' 59' ' ' ILE . 98.1 m-85 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.412 0.625 . . . . 0.0 109.959 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.91 133.09 23.02 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.457 -0.777 . . . . 0.0 109.123 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.44 ' HB3' HG22 ' A' ' 35' ' ' VAL . 17.1 p -115.87 134.61 54.82 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.206 -0.933 . . . . 0.0 109.502 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.668 ' OG ' ' NH2' ' A' ' 36' ' ' ARG . 70.7 m -98.65 146.15 26.15 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.597 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' ' 33' ' ' PHE . 67.6 t -129.37 160.8 39.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.435 -0.79 . . . . 0.0 108.871 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.551 ' N ' HG12 ' A' ' 48' ' ' VAL . 63.2 t -118.5 128.33 75.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.702 HG23 ' CG2' ' A' ' 99' ' ' VAL . 9.3 p -126.03 156.37 36.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.859 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.442 ' N ' HG22 ' A' ' 50' ' ' VAL . 97.9 m-20 -48.84 -18.39 0.27 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.639 0.733 . . . . 0.0 109.911 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.587 ' H ' HG13 ' A' ' 50' ' ' VAL . . . -85.22 -59.57 1.93 Allowed Glycine 0 C--N 1.284 -2.348 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.425 ' H ' HG13 ' A' ' 50' ' ' VAL . 21.9 pt-20 -164.85 -165.93 0.98 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.169 -1.195 . . . . 0.0 110.629 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.541 ' CG1' HD13 ' A' ' 25' ' ' LEU . 79.5 t -95.05 130.62 43.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.643 ' HZ2' HG11 ' A' ' 50' ' ' VAL . 0.7 OUTLIER -117.75 156.81 27.63 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.71 -1.244 . . . . 0.0 110.823 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.513 ' ND1' ' OG ' ' A' ' 47' ' ' SER . 25.5 m-70 -120.83 71.32 0.93 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.8 m -60.17 143.84 51.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 109.804 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.13 143.08 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.672 -0.643 . . . . 0.0 110.58 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.495 ' O ' ' O ' ' A' ' 44' ' ' TYR . 44.8 mm -115.49 140.44 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.2 m120 . . . . . 0 N--CA 1.497 1.888 0 O-C-N 120.553 -1.342 . . . . 0.0 110.549 -179.111 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.36 0.6 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.2 mt -57.28 -34.67 68.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.363 -0.835 . . . . 0.0 109.301 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -58.65 -40.14 82.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 0.0 108.612 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.24 -40.12 89.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.339 -0.851 . . . . 0.0 109.287 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.43 -46.49 89.89 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.208 -0.932 . . . . 0.0 109.132 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.51 -43.7 83.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.464 -0.772 . . . . 0.0 108.987 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 tp -65.86 -45.16 83.17 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.243 -0.911 . . . . 0.0 110.214 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -64.44 -40.28 95.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.978 -1.076 . . . . 0.0 111.182 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -75.51 -14.85 60.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.928 -1.108 . . . . 0.0 111.738 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.816 ' NE2' ' NE2' ' A' ' 5' ' ' HIS . 1.6 pt20 -66.86 -25.59 66.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.507 -1.37 . . . . 0.0 108.853 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -88.17 -36.41 16.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 109.896 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.487 ' O ' HG22 ' A' ' 100' ' ' THR . 91.2 m -83.26 149.42 26.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 0.0 110.513 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.0 m -99.05 130.21 45.37 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.573 0.702 . . . . 0.0 110.549 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.707 ' O ' ' N ' ' A' ' 92' ' ' GLN . 1.8 mt -62.06 -15.73 46.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.49 -0.756 . . . . 0.0 110.034 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.755 ' N ' ' O ' ' A' ' 97' ' ' LEU . 9.1 p -21.63 -38.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.87 -0.519 . . . . 0.0 111.297 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.707 ' N ' ' O ' ' A' ' 90' ' ' LEU . 5.3 pt20 -60.67 -42.83 97.85 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.509 ' N ' ' HG3' ' A' ' 92' ' ' GLN . 43.2 m-70 -59.73 -44.3 93.83 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.739 ' O ' ' N ' ' A' ' 96' ' ' SER . 98.1 m-20 -131.68 116.31 17.17 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 94' ' ' ASN . 80.7 m-20 -40.87 -12.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.288 -0.882 . . . . 0.0 109.892 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.739 ' N ' ' O ' ' A' ' 94' ' ' ASN . 46.1 t -112.75 22.07 14.89 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.74 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.755 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.9 mt -95.67 56.62 1.79 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.783 -1.198 . . . . 0.0 108.896 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 98' ' ' ASN . 3.3 t-20 -77.85 69.72 4.12 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.124 -0.985 . . . . 0.0 108.87 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.702 ' CG2' HG23 ' A' ' 50' ' ' VAL . 86.2 t -149.55 154.33 9.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 86' ' ' GLN . 9.8 p -129.46 164.16 24.3 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.674 HD22 ' CG ' ' A' ' 33' ' ' PHE . 28.5 mt -78.78 70.63 5.15 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.894 -1.129 . . . . 0.0 108.169 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.91 -31.33 13.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.804 . . . . 0.0 112.356 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 32' ' ' THR . 59.7 m-85 -113.45 113.57 48.22 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 120.23 -1.544 . . . . 0.0 111.763 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.5 146.83 96.16 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.726 1.617 . . . . 0.0 110.615 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 106' ' ' TYR . 9.0 p -67.95 -38.1 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.013 -1.054 . . . . 0.0 110.442 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.462 ' HE2' HG22 ' A' ' 13' ' ' VAL . 53.7 m-85 -101.24 27.62 6.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.064 -1.023 . . . . 0.0 109.974 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.12 -0.988 . . . . 0.0 110.156 -179.832 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.526 ' N ' HD22 ' A' ' 3' ' ' LEU . 4.1 mm? . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.44 ' HB3' HG21 ' A' ' 10' ' ' THR . 15.2 Cg_exo -57.2 -12.43 10.1 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.721 1.614 . . . . 0.0 111.445 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -54.9 -25.99 32.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.627 -0.671 . . . . 0.0 110.424 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -61.39 -28.93 69.6 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.957 -1.089 . . . . 0.0 110.293 -179.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.655 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 88.9 m-20 -98.14 131.82 44.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.724 -1.235 . . . . 0.0 110.743 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.685 ' O ' ' N ' ' A' ' 12' ' ' ASN . 79.5 mt-10 -67.34 -27.13 66.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.467 -0.771 . . . . 0.0 109.139 179.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.47 ' CG ' ' N ' ' A' ' 10' ' ' THR . 37.6 pttt -59.64 -34.54 72.94 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.424 -0.797 . . . . 0.0 110.825 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.69 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 49.0 p -67.91 -26.34 65.93 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.392 -0.817 . . . . 0.0 111.013 -178.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.69 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -125.79 -25.15 3.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.617 -1.302 . . . . 0.0 110.543 179.636 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.685 ' N ' ' O ' ' A' ' 8' ' ' GLU . 8.8 p-10 -91.03 138.13 31.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.784 -1.197 . . . . 0.0 110.191 -178.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.0 p -111.52 -9.78 11.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.325 -0.859 . . . . 0.0 109.738 -179.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.82 50.39 3.53 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.797 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.52 ' HA ' ' H ' ' A' ' 37' ' ' GLU . 17.3 t 59.07 65.81 1.15 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.889 -1.36 . . . . 0.0 110.766 178.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.628 ' O ' ' CZ ' ' A' ' 36' ' ' ARG . 95.5 p -77.78 166.67 22.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.169 -0.957 . . . . 0.0 109.659 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.651 ' C ' HH12 ' A' ' 36' ' ' ARG . 86.1 m-20 -73.34 142.95 47.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.977 -1.077 . . . . 0.0 109.238 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.629 ' N ' HH12 ' A' ' 36' ' ' ARG . 35.0 mtm180 -60.22 -35.66 75.93 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.402 -0.811 . . . . 0.0 109.639 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -64.07 -43.71 94.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.939 -1.1 . . . . 0.0 109.08 179.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -68.46 -37.82 80.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.902 -1.124 . . . . 0.0 108.74 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.6 72.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.175 -0.953 . . . . 0.0 109.012 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 26' ' ' ARG . 67.3 tt0 -59.67 -48.85 80.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.241 -0.912 . . . . 0.0 108.827 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -60.25 -41.09 92.46 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.0 mt -66.76 -36.51 82.6 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.3 mt -86.93 -10.07 54.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.086 -1.009 . . . . 0.0 108.606 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.55 HH11 ' HG3' ' A' ' 26' ' ' ARG . 11.9 mmm-85 -100.45 135.36 42.01 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.418 0.628 . . . . 0.0 110.241 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.28 2.91 90.69 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -105.06 141.85 35.89 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.146 -1.208 . . . . 0.0 109.482 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -66.21 153.56 42.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.572 -0.705 . . . . 0.0 110.025 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.578 ' OD2' ' CA ' ' A' ' 51' ' ' ASP . 84.5 m-20 -58.74 144.67 42.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 0.0 109.486 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.41 -20.88 34.07 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.499 HG23 ' HD2' ' A' ' 103' ' ' TYR . 62.5 m -86.45 119.95 27.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.244 -1.151 . . . . 0.0 108.972 179.234 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.709 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -136.73 167.92 20.51 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.107 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.654 ' CD1' ' OG ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -140.29 157.11 46.08 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.002 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.443 HG22 ' SG ' ' A' ' 46' ' ' CYS . 47.4 t -106.97 133.47 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.991 -1.068 . . . . 0.0 108.604 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.651 HH12 ' C ' ' A' ' 17' ' ' ASN . 14.2 ptm180 -152.37 -177.52 6.25 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.112 -0.992 . . . . 0.0 109.35 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.52 ' H ' ' HA ' ' A' ' 15' ' ' SER . 32.9 tt0 . . . . . 0 C--N 1.3 -1.571 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -168.39 139.3 2.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.988 -1.07 . . . . 0.0 110.324 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.443 ' SG ' HG22 ' A' ' 35' ' ' VAL . 63.1 m -108.64 126.47 53.01 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.654 ' OG ' ' CD1' ' A' ' 34' ' ' LEU . 3.0 p -110.62 129.87 55.71 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.874 -1.141 . . . . 0.0 110.15 -179.01 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.587 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.2 p -127.53 161.47 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.039 -1.038 . . . . 0.0 109.812 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.587 ' N ' HG22 ' A' ' 48' ' ' VAL . 45.1 t -101.74 129.13 53.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.773 HG11 ' HZ1' ' A' ' 55' ' ' LYS . 48.0 t -122.71 154.57 27.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 120.87 -1.144 . . . . 0.0 110.367 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.578 ' CA ' ' OD2' ' A' ' 30' ' ' ASP . 59.0 t0 -49.01 -17.68 0.22 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.546 0.688 . . . . 0.0 110.026 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.76 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -94.52 -56.96 1.3 Allowed Glycine 0 C--N 1.283 -2.409 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -165.34 170.25 14.85 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.028 -1.277 . . . . 0.0 110.65 -179.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.2 m -73.19 137.24 23.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.773 ' HZ1' HG11 ' A' ' 50' ' ' VAL . 8.4 mttt -125.27 156.13 39.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.753 -1.217 . . . . 0.0 111.366 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -121.96 78.07 1.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 46' ' ' CYS . 74.5 m -58.95 131.57 51.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.444 -1.41 . . . . 0.0 108.138 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.95 125.8 62.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.411 -0.805 . . . . 0.0 110.993 -178.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.87 134.56 61.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 23.4 p30 . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.013 -1.055 . . . . 0.0 110.004 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.0 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.841 0.829 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mt -60.25 -35.77 76.26 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.202 0.525 . . . . 0.0 109.928 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.523 ' O ' HG12 ' A' ' 82' ' ' VAL . 71.1 tttt -52.44 -49.07 65.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.019 -1.051 . . . . 0.0 109.923 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -74.33 -20.24 60.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.942 -1.099 . . . . 0.0 108.71 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.984 HD21 ' CE2' ' A' ' 85' ' ' TYR . 7.4 tt -67.17 -43.88 81.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.554 -0.716 . . . . 0.0 109.606 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 83' ' ' LEU . 3.0 p -65.17 -43.93 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.077 -1.015 . . . . 0.0 109.027 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.533 ' N ' ' CG1' ' A' ' 82' ' ' VAL . 66.1 tp -67.68 -43.87 79.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.425 -0.797 . . . . 0.0 109.567 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -61.79 -39.97 93.55 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.495 -0.753 . . . . 0.0 110.167 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.984 ' CE2' HD21 ' A' ' 81' ' ' LEU . 5.8 m-30 -63.53 -27.36 69.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.92 -1.112 . . . . 0.0 109.187 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.535 ' HG3' ' HB2' ' A' ' 102' ' ' ALA . 17.6 tt0 -64.69 -35.23 80.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 110.071 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -91.06 -18.32 24.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.105 -0.997 . . . . 0.0 109.726 -179.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.7 m -101.76 122.96 44.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.897 . . . . 0.0 109.33 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.617 ' HA ' HG22 ' A' ' 100' ' ' THR . 20.3 t -72.22 133.95 45.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.326 -0.859 . . . . 0.0 109.026 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.761 ' O ' ' N ' ' A' ' 92' ' ' GLN . 66.2 mt -60.84 -43.85 97.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 111.066 -179.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.698 ' N ' ' O ' ' A' ' 97' ' ' LEU . 74.6 t 18.71 -79.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 CA-C-N 118.436 0.562 . . . . 0.0 109.649 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.761 ' N ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER 73.05 -176.23 0.17 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.378 -0.826 . . . . 0.0 110.854 178.247 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.413 ' H ' ' HG2' ' A' ' 92' ' ' GLN . 82.7 t60 -59.72 -38.88 82.88 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.383 -0.823 . . . . 0.0 109.114 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -55.05 -28.73 54.47 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.442 ' HA ' HG13 ' A' ' 91' ' ' VAL . 97.1 m-20 61.21 36.73 17.83 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.81 -0.556 . . . . 0.0 109.797 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.5 p -138.67 0.49 2.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.865 -1.147 . . . . 0.0 111.153 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.698 ' O ' ' N ' ' A' ' 91' ' ' VAL . 63.4 mt -100.21 61.69 1.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.755 -1.216 . . . . 0.0 107.976 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -80.68 69.3 7.18 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.971 -1.081 . . . . 0.0 109.92 -178.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.764 HG21 HG22 ' A' ' 50' ' ' VAL . 87.2 t -152.99 149.63 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.617 HG22 ' HA ' ' A' ' 89' ' ' SER . 26.1 p -119.81 152.06 37.85 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.288 -0.883 . . . . 0.0 108.863 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.709 HD22 ' CG ' ' A' ' 33' ' ' PHE . 31.9 mt -76.22 69.09 2.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.535 ' HB2' ' HG3' ' A' ' 86' ' ' GLN . . . -100.25 -23.99 14.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.461 -0.774 . . . . 0.0 113.031 -177.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.499 ' HD2' HG23 ' A' ' 32' ' ' THR . 78.2 t80 -114.52 105.66 53.37 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.15 -1.594 . . . . 0.0 110.795 -178.42 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.438 ' CB ' ' O ' ' A' ' 10' ' ' THR . 19.3 Cg_exo -59.75 144.98 99.34 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.976 1.784 . . . . 0.0 111.024 178.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.728 HG13 ' CD2' ' A' ' 106' ' ' TYR . 8.2 p -67.24 -22.6 29.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.024 -1.047 . . . . 0.0 109.279 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.728 ' CD2' HG13 ' A' ' 105' ' ' VAL . 67.5 m-85 -123.79 63.28 1.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.545 0.688 . . . . 0.0 110.738 -179.273 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 24.7 mt . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.479 ' O ' ' OG1' ' A' ' 10' ' ' THR . 37.1 Cg_endo -69.2 -3.84 12.45 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.288 1.992 . . . . 0.0 111.812 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.411 ' HA ' ' HE1' ' A' ' 11' ' ' TRP . 96.8 m-70 -83.97 -16.26 44.77 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.46 -0.775 . . . . 0.0 109.68 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.43 ' O ' ' NZ ' ' A' ' 79' ' ' LYS . 90.2 m-70 -61.75 -36.49 81.17 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.585 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 54.2 p-10 -106.2 130.11 54.13 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.595 0.712 . . . . 0.0 109.497 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.575 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.7 OUTLIER -70.24 -9.43 55.86 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 109.725 -179.687 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HA ' ' OD1' ' A' ' 12' ' ' ASN . 2.2 ttpt -61.5 -36.93 81.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.603 -0.685 . . . . 0.0 110.864 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.516 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 54.3 p -66.47 -20.07 65.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 112.416 -177.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.561 ' CZ3' ' HG2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -134.43 -12.7 2.38 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 119.965 -1.709 . . . . 0.0 111.168 179.168 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.659 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 19.3 p-10 -95.66 127.06 41.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.588 -1.32 . . . . 0.0 111.571 -178.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.2 m -146.01 34.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.9 -34.43 7.27 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.2 p -66.69 -12.17 57.27 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.143 -1.21 . . . . 0.0 109.508 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.613 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 57.8 m -79.78 142.71 35.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.237 -0.914 . . . . 0.0 110.753 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.696 ' C ' HH12 ' A' ' 36' ' ' ARG . 8.4 p30 -80.13 156.47 26.99 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.416 -0.802 . . . . 0.0 109.609 179.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.833 ' N ' HH22 ' A' ' 36' ' ' ARG . 45.8 mtm180 -63.63 -37.31 86.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.122 -0.986 . . . . 0.0 110.713 -178.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.675 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 46.3 p-10 -57.92 -43.96 86.57 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.431 -1.418 . . . . 0.0 108.689 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.675 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 42.7 tttt -66.24 -31.06 71.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.928 -1.108 . . . . 0.0 108.301 178.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.56 ' HB2' ' NH1' ' A' ' 36' ' ' ARG . . . -60.31 -38.6 84.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.893 . . . . 0.0 108.831 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 26' ' ' ARG . 98.1 mt-10 -59.02 -47.59 84.65 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -60.19 -43.45 95.9 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.487 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 99.1 mt -66.18 -36.66 83.68 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.614 HD23 HG23 ' A' ' 49' ' ' VAL . 10.3 mt -89.2 -7.52 55.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.843 . . . . 0.0 109.513 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 22' ' ' GLU . 14.6 mmm180 -96.37 -25.94 15.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.99 -1.069 . . . . 0.0 109.691 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.09 10.31 56.83 Favored Glycine 0 C--N 1.288 -2.12 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 178.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.816 ' CD ' HG21 ' A' ' 32' ' ' THR . 7.7 mmpt? -114.53 141.33 47.87 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.428 -1.042 . . . . 0.0 110.568 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.93 168.42 15.03 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.491 0.663 . . . . 0.0 110.042 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.539 ' OD1' ' CG2' ' A' ' 99' ' ' VAL . 67.6 t0 -56.28 141.95 39.5 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.39 -0.819 . . . . 0.0 109.709 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.495 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 107.64 -31.85 7.66 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.816 HG21 ' CD ' ' A' ' 28' ' ' LYS . 97.4 m -86.37 127.41 34.81 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.166 -1.196 . . . . 0.0 109.539 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.751 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -139.46 172.45 12.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.63 -1.294 . . . . 0.0 109.806 178.896 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.655 ' HB3' HG11 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -139.51 169.24 18.11 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.66 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.561 HG22 ' SG ' ' A' ' 46' ' ' CYS . 71.5 t -120.17 132.94 68.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 -179.587 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.833 HH22 ' N ' ' A' ' 18' ' ' ARG . 40.7 mtp180 -144.01 -156.8 0.72 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.367 -0.833 . . . . 0.0 108.976 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 . . . . . 0 C--N 1.304 -1.385 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.51 -179.922 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 59' ' ' ILE . 58.7 m-85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.094 0.473 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -159.21 135.13 8.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 109.032 178.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 59' ' ' ILE . 4.6 m -115.16 139.98 49.46 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.516 ' OG ' ' CD1' ' A' ' 25' ' ' LEU . 46.4 t -108.21 133.39 52.52 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.941 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.585 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.6 p -129.74 157.67 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 121.905 0.86 . . . . 0.0 110.307 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.614 HG23 HD23 ' A' ' 25' ' ' LEU . 89.4 t -99.45 134.82 37.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.75 HG22 HG11 ' A' ' 99' ' ' VAL . 75.7 t -121.29 150.52 24.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.725 -1.235 . . . . 0.0 109.793 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -46.97 -18.8 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.813 0.816 . . . . 0.0 109.757 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -92.35 -56.25 1.59 Allowed Glycine 0 C--N 1.283 -2.405 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -164.04 -176.47 4.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -1.155 . . . . 0.0 110.444 -179.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.416 HG22 HG22 ' A' ' 49' ' ' VAL . 53.9 t -87.49 135.85 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.203 -0.936 . . . . 0.0 108.764 178.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.47 ' HZ2' HG21 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -133.22 157.53 45.16 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.004 -1.06 . . . . 0.0 111.318 -178.837 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -113.19 97.53 6.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.6 m -71.53 141.71 50.11 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.65 134.12 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.867 -1.146 . . . . 0.0 112.46 -177.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.675 HD11 ' SG ' ' A' ' 46' ' ' CYS . 96.1 mt -105.72 139.71 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 177.489 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.0 m120 . . . . . 0 N--CA 1.502 2.138 0 O-C-N 120.368 -1.457 . . . . 0.0 111.976 -177.656 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.457 0.646 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 71.0 mt -62.68 -32.71 73.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.425 -0.797 . . . . 0.0 109.523 179.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.43 ' NZ ' ' O ' ' A' ' 6' ' ' HIS . 17.6 mtpp -60.09 -42.38 94.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.209 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -65.71 -28.89 69.39 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.754 HD23 ' O ' ' A' ' 81' ' ' LEU . 6.7 tt -58.33 -46.44 86.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.629 -0.669 . . . . 0.0 110.006 -179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.531 HG21 ' CE3' ' A' ' 11' ' ' TRP . 81.0 t -73.72 -41.96 54.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.942 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.429 HD23 HE22 ' A' ' 86' ' ' GLN . 68.6 mt -65.39 -43.88 89.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.375 -0.828 . . . . 0.0 109.79 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.531 ' O ' ' OG1' ' A' ' 88' ' ' THR . 58.8 t-80 -62.24 -42.08 99.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.011 -1.056 . . . . 0.0 110.146 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.411 ' HA ' ' OG1' ' A' ' 88' ' ' THR . 5.6 m-85 -70.22 -27.79 64.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 111.171 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.503 ' HG2' ' N ' ' A' ' 87' ' ' HIS . 0.4 OUTLIER -64.6 -32.76 74.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.651 -1.28 . . . . 0.0 109.368 -179.118 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.503 ' N ' ' HG2' ' A' ' 86' ' ' GLN . 43.4 m170 -89.78 -30.1 18.22 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.268 -0.895 . . . . 0.0 109.083 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 2.9 p -95.52 140.52 30.25 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.42 -0.8 . . . . 0.0 110.127 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.6 p -80.23 140.16 36.38 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.691 -0.63 . . . . 0.0 109.817 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.689 ' O ' ' C ' ' A' ' 91' ' ' VAL . 7.9 mp -67.32 -26.98 66.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 110.549 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.747 ' N ' ' O ' ' A' ' 97' ' ' LEU . 95.9 t -1.75 -67.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 CA-C-O 121.62 0.724 . . . . 0.0 110.056 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.675 ' N ' ' O ' ' A' ' 90' ' ' LEU . 32.8 mm-40 35.15 -123.91 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.485 0.659 . . . . 0.0 111.175 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 95' ' ' ASP . 19.1 p80 -71.55 165.65 23.46 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.475 -0.766 . . . . 0.0 109.862 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.654 ' O ' ' N ' ' A' ' 96' ' ' SER . 9.2 m120 61.89 2.86 0.81 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 94' ' ' ASN . 94.9 m-20 33.37 28.65 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.746 -0.596 . . . . 0.0 109.592 179.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.654 ' N ' ' O ' ' A' ' 94' ' ' ASN . 80.1 p -130.02 3.28 4.83 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.852 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.747 ' O ' ' N ' ' A' ' 91' ' ' VAL . 87.2 mt -83.31 56.75 3.67 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.553 -1.342 . . . . 0.0 107.723 178.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.41 90.22 4.42 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.082 0.944 . . . . 0.0 109.53 -179.275 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.75 HG11 HG22 ' A' ' 50' ' ' VAL . 4.2 p -169.48 159.13 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.502 ' N ' HG22 ' A' ' 99' ' ' VAL . 66.7 p -128.06 151.52 49.08 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.19 -0.944 . . . . 0.0 109.984 -179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.751 HD22 ' CG ' ' A' ' 33' ' ' PHE . 32.4 mt -84.46 65.72 9.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.02 -1.05 . . . . 0.0 108.425 179.438 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -94.4 -22.6 18.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.387 -0.821 . . . . 0.0 112.519 -177.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -118.09 112.19 38.24 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.111 -1.618 . . . . 0.0 111.071 -178.676 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.455 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 33.1 Cg_exo -58.0 143.87 95.48 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.492 2.128 . . . . 0.0 111.406 177.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.655 HG11 ' HB3' ' A' ' 34' ' ' LEU . 11.6 p -71.88 -27.67 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.064 -1.022 . . . . 0.0 109.614 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.424 ' HD1' HG13 ' A' ' 105' ' ' VAL . 3.2 m-85 -114.05 29.28 8.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.194 -0.941 . . . . 0.0 109.769 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.455 ' HB2' ' HB2' ' A' ' 104' ' ' PRO . . . . . . . . 0 C--N 1.302 -1.479 0 O-C-N 121.108 -0.995 . . . . 0.0 109.525 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.707 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.5 mm? . . . . . 0 N--CA 1.502 2.128 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.411 ' CB ' HG21 ' A' ' 10' ' ' THR . 38.3 Cg_endo -69.35 -2.04 9.19 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.683 2.255 . . . . 0.0 112.301 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.763 ' CD2' HD21 ' A' ' 83' ' ' LEU . 91.6 m-70 -73.6 -24.52 60.06 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.37 -0.831 . . . . 0.0 110.028 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -60.3 -34.03 73.2 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.215 -0.928 . . . . 0.0 108.791 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.684 ' OD2' ' NZ ' ' A' ' 9' ' ' LYS . 99.9 m-20 -109.02 119.06 38.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.093 -1.005 . . . . 0.0 109.91 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 12' ' ' ASN . 94.6 mt-10 -65.16 -16.37 63.43 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.684 ' NZ ' ' OD2' ' A' ' 7' ' ' ASP . 26.2 pttt -59.71 -37.48 78.99 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.17 -0.956 . . . . 0.0 110.396 -179.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.681 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 23.3 p -55.79 -35.97 66.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.512 -0.743 . . . . 0.0 110.212 -179.263 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.681 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -121.59 -33.01 3.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.77 -1.206 . . . . 0.0 110.723 179.634 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 8' ' ' GLU . 64.0 t30 -83.08 128.18 34.25 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.02 -1.05 . . . . 0.0 111.366 -178.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.741 ' O ' ' N ' ' A' ' 16' ' ' SER . 24.0 m -139.7 30.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.567 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -24.78 -45.23 0.01 OUTLIER Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 13' ' ' VAL . 81.5 p -51.69 -16.78 0.71 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.547 -0.972 . . . . 0.0 108.807 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.741 ' N ' ' O ' ' A' ' 13' ' ' VAL . 89.1 p -70.0 159.49 33.69 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.692 0.758 . . . . 0.0 110.011 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.528 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 79.6 m-20 -122.98 165.16 17.2 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -59.75 -43.35 94.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.641 -1.287 . . . . 0.0 109.312 -179.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -64.47 -42.98 95.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 108.622 179.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.528 ' HB3' ' H ' ' A' ' 17' ' ' ASN . 21.1 ttmm -69.07 -35.52 76.61 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.51 74.85 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 26' ' ' ARG . 88.0 tt0 -57.78 -47.2 83.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.935 -1.103 . . . . 0.0 108.741 179.195 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -60.03 -43.81 95.07 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.429 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 89.8 mt -67.71 -27.59 66.95 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.569 HD11 ' OG ' ' A' ' 47' ' ' SER . 12.0 mt -94.28 -5.43 46.76 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.314 -0.866 . . . . 0.0 109.239 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.68 HH11 ' HG2' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -94.04 123.87 37.69 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.784 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.06 4.52 74.65 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 24' ' ' LEU . 24.2 mmtm -99.91 134.74 42.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.101 -1.235 . . . . 0.0 109.811 179.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -69.94 159.72 33.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.518 -0.739 . . . . 0.0 109.615 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.67 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 88.3 m-20 -59.72 147.32 38.2 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.635 0.731 . . . . 0.0 110.039 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.63 -22.89 37.85 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -179.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 67.6 m -81.37 114.02 19.86 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.294 -1.121 . . . . 0.0 108.831 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -132.21 170.49 14.95 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.086 -179.475 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.68 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 1.9 pp -147.37 157.88 43.75 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.56 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.521 HG22 ' SG ' ' A' ' 46' ' ' CYS . 48.3 t -103.9 128.5 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.156 -0.965 . . . . 0.0 108.443 178.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.713 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -144.02 173.85 11.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 108.823 -179.364 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--N 1.307 -1.271 0 O-C-N 120.827 -1.171 . . . . 0.0 108.382 179.569 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.588 ' O ' ' O ' ' A' ' 59' ' ' ILE . 92.8 m-85 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 120.974 0.416 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.576 ' HB1' HH12 ' A' ' 36' ' ' ARG . . . -162.54 133.83 5.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.858 -1.152 . . . . 0.0 109.544 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.521 ' SG ' HG22 ' A' ' 35' ' ' VAL . 60.0 m -108.18 130.64 55.12 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.569 ' OG ' HD11 ' A' ' 25' ' ' LEU . 32.9 t -108.18 134.5 50.95 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.196 -0.94 . . . . 0.0 109.953 -178.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.586 HG22 ' N ' ' A' ' 49' ' ' VAL . 9.2 p -133.58 167.72 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.21 -0.931 . . . . 0.0 110.278 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.586 ' N ' HG22 ' A' ' 48' ' ' VAL . 40.3 t -121.23 133.69 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.609 -0.682 . . . . 0.0 109.667 179.522 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.798 HG12 ' HZ2' ' A' ' 55' ' ' LYS . 7.3 p -127.61 160.29 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.076 -1.015 . . . . 0.0 109.968 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.67 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 54.5 m-20 -50.21 -20.35 1.01 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.712 0.768 . . . . 0.0 110.078 -179.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.63 ' H ' HG13 ' A' ' 50' ' ' VAL . . . -83.81 -58.68 2.2 Favored Glycine 0 C--N 1.285 -2.253 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.807 ' H ' ' NZ ' ' A' ' 55' ' ' LYS . 1.3 tt0 -167.07 -165.09 0.67 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.292 -1.122 . . . . 0.0 111.322 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.564 ' CG1' HD13 ' A' ' 25' ' ' LEU . 84.3 t -97.59 123.8 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.485 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.807 ' NZ ' ' H ' ' A' ' 53' ' ' GLU . 11.5 mptt -118.95 152.48 36.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.465 -1.397 . . . . 0.0 110.941 -179.334 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -115.16 112.64 22.84 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 46' ' ' CYS . 49.1 t -88.21 124.74 34.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.077 -1.014 . . . . 0.0 108.536 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 58' ' ' VAL . 4.8 p -101.07 122.64 53.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.079 -1.013 . . . . 0.0 110.906 -178.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.588 ' O ' ' O ' ' A' ' 44' ' ' TYR . 88.6 mt -116.57 137.96 48.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.7 t30 . . . . . 0 N--CA 1.498 1.968 0 O-C-N 120.566 -1.334 . . . . 0.0 111.511 -178.618 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.539 ' OG ' ' OE2' ' A' ' 80' ' ' GLU . 84.5 p . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 121.403 0.621 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.4 -43.77 98.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.417 -0.802 . . . . 0.0 110.879 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.459 ' O ' HG12 ' A' ' 82' ' ' VAL . 19.9 tttt -60.86 -39.75 90.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.755 -1.215 . . . . 0.0 108.707 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.614 ' N ' ' OE1' ' A' ' 80' ' ' GLU . 0.3 OUTLIER -73.43 -40.03 64.55 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.177 -0.952 . . . . 0.0 109.383 179.006 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.9 -49.51 77.4 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.839 -0.538 . . . . 0.0 110.599 -178.373 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 83' ' ' LEU . 4.3 p -59.76 -44.22 93.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.913 -1.117 . . . . 0.0 108.495 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.763 HD21 ' CD2' ' A' ' 5' ' ' HIS . 91.2 mt -61.69 -45.39 94.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.208 -0.932 . . . . 0.0 111.273 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -61.25 -40.39 93.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.756 -1.215 . . . . 0.0 110.001 -178.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.812 ' HB3' HD13 ' A' ' 101' ' ' LEU . 22.4 m-85 -71.41 -26.75 62.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.249 -0.907 . . . . 0.0 111.311 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.595 ' OE1' ' O ' ' A' ' 101' ' ' LEU . 2.2 mt-30 -65.01 -33.65 76.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.662 -1.274 . . . . 0.0 109.163 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -96.76 -19.28 19.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.013 -1.054 . . . . 0.0 110.753 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.4 m -99.53 131.18 45.7 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.804 -1.185 . . . . 0.0 109.726 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.3 p -74.97 135.65 41.34 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.514 0.673 . . . . 0.0 109.939 -179.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.743 ' O ' ' N ' ' A' ' 92' ' ' GLN . 0.6 OUTLIER -61.74 -43.7 98.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.531 -0.731 . . . . 0.0 110.627 -179.679 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.757 ' N ' ' O ' ' A' ' 97' ' ' LEU . 72.0 t 26.79 -84.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.743 ' N ' ' O ' ' A' ' 90' ' ' LEU . 18.0 tt0 77.32 -179.51 0.14 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.787 178.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.497 ' H ' ' HG2' ' A' ' 92' ' ' GLN . 81.6 t60 -56.08 -39.84 72.72 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.58 ' C ' HD22 ' A' ' 94' ' ' ASN . 0.2 OUTLIER -50.44 -28.3 8.01 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.178 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 60.1 t0 63.88 24.36 13.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.78 -0.575 . . . . 0.0 110.309 178.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 68.9 m -136.91 10.89 3.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.03 -1.044 . . . . 0.0 110.167 179.636 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.757 ' O ' ' N ' ' A' ' 91' ' ' VAL . 87.1 mt -99.78 50.96 0.92 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.582 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 42.1 p30 -77.43 60.09 1.99 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.501 -0.749 . . . . 0.0 110.646 -178.397 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.667 ' HB ' HG23 ' A' ' 50' ' ' VAL . 7.6 p -133.98 162.96 38.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.548 ' N ' HG22 ' A' ' 99' ' ' VAL . 82.3 p -125.06 168.87 12.77 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.312 1.053 . . . . 0.0 110.611 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.812 HD13 ' HB3' ' A' ' 85' ' ' TYR . 6.9 mp -98.17 33.41 2.18 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.427 ' HA ' ' NE2' ' A' ' 86' ' ' GLN . . . -74.39 -15.49 60.92 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.64 -0.663 . . . . 0.0 112.13 -178.093 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 32' ' ' THR . 96.8 m-85 -114.91 108.48 48.57 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.249 -1.532 . . . . 0.0 111.339 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.54 145.65 95.41 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.257 1.971 . . . . 0.0 110.845 177.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.5 -33.07 61.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.896 -1.128 . . . . 0.0 109.335 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -122.69 50.46 1.5 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.018 -1.051 . . . . 0.0 110.067 179.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 109.592 179.766 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HB3' HG21 ' A' ' 10' ' ' THR . 16.5 Cg_exo -57.33 -9.33 4.75 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.745 1.63 . . . . 0.0 111.55 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.46 ' CB ' HD21 ' A' ' 83' ' ' LEU . 82.6 m-70 -60.44 -29.15 68.83 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.607 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -68.0 -23.03 64.97 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.696 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 83.7 m-20 -90.05 120.64 31.41 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.388 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 45.0 tt0 -67.63 -30.67 70.29 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.393 -0.817 . . . . 0.0 110.294 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.597 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -63.36 -31.71 72.93 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.264 -0.898 . . . . 0.0 111.573 -178.805 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -66.49 -29.66 69.82 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.226 -0.921 . . . . 0.0 111.641 -177.044 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.696 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -123.02 -8.44 8.3 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.652 -1.28 . . . . 0.0 110.585 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 8' ' ' GLU . 13.5 t-20 -97.92 118.3 34.19 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.1 -1.0 . . . . 0.0 110.629 -178.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 16' ' ' SER . 10.2 m -140.46 27.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.489 -0.757 . . . . 0.0 109.179 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -41.32 -30.56 0.49 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.391 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.8 t -59.84 -34.58 73.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -1.076 . . . . 0.0 108.827 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 13' ' ' VAL . 70.1 m -60.48 142.2 55.48 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.584 0.707 . . . . 0.0 110.654 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -79.9 162.44 24.99 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.624 0.726 . . . . 0.0 109.568 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.524 ' CB ' HH12 ' A' ' 36' ' ' ARG . 22.9 ttp180 -57.31 -44.9 84.55 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.89 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -39.34 91.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.149 -0.969 . . . . 0.0 108.713 179.064 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -63.78 -27.74 69.39 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.381 0.61 . . . . 0.0 109.46 179.529 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.55 96.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.905 . . . . 0.0 109.672 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 26' ' ' ARG . 96.3 mt-10 -60.57 -41.23 94.18 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -60.37 -41.61 94.11 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' CD ' ' A' ' 28' ' ' LYS . 77.0 mt -67.26 -29.36 68.96 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.433 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -89.74 -14.11 35.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.351 -0.843 . . . . 0.0 108.933 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 22' ' ' GLU . 5.1 mtp180 -88.37 129.88 35.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.502 -0.749 . . . . 0.0 110.882 -179.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.27 3.27 90.2 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.498 ' CD ' ' O ' ' A' ' 24' ' ' LEU . 12.3 mtpt -103.56 131.08 51.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.282 -1.128 . . . . 0.0 110.359 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.733 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.1 OUTLIER -60.56 147.37 41.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 110.348 -179.115 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.559 ' OD2' ' OD1' ' A' ' 51' ' ' ASP . 65.1 m-20 -50.1 151.93 1.84 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.75 -37.93 3.46 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.419 HG21 ' CE ' ' A' ' 28' ' ' LYS . 88.4 m -68.14 128.28 35.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.43 -1.041 . . . . 0.0 109.151 179.742 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.722 ' CE2' HD23 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -139.04 161.8 36.48 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.856 179.968 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.68 ' CB ' HG11 ' A' ' 105' ' ' VAL . 0.7 OUTLIER -137.29 162.86 32.4 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.547 0.689 . . . . 0.0 110.167 -179.498 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 11' ' ' TRP . 90.6 t -118.12 131.14 71.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.524 HH12 ' CB ' ' A' ' 18' ' ' ARG . 11.0 ptm180 -135.56 -176.0 4.13 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 109.584 -179.226 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 C--N 1.304 -1.382 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.703 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.457 ' O ' ' N ' ' A' ' 59' ' ' ILE . 96.8 m-85 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.487 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -139.39 135.06 33.28 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.563 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.729 ' SG ' HD11 ' A' ' 59' ' ' ILE . 28.9 p -107.92 124.88 50.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.235 -0.916 . . . . 0.0 108.8 179.36 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.7 p -109.63 139.67 44.37 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.531 -0.731 . . . . 0.0 110.275 -179.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.8 p -129.26 159.73 40.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.275 -0.891 . . . . 0.0 109.787 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.503 ' N ' HG22 ' A' ' 48' ' ' VAL . 39.4 t -96.6 134.13 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.897 HG12 ' H ' ' A' ' 52' ' ' GLY . 62.0 t -125.44 145.61 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.758 -1.214 . . . . 0.0 110.561 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.559 ' OD1' ' OD2' ' A' ' 30' ' ' ASP . 15.1 m-20 -44.15 -20.42 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.897 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -90.17 -59.87 1.44 Allowed Glycine 0 C--N 1.291 -1.948 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.581 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 70.0 mt-10 -162.18 169.64 20.45 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.952 -1.322 . . . . 0.0 110.312 -178.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.0 m -65.33 138.51 23.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.52 ' HZ2' ' HB2' ' A' ' 53' ' ' GLU . 16.6 mmtm -116.3 140.66 49.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.629 -1.294 . . . . 0.0 111.966 -178.053 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -115.3 96.77 5.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 46' ' ' CYS . 80.2 m -99.49 122.12 42.12 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.083 -1.011 . . . . 0.0 108.92 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.9 t -76.89 140.01 17.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.553 0.692 . . . . 0.0 110.545 -179.278 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.729 HD11 ' SG ' ' A' ' 46' ' ' CYS . 47.2 mm -108.96 129.96 62.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.4 m120 . . . . . 0 N--CA 1.498 1.936 0 O-C-N 121.168 -0.958 . . . . 0.0 110.084 -179.109 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.69 0.757 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 81' ' ' LEU . 89.6 mt -62.08 -34.71 76.8 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.465 -0.772 . . . . 0.0 109.516 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 78' ' ' LEU . 87.3 mttt -47.74 -42.04 24.46 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 65.6 mt-10 -64.87 -37.31 87.19 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.723 HD23 ' C ' ' A' ' 81' ' ' LEU . 8.2 tt -59.63 -42.62 93.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.566 -0.709 . . . . 0.0 110.164 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.8 t -65.77 -44.97 92.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.99 -1.069 . . . . 0.0 109.467 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.46 HD21 ' CB ' ' A' ' 5' ' ' HIS . 81.2 mt -68.34 -39.02 82.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.395 -0.816 . . . . 0.0 111.274 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.558 ' O ' ' CE1' ' A' ' 87' ' ' HIS . 52.8 m80 -64.66 -42.43 95.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.016 -1.052 . . . . 0.0 110.192 -178.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.633 ' CB ' HD13 ' A' ' 101' ' ' LEU . 7.1 m-30 -73.83 -16.68 61.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.857 -1.152 . . . . 0.0 109.34 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -67.81 -35.87 79.4 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.282 -0.886 . . . . 0.0 109.234 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 84' ' ' HIS . 22.8 p-80 -92.61 -22.66 19.35 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.267 -0.896 . . . . 0.0 109.664 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.8 m -92.41 128.42 38.26 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.134 -0.979 . . . . 0.0 109.386 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.584 ' HA ' HG22 ' A' ' 100' ' ' THR . 24.6 p -77.67 131.58 37.8 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.437 -0.79 . . . . 0.0 109.665 -179.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.524 ' O ' ' C ' ' A' ' 91' ' ' VAL . 98.9 mt -69.74 -17.46 63.45 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.498 -0.751 . . . . 0.0 110.024 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.749 ' N ' ' O ' ' A' ' 97' ' ' LEU . 9.7 p -31.99 -46.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 121.205 -0.934 . . . . 0.0 110.382 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.649 ' N ' HG13 ' A' ' 91' ' ' VAL . 18.1 tt0 -43.97 -27.68 0.39 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.227 0.537 . . . . 0.0 110.128 -179.388 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.485 ' O ' HD23 ' A' ' 97' ' ' LEU . 94.5 m-70 -81.66 119.54 23.95 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.005 -1.059 . . . . 0.0 108.189 178.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 11.3 m120 61.42 2.61 0.67 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.64 -0.663 . . . . 0.0 109.507 -179.244 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.59 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 66.7 t0 57.44 23.65 9.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.551 -0.718 . . . . 0.0 110.349 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.9 m -140.68 11.35 2.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.81 -1.181 . . . . 0.0 109.688 179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.749 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.8 mm? -97.93 66.2 1.85 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.913 -1.117 . . . . 0.0 108.679 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.836 ' O ' HG23 ' A' ' 99' ' ' VAL . 16.5 p30 -79.16 78.86 5.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.938 -1.101 . . . . 0.0 110.37 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 98' ' ' ASN . 40.8 t -166.38 154.26 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.522 -0.736 . . . . 0.0 109.816 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 89' ' ' SER . 70.8 p -130.53 164.29 25.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.893 . . . . 0.0 109.452 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.85 ' N ' HD12 ' A' ' 101' ' ' LEU . 4.2 mp -79.17 67.31 4.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -92.16 -22.76 19.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 111.519 -178.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.65 137.94 28.65 Favored Pre-proline 0 C--N 1.307 -1.277 0 O-C-N 120.713 -1.242 . . . . 0.0 111.006 -178.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.459 ' HB2' HG22 ' A' ' 10' ' ' THR . 93.3 Cg_endo -78.09 157.23 30.32 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.277 2.652 . . . . 0.0 111.582 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.68 HG11 ' CB ' ' A' ' 34' ' ' LEU . 12.2 p -92.76 -27.68 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.345 -0.847 . . . . 0.0 112.089 -178.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 73.1 t80 -132.52 64.99 1.6 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.411 -1.431 . . . . 0.0 111.87 -178.069 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.682 ' HB2' HG22 ' A' ' 10' ' ' THR . . . . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.058 -1.026 . . . . 0.0 109.006 178.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.5 mt . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -49.06 -19.54 2.52 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.888 2.392 . . . . 0.0 111.659 178.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 83' ' ' LEU . 85.1 m-70 -65.11 -17.01 64.11 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.655 0.741 . . . . 0.0 109.438 -178.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -64.98 -36.76 85.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.503 -0.748 . . . . 0.0 109.57 178.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -96.79 129.55 44.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 110.431 -179.068 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.676 ' O ' ' N ' ' A' ' 12' ' ' ASN . 96.6 mt-10 -72.32 -31.32 65.57 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.562 0.696 . . . . 0.0 109.824 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -59.83 -24.82 64.49 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.684 -179.636 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.67 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 52.2 p -67.85 -29.35 68.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.111 -0.993 . . . . 0.0 110.347 -179.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.67 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.8 -23.77 2.78 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.916 -1.115 . . . . 0.0 109.572 178.652 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.676 ' N ' ' O ' ' A' ' 8' ' ' GLU . 65.6 t30 -80.57 125.84 30.49 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.09 0.948 . . . . 0.0 111.284 -178.396 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 13' ' ' VAL . 93.8 t -132.57 32.79 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 13' ' ' VAL . . . -42.64 177.19 0.01 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.9 t 61.47 27.4 16.96 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.516 -0.991 . . . . 0.0 108.711 -179.499 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.514 ' OG ' HG12 ' A' ' 13' ' ' VAL . 69.2 m -129.08 136.81 50.74 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.459 -0.775 . . . . 0.0 109.673 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.588 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 26.7 p30 -80.19 167.81 19.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.53 -0.731 . . . . 0.0 109.782 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 36' ' ' ARG . 41.7 mtt-85 -63.65 -32.73 74.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.94 . . . . 0.0 110.039 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -64.29 -46.46 83.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.243 -0.911 . . . . 0.0 109.113 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.588 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 18.0 ttmm -62.34 -40.32 95.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -0.834 . . . . 0.0 109.218 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -59.9 -38.11 81.34 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.366 -0.834 . . . . 0.0 109.332 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.573 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 55.3 tt0 -59.98 -44.07 94.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.869 -1.144 . . . . 0.0 108.892 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -62.26 -39.14 91.92 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 77.7 mt -73.67 -31.78 63.65 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.464 HD23 HG23 ' A' ' 49' ' ' VAL . 7.9 mt -89.38 -10.23 47.37 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.573 ' NH2' ' OE2' ' A' ' 22' ' ' GLU . 75.3 mtt180 -88.75 120.34 30.06 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.136 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.46 -4.99 62.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.507 ' HE3' HG23 ' A' ' 105' ' ' VAL . 25.7 mmtt -87.06 150.9 23.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.35 -1.088 . . . . 0.0 109.598 179.644 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.565 ' HG2' HH11 ' A' ' 29' ' ' ARG . 7.1 mmt-85 -82.67 154.96 24.61 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.316 0.579 . . . . 0.0 110.479 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -55.12 139.72 40.72 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.35 -15.46 56.16 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 35.3 m -88.55 121.79 31.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.402 -1.057 . . . . 0.0 109.197 179.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -138.44 167.46 21.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.007 -1.058 . . . . 0.0 110.742 179.888 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.53 156.23 44.55 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.485 -179.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' TRP . 46.0 t -108.11 124.26 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.875 . . . . 0.0 108.82 179.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -138.75 178.88 6.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 108.974 -179.486 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.515 ' O ' ' CZ ' ' A' ' 36' ' ' ARG . 10.8 tt0 . . . . . 0 N--CA 1.485 1.287 0 O-C-N 120.814 -1.179 . . . . 0.0 108.67 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.63 ' O ' ' O ' ' A' ' 59' ' ' ILE . 96.1 m-85 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.603 0.716 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 59' ' ' ILE . . . -157.8 135.97 10.93 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.967 -1.083 . . . . 0.0 109.486 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.552 ' SG ' HD13 ' A' ' 59' ' ' ILE . 70.6 m -108.03 117.15 33.39 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.8 m -102.18 133.81 46.44 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.854 -1.154 . . . . 0.0 109.704 -178.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.641 HG11 HD22 ' A' ' 90' ' ' LEU . 2.4 p -129.73 160.28 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.295 -0.878 . . . . 0.0 109.642 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.538 ' N ' HG22 ' A' ' 48' ' ' VAL . 55.8 t -108.47 136.76 43.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.743 HG12 ' H ' ' A' ' 52' ' ' GLY . 74.8 t -121.59 151.45 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.093 -1.004 . . . . 0.0 109.978 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -49.71 -15.24 0.16 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.067 0.937 . . . . 0.0 108.796 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.743 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -94.21 -59.21 1.18 Allowed Glycine 0 C--N 1.285 -2.28 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -162.15 176.66 10.43 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.122 -1.222 . . . . 0.0 110.384 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.06 138.96 18.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HE3' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -125.58 162.05 25.83 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.761 -179.919 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -128.64 80.31 1.96 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.488 -0.758 . . . . 0.0 110.336 -179.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 46' ' ' CYS . 82.1 m -59.8 145.02 46.9 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.788 -1.195 . . . . 0.0 108.402 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 58' ' ' VAL . 8.7 p -115.98 130.42 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.013 -1.054 . . . . 0.0 111.272 -178.331 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.63 ' O ' ' O ' ' A' ' 44' ' ' TYR . 3.7 mp -123.04 128.4 75.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 . . . . . 0 N--CA 1.497 1.886 0 O-C-N 120.557 -1.34 . . . . 0.0 109.455 179.512 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.2 m . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.226 0.536 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.4 mt -60.02 -36.29 76.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.299 -0.876 . . . . 0.0 109.764 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -59.38 -41.05 88.44 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.101 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.439 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 81.9 mt-10 -61.66 -35.06 76.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 108.656 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.0 tt -58.12 -42.55 86.02 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.557 -0.714 . . . . 0.0 109.436 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.34 -39.56 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.007 -1.058 . . . . 0.0 108.582 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.453 ' CD2' ' CD2' ' A' ' 5' ' ' HIS . 92.6 mt -66.44 -41.8 88.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.402 -0.812 . . . . 0.0 109.718 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.439 ' CD2' ' O ' ' A' ' 80' ' ' GLU . 14.6 m170 -60.47 -42.36 96.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 110.382 -179.213 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.5 ' HB2' HD12 ' A' ' 101' ' ' LEU . 3.7 m-85 -69.53 -23.62 63.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.783 -1.198 . . . . 0.0 108.979 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -64.02 -38.12 89.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.491 -0.756 . . . . 0.0 109.231 179.541 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -90.26 -19.69 23.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 0.0 109.199 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 85' ' ' TYR . 42.1 m -99.01 140.99 32.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.529 -0.732 . . . . 0.0 109.256 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.3 t -89.65 128.94 36.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.868 . . . . 0.0 109.47 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.667 ' O ' ' N ' ' A' ' 92' ' ' GLN . 10.1 mp -60.56 -22.85 64.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.344 -0.847 . . . . 0.0 110.467 -179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.719 ' N ' ' O ' ' A' ' 97' ' ' LEU . 11.6 p -26.56 -37.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.346 -0.846 . . . . 0.0 110.584 -179.184 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.667 ' N ' ' O ' ' A' ' 90' ' ' LEU . 35.0 mt-30 -40.8 179.25 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.885 0.85 . . . . 0.0 111.756 -178.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 61.25 -108.84 0.35 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.496 0.665 . . . . 0.0 109.972 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -60.72 -5.43 1.28 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.494 -0.754 . . . . 0.0 110.366 -179.358 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 65.7 t0 57.27 28.47 15.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.772 -1.205 . . . . 0.0 109.128 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -143.22 13.04 1.8 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 110.304 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.719 ' O ' ' N ' ' A' ' 91' ' ' VAL . 7.7 mp -101.23 70.14 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.875 -1.14 . . . . 0.0 107.955 178.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -78.79 87.4 4.67 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.389 -0.819 . . . . 0.0 110.114 -178.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.51 HG22 ' N ' ' A' ' 100' ' ' THR . 12.6 p -163.05 160.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 121.686 0.755 . . . . 0.0 109.158 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.51 ' N ' HG22 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -130.8 133.47 45.99 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.14 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.68 HD22 ' CG ' ' A' ' 33' ' ' PHE . 37.6 mt -69.62 74.5 0.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -116.56 -10.04 11.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.832 . . . . 0.0 110.952 -178.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 32' ' ' THR . 69.2 t80 -120.65 103.4 43.7 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.619 -1.301 . . . . 0.0 110.433 -178.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.97 146.53 86.66 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.622 2.215 . . . . 0.0 111.533 178.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.507 HG23 ' HE3' ' A' ' 28' ' ' LYS . 9.5 p -69.43 -35.37 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.911 -1.118 . . . . 0.0 109.57 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.457 ' CD2' HG13 ' A' ' 105' ' ' VAL . 38.8 m-85 -119.39 54.88 0.97 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.157 -0.964 . . . . 0.0 110.74 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.539 0 O-C-N 121.133 -0.979 . . . . 0.0 108.376 178.812 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.5 mt . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -49.06 -19.54 2.52 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.888 2.392 . . . . 0.0 111.659 178.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 83' ' ' LEU . 85.1 m-70 -65.11 -17.01 64.11 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.655 0.741 . . . . 0.0 109.438 -178.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -64.98 -36.76 85.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.503 -0.748 . . . . 0.0 109.57 178.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -96.79 129.55 44.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 110.431 -179.068 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.676 ' O ' ' N ' ' A' ' 12' ' ' ASN . 96.6 mt-10 -72.32 -31.32 65.57 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.562 0.696 . . . . 0.0 109.824 179.717 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -59.83 -24.82 64.49 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.684 -179.636 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.67 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 52.2 p -67.85 -29.35 68.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.111 -0.993 . . . . 0.0 110.347 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.67 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.8 -23.77 2.78 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.916 -1.115 . . . . 0.0 109.572 178.652 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.676 ' N ' ' O ' ' A' ' 8' ' ' GLU . 65.6 t30 -80.57 125.84 30.49 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.09 0.948 . . . . 0.0 111.284 -178.396 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 13' ' ' VAL . 93.8 t -132.57 32.79 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 13' ' ' VAL . . . -42.64 177.19 0.01 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.9 t 61.47 27.4 16.96 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.516 -0.991 . . . . 0.0 108.711 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.514 ' OG ' HG12 ' A' ' 13' ' ' VAL . 69.2 m -129.08 136.81 50.74 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.459 -0.775 . . . . 0.0 109.673 -179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.588 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 26.7 p30 -80.19 167.81 19.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.53 -0.731 . . . . 0.0 109.782 -179.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 36' ' ' ARG . 41.7 mtt-85 -63.65 -32.73 74.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.94 . . . . 0.0 110.039 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -64.29 -46.46 83.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.243 -0.911 . . . . 0.0 109.113 -179.345 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.588 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 18.0 ttmm -62.34 -40.32 95.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -0.834 . . . . 0.0 109.218 179.566 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -59.9 -38.11 81.34 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.366 -0.834 . . . . 0.0 109.332 -179.584 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.573 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 55.3 tt0 -59.98 -44.07 94.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.869 -1.144 . . . . 0.0 108.892 179.548 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -62.26 -39.14 91.92 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 77.7 mt -73.67 -31.78 63.65 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.432 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.464 HD23 HG23 ' A' ' 49' ' ' VAL . 7.9 mt -89.38 -10.23 47.37 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.573 ' NH2' ' OE2' ' A' ' 22' ' ' GLU . 75.3 mtt180 -88.75 120.34 30.06 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.136 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.46 -4.99 62.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.715 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.507 ' HE3' HG23 ' A' ' 105' ' ' VAL . 25.7 mmtt -87.06 150.9 23.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.35 -1.088 . . . . 0.0 109.598 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.565 ' HG2' HH11 ' A' ' 29' ' ' ARG . 7.1 mmt-85 -82.67 154.96 24.61 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.316 0.579 . . . . 0.0 110.479 -179.475 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -55.12 139.72 40.72 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.35 -15.46 56.16 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 35.3 m -88.55 121.79 31.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.402 -1.057 . . . . 0.0 109.197 179.315 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -138.44 167.46 21.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.007 -1.058 . . . . 0.0 110.742 179.888 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.53 156.23 44.55 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.485 -179.325 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' TRP . 46.0 t -108.11 124.26 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.875 . . . . 0.0 108.82 179.521 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -138.75 178.88 6.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 108.974 -179.486 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.515 ' O ' ' CZ ' ' A' ' 36' ' ' ARG . 10.8 tt0 . . . . . 0 N--CA 1.485 1.287 0 O-C-N 120.814 -1.179 . . . . 0.0 108.67 179.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.63 ' O ' ' O ' ' A' ' 59' ' ' ILE . 96.1 m-85 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.603 0.716 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 59' ' ' ILE . . . -157.8 135.97 10.93 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.967 -1.083 . . . . 0.0 109.486 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.552 ' SG ' HD13 ' A' ' 59' ' ' ILE . 70.6 m -108.03 117.15 33.39 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.648 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.8 m -102.18 133.81 46.44 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.854 -1.154 . . . . 0.0 109.704 -178.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.641 HG11 HD22 ' A' ' 90' ' ' LEU . 2.4 p -129.73 160.28 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.295 -0.878 . . . . 0.0 109.642 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.538 ' N ' HG22 ' A' ' 48' ' ' VAL . 55.8 t -108.47 136.76 43.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.743 HG12 ' H ' ' A' ' 52' ' ' GLY . 74.8 t -121.59 151.45 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.093 -1.004 . . . . 0.0 109.978 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -49.71 -15.24 0.16 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.067 0.937 . . . . 0.0 108.796 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.743 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -94.21 -59.21 1.18 Allowed Glycine 0 C--N 1.285 -2.28 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.65 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -162.15 176.66 10.43 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.122 -1.222 . . . . 0.0 110.384 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.06 138.96 18.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HE3' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -125.58 162.05 25.83 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.761 -179.919 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -128.64 80.31 1.96 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.488 -0.758 . . . . 0.0 110.336 -179.566 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 46' ' ' CYS . 82.1 m -59.8 145.02 46.9 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.788 -1.195 . . . . 0.0 108.402 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 58' ' ' VAL . 8.7 p -115.98 130.42 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.013 -1.054 . . . . 0.0 111.272 -178.331 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.63 ' O ' ' O ' ' A' ' 44' ' ' TYR . 3.7 mp -123.04 128.4 75.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.361 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 . . . . . 0 N--CA 1.497 1.886 0 O-C-N 120.557 -1.34 . . . . 0.0 109.455 179.512 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.2 m . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.226 0.536 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.4 mt -60.02 -36.29 76.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.299 -0.876 . . . . 0.0 109.764 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -59.38 -41.05 88.44 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.101 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.439 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 81.9 mt-10 -61.66 -35.06 76.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 108.656 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.0 tt -58.12 -42.55 86.02 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.557 -0.714 . . . . 0.0 109.436 179.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.34 -39.56 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.007 -1.058 . . . . 0.0 108.582 179.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.453 ' CD2' ' CD2' ' A' ' 5' ' ' HIS . 92.6 mt -66.44 -41.8 88.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.402 -0.812 . . . . 0.0 109.718 179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.439 ' CD2' ' O ' ' A' ' 80' ' ' GLU . 14.6 m170 -60.47 -42.36 96.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 110.382 -179.213 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.5 ' HB2' HD12 ' A' ' 101' ' ' LEU . 3.7 m-85 -69.53 -23.62 63.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.783 -1.198 . . . . 0.0 108.979 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -64.02 -38.12 89.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.491 -0.756 . . . . 0.0 109.231 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -90.26 -19.69 23.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 0.0 109.199 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 85' ' ' TYR . 42.1 m -99.01 140.99 32.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.529 -0.732 . . . . 0.0 109.256 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.3 t -89.65 128.94 36.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.868 . . . . 0.0 109.47 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.667 ' O ' ' N ' ' A' ' 92' ' ' GLN . 10.1 mp -60.56 -22.85 64.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.344 -0.847 . . . . 0.0 110.467 -179.558 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.719 ' N ' ' O ' ' A' ' 97' ' ' LEU . 11.6 p -26.56 -37.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.346 -0.846 . . . . 0.0 110.584 -179.184 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.667 ' N ' ' O ' ' A' ' 90' ' ' LEU . 35.0 mt-30 -40.8 179.25 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.885 0.85 . . . . 0.0 111.756 -178.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 61.25 -108.84 0.35 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.496 0.665 . . . . 0.0 109.972 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -60.72 -5.43 1.28 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.494 -0.754 . . . . 0.0 110.366 -179.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 65.7 t0 57.27 28.47 15.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.772 -1.205 . . . . 0.0 109.128 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -143.22 13.04 1.8 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 110.304 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.719 ' O ' ' N ' ' A' ' 91' ' ' VAL . 7.7 mp -101.23 70.14 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.875 -1.14 . . . . 0.0 107.955 178.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -78.79 87.4 4.67 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.389 -0.819 . . . . 0.0 110.114 -178.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.51 HG22 ' N ' ' A' ' 100' ' ' THR . 12.6 p -163.05 160.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 121.686 0.755 . . . . 0.0 109.158 179.306 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.51 ' N ' HG22 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -130.8 133.47 45.99 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.14 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.68 HD22 ' CG ' ' A' ' 33' ' ' PHE . 37.6 mt -69.62 74.5 0.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -116.56 -10.04 11.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.832 . . . . 0.0 110.952 -178.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 32' ' ' THR . 69.2 t80 -120.65 103.4 43.7 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.619 -1.301 . . . . 0.0 110.433 -178.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.97 146.53 86.66 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.622 2.215 . . . . 0.0 111.533 178.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.507 HG23 ' HE3' ' A' ' 28' ' ' LYS . 9.5 p -69.43 -35.37 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.911 -1.118 . . . . 0.0 109.57 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.457 ' CD2' HG13 ' A' ' 105' ' ' VAL . 38.8 m-85 -119.39 54.88 0.97 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.157 -0.964 . . . . 0.0 110.74 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.539 0 O-C-N 121.133 -0.979 . . . . 0.0 108.376 178.812 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -51.27 -17.86 4.49 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.013 1.809 . . . . 0.0 111.563 178.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -63.24 -23.26 67.34 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.523 -0.735 . . . . 0.0 110.4 -179.074 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -66.1 -37.95 87.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.815 -1.178 . . . . 0.0 109.599 -179.219 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.572 ' O ' ' OG1' ' A' ' 10' ' ' THR . 84.9 m-20 -96.44 127.2 42.21 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.156 -0.965 . . . . 0.0 109.535 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.522 ' HG3' ' CH2' ' A' ' 11' ' ' TRP . 38.1 mp0 -71.08 -28.45 64.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 109.21 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -58.67 -22.54 57.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.657 -179.422 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.732 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 17.2 p -66.03 -31.62 72.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 179.584 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.732 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.6 -31.77 1.98 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.83 -1.169 . . . . 0.0 110.64 -179.387 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.637 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 6.6 p-10 -80.26 146.48 31.64 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 110.422 -178.496 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.54 -3.95 5.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.9 -130.44 33.32 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.6 m -67.75 137.62 55.58 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.229 -1.16 . . . . 0.0 108.641 179.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -163.67 165.01 23.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.478 -0.764 . . . . 0.0 108.954 -179.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.54 ' C ' HH12 ' A' ' 36' ' ' ARG . 68.3 m-80 -106.36 141.03 38.35 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 179.156 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.537 ' HG3' HH11 ' A' ' 18' ' ' ARG . 14.8 mtm-85 -61.24 -36.91 81.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.761 -1.212 . . . . 0.0 109.649 -179.565 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -60.1 -49.32 78.11 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.069 -1.02 . . . . 0.0 110.165 -179.37 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 17' ' ' ASN . 7.6 pttt -68.03 -27.27 66.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.722 -1.236 . . . . 0.0 108.579 179.531 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.41 -33.44 73.71 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.816 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 26' ' ' ARG . 97.9 mt-10 -60.9 -47.45 86.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.52 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -60.01 -44.3 94.66 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.694 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 59.3 mt -69.11 -25.24 64.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.968 -1.082 . . . . 0.0 108.196 178.343 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.525 HD11 ' HB3' ' A' ' 47' ' ' SER . 44.1 mt -96.3 -10.07 28.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.837 . . . . 0.0 109.318 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.666 ' N ' ' O ' ' A' ' 22' ' ' GLU . 61.7 mtm180 -107.48 131.25 54.51 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.431 -0.793 . . . . 0.0 110.582 -179.19 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.42 -4.28 43.78 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.208 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.694 ' NZ ' ' O ' ' A' ' 24' ' ' LEU . 14.6 ptpt -122.98 154.85 37.87 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.003 -1.293 . . . . 0.0 110.929 -179.384 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.482 ' HG2' ' N ' ' A' ' 30' ' ' ASP . 26.9 ttm180 -73.95 160.01 31.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.529 0.681 . . . . 0.0 110.871 -179.004 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.482 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 8.9 p-10 -59.19 167.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.7 0.762 . . . . 0.0 110.128 179.598 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.13 -33.94 5.6 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.4 m -82.06 119.9 24.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -1.114 . . . . 0.0 108.891 179.559 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.808 ' CG ' HD22 ' A' ' 101' ' ' LEU . 1.0 OUTLIER -136.23 164.65 27.59 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.598 -1.241 . . . . 0.0 110.964 -179.521 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.784 HD23 HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -131.89 165.75 23.17 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.509 0.671 . . . . 0.0 110.152 -179.567 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG22 ' SG ' ' A' ' 46' ' ' CYS . 55.1 t -116.67 121.95 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.078 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.54 HH12 ' C ' ' A' ' 17' ' ' ASN . 14.7 ptm180 -142.4 -176.21 4.75 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.592 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.602 ' O ' ' O ' ' A' ' 59' ' ' ILE . 93.8 m-85 . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.413 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -154.98 140.63 17.99 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.659 -1.276 . . . . 0.0 110.245 -179.147 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 59' ' ' ILE . 84.1 m -106.29 118.34 36.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.525 ' HB3' HD11 ' A' ' 25' ' ' LEU . 74.0 m -91.93 127.46 37.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.504 -0.748 . . . . 0.0 109.259 -179.479 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.81 145.96 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.856 -1.153 . . . . 0.0 110.423 -179.559 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.0 t -92.29 144.03 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.349 -0.844 . . . . 0.0 108.743 178.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.675 HG12 ' H ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -123.23 158.95 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.035 -1.04 . . . . 0.0 109.624 179.833 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -65.8 57.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.535 -0.728 . . . . 0.0 110.492 -178.535 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 169.46 -33.54 0.18 Allowed Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.307 -1.425 . . . . 0.0 111.295 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.675 ' H ' HG12 ' A' ' 50' ' ' VAL . 88.8 mt-10 -159.74 165.61 32.14 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.9 -1.353 . . . . 0.0 110.486 -179.544 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 t -97.32 125.78 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.801 . . . . 0.0 109.19 178.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HE2' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -120.38 146.01 46.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.927 -1.108 . . . . 0.0 110.745 -179.273 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -111.75 87.76 2.64 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.446 -0.784 . . . . 0.0 108.918 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 63.2 m -66.9 139.42 57.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.908 . . . . 0.0 109.186 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -106.57 134.36 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.277 -179.19 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.699 HD12 ' SG ' ' A' ' 46' ' ' CYS . 31.4 mt -121.85 144.87 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.4 -0.813 . . . . 0.0 108.822 179.233 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.019 -1.05 . . . . 0.0 109.032 -179.703 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.7 p . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.523 0.678 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.65 -27.1 68.7 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.612 -0.68 . . . . 0.0 109.715 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 83' ' ' LEU . 64.0 mttp -59.55 -44.78 93.15 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.826 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.38 -37.96 87.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.336 -0.853 . . . . 0.0 109.328 179.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 81' ' ' LEU . 7.5 tt -57.6 -41.95 82.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 108.914 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.47 -45.23 98.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.048 -1.033 . . . . 0.0 109.298 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.495 ' H ' HD12 ' A' ' 83' ' ' LEU . 6.4 mp -62.53 -37.74 87.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.871 -1.143 . . . . 0.0 109.58 179.417 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.405 ' O ' ' OG1' ' A' ' 88' ' ' THR . 11.6 t-160 -59.53 -46.69 88.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.524 -0.735 . . . . 0.0 110.966 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.584 ' HB2' HD12 ' A' ' 101' ' ' LEU . 4.4 m-85 -67.59 -28.4 67.73 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.498 -1.376 . . . . 0.0 109.585 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.505 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 1.2 tm0? -58.91 -38.06 78.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 109.164 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -86.14 -36.16 19.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.134 -0.979 . . . . 0.0 109.276 179.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.544 ' O ' ' O ' ' A' ' 85' ' ' TYR . 1.8 p -90.05 139.38 30.67 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.373 -0.83 . . . . 0.0 109.675 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.445 ' HA ' HG22 ' A' ' 100' ' ' THR . 37.3 m -93.1 140.57 29.35 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.601 0.715 . . . . 0.0 109.835 -179.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.655 ' O ' ' C ' ' A' ' 91' ' ' VAL . 5.8 mt -61.09 -41.14 96.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 111.238 -178.905 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.783 ' N ' ' O ' ' A' ' 97' ' ' LEU . 87.2 t 16.29 -83.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 121.41 -0.806 . . . . 0.0 109.834 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 90' ' ' LEU . 1.3 tp60 75.77 -176.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 110.222 179.282 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -60.09 -38.74 83.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.642 -0.661 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -52.52 -24.95 9.04 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.013 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 61.53 20.31 11.12 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 178.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.0 m -130.51 7.26 4.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.693 -1.254 . . . . 0.0 111.172 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.783 ' O ' ' N ' ' A' ' 91' ' ' VAL . 83.2 mt -98.5 53.67 1.04 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.09 78.47 3.63 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.548 -178.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.626 HG21 HG23 ' A' ' 50' ' ' VAL . 53.2 t -154.31 147.92 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.809 0.814 . . . . 0.0 109.533 179.377 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 89' ' ' SER . 48.2 p -121.24 153.67 37.34 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.316 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.808 HD22 ' CG ' ' A' ' 33' ' ' PHE . 79.0 mt -82.25 71.05 9.31 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . . . -107.38 -17.87 14.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.62 -0.675 . . . . 0.0 112.074 -178.09 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -110.91 123.77 34.59 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.573 -1.329 . . . . 0.0 110.083 -178.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 55.2 Cg_endo -77.45 145.06 23.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.488 2.125 . . . . 0.0 110.636 178.87 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.905 HG13 ' CD2' ' A' ' 106' ' ' TYR . 12.0 p -72.21 -22.01 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.535 -1.353 . . . . 0.0 109.38 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.905 ' CD2' HG13 ' A' ' 105' ' ' VAL . 72.3 m-85 -129.19 64.35 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.768 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 108.819 179.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -51.27 -17.86 4.49 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.013 1.809 . . . . 0.0 111.563 178.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -63.24 -23.26 67.34 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.523 -0.735 . . . . 0.0 110.4 -179.074 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -66.1 -37.95 87.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.815 -1.178 . . . . 0.0 109.599 -179.219 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.572 ' O ' ' OG1' ' A' ' 10' ' ' THR . 84.9 m-20 -96.44 127.2 42.21 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.156 -0.965 . . . . 0.0 109.535 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.522 ' HG3' ' CH2' ' A' ' 11' ' ' TRP . 38.1 mp0 -71.08 -28.45 64.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 109.21 179.56 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -58.67 -22.54 57.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.657 -179.422 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.732 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 17.2 p -66.03 -31.62 72.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.732 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.6 -31.77 1.98 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.83 -1.169 . . . . 0.0 110.64 -179.387 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.637 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 6.6 p-10 -80.26 146.48 31.64 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 110.422 -178.496 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.54 -3.95 5.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.9 -130.44 33.32 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.6 m -67.75 137.62 55.58 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.229 -1.16 . . . . 0.0 108.641 179.369 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -163.67 165.01 23.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.478 -0.764 . . . . 0.0 108.954 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.54 ' C ' HH12 ' A' ' 36' ' ' ARG . 68.3 m-80 -106.36 141.03 38.35 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 179.156 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.537 ' HG3' HH11 ' A' ' 18' ' ' ARG . 14.8 mtm-85 -61.24 -36.91 81.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.761 -1.212 . . . . 0.0 109.649 -179.565 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -60.1 -49.32 78.11 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.069 -1.02 . . . . 0.0 110.165 -179.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 17' ' ' ASN . 7.6 pttt -68.03 -27.27 66.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.722 -1.236 . . . . 0.0 108.579 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.41 -33.44 73.71 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 26' ' ' ARG . 97.9 mt-10 -60.9 -47.45 86.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.52 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -60.01 -44.3 94.66 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.694 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 59.3 mt -69.11 -25.24 64.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.968 -1.082 . . . . 0.0 108.196 178.343 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.525 HD11 ' HB3' ' A' ' 47' ' ' SER . 44.1 mt -96.3 -10.07 28.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.837 . . . . 0.0 109.318 179.683 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.666 ' N ' ' O ' ' A' ' 22' ' ' GLU . 61.7 mtm180 -107.48 131.25 54.51 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.431 -0.793 . . . . 0.0 110.582 -179.19 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.42 -4.28 43.78 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.208 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.694 ' NZ ' ' O ' ' A' ' 24' ' ' LEU . 14.6 ptpt -122.98 154.85 37.87 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.003 -1.293 . . . . 0.0 110.929 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.482 ' HG2' ' N ' ' A' ' 30' ' ' ASP . 26.9 ttm180 -73.95 160.01 31.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.529 0.681 . . . . 0.0 110.871 -179.004 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.482 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 8.9 p-10 -59.19 167.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.7 0.762 . . . . 0.0 110.128 179.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.13 -33.94 5.6 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.561 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.4 m -82.06 119.9 24.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -1.114 . . . . 0.0 108.891 179.559 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.808 ' CG ' HD22 ' A' ' 101' ' ' LEU . 1.0 OUTLIER -136.23 164.65 27.59 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.598 -1.241 . . . . 0.0 110.964 -179.521 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.784 HD23 HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -131.89 165.75 23.17 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.509 0.671 . . . . 0.0 110.152 -179.567 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG22 ' SG ' ' A' ' 46' ' ' CYS . 55.1 t -116.67 121.95 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.078 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.54 HH12 ' C ' ' A' ' 17' ' ' ASN . 14.7 ptm180 -142.4 -176.21 4.75 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.41 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.592 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.602 ' O ' ' O ' ' A' ' 59' ' ' ILE . 93.8 m-85 . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.413 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -154.98 140.63 17.99 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.659 -1.276 . . . . 0.0 110.245 -179.147 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 59' ' ' ILE . 84.1 m -106.29 118.34 36.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.525 ' HB3' HD11 ' A' ' 25' ' ' LEU . 74.0 m -91.93 127.46 37.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.504 -0.748 . . . . 0.0 109.259 -179.479 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.81 145.96 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.856 -1.153 . . . . 0.0 110.423 -179.559 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.0 t -92.29 144.03 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.349 -0.844 . . . . 0.0 108.743 178.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.675 HG12 ' H ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -123.23 158.95 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.035 -1.04 . . . . 0.0 109.624 179.833 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -65.8 57.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.535 -0.728 . . . . 0.0 110.492 -178.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 169.46 -33.54 0.18 Allowed Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.307 -1.425 . . . . 0.0 111.295 179.089 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.675 ' H ' HG12 ' A' ' 50' ' ' VAL . 88.8 mt-10 -159.74 165.61 32.14 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.9 -1.353 . . . . 0.0 110.486 -179.544 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 t -97.32 125.78 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.801 . . . . 0.0 109.19 178.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HE2' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -120.38 146.01 46.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.927 -1.108 . . . . 0.0 110.745 -179.273 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -111.75 87.76 2.64 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.446 -0.784 . . . . 0.0 108.918 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 63.2 m -66.9 139.42 57.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.908 . . . . 0.0 109.186 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -106.57 134.36 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.277 -179.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.699 HD12 ' SG ' ' A' ' 46' ' ' CYS . 31.4 mt -121.85 144.87 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.4 -0.813 . . . . 0.0 108.822 179.233 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.019 -1.05 . . . . 0.0 109.032 -179.703 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.7 p . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.523 0.678 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.65 -27.1 68.7 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.612 -0.68 . . . . 0.0 109.715 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 83' ' ' LEU . 64.0 mttp -59.55 -44.78 93.15 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.826 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.38 -37.96 87.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.336 -0.853 . . . . 0.0 109.328 179.103 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 81' ' ' LEU . 7.5 tt -57.6 -41.95 82.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 108.914 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.47 -45.23 98.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.048 -1.033 . . . . 0.0 109.298 179.591 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.495 ' H ' HD12 ' A' ' 83' ' ' LEU . 6.4 mp -62.53 -37.74 87.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.871 -1.143 . . . . 0.0 109.58 179.417 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.405 ' O ' ' OG1' ' A' ' 88' ' ' THR . 11.6 t-160 -59.53 -46.69 88.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.524 -0.735 . . . . 0.0 110.966 -179.217 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.584 ' HB2' HD12 ' A' ' 101' ' ' LEU . 4.4 m-85 -67.59 -28.4 67.73 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.498 -1.376 . . . . 0.0 109.585 -179.624 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.505 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 1.2 tm0? -58.91 -38.06 78.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 109.164 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -86.14 -36.16 19.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.134 -0.979 . . . . 0.0 109.276 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.544 ' O ' ' O ' ' A' ' 85' ' ' TYR . 1.8 p -90.05 139.38 30.67 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.373 -0.83 . . . . 0.0 109.675 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.445 ' HA ' HG22 ' A' ' 100' ' ' THR . 37.3 m -93.1 140.57 29.35 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.601 0.715 . . . . 0.0 109.835 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.655 ' O ' ' C ' ' A' ' 91' ' ' VAL . 5.8 mt -61.09 -41.14 96.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 111.238 -178.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.783 ' N ' ' O ' ' A' ' 97' ' ' LEU . 87.2 t 16.29 -83.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 121.41 -0.806 . . . . 0.0 109.834 -179.44 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 90' ' ' LEU . 1.3 tp60 75.77 -176.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 110.222 179.282 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -60.09 -38.74 83.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.642 -0.661 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -52.52 -24.95 9.04 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.013 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 61.53 20.31 11.12 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 178.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.0 m -130.51 7.26 4.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.693 -1.254 . . . . 0.0 111.172 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.783 ' O ' ' N ' ' A' ' 91' ' ' VAL . 83.2 mt -98.5 53.67 1.04 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.09 78.47 3.63 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.548 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.626 HG21 HG23 ' A' ' 50' ' ' VAL . 53.2 t -154.31 147.92 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.809 0.814 . . . . 0.0 109.533 179.377 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 89' ' ' SER . 48.2 p -121.24 153.67 37.34 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.316 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.808 HD22 ' CG ' ' A' ' 33' ' ' PHE . 79.0 mt -82.25 71.05 9.31 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.244 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . . . -107.38 -17.87 14.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.62 -0.675 . . . . 0.0 112.074 -178.09 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -110.91 123.77 34.59 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.573 -1.329 . . . . 0.0 110.083 -178.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 55.2 Cg_endo -77.45 145.06 23.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.488 2.125 . . . . 0.0 110.636 178.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.905 HG13 ' CD2' ' A' ' 106' ' ' TYR . 12.0 p -72.21 -22.01 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.535 -1.353 . . . . 0.0 109.38 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.905 ' CD2' HG13 ' A' ' 105' ' ' VAL . 72.3 m-85 -129.19 64.35 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.768 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 108.819 179.451 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 3' ' ' LEU . 96.8 mt . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.416 ' O ' ' OG1' ' A' ' 10' ' ' THR . 24.2 Cg_endo -65.11 -8.44 18.42 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.175 1.917 . . . . 0.0 111.778 -179.216 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.686 ' CG ' HD21 ' A' ' 83' ' ' LEU . 89.9 m-70 -65.94 -26.5 67.61 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.538 -0.726 . . . . 0.0 109.809 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -64.23 -29.82 70.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.982 -1.074 . . . . 0.0 110.036 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.488 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 95.6 m-20 -105.06 131.52 52.46 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.085 -1.01 . . . . 0.0 110.332 -179.545 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 12' ' ' ASN . 91.5 mt-10 -69.69 -23.3 63.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.536 -0.727 . . . . 0.0 109.504 179.325 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.43 ' CG ' ' N ' ' A' ' 10' ' ' THR . 34.5 pttt -61.36 -31.57 71.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.409 -0.807 . . . . 0.0 111.367 -178.823 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.559 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 53.6 p -70.61 -24.9 62.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.769 -1.207 . . . . 0.0 110.914 -178.452 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.605 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -124.51 -29.6 3.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.643 -1.285 . . . . 0.0 110.419 179.057 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 8' ' ' GLU . 49.0 t-20 -86.3 123.38 31.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 110.651 -178.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 13' ' ' VAL . 7.4 p -101.62 0.59 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.43 -0.794 . . . . 0.0 109.19 179.278 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.49 -153.69 52.22 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 88.2 p -68.9 148.32 50.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.378 -1.072 . . . . 0.0 108.429 179.201 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.56 ' O ' ' CZ ' ' A' ' 36' ' ' ARG . 47.3 t -175.16 156.34 2.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 108.826 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.641 ' ND2' ' CG ' ' A' ' 19' ' ' ASN . 49.9 t30 -78.19 140.8 38.94 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.543 179.832 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.948 ' N ' HH22 ' A' ' 36' ' ' ARG . 42.3 mtt-85 -60.18 -34.42 73.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.253 -0.904 . . . . 0.0 110.701 -179.181 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.645 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 42.3 p-10 -60.02 -40.33 88.94 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.804 -1.185 . . . . 0.0 108.702 179.773 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.645 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 62.1 tttp -64.24 -40.92 97.03 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.322 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.01 76.99 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.31 -0.869 . . . . 0.0 108.91 179.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 26' ' ' ARG . 98.1 mt-10 -59.57 -48.94 79.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.175 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.687 ' OD1' ' N ' ' A' ' 24' ' ' LEU . 8.6 p30 -60.02 -40.06 87.98 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.687 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 85.1 mt -66.99 -29.96 69.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.245 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.7 mt -93.7 -7.7 42.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.628 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 22' ' ' GLU . 2.0 ttm180 -97.23 128.77 44.4 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.277 -0.89 . . . . 0.0 109.789 -179.526 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.69 16.99 78.31 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.464 ' O ' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -110.16 133.37 53.29 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.537 -0.978 . . . . 0.0 109.642 -179.91 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -60.65 156.73 16.03 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.901 0.858 . . . . 0.0 111.106 -179.488 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 50' ' ' VAL . 87.7 m-20 -63.85 151.85 41.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.586 -0.696 . . . . 0.0 109.383 179.012 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.401 ' HA2' HG13 ' A' ' 99' ' ' VAL . . . 99.03 -22.04 42.9 Favored Glycine 0 N--CA 1.499 2.888 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.165 179.473 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.2 m -83.57 121.41 27.2 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.085 -1.244 . . . . 0.0 108.604 179.427 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.524 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -137.74 162.95 32.54 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.902 -1.124 . . . . 0.0 110.066 179.941 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.11 147.37 40.14 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.067 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 11' ' ' TRP . 54.9 t -92.58 132.03 38.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.04 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.948 HH22 ' N ' ' A' ' 18' ' ' ARG . 7.6 ttt180 -142.41 -172.65 3.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.267 -0.896 . . . . 0.0 108.86 -178.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.719 ' H ' ' CG ' ' A' ' 36' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--N 1.304 -1.371 0 O-C-N 120.985 -1.072 . . . . 0.0 108.952 -179.948 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.595 ' O ' ' O ' ' A' ' 59' ' ' ILE . 30.5 m-85 . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.445 0.641 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.598 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -175.8 145.12 0.66 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.062 -1.024 . . . . 0.0 108.477 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 57' ' ' CYS . 31.8 p -125.24 154.85 41.03 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.561 -1.337 . . . . 0.0 109.268 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.568 ' OG ' ' O ' ' A' ' 55' ' ' LYS . 41.1 t -119.75 138.9 53.04 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.636 0.731 . . . . 0.0 110.344 -178.519 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -130.73 146.0 34.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.463 -0.773 . . . . 0.0 109.388 179.88 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 28' ' ' LYS . 40.1 t -91.75 133.36 33.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.475 -0.766 . . . . 0.0 109.13 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 52' ' ' GLY . 0.7 OUTLIER -122.49 163.13 21.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.256 -0.977 . . . . 0.0 110.667 -179.77 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.528 ' C ' ' OD1' ' A' ' 51' ' ' ASP . 47.5 p30 -62.89 50.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.665 -179.06 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 178.48 -43.22 0.09 OUTLIER Glycine 0 C--N 1.295 -1.695 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.896 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 44.6 mm-40 -158.87 166.81 31.02 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.07 -1.253 . . . . 0.0 111.224 -179.324 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.424 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 5.3 m -73.11 146.92 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.525 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.568 ' O ' ' OG ' ' A' ' 47' ' ' SER . 11.2 mmtm -113.63 146.66 39.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.889 -1.132 . . . . 0.0 110.557 -179.335 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -125.54 65.79 1.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.61 -0.681 . . . . 0.0 109.687 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 74.4 m -59.47 144.91 45.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.073 -1.017 . . . . 0.0 108.891 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.4 138.49 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.932 0.872 . . . . 0.0 112.127 -178.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.595 ' O ' ' O ' ' A' ' 44' ' ' TYR . 48.4 mm -115.74 133.45 62.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.141 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.503 2.204 0 O-C-N 120.564 -1.335 . . . . 0.0 110.917 -178.287 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.278 0.561 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 78' ' ' LEU . 76.5 mt -59.56 -40.36 87.04 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -55.38 -40.61 71.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.444 -0.785 . . . . 0.0 109.379 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.19 -40.49 96.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.442 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.8 tt -58.82 -43.7 90.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.098 -179.349 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.67 -38.64 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.76 -1.212 . . . . 0.0 109.188 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.686 HD21 ' CG ' ' A' ' 5' ' ' HIS . 90.7 mt -74.89 -38.53 61.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.063 -1.023 . . . . 0.0 110.437 -179.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 -64.7 -39.36 93.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.802 -1.186 . . . . 0.0 109.792 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -66.82 -27.66 67.74 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.149 -0.97 . . . . 0.0 108.875 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.644 ' HG3' ' HB2' ' A' ' 102' ' ' ALA . 41.6 tt0 -63.79 -34.72 78.53 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.539 -0.726 . . . . 0.0 109.292 178.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -90.62 -13.47 34.3 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.028 -1.045 . . . . 0.0 110.163 -179.152 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.1 m -100.71 136.04 41.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 110.438 -179.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 t -85.99 125.55 33.47 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.282 -0.886 . . . . 0.0 108.934 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.722 ' O ' ' N ' ' A' ' 92' ' ' GLN . 87.1 mt -66.87 -20.05 65.85 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.407 -0.808 . . . . 0.0 110.332 -179.243 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.728 ' N ' ' O ' ' A' ' 97' ' ' LEU . 11.8 p -15.17 -48.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 O-C-N 121.684 -0.635 . . . . 0.0 110.372 179.457 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.722 ' N ' ' O ' ' A' ' 90' ' ' LEU . 34.0 tt0 53.92 179.41 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.483 -0.761 . . . . 0.0 110.807 178.777 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.547 ' H ' ' CG ' ' A' ' 92' ' ' GLN . 91.4 m-70 -60.06 -29.53 68.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.587 -0.695 . . . . 0.0 109.383 -179.719 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -56.96 -24.01 49.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.083 -1.011 . . . . 0.0 108.795 179.361 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.474 ' HA ' HG22 ' A' ' 91' ' ' VAL . 27.5 t70 61.93 41.67 11.09 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.518 -0.739 . . . . 0.0 110.432 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.7 m -148.19 -2.56 0.52 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.648 -1.283 . . . . 0.0 111.151 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 92.8 mt -102.16 52.0 0.81 Allowed 'General case' 0 C--N 1.29 -2.006 0 O-C-N 121.13 -0.982 . . . . 0.0 108.413 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.63 ' ND2' HG23 ' A' ' 91' ' ' VAL . 3.3 m-80 -78.09 70.35 4.44 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.769 0.795 . . . . 0.0 109.807 -178.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.401 HG13 ' HA2' ' A' ' 31' ' ' GLY . 25.9 t -149.67 153.02 11.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.2 p -124.21 156.99 35.83 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.524 HD22 ' CG ' ' A' ' 33' ' ' PHE . 30.7 mt -82.58 69.48 9.36 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.912 -1.117 . . . . 0.0 108.694 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.644 ' HB2' ' HG3' ' A' ' 86' ' ' GLN . . . -105.09 -18.79 14.03 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.508 -0.745 . . . . 0.0 112.077 -178.004 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -112.44 109.62 53.59 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.414 -1.429 . . . . 0.0 112.101 -177.709 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.404 ' HG2' ' CG ' ' A' ' 4' ' ' PRO . 23.4 Cg_exo -62.35 143.72 94.12 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.074 1.85 . . . . 0.0 111.169 178.153 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.537 HG13 ' CD2' ' A' ' 106' ' ' TYR . 12.5 p -68.66 -36.92 76.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 120.745 -1.222 . . . . 0.0 108.904 179.345 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.537 ' CD2' HG13 ' A' ' 105' ' ' VAL . 55.7 m-85 -109.13 42.48 1.43 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.386 -0.821 . . . . 0.0 109.61 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 108.857 -179.986 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -51.51 -14.64 2.05 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.812 1.675 . . . . 0.0 110.925 179.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.466 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 91.1 m-70 -66.47 -12.93 59.84 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.541 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -63.42 -32.28 73.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 108.85 179.011 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.575 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 92.3 m-20 -100.53 134.19 43.85 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.352 -0.843 . . . . 0.0 110.004 -179.666 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 12' ' ' ASN . 95.5 mt-10 -69.27 -27.26 65.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 109.988 179.566 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.507 ' CG ' ' N ' ' A' ' 10' ' ' THR . 33.3 pttt -60.79 -35.46 76.53 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 110.508 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.669 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 10.6 p -59.75 -33.39 71.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 110.113 -178.827 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.669 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -120.78 -37.27 3.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.893 -1.129 . . . . 0.0 110.165 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -86.21 123.85 31.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.993 -1.067 . . . . 0.0 110.47 -179.214 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.474 ' O ' HG12 ' A' ' 13' ' ' VAL . 74.5 t -94.05 -4.95 10.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.79 -162.15 19.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.498 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -80.68 61.55 4.4 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.318 -1.107 . . . . 0.0 109.417 -179.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.1 p -79.2 156.7 28.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.299 -0.876 . . . . 0.0 109.092 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -70.18 142.72 52.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.191 -0.943 . . . . 0.0 109.453 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.618 HH11 ' NH2' ' A' ' 36' ' ' ARG . 48.6 mtt-85 -59.46 -38.81 81.75 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.054 -1.029 . . . . 0.0 109.388 179.816 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.65 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 40.0 p-10 -62.65 -42.82 99.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.0 -1.062 . . . . 0.0 108.484 179.363 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.65 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 80.3 tttt -60.51 -36.6 78.74 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.233 -0.917 . . . . 0.0 109.066 179.41 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.71 ' CB ' HH11 ' A' ' 36' ' ' ARG . . . -58.57 -34.03 70.59 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.647 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 75.3 tt0 -58.7 -42.63 89.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.247 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.68 -46.94 87.54 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.697 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -67.16 -33.86 76.32 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.863 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.883 HD11 ' OG ' ' A' ' 47' ' ' SER . 22.7 mt -80.85 -16.01 54.82 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.146 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.742 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -74.61 122.43 23.15 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.555 -179.727 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.82 19.54 78.83 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.518 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.505 ' HE2' HG21 ' A' ' 32' ' ' THR . 0.2 OUTLIER -97.18 135.79 38.62 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.359 -1.083 . . . . 0.0 109.685 -179.446 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.699 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.9 OUTLIER -74.88 157.63 34.74 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.66 0.743 . . . . 0.0 110.157 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.513 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 48.4 p30 -62.25 169.36 2.85 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.283 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.88 -28.44 1.89 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.505 HG21 ' HE2' ' A' ' 28' ' ' LYS . 76.7 m -80.56 121.03 25.29 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.869 -1.371 . . . . 0.0 108.984 179.658 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.806 ' HB2' HG22 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -136.06 167.26 21.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.908 -1.12 . . . . 0.0 110.517 -179.32 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 1.1 pt? -148.91 161.29 42.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.454 -0.779 . . . . 0.0 110.588 179.475 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.475 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 65.8 t -106.74 132.73 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.37 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.71 HH11 ' CB ' ' A' ' 21' ' ' ALA . 35.6 ptt180 -147.75 173.14 13.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 108.884 -178.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.479 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 53.0 mt-10 . . . . . 0 C--N 1.304 -1.389 0 O-C-N 120.83 -1.169 . . . . 0.0 109.268 179.447 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.608 ' O ' ' O ' ' A' ' 59' ' ' ILE . 57.2 m-85 . . . . . 0 N--CA 1.495 1.775 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 57' ' ' CYS . . . -159.75 153.88 23.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.77 -1.207 . . . . 0.0 109.973 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' CYS . 85.4 m -109.5 125.86 52.93 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.563 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.883 ' OG ' HD11 ' A' ' 25' ' ' LEU . 26.1 t -92.05 127.0 37.36 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.06 -179.682 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.806 HG22 ' HB2' ' A' ' 33' ' ' PHE . 74.3 t -126.1 163.71 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.187 -0.946 . . . . 0.0 109.978 -179.403 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.602 ' N ' HG12 ' A' ' 48' ' ' VAL . 39.2 t -124.6 132.76 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.701 HG23 ' CG2' ' A' ' 99' ' ' VAL . 11.4 p -123.34 156.35 29.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.995 -1.066 . . . . 0.0 109.671 -179.782 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.423 ' OD1' ' OD2' ' A' ' 30' ' ' ASP . 87.2 m-20 -49.97 -17.17 0.35 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.943 0.878 . . . . 0.0 109.634 -179.429 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.581 ' O ' ' OE2' ' A' ' 53' ' ' GLU . . . -86.18 -59.22 1.88 Allowed Glycine 0 C--N 1.287 -2.142 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.667 -179.175 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.581 ' OE2' ' O ' ' A' ' 52' ' ' GLY . 61.3 mm-40 -163.22 -165.53 1.1 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.25 -1.147 . . . . 0.0 110.554 -178.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.56 ' CG1' HD13 ' A' ' 25' ' ' LEU . 88.8 t -93.36 123.37 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.319 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.455 ' NZ ' HG11 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -122.45 149.15 44.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.911 -1.118 . . . . 0.0 110.905 -179.495 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.704 ' CD2' ' NH2' ' A' ' 36' ' ' ARG . 23.6 m80 -113.31 101.88 9.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.579 -0.701 . . . . 0.0 109.544 179.194 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' CYS . 52.5 t -72.91 130.04 39.5 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.26 138.63 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.246 -0.909 . . . . 0.0 111.878 -177.876 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.608 ' O ' ' O ' ' A' ' 44' ' ' TYR . 10.9 mm -124.93 111.59 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 . . . . . 0 N--CA 1.5 2.055 0 O-C-N 120.647 -1.283 . . . . 0.0 112.182 -178.248 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.559 0.695 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.16 -34.05 73.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 110.03 179.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.72 -43.74 80.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.188 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -66.9 -30.53 70.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.228 -0.92 . . . . 0.0 108.856 179.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.904 HD21 ' CE2' ' A' ' 85' ' ' TYR . 9.2 tt -60.6 -40.9 93.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 108.987 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.2 t -66.86 -44.17 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.361 -0.837 . . . . 0.0 109.819 179.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.426 HD21 ' CB ' ' A' ' 5' ' ' HIS . 85.0 mt -67.45 -43.09 81.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.419 -0.8 . . . . 0.0 110.439 -179.119 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -60.02 -40.56 89.72 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.215 -179.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.904 ' CE2' HD21 ' A' ' 81' ' ' LEU . 7.4 m-30 -67.34 -24.31 65.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 0.0 108.789 -179.783 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.453 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 38.1 tt0 -61.32 -36.94 81.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 178.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -91.44 -16.71 26.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.303 -0.873 . . . . 0.0 109.592 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.4 m -100.84 129.92 46.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.131 -0.981 . . . . 0.0 109.228 179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.543 ' HA ' HG22 ' A' ' 100' ' ' THR . 34.8 t -81.67 132.56 35.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 109.915 -179.627 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 91' ' ' VAL . 76.2 mt -69.01 -13.07 62.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.477 -0.764 . . . . 0.0 109.715 179.23 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.76 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.8 p -36.66 -33.75 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.464 -0.773 . . . . 0.0 110.011 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.45 ' N ' HG13 ' A' ' 91' ' ' VAL . 20.0 tt0 -65.86 -50.07 65.86 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 -178.658 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLN . 84.3 t60 -51.43 -47.53 63.0 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 179.443 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.689 ' O ' ' N ' ' A' ' 96' ' ' SER . 13.1 t-20 -126.29 111.25 14.33 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.477 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.54 ' C ' ' O ' ' A' ' 94' ' ' ASN . 99.7 m-20 -35.98 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.886 -178.488 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 94' ' ' ASN . 71.1 m -108.37 27.07 9.71 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.736 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.76 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.5 mt -97.96 65.84 1.81 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.563 -1.336 . . . . 0.0 108.2 178.676 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.403 ' C ' HG23 ' A' ' 99' ' ' VAL . 0.8 OUTLIER -79.79 75.57 6.47 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.81 -1.182 . . . . 0.0 109.41 -178.998 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.701 ' CG2' HG23 ' A' ' 50' ' ' VAL . 84.5 t -153.56 153.62 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.522 -0.736 . . . . 0.0 109.805 -179.266 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.543 HG22 ' HA ' ' A' ' 89' ' ' SER . 70.2 p -134.33 156.79 47.85 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.154 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.57 HD22 ' CG ' ' A' ' 33' ' ' PHE . 11.6 mt -76.48 71.65 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.706 -1.246 . . . . 0.0 108.007 179.333 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.3 -33.76 9.91 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.169 -0.957 . . . . 0.0 112.111 -177.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.4 m-85 -113.97 109.29 49.93 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.503 -1.373 . . . . 0.0 111.977 -177.654 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.523 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 19.0 Cg_exo -59.97 148.61 88.21 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.083 1.855 . . . . 0.0 110.276 176.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.502 HG13 ' CD2' ' A' ' 106' ' ' TYR . 9.1 p -67.25 -34.59 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.822 -1.174 . . . . 0.0 108.77 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.502 ' CD2' HG13 ' A' ' 105' ' ' VAL . 38.6 m-85 -108.14 39.4 1.97 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.447 -0.783 . . . . 0.0 110.191 179.828 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.523 ' HB2' ' CG ' ' A' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.497 1.905 0 O-C-N 120.996 -1.065 . . . . 0.0 109.599 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 121.438 0.637 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -67.08 145.58 55.19 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.293 -0.879 . . . . 0.0 108.845 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.9 mt -93.84 139.26 22.63 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.57 -3.02 10.29 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.612 2.208 . . . . 0.0 112.103 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -66.78 -29.71 69.73 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -63.36 -22.37 66.84 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.583 ' O ' ' OG1' ' A' ' 10' ' ' THR . 94.9 m-20 -92.25 119.95 32.34 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.52 0.676 . . . . 0.0 110.441 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 72.3 tt0 -69.32 -40.33 77.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.59 -0.694 . . . . 0.0 109.496 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.58 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -64.1 -20.53 66.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.655 -0.653 . . . . 0.0 111.443 -178.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.583 ' OG1' ' O ' ' A' ' 7' ' ' ASP . 7.6 p -64.49 -37.31 87.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.794 -1.191 . . . . 0.0 110.196 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.588 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -119.24 -14.81 9.23 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.939 -1.1 . . . . 0.0 109.819 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 8' ' ' GLU . 62.6 t30 -89.7 120.07 30.65 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 110.599 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.715 ' CG2' HD13 ' A' ' 34' ' ' LEU . 27.7 m -137.97 36.28 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.89 -33.54 20.74 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 85.6 p -63.05 -31.98 73.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.945 -1.327 . . . . 0.0 109.036 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.8 t -61.6 138.51 58.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.379 -0.826 . . . . 0.0 109.718 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -81.57 163.91 22.29 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.299 -0.876 . . . . 0.0 109.867 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -57.17 -44.78 83.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -0.817 . . . . 0.0 109.465 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -65.36 -42.72 92.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.069 -1.019 . . . . 0.0 108.638 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -61.05 -36.25 79.09 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.48 -37.33 77.97 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.53 -0.731 . . . . 0.0 109.646 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 26' ' ' ARG . 81.3 mm-40 -58.39 -45.19 88.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.109 -0.994 . . . . 0.0 108.384 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 23' ' ' ASN . 9.8 m120 -62.09 -44.19 97.21 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.421 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 82.4 mt -64.4 -40.2 95.32 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.413 -0.804 . . . . 0.0 108.87 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.729 HD13 ' CG1' ' A' ' 54' ' ' VAL . 36.7 mt -75.73 -29.93 59.06 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.568 ' NH1' ' HG2' ' A' ' 26' ' ' ARG . 31.6 mtt-85 -79.63 136.3 36.79 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.717 -0.614 . . . . 0.0 109.645 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.78 -8.65 76.45 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 24' ' ' LEU . 28.7 mmtm -96.12 137.85 34.58 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.242 -1.152 . . . . 0.0 109.878 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -69.52 162.78 26.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.459 -0.775 . . . . 0.0 109.191 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.611 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 73.9 m-20 -60.18 142.91 53.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.372 -0.83 . . . . 0.0 109.189 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.39 -30.51 8.47 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.0 m -76.16 135.78 39.79 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.239 -1.154 . . . . 0.0 109.044 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.889 ' CD1' HD13 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -140.84 162.94 34.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.938 -1.101 . . . . 0.0 108.923 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.715 HD13 ' CG2' ' A' ' 13' ' ' VAL . 2.8 pp -134.16 154.55 51.15 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.122 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.043 HG22 ' SG ' ' A' ' 46' ' ' CYS . 95.5 t -113.65 138.24 44.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.559 ' NH1' ' HG3' ' A' ' 36' ' ' ARG . 5.4 ptm180 -150.51 169.96 20.26 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.037 -1.04 . . . . 0.0 109.362 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.586 ' C ' ' H ' ' A' ' 39' ' ' SER . 3.2 pt-20 -101.23 175.8 5.46 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.938 -1.101 . . . . 0.0 108.838 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.598 ' O ' ' OG ' ' A' ' 39' ' ' SER . 39.8 m -77.86 9.09 3.8 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.607 ' OG ' ' N ' ' A' ' 40' ' ' LYS . 21.2 p 85.19 -77.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.366 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.607 ' N ' ' OG ' ' A' ' 39' ' ' SER . 96.7 mttt -100.09 -25.92 14.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -0.967 . . . . 0.0 110.187 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -84.14 150.41 25.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.004 -1.06 . . . . 0.0 109.229 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.32 5.48 20.5 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 120.277 -0.963 . . . . 0.0 110.893 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.6 t -78.77 143.58 35.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.811 -1.406 . . . . 0.0 109.036 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.593 ' O ' ' O ' ' A' ' 59' ' ' ILE . 97.7 m-85 -113.16 161.24 17.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.135 -0.978 . . . . 0.0 109.903 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -164.66 144.4 7.35 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.022 -1.049 . . . . 0.0 109.357 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 1.043 ' SG ' HG22 ' A' ' 35' ' ' VAL . 78.5 m -121.02 136.84 54.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.495 ' OG ' HD11 ' A' ' 25' ' ' LEU . 92.6 p -105.19 143.36 33.47 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.554 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.806 HG22 ' HB2' ' A' ' 33' ' ' PHE . 43.7 t -125.06 158.95 32.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.574 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.454 ' N ' HG12 ' A' ' 48' ' ' VAL . 67.9 t -109.92 130.99 62.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.935 HG12 ' H ' ' A' ' 52' ' ' GLY . 9.9 t -123.22 152.13 27.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.132 -0.98 . . . . 0.0 110.652 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.611 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 66.0 t0 -50.34 -12.03 0.08 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.547 0.689 . . . . 0.0 109.858 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.935 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -104.9 -49.96 0.98 Allowed Glycine 0 C--N 1.287 -2.142 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.253 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.55 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 75.0 mt-10 -161.29 177.01 10.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.885 -1.362 . . . . 0.0 111.209 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.729 ' CG1' HD13 ' A' ' 25' ' ' LEU . 53.5 t -89.64 135.13 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.8 161.9 18.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.986 -1.071 . . . . 0.0 111.484 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -124.06 76.07 1.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 88.4 m -60.83 146.45 46.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.168 -0.957 . . . . 0.0 109.382 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 58' ' ' VAL . 5.5 p -106.26 135.87 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.22 -0.925 . . . . 0.0 111.467 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.73 HD12 ' SG ' ' A' ' 46' ' ' CYS . 64.6 mt -124.81 141.47 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 66' ' ' TYR . 49.3 t30 -143.51 119.72 10.82 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.162 -1.586 . . . . 0.0 111.331 -177.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' NZ ' ' CB ' ' A' ' 61' ' ' LYS . 8.6 mtmp? -94.16 119.57 33.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.491 -0.756 . . . . 0.0 110.465 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.552 ' O ' ' C ' ' A' ' 63' ' ' ALA . 91.5 m -138.96 165.92 25.84 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.552 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -37.55 -35.78 0.14 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.902 -1.124 . . . . 0.0 108.077 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.685 HG22 ' O ' ' A' ' 64' ' ' THR . 84.1 m -138.03 39.34 2.34 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.773 -0.579 . . . . 0.0 109.593 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.702 ' O ' ' CD2' ' A' ' 66' ' ' TYR . . . -139.55 158.05 25.37 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.702 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 97.6 m-85 -168.07 -8.17 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.527 -0.984 . . . . 0.0 109.207 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.01 -72.94 0.23 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 76.8 m-85 -97.33 110.63 23.15 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 68' ' ' PHE . . . 176.8 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.878 -1.139 . . . . 0.0 109.617 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.646 ' O ' ' O ' ' A' ' 73' ' ' ASN . 76.6 mm-40 -119.57 153.81 54.27 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.476 ' C ' ' O ' ' A' ' 70' ' ' GLU . 84.0 Cg_exo -34.29 -41.62 0.24 Allowed 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 121.835 1.69 . . . . 0.0 111.022 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -69.22 -44.33 72.28 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.282 -0.886 . . . . 0.0 109.041 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.646 ' O ' ' O ' ' A' ' 70' ' ' GLU . 52.3 p30 -122.36 142.98 49.94 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.524 -0.735 . . . . 0.0 109.887 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 98.8 mt -145.34 99.54 3.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.626 -1.296 . . . . 0.0 109.683 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.69 ' OH ' ' ND1' ' A' ' 84' ' ' HIS . 92.5 m-85 -79.88 130.25 35.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 110.25 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.0 m -90.75 -34.59 15.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.406 -0.809 . . . . 0.0 111.022 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.7 m -126.67 155.93 41.84 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.639 -1.288 . . . . 0.0 110.545 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 78' ' ' LEU . 82.1 mt -68.02 -29.84 68.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.731 . . . . 0.0 110.053 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -58.9 -42.83 90.53 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -68.61 -35.39 77.26 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.568 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.5 tt -59.49 -49.49 77.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.396 -0.815 . . . . 0.0 109.204 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.803 HG13 HD21 ' A' ' 101' ' ' LEU . 99.0 t -61.28 -43.22 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.581 -0.699 . . . . 0.0 109.745 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.61 -51.5 67.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.035 -1.041 . . . . 0.0 110.608 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.699 ' CE1' ' OG1' ' A' ' 88' ' ' THR . 59.3 t-80 -71.47 -36.36 71.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.77 -1.206 . . . . 0.0 110.457 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.751 ' OH ' HD21 ' A' ' 90' ' ' LEU . 29.1 t80 -59.98 -20.62 58.62 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.909 -1.119 . . . . 0.0 108.842 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.503 ' CG ' ' O ' ' A' ' 101' ' ' LEU . 1.1 tm0? -80.07 -25.8 39.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.234 -0.916 . . . . 0.0 108.626 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -97.8 -7.56 30.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.218 -0.926 . . . . 0.0 109.07 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.699 ' OG1' ' CE1' ' A' ' 84' ' ' HIS . 32.4 m -96.99 139.77 32.51 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.214 -0.929 . . . . 0.0 109.152 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.527 ' OG ' HG12 ' A' ' 91' ' ' VAL . 40.6 t -87.65 130.24 34.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.14 -0.975 . . . . 0.0 109.358 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.751 HD21 ' OH ' ' A' ' 85' ' ' TYR . 10.4 mp -71.82 -17.23 62.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.316 -0.865 . . . . 0.0 109.972 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.703 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.6 p -37.52 -41.93 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.175 -0.953 . . . . 0.0 110.162 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.473 ' N ' HG13 ' A' ' 91' ' ' VAL . 54.9 tt0 -47.95 -30.34 4.15 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.484 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.842 ' HB2' HD12 ' A' ' 97' ' ' LEU . 94.4 m-70 -83.44 130.31 35.02 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.089 -1.007 . . . . 0.0 108.989 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 58.22 7.73 0.7 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.46 ' H ' ' C ' ' A' ' 93' ' ' HIS . 54.7 t0 45.25 35.01 1.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.418 -0.801 . . . . 0.0 109.197 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 55.9 m -156.95 15.48 0.28 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.817 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.842 HD12 ' HB2' ' A' ' 93' ' ' HIS . 68.0 mt -101.62 73.91 1.48 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -79.1 85.15 5.02 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.727 0.775 . . . . 0.0 109.928 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.401 HG22 ' N ' ' A' ' 100' ' ' THR . 8.1 p -165.44 163.57 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.733 0.778 . . . . 0.0 109.081 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 102' ' ' ALA . 68.0 p -135.16 131.96 37.42 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.937 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -52.43 95.57 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.406 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -91.81 -51.53 5.18 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.403 -1.436 . . . . 0.0 111.888 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -129.06 137.37 30.86 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.743 -1.223 . . . . 0.0 112.043 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.46 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 32.6 Cg_exo -52.98 160.53 4.1 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.232 1.955 . . . . 0.0 111.28 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.413 ' H ' HG12 ' A' ' 105' ' ' VAL . 3.2 p -74.27 -31.82 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.685 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -112.03 34.14 4.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.875 . . . . 0.0 109.281 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 104' ' ' PRO . . . -77.65 -42.09 35.97 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.548 -0.72 . . . . 0.0 109.706 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -67.78 -29.85 69.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.892 . . . . 0.0 110.508 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -93.1 126.02 37.99 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.086 -1.009 . . . . 0.0 110.234 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -130.2 150.14 51.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.372 -0.83 . . . . 0.0 109.448 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.716 ' CG ' HH11 ' A' ' 111' ' ' ARG . 1.4 mtt-85 . . . . . 0 C--N 1.298 -1.656 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.23 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.469 0.652 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.33 140.25 58.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -0.966 . . . . 0.0 109.265 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.1 mt -100.79 134.1 20.72 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.14 -0.975 . . . . 0.0 109.392 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -51.51 -14.64 2.05 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.812 1.675 . . . . 0.0 110.925 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.466 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 91.1 m-70 -66.47 -12.93 59.84 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -63.42 -32.28 73.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 108.85 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.575 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 92.3 m-20 -100.53 134.19 43.85 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.352 -0.843 . . . . 0.0 110.004 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 12' ' ' ASN . 95.5 mt-10 -69.27 -27.26 65.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 109.988 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.507 ' CG ' ' N ' ' A' ' 10' ' ' THR . 33.3 pttt -60.79 -35.46 76.53 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 110.508 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.669 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 10.6 p -59.75 -33.39 71.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 110.113 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.669 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -120.78 -37.27 3.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.893 -1.129 . . . . 0.0 110.165 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -86.21 123.85 31.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.993 -1.067 . . . . 0.0 110.47 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.474 ' O ' HG12 ' A' ' 13' ' ' VAL . 74.5 t -94.05 -4.95 10.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.79 -162.15 19.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -80.68 61.55 4.4 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.318 -1.107 . . . . 0.0 109.417 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.1 p -79.2 156.7 28.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.299 -0.876 . . . . 0.0 109.092 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -70.18 142.72 52.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.191 -0.943 . . . . 0.0 109.453 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.618 HH11 ' NH2' ' A' ' 36' ' ' ARG . 48.6 mtt-85 -59.46 -38.81 81.75 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.054 -1.029 . . . . 0.0 109.388 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.65 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 40.0 p-10 -62.65 -42.82 99.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.0 -1.062 . . . . 0.0 108.484 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.65 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 80.3 tttt -60.51 -36.6 78.74 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.233 -0.917 . . . . 0.0 109.066 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.71 ' CB ' HH11 ' A' ' 36' ' ' ARG . . . -58.57 -34.03 70.59 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.647 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 75.3 tt0 -58.7 -42.63 89.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.68 -46.94 87.54 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.697 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -67.16 -33.86 76.32 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.883 HD11 ' OG ' ' A' ' 47' ' ' SER . 22.7 mt -80.85 -16.01 54.82 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.742 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -74.61 122.43 23.15 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.555 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.82 19.54 78.83 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.505 ' HE2' HG21 ' A' ' 32' ' ' THR . 0.2 OUTLIER -97.18 135.79 38.62 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.359 -1.083 . . . . 0.0 109.685 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.699 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.9 OUTLIER -74.88 157.63 34.74 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.66 0.743 . . . . 0.0 110.157 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.513 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 48.4 p30 -62.25 169.36 2.85 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.88 -28.44 1.89 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.505 HG21 ' HE2' ' A' ' 28' ' ' LYS . 76.7 m -80.56 121.03 25.29 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.869 -1.371 . . . . 0.0 108.984 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.806 ' HB2' HG22 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -136.06 167.26 21.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.908 -1.12 . . . . 0.0 110.517 -179.32 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 1.1 pt? -148.91 161.29 42.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.454 -0.779 . . . . 0.0 110.588 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.475 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 65.8 t -106.74 132.73 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.71 HH11 ' CB ' ' A' ' 21' ' ' ALA . 35.6 ptt180 -147.75 173.14 13.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 108.884 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.661 ' C ' ' H ' ' A' ' 39' ' ' SER . 53.0 mt-10 -124.33 170.54 10.7 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.83 -1.169 . . . . 0.0 109.268 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.646 ' O ' ' CB ' ' A' ' 39' ' ' SER . 57.7 m -75.39 15.51 0.45 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.661 ' H ' ' C ' ' A' ' 37' ' ' GLU . 6.4 t 97.86 131.03 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.828 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.473 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 67.1 mmtt 62.32 -143.77 0.4 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.508 -0.745 . . . . 0.0 109.103 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -101.57 20.11 16.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -0.847 . . . . 0.0 109.629 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.06 -52.62 51.03 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.062 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 44' ' ' TYR . 53.1 t -161.0 166.58 28.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.99 -1.3 . . . . 0.0 110.246 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.608 ' O ' ' O ' ' A' ' 59' ' ' ILE . 57.2 m-85 -123.66 145.83 48.67 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.279 -0.888 . . . . 0.0 109.048 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 57' ' ' CYS . . . -159.75 153.88 23.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.77 -1.207 . . . . 0.0 109.973 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' CYS . 85.4 m -109.5 125.86 52.93 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.883 ' OG ' HD11 ' A' ' 25' ' ' LEU . 26.1 t -92.05 127.0 37.36 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.06 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.806 HG22 ' HB2' ' A' ' 33' ' ' PHE . 74.3 t -126.1 163.71 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.187 -0.946 . . . . 0.0 109.978 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.602 ' N ' HG12 ' A' ' 48' ' ' VAL . 39.2 t -124.6 132.76 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.701 HG23 ' CG2' ' A' ' 99' ' ' VAL . 11.4 p -123.34 156.35 29.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.995 -1.066 . . . . 0.0 109.671 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.423 ' OD1' ' OD2' ' A' ' 30' ' ' ASP . 87.2 m-20 -49.97 -17.17 0.35 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.943 0.878 . . . . 0.0 109.634 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.581 ' O ' ' OE2' ' A' ' 53' ' ' GLU . . . -86.18 -59.22 1.88 Allowed Glycine 0 C--N 1.287 -2.142 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.667 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.581 ' OE2' ' O ' ' A' ' 52' ' ' GLY . 61.3 mm-40 -163.22 -165.53 1.1 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.25 -1.147 . . . . 0.0 110.554 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.56 ' CG1' HD13 ' A' ' 25' ' ' LEU . 88.8 t -93.36 123.37 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' NZ ' HG11 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -122.45 149.15 44.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.911 -1.118 . . . . 0.0 110.905 -179.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.704 ' CD2' ' NH2' ' A' ' 36' ' ' ARG . 23.6 m80 -113.31 101.88 9.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.579 -0.701 . . . . 0.0 109.544 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' CYS . 52.5 t -72.91 130.04 39.5 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.26 138.63 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.246 -0.909 . . . . 0.0 111.878 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.608 ' O ' ' O ' ' A' ' 44' ' ' TYR . 10.9 mm -124.93 111.59 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.695 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 83.6 m-20 -118.59 170.48 8.92 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.647 -1.283 . . . . 0.0 112.182 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -128.29 30.52 5.18 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.327 -1.483 . . . . 0.0 108.985 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.7 p -79.45 -174.93 4.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.314 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.37 -28.35 66.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.19 -0.944 . . . . 0.0 109.616 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.9 p -79.0 -5.59 54.27 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.217 -0.927 . . . . 0.0 109.206 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.797 ' HA3' ' HB3' ' A' ' 69' ' ' ALA . . . 81.54 171.54 45.62 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.893 ' CE1' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -64.44 30.8 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.951 -1.323 . . . . 0.0 110.537 -179.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.623 ' H ' ' C ' ' A' ' 65' ' ' GLY . . . 88.51 -42.89 3.08 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.63 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 89.7 m-85 -90.43 -6.08 55.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.347 -1.09 . . . . 0.0 110.278 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.893 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . . . -99.63 3.88 45.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.213 -0.929 . . . . 0.0 109.154 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.702 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 46.2 tt0 -59.64 -35.31 28.44 Favored Pre-proline 0 C--N 1.304 -1.379 0 C-N-CA 119.006 -1.078 . . . . 0.0 108.678 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 9.8 Cg_exo -72.81 174.16 12.29 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.634 2.222 . . . . 0.0 111.071 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -62.57 -12.32 22.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.034 -1.041 . . . . 0.0 109.566 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -101.36 102.56 13.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.912 -1.117 . . . . 0.0 110.472 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.614 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 5.6 mp -106.25 7.4 31.4 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.633 ' OH ' ' CD2' ' A' ' 84' ' ' HIS . 71.4 m-85 60.58 175.02 0.1 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.371 -0.83 . . . . 0.0 109.19 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.7 t -103.71 -48.72 3.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.122 -0.986 . . . . 0.0 110.048 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.8 m -126.3 154.77 42.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.094 -1.004 . . . . 0.0 110.183 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.16 -34.05 73.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 110.03 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.72 -43.74 80.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.188 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -66.9 -30.53 70.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.228 -0.92 . . . . 0.0 108.856 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.904 HD21 ' CE2' ' A' ' 85' ' ' TYR . 9.2 tt -60.6 -40.9 93.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 108.987 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.2 t -66.86 -44.17 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.361 -0.837 . . . . 0.0 109.819 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.426 HD21 ' CB ' ' A' ' 5' ' ' HIS . 85.0 mt -67.45 -43.09 81.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.419 -0.8 . . . . 0.0 110.439 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.633 ' CD2' ' OH ' ' A' ' 75' ' ' TYR . 83.9 t60 -60.02 -40.56 89.72 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.215 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.904 ' CE2' HD21 ' A' ' 81' ' ' LEU . 7.4 m-30 -67.34 -24.31 65.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 0.0 108.789 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.453 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 38.1 tt0 -61.32 -36.94 81.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -91.44 -16.71 26.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.303 -0.873 . . . . 0.0 109.592 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.4 m -100.84 129.92 46.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.131 -0.981 . . . . 0.0 109.228 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.543 ' HA ' HG22 ' A' ' 100' ' ' THR . 34.8 t -81.67 132.56 35.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 109.915 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 91' ' ' VAL . 76.2 mt -69.01 -13.07 62.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.477 -0.764 . . . . 0.0 109.715 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.76 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.8 p -36.66 -33.75 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.464 -0.773 . . . . 0.0 110.011 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.45 ' N ' HG13 ' A' ' 91' ' ' VAL . 20.0 tt0 -65.86 -50.07 65.86 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLN . 84.3 t60 -51.43 -47.53 63.0 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.689 ' O ' ' N ' ' A' ' 96' ' ' SER . 13.1 t-20 -126.29 111.25 14.33 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.54 ' C ' ' O ' ' A' ' 94' ' ' ASN . 99.7 m-20 -35.98 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.886 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 94' ' ' ASN . 71.1 m -108.37 27.07 9.71 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.736 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.76 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.5 mt -97.96 65.84 1.81 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.563 -1.336 . . . . 0.0 108.2 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.403 ' C ' HG23 ' A' ' 99' ' ' VAL . 0.8 OUTLIER -79.79 75.57 6.47 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.81 -1.182 . . . . 0.0 109.41 -178.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.701 ' CG2' HG23 ' A' ' 50' ' ' VAL . 84.5 t -153.56 153.62 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.522 -0.736 . . . . 0.0 109.805 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.543 HG22 ' HA ' ' A' ' 89' ' ' SER . 70.2 p -134.33 156.79 47.85 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.57 HD22 ' CG ' ' A' ' 33' ' ' PHE . 11.6 mt -76.48 71.65 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.706 -1.246 . . . . 0.0 108.007 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.3 -33.76 9.91 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.169 -0.957 . . . . 0.0 112.111 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.4 m-85 -113.97 109.29 49.93 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.503 -1.373 . . . . 0.0 111.977 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.523 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 19.0 Cg_exo -59.97 148.61 88.21 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.083 1.855 . . . . 0.0 110.276 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.567 ' O ' ' OE1' ' A' ' 109' ' ' GLN . 9.1 p -67.25 -34.59 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.822 -1.174 . . . . 0.0 108.77 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.502 ' CD2' HG13 ' A' ' 105' ' ' VAL . 38.6 m-85 -108.14 39.4 1.97 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.447 -0.783 . . . . 0.0 110.191 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.523 ' HB2' ' CG ' ' A' ' 104' ' ' PRO . . . -83.99 117.4 23.36 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.996 -1.065 . . . . 0.0 109.599 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 49.46 45.93 23.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.334 -0.854 . . . . 0.0 109.975 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.567 ' OE1' ' O ' ' A' ' 105' ' ' VAL . 41.9 mt-30 -104.42 135.01 46.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.795 -1.191 . . . . 0.0 110.122 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -61.38 -35.44 77.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.578 -0.701 . . . . 0.0 110.146 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.498 ' HA ' ' HE ' ' A' ' 111' ' ' ARG . 4.6 tpm_? . . . . . 0 N--CA 1.493 1.716 0 O-C-N 120.961 -1.087 . . . . 0.0 109.217 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -63.33 133.46 54.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.222 -0.924 . . . . 0.0 110.059 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.5 mt -90.32 145.61 33.0 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.427 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 28.5 Cg_endo -64.3 -6.9 12.59 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.7 2.267 . . . . 0.0 112.288 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.49 ' CD2' HG11 ' A' ' 82' ' ' VAL . 7.3 m80 -67.37 -21.31 65.63 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 108.965 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -59.68 -34.2 72.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.776 -1.203 . . . . 0.0 108.236 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -97.18 126.76 42.57 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.175 -0.953 . . . . 0.0 109.354 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.614 ' CG ' ' OD1' ' A' ' 12' ' ' ASN . 23.2 tt0 -68.07 -28.27 67.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.6 -0.688 . . . . 0.0 110.125 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.706 ' NZ ' ' O ' ' A' ' 106' ' ' TYR . 2.3 tmpt? -62.44 -27.19 68.94 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.261 -0.9 . . . . 0.0 111.623 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.717 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 41.7 p -62.57 -29.74 70.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.991 -1.068 . . . . 0.0 112.127 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.759 ' CE3' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -123.86 -31.23 3.44 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.189 -1.57 . . . . 0.0 110.34 179.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.759 ' ND2' ' CE3' ' A' ' 11' ' ' TRP . 1.2 m-80 -73.74 130.81 40.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.132 -0.98 . . . . 0.0 109.663 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 13' ' ' VAL . 60.9 t -115.79 -11.16 12.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.633 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.81 -152.42 21.81 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.1 p -83.46 112.07 19.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -1.123 . . . . 0.0 109.524 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.0 m -126.07 143.13 51.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.073 -1.017 . . . . 0.0 110.152 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.653 ' ND2' ' ND2' ' A' ' 19' ' ' ASN . 59.5 t-20 -67.11 148.38 51.93 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.576 -0.702 . . . . 0.0 109.26 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.545 ' HA ' HH12 ' A' ' 36' ' ' ARG . 85.5 mtm180 -61.05 -40.35 93.29 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 110.022 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 44.0 p30 -61.49 -33.14 73.27 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.085 -1.009 . . . . 0.0 108.977 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.674 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 7.3 tppt? -77.76 -34.75 52.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.127 -0.983 . . . . 0.0 108.945 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.5 92.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -0.793 . . . . 0.0 109.349 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 26' ' ' ARG . 14.4 pt-20 -60.12 -46.01 91.07 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.0 -1.063 . . . . 0.0 108.442 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.437 ' N ' ' HG3' ' A' ' 22' ' ' GLU . 98.3 m-20 -56.07 -42.44 76.67 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.31 -29.75 67.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.319 -0.863 . . . . 0.0 109.163 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.467 HD13 ' CG1' ' A' ' 54' ' ' VAL . 11.5 mt -91.68 -9.93 42.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -0.792 . . . . 0.0 109.134 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 22' ' ' GLU . 1.1 ttt180 -90.75 125.8 35.81 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.195 -0.94 . . . . 0.0 109.476 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.2 1.02 61.23 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -96.9 141.1 30.5 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.403 -1.057 . . . . 0.0 108.16 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -72.82 151.74 41.89 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.275 -0.891 . . . . 0.0 108.854 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -50.95 147.99 4.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 109.287 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.79 -20.82 44.52 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.446 HG23 ' HD2' ' A' ' 103' ' ' TYR . 58.5 m -86.27 122.33 30.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -1.079 . . . . 0.0 110.074 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.875 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.8 OUTLIER -136.46 167.22 21.76 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.366 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 pp -140.63 160.12 40.7 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.664 -0.815 . . . . 0.0 109.545 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.36 125.65 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.416 -0.803 . . . . 0.0 109.756 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.545 HH12 ' HA ' ' A' ' 18' ' ' ARG . 29.0 ptt180 -143.9 -174.06 4.16 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.671 ' C ' ' H ' ' A' ' 39' ' ' SER . 0.3 OUTLIER -105.08 173.55 6.26 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.825 -1.172 . . . . 0.0 108.985 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.66 ' O ' ' CB ' ' A' ' 39' ' ' SER . 70.9 m -76.75 14.22 0.86 Allowed 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.671 ' H ' ' C ' ' A' ' 37' ' ' GLU . 83.3 p 112.76 -37.58 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.222 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.497 ' C ' ' OE1' ' A' ' 37' ' ' GLU . 65.3 tttm -96.18 123.32 39.75 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.565 ' C ' ' OE1' ' A' ' 41' ' ' GLN . 1.1 tm0? -47.94 -16.95 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.464 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.485 ' H ' ' HG2' ' A' ' 40' ' ' LYS . . . -64.27 -37.53 94.65 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 120.217 -0.992 . . . . 0.0 110.837 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.3 t -111.51 152.3 27.64 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.801 -1.411 . . . . 0.0 110.05 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.585 ' O ' ' O ' ' A' ' 59' ' ' ILE . 31.9 m-85 -115.48 155.69 27.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.396 -0.815 . . . . 0.0 109.054 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.415 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -155.42 138.72 15.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.904 -1.122 . . . . 0.0 110.059 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 57' ' ' CYS . 29.5 p -111.1 125.42 53.75 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.913 -1.117 . . . . 0.0 108.237 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 55' ' ' LYS . 44.2 t -108.21 138.13 45.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 0.0 109.845 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.579 HG22 ' N ' ' A' ' 49' ' ' VAL . 10.2 p -131.97 164.22 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.052 -1.03 . . . . 0.0 110.31 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.579 ' N ' HG22 ' A' ' 48' ' ' VAL . 86.7 t -109.93 127.33 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.821 HG13 ' HZ3' ' A' ' 55' ' ' LYS . 7.9 p -160.02 168.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.888 -1.133 . . . . 0.0 110.909 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.646 ' N ' HG22 ' A' ' 50' ' ' VAL . 61.6 t0 40.88 24.28 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.831 -0.543 . . . . 0.0 110.731 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 80.1 -1.85 78.35 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.053 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.855 ' HB3' ' HZ1' ' A' ' 55' ' ' LYS . 15.3 tp10 -119.88 143.58 47.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.335 . . . . 0.0 110.489 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.467 ' CG1' HD13 ' A' ' 25' ' ' LEU . 83.7 t -82.59 127.66 39.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.566 0.698 . . . . 0.0 109.163 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.855 ' HZ1' ' HB3' ' A' ' 53' ' ' GLU . 6.6 mptt -110.16 158.15 18.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.0 110.933 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -130.36 73.96 1.56 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.422 -0.798 . . . . 0.0 109.539 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 42.2 t -63.92 136.78 57.64 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.404 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.78 139.84 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.84 0.829 . . . . 0.0 111.989 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.585 ' O ' ' O ' ' A' ' 44' ' ' TYR . 20.0 mm -118.23 144.96 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 22.6 m120 -112.32 161.08 17.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.842 -1.161 . . . . 0.0 109.631 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -122.09 21.07 10.6 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.869 -1.144 . . . . 0.0 110.193 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.47 ' C ' ' H ' ' A' ' 65' ' ' GLY . 89.6 m -96.6 154.79 17.07 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.89 -1.131 . . . . 0.0 109.128 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -43.95 -52.48 6.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.797 -1.19 . . . . 0.0 109.017 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 64' ' ' THR . 85.0 m -89.16 -0.75 57.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.026 -1.046 . . . . 0.0 108.414 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 66' ' ' TYR . . . -79.62 -97.39 0.3 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.623 ' HB3' HD11 ' A' ' 74' ' ' LEU . 43.7 m-85 46.75 -178.95 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.586 -0.949 . . . . 0.0 109.215 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.68 -39.45 93.73 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.628 ' CE2' ' OH ' ' A' ' 85' ' ' TYR . 35.5 m-85 -131.2 -58.8 0.99 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.112 -1.228 . . . . 0.0 109.062 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 68' ' ' PHE . . . 68.0 30.19 6.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.92 . . . . 0.0 110.377 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -69.02 155.41 93.62 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.166 -0.959 . . . . 0.0 109.291 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -43.04 -21.25 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.956 2.437 . . . . 0.0 112.579 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.424 ' O ' ' HB3' ' A' ' 73' ' ' ASN . 98.0 m-85 -68.08 -6.92 25.34 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.353 -0.842 . . . . 0.0 109.19 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 53.2 t30 64.02 141.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.366 -0.834 . . . . 0.0 109.191 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.623 HD11 ' HB3' ' A' ' 66' ' ' TYR . 98.2 mt -74.17 -118.15 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.217 -0.927 . . . . 0.0 109.215 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.676 ' CD1' ' OE2' ' A' ' 80' ' ' GLU . 50.6 m-85 -149.13 -165.04 2.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.867 -1.146 . . . . 0.0 111.164 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.1 t -67.86 -40.99 83.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.258 -0.901 . . . . 0.0 111.878 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -137.56 157.9 45.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.484 -1.385 . . . . 0.0 111.424 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.6 mt -59.63 -28.28 67.08 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -53.27 -42.39 66.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.83 -1.168 . . . . 0.0 108.016 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.676 ' OE2' ' CD1' ' A' ' 75' ' ' TYR . 7.2 tm-20 -63.92 -37.04 85.96 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.709 HD23 ' C ' ' A' ' 81' ' ' LEU . 8.2 tt -59.2 -48.04 83.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 0.0 109.203 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.49 HG11 ' CD2' ' A' ' 5' ' ' HIS . 97.2 t -60.68 -39.31 81.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.042 -1.036 . . . . 0.0 108.579 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 86' ' ' GLN . 79.6 mt -64.17 -35.12 79.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.384 -0.822 . . . . 0.0 109.965 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.615 ' CE1' ' OE2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -56.27 -48.65 76.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.723 -1.236 . . . . 0.0 110.027 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.743 ' HB2' HD12 ' A' ' 101' ' ' LEU . 73.3 m-85 -61.74 -30.09 70.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.914 -1.116 . . . . 0.0 109.353 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 83' ' ' LEU . 37.3 tt0 -60.96 -34.87 75.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.43 -0.793 . . . . 0.0 109.558 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -96.4 -11.18 26.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 110.621 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.2 m -114.34 129.74 56.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.748 -1.22 . . . . 0.0 110.746 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.7 t -76.47 124.6 27.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.759 -0.588 . . . . 0.0 109.786 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.726 ' O ' ' N ' ' A' ' 92' ' ' GLN . 5.0 mp -67.41 -31.44 71.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.478 -0.763 . . . . 0.0 111.316 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.015 HG13 ' H ' ' A' ' 92' ' ' GLN . 7.6 p 12.31 -75.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.597 0 O-C-N 121.844 -0.535 . . . . 0.0 110.285 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 1.015 ' H ' HG13 ' A' ' 91' ' ' VAL . 26.5 tt0 62.63 -175.98 0.14 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.421 -0.8 . . . . 0.0 111.105 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.68 ' H ' ' CG ' ' A' ' 92' ' ' GLN . 88.4 m-70 -58.44 -35.54 72.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.55 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -50.64 -25.48 4.28 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 60.0 14.6 4.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.678 -0.639 . . . . 0.0 109.751 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.431 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 54.7 p -132.33 9.19 4.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.968 -1.082 . . . . 0.0 109.751 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.732 ' O ' ' N ' ' A' ' 91' ' ' VAL . 83.9 mt -96.58 36.57 1.36 Allowed 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.438 ' OD1' HG23 ' A' ' 91' ' ' VAL . 98.7 m-20 -75.98 70.34 2.68 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.487 ' O ' HD12 ' A' ' 90' ' ' LEU . 12.8 p -159.47 159.35 2.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.477 ' N ' HG22 ' A' ' 99' ' ' VAL . 31.0 p -121.8 149.21 43.65 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.875 HD22 ' CG ' ' A' ' 33' ' ' PHE . 56.3 mt -73.94 69.13 1.4 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.428 ' HA ' HE21 ' A' ' 86' ' ' GLN . . . -98.2 -24.62 15.2 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.444 -0.785 . . . . 0.0 112.548 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.455 ' CE2' ' O ' ' A' ' 104' ' ' PRO . 80.8 t80 -114.02 131.01 23.37 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.268 -1.52 . . . . 0.0 110.97 -178.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.786 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 63.3 Cg_endo -76.14 149.33 32.08 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 123.354 2.703 . . . . 0.0 112.182 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.648 HG13 ' CD2' ' A' ' 106' ' ' TYR . 14.5 p -78.5 -17.83 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.025 -1.047 . . . . 0.0 109.776 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.706 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . 33.9 m-85 -132.18 56.35 1.83 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.025 -1.047 . . . . 0.0 110.569 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.786 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . -64.84 132.97 50.9 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.15 -0.969 . . . . 0.0 109.844 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -67.74 -43.33 80.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.144 -0.972 . . . . 0.0 109.468 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 51.73 57.86 6.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.322 -0.861 . . . . 0.0 109.314 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.751 HH11 ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -61.69 -33.14 73.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.0 109.771 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.753 ' CG ' HH11 ' A' ' 111' ' ' ARG . 2.2 mtt-85 . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.115 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.9 p30 -73.28 175.39 6.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.338 -0.851 . . . . 0.0 109.725 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 3' ' ' LEU . 95.7 mt -93.01 129.72 38.65 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.226 -0.922 . . . . 0.0 109.669 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.495 ' O ' ' OG1' ' A' ' 10' ' ' THR . 28.9 Cg_endo -68.55 -3.86 11.92 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.35 2.033 . . . . 0.0 111.974 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -80.93 -6.33 58.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 110.016 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -76.11 -31.14 58.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.197 -0.939 . . . . 0.0 110.111 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -105.18 132.78 50.97 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.235 -0.916 . . . . 0.0 109.981 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.675 ' O ' ' N ' ' A' ' 12' ' ' ASN . 95.9 mt-10 -66.77 -29.33 69.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.477 -0.764 . . . . 0.0 110.57 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.46 ' CG ' ' N ' ' A' ' 10' ' ' THR . 3.0 pttt -57.66 -33.58 68.46 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.336 -0.853 . . . . 0.0 111.0 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.696 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 47.2 p -65.67 -30.91 71.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.888 -1.132 . . . . 0.0 110.704 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.696 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -119.82 -28.86 5.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.673 -1.267 . . . . 0.0 109.78 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' A' ' 8' ' ' GLU . 56.2 t-20 -83.63 130.62 34.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.605 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.49 HG22 ' HE2' ' A' ' 106' ' ' TYR . 45.0 t -96.35 -12.82 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.287 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.13 -157.96 34.1 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 95.2 p -63.83 132.68 51.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.149 -1.207 . . . . 0.0 109.801 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.9 t -176.71 165.46 2.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 109.619 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -95.12 147.8 23.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.468 -0.77 . . . . 0.0 109.747 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.646 HH12 ' C ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -59.72 -35.57 74.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.164 -0.96 . . . . 0.0 110.016 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -57.17 -46.06 83.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.684 -1.26 . . . . 0.0 108.43 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.695 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 79.9 tttt -59.98 -35.11 74.31 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 18' ' ' ARG . . . -60.04 -38.93 84.2 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' ARG . 97.1 mt-10 -53.64 -47.51 70.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.863 . . . . 0.0 108.823 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.695 ' ND2' ' O ' ' A' ' 20' ' ' LYS . 9.5 p30 -62.11 -41.29 98.08 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.674 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 79.2 mt -65.09 -30.21 71.14 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 21' ' ' ALA . 19.2 mt -93.1 -10.73 34.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.444 -0.785 . . . . 0.0 109.817 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.564 ' CG ' ' N ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -79.71 -49.53 11.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 109.635 -179.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.564 ' N ' ' CG ' ' A' ' 26' ' ' ARG . . . -87.99 25.95 8.21 Favored Glycine 0 C--N 1.287 -2.188 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -115.11 125.34 53.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.25 -1.147 . . . . 0.0 110.521 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -72.77 159.33 33.97 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.497 -0.752 . . . . 0.0 109.142 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 59.9 p30 -57.36 151.2 16.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.056 -1.028 . . . . 0.0 110.172 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.17 -18.46 55.55 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.1 m -100.67 127.43 47.08 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.165 -1.197 . . . . 0.0 109.09 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.64 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -130.4 161.27 31.72 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.034 178.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.412 ' HB3' HG21 ' A' ' 105' ' ' VAL . 1.5 pp -129.35 155.07 46.23 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.636 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.6 t -116.26 131.14 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.777 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.632 ' CB ' ' CZ ' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -146.11 -141.91 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 108.928 179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.659 ' C ' ' H ' ' A' ' 39' ' ' SER . 45.9 mp0 -107.56 174.91 5.68 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.646 ' C ' HH12 ' A' ' 18' ' ' ARG . 61.0 m -76.37 15.66 0.57 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.659 ' H ' ' C ' ' A' ' 37' ' ' GLU . 4.0 m 101.97 -43.47 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.089 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -89.51 149.31 22.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 108.968 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -67.4 144.97 55.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.026 -1.046 . . . . 0.0 109.693 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.45 6.45 62.66 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.5 m -129.66 159.25 37.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.042 -1.27 . . . . 0.0 110.031 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.594 ' O ' ' O ' ' A' ' 59' ' ' ILE . 74.8 m-85 -122.61 149.58 43.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.031 -1.043 . . . . 0.0 109.015 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.517 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -169.05 142.36 2.82 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.094 -1.004 . . . . 0.0 109.053 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 57' ' ' CYS . 16.8 p -124.93 148.15 48.5 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.264 -0.898 . . . . 0.0 108.808 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.3 p -120.21 143.2 48.39 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.684 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.856 HG13 ' NZ ' ' A' ' 55' ' ' LYS . 1.5 p -130.6 155.23 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.476 -0.765 . . . . 0.0 109.766 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.453 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 69.9 t -110.8 132.64 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.761 -0.587 . . . . 0.0 110.099 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.669 HG13 ' H ' ' A' ' 52' ' ' GLY . 8.3 p -122.04 156.27 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.0 -1.063 . . . . 0.0 108.876 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 59.4 t0 -49.3 -18.3 0.35 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.873 0.844 . . . . 0.0 110.022 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.669 ' H ' HG13 ' A' ' 50' ' ' VAL . . . -92.1 -52.81 2.15 Favored Glycine 0 C--N 1.286 -2.23 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.585 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.565 ' H ' ' CG1' ' A' ' 50' ' ' VAL . 44.6 mt-10 -161.11 169.37 22.51 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.724 -1.456 . . . . 0.0 112.028 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.8 t -85.86 136.78 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.856 ' NZ ' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -131.8 150.86 52.02 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.576 -1.328 . . . . 0.0 111.776 -178.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.571 ' CD2' ' HE ' ' A' ' 18' ' ' ARG . 29.2 m80 -110.66 117.45 33.52 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' A' ' 46' ' ' CYS . 48.8 t -104.08 129.23 51.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.87 -1.144 . . . . 0.0 108.574 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 58' ' ' VAL . 4.7 p -94.68 132.72 37.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 111.292 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.594 ' O ' ' O ' ' A' ' 44' ' ' TYR . 98.0 mt -118.12 140.89 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 96.5 m-20 -112.31 148.25 34.6 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.967 -1.083 . . . . 0.0 109.349 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.46 ' HD2' ' CE1' ' A' ' 44' ' ' TYR . 11.5 ttmt -113.68 103.19 10.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.826 -1.171 . . . . 0.0 110.08 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.618 HG22 ' N ' ' A' ' 63' ' ' ALA . 89.1 m -162.21 170.11 19.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 109.298 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.618 ' N ' HG22 ' A' ' 62' ' ' THR . . . -59.95 -41.67 92.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.114 -0.991 . . . . 0.0 109.805 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 64' ' ' THR . 86.5 m -112.94 5.55 17.36 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.104 -0.997 . . . . 0.0 109.822 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.68 -88.01 1.2 Allowed Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.709 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 62' ' ' THR . 82.3 m-85 56.66 177.62 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.08 -1.247 . . . . 0.0 109.604 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.38 -87.61 0.27 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.692 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 6.9 m-30 -87.78 131.91 34.34 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.101 -1.235 . . . . 0.0 109.405 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.99 -5.58 6.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.031 -1.043 . . . . 0.0 109.19 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.748 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 69.2 mm-40 -68.26 -32.41 3.9 Favored Pre-proline 0 C--N 1.307 -1.281 0 O-C-N 121.127 -0.983 . . . . 0.0 109.254 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.748 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 17.0 Cg_exo -65.51 -7.47 16.25 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.348 2.032 . . . . 0.0 111.297 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.703 ' CD1' ' O ' ' A' ' 71' ' ' PRO . 50.2 p90 45.52 44.59 10.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.337 -0.852 . . . . 0.0 109.568 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 74' ' ' LEU . 10.9 m120 -109.98 -16.34 13.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.455 -0.778 . . . . 0.0 109.866 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 73' ' ' ASN . 57.5 tp 43.6 84.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.958 -1.089 . . . . 0.0 109.301 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -59.87 133.53 56.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.038 -1.038 . . . . 0.0 109.719 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.1 m -68.02 -37.68 81.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.474 -0.766 . . . . 0.0 110.216 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.4 t -140.69 156.86 46.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.954 -1.091 . . . . 0.0 110.147 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.403 HD11 ' HE3' ' A' ' 61' ' ' LYS . 93.3 mt -60.93 -37.39 82.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.548 -0.72 . . . . 0.0 109.461 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -56.71 -42.82 79.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.476 -0.765 . . . . 0.0 109.044 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -64.63 -33.53 76.16 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.229 -0.919 . . . . 0.0 109.15 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 10.2 tt -59.82 -48.17 82.77 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 109.535 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 95.5 t -67.53 -37.19 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.204 -0.935 . . . . 0.0 109.17 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.547 HD12 ' OE1' ' A' ' 86' ' ' GLN . 52.3 tp -66.49 -47.73 72.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.285 -0.884 . . . . 0.0 110.359 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -63.11 -40.43 97.61 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.994 -1.066 . . . . 0.0 110.317 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.692 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 3.9 m-85 -62.15 -29.67 70.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.469 -0.769 . . . . 0.0 111.501 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.612 ' O ' ' OG1' ' A' ' 100' ' ' THR . 5.8 pt20 -66.91 -29.09 68.88 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.301 -1.499 . . . . 0.0 108.334 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -79.18 -39.65 32.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.401 -0.812 . . . . 0.0 109.829 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 85' ' ' TYR . 5.0 t -79.61 154.21 28.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.006 . . . . 0.0 109.993 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.5 t -104.55 133.18 49.85 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.816 ' N ' HD22 ' A' ' 90' ' ' LEU . 3.1 mm? -70.51 -10.92 60.44 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.513 -0.742 . . . . 0.0 110.319 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.685 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.4 p -40.14 -43.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.135 -0.978 . . . . 0.0 109.812 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.605 ' N ' HG13 ' A' ' 91' ' ' VAL . 9.7 tt0 -38.58 -36.63 0.26 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.906 -0.496 . . . . 0.0 110.766 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.707 ' O ' ' N ' ' A' ' 95' ' ' ASP . 23.4 t-160 -64.87 124.65 22.57 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.951 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.512 ' ND2' ' NE2' ' A' ' 93' ' ' HIS . 78.5 m-20 44.28 9.71 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.034 -1.041 . . . . 0.0 109.278 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 93' ' ' HIS . 81.8 m-20 57.62 43.78 21.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.299 -0.876 . . . . 0.0 110.873 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.61 ' C ' HD22 ' A' ' 97' ' ' LEU . 34.2 m -151.61 4.64 0.43 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.556 -1.34 . . . . 0.0 111.415 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.962 HD22 ' N ' ' A' ' 97' ' ' LEU . 2.1 mm? -100.47 70.68 1.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.607 -1.308 . . . . 0.0 107.774 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -79.73 94.63 5.78 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.049 0.928 . . . . 0.0 109.748 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.765 HG22 ' H ' ' A' ' 100' ' ' THR . 7.1 p -174.06 -177.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.765 ' H ' HG22 ' A' ' 99' ' ' VAL . 9.0 t -160.42 166.73 28.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.014 -1.054 . . . . 0.0 109.501 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.64 HD22 ' CG ' ' A' ' 33' ' ' PHE . 18.6 mt -79.96 63.73 4.58 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.44 -26.46 19.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.937 -0.477 . . . . 0.0 112.092 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -122.41 134.22 24.76 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.279 -1.513 . . . . 0.0 111.455 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.55 148.98 43.28 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 122.699 2.266 . . . . 0.0 111.302 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.744 HG13 ' CD2' ' A' ' 106' ' ' TYR . 9.0 p -72.41 -18.61 19.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.266 -0.896 . . . . 0.0 108.756 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.744 ' CD2' HG13 ' A' ' 105' ' ' VAL . 39.7 m-85 -131.42 65.18 1.57 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.478 -0.764 . . . . 0.0 110.023 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.52 144.56 51.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.962 -1.086 . . . . 0.0 110.024 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -58.13 136.94 57.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.281 -0.887 . . . . 0.0 110.258 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -74.91 151.26 38.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.316 -0.865 . . . . 0.0 108.98 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 111' ' ' ARG . 56.2 mtp180 -120.71 150.08 41.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.904 -1.123 . . . . 0.0 108.949 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.589 ' HG2' HH11 ' A' ' 111' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.008 -1.057 . . . . 0.0 109.274 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -74.95 163.38 27.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.994 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 3' ' ' LEU . 7.0 mp -102.58 147.74 34.48 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.535 -0.728 . . . . 0.0 110.204 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.19 -2.93 6.46 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.696 2.264 . . . . 0.0 111.443 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -65.89 -31.91 73.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.34 -0.85 . . . . 0.0 108.96 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -61.31 -18.27 57.75 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.627 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.675 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 94.6 m-20 -96.9 110.14 22.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.33 -0.856 . . . . 0.0 110.314 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.537 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 80.1 tt0 -69.27 -30.64 68.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.423 -0.798 . . . . 0.0 109.78 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 pttt -69.56 -11.56 60.93 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.431 -0.793 . . . . 0.0 110.76 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.509 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 43.9 p -85.32 -22.88 28.33 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.821 -1.175 . . . . 0.0 112.258 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.675 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -122.51 -26.77 4.52 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.256 -1.528 . . . . 0.0 109.839 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.632 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 14.9 p-10 -80.14 142.07 35.13 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.874 -1.141 . . . . 0.0 109.855 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 35' ' ' VAL . 10.1 p -112.34 -16.84 8.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.05 -164.0 51.16 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.0 p -58.11 133.74 55.85 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.212 -1.169 . . . . 0.0 108.578 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.6 t -172.09 154.74 3.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.313 -0.867 . . . . 0.0 109.385 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -76.16 144.73 40.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.972 -1.08 . . . . 0.0 109.357 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.46 ' HG2' ' HE ' ' A' ' 36' ' ' ARG . 86.0 mtm180 -59.85 -39.51 85.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -57.9 -38.9 76.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.818 -1.176 . . . . 0.0 109.017 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -58.18 -34.25 70.12 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -62.51 -35.97 81.08 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.521 ' CG ' ' NE ' ' A' ' 26' ' ' ARG . 71.7 tt0 -55.95 -50.14 71.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.081 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -60.31 -44.17 95.69 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.976 -1.078 . . . . 0.0 108.272 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -66.72 -30.3 70.51 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.574 HD13 ' CG1' ' A' ' 54' ' ' VAL . 7.0 mt -92.86 -6.44 48.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.213 -0.93 . . . . 0.0 109.505 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.586 HH11 ' HG2' ' A' ' 26' ' ' ARG . 20.7 mtt-85 -100.59 137.39 39.05 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.328 -0.857 . . . . 0.0 109.641 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.44 -2.17 86.28 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.563 ' HD3' HG21 ' A' ' 32' ' ' THR . 4.5 mtpt -103.39 147.08 27.55 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.998 -1.295 . . . . 0.0 110.004 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.741 ' CG ' HH11 ' A' ' 29' ' ' ARG . 2.1 mtt-85 -74.73 161.61 29.47 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.598 0.713 . . . . 0.0 110.75 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.555 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 60.3 t0 -59.91 143.09 52.37 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.429 -0.794 . . . . 0.0 109.677 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 106.98 -25.04 23.58 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.563 HG21 ' HD3' ' A' ' 28' ' ' LYS . 60.6 m -78.99 122.46 26.2 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.258 -1.142 . . . . 0.0 108.775 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.845 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -134.19 173.64 11.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.712 -1.243 . . . . 0.0 110.713 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.46 ' CB ' HG11 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -149.74 159.84 44.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.723 -0.61 . . . . 0.0 109.676 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 13' ' ' VAL . 50.7 t -110.2 127.75 66.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.278 -0.889 . . . . 0.0 108.758 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.759 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -145.2 -175.85 4.86 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.678 ' C ' ' H ' ' A' ' 39' ' ' SER . 97.8 mt-10 -103.83 169.78 8.31 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.928 -1.107 . . . . 0.0 108.378 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.631 ' O ' ' CB ' ' A' ' 39' ' ' SER . 97.8 p -75.76 12.1 1.17 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 178.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.678 ' H ' ' C ' ' A' ' 37' ' ' GLU . 16.5 p 99.71 -17.2 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 113.533 -1.667 . . . . 0.0 108.301 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -87.65 141.4 28.63 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -60.33 -36.02 76.98 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.968 -1.083 . . . . 0.0 109.739 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.71 32.24 5.95 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.566 -1.302 . . . . 0.0 111.689 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.514 ' CB ' ' HG ' ' A' ' 38' ' ' SER . 48.1 t -137.51 149.56 46.87 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.715 -1.462 . . . . 0.0 109.681 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -127.5 143.0 51.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.225 -0.922 . . . . 0.0 109.84 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -160.31 133.51 6.73 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.59 -1.318 . . . . 0.0 110.292 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' ' 57' ' ' CYS . 14.3 p -106.31 135.11 48.38 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.684 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.462 ' CB ' HD11 ' A' ' 25' ' ' LEU . 55.0 m -104.74 138.22 41.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' ' 33' ' ' PHE . 12.2 t -131.99 152.93 37.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.188 -0.945 . . . . 0.0 109.921 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.555 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 58.0 t -100.71 122.05 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.689 HG22 ' N ' ' A' ' 51' ' ' ASP . 13.4 p -160.47 172.44 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.678 -1.264 . . . . 0.0 111.861 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.689 ' N ' HG22 ' A' ' 50' ' ' VAL . 64.6 t0 48.44 20.52 0.3 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.526 0.679 . . . . 0.0 109.57 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.31 10.74 85.7 Favored Glycine 0 C--N 1.295 -1.749 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.106 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.663 ' CG ' ' NZ ' ' A' ' 55' ' ' LYS . 16.7 pt-20 -139.98 157.84 45.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.727 -1.455 . . . . 0.0 110.472 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.574 ' CG1' HD13 ' A' ' 25' ' ' LEU . 74.9 t -78.85 142.09 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 110.097 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.663 ' NZ ' ' CG ' ' A' ' 53' ' ' GLU . 0.9 OUTLIER -119.83 153.54 35.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.496 -0.753 . . . . 0.0 110.419 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -126.98 74.94 1.54 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.439 -0.788 . . . . 0.0 108.947 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.508 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 44.3 t -65.97 138.86 58.1 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.369 -0.832 . . . . 0.0 109.365 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.78 139.89 23.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.508 -0.745 . . . . 0.0 110.547 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.9 mt -118.44 129.97 73.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.596 ' O ' ' O ' ' A' ' 66' ' ' TYR . 90.5 m-20 -129.52 123.7 32.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.01 -1.056 . . . . 0.0 110.867 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 20.8 ptmt -109.36 123.42 49.28 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.336 -0.852 . . . . 0.0 109.764 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.7 ' O ' ' N ' ' A' ' 64' ' ' THR . 14.2 m -132.22 97.75 4.22 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 108.591 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 54.29 -81.4 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.843 -1.161 . . . . 0.0 108.055 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.7 ' N ' ' O ' ' A' ' 62' ' ' THR . 64.1 p -112.88 19.89 16.92 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.729 ' O ' ' CG ' ' A' ' 66' ' ' TYR . . . -94.59 175.07 33.96 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.729 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 89.3 m-85 -169.55 -163.51 0.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.492 ' HA2' ' H ' ' A' ' 60' ' ' ASN . . . -74.73 -50.5 9.12 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.682 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 96.9 m-85 -113.33 125.21 54.03 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.456 -1.026 . . . . 0.0 109.768 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.31 0.52 7.04 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.011 -1.056 . . . . 0.0 109.734 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.639 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 55.1 tt0 -63.19 -38.0 37.21 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.92 . . . . 0.0 110.543 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 37.8 Cg_endo -85.22 159.06 11.3 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.773 2.315 . . . . 0.0 111.311 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 72' ' ' TYR . 78.3 t80 -86.89 59.85 5.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.877 -1.14 . . . . 0.0 108.234 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.717 ' C ' HD22 ' A' ' 73' ' ' ASN . 0.2 OUTLIER -104.11 -48.69 3.8 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.046 -1.034 . . . . 0.0 110.779 -178.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 74' ' ' LEU . 96.4 mt 54.89 68.58 0.84 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.799 -1.188 . . . . 0.0 109.05 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.457 ' CE2' HD23 ' A' ' 81' ' ' LEU . 92.5 m-85 -53.22 127.2 23.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.12 -0.987 . . . . 0.0 109.855 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.9 m -72.3 -36.0 68.81 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.512 -0.743 . . . . 0.0 110.118 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.1 p -143.09 158.66 43.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.163 -0.961 . . . . 0.0 110.35 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.4 mt -59.9 -35.27 74.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.413 -0.804 . . . . 0.0 110.082 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.4 ' O ' HG12 ' A' ' 82' ' ' VAL . 38.1 ttmt -57.37 -40.85 79.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.01 -1.056 . . . . 0.0 109.212 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -69.86 -34.65 73.88 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.082 -1.011 . . . . 0.0 109.228 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.802 ' C ' HD13 ' A' ' 81' ' ' LEU . 3.0 tm? -60.64 -49.29 78.13 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.098 -1.001 . . . . 0.0 110.819 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.434 ' CG1' ' N ' ' A' ' 83' ' ' LEU . 2.4 p -65.5 -37.64 80.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 120.844 -1.16 . . . . 0.0 109.485 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.434 ' N ' ' CG1' ' A' ' 82' ' ' VAL . 54.6 tp -68.52 -45.74 71.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.299 -0.876 . . . . 0.0 110.842 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -61.85 -40.02 93.89 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.119 -0.988 . . . . 0.0 110.143 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.682 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 1.8 m-85 -71.02 -24.28 62.34 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.943 -1.098 . . . . 0.0 110.91 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.585 ' O ' ' OE1' ' A' ' 86' ' ' GLN . 0.7 OUTLIER -61.66 -22.92 65.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.023 -1.048 . . . . 0.0 108.768 179.156 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -101.59 -33.85 9.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.4 -0.812 . . . . 0.0 108.98 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.5 m -82.55 142.62 31.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.407 -0.808 . . . . 0.0 109.893 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.3 m -96.68 129.94 43.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.596 -0.69 . . . . 0.0 109.97 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.727 ' O ' ' N ' ' A' ' 92' ' ' GLN . 1.6 mt -65.6 -12.48 53.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.38 -0.825 . . . . 0.0 111.794 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.738 ' N ' ' O ' ' A' ' 97' ' ' LEU . 8.2 p -9.23 -53.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.015 0 O-C-N 121.409 -0.807 . . . . 0.0 111.466 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.727 ' N ' ' O ' ' A' ' 90' ' ' LEU . 54.3 tt0 -36.41 146.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 109.575 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.683 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 7.7 t-160 103.94 -120.13 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.192 0.52 . . . . 0.0 109.777 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 30.4 m120 -72.16 13.3 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 109.387 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 93' ' ' HIS . 94.5 m-20 62.39 3.74 1.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.632 -0.667 . . . . 0.0 109.751 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 98' ' ' ASN . 14.6 m -116.19 7.94 14.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.943 -1.098 . . . . 0.0 109.006 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.803 HD22 ' N ' ' A' ' 97' ' ' LEU . 2.4 mm? -84.05 26.45 0.74 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.463 ' N ' ' HA ' ' A' ' 91' ' ' VAL . 11.7 t-20 -75.41 75.21 2.49 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 122.277 1.037 . . . . 0.0 108.824 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.521 HG13 HD12 ' A' ' 90' ' ' LEU . 6.7 p -147.4 158.07 9.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.457 ' N ' HG22 ' A' ' 99' ' ' VAL . 18.8 p -125.11 159.54 31.21 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.83 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.845 HD22 ' CG ' ' A' ' 33' ' ' PHE . 51.6 mt -80.02 70.35 6.58 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.523 ' CB ' HE22 ' A' ' 86' ' ' GLN . . . -96.69 -27.24 14.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.453 -0.779 . . . . 0.0 111.7 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -114.06 107.86 51.49 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.621 -1.299 . . . . 0.0 111.215 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.412 ' CB ' ' HB ' ' A' ' 10' ' ' THR . 20.8 Cg_exo -59.65 145.03 99.24 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.236 1.957 . . . . 0.0 110.509 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.753 HG13 ' CD2' ' A' ' 106' ' ' TYR . 7.0 p -70.57 -31.61 46.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.072 -1.018 . . . . 0.0 108.893 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.753 ' CD2' HG13 ' A' ' 105' ' ' VAL . 75.9 m-85 -111.54 31.51 6.08 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.558 -0.714 . . . . 0.0 109.737 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 106' ' ' TYR . . . -42.0 128.6 3.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.948 . . . . 0.0 109.311 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -127.68 138.8 52.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.124 -0.985 . . . . 0.0 110.076 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -74.05 148.85 41.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -0.987 . . . . 0.0 108.934 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.765 HH11 ' CG ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -66.4 136.87 56.37 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.333 -0.854 . . . . 0.0 109.926 -179.286 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 117.84 -1.076 . . . . 0.0 108.815 179.425 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.493 ' C ' ' OD1' ' A' ' 2' ' ' ASP . 55.3 p30 -70.68 163.61 26.75 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.336 -0.853 . . . . 0.0 109.793 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.7 mt -98.65 135.01 21.2 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -70.85 -4.33 14.55 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.805 1.67 . . . . 0.0 111.189 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -73.05 -22.61 60.59 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -60.94 -31.69 71.23 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.938 -1.102 . . . . 0.0 109.4 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.51 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 81.6 m-20 -92.53 131.99 37.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.091 -1.006 . . . . 0.0 110.16 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.557 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 60.8 tt0 -70.46 -31.61 68.83 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.847 0.832 . . . . 0.0 109.901 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 tmpt? -62.14 -27.42 68.93 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.75 -0.594 . . . . 0.0 112.368 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.599 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 23.6 p -68.83 -27.14 65.58 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.487 -1.383 . . . . 0.0 112.187 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.652 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -120.04 -28.47 5.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.239 -1.538 . . . . 0.0 109.445 179.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -79.75 125.1 29.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.237 -0.915 . . . . 0.0 109.531 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 13' ' ' VAL . 60.0 t -99.81 -3.23 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 109.528 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.8 -148.74 26.21 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.1 m -83.08 102.98 12.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.254 . . . . 0.0 109.985 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.467 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 32.9 t -124.37 146.29 48.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.432 -0.792 . . . . 0.0 109.401 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.68 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 57.4 p30 -79.72 154.34 28.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 108.77 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.581 ' CG ' ' NH2' ' A' ' 36' ' ' ARG . 74.5 mtt180 -59.83 -35.89 75.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.144 -0.973 . . . . 0.0 109.603 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -59.75 -42.87 94.19 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.45 -0.781 . . . . 0.0 109.651 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.68 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 79.6 tttt -68.12 -37.75 81.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.855 -1.153 . . . . 0.0 109.257 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.55 -31.35 72.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.443 -0.786 . . . . 0.0 108.967 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 26' ' ' ARG . 61.7 tt0 -59.49 -49.6 77.15 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -57.84 -39.02 76.71 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 24' ' ' LEU . 78.0 mt -71.25 -27.15 63.25 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.249 -0.907 . . . . 0.0 108.869 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.405 HD23 ' CG2' ' A' ' 49' ' ' VAL . 25.2 mt -96.78 -9.56 28.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 109.302 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -91.85 124.5 36.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.8 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.64 21.94 79.3 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.771 ' HE2' HG21 ' A' ' 32' ' ' THR . 41.7 tptt -104.62 126.66 51.92 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -57.82 144.69 37.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.461 -0.774 . . . . 0.0 110.514 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 54.8 p30 -54.34 155.85 3.6 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.659 -0.651 . . . . 0.0 109.439 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.81 -30.96 9.28 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.771 HG21 ' HE2' ' A' ' 28' ' ' LYS . 93.8 m -81.81 127.28 32.81 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.522 -0.987 . . . . 0.0 109.067 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 101' ' ' LEU . 0.6 OUTLIER -134.45 153.37 51.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.053 -1.029 . . . . 0.0 108.986 179.464 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.753 HD22 HG21 ' A' ' 105' ' ' VAL . 6.7 mt -107.28 172.26 6.93 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.004 0.907 . . . . 0.0 110.589 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.486 HG22 ' SG ' ' A' ' 46' ' ' CYS . 73.4 t -147.21 110.12 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.581 ' NH2' ' CG ' ' A' ' 18' ' ' ARG . 2.8 ptt180 -145.54 -179.3 6.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.016 -1.052 . . . . 0.0 109.834 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.667 ' C ' ' H ' ' A' ' 39' ' ' SER . 8.0 pt-20 -91.65 173.79 7.7 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.683 ' O ' ' N ' ' A' ' 40' ' ' LYS . 67.4 m -78.11 18.39 0.52 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.667 ' H ' ' C ' ' A' ' 37' ' ' GLU . 44.3 m 61.09 -51.42 0.11 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.652 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 38' ' ' SER . 61.0 tttp -101.31 128.9 47.25 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.659 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 2.6 tt0 85.25 -173.6 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.448 -0.783 . . . . 0.0 109.217 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.484 ' H ' ' HG2' ' A' ' 41' ' ' GLN . . . -107.78 32.2 7.31 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.406 ' HB2' ' OG ' ' A' ' 38' ' ' SER . 90.6 m -85.91 153.89 21.89 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.999 -1.295 . . . . 0.0 109.002 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' ILE . 70.8 m-85 -124.93 148.25 48.46 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.44 144.57 22.96 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.044 -1.035 . . . . 0.0 108.94 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.486 ' SG ' HG22 ' A' ' 35' ' ' VAL . 20.8 m -114.07 126.61 55.29 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 108.451 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 34' ' ' LEU . 50.5 m -88.59 131.24 35.03 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.499 -0.75 . . . . 0.0 109.382 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.449 HG21 ' CD1' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -125.28 142.11 43.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.139 -0.976 . . . . 0.0 109.459 179.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.405 ' CG2' HD23 ' A' ' 25' ' ' LEU . 21.5 t -108.95 127.06 65.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.357 -0.839 . . . . 0.0 109.833 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 53' ' ' GLU . 4.9 p -111.84 161.45 10.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.082 -1.011 . . . . 0.0 109.957 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -65.48 60.14 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 169.32 -36.28 0.19 Allowed Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.6 -1.286 . . . . 0.0 111.126 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.565 ' O ' HG12 ' A' ' 50' ' ' VAL . 78.2 tt0 -156.36 143.22 18.75 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.389 -1.653 . . . . 0.0 112.396 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.62 134.33 27.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.575 ' HB2' ' HZ2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -124.97 161.08 27.46 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.824 -1.172 . . . . 0.0 111.695 -178.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -121.35 100.85 7.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.392 0.615 . . . . 0.0 109.362 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.46 ' O ' ' N ' ' A' ' 46' ' ' CYS . 49.2 t -85.3 129.33 34.83 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.85 135.86 28.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.423 -0.798 . . . . 0.0 111.145 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.809 HG23 ' O ' ' A' ' 66' ' ' TYR . 48.7 mm -106.53 128.01 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' A' ' 66' ' ' TYR . 8.2 m120 -116.08 116.18 27.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.974 -1.079 . . . . 0.0 110.358 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.727 ' NZ ' HD11 ' A' ' 78' ' ' LEU . 12.9 mttp -99.67 120.69 40.09 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.388 -0.82 . . . . 0.0 109.645 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.663 ' O ' ' N ' ' A' ' 64' ' ' THR . 45.9 p -140.43 55.66 1.6 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 109.411 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 62' ' ' THR . . . 63.4 -47.29 0.23 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.663 ' N ' ' O ' ' A' ' 62' ' ' THR . 52.2 m -118.93 -17.07 9.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.349 -0.844 . . . . 0.0 109.502 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.75 ' O ' ' CG ' ' A' ' 66' ' ' TYR . . . -87.13 170.33 41.11 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.809 ' O ' HG23 ' A' ' 59' ' ' ILE . 98.3 m-85 -168.32 -11.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.839 -0.801 . . . . 0.0 109.29 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.43 145.69 8.98 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.705 ' CD2' ' OH ' ' A' ' 85' ' ' TYR . 2.5 m-85 59.0 36.79 24.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.953 -1.322 . . . . 0.0 108.402 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.815 ' HB1' ' OD1' ' A' ' 73' ' ' ASN . . . -57.85 148.49 25.17 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 108.88 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.753 ' O ' ' N ' ' A' ' 72' ' ' TYR . 66.3 tt0 -135.11 145.11 52.91 Favored Pre-proline 0 C--N 1.296 -1.719 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.482 ' C ' ' O ' ' A' ' 70' ' ' GLU . 51.4 Cg_exo -25.85 -29.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.909 2.406 . . . . 0.0 111.946 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.753 ' N ' ' O ' ' A' ' 70' ' ' GLU . 45.5 p90 -122.74 61.23 1.01 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.815 ' OD1' ' HB1' ' A' ' 69' ' ' ALA . 82.5 m-20 -44.78 144.89 1.03 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.469 -0.769 . . . . 0.0 109.914 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.0 tp -166.09 87.81 0.37 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.699 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.477 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 97.1 m-85 -145.5 86.21 1.74 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.166 -0.959 . . . . 0.0 109.279 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.9 p -66.7 -41.17 88.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.331 -0.855 . . . . 0.0 109.884 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.1 m -130.8 155.2 47.09 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.129 -0.982 . . . . 0.0 111.667 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.727 HD11 ' NZ ' ' A' ' 61' ' ' LYS . 79.1 mt -65.62 -31.65 72.79 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.527 0.68 . . . . 0.0 109.239 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -60.52 -41.24 94.01 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.392 -0.818 . . . . 0.0 108.941 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.507 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 99.0 mt-10 -62.79 -43.83 97.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.146 -0.971 . . . . 0.0 109.158 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.767 HD23 ' C ' ' A' ' 81' ' ' LEU . 7.1 tt -61.27 -43.58 98.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 109.907 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 82.2 t -71.1 -37.29 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 86' ' ' GLN . 86.4 mt -67.58 -42.87 81.81 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.241 -0.912 . . . . 0.0 109.634 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 80' ' ' GLU . 84.0 m-70 -69.11 -38.26 78.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.073 -1.017 . . . . 0.0 110.9 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.705 ' OH ' ' CD2' ' A' ' 68' ' ' PHE . 5.4 m-85 -72.36 -17.71 61.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.37 -0.831 . . . . 0.0 111.876 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.26 -24.56 51.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.287 -1.508 . . . . 0.0 108.241 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.43 ' N ' ' HG3' ' A' ' 86' ' ' GLN . 83.0 t60 -96.47 -15.31 21.8 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.533 -0.729 . . . . 0.0 109.59 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.4 m -102.87 139.94 37.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.062 -1.024 . . . . 0.0 109.007 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.438 ' OG ' HG12 ' A' ' 91' ' ' VAL . 25.1 p -88.6 135.5 33.46 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.465 -0.772 . . . . 0.0 110.685 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.527 ' O ' ' C ' ' A' ' 91' ' ' VAL . 77.0 mt -69.73 -10.27 57.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.642 -0.661 . . . . 0.0 110.088 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.728 ' N ' ' O ' ' A' ' 97' ' ' LEU . 9.9 p -33.98 -40.56 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.975 -1.078 . . . . 0.0 110.132 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.537 ' N ' HG13 ' A' ' 91' ' ' VAL . 81.2 mt-30 -75.97 -5.9 48.46 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.356 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.586 ' HB3' HD23 ' A' ' 97' ' ' LEU . 53.4 t-80 -59.53 -43.55 93.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.66 -1.275 . . . . 0.0 108.42 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.636 ' H ' HD23 ' A' ' 97' ' ' LEU . 16.3 t30 -148.71 19.85 1.02 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.415 ' CA ' ' O ' ' A' ' 91' ' ' VAL . 49.1 t0 64.68 38.77 6.81 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.365 0.602 . . . . 0.0 109.773 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.432 ' H ' HD22 ' A' ' 97' ' ' LEU . 62.6 m -168.19 2.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.851 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.978 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.0 OUTLIER -101.62 64.47 0.99 Allowed 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.16 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -79.06 71.11 5.52 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.275 -0.891 . . . . 0.0 110.723 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.564 ' CG1' HG23 ' A' ' 50' ' ' VAL . 6.9 p -148.5 158.41 7.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.49 ' N ' HG22 ' A' ' 99' ' ' VAL . 58.7 p -122.27 150.66 42.01 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.666 ' O ' HD12 ' A' ' 101' ' ' LEU . 2.2 pp -88.34 47.14 1.46 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.204 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.33 -4.83 57.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.7 -0.625 . . . . 0.0 111.368 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 32' ' ' THR . 88.1 m-85 -112.96 120.4 40.69 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.612 -1.305 . . . . 0.0 110.068 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.793 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 26.5 Cg_endo -73.29 146.48 40.39 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.681 2.254 . . . . 0.0 112.04 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.753 HG21 HD22 ' A' ' 34' ' ' LEU . 9.2 p -80.88 -25.46 10.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.574 -0.704 . . . . 0.0 110.667 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.56 ' HD1' HG13 ' A' ' 105' ' ' VAL . 2.4 m-85 -112.8 47.62 1.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.222 -0.924 . . . . 0.0 110.577 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.793 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . -80.41 95.32 6.38 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.928 -1.107 . . . . 0.0 108.242 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -65.54 -37.6 87.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.306 -0.872 . . . . 0.0 109.775 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -60.69 -41.77 95.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.674 -0.641 . . . . 0.0 110.668 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.491 ' O ' ' OXT' ' A' ' 111' ' ' ARG . 33.3 mmt180 -75.22 -28.85 60.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.983 -1.073 . . . . 0.0 109.27 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.491 ' OXT' ' O ' ' A' ' 110' ' ' ARG . 32.4 ttm180 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.691 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.464 ' C ' ' OD1' ' A' ' 2' ' ' ASP . 53.0 p30 -76.97 170.41 16.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.157 -0.964 . . . . 0.0 109.134 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.805 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.2 mm? -71.51 139.73 84.1 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.178 -0.951 . . . . 0.0 108.899 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.36 -1.85 9.63 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.907 2.404 . . . . 0.0 111.383 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.591 ' ND1' HG12 ' A' ' 82' ' ' VAL . 30.2 m170 -65.63 -21.42 66.57 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.793 -0.567 . . . . 0.0 109.767 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.411 ' O ' ' HE3' ' A' ' 79' ' ' LYS . 85.7 m-70 -58.97 -23.5 61.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.116 -0.99 . . . . 0.0 109.427 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.714 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 72.8 m-20 -105.74 134.38 48.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 109.915 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 12' ' ' ASN . 92.5 mt-10 -71.31 -30.01 65.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.952 . . . . 0.0 110.341 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.717 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -60.26 -31.38 70.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.041 -1.037 . . . . 0.0 110.23 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.785 HG22 ' HA ' ' A' ' 107' ' ' ALA . 22.7 p -67.39 -32.21 72.96 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.345 -0.847 . . . . 0.0 110.926 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.714 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -131.72 -3.72 3.68 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.534 -1.354 . . . . 0.0 111.199 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 8' ' ' GLU . 58.4 t30 -96.1 117.74 31.31 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.477 -1.389 . . . . 0.0 111.524 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.637 HG12 ' CB ' ' A' ' 16' ' ' SER . 11.9 t -134.71 33.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.6 -30.21 26.79 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.3 m -60.29 -38.5 83.81 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.058 -1.26 . . . . 0.0 109.414 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.637 ' CB ' HG12 ' A' ' 13' ' ' VAL . 74.4 m -67.11 142.2 57.17 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.3 -0.875 . . . . 0.0 110.746 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -83.55 166.14 18.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.597 -0.689 . . . . 0.0 109.205 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.571 ' CG ' HH12 ' A' ' 36' ' ' ARG . 38.0 ttp180 -59.35 -40.7 87.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.092 -1.005 . . . . 0.0 109.426 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -59.74 -45.67 91.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.049 -1.032 . . . . 0.0 108.504 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -67.96 -33.62 75.01 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.64 92.77 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 26' ' ' ARG . 99.0 mt-10 -55.43 -48.04 75.04 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -60.57 -44.19 96.45 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.11 -41.18 97.34 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.623 HD11 ' HB3' ' A' ' 47' ' ' SER . 17.7 mt -69.31 -32.65 71.91 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' GLU . 97.6 mtt180 -85.25 2.46 43.82 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.409 0.623 . . . . 0.0 109.801 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.56 8.47 32.38 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.831 ' HZ2' ' HB ' ' A' ' 105' ' ' VAL . 11.9 pttt -142.82 157.51 44.54 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.89 -1.359 . . . . 0.0 110.69 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.73 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.0 OUTLIER -85.56 163.86 18.12 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.029 0.919 . . . . 0.0 111.577 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.556 ' OD1' ' C ' ' A' ' 50' ' ' VAL . 76.4 m-20 -42.96 159.81 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.63 0.728 . . . . 0.0 110.442 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.47 -27.08 5.36 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.7 m -86.4 124.77 33.11 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.326 -1.102 . . . . 0.0 108.432 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.786 ' HB2' HG22 ' A' ' 48' ' ' VAL . 0.5 OUTLIER -132.9 173.12 11.73 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.137 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.652 ' CB ' HG11 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -150.3 166.46 29.9 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.23 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.507 HG22 ' SG ' ' A' ' 46' ' ' CYS . 46.8 t -112.31 140.36 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.571 HH12 ' CG ' ' A' ' 18' ' ' ARG . 12.6 ptt180 -153.71 178.2 10.13 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.014 -1.054 . . . . 0.0 109.036 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.656 ' C ' ' H ' ' A' ' 39' ' ' SER . 11.3 pm0 -87.4 169.69 12.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.83 -1.169 . . . . 0.0 108.237 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.734 ' N ' ' O ' ' A' ' 43' ' ' CYS . 58.8 p -76.63 9.43 2.77 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.656 ' H ' ' C ' ' A' ' 37' ' ' GLU . 6.2 m 83.13 -116.58 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.569 -1.651 . . . . 0.0 109.725 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -91.3 -2.25 57.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.988 -1.07 . . . . 0.0 110.232 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -70.01 -33.24 71.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.864 -1.147 . . . . 0.0 110.024 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.08 -5.91 42.61 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.734 ' O ' ' N ' ' A' ' 38' ' ' SER . 71.2 m -103.62 169.15 8.7 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.225 -1.162 . . . . 0.0 109.799 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -106.58 162.23 13.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.347 -0.846 . . . . 0.0 109.758 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.03 148.91 17.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.213 -0.929 . . . . 0.0 110.695 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.518 ' SG ' HD11 ' A' ' 59' ' ' ILE . 75.8 m -111.2 124.31 51.96 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.198 -0.939 . . . . 0.0 108.631 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.623 ' HB3' HD11 ' A' ' 25' ' ' LEU . 69.0 m -91.2 139.82 30.39 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.115 -0.99 . . . . 0.0 110.151 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.786 HG22 ' HB2' ' A' ' 33' ' ' PHE . 56.2 t -133.51 157.44 42.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.44 ' N ' HG12 ' A' ' 48' ' ' VAL . 96.0 t -112.9 135.97 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.556 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -123.78 158.51 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.747 -1.221 . . . . 0.0 109.664 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.542 ' CA ' ' OD2' ' A' ' 30' ' ' ASP . 66.2 t0 -67.23 61.79 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.633 0.73 . . . . 0.0 109.934 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 172.1 -40.38 0.17 Allowed Glycine 0 C--N 1.292 -1.888 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.497 ' H ' HG12 ' A' ' 50' ' ' VAL . 79.0 tt0 -162.38 160.49 26.56 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.118 -1.225 . . . . 0.0 110.84 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.553 ' CG1' HD13 ' A' ' 25' ' ' LEU . 43.8 t -88.13 126.33 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' NZ ' ' HB3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -114.52 155.71 25.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.841 -1.162 . . . . 0.0 110.297 -178.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 57.3 m170 -116.43 119.83 36.88 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.415 -0.803 . . . . 0.0 108.888 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.507 ' O ' ' N ' ' A' ' 46' ' ' CYS . 41.8 t -92.46 124.2 36.32 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 58' ' ' VAL . 2.8 p -96.28 133.4 37.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 121.114 -0.991 . . . . 0.0 111.094 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD11 ' SG ' ' A' ' 46' ' ' CYS . 96.7 mt -119.33 130.31 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.58 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 75.5 m-20 -111.22 123.59 50.5 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.076 -1.015 . . . . 0.0 110.097 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -92.79 38.07 1.02 Allowed 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.818 HG22 ' H ' ' A' ' 63' ' ' ALA . 75.1 m -105.69 -177.25 3.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.655 -0.653 . . . . 0.0 109.343 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.818 ' H ' HG22 ' A' ' 62' ' ' THR . . . -44.3 -8.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 109.656 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.698 ' N ' ' O ' ' A' ' 62' ' ' THR . 60.5 p -81.47 -8.75 59.77 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.203 -0.936 . . . . 0.0 108.531 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.57 80.06 0.14 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.58 ' CA ' ' O ' ' A' ' 60' ' ' ASN . 86.5 m-85 57.46 -132.87 1.3 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.075 -1.25 . . . . 0.0 109.783 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -140.65 173.89 22.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.71 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 7.2 m-30 58.59 36.43 25.1 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.171 -1.193 . . . . 0.0 109.53 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.411 ' C ' ' HD2' ' A' ' 71' ' ' PRO . . . -95.48 2.54 54.46 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.088 -1.007 . . . . 0.0 109.621 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.629 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 55.9 mp0 -63.5 -35.94 19.83 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 110.652 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 61.5 Cg_endo -84.24 15.6 2.13 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.959 1.773 . . . . 0.0 111.44 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 60.1 37.78 20.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.676 -0.64 . . . . 0.0 109.288 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.484 ' OD1' ' CE1' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -132.32 75.8 1.66 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 110.006 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.839 ' O ' HD12 ' A' ' 74' ' ' LEU . 3.0 pp -119.52 104.09 10.0 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.574 ' CD2' ' OE1' ' A' ' 80' ' ' GLU . 78.9 m-85 -67.68 156.06 37.78 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.276 -0.89 . . . . 0.0 109.98 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 90.9 p -85.42 -11.78 53.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.7 -0.625 . . . . 0.0 111.423 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 t -114.36 141.74 47.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.655 -1.278 . . . . 0.0 110.391 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.7 mt -61.4 -38.13 85.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.383 -0.823 . . . . 0.0 109.545 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 6' ' ' HIS . 24.0 mmtm -59.68 -39.09 83.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.269 -0.895 . . . . 0.0 108.807 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.574 ' OE1' ' CD2' ' A' ' 75' ' ' TYR . 20.6 mm-40 -65.58 -42.5 91.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 109.001 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.571 HD23 ' C ' ' A' ' 81' ' ' LEU . 8.4 tt -61.09 -42.83 99.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.367 -0.833 . . . . 0.0 109.183 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.591 HG12 ' ND1' ' A' ' 5' ' ' HIS . 70.5 t -67.09 -47.04 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.306 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.1 mt -67.48 -43.04 81.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.481 -0.762 . . . . 0.0 110.104 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.484 ' CE1' ' OD1' ' A' ' 73' ' ' ASN . 85.7 t60 -61.47 -42.58 99.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 0.0 109.885 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.894 ' HB3' HD13 ' A' ' 101' ' ' LEU . 5.0 m-85 -60.58 -28.38 68.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.16 -0.962 . . . . 0.0 109.632 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -65.4 -34.92 79.44 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.935 -1.103 . . . . 0.0 108.769 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -84.56 -25.18 28.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.349 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.1 m -88.78 129.33 35.58 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.911 -1.118 . . . . 0.0 109.679 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.608 ' HA ' HG22 ' A' ' 100' ' ' THR . 66.5 m -81.51 133.52 35.4 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 91' ' ' VAL . 86.6 mt -71.84 -19.04 62.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.297 -0.877 . . . . 0.0 111.964 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.785 ' O ' ' N ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -34.23 -51.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.874 -1.142 . . . . 0.0 110.228 -178.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -54.72 -29.13 52.57 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.077 0.465 . . . . 0.0 110.56 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.798 ' HB3' HD12 ' A' ' 97' ' ' LEU . 64.4 t-80 -50.05 -48.14 53.09 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.939 -1.101 . . . . 0.0 108.797 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.485 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 64.9 t-20 -140.18 19.85 2.43 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.785 ' N ' ' O ' ' A' ' 91' ' ' VAL . 53.5 t0 59.92 8.16 1.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.1 p -137.22 11.56 3.04 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.278 -0.889 . . . . 0.0 109.571 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.798 HD12 ' HB3' ' A' ' 93' ' ' HIS . 23.7 mt -103.32 69.94 1.03 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.705 -1.247 . . . . 0.0 108.509 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.523 ' CA ' HG13 ' A' ' 91' ' ' VAL . 41.5 p-10 -78.25 69.28 4.43 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.608 0.718 . . . . 0.0 110.395 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 100' ' ' THR . 53.9 t -156.38 158.09 3.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.469 0.652 . . . . 0.0 109.514 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.608 HG22 ' HA ' ' A' ' 89' ' ' SER . 72.8 p -131.17 164.09 26.27 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.575 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.894 HD13 ' HB3' ' A' ' 85' ' ' TYR . 6.2 mp -82.71 68.12 9.05 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -97.94 -27.02 14.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.601 -0.687 . . . . 0.0 111.225 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -112.66 132.67 22.13 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 120.692 -1.255 . . . . 0.0 111.091 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.495 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 73.6 Cg_endo -76.14 142.67 24.76 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.764 2.976 . . . . 0.0 111.975 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.831 ' HB ' ' HZ2' ' A' ' 28' ' ' LYS . 9.7 p -76.7 -33.13 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.159 -0.963 . . . . 0.0 111.954 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -130.15 60.56 1.61 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.55 -1.344 . . . . 0.0 110.889 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.785 ' HA ' HG22 ' A' ' 10' ' ' THR . . . -87.97 134.87 33.63 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.271 -0.971 . . . . 0.0 109.524 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.28 139.35 46.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.529 -0.732 . . . . 0.0 110.205 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -93.35 0.82 57.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 109.599 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -61.93 -40.73 96.51 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.179 -0.951 . . . . 0.0 110.503 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.784 ' CB ' HH11 ' A' ' 111' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 O-C-N 120.901 -1.124 . . . . 0.0 109.48 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.474 ' C ' ' OD1' ' A' ' 2' ' ' ASP . 58.3 p30 -76.02 169.42 18.21 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.415 -0.803 . . . . 0.0 109.17 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.4 mt -91.84 116.08 65.79 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.104 -0.997 . . . . 0.0 109.985 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.51 -16.92 5.91 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.671 2.247 . . . . 0.0 111.771 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.619 ' NE2' ' OE1' ' A' ' 86' ' ' GLN . 96.4 m-70 -67.18 -19.94 65.65 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.377 -0.827 . . . . 0.0 109.872 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -60.19 -36.59 77.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.868 -1.145 . . . . 0.0 109.506 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.633 ' OD2' ' NZ ' ' A' ' 9' ' ' LYS . 47.9 t0 -92.17 123.23 35.36 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.078 -1.014 . . . . 0.0 109.827 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.519 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 19.8 tt0 -64.44 -30.54 71.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.725 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.633 ' NZ ' ' OD2' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -61.48 -35.18 76.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.702 -0.624 . . . . 0.0 111.553 -179.327 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.715 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 13.7 p -51.63 -39.91 58.95 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.996 -1.065 . . . . 0.0 110.389 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.715 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -117.09 -19.29 9.79 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.857 -1.152 . . . . 0.0 110.684 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.437 ' CB ' ' HG2' ' A' ' 8' ' ' GLU . 49.4 t-20 -89.53 123.76 33.92 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.872 -1.142 . . . . 0.0 111.253 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 35' ' ' VAL . 27.0 m -100.7 -16.0 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.302 -0.873 . . . . 0.0 109.207 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASN . . . 78.87 -141.37 24.29 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.515 ' HA ' ' NH2' ' A' ' 36' ' ' ARG . 36.8 t -81.76 104.53 12.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -1.093 . . . . 0.0 108.748 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 t -135.29 135.09 40.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.448 -0.782 . . . . 0.0 109.93 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -64.61 143.39 57.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.112 -0.993 . . . . 0.0 109.694 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.597 ' CZ ' ' OG ' ' A' ' 39' ' ' SER . 37.9 mtt-85 -60.17 -33.44 72.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.0 108.779 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -59.67 -43.41 94.01 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -62.41 -34.3 76.47 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.09 -35.13 76.18 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 26' ' ' ARG . 94.9 mt-10 -60.07 -45.83 91.58 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.819 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -63.17 -43.0 99.48 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.29 -36.66 79.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.0 109.27 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.633 HD23 ' HD2' ' A' ' 28' ' ' LYS . 56.1 mt -87.21 -15.13 39.13 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.141 -0.974 . . . . 0.0 109.047 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 22' ' ' GLU . 16.1 mtp180 -77.71 -22.42 50.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.13 -0.981 . . . . 0.0 109.372 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.43 19.84 23.79 Favored Glycine 0 C--N 1.285 -2.282 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.68 ' NZ ' HG23 ' A' ' 105' ' ' VAL . 5.1 ttmm -105.91 131.15 53.57 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.571 -0.958 . . . . 0.0 111.456 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -85.39 166.44 16.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.681 -0.637 . . . . 0.0 110.149 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.633 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 63.4 t0 -63.15 142.08 58.52 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.446 -0.784 . . . . 0.0 110.475 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.627 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 100.87 -19.28 52.85 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.43 ' HB ' ' CG ' ' A' ' 28' ' ' LYS . 60.4 m -97.14 136.35 37.8 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.136 -1.214 . . . . 0.0 109.272 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.583 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -139.37 172.79 12.3 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.755 -1.216 . . . . 0.0 109.892 179.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.435 ' CD2' HD21 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -139.7 153.96 47.36 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.816 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.58 ' O ' HG22 ' A' ' 13' ' ' VAL . 67.5 t -104.63 136.8 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.969 -1.082 . . . . 0.0 108.527 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.712 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -144.69 -169.9 3.27 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 108.924 -178.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.712 ' H ' ' CD ' ' A' ' 36' ' ' ARG . 9.8 mt-10 -100.66 -178.53 3.81 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.909 -1.12 . . . . 0.0 108.234 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.5 m -77.86 14.21 1.15 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.607 ' H ' ' C ' ' A' ' 37' ' ' GLU . 50.8 m 62.45 15.39 7.75 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.178 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -172.02 -76.99 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.537 -0.727 . . . . 0.0 109.688 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.576 ' C ' ' H ' ' A' ' 43' ' ' CYS . 97.5 mt-30 -60.34 147.95 38.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.087 -1.008 . . . . 0.0 109.874 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.82 9.86 0.1 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.576 ' H ' ' C ' ' A' ' 41' ' ' GLN . 80.3 m -80.44 168.85 18.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -1.195 . . . . 0.0 109.144 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.537 ' O ' ' O ' ' A' ' 59' ' ' ILE . 94.9 m-85 -108.53 155.62 20.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.979 -1.076 . . . . 0.0 110.732 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.422 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -155.4 129.5 8.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.436 -0.79 . . . . 0.0 109.154 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 57' ' ' CYS . 20.6 p -112.93 154.44 26.4 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.5 m -118.73 142.89 47.26 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.089 -0.645 . . . . 0.0 109.493 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.54 HG22 ' N ' ' A' ' 49' ' ' VAL . 1.9 p -132.58 161.3 41.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.298 -0.876 . . . . 0.0 108.901 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.54 ' N ' HG22 ' A' ' 48' ' ' VAL . 47.5 t -117.44 132.47 67.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.655 ' HB ' ' HZ2' ' A' ' 55' ' ' LYS . 8.6 p -115.91 164.44 12.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.224 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.633 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 95.9 m-20 -59.66 28.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.981 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -154.58 -38.0 0.02 OUTLIER Glycine 0 N--CA 1.483 1.785 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.629 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.569 ' CD ' ' O ' ' A' ' 52' ' ' GLY . 55.0 mp0 -159.26 164.58 34.84 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.65 -1.5 . . . . 0.0 112.512 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.8 t -89.33 141.15 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.655 ' HZ2' ' HB ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -131.04 165.71 22.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.843 -1.161 . . . . 0.0 111.617 -178.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -128.42 75.84 1.66 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.48 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 46.3 t -56.6 134.24 54.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.205 -0.934 . . . . 0.0 109.62 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.86 134.41 42.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.582 0.705 . . . . 0.0 110.112 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.537 ' O ' ' O ' ' A' ' 44' ' ' TYR . 49.5 mm -108.41 129.34 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.522 ' O ' ' O ' ' A' ' 66' ' ' TYR . 77.5 m-20 -114.67 126.69 55.16 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.857 -1.152 . . . . 0.0 110.793 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -111.07 122.31 47.55 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.153 -0.967 . . . . 0.0 109.485 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.714 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 54.4 m -119.6 -12.14 9.34 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 62' ' ' THR . . . 155.2 -48.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.1 m -153.99 60.01 0.72 Allowed 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.47 -49.56 0.03 OUTLIER Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.38 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.522 ' O ' ' O ' ' A' ' 60' ' ' ASN . 96.7 m-85 58.65 -132.42 1.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -1.151 . . . . 0.0 109.106 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 66' ' ' TYR . . . -59.7 -148.48 0.01 OUTLIER Glycine 0 N--CA 1.493 2.5 0 O-C-N 121.023 -1.048 . . . . 0.0 110.586 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.649 ' CE2' ' NE2' ' A' ' 93' ' ' HIS . 42.7 p90 -69.62 130.59 42.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.822 -1.399 . . . . 0.0 109.636 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.62 139.35 53.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.121 -0.987 . . . . 0.0 109.771 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.708 ' O ' ' N ' ' A' ' 72' ' ' TYR . 69.4 mt-10 -70.6 157.54 89.9 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.463 ' C ' ' O ' ' A' ' 70' ' ' GLU . 76.8 Cg_exo -30.96 -25.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.41 2.073 . . . . 0.0 111.485 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.708 ' N ' ' O ' ' A' ' 70' ' ' GLU . 94.2 m-85 -119.73 117.18 27.55 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -60.93 125.11 22.5 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.361 -0.837 . . . . 0.0 109.664 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.5 mt -116.86 0.16 12.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.408 -0.808 . . . . 0.0 109.384 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -94.6 130.99 40.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 0.0 110.384 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.7 t -106.74 -43.07 4.79 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.905 -1.122 . . . . 0.0 110.652 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.0 p -137.48 166.14 24.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.848 -1.158 . . . . 0.0 109.823 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.29 -32.06 72.74 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.559 -0.713 . . . . 0.0 109.395 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.403 ' O ' HG12 ' A' ' 82' ' ' VAL . 61.3 mttp -59.6 -41.19 89.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.896 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -75.41 -26.68 58.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.094 -1.004 . . . . 0.0 109.601 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.6 tt -67.99 -42.25 81.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.164 -0.96 . . . . 0.0 110.371 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 83' ' ' LEU . 4.3 p -68.61 -46.73 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.204 -0.935 . . . . 0.0 110.359 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.53 ' N ' HG13 ' A' ' 82' ' ' VAL . 85.9 mt -66.02 -40.05 90.73 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.898 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.451 ' HA ' ' CD2' ' A' ' 87' ' ' HIS . 21.3 t60 -58.65 -41.21 85.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.297 -0.877 . . . . 0.0 110.233 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.597 ' CZ ' ' CZ ' ' A' ' 68' ' ' PHE . 7.2 m-30 -74.62 -25.75 59.43 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.088 -1.007 . . . . 0.0 109.67 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.619 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 30.5 tt0 -63.92 -36.57 84.4 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.998 -1.064 . . . . 0.0 110.33 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.471 ' CE1' ' OG1' ' A' ' 88' ' ' THR . 21.7 p80 -93.21 -7.05 46.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.057 -1.027 . . . . 0.0 109.272 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' CE1' ' A' ' 87' ' ' HIS . 33.3 m -105.59 138.3 42.01 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 108.895 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.522 ' HA ' HG22 ' A' ' 100' ' ' THR . 2.8 m -89.79 130.14 36.09 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 109.268 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.562 ' O ' ' C ' ' A' ' 91' ' ' VAL . 83.0 mt -71.27 -18.65 62.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.658 -0.651 . . . . 0.0 110.246 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.73 ' N ' ' O ' ' A' ' 97' ' ' LEU . 14.7 p -31.36 -47.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.314 -0.866 . . . . 0.0 109.638 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.692 ' N ' HG13 ' A' ' 91' ' ' VAL . 76.6 mt-30 -57.61 -45.66 85.08 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.131 -178.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.649 ' NE2' ' CE2' ' A' ' 68' ' ' PHE . 75.1 m80 -48.53 -50.42 32.1 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.807 ' O ' ' N ' ' A' ' 96' ' ' SER . 97.7 m-20 -134.31 114.19 12.74 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 94' ' ' ASN . 84.1 m-20 -31.73 -19.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.525 -0.734 . . . . 0.0 111.393 -177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.807 ' N ' ' O ' ' A' ' 94' ' ' ASN . 54.6 m -107.66 20.46 18.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.635 -1.291 . . . . 0.0 111.698 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.73 ' O ' ' N ' ' A' ' 91' ' ' VAL . 8.3 mt -97.7 57.43 1.35 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.444 -1.41 . . . . 0.0 109.263 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -78.32 86.03 4.43 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.386 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.539 HG13 HD12 ' A' ' 90' ' ' LEU . 13.9 p -168.7 151.88 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.522 HG22 ' HA ' ' A' ' 89' ' ' SER . 34.9 p -131.68 159.34 38.64 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.469 -0.77 . . . . 0.0 109.342 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.583 HD22 ' CG ' ' A' ' 33' ' ' PHE . 19.2 mt -78.22 69.79 4.48 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.942 -1.099 . . . . 0.0 108.175 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.57 -31.45 16.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.451 -0.78 . . . . 0.0 112.714 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -122.53 136.14 26.31 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.507 -1.371 . . . . 0.0 111.393 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.785 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 68.0 Cg_endo -77.08 152.88 31.81 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 123.133 2.556 . . . . 0.0 111.956 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.68 HG23 ' NZ ' ' A' ' 28' ' ' LYS . 9.6 p -79.16 -16.41 13.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.093 -1.004 . . . . 0.0 110.626 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.433 ' HE2' HG12 ' A' ' 13' ' ' VAL . 13.2 m-85 -129.73 61.18 1.57 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.073 -1.017 . . . . 0.0 111.016 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.785 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . -85.69 119.18 25.74 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.132 -0.98 . . . . 0.0 108.795 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -114.87 124.82 52.7 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.945 -1.097 . . . . 0.0 109.538 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -111.46 -12.67 13.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.378 -0.826 . . . . 0.0 109.005 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.719 HH11 ' CG ' ' A' ' 110' ' ' ARG . 1.5 mtt-85 -121.63 146.52 46.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.897 . . . . 0.0 110.458 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.75 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.43 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.528 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.0 0.428 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -79.7 124.76 28.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.17 -0.956 . . . . 0.0 109.834 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.0 mt -101.45 118.7 59.37 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 108.679 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -58.96 -11.77 13.33 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.948 1.765 . . . . 0.0 111.576 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.608 ' HB2' HD11 ' A' ' 83' ' ' LEU . 98.0 m-70 -67.2 -31.7 72.27 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.803 -0.561 . . . . 0.0 110.749 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.556 ' ND1' ' N ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -63.06 -15.4 56.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 0.0 110.153 -178.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.693 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 27.1 t0 -102.51 126.14 49.47 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.723 ' O ' ' N ' ' A' ' 12' ' ' ASN . 4.0 mp0 -66.18 -27.29 67.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 110.644 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.679 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -62.69 -39.05 92.77 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.988 -1.07 . . . . 0.0 109.689 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.764 HG22 ' HA ' ' A' ' 107' ' ' ALA . 22.1 p -59.04 -33.76 71.13 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.694 -0.629 . . . . 0.0 109.909 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.693 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -123.91 -31.59 3.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.808 -1.183 . . . . 0.0 111.728 -179.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.723 ' N ' ' O ' ' A' ' 8' ' ' GLU . 28.5 t-20 -87.84 130.65 34.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.539 -1.35 . . . . 0.0 110.857 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -107.48 -6.52 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASN . . . 92.77 -161.86 26.13 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.4 p -67.44 153.59 43.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -1.14 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 t -163.59 150.51 12.23 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.424 -0.797 . . . . 0.0 109.407 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 18' ' ' ARG . 11.0 m120 -88.12 7.95 29.18 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 4.5 mmp_? 66.73 9.01 6.37 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.468 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.715 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 36.5 p-10 -77.52 -53.67 7.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.071 -1.018 . . . . 0.0 108.27 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.715 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 45.1 pttt -68.88 -26.29 65.05 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -56.62 -45.62 81.39 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 26' ' ' ARG . 59.2 mm-40 -59.16 -47.04 86.78 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -62.8 -42.68 99.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 24' ' ' LEU . 79.0 mt -69.94 -29.97 67.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 109.504 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.536 HD11 ' OG ' ' A' ' 47' ' ' SER . 16.0 mt -89.79 -13.28 36.98 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 22' ' ' GLU . 89.5 mtt180 -91.5 115.27 27.9 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.62 2.89 50.05 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.536 ' O ' HG11 ' A' ' 49' ' ' VAL . 36.4 mmtt -100.77 137.82 38.64 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.225 -1.162 . . . . 0.0 109.212 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -69.64 156.49 38.87 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.664 -0.648 . . . . 0.0 109.695 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 63.2 t0 -57.81 141.92 47.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.587 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 108.7 -27.82 12.62 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.465 ' HG1' ' HD2' ' A' ' 103' ' ' TYR . 86.4 m -79.85 120.8 24.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.133 -1.216 . . . . 0.0 108.437 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -139.89 176.57 8.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.851 -1.156 . . . . 0.0 110.931 -178.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.68 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -150.76 161.63 42.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.576 -0.703 . . . . 0.0 110.233 179.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.493 HG22 ' SG ' ' A' ' 46' ' ' CYS . 43.7 t -107.16 139.97 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.656 ' NH1' ' HB3' ' A' ' 45' ' ' ALA . 1.1 ppt_? -158.72 -160.21 0.85 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.615 ' C ' ' H ' ' A' ' 39' ' ' SER . 82.7 mt-10 -100.19 174.27 6.23 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.567 -1.333 . . . . 0.0 109.079 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.668 ' N ' ' O ' ' A' ' 43' ' ' CYS . 33.6 m -76.67 12.98 1.1 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.615 ' H ' ' C ' ' A' ' 37' ' ' GLU . 7.2 t 85.85 -113.61 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.757 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -86.9 -9.72 55.04 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.123 -0.985 . . . . 0.0 110.722 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -71.56 -35.89 70.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.74 -1.225 . . . . 0.0 110.062 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.3 -14.55 58.15 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.668 ' O ' ' N ' ' A' ' 38' ' ' SER . 76.9 m -79.73 160.06 26.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.28 . . . . 0.0 109.329 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -85.65 154.43 21.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.016 -1.053 . . . . 0.0 109.187 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.656 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . . . -159.38 151.61 21.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.978 -1.076 . . . . 0.0 110.062 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.65 ' SG ' HD11 ' A' ' 59' ' ' ILE . 77.0 m -113.46 124.07 51.53 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.536 ' OG ' HD11 ' A' ' 25' ' ' LEU . 45.2 t -94.7 130.81 41.06 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.106 -0.997 . . . . 0.0 109.022 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.565 HG22 ' N ' ' A' ' 49' ' ' VAL . 9.9 p -135.19 168.44 23.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.482 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.565 ' N ' HG22 ' A' ' 48' ' ' VAL . 67.6 t -115.19 134.3 58.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.1 t -112.85 161.25 11.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.044 -1.035 . . . . 0.0 109.801 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 50' ' ' VAL . 64.6 m-20 -62.25 56.13 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.029 0.443 . . . . 0.0 109.99 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 164.37 -36.71 0.29 Allowed Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.208 -1.472 . . . . 0.0 111.018 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.511 ' OE1' ' C ' ' A' ' 52' ' ' GLY . 60.7 mp0 -153.91 161.06 42.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.638 -1.507 . . . . 0.0 110.972 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.405 ' CG1' HD13 ' A' ' 25' ' ' LEU . 97.1 t -91.9 138.47 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' CE ' ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -124.07 168.73 12.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.903 -1.123 . . . . 0.0 110.948 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.475 ' HB3' HH22 ' A' ' 36' ' ' ARG . 71.0 m-70 -129.79 73.67 1.54 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.587 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 73.0 m -50.7 148.1 4.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.315 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.1 t -116.16 134.5 59.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.891 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.878 HG23 ' O ' ' A' ' 66' ' ' TYR . 67.1 mt -117.46 139.17 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.532 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 10.0 m120 -126.58 131.55 51.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.8 -1.187 . . . . 0.0 109.689 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -97.54 120.75 38.48 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.338 -0.851 . . . . 0.0 110.435 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 1.029 HG23 ' H ' ' A' ' 64' ' ' THR . 4.9 t -153.56 175.48 13.16 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.412 -0.805 . . . . 0.0 108.927 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.97 -19.33 6.52 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.314 -0.866 . . . . 0.0 108.952 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 1.029 ' H ' HG23 ' A' ' 62' ' ' THR . 12.4 t -162.92 78.69 0.46 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.111 -0.993 . . . . 0.0 109.95 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.621 ' C ' ' H ' ' A' ' 67' ' ' GLY . . . -161.64 -71.73 0.02 OUTLIER Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.806 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.878 ' O ' HG23 ' A' ' 59' ' ' ILE . 83.4 m-85 57.63 -4.98 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.22 -1.165 . . . . 0.0 109.548 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.621 ' H ' ' C ' ' A' ' 65' ' ' GLY . . . 134.57 -97.72 0.3 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.401 ' O ' ' OH ' ' A' ' 75' ' ' TYR . 27.2 m-85 -80.22 130.94 35.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.349 -1.089 . . . . 0.0 108.79 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.04 -14.3 4.97 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.675 -1.266 . . . . 0.0 110.022 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.67 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 11.3 tp10 -64.47 -36.79 19.9 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.018 -1.051 . . . . 0.0 109.422 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 69.5 Cg_endo -89.97 -58.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.624 2.216 . . . . 0.0 110.68 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -122.92 105.45 10.01 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.549 ' C ' ' OD1' ' A' ' 73' ' ' ASN . 42.2 p30 -90.66 22.19 3.65 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.19 -0.944 . . . . 0.0 109.645 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.2 tp -158.14 103.5 1.83 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.22 -0.925 . . . . 0.0 110.166 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.496 ' CD1' ' HB2' ' A' ' 66' ' ' TYR . 27.6 m-85 -95.64 139.71 31.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.358 -0.839 . . . . 0.0 109.64 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.524 ' OG ' ' CD ' ' A' ' 80' ' ' GLU . 84.1 p -65.45 -44.37 87.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.203 -0.935 . . . . 0.0 110.901 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -166.93 162.44 15.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.924 -1.11 . . . . 0.0 109.489 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.61 -37.73 88.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.481 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 3.7 ttmp? -58.91 -45.33 90.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.887 -1.133 . . . . 0.0 109.175 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.524 ' CD ' ' OG ' ' A' ' 76' ' ' SER . 51.7 mt-10 -67.13 -29.14 68.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.19 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.595 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.6 tt -58.6 -43.75 89.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.285 -0.885 . . . . 0.0 110.014 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.84 -44.39 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.716 -1.24 . . . . 0.0 109.718 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 5' ' ' HIS . 3.8 mm? -67.15 -42.38 84.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 109.555 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.676 ' O ' ' CE1' ' A' ' 87' ' ' HIS . 60.1 t60 -60.28 -39.73 87.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.417 -0.802 . . . . 0.0 110.801 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.467 ' HA ' ' OG1' ' A' ' 88' ' ' THR . 4.9 m-30 -71.08 -25.5 62.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.478 -0.764 . . . . 0.0 112.526 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 83' ' ' LEU . 9.2 pt20 -61.23 -30.56 70.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.348 -1.47 . . . . 0.0 110.312 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.676 ' CE1' ' O ' ' A' ' 84' ' ' HIS . 31.2 p-80 -92.7 -5.49 51.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.75 -1.219 . . . . 0.0 109.188 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.688 ' O ' HG22 ' A' ' 100' ' ' THR . 56.2 p -98.36 139.76 33.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.158 -0.964 . . . . 0.0 109.455 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.2 t -97.81 126.73 43.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.451 -0.781 . . . . 0.0 109.452 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.731 HD12 HG13 ' A' ' 99' ' ' VAL . 81.8 mt -67.05 -20.04 65.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.983 -1.073 . . . . 0.0 109.833 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.774 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.7 p -10.67 -58.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.834 -0.542 . . . . 0.0 110.171 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.773 ' H ' HG13 ' A' ' 91' ' ' VAL . 9.5 tp-100 -35.17 155.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 92' ' ' GLN . 59.5 t-80 55.49 107.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.814 ' O ' ' N ' ' A' ' 96' ' ' SER . 70.9 m-20 56.69 71.84 0.54 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.603 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 94.2 m-20 -29.84 -20.0 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.814 ' N ' ' O ' ' A' ' 94' ' ' ASN . 87.1 p -77.43 15.5 0.77 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.671 -1.268 . . . . 0.0 110.922 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.774 ' O ' ' N ' ' A' ' 91' ' ' VAL . 70.5 mt -95.68 41.67 1.1 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 95' ' ' ASP . 64.1 m-80 -78.39 79.28 4.83 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.321 -0.862 . . . . 0.0 110.073 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.731 HG13 HD12 ' A' ' 90' ' ' LEU . 7.4 p -153.31 157.93 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 88' ' ' THR . 31.8 p -130.26 157.46 42.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.105 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.515 HD22 ' CG ' ' A' ' 33' ' ' PHE . 19.0 mt -82.21 65.73 7.47 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.7 -28.37 12.52 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.489 ' CD1' ' HD2' ' A' ' 104' ' ' PRO . 68.1 t80 -110.48 127.09 27.57 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.14 -1.6 . . . . 0.0 110.973 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.497 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 61.1 Cg_endo -74.82 146.81 33.92 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 123.039 2.493 . . . . 0.0 112.533 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' A' ' 34' ' ' LEU . 9.9 p -83.26 -32.05 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.122 -0.986 . . . . 0.0 110.604 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.541 ' CD2' HG13 ' A' ' 105' ' ' VAL . 35.2 m-85 -129.64 59.35 1.61 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.787 -1.196 . . . . 0.0 110.856 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.764 ' HA ' HG22 ' A' ' 10' ' ' THR . . . -94.28 144.49 25.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.416 -0.802 . . . . 0.0 109.772 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -117.45 157.07 26.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.515 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -78.16 124.0 27.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.272 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.531 ' NH1' ' HG2' ' A' ' 110' ' ' ARG . 2.0 mtt-85 -128.87 170.58 13.21 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.237 -0.914 . . . . 0.0 109.517 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.741 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.604 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.009 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.0 0.428 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -79.7 124.76 28.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.17 -0.956 . . . . 0.0 109.834 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.0 mt -101.45 118.7 59.37 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 108.679 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -58.96 -11.77 13.33 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.948 1.765 . . . . 0.0 111.576 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.608 ' HB2' HD11 ' A' ' 83' ' ' LEU . 98.0 m-70 -67.2 -31.7 72.27 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.803 -0.561 . . . . 0.0 110.749 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.556 ' ND1' ' N ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -63.06 -15.4 56.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 0.0 110.153 -178.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.693 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 27.1 t0 -102.51 126.14 49.47 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.723 ' O ' ' N ' ' A' ' 12' ' ' ASN . 4.0 mp0 -66.18 -27.29 67.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 110.644 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.679 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -62.69 -39.05 92.77 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.988 -1.07 . . . . 0.0 109.689 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.764 HG22 ' HA ' ' A' ' 107' ' ' ALA . 22.1 p -59.04 -33.76 71.13 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.694 -0.629 . . . . 0.0 109.909 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.693 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -123.91 -31.59 3.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.808 -1.183 . . . . 0.0 111.728 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.723 ' N ' ' O ' ' A' ' 8' ' ' GLU . 28.5 t-20 -87.84 130.65 34.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.539 -1.35 . . . . 0.0 110.857 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -107.48 -6.52 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASN . . . 92.77 -161.86 26.13 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.4 p -67.44 153.59 43.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -1.14 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 t -163.59 150.51 12.23 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.424 -0.797 . . . . 0.0 109.407 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 18' ' ' ARG . 11.0 m120 -88.12 7.95 29.18 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 4.5 mmp_? 66.73 9.01 6.37 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.468 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.715 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 36.5 p-10 -77.52 -53.67 7.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.071 -1.018 . . . . 0.0 108.27 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.715 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 45.1 pttt -68.88 -26.29 65.05 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -56.62 -45.62 81.39 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 26' ' ' ARG . 59.2 mm-40 -59.16 -47.04 86.78 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -62.8 -42.68 99.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 24' ' ' LEU . 79.0 mt -69.94 -29.97 67.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 109.504 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.536 HD11 ' OG ' ' A' ' 47' ' ' SER . 16.0 mt -89.79 -13.28 36.98 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 22' ' ' GLU . 89.5 mtt180 -91.5 115.27 27.9 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.62 2.89 50.05 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.536 ' O ' HG11 ' A' ' 49' ' ' VAL . 36.4 mmtt -100.77 137.82 38.64 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.225 -1.162 . . . . 0.0 109.212 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -69.64 156.49 38.87 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.664 -0.648 . . . . 0.0 109.695 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 63.2 t0 -57.81 141.92 47.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.587 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 108.7 -27.82 12.62 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.465 ' HG1' ' HD2' ' A' ' 103' ' ' TYR . 86.4 m -79.85 120.8 24.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.133 -1.216 . . . . 0.0 108.437 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -139.89 176.57 8.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.851 -1.156 . . . . 0.0 110.931 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.68 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -150.76 161.63 42.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.576 -0.703 . . . . 0.0 110.233 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.493 HG22 ' SG ' ' A' ' 46' ' ' CYS . 43.7 t -107.16 139.97 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.656 ' NH1' ' HB3' ' A' ' 45' ' ' ALA . 1.1 ppt_? -158.72 -160.21 0.85 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.615 ' C ' ' H ' ' A' ' 39' ' ' SER . 82.7 mt-10 -100.19 174.27 6.23 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.567 -1.333 . . . . 0.0 109.079 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.668 ' N ' ' O ' ' A' ' 43' ' ' CYS . 33.6 m -76.67 12.98 1.1 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.615 ' H ' ' C ' ' A' ' 37' ' ' GLU . 7.2 t 85.85 -113.61 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.757 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -86.9 -9.72 55.04 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.123 -0.985 . . . . 0.0 110.722 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -71.56 -35.89 70.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.74 -1.225 . . . . 0.0 110.062 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.3 -14.55 58.15 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.668 ' O ' ' N ' ' A' ' 38' ' ' SER . 76.9 m -79.73 160.06 26.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.28 . . . . 0.0 109.329 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -85.65 154.43 21.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.016 -1.053 . . . . 0.0 109.187 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.656 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . . . -159.38 151.61 21.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.978 -1.076 . . . . 0.0 110.062 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.65 ' SG ' HD11 ' A' ' 59' ' ' ILE . 77.0 m -113.46 124.07 51.53 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.536 ' OG ' HD11 ' A' ' 25' ' ' LEU . 45.2 t -94.7 130.81 41.06 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.106 -0.997 . . . . 0.0 109.022 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.565 HG22 ' N ' ' A' ' 49' ' ' VAL . 9.9 p -135.19 168.44 23.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.482 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.565 ' N ' HG22 ' A' ' 48' ' ' VAL . 67.6 t -115.19 134.3 58.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.1 t -112.85 161.25 11.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.044 -1.035 . . . . 0.0 109.801 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 50' ' ' VAL . 64.6 m-20 -62.25 56.13 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.029 0.443 . . . . 0.0 109.99 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 164.37 -36.71 0.29 Allowed Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.208 -1.472 . . . . 0.0 111.018 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.511 ' OE1' ' C ' ' A' ' 52' ' ' GLY . 60.7 mp0 -153.91 161.06 42.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.638 -1.507 . . . . 0.0 110.972 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.405 ' CG1' HD13 ' A' ' 25' ' ' LEU . 97.1 t -91.9 138.47 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' CE ' ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -124.07 168.73 12.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.903 -1.123 . . . . 0.0 110.948 -179.445 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.475 ' HB3' HH22 ' A' ' 36' ' ' ARG . 71.0 m-70 -129.79 73.67 1.54 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.587 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 73.0 m -50.7 148.1 4.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.315 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.1 t -116.16 134.5 59.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.891 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.878 HG23 ' O ' ' A' ' 66' ' ' TYR . 67.1 mt -117.46 139.17 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.532 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 10.0 m120 -126.58 131.55 51.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.8 -1.187 . . . . 0.0 109.689 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -97.54 120.75 38.48 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.338 -0.851 . . . . 0.0 110.435 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 1.029 HG23 ' H ' ' A' ' 64' ' ' THR . 4.9 t -153.56 175.48 13.16 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.412 -0.805 . . . . 0.0 108.927 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.97 -19.33 6.52 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.314 -0.866 . . . . 0.0 108.952 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 1.029 ' H ' HG23 ' A' ' 62' ' ' THR . 12.4 t -162.92 78.69 0.46 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.111 -0.993 . . . . 0.0 109.95 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.621 ' C ' ' H ' ' A' ' 67' ' ' GLY . . . -161.64 -71.73 0.02 OUTLIER Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.806 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.878 ' O ' HG23 ' A' ' 59' ' ' ILE . 83.4 m-85 57.63 -4.98 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.22 -1.165 . . . . 0.0 109.548 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.621 ' H ' ' C ' ' A' ' 65' ' ' GLY . . . 134.57 -97.72 0.3 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.401 ' O ' ' OH ' ' A' ' 75' ' ' TYR . 27.2 m-85 -80.22 130.94 35.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.349 -1.089 . . . . 0.0 108.79 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.04 -14.3 4.97 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.675 -1.266 . . . . 0.0 110.022 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.67 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 11.3 tp10 -64.47 -36.79 19.9 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.018 -1.051 . . . . 0.0 109.422 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 69.5 Cg_endo -89.97 -58.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.624 2.216 . . . . 0.0 110.68 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -122.92 105.45 10.01 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.549 ' C ' ' OD1' ' A' ' 73' ' ' ASN . 42.2 p30 -90.66 22.19 3.65 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.19 -0.944 . . . . 0.0 109.645 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.2 tp -158.14 103.5 1.83 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.22 -0.925 . . . . 0.0 110.166 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.496 ' CD1' ' HB2' ' A' ' 66' ' ' TYR . 27.6 m-85 -95.64 139.71 31.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.358 -0.839 . . . . 0.0 109.64 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.524 ' OG ' ' CD ' ' A' ' 80' ' ' GLU . 84.1 p -65.45 -44.37 87.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.203 -0.935 . . . . 0.0 110.901 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -166.93 162.44 15.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.924 -1.11 . . . . 0.0 109.489 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.61 -37.73 88.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.481 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 3.7 ttmp? -58.91 -45.33 90.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.887 -1.133 . . . . 0.0 109.175 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.524 ' CD ' ' OG ' ' A' ' 76' ' ' SER . 51.7 mt-10 -67.13 -29.14 68.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.19 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.595 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.6 tt -58.6 -43.75 89.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.285 -0.885 . . . . 0.0 110.014 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.84 -44.39 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.716 -1.24 . . . . 0.0 109.718 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 5' ' ' HIS . 3.8 mm? -67.15 -42.38 84.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 109.555 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.676 ' O ' ' CE1' ' A' ' 87' ' ' HIS . 60.1 t60 -60.28 -39.73 87.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.417 -0.802 . . . . 0.0 110.801 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.467 ' HA ' ' OG1' ' A' ' 88' ' ' THR . 4.9 m-30 -71.08 -25.5 62.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.478 -0.764 . . . . 0.0 112.526 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 83' ' ' LEU . 9.2 pt20 -61.23 -30.56 70.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.348 -1.47 . . . . 0.0 110.312 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.676 ' CE1' ' O ' ' A' ' 84' ' ' HIS . 31.2 p-80 -92.7 -5.49 51.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.75 -1.219 . . . . 0.0 109.188 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.688 ' O ' HG22 ' A' ' 100' ' ' THR . 56.2 p -98.36 139.76 33.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.158 -0.964 . . . . 0.0 109.455 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.2 t -97.81 126.73 43.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.451 -0.781 . . . . 0.0 109.452 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.731 HD12 HG13 ' A' ' 99' ' ' VAL . 81.8 mt -67.05 -20.04 65.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.983 -1.073 . . . . 0.0 109.833 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.774 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.7 p -10.67 -58.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.834 -0.542 . . . . 0.0 110.171 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.773 ' H ' HG13 ' A' ' 91' ' ' VAL . 9.5 tp-100 -35.17 155.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 92' ' ' GLN . 59.5 t-80 55.49 107.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.814 ' O ' ' N ' ' A' ' 96' ' ' SER . 70.9 m-20 56.69 71.84 0.54 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.603 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 94.2 m-20 -29.84 -20.0 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.814 ' N ' ' O ' ' A' ' 94' ' ' ASN . 87.1 p -77.43 15.5 0.77 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.671 -1.268 . . . . 0.0 110.922 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.774 ' O ' ' N ' ' A' ' 91' ' ' VAL . 70.5 mt -95.68 41.67 1.1 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 95' ' ' ASP . 64.1 m-80 -78.39 79.28 4.83 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.321 -0.862 . . . . 0.0 110.073 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.731 HG13 HD12 ' A' ' 90' ' ' LEU . 7.4 p -153.31 157.93 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 88' ' ' THR . 31.8 p -130.26 157.46 42.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.105 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.515 HD22 ' CG ' ' A' ' 33' ' ' PHE . 19.0 mt -82.21 65.73 7.47 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.7 -28.37 12.52 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.489 ' CD1' ' HD2' ' A' ' 104' ' ' PRO . 68.1 t80 -110.48 127.09 27.57 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.14 -1.6 . . . . 0.0 110.973 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.497 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 61.1 Cg_endo -74.82 146.81 33.92 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 123.039 2.493 . . . . 0.0 112.533 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' A' ' 34' ' ' LEU . 9.9 p -83.26 -32.05 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.122 -0.986 . . . . 0.0 110.604 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.541 ' CD2' HG13 ' A' ' 105' ' ' VAL . 35.2 m-85 -129.64 59.35 1.61 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.787 -1.196 . . . . 0.0 110.856 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.764 ' HA ' HG22 ' A' ' 10' ' ' THR . . . -94.28 144.49 25.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.416 -0.802 . . . . 0.0 109.772 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -117.45 157.07 26.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.515 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -78.16 124.0 27.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.272 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.531 ' NH1' ' HG2' ' A' ' 110' ' ' ARG . 2.0 mtt-85 -128.87 170.58 13.21 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.237 -0.914 . . . . 0.0 109.517 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.741 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.604 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.009 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.538 0.685 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 64.6 t0 -58.44 139.35 55.66 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.418 -0.802 . . . . 0.0 109.559 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.504 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 92.6 mt -94.71 129.57 35.85 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 109.583 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.4 -2.35 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.613 2.209 . . . . 0.0 111.998 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.665 ' CD2' ' OE1' ' A' ' 86' ' ' GLN . 4.7 m80 -67.76 -24.52 65.35 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.898 -1.126 . . . . 0.0 109.493 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -58.13 -29.85 65.86 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.595 ' O ' ' OG1' ' A' ' 10' ' ' THR . 94.5 m-20 -89.0 121.73 31.65 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 46.5 tt0 -69.9 -34.58 73.71 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.07 -1.019 . . . . 0.0 109.585 -178.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.469 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -66.46 -21.98 66.2 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 110.95 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 7' ' ' ASP . 8.1 p -64.05 -35.29 80.26 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.776 -1.203 . . . . 0.0 109.978 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.608 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -115.97 -34.3 4.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.94 -1.1 . . . . 0.0 110.182 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -88.1 125.69 34.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.071 -1.018 . . . . 0.0 110.543 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.575 HG21 HH21 ' A' ' 36' ' ' ARG . 24.5 m -108.59 -13.13 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.2 -158.59 30.34 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.482 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 73.7 m -61.52 148.41 42.16 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.18 -1.188 . . . . 0.0 108.524 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.481 ' HB3' ' NE ' ' A' ' 36' ' ' ARG . 40.4 t -168.87 167.61 10.85 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 109.355 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 86.7 m-20 -88.89 134.7 33.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.235 -0.916 . . . . 0.0 109.281 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.496 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 44.8 mtt-85 -59.98 -36.22 76.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.845 -1.159 . . . . 0.0 110.287 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 19' ' ' ASN . 10.2 m120 -54.53 -48.24 72.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 0.0 111.121 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 17' ' ' ASN . 14.6 ptpt -69.57 -26.43 64.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.385 -1.447 . . . . 0.0 109.3 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.041 ' HB2' HH12 ' A' ' 36' ' ' ARG . . . -57.34 -43.44 83.43 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -59.58 -44.02 93.47 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -60.15 -48.63 80.91 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.27 -36.49 83.83 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.646 HD13 ' CG1' ' A' ' 54' ' ' VAL . 4.0 mt -82.01 -4.43 56.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.221 -0.924 . . . . 0.0 109.432 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.17 131.38 37.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.33 -0.856 . . . . 0.0 110.5 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.06 1.79 88.52 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.74 ' O ' HG11 ' A' ' 49' ' ' VAL . 36.0 mmtt -100.23 128.19 46.35 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.209 -1.171 . . . . 0.0 110.108 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 30' ' ' ASP . 41.9 ttm180 -62.29 147.75 47.12 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 53.3 p-10 -47.39 156.0 0.3 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.928 -1.107 . . . . 0.0 108.769 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.499 ' H ' HG21 ' A' ' 99' ' ' VAL . . . 99.47 -33.87 5.87 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 60.0 m -72.54 123.93 24.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.167 -1.196 . . . . 0.0 108.831 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.736 ' CD1' ' N ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -145.4 172.24 13.47 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 118.385 -1.326 . . . . 0.0 111.051 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.736 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -148.75 159.76 43.83 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.184 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 11' ' ' TRP . 14.7 t -101.5 138.85 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 1.041 HH12 ' HB2' ' A' ' 21' ' ' ALA . 32.2 ttm180 -150.58 160.38 43.84 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 109.5 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.589 ' C ' ' H ' ' A' ' 39' ' ' SER . 16.0 pm0 -102.24 174.65 5.83 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.63 -1.294 . . . . 0.0 109.304 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.584 ' O ' ' CB ' ' A' ' 39' ' ' SER . 60.3 p -75.48 3.93 8.38 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 178.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.589 ' H ' ' C ' ' A' ' 37' ' ' GLU . 1.8 m 91.9 -19.93 0.11 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.497 -1.683 . . . . 0.0 109.349 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -90.36 120.47 31.51 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -49.33 132.55 20.18 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.224 -0.923 . . . . 0.0 109.351 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.99 0.85 41.9 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 42.2 t -131.67 140.16 49.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.34 -1.094 . . . . 0.0 109.074 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' A' ' 59' ' ' ILE . 44.2 m-85 -127.11 163.38 23.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.164 -0.96 . . . . 0.0 109.84 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.625 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -171.77 155.9 4.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.165 -0.96 . . . . 0.0 108.984 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 57' ' ' CYS . 22.1 p -133.13 142.91 48.93 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.496 -1.377 . . . . 0.0 109.285 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.2 p -116.86 139.28 50.79 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.53 -0.731 . . . . 0.0 109.744 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.625 HG22 ' N ' ' A' ' 49' ' ' VAL . 14.9 p -133.29 166.6 28.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.383 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.74 HG11 ' O ' ' A' ' 28' ' ' LYS . 53.7 t -103.69 137.49 32.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.623 ' C ' ' H ' ' A' ' 52' ' ' GLY . 41.4 t -116.99 152.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.153 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.495 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 62.1 t0 -52.7 2.2 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.095 0.474 . . . . 0.0 110.328 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.623 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -136.19 -32.66 0.26 Allowed Glycine 0 N--CA 1.485 1.952 0 C-N-CA 118.894 -1.622 . . . . 0.0 112.248 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 64.2 mt-10 -158.52 163.57 36.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.444 -1.621 . . . . 0.0 111.399 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.646 ' CG1' HD13 ' A' ' 25' ' ' LEU . 66.1 t -76.63 136.99 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 54' ' ' VAL . 60.8 mmtt -114.9 150.89 34.92 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.823 -1.173 . . . . 0.0 111.347 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -131.69 70.04 1.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.466 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 98.0 m -62.22 142.71 57.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 109.566 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 58' ' ' VAL . 7.7 p -106.7 138.28 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.49 -0.756 . . . . 0.0 109.496 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.558 ' O ' ' O ' ' A' ' 44' ' ' TYR . 90.9 mt -123.08 136.64 59.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.282 -0.886 . . . . 0.0 109.183 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 12.3 m120 -102.55 166.85 10.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.88 -1.138 . . . . 0.0 109.301 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.36 10.33 9.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.582 -1.324 . . . . 0.0 110.092 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 63' ' ' ALA . 87.9 m -79.51 167.62 20.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.085 -1.009 . . . . 0.0 109.446 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.604 ' N ' HG22 ' A' ' 62' ' ' THR . . . -55.68 -50.18 70.96 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.293 -0.88 . . . . 0.0 108.963 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 64' ' ' THR . 92.3 m -92.97 -0.41 57.22 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.296 -0.878 . . . . 0.0 108.98 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 66' ' ' TYR . . . -78.69 -101.13 0.22 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.575 ' O ' ' O ' ' A' ' 65' ' ' GLY . 69.7 m-85 53.47 164.79 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.192 -1.181 . . . . 0.0 108.496 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.35 -77.41 0.26 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.71 ' CE1' ' OH ' ' A' ' 85' ' ' TYR . 35.5 m-85 -106.36 118.15 35.9 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.467 -1.019 . . . . 0.0 109.247 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 73' ' ' ASN . . . -107.98 -54.54 2.48 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.139 -0.975 . . . . 0.0 110.336 -179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.62 175.31 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.059 -1.026 . . . . 0.0 108.487 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -51.89 -32.78 48.65 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.24 1.96 . . . . 0.0 112.987 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -151.32 8.65 0.54 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.921 -1.112 . . . . 0.0 111.157 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 69' ' ' ALA . 29.5 m120 -100.34 81.21 2.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.386 -1.446 . . . . 0.0 109.324 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.61 98.37 6.35 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.586 ' OH ' ' CG ' ' A' ' 84' ' ' HIS . 87.7 m-85 -54.6 130.84 41.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.379 -0.826 . . . . 0.0 109.702 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.1 t -68.97 -36.22 77.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.426 -0.796 . . . . 0.0 111.671 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.4 m -130.54 159.49 36.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.579 -1.326 . . . . 0.0 110.742 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.23 -37.63 86.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.871 . . . . 0.0 109.084 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -53.77 -44.09 69.77 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.02 -42.5 72.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.386 -0.821 . . . . 0.0 109.989 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.772 HD23 ' C ' ' A' ' 81' ' ' LEU . 6.9 tt -59.8 -46.13 90.18 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.254 -0.904 . . . . 0.0 109.338 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.44 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 72.0 t -63.06 -45.93 97.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 109.599 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.67 HD23 ' OE1' ' A' ' 86' ' ' GLN . 68.6 mt -61.53 -40.1 93.46 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.539 -0.726 . . . . 0.0 110.305 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.586 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 60.1 t-80 -52.0 -48.67 64.33 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.165 -0.959 . . . . 0.0 110.195 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.803 ' HB2' HD12 ' A' ' 101' ' ' LEU . 27.2 m-85 -71.48 -20.71 62.04 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.126 -0.984 . . . . 0.0 112.027 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.67 ' OE1' HD23 ' A' ' 83' ' ' LEU . 27.7 mt-30 -61.56 -36.02 79.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.645 -1.284 . . . . 0.0 109.382 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -93.5 -37.09 12.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.432 -0.792 . . . . 0.0 109.033 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.58 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 7.7 p -89.6 139.82 30.16 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.431 -0.793 . . . . 0.0 110.29 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.6 t -81.39 136.84 35.72 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.564 -0.71 . . . . 0.0 109.48 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.769 ' O ' ' N ' ' A' ' 92' ' ' GLN . 8.0 mt -61.46 -41.8 97.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.434 -0.791 . . . . 0.0 111.012 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.049 HG22 ' OD1' ' A' ' 98' ' ' ASN . 71.8 t 40.29 -81.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.225 -0.922 . . . . 0.0 109.234 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.769 ' N ' ' O ' ' A' ' 90' ' ' LEU . 0.7 OUTLIER 84.44 171.86 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 0.0 110.475 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.422 ' H ' ' HG3' ' A' ' 92' ' ' GLN . 65.0 m80 -60.93 -37.85 83.74 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 88.4 m-20 -57.93 -18.13 21.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 94' ' ' ASN . 97.7 m-20 61.28 23.23 13.49 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.8 m -134.01 11.49 3.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.57 -1.332 . . . . 0.0 111.195 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.614 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.4 mp -104.02 46.24 0.93 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 1.049 ' OD1' HG22 ' A' ' 91' ' ' VAL . 74.3 m-20 -78.08 67.46 3.92 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.448 -177.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.499 HG21 ' H ' ' A' ' 31' ' ' GLY . 7.4 p -132.2 159.04 43.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.447 ' N ' HG22 ' A' ' 99' ' ' VAL . 40.5 p -110.65 152.36 26.58 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.273 -0.892 . . . . 0.0 108.793 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.803 HD12 ' HB2' ' A' ' 85' ' ' TYR . 91.5 mt -93.26 30.23 1.73 Allowed 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.7 -9.19 58.49 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 32' ' ' THR . 73.7 m-85 -121.83 103.77 39.82 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.375 -1.453 . . . . 0.0 111.602 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -61.01 160.92 24.01 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.02 1.813 . . . . 0.0 110.805 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.09 -22.9 7.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.205 -0.935 . . . . 0.0 109.78 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -111.13 34.39 4.08 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.093 -1.004 . . . . 0.0 110.254 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.33 152.01 46.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.308 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -77.05 161.15 28.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.002 -1.061 . . . . 0.0 110.053 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 60.35 32.49 20.69 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.586 -0.696 . . . . 0.0 109.962 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.539 ' NH1' ' HG3' ' A' ' 110' ' ' ARG . 29.9 ttm-85 -127.62 137.78 52.65 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.006 -1.059 . . . . 0.0 109.442 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.734 ' CG ' HH11 ' A' ' 111' ' ' ARG . 1.6 mtt-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.643 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.44 144.49 49.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.362 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 3' ' ' LEU . 5.4 mp -94.32 143.33 26.17 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.34 -0.85 . . . . 0.0 109.656 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.412 ' CG ' ' HG2' ' A' ' 104' ' ' PRO . 33.8 Cg_endo -67.52 -1.31 6.36 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.234 1.956 . . . . 0.0 111.988 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.63 ' NE2' ' OE1' ' A' ' 86' ' ' GLN . 88.7 m-70 -69.69 -32.36 70.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.106 -0.996 . . . . 0.0 108.606 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -60.99 -32.78 72.34 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.343 -0.848 . . . . 0.0 108.807 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.4 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 68.6 m-20 -92.67 129.22 38.66 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.686 0.755 . . . . 0.0 110.814 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.536 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 75.6 tt0 -77.73 -23.45 49.36 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.3 -0.875 . . . . 0.0 110.68 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -17.85 63.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.187 -0.946 . . . . 0.0 111.528 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.606 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 47.1 p -73.42 -26.69 61.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.732 -1.23 . . . . 0.0 111.305 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.606 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -123.58 -21.91 5.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.505 -1.372 . . . . 0.0 109.773 179.073 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -83.62 121.35 27.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 110.882 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' A' ' 15' ' ' SER . 2.2 t -134.61 33.32 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -30.96 -31.68 0.01 OUTLIER Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.63 ' N ' ' O ' ' A' ' 13' ' ' VAL . 89.2 p -69.54 -21.18 63.67 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.804 -1.409 . . . . 0.0 109.965 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 13' ' ' VAL . 41.9 t -66.62 149.38 50.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.068 -1.02 . . . . 0.0 110.269 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.49 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 92.7 m-20 -114.52 167.57 10.62 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.061 -1.024 . . . . 0.0 109.654 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -56.84 -43.54 81.22 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.266 -0.897 . . . . 0.0 109.26 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -65.82 -46.55 78.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.161 -0.962 . . . . 0.0 108.717 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.49 ' HB3' ' H ' ' A' ' 17' ' ' ASN . 82.3 tttt -65.02 -36.37 84.18 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -57.13 -37.81 72.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 108.878 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.603 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 97.1 mt-10 -59.01 -44.17 91.65 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -63.84 -44.1 94.19 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.447 -0.783 . . . . 0.0 108.975 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.622 ' O ' ' CD ' ' A' ' 28' ' ' LYS . 96.1 mt -71.23 -26.19 62.82 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.335 -0.853 . . . . 0.0 108.837 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.445 HD23 HG23 ' A' ' 49' ' ' VAL . 21.1 mt -94.09 -11.84 29.75 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.603 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 16.6 mmt180 -97.74 134.48 40.85 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.28 -0.38 88.95 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.622 ' CD ' ' O ' ' A' ' 24' ' ' LEU . 19.0 mtpp -105.06 136.65 44.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.094 -1.239 . . . . 0.0 109.468 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -68.27 160.69 28.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.163 -0.96 . . . . 0.0 110.476 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.691 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 84.4 m-20 -57.99 149.45 23.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.518 -0.739 . . . . 0.0 110.218 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 100' ' ' THR . . . 104.71 -30.64 9.71 Favored Glycine 0 N--CA 1.486 2.015 0 C-N-CA 119.41 -1.376 . . . . 0.0 110.222 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.541 HG21 ' CE ' ' A' ' 28' ' ' LYS . 85.0 m -80.17 120.35 24.18 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.418 -1.048 . . . . 0.0 108.207 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.53 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -135.61 164.96 26.65 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 118.806 -1.158 . . . . 0.0 109.656 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -134.01 157.0 47.21 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.398 179.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 11' ' ' TRP . 85.5 t -115.41 124.79 72.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.37 -0.831 . . . . 0.0 108.985 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.691 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -152.56 177.35 10.74 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.686 ' C ' ' H ' ' A' ' 39' ' ' SER . 4.3 pm0 -101.88 168.09 9.65 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.088 -1.007 . . . . 0.0 108.861 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.639 ' O ' ' CB ' ' A' ' 39' ' ' SER . 59.8 p -74.22 9.01 1.81 Allowed 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.686 ' H ' ' C ' ' A' ' 37' ' ' GLU . 12.4 p 93.32 -22.18 0.07 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.729 -1.578 . . . . 0.0 108.452 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -74.41 149.85 40.27 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.508 -0.745 . . . . 0.0 109.147 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -76.42 131.71 39.24 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.297 -0.877 . . . . 0.0 109.195 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.49 -1.81 79.67 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 87.7 m -111.54 135.66 51.8 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.351 -1.087 . . . . 0.0 109.605 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.655 ' O ' ' O ' ' A' ' 59' ' ' ILE . 96.0 m-85 -126.92 149.24 49.9 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.965 -1.084 . . . . 0.0 109.146 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.508 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -158.15 137.49 11.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.348 -1.47 . . . . 0.0 109.794 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 20.9 p -116.9 129.87 56.34 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.149 -0.969 . . . . 0.0 109.092 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.7 t -107.58 138.7 43.33 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.657 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.733 HG22 ' N ' ' A' ' 49' ' ' VAL . 10.4 p -128.56 170.75 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.498 -0.751 . . . . 0.0 109.766 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.733 ' N ' HG22 ' A' ' 48' ' ' VAL . 85.4 t -114.71 134.12 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.885 HG13 ' H ' ' A' ' 52' ' ' GLY . 3.9 p -125.25 157.48 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.696 -1.253 . . . . 0.0 110.161 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.691 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 43.2 p30 -49.59 -10.31 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.662 0.744 . . . . 0.0 110.398 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.885 ' H ' HG13 ' A' ' 50' ' ' VAL . . . -98.33 -58.41 0.96 Allowed Glycine 0 C--N 1.287 -2.179 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.567 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 61.5 mt-10 -164.68 -175.21 3.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.395 -1.062 . . . . 0.0 109.725 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 54' ' ' VAL . 18.0 m -90.84 119.87 38.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -119.54 156.71 29.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.435 -1.416 . . . . 0.0 110.454 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -111.76 127.87 55.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.48 -0.762 . . . . 0.0 109.974 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.7 t -105.24 128.56 53.49 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 p -86.35 136.51 22.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.845 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.655 ' O ' ' O ' ' A' ' 44' ' ' TYR . 51.5 mm -118.96 126.74 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.638 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 25.7 m120 -121.62 171.54 8.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.586 -1.321 . . . . 0.0 110.436 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -132.2 61.97 1.65 Allowed 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.3 -1.5 . . . . 0.0 108.772 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.679 ' O ' ' N ' ' A' ' 64' ' ' THR . 32.4 m -135.76 171.24 14.75 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.573 ' N ' HG22 ' A' ' 62' ' ' THR . . . -45.88 -6.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.379 -0.826 . . . . 0.0 109.918 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.679 ' N ' ' O ' ' A' ' 62' ' ' THR . 91.2 m -78.65 -21.09 48.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.149 -0.97 . . . . 0.0 109.537 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 67' ' ' GLY . . . 81.85 67.8 1.49 Allowed Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.638 ' HA ' ' O ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER 33.73 32.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.567 -0.961 . . . . 0.0 110.221 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 65' ' ' GLY . . . 90.01 -40.81 3.0 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.642 ' CD2' ' OH ' ' A' ' 85' ' ' TYR . 97.5 m-85 -95.9 123.69 39.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -1.08 . . . . 0.0 109.38 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.96 7.66 5.58 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.152 -0.967 . . . . 0.0 109.629 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.789 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 19.4 pt-20 -126.51 13.5 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.001 -1.062 . . . . 0.0 111.572 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.789 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 39.6 Cg_endo -71.31 -69.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.489 1.46 . . . . 0.0 112.024 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -143.49 60.01 1.39 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.887 . . . . 0.0 110.247 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 36.1 m120 58.39 48.81 11.74 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.324 -0.86 . . . . 0.0 110.437 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.0 mt 61.97 115.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.267 -0.896 . . . . 0.0 110.43 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -57.77 134.05 55.92 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.486 -0.759 . . . . 0.0 109.688 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.5 m -66.81 -38.55 86.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.825 . . . . 0.0 110.359 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.2 p -142.63 161.37 38.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.913 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.6 mt -61.42 -39.8 92.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.367 -0.833 . . . . 0.0 109.606 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -59.04 -40.07 83.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.124 -0.985 . . . . 0.0 108.946 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.407 ' HG2' ' HD1' ' A' ' 84' ' ' HIS . 85.0 tt0 -64.2 -36.52 84.32 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.4 -0.812 . . . . 0.0 109.192 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.5 tt -59.86 -46.02 90.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.053 -1.029 . . . . 0.0 110.225 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.4 t -63.24 -41.18 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.006 -1.059 . . . . 0.0 109.647 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.464 HD21 ' CD2' ' A' ' 5' ' ' HIS . 76.3 mt -63.16 -43.77 97.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.924 -1.11 . . . . 0.0 111.323 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.407 ' HD1' ' HG2' ' A' ' 80' ' ' GLU . 36.4 m80 -64.84 -43.74 92.06 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.863 -1.148 . . . . 0.0 111.021 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.642 ' OH ' ' CD2' ' A' ' 68' ' ' PHE . 19.0 m-85 -65.64 -24.64 67.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.616 -1.302 . . . . 0.0 109.055 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.671 ' HG3' ' HB2' ' A' ' 102' ' ' ALA . 33.5 tt0 -67.57 -33.16 74.46 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.376 -0.827 . . . . 0.0 109.607 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -95.0 -14.09 24.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.119 -0.988 . . . . 0.0 109.292 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.9 m -108.05 129.97 55.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 109.527 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.0 t -72.95 139.9 47.05 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.978 -1.076 . . . . 0.0 108.614 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.687 ' O ' ' C ' ' A' ' 91' ' ' VAL . 7.6 mp -69.0 -16.03 63.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.116 -0.99 . . . . 0.0 110.688 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.695 ' N ' ' O ' ' A' ' 97' ' ' LEU . 74.6 t -10.15 -64.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.589 0 O-C-N 121.75 -0.594 . . . . 0.0 109.918 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 90' ' ' LEU . 91.3 mt-30 34.71 -142.24 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.402 ' O ' ' N ' ' A' ' 95' ' ' ASP . 82.9 t60 -52.44 -50.07 63.33 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.711 ' O ' ' N ' ' A' ' 96' ' ' SER . 7.7 m120 -69.7 83.3 0.44 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 94' ' ' ASN . 62.9 t0 -44.03 -10.74 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.421 -0.799 . . . . 0.0 108.903 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.711 ' N ' ' O ' ' A' ' 94' ' ' ASN . 89.3 p -100.56 4.45 43.48 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.507 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.695 ' O ' ' N ' ' A' ' 91' ' ' VAL . 8.3 mt -76.83 50.31 0.7 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.078 -1.639 . . . . 0.0 108.404 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -77.37 80.62 3.87 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.252 -0.905 . . . . 0.0 109.861 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.626 ' HB ' HG23 ' A' ' 50' ' ' VAL . 6.6 p -161.53 162.94 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.544 ' N ' HG22 ' A' ' 99' ' ' VAL . 44.4 p -129.94 155.85 45.39 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.087 -1.008 . . . . 0.0 109.936 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.53 HD22 ' CG ' ' A' ' 33' ' ' PHE . 18.4 mt -89.15 53.9 2.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.021 -1.049 . . . . 0.0 108.673 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.671 ' HB2' ' HG3' ' A' ' 86' ' ' GLN . . . -89.66 -18.09 27.12 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.73 -0.606 . . . . 0.0 112.37 -178.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.484 ' HD2' ' HG1' ' A' ' 32' ' ' THR . 88.4 t80 -116.61 110.16 42.81 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 120.265 -1.522 . . . . 0.0 110.448 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.412 ' HG2' ' CG ' ' A' ' 4' ' ' PRO . 22.7 Cg_exo -59.6 146.96 93.8 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.875 1.716 . . . . 0.0 110.926 178.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.681 HG13 ' CD2' ' A' ' 106' ' ' TYR . 11.4 p -67.99 -22.43 27.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.686 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.681 ' CD2' HG13 ' A' ' 105' ' ' VAL . 59.9 m-85 -128.75 60.88 1.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.903 . . . . 0.0 109.39 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.97 -4.86 14.49 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.971 -1.081 . . . . 0.0 108.657 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -109.03 137.8 46.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 110.051 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -63.89 145.61 55.52 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.412 -0.805 . . . . 0.0 109.273 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 1.243 ' CZ ' ' NH2' ' A' ' 110' ' ' ARG . 42.4 mtp180 -88.82 130.47 35.37 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 . . . . . 0 N--CA 1.494 1.754 0 O-C-N 120.954 -1.091 . . . . 0.0 108.97 -179.757 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -68.7 146.43 52.98 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 109.559 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.467 ' HB3' ' CD2' ' A' ' 6' ' ' HIS . 13.8 tp -88.88 125.99 60.83 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 121.076 -1.015 . . . . 0.0 108.364 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -49.86 -20.95 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.994 1.796 . . . . 0.0 112.082 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.732 ' CD2' HE22 ' A' ' 86' ' ' GLN . 30.2 m-70 -71.57 -29.69 65.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.453 -0.78 . . . . 0.0 109.838 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.467 ' CD2' ' HB3' ' A' ' 3' ' ' LEU . 80.3 m-70 -67.48 -21.68 65.51 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.566 ' O ' ' OG1' ' A' ' 10' ' ' THR . 76.3 m-20 -95.84 113.33 24.95 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.454 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 32.0 tt0 -70.31 -32.97 70.96 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.473 -0.767 . . . . 0.0 110.801 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.572 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -71.2 -13.62 61.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.758 -1.214 . . . . 0.0 110.945 -178.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.573 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 6.6 p -62.97 -37.49 87.32 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.68 -1.262 . . . . 0.0 108.666 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.719 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -117.33 -27.8 6.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.944 -1.098 . . . . 0.0 110.074 179.042 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -86.6 119.66 27.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.924 -1.11 . . . . 0.0 110.442 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 15' ' ' SER . 9.8 p -140.72 31.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -39.12 -20.34 0.01 OUTLIER Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.608 ' N ' ' O ' ' A' ' 13' ' ' VAL . 87.5 p -61.42 -17.52 54.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -1.131 . . . . 0.0 108.589 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.1 m -94.15 145.16 24.89 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.725 0.774 . . . . 0.0 110.731 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.621 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 54.8 p30 -79.64 167.39 20.75 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.394 -0.816 . . . . 0.0 109.335 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.523 ' CG ' ' NH1' ' A' ' 36' ' ' ARG . 81.1 mtm180 -61.05 -39.9 91.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.596 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -63.05 -44.29 96.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.645 -1.285 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.621 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 22.5 tptm -61.13 -35.51 77.26 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.221 -0.924 . . . . 0.0 108.901 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.04 74.32 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 26' ' ' ARG . 94.8 mt-10 -57.63 -45.4 85.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.35 -40.33 93.86 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 24' ' ' LEU . 79.8 mt -67.95 -39.56 83.38 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.543 HD11 ' OG ' ' A' ' 47' ' ' SER . 3.6 mt -82.83 -16.82 46.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.342 -0.848 . . . . 0.0 108.799 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' GLU . 10.6 mmm180 -93.78 -28.4 15.92 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.959 0.885 . . . . 0.0 109.691 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.99 9.17 70.42 Favored Glycine 0 C--N 1.286 -2.231 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.526 ' O ' HG11 ' A' ' 49' ' ' VAL . 29.8 mmtm -124.2 145.54 49.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.499 -1.0 . . . . 0.0 110.001 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -77.67 165.53 24.14 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.395 0.617 . . . . 0.0 110.199 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.538 ' CG ' ' OD1' ' A' ' 51' ' ' ASP . 18.2 p-10 -53.02 158.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.92 -33.8 4.51 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.2 m -77.07 125.61 29.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -1.032 . . . . 0.0 108.311 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 101' ' ' LEU . 0.4 OUTLIER -135.88 170.65 15.66 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.966 -1.083 . . . . 0.0 110.274 -178.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -149.26 165.85 30.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.196 -0.94 . . . . 0.0 111.007 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.557 HG22 ' SG ' ' A' ' 46' ' ' CYS . 73.9 t -120.51 121.48 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.731 ' NH1' ' O ' ' A' ' 37' ' ' GLU . 6.8 ptm180 -134.84 -176.24 4.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.438 -0.788 . . . . 0.0 108.949 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.731 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 56.0 mt-10 -94.18 175.25 6.77 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.871 -1.143 . . . . 0.0 108.494 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.648 ' O ' ' CB ' ' A' ' 39' ' ' SER . 20.9 m -75.95 11.27 1.48 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 178.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.648 ' CB ' ' O ' ' A' ' 38' ' ' SER . 4.8 t 98.45 -71.89 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.602 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -110.08 -45.96 3.52 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.462 -1.399 . . . . 0.0 111.831 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.471 ' NE2' ' SG ' ' A' ' 43' ' ' CYS . 6.7 pt20 -69.41 160.54 31.16 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.306 -1.496 . . . . 0.0 110.049 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.54 48.21 2.85 Favored Glycine 0 N--CA 1.496 2.67 0 O-C-N 121.163 -0.96 . . . . 0.0 110.972 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.471 ' SG ' ' NE2' ' A' ' 41' ' ' GLN . 89.5 m -114.81 155.03 27.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.999 -1.295 . . . . 0.0 109.029 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' ILE . 98.1 m-85 -115.46 153.19 31.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.071 -1.018 . . . . 0.0 110.705 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -145.74 133.43 21.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.711 -0.618 . . . . 0.0 109.924 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.609 ' O ' ' CB ' ' A' ' 57' ' ' CYS . 57.3 m -100.0 113.89 26.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.544 -1.347 . . . . 0.0 107.893 178.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.543 ' OG ' HD11 ' A' ' 25' ' ' LEU . 33.4 t -91.71 140.77 29.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.133 -0.98 . . . . 0.0 109.83 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.521 HG13 ' CB ' ' A' ' 33' ' ' PHE . 1.5 t -130.89 156.31 42.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.46 -0.775 . . . . 0.0 109.888 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 28' ' ' LYS . 89.4 t -101.12 135.94 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.799 HG12 ' H ' ' A' ' 52' ' ' GLY . 2.6 t -122.05 147.78 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.542 -1.349 . . . . 0.0 111.124 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.538 ' OD1' ' CG ' ' A' ' 30' ' ' ASP . 82.0 m-20 -55.06 9.36 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.231 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.799 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -135.97 -39.09 0.16 Allowed Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.619 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.539 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 21.6 tt0 -163.14 164.17 25.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.572 -1.546 . . . . 0.0 110.537 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.539 ' N ' ' CG ' ' A' ' 53' ' ' GLU . 96.1 t -67.42 134.69 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.075 -1.015 . . . . 0.0 108.686 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HE3' HD13 ' A' ' 97' ' ' LEU . 40.2 mmtt -112.04 139.02 47.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.831 -1.168 . . . . 0.0 109.12 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -120.57 87.74 2.81 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.609 ' CB ' ' O ' ' A' ' 46' ' ' CYS . 0.5 OUTLIER -70.79 139.66 51.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.154 -0.966 . . . . 0.0 108.723 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.41 129.57 62.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 111.241 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 44' ' ' TYR . 46.8 mm -108.13 117.05 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.656 ' H ' ' CA ' ' A' ' 67' ' ' GLY . 64.4 t30 -95.17 113.02 24.66 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.943 -1.098 . . . . 0.0 110.312 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -83.86 119.37 24.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.822 -1.174 . . . . 0.0 109.871 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 63' ' ' ALA . 86.4 m -141.11 158.65 43.63 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.447 ' N ' HG22 ' A' ' 62' ' ' THR . . . -54.74 -42.07 71.15 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.975 -1.078 . . . . 0.0 108.937 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 62' ' ' THR . 32.5 p -113.15 12.99 19.21 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.099 -1.0 . . . . 0.0 111.124 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 66' ' ' TYR . . . -126.95 -145.57 6.28 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.378 -1.391 . . . . 0.0 110.258 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.598 ' C ' ' O ' ' A' ' 60' ' ' ASN . 38.1 t80 163.78 -14.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.656 ' CA ' ' H ' ' A' ' 60' ' ' ASN . . . 135.67 -83.14 0.28 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.249 -1.941 . . . . 0.0 108.249 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.693 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 35.3 m-85 -80.45 151.88 29.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.334 -1.098 . . . . 0.0 109.684 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.36 33.26 3.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 110.472 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.733 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 7.8 tp10 -61.15 -35.44 23.99 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.754 -1.216 . . . . 0.0 108.673 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.733 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 73.4 Cg_endo -95.62 19.07 0.63 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 123.485 2.79 . . . . 0.0 110.795 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 71' ' ' PRO . 59.3 m-85 68.9 38.45 2.06 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.8 m120 57.57 43.77 22.07 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 74' ' ' LEU . 96.0 mt -114.82 31.11 6.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.183 -0.948 . . . . 0.0 110.67 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.547 ' CD1' HD23 ' A' ' 81' ' ' LEU . 53.3 m-85 -58.83 149.01 27.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.926 -1.109 . . . . 0.0 109.212 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.3 t -96.03 -44.97 7.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.05 -1.031 . . . . 0.0 110.044 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.1 t -139.98 151.21 45.32 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 110.18 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 78' ' ' LEU . 93.9 mt -66.09 -40.62 90.94 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.708 -0.62 . . . . 0.0 109.875 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -64.95 -40.17 94.6 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.974 -1.078 . . . . 0.0 108.533 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -67.31 -33.07 74.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.369 -0.832 . . . . 0.0 109.029 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.849 ' C ' HD13 ' A' ' 81' ' ' LEU . 2.5 tm? -60.54 -45.18 94.81 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.213 -0.93 . . . . 0.0 108.613 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.98 -42.92 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.347 -0.846 . . . . 0.0 109.176 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.712 HD23 ' NE2' ' A' ' 86' ' ' GLN . 96.5 mt -60.23 -43.87 95.68 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.435 -0.791 . . . . 0.0 111.177 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -63.44 -40.14 96.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.533 -1.354 . . . . 0.0 110.565 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.693 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 5.4 m-85 -64.12 -22.63 67.01 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.901 -1.124 . . . . 0.0 110.698 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.732 HE22 ' CD2' ' A' ' 5' ' ' HIS . 6.7 mt-30 -68.99 -32.62 72.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.456 -1.402 . . . . 0.0 109.024 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -88.14 -19.29 27.18 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.323 -0.861 . . . . 0.0 109.648 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 79.0 m -100.64 127.74 46.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.571 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.556 ' HA ' HG22 ' A' ' 100' ' ' THR . 24.1 p -81.27 139.7 35.29 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.513 -0.742 . . . . 0.0 109.401 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.654 HD23 ' CD2' ' A' ' 93' ' ' HIS . 4.3 mp -75.86 -17.64 59.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.535 -0.728 . . . . 0.0 109.996 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.707 ' N ' ' O ' ' A' ' 97' ' ' LEU . 5.1 p -31.23 -44.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.355 -0.84 . . . . 0.0 110.482 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.562 ' N ' HG13 ' A' ' 91' ' ' VAL . 9.7 pt20 -66.16 -10.91 45.71 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.264 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.654 ' CD2' HD23 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -63.26 -47.0 84.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.582 -1.324 . . . . 0.0 107.893 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 93' ' ' HIS . 10.6 m120 -138.43 20.2 2.74 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.627 ' N ' ' O ' ' A' ' 91' ' ' VAL . 94.6 m-20 61.05 17.33 7.89 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.457 ' C ' HD22 ' A' ' 97' ' ' LEU . 67.2 m -146.54 9.56 1.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.707 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.6 mm? -97.25 68.18 2.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -78.36 79.76 4.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 110.358 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.456 HG22 ' N ' ' A' ' 100' ' ' THR . 7.6 p -163.69 156.24 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 121.573 0.701 . . . . 0.0 109.59 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 89' ' ' SER . 32.1 p -130.44 153.94 48.25 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.139 -0.975 . . . . 0.0 108.681 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.525 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 17.7 mt -78.61 67.85 4.46 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.51 -27.65 14.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.126 -0.984 . . . . 0.0 111.897 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.47 130.84 24.38 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 120.77 -1.206 . . . . 0.0 111.43 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.54 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 38.1 Cg_endo -74.51 153.41 44.35 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.734 2.289 . . . . 0.0 110.897 177.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.564 HG13 ' CD2' ' A' ' 106' ' ' TYR . 7.7 p -76.74 -30.9 19.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.187 -0.945 . . . . 0.0 109.791 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.564 ' CD2' HG13 ' A' ' 105' ' ' VAL . 50.0 m-85 -113.61 54.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.148 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.54 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . -62.54 136.78 58.06 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.417 0.627 . . . . 0.0 109.913 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -80.31 -4.09 51.99 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.082 -1.011 . . . . 0.0 109.133 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -72.54 143.08 48.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.046 -1.034 . . . . 0.0 108.947 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.708 HH11 ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER 59.42 49.91 8.2 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.507 -0.746 . . . . 0.0 109.111 -179.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.683 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.169 -0.92 . . . . 0.0 109.348 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -68.7 146.43 52.98 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 109.559 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.467 ' HB3' ' CD2' ' A' ' 6' ' ' HIS . 13.8 tp -88.88 125.99 60.83 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 121.076 -1.015 . . . . 0.0 108.364 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -49.86 -20.95 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.994 1.796 . . . . 0.0 112.082 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.732 ' CD2' HE22 ' A' ' 86' ' ' GLN . 30.2 m-70 -71.57 -29.69 65.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.453 -0.78 . . . . 0.0 109.838 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.467 ' CD2' ' HB3' ' A' ' 3' ' ' LEU . 80.3 m-70 -67.48 -21.68 65.51 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.566 ' O ' ' OG1' ' A' ' 10' ' ' THR . 76.3 m-20 -95.84 113.33 24.95 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.454 ' HA ' ' CZ2' ' A' ' 11' ' ' TRP . 32.0 tt0 -70.31 -32.97 70.96 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.473 -0.767 . . . . 0.0 110.801 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.572 ' HE2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -71.2 -13.62 61.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.758 -1.214 . . . . 0.0 110.945 -178.288 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.573 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 6.6 p -62.97 -37.49 87.32 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.68 -1.262 . . . . 0.0 108.666 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.719 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -117.33 -27.8 6.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.944 -1.098 . . . . 0.0 110.074 179.042 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -86.6 119.66 27.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.924 -1.11 . . . . 0.0 110.442 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 15' ' ' SER . 9.8 p -140.72 31.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -39.12 -20.34 0.01 OUTLIER Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.608 ' N ' ' O ' ' A' ' 13' ' ' VAL . 87.5 p -61.42 -17.52 54.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -1.131 . . . . 0.0 108.589 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.1 m -94.15 145.16 24.89 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.725 0.774 . . . . 0.0 110.731 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.621 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 54.8 p30 -79.64 167.39 20.75 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.394 -0.816 . . . . 0.0 109.335 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.523 ' CG ' ' NH1' ' A' ' 36' ' ' ARG . 81.1 mtm180 -61.05 -39.9 91.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.596 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -63.05 -44.29 96.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.645 -1.285 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.621 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 22.5 tptm -61.13 -35.51 77.26 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.221 -0.924 . . . . 0.0 108.901 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.04 74.32 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 26' ' ' ARG . 94.8 mt-10 -57.63 -45.4 85.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.35 -40.33 93.86 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 24' ' ' LEU . 79.8 mt -67.95 -39.56 83.38 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.543 HD11 ' OG ' ' A' ' 47' ' ' SER . 3.6 mt -82.83 -16.82 46.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.342 -0.848 . . . . 0.0 108.799 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' GLU . 10.6 mmm180 -93.78 -28.4 15.92 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.959 0.885 . . . . 0.0 109.691 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.99 9.17 70.42 Favored Glycine 0 C--N 1.286 -2.231 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.526 ' O ' HG11 ' A' ' 49' ' ' VAL . 29.8 mmtm -124.2 145.54 49.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.499 -1.0 . . . . 0.0 110.001 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -77.67 165.53 24.14 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.395 0.617 . . . . 0.0 110.199 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.538 ' CG ' ' OD1' ' A' ' 51' ' ' ASP . 18.2 p-10 -53.02 158.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.92 -33.8 4.51 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.2 m -77.07 125.61 29.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -1.032 . . . . 0.0 108.311 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 101' ' ' LEU . 0.4 OUTLIER -135.88 170.65 15.66 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.966 -1.083 . . . . 0.0 110.274 -178.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -149.26 165.85 30.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.196 -0.94 . . . . 0.0 111.007 -179.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.557 HG22 ' SG ' ' A' ' 46' ' ' CYS . 73.9 t -120.51 121.48 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.731 ' NH1' ' O ' ' A' ' 37' ' ' GLU . 6.8 ptm180 -134.84 -176.24 4.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.438 -0.788 . . . . 0.0 108.949 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.731 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 56.0 mt-10 -94.18 175.25 6.77 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.871 -1.143 . . . . 0.0 108.494 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.648 ' O ' ' CB ' ' A' ' 39' ' ' SER . 20.9 m -75.95 11.27 1.48 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.648 ' CB ' ' O ' ' A' ' 38' ' ' SER . 4.8 t 98.45 -71.89 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.602 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -110.08 -45.96 3.52 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.462 -1.399 . . . . 0.0 111.831 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.471 ' NE2' ' SG ' ' A' ' 43' ' ' CYS . 6.7 pt20 -69.41 160.54 31.16 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.306 -1.496 . . . . 0.0 110.049 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.54 48.21 2.85 Favored Glycine 0 N--CA 1.496 2.67 0 O-C-N 121.163 -0.96 . . . . 0.0 110.972 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.471 ' SG ' ' NE2' ' A' ' 41' ' ' GLN . 89.5 m -114.81 155.03 27.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.999 -1.295 . . . . 0.0 109.029 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' ILE . 98.1 m-85 -115.46 153.19 31.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.071 -1.018 . . . . 0.0 110.705 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -145.74 133.43 21.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.711 -0.618 . . . . 0.0 109.924 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.609 ' O ' ' CB ' ' A' ' 57' ' ' CYS . 57.3 m -100.0 113.89 26.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.544 -1.347 . . . . 0.0 107.893 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.543 ' OG ' HD11 ' A' ' 25' ' ' LEU . 33.4 t -91.71 140.77 29.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.133 -0.98 . . . . 0.0 109.83 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.521 HG13 ' CB ' ' A' ' 33' ' ' PHE . 1.5 t -130.89 156.31 42.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.46 -0.775 . . . . 0.0 109.888 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 28' ' ' LYS . 89.4 t -101.12 135.94 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.799 HG12 ' H ' ' A' ' 52' ' ' GLY . 2.6 t -122.05 147.78 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.542 -1.349 . . . . 0.0 111.124 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.538 ' OD1' ' CG ' ' A' ' 30' ' ' ASP . 82.0 m-20 -55.06 9.36 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.231 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.799 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -135.97 -39.09 0.16 Allowed Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.619 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.539 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 21.6 tt0 -163.14 164.17 25.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.572 -1.546 . . . . 0.0 110.537 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.539 ' N ' ' CG ' ' A' ' 53' ' ' GLU . 96.1 t -67.42 134.69 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.075 -1.015 . . . . 0.0 108.686 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HE3' HD13 ' A' ' 97' ' ' LEU . 40.2 mmtt -112.04 139.02 47.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.831 -1.168 . . . . 0.0 109.12 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -120.57 87.74 2.81 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.609 ' CB ' ' O ' ' A' ' 46' ' ' CYS . 0.5 OUTLIER -70.79 139.66 51.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.154 -0.966 . . . . 0.0 108.723 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.41 129.57 62.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 111.241 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 44' ' ' TYR . 46.8 mm -108.13 117.05 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.656 ' H ' ' CA ' ' A' ' 67' ' ' GLY . 64.4 t30 -95.17 113.02 24.66 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.943 -1.098 . . . . 0.0 110.312 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -83.86 119.37 24.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.822 -1.174 . . . . 0.0 109.871 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 63' ' ' ALA . 86.4 m -141.11 158.65 43.63 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.447 ' N ' HG22 ' A' ' 62' ' ' THR . . . -54.74 -42.07 71.15 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.975 -1.078 . . . . 0.0 108.937 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 62' ' ' THR . 32.5 p -113.15 12.99 19.21 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.099 -1.0 . . . . 0.0 111.124 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 66' ' ' TYR . . . -126.95 -145.57 6.28 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.378 -1.391 . . . . 0.0 110.258 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.598 ' C ' ' O ' ' A' ' 60' ' ' ASN . 38.1 t80 163.78 -14.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.656 ' CA ' ' H ' ' A' ' 60' ' ' ASN . . . 135.67 -83.14 0.28 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.249 -1.941 . . . . 0.0 108.249 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.693 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 35.3 m-85 -80.45 151.88 29.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.334 -1.098 . . . . 0.0 109.684 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.36 33.26 3.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 110.472 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.733 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 7.8 tp10 -61.15 -35.44 23.99 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.754 -1.216 . . . . 0.0 108.673 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.733 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 73.4 Cg_endo -95.62 19.07 0.63 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 123.485 2.79 . . . . 0.0 110.795 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 71' ' ' PRO . 59.3 m-85 68.9 38.45 2.06 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.8 m120 57.57 43.77 22.07 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 74' ' ' LEU . 96.0 mt -114.82 31.11 6.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.183 -0.948 . . . . 0.0 110.67 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.547 ' CD1' HD23 ' A' ' 81' ' ' LEU . 53.3 m-85 -58.83 149.01 27.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.926 -1.109 . . . . 0.0 109.212 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.3 t -96.03 -44.97 7.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.05 -1.031 . . . . 0.0 110.044 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.1 t -139.98 151.21 45.32 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 110.18 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 78' ' ' LEU . 93.9 mt -66.09 -40.62 90.94 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.708 -0.62 . . . . 0.0 109.875 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -64.95 -40.17 94.6 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.974 -1.078 . . . . 0.0 108.533 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -67.31 -33.07 74.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.369 -0.832 . . . . 0.0 109.029 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.849 ' C ' HD13 ' A' ' 81' ' ' LEU . 2.5 tm? -60.54 -45.18 94.81 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.213 -0.93 . . . . 0.0 108.613 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.98 -42.92 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.347 -0.846 . . . . 0.0 109.176 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.712 HD23 ' NE2' ' A' ' 86' ' ' GLN . 96.5 mt -60.23 -43.87 95.68 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.435 -0.791 . . . . 0.0 111.177 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -63.44 -40.14 96.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.533 -1.354 . . . . 0.0 110.565 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.693 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 5.4 m-85 -64.12 -22.63 67.01 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.901 -1.124 . . . . 0.0 110.698 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.732 HE22 ' CD2' ' A' ' 5' ' ' HIS . 6.7 mt-30 -68.99 -32.62 72.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.456 -1.402 . . . . 0.0 109.024 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -88.14 -19.29 27.18 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.323 -0.861 . . . . 0.0 109.648 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 79.0 m -100.64 127.74 46.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.571 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.556 ' HA ' HG22 ' A' ' 100' ' ' THR . 24.1 p -81.27 139.7 35.29 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.513 -0.742 . . . . 0.0 109.401 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.654 HD23 ' CD2' ' A' ' 93' ' ' HIS . 4.3 mp -75.86 -17.64 59.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.535 -0.728 . . . . 0.0 109.996 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.707 ' N ' ' O ' ' A' ' 97' ' ' LEU . 5.1 p -31.23 -44.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.355 -0.84 . . . . 0.0 110.482 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.562 ' N ' HG13 ' A' ' 91' ' ' VAL . 9.7 pt20 -66.16 -10.91 45.71 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.264 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.654 ' CD2' HD23 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -63.26 -47.0 84.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.582 -1.324 . . . . 0.0 107.893 179.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 93' ' ' HIS . 10.6 m120 -138.43 20.2 2.74 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.627 ' N ' ' O ' ' A' ' 91' ' ' VAL . 94.6 m-20 61.05 17.33 7.89 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.457 ' C ' HD22 ' A' ' 97' ' ' LEU . 67.2 m -146.54 9.56 1.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.707 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.6 mm? -97.25 68.18 2.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -78.36 79.76 4.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 110.358 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.456 HG22 ' N ' ' A' ' 100' ' ' THR . 7.6 p -163.69 156.24 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 121.573 0.701 . . . . 0.0 109.59 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 89' ' ' SER . 32.1 p -130.44 153.94 48.25 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.139 -0.975 . . . . 0.0 108.681 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.525 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 17.7 mt -78.61 67.85 4.46 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.51 -27.65 14.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.126 -0.984 . . . . 0.0 111.897 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.47 130.84 24.38 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 120.77 -1.206 . . . . 0.0 111.43 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.54 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 38.1 Cg_endo -74.51 153.41 44.35 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.734 2.289 . . . . 0.0 110.897 177.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.564 HG13 ' CD2' ' A' ' 106' ' ' TYR . 7.7 p -76.74 -30.9 19.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.187 -0.945 . . . . 0.0 109.791 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.564 ' CD2' HG13 ' A' ' 105' ' ' VAL . 50.0 m-85 -113.61 54.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.148 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.54 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . -62.54 136.78 58.06 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.417 0.627 . . . . 0.0 109.913 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -80.31 -4.09 51.99 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.082 -1.011 . . . . 0.0 109.133 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -72.54 143.08 48.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.046 -1.034 . . . . 0.0 108.947 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.708 HH11 ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER 59.42 49.91 8.2 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.507 -0.746 . . . . 0.0 109.111 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.683 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.169 -0.92 . . . . 0.0 109.348 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -71.37 144.32 49.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.403 -0.811 . . . . 0.0 110.484 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.2 mt -98.6 136.19 20.85 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.41 -4.53 8.24 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.403 2.069 . . . . 0.0 112.661 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.51 ' HA ' ' HE1' ' A' ' 11' ' ' TRP . 93.6 m-70 -79.45 -16.32 56.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.156 -0.965 . . . . 0.0 109.712 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -61.3 -48.35 81.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.703 -1.248 . . . . 0.0 109.331 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.5 129.86 45.71 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.589 ' O ' ' N ' ' A' ' 12' ' ' ASN . 7.4 pm0 -73.03 -2.61 21.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.119 -0.988 . . . . 0.0 109.932 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.56 ' CG ' ' N ' ' A' ' 10' ' ' THR . 36.7 pttt -59.82 -35.95 75.79 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 109.392 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.644 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 69.4 p -66.76 -28.83 68.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.654 -0.653 . . . . 0.0 111.398 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.644 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -126.69 -15.23 5.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.418 -1.426 . . . . 0.0 111.679 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 8' ' ' GLU . 46.4 t30 -102.67 118.55 37.09 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.406 -1.434 . . . . 0.0 111.511 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.733 ' CG1' ' HE ' ' A' ' 36' ' ' ARG . 9.9 p -135.89 37.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -31.59 -26.42 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 13' ' ' VAL . 99.0 p -61.61 -4.94 1.57 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.659 -1.495 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.1 m -93.77 162.01 14.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.669 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -113.77 164.83 13.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.771 HH21 ' CD2' ' A' ' 56' ' ' HIS . 5.5 mmm180 -58.36 -42.22 86.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.004 -1.06 . . . . 0.0 109.988 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -61.91 -44.14 97.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.865 -1.147 . . . . 0.0 108.817 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -66.06 -29.67 70.05 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.422 -0.798 . . . . 0.0 109.1 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.543 ' CB ' HH12 ' A' ' 36' ' ' ARG . . . -61.61 -40.52 95.11 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.354 -0.841 . . . . 0.0 109.225 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.33 -43.55 96.31 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -64.4 -43.49 94.26 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.417 HD12 ' NH2' ' A' ' 36' ' ' ARG . 73.2 mt -70.33 -36.41 74.24 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.317 -0.865 . . . . 0.0 108.878 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.534 HD21 ' OG ' ' A' ' 47' ' ' SER . 41.3 mt -75.87 -12.6 60.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.73 126.07 30.48 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.57 9.49 78.58 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' CD ' HG21 ' A' ' 32' ' ' THR . 5.1 mmpp? -99.2 126.67 45.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.149 -1.206 . . . . 0.0 109.476 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -77.97 160.76 27.99 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 67.2 t0 -53.92 140.93 29.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.68 . . . . 0.0 110.617 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 110.09 -28.61 10.2 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 91.4 m -83.73 121.0 26.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.254 -1.144 . . . . 0.0 110.062 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.717 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -133.68 156.35 48.08 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.738 -1.226 . . . . 0.0 111.301 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.716 HD22 ' C ' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -111.37 160.15 17.33 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.697 0.761 . . . . 0.0 111.058 -177.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.75 HG22 ' SG ' ' A' ' 46' ' ' CYS . 37.8 t -132.21 112.69 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.733 ' HE ' ' CG1' ' A' ' 13' ' ' VAL . 69.5 mtt180 -136.92 172.99 12.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.925 -1.109 . . . . 0.0 110.033 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.663 ' C ' ' H ' ' A' ' 39' ' ' SER . 8.6 pt-20 -85.82 172.1 11.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.019 -1.051 . . . . 0.0 108.385 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.658 ' N ' ' O ' ' A' ' 43' ' ' CYS . 73.2 m -79.18 18.31 0.68 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 177.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.663 ' H ' ' C ' ' A' ' 37' ' ' GLU . 40.9 p 67.16 -110.05 0.13 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.727 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.625 ' N ' ' OG ' ' A' ' 39' ' ' SER . 58.8 tttm -60.29 -40.04 89.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.928 -1.108 . . . . 0.0 110.182 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -78.57 150.72 32.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.917 -1.114 . . . . 0.0 109.369 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.6 4.72 49.81 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.658 ' O ' ' N ' ' A' ' 38' ' ' SER . 88.7 m -79.25 156.61 28.04 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.163 -1.198 . . . . 0.0 109.789 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' A' ' 59' ' ' ILE . 91.5 m-85 -119.93 149.78 41.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.633 -0.667 . . . . 0.0 110.155 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.2 137.57 24.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 108.589 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.75 ' SG ' HG22 ' A' ' 35' ' ' VAL . 33.3 m -107.26 131.18 54.48 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.892 -1.13 . . . . 0.0 108.872 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.534 ' OG ' HD21 ' A' ' 25' ' ' LEU . 1.3 p -90.4 132.82 35.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.414 -0.804 . . . . 0.0 110.183 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 49' ' ' VAL . 3.7 p -132.83 157.02 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.937 -1.102 . . . . 0.0 110.583 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.679 HG13 HG22 ' A' ' 54' ' ' VAL . 60.4 t -118.14 146.66 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.954 HG23 ' HZ3' ' A' ' 55' ' ' LYS . 13.2 t -120.44 161.31 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 0.0 110.296 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.567 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 43.4 p-10 -58.21 6.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.696 -0.628 . . . . 0.0 110.27 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -149.61 -19.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.364 0 C-N-CA 118.958 -1.591 . . . . 0.0 112.252 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.738 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 68.8 tt0 -156.49 169.01 25.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.193 -1.769 . . . . 0.0 111.224 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.679 HG22 HG13 ' A' ' 49' ' ' VAL . 96.9 t -118.53 128.14 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.381 -0.824 . . . . 0.0 109.207 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.954 ' HZ3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -122.05 179.82 4.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.774 -1.204 . . . . 0.0 110.447 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.771 ' CD2' HH21 ' A' ' 18' ' ' ARG . 23.6 m80 -127.63 82.43 2.09 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.3 m -56.22 135.14 53.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.015 -1.053 . . . . 0.0 108.83 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 58' ' ' VAL . 9.8 p -104.23 133.54 47.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 110.422 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.555 HG23 ' O ' ' A' ' 66' ' ' TYR . 27.1 mm -104.63 123.01 58.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.636 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 10.2 m120 -108.19 122.77 47.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.922 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -108.37 128.47 54.79 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.95 HG23 ' H ' ' A' ' 64' ' ' THR . 1.8 t -130.41 -175.6 3.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.971 -1.08 . . . . 0.0 108.786 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.515 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -42.02 -26.8 0.1 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.95 ' H ' HG23 ' A' ' 62' ' ' THR . 74.6 m -160.25 72.47 0.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.734 ' O ' ' CG ' ' A' ' 66' ' ' TYR . . . -160.56 179.99 35.7 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.393 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.734 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 88.2 m-85 -168.0 -4.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.44 ' H ' ' H ' ' A' ' 66' ' ' TYR . . . 165.96 -130.64 2.19 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.693 ' CZ ' ' OH ' ' A' ' 75' ' ' TYR . 41.8 p90 -96.12 110.53 22.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.876 -1.367 . . . . 0.0 109.149 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.559 ' HB1' HD23 ' A' ' 74' ' ' LEU . . . -116.49 127.53 54.65 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.668 0.746 . . . . 0.0 109.49 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.656 ' O ' ' N ' ' A' ' 73' ' ' ASN . 98.3 mt-10 -125.57 155.13 72.6 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.494 ' C ' ' O ' ' A' ' 70' ' ' GLU . 50.0 Cg_exo -33.7 -32.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.629 1.553 . . . . 0.0 110.684 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 70' ' ' GLU . 73.7 t80 -94.27 -33.22 13.33 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.656 ' N ' ' O ' ' A' ' 70' ' ' GLU . 11.4 m120 -101.6 127.6 48.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.752 -0.592 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.559 HD23 ' HB1' ' A' ' 69' ' ' ALA . 93.7 mt -151.28 96.75 2.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.29 -0.881 . . . . 0.0 109.932 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.693 ' OH ' ' CZ ' ' A' ' 68' ' ' PHE . 71.4 m-85 -62.6 127.49 31.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.874 -1.141 . . . . 0.0 109.17 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 72.6 p -89.18 -52.44 5.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 0.0 109.571 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.5 m -141.45 168.65 19.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.371 -0.83 . . . . 0.0 109.032 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 78' ' ' LEU . 89.1 mt -63.75 -37.71 88.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.097 . . . . 0.0 109.635 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -58.49 -40.09 81.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.967 -1.083 . . . . 0.0 108.568 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.1 -32.83 73.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.453 0.645 . . . . 0.0 109.455 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.511 HD12 ' CE1' ' A' ' 75' ' ' TYR . 14.7 tp -53.96 -48.71 70.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.331 -0.855 . . . . 0.0 109.524 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.5 t -66.22 -43.51 91.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 108.825 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.52 -44.0 83.71 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.497 -0.752 . . . . 0.0 110.115 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -60.44 -44.09 96.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 111.152 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.615 ' CB ' HD12 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -75.78 -21.84 57.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.046 -1.034 . . . . 0.0 110.373 -179.182 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.773 ' OE1' ' HB2' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -67.36 -41.99 84.19 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.004 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -73.97 -39.79 63.46 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.652 -0.655 . . . . 0.0 110.037 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 85' ' ' TYR . 33.1 m -97.7 140.39 32.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.145 -0.972 . . . . 0.0 110.558 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.407 ' OG ' HG12 ' A' ' 91' ' ' VAL . 54.1 p -84.81 143.22 29.23 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.72 -0.612 . . . . 0.0 109.981 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 90' ' ' LEU . 8.3 mp -73.02 -18.24 61.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.325 -0.86 . . . . 0.0 109.497 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.709 ' N ' ' O ' ' A' ' 97' ' ' LEU . 3.9 p -34.0 -44.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.196 -0.94 . . . . 0.0 109.911 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.554 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 10.2 tp-100 -47.8 -45.9 30.04 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.714 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.61 ' C ' ' H ' ' A' ' 95' ' ' ASP . 83.7 t60 -62.32 131.71 50.24 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.579 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.446 ' ND2' ' CD2' ' A' ' 93' ' ' HIS . 88.1 m-20 54.27 -0.65 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.61 ' H ' ' C ' ' A' ' 93' ' ' HIS . 89.8 m-20 56.77 24.44 9.1 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.08 -1.012 . . . . 0.0 110.26 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.6 m -144.27 12.07 1.55 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.778 -1.201 . . . . 0.0 110.593 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.709 ' O ' ' N ' ' A' ' 91' ' ' VAL . 6.8 mp -99.14 73.76 1.93 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -78.2 75.98 4.73 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.432 ' CG1' HG22 ' A' ' 50' ' ' VAL . 2.6 p -152.69 155.18 6.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.552 0.692 . . . . 0.0 109.734 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 102' ' ' ALA . 81.4 p -129.31 135.46 48.78 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.717 HD22 ' CG ' ' A' ' 33' ' ' PHE . 62.1 mt -72.52 70.12 0.89 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.773 ' HB2' ' OE1' ' A' ' 86' ' ' GLN . . . -117.23 -7.54 11.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.848 -0.532 . . . . 0.0 111.935 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 32' ' ' THR . 97.5 m-85 -120.73 100.89 46.23 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.398 -1.439 . . . . 0.0 110.67 -178.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.536 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 37.2 Cg_exo -59.67 145.64 97.58 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.613 1.542 . . . . 0.0 110.309 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.465 HG21 HD11 ' A' ' 34' ' ' LEU . 2.6 p -67.86 -34.11 65.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 120.882 -1.136 . . . . 0.0 108.482 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.459 ' CD2' HG13 ' A' ' 105' ' ' VAL . 57.9 m-85 -106.08 44.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.437 -0.789 . . . . 0.0 110.584 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 104' ' ' PRO . . . -96.84 -70.55 0.71 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 0.0 109.418 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -59.93 -41.08 91.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 109.269 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -95.25 133.65 38.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.279 -0.888 . . . . 0.0 109.844 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.482 ' O ' ' C ' ' A' ' 111' ' ' ARG . 71.0 mtm180 -116.99 143.7 45.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 108.784 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.598 HH11 ' HB3' ' A' ' 111' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.108 -0.949 . . . . 0.0 110.225 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -71.37 144.32 49.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.403 -0.811 . . . . 0.0 110.484 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.2 mt -98.6 136.19 20.85 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.41 -4.53 8.24 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.403 2.069 . . . . 0.0 112.661 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.51 ' HA ' ' HE1' ' A' ' 11' ' ' TRP . 93.6 m-70 -79.45 -16.32 56.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.156 -0.965 . . . . 0.0 109.712 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -61.3 -48.35 81.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.703 -1.248 . . . . 0.0 109.331 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.5 129.86 45.71 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.589 ' O ' ' N ' ' A' ' 12' ' ' ASN . 7.4 pm0 -73.03 -2.61 21.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.119 -0.988 . . . . 0.0 109.932 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.56 ' CG ' ' N ' ' A' ' 10' ' ' THR . 36.7 pttt -59.82 -35.95 75.79 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 109.392 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.644 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 69.4 p -66.76 -28.83 68.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.654 -0.653 . . . . 0.0 111.398 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.644 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -126.69 -15.23 5.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.418 -1.426 . . . . 0.0 111.679 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 8' ' ' GLU . 46.4 t30 -102.67 118.55 37.09 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.406 -1.434 . . . . 0.0 111.511 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.733 ' CG1' ' HE ' ' A' ' 36' ' ' ARG . 9.9 p -135.89 37.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -31.59 -26.42 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 13' ' ' VAL . 99.0 p -61.61 -4.94 1.57 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.659 -1.495 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.1 m -93.77 162.01 14.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.669 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -113.77 164.83 13.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.771 HH21 ' CD2' ' A' ' 56' ' ' HIS . 5.5 mmm180 -58.36 -42.22 86.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.004 -1.06 . . . . 0.0 109.988 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -61.91 -44.14 97.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.865 -1.147 . . . . 0.0 108.817 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -66.06 -29.67 70.05 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.422 -0.798 . . . . 0.0 109.1 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.543 ' CB ' HH12 ' A' ' 36' ' ' ARG . . . -61.61 -40.52 95.11 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.354 -0.841 . . . . 0.0 109.225 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.33 -43.55 96.31 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -64.4 -43.49 94.26 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.417 HD12 ' NH2' ' A' ' 36' ' ' ARG . 73.2 mt -70.33 -36.41 74.24 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.317 -0.865 . . . . 0.0 108.878 178.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.534 HD21 ' OG ' ' A' ' 47' ' ' SER . 41.3 mt -75.87 -12.6 60.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.73 126.07 30.48 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.57 9.49 78.58 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' CD ' HG21 ' A' ' 32' ' ' THR . 5.1 mmpp? -99.2 126.67 45.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.149 -1.206 . . . . 0.0 109.476 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -77.97 160.76 27.99 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 67.2 t0 -53.92 140.93 29.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.68 . . . . 0.0 110.617 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 110.09 -28.61 10.2 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 91.4 m -83.73 121.0 26.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.254 -1.144 . . . . 0.0 110.062 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.717 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -133.68 156.35 48.08 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.738 -1.226 . . . . 0.0 111.301 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.716 HD22 ' C ' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -111.37 160.15 17.33 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.697 0.761 . . . . 0.0 111.058 -177.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.75 HG22 ' SG ' ' A' ' 46' ' ' CYS . 37.8 t -132.21 112.69 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.733 ' HE ' ' CG1' ' A' ' 13' ' ' VAL . 69.5 mtt180 -136.92 172.99 12.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.925 -1.109 . . . . 0.0 110.033 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.663 ' C ' ' H ' ' A' ' 39' ' ' SER . 8.6 pt-20 -85.82 172.1 11.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.019 -1.051 . . . . 0.0 108.385 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.658 ' N ' ' O ' ' A' ' 43' ' ' CYS . 73.2 m -79.18 18.31 0.68 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 177.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.663 ' H ' ' C ' ' A' ' 37' ' ' GLU . 40.9 p 67.16 -110.05 0.13 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.727 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.625 ' N ' ' OG ' ' A' ' 39' ' ' SER . 58.8 tttm -60.29 -40.04 89.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.928 -1.108 . . . . 0.0 110.182 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -78.57 150.72 32.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.917 -1.114 . . . . 0.0 109.369 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.6 4.72 49.81 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.658 ' O ' ' N ' ' A' ' 38' ' ' SER . 88.7 m -79.25 156.61 28.04 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.163 -1.198 . . . . 0.0 109.789 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' A' ' 59' ' ' ILE . 91.5 m-85 -119.93 149.78 41.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.633 -0.667 . . . . 0.0 110.155 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.2 137.57 24.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 108.589 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.75 ' SG ' HG22 ' A' ' 35' ' ' VAL . 33.3 m -107.26 131.18 54.48 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.892 -1.13 . . . . 0.0 108.872 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.534 ' OG ' HD21 ' A' ' 25' ' ' LEU . 1.3 p -90.4 132.82 35.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.414 -0.804 . . . . 0.0 110.183 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 49' ' ' VAL . 3.7 p -132.83 157.02 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.937 -1.102 . . . . 0.0 110.583 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.679 HG13 HG22 ' A' ' 54' ' ' VAL . 60.4 t -118.14 146.66 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.954 HG23 ' HZ3' ' A' ' 55' ' ' LYS . 13.2 t -120.44 161.31 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 0.0 110.296 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.567 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 43.4 p-10 -58.21 6.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.696 -0.628 . . . . 0.0 110.27 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . -149.61 -19.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.364 0 C-N-CA 118.958 -1.591 . . . . 0.0 112.252 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.738 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 68.8 tt0 -156.49 169.01 25.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.193 -1.769 . . . . 0.0 111.224 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.679 HG22 HG13 ' A' ' 49' ' ' VAL . 96.9 t -118.53 128.14 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.381 -0.824 . . . . 0.0 109.207 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.954 ' HZ3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -122.05 179.82 4.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.774 -1.204 . . . . 0.0 110.447 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.771 ' CD2' HH21 ' A' ' 18' ' ' ARG . 23.6 m80 -127.63 82.43 2.09 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.3 m -56.22 135.14 53.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.015 -1.053 . . . . 0.0 108.83 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 58' ' ' VAL . 9.8 p -104.23 133.54 47.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 110.422 -178.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.555 HG23 ' O ' ' A' ' 66' ' ' TYR . 27.1 mm -104.63 123.01 58.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.636 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 10.2 m120 -108.19 122.77 47.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.922 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -108.37 128.47 54.79 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.95 HG23 ' H ' ' A' ' 64' ' ' THR . 1.8 t -130.41 -175.6 3.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.971 -1.08 . . . . 0.0 108.786 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.515 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -42.02 -26.8 0.1 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.95 ' H ' HG23 ' A' ' 62' ' ' THR . 74.6 m -160.25 72.47 0.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.734 ' O ' ' CG ' ' A' ' 66' ' ' TYR . . . -160.56 179.99 35.7 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.393 -178.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.734 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 88.2 m-85 -168.0 -4.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.44 ' H ' ' H ' ' A' ' 66' ' ' TYR . . . 165.96 -130.64 2.19 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.693 ' CZ ' ' OH ' ' A' ' 75' ' ' TYR . 41.8 p90 -96.12 110.53 22.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.876 -1.367 . . . . 0.0 109.149 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.559 ' HB1' HD23 ' A' ' 74' ' ' LEU . . . -116.49 127.53 54.65 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.668 0.746 . . . . 0.0 109.49 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.656 ' O ' ' N ' ' A' ' 73' ' ' ASN . 98.3 mt-10 -125.57 155.13 72.6 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.494 ' C ' ' O ' ' A' ' 70' ' ' GLU . 50.0 Cg_exo -33.7 -32.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.629 1.553 . . . . 0.0 110.684 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 70' ' ' GLU . 73.7 t80 -94.27 -33.22 13.33 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.656 ' N ' ' O ' ' A' ' 70' ' ' GLU . 11.4 m120 -101.6 127.6 48.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.752 -0.592 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.559 HD23 ' HB1' ' A' ' 69' ' ' ALA . 93.7 mt -151.28 96.75 2.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.29 -0.881 . . . . 0.0 109.932 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.693 ' OH ' ' CZ ' ' A' ' 68' ' ' PHE . 71.4 m-85 -62.6 127.49 31.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.874 -1.141 . . . . 0.0 109.17 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 72.6 p -89.18 -52.44 5.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 0.0 109.571 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.5 m -141.45 168.65 19.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.371 -0.83 . . . . 0.0 109.032 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 78' ' ' LEU . 89.1 mt -63.75 -37.71 88.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.097 . . . . 0.0 109.635 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -58.49 -40.09 81.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.967 -1.083 . . . . 0.0 108.568 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.1 -32.83 73.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.453 0.645 . . . . 0.0 109.455 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.511 HD12 ' CE1' ' A' ' 75' ' ' TYR . 14.7 tp -53.96 -48.71 70.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.331 -0.855 . . . . 0.0 109.524 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.5 t -66.22 -43.51 91.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 108.825 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.52 -44.0 83.71 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.497 -0.752 . . . . 0.0 110.115 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -60.44 -44.09 96.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 111.152 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.615 ' CB ' HD12 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -75.78 -21.84 57.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.046 -1.034 . . . . 0.0 110.373 -179.182 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.773 ' OE1' ' HB2' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -67.36 -41.99 84.19 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.004 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -73.97 -39.79 63.46 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.652 -0.655 . . . . 0.0 110.037 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 85' ' ' TYR . 33.1 m -97.7 140.39 32.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.145 -0.972 . . . . 0.0 110.558 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.407 ' OG ' HG12 ' A' ' 91' ' ' VAL . 54.1 p -84.81 143.22 29.23 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.72 -0.612 . . . . 0.0 109.981 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 90' ' ' LEU . 8.3 mp -73.02 -18.24 61.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.325 -0.86 . . . . 0.0 109.497 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.709 ' N ' ' O ' ' A' ' 97' ' ' LEU . 3.9 p -34.0 -44.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.196 -0.94 . . . . 0.0 109.911 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.554 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 10.2 tp-100 -47.8 -45.9 30.04 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.714 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.61 ' C ' ' H ' ' A' ' 95' ' ' ASP . 83.7 t60 -62.32 131.71 50.24 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.579 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.446 ' ND2' ' CD2' ' A' ' 93' ' ' HIS . 88.1 m-20 54.27 -0.65 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.61 ' H ' ' C ' ' A' ' 93' ' ' HIS . 89.8 m-20 56.77 24.44 9.1 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.08 -1.012 . . . . 0.0 110.26 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.6 m -144.27 12.07 1.55 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.778 -1.201 . . . . 0.0 110.593 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.709 ' O ' ' N ' ' A' ' 91' ' ' VAL . 6.8 mp -99.14 73.76 1.93 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -78.2 75.98 4.73 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.432 ' CG1' HG22 ' A' ' 50' ' ' VAL . 2.6 p -152.69 155.18 6.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.552 0.692 . . . . 0.0 109.734 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 102' ' ' ALA . 81.4 p -129.31 135.46 48.78 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.717 HD22 ' CG ' ' A' ' 33' ' ' PHE . 62.1 mt -72.52 70.12 0.89 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.773 ' HB2' ' OE1' ' A' ' 86' ' ' GLN . . . -117.23 -7.54 11.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.848 -0.532 . . . . 0.0 111.935 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 32' ' ' THR . 97.5 m-85 -120.73 100.89 46.23 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.398 -1.439 . . . . 0.0 110.67 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.536 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 37.2 Cg_exo -59.67 145.64 97.58 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.613 1.542 . . . . 0.0 110.309 178.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.465 HG21 HD11 ' A' ' 34' ' ' LEU . 2.6 p -67.86 -34.11 65.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 120.882 -1.136 . . . . 0.0 108.482 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.459 ' CD2' HG13 ' A' ' 105' ' ' VAL . 57.9 m-85 -106.08 44.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.437 -0.789 . . . . 0.0 110.584 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 104' ' ' PRO . . . -96.84 -70.55 0.71 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 0.0 109.418 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -59.93 -41.08 91.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 109.269 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -95.25 133.65 38.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.279 -0.888 . . . . 0.0 109.844 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.482 ' O ' ' C ' ' A' ' 111' ' ' ARG . 71.0 mtm180 -116.99 143.7 45.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 108.784 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.598 HH11 ' HB3' ' A' ' 111' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.108 -0.949 . . . . 0.0 110.225 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.297 0.57 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -97.22 18.54 14.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 109.788 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.561 ' HB3' ' CD2' ' A' ' 6' ' ' HIS . 25.0 tp -115.41 115.92 41.96 Favored Pre-proline 0 C--N 1.297 -1.687 0 O-C-N 121.433 -0.792 . . . . 0.0 109.172 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -56.03 -6.25 1.2 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.04 1.826 . . . . 0.0 111.744 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.535 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 84.0 m-70 -88.67 -12.72 41.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 110.641 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.561 ' CD2' ' HB3' ' A' ' 3' ' ' LEU . 78.7 m-70 -60.94 -40.52 93.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.779 -1.201 . . . . 0.0 108.963 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.424 ' CB ' ' HE2' ' A' ' 9' ' ' LYS . 79.1 m-20 -108.96 130.15 55.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.283 -0.885 . . . . 0.0 109.244 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.684 ' O ' ' N ' ' A' ' 12' ' ' ASN . 3.6 pm0 -73.59 -7.68 52.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.038 -1.039 . . . . 0.0 110.304 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.508 ' CG ' ' N ' ' A' ' 10' ' ' THR . 6.1 pttt -60.54 -36.4 78.35 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.065 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.641 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 38.0 p -61.51 -31.97 71.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.564 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.641 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -121.44 -12.6 8.55 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.916 -1.115 . . . . 0.0 110.457 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 8' ' ' GLU . 57.8 t30 -88.69 116.55 27.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.908 -1.12 . . . . 0.0 111.231 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 15' ' ' SER . 9.9 p -140.08 31.67 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 CA-C-O 122.007 0.908 . . . . 0.0 108.831 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -42.82 -22.43 0.15 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 13' ' ' VAL . 59.5 m -67.99 -36.77 80.56 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.019 -1.283 . . . . 0.0 110.106 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.667 ' C ' ' HE ' ' A' ' 36' ' ' ARG . 47.3 t -65.71 147.66 53.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.302 -0.874 . . . . 0.0 110.133 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.516 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 76.1 m-20 -86.66 163.65 17.26 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 61.5 mtp180 -60.0 -40.65 89.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.093 -1.005 . . . . 0.0 109.767 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -60.06 -42.97 95.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.008 -1.057 . . . . 0.0 109.503 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.5 tttm -64.89 -28.77 69.76 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.144 -0.972 . . . . 0.0 108.455 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.905 ' HB2' HH22 ' A' ' 36' ' ' ARG . . . -58.43 -41.83 85.92 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 98.4 mt-10 -61.13 -44.73 96.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.106 -0.996 . . . . 0.0 108.343 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -60.36 -46.29 90.48 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.474 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 79.7 mt -63.17 -40.17 96.76 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.644 HD23 HG23 ' A' ' 49' ' ' VAL . 4.5 mt -72.19 -31.95 66.36 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.526 ' NH1' ' HG3' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -68.28 132.61 47.42 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.806 -0.559 . . . . 0.0 109.59 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.17 9.76 84.69 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.503 ' HB2' HG21 ' A' ' 49' ' ' VAL . 47.7 mmtt -108.74 133.29 53.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.07 -1.253 . . . . 0.0 109.438 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -75.6 168.87 19.2 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.344 -0.847 . . . . 0.0 109.41 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 31' ' ' GLY . 59.1 t0 -59.07 140.83 55.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.587 -0.695 . . . . 0.0 110.328 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.457 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 109.01 -26.57 14.99 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 48' ' ' VAL . 84.9 m -63.35 121.47 13.85 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.695 ' CD2' HD22 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -138.41 145.13 40.62 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.96 -1.088 . . . . 0.0 111.406 -178.113 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.495 HD23 ' N ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -142.95 157.9 44.12 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.621 0.724 . . . . 0.0 109.905 178.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.548 HG22 ' SG ' ' A' ' 46' ' ' CYS . 97.7 t -104.05 139.52 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.905 HH22 ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -147.88 164.07 34.84 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.717 -1.239 . . . . 0.0 108.751 -177.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.673 ' OE1' ' CE1' ' A' ' 44' ' ' TYR . 66.6 mm-40 -87.03 170.24 11.72 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.522 -1.361 . . . . 0.0 108.122 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.652 ' N ' ' O ' ' A' ' 43' ' ' CYS . 88.2 p -77.1 12.98 1.21 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.668 ' H ' ' C ' ' A' ' 37' ' ' GLU . 1.7 t 91.27 -129.25 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.128 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -90.01 1.85 55.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.104 -0.998 . . . . 0.0 109.468 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -69.56 -30.12 67.84 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.126 -0.984 . . . . 0.0 110.525 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.94 -13.14 49.63 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.652 ' O ' ' N ' ' A' ' 38' ' ' SER . 95.1 m -89.93 160.51 16.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -1.168 . . . . 0.0 109.269 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.673 ' CE1' ' OE1' ' A' ' 37' ' ' GLU . 98.5 m-85 -105.02 157.03 17.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 110.159 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.598 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -163.34 143.49 8.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.008 -1.058 . . . . 0.0 109.905 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.548 ' SG ' HG22 ' A' ' 35' ' ' VAL . 60.6 m -115.13 143.41 45.25 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.581 ' HB2' HD11 ' A' ' 25' ' ' LEU . 97.0 p -113.6 144.69 42.48 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.931 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -152.97 158.56 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 121.675 0.75 . . . . 0.0 110.257 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.644 HG23 HD23 ' A' ' 25' ' ' LEU . 53.3 t -98.78 142.5 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.544 ' CG1' ' CD ' ' A' ' 55' ' ' LYS . 12.8 p -155.59 150.52 10.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 C-N-CA 118.128 -1.429 . . . . 0.0 112.166 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.613 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 65.5 t0 36.13 33.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.813 -0.554 . . . . 0.0 111.954 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 81.36 3.99 90.53 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 118.958 -1.591 . . . . 0.0 111.307 178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -127.24 134.53 50.07 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.845 -1.386 . . . . 0.0 110.077 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.635 ' CG1' HD13 ' A' ' 25' ' ' LEU . 72.3 t -81.41 129.12 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.301 0.572 . . . . 0.0 109.522 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.544 ' CD ' ' CG1' ' A' ' 50' ' ' VAL . 5.7 mptt -130.82 148.15 52.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.359 -0.838 . . . . 0.0 110.292 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -107.3 107.18 17.99 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.65 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.543 ' N ' ' O ' ' A' ' 46' ' ' CYS . 52.6 t -68.96 126.71 30.64 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.9 t -93.3 131.41 40.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.387 -0.821 . . . . 0.0 111.279 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 66' ' ' TYR . 37.9 mm -108.65 133.29 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 66' ' ' TYR . 26.3 m120 -121.13 126.99 51.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.778 -1.201 . . . . 0.0 110.875 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -105.85 125.72 51.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.47 -0.769 . . . . 0.0 109.023 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.707 HG22 ' N ' ' A' ' 63' ' ' ALA . 99.5 m -127.58 174.81 8.75 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.707 ' N ' HG22 ' A' ' 62' ' ' THR . . . -36.12 -30.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 108.894 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.606 ' N ' ' O ' ' A' ' 62' ' ' THR . 88.7 m -153.23 58.41 0.77 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.264 -0.897 . . . . 0.0 109.627 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -150.58 -168.93 15.94 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.581 ' O ' ' N ' ' A' ' 60' ' ' ASN . 88.8 t80 -165.3 -61.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.43 -1.041 . . . . 0.0 109.055 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.718 ' H ' HD13 ' A' ' 74' ' ' LEU . . . -118.26 -165.53 13.43 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.58 ' O ' HD21 ' A' ' 74' ' ' LEU . 25.7 p90 -66.78 145.35 55.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.999 -1.295 . . . . 0.0 109.24 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.54 144.83 32.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.409 -0.807 . . . . 0.0 109.818 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.691 ' O ' ' N ' ' A' ' 72' ' ' TYR . 70.6 mm-40 -132.69 158.83 74.73 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.479 ' C ' ' O ' ' A' ' 70' ' ' GLU . 50.4 Cg_exo -33.72 -24.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.62 1.547 . . . . 0.0 110.756 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.691 ' N ' ' O ' ' A' ' 70' ' ' GLU . 97.6 m-85 -114.44 122.04 45.4 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 72' ' ' TYR . 36.9 p-10 -43.56 158.11 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.287 -0.883 . . . . 0.0 109.834 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.718 HD13 ' H ' ' A' ' 67' ' ' GLY . 95.1 mt -68.8 174.24 4.54 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.266 1.032 . . . . 0.0 109.008 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.832 ' CZ ' ' CG ' ' A' ' 84' ' ' HIS . 97.5 m-85 -82.28 152.37 26.36 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.899 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 80.2 p -74.65 -22.97 58.61 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.494 -0.754 . . . . 0.0 111.535 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.8 p -120.54 146.25 46.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.545 -1.347 . . . . 0.0 110.213 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.581 HD22 ' CE1' ' A' ' 66' ' ' TYR . 88.1 mt -60.22 -43.95 95.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.714 . . . . 0.0 109.266 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -61.08 -43.17 99.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.436 -0.79 . . . . 0.0 109.841 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -63.65 -40.1 96.0 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.056 -1.027 . . . . 0.0 109.773 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.725 HD23 ' C ' ' A' ' 81' ' ' LEU . 8.5 tt -61.27 -44.9 96.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.963 . . . . 0.0 109.909 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.547 HG21 ' CZ3' ' A' ' 11' ' ' TRP . 91.8 t -64.01 -38.73 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.066 -1.021 . . . . 0.0 109.175 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 86' ' ' GLN . 62.5 tp -63.93 -46.82 83.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.746 . . . . 0.0 111.227 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.832 ' CG ' ' CZ ' ' A' ' 75' ' ' TYR . 48.0 m80 -67.91 -40.45 83.43 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.624 -1.297 . . . . 0.0 110.764 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.453 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 5.2 m-85 -61.24 -29.09 69.62 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.396 -0.815 . . . . 0.0 110.247 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -68.01 -13.83 62.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.756 -1.215 . . . . 0.0 109.85 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -103.21 -31.07 10.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.043 -1.036 . . . . 0.0 109.948 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 94.0 m -87.37 141.28 28.75 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.074 -1.016 . . . . 0.0 110.737 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.0 m -88.79 124.18 33.91 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.764 ' O ' ' N ' ' A' ' 92' ' ' GLN . 21.7 mt -60.76 -40.69 93.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.835 . . . . 0.0 111.18 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.727 HG12 ' N ' ' A' ' 92' ' ' GLN . 4.2 t 31.84 -81.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.595 0 O-C-N 120.959 -1.088 . . . . 0.0 110.001 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.764 ' N ' ' O ' ' A' ' 90' ' ' LEU . 54.9 mt-30 56.22 -159.2 0.22 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.568 -0.708 . . . . 0.0 111.779 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.437 ' H ' ' HB3' ' A' ' 92' ' ' GLN . 79.6 m-70 -55.11 -44.11 74.65 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.321 -0.862 . . . . 0.0 109.286 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.678 ' O ' ' N ' ' A' ' 96' ' ' SER . 30.1 m120 -81.14 91.13 6.09 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 94' ' ' ASN . 50.5 t0 -43.64 -8.95 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.474 -0.766 . . . . 0.0 110.43 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 94' ' ' ASN . 95.0 p -89.77 -0.09 57.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.832 -1.167 . . . . 0.0 112.19 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.721 ' O ' ' N ' ' A' ' 91' ' ' VAL . 68.7 mt -83.81 30.83 0.49 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.646 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 16.6 p30 -76.26 53.9 0.85 Allowed 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.97 0.891 . . . . 0.0 108.973 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.5 150.88 33.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 102' ' ' ALA . 43.7 p -114.28 150.68 34.05 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.695 HD22 ' CD2' ' A' ' 33' ' ' PHE . 30.4 mt -71.7 68.06 0.59 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -100.87 -25.41 14.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 112.228 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -116.05 104.05 52.7 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.376 -1.453 . . . . 0.0 111.181 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 107' ' ' ALA . 31.6 Cg_exo -57.89 159.41 17.91 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.609 2.206 . . . . 0.0 110.433 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.518 HG13 ' CD2' ' A' ' 106' ' ' TYR . 13.2 p -78.59 -28.71 14.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 120.737 -1.227 . . . . 0.0 108.115 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.518 ' CD2' HG13 ' A' ' 105' ' ' VAL . 57.1 m-85 -112.07 29.98 7.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.487 -0.758 . . . . 0.0 109.159 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.51 ' HB2' ' HD2' ' A' ' 104' ' ' PRO . . . -58.81 141.02 54.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.903 . . . . 0.0 109.082 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 58.65 55.53 4.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.458 -0.776 . . . . 0.0 109.522 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -87.41 137.69 32.12 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 108.862 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.455 ' O ' ' OXT' ' A' ' 111' ' ' ARG . 41.8 ttm180 -109.83 128.81 55.56 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.091 -1.006 . . . . 0.0 109.124 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.643 ' HG2' HH11 ' A' ' 111' ' ' ARG . 7.3 ttt-85 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.221 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.272 0.558 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -82.17 124.89 30.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.0 108.854 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.2 tp -99.3 128.4 31.89 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 120.818 -1.176 . . . . 0.0 108.623 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.505 ' O ' ' OG1' ' A' ' 10' ' ' THR . 78.5 Cg_exo -48.66 -19.99 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.39 2.06 . . . . 0.0 112.675 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -67.35 -26.08 66.3 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.925 -1.109 . . . . 0.0 109.741 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -63.4 -39.21 93.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.196 -0.94 . . . . 0.0 110.8 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.528 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 69.2 m-20 -93.16 128.7 39.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.991 -1.068 . . . . 0.0 110.421 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.707 ' O ' ' N ' ' A' ' 12' ' ' ASN . 94.0 mt-10 -66.87 -26.55 66.95 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.239 -0.913 . . . . 0.0 110.479 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.501 ' HG2' ' N ' ' A' ' 10' ' ' THR . 1.2 pttp -60.86 -35.92 77.82 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.194 -0.941 . . . . 0.0 111.339 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.535 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 2.7 p -60.23 -33.14 71.85 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 109.895 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.654 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -122.67 -20.84 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 111.098 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.707 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -91.82 119.21 31.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.723 -1.235 . . . . 0.0 110.257 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.98 -4.54 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.301 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.83 -142.21 30.54 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -82.49 121.2 26.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.324 . . . . 0.0 109.115 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.0 t -141.24 148.14 39.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 110.154 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.698 HD22 ' N ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -74.24 134.3 42.68 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.163 -0.961 . . . . 0.0 108.752 178.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.698 ' N ' HD22 ' A' ' 17' ' ' ASN . 23.7 mtp180 -59.36 -33.06 70.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.489 -0.757 . . . . 0.0 109.836 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 13.9 p-10 -59.71 -46.3 89.51 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.857 -1.137 . . . . 0.0 108.41 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 29.5 tttt -64.62 -39.78 94.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 109.034 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.78 78.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.086 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.22 -40.48 77.59 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -60.15 -44.71 94.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 24' ' ' LEU . 91.1 mt -66.16 -31.79 72.84 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.468 -0.77 . . . . 0.0 109.263 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.525 HD23 ' CG2' ' A' ' 49' ' ' VAL . 9.9 mt -91.3 -4.12 56.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.551 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 27' ' ' GLY . 2.9 tpt180 -91.58 125.51 36.34 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.476 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . 70.63 24.99 76.43 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.831 ' HE2' HG21 ' A' ' 32' ' ' THR . 37.9 tptt -106.67 139.97 40.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -1.214 . . . . 0.0 108.676 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -71.43 149.09 46.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.326 -0.859 . . . . 0.0 110.867 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.557 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 64.3 t0 -58.7 144.17 44.37 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.498 0.666 . . . . 0.0 110.072 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 104.66 -24.87 27.38 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.831 HG21 ' HE2' ' A' ' 28' ' ' LYS . 85.4 m -81.58 124.86 29.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.986 -1.302 . . . . 0.0 109.128 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.582 ' CG ' HD22 ' A' ' 101' ' ' LEU . 1.1 p90 -140.03 164.89 28.81 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.16 -1.416 . . . . 0.0 111.601 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 34' ' ' LEU . 1.1 pt? -137.27 156.97 47.64 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.673 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 11' ' ' TRP . 53.1 t -110.43 134.4 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.629 HH12 ' CG ' ' A' ' 18' ' ' ARG . 75.7 mtm180 -130.39 -179.49 5.29 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.426 -0.796 . . . . 0.0 109.235 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.678 ' C ' ' H ' ' A' ' 39' ' ' SER . 8.7 pt-20 -105.27 173.03 6.48 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 108.999 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 43' ' ' CYS . 51.3 m -78.49 18.29 0.58 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.678 ' H ' ' C ' ' A' ' 37' ' ' GLU . 33.2 t 61.08 142.58 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.988 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 41' ' ' GLN . 37.7 mttp 59.27 34.26 22.93 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -0.916 . . . . 0.0 109.131 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 40' ' ' LYS . 59.9 tt0 58.52 148.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.827 . . . . 0.0 109.512 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.584 ' O ' ' SG ' ' A' ' 43' ' ' CYS . . . 151.81 -66.29 0.35 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 42' ' ' GLY . 82.0 m -156.19 -172.63 4.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.686 -1.479 . . . . 0.0 109.643 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.454 ' O ' ' O ' ' A' ' 59' ' ' ILE . 86.8 m-85 -117.45 158.68 24.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 109.617 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.49 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -147.15 132.87 18.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 109.686 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 27.4 p -102.6 117.69 35.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 108.974 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.5 m -98.77 127.28 44.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 108.868 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.65 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.5 p -127.89 166.39 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 110.536 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.65 ' N ' HG22 ' A' ' 48' ' ' VAL . 15.5 t -108.16 138.18 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.876 HG12 ' H ' ' A' ' 52' ' ' GLY . 54.2 t -114.24 148.32 17.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.421 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 61.4 t0 -50.64 -12.96 0.11 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.119 0.961 . . . . 0.0 108.601 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.876 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -102.95 -51.1 1.03 Allowed Glycine 0 C--N 1.289 -2.05 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.593 ' HB2' ' HZ1' ' A' ' 55' ' ' LYS . 70.6 mm-40 -160.32 -177.44 6.25 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.865 -1.373 . . . . 0.0 110.428 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -94.21 128.27 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.552 -0.718 . . . . 0.0 109.405 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.593 ' HZ1' ' HB2' ' A' ' 53' ' ' GLU . 9.3 mptt -128.89 148.63 50.93 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.262 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -104.55 98.22 8.02 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.2 m -82.61 145.12 29.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.715 -1.241 . . . . 0.0 109.103 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 58' ' ' VAL . 6.9 p -107.11 139.85 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.233 -0.917 . . . . 0.0 112.877 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 66' ' ' TYR . 49.9 mm -107.11 126.77 63.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 176.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.64 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 21.6 m120 -114.9 125.28 53.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.827 -1.171 . . . . 0.0 110.81 -177.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -109.36 122.68 47.9 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.506 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.694 ' O ' ' N ' ' A' ' 64' ' ' THR . 74.3 p -140.22 167.48 22.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 109.554 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -40.07 -18.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.694 ' N ' ' O ' ' A' ' 62' ' ' THR . 84.8 m -153.47 40.77 0.53 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.576 -0.703 . . . . 0.0 109.431 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.677 ' O ' ' CD2' ' A' ' 66' ' ' TYR . . . -144.5 169.3 26.5 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.391 -1.385 . . . . 0.0 110.693 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.677 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 59.0 m-85 -168.19 -18.94 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.69 -85.56 0.11 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 73' ' ' ASN . 51.3 m-85 -103.43 139.2 39.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.145 -1.209 . . . . 0.0 109.336 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 73' ' ' ASN . . . -127.0 7.65 6.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.182 -0.949 . . . . 0.0 110.332 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.737 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 35.7 mp0 -106.22 -27.0 0.19 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.912 -1.118 . . . . 0.0 110.935 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 94.5 Cg_endo -89.17 -59.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.6 2.2 . . . . 0.0 111.991 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.712 ' CE1' ' NE2' ' A' ' 84' ' ' HIS . 93.7 m-85 -118.13 16.07 14.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.134 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.494 ' HB3' HD22 ' A' ' 74' ' ' LEU . 35.1 m120 61.77 -124.59 0.8 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.389 -0.82 . . . . 0.0 110.7 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.641 HD22 ' N ' ' A' ' 74' ' ' LEU . 1.2 mm? -102.13 107.55 18.67 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.222 -0.924 . . . . 0.0 108.54 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.586 ' CD2' HD23 ' A' ' 81' ' ' LEU . 98.8 m-85 -50.34 145.04 6.67 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.6 m -60.17 -43.47 95.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.522 -0.736 . . . . 0.0 111.313 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p -152.11 169.21 22.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.861 -1.149 . . . . 0.0 109.995 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -36.72 77.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.703 -0.623 . . . . 0.0 109.672 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -60.0 -40.89 90.74 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.011 -1.055 . . . . 0.0 108.63 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.11 -31.1 70.47 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.745 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.3 tm? -59.73 -45.77 91.15 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.432 HG21 ' CZ3' ' A' ' 11' ' ' TRP . 98.0 t -65.01 -45.0 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.03 . . . . 0.0 108.81 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.47 -43.01 77.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 110.057 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.712 ' NE2' ' CE1' ' A' ' 72' ' ' TYR . 53.6 t-80 -60.72 -42.71 97.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.353 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.504 ' CE2' HD11 ' A' ' 81' ' ' LEU . 4.6 m-30 -68.87 -25.1 64.46 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.083 -1.01 . . . . 0.0 109.387 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.579 ' OE1' ' ND1' ' A' ' 87' ' ' HIS . 1.3 tm0? -61.95 -34.68 76.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.217 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.579 ' ND1' ' OE1' ' A' ' 86' ' ' GLN . 87.9 m-70 -95.08 -18.73 20.74 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.015 -1.053 . . . . 0.0 110.888 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -102.67 133.09 48.27 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.036 -1.04 . . . . 0.0 109.9 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.3 t -74.21 133.51 42.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.417 -0.802 . . . . 0.0 109.48 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 92' ' ' GLN . 8.8 mp -62.51 -29.23 70.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.476 -0.765 . . . . 0.0 110.573 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.936 HG13 ' H ' ' A' ' 92' ' ' GLN . 8.6 p 2.34 -66.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 121.318 0.58 . . . . 0.0 111.492 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.936 ' H ' HG13 ' A' ' 91' ' ' VAL . 19.6 pt20 35.28 -149.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.826 0.822 . . . . 0.0 111.503 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.734 ' C ' ' H ' ' A' ' 95' ' ' ASP . 63.8 m80 -50.55 171.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.37 -0.831 . . . . 0.0 109.951 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 13.4 m120 63.02 -22.19 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.734 ' H ' ' C ' ' A' ' 93' ' ' HIS . 86.0 m-20 53.95 31.37 13.31 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.739 -0.601 . . . . 0.0 109.676 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.7 m -134.33 -0.5 2.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.807 -1.183 . . . . 0.0 111.24 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 96.0 mt -82.09 57.55 3.59 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -79.7 84.77 5.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.647 0.737 . . . . 0.0 109.33 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.554 ' O ' HD13 ' A' ' 90' ' ' LEU . 3.0 p -159.94 155.98 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.428 ' N ' HG22 ' A' ' 99' ' ' VAL . 32.5 p -122.42 146.06 47.7 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.082 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.582 HD22 ' CG ' ' A' ' 33' ' ' PHE . 34.8 mt -80.19 65.86 5.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 108.698 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . . . -99.68 -22.86 15.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.855 . . . . 0.0 112.296 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.2 m-85 -115.18 114.05 43.46 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.46 -1.4 . . . . 0.0 110.897 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.408 ' CB ' ' O ' ' A' ' 10' ' ' THR . 10.5 Cg_exo -63.06 156.27 55.9 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.982 1.788 . . . . 0.0 111.227 178.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.73 -30.33 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.942 -1.099 . . . . 0.0 109.455 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -99.88 30.98 3.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.082 -1.011 . . . . 0.0 110.208 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.95 20.07 0.5 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 109.143 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -53.71 137.61 37.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.271 -0.893 . . . . 0.0 109.528 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -94.13 140.81 29.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.97 . . . . 0.0 109.708 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.687 HH11 ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -104.99 132.37 51.31 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.216 -0.927 . . . . 0.0 109.248 179.383 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 . . . . . 0 C--N 1.299 -1.628 0 CA-C-O 118.159 -0.924 . . . . 0.0 109.339 179.43 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.272 0.558 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -82.17 124.89 30.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.0 108.854 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.2 tp -99.3 128.4 31.89 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 120.818 -1.176 . . . . 0.0 108.623 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.505 ' O ' ' OG1' ' A' ' 10' ' ' THR . 78.5 Cg_exo -48.66 -19.99 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.39 2.06 . . . . 0.0 112.675 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -67.35 -26.08 66.3 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.925 -1.109 . . . . 0.0 109.741 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -63.4 -39.21 93.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.196 -0.94 . . . . 0.0 110.8 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.528 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 69.2 m-20 -93.16 128.7 39.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.991 -1.068 . . . . 0.0 110.421 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.707 ' O ' ' N ' ' A' ' 12' ' ' ASN . 94.0 mt-10 -66.87 -26.55 66.95 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.239 -0.913 . . . . 0.0 110.479 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.501 ' HG2' ' N ' ' A' ' 10' ' ' THR . 1.2 pttp -60.86 -35.92 77.82 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.194 -0.941 . . . . 0.0 111.339 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.535 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 2.7 p -60.23 -33.14 71.85 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 109.895 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.654 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -122.67 -20.84 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 111.098 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.707 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -91.82 119.21 31.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.723 -1.235 . . . . 0.0 110.257 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.98 -4.54 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.301 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.83 -142.21 30.54 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -82.49 121.2 26.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.324 . . . . 0.0 109.115 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.0 t -141.24 148.14 39.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 110.154 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.698 HD22 ' N ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -74.24 134.3 42.68 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.163 -0.961 . . . . 0.0 108.752 178.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.698 ' N ' HD22 ' A' ' 17' ' ' ASN . 23.7 mtp180 -59.36 -33.06 70.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.489 -0.757 . . . . 0.0 109.836 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 13.9 p-10 -59.71 -46.3 89.51 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.857 -1.137 . . . . 0.0 108.41 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 29.5 tttt -64.62 -39.78 94.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 109.034 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.78 78.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.086 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.22 -40.48 77.59 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -60.15 -44.71 94.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 24' ' ' LEU . 91.1 mt -66.16 -31.79 72.84 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.468 -0.77 . . . . 0.0 109.263 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.525 HD23 ' CG2' ' A' ' 49' ' ' VAL . 9.9 mt -91.3 -4.12 56.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.551 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 27' ' ' GLY . 2.9 tpt180 -91.58 125.51 36.34 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.476 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . 70.63 24.99 76.43 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.831 ' HE2' HG21 ' A' ' 32' ' ' THR . 37.9 tptt -106.67 139.97 40.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -1.214 . . . . 0.0 108.676 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -71.43 149.09 46.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.326 -0.859 . . . . 0.0 110.867 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.557 ' OD1' ' O ' ' A' ' 49' ' ' VAL . 64.3 t0 -58.7 144.17 44.37 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.498 0.666 . . . . 0.0 110.072 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 104.66 -24.87 27.38 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.831 HG21 ' HE2' ' A' ' 28' ' ' LYS . 85.4 m -81.58 124.86 29.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.986 -1.302 . . . . 0.0 109.128 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.582 ' CG ' HD22 ' A' ' 101' ' ' LEU . 1.1 p90 -140.03 164.89 28.81 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.16 -1.416 . . . . 0.0 111.601 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 34' ' ' LEU . 1.1 pt? -137.27 156.97 47.64 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.673 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 11' ' ' TRP . 53.1 t -110.43 134.4 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.629 HH12 ' CG ' ' A' ' 18' ' ' ARG . 75.7 mtm180 -130.39 -179.49 5.29 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.426 -0.796 . . . . 0.0 109.235 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.678 ' C ' ' H ' ' A' ' 39' ' ' SER . 8.7 pt-20 -105.27 173.03 6.48 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 108.999 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 43' ' ' CYS . 51.3 m -78.49 18.29 0.58 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.678 ' H ' ' C ' ' A' ' 37' ' ' GLU . 33.2 t 61.08 142.58 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.988 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 41' ' ' GLN . 37.7 mttp 59.27 34.26 22.93 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -0.916 . . . . 0.0 109.131 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 40' ' ' LYS . 59.9 tt0 58.52 148.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.827 . . . . 0.0 109.512 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.584 ' O ' ' SG ' ' A' ' 43' ' ' CYS . . . 151.81 -66.29 0.35 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 42' ' ' GLY . 82.0 m -156.19 -172.63 4.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.686 -1.479 . . . . 0.0 109.643 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.454 ' O ' ' O ' ' A' ' 59' ' ' ILE . 86.8 m-85 -117.45 158.68 24.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 109.617 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.49 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -147.15 132.87 18.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 109.686 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 27.4 p -102.6 117.69 35.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 108.974 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.5 m -98.77 127.28 44.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 108.868 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.65 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.5 p -127.89 166.39 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 110.536 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.65 ' N ' HG22 ' A' ' 48' ' ' VAL . 15.5 t -108.16 138.18 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.876 HG12 ' H ' ' A' ' 52' ' ' GLY . 54.2 t -114.24 148.32 17.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.421 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 61.4 t0 -50.64 -12.96 0.11 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.119 0.961 . . . . 0.0 108.601 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.876 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -102.95 -51.1 1.03 Allowed Glycine 0 C--N 1.289 -2.05 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.593 ' HB2' ' HZ1' ' A' ' 55' ' ' LYS . 70.6 mm-40 -160.32 -177.44 6.25 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.865 -1.373 . . . . 0.0 110.428 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -94.21 128.27 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.552 -0.718 . . . . 0.0 109.405 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.593 ' HZ1' ' HB2' ' A' ' 53' ' ' GLU . 9.3 mptt -128.89 148.63 50.93 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.262 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -104.55 98.22 8.02 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.2 m -82.61 145.12 29.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.715 -1.241 . . . . 0.0 109.103 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 58' ' ' VAL . 6.9 p -107.11 139.85 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.233 -0.917 . . . . 0.0 112.877 -176.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 66' ' ' TYR . 49.9 mm -107.11 126.77 63.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 176.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.64 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 21.6 m120 -114.9 125.28 53.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.827 -1.171 . . . . 0.0 110.81 -177.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -109.36 122.68 47.9 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.506 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.694 ' O ' ' N ' ' A' ' 64' ' ' THR . 74.3 p -140.22 167.48 22.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 109.554 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -40.07 -18.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.694 ' N ' ' O ' ' A' ' 62' ' ' THR . 84.8 m -153.47 40.77 0.53 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.576 -0.703 . . . . 0.0 109.431 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.677 ' O ' ' CD2' ' A' ' 66' ' ' TYR . . . -144.5 169.3 26.5 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.391 -1.385 . . . . 0.0 110.693 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.677 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 59.0 m-85 -168.19 -18.94 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.69 -85.56 0.11 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 73' ' ' ASN . 51.3 m-85 -103.43 139.2 39.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.145 -1.209 . . . . 0.0 109.336 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 73' ' ' ASN . . . -127.0 7.65 6.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.182 -0.949 . . . . 0.0 110.332 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.737 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 35.7 mp0 -106.22 -27.0 0.19 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.912 -1.118 . . . . 0.0 110.935 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 94.5 Cg_endo -89.17 -59.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.6 2.2 . . . . 0.0 111.991 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.712 ' CE1' ' NE2' ' A' ' 84' ' ' HIS . 93.7 m-85 -118.13 16.07 14.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.134 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.494 ' HB3' HD22 ' A' ' 74' ' ' LEU . 35.1 m120 61.77 -124.59 0.8 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.389 -0.82 . . . . 0.0 110.7 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.641 HD22 ' N ' ' A' ' 74' ' ' LEU . 1.2 mm? -102.13 107.55 18.67 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.222 -0.924 . . . . 0.0 108.54 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.586 ' CD2' HD23 ' A' ' 81' ' ' LEU . 98.8 m-85 -50.34 145.04 6.67 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.6 m -60.17 -43.47 95.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.522 -0.736 . . . . 0.0 111.313 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p -152.11 169.21 22.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.861 -1.149 . . . . 0.0 109.995 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -36.72 77.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.703 -0.623 . . . . 0.0 109.672 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -60.0 -40.89 90.74 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.011 -1.055 . . . . 0.0 108.63 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.11 -31.1 70.47 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.745 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.3 tm? -59.73 -45.77 91.15 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.432 HG21 ' CZ3' ' A' ' 11' ' ' TRP . 98.0 t -65.01 -45.0 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.03 . . . . 0.0 108.81 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.47 -43.01 77.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 110.057 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.712 ' NE2' ' CE1' ' A' ' 72' ' ' TYR . 53.6 t-80 -60.72 -42.71 97.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.353 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.504 ' CE2' HD11 ' A' ' 81' ' ' LEU . 4.6 m-30 -68.87 -25.1 64.46 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.083 -1.01 . . . . 0.0 109.387 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.579 ' OE1' ' ND1' ' A' ' 87' ' ' HIS . 1.3 tm0? -61.95 -34.68 76.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.217 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.579 ' ND1' ' OE1' ' A' ' 86' ' ' GLN . 87.9 m-70 -95.08 -18.73 20.74 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.015 -1.053 . . . . 0.0 110.888 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -102.67 133.09 48.27 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.036 -1.04 . . . . 0.0 109.9 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.3 t -74.21 133.51 42.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.417 -0.802 . . . . 0.0 109.48 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 92' ' ' GLN . 8.8 mp -62.51 -29.23 70.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.476 -0.765 . . . . 0.0 110.573 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.936 HG13 ' H ' ' A' ' 92' ' ' GLN . 8.6 p 2.34 -66.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 121.318 0.58 . . . . 0.0 111.492 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.936 ' H ' HG13 ' A' ' 91' ' ' VAL . 19.6 pt20 35.28 -149.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.826 0.822 . . . . 0.0 111.503 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.734 ' C ' ' H ' ' A' ' 95' ' ' ASP . 63.8 m80 -50.55 171.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.37 -0.831 . . . . 0.0 109.951 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 13.4 m120 63.02 -22.19 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.734 ' H ' ' C ' ' A' ' 93' ' ' HIS . 86.0 m-20 53.95 31.37 13.31 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.739 -0.601 . . . . 0.0 109.676 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.7 m -134.33 -0.5 2.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.807 -1.183 . . . . 0.0 111.24 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 96.0 mt -82.09 57.55 3.59 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -79.7 84.77 5.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.647 0.737 . . . . 0.0 109.33 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.554 ' O ' HD13 ' A' ' 90' ' ' LEU . 3.0 p -159.94 155.98 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.428 ' N ' HG22 ' A' ' 99' ' ' VAL . 32.5 p -122.42 146.06 47.7 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.082 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.582 HD22 ' CG ' ' A' ' 33' ' ' PHE . 34.8 mt -80.19 65.86 5.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 108.698 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . . . -99.68 -22.86 15.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.855 . . . . 0.0 112.296 -178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.2 m-85 -115.18 114.05 43.46 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.46 -1.4 . . . . 0.0 110.897 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.408 ' CB ' ' O ' ' A' ' 10' ' ' THR . 10.5 Cg_exo -63.06 156.27 55.9 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.982 1.788 . . . . 0.0 111.227 178.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.73 -30.33 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.942 -1.099 . . . . 0.0 109.455 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -99.88 30.98 3.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.082 -1.011 . . . . 0.0 110.208 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.95 20.07 0.5 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 109.143 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -53.71 137.61 37.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.271 -0.893 . . . . 0.0 109.528 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -94.13 140.81 29.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.97 . . . . 0.0 109.708 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.687 HH11 ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -104.99 132.37 51.31 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.216 -0.927 . . . . 0.0 109.248 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 . . . . . 0 C--N 1.299 -1.628 0 CA-C-O 118.159 -0.924 . . . . 0.0 109.339 179.43 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.323 0.582 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -66.88 132.6 48.33 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.132 -0.98 . . . . 0.0 109.149 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 mp -94.46 126.49 47.76 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.307 -0.871 . . . . 0.0 109.558 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -54.88 -12.06 4.32 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.145 1.897 . . . . 0.0 111.612 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.816 ' NE2' ' NE2' ' A' ' 86' ' ' GLN . 83.8 m-70 -65.22 -31.8 73.15 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.354 -0.841 . . . . 0.0 109.349 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -61.85 -22.02 65.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.387 -0.82 . . . . 0.0 109.234 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.715 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 71.6 m-20 -90.93 114.47 26.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.31 -0.869 . . . . 0.0 109.443 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.552 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 39.7 tt0 -67.22 -37.86 84.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.015 -1.053 . . . . 0.0 109.898 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HG2' ' N ' ' A' ' 10' ' ' THR . 0.4 OUTLIER -62.89 -29.06 70.47 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.487 -0.758 . . . . 0.0 110.642 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.627 ' OG1' ' O ' ' A' ' 7' ' ' ASP . 9.6 p -59.65 -35.12 73.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.132 -0.98 . . . . 0.0 110.381 -178.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.715 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -124.77 -5.69 7.49 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.738 -1.226 . . . . 0.0 110.125 179.568 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 8' ' ' GLU . 51.3 t-20 -96.76 129.2 44.22 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.989 -1.069 . . . . 0.0 110.441 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 13' ' ' VAL . 97.9 t -107.13 -12.04 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.84 . . . . 0.0 109.524 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.42 -154.16 50.09 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 88.7 p -68.57 143.13 54.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.05 -1.264 . . . . 0.0 109.622 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.7 p -157.98 154.94 28.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 109.81 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.645 ' C ' ' H ' ' A' ' 19' ' ' ASN . 58.9 t30 -89.02 19.81 3.97 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.537 ' CG ' HH11 ' A' ' 18' ' ' ARG . 0.0 OUTLIER 58.8 -12.89 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.389 -0.819 . . . . 0.0 109.787 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.645 ' H ' ' C ' ' A' ' 17' ' ' ASN . 57.8 t-20 -67.53 -46.7 72.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.615 -1.303 . . . . 0.0 108.425 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.37 -27.34 68.5 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -57.28 -43.94 83.56 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.573 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 68.4 mm-40 -61.14 -44.91 96.6 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -63.53 -45.63 89.72 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.445 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 83.0 mt -67.19 -36.83 82.57 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.541 HD13 ' CG1' ' A' ' 54' ' ' VAL . 55.4 mt -82.05 -9.01 59.69 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.573 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 14.2 mmm180 -102.69 123.4 46.32 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.9 -4.49 63.18 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 34.4 mmtt -98.64 138.99 35.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.079 -1.248 . . . . 0.0 109.504 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -73.24 161.21 30.81 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.698 -0.626 . . . . 0.0 109.76 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 57.4 p-10 -58.66 149.47 25.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.23 -0.919 . . . . 0.0 109.9 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.27 -25.53 27.88 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 27.7 m -80.51 120.37 24.4 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.424 -1.045 . . . . 0.0 108.696 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.782 ' HB2' HG22 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -130.67 161.69 31.08 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.389 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.451 HD21 HD21 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -132.55 167.79 19.38 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.699 -178.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 46' ' ' CYS . 82.7 t -130.81 129.27 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.908 -1.12 . . . . 0.0 110.654 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.668 ' NH2' ' OG ' ' A' ' 47' ' ' SER . 67.8 mtm180 -129.45 -149.77 0.41 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' A' ' 39' ' ' SER . 71.7 mm-40 -105.65 173.32 6.36 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.655 ' O ' ' CB ' ' A' ' 39' ' ' SER . 63.3 p -78.19 5.43 10.25 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 177.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.67 ' OG ' ' N ' ' A' ' 40' ' ' LYS . 23.0 p 99.02 -91.05 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.734 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.67 ' N ' ' OG ' ' A' ' 39' ' ' SER . 7.2 pttm -121.84 0.74 9.83 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.094 -1.004 . . . . 0.0 109.552 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -79.2 -15.5 57.96 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.206 -0.934 . . . . 0.0 109.828 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.16 -12.14 68.77 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.603 ' O ' ' N ' ' A' ' 38' ' ' SER . 97.1 m -87.44 177.07 7.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.165 -1.197 . . . . 0.0 109.404 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.495 ' O ' ' O ' ' A' ' 59' ' ' ILE . 98.1 m-85 -110.69 153.35 25.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.903 -1.123 . . . . 0.0 109.959 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.91 133.09 23.02 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.457 -0.777 . . . . 0.0 109.123 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.44 ' HB3' HG22 ' A' ' 35' ' ' VAL . 17.1 p -115.87 134.61 54.82 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.206 -0.933 . . . . 0.0 109.502 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.668 ' OG ' ' NH2' ' A' ' 36' ' ' ARG . 70.7 m -98.65 146.15 26.15 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.597 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' ' 33' ' ' PHE . 67.6 t -129.37 160.8 39.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.435 -0.79 . . . . 0.0 108.871 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.551 ' N ' HG12 ' A' ' 48' ' ' VAL . 63.2 t -118.5 128.33 75.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.702 HG23 ' CG2' ' A' ' 99' ' ' VAL . 9.3 p -126.03 156.37 36.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.859 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.442 ' N ' HG22 ' A' ' 50' ' ' VAL . 97.9 m-20 -48.84 -18.39 0.27 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.639 0.733 . . . . 0.0 109.911 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.587 ' H ' HG13 ' A' ' 50' ' ' VAL . . . -85.22 -59.57 1.93 Allowed Glycine 0 C--N 1.284 -2.348 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.425 ' H ' HG13 ' A' ' 50' ' ' VAL . 21.9 pt-20 -164.85 -165.93 0.98 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.169 -1.195 . . . . 0.0 110.629 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.541 ' CG1' HD13 ' A' ' 25' ' ' LEU . 79.5 t -95.05 130.62 43.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.643 ' HZ2' HG11 ' A' ' 50' ' ' VAL . 0.7 OUTLIER -117.75 156.81 27.63 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.71 -1.244 . . . . 0.0 110.823 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.513 ' ND1' ' OG ' ' A' ' 47' ' ' SER . 25.5 m-70 -120.83 71.32 0.93 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.8 m -60.17 143.84 51.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 109.804 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.13 143.08 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.672 -0.643 . . . . 0.0 110.58 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.495 ' O ' ' O ' ' A' ' 44' ' ' TYR . 44.8 mm -115.49 140.44 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.592 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 11.2 m120 -114.34 129.44 56.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.553 -1.342 . . . . 0.0 110.549 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -90.45 120.02 31.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.412 -0.805 . . . . 0.0 110.139 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 63' ' ' ALA . 90.7 m -159.63 165.41 32.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.276 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.566 ' N ' HG22 ' A' ' 62' ' ' THR . . . -60.68 -41.58 95.4 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.27 30.06 6.18 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.454 -0.779 . . . . 0.0 110.535 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.607 ' C ' ' H ' ' A' ' 67' ' ' GLY . . . -120.66 -75.29 0.41 Allowed Glycine 0 N--CA 1.497 2.766 0 C-N-CA 119.355 -1.402 . . . . 0.0 110.939 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.592 ' CA ' ' O ' ' A' ' 60' ' ' ASN . 81.7 m-85 63.08 -9.82 0.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.181 -1.188 . . . . 0.0 108.94 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 65' ' ' GLY . . . 135.86 -68.03 0.54 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.821 ' CE2' ' CZ ' ' A' ' 85' ' ' TYR . 91.9 m-85 -105.15 129.87 53.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.98 -1.306 . . . . 0.0 109.092 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.31 -6.94 0.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.044 -1.035 . . . . 0.0 109.857 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.702 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 32.0 tt0 -65.94 -35.31 10.63 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.151 -0.968 . . . . 0.0 109.93 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 1.4 Cg_endo -80.61 -46.16 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.87 2.38 . . . . 0.0 112.205 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.497 ' CE2' HD23 ' A' ' 74' ' ' LEU . 54.5 t80 -157.14 142.56 17.35 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -97.69 111.36 23.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.248 -0.907 . . . . 0.0 110.108 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.497 HD23 ' CE2' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -158.58 -125.48 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.479 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 47.1 m-85 58.76 51.7 7.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.12 -0.987 . . . . 0.0 109.785 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.467 ' N ' ' OE1' ' A' ' 80' ' ' GLU . 74.7 m -56.09 -33.63 65.25 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.25 -0.906 . . . . 0.0 109.538 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.9 t -128.17 151.3 49.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.96 . . . . 0.0 109.879 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.2 mt -57.28 -34.67 68.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.363 -0.835 . . . . 0.0 109.301 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -58.65 -40.14 82.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 0.0 108.612 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 76' ' ' SER . 98.0 mt-10 -60.24 -40.12 89.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.339 -0.851 . . . . 0.0 109.287 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.43 -46.49 89.89 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.208 -0.932 . . . . 0.0 109.132 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.51 -43.7 83.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.464 -0.772 . . . . 0.0 108.987 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 tp -65.86 -45.16 83.17 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.243 -0.911 . . . . 0.0 110.214 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -64.44 -40.28 95.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.978 -1.076 . . . . 0.0 111.182 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.821 ' CZ ' ' CE2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -75.51 -14.85 60.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.928 -1.108 . . . . 0.0 111.738 -178.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.816 ' NE2' ' NE2' ' A' ' 5' ' ' HIS . 1.6 pt20 -66.86 -25.59 66.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.507 -1.37 . . . . 0.0 108.853 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -88.17 -36.41 16.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 109.896 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.487 ' O ' HG22 ' A' ' 100' ' ' THR . 91.2 m -83.26 149.42 26.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 0.0 110.513 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.0 m -99.05 130.21 45.37 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.573 0.702 . . . . 0.0 110.549 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.707 ' O ' ' N ' ' A' ' 92' ' ' GLN . 1.8 mt -62.06 -15.73 46.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.49 -0.756 . . . . 0.0 110.034 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.755 ' N ' ' O ' ' A' ' 97' ' ' LEU . 9.1 p -21.63 -38.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.87 -0.519 . . . . 0.0 111.297 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.707 ' N ' ' O ' ' A' ' 90' ' ' LEU . 5.3 pt20 -60.67 -42.83 97.85 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.509 ' N ' ' HG3' ' A' ' 92' ' ' GLN . 43.2 m-70 -59.73 -44.3 93.83 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.739 ' O ' ' N ' ' A' ' 96' ' ' SER . 98.1 m-20 -131.68 116.31 17.17 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 94' ' ' ASN . 80.7 m-20 -40.87 -12.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.288 -0.882 . . . . 0.0 109.892 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.739 ' N ' ' O ' ' A' ' 94' ' ' ASN . 46.1 t -112.75 22.07 14.89 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.74 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.755 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.9 mt -95.67 56.62 1.79 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.783 -1.198 . . . . 0.0 108.896 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 98' ' ' ASN . 3.3 t-20 -77.85 69.72 4.12 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.124 -0.985 . . . . 0.0 108.87 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.702 ' CG2' HG23 ' A' ' 50' ' ' VAL . 86.2 t -149.55 154.33 9.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 86' ' ' GLN . 9.8 p -129.46 164.16 24.3 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.674 HD22 ' CG ' ' A' ' 33' ' ' PHE . 28.5 mt -78.78 70.63 5.15 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.894 -1.129 . . . . 0.0 108.169 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.91 -31.33 13.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.804 . . . . 0.0 112.356 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 32' ' ' THR . 59.7 m-85 -113.45 113.57 48.22 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 120.23 -1.544 . . . . 0.0 111.763 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.5 146.83 96.16 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.726 1.617 . . . . 0.0 110.615 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 106' ' ' TYR . 9.0 p -67.95 -38.1 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.013 -1.054 . . . . 0.0 110.442 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.462 ' HE2' HG22 ' A' ' 13' ' ' VAL . 53.7 m-85 -101.24 27.62 6.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.064 -1.023 . . . . 0.0 109.974 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.43 140.49 58.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.12 -0.988 . . . . 0.0 110.156 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -92.44 135.63 33.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.915 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -93.82 2.61 56.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.0 109.479 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.467 ' O ' ' OXT' ' A' ' 111' ' ' ARG . 23.0 tpt180 -115.67 139.1 50.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.051 -1.03 . . . . 0.0 109.424 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.467 ' OXT' ' O ' ' A' ' 110' ' ' ARG . 93.1 mtt180 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.855 -1.069 . . . . 0.0 109.665 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 49.8 p-10 -64.93 148.61 51.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.398 -0.814 . . . . 0.0 109.682 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.526 ' N ' HD22 ' A' ' 3' ' ' LEU . 4.1 mm? -89.35 138.07 28.8 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.208 -0.932 . . . . 0.0 108.992 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.44 ' HB3' HG21 ' A' ' 10' ' ' THR . 15.2 Cg_exo -57.2 -12.43 10.1 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.721 1.614 . . . . 0.0 111.445 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -54.9 -25.99 32.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.627 -0.671 . . . . 0.0 110.424 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -61.39 -28.93 69.6 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.957 -1.089 . . . . 0.0 110.293 -179.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.655 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 88.9 m-20 -98.14 131.82 44.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.724 -1.235 . . . . 0.0 110.743 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.685 ' O ' ' N ' ' A' ' 12' ' ' ASN . 79.5 mt-10 -67.34 -27.13 66.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.467 -0.771 . . . . 0.0 109.139 179.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.47 ' CG ' ' N ' ' A' ' 10' ' ' THR . 37.6 pttt -59.64 -34.54 72.94 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.424 -0.797 . . . . 0.0 110.825 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.69 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 49.0 p -67.91 -26.34 65.93 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.392 -0.817 . . . . 0.0 111.013 -178.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.69 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -125.79 -25.15 3.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.617 -1.302 . . . . 0.0 110.543 179.636 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.685 ' N ' ' O ' ' A' ' 8' ' ' GLU . 8.8 p-10 -91.03 138.13 31.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.784 -1.197 . . . . 0.0 110.191 -178.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.0 p -111.52 -9.78 11.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.325 -0.859 . . . . 0.0 109.738 -179.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.82 50.39 3.53 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.797 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.52 ' HA ' ' H ' ' A' ' 37' ' ' GLU . 17.3 t 59.07 65.81 1.15 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.889 -1.36 . . . . 0.0 110.766 178.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.628 ' O ' ' CZ ' ' A' ' 36' ' ' ARG . 95.5 p -77.78 166.67 22.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.169 -0.957 . . . . 0.0 109.659 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.651 ' C ' HH12 ' A' ' 36' ' ' ARG . 86.1 m-20 -73.34 142.95 47.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.977 -1.077 . . . . 0.0 109.238 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.629 ' N ' HH12 ' A' ' 36' ' ' ARG . 35.0 mtm180 -60.22 -35.66 75.93 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.402 -0.811 . . . . 0.0 109.639 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -64.07 -43.71 94.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.939 -1.1 . . . . 0.0 109.08 179.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -68.46 -37.82 80.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.902 -1.124 . . . . 0.0 108.74 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.6 72.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.175 -0.953 . . . . 0.0 109.012 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 26' ' ' ARG . 67.3 tt0 -59.67 -48.85 80.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.241 -0.912 . . . . 0.0 108.827 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -60.25 -41.09 92.46 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.0 mt -66.76 -36.51 82.6 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.3 mt -86.93 -10.07 54.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.086 -1.009 . . . . 0.0 108.606 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.55 HH11 ' HG3' ' A' ' 26' ' ' ARG . 11.9 mmm-85 -100.45 135.36 42.01 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.418 0.628 . . . . 0.0 110.241 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.28 2.91 90.69 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -105.06 141.85 35.89 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.146 -1.208 . . . . 0.0 109.482 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -66.21 153.56 42.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.572 -0.705 . . . . 0.0 110.025 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.578 ' OD2' ' CA ' ' A' ' 51' ' ' ASP . 84.5 m-20 -58.74 144.67 42.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 0.0 109.486 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.41 -20.88 34.07 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.499 HG23 ' HD2' ' A' ' 103' ' ' TYR . 62.5 m -86.45 119.95 27.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.244 -1.151 . . . . 0.0 108.972 179.234 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.709 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -136.73 167.92 20.51 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.107 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.654 ' CD1' ' OG ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -140.29 157.11 46.08 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.002 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.443 HG22 ' SG ' ' A' ' 46' ' ' CYS . 47.4 t -106.97 133.47 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.991 -1.068 . . . . 0.0 108.604 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.651 HH12 ' C ' ' A' ' 17' ' ' ASN . 14.2 ptm180 -152.37 -177.52 6.25 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.112 -0.992 . . . . 0.0 109.35 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.72 ' C ' ' H ' ' A' ' 39' ' ' SER . 32.9 tt0 -106.58 166.15 10.77 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.612 ' O ' ' OG ' ' A' ' 39' ' ' SER . 60.1 m -76.28 19.75 0.23 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 177.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.72 ' H ' ' C ' ' A' ' 37' ' ' GLU . 99.8 p 60.83 -77.36 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.74 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.697 ' O ' ' CB ' ' A' ' 41' ' ' GLN . 61.1 tttp -92.65 131.37 37.8 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.697 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 65.4 tt0 116.79 -33.92 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.44 2.94 84.72 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.3 t -78.52 134.36 37.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.179 -1.189 . . . . 0.0 109.692 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -81.32 165.01 21.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.872 . . . . 0.0 109.666 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -168.39 139.3 2.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.988 -1.07 . . . . 0.0 110.324 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.443 ' SG ' HG22 ' A' ' 35' ' ' VAL . 63.1 m -108.64 126.47 53.01 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.654 ' OG ' ' CD1' ' A' ' 34' ' ' LEU . 3.0 p -110.62 129.87 55.71 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.874 -1.141 . . . . 0.0 110.15 -179.01 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.587 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.2 p -127.53 161.47 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.039 -1.038 . . . . 0.0 109.812 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.587 ' N ' HG22 ' A' ' 48' ' ' VAL . 45.1 t -101.74 129.13 53.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.773 HG11 ' HZ1' ' A' ' 55' ' ' LYS . 48.0 t -122.71 154.57 27.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 120.87 -1.144 . . . . 0.0 110.367 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.578 ' CA ' ' OD2' ' A' ' 30' ' ' ASP . 59.0 t0 -49.01 -17.68 0.22 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.546 0.688 . . . . 0.0 110.026 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.76 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -94.52 -56.96 1.3 Allowed Glycine 0 C--N 1.283 -2.409 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -165.34 170.25 14.85 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.028 -1.277 . . . . 0.0 110.65 -179.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.2 m -73.19 137.24 23.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.773 ' HZ1' HG11 ' A' ' 50' ' ' VAL . 8.4 mttt -125.27 156.13 39.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.753 -1.217 . . . . 0.0 111.366 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -121.96 78.07 1.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 46' ' ' CYS . 74.5 m -58.95 131.57 51.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.444 -1.41 . . . . 0.0 108.138 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.95 125.8 62.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.411 -0.805 . . . . 0.0 110.993 -178.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.616 HG22 ' HA3' ' A' ' 67' ' ' GLY . 1.2 pt -117.87 134.56 61.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.604 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 23.4 p30 -123.98 133.81 53.61 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.013 -1.055 . . . . 0.0 110.004 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.422 ' O ' ' CG ' ' A' ' 61' ' ' LYS . 17.1 pttp -100.29 120.63 40.22 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.965 0.888 . . . . 0.0 109.992 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.603 ' O ' ' C ' ' A' ' 63' ' ' ALA . 85.6 m -144.05 153.71 42.48 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.603 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -30.71 -43.88 0.05 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.371 -0.83 . . . . 0.0 109.284 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 62' ' ' THR . 0.1 OUTLIER -120.71 22.96 10.99 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.23 -0.919 . . . . 0.0 109.976 179.495 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.713 ' O ' ' CG ' ' A' ' 66' ' ' TYR . . . -128.01 170.03 19.55 Favored Glycine 0 N--CA 1.497 2.741 0 C-N-CA 119.28 -1.438 . . . . 0.0 111.167 -178.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.713 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 97.3 m-85 -168.45 -30.17 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.731 0.777 . . . . 0.0 109.322 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.616 ' HA3' HG22 ' A' ' 59' ' ' ILE . . . 145.43 -163.31 28.19 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 -179.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -67.11 -1.82 4.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.851 -1.382 . . . . 0.0 108.045 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.699 ' HB1' ' HG ' ' A' ' 74' ' ' LEU . . . -49.99 142.32 9.46 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.437 0.636 . . . . 0.0 109.918 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.542 ' H ' HD22 ' A' ' 73' ' ' ASN . 57.0 tt0 -108.03 138.97 20.25 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -39.28 -38.09 1.26 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.828 1.685 . . . . 0.0 111.737 -179.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -64.0 -35.77 81.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.329 -0.857 . . . . 0.0 109.274 179.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.743 ' O ' ' N ' ' A' ' 75' ' ' TYR . 81.0 m-20 -75.93 -82.82 0.07 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.247 -0.908 . . . . 0.0 109.316 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.699 ' HG ' ' HB1' ' A' ' 69' ' ' ALA . 57.8 mt -27.51 82.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.497 0.665 . . . . 0.0 110.085 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.743 ' N ' ' O ' ' A' ' 73' ' ' ASN . 57.7 t80 -64.12 -41.65 97.16 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.417 -0.802 . . . . 0.0 109.632 -179.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.456 ' OG ' ' OE1' ' A' ' 80' ' ' GLU . 83.5 p -162.94 -49.51 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.344 -0.942 . . . . 0.0 111.496 -179.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.0 p -143.08 173.62 11.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.674 -1.266 . . . . 0.0 111.108 -178.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mt -60.25 -35.77 76.26 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.202 0.525 . . . . 0.0 109.928 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.523 ' O ' HG12 ' A' ' 82' ' ' VAL . 71.1 tttt -52.44 -49.07 65.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.019 -1.051 . . . . 0.0 109.923 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.456 ' OE1' ' OG ' ' A' ' 76' ' ' SER . 84.3 mt-10 -74.33 -20.24 60.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.942 -1.099 . . . . 0.0 108.71 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.984 HD21 ' CE2' ' A' ' 85' ' ' TYR . 7.4 tt -67.17 -43.88 81.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.554 -0.716 . . . . 0.0 109.606 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 83' ' ' LEU . 3.0 p -65.17 -43.93 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.077 -1.015 . . . . 0.0 109.027 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.533 ' N ' ' CG1' ' A' ' 82' ' ' VAL . 66.1 tp -67.68 -43.87 79.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.425 -0.797 . . . . 0.0 109.567 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -61.79 -39.97 93.55 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.495 -0.753 . . . . 0.0 110.167 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.984 ' CE2' HD21 ' A' ' 81' ' ' LEU . 5.8 m-30 -63.53 -27.36 69.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.92 -1.112 . . . . 0.0 109.187 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.535 ' HG3' ' HB2' ' A' ' 102' ' ' ALA . 17.6 tt0 -64.69 -35.23 80.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 110.071 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -91.06 -18.32 24.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.105 -0.997 . . . . 0.0 109.726 -179.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.7 m -101.76 122.96 44.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.897 . . . . 0.0 109.33 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.617 ' HA ' HG22 ' A' ' 100' ' ' THR . 20.3 t -72.22 133.95 45.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.326 -0.859 . . . . 0.0 109.026 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.761 ' O ' ' N ' ' A' ' 92' ' ' GLN . 66.2 mt -60.84 -43.85 97.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 111.066 -179.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.698 ' N ' ' O ' ' A' ' 97' ' ' LEU . 74.6 t 18.71 -79.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 CA-C-N 118.436 0.562 . . . . 0.0 109.649 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.761 ' N ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER 73.05 -176.23 0.17 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.378 -0.826 . . . . 0.0 110.854 178.247 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.413 ' H ' ' HG2' ' A' ' 92' ' ' GLN . 82.7 t60 -59.72 -38.88 82.88 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.383 -0.823 . . . . 0.0 109.114 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -55.05 -28.73 54.47 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.442 ' HA ' HG13 ' A' ' 91' ' ' VAL . 97.1 m-20 61.21 36.73 17.83 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.81 -0.556 . . . . 0.0 109.797 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.5 p -138.67 0.49 2.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.865 -1.147 . . . . 0.0 111.153 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.698 ' O ' ' N ' ' A' ' 91' ' ' VAL . 63.4 mt -100.21 61.69 1.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.755 -1.216 . . . . 0.0 107.976 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -80.68 69.3 7.18 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.971 -1.081 . . . . 0.0 109.92 -178.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.764 HG21 HG22 ' A' ' 50' ' ' VAL . 87.2 t -152.99 149.63 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.617 HG22 ' HA ' ' A' ' 89' ' ' SER . 26.1 p -119.81 152.06 37.85 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.288 -0.883 . . . . 0.0 108.863 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.709 HD22 ' CG ' ' A' ' 33' ' ' PHE . 31.9 mt -76.22 69.09 2.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.535 ' HB2' ' HG3' ' A' ' 86' ' ' GLN . . . -100.25 -23.99 14.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.461 -0.774 . . . . 0.0 113.031 -177.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.499 ' HD2' HG23 ' A' ' 32' ' ' THR . 78.2 t80 -114.52 105.66 53.37 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.15 -1.594 . . . . 0.0 110.795 -178.42 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.438 ' CB ' ' O ' ' A' ' 10' ' ' THR . 19.3 Cg_exo -59.75 144.98 99.34 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.976 1.784 . . . . 0.0 111.024 178.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.728 HG13 ' CD2' ' A' ' 106' ' ' TYR . 8.2 p -67.24 -22.6 29.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.024 -1.047 . . . . 0.0 109.279 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.728 ' CD2' HG13 ' A' ' 105' ' ' VAL . 67.5 m-85 -123.79 63.28 1.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.51 -143.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.545 0.688 . . . . 0.0 110.738 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -83.16 -154.85 0.15 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.403 -0.81 . . . . 0.0 109.919 -179.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 63.45 39.49 9.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.719 . . . . 0.0 109.587 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.551 ' O ' ' OXT' ' A' ' 111' ' ' ARG . 12.7 mtm180 -134.28 154.47 51.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.507 -0.745 . . . . 0.0 109.057 179.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.551 ' OXT' ' O ' ' A' ' 110' ' ' ARG . 30.0 ttm-85 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.452 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.317 0.579 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -91.03 123.38 34.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.465 -0.772 . . . . 0.0 109.314 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 24.7 mt -96.1 138.85 21.59 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.967 -1.083 . . . . 0.0 109.242 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.479 ' O ' ' OG1' ' A' ' 10' ' ' THR . 37.1 Cg_endo -69.2 -3.84 12.45 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.288 1.992 . . . . 0.0 111.812 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.411 ' HA ' ' HE1' ' A' ' 11' ' ' TRP . 96.8 m-70 -83.97 -16.26 44.77 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.46 -0.775 . . . . 0.0 109.68 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.43 ' O ' ' NZ ' ' A' ' 79' ' ' LYS . 90.2 m-70 -61.75 -36.49 81.17 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.585 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 54.2 p-10 -106.2 130.11 54.13 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.595 0.712 . . . . 0.0 109.497 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.575 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.7 OUTLIER -70.24 -9.43 55.86 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 109.725 -179.687 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HA ' ' OD1' ' A' ' 12' ' ' ASN . 2.2 ttpt -61.5 -36.93 81.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.603 -0.685 . . . . 0.0 110.864 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.516 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 54.3 p -66.47 -20.07 65.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 112.416 -177.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.561 ' CZ3' ' HG2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -134.43 -12.7 2.38 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 119.965 -1.709 . . . . 0.0 111.168 179.168 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.659 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 19.3 p-10 -95.66 127.06 41.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.588 -1.32 . . . . 0.0 111.571 -178.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.2 m -146.01 34.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.9 -34.43 7.27 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.2 p -66.69 -12.17 57.27 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.143 -1.21 . . . . 0.0 109.508 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.613 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 57.8 m -79.78 142.71 35.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.237 -0.914 . . . . 0.0 110.753 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.696 ' C ' HH12 ' A' ' 36' ' ' ARG . 8.4 p30 -80.13 156.47 26.99 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.416 -0.802 . . . . 0.0 109.609 179.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.833 ' N ' HH22 ' A' ' 36' ' ' ARG . 45.8 mtm180 -63.63 -37.31 86.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.122 -0.986 . . . . 0.0 110.713 -178.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.675 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 46.3 p-10 -57.92 -43.96 86.57 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.431 -1.418 . . . . 0.0 108.689 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.675 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 42.7 tttt -66.24 -31.06 71.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.928 -1.108 . . . . 0.0 108.301 178.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.56 ' HB2' ' NH1' ' A' ' 36' ' ' ARG . . . -60.31 -38.6 84.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.893 . . . . 0.0 108.831 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 26' ' ' ARG . 98.1 mt-10 -59.02 -47.59 84.65 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -60.19 -43.45 95.9 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.487 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 99.1 mt -66.18 -36.66 83.68 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.614 HD23 HG23 ' A' ' 49' ' ' VAL . 10.3 mt -89.2 -7.52 55.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.843 . . . . 0.0 109.513 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 22' ' ' GLU . 14.6 mmm180 -96.37 -25.94 15.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.99 -1.069 . . . . 0.0 109.691 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.09 10.31 56.83 Favored Glycine 0 C--N 1.288 -2.12 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 178.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.816 ' CD ' HG21 ' A' ' 32' ' ' THR . 7.7 mmpt? -114.53 141.33 47.87 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.428 -1.042 . . . . 0.0 110.568 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.93 168.42 15.03 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.491 0.663 . . . . 0.0 110.042 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.539 ' OD1' ' CG2' ' A' ' 99' ' ' VAL . 67.6 t0 -56.28 141.95 39.5 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.39 -0.819 . . . . 0.0 109.709 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.495 ' N ' ' OD1' ' A' ' 30' ' ' ASP . . . 107.64 -31.85 7.66 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.816 HG21 ' CD ' ' A' ' 28' ' ' LYS . 97.4 m -86.37 127.41 34.81 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.166 -1.196 . . . . 0.0 109.539 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.751 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -139.46 172.45 12.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.63 -1.294 . . . . 0.0 109.806 178.896 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.655 ' HB3' HG11 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -139.51 169.24 18.11 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.66 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.561 HG22 ' SG ' ' A' ' 46' ' ' CYS . 71.5 t -120.17 132.94 68.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 -179.587 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.833 HH22 ' N ' ' A' ' 18' ' ' ARG . 40.7 mtp180 -144.01 -156.8 0.72 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.367 -0.833 . . . . 0.0 108.976 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.667 ' C ' ' H ' ' A' ' 39' ' ' SER . 63.9 mm-40 -108.26 172.74 6.66 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.51 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.673 ' O ' ' CB ' ' A' ' 39' ' ' SER . 82.6 p -76.16 12.71 1.08 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.673 ' CB ' ' O ' ' A' ' 38' ' ' SER . 19.0 t 111.06 127.83 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.958 -1.473 . . . . 0.0 108.261 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt 60.96 -148.78 0.42 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.445 ' N ' ' CD ' ' A' ' 41' ' ' GLN . 27.3 mp0 -109.05 143.18 38.71 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.198 -0.939 . . . . 0.0 109.656 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.99 -61.65 0.39 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.332 179.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 75.4 m -130.81 -176.12 3.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -1.085 . . . . 0.0 109.546 -179.529 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 59' ' ' ILE . 58.7 m-85 -118.24 154.22 32.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.839 . . . . 0.0 109.886 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -159.21 135.13 8.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 109.032 178.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 59' ' ' ILE . 4.6 m -115.16 139.98 49.46 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.516 ' OG ' ' CD1' ' A' ' 25' ' ' LEU . 46.4 t -108.21 133.39 52.52 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.941 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.585 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.6 p -129.74 157.67 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 121.905 0.86 . . . . 0.0 110.307 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.614 HG23 HD23 ' A' ' 25' ' ' LEU . 89.4 t -99.45 134.82 37.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.75 HG22 HG11 ' A' ' 99' ' ' VAL . 75.7 t -121.29 150.52 24.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.725 -1.235 . . . . 0.0 109.793 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -46.97 -18.8 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.813 0.816 . . . . 0.0 109.757 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -92.35 -56.25 1.59 Allowed Glycine 0 C--N 1.283 -2.405 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -164.04 -176.47 4.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -1.155 . . . . 0.0 110.444 -179.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.416 HG22 HG22 ' A' ' 49' ' ' VAL . 53.9 t -87.49 135.85 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.203 -0.936 . . . . 0.0 108.764 178.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.47 ' HZ2' HG21 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -133.22 157.53 45.16 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.004 -1.06 . . . . 0.0 111.318 -178.837 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -113.19 97.53 6.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.6 m -71.53 141.71 50.11 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.65 134.12 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.867 -1.146 . . . . 0.0 112.46 -177.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.675 HD11 ' SG ' ' A' ' 46' ' ' CYS . 96.1 mt -105.72 139.71 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 177.489 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.631 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 33.0 m120 -124.22 134.14 53.34 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.368 -1.457 . . . . 0.0 111.976 -177.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -107.34 121.75 45.2 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.585 0.707 . . . . 0.0 109.494 178.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.639 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 32.3 p -130.63 176.87 7.82 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -45.05 -30.69 1.12 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.42 -0.8 . . . . 0.0 109.391 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.3 t -144.04 7.56 1.4 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.185 -0.947 . . . . 0.0 109.125 179.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.639 ' N ' ' OG1' ' A' ' 62' ' ' THR . . . -93.26 -170.65 39.59 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.631 ' CA ' ' O ' ' A' ' 60' ' ' ASN . 0.4 OUTLIER 178.1 -26.13 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.429 -1.042 . . . . 0.0 109.162 179.903 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.96 -145.11 7.43 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.2 m-30 -52.48 146.21 10.18 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.82 -1.4 . . . . 0.0 108.313 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.58 27.37 4.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.593 -1.317 . . . . 0.0 110.265 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.718 ' H ' ' CD ' ' A' ' 71' ' ' PRO . 12.7 tp10 -107.26 -35.61 0.17 Allowed Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 120.73 -1.232 . . . . 0.0 109.593 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.718 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 56.5 Cg_endo -87.65 -30.62 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.414 2.076 . . . . 0.0 113.044 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.467 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 44.9 p90 -154.38 160.19 41.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.967 . . . . 0.0 110.037 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 73' ' ' ASN . 6.5 p-10 -106.38 105.6 15.71 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.9 tp 49.42 95.69 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.188 -0.945 . . . . 0.0 111.007 178.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.72 ' CZ ' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -56.11 153.54 8.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.025 -1.047 . . . . 0.0 109.296 178.847 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.4 p -58.83 -40.4 84.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -0.846 . . . . 0.0 110.8 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.7 m -149.21 159.52 44.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.897 -1.127 . . . . 0.0 110.176 -179.172 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.529 HD21 ' HE1' ' A' ' 66' ' ' TYR . 71.0 mt -62.68 -32.71 73.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.425 -0.797 . . . . 0.0 109.523 179.424 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.43 ' NZ ' ' O ' ' A' ' 6' ' ' HIS . 17.6 mtpp -60.09 -42.38 94.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.209 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -65.71 -28.89 69.39 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.754 HD23 ' O ' ' A' ' 81' ' ' LEU . 6.7 tt -58.33 -46.44 86.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.629 -0.669 . . . . 0.0 110.006 -179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.531 HG21 ' CE3' ' A' ' 11' ' ' TRP . 81.0 t -73.72 -41.96 54.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.942 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.429 HD23 HE22 ' A' ' 86' ' ' GLN . 68.6 mt -65.39 -43.88 89.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.375 -0.828 . . . . 0.0 109.79 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.531 ' O ' ' OG1' ' A' ' 88' ' ' THR . 58.8 t-80 -62.24 -42.08 99.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.011 -1.056 . . . . 0.0 110.146 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.411 ' HA ' ' OG1' ' A' ' 88' ' ' THR . 5.6 m-85 -70.22 -27.79 64.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 111.171 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.503 ' HG2' ' N ' ' A' ' 87' ' ' HIS . 0.4 OUTLIER -64.6 -32.76 74.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.651 -1.28 . . . . 0.0 109.368 -179.118 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.503 ' N ' ' HG2' ' A' ' 86' ' ' GLN . 43.4 m170 -89.78 -30.1 18.22 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.268 -0.895 . . . . 0.0 109.083 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 84' ' ' HIS . 2.9 p -95.52 140.52 30.25 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.42 -0.8 . . . . 0.0 110.127 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.6 p -80.23 140.16 36.38 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.691 -0.63 . . . . 0.0 109.817 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.689 ' O ' ' C ' ' A' ' 91' ' ' VAL . 7.9 mp -67.32 -26.98 66.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 110.549 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.747 ' N ' ' O ' ' A' ' 97' ' ' LEU . 95.9 t -1.75 -67.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 CA-C-O 121.62 0.724 . . . . 0.0 110.056 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.675 ' N ' ' O ' ' A' ' 90' ' ' LEU . 32.8 mm-40 35.15 -123.91 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.485 0.659 . . . . 0.0 111.175 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 95' ' ' ASP . 19.1 p80 -71.55 165.65 23.46 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.475 -0.766 . . . . 0.0 109.862 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.654 ' O ' ' N ' ' A' ' 96' ' ' SER . 9.2 m120 61.89 2.86 0.81 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 94' ' ' ASN . 94.9 m-20 33.37 28.65 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.746 -0.596 . . . . 0.0 109.592 179.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.654 ' N ' ' O ' ' A' ' 94' ' ' ASN . 80.1 p -130.02 3.28 4.83 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.852 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.747 ' O ' ' N ' ' A' ' 91' ' ' VAL . 87.2 mt -83.31 56.75 3.67 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.553 -1.342 . . . . 0.0 107.723 178.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.41 90.22 4.42 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.082 0.944 . . . . 0.0 109.53 -179.275 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.75 HG11 HG22 ' A' ' 50' ' ' VAL . 4.2 p -169.48 159.13 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.502 ' N ' HG22 ' A' ' 99' ' ' VAL . 66.7 p -128.06 151.52 49.08 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.19 -0.944 . . . . 0.0 109.984 -179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.751 HD22 ' CG ' ' A' ' 33' ' ' PHE . 32.4 mt -84.46 65.72 9.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.02 -1.05 . . . . 0.0 108.425 179.438 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -94.4 -22.6 18.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.387 -0.821 . . . . 0.0 112.519 -177.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -118.09 112.19 38.24 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.111 -1.618 . . . . 0.0 111.071 -178.676 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.455 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 33.1 Cg_exo -58.0 143.87 95.48 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.492 2.128 . . . . 0.0 111.406 177.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.655 HG11 ' HB3' ' A' ' 34' ' ' LEU . 11.6 p -71.88 -27.67 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.064 -1.022 . . . . 0.0 109.614 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.424 ' HD1' HG13 ' A' ' 105' ' ' VAL . 3.2 m-85 -114.05 29.28 8.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.194 -0.941 . . . . 0.0 109.769 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.455 ' HB2' ' HB2' ' A' ' 104' ' ' PRO . . . -60.89 130.59 47.24 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.108 -0.995 . . . . 0.0 109.525 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -119.72 147.22 44.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 109.212 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -98.67 134.65 41.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.956 -1.09 . . . . 0.0 109.56 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -66.0 -39.54 90.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.315 -0.866 . . . . 0.0 110.375 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 0.0 109.831 -179.211 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.494 ' OE1' ' N ' ' A' ' 1' ' ' GLU . 58.7 mp0 . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -114.88 33.01 5.64 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.603 -0.685 . . . . 0.0 109.656 179.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.707 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.5 mm? -70.9 148.16 94.47 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 121.497 -0.752 . . . . 0.0 109.674 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' CB ' HG21 ' A' ' 10' ' ' THR . 38.3 Cg_endo -69.35 -2.04 9.19 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.683 2.255 . . . . 0.0 112.301 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.763 ' CD2' HD21 ' A' ' 83' ' ' LEU . 91.6 m-70 -73.6 -24.52 60.06 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.37 -0.831 . . . . 0.0 110.028 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -60.3 -34.03 73.2 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.215 -0.928 . . . . 0.0 108.791 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.684 ' OD2' ' NZ ' ' A' ' 9' ' ' LYS . 99.9 m-20 -109.02 119.06 38.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.093 -1.005 . . . . 0.0 109.91 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 12' ' ' ASN . 94.6 mt-10 -65.16 -16.37 63.43 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.684 ' NZ ' ' OD2' ' A' ' 7' ' ' ASP . 26.2 pttt -59.71 -37.48 78.99 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.17 -0.956 . . . . 0.0 110.396 -179.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.681 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 23.3 p -55.79 -35.97 66.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.512 -0.743 . . . . 0.0 110.212 -179.263 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.681 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -121.59 -33.01 3.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.77 -1.206 . . . . 0.0 110.723 179.634 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 8' ' ' GLU . 64.0 t30 -83.08 128.18 34.25 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.02 -1.05 . . . . 0.0 111.366 -178.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.741 ' O ' ' N ' ' A' ' 16' ' ' SER . 24.0 m -139.7 30.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.567 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -24.78 -45.23 0.01 OUTLIER Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 13' ' ' VAL . 81.5 p -51.69 -16.78 0.71 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.547 -0.972 . . . . 0.0 108.807 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.741 ' N ' ' O ' ' A' ' 13' ' ' VAL . 89.1 p -70.0 159.49 33.69 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.692 0.758 . . . . 0.0 110.011 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.528 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 79.6 m-20 -122.98 165.16 17.2 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -59.75 -43.35 94.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.641 -1.287 . . . . 0.0 109.312 -179.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -64.47 -42.98 95.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 108.622 179.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.528 ' HB3' ' H ' ' A' ' 17' ' ' ASN . 21.1 ttmm -69.07 -35.52 76.61 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.51 74.85 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 26' ' ' ARG . 88.0 tt0 -57.78 -47.2 83.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.935 -1.103 . . . . 0.0 108.741 179.195 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -60.03 -43.81 95.07 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.429 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 89.8 mt -67.71 -27.59 66.95 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.569 HD11 ' OG ' ' A' ' 47' ' ' SER . 12.0 mt -94.28 -5.43 46.76 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.314 -0.866 . . . . 0.0 109.239 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.68 HH11 ' HG2' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -94.04 123.87 37.69 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.784 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.06 4.52 74.65 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 24' ' ' LEU . 24.2 mmtm -99.91 134.74 42.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.101 -1.235 . . . . 0.0 109.811 179.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -69.94 159.72 33.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.518 -0.739 . . . . 0.0 109.615 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.67 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 88.3 m-20 -59.72 147.32 38.2 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.635 0.731 . . . . 0.0 110.039 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.63 -22.89 37.85 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -179.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 67.6 m -81.37 114.02 19.86 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.294 -1.121 . . . . 0.0 108.831 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -132.21 170.49 14.95 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.086 -179.475 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.68 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 1.9 pp -147.37 157.88 43.75 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.56 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.521 HG22 ' SG ' ' A' ' 46' ' ' CYS . 48.3 t -103.9 128.5 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.156 -0.965 . . . . 0.0 108.443 178.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.713 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -144.02 173.85 11.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 108.823 -179.364 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.7 ' C ' ' H ' ' A' ' 39' ' ' SER . 6.0 tt0 -106.96 164.11 12.41 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 120.827 -1.171 . . . . 0.0 108.382 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.548 ' C ' ' H ' ' A' ' 40' ' ' LYS . 53.6 m -75.83 30.09 0.11 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.7 ' H ' ' C ' ' A' ' 37' ' ' GLU . 68.8 m 67.19 -11.92 0.26 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.08 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.588 ' O ' ' CD ' ' A' ' 37' ' ' GLU . 61.4 tttt -91.42 120.59 32.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.54 -0.725 . . . . 0.0 109.73 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -47.67 126.08 9.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.996 -1.065 . . . . 0.0 110.677 -179.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.31 4.42 66.37 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.66 178.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.541 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 52.8 t -111.58 151.31 28.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.848 -1.383 . . . . 0.0 108.018 178.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.588 ' O ' ' O ' ' A' ' 59' ' ' ILE . 92.8 m-85 -130.13 151.87 50.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.901 -1.125 . . . . 0.0 109.92 -179.01 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.576 ' HB1' HH12 ' A' ' 36' ' ' ARG . . . -162.54 133.83 5.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.858 -1.152 . . . . 0.0 109.544 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.521 ' SG ' HG22 ' A' ' 35' ' ' VAL . 60.0 m -108.18 130.64 55.12 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.569 ' OG ' HD11 ' A' ' 25' ' ' LEU . 32.9 t -108.18 134.5 50.95 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.196 -0.94 . . . . 0.0 109.953 -178.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.586 HG22 ' N ' ' A' ' 49' ' ' VAL . 9.2 p -133.58 167.72 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.21 -0.931 . . . . 0.0 110.278 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.586 ' N ' HG22 ' A' ' 48' ' ' VAL . 40.3 t -121.23 133.69 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.609 -0.682 . . . . 0.0 109.667 179.522 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.798 HG12 ' HZ2' ' A' ' 55' ' ' LYS . 7.3 p -127.61 160.29 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.076 -1.015 . . . . 0.0 109.968 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.67 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 54.5 m-20 -50.21 -20.35 1.01 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.712 0.768 . . . . 0.0 110.078 -179.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.63 ' H ' HG13 ' A' ' 50' ' ' VAL . . . -83.81 -58.68 2.2 Favored Glycine 0 C--N 1.285 -2.253 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.807 ' H ' ' NZ ' ' A' ' 55' ' ' LYS . 1.3 tt0 -167.07 -165.09 0.67 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.292 -1.122 . . . . 0.0 111.322 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.564 ' CG1' HD13 ' A' ' 25' ' ' LEU . 84.3 t -97.59 123.8 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.485 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.807 ' NZ ' ' H ' ' A' ' 53' ' ' GLU . 11.5 mptt -118.95 152.48 36.27 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.465 -1.397 . . . . 0.0 110.941 -179.334 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -115.16 112.64 22.84 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 46' ' ' CYS . 49.1 t -88.21 124.74 34.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.077 -1.014 . . . . 0.0 108.536 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 58' ' ' VAL . 4.8 p -101.07 122.64 53.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.079 -1.013 . . . . 0.0 110.906 -178.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 66' ' ' TYR . 88.6 mt -116.57 137.96 48.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.682 ' O ' ' N ' ' A' ' 67' ' ' GLY . 50.7 t30 -132.97 144.73 50.31 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.566 -1.334 . . . . 0.0 111.511 -178.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -95.16 96.02 8.93 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.447 -0.783 . . . . 0.0 108.993 179.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.6 p -151.12 -134.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.83 . . . . 0.0 109.256 -179.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.9 -32.78 61.4 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.659 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 46.1 p -93.67 -2.6 53.74 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.562 -0.711 . . . . 0.0 109.332 179.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.628 ' O ' ' CG ' ' A' ' 66' ' ' TYR . . . 54.53 4.27 0.36 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.672 ' O ' HG23 ' A' ' 59' ' ' ILE . 91.8 m-85 -160.38 5.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.957 -1.319 . . . . 0.0 109.398 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.682 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 53.68 -91.73 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 107.824 -2.111 . . . . 0.0 107.824 -179.246 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.599 ' CE2' ' OH ' ' A' ' 85' ' ' TYR . 5.2 t80 -63.91 117.25 6.71 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.302 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.568 ' O ' ' O ' ' A' ' 70' ' ' GLU . . . 177.27 27.63 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.267 -0.896 . . . . 0.0 109.512 -178.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.568 ' O ' ' O ' ' A' ' 69' ' ' ALA . 99.5 mt-10 56.75 153.26 0.07 OUTLIER Pre-proline 0 C--N 1.304 -1.392 0 C-N-CA 119.541 -0.864 . . . . 0.0 108.813 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.38 -22.25 0.34 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.364 2.043 . . . . 0.0 111.817 179.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.488 ' O ' ' O ' ' A' ' 69' ' ' ALA . 99.8 m-85 -110.22 134.26 52.41 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 64' ' ' THR . 11.2 m120 -82.27 107.66 15.12 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.151 -0.968 . . . . 0.0 109.237 -179.42 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 79.8 mt -111.07 4.22 19.24 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.397 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.708 ' CD2' ' CD1' ' A' ' 81' ' ' LEU . 4.7 m-30 -94.93 133.44 38.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.048 -1.033 . . . . 0.0 109.394 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.415 ' O ' ' OH ' ' A' ' 66' ' ' TYR . 86.4 p -94.6 -44.8 7.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.525 -0.734 . . . . 0.0 111.326 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.539 ' OG ' ' OE2' ' A' ' 80' ' ' GLU . 84.5 p -155.6 165.7 35.78 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.817 -1.177 . . . . 0.0 110.301 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.4 -43.77 98.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.417 -0.802 . . . . 0.0 110.879 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.459 ' O ' HG12 ' A' ' 82' ' ' VAL . 19.9 tttt -60.86 -39.75 90.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.755 -1.215 . . . . 0.0 108.707 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.614 ' N ' ' OE1' ' A' ' 80' ' ' GLU . 0.3 OUTLIER -73.43 -40.03 64.55 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.177 -0.952 . . . . 0.0 109.383 179.006 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.708 ' CD1' ' CD2' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -59.9 -49.51 77.4 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.839 -0.538 . . . . 0.0 110.599 -178.373 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 83' ' ' LEU . 4.3 p -59.76 -44.22 93.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.913 -1.117 . . . . 0.0 108.495 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.763 HD21 ' CD2' ' A' ' 5' ' ' HIS . 91.2 mt -61.69 -45.39 94.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.208 -0.932 . . . . 0.0 111.273 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -61.25 -40.39 93.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.756 -1.215 . . . . 0.0 110.001 -178.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.812 ' HB3' HD13 ' A' ' 101' ' ' LEU . 22.4 m-85 -71.41 -26.75 62.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.249 -0.907 . . . . 0.0 111.311 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.595 ' OE1' ' O ' ' A' ' 101' ' ' LEU . 2.2 mt-30 -65.01 -33.65 76.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.662 -1.274 . . . . 0.0 109.163 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -96.76 -19.28 19.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.013 -1.054 . . . . 0.0 110.753 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.4 m -99.53 131.18 45.7 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.804 -1.185 . . . . 0.0 109.726 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.3 p -74.97 135.65 41.34 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.514 0.673 . . . . 0.0 109.939 -179.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.743 ' O ' ' N ' ' A' ' 92' ' ' GLN . 0.6 OUTLIER -61.74 -43.7 98.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.531 -0.731 . . . . 0.0 110.627 -179.679 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.757 ' N ' ' O ' ' A' ' 97' ' ' LEU . 72.0 t 26.79 -84.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.743 ' N ' ' O ' ' A' ' 90' ' ' LEU . 18.0 tt0 77.32 -179.51 0.14 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.787 178.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.497 ' H ' ' HG2' ' A' ' 92' ' ' GLN . 81.6 t60 -56.08 -39.84 72.72 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.58 ' C ' HD22 ' A' ' 94' ' ' ASN . 0.2 OUTLIER -50.44 -28.3 8.01 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.178 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 60.1 t0 63.88 24.36 13.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.78 -0.575 . . . . 0.0 110.309 178.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 68.9 m -136.91 10.89 3.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.03 -1.044 . . . . 0.0 110.167 179.636 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.757 ' O ' ' N ' ' A' ' 91' ' ' VAL . 87.1 mt -99.78 50.96 0.92 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.582 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 42.1 p30 -77.43 60.09 1.99 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.501 -0.749 . . . . 0.0 110.646 -178.397 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.667 ' HB ' HG23 ' A' ' 50' ' ' VAL . 7.6 p -133.98 162.96 38.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.548 ' N ' HG22 ' A' ' 99' ' ' VAL . 82.3 p -125.06 168.87 12.77 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.312 1.053 . . . . 0.0 110.611 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.812 HD13 ' HB3' ' A' ' 85' ' ' TYR . 6.9 mp -98.17 33.41 2.18 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.427 ' HA ' ' NE2' ' A' ' 86' ' ' GLN . . . -74.39 -15.49 60.92 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.64 -0.663 . . . . 0.0 112.13 -178.093 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 32' ' ' THR . 96.8 m-85 -114.91 108.48 48.57 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.249 -1.532 . . . . 0.0 111.339 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.54 145.65 95.41 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.257 1.971 . . . . 0.0 110.845 177.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.5 -33.07 61.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.896 -1.128 . . . . 0.0 109.335 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -122.69 50.46 1.5 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.018 -1.051 . . . . 0.0 110.067 179.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.5 141.09 58.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 109.592 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -57.36 134.97 56.46 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 108.832 179.327 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -80.71 146.22 31.18 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -124.06 156.52 36.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.352 -0.842 . . . . 0.0 109.411 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.671 179.948 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.55 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 46.4 p30 -66.71 150.94 48.35 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.13 -0.981 . . . . 0.0 109.336 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.5 mt -104.56 120.24 51.09 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.433 -0.792 . . . . 0.0 109.205 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HB3' HG21 ' A' ' 10' ' ' THR . 16.5 Cg_exo -57.33 -9.33 4.75 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.745 1.63 . . . . 0.0 111.55 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.46 ' CB ' HD21 ' A' ' 83' ' ' LEU . 82.6 m-70 -60.44 -29.15 68.83 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.607 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -68.0 -23.03 64.97 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.696 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 83.7 m-20 -90.05 120.64 31.41 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.388 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 12' ' ' ASN . 45.0 tt0 -67.63 -30.67 70.29 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.393 -0.817 . . . . 0.0 110.294 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.597 ' CE ' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -63.36 -31.71 72.93 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.264 -0.898 . . . . 0.0 111.573 -178.805 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -66.49 -29.66 69.82 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.226 -0.921 . . . . 0.0 111.641 -177.044 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.696 ' NE1' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -123.02 -8.44 8.3 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.652 -1.28 . . . . 0.0 110.585 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 8' ' ' GLU . 13.5 t-20 -97.92 118.3 34.19 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.1 -1.0 . . . . 0.0 110.629 -178.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 16' ' ' SER . 10.2 m -140.46 27.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.489 -0.757 . . . . 0.0 109.179 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 13' ' ' VAL . . . -41.32 -30.56 0.49 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.391 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.8 t -59.84 -34.58 73.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -1.076 . . . . 0.0 108.827 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 13' ' ' VAL . 70.1 m -60.48 142.2 55.48 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.584 0.707 . . . . 0.0 110.654 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -79.9 162.44 24.99 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.624 0.726 . . . . 0.0 109.568 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.524 ' CB ' HH12 ' A' ' 36' ' ' ARG . 22.9 ttp180 -57.31 -44.9 84.55 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.89 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -39.34 91.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.149 -0.969 . . . . 0.0 108.713 179.064 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -63.78 -27.74 69.39 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.381 0.61 . . . . 0.0 109.46 179.529 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.55 96.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.905 . . . . 0.0 109.672 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 26' ' ' ARG . 96.3 mt-10 -60.57 -41.23 94.18 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -60.37 -41.61 94.11 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' CD ' ' A' ' 28' ' ' LYS . 77.0 mt -67.26 -29.36 68.96 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.433 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -89.74 -14.11 35.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.351 -0.843 . . . . 0.0 108.933 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 22' ' ' GLU . 5.1 mtp180 -88.37 129.88 35.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.502 -0.749 . . . . 0.0 110.882 -179.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.27 3.27 90.2 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.498 ' CD ' ' O ' ' A' ' 24' ' ' LEU . 12.3 mtpt -103.56 131.08 51.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.282 -1.128 . . . . 0.0 110.359 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.733 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.1 OUTLIER -60.56 147.37 41.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 110.348 -179.115 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.559 ' OD2' ' OD1' ' A' ' 51' ' ' ASP . 65.1 m-20 -50.1 151.93 1.84 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.75 -37.93 3.46 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.419 HG21 ' CE ' ' A' ' 28' ' ' LYS . 88.4 m -68.14 128.28 35.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.43 -1.041 . . . . 0.0 109.151 179.742 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.722 ' CE2' HD23 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -139.04 161.8 36.48 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.856 179.968 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.68 ' CB ' HG11 ' A' ' 105' ' ' VAL . 0.7 OUTLIER -137.29 162.86 32.4 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.547 0.689 . . . . 0.0 110.167 -179.498 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 11' ' ' TRP . 90.6 t -118.12 131.14 71.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.524 HH12 ' CB ' ' A' ' 18' ' ' ARG . 11.0 ptm180 -135.56 -176.0 4.13 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 109.584 -179.226 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.632 ' C ' ' H ' ' A' ' 39' ' ' SER . 10.4 pt-20 -100.07 166.59 10.95 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.553 ' O ' ' CB ' ' A' ' 39' ' ' SER . 24.9 m -75.84 8.53 3.01 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 177.524 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.632 ' H ' ' C ' ' A' ' 37' ' ' GLU . 11.6 m 96.9 -99.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.099 -1.409 . . . . 0.0 110.054 178.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -91.01 -5.45 55.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.826 -1.171 . . . . 0.0 110.577 -179.149 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.631 ' O ' ' N ' ' A' ' 43' ' ' CYS . 98.7 mt-30 -96.03 137.03 35.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.99 -1.068 . . . . 0.0 110.461 -179.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.87 36.61 0.06 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.631 ' N ' ' O ' ' A' ' 41' ' ' GLN . 77.8 m -112.89 159.76 18.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.304 . . . . 0.0 110.012 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.457 ' O ' ' N ' ' A' ' 59' ' ' ILE . 96.8 m-85 -120.62 149.88 41.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.359 -0.838 . . . . 0.0 109.152 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.487 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -139.39 135.06 33.28 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.563 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.729 ' SG ' HD11 ' A' ' 59' ' ' ILE . 28.9 p -107.92 124.88 50.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.235 -0.916 . . . . 0.0 108.8 179.36 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.7 p -109.63 139.67 44.37 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.531 -0.731 . . . . 0.0 110.275 -179.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 49' ' ' VAL . 7.8 p -129.26 159.73 40.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.275 -0.891 . . . . 0.0 109.787 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.503 ' N ' HG22 ' A' ' 48' ' ' VAL . 39.4 t -96.6 134.13 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.897 HG12 ' H ' ' A' ' 52' ' ' GLY . 62.0 t -125.44 145.61 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.758 -1.214 . . . . 0.0 110.561 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.559 ' OD1' ' OD2' ' A' ' 30' ' ' ASP . 15.1 m-20 -44.15 -20.42 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.897 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -90.17 -59.87 1.44 Allowed Glycine 0 C--N 1.291 -1.948 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.581 ' CG ' ' O ' ' A' ' 52' ' ' GLY . 70.0 mt-10 -162.18 169.64 20.45 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.952 -1.322 . . . . 0.0 110.312 -178.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.0 m -65.33 138.51 23.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.52 ' HZ2' ' HB2' ' A' ' 53' ' ' GLU . 16.6 mmtm -116.3 140.66 49.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.629 -1.294 . . . . 0.0 111.966 -178.053 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -115.3 96.77 5.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 46' ' ' CYS . 80.2 m -99.49 122.12 42.12 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.083 -1.011 . . . . 0.0 108.92 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.9 t -76.89 140.01 17.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.553 0.692 . . . . 0.0 110.545 -179.278 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.729 HD11 ' SG ' ' A' ' 46' ' ' CYS . 47.2 mm -108.96 129.96 62.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.574 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 8.4 m120 -116.66 108.16 15.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.168 -0.958 . . . . 0.0 110.084 -179.109 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -96.4 117.94 31.9 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.393 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.67 ' OG1' ' N ' ' A' ' 65' ' ' GLY . 62.5 p -147.22 170.09 17.98 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.332 -0.855 . . . . 0.0 108.738 179.328 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.51 -39.15 70.12 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.064 -1.023 . . . . 0.0 109.669 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.0 m -115.59 -12.78 11.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.129 -0.982 . . . . 0.0 110.718 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.67 ' N ' ' OG1' ' A' ' 62' ' ' THR . . . -93.45 -170.39 39.21 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 119.906 -1.14 . . . . 0.0 110.676 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.574 ' CA ' ' O ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER 175.22 -167.18 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.595 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.504 ' HA3' HD11 ' A' ' 81' ' ' LEU . . . -50.94 -48.56 45.06 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.564 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.771 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 54.9 m-85 -111.22 -17.71 13.13 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.572 -0.957 . . . . 0.0 108.984 178.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 56.09 36.9 28.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.462 -0.774 . . . . 0.0 111.323 179.119 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.703 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 97.8 mt-10 -102.88 137.37 19.27 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.92 -1.113 . . . . 0.0 108.811 179.536 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -39.79 -17.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.747 2.298 . . . . 0.0 113.072 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 70' ' ' GLU . 94.5 m-85 -90.17 -2.69 58.1 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.899 -1.125 . . . . 0.0 110.219 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.792 ' ND2' ' N ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -106.2 -111.29 0.28 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.225 -0.922 . . . . 0.0 109.307 -179.835 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.792 ' N ' ' ND2' ' A' ' 73' ' ' ASN . 90.5 mt 60.02 29.54 19.1 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.762 -1.211 . . . . 0.0 110.025 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.736 ' CE1' ' NE2' ' A' ' 84' ' ' HIS . 80.1 m-85 -57.19 151.79 14.92 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.171 -0.956 . . . . 0.0 109.0 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 96.0 p -66.67 -30.34 70.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.433 -0.792 . . . . 0.0 111.712 -177.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 t -139.71 155.87 47.11 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.716 -1.24 . . . . 0.0 111.338 -178.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 81' ' ' LEU . 89.6 mt -62.08 -34.71 76.8 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.465 -0.772 . . . . 0.0 109.516 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 78' ' ' LEU . 87.3 mttt -47.74 -42.04 24.46 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 65.6 mt-10 -64.87 -37.31 87.19 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.723 HD23 ' C ' ' A' ' 81' ' ' LEU . 8.2 tt -59.63 -42.62 93.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.566 -0.709 . . . . 0.0 110.164 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.8 t -65.77 -44.97 92.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.99 -1.069 . . . . 0.0 109.467 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.46 HD21 ' CB ' ' A' ' 5' ' ' HIS . 81.2 mt -68.34 -39.02 82.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.395 -0.816 . . . . 0.0 111.274 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.736 ' NE2' ' CE1' ' A' ' 75' ' ' TYR . 52.8 m80 -64.66 -42.43 95.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.016 -1.052 . . . . 0.0 110.192 -178.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.771 ' CZ ' ' CD2' ' A' ' 68' ' ' PHE . 7.1 m-30 -73.83 -16.68 61.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.857 -1.152 . . . . 0.0 109.34 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -67.81 -35.87 79.4 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.282 -0.886 . . . . 0.0 109.234 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 84' ' ' HIS . 22.8 p-80 -92.61 -22.66 19.35 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.267 -0.896 . . . . 0.0 109.664 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.8 m -92.41 128.42 38.26 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.134 -0.979 . . . . 0.0 109.386 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.584 ' HA ' HG22 ' A' ' 100' ' ' THR . 24.6 p -77.67 131.58 37.8 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.437 -0.79 . . . . 0.0 109.665 -179.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.524 ' O ' ' C ' ' A' ' 91' ' ' VAL . 98.9 mt -69.74 -17.46 63.45 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.498 -0.751 . . . . 0.0 110.024 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.749 ' N ' ' O ' ' A' ' 97' ' ' LEU . 9.7 p -31.99 -46.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 121.205 -0.934 . . . . 0.0 110.382 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.649 ' N ' HG13 ' A' ' 91' ' ' VAL . 18.1 tt0 -43.97 -27.68 0.39 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.227 0.537 . . . . 0.0 110.128 -179.388 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.554 ' NE2' ' CE1' ' A' ' 68' ' ' PHE . 94.5 m-70 -81.66 119.54 23.95 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.005 -1.059 . . . . 0.0 108.189 178.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 11.3 m120 61.42 2.61 0.67 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.64 -0.663 . . . . 0.0 109.507 -179.244 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.59 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 66.7 t0 57.44 23.65 9.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.551 -0.718 . . . . 0.0 110.349 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.9 m -140.68 11.35 2.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.81 -1.181 . . . . 0.0 109.688 179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.749 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.8 mm? -97.93 66.2 1.85 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.913 -1.117 . . . . 0.0 108.679 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.836 ' O ' HG23 ' A' ' 99' ' ' VAL . 16.5 p30 -79.16 78.86 5.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.938 -1.101 . . . . 0.0 110.37 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 98' ' ' ASN . 40.8 t -166.38 154.26 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.522 -0.736 . . . . 0.0 109.816 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 89' ' ' SER . 70.8 p -130.53 164.29 25.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.893 . . . . 0.0 109.452 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.85 ' N ' HD12 ' A' ' 101' ' ' LEU . 4.2 mp -79.17 67.31 4.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -92.16 -22.76 19.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 111.519 -178.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.65 137.94 28.65 Favored Pre-proline 0 C--N 1.307 -1.277 0 O-C-N 120.713 -1.242 . . . . 0.0 111.006 -178.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.459 ' HB2' HG22 ' A' ' 10' ' ' THR . 93.3 Cg_endo -78.09 157.23 30.32 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.277 2.652 . . . . 0.0 111.582 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.68 HG11 ' CB ' ' A' ' 34' ' ' LEU . 12.2 p -92.76 -27.68 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.345 -0.847 . . . . 0.0 112.089 -178.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 73.1 t80 -132.52 64.99 1.6 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.411 -1.431 . . . . 0.0 111.87 -178.069 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.682 ' HB2' HG22 ' A' ' 10' ' ' THR . . . -89.69 140.56 29.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.058 -1.026 . . . . 0.0 109.006 178.156 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.407 ' O ' ' HG3' ' A' ' 108' ' ' GLN . 21.4 pt20 -61.71 136.78 58.13 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.954 -1.091 . . . . 0.0 109.849 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -100.51 -9.04 22.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 108.844 179.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -76.83 130.31 37.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.498 -0.751 . . . . 0.0 109.818 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 . . . . . 0 C--N 1.301 -1.521 0 CA-C-O 117.911 -1.042 . . . . 0.0 109.033 179.514 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.484 ' HB2' ' ND1' ' A' ' 6' ' ' HIS . 58.0 p30 -76.76 170.06 17.16 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.5 mt -91.5 136.26 26.97 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.864 -1.147 . . . . 0.0 109.702 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -49.06 -19.54 2.52 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.888 2.392 . . . . 0.0 111.659 178.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 83' ' ' LEU . 85.1 m-70 -65.11 -17.01 64.11 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.655 0.741 . . . . 0.0 109.438 -178.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.484 ' ND1' ' HB2' ' A' ' 2' ' ' ASP . 38.2 m170 -64.98 -36.76 85.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.503 -0.748 . . . . 0.0 109.57 178.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -96.79 129.55 44.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 110.431 -179.068 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.676 ' O ' ' N ' ' A' ' 12' ' ' ASN . 96.6 mt-10 -72.32 -31.32 65.57 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.562 0.696 . . . . 0.0 109.824 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -59.83 -24.82 64.49 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.684 -179.636 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.67 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 52.2 p -67.85 -29.35 68.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.111 -0.993 . . . . 0.0 110.347 -179.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.67 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.8 -23.77 2.78 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.916 -1.115 . . . . 0.0 109.572 178.652 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.676 ' N ' ' O ' ' A' ' 8' ' ' GLU . 65.6 t30 -80.57 125.84 30.49 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.09 0.948 . . . . 0.0 111.284 -178.396 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 13' ' ' VAL . 93.8 t -132.57 32.79 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 13' ' ' VAL . . . -42.64 177.19 0.01 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.9 t 61.47 27.4 16.96 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.516 -0.991 . . . . 0.0 108.711 -179.499 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.514 ' OG ' HG12 ' A' ' 13' ' ' VAL . 69.2 m -129.08 136.81 50.74 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.459 -0.775 . . . . 0.0 109.673 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.588 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 26.7 p30 -80.19 167.81 19.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.53 -0.731 . . . . 0.0 109.782 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 36' ' ' ARG . 41.7 mtt-85 -63.65 -32.73 74.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.94 . . . . 0.0 110.039 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -64.29 -46.46 83.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.243 -0.911 . . . . 0.0 109.113 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.588 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 18.0 ttmm -62.34 -40.32 95.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -0.834 . . . . 0.0 109.218 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -59.9 -38.11 81.34 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.366 -0.834 . . . . 0.0 109.332 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.573 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 55.3 tt0 -59.98 -44.07 94.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.869 -1.144 . . . . 0.0 108.892 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -62.26 -39.14 91.92 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 77.7 mt -73.67 -31.78 63.65 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.464 HD23 HG23 ' A' ' 49' ' ' VAL . 7.9 mt -89.38 -10.23 47.37 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.573 ' NH2' ' OE2' ' A' ' 22' ' ' GLU . 75.3 mtt180 -88.75 120.34 30.06 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.136 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.46 -4.99 62.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.507 ' HE3' HG23 ' A' ' 105' ' ' VAL . 25.7 mmtt -87.06 150.9 23.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.35 -1.088 . . . . 0.0 109.598 179.644 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.565 ' HG2' HH11 ' A' ' 29' ' ' ARG . 7.1 mmt-85 -82.67 154.96 24.61 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.316 0.579 . . . . 0.0 110.479 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -55.12 139.72 40.72 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.35 -15.46 56.16 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 35.3 m -88.55 121.79 31.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.402 -1.057 . . . . 0.0 109.197 179.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -138.44 167.46 21.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.007 -1.058 . . . . 0.0 110.742 179.888 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.53 156.23 44.55 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.485 -179.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' TRP . 46.0 t -108.11 124.26 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.875 . . . . 0.0 108.82 179.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -138.75 178.88 6.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 108.974 -179.486 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.735 ' C ' ' H ' ' A' ' 39' ' ' SER . 10.8 tt0 -99.33 164.09 12.27 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.814 -1.179 . . . . 0.0 108.67 179.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.632 ' C ' ' H ' ' A' ' 40' ' ' LYS . 50.8 m -75.73 33.14 0.11 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.272 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.735 ' H ' ' C ' ' A' ' 37' ' ' GLU . 49.5 m 64.88 -14.6 0.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.677 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.632 ' H ' ' C ' ' A' ' 38' ' ' SER . 39.3 ttpt -98.91 125.75 44.41 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -49.85 133.88 21.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.462 -0.774 . . . . 0.0 110.92 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.14 3.07 70.33 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.242 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 80.8 m -112.84 150.51 31.59 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.907 -1.349 . . . . 0.0 109.76 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.63 ' O ' ' O ' ' A' ' 59' ' ' ILE . 96.1 m-85 -133.47 151.19 51.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.055 -1.028 . . . . 0.0 110.281 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 59' ' ' ILE . . . -157.8 135.97 10.93 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.967 -1.083 . . . . 0.0 109.486 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.552 ' SG ' HD13 ' A' ' 59' ' ' ILE . 70.6 m -108.03 117.15 33.39 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.8 m -102.18 133.81 46.44 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.854 -1.154 . . . . 0.0 109.704 -178.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.641 HG11 HD22 ' A' ' 90' ' ' LEU . 2.4 p -129.73 160.28 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.295 -0.878 . . . . 0.0 109.642 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.538 ' N ' HG22 ' A' ' 48' ' ' VAL . 55.8 t -108.47 136.76 43.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.743 HG12 ' H ' ' A' ' 52' ' ' GLY . 74.8 t -121.59 151.45 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.093 -1.004 . . . . 0.0 109.978 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -49.71 -15.24 0.16 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.067 0.937 . . . . 0.0 108.796 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.743 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -94.21 -59.21 1.18 Allowed Glycine 0 C--N 1.285 -2.28 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -162.15 176.66 10.43 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.122 -1.222 . . . . 0.0 110.384 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.06 138.96 18.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HE3' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -125.58 162.05 25.83 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.761 -179.919 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -128.64 80.31 1.96 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.488 -0.758 . . . . 0.0 110.336 -179.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 46' ' ' CYS . 82.1 m -59.8 145.02 46.9 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.788 -1.195 . . . . 0.0 108.402 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 58' ' ' VAL . 8.7 p -115.98 130.42 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.013 -1.054 . . . . 0.0 111.272 -178.331 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.63 ' O ' ' O ' ' A' ' 44' ' ' TYR . 3.7 mp -123.04 128.4 75.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.641 ' O ' ' N ' ' A' ' 66' ' ' TYR . 92.4 m-20 -115.97 119.25 35.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.557 -1.34 . . . . 0.0 109.455 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -75.23 106.9 6.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.785 -1.197 . . . . 0.0 109.311 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.896 HG22 ' H ' ' A' ' 63' ' ' ALA . 72.0 m -160.56 -176.28 5.48 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.896 ' H ' HG22 ' A' ' 62' ' ' THR . . . -56.33 -47.21 79.21 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 64' ' ' THR . 91.0 m -141.95 48.77 1.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.505 -0.747 . . . . 0.0 109.461 179.223 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.69 ' O ' ' N ' ' A' ' 67' ' ' GLY . . . -118.85 -18.83 4.61 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.741 ' CD1' ' OH ' ' A' ' 75' ' ' TYR . 96.0 m-85 -36.99 -23.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.048 -1.266 . . . . 0.0 109.247 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.69 ' N ' ' O ' ' A' ' 65' ' ' GLY . . . 96.74 -102.86 2.83 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.503 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.657 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 73.1 m-85 -53.58 146.83 12.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.038 -1.272 . . . . 0.0 110.401 -179.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.18 133.83 15.63 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.6 ' O ' ' OD1' ' A' ' 73' ' ' ASN . 70.6 mt-10 -115.89 155.88 47.24 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.357 -0.839 . . . . 0.0 109.342 -179.141 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.649 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 84.7 Cg_exo -45.92 110.05 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.315 2.01 . . . . 0.0 112.349 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.745 ' CD2' ' O ' ' A' ' 72' ' ' TYR . 54.0 p90 44.19 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.674 -0.641 . . . . 0.0 110.06 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.656 ' OD1' ' N ' ' A' ' 74' ' ' LEU . 5.7 p30 166.99 -73.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -1.0 . . . . 0.0 109.532 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.751 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 25.3 mt 55.87 23.8 6.88 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.214 -0.929 . . . . 0.0 109.373 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.751 ' CG ' ' O ' ' A' ' 74' ' ' LEU . 52.2 p90 48.82 118.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.666 0.746 . . . . 0.0 109.61 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.5 p -61.37 -37.88 84.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.092 -1.005 . . . . 0.0 110.692 -178.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.2 m -127.12 153.67 45.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.88 -1.137 . . . . 0.0 110.104 -178.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.4 mt -60.02 -36.29 76.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.299 -0.876 . . . . 0.0 109.764 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -59.38 -41.05 88.44 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.101 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.439 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 81.9 mt-10 -61.66 -35.06 76.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 108.656 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.477 HD12 ' CE2' ' A' ' 75' ' ' TYR . 8.0 tt -58.12 -42.55 86.02 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.557 -0.714 . . . . 0.0 109.436 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.34 -39.56 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.007 -1.058 . . . . 0.0 108.582 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.453 ' CD2' ' CD2' ' A' ' 5' ' ' HIS . 92.6 mt -66.44 -41.8 88.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.402 -0.812 . . . . 0.0 109.718 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.439 ' CD2' ' O ' ' A' ' 80' ' ' GLU . 14.6 m170 -60.47 -42.36 96.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 110.382 -179.213 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.657 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 3.7 m-85 -69.53 -23.62 63.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.783 -1.198 . . . . 0.0 108.979 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -64.02 -38.12 89.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.491 -0.756 . . . . 0.0 109.231 179.541 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -90.26 -19.69 23.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 0.0 109.199 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 85' ' ' TYR . 42.1 m -99.01 140.99 32.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.529 -0.732 . . . . 0.0 109.256 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.3 t -89.65 128.94 36.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.868 . . . . 0.0 109.47 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.667 ' O ' ' N ' ' A' ' 92' ' ' GLN . 10.1 mp -60.56 -22.85 64.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.344 -0.847 . . . . 0.0 110.467 -179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.719 ' N ' ' O ' ' A' ' 97' ' ' LEU . 11.6 p -26.56 -37.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.346 -0.846 . . . . 0.0 110.584 -179.184 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.667 ' N ' ' O ' ' A' ' 90' ' ' LEU . 35.0 mt-30 -40.8 179.25 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.885 0.85 . . . . 0.0 111.756 -178.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.439 ' HE2' ' HE2' ' A' ' 68' ' ' PHE . 87.2 m-70 61.25 -108.84 0.35 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.496 0.665 . . . . 0.0 109.972 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -60.72 -5.43 1.28 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.494 -0.754 . . . . 0.0 110.366 -179.358 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 65.7 t0 57.27 28.47 15.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.772 -1.205 . . . . 0.0 109.128 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -143.22 13.04 1.8 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 110.304 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.719 ' O ' ' N ' ' A' ' 91' ' ' VAL . 7.7 mp -101.23 70.14 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.875 -1.14 . . . . 0.0 107.955 178.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -78.79 87.4 4.67 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.389 -0.819 . . . . 0.0 110.114 -178.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.51 HG22 ' N ' ' A' ' 100' ' ' THR . 12.6 p -163.05 160.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 121.686 0.755 . . . . 0.0 109.158 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.51 ' N ' HG22 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -130.8 133.47 45.99 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.14 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.68 HD22 ' CG ' ' A' ' 33' ' ' PHE . 37.6 mt -69.62 74.5 0.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -116.56 -10.04 11.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.832 . . . . 0.0 110.952 -178.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 32' ' ' THR . 69.2 t80 -120.65 103.4 43.7 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.619 -1.301 . . . . 0.0 110.433 -178.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.97 146.53 86.66 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.622 2.215 . . . . 0.0 111.533 178.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.507 HG23 ' HE3' ' A' ' 28' ' ' LYS . 9.5 p -69.43 -35.37 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.911 -1.118 . . . . 0.0 109.57 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.457 ' CD2' HG13 ' A' ' 105' ' ' VAL . 38.8 m-85 -119.39 54.88 0.97 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.157 -0.964 . . . . 0.0 110.74 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.73 116.97 8.22 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.133 -0.979 . . . . 0.0 108.376 178.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -60.11 -37.99 81.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.12 -0.988 . . . . 0.0 110.2 -179.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -62.22 -43.55 98.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.834 -1.166 . . . . 0.0 109.23 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -66.55 -34.44 77.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 109.722 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.274 -179.416 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.484 ' HB2' ' ND1' ' A' ' 6' ' ' HIS . 58.0 p30 -76.76 170.06 17.16 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.5 mt -91.5 136.26 26.97 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.864 -1.147 . . . . 0.0 109.702 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -49.06 -19.54 2.52 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.888 2.392 . . . . 0.0 111.659 178.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 83' ' ' LEU . 85.1 m-70 -65.11 -17.01 64.11 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.655 0.741 . . . . 0.0 109.438 -178.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.484 ' ND1' ' HB2' ' A' ' 2' ' ' ASP . 38.2 m170 -64.98 -36.76 85.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.503 -0.748 . . . . 0.0 109.57 178.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -96.79 129.55 44.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 110.431 -179.068 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.676 ' O ' ' N ' ' A' ' 12' ' ' ASN . 96.6 mt-10 -72.32 -31.32 65.57 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.562 0.696 . . . . 0.0 109.824 179.717 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -59.83 -24.82 64.49 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.684 -179.636 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.67 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 52.2 p -67.85 -29.35 68.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.111 -0.993 . . . . 0.0 110.347 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.67 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.8 -23.77 2.78 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.916 -1.115 . . . . 0.0 109.572 178.652 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.676 ' N ' ' O ' ' A' ' 8' ' ' GLU . 65.6 t30 -80.57 125.84 30.49 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.09 0.948 . . . . 0.0 111.284 -178.396 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 13' ' ' VAL . 93.8 t -132.57 32.79 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 13' ' ' VAL . . . -42.64 177.19 0.01 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.9 t 61.47 27.4 16.96 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.516 -0.991 . . . . 0.0 108.711 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.514 ' OG ' HG12 ' A' ' 13' ' ' VAL . 69.2 m -129.08 136.81 50.74 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.459 -0.775 . . . . 0.0 109.673 -179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.588 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 26.7 p30 -80.19 167.81 19.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.53 -0.731 . . . . 0.0 109.782 -179.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 36' ' ' ARG . 41.7 mtt-85 -63.65 -32.73 74.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.94 . . . . 0.0 110.039 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -64.29 -46.46 83.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.243 -0.911 . . . . 0.0 109.113 -179.345 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.588 ' N ' ' OD1' ' A' ' 17' ' ' ASN . 18.0 ttmm -62.34 -40.32 95.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -0.834 . . . . 0.0 109.218 179.566 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -59.9 -38.11 81.34 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.366 -0.834 . . . . 0.0 109.332 -179.584 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.573 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 55.3 tt0 -59.98 -44.07 94.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.869 -1.144 . . . . 0.0 108.892 179.548 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -62.26 -39.14 91.92 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 77.7 mt -73.67 -31.78 63.65 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.432 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.464 HD23 HG23 ' A' ' 49' ' ' VAL . 7.9 mt -89.38 -10.23 47.37 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.573 ' NH2' ' OE2' ' A' ' 22' ' ' GLU . 75.3 mtt180 -88.75 120.34 30.06 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.136 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.46 -4.99 62.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.715 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.507 ' HE3' HG23 ' A' ' 105' ' ' VAL . 25.7 mmtt -87.06 150.9 23.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.35 -1.088 . . . . 0.0 109.598 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.565 ' HG2' HH11 ' A' ' 29' ' ' ARG . 7.1 mmt-85 -82.67 154.96 24.61 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.316 0.579 . . . . 0.0 110.479 -179.475 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -55.12 139.72 40.72 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.35 -15.46 56.16 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 35.3 m -88.55 121.79 31.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.402 -1.057 . . . . 0.0 109.197 179.315 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.68 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -138.44 167.46 21.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.007 -1.058 . . . . 0.0 110.742 179.888 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.53 156.23 44.55 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.485 -179.325 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' TRP . 46.0 t -108.11 124.26 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.875 . . . . 0.0 108.82 179.521 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.642 ' NH1' ' NH1' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -138.75 178.88 6.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 108.974 -179.486 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.735 ' C ' ' H ' ' A' ' 39' ' ' SER . 10.8 tt0 -99.33 164.09 12.27 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.814 -1.179 . . . . 0.0 108.67 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.632 ' C ' ' H ' ' A' ' 40' ' ' LYS . 50.8 m -75.73 33.14 0.11 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.272 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.735 ' H ' ' C ' ' A' ' 37' ' ' GLU . 49.5 m 64.88 -14.6 0.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.677 -178.57 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.632 ' H ' ' C ' ' A' ' 38' ' ' SER . 39.3 ttpt -98.91 125.75 44.41 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.658 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -49.85 133.88 21.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.462 -0.774 . . . . 0.0 110.92 -178.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.14 3.07 70.33 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.242 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 80.8 m -112.84 150.51 31.59 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.907 -1.349 . . . . 0.0 109.76 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.63 ' O ' ' O ' ' A' ' 59' ' ' ILE . 96.1 m-85 -133.47 151.19 51.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.055 -1.028 . . . . 0.0 110.281 -179.399 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 59' ' ' ILE . . . -157.8 135.97 10.93 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.967 -1.083 . . . . 0.0 109.486 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.552 ' SG ' HD13 ' A' ' 59' ' ' ILE . 70.6 m -108.03 117.15 33.39 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.648 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.8 m -102.18 133.81 46.44 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.854 -1.154 . . . . 0.0 109.704 -178.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.641 HG11 HD22 ' A' ' 90' ' ' LEU . 2.4 p -129.73 160.28 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.295 -0.878 . . . . 0.0 109.642 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.538 ' N ' HG22 ' A' ' 48' ' ' VAL . 55.8 t -108.47 136.76 43.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.743 HG12 ' H ' ' A' ' 52' ' ' GLY . 74.8 t -121.59 151.45 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.093 -1.004 . . . . 0.0 109.978 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -49.71 -15.24 0.16 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.067 0.937 . . . . 0.0 108.796 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.743 ' H ' HG12 ' A' ' 50' ' ' VAL . . . -94.21 -59.21 1.18 Allowed Glycine 0 C--N 1.285 -2.28 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.65 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -162.15 176.66 10.43 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.122 -1.222 . . . . 0.0 110.384 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.06 138.96 18.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HE3' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -125.58 162.05 25.83 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.761 -179.919 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -128.64 80.31 1.96 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.488 -0.758 . . . . 0.0 110.336 -179.566 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 46' ' ' CYS . 82.1 m -59.8 145.02 46.9 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.788 -1.195 . . . . 0.0 108.402 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 58' ' ' VAL . 8.7 p -115.98 130.42 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.013 -1.054 . . . . 0.0 111.272 -178.331 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.63 ' O ' ' O ' ' A' ' 44' ' ' TYR . 3.7 mp -123.04 128.4 75.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.361 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.641 ' O ' ' N ' ' A' ' 66' ' ' TYR . 92.4 m-20 -115.97 119.25 35.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.557 -1.34 . . . . 0.0 109.455 179.512 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -75.23 106.9 6.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.785 -1.197 . . . . 0.0 109.311 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.896 HG22 ' H ' ' A' ' 63' ' ' ALA . 72.0 m -160.56 -176.28 5.48 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.896 ' H ' HG22 ' A' ' 62' ' ' THR . . . -56.33 -47.21 79.21 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.691 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 64' ' ' THR . 91.0 m -141.95 48.77 1.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.505 -0.747 . . . . 0.0 109.461 179.223 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.69 ' O ' ' N ' ' A' ' 67' ' ' GLY . . . -118.85 -18.83 4.61 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.837 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.741 ' CD1' ' OH ' ' A' ' 75' ' ' TYR . 96.0 m-85 -36.99 -23.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.048 -1.266 . . . . 0.0 109.247 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.69 ' N ' ' O ' ' A' ' 65' ' ' GLY . . . 96.74 -102.86 2.83 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.657 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 73.1 m-85 -53.58 146.83 12.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.038 -1.272 . . . . 0.0 110.401 -179.451 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.18 133.83 15.63 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.365 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.6 ' O ' ' OD1' ' A' ' 73' ' ' ASN . 70.6 mt-10 -115.89 155.88 47.24 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.357 -0.839 . . . . 0.0 109.342 -179.141 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.649 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 84.7 Cg_exo -45.92 110.05 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.315 2.01 . . . . 0.0 112.349 -179.754 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.745 ' CD2' ' O ' ' A' ' 72' ' ' TYR . 54.0 p90 44.19 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.674 -0.641 . . . . 0.0 110.06 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.656 ' OD1' ' N ' ' A' ' 74' ' ' LEU . 5.7 p30 166.99 -73.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -1.0 . . . . 0.0 109.532 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.751 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 25.3 mt 55.87 23.8 6.88 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.214 -0.929 . . . . 0.0 109.373 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.751 ' CG ' ' O ' ' A' ' 74' ' ' LEU . 52.2 p90 48.82 118.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.666 0.746 . . . . 0.0 109.61 -179.588 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.5 p -61.37 -37.88 84.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.092 -1.005 . . . . 0.0 110.692 -178.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.2 m -127.12 153.67 45.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.88 -1.137 . . . . 0.0 110.104 -178.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.4 mt -60.02 -36.29 76.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.299 -0.876 . . . . 0.0 109.764 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -59.38 -41.05 88.44 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.101 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.439 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 81.9 mt-10 -61.66 -35.06 76.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 108.656 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.477 HD12 ' CE2' ' A' ' 75' ' ' TYR . 8.0 tt -58.12 -42.55 86.02 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.557 -0.714 . . . . 0.0 109.436 179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.34 -39.56 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.007 -1.058 . . . . 0.0 108.582 179.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.453 ' CD2' ' CD2' ' A' ' 5' ' ' HIS . 92.6 mt -66.44 -41.8 88.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.402 -0.812 . . . . 0.0 109.718 179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.439 ' CD2' ' O ' ' A' ' 80' ' ' GLU . 14.6 m170 -60.47 -42.36 96.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 110.382 -179.213 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.657 ' OH ' ' CG ' ' A' ' 68' ' ' PHE . 3.7 m-85 -69.53 -23.62 63.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.783 -1.198 . . . . 0.0 108.979 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -64.02 -38.12 89.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.491 -0.756 . . . . 0.0 109.231 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -90.26 -19.69 23.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 0.0 109.199 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 85' ' ' TYR . 42.1 m -99.01 140.99 32.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.529 -0.732 . . . . 0.0 109.256 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.3 t -89.65 128.94 36.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.868 . . . . 0.0 109.47 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.667 ' O ' ' N ' ' A' ' 92' ' ' GLN . 10.1 mp -60.56 -22.85 64.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.344 -0.847 . . . . 0.0 110.467 -179.558 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.719 ' N ' ' O ' ' A' ' 97' ' ' LEU . 11.6 p -26.56 -37.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.346 -0.846 . . . . 0.0 110.584 -179.184 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.667 ' N ' ' O ' ' A' ' 90' ' ' LEU . 35.0 mt-30 -40.8 179.25 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.885 0.85 . . . . 0.0 111.756 -178.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.439 ' HE2' ' HE2' ' A' ' 68' ' ' PHE . 87.2 m-70 61.25 -108.84 0.35 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.496 0.665 . . . . 0.0 109.972 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -60.72 -5.43 1.28 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.494 -0.754 . . . . 0.0 110.366 -179.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 65.7 t0 57.27 28.47 15.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.772 -1.205 . . . . 0.0 109.128 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -143.22 13.04 1.8 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 110.304 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.719 ' O ' ' N ' ' A' ' 91' ' ' VAL . 7.7 mp -101.23 70.14 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.875 -1.14 . . . . 0.0 107.955 178.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -78.79 87.4 4.67 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.389 -0.819 . . . . 0.0 110.114 -178.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.51 HG22 ' N ' ' A' ' 100' ' ' THR . 12.6 p -163.05 160.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 121.686 0.755 . . . . 0.0 109.158 179.306 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.51 ' N ' HG22 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -130.8 133.47 45.99 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.14 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.68 HD22 ' CG ' ' A' ' 33' ' ' PHE . 37.6 mt -69.62 74.5 0.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' THR . . . -116.56 -10.04 11.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.832 . . . . 0.0 110.952 -178.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 32' ' ' THR . 69.2 t80 -120.65 103.4 43.7 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.619 -1.301 . . . . 0.0 110.433 -178.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.97 146.53 86.66 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.622 2.215 . . . . 0.0 111.533 178.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.507 HG23 ' HE3' ' A' ' 28' ' ' LYS . 9.5 p -69.43 -35.37 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.911 -1.118 . . . . 0.0 109.57 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.457 ' CD2' HG13 ' A' ' 105' ' ' VAL . 38.8 m-85 -119.39 54.88 0.97 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.157 -0.964 . . . . 0.0 110.74 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.73 116.97 8.22 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.133 -0.979 . . . . 0.0 108.376 178.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -60.11 -37.99 81.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.12 -0.988 . . . . 0.0 110.2 -179.582 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -62.22 -43.55 98.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.834 -1.166 . . . . 0.0 109.23 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -66.55 -34.44 77.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 109.722 -179.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.274 -179.416 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.379 0.609 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -82.02 122.63 28.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.115 -0.991 . . . . 0.0 109.18 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.3 mt -94.53 127.76 42.71 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 -179.47 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -51.27 -17.86 4.49 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.013 1.809 . . . . 0.0 111.563 178.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -63.24 -23.26 67.34 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.523 -0.735 . . . . 0.0 110.4 -179.074 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -66.1 -37.95 87.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.815 -1.178 . . . . 0.0 109.599 -179.219 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.572 ' O ' ' OG1' ' A' ' 10' ' ' THR . 84.9 m-20 -96.44 127.2 42.21 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.156 -0.965 . . . . 0.0 109.535 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.522 ' HG3' ' CH2' ' A' ' 11' ' ' TRP . 38.1 mp0 -71.08 -28.45 64.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 109.21 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -58.67 -22.54 57.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.657 -179.422 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.732 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 17.2 p -66.03 -31.62 72.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 179.584 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.732 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.6 -31.77 1.98 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.83 -1.169 . . . . 0.0 110.64 -179.387 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.637 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 6.6 p-10 -80.26 146.48 31.64 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 110.422 -178.496 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.54 -3.95 5.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.9 -130.44 33.32 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.6 m -67.75 137.62 55.58 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.229 -1.16 . . . . 0.0 108.641 179.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -163.67 165.01 23.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.478 -0.764 . . . . 0.0 108.954 -179.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.54 ' C ' HH12 ' A' ' 36' ' ' ARG . 68.3 m-80 -106.36 141.03 38.35 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 179.156 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.537 ' HG3' HH11 ' A' ' 18' ' ' ARG . 14.8 mtm-85 -61.24 -36.91 81.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.761 -1.212 . . . . 0.0 109.649 -179.565 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -60.1 -49.32 78.11 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.069 -1.02 . . . . 0.0 110.165 -179.37 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 17' ' ' ASN . 7.6 pttt -68.03 -27.27 66.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.722 -1.236 . . . . 0.0 108.579 179.531 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.41 -33.44 73.71 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.816 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 26' ' ' ARG . 97.9 mt-10 -60.9 -47.45 86.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.52 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -60.01 -44.3 94.66 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.694 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 59.3 mt -69.11 -25.24 64.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.968 -1.082 . . . . 0.0 108.196 178.343 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.525 HD11 ' HB3' ' A' ' 47' ' ' SER . 44.1 mt -96.3 -10.07 28.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.837 . . . . 0.0 109.318 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.666 ' N ' ' O ' ' A' ' 22' ' ' GLU . 61.7 mtm180 -107.48 131.25 54.51 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.431 -0.793 . . . . 0.0 110.582 -179.19 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.42 -4.28 43.78 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.208 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.694 ' NZ ' ' O ' ' A' ' 24' ' ' LEU . 14.6 ptpt -122.98 154.85 37.87 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.003 -1.293 . . . . 0.0 110.929 -179.384 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.482 ' HG2' ' N ' ' A' ' 30' ' ' ASP . 26.9 ttm180 -73.95 160.01 31.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.529 0.681 . . . . 0.0 110.871 -179.004 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.482 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 8.9 p-10 -59.19 167.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.7 0.762 . . . . 0.0 110.128 179.598 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.13 -33.94 5.6 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.4 m -82.06 119.9 24.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -1.114 . . . . 0.0 108.891 179.559 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.808 ' CG ' HD22 ' A' ' 101' ' ' LEU . 1.0 OUTLIER -136.23 164.65 27.59 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.598 -1.241 . . . . 0.0 110.964 -179.521 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.784 HD23 HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -131.89 165.75 23.17 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.509 0.671 . . . . 0.0 110.152 -179.567 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG22 ' SG ' ' A' ' 46' ' ' CYS . 55.1 t -116.67 121.95 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.078 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.54 HH12 ' C ' ' A' ' 17' ' ' ASN . 14.7 ptm180 -142.4 -176.21 4.75 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.746 ' C ' ' H ' ' A' ' 39' ' ' SER . 36.7 tt0 -100.74 163.66 12.22 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.592 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.444 ' N ' ' HG2' ' A' ' 37' ' ' GLU . 29.2 t -75.88 16.9 0.36 Allowed 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 178.092 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.746 ' H ' ' C ' ' A' ' 37' ' ' GLU . 10.4 t 71.78 -65.7 0.33 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.012 -1.449 . . . . 0.0 108.143 -178.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 86.9 mttt -100.28 166.8 10.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.748 -0.595 . . . . 0.0 109.548 179.361 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 43' ' ' CYS . 1.8 mm-40 68.83 13.14 8.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.74 . . . . 0.0 109.694 179.636 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . 40.05 28.01 0.15 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.586 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' GLN . 31.4 t -86.41 135.13 33.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.267 . . . . 0.0 109.771 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.602 ' O ' ' O ' ' A' ' 59' ' ' ILE . 93.8 m-85 -79.97 152.04 29.71 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.448 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.413 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -154.98 140.63 17.99 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.659 -1.276 . . . . 0.0 110.245 -179.147 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 59' ' ' ILE . 84.1 m -106.29 118.34 36.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.525 ' HB3' HD11 ' A' ' 25' ' ' LEU . 74.0 m -91.93 127.46 37.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.504 -0.748 . . . . 0.0 109.259 -179.479 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.81 145.96 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.856 -1.153 . . . . 0.0 110.423 -179.559 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.0 t -92.29 144.03 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.349 -0.844 . . . . 0.0 108.743 178.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.675 HG12 ' H ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -123.23 158.95 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.035 -1.04 . . . . 0.0 109.624 179.833 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -65.8 57.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.535 -0.728 . . . . 0.0 110.492 -178.535 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 169.46 -33.54 0.18 Allowed Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.307 -1.425 . . . . 0.0 111.295 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.675 ' H ' HG12 ' A' ' 50' ' ' VAL . 88.8 mt-10 -159.74 165.61 32.14 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.9 -1.353 . . . . 0.0 110.486 -179.544 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 t -97.32 125.78 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.801 . . . . 0.0 109.19 178.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HE2' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -120.38 146.01 46.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.927 -1.108 . . . . 0.0 110.745 -179.273 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -111.75 87.76 2.64 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.446 -0.784 . . . . 0.0 108.918 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 63.2 m -66.9 139.42 57.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.908 . . . . 0.0 109.186 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.411 HG22 ' SG ' ' A' ' 43' ' ' CYS . 5.4 p -106.57 134.36 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.277 -179.19 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.699 HD12 ' SG ' ' A' ' 46' ' ' CYS . 31.4 mt -121.85 144.87 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.4 -0.813 . . . . 0.0 108.822 179.233 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.444 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 14.4 t-20 -114.13 119.24 36.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.019 -1.05 . . . . 0.0 109.032 -179.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -84.49 114.76 22.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.853 -1.154 . . . . 0.0 109.719 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.544 HG22 ' N ' ' A' ' 63' ' ' ALA . 58.7 m -148.5 164.05 35.36 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.535 -0.728 . . . . 0.0 109.214 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.544 ' N ' HG22 ' A' ' 62' ' ' THR . . . -57.1 -50.93 71.24 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 108.929 179.368 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.4 p -116.99 18.91 14.54 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.117 -0.989 . . . . 0.0 111.433 -179.329 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.926 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -107.52 -78.92 1.15 Allowed Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.133 -1.508 . . . . 0.0 111.582 -178.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.498 ' O ' ' O ' ' A' ' 67' ' ' GLY . 93.8 m-85 68.28 -162.9 0.2 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.235 -1.156 . . . . 0.0 109.437 -178.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.625 ' CA ' HG23 ' A' ' 59' ' ' ILE . . . -54.29 -114.63 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.569 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 29.9 m-85 -59.98 -45.91 91.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -1.121 . . . . 0.0 109.706 -179.226 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.926 ' HB2' ' O ' ' A' ' 65' ' ' GLY . . . 68.79 7.51 6.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.367 -0.833 . . . . 0.0 109.997 179.816 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.675 ' H ' ' CD ' ' A' ' 71' ' ' PRO . 98.0 mt-10 -109.23 -33.28 0.16 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.877 -1.139 . . . . 0.0 110.748 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.675 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 97.0 Cg_endo -92.27 44.25 0.38 Allowed 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.961 2.44 . . . . 0.0 112.449 -179.79 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 59.27 49.77 8.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.46 -0.775 . . . . 0.0 109.615 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 75' ' ' TYR . 3.8 m120 -99.64 12.22 37.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.363 -179.714 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.14 65.18 0.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.938 -1.101 . . . . 0.0 108.936 179.811 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.709 ' OH ' ' CG ' ' A' ' 84' ' ' HIS . 58.8 m-85 -75.48 146.6 40.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.457 -0.777 . . . . 0.0 110.206 -179.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.5 t -60.53 -38.49 84.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.525 -0.734 . . . . 0.0 110.19 -179.485 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.7 p -134.38 157.12 47.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.03 -1.044 . . . . 0.0 110.118 -178.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.65 -27.1 68.7 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.612 -0.68 . . . . 0.0 109.715 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 83' ' ' LEU . 64.0 mttp -59.55 -44.78 93.15 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.826 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.38 -37.96 87.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.336 -0.853 . . . . 0.0 109.328 179.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 81' ' ' LEU . 7.5 tt -57.6 -41.95 82.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 108.914 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.47 -45.23 98.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.048 -1.033 . . . . 0.0 109.298 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.495 ' H ' HD12 ' A' ' 83' ' ' LEU . 6.4 mp -62.53 -37.74 87.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.871 -1.143 . . . . 0.0 109.58 179.417 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.709 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 11.6 t-160 -59.53 -46.69 88.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.524 -0.735 . . . . 0.0 110.966 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.584 ' HB2' HD12 ' A' ' 101' ' ' LEU . 4.4 m-85 -67.59 -28.4 67.73 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.498 -1.376 . . . . 0.0 109.585 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.505 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 1.2 tm0? -58.91 -38.06 78.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 109.164 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -86.14 -36.16 19.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.134 -0.979 . . . . 0.0 109.276 179.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.544 ' O ' ' O ' ' A' ' 85' ' ' TYR . 1.8 p -90.05 139.38 30.67 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.373 -0.83 . . . . 0.0 109.675 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.445 ' HA ' HG22 ' A' ' 100' ' ' THR . 37.3 m -93.1 140.57 29.35 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.601 0.715 . . . . 0.0 109.835 -179.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.655 ' O ' ' C ' ' A' ' 91' ' ' VAL . 5.8 mt -61.09 -41.14 96.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 111.238 -178.905 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.783 ' N ' ' O ' ' A' ' 97' ' ' LEU . 87.2 t 16.29 -83.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 121.41 -0.806 . . . . 0.0 109.834 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 90' ' ' LEU . 1.3 tp60 75.77 -176.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 110.222 179.282 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -60.09 -38.74 83.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.642 -0.661 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -52.52 -24.95 9.04 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.013 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 61.53 20.31 11.12 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 178.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.0 m -130.51 7.26 4.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.693 -1.254 . . . . 0.0 111.172 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.783 ' O ' ' N ' ' A' ' 91' ' ' VAL . 83.2 mt -98.5 53.67 1.04 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.09 78.47 3.63 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.548 -178.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.626 HG21 HG23 ' A' ' 50' ' ' VAL . 53.2 t -154.31 147.92 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.809 0.814 . . . . 0.0 109.533 179.377 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 89' ' ' SER . 48.2 p -121.24 153.67 37.34 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.316 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.808 HD22 ' CG ' ' A' ' 33' ' ' PHE . 79.0 mt -82.25 71.05 9.31 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . . . -107.38 -17.87 14.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.62 -0.675 . . . . 0.0 112.074 -178.09 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -110.91 123.77 34.59 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.573 -1.329 . . . . 0.0 110.083 -178.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 55.2 Cg_endo -77.45 145.06 23.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.488 2.125 . . . . 0.0 110.636 178.87 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.905 HG13 ' CD2' ' A' ' 106' ' ' TYR . 12.0 p -72.21 -22.01 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.535 -1.353 . . . . 0.0 109.38 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.905 ' CD2' HG13 ' A' ' 105' ' ' VAL . 72.3 m-85 -129.19 64.35 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.768 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . -57.11 -40.88 77.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 108.819 179.451 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -156.34 57.02 0.57 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 59.03 31.87 21.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.842 . . . . 0.0 110.174 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.63 ' HG2' HH11 ' A' ' 110' ' ' ARG . 24.1 ttt-85 -68.75 144.04 54.48 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.011 -1.055 . . . . 0.0 109.207 -179.87 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.743 ' CG ' HH11 ' A' ' 111' ' ' ARG . 1.9 mtt-85 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.087 -1.008 . . . . 0.0 109.324 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.379 0.609 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -82.02 122.63 28.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.115 -0.991 . . . . 0.0 109.18 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.3 mt -94.53 127.76 42.71 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 -179.47 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -51.27 -17.86 4.49 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.013 1.809 . . . . 0.0 111.563 178.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -63.24 -23.26 67.34 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.523 -0.735 . . . . 0.0 110.4 -179.074 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -66.1 -37.95 87.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.815 -1.178 . . . . 0.0 109.599 -179.219 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.572 ' O ' ' OG1' ' A' ' 10' ' ' THR . 84.9 m-20 -96.44 127.2 42.21 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.156 -0.965 . . . . 0.0 109.535 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.522 ' HG3' ' CH2' ' A' ' 11' ' ' TRP . 38.1 mp0 -71.08 -28.45 64.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 109.21 179.56 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -58.67 -22.54 57.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.657 -179.422 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.732 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 17.2 p -66.03 -31.62 72.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.732 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -129.6 -31.77 1.98 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.83 -1.169 . . . . 0.0 110.64 -179.387 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.637 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 6.6 p-10 -80.26 146.48 31.64 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 110.422 -178.496 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.54 -3.95 5.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.9 -130.44 33.32 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.6 m -67.75 137.62 55.58 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.229 -1.16 . . . . 0.0 108.641 179.369 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -163.67 165.01 23.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.478 -0.764 . . . . 0.0 108.954 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.54 ' C ' HH12 ' A' ' 36' ' ' ARG . 68.3 m-80 -106.36 141.03 38.35 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 179.156 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.537 ' HG3' HH11 ' A' ' 18' ' ' ARG . 14.8 mtm-85 -61.24 -36.91 81.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.761 -1.212 . . . . 0.0 109.649 -179.565 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -60.1 -49.32 78.11 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.069 -1.02 . . . . 0.0 110.165 -179.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 17' ' ' ASN . 7.6 pttt -68.03 -27.27 66.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.722 -1.236 . . . . 0.0 108.579 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' LEU . . . -61.41 -33.44 73.71 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 26' ' ' ARG . 97.9 mt-10 -60.9 -47.45 86.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.52 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -60.01 -44.3 94.66 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.694 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 59.3 mt -69.11 -25.24 64.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.968 -1.082 . . . . 0.0 108.196 178.343 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.525 HD11 ' HB3' ' A' ' 47' ' ' SER . 44.1 mt -96.3 -10.07 28.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.837 . . . . 0.0 109.318 179.683 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.666 ' N ' ' O ' ' A' ' 22' ' ' GLU . 61.7 mtm180 -107.48 131.25 54.51 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.431 -0.793 . . . . 0.0 110.582 -179.19 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.42 -4.28 43.78 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.208 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.694 ' NZ ' ' O ' ' A' ' 24' ' ' LEU . 14.6 ptpt -122.98 154.85 37.87 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.003 -1.293 . . . . 0.0 110.929 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.482 ' HG2' ' N ' ' A' ' 30' ' ' ASP . 26.9 ttm180 -73.95 160.01 31.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.529 0.681 . . . . 0.0 110.871 -179.004 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.482 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 8.9 p-10 -59.19 167.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.7 0.762 . . . . 0.0 110.128 179.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.13 -33.94 5.6 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.561 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.4 m -82.06 119.9 24.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -1.114 . . . . 0.0 108.891 179.559 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.808 ' CG ' HD22 ' A' ' 101' ' ' LEU . 1.0 OUTLIER -136.23 164.65 27.59 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.598 -1.241 . . . . 0.0 110.964 -179.521 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.784 HD23 HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -131.89 165.75 23.17 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.509 0.671 . . . . 0.0 110.152 -179.567 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG22 ' SG ' ' A' ' 46' ' ' CYS . 55.1 t -116.67 121.95 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.078 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.54 HH12 ' C ' ' A' ' 17' ' ' ASN . 14.7 ptm180 -142.4 -176.21 4.75 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.41 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.746 ' C ' ' H ' ' A' ' 39' ' ' SER . 36.7 tt0 -100.74 163.66 12.22 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.592 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.444 ' N ' ' HG2' ' A' ' 37' ' ' GLU . 29.2 t -75.88 16.9 0.36 Allowed 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 178.092 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.746 ' H ' ' C ' ' A' ' 37' ' ' GLU . 10.4 t 71.78 -65.7 0.33 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.012 -1.449 . . . . 0.0 108.143 -178.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 86.9 mttt -100.28 166.8 10.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.748 -0.595 . . . . 0.0 109.548 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 43' ' ' CYS . 1.8 mm-40 68.83 13.14 8.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.74 . . . . 0.0 109.694 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 41' ' ' GLN . . . 40.05 28.01 0.15 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.586 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' GLN . 31.4 t -86.41 135.13 33.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.267 . . . . 0.0 109.771 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.602 ' O ' ' O ' ' A' ' 59' ' ' ILE . 93.8 m-85 -79.97 152.04 29.71 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.448 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.413 ' HA ' ' H ' ' A' ' 59' ' ' ILE . . . -154.98 140.63 17.99 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.659 -1.276 . . . . 0.0 110.245 -179.147 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 59' ' ' ILE . 84.1 m -106.29 118.34 36.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.525 ' HB3' HD11 ' A' ' 25' ' ' LEU . 74.0 m -91.93 127.46 37.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.504 -0.748 . . . . 0.0 109.259 -179.479 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.81 145.96 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.856 -1.153 . . . . 0.0 110.423 -179.559 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.0 t -92.29 144.03 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.349 -0.844 . . . . 0.0 108.743 178.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.675 HG12 ' H ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -123.23 158.95 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.035 -1.04 . . . . 0.0 109.624 179.833 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -65.8 57.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.535 -0.728 . . . . 0.0 110.492 -178.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 169.46 -33.54 0.18 Allowed Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.307 -1.425 . . . . 0.0 111.295 179.089 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.675 ' H ' HG12 ' A' ' 50' ' ' VAL . 88.8 mt-10 -159.74 165.61 32.14 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.9 -1.353 . . . . 0.0 110.486 -179.544 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 t -97.32 125.78 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.801 . . . . 0.0 109.19 178.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HE2' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -120.38 146.01 46.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.927 -1.108 . . . . 0.0 110.745 -179.273 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -111.75 87.76 2.64 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.446 -0.784 . . . . 0.0 108.918 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 63.2 m -66.9 139.42 57.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.908 . . . . 0.0 109.186 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.411 HG22 ' SG ' ' A' ' 43' ' ' CYS . 5.4 p -106.57 134.36 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.277 -179.19 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.699 HD12 ' SG ' ' A' ' 46' ' ' CYS . 31.4 mt -121.85 144.87 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.4 -0.813 . . . . 0.0 108.822 179.233 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.444 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 14.4 t-20 -114.13 119.24 36.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.019 -1.05 . . . . 0.0 109.032 -179.703 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -84.49 114.76 22.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.853 -1.154 . . . . 0.0 109.719 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.544 HG22 ' N ' ' A' ' 63' ' ' ALA . 58.7 m -148.5 164.05 35.36 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.535 -0.728 . . . . 0.0 109.214 179.782 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.544 ' N ' HG22 ' A' ' 62' ' ' THR . . . -57.1 -50.93 71.24 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 108.929 179.368 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.4 p -116.99 18.91 14.54 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.117 -0.989 . . . . 0.0 111.433 -179.329 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.926 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -107.52 -78.92 1.15 Allowed Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.133 -1.508 . . . . 0.0 111.582 -178.894 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.498 ' O ' ' O ' ' A' ' 67' ' ' GLY . 93.8 m-85 68.28 -162.9 0.2 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.235 -1.156 . . . . 0.0 109.437 -178.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.625 ' CA ' HG23 ' A' ' 59' ' ' ILE . . . -54.29 -114.63 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.671 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.569 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 29.9 m-85 -59.98 -45.91 91.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -1.121 . . . . 0.0 109.706 -179.226 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.926 ' HB2' ' O ' ' A' ' 65' ' ' GLY . . . 68.79 7.51 6.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.367 -0.833 . . . . 0.0 109.997 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.675 ' H ' ' CD ' ' A' ' 71' ' ' PRO . 98.0 mt-10 -109.23 -33.28 0.16 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.877 -1.139 . . . . 0.0 110.748 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.675 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 97.0 Cg_endo -92.27 44.25 0.38 Allowed 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.961 2.44 . . . . 0.0 112.449 -179.79 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 59.27 49.77 8.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.46 -0.775 . . . . 0.0 109.615 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 75' ' ' TYR . 3.8 m120 -99.64 12.22 37.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.363 -179.714 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.14 65.18 0.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.938 -1.101 . . . . 0.0 108.936 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.709 ' OH ' ' CG ' ' A' ' 84' ' ' HIS . 58.8 m-85 -75.48 146.6 40.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.457 -0.777 . . . . 0.0 110.206 -179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.5 t -60.53 -38.49 84.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.525 -0.734 . . . . 0.0 110.19 -179.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.7 p -134.38 157.12 47.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.03 -1.044 . . . . 0.0 110.118 -178.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.65 -27.1 68.7 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.612 -0.68 . . . . 0.0 109.715 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 83' ' ' LEU . 64.0 mttp -59.55 -44.78 93.15 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.826 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.38 -37.96 87.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.336 -0.853 . . . . 0.0 109.328 179.103 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 81' ' ' LEU . 7.5 tt -57.6 -41.95 82.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 108.914 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.47 -45.23 98.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.048 -1.033 . . . . 0.0 109.298 179.591 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.495 ' H ' HD12 ' A' ' 83' ' ' LEU . 6.4 mp -62.53 -37.74 87.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.871 -1.143 . . . . 0.0 109.58 179.417 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.709 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 11.6 t-160 -59.53 -46.69 88.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.524 -0.735 . . . . 0.0 110.966 -179.217 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.584 ' HB2' HD12 ' A' ' 101' ' ' LEU . 4.4 m-85 -67.59 -28.4 67.73 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.498 -1.376 . . . . 0.0 109.585 -179.624 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.505 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 1.2 tm0? -58.91 -38.06 78.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 109.164 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -86.14 -36.16 19.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.134 -0.979 . . . . 0.0 109.276 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.544 ' O ' ' O ' ' A' ' 85' ' ' TYR . 1.8 p -90.05 139.38 30.67 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.373 -0.83 . . . . 0.0 109.675 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.445 ' HA ' HG22 ' A' ' 100' ' ' THR . 37.3 m -93.1 140.57 29.35 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.601 0.715 . . . . 0.0 109.835 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.655 ' O ' ' C ' ' A' ' 91' ' ' VAL . 5.8 mt -61.09 -41.14 96.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 111.238 -178.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.783 ' N ' ' O ' ' A' ' 97' ' ' LEU . 87.2 t 16.29 -83.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 121.41 -0.806 . . . . 0.0 109.834 -179.44 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 90' ' ' LEU . 1.3 tp60 75.77 -176.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 110.222 179.282 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -60.09 -38.74 83.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.642 -0.661 . . . . 0.0 109.435 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -52.52 -24.95 9.04 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.013 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 61.53 20.31 11.12 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 178.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.0 m -130.51 7.26 4.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.693 -1.254 . . . . 0.0 111.172 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.783 ' O ' ' N ' ' A' ' 91' ' ' VAL . 83.2 mt -98.5 53.67 1.04 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.09 78.47 3.63 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.548 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.626 HG21 HG23 ' A' ' 50' ' ' VAL . 53.2 t -154.31 147.92 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.809 0.814 . . . . 0.0 109.533 179.377 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 89' ' ' SER . 48.2 p -121.24 153.67 37.34 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.316 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.808 HD22 ' CG ' ' A' ' 33' ' ' PHE . 79.0 mt -82.25 71.05 9.31 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.244 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . . . -107.38 -17.87 14.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.62 -0.675 . . . . 0.0 112.074 -178.09 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -110.91 123.77 34.59 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.573 -1.329 . . . . 0.0 110.083 -178.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 107' ' ' ALA . 55.2 Cg_endo -77.45 145.06 23.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.488 2.125 . . . . 0.0 110.636 178.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.905 HG13 ' CD2' ' A' ' 106' ' ' TYR . 12.0 p -72.21 -22.01 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.535 -1.353 . . . . 0.0 109.38 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.905 ' CD2' HG13 ' A' ' 105' ' ' VAL . 72.3 m-85 -129.19 64.35 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.768 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 104' ' ' PRO . . . -57.11 -40.88 77.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 108.819 179.451 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -156.34 57.02 0.57 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 59.03 31.87 21.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.842 . . . . 0.0 110.174 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.63 ' HG2' HH11 ' A' ' 110' ' ' ARG . 24.1 ttt-85 -68.75 144.04 54.48 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.011 -1.055 . . . . 0.0 109.207 -179.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.743 ' CG ' HH11 ' A' ' 111' ' ' ARG . 1.9 mtt-85 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.087 -1.008 . . . . 0.0 109.324 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -67.44 146.64 53.81 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.989 -1.069 . . . . 0.0 109.034 179.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 3' ' ' LEU . 96.8 mt -82.11 141.49 46.78 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.13 -0.981 . . . . 0.0 108.76 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.416 ' O ' ' OG1' ' A' ' 10' ' ' THR . 24.2 Cg_endo -65.11 -8.44 18.42 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.175 1.917 . . . . 0.0 111.778 -179.216 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.686 ' CG ' HD21 ' A' ' 83' ' ' LEU . 89.9 m-70 -65.94 -26.5 67.61 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.538 -0.726 . . . . 0.0 109.809 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -64.23 -29.82 70.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.982 -1.074 . . . . 0.0 110.036 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.488 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 95.6 m-20 -105.06 131.52 52.46 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.085 -1.01 . . . . 0.0 110.332 -179.545 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 12' ' ' ASN . 91.5 mt-10 -69.69 -23.3 63.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.536 -0.727 . . . . 0.0 109.504 179.325 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.43 ' CG ' ' N ' ' A' ' 10' ' ' THR . 34.5 pttt -61.36 -31.57 71.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.409 -0.807 . . . . 0.0 111.367 -178.823 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.559 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 53.6 p -70.61 -24.9 62.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.769 -1.207 . . . . 0.0 110.914 -178.452 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.605 ' CD1' ' N ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -124.51 -29.6 3.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.643 -1.285 . . . . 0.0 110.419 179.057 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 8' ' ' GLU . 49.0 t-20 -86.3 123.38 31.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 110.651 -178.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 13' ' ' VAL . 7.4 p -101.62 0.59 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.43 -0.794 . . . . 0.0 109.19 179.278 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.49 -153.69 52.22 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 88.2 p -68.9 148.32 50.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.378 -1.072 . . . . 0.0 108.429 179.201 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.56 ' O ' ' CZ ' ' A' ' 36' ' ' ARG . 47.3 t -175.16 156.34 2.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 108.826 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.641 ' ND2' ' CG ' ' A' ' 19' ' ' ASN . 49.9 t30 -78.19 140.8 38.94 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.543 179.832 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.948 ' N ' HH22 ' A' ' 36' ' ' ARG . 42.3 mtt-85 -60.18 -34.42 73.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.253 -0.904 . . . . 0.0 110.701 -179.181 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.645 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 42.3 p-10 -60.02 -40.33 88.94 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.804 -1.185 . . . . 0.0 108.702 179.773 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.645 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 62.1 tttp -64.24 -40.92 97.03 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.322 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.01 76.99 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.31 -0.869 . . . . 0.0 108.91 179.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 26' ' ' ARG . 98.1 mt-10 -59.57 -48.94 79.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.175 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.687 ' OD1' ' N ' ' A' ' 24' ' ' LEU . 8.6 p30 -60.02 -40.06 87.98 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.687 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 85.1 mt -66.99 -29.96 69.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.245 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.7 mt -93.7 -7.7 42.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.628 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 22' ' ' GLU . 2.0 ttm180 -97.23 128.77 44.4 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.277 -0.89 . . . . 0.0 109.789 -179.526 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.69 16.99 78.31 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.464 ' O ' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -110.16 133.37 53.29 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.537 -0.978 . . . . 0.0 109.642 -179.91 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -60.65 156.73 16.03 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.901 0.858 . . . . 0.0 111.106 -179.488 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 50' ' ' VAL . 87.7 m-20 -63.85 151.85 41.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.586 -0.696 . . . . 0.0 109.383 179.012 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.401 ' HA2' HG13 ' A' ' 99' ' ' VAL . . . 99.03 -22.04 42.9 Favored Glycine 0 N--CA 1.499 2.888 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.165 179.473 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.2 m -83.57 121.41 27.2 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.085 -1.244 . . . . 0.0 108.604 179.427 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.524 ' CG ' HD22 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -137.74 162.95 32.54 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.902 -1.124 . . . . 0.0 110.066 179.941 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.11 147.37 40.14 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.067 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 11' ' ' TRP . 54.9 t -92.58 132.03 38.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.04 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.948 HH22 ' N ' ' A' ' 18' ' ' ARG . 7.6 ttt180 -142.41 -172.65 3.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.267 -0.896 . . . . 0.0 108.86 -178.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.719 ' H ' ' CG ' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -105.89 169.2 8.62 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.985 -1.072 . . . . 0.0 108.952 -179.948 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.644 ' O ' ' CB ' ' A' ' 39' ' ' SER . 21.7 m -77.65 17.17 0.56 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 177.378 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.682 ' H ' ' C ' ' A' ' 37' ' ' GLU . 4.7 m 101.44 -30.58 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.257 -179.416 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 71.3 mmtt -85.98 147.15 26.35 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -67.17 -29.83 69.63 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.253 -0.904 . . . . 0.0 110.352 -179.16 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.23 11.89 70.8 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.346 -179.261 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 40' ' ' LYS . 89.2 m -118.57 156.54 28.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.207 -1.172 . . . . 0.0 109.185 179.505 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.595 ' O ' ' O ' ' A' ' 59' ' ' ILE . 30.5 m-85 -130.68 153.84 48.55 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.317 -0.864 . . . . 0.0 110.023 -179.569 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.598 ' O ' ' O ' ' A' ' 36' ' ' ARG . . . -175.8 145.12 0.66 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.062 -1.024 . . . . 0.0 108.477 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 57' ' ' CYS . 31.8 p -125.24 154.85 41.03 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.561 -1.337 . . . . 0.0 109.268 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.568 ' OG ' ' O ' ' A' ' 55' ' ' LYS . 41.1 t -119.75 138.9 53.04 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.636 0.731 . . . . 0.0 110.344 -178.519 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -130.73 146.0 34.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.463 -0.773 . . . . 0.0 109.388 179.88 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 28' ' ' LYS . 40.1 t -91.75 133.36 33.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.475 -0.766 . . . . 0.0 109.13 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 52' ' ' GLY . 0.7 OUTLIER -122.49 163.13 21.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.256 -0.977 . . . . 0.0 110.667 -179.77 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.528 ' C ' ' OD1' ' A' ' 51' ' ' ASP . 47.5 p30 -62.89 50.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.665 -179.06 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 178.48 -43.22 0.09 OUTLIER Glycine 0 C--N 1.295 -1.695 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.896 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 44.6 mm-40 -158.87 166.81 31.02 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.07 -1.253 . . . . 0.0 111.224 -179.324 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.424 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 5.3 m -73.11 146.92 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.525 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.568 ' O ' ' OG ' ' A' ' 47' ' ' SER . 11.2 mmtm -113.63 146.66 39.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.889 -1.132 . . . . 0.0 110.557 -179.335 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -125.54 65.79 1.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.61 -0.681 . . . . 0.0 109.687 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 74.4 m -59.47 144.91 45.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.073 -1.017 . . . . 0.0 108.891 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.4 138.49 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.932 0.872 . . . . 0.0 112.127 -178.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.919 HG23 ' O ' ' A' ' 66' ' ' TYR . 48.4 mm -115.74 133.45 62.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.141 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 62' ' ' THR . 81.3 m-20 -116.69 102.57 9.56 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.564 -1.335 . . . . 0.0 110.917 -178.287 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.469 ' HB2' ' CD1' ' A' ' 44' ' ' TYR . 59.6 tttp -62.71 80.29 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.651 -1.28 . . . . 0.0 108.841 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 60' ' ' ASN . 69.1 p -131.8 176.45 8.34 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.361 -0.837 . . . . 0.0 109.109 -179.661 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.75 -42.93 68.73 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 64' ' ' THR . 12.6 t -147.7 66.22 1.11 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.438 -0.789 . . . . 0.0 109.711 -179.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 60' ' ' ASN . . . -157.0 -10.64 0.05 OUTLIER Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.601 -1.285 . . . . 0.0 111.107 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.919 ' O ' HG23 ' A' ' 59' ' ' ILE . 42.3 p90 -57.42 -6.89 0.5 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.539 -1.565 . . . . 0.0 109.944 -179.276 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 65' ' ' GLY . . . -151.03 -166.78 14.05 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.663 ' CD2' ' OH ' ' A' ' 85' ' ' TYR . 35.8 m-85 -66.84 158.11 31.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -1.173 . . . . 0.0 108.777 179.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.38 7.72 45.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.788 . . . . 0.0 109.503 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.699 ' O ' ' N ' ' A' ' 72' ' ' TYR . 98.3 mt-10 -51.76 154.54 3.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.452 -0.78 . . . . 0.0 109.795 -179.701 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 73' ' ' ASN . 71.3 Cg_exo -39.72 -9.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.737 2.291 . . . . 0.0 111.769 179.367 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.699 ' N ' ' O ' ' A' ' 70' ' ' GLU . 9.4 m-30 -52.05 -20.69 2.6 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.174 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.59 ' O ' ' O ' ' A' ' 74' ' ' LEU . 88.1 m-20 64.06 40.54 7.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.773 -0.58 . . . . 0.0 111.498 178.857 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.811 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.0 mm? 52.77 115.64 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.926 -1.109 . . . . 0.0 110.099 178.58 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.718 ' OH ' ' CG ' ' A' ' 84' ' ' HIS . 97.8 m-85 -60.05 147.6 38.68 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.952 0.882 . . . . 0.0 110.781 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 64.6 m -65.18 -39.76 93.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.437 -0.789 . . . . 0.0 111.532 -178.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.7 m -123.38 147.19 47.33 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.659 -1.276 . . . . 0.0 110.123 -178.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 78' ' ' LEU . 76.5 mt -59.56 -40.36 87.04 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -55.38 -40.61 71.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.444 -0.785 . . . . 0.0 109.379 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.19 -40.49 96.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.442 HD23 ' C ' ' A' ' 81' ' ' LEU . 9.8 tt -58.82 -43.7 90.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.098 -179.349 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.67 -38.64 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.76 -1.212 . . . . 0.0 109.188 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.686 HD21 ' CG ' ' A' ' 5' ' ' HIS . 90.7 mt -74.89 -38.53 61.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.063 -1.023 . . . . 0.0 110.437 -179.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.718 ' CG ' ' OH ' ' A' ' 75' ' ' TYR . 65.8 t-80 -64.7 -39.36 93.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.802 -1.186 . . . . 0.0 109.792 -179.631 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.663 ' OH ' ' CD2' ' A' ' 68' ' ' PHE . 4.8 m-30 -66.82 -27.66 67.74 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.149 -0.97 . . . . 0.0 108.875 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.644 ' HG3' ' HB2' ' A' ' 102' ' ' ALA . 41.6 tt0 -63.79 -34.72 78.53 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.539 -0.726 . . . . 0.0 109.292 178.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -90.62 -13.47 34.3 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.028 -1.045 . . . . 0.0 110.163 -179.152 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.1 m -100.71 136.04 41.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 110.438 -179.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 t -85.99 125.55 33.47 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.282 -0.886 . . . . 0.0 108.934 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.722 ' O ' ' N ' ' A' ' 92' ' ' GLN . 87.1 mt -66.87 -20.05 65.85 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.407 -0.808 . . . . 0.0 110.332 -179.243 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.728 ' N ' ' O ' ' A' ' 97' ' ' LEU . 11.8 p -15.17 -48.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 O-C-N 121.684 -0.635 . . . . 0.0 110.372 179.457 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.722 ' N ' ' O ' ' A' ' 90' ' ' LEU . 34.0 tt0 53.92 179.41 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.483 -0.761 . . . . 0.0 110.807 178.777 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.547 ' H ' ' CG ' ' A' ' 92' ' ' GLN . 91.4 m-70 -60.06 -29.53 68.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.587 -0.695 . . . . 0.0 109.383 -179.719 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -56.96 -24.01 49.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.083 -1.011 . . . . 0.0 108.795 179.361 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.474 ' HA ' HG22 ' A' ' 91' ' ' VAL . 27.5 t70 61.93 41.67 11.09 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.518 -0.739 . . . . 0.0 110.432 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.7 m -148.19 -2.56 0.52 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.648 -1.283 . . . . 0.0 111.151 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.728 ' O ' ' N ' ' A' ' 91' ' ' VAL . 92.8 mt -102.16 52.0 0.81 Allowed 'General case' 0 C--N 1.29 -2.006 0 O-C-N 121.13 -0.982 . . . . 0.0 108.413 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.63 ' ND2' HG23 ' A' ' 91' ' ' VAL . 3.3 m-80 -78.09 70.35 4.44 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.769 0.795 . . . . 0.0 109.807 -178.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.401 HG13 ' HA2' ' A' ' 31' ' ' GLY . 25.9 t -149.67 153.02 11.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.2 p -124.21 156.99 35.83 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.524 HD22 ' CG ' ' A' ' 33' ' ' PHE . 30.7 mt -82.58 69.48 9.36 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.912 -1.117 . . . . 0.0 108.694 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.644 ' HB2' ' HG3' ' A' ' 86' ' ' GLN . . . -105.09 -18.79 14.03 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.508 -0.745 . . . . 0.0 112.077 -178.004 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -112.44 109.62 53.59 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.414 -1.429 . . . . 0.0 112.101 -177.709 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.404 ' HG2' ' CG ' ' A' ' 4' ' ' PRO . 23.4 Cg_exo -62.35 143.72 94.12 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.074 1.85 . . . . 0.0 111.169 178.153 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.537 HG13 ' CD2' ' A' ' 106' ' ' TYR . 12.5 p -68.66 -36.92 76.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 120.745 -1.222 . . . . 0.0 108.904 179.345 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.537 ' CD2' HG13 ' A' ' 105' ' ' VAL . 55.7 m-85 -109.13 42.48 1.43 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.386 -0.821 . . . . 0.0 109.61 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.91 126.15 24.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 108.857 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -130.72 141.55 50.39 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.972 -1.08 . . . . 0.0 109.148 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -102.34 127.26 49.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.005 -1.059 . . . . 0.0 110.035 -179.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.412 ' HG2' ' N ' ' A' ' 111' ' ' ARG . 7.8 ttt180 -130.04 148.64 51.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.313 -0.867 . . . . 0.0 109.385 179.668 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.412 ' N ' ' HG2' ' A' ' 110' ' ' ARG . 61.7 mtp180 . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.037 -1.039 . . . . 0.0 109.769 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.469 0.652 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.33 140.25 58.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -0.966 . . . . 0.0 109.265 179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.1 mt -100.79 134.1 20.72 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.14 -0.975 . . . . 0.0 109.392 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -51.51 -14.64 2.05 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.812 1.675 . . . . 0.0 110.925 179.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.466 ' HA ' ' NE1' ' A' ' 11' ' ' TRP . 91.1 m-70 -66.47 -12.93 59.84 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.541 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -63.42 -32.28 73.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 108.85 179.011 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.575 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 92.3 m-20 -100.53 134.19 43.85 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.352 -0.843 . . . . 0.0 110.004 -179.666 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 12' ' ' ASN . 95.5 mt-10 -69.27 -27.26 65.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 109.988 179.566 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.507 ' CG ' ' N ' ' A' ' 10' ' ' THR . 33.3 pttt -60.79 -35.46 76.53 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 110.508 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.669 ' OG1' ' CD1' ' A' ' 11' ' ' TRP . 10.6 p -59.75 -33.39 71.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 110.113 -178.827 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.669 ' CD1' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -120.78 -37.27 3.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.893 -1.129 . . . . 0.0 110.165 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 8' ' ' GLU . 63.8 t30 -86.21 123.85 31.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.993 -1.067 . . . . 0.0 110.47 -179.214 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.474 ' O ' HG12 ' A' ' 13' ' ' VAL . 74.5 t -94.05 -4.95 10.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.79 -162.15 19.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.498 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -80.68 61.55 4.4 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.318 -1.107 . . . . 0.0 109.417 -179.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.1 p -79.2 156.7 28.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.299 -0.876 . . . . 0.0 109.092 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -70.18 142.72 52.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.191 -0.943 . . . . 0.0 109.453 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.618 HH11 ' NH2' ' A' ' 36' ' ' ARG . 48.6 mtt-85 -59.46 -38.81 81.75 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.054 -1.029 . . . . 0.0 109.388 179.816 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.65 ' OD1' ' N ' ' A' ' 20' ' ' LYS . 40.0 p-10 -62.65 -42.82 99.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.0 -1.062 . . . . 0.0 108.484 179.363 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.65 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 80.3 tttt -60.51 -36.6 78.74 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.233 -0.917 . . . . 0.0 109.066 179.41 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.71 ' CB ' HH11 ' A' ' 36' ' ' ARG . . . -58.57 -34.03 70.59 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.647 ' OE2' ' NH2' ' A' ' 26' ' ' ARG . 75.3 tt0 -58.7 -42.63 89.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.247 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.68 -46.94 87.54 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.697 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -67.16 -33.86 76.32 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.863 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.883 HD11 ' OG ' ' A' ' 47' ' ' SER . 22.7 mt -80.85 -16.01 54.82 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.146 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.742 ' CG ' HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -74.61 122.43 23.15 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.555 -179.727 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.82 19.54 78.83 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.518 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.505 ' HE2' HG21 ' A' ' 32' ' ' THR . 0.2 OUTLIER -97.18 135.79 38.62 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.359 -1.083 . . . . 0.0 109.685 -179.446 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.699 ' CG ' HH11 ' A' ' 29' ' ' ARG . 0.9 OUTLIER -74.88 157.63 34.74 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.66 0.743 . . . . 0.0 110.157 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.513 ' C ' ' OD1' ' A' ' 30' ' ' ASP . 48.4 p30 -62.25 169.36 2.85 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.283 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.88 -28.44 1.89 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.505 HG21 ' HE2' ' A' ' 28' ' ' LYS . 76.7 m -80.56 121.03 25.29 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.869 -1.371 . . . . 0.0 108.984 179.658 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.806 ' HB2' HG22 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -136.06 167.26 21.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.908 -1.12 . . . . 0.0 110.517 -179.32 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 1.1 pt? -148.91 161.29 42.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.454 -0.779 . . . . 0.0 110.588 179.475 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.475 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 65.8 t -106.74 132.73 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.37 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.71 HH11 ' CB ' ' A' ' 21' ' ' ALA . 35.6 ptt180 -147.75 173.14 13.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 108.884 -178.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.661 ' C ' ' H ' ' A' ' 39' ' ' SER . 53.0 mt-10 -124.33 170.54 10.7 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.83 -1.169 . . . . 0.0 109.268 179.447 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.646 ' O ' ' CB ' ' A' ' 39' ' ' SER . 57.7 m -75.39 15.51 0.45 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 178.164 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.661 ' H ' ' C ' ' A' ' 37' ' ' GLU . 6.4 t 97.86 131.03 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.828 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.473 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 67.1 mmtt 62.32 -143.77 0.4 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.508 -0.745 . . . . 0.0 109.103 -179.474 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -101.57 20.11 16.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -0.847 . . . . 0.0 109.629 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.06 -52.62 51.03 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.062 -179.325 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 44' ' ' TYR . 53.1 t -161.0 166.58 28.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.99 -1.3 . . . . 0.0 110.246 -179.646 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.608 ' O ' ' O ' ' A' ' 59' ' ' ILE . 57.2 m-85 -123.66 145.83 48.67 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.279 -0.888 . . . . 0.0 109.048 179.168 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 57' ' ' CYS . . . -159.75 153.88 23.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.77 -1.207 . . . . 0.0 109.973 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' CYS . 85.4 m -109.5 125.86 52.93 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.563 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.883 ' OG ' HD11 ' A' ' 25' ' ' LEU . 26.1 t -92.05 127.0 37.36 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.06 -179.682 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.806 HG22 ' HB2' ' A' ' 33' ' ' PHE . 74.3 t -126.1 163.71 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.187 -0.946 . . . . 0.0 109.978 -179.403 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.602 ' N ' HG12 ' A' ' 48' ' ' VAL . 39.2 t -124.6 132.76 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.701 HG23 ' CG2' ' A' ' 99' ' ' VAL . 11.4 p -123.34 156.35 29.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.995 -1.066 . . . . 0.0 109.671 -179.782 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.423 ' OD1' ' OD2' ' A' ' 30' ' ' ASP . 87.2 m-20 -49.97 -17.17 0.35 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.943 0.878 . . . . 0.0 109.634 -179.429 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.581 ' O ' ' OE2' ' A' ' 53' ' ' GLU . . . -86.18 -59.22 1.88 Allowed Glycine 0 C--N 1.287 -2.142 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.667 -179.175 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.581 ' OE2' ' O ' ' A' ' 52' ' ' GLY . 61.3 mm-40 -163.22 -165.53 1.1 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.25 -1.147 . . . . 0.0 110.554 -178.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.56 ' CG1' HD13 ' A' ' 25' ' ' LEU . 88.8 t -93.36 123.37 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.319 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' NZ ' HG11 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -122.45 149.15 44.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.911 -1.118 . . . . 0.0 110.905 -179.495 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.704 ' CD2' ' NH2' ' A' ' 36' ' ' ARG . 23.6 m80 -113.31 101.88 9.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.579 -0.701 . . . . 0.0 109.544 179.194 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 46' ' ' CYS . 52.5 t -72.91 130.04 39.5 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.26 138.63 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.246 -0.909 . . . . 0.0 111.878 -177.876 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.608 ' O ' ' O ' ' A' ' 44' ' ' TYR . 10.9 mm -124.93 111.59 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.695 ' O ' ' CA ' ' A' ' 66' ' ' TYR . 83.6 m-20 -118.59 170.48 8.92 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.647 -1.283 . . . . 0.0 112.182 -178.248 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -128.29 30.52 5.18 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.327 -1.483 . . . . 0.0 108.985 179.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.7 p -79.45 -174.93 4.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.314 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.37 -28.35 66.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.19 -0.944 . . . . 0.0 109.616 -179.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.9 p -79.0 -5.59 54.27 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.217 -0.927 . . . . 0.0 109.206 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.797 ' HA3' ' HB3' ' A' ' 69' ' ' ALA . . . 81.54 171.54 45.62 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.893 ' CE1' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -64.44 30.8 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.951 -1.323 . . . . 0.0 110.537 -179.244 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.623 ' H ' ' C ' ' A' ' 65' ' ' GLY . . . 88.51 -42.89 3.08 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.63 ' CG ' ' OH ' ' A' ' 85' ' ' TYR . 89.7 m-85 -90.43 -6.08 55.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.347 -1.09 . . . . 0.0 110.278 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.893 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . . . -99.63 3.88 45.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.213 -0.929 . . . . 0.0 109.154 179.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.702 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 46.2 tt0 -59.64 -35.31 28.44 Favored Pre-proline 0 C--N 1.304 -1.379 0 C-N-CA 119.006 -1.078 . . . . 0.0 108.678 -179.667 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 9.8 Cg_exo -72.81 174.16 12.29 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.634 2.222 . . . . 0.0 111.071 178.451 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -62.57 -12.32 22.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.034 -1.041 . . . . 0.0 109.566 179.609 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -101.36 102.56 13.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.912 -1.117 . . . . 0.0 110.472 -179.316 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.614 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 5.6 mp -106.25 7.4 31.4 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.633 ' OH ' ' CD2' ' A' ' 84' ' ' HIS . 71.4 m-85 60.58 175.02 0.1 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.371 -0.83 . . . . 0.0 109.19 -179.481 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.7 t -103.71 -48.72 3.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.122 -0.986 . . . . 0.0 110.048 -179.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.8 m -126.3 154.77 42.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.094 -1.004 . . . . 0.0 110.183 -179.104 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.16 -34.05 73.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 110.03 179.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.72 -43.74 80.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.188 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -66.9 -30.53 70.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.228 -0.92 . . . . 0.0 108.856 179.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.904 HD21 ' CE2' ' A' ' 85' ' ' TYR . 9.2 tt -60.6 -40.9 93.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 108.987 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.2 t -66.86 -44.17 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.361 -0.837 . . . . 0.0 109.819 179.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.426 HD21 ' CB ' ' A' ' 5' ' ' HIS . 85.0 mt -67.45 -43.09 81.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.419 -0.8 . . . . 0.0 110.439 -179.119 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.633 ' CD2' ' OH ' ' A' ' 75' ' ' TYR . 83.9 t60 -60.02 -40.56 89.72 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.215 -179.194 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.904 ' CE2' HD21 ' A' ' 81' ' ' LEU . 7.4 m-30 -67.34 -24.31 65.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 0.0 108.789 -179.783 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.453 ' OE1' ' NE2' ' A' ' 5' ' ' HIS . 38.1 tt0 -61.32 -36.94 81.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 178.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -91.44 -16.71 26.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.303 -0.873 . . . . 0.0 109.592 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.4 m -100.84 129.92 46.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.131 -0.981 . . . . 0.0 109.228 179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.543 ' HA ' HG22 ' A' ' 100' ' ' THR . 34.8 t -81.67 132.56 35.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 109.915 -179.627 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 91' ' ' VAL . 76.2 mt -69.01 -13.07 62.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.477 -0.764 . . . . 0.0 109.715 179.23 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.76 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.8 p -36.66 -33.75 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.464 -0.773 . . . . 0.0 110.011 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.45 ' N ' HG13 ' A' ' 91' ' ' VAL . 20.0 tt0 -65.86 -50.07 65.86 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 -178.658 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLN . 84.3 t60 -51.43 -47.53 63.0 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 179.443 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.689 ' O ' ' N ' ' A' ' 96' ' ' SER . 13.1 t-20 -126.29 111.25 14.33 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.477 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.54 ' C ' ' O ' ' A' ' 94' ' ' ASN . 99.7 m-20 -35.98 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.886 -178.488 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 94' ' ' ASN . 71.1 m -108.37 27.07 9.71 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.736 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.76 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.5 mt -97.96 65.84 1.81 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.563 -1.336 . . . . 0.0 108.2 178.676 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.403 ' C ' HG23 ' A' ' 99' ' ' VAL . 0.8 OUTLIER -79.79 75.57 6.47 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.81 -1.182 . . . . 0.0 109.41 -178.998 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.701 ' CG2' HG23 ' A' ' 50' ' ' VAL . 84.5 t -153.56 153.62 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.522 -0.736 . . . . 0.0 109.805 -179.266 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.543 HG22 ' HA ' ' A' ' 89' ' ' SER . 70.2 p -134.33 156.79 47.85 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.154 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.57 HD22 ' CG ' ' A' ' 33' ' ' PHE . 11.6 mt -76.48 71.65 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.706 -1.246 . . . . 0.0 108.007 179.333 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.3 -33.76 9.91 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.169 -0.957 . . . . 0.0 112.111 -177.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.4 m-85 -113.97 109.29 49.93 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.503 -1.373 . . . . 0.0 111.977 -177.654 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.523 ' CG ' ' HB2' ' A' ' 107' ' ' ALA . 19.0 Cg_exo -59.97 148.61 88.21 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.083 1.855 . . . . 0.0 110.276 176.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.567 ' O ' ' OE1' ' A' ' 109' ' ' GLN . 9.1 p -67.25 -34.59 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.822 -1.174 . . . . 0.0 108.77 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.502 ' CD2' HG13 ' A' ' 105' ' ' VAL . 38.6 m-85 -108.14 39.4 1.97 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.447 -0.783 . . . . 0.0 110.191 179.828 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.523 ' HB2' ' CG ' ' A' ' 104' ' ' PRO . . . -83.99 117.4 23.36 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.996 -1.065 . . . . 0.0 109.599 179.462 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 49.46 45.93 23.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.334 -0.854 . . . . 0.0 109.975 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.567 ' OE1' ' O ' ' A' ' 105' ' ' VAL . 41.9 mt-30 -104.42 135.01 46.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.795 -1.191 . . . . 0.0 110.122 -179.801 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -61.38 -35.44 77.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.578 -0.701 . . . . 0.0 110.146 -179.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.498 ' HA ' ' HE ' ' A' ' 111' ' ' ARG . 4.6 tpm_? . . . . . 0 N--CA 1.493 1.716 0 O-C-N 120.961 -1.087 . . . . 0.0 109.217 179.765 . . . . . . . . 1 1 . 1 stop_ save_